PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Santens, S; Goossens, S; Verguts, T				Santens, Seppe; Goossens, Sofie; Verguts, Tom			Distance in Motion: Response Trajectories Reveal the Dynamics of Number Comparison	PLOS ONE			English	Article							SPACE; MODEL	Cognitive and neuroscientific evidence has challenged the widespread view that perception, cognition and action constitute independent, discrete stages. For example, in continuous response trajectories toward a target response location, evidence suggests that a decision on which target to reach for (i.e., the cognition stage) is not reached before the movement starts (i.e., the action stage). As a result, instead of a straight trajectory to the correct target response, movement trajectories may curve toward competing responses or away from inhibited responses. In the present study, we examined response trajectories during a number comparison task. Participants had to decide whether a target number was smaller or larger than 5. They had to respond by moving to a left or a right response location. Replicating previous results, response trajectories were more curved toward the incorrect response location when distance to 5 was small (e. g., target number 4) than when distance to 5 was large (e. g., target number 1). Importantly, we manipulated the response mapping, which allowed us to demonstrate that this response trajectory effect results from the relative amount of evidence for the available responses across time. In this way, the present study stresses the tight coupling of number representations (i.e., cognition) and response related processes (i.e., action) and shows that these stages are not separable in time.	[Santens, Seppe; Goossens, Sofie; Verguts, Tom] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	Santens, S (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	Seppe.Santens@ugent.be	Verguts, Tom/A-4792-2008; Mira, Antonio/E-5715-2010; Carvalho, Filipe/E-4902-2010	Verguts, Tom/0000-0002-7783-4754; Lauwereyns, Jan/0000-0003-0551-2550; Santos, Sara/0000-0003-4931-1080; Mira, Antonio/0000-0001-6152-0454; Carvalho, Filipe/0000-0003-2161-5293	Ghent University Research Council [01J01406]; Research Foundation Flanders; Ghent University [BOF08/GOA/011]	Ghent University Research Council(Ghent University); Research Foundation Flanders(FWO); Ghent University(Ghent University)	This work was supported by the Ghent University Research Council BOF Grant 01J01406 and a postdoctoral fellowship by the Research Foundation Flanders (to Seppe Santens), and Ghent University BOF/GOA Grant BOF08/GOA/011 and the Ghent University Multidisciplinary Research Partnership "The Inegrative Neuroscience of Behavioral Control" (to Tom Verguts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS RA, 1991, SCIENCE, V253, P1227, DOI 10.1126/science.253.5025.1227; Buetti S, 2009, J EXP PSYCHOL HUMAN, V35, P816, DOI 10.1037/a0011092; Chen Q, 2010, COGNITIVE PSYCHOL, V60, P218, DOI 10.1016/j.cogpsych.2010.01.001; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Gevers W, 2006, J EXP PSYCHOL HUMAN, V32, P32, DOI 10.1037/0096-1523.32.1.32; Gevers W, 2010, J EXP PSYCHOL GEN, V139, P180, DOI 10.1037/a0017688; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; McKinstry C, 2008, PSYCHOL SCI, V19, P22, DOI 10.1111/j.1467-9280.2008.02041.x; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Posner MI, 1976, CHRONOMETRIC EXPLORA; Santens S, 2008, COGNITION, V108, P263, DOI 10.1016/j.cognition.2008.01.002; Santens S, 2011, COGNITION, V118, P94, DOI 10.1016/j.cognition.2010.10.014; Song JH, 2008, COGNITION, V106, P994, DOI 10.1016/j.cognition.2007.03.014; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Thelen E, 2001, BEHAV BRAIN SCI, V24, P1, DOI 10.1017/S0140525X01003910; Verguts T, 2005, PSYCHON B REV, V12, P66, DOI 10.3758/BF03196349	21	82	94	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25429	10.1371/journal.pone.0025429	http://dx.doi.org/10.1371/journal.pone.0025429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IZ	21980437	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100060
J	Giannaki, CD; Sakkas, GK; Karatzaferi, C; Hadjigeorgiou, GM; Lavdas, E; Liakopoulos, V; Tsianas, N; Koukoulis, GN; Koutedakis, Y; Stefanidis, I				Giannaki, Christoforos D.; Sakkas, Giorgos K.; Karatzaferi, Christina; Hadjigeorgiou, Georgios M.; Lavdas, Eleftherios; Liakopoulos, Vassilios; Tsianas, Nikolaos; Koukoulis, Georgios N.; Koutedakis, Yiannis; Stefanidis, Ioannis			Evidence of Increased Muscle Atrophy and Impaired Quality of Life Parameters in Patients with Uremic Restless Legs Syndrome	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; HEMODIALYSIS-PATIENTS; PHYSICAL FUNCTION; SLEEP DISORDERS; RISK-FACTORS; MAINTENANCE DIALYSIS; FUNCTIONAL-CAPACITY; CARDIOVASCULAR RISK	Background: Restless Legs Syndrome is a very common disorder in hemodialysis patients. Restless Legs Syndrome negatively affects quality of life; however it is not clear whether this is due to mental or physical parameters and whether an association exists between the syndrome and parameters affecting survival. Methodology/Principal Findings: Using the Restless Legs Syndrome criteria and the presence of Periodic Limb Movements in Sleep (PLMS/h >15), 70 clinically stable hemodialysis patients were assessed and divided into the RLS (n = 30) and non-RLS (n = 40) groups. Physical performance was evaluated by a battery of tests: body composition by dual energy X ray absorptiometry, muscle size and composition by computer tomography, while depression symptoms, perception of sleep quality and quality of life were assessed through validated questionnaires. In this cross sectional analysis, the RLS group showed evidence of thigh muscle atrophy compared to the non-RLS group. Sleep quality and depression score were found to be significantly impaired in the RLS group. The mental component of the quality of life questionnaire appeared significantly diminished in the RLS group, reducing thus the overall quality of life score. In contrast, there were no significant differences between groups in any of the physical performance tests, body and muscle composition. Conclusions: The low level of quality of life reported by the HD patients with Restless Legs Syndrome seems to be due mainly to mental health and sleep related aspects. Increased evidence of muscle atrophy is also observed in the RLS group and possibly can be attributed to the lack of restorative sleep.	[Giannaki, Christoforos D.; Sakkas, Giorgos K.; Liakopoulos, Vassilios; Stefanidis, Ioannis] Univ Thessaly, Dept Nephrol, Larisa, Thessaly, Greece; [Hadjigeorgiou, Georgios M.] Univ Thessaly, Dept Neurol, Larisa, Thessaly, Greece; [Koukoulis, Georgios N.] Univ Thessaly, Dept Endocrinol, Sch Med, Larisa, Thessaly, Greece; [Lavdas, Eleftherios] Technol Educ Inst Athens, Dept Med Radiol Technologists, Athens, Attika, Greece; [Karatzaferi, Christina; Koutedakis, Yiannis] Univ Thessaly, Dept Sport Sci, Trikala, Thessaly, Greece; [Giannaki, Christoforos D.; Sakkas, Giorgos K.; Karatzaferi, Christina; Hadjigeorgiou, Georgios M.; Koutedakis, Yiannis; Stefanidis, Ioannis] Ctr Res & Technol Thessaly, Volos, Thessaly, Greece; [Tsianas, Nikolaos] Gen Hosp Trikala, Dept Nephrol, Trikala, Thessaly, Greece; [Giannaki, Christoforos D.] Univ Nicosia, Dept Life & Hlth Sci, Nicosia, Cyprus	University of Thessaly; University of Thessaly; University of Thessaly; University of West Attica; University of Thessaly; University of Nicosia	Giannaki, CD (corresponding author), Univ Thessaly, Dept Nephrol, Larisa, Thessaly, Greece.	gsakkas@med.uth.gr	Karatzaferi, Christina/AAM-7344-2021; Sakkas, Giorgos K./AAJ-4745-2021; Liakopoulos, Vassilios/AAN-1640-2020; Karatzaferi, Christina/ABA-9876-2020	Sakkas, Giorgos K./0000-0002-2462-995X; Liakopoulos, Vassilios/0000-0002-7564-2724; Karatzaferi, Christina/0000-0002-8266-5780; Stefanidis, Ioannis/0000-0002-5515-8089; Koutedakis, Yiannis/0000-0002-7065-9447; Giannaki, Christoforos/0000-0003-0029-1189	Greek Ministry of Development-General Secretariat of Research and Technology; E.U.;  [03ED375]	Greek Ministry of Development-General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); E.U.(European Commission); 	This study was supported by the 03ED375 research grant, implemented within the framework of the "Reinforcement Programme of Human Research Manpower'' (ENTER) and co-financed by National and Community Funds (25% from the Greek Ministry of Development-General Secretariat of Research and Technology and 75% from E.U. European Social Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Benz RL, 2000, AM J KIDNEY DIS, V35, P1052, DOI 10.1016/S0272-6386(00)70039-4; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; ENIA G, 1993, NEPHROL DIAL TRANSPL, V8, P1094; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; Gigli GL, 2004, SLEEP MED, V5, P309, DOI 10.1016/j.sleep.2004.01.014; Johansen KL, 2009, ADV CHRONIC KIDNEY D, V16, P501, DOI 10.1053/j.ackd.2009.07.007; Johansen KL, 2003, AM J CLIN NUTR, V77, P842, DOI 10.1093/ajcn/77.4.842; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Johansen KL, 2001, KIDNEY INT, V60, P1586, DOI 10.1046/j.1523-1755.2001.00972.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kakiya R, 2006, KIDNEY INT, V70, P549, DOI 10.1038/sj.ki.5000331; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Kavanagh D, 2004, AM J KIDNEY DIS, V43, P763, DOI 10.1053/j.ajkd.2004.01.007; Kawauchi A, 2006, CLIN NEPHROL, V66, P440; Kimmel PL, 2006, CLIN J AM SOC NEPHRO, V1, P349, DOI 10.2215/CJN.00890306; Kimmel PL, 2001, KIDNEY INT, V59, P1599, DOI 10.1046/j.1523-1755.2001.0590041599.x; Koufaki P, 2002, CLIN PHYSIOL FUNCT I, V22, P115, DOI 10.1046/j.1365-2281.2002.00405.x; Koufaki P, 2009, ADV CHRONIC KIDNEY D, V16, P410, DOI 10.1053/j.ackd.2009.08.010; La Manna G, 2011, NEPHROL DIAL TRANSPL, V26, P1976, DOI 10.1093/ndt/gfq681; Larsson BW, 2007, EUR NEUROL, V58, P133, DOI 10.1159/000104712; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; McIntyre CW, 2006, NEPHROL DIAL TRANSPL, V21, P2210, DOI 10.1093/ndt/gfl064; Mercer TH, 1998, NEPHROL DIAL TRANSPL, V13, P2023, DOI 10.1093/ndt/13.8.2023; Merlino G, 2006, NEPHROL DIAL TRANSPL, V21, P184, DOI 10.1093/ndt/gfi144; Merlino G, 2010, DIABETES EDUCATOR, V36, P79, DOI 10.1177/0145721709351252; Mucsi F, 2005, NEPHROL DIAL TRANSPL, V20, P571, DOI 10.1093/ndt/gfh654; Pai MF, 2007, RENAL FAILURE, V29, P673, DOI 10.1080/08860220701459642; Painter Patricia, 2005, Hemodial Int, V9, P218, DOI 10.1111/j.1492-7535.2005.01136.x; Parker KP, 2003, SLEEP MED REV, V7, P131, DOI 10.1053/smrv.2001.0240; Perl J, 2006, KIDNEY INT, V70, P1687, DOI 10.1038/sj.ki.5001791; Rijsman RM, 2004, NEPHROLOGY, V9, P353, DOI 10.1111/j.1440-1797.2004.00330.x; Rothdach AJ, 2000, NEUROLOGY, V54, P1064, DOI 10.1212/WNL.54.5.1064; Sakkas GK, 2008, NEPHROL DIAL TRANSPL, V23, P336, DOI 10.1093/ndt/gfm559; Sakkas GK, 2008, AM J PHYSIOL-REG I, V295, pR1721, DOI 10.1152/ajpregu.00935.2007; Sakkas GK, 2003, NEPHROL DIAL TRANSPL, V18, P2074, DOI 10.1093/ndt/gfg325; Schlesinger I, 2009, MOVEMENT DISORD, V24, P1587, DOI 10.1002/mds.22486; Sforza E, 2005, SLEEP MED, V6, P259, DOI 10.1016/j.sleep.2004.11.006; Siddiqui S, 2005, NEPHRON CLIN PRACT, V101, P155, DOI 10.1159/000087073; Suh MR, 2002, RENAL FAILURE, V24, P337; SVENDSEN OL, 1993, BASIC LIFE SCI, P381; Szentkiralyi A, 2009, J PSYCHOSOM RES, V67, P173, DOI 10.1016/j.jpsychores.2009.05.004; Tuncel D, RESTLESS LEGS SYNDRO; Unruh ML, 2004, AM J KIDNEY DIS, V43, P900, DOI 10.1053/j.ajkd.2004.01.013; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Zucconi M, 2006, SLEEP MED, V7, P175, DOI 10.1016/j.sleep.2006.01.001; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	50	40	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25180	10.1371/journal.pone.0025180	http://dx.doi.org/10.1371/journal.pone.0025180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984901	gold, Green Published			2022-12-27	WOS:000295943000012
J	Hastings, J; Chepelev, L; Willighagen, E; Adams, N; Steinbeck, C; Dumontier, M				Hastings, Janna; Chepelev, Leonid; Willighagen, Egon; Adams, Nico; Steinbeck, Christoph; Dumontier, Michel			The Chemical Information Ontology: Provenance and Disambiguation for Chemical Data on the Biological Semantic Web	PLOS ONE			English	Article							DRUG DISCOVERY; CHEMISTRY; KNOWLEDGE; EXCHANGE; LANGUAGE; OWL	Cheminformatics is the application of informatics techniques to solve chemical problems in silico. There are many areas in biology where cheminformatics plays an important role in computational research, including metabolism, proteomics, and systems biology. One critical aspect in the application of cheminformatics in these fields is the accurate exchange of data, which is increasingly accomplished through the use of ontologies. Ontologies are formal representations of objects and their properties using a logic-based ontology language. Many such ontologies are currently being developed to represent objects across all the domains of science. Ontologies enable the definition, classification, and support for querying objects in a particular domain, enabling intelligent computer applications to be built which support the work of scientists both within the domain of interest and across interrelated neighbouring domains. Modern chemical research relies on computational techniques to filter and organise data to maximise research productivity. The objects which are manipulated in these algorithms and procedures, as well as the algorithms and procedures themselves, enjoy a kind of virtual life within computers. We will call these information entities. Here, we describe our work in developing an ontology of chemical information entities, with a primary focus on data-driven research and the integration of calculated properties (descriptors) of chemical entities within a semantic web context. Our ontology distinguishes algorithmic, or procedural information from declarative, or factual information, and renders of particular importance the annotation of provenance to calculated data. The Chemical Information Ontology is being developed as an open collaborative project. More details, together with a downloadable OWL file, are available at http://code.google.com/p/semanticchemistry/ (license: CC-BY-SA).	[Hastings, Janna; Adams, Nico; Steinbeck, Christoph] European Bioinformat Inst, Hinxton, England; [Chepelev, Leonid; Dumontier, Michel] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Willighagen, Egon] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Adams, Nico] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	European Molecular Biology Laboratory (EMBL); Carleton University; Uppsala University; University of Cambridge	Hastings, J (corresponding author), European Bioinformat Inst, Hinxton, England.	hastings@ebi.ac.uk	Adams, Nico/E-2480-2011; Willighagen, Egon/C-6136-2008; Steinbeck, Christoph/B-4131-2008	Adams, Nico/0000-0003-3136-1338; Willighagen, Egon/0000-0001-7542-0286; Steinbeck, Christoph/0000-0001-6966-0814; Hastings, Janna/0000-0002-3469-4923; Dumontier, Michel/0000-0003-4727-9435	BBSRC [BB/G022747/1]; Uppsala University [KoF 07]; Biotechnology and Biological Sciences Research Council [BB/G022747/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Uppsala University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially funded by the BBSRC, grant agreement number BB/G022747/1 within the "Bioinformatics and biological resources" fund and Uppsala University (KoF 07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; BERNERSLEE T, 2001, SEMANTIC WEB; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-255; Chepelev L, 2011, J CHEMINFORMATICS, V3; Chiang RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000142; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Dearden JC, 2003, J COMPUT AID MOL DES, V17, P119, DOI 10.1023/A:1025361621494; DUMONTIER M, 2010, P 6 FORM ONT INF SYS; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Ekins S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000594; Floris M., 2011, BLUE OBELISK DESCRIP; Gangemi A, 2002, LECT NOTES ARTIF INT, V2473, P166; *GEN ONT CONS, 2011, OBO LANG VERS 1 2; GORDON JE, 1988, J CHEM INF COMP SCI, V28, P100, DOI 10.1021/ci00058a011; Grau BC, 2008, J WEB SEMANT, V6, P309, DOI 10.1016/j.websem.2008.05.001; Grenon P, 2004, STUD HEALTH TECHNOL, V102, P20; Gruber T., 2009, ENCY DATABASE SYSTEM; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; HASTINGS J, 2010, P 6 FORM ONT INF SYS; HASTINGS J, 2011, CHEMINF ONTOLOGY OWL; Hastings J., 2011, P ICBO 2011 INT C BI; Hemmer M.C., 2008, EXPERT SYSTEMS CHEM; Herre H., 2006, 8 U LEIPZ I MED INF; Horridge M, 2009, OWL 2 WEB ONTOLOGY L; Horrocks I., 2007, OWL DESCRIPTION LOGI, V2nd; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; KABSCH W, 1976, ACTA CRYSTALLOGRAPHI, V32; Katritzky Alan R., 2002, Current Topics in Medicinal Chemistry, V2, P1333, DOI 10.2174/1568026023392922; Katritzky AR, 2010, CHEM REV, V110, P5714, DOI 10.1021/cr900238d; Katritzky AR, 1997, PURE APPL CHEM, V69, P245, DOI 10.1351/pac199769020245; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005440; Kontijevskis A, 2007, PLOS COMPUT BIOL, V3, P424, DOI 10.1371/journal.pcbi.0030048; Konyk M, 2008, LECT N BIOINFORMAT, V5109, P169, DOI 10.1007/978-3-540-69828-9_17; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Mu FP, 2007, BIOINFORMATICS, V23, P3193, DOI 10.1093/bioinformatics/btm498; Murray-Rust P, 2001, NEW J CHEM, V25, P618, DOI 10.1039/b008780g; MURUGAN R, 1994, PREDICTING PHYS PROP, P24; *OP BAB PROJ, 2011, OP BAB OP SOURC CHEM; OpenEye Scientific Software, 2011, OECHEM; Ott MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-517; Reynes C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000695; RUTTENBURG A, 2011, INFORM ARTIFACT ONTO; Samwald M, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-19; SAYERS E, 2005, NLM TECH B       JAN; Selassie C.D., 2003, BURGERS MED CHEM DRU, P1, DOI DOI 10.1002/0471266949.BMC001; Sirin E., 2007, OWLED; Sirin E, 2007, J WEB SEMANT, V5, P51, DOI 10.1016/j.websem.2007.03.004; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2004, DIALECTICA, V58, P279, DOI 10.1111/j.1746-8361.2004.tb00305.x; Smith B, 2010, METHOD INFORM MED, V49, P135, DOI 10.3414/ME9302; Smith B., 1998, FORMAL ONTOLOGY INFO; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; SMITH MK, 2011, WEB ONTOLOGY LANGUAG; Spjuth O, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-5; Spjuth O, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-397; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; SUMATHY K, 2011, CHEM DESCRIPTORS QSA; *SYM, 2011, CTFILE FORM INCL MOL; Taylor KR, 2006, J WEB SEMANT, V4, P84, DOI 10.1016/j.websem.2006.03.003; Taylor KR, 2006, J CHEM INF MODEL, V46, P939, DOI 10.1021/ci050378m; Trinajstic N., 2018, CHEM GRAPH THEORY; TUDORACHE T, 2011, COLLABORATIVE PROTEG; Warr W, 2009, J COMPUT AID MOL DES, V23, P195, DOI 10.1007/s10822-009-9260-9; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Willighagen Egon L, 2011, J Biomed Semantics, V2 Suppl 1, pS6, DOI 10.1186/2041-1480-2-S1-S6; WILLIGHAGEN EL, 2010, SWAT4LS 2009 SEMANTI, V559; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; PROTEGE ONTOLOGY EDI	71	72	73	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25513	10.1371/journal.pone.0025513	http://dx.doi.org/10.1371/journal.pone.0025513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991315	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000034
J	Berta, AI; Boesze-Battaglia, K; Genini, S; Goldstein, O; O'Brien, PJ; Szel, A; Acland, GM; Beltran, WA; Aguirre, GD				Berta, Agnes I.; Boesze-Battaglia, Kathleen; Genini, Sem; Goldstein, Orly; O'Brien, Paul J.; Szel, Agoston; Acland, Gregory M.; Beltran, William A.; Aguirre, Gustavo D.			Photoreceptor Cell Death, Proliferation and Formation of Hybrid Rod/S-Cone Photoreceptors in the Degenerating STK38L Mutant Retina	PLOS ONE			English	Article							NUCLEAR RECEPTOR NR2E3; NEURAL REGENERATION; EXPRESSION; TRANSCRIPTION; NEUROGENESIS; MUTATIONS; MULTIPLE; MODEL	A homozygous mutation in STK38L in dogs impairs the late phase of photoreceptor development, and is followed by photoreceptor cell death (TUNEL) and proliferation (PCNA, PHH3) events that occur independently in different cells between 7-14 weeks of age. During this period, the outer nuclear layer (ONL) cell number is unchanged. The dividing cells are of photoreceptor origin, have rod opsin labeling, and do not label with markers specific for macrophages/microglia (CD18) or Muller cells (glutamine synthetase, PAX6). Nestin labeling is absent from the ONL although it labels the peripheral retina and ciliary marginal zone equally in normals and mutants. Cell proliferation is associated with increased cyclin A1 and LATS1 mRNA expression, but CRX protein expression is unchanged. Coincident with photoreceptor proliferation is a change in the photoreceptor population. Prior to cell death the photoreceptor mosaic is composed of L/M-and S-cones, and rods. After proliferation, both cone types remain, but the majority of rods are now hybrid photoreceptors that express rod opsin and, to a lesser extent, cone S-opsin, and lack NR2E3 expression. The hybrid photoreceptors renew their outer segments diffusely, a characteristic of cones. The results indicate the capacity for terminally differentiated, albeit mutant, photoreceptors to divide with mutations in this novel retinal degeneration gene.	[Berta, Agnes I.; Genini, Sem; Beltran, William A.; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Berta, Agnes I.; Szel, Agoston] Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary; [Boesze-Battaglia, Kathleen] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA; [Goldstein, Orly; Acland, Gregory M.] Cornell Univ, Coll Vet Med, JA Baker Inst, Ithaca, NY 14853 USA; [O'Brien, Paul J.] NEI, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Pennsylvania; Semmelweis University; University of Pennsylvania; Cornell University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Berta, AI (corresponding author), Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.	gda@vet.upenn.edu	Berta-Antalics, Agnes/AAK-5788-2021	Berta-Antalics, Agnes/0000-0001-9000-8177; Aguirre, Gustavo/0000-0002-5228-256X	National Eye Institute, National Institutes of Health [EY-06855, -13132, -17549, -10420, 18705, P30 EY-001583]; Foundation Fighting Blindness center; Van Sloun Fund for Canine Genetic Research; Hope for Vision; ONCE International Prize for R&D in Biomedicine; New Technologies for the Blind; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018705, P30EY001583, R01EY006855, R01EY010420, R01EY013132, R29EY010420, R01EY017549] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness center; Van Sloun Fund for Canine Genetic Research; Hope for Vision; ONCE International Prize for R&D in Biomedicine; New Technologies for the Blind; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, National Institutes of Health grants EY-06855, -13132, -17549, -10420, 18705, P30 EY-001583, a Fulbright Educational Exchange Program Fellowship, Foundation Fighting Blindness center and individual grants, Van Sloun Fund for Canine Genetic Research, Hope for Vision, The ONCE International Prize for R&D in Biomedicine, and New Technologies for the Blind. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACLAND GM, 1987, EXP EYE RES, V44, P491, DOI 10.1016/S0014-4835(87)80160-4; AGUIRRE G, 1986, INVEST OPHTH VIS SCI, V27, P635; Aguirre GD, 2006, COLD SPRING HARB MON, V44, P291; Akhmedov NB, 2005, BBA-GENE STRUCT EXPR, V1728, P11, DOI 10.1016/j.bbaexp.2005.01.003; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2007, EXP EYE RES, V84, P753, DOI 10.1016/j.exer.2006.12.019; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Conley SM, 2010, BIOCHEMISTRY-US, V49, P905, DOI 10.1021/bi901622w; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; dit Huart LM, 2004, MOL CELL NEUROSCI, V26, P441, DOI 10.1016/j.mcn.2004.04.002; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Mowat FM, 2008, MOL VIS, V14, P2518; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; ROHLICH P, 1993, CURR EYE RES, V12, P935, DOI 10.3109/02713689309020400; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; SZEL A, 1986, EXP EYE RES, V43, P871, DOI 10.1016/0014-4835(86)90066-7; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; YOUNG RW, 1969, INVEST OPHTH VISUAL, V8, P222; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P971, DOI 10.1167/iovs.03-0301; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	40	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24074	10.1371/journal.pone.0024074	http://dx.doi.org/10.1371/journal.pone.0024074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980341	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300004
J	Bushell, KN; Leeman, SE; Gillespie, E; Gower, AC; Reed, KL; Stucchi, AF; Becker, JM; Amar, S				Bushell, Kristen N.; Leeman, Susan E.; Gillespie, Earl; Gower, Adam C.; Reed, Karen L.; Stucchi, Arthur F.; Becker, James M.; Amar, Salomon			LITAF Mediation of Increased TNF-alpha Secretion from Inflamed Colonic Lamina Propria Macrophages	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; TRANSCRIPTION FACTOR; GENE-EXPRESSION; NEUROKININ-1 RECEPTOR; MOLECULAR-CLONING; CROHNS-DISEASE; PROMOTER; LIPOPOLYSACCHARIDE; ACTIVATION	Dysregulation of TNF-alpha in lamina propria macrophages (LPM) is a feature of inflammatory bowel diseases (IBD). LPS-Induced-TNF-Alpha-Factor (LITAF) is a transcription factor that mediates TNF-alpha expression. To determine whether LITAF participates in the mediation of TNF-alpha expression in acutely inflamed colonic tissues, we first established the TNBS-induced colonic inflammation model in C57BL/6 mice. LPM were harvested from non-inflamed and inflamed colonic tissue and inflammatory parameters TNF-alpha and LITAF mRNA and protein levels were measured ex-vivo. LPM from TNBS-treated mice secreted significantly more TNF-alpha at basal state and in response to LPS than LPM from untreated mice (p<0.05). LITAF mRNA and protein levels were elevated in LPM from TNBS compared with untreated animals and LPS further increased LITAF protein levels in LPM from inflamed tissue (P<0.05). To further confirm the role of LITAF in acutely inflamed colonic tissues, TNBS-induced colonic inflammation was produced in LITAF macrophage specific knockout mice (LITAF mac-/-mice) and compared to wild type (WT) C57BL/6. Twenty four hours following TNBS administration, colonic tissue from LITAF mac-/-mice had less MPO activity and reduced colonic TNF-alpha mRNA then WT C57BL/6 mice (p<0.05). LPM harvested from LITAF mac-/-secreted significantly less TNF-alpha in response to LPS than wild type (WT) C57BL/6 (p<0.05). This study provides evidence that LITAF contributes to the regulation of TNF-alpha in LPM harvested following acute inflammation or LPS treatment paving the way for future work focusing on LITAF inhibitors in the treatment of TNF-alpha-mediated inflammatory conditions.	[Bushell, Kristen N.; Leeman, Susan E.; Gillespie, Earl] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Gower, Adam C.; Reed, Karen L.; Stucchi, Arthur F.; Becker, James M.] Boston Univ, Med Ctr, Dept Surg, Boston, MA 02118 USA; [Amar, Salomon] Boston Univ, Goldman Sch Dent Med, Ctr Antiinflammatory Therapeut, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Bushell, KN (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	samar@bu.edu		Amar, Salomon/0000-0002-0017-5930; Gower, Adam/0000-0002-6122-7511; Leeman, Susan/0000-0002-0951-5364; Stucchi, Arthur/0000-0002-9240-9844	Department of Surgery, Boston University Medical Center, NIH/NIDCR [R01 DE 014079 SA]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014079] Funding Source: NIH RePORTER	Department of Surgery, Boston University Medical Center, NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Smithwick and Tyler Endowment Fund, Department of Surgery, Boston University Medical Center, NIH/NIDCR grant # R01 DE 014079 SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud PA, 2008, EUR J PHARMACOL, V579, P411, DOI 10.1016/j.ejphar.2007.10.053; ALLISON MC, 1988, GUT, V29, P1531, DOI 10.1136/gut.29.11.1531; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P728, DOI 10.1006/bcmd.2001.0441; Bolcato-Bellemin AL, 2004, J ENDOTOXIN RES, V10, P15, DOI 10.1179/096805104225003780; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim HJ, 2006, TOXICOLOGY, V225, P36, DOI 10.1016/j.tox.2006.04.053; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; KRAMER B, 1994, BBA-GENE STRUCT EXPR, V1219, P413, DOI 10.1016/0167-4781(94)90066-3; KRAMER B, 1995, J BIOL CHEM, V270, P6577; LEITMAN DC, 1991, J BIOL CHEM, V266, P9343; Lo CJ, 2003, J SURG RES, V113, P189, DOI 10.1016/S0022-4804(03)00186-0; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Mannel DN, 2000, CHEM IMMUNOL, V74, P141; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Pollastri MP, 2009, CHEM BIOL DRUG DES, V74, P121, DOI 10.1111/j.1747-0285.2009.00838.x; Reed KL, 2005, DIGEST DIS SCI, V50, P2366, DOI 10.1007/s10620-005-3066-y; Reed KL, 2004, P NATL ACAD SCI USA, V101, P9115, DOI 10.1073/pnas.0403210101; RHOADES KL, 1992, J BIOL CHEM, V267, P22102; Sandborn William J, 2005, Rev Gastroenterol Disord, V5, P10; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; SRINIVASAN S, 2008, THESIS BOSTON U, V17; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Stucchi A, 2006, INFLAMM BOWEL DIS, V12, P581, DOI 10.1097/01.MIB.0000225338.14356.d5; Su C, 2005, ADV DRUG DELIVER REV, V57, P237, DOI 10.1016/j.addr.2004.08.006; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tang XR, 2005, P NATL ACAD SCI USA, V102, P5132, DOI 10.1073/pnas.0501159102; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Togashi H, 2003, GUT, V52, P1291, DOI 10.1136/gut.52.9.1291; UEDA Y, INT IMMUNOLOGY, V22, P953; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; ZHOU J, ONCOGENE, V30, P1892; Zhu Y, 2005, EUR J IMMUNOL, V35, P217, DOI 10.1002/eji.200425491	41	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25849	10.1371/journal.pone.0025849	http://dx.doi.org/10.1371/journal.pone.0025849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984950	gold, Green Published			2022-12-27	WOS:000295941300061
J	Campbell, JJ; Davidenko, N; Caffarel, MM; Cameron, RE; Watson, CJ				Campbell, Jonathan J.; Davidenko, Natalia; Caffarel, Maria M.; Cameron, Ruth E.; Watson, Christine J.			A Multifunctional 3D Co-Culture System for Studies of Mammary Tissue Morphogenesis and Stem Cell Biology	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; HYALURONAN; CD44; EXPRESSION; GLYCOSAMINOGLYCANS; ORGANIZATION; ADHESION; KINASE	Studies on the stem cell niche and the efficacy of cancer therapeutics require complex multicellular structures and interactions between different cell types and extracellular matrix (ECM) in three dimensional (3D) space. We have engineered a 3D in vitro model of mammary gland that encompasses a defined, porous collagen/hyaluronic acid (HA) scaffold forming a physiologically relevant foundation for epithelial and adipocyte co-culture. Polarized ductal and acinar structures form within this scaffold recapitulating normal tissue morphology in the absence of reconstituted basement membrane (rBM) hydrogel. Furthermore, organoid developmental outcome can be controlled by the ratio of collagen to HA, with a higher HA concentration favouring acinar morphological development. Importantly, this culture system recapitulates the stem cell niche as primary mammary stem cells form complex organoids, emphasising the utility of this approach for developmental and tumorigenic studies using genetically altered animals or human biopsy material, and for screening cancer therapeutics for personalised medicine.	[Campbell, Jonathan J.; Caffarel, Maria M.; Watson, Christine J.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Davidenko, Natalia; Cameron, Ruth E.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge; University of Cambridge	Campbell, JJ (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	jjc55@cam.ac.uk; cjw53@cam.ac.uk	watson, Christine J/B-1431-2012	Cameron, Ruth/0000-0003-1573-4923; Caffarel, Maria/0000-0002-7442-6827	Biotechnology and Biological Sciences Research Council [BB/F000871/1]; BBSRC [BB/F000871/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council, BB/F000871/1 (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARATANI Y, 1988, J BIOL CHEM, V263, P16163; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Cabrera PV, 2004, INFLAMM RES, V53, P556, DOI 10.1007/s00011-004-1295-8; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162; Cohen M, 2003, BIOPHYS J, V85, P1996, DOI 10.1016/S0006-3495(03)74627-X; Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Eheman CR, 2009, CANCER EPIDEM BIOMAR, V18, P1763, DOI 10.1158/1055-9965.EPI-08-1082; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Fujita Y, 2002, FEBS LETT, V528, P101, DOI 10.1016/S0014-5793(02)03262-3; Gakunga P, 1997, DEVELOPMENT, V124, P3987; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gordon KE, 2000, BREAST CANCER RES, V2, P222, DOI 10.1186/bcr57; Gudjonsson T, 2002, J CELL SCI, V115, P39; He Y, 2008, AM J PHYSIOL-GASTR L, V295, pG305, DOI 10.1152/ajpgi.90229.2008; KEELY PJ, 1995, DIFFERENTIATION, V59, P1, DOI 10.1046/j.1432-0436.1995.5910001.x; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Mori H, 2009, P NATL ACAD SCI USA, V106, P14890, DOI 10.1073/pnas.0901269106; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Pohl M, 2000, DEV BIOL, V224, P312, DOI 10.1006/dbio.2000.9783; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; SILBERSTEIN GB, 1982, DEV BIOL, V90, P215, DOI 10.1016/0012-1606(82)90228-7; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; Sunil N, 2000, ACTA PHYSIOL SCAND, V168, P385, DOI 10.1046/j.1365-201x.2000.00675.x; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; WIENS D, 1987, DEV BIOL, V120, P245, DOI 10.1016/0012-1606(87)90122-9; Zangani D, 1999, EXP CELL RES, V247, P399, DOI 10.1006/excr.1998.4373; ZIMMERMAN E, 2008, BIOPHYS J, V82, P1848	38	78	78	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25661	10.1371/journal.pone.0025661	http://dx.doi.org/10.1371/journal.pone.0025661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984937	Green Submitted, gold, Green Published			2022-12-27	WOS:000295941300047
J	Jones, EA; van Remoortere, A; van Zeijl, RJM; Hogendoorn, PCW; Bovee, JVMG; Deelder, AM; McDonnell, LA				Jones, Emrys A.; van Remoortere, Alexandra; van Zeijl, Rene J. M.; Hogendoorn, Pancras C. W.; Bovee, Judith V. M. G.; Deelder, Andre M.; McDonnell, Liam A.			Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma	PLOS ONE			English	Article							MS; CANCER; HISTOLOGY; CLASSIFICATION; PROTEINS; FRAGMENT; COMPLEX; IMAGES; GRADE	MALDI mass spectrometry can generate profiles that contain hundreds of biomolecular ions directly from tissue. Spatially-correlated analysis, MALDI imaging MS, can simultaneously reveal how each of these biomolecular ions varies in clinical tissue samples. The use of statistical data analysis tools to identify regions containing correlated mass spectrometry profiles is referred to as imaging MS-based molecular histology because of its ability to annotate tissues solely on the basis of the imaging MS data. Several reports have indicated that imaging MS-based molecular histology may be able to complement established histological and histochemical techniques by distinguishing between pathologies with overlapping/identical morphologies and revealing biomolecular intratumor heterogeneity. A data analysis pipeline that identifies regions of imaging MS datasets with correlated mass spectrometry profiles could lead to the development of novel methods for improved diagnosis (differentiating subgroups within distinct histological groups) and annotating the spatio-chemical makeup of tumors. Here it is demonstrated that highlighting the regions within imaging MS datasets whose mass spectrometry profiles were found to be correlated by five independent multivariate methods provides a consistently accurate summary of the spatio-chemical heterogeneity. The corroboration provided by using multiple multivariate methods, efficiently applied in an automated routine, provides assurance that the identified regions are indeed characterized by distinct mass spectrometry profiles, a crucial requirement for its development as a complementary histological tool. When simultaneously applied to imaging MS datasets from multiple patient samples of intermediate-grade myxofibrosarcoma, a heterogeneous soft tissue sarcoma, nodules with mass spectrometry profiles found to be distinct by five different multivariate methods were detected within morphologically identical regions of all patient tissue samples. To aid the further development of imaging MS based molecular histology as a complementary histological tool the Mat lab code of the agreement analysis, instructions and a reduced dataset are included as supporting information.	[Jones, Emrys A.; van Remoortere, Alexandra; van Zeijl, Rene J. M.; Deelder, Andre M.; McDonnell, Liam A.] Leiden Univ Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands; [Hogendoorn, Pancras C. W.; Bovee, Judith V. M. G.] Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Jones, EA (corresponding author), Leiden Univ Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands.	l.a.mcdonnell@lumc.nl	Hogendoorn, Pancras/O-6494-2019; Hogendoorn, Pancras C.W./H-5859-2015	Hogendoorn, Pancras/0000-0002-1513-8104; Hogendoorn, Pancras C.W./0000-0002-1513-8104; McDonnell, Liam/0000-0003-0595-9491; Bovee, Judith/0000-0003-1155-0481; Jones, Emrys/0000-0001-9834-217X	ZonMw [93519026, 93511027]	ZonMw(Netherlands Organization for Health Research and Development)	EAJ and LMD were supported by the following ZonMw grants (both awarded to LMD, www.zonmw.nl): Multiplex Imaging of Tissue Arrays, Project Number 93519026, and Targeted, quantitative, multiplex, imaging mass spectrometry, Project Number 93511027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov T, 2010, J PROTEOME RES, V9, P6535, DOI 10.1021/pr100734z; Broersen A, 2008, J AM SOC MASS SPECTR, V19, P823, DOI 10.1016/j.jasms.2008.02.015; Caldwell Robert L., 2006, Cancer Genomics & Proteomics, V3, P279; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chaurand P, 2004, ANAL CHEM, V76, p86A, DOI 10.1021/ac0415197; Chaurand P, 2004, ANAL CHEM, V76, P1145, DOI 10.1021/ac0351264; Chaurand P, 2007, J MASS SPECTROM, V42, P476, DOI 10.1002/jms.1180; Chen XY, 2003, ANAL CHEM, V75, P5944, DOI 10.1021/ac030127h; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Cohen SL, 1996, ANAL CHEM, V68, P31, DOI 10.1021/ac9507956; Cornett DS, 2006, MOL CELL PROTEOMICS, V5, P1975, DOI 10.1074/mcp.M600119-MCP200; Corney D, 2010, CLUSTERING MATLAB; Deininger SO, 2008, J PROTEOME RES, V7, P5230, DOI 10.1021/pr8005777; Djidja MC, 2009, J PROTEOME RES, V8, P4876, DOI 10.1021/pr900522m; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hanselmann M, 2008, ANAL CHEM, V80, P9649, DOI 10.1021/ac801303x; Hilario M, 2006, MASS SPECTROM REV, V25, P409, DOI 10.1002/mas.20072; Kang S, 2010, J PROTEOME RES, V9, P1157, DOI 10.1021/pr900666q; Klerk LA, 2007, INT J MASS SPECTROM, V260, P222, DOI 10.1016/j.ijms.2006.11.014; Lagarrigue M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005991; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lemaire R, 2007, J PROTEOME RES, V6, P4127, DOI 10.1021/pr0702722; Mantini D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-101; McCombie G, 2005, ANAL CHEM, V77, P6118, DOI 10.1021/ac051081q; McDonnell LA, 2008, J PROTEOME RES, V7, P3619, DOI 10.1021/pr800214d; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; McDonnell LA, 2010, J AM SOC MASS SPECTR, V21, P1969, DOI 10.1016/j.jasms.2010.08.008; McDonnell LA, 2010, J PROTEOMICS, V73, P1921, DOI 10.1016/j.jprot.2010.05.007; Mentzel T, 2004, TUMOURS SOFT TISSUE, P102; Nielsen AA, 2010, MAXIMUM AUTOCORRELAT; Norris JL, 2007, INT J MASS SPECTROM, V260, P212, DOI 10.1016/j.ijms.2006.10.005; Oppenheimer SR, 2010, J PROTEOME RES, V9, P2182, DOI 10.1021/pr900936z; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Rompp A, 2010, ANGEW CHEM INT EDIT, V49, P3834, DOI 10.1002/anie.200905559; Schwamborn K, 2007, INT J MOL MED, V20, P155; Stoeckli M, 2007, INT J MASS SPECTROM, V260, P195, DOI 10.1016/j.ijms.2006.10.007; Switzer P., 1985, Computer Science and Statistics. Proceedings of the Sixteenth Symposium on the Interface, P13; van Hove ERA, 2010, CANCER RES, V70, P9012, DOI 10.1158/0008-5472.CAN-10-0360; Willems SM, 2006, MODERN PATHOL, V19, P407, DOI 10.1038/modpathol.3800550; Willems SM, 2010, J PATHOL, V222, P400, DOI 10.1002/path.2771; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8	43	83	85	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24913	10.1371/journal.pone.0024913	http://dx.doi.org/10.1371/journal.pone.0024913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980364	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600008
J	Osada, N				Osada, Naoki			Phylogenetic Inconsistency Caused by Ancient Sex-Biased Gene Migration	PLOS ONE			English	Article							NUCLEAR; FLOW; INTROGRESSION; HYBRIDIZATION; DIVERGENCE; DISPERSAL; MONKEYS; DNA; INCONGRUENCE; POPULATIONS	Inferences of ancient sex-biased migration patterns using sex-linked genetic markers are usually difficult because of a stochastic process of allele fixation. Nevertheless, incongruent phylogenetic trees between different sex-linked markers and between sex-linked and autosomal markers are frequently interpreted as a signature of sex-biased migration without further statistical evaluation. I investigated the types of incongruent phylogenetic trees from which past sex-biased migration events can be statistically supported under the coalescent model. In the case of mammals, detecting a sex-biased migration pattern is not guaranteed by comparing the phylogenetic pattern of mitochondrial and Y-chromosomal loci Likewise, evidence of introgression at a mitochondrial locus, but not at autosomal loci, does not support the hypothesis of an ancient female-biased migration pattern with statistical significance. In contrast, evidence of introgression at >= 5 unlinked autosomal loci, but not at a Y-chromosomal locus, would reject the null hypothesis of a sexually equal migration ate with statistical significance. A similar argument can be made to infer a male-biased migration pattern. Furthermore, the Investigation of many recombining sex-biased markers such as X-chromosomal loci in mammals has the potential to efficiently detect ancient sex-biased demographic patterns.	[Osada, Naoki] Natl Inst Genet, Dept Populat Genet, Mishima, Shizuoka 411, Japan; [Osada, Naoki] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Osada, N (corresponding author), Natl Inst Genet, Dept Populat Genet, Mishima, Shizuoka 411, Japan.	nosada@lab.nig.ac.jp	Osada, Naoki/B-2938-2009; Osada, Naoki/J-3790-2019	Osada, Naoki/0000-0003-0180-5372	Scientific Research (KAKENHI); Grant-in-Aid for Young Scientists [(A)(22687021)]	Scientific Research (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant-in-Aid for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI), Grant-in-Aid for Young Scientists (A)(22687021). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KMA, 2005, EVOLUTION, V59, P720; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Egger B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-137; Evans BJ, 2010, GENETICS, V185, P923, DOI 10.1534/genetics.110.116228; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2004, MOL ECOL, V13, P909, DOI 10.1046/j.1365-294X.2003.02031.x; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Osada N, 2010, MOL ECOL, V19, P2884, DOI 10.1111/j.1365-294X.2010.04687.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Rieseberg LH, 1996, ACTA BOT NEERL, V45, P243; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Schubert G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021514; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; Yannic G, 2010, MOL PHYLOGENET EVOL, V57, P1062, DOI 10.1016/j.ympev.2010.09.015; Zinner D, 2011, EVOL ANTHROPOL, V20, P96, DOI 10.1002/evan.20301	26	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25549	10.1371/journal.pone.0025549	http://dx.doi.org/10.1371/journal.pone.0025549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980490	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600035
J	Wong, ZS; Hedges, LM; Brownlie, JC; Johnson, KN				Wong, Zhee Sheen; Hedges, Lauren M.; Brownlie, Jeremy C.; Johnson, Karyn N.			Wolbachia-Mediated Antibacterial Protection and Immune Gene Regulation in Drosophila	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; HOST-DEFENSE; INFECTION; INCOMPATIBILITY; INDUCTION; SIMULANS; POPULATIONS; CHIKUNGUNYA; PHYLOGENY	The outcome of microbial infection of insects is dependent not only on interactions between the host and pathogen, but also on the interactions between microbes that co-infect the host. Recently the maternally inherited endosymbiotic bacteria Wolbachia has been shown to protect insects from a range of microbial and eukaryotic pathogens. Mosquitoes experimentally infected with Wolbachia have upregulated immune responses and are protected from a number of pathogens including viruses, bacteria, Plasmodium and filarial nematodes. It has been hypothesised that immune upregulation underpins Wolbachia-mediated protection. Drosophila is a strong model for understanding host-Wolbachia-pathogen interactions. Wolbachia-mediated antiviral protection in Drosophila has been demonstrated for a number of different Wolbachia strains. In this study we investigate whether Wolbachia-infected flies are also protected against pathogenic bacteria. Drosophila simulans lines infected with five different Wolbachia strains were challenged with the pathogenic bacteria Pseudomonas aeruginosa PAW, Serratia marcescens and Erwinia carotovora and mortality compared to paired lines without Wolbachia. No difference in mortality was observed in the flies with or without Wolbachia. Similarly no antibacterial protection was observed for D. melanogaster infected with Wolbachia. Interestingly, D. melanogaster Oregon RC flies which are naturally infected with Wolbachia showed no upregulation of the antibacterial immune genes TepIV, Defensin, Diptericin B, PGRP-SD, Cecropin A1 and Attacin D compared to paired flies without Wolbachia. Taken together these results indicate that Wolbachia-mediated antibacterial protection is not ubiquitous in insects and furthermore that the mechanisms of antibacterial and antiviral protection are independent. We suggest that the immune priming and antibacterial protection observed in Wolbachia-infected mosquitoes may be a consequence of the recent artificial introduction of the symbiont into insects that normally do not carry Wolbachia and that antibacterial protection is unlikely to be found in insects carrying long-term Wolbachia infections.	[Wong, Zhee Sheen; Hedges, Lauren M.; Johnson, Karyn N.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Brownlie, Jeremy C.] Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia	University of Queensland; Griffith University	Wong, ZS (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	karynj@uq.edu.au	Johnson, Karyn N/B-7980-2008	Johnson, Karyn N/0000-0001-8647-8985; Brownlie, Jeremy/0000-0003-0161-2204	Australian Research Council [DP1092492]	Australian Research Council(Australian Research Council)	This research was supported by funds from the Australian Research Council (grant DP1092492). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Chevalier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018531; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Fenton A, 2011, AM NAT, V178, P333, DOI 10.1086/661247; Glaser RL, 2011, PLOS ONE, V5, pe11977; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hedges LM, 2008, J GEN VIROL, V89, P1497, DOI 10.1099/vir.0.83684-0; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Huston WM, 2002, MOL MICROBIOL, V45, P1741, DOI 10.1046/j.1365-2958.2002.03132.x; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Mercot H, 1998, ENTOMOL EXP APPL, V86, P97, DOI 10.1023/A:1003170928067; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; Osborne RJ, 1996, J GEN VIROL, V77, P839, DOI 10.1099/0022-1317-77-5-839; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Poinsot D, 1998, GENETICS, V150, P227; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Rozen S, 2000, Methods Mol Biol, V132, P365; Siozios S, 2008, INSECT SCI, V15, P89, DOI 10.1111/j.1744-7917.2008.00189.x; Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09; Teixeira L, 2008, PLOS BIOL, V6, DOI doi:1000010.1001371/journal.pbio.1000002; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; XI ZY, 2008, BMC GENOMICS, V9; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	42	88	94	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25430	10.1371/journal.pone.0025430	http://dx.doi.org/10.1371/journal.pone.0025430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980455	Green Published, gold			2022-12-27	WOS:000295939600026
J	Clague, J; Wilhoite, G; Adamson, A; Bailis, A; Weitzel, JN; Neuhausen, SL				Clague, Jessica; Wilhoite, Greg; Adamson, Aaron; Bailis, Adam; Weitzel, Jeffrey N.; Neuhausen, Susan L.			RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; PROTEIN; INSTABILITY; BRCA2	BRCA1 and BRCA2 are the most well-known breast cancer susceptibility genes. Additional genes involved in DNA repair have been identified as predisposing to breast cancer. One such gene, RAD51C, is essential for homologous recombination repair. Several likely pathogenic RAD51C mutations have been identified in BRCA1- and BRCA2-negative breast and ovarian cancer families. We performed complete sequencing of RAD51C in germline DNA of 286 female breast and/or ovarian cancer cases with a family history of breast and ovarian cancers, who had previously tested negative for mutations in BRCA1 and BRCA2. We screened 133 breast cancer cases, 119 ovarian cancer cases, and 34 with both breast and ovarian cancers. Fifteen DNA sequence variants were identified; including four intronic, one 5' UTR, one promoter, three synonymous, and six non-synonymous variants. None were truncating. The in-silico SIFT and Polyphen programs were used to predict possible pathogenicity of the six non-synonomous variants based on sequence conservation. G153D and T287A were predicted to be likely pathogenic. Two additional variants, A126T and R214C alter amino acids in important domains of the protein such that they could be pathogenic. Two-hybrid screening and immunoblot analyses were performed to assess the functionality of these four non-synonomous variants in yeast. The RAD51C-G153D protein displayed no detectable interaction with either XRCC3 or RAD51B, and RAD51C-R214C displayed significantly decreased interaction with both XRCC3 and RAD51B (p<0.001). Immunoblots of RAD51C-Gal4 activation domain fusion peptides showed protein levels of RAD51C-G153D and RAD51C-R214C that were 50% and 60% of the wild-type, respectively. Based on these data, the RAD51C-G153D variant is likely to be pathogenic, while the RAD51C-R214C variant is hypomorphic of uncertain pathogenicity. These results provide further support that RAD51C is a rare breast and ovarian cancer susceptibility gene.	[Clague, Jessica; Weitzel, Jeffrey N.] City Hope Natl Med Ctr, Beckman Res Inst, Div Clin Canc Genet, Duarte, CA 91010 USA; [Wilhoite, Greg; Adamson, Aaron; Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Bailis, Adam] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Clague, J (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Clin Canc Genet, Duarte, CA 91010 USA.	sneuhausen@coh.org		Bailis, Adam/0000-0001-5628-0468	National Cancer Institute [RC4A153828, R25 CA85771]; Office of the Director, National Institutes of Health; Morris and Horowitz Families Endowed Professorship; Markel/Friedman Peritoneal Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R25CA085771] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morris and Horowitz Families Endowed Professorship; Markel/Friedman Peritoneal Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The City of Hope Clinical Cancer Genetics Community Research Network is supported by Award Number RC4A153828 (PI : JNW) from the National Cancer Institute and the Office of the Director, National Institutes of Health. JC is supported by National Cancer Institute grant R25 CA85771. SLN is partially supported by the Morris and Horowitz Families Endowed Professorship. JNW is partially supported by Markel/Friedman Peritoneal Ovarian Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2619; Barlund M, 2000, CANCER RES, V60, P5340; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Jemal A, 2010, CA CANC J CLIN, V60; Kurumizaka H, 2003, NUCLEIC ACIDS RES, V31, P4041, DOI 10.1093/nar/gkg442; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Miller KA, 2004, NUCLEIC ACIDS RES, V32, P169, DOI 10.1093/nar/gkg925; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; Pang Z., 2011, BREAST CANC RES TREA; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; ROMERO A, 2011, BREAST CANC RES TREA; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Smeenk G, 2010, MUTAT RES-FUND MOL M, V689, P50, DOI 10.1016/j.mrfmmm.2010.05.001; Sowter HM, 2005, CARCINOGENESIS, V26, P1651, DOI 10.1093/carcin/bgi136; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; VUORELA M, 2011, BREAST CANC RES TREA; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; ZHENG Y, 2010, BREAST CANC RES TREA	21	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25632	10.1371/journal.pone.0025632	http://dx.doi.org/10.1371/journal.pone.0025632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980511	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900083
J	Gaiser, AM; Kaiser, CJO; Haslbeck, V; Richter, K				Gaiser, Andreas M.; Kaiser, Christoph J. O.; Haslbeck, Veronika; Richter, Klaus			Downregulation of the Hsp90 System Causes Defects in Muscle Cells of Caenorhabditis Elegans	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; MOLECULAR CHAPERONE; CONFORMATIONAL-CHANGES; SKELETAL-MUSCLES; DAUER FORMATION; PROTEIN; UNC-45; MYOSIN; GENE; GELDANAMYCIN	The ATP-dependent molecular chaperone Hsp90 is required for the activation of a variety of client proteins involved in various cellular processes. Despite the abundance of known client proteins, functions of Hsp90 in the organismal context are not fully explored. In Caenorhabditis elegans, Hsp90 (DAF-21) has been implicated in the regulation of the stress-resistant dauer state, in chemosensing and in gonad formation. In a C. elegans strain carrying a DAF-21 mutation with a lower ATP turnover, we observed motility defects. Similarly, a reduction of DAF-21 levels in wild type nematodes leads to reduced motility and induction of the muscular stress response. Furthermore, aggregates of the myosin MYO-3 are visible in muscle cells, if DAF-21 is depleted, implying a role of Hsp90 in the maintenance of muscle cell functionality. Similar defects can also be observed upon knockdown of the Hsp90-cochaperone UNC-45. In life nematodes YFP-DAF-21 localizes to the I-band and the M-line of the muscular ultrastructure, but the protein is not stably attached there. The Hsp90-cofactor UNC-45-CFP contrarily can be found in all bands of the nematode muscle ultrastructure and stably associates with the UNC-54 containing A-band. Thus, despite the physical interaction between DAF-21 and UNC-45, apparently the two proteins are not always localized to the same muscular structures. While UNC-45 can stably bind to myofilaments in the muscular ultrastructure, Hsp90 (DAF-21) appears to participate in the maintenance of muscle structures as a transiently associated diffusible factor.	[Gaiser, Andreas M.] Dept Chem, Munich, Germany; CIPSM, Munich, Germany; Tech Univ Munich, Munich, Germany	University of Munich; Technical University of Munich	Gaiser, AM (corresponding author), Dept Chem, Munich, Germany.	klaus.richter@tum.de	Richter, Klaus/A-2673-2010; Kaiser, Christoph JO/C-5609-2013	Richter, Klaus/0000-0002-8952-9642; Kaiser, Christoph JO/0000-0002-8481-6845	Deutsche Forschungsgemeinschaft (DFG) [RI1873-1/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by grant no. RI1873-1/1 of Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/index.jsp) provided to Klaus Richter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Altun Z. F., 2009, MUSCLE SYSTEM SOMATI; Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Birnby DA, 2000, GENETICS, V155, P85; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BRENNER S, 1974, GENETICS, V77, P71; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chang YS, 2006, J CELL BIOCHEM, V97, P156, DOI 10.1002/jcb.20623; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Gaiser AM, 2010, J BIOL CHEM, V285, P40921, DOI 10.1074/jbc.M110.131086; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Gillan V, 2009, INT J PARASITOL, V39, P1071, DOI 10.1016/j.ijpara.2009.02.024; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; Haslbeck M, 2003, J CHROMATOGR B, V786, P127, DOI 10.1016/S1570-0232(02)00716-X; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Inoue T, 2006, DEV GROWTH DIFFER, V48, P25, DOI [10.1111/j.1440-169x.2006.00841.x, 10.1111/j.1440-169X.2006.00841.x]; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/713803536; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, J CELL SCI, V124, P699, DOI 10.1242/jcs.078964; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mori I, 1993, WORM BREEDERS GAZETT; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; SMITH DF, 1992, J BIOL CHEM, V267, P1350; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; THOMAS JH, 1993, GENETICS, V134, P1105; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; VENOLIA L, 1990, GENETICS, V126, P345; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voss AK, 2000, DEVELOPMENT, V127, P1; VOWELS JJ, 1992, GENETICS, V130, P105; Waterston R., 1988, NEMATODE C ELEGANS, P281; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043	69	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25485	10.1371/journal.pone.0025485	http://dx.doi.org/10.1371/journal.pone.0025485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980476	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900071
J	Jiang, JH; Yun, YZ; Yang, QQ; Shim, WB; Wang, ZY; Ma, ZH				Jiang, Jinhua; Yun, Yingzi; Yang, Qianqian; Shim, Won-Bo; Wang, Zhengyi; Ma, Zhonghua			A Type 2C Protein Phosphatase FgPtc3 Is Involved in Cell Wall Integrity, Lipid Metabolism, and Virulence in Fusarium graminearum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAGNAPORTHE-GRISEA; SER/THR PHOSPHATASE; GIBBERELLA-ZEAE; APPRESSORIUM TURGOR; REDUCED VIRULENCE; CANDIDA-ALBICANS; LITHIUM TOXICITY; GENE-EXPRESSION; LYTIC SYSTEM	Type 2C protein phosphatases (PP2Cs) play important roles in regulating many biological processes in eukaryotes. Currently, little is known about functions of PP2Cs in filamentous fungi. The causal agent of wheat head blight, Fusarium graminearum, contains seven putative PP2C genes, FgPTC1, -3, -5, -5R, -6, -7 and -7R. In order to investigate roles of these PP2Cs, we constructed deletion mutants for all seven PP2C genes in this study. The FgPTC3 deletion mutant (Delta FgPtc3-8) exhibited reduced aerial hyphae formation and deoxynivalenol (DON) production, but increased production of conidia. The mutant showed increased resistance to osmotic stress and cell wall-damaging agents on potato dextrose agar plates. Pathogencity assays showed that Delta FgPtc3-8 is unable to infect flowering wheat head. All of the defects were restored when Delta FgPtc3-8 was complemented with the wild-type FgPTC3 gene. Additionally, the FgPTC3 partially rescued growth defect of a yeast PTC1 deletion mutant under various stress conditions. Ultrastructural and histochemical analyses showed that conidia of Delta FgPtc3-8 contained an unusually high number of large lipid droplets. Furthermore, the mutant accumulated a higher basal level of glycerol than the wild-type progenitor. Quantitative real-time PCR assays showed that basal expression of FgOS2, FgSLT2 and FgMKK1 in the mutant was significantly higher than that in the wild-type strain. Serial analysis of gene expression in Delta FgPtc3-8 revealed that FgPTC3 is associated with various metabolic pathways. In contrast to the FgPTC3 mutant, the deletion mutants of FgPTC1, FgPTC5, FgPTC5R, FgPTC6, FgPTC7 or FgPTC7R did not show aberrant phenotypic features when grown on PDA medium or inoculated on wheat head. These results indicate FgPtc3 is the key PP2C that plays a critical role in a variety of cellular and biological functions, including cell wall integrity, lipid and secondary metabolisms, and virulence in F. graminearum.	[Jiang, Jinhua; Yun, Yingzi; Yang, Qianqian; Wang, Zhengyi; Ma, Zhonghua] Zhejiang Univ, Inst Biotechnol, Key Lab Mol Biol Crop Pathogens & Insects, Hangzhou 310003, Zhejiang, Peoples R China; [Shim, Won-Bo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA	Zhejiang University; Texas A&M University System; Texas A&M University College Station	Jiang, JH (corresponding author), Zhejiang Univ, Inst Biotechnol, Key Lab Mol Biol Crop Pathogens & Insects, Hangzhou 310003, Zhejiang, Peoples R China.	zhma@zju.edu.cn	Ma, Zhonghua/J-6972-2014	Ma, Zhonghua/0000-0002-5426-0997	earmarked fund for Modern Agro-industry Technology Research System [CARS-3-1-15]; Zhejiang Provincial Natural Science Foundation [Z3110057]; Fundamental Research Funds for the Central Universities	earmarked fund for Modern Agro-industry Technology Research System; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-3-1-15), Zhejiang Provincial Natural Science Foundation (Z3110057), and the Fundamental Research Funds for the Central Universities to Dr. Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARINO J, 2010, EYKARYOTIC CELL, V10, P21; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai GH, 1996, PLANT DIS, V80, P975, DOI 10.1094/PD-80-0975; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Blandino M, 2006, EUR J AGRON, V25, P193, DOI 10.1016/j.eja.2006.05.001; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Desjardins AE, 1996, MOL PLANT MICROBE IN, V9, P775, DOI 10.1094/MPMI-9-0775; Dong B, 2009, AUTOPHAGY, V5, P946, DOI 10.4161/auto.5.7.9161; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Faucher SP, 2008, FEMS MICROBIOL LETT, V281, P160, DOI 10.1111/j.1574-6968.2008.01094.x; Gaits F, 1999, MOL BIOL CELL, V10, P2647, DOI 10.1091/mbc.10.8.2647; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Jiang JH, 2011, MOL PLANT PATHOL, V12, P425, DOI 10.1111/j.1364-3703.2010.00684.x; Jiang LH, 2001, FEBS LETT, V509, P142, DOI 10.1016/S0014-5793(01)03125-8; Jiang LH, 2010, MOL PLANT PATHOL, V11, P277, DOI 10.1111/j.1364-3703.2009.00598.x; Jin Y, 2009, MOL BIOL CELL, V20, P1312, DOI 10.1091/mbc.E08-09-0954; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Liu X, 2010, PLANT DIS, V94, P1137, DOI 10.1094/PDIS-94-9-1137; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Meskiene I, 2003, J BIOL CHEM, V278, P18945, DOI 10.1074/jbc.M300878200; Mirocha CJ, 1998, J AGR FOOD CHEM, V46, P1414, DOI 10.1021/jf970857o; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Ochiai N, 2007, BIOCHEM BIOPH RES CO, V363, P639, DOI 10.1016/j.bbrc.2007.09.027; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Ramos CW, 2000, IUBMB LIFE, V50, P371, DOI 10.1080/152165400300089411; ROBINSON MK, 1994, MOL CELL BIOL, V14, P3634, DOI 10.1128/MCB.14.6.3634; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; Ruiz A, 2006, MOL MICROBIOL, V62, P263, DOI 10.1111/j.1365-2958.2006.05370.x; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; Sasaki M, 2007, MECH DEVELOP, V124, P489, DOI 10.1016/j.mod.2007.04.001; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shitamukai A, 2004, J BIOL CHEM, V279, P3651, DOI 10.1074/jbc.M306098200; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Steensma HY, 2008, YEAST, V25, P9, DOI 10.1002/yea.1543; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Weber RWS, 1999, HISTOCHEM J, V31, P293, DOI 10.1023/A:1003713901179; Wojda I, 2003, MICROBIOL-SGM, V149, P1193, DOI 10.1099/mic.0.26110-0; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yin Y, 2009, LETT APPL MICROBIOL, V48, P680, DOI 10.1111/j.1472-765X.2009.02595.x; Young C, 2002, EUKARYOT CELL, V1, P1032, DOI 10.1128/EC.1.6.1032-1040.2002; Zhao XM, 2009, J PROTEOME RES, V8, P4714, DOI 10.1021/pr900415b	59	32	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25311	10.1371/journal.pone.0025311	http://dx.doi.org/10.1371/journal.pone.0025311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980420	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900049
J	Wokke, ME; van Gaal, S; Scholte, HS; Ridderinkhof, KR; Lamme, VAF				Wokke, Martijn E.; van Gaal, Simon; Scholte, H. Steven; Ridderinkhof, K. Richard; Lamme, Victor A. F.			The Flexible Nature of Unconscious Cognition	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; RESPONSE-INHIBITION; ATTENTIONAL MODULATION; SPATIAL ATTENTION; ERP COMPONENTS; GO/NOGO TASK; STIMULI; CORTEX; WORDS; BRAIN	The cognitive signature of unconscious processes is hotly debated recently. Generally, consciousness is thought to mediate flexible, adaptive and goal-directed behavior, but in the last decade unconscious processing has rapidly gained ground on traditional conscious territory. In this study we demonstrate that the scope and impact of unconscious information on behavior and brain activity can be modulated dynamically on a trial-by-trial basis. Participants performed a Go/No-Go experiment in which an unconscious (masked) stimulus preceding a conscious target could be associated with either a Go or No-Go response. Importantly, the mapping of stimuli onto these actions varied on a trial-by-trial basis, preventing the formation of stable associations and hence the possibility that unconscious stimuli automatically activate these control actions. By eliminating stimulus-response associations established through practice we demonstrate that unconscious information can be processed in a flexible and adaptive manner. In this experiment we show that the same unconscious stimulus can have a substantially different effect on behavior and (prefrontal) brain activity depending on the rapidly changing task context in which it is presented. This work suggests that unconscious information processing shares many sophisticated characteristics (including flexibility and context-specificity) with its conscious counterpart.	[Wokke, Martijn E.; van Gaal, Simon; Scholte, H. Steven; Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands; [van Gaal, Simon] INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [van Gaal, Simon] Neurospin Ctr, Commissariat Energie Atom, Gif Sur Yvette, France; [Ridderinkhof, K. Richard] Univ Amsterdam, Dept Psychol, Amsterdam Ctr Study Adapt Control Brain & Behav A, Amsterdam, Netherlands; [Ridderinkhof, K. Richard; Lamme, Victor A. F.] Univ Amsterdam, Ctr Cognit Sci, Amsterdam, Netherlands	University of Amsterdam; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Amsterdam; University of Amsterdam	Wokke, ME (corresponding author), Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands.	martijnwokke@gmail.com	Wokke, Martijn/AAC-2774-2021; Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788; van Gaal, Simon/0000-0001-6628-4534	European Research Council (ERC); Netherlands Organization of Scientific Research (NWO)	European Research Council (ERC)(European Research Council (ERC)); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is supported by an Advanced Investigator Grant from the European Research Council (ERC), funding from the Netherlands Organization of Scientific Research (NWO) to VAFL, a Vici Grant from the Netherlands Organisation of Scientific Research (NWO) to KRR and a Rubicon Grant from the Netherlands Organisation of Scientific Research (NWO) to SvG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RL, 2000, PSYCHOL SCI, V11, P118, DOI 10.1111/1467-9280.00226; Ansorge U, 2005, J EXP PSYCHOL HUMAN, V31, P762, DOI 10.1037/0096-1523.31.4.762; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Bahrami B, 2008, PERCEPTION, V37, P1520, DOI 10.1068/p5999; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Damian MF, 2001, J EXP PSYCHOL HUMAN, V27, P154, DOI 10.1037/0096-1523.27.1.154; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Elsner K, 2008, CONSCIOUS COGN, V17, P657, DOI 10.1016/j.concog.2007.06.007; Fabre L, 2007, COGNITION, V105, P513, DOI 10.1016/j.cognition.2006.10.011; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Finkbeiner M, 2009, PSYCHOL SCI, V20, P42, DOI 10.1111/j.1467-9280.2008.02256.x; Forster KI, 2004, BRAIN LANG, V90, P276, DOI 10.1016/S0093-934X(03)00440-1; Greenwald AG, 2003, J EXP PSYCHOL LEARN, V29, P235, DOI 10.1037/0278-7393.29.2.235; GREENWALD AG, 1995, J EXP PSYCHOL GEN, V124, P22, DOI 10.1037/0096-3445.124.1.22; Hannula DE, 2005, NAT REV NEUROSCI, V6, P247, DOI 10.1038/nrn1630; Hughes G, 2009, PSYCHOPHYSIOLOGY, V46, P1258, DOI 10.1111/j.1469-8986.2009.00873.x; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Kentridge RW, 2008, NEUROPSYCHOLOGIA, V46, P864, DOI 10.1016/j.neuropsychologia.2007.11.036; Kentridge RW, 2004, NEUROPSYCHOLOGIA, V42, P831, DOI 10.1016/j.neuropsychologia.2003.11.001; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kiefer M, 2001, MEM COGNITION, V29, P100, DOI 10.3758/BF03195745; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Kiefer M, 2010, J EXP PSYCHOL GEN, V139, P464, DOI 10.1037/a0019561; Kouider S, 2009, EXP PSYCHOL, V56, P418, DOI 10.1027/1618-3169.56.6.418; Kunde W, 2003, COGNITION, V88, P223, DOI 10.1016/S0010-0277(03)00023-4; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; Lavric A, 2004, EUR J NEUROSCI, V20, P2483, DOI 10.1111/j.1460-9568.2004.03683.x; Lins Otavio G., 1993, Brain Topography, V6, P65, DOI 10.1007/BF01234128; Marzouki Y, 2007, ACTA PSYCHOL, V126, P34, DOI 10.1016/j.actpsy.2006.11.002; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Naccache L, 2001, COGNITION, V80, P215, DOI 10.1016/S0010-0277(00)00139-6; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; Nakamura K, 2007, P NATL ACAD SCI USA, V104, P19643, DOI 10.1073/pnas.0704487104; NEUMANN O, 1994, MOTOR RESPONSES NONR, P123; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; RIDDERINKHOF KR, WILEY INTER IN PRESS; Sumner P, 2006, P NATL ACAD SCI USA, V103, P10520, DOI 10.1073/pnas.0601974103; Van den Bussche E, 2008, CONSCIOUS COGN, V17, P1345, DOI 10.1016/j.concog.2007.08.005; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; van Gaal S, 2008, J NEUROSCI, V28, P8053, DOI 10.1523/JNEUROSCI.1278-08.2008; van Gaal S, 2011, J COGNITIVE NEUROSCI, V23, P91, DOI 10.1162/jocn.2010.21431; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; van Gaal S, 2009, J EXP PSYCHOL HUMAN, V35, P1129, DOI 10.1037/a0013551; VANOPSTAL F, 2010, CONSCIOUSNESS COGNIT; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054	53	31	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25729	10.1371/journal.pone.0025729	http://dx.doi.org/10.1371/journal.pone.0025729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21980530	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900093
J	Bowern, C; Epps, P; Gray, R; Hill, J; Hunley, K; McConvell, P; Zentz, J				Bowern, Claire; Epps, Patience; Gray, Russell; Hill, Jane; Hunley, Keith; McConvell, Patrick; Zentz, Jason			Does Lateral Transmission Obscure Inheritance in Hunter-Gatherer Languages?	PLOS ONE			English	Article							DIFFUSION	In recent years, linguists have begun to increasingly rely on quantitative phylogenetic approaches to examine language evolution. Some linguists have questioned the suitability of phylogenetic approaches on the grounds that linguistic evolution is largely reticulate due to extensive lateral transmission, or borrowing, among languages. The problem may be particularly pronounced in hunter-gatherer languages, where the conventional wisdom among many linguists is that lexical borrowing rates are so high that tree building approaches cannot provide meaningful insights into evolutionary processes. However, this claim has never been systematically evaluated, in large part because suitable data were unavailable. In addition, little is known about the subsistence, demographic, ecological, and social factors that might mediate variation in rates of borrowing among languages. Here, we evaluate these claims with a large sample of hunter-gatherer languages from three regions around the world. In this study, a list of 204 basic vocabulary items was collected for 122 hunter-gatherer and small-scale cultivator languages from three ecologically diverse case study areas: northern Australia, northwest Amazonia, and California and the Great Basin. Words were rigorously coded for etymological (inheritance) status, and loan rates were calculated. Loan rate variability was examined with respect to language area, subsistence mode, and population size, density, and mobility; these results were then compared to the sample of 41 primarily agriculturalist languages in [ 1]. Though loan levels varied both within and among regions, they were generally low in all regions (mean 5.06%, median 2.49%, and SD 7.56), despite substantial demographic, ecological, and social variation. Amazonian levels were uniformly very low, with no language exhibiting more than 4%. Rates were low but more variable in the other two study regions, in part because of several outlier languages where rates of borrowing were especially high. High mobility, prestige asymmetries, and language shift may contribute to the high rates in these outliers. No support was found for claims that hunter-gatherer languages borrow more than agriculturalist languages. These results debunk the myth of high borrowing in hunter-gatherer languages and suggest that the evolution of these languages is governed by the same type of rules as those operating in large-scale agriculturalist speech communities. The results also show that local factors are likely to be more critical than general processes in determining high (or low) loan rates.	[Bowern, Claire; Zentz, Jason] Yale Univ, Dept Linguist, New Haven, CT 06520 USA; [Epps, Patience] Univ Texas Austin, Dept Linguist, Austin, TX 78712 USA; [Gray, Russell] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Hill, Jane] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Hunley, Keith] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [McConvell, Patrick] Australian Natl Univ, Coll Arts & Social Sci, Canberra, ACT, Australia	Yale University; University of Texas System; University of Texas Austin; University of Auckland; University of Arizona; University of New Mexico; Australian National University	Bowern, C (corresponding author), Yale Univ, Dept Linguist, New Haven, CT 06520 USA.	claire.bowern@yale.edu	Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191; Bowern, Claire/0000-0002-9512-4393; Hunley, Keith/0000-0003-0987-8277	National Science Foundation [HSD-902114]	National Science Foundation(National Science Foundation (NSF))	The authors are funded by National Science Foundation grant HSD-902114. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikhenvald Alexandra Y., 2003, LANGUAGE CONTACT AMA; Alpher B., 1999, AUST J LINGUIST, V19, P5, DOI [10.1080/07268609908599573, DOI 10.1080/07268609908599573]; Atkinson QD, 2005, SYST BIOL, V54, P513, DOI 10.1080/10635150590950317; Balee W., 1992, CONSERVATION NEOTROP, P35; Bowern C, 2010, LANG LINGUIST COMPAS, V4, P665, DOI 10.1111/j.1749-818x.2010.00220.x; Bright W, STUDIES CALIFORNIAN; Callaghan Catherine A., 1964, STUDIES CALIFORNIAN, V34, P46; Campbell Lyle, 1997, AM INDIAN LANGUAGES; Crowley T., 2010, INTRO HIST LINGUISTI, V4th edn; Darwin C., 1871, P423; Darwin C, 1859, ORIGIN SPECIES MEANS; Dench Alan., 2001, AREAL DIFFUSION GENE, P105; Dixon R.M.W., 1997, RISE FALL LANGUAGES; Dixon Roland, 1919, U CALIFORNIA PUBLICA, V16, P47; Dunn M, 2005, SCIENCE, V309, P2072, DOI 10.1126/science.1114615; Elsik V, 2009, LOANWORDS IN THE WORLD'S LANGUAGES, P260, DOI 10.1515/9783110218442.260; Epps P, 2005, STUD LANG, V29, P617, DOI 10.1075/sl.29.3.04epp; Epps P, 2006, GRAMMARS CONTACT CRO, P267; Epps P, 2009, LANG LINGUIST COMPAS, V3, P581, DOI 10.1111/j.1749-818x.2009.00126.x; Fox Anthony, 1995, LINGUISTIC RECONSTRU; Friedlaender J, 2009, SCIENCE, V324, P464, DOI 10.1126/science.324_464c; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Haspelmath M., 2009, WORLD LOANWORD DATAB; Haspelmath M, LOANWORDS WORLDS LAN; HEATH J, 1981, LANGUAGE, V57, P335, DOI 10.2307/413694; Heath Jeffrey., 1978, LINGUISTIC DIFFUSION; HINTON L, 1991, INT J AM LINGUIST, V57, P133, DOI 10.1086/ijal.57.2.3519764; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson Jean. E., 1983, FISH PEOPLE LINGUIST; Laughren Mary., 2004, AUSTR LANGUAGES CLAS, P151; LAYTON R, 1986, MAN, V21, P18, DOI 10.2307/2802644; Lourandos H., 1997, CONTINENT HUNTER GAT; McConvell P, 2010, HDB LANGUAGE CONTACT, P770; McConvell P, 2009, LOANWORDS IN THE WORLD'S LANGUAGES, P790, DOI 10.1515/9783110218442.790; McMahon A, 1995, GENETICS, V141, P743; Meehan B, HUNTER GATHERER DEMO; Merriam CH, 1932, VOCABULARIES N AM IN, P167; Moravcsik E., 1975, WIENER LINGUISTISCHE, V8, P3; Muhlhausler P., 1996, LINGUISTIC ECOLOGY; Murdock GP, 1964, ETHNOGRAPHIC ATLAS; Nelson-Sathi S, 2011, P ROY SOC B-BIOL SCI, V278, P1794, DOI 10.1098/rspb.2010.1917; NETTLE DANIEL, 1999, LINGUISTIC DIVERSITY; Panter-Brick C, HUNTER GATHERERS INT; PETERSON JT, 1978, AM ANTHROPOL, V80, P335, DOI 10.1525/aa.1978.80.2.02a00050; Sapir Edward, 2014, LANGUAGE INTRO STUDY, P14, DOI 10.1016/j.livsci.2008.10.015; Swadesh Morris, 1971, ORIGIN DIVERSIFICATI; Tadmor U, 2010, DIACHRONICA, V27, P226, DOI 10.1075/dia.27.2.04tad; Thurston WR, 1987, PROCESSES CHANGE L B; Walker RS, 2011, P ROY SOC B-BIOL SCI, V278, P2562, DOI 10.1098/rspb.2010.2579; William Labov, 2001, PRINCIPLES LINGUISTI, V2; Wohlgemuth J, 2009, TRENDS LINGUIST-STUD, V211, P1, DOI 10.1515/9783110219340	53	53	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25195	10.1371/journal.pone.0025195	http://dx.doi.org/10.1371/journal.pone.0025195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	834BW	21980394	Green Published, gold			2022-12-27	WOS:000295933700020
J	Sun, L; Yau, HY; Lau, OC; Huang, Y; Yao, XQ				Sun, Lei; Yau, Ho-Yan; Lau, On-Chai; Huang, Yu; Yao, Xiaoqiang			Effect of Hydrogen Peroxide and Superoxide Anions on Cytosolic Ca2+: Comparison of Endothelial Cells from Large-Sized and Small-Sized Arteries	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR CALCIUM; DILATION; INVOLVEMENT; GENERATION; INCREASES	We compared the Ca2+ responses to reactive oxygen species (ROS) between mouse endothelial cells derived from large-sized arteries, aortas (aortic ECs), and small-sized arteries, mesenteric arteries (MAECs). Application of hydrogen peroxide (H2O2) caused an increase in cytosolic Ca2+ levels ([Ca2+](i)) in both cell types. The [Ca2+](i) rises diminished in the presence of U73122, a phospholipase C inhibitor, or Xestospongin C (XeC), an inhibitor for inositol-1,4,5-trisphosphate (IP3) receptors. Removal of Ca2+ from the bath also decreased the [Ca2+](i) rises in response to H2O2. In addition, treatment of endothelial cells with H2O2 reduced the [Ca2+](i) responses to subsequent challenge of ATP. The decreased [Ca2+](i) responses to ATP were resulted from a pre-depletion of intracellular Ca2+ stores by H2O2. Interestingly, we also found that Ca2+ store depletion was more sensitive to H2O2 treatment in endothelial cells of mesenteric arteries than those of aortas. Hypoxanthine-xanthine oxidase (HX-XO) was also found to induce [Ca2+](i) rises in both types of endothelial cells, the effect of which was mediated by superoxide anions and H2O2 but not by hydroxyl radical. H2O2 contribution in HX-XO-induced [Ca2+](i) rises were more significant in endothelial cells from mesenteric arteries than those from aortas. In summary, H2O2 could induce store Ca2+ release via phospholipase C-IP3 pathway in endothelial cells. Resultant emptying of intracellular Ca2+ stores contributed to the reduced [Ca2+](i) responses to subsequent ATP challenge. The [Ca2+](i) responses were more sensitive to H2O2 in endothelial cells of small-sized arteries than those of large-sized arteries.	[Sun, Lei] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Sun, L (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Yao, Xiaoqiang/I-5413-2016; Huang, Yu/K-2866-2017	Yao, Xiaoqiang/0000-0002-0687-8186; Huang, Yu/0000-0002-1277-6784; Lau, Eva On-Chai/0000-0001-7998-0061	Hong Kong Research Grant Council [CUHK477408, CUHK479109, CUHK478710]; Strategic Research Investment Scheme C; Li Ka Shing Institute of Health Sciences	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Strategic Research Investment Scheme C; Li Ka Shing Institute of Health Sciences	This work was supported by CUHK477408, CUHK479109 and CUHK478710 from the Hong Kong Research Grant Council, Strategic Research Investment Scheme C and Li Ka Shing Institute of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley RA, 2002, PEDIATR RES, V51, P472, DOI 10.1203/00006450-200204000-00012; Az-ma T, 1999, BRIT J PHARMACOL, V126, P1462, DOI 10.1038/sj.bjp.0702438; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; DOAN TN, 1994, BIOCHEM J, V297, P209, DOI 10.1042/bj2970209; DREHER D, 1995, J CELL PHYSIOL, V162, P147, DOI 10.1002/jcp.1041620118; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Graier WF, 1998, ARTERIOSCL THROM VAS, V18, P1470, DOI 10.1161/01.ATV.18.9.1470; Harmer AR, 2002, BIOCHEM J, V367, P137, DOI 10.1042/BJ20020305; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200; Hu QH, 1998, CIRCULATION, V97, P268, DOI 10.1161/01.CIR.97.3.268; Kimura C, 2000, AM J PHYSIOL-HEART C, V279, pH2310, DOI 10.1152/ajpheart.2000.279.5.H2310; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Liu YP, 2003, CIRC RES, V93, P573, DOI 10.1161/01.RES.0000091261.19387.AE; Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB; Owicki JC, 2000, J BIOMOL SCREEN, V5, P297, DOI 10.1177/108705710000500501; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; SiflingerBirnboim A, 1996, AM J PHYSIOL-LUNG C, V270, pL973, DOI 10.1152/ajplung.1996.270.6.L973; Thengchaisri N, 2003, AM J PHYSIOL-HEART C, V285, pH2255, DOI 10.1152/ajpheart.00487.2003; Thomas TW, 1998, CELL CALCIUM, V24, P285, DOI 10.1016/S0143-4160(98)90052-5; Volk T, 1997, MOL CELL BIOCHEM, V171, P11, DOI 10.1023/A:1006886215193; Wesson Donald E., 1995, Microcirculation (New York), V2, P195, DOI 10.3109/10739689509146767; Yang ZW, 1999, GEN PHARMACOL-VASC S, V33, P325, DOI 10.1016/S0306-3623(99)00019-1; Zheng Y, 2005, REDOX REP, V10, P29, DOI 10.1179/135100005X21660	27	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25432	10.1371/journal.pone.0025432	http://dx.doi.org/10.1371/journal.pone.0025432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966527	Green Published, gold, Green Submitted			2022-12-27	WOS:000295932100039
J	Sweeney, TE; Suliman, HB; Hollingsworth, JW; Welty-Wolf, KE; Piantadosi, CA				Sweeney, Timothy E.; Suliman, Hagir B.; Hollingsworth, John W.; Welty-Wolf, Karen E.; Piantadosi, Claude A.			A Toll-Like Receptor 2 Pathway Regulates the Ppargc1a/b Metabolic Co-Activators in Mice with Staphylococcal aureus Sepsis	PLOS ONE			English	Article							NF-KAPPA-B; MITOCHONDRIAL BIOGENESIS; IMMUNE-RESPONSE; ORGAN DYSFUNCTION; LIPOTEICHOIC ACID; ADAPTER MOLECULE; CUTTING EDGE; ACTIVATION; TLR4; INTERFERON	Activation of the host antibacterial defenses by the toll-like receptors (TLR) also selectively activates energy-sensing and metabolic pathways, but the mechanisms are poorly understood. This includes the metabolic and mitochondrial biogenesis master co-activators, Ppargc1a (PGC-1 alpha) and Ppargc1b (PGC-1 beta) in Staphylococcus aureus (S. aureus) sepsis. The expression of these genes in the liver is markedly attenuated in TLR2(-/-) mice and markedly accentuated in TLR4(-/-) mice compared with wild type (WT) mice. We sought to explain this difference by using specific TLR-pathway knockout mice to test the hypothesis that these co-activator genes are directly regulated through TLR2 signaling. By comparing their responses to S. aureus with WT mice, we found that MyD88-deficient and MAL-deficient mice expressed hepatic Ppargc1a and Ppargc1b normally, but that neither gene was activated in TRAM-deficient mice. Ppargc1a/b activation did not require NF-k beta, but did require an interferon response factor (IRF), because neither gene was activated in IRF-3/7 double-knockout mice in sepsis, but both were activated normally in Unc93b1-deficient (3d) mice. Nuclear IRF-7 levels in TLR2(-/-) and TLR4(-/-) mice decreased and increased respectively post-inoculation and IRF-7 DNA-binding at the Ppargc1a promoter was demonstrated by chromatin immunoprecipitation. Also, a TLR2-TLR4-TRAM native hepatic protein complex was detected by immunoprecipitation within 6 h of S. aureus inoculation that could support MyD88-independent signaling to Ppargc1a/b. Overall, these findings disclose a novel MyD88-independent pathway in S. aureus sepsis that links TLR2 and TLR4 signaling in innate immunity to Ppargc1a/b gene regulation in a critical metabolic organ, the liver, by means of TRAM, TRIF, and IRF-7.	[Sweeney, Timothy E.; Piantadosi, Claude A.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Suliman, Hagir B.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Hollingsworth, John W.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Hollingsworth, John W.; Welty-Wolf, Karen E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Sweeney, TE (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	piant001@mc.duke.edu		Sweeney, Timothy/0000-0002-3596-1093	National Institutes of Health [AI064769, ES016126, GM084116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health AI064769, ES016126, and GM084116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alvira CM, 2007, AM J RESP CRIT CARE, V175, P805, DOI 10.1164/rccm.200608-1162OC; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Cox KH, 2007, INFECT IMMUN, V75, P2638, DOI 10.1128/IAI.01320-06; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Demoulins T, 2009, VIROLOGY, V386, P225, DOI 10.1016/j.virol.2009.01.024; Dessing MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007993; Dewan MZ, 2003, J VIROL, V77, P5286, DOI 10.1128/JVI.77.9.5286-5294.2003; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hoshino K, 1999, J IMMUNOL, V162, P3749; Inden K, 2009, MICROBES INFECT, V11, P245, DOI 10.1016/j.micinf.2008.11.013; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kielian T, 2007, J IMMUNOL, V178, P4528, DOI 10.4049/jimmunol.178.7.4528; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Levy RJ, 2004, SHOCK, V21, P110, DOI 10.1097/01.shk.0000108400.56565.ab; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; Murphey ED, 2008, CRIT CARE MED, V36, P3067, DOI 10.1097/CCM.0b013e31818c6fb7; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Phelps CB, 2000, J BIOL CHEM, V275, P29840, DOI 10.1074/jbc.M004899200; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011606, 10.1371/journal.pone.0009518]; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001	62	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25249	10.1371/journal.pone.0025249	http://dx.doi.org/10.1371/journal.pone.0025249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966468	gold, Green Published, Green Submitted			2022-12-27	WOS:000295932100028
J	Wang, GY; Yang, Y; Li, H; Zhang, J; Jiang, N; Li, MR; Zhu, HB; Zhang, Q; Chen, GH				Wang, Guo-Ying; Yang, Yang; Li, Hua; Zhang, Jian; Jiang, Nan; Li, Min-Ru; Zhu, Huan-Bing; Zhang, Qi; Chen, Gui-Hua			A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PREOPERATIVE NEUTROPHIL; NEUTROPHIL/LYMPHOCYTE RATIO; CURATIVE RESECTION; COLORECTAL-CANCER; HEPATIC RESECTION; VASCULAR INVASION; GASTRIC-CANCER; POOR SURVIVAL; CRITERIA	Background: Neutrophil to lymphocyte ratio (NLR) has been proposed to predict prognosis of hepatocellular carcinoma (HCC). However, the cut-off values are empirical. We determined the optimal cut-off value to predict HCC recurrence after liver transplantation (LT) and further established a scoring model based on NLR. Methodology/Principal Findings: We analyzed the outcome of 101 HBV-associated HCC patients undergoing LT. Preoperative risk factors for tumor recurrence were evaluated by univariate analysis. By using ROC analysis, NLR >= 3 was considered elevated. The disease-free survival (DFS) and overall survival (OS) for patients with high NLR was significantly worse than that for patients with normal NLR (the 5-year DFS and OS of 28.5% and 19.5% vs. 64.9% and 61.8%, respectively; P, 0.001). Univariate analysis revealed that tumor size >5 cm, tumor number >3, macrovascular invasion, AFP >= 400 mu g/L, NLR >= 3, and HBV-DNA level >5 log 10 copies/mL were preoperative predictors of DFS. Cox regression analysis showed macrovascular invasion, tumor number, and high NLR were independent prognostic factors. We then established a preoperative prognostic score based on multivariate analysis. Each factor was given a score of 1. Area under the ROC curve of the score was 0.781. All nine patients with score 3 developed recurrence within 6 months after LT. Of 71 patients without vascular invasion, three patients with both tumor number >3 and NLR >= 3 developed recurrence within 14 months after LT while the 5-year DFS and OS for patients with a score of 0 or 1 were 68.1% and 62.8%, respectively. Conclusions/Significance: Preoperative elevated NLR significantly increases the risk of recurrence in patients underwent LT for HCC. Patients with both NLR >= 3 and tumor number >3 are not a good indication for LT. Our score model may aid in the selection of patients that would most benefit from transplantation for HCC.	[Wang, Guo-Ying; Yang, Yang; Li, Hua; Zhang, Jian; Jiang, Nan; Li, Min-Ru; Zhu, Huan-Bing; Chen, Gui-Hua] Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Qi; Chen, Gui-Hua] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wang, GY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China.	kee_kee@126.com; chgh1955@263.net	peng-cheng, chen/K-8100-2013	peng-cheng, chen/0000-0001-9763-6459; Zhang, Qi/0000-0001-9916-8919	Major State Basic Research Development Program of China (973 Program) [2009CB522404]; National Natural Science Foundation of China [30972914, 81000190, U0932006]; State Key Projects on Infection Diseases of China [2008ZX10002-025, 2008ZX10002-026]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Projects on Infection Diseases of China	This work was supported by the Major State Basic Research Development Program of China (973 Program) (No. 2009CB522404, http://www.most.gov.cn/kjjh/), the National Natural Science Foundation of China (No. 30972914, No. 81000190, and No. U0932006, http://www.nsfc.gov.cn/), and State Key Projects on Infection Diseases of China (2008ZX10002-025 and 026, http://www.most.gov.cn/kjjh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Amano H, 2005, J GASTROENTEROL, V40, P1158, DOI 10.1007/s00535-005-1715-8; Araki K, 2007, LIVER INT, V27, P716, DOI 10.1111/j.1478-3231.2007.01468.x; BERTUZZO VR, TRANSPLANTATION, V91, P1279; Chen GH, 2009, CHINESE MED J-PEKING, V122, P2229, DOI 10.3760/cma.j.issn.0366-6999.2009.19.006; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Cillo U, 2004, ANN SURG, V239, P150, DOI 10.1097/01.sla.0000109146.72827.76; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Duffy JP, 2007, ANN SURG, V246, P502, DOI 10.1097/SLA.0b013e318148c704; Freeman RB, 2006, LIVER TRANSPLANT, V12, P12, DOI 10.1002/lt.20664; GARCEA G, 2011, WORLD J SURG, V35, P1; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Gomez D, 2008, J SURG ONCOL, V97, P513, DOI 10.1002/jso.21001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Herrero JI, 2008, LIVER TRANSPLANT, V14, P272, DOI 10.1002/lt.21368; Ishizaki Y, 2008, J GASTROENTEROL, V43, P18, DOI 10.1007/s00535-007-2141-x; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kim HS, 2010, EJSO-EUR J SURG ONC, V36, P691, DOI 10.1016/j.ejso.2010.05.004; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Lohe F, 2007, CLIN TRANSPLANT, V21, P696, DOI 10.1111/j.1399-0012.2007.00707.x; Malik HZ, 2007, ANN SURG, V246, P806, DOI 10.1097/SLA.0b013e318142d964; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; McCormack L, 2005, EUR J GASTROEN HEPAT, V17, P497, DOI 10.1097/00042737-200505000-00005; Mohri Y, 2010, WORLD J SURG, V34, P285, DOI 10.1007/s00268-009-0302-1; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; SHARAIHA RZ, 2011, ANN SURG ONCOL; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Silva M, 2008, LIVER TRANSPLANT, V14, P1449, DOI 10.1002/lt.21576; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Toso C, 2009, HEPATOLOGY, V49, P832, DOI 10.1002/hep.22693; Ubukata H, 2010, J SURG ONCOL, V102, P742, DOI 10.1002/jso.21725; Unitt E, 2006, J HEPATOL, V45, P246, DOI 10.1016/j.jhep.2005.12.027; Vibert E, 2010, AM J TRANSPLANT, V10, P129, DOI 10.1111/j.1600-6143.2009.02750.x; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Yu DC, 2007, CLIN CANCER RES, V13, P3814, DOI 10.1158/1078-0432.CCR-06-2594; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	42	71	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25295	10.1371/journal.pone.0025295	http://dx.doi.org/10.1371/journal.pone.0025295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966488	Green Published, Green Submitted, gold			2022-12-27	WOS:000295932100033
J	Xiong, J; Miller, VM; Hunter, LW; Li, YM; Jayachandran, M				Xiong, Jing; Miller, Virginia M.; Hunter, Larry W.; Li, Yunman; Jayachandran, Muthuvel			Leukocyte- and Platelet-Derived Microvesicle Interactions following In Vitro and In Vivo Activation of Toll-Like Receptor 4 by Lipopolysaccharide	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; INFLAMMATION; AGGREGATION; MACROPHAGES; INVOLVEMENT; COAGULATION; EXPRESSION; INFECTION; CORRELATE	Background: Pro-coagulant membrane microvesicles (MV) derived from platelets and leukocytes are shed into the circulation following receptor-mediated activation, cell-cell interaction, and apoptosis. Platelets are sentinel markers of toll-like receptor 4 (TLR4) activation. Experiments were designed to evaluate the time course and mechanism of direct interactions between platelets and leukocytes following acute activation of TLR4 by bacterial lipopolysaccharide (LPS). Methodology/Principal Findings: Blood from age-matched male and female wild type (WT) and TLR4 gene deleted (dTLR4) mice was incubated with ultra-pure E. coli LPS (500 ng/ml) for up to one hour. At designated periods, leukocyte antigen positive platelets, platelet antigen positive leukocytes and cell-derived MV were quantified by flow cytometry. Numbers of platelet-or leukocyte-derived MV did not increase within one hour following in vitro exposure of blood to LPS. However, with LPS stimulation numbers of platelets staining positive for both platelet-and leukocyte-specific antigens increased in blood derived from WT but not dTLR4 mice. This effect was blocked by inhibition of TLR4 signaling mediated by My88 and TRIF. Seven days after a single intravenous injection of LPS (500 ng/mouse or 20 ng/gm body wt) to WT mice, none of the platelets stained for leukocyte antigen. However, granulocytes, monocytes and apoptotic bodies stained positive for platelet antigens. Conclusions/Significance: Within one hour of exposure to LPS, leukocytes exchange surface antigens with platelets through TLR4 activation. In vivo, leukocyte expression of platelet antigen is retained after a single exposure to LPS following turn over of the platelet pool. Acute expression of leukocyte antigen on platelets within one hour of exposure to LPS and the sustained expression of platelet antigen on leukocytes following a single acute exposure to LPS in vivo explains, in part, associations of platelets and leukocytes in response to bacterial infection and changes in thrombotic propensity of the blood.	[Xiong, Jing; Li, Yunman] China Pharmaceut Univ, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China; [Xiong, Jing; Miller, Virginia M.; Hunter, Larry W.] Mayo Clin, Dept Surg, Rochester, MN USA; [Miller, Virginia M.; Jayachandran, Muthuvel] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	China Pharmaceutical University; Mayo Clinic; Mayo Clinic	Xiong, J (corresponding author), China Pharmaceut Univ, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China.	miller.virginia@mayo.edu; yunmanlicpu@126.com	Jayachandran, Muthuvel/AAG-6532-2019	Jayachandran, Muthuvel/0000-0002-3007-0769; Xiong, Jing/0000-0002-9712-6771	American Heart Association [AHA30503Z]; Mayo Clinic; China Scholarship Council	American Heart Association(American Heart Association); Mayo Clinic; China Scholarship Council(China Scholarship Council)	This work was funded by grants from the American Heart Association AHA30503Z and the Mayo Clinic and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Baj-Krzyworzeka M, 2002, EXP HEMATOL, V30, P450, DOI 10.1016/S0301-472X(02)00791-9; Bernal-Mizrachi L, 2004, INT J CARDIOL, V97, P439, DOI 10.1016/j.ijcard.2003.10.029; Brogan PA, 2004, ARTHRITIS RHEUM, V50, P927, DOI 10.1002/art.20199; Cerletti C, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.023; Comfurius P, 1996, BIOCHEMISTRY-US, V35, P7631, DOI 10.1021/bi9606859; Corti R, 2004, J THROMB THROMBOLYS, V17, P35, DOI 10.1023/B:THRO.0000036027.39353.70; DACHARYPRIGENT J, 1995, BIOCHEMISTRY-US, V34, P11625, DOI 10.1021/bi00036a039; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; Eriksson M, 1998, ACTA ANAESTH SCAND, V42, P551, DOI 10.1111/j.1399-6576.1998.tb05165.x; Hashimoto K, 2009, J CARDIOVASC PHARM, V54, P57, DOI 10.1097/FJC.0b013e3181ab373d; Jayachandran M, 2009, CLIMACTERIC, V12, P177, DOI 10.1080/13697130802488607; Jayachandran M, 2011, J CARDIOVASC TRANSL, DOI 101007/s12265-011-9296-9; Jayachandran M, 2008, AM J PHYSIOL-HEART C, V295, pH931, DOI 10.1152/ajpheart.00193.2008; Jayachandran M, 2007, J APPL PHYSIOL, V102, P429, DOI 10.1152/japplphysiol.01576.2005; Jayachandran M, 2010, THROMB RES, V126, P414, DOI 10.1016/j.thromres.2009.05.005; Jayachandran M, 2010, AGE, V32, P109, DOI 10.1007/s11357-009-9119-y; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Kalvegren H, 2003, ARTERIOSCL THROM VAS, V23, P1677, DOI 10.1161/01.ATV.0000084810.52464.D5; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li XM, 2009, TEX HEART I J, V36, P134; Li ZY, 2011, THROMB RES, V127, P184, DOI 10.1016/j.thromres.2010.10.010; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; May AE, 2007, SEMIN THROMB HEMOST, V33, P123, DOI 10.1055/s-2007-969023; Mostefai HA, 2008, PHYSIOL RES, V57, P311, DOI 10.33549/physiolres.931533; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; Pasceri V, 2006, AM HEART J, V151, P1215, DOI 10.1016/j.ahj.2005.06.041; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Poltorak A, 2001, J IMMUNOL, V167, P2106, DOI 10.4049/jimmunol.167.4.2106; Premkumar Vummidigiridhar, 2010, BMC Chemical Biology, V10, P3, DOI 10.1186/1472-6769-10-3; Ratajczak MZ, 2009, BLOOD, V113, P981, DOI 10.1182/blood-2008-10-182964; Seizer P, 2008, CURR MED CHEM, V15, P1976, DOI 10.2174/092986708785132852; Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Spiewak R, 2008, ANN AGR ENV MED, V15, P153; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Turgut B, 2011, J NEUROL SCI, V305, P126, DOI 10.1016/j.jns.2011.02.026; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Varon David, 2009, Discov Med, V8, P237; Wang JG, 2009, J THROMB HAEMOST, V7, P1092, DOI 10.1111/j.1538-7836.2009.03448.x; Weerheim AM, 2002, ANAL BIOCHEM, V302, P191, DOI 10.1006/abio.2001.5552; Willershausen B, 2009, J ENDODONT, V35, P626, DOI 10.1016/j.joen.2009.01.012; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Xiong J, 2011, J CARDIOVASC PHARM, DOI 101097/FJC0b013e31820c6254; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zheng H, 2010, EUR J IMMUNOL, V40, P162, DOI 10.1002/eji.200839156	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25504	10.1371/journal.pone.0025504	http://dx.doi.org/10.1371/journal.pone.0025504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966536	Green Published, gold, Green Submitted			2022-12-27	WOS:000295932100044
J	Shuya, LL; Menkhorst, EM; Yap, J; Li, P; Lane, N; Dimitriadis, E				Shuya, Lorraine Lin; Menkhorst, Ellen Melaleuca; Yap, Joanne; Li, Priscilla; Lane, Natalie; Dimitriadis, Evdokia			Leukemia Inhibitory Factor Enhances Endometrial Stromal Cell Decidualization in Humans and Mice	PLOS ONE			English	Article							EARLY-PREGNANCY; LIF-RECEPTOR; MOUSE UTERUS; BLASTOCYST IMPLANTATION; EMBRYO IMPLANTATION; IN-VITRO; EXPRESSION; INTERLEUKIN-11; PROGESTERONE; DIFFERENTIATION	Adequate differentiation or decidualization of endometrial stromal cells (ESC) is critical for successful pregnancy in humans and rodents. Here, we investigated the role of leukemia inhibitory factor (LIF) in human and murine decidualization. Ex vivo human (H) ESC decidualization was induced by estrogen (E, 10(-8) M) plus medroxyprogesterone acetate (MPA, 10(-7) M). Exogenous LIF (>= 50 ng/ml) induced STAT3 phosphorylation in non-decidualized and decidualized HESC and enhanced E+MPA-induced decidualization (measured by PRL secretion, P<0.05). LIF mRNA in HESC was down-regulated by decidualization treatment (E+MPA) whereas LIF receptor (R) mRNA was up-regulated, suggesting that the decidualization stimulus 'primed' HESC for LIF action, but that factors not present in our in vitro model were required to induce LIF expression. Ex vivo first trimester decidual biopsies secreted >100 pg/mg G-CSF, IL6, IL8, and MCP1. Decidualized HESC secreted IL6, IL8, IL15 and MCP1. LIF (50 ng/ml) up-regulated IL6 and IL15 (P<0.05) secretion in decidualized HESC compared to 0.5 ng/ml LIF. In murine endometrium, LIF and LIFR immunolocalized to decidualized stromal cells on day 5 of gestation (day 0 = day of plug detection). Western blotting confirmed that LIF and the LIFR were up-regulated in intra-implantation sites compared to inter-implantation sites on Day 5 of gestation. To determine the role of LIF during in vivo murine decidualization, intra-peritoneal injections of a long-acting LIF antagonist (PEGLA; 900 or 1200 mu g) were given just post-attachment, during the initiation of decidualization on day 4. PEGLA treatment reduced implantation site decidual area (P<0.05) and desmin staining immuno-intensity (P<0.05) compared to control on day 6 of gestation. This study demonstrated that LIF was an important regulator of decidualization in humans and mice and data provides insight into the processes underlying decidualization, which are important for understanding implantation and placentation.	[Shuya, Lorraine Lin; Menkhorst, Ellen Melaleuca; Yap, Joanne; Li, Priscilla; Lane, Natalie; Dimitriadis, Evdokia] Prince Henrys Inst, Embryo Implantat Lab, Melbourne, Vic, Australia; [Shuya, Lorraine Lin; Dimitriadis, Evdokia] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia	Prince Henry's Institute of Medical Research; Monash University	Shuya, LL (corresponding author), Prince Henrys Inst, Embryo Implantat Lab, Melbourne, Vic, Australia.	evdokia.dimitriadis@princehenrys.org	Menkhorst, Ellen/P-5759-2014; Menkhorst, Ellen/AAU-4329-2021; dimitriadis, e/AAD-7601-2021	Menkhorst, Ellen/0000-0003-2440-6665; dimitriadis, eva/0000-0003-1425-950X; Dimitriadis, Eva/0000-0001-8698-1927	Consortium for Industrial Collaboration in Contraceptive Research, Eastern Virginia Medical School [CIG-07-116]; National Health and Medical Research Council (Australia) [550905, 611827]; Victorian (Australia) Government	Consortium for Industrial Collaboration in Contraceptive Research, Eastern Virginia Medical School; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian (Australia) Government	This work was supported by the Consortium for Industrial Collaboration in Contraceptive Research Program of the Contraceptive Research and Development Program, Eastern Virginia Medical School (Sub-project CIG-07-116), the National Health and Medical Research Council (Australia) fellowships to ED (#550905) and EM (#611827), and the Victorian (Australia) Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610; Aghajanova L, 2003, FERTIL STERIL, V79, P808, DOI 10.1016/S0015-0282(02)04830-6; Aghajanova L, 2009, FERTIL STERIL, V91, P2602, DOI 10.1016/j.fertnstert.2008.04.010; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; CHARNOCKJONES DS, 1994, J REPROD FERTIL, V101, P421; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Dimitriadis E, 2006, ENDOCRINOLOGY, V147, P3809, DOI 10.1210/en.2006-0264; Ding T, 2008, REPRODUCTION, V135, P41, DOI 10.1530/REP-07-0013; Evans J, 2009, FASEB J, pfj08; Fairlie WD, 2004, J BIOL CHEM, V279, P2125, DOI 10.1074/jbc.M310103200; Garcia MG, 2007, PLACENTA, V28, P650, DOI 10.1016/j.placenta.2006.09.010; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Jones RL, 2002, J CLIN ENDOCR METAB, V87, P4001, DOI 10.1210/jc.87.8.4001; Kitaya K, 2000, BIOL REPROD, V63, P683, DOI 10.1095/biolreprod63.3.683; Marwood M, 2009, ENDOCRINOLOGY, V150, P2915, DOI 10.1210/en.2008-1538; MASLAR IA, 1979, AM J OBSTET GYNECOL, V135, P751, DOI 10.1016/0002-9378(79)90386-7; Menkhorst E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019665; Menkhorst E, 2009, BIOL REPROD, V80, P920, DOI 10.1095/biolreprod.108.073601; Mohamet L, 2009, REPRODUCTION, V138, P827, DOI 10.1530/REP-09-0113; Nakajima S, 2003, INT J MOL MED, V11, P353; Nashta AAF, 2004, J ENDOCRINOL, V181, P477, DOI 10.1677/joe.0.1810477; Ni H, 2002, MOL REPROD DEV, V63, P143, DOI 10.1002/mrd.10168; Nilsson U, 2010, REPROD FERT DEVELOP, V22, P71; Okada S, 2000, MOL HUM REPROD, V6, P75, DOI 10.1093/molehr/6.1.75; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Sawai K, 1997, BIOL REPROD, V56, P1274, DOI 10.1095/biolreprod56.5.1274; Sharkey AM, 1999, BIOL REPROD, V60, P355, DOI 10.1095/biolreprod60.2.355; Simpson KJ, 2000, J BIOL CHEM, V275, P23074, DOI 10.1074/jbc.M002161200; Song G, 2009, REPRODUCTION, V137, P553, DOI 10.1530/REP-08-0437; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; YANG ZM, 1995, MOL REPROD DEV, V42, P407, DOI 10.1002/mrd.1080420406	44	66	70	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25288	10.1371/journal.pone.0025288	http://dx.doi.org/10.1371/journal.pone.0025288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966484	Green Published, gold			2022-12-27	WOS:000295267100040
J	Wong, M; Hackeman, E; Hurd, C; Goldreich, D				Wong, Michael; Hackeman, Erik; Hurd, Caitlin; Goldreich, Daniel			Short-Term Visual Deprivation Does Not Enhance Passive Tactile Spatial Acuity	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; BLIND BRAILLE READERS; CUTANEOUS SENSITIVITY; SENSORY DEPRIVATION; GRATING ORIENTATION; CONGENITALLY BLIND; LIGHT DEPRIVATION; HUMANS; DISCRIMINATION; RESOLUTION	An important unresolved question in sensory neuroscience is whether, and if so with what time course, tactile perception is enhanced by visual deprivation. In three experiments involving 158 normally sighted human participants, we assessed whether tactile spatial acuity improves with short-term visual deprivation over periods ranging from under 10 to over 110 minutes. We used an automated, precisely controlled two-interval forced-choice grating orientation task to assess each participant's ability to discern the orientation of square-wave gratings pressed against the stationary index finger pad of the dominant hand. A two-down one-up staircase (Experiment 1) or a Bayesian adaptive procedure (Experiments 2 and 3) was used to determine the groove width of the grating whose orientation each participant could reliably discriminate. The experiments consistently showed that tactile grating orientation discrimination does not improve with short-term visual deprivation. In fact, we found that tactile performance degraded slightly but significantly upon a brief period of visual deprivation (Experiment 1) and did not improve over periods of up to 110 minutes of deprivation (Experiments 2 and 3). The results additionally showed that grating orientation discrimination tends to improve upon repeated testing, and confirmed that women significantly outperform men on the grating orientation task. We conclude that, contrary to two recent reports but consistent with an earlier literature, passive tactile spatial acuity is not enhanced by short-term visual deprivation. Our findings have important theoretical and practical implications. On the theoretical side, the findings set limits on the time course over which neural mechanisms such as crossmodal plasticity may operate to drive sensory changes; on the practical side, the findings suggest that researchers who compare tactile acuity of blind and sighted participants should not blindfold the sighted participants.	[Wong, Michael; Goldreich, Daniel] McMaster Univ, McMaster Integrat Neurosci Discovery & Study, Hamilton, ON, Canada; [Hackeman, Erik; Goldreich, Daniel] Duquesne Univ, Dept Occupat Therapy, Pittsburgh, PA 15219 USA; [Hurd, Caitlin; Goldreich, Daniel] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University; Duquesne University; McMaster University	Wong, M (corresponding author), McMaster Univ, McMaster Integrat Neurosci Discovery & Study, Hamilton, ON, Canada.	goldrd@mcmaster.ca	Wong, Michael/AAU-3088-2021	Wong, Michael/0000-0002-8491-4787; Goldreich, Daniel/0000-0002-5104-2185	National Eye Institute [R15 EY13649-01]; Natural Sciences and Engineering Research Council of Canada; NATIONAL EYE INSTITUTE [R15EY013649] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by grants to DG from the National Eye Institute (R15 EY13649-01) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary F, 2008, EXP BRAIN RES, V187, P587, DOI 10.1007/s00221-008-1327-7; Bhattacharjee A, 2010, J NEUROSCI, V30, P14288, DOI 10.1523/JNEUROSCI.1447-10.2010; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; COHEN SI, 1962, J PSYCHOSOM RES, V6, P259, DOI 10.1016/0022-3999(62)90037-5; Craig JC, 1999, SOMATOSENS MOT RES, V16, P197, DOI 10.1080/08990229970456; Craig JC, 2000, CURR DIR PSYCHOL SCI, V9, P29, DOI 10.1111/1467-8721.00054; CULVER CM, 1964, ANONYMOUS RECENT ADV, P119; DOANE BK, 1959, CAN J PSYCHOLOGY, V13, P210, DOI 10.1037/h0083772; Facchini S, 2003, NEUROLOGY, V60, P1998, DOI 10.1212/01.WNL.0000068026.15208.D0; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Goldreich D, 2003, J NEUROSCI, V23, P3439; GOLDREICH D, 2009, J VIS EXP, V28, P1374; Goldreich D, 2006, PERCEPT PSYCHOPHYS, V68, P1363, DOI 10.3758/BF03193735; HYLLIENMARK L, 1995, DIABETOLOGIA, V38, P685, DOI 10.1007/s001250050338; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; KAMCHATNOV V P, 1962, Zh Vyssh Nerv Deiat Im I P Pavlova, V12, P37; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Legge GE, 2008, PERCEPT PSYCHOPHYS, V70, P1471, DOI 10.3758/PP.70.8.1471; Leon-Sarmiento FE, 2008, NEUROSCI LETT, V441, P332, DOI 10.1016/j.neulet.2008.06.016; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; NAGATSUKA Y, 1963, TOHOKU PSYCHOL FOLIA, V22, P5; NAGATSUKA Y, 1964, TOHOKU PSYCHOL FOLIA, V22, P64; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P2323, DOI 10.3758/s13414-011-0160-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peters RM, 2009, J NEUROSCI, V29, P15756, DOI 10.1523/JNEUROSCI.3684-09.2009; Pitskel NB, 2007, NEUROREPORT, V18, P1703, DOI 10.1097/WNR.0b013e3282f0d2c1; POLLARD JC, 1963, ARCH GEN PSYCHIAT, V8, P435; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; REITMAN EE, 1964, J ABNORM SOC PSYCH, V68, P168, DOI 10.1037/h0046252; Sadato N, 2004, NEUROSCI LETT, V359, P49, DOI 10.1016/j.neulet.2004.02.005; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 1997, PERCEPT PSYCHOPHYS, V59, P119, DOI 10.3758/BF03206854; Stevens JC, 1996, J EXP PSYCHOL-APPL, V2, P91, DOI 10.1037/1076-898X.2.2.91; Taylor-Clarke M, 2004, NEUROSCI LETT, V354, P22, DOI 10.1016/j.neulet.2003.09.068; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; Van Boven RW, 2000, NEUROLOGY, V54, P2230; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Weisser V, 2005, EXP BRAIN RES, V166, P572, DOI 10.1007/s00221-005-2397-4; Wong M, 2011, J NEUROSCI, V31, P7028, DOI 10.1523/JNEUROSCI.6461-10.2011; Zubek J. P., 1969, SENSORY DEPRIVATION; ZUBEK JOHN P., 1964, PERCEPT MOT SKILLS, V18, P413; ZUBEK JP, 1964, PSYCHON SCI, V1, P283, DOI 10.3758/BF03342913; ZUBEK JP, 1964, SCIENCE, V144, P1591, DOI 10.1126/science.144.3626.1591	51	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25277	10.1371/journal.pone.0025277	http://dx.doi.org/10.1371/journal.pone.0025277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966478	Green Submitted, gold, Green Published			2022-12-27	WOS:000295267100038
J	Gould, NS; Min, E; Day, BJ				Gould, Neal S.; Min, Elysia; Day, Brian J.			Macropinocytosis of Extracellular Glutathione Ameliorates Tumor Necrosis Factor alpha Release in Activated Macrophages	PLOS ONE			English	Article							RESPIRATORY BURST; TOBACCO-SMOKE; LUNG; FLUID; MECHANISMS; RESPONSES; GAMMA; PHAGOCYTOSIS; DEFENSE; STATE	A number of inflammatory lung diseases have abnormally low glutathione (GSH) levels in the airway fluids. Lung macrophages are common mediators of inflammation, make up the majority of cells that are found in the airway epithelial lining fluid (ELF), and are commonly elevated in many lung diseases. Several animal models with altered ELF GSH levels are associated with similar alterations in the intracellular GSH levels of bronchoalveolar lavage (BAL) cells. The possible mechanisms and outcomes for this association between ELF GSH levels and intracellular BAL cell GSH are unknown. To investigate these issues, macrophages were grown in media supplemented with 500 mu M GSH. GSH supplementation resulted in a 2-3 fold increase in macrophage intracellular GSH levels. The increase in macrophage intracellular GSH levels was associated with a significant reduction in NF-kappa B nuclear translocation and tumor necrosis factor alpha (TNF alpha) release upon LPS stimulation. Furthermore, co-treatment of macrophages with GSH and inhibitors of GSH breakdown or synthesis did not block GSH accumulation. In contrast, treatment with cytochalasin D, an inhibitor of actin dependent endocytosis, and amiloride, an inhibitor of macropinocytosis blocked, at least in part, GSH uptake. Furthermore, using two cigarette smoke exposure paradigms that result in two different GSH levels in the ELF and thus in the BAL cells resulted in modulation of cytokine release when stimulated with LPS ex vivo. These data suggest that macrophages are able to utilize extracellular GSH which can then modulate inflammatory signaling in response to proinflammatory stimuli. This data also suggests the lung can modulate inflammatory responses triggered by proinflammatory stimuli by altering ELF GSH levels and may help explain the dysregulated inflammation associated with lung diseases that have low ELF GSH levels.	[Gould, Neal S.; Min, Elysia; Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Gould, Neal S.; Day, Brian J.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO USA; [Day, Brian J.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Day, Brian J.] Univ Colorado Denver, Dept Immunol, Aurora, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Gould, NS (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	dayb@njhealth.org			National Institutes of Health [HL084469]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part from National Institutes of Health grant HL084469 to BJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alam K, 2010, J IMMUNOL, V184, P2918, DOI 10.4049/jimmunol.0900439; Allen TC, 2010, ARCH PATHOL LAB MED, V134, P702, DOI 10.1043/1543-2165-134.5.702; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Bishop C, 2005, CHEST, V127, P308, DOI 10.1378/chest.127.1.308; Brennan S, 2009, EUR RESPIR J, V34, P655, DOI 10.1183/09031936.00178508; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; BUHL R, 1990, P NATL ACAD SCI USA, V87, P4063, DOI 10.1073/pnas.87.11.4063; CANTIN AM, 1991, LUNG, V169, P123, DOI 10.1007/BF02714149; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004; Dobashi K, 2001, CLIN EXP IMMUNOL, V124, P290, DOI 10.1046/j.1365-2249.2001.01535.x; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Eun JS, 2000, ARCH PHARM RES, V23, P531, DOI 10.1007/BF02976585; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Ghezzi P, 2011, INT J GEN MED, V4, P105, DOI 10.2147/IJGM.S15618; Gosset P, 1999, EUR RESPIR J, V14, P98, DOI 10.1034/j.1399-3003.1999.14a17.x; Gould NS, 2011, BIOCHEM PHARMACOL, V81, P187, DOI 10.1016/j.bcp.2010.10.001; Gould NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-119; GOULD NS, 2010, AM J RESP CRIT CARE; Griese M, 2004, AM J RESP CRIT CARE, V169, P822, DOI 10.1164/rccm.200308-1104OC; Haddad JJ, 2001, EUR CYTOKINE NETW, V12, P614; Haddad JJ, 2002, BIOCHEM PHARMACOL, V63, P305, DOI 10.1016/S0006-2952(01)00870-X; Haddad JJ, 2000, CYTOKINES CELL MOL T, V6, P177, DOI 10.1080/mccm.6.4.177.187; Hashimoto S, 2001, CLIN EXP ALLERGY, V31, P144, DOI 10.1046/j.1365-2222.2001.00967.x; Iyer SS, 2009, AM J PHYSIOL-LUNG C, V296, pL37, DOI 10.1152/ajplung.90401.2008; Kariya C, 2008, INFECT IMMUN, V76, P4455, DOI 10.1128/IAI.00136-08; Kelly F J, 1996, Cent Eur J Public Health, V4 Suppl, P11; Kinnula VL, 2002, ANTIOXID REDOX SIGN, V4, P27, DOI 10.1089/152308602753625825; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lensmar C, 1998, EUR RESPIR J, V12, P595, DOI 10.1183/09031936.98.12030595; MORRIS PE, 1994, AM J MED SCI, V307, P119, DOI 10.1097/00000441-199402000-00010; Ng AW, 2004, LUNG, V182, P297, DOI 10.1007/s00408-004-2511-6; Pietarinen-Runtti P, 2000, AM J PHYSIOL-CELL PH, V278, pC118, DOI 10.1152/ajpcell.2000.278.1.C118; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Rottner M, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-23; Seres T, 2000, J IMMUNOL, V165, P3333, DOI 10.4049/jimmunol.165.6.3333; Sixt Stephan Urs, 2010, Proc Am Thorac Soc, V7, P91, DOI 10.1513/pats.200906-035JS; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; TERAMOTO S, 1994, LUNG, V172, P223, DOI 10.1007/BF00164439; Tetley Teresa D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P607, DOI 10.2174/156801005774912824; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Willemse BWM, 2004, EUR RESPIR J, V24, P391, DOI 10.1183/09031936.04.00117603	46	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25704	10.1371/journal.pone.0025704	http://dx.doi.org/10.1371/journal.pone.0025704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991336	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000057
J	Kittinger, JN; Pandolfi, JM; Blodgett, JH; Hunt, TL; Jiang, H; Maly, K; McClenachan, LE; Schultz, JK; Wilcox, BA				Kittinger, John N.; Pandolfi, John M.; Blodgett, Jonathan H.; Hunt, Terry L.; Jiang, Hong; Maly, Kepa; McClenachan, Loren E.; Schultz, Jennifer K.; Wilcox, Bruce A.			Historical Reconstruction Reveals Recovery in Hawaiian Coral Reefs	PLOS ONE			English	Article							HUMAN IMPACTS; CLIMATE-CHANGE; ENVIRONMENT; COLLAPSE; ECOLOGY; SUSTAINABILITY; CONSERVATION; AGRICULTURE; DEGRADATION; LANDSCAPE	Coral reef ecosystems are declining worldwide, yet regional differences in the trajectories, timing and extent of degradation highlight the need for in-depth regional case studies to understand the factors that contribute to either ecosystem sustainability or decline. We reconstructed social-ecological interactions in Hawaiian coral reef environments over 700 years using detailed datasets on ecological conditions, proximate anthropogenic stressor regimes and social change. Here we report previously undetected recovery periods in Hawaiian coral reefs, including a historical recovery in the MHI (similar to AD 1400-1820) and an ongoing recovery in the NWHI (similar to AD 1950-2009+). These recovery periods appear to be attributed to a complex set of changes in underlying social systems, which served to release reefs from direct anthropogenic stressor regimes. Recovery at the ecosystem level is associated with reductions in stressors over long time periods (decades+) and large spatial scales (>10(3) km(2)). Our results challenge conventional assumptions and reported findings that human impacts to ecosystems are cumulative and lead only to long-term trajectories of environmental decline. In contrast, recovery periods reveal that human societies have interacted sustainably with coral reef environments over long time periods, and that degraded ecosystems may still retain the adaptive capacity and resilience to recover from human impacts.	[Kittinger, John N.; Jiang, Hong] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Pandolfi, John M.; Blodgett, Jonathan H.] Univ Queensland, Ctr Marine Sci, Sch Biol Sci, Australian Res Council Ctr Excellence Coral Reef, Brisbane, Qld, Australia; [Hunt, Terry L.] Univ Hawaii Manoa, Dept Anthropol, Honolulu, HI 96822 USA; [Maly, Kepa] Kumu Pono Associates LLC, Lanai City, HI USA; [McClenachan, Loren E.] Simon Fraser Univ, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Schultz, Jennifer K.] Univ Hawaii, Hawaii Inst Marine Biol, Sch Ocean & Earth Sci & Technol, Kaneohe, HI USA; [Wilcox, Bruce A.] Univ Hawaii, Off Publ Hlth Studies, Global Hlth Program, Honolulu, HI 96822 USA; [Kittinger, John N.; Schultz, Jennifer K.; Wilcox, Bruce A.] Univ Hawaii Manoa, Natl Sci Fdn Integrated Grad Educ Res & Training, Program Ecol Conservat & Pathogen Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Queensland; University of Hawaii System; University of Hawaii Manoa; Simon Fraser University; University of Hawaii System; University of Hawaii System; National Science Foundation (NSF); University of Hawaii System; University of Hawaii Manoa	Kittinger, JN (corresponding author), Stanford Univ, Ctr Ocean Solut, Woods Inst Environm, Monterey, CA 92109 USA.	jkittinger@gmail.com	Pandolfi, John M/A-3121-2009	Pandolfi, John M/0000-0003-3047-6694	Institute for Ocean Conservation Science (PI); National Science Foundation [0926768, 0549514]; Australian Research Council's Centre of Excellence for Coral Reef Studies (PI); Marine Conservation Biology Institute; Division Of Behavioral and Cognitive Sci [0926768] Funding Source: National Science Foundation	Institute for Ocean Conservation Science (PI); National Science Foundation(National Science Foundation (NSF)); Australian Research Council's Centre of Excellence for Coral Reef Studies (PI)(Australian Research Council); Marine Conservation Biology Institute; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by the Institute for Ocean Conservation Science (PI Wilcox), the National Science Foundation (#0926768, PI Jiang-Kittinger and # 0549514, PI Wilcox), the Australian Research Council's Centre of Excellence for Coral Reef Studies (PI Pandolfi), and the Marine Conservation Biology Institute's 2008 Mia J. Tegner Memorial Research Grant in Marine Environmental History and Historical Marine Ecology (PI Kittinger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kepa Maly is an employee of Kumu Pono Associates and contributed to the study.	Allen MS, 2007, CORAL REEFS, V26, P959, DOI 10.1007/s00338-007-0234-x; Anderson A, 2002, WORLD ARCHAEOL, V33, P375, DOI 10.1080/00438240120107431; Balazs GH, 2004, BIOL CONSERV, V117, P491, DOI 10.1016/j.biocon.2003.08.008; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; Bohnsack J.A., 2002, P615; Burney DA, 2001, ECOL MONOGR, V71, P615, DOI 10.1890/0012-9615(2001)071[0615:FEFADB]2.0.CO;2; CHIU MY, 2002, NZ J ARCHAEOLOGY, V24, P61; Cinner JE, 2007, BIOL CONSERV, V140, P201, DOI 10.1016/j.biocon.2007.08.008; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; CLIFFORD DM, 1991, THESIS PRINCETON U; Costanza R, 2007, AMBIO, V36, P522, DOI 10.1579/0044-7447(2007)36[522:SOCWCW]2.0.CO;2; Cronon William, 1983, CHANGES LAND INDIANS; CULLINEY JL, 2006, ISLANDS FAR SEA FATE; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; DINARDO GT, 2006, ATOLL RES B, V543; Dixon B., 1999, ASIAN PERSPECT, V38, P229; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dye T., 1992, NZ J ARCHAEOL, V14, P113; Eddy TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013670; Field JS, 2011, P NATL ACAD SCI USA, V108, P7327, DOI 10.1073/pnas.1103805108; Foale S, 2011, FISH FISH, V12, P357, DOI 10.1111/j.1467-2979.2010.00395.x; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Goto A., 1986, THESIS U HAWAII HONO; Goto A., 1990, MAN CULTURE OCEANIA, V6, P1; Grayson D.K., 1984, QUANTITATIVE ZOOARCH; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Grayson DK, 1981, J ETHNOBIOL, V1, P28; GRIFFIN PB, 1984, HAWAIIAN ARCHAEOLOGY, V1, P1; GRIGG RW, 1984, UNIHISEAGRANTMR8401; GRIGG RW, 1980, UNIHISEAGRANTMR8004; HAMMATT HH, 1978, ARCHAEOLOGICAL INVES; Handy Elizabeth Green, 1972, NATIVE PLANTERS OLD; Hardt MJ, 2009, FISH FISH, V10, P143, DOI 10.1111/j.1467-2979.2008.00308.x; HAU S, 1984, UNIHISEAGRANTMR8401; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; IVERSON RTB, 1990, NATIVE HAWAIIAN FISH; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JAMES HF, 1987, P NATL ACAD SCI USA, V84, P2350, DOI 10.1073/pnas.84.8.2350; Johannes RE., 2002, SPC TRADITIONAL MARI, V14, P3; JONES S, 2007, HAWAIIAN ARCHAEOLOGY, V11, P39; KALAKAUA D, 1869, HAWAIIAN ETHNOLOGICA, V2, P241; Kamakau S.M., 1976, WORKS PEOPLE OLD NA; Kamakau Samuel M., 1961, RULING CHIEFS HAWAII; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; KIKILOI K, 2010, COMMUNICATION; KIKILOI K, 2010, MULTIDISPLINARY RES, V6, P73; Kirch P.V., 1997, HIST ECOLOGY PACIFIC; Kirch P.V., 1975, PREHISTORY ECOLOGY W, V24; Kirch P.V., 1985, FEATHERED GODS FISHH; Kirch PV, 2007, J POLYNESIAN SOC, V116, P385; Kirch PV, 2007, AM ANTHROPOL, V109, P8, DOI 10.1525/AA.2007.109.1.8; Kirch Patrick V., 2010, CHIEFS BECAME KINGS; KIRCH PV, 1982, HUM ECOL, V10, P455, DOI 10.1007/BF01531167; Kirch PV, 2005, WORLD ARCHAEOL, V37, P240, DOI 10.1080/00438240500095074; Kirch PV, 2005, SCIENCE, V307, P102, DOI 10.1126/science.1105432; Kirch PV, 2004, P NATL ACAD SCI USA, V101, P9936, DOI 10.1073/pnas.0403470101; Kirch PV, 2003, WORLD ARCHAEOL, V34, P484, DOI 10.1080/0043824021000026468; KIRCH PV, 1980, AM SCI, V68, P39; KIRCH PV, 1979, 29 DEP ANTHR; Kittinger JN, 2010, MAR POLICY, V34, P208, DOI 10.1016/j.marpol.2009.06.007; Kuykendall Ralph, 1938, HAWAIIAN KINGDOM, V1; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Malo D., 1951, HAWAIIAN ANTIQUITIES; MARAGOS JE, 1993, COAST MANAGE, V21, P235, DOI 10.1080/08920759309362207; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Mccoy MD, 2008, PAC SCI, V62, P21, DOI 10.2984/1534-6188(2008)62[21:HLHIHP]2.0.CO;2; MILLER GM, 1989, THESIS U HAWAII MANO; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Morrison AE, 2007, PAC SCI, V61, P325, DOI 10.2984/1534-6188(2007)61[325:HIOTNE]2.0.CO;2; NORDYKE EC, 1989, PEOPLING HAWAII; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pooley SG, 1993, US NMFS MAR FISH REV, V55, P7; RALSTON C, 1984, J PAC HIST, V19, P21, DOI 10.1080/00223348408572478; Ralston C., 1978, GRASS HUTS WAREHOUSE; Rieth TM, 2011, J ARCHAEOL SCI, V38, P2740, DOI 10.1016/j.jas.2011.06.017; Robinson J. A., 2010, NATURAL EXPT HIST; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; SCHILT R, 1984, 841 DEP ANTHR; Schultz Jennifer K., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/749131; Seaton S. Lee, 1974, AM ETHNOL, V1, P193, DOI DOI 10.1525/AE.1974.1.1.02A00100; Smith EA, 2000, ANNU REV ANTHROPOL, V29, P493, DOI 10.1146/annurev.anthro.29.1.493; Smith EA., 1992, EVOL ANTHROPOL, V1, P20; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Stern PC, 1992, GLOBAL ENV CHANGE UN; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Titcomb M., 1972, NATIVE USE FISH HAWA; TOMONARITUGGLE MJ, 2000, ARCHAEOLOGY S COAST, V1; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; TURNER BL, 1990, GLOBAL ENVIRON CHANG, V1, P14, DOI 10.1016/0959-3780(90)90004-S; Vitousek P, 2006, J ECOL, V94, P510, DOI 10.1111/j.1365-2745.2006.01119.x; Vitousek PM, 2004, SCIENCE, V304, P1665, DOI 10.1126/science.1099619; WATSON TK, 2011, AQUATIC MAM IN PRESS, V37; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51	107	63	64	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25460	10.1371/journal.pone.0025460	http://dx.doi.org/10.1371/journal.pone.0025460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	21991311	Green Published, gold			2022-12-27	WOS:000295943000030
J	Tsuchiya, M; Ogawa, H; Suzuki, T; Sugiyama, N; Haraguchi, T; Hiraoka, Y				Tsuchiya, Megumi; Ogawa, Hidesato; Suzuki, Taiga; Sugiyama, Noriyuki; Haraguchi, Tokuko; Hiraoka, Yasushi			Exportin 4 Interacts with Sox9 through the HMG Box and Inhibits the DNA Binding of Sox9	PLOS ONE			English	Article							AUTOSOMAL SEX REVERSAL; NUCLEAR-LOCALIZATION SIGNALS; SRY-RELATED GENE; TRANSCRIPTION FACTORS; CAMPOMELIC DYSPLASIA; COLLAGEN GENE; ASSOCIATION; PROTEINS; CHONDROGENESIS; EXPRESSION	Sox9 is a transcription factor that is required for tissue development in mammals. In general, such transcription factors require co-regulators for precise temporal and spatial control of the activation and inactivation of the numerous genes necessary for precise development during embryogenesis. Here we identify a new Sox9 co-regulator: Using affinity chromatography with immobilized Sox9 protein, we identified exportin 4 (Exp4) as an interacting protein of Sox9 in human cultured cells. Interaction between endogenous Exp4 and Sox9 proteins was confirmed in the human osteosarcoma U2OS cells by immunoprecipitation experiments using anti-Sox9 antibody. siRNA depletion of Exp4 enhanced transcription of Sox9 target genes in U2OS cells, but did not affect nuclear localization of Sox9. These results suggest that Exp4 regulates Sox9 activity in the nucleus. Furthermore we found that the HMG box of Sox9 was responsible for binding to Exp4, and the HMG box was required for suppression of Sox9-mediated transcription. This contrasts with the known Sox9 co-regulators which bind to its transcriptional activation domain. Chromatin immunoprecipitation analyses revealed that Exp4 prevents Sox9 binding to the enhancers of its target genes. These results demonstrate that Exp4 acts as a Sox9 co-regulator that directly regulates binding of Sox9 to its target genes.	[Tsuchiya, Megumi; Ogawa, Hidesato; Haraguchi, Tokuko; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tsuchiya, Megumi; Ogawa, Hidesato] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Sex Differentiat, Okazaki, Aichi 4448585, Japan; [Ogawa, Hidesato; Haraguchi, Tokuko; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo, Japan; [Suzuki, Taiga] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Sugiyama, Noriyuki] Kyoto Prefectural Univ Med, Kyoto, Japan	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institute of Information & Communications Technology (NICT) - Japan; University of California System; University of California Santa Barbara; Kyoto Prefectural University of Medicine	Tsuchiya, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	hidesato@nict.go.jp; hiraoka@fbs.osaka-u.ac.jp	Hiraoka, Yasushi/B-5111-2009; Ogawa, Hidesato/A-2079-2016; Ogawa, Hidesato/M-3778-2019	Hiraoka, Yasushi/0000-0001-9407-8228; Ogawa, Hidesato/0000-0001-9740-9010	Japan Ministry of Education, Culture, Sports, Science and Technology [23570219, 21370094, 20114002, 23114724]; Grants-in-Aid for Scientific Research [23570219] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by grants from the Japan Ministry of Education, Culture, Sports, Science and Technology (www.jsps.go.jp/english/e-grants/grants.html): a Grant-in-Aid for Scientific Research (C) #23570219 to HO, a Grant-in-Aid for Scientific Research (B) #21370094 to TH, a Grant-in-Aid for Scientific Research on Innovative Areas #20114002 to YH, and a Grant-in-Aid for Scientific Research on Innovative Areas #23114724 to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Chan CK, 1999, FEBS LETT, V462, P221, DOI 10.1016/S0014-5793(99)01515-X; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Hattori T, 2008, NUCLEIC ACIDS RES, V36, P3011, DOI 10.1093/nar/gkn150; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Malki S, 2009, INT J BIOCH CELL BIO; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ogawa H, 2009, MOL BIOL CELL, V20, P4235, DOI 10.1091/mbc.E08-12-1247; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Sim H, 2008, TRENDS ENDOCRIN MET, V19, P213, DOI 10.1016/j.tem.2008.04.002; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Suzuki T, 2003, MOL CELL BIOL, V23, P238, DOI 10.1128/MCB.23.1.238-249.2003; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450; Zhou RJ, 2002, NUCLEIC ACIDS RES, V30, P3245, DOI 10.1093/nar/gkf443	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25694	10.1371/journal.pone.0025694	http://dx.doi.org/10.1371/journal.pone.0025694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991335	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000056
J	Chow, YP; Wan, KL; Blake, DP; Tomley, F; Nathan, S				Chow, Yock-Ping; Wan, Kiew-Lian; Blake, Damer P.; Tomley, Fiona; Nathan, Sheila			Immunogenic Eimeria tenella Glycosylphosphatidylinositol-Anchored Surface Antigens (SAGs) Induce Inflammatory Responses in Avian Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; DEVELOPMENT IN-VITRO; PROTECTIVE IMMUNITY; TOXOPLASMA-GONDII; ANTIBODY-RESPONSE; LAMINA PROPRIA; CHICKENS; INFECTIONS; PROTEINS; COCCIDIOSIS	Background: At least 19 glycosylphosphatidylinositol (GPI)-anchored surface antigens (SAGs) are expressed specifically by second-generation merozoites of Eimeria tenella, but the ability of these proteins to stimulate immune responses in the chicken is unknown. Methodology/Principal Findings: Ten SAGs, belonging to two previously defined multigene families (A and B), were expressed as soluble recombinant (r) fusion proteins in E. coli. Chicken macrophages were treated with purified rSAGs and changes in macrophage nitrite production, and in mRNA expression profiles of inducible nitric oxide synthase (iNOS) and of a panel of cytokines were measured. Treatment with rSAGs 4, 5, and 12 induced high levels of macrophage nitric oxide production and IL-1 beta mRNA transcription that may contribute to the inflammatory response observed during E. tenella infection. Concomitantly, treatment with rSAGs 4, 5 and 12 suppressed the expression of IL-12 and IFN-gamma and elevated that of IL-10, suggesting that during infection these molecules may specifically impair the development of cellular mediated immunity. Conclusions/Significance: In summary, some E. tenella SAGs appear to differentially modulate chicken innate and humoral immune responses and those derived from multigene family A (especially rSAG 12) may be more strongly linked with E. tenella pathogenicity associated with the endogenous second generation stages.	[Chow, Yock-Ping; Wan, Kiew-Lian; Nathan, Sheila] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor DE, Malaysia; [Wan, Kiew-Lian; Nathan, Sheila] Malaysia Genome Inst, Kajang, Selangor DE, Malaysia; [Blake, Damer P.; Tomley, Fiona] Univ London, Royal Vet Coll, N Mymms, England	Universiti Kebangsaan Malaysia; University of London; University of London Royal Veterinary College	Chow, YP (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor DE, Malaysia.	sheila@ukm.my	Nathan, Sheila/C-1182-2011; Tomley, Fiona/GWM-9070-2022; Wan, Kiew-Lian/A-4632-2012	Nathan, Sheila/0000-0002-2132-2346; Tomley, Fiona/0000-0003-2188-8013; Blake, Damer/0000-0003-1077-2306; Wan, Kiew-Lian/0000-0003-4027-1211	Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia [07-05-16-MGI-GMB006]; Biotechnology and Biological Sciences Research Council [BBS/B/04196, BB/F002564/1] Funding Source: researchfish; BBSRC [BB/F002564/1] Funding Source: UKRI	Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Genomics and Molecular Biology Initiatives Programme of the Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia (grant number 07-05-16-MGI-GMB006). The funder had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Allen PC, 1997, POULTRY SCI, V76, P810, DOI 10.1093/ps/76.6.810; Arondel J, 1999, INFECT IMMUN, V67, P6056, DOI 10.1128/IAI.67.11.6056-6066.1999; Brunet LR, 2001, INT IMMUNOPHARMACOL, V1, P1457, DOI 10.1016/S1567-5769(01)00090-X; Constantiniou CC, 2007, VET PARASITOL, V150, P306, DOI 10.1016/j.vetpar.2007.09.019; Constantinoiu CC, 2008, VET PARASITOL, V154, P193, DOI 10.1016/j.vetpar.2008.03.029; Dalloul RA, 2007, MOL IMMUNOL, V44, P558, DOI 10.1016/j.molimm.2006.02.004; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; Dimier IH, 1998, AVIAN DIS, V42, P239, DOI 10.2307/1592473; Espinoza EY, 2002, PARASITE IMMUNOL, V24, P511, DOI 10.1046/j.1365-3024.2002.00598.x; FERNANDO MA, 1983, PARASITOLOGY, V86, P391, DOI 10.1017/S0031182000050587; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; Howe DK, 2005, INFECT IMMUN, V73, P1023, DOI 10.1128/IAI.73.2.1023-1033.2005; Jeurissen SHM, 1996, VET IMMUNOL IMMUNOP, V54, P231, DOI 10.1016/S0165-2427(96)05689-9; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laurent F, 2001, INFECT IMMUN, V69, P2527, DOI 10.1128/IAI.69.4.2527-2534.2001; Lillehoj HS, 1998, AVIAN DIS, V42, P307, DOI 10.2307/1592481; LILLEHOJ HS, 1987, INFECT IMMUN, V55, P1616, DOI 10.1128/IAI.55.7.1616-1621.1987; LILLEHOJ HS, 1987, AVIAN DIS, V31, P112, DOI 10.2307/1590782; Liu LH, 2009, VET PARASITOL, V164, P173, DOI 10.1016/j.vetpar.2009.05.016; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Mattner F, 1997, INFECT IMMUN, V65, P4378, DOI 10.1128/IAI.65.11.4378-4383.1997; Mattner J, 2004, J IMMUNOL, V172, P7574, DOI 10.4049/jimmunol.172.12.7574; MCDONALD V, 1988, PARASITE IMMUNOL, V10, P649, DOI 10.1111/j.1365-3024.1988.tb00251.x; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rath NC, 2003, VET IMMUNOL IMMUNOP, V96, P93, DOI 10.1016/S0165-2427(03)00143-0; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Shirley MW, 1995, BIOTECHNOLOGY GUIDEL, VXII, P1; SMITH NC, 1993, VET PARASITOL, V51, P13, DOI 10.1016/0304-4017(93)90191-O; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; Tabares E, 2004, MOL BIOCHEM PARASIT, V135, P123, DOI 10.1016/j.molbiopara.2004.01.013; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; VERVELDE L, 1995, ADV EXP MED BIOL, V371, P953; Vervelde L, 1996, PARASITE IMMUNOL, V18, P247, DOI 10.1046/j.1365-3024.1996.d01-94.x; Wallach M, 2010, TRENDS PARASITOL, V26, P382, DOI 10.1016/j.pt.2010.04.004; Wan KL, 1999, INT J PARASITOL, V29, P1885, DOI 10.1016/S0020-7519(99)00160-5; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628	43	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25233	10.1371/journal.pone.0025233	http://dx.doi.org/10.1371/journal.pone.0025233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980402	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900036
J	Filippov, AA; Sergueev, KV; He, YX; Huang, XZ; Gnade, BT; Mueller, AJ; Fernandez-Prada, CM; Nikolich, MP				Filippov, Andrey A.; Sergueev, Kirill V.; He, Yunxiu; Huang, Xiao-Zhe; Gnade, Bryan T.; Mueller, Allen J.; Fernandez-Prada, Carmen M.; Nikolich, Mikeljon P.			Bacteriophage-Resistant Mutants in Yersinia pestis: Identification of Phage Receptors and Attenuation for Mice	PLOS ONE			English	Article							GENERALIZED TRANSDUCING PHAGE; LIPOPOLYSACCHARIDE OUTER CORE; ESCHERICHIA-COLI DIARRHEA; PASTEURELLA-PESTIS; GENOME SEQUENCE; ANTIMICROBIAL PEPTIDES; NUCLEOTIDE-SEQUENCE; BUBONIC PLAGUE; PLATING MEDIUM; MUTATION-RATE	Background: Bacteriophages specific for Yersinia pestis are routinely used for plague diagnostics and could be an alternative to antibiotics in case of drug-resistant plague. A major concern of bacteriophage therapy is the emergence of phage-resistant mutants. The use of phage cocktails can overcome this problem but only if the phages exploit different receptors. Some phage-resistant mutants lose virulence and therefore should not complicate bacteriophage therapy. Methodology/Principal Findings: The purpose of this work was to identify Y. pestis phage receptors using site-directed mutagenesis and trans-complementation and to determine potential attenuation of phage-resistant mutants for mice. Six receptors for eight phages were found in different parts of the lipopolysaccharide (LPS) inner and outer core. The receptor for R phage was localized beyond the LPS core. Most spontaneous and defined phage-resistant mutants of Y. pestis were attenuated, showing increase in LD50 and time to death. The loss of different LPS core biosynthesis enzymes resulted in the reduction of Y. pestis virulence and there was a correlation between the degree of core truncation and the impact on virulence. The yrbH and waaA mutants completely lost their virulence. Conclusions/Significance: We identified Y. pestis receptors for eight bacteriophages. Nine phages together use at least seven different Y. pestis receptors that makes some of them promising for formulation of plague therapeutic cocktails. Most phage-resistant Y. pestis mutants become attenuated and thus should not pose a serious problem for bacteriophage therapy of plague. LPS is a critical virulence factor of Y. pestis.	[Filippov, Andrey A.; Sergueev, Kirill V.; He, Yunxiu; Huang, Xiao-Zhe; Gnade, Bryan T.; Mueller, Allen J.; Fernandez-Prada, Carmen M.; Nikolich, Mikeljon P.] Walter Reed Army Inst Res, Div Bacterial & Rickettsial Dis, Dept Emerging Bacterial Infect, Silver Spring, MD 20910 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Filippov, AA (corresponding author), Walter Reed Army Inst Res, Div Bacterial & Rickettsial Dis, Dept Emerging Bacterial Infect, Silver Spring, MD 20910 USA.	andrey.filippov@amedd.army.mil	Nikolich, Mikeljon P/ABC-9871-2021; Nikolich, Mikeljon/ABD-5270-2020	Nikolich, Mikeljon P/0000-0001-5770-8980; Filippov, Andrey/0000-0003-2256-861X	Defense Threat Reduction Agency, Joint Science and Technology Office, Medical ST Division [2.10052_08_WR_B]	Defense Threat Reduction Agency, Joint Science and Technology Office, Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by the Defense Threat Reduction Agency, Joint Science and Technology Office, Medical S&T Division (http://www.dtra.mil/Research.aspx), grant #2.10052_08_WR_B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN.HW, 1969, REV CAN BIOL EXPTL, V28, P201; ADVIER M., 1933, Bulletin de la Societe de Pathologie Exotique, V26, P94; ALHENDY A, 1991, MICROB PATHOGENESIS, V10, P47, DOI 10.1016/0882-4010(91)90065-I; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Anisimov AP, 2006, J MED MICROBIOL, V55, P1461, DOI 10.1099/jmm.0.46697-0; Anisimov AP, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P77, DOI 10.1007/978-90-481-9054-6_8; Anisimov AP, 2005, INFECT IMMUN, V73, P7324, DOI 10.1128/IAI.73.11.7324-7331.2005; APPLEYARD RK, 1954, GENETICS, V39, P440; Arutyunov YI, 1970, ZH MIKROBIOL EPIDEMI, V8, P106; Batson HC, 1956, INTRO STAT MED SCI; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; Begum YA, 2010, J MED MICROBIOL, V59, P266, DOI 10.1099/jmm.0.014795-0; BERTANI LE, 1957, VIROLOGY, V4, P53, DOI 10.1016/0042-6822(57)90043-0; BOBROV AG, 1999, PROBL PARTICULARLY D, V79, P138; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; BURROWS TW, 1960, BRIT J EXP PATHOL, V41, P38; Chu MC., 2000, LAB MANUAL PLAGUE DI; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deresinski S, 2009, CLIN INFECT DIS, V48, P1096, DOI 10.1086/597405; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Feodorova VA, 2007, VACCINE, V25, P7620, DOI 10.1016/j.vaccine.2007.08.055; Feodorova VA, 2009, VACCINE, V27, P2240, DOI 10.1016/j.vaccine.2009.02.020; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Garcia E, 2003, J BACTERIOL, V185, P5248, DOI 10.1128/JB.185.17.5248-5262.2003; Garcia E, 2008, VIROLOGY, V372, P85, DOI 10.1016/j.virol.2007.10.032; Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311; GOGUEN JD, 1984, J BACTERIOL, V160, P842, DOI 10.1128/JB.160.3.842-848.1984; Goodridge LD, 2010, CURR PHARM BIOTECHNO, V11, P15, DOI 10.2174/138920110790725348; GUNNISON JB, 1951, J INFECT DIS, V88, P254, DOI 10.1093/infdis/88.3.254; Gurleva GG, 1981, ZH MIKROBIOL EPIDEMI, V5, P65; HELLER KJ, 1992, ARCH MICROBIOL, V158, P235, DOI 10.1007/BF00245239; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HERTMAN I, 1964, J BACTERIOL, V88, P1002, DOI 10.1128/JB.88.4.1002-1005.1964; HIGUCHI K, 1961, J BACTERIOL, V81, P605, DOI 10.1128/JB.81.4.605-608.1961; Housby JN, 2009, DRUG DISCOV TODAY, V14, P536, DOI 10.1016/j.drudis.2009.03.006; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; ITEMAN I, 1993, INFECT IMMUN, V61, P2717, DOI 10.1128/IAI.61.6.2717-2722.1993; JACKSON S, 1956, BRIT J EXP PATHOL, V37, P570; Jawetz E, 1943, J INFECT DIS, V73, P124, DOI 10.1093/infdis/73.2.124; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KERBY GP, 1949, J IMMUNOL, V63, P93; KNAPP W., 1964, ARCH GESAMTE VIRUSFORSCH, V14, P563, DOI 10.1007/BF01555086; KNAPP W, 1963, ZBL BAKT PARASIT, V190, P39; Kotlyarova RI, 1956, P RES ANT I CAUC TRA, P234; Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401; Kutyrev V V, 1989, Mol Gen Mikrobiol Virusol, P42; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Larina VS, 1970, PROBL PARTICULARLY D, V11, P132; Lebedeva SA, 2000, ZH MIKROBIOL EPIDEMI, V3, P99; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; NAUMOV AV, 1992, MANUAL PROPHYLAXIS P; NOVOSELTSEV NN, 1990, ZH MIKROB EPID IMMUN, P9; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; OPULSKI A, 1992, JAMA-J AM MED ASSOC, V268, P2146; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Petty NK, 2007, MICROBIOL-SGM, V153, P2984, DOI 10.1099/mic.0.2007/008888-0; Petty NK, 2006, MICROBIOL-SGM, V152, P1701, DOI 10.1099/mic.0.28712-0; Pickard D, 2010, J BACTERIOL, V192, P5746, DOI 10.1128/JB.00659-10; Plotnikov OP, 1982, SELECTION GENETICS C, P56; POKROVSKAYA MP, 1929, GIGIENA EPIDEMIOL, V12, P31; PRUZZO C, 1983, INFECT IMMUN, V39, P520, DOI 10.1128/IAI.39.2.520-527.1983; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Ramjeet M, 2005, J BIOL CHEM, V280, P39104, DOI 10.1074/jbc.M502852200; Ricci V, 2010, APPL ENVIRON MICROB, V76, P1704, DOI 10.1128/AEM.02681-09; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schofield DA, 2009, J CLIN MICROBIOL, V47, P3887, DOI 10.1128/JCM.01533-09; SCHOONEJANS E, 1987, J BACTERIOL, V169, P4011, DOI 10.1128/jb.169.9.4011-4017.1987; Schwudke D, 2008, J BACTERIOL, V190, P332, DOI 10.1128/JB.01402-07; Sergueev KV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011337; Shashaev MA, 1966, PRODUCTION BACTERIAL, P350; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; SMITH DA, 1962, NATURE, V193, P397, DOI 10.1038/193397a0; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Spears PA, 2008, INFECT IMMUN, V76, P4046, DOI 10.1128/IAI.00283-08; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; SUNSHINE MG, 1971, VIROLOGY, V46, P691, DOI 10.1016/0042-6822(71)90071-7; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Tan L, 2005, J BACTERIOL, V187, P6599, DOI 10.1128/JB.187.18.6599-6600.2005; Tan L, 2006, MOL MICROBIOL, V61, P861, DOI 10.1111/j.1365-2958.2006.05265.x; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; WRIGHT A, 1971, J BACTERIOL, V105, P927, DOI 10.1128/JB.105.3.927-936.1971; Yethon JA, 2000, INFECT IMMUN, V68, P4485, DOI 10.1128/IAI.68.8.4485-4491.2000; ZHANG LJ, 1994, J BACTERIOL, V176, P1756, DOI 10.1128/jb.176.6.1756-1760.1994; Zhao XN, 2011, J GEN VIROL, V92, P216, DOI 10.1099/vir.0.026328-0; ZINDER ND, 1958, VIROLOGY, V5, P291, DOI 10.1016/0042-6822(58)90025-4	95	109	117	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25486	10.1371/journal.pone.0025486	http://dx.doi.org/10.1371/journal.pone.0025486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980477	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900072
J	Lackey, SWK; Wideman, JG; Kennedy, EK; Go, NE; Nargang, FE				Lackey, Sebastian W. K.; Wideman, Jeremy G.; Kennedy, Erin K.; Go, Nancy E.; Nargang, Frank E.			The Neurospora crassa TOB Complex: Analysis of the Topology and Function of Tob38 and Tob37	PLOS ONE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BETA-BARREL PROTEINS; BLUE NATIVE ELECTROPHORESIS; ASSEMBLY PATHWAY; ADP/ATP CARRIER; IMPORT CHANNEL; PREPROTEIN TRANSLOCASE; ESSENTIAL COMPONENT; SAM COMPLEX; BIOGENESIS	The TOB or SAM complex is responsible for assembling several proteins into the mitochondrial outer membrane, including all beta-barrel proteins. We have identified several forms of the complex in Neurospora crassa. One form contains Tob55, Tob38, and Tob37; another contains these three subunits plus the Mdm10 protein; while additional complexes contain only Tob55. As previously shown for Tob55, both Tob37 and Tob38 are essential for viability of the organism. Mitochondria deficient in Tob37 or Tob38 have reduced ability to assemble beta-barrel proteins. The function of two hydrophobic domains in the C-terminal region of the Tob37 protein was investigated. Mutant Tob37 proteins lacking either or both of these regions are able to restore viability to cells lacking the protein. One of the domains was found to anchor the protein to the outer mitochondrial membrane but was not necessary for targeting or association of the protein with mitochondria. Examination of the import properties of mitochondria containing Tob37 with deletions of the hydrophobic domains reveals that the topology of Tob37 may be important for interactions between specific classes of beta-barrel precursors and the TOB complex.	[Lackey, Sebastian W. K.; Wideman, Jeremy G.; Kennedy, Erin K.; Go, Nancy E.; Nargang, Frank E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Lackey, SWK (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	frank.nargang@ualberta.ca		Wideman, Jeremy/0000-0002-4426-9533	Canadian Institutes for Health Research [MOP84284]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant #MOP84284 to FEN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Armstrong LC, 1999, J CELL BIOCHEM, V74, P11, DOI 10.1002/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V; Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; AUSTIN B, 1990, GENE, V93, P157, DOI 10.1016/0378-1119(90)90152-H; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Becker T, 2010, MOL BIOL CELL, V21, P3106, DOI 10.1091/mbc.E10-06-0518; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; BORKOVICH KA, 1987, J BACTERIOL, V169, P5510, DOI 10.1128/jb.169.12.5510-5517.1987; BORNSTEIN P, 1995, P NATL ACAD SCI USA, V92, P4547, DOI 10.1073/pnas.92.10.4547; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dagley MJ, 2011, MOL MICROBIOL, V79, P968, DOI 10.1111/j.1365-2958.2010.07503.x; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Dukanovic J, 2009, MOL CELL BIOL, V29, P5975, DOI 10.1128/MCB.00069-09; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Grad LI, 1999, CURR GENET, V36, P137, DOI 10.1007/s002940050483; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; GROTELUESCHEN J, 1995, GENETICS, V139, P1545; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hoppins SC, 2007, GENETICS, V177, P137, DOI 10.1534/genetics.107.075051; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Marathe S, 1998, J BIOL CHEM, V273, P29776, DOI 10.1074/jbc.273.45.29776; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; NARGANG FE, 1995, EMBO J, V14, P1099, DOI 10.1002/j.1460-2075.1995.tb07093.x; Nargang FE, 2007, MITOCHONDRIA PRACTIC; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2004, TOP CURR GENET, V8, P37; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schlossmann J, 1996, J BIOL CHEM, V271, P17890, DOI 10.1074/jbc.271.30.17890; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sherman EL, 2005, MOL BIOL CELL, V16, P4172, DOI 10.1091/mbc.E05-03-0187; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Stroud DA, 2011, MOL BIOL CELL, V22, P2823, DOI 10.1091/mbc.E11-02-0148; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283	71	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25650	10.1371/journal.pone.0025650	http://dx.doi.org/10.1371/journal.pone.0025650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980517	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900086
J	Majumder, S; Richardson, A; Strong, R; Oddo, S				Majumder, Smita; Richardson, Arlan; Strong, Randy; Oddo, Salvatore			Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits	PLOS ONE			English	Article							EXACERBATES TAU PATHOLOGY; P70 S6 KINASE; A-BETA; ALZHEIMERS-DISEASE; LIFE-SPAN; AMYLOID-BETA; MOUSE MODEL; TRANSGENIC MODEL; SIGNALING PATHWAY; MAMMALIAN TARGET	Previous studies have shown that inducing autophagy ameliorates early cognitive deficits associated with the build-up of soluble amyloid-beta (A beta). However, the effects of inducing autophagy on plaques and tangles are yet to be determined. While soluble A beta and tau represent toxic species in Alzheimer's disease (AD) pathogenesis, there is well documented evidence that plaques and tangles also are detrimental to normal brain function. Thus, it is critical to assess the effects of inducing autophagy in an animal model with established plaques and tangles. Here we show that rapamycin, when given prophylactically to 2-month-old 3xTg-AD mice throughout their life, induces autophagy and significantly reduces plaques, tangles and cognitive deficits. In contrast, inducing autophagy in 15-month-old 3xTg-AD mice, which have established plaques and tangles, has no effects on AD-like pathology and cognitive deficits. In conclusion, we show that autophagy induction via rapamycin may represent a valid therapeutic strategy in AD when administered early in the disease progression.	[Majumder, Smita; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Majumder, Smita; Richardson, Arlan; Strong, Randy; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Majumder, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	oddo@uthscsa.edu		Oddo, Salvatore/0000-0001-7304-7430	National Institute on Aging (NIA) [K99/R00AG29729-4, R01AG037637]; William and Ella Owens Medical Research Foundation;  [RC2AG036613]; NATIONAL INSTITUTE ON AGING [R01AG037637, RC2AG036613, K99AG029729] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); William and Ella Owens Medical Research Foundation; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging (NIA) grant awards K99/R00AG29729-4 and R01AG037637 (Oddo, Principal Investigator), RC2AG036613 (Richardson, Principal Investigator, Strong and Oddo, Project Co-leaders), and by an award from the William and Ella Owens Medical Research Foundation to S.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Blagosklonny MV, 2010, CELL CYCLE, V9, P4788, DOI 10.4161/cc.9.24.14360; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Caccamo A, 2011, J BIOL CHEM, V286, P8924, DOI 10.1074/jbc.M110.180638; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fasolo A, 2011, EXPERT OPIN INV DRUG, V20, P381, DOI 10.1517/13543784.2011.541154; Galimberti Daniela, 2011, Front Biosci (Schol Ed), V3, P252, DOI 10.2741/s149; Gallardo G, 2008, NAT NEUROSCI, V11, P301, DOI 10.1038/nn2058; Geissler EK, 2010, KIDNEY INT, V78, P1075, DOI 10.1038/ki.2010.324; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Khandelwal PJ, 2011, HUM MOL GENET, V20, P2091, DOI 10.1093/hmg/ddr091; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Lafay-Chebassier C, 2006, J NEUROSCI RES, V84, P1323, DOI 10.1002/jnr.21039; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Ling DJ, 2009, AUTOPHAGY, V5, P738, DOI 10.4161/auto.5.5.8626; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Madeo F, 2009, GENE DEV, V23, P2253, DOI 10.1101/gad.1858009; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Nunomura A, 2010, NEUROBIOL DIS, V37, P731, DOI 10.1016/j.nbd.2009.12.012; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; Oddo S, 2009, BRAIN PATHOL, V19, P421, DOI 10.1111/j.1750-3639.2008.00194.x; Oddo S, 2008, J NEUROSCI, V28, P12163, DOI 10.1523/JNEUROSCI.2464-08.2008; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Onuki R, 2004, EMBO J, V23, P959, DOI 10.1038/sj.emboj.7600049; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Serkova N, 2001, BRIT J PHARMACOL, V133, P875, DOI 10.1038/sj.bjp.0704142; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; SUPKO JG, 1994, CANCER CHEMOTH PHARM, V33, P325; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	95	281	295	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25416	10.1371/journal.pone.0025416	http://dx.doi.org/10.1371/journal.pone.0025416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980451	Green Published, gold			2022-12-27	WOS:000295936900063
J	Tse, H; Tsoi, HW; Teng, JLL; Chen, XC; Liu, HY; Zhou, BP; Zheng, BJ; Woo, PCY; Lau, SKP; Yuen, KY				Tse, Herman; Tsoi, Hoi-Wah; Teng, Jade L. L.; Chen, Xin-Chun; Liu, Haiying; Zhou, Boping; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung			Discovery and Genomic Characterization of a Novel Ovine Partetravirus and a New Genotype of Bovine Partetravirus	PLOS ONE			English	Article							HUMAN PARVOVIRUS PARV4; HUMAN BOCAVIRUS; MOLECULAR EPIDEMIOLOGY; ADENOASSOCIATED VIRUS; BLOOD-DONORS; HUMAN PLASMA; IDENTIFICATION; B19; DNA; PERSISTENCE	Partetravirus is a recently described group of animal parvoviruses which include the human partetravirus, bovine partetravirus and porcine partetravirus (previously known as human parvovirus 4, bovine hokovirus and porcine hokovirus respectively). In this report, we describe the discovery and genomic characterization of partetraviruses in bovine and ovine samples from China. These partetraviruses were detected by PCR in 1.8% of bovine liver samples, 66.7% of ovine liver samples and 71.4% of ovine spleen samples. One of the bovine partetraviruses detected in the present samples is phylogenetically distinct from previously reported bovine partetraviruses and likely represents a novel genotype. The ovine partetravirus is a novel partetravirus and phylogenetically most related to the bovine partetraviruses. The genome organization is conserved amongst these viruses, including the presence of a putative transmembrane protein encoded by an overlapping reading frame in ORF2. Results from the present study provide further support to the classification of partetraviruses as a separate genus in Parvovirinae.	[Tse, Herman; Tsoi, Hoi-Wah; Teng, Jade L. L.; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immun, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China; [Chen, Xin-Chun; Zhou, Boping] Shenzhen Third Peoples Hosp, Shenzhen Inst Hepatol, Shenzhen Hong Kong Inst Infect Dis, Shenzhen, Peoples R China; [Liu, Haiying] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Haiying] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Tse, H (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Lau, Susanna Kar Pui/AAJ-6848-2020; Woo, Patrick Chiu Yat/C-4449-2009	Lau, Susanna Kar Pui/0000-0002-1383-7374; Yuen, Kwok-yung/0000-0002-2083-1552; Woo, Patrick Chiu Yat/0000-0001-9401-1832	Health, Welfare and Food Bureau [08070712]; Research Grants Council; University of Hong Kong; Tung Wah Group of Hospitals; Providence Foundation Limited	Health, Welfare and Food Bureau; Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); Tung Wah Group of Hospitals; Providence Foundation Limited	This work is partly supported by the HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau (project no.: 08070712) (http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html); Research Grants Council grant (http://www.ugc.edu.hk/eng/rgc/index.htm); University Development Fund, and Outstanding Young Researcher Award, The University of Hong Kong (http://www.hku.hk/rss/index4.htm); The Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; and the Providence Foundation Limited in memory of the late Dr. Lui Hac Minh. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlhoch C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-171; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Battilani M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-43; Besselsen DG, 2006, J GEN VIROL, V87, P1543, DOI 10.1099/vir.0.81547-0; BLOOM ME, 1988, J VIROL, V62, P2903, DOI 10.1128/JVI.62.8.2903-2915.1988; Burns K, 2007, FIELDS VIROLOGY, P2437; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P959, DOI 10.1097/INF.0b013e3181256583; Corcioli F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-272; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Darriba D., 2011, BIOINFORMATICS; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fryer JF, 2007, VOX SANG, V93, P341, DOI 10.1111/j.1423-0410.2007.00979.x; Fryer JF, 2007, J GEN VIROL, V88, P2162, DOI 10.1099/vir.0.82620-0; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Fryer JF, 2006, EMERG INFECT DIS, V12, P151, DOI 10.3201/eid1201.050916; Gagliardi TB, 2009, EPIDEMIOL INFECT, V137, P1032, DOI 10.1017/S0950268808001842; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton H, 2004, J VIROL, V78, P7874, DOI 10.1128/JVI.78.15.7874-7882.2004; Hokynar K, 2002, VIROLOGY, V302, P224, DOI 10.1006/viro.2002.1673; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Longhi E, 2007, AIDS, V21, P1481, DOI 10.1097/QAD.0b013e3281e38558; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Lurcharchaiwong W, 2008, INFECTION, V36, P488, DOI 10.1007/s15010-008-7336-4; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Moriyama Y, 2010, EUR J PEDIATR, V169, P1087, DOI 10.1007/s00431-010-1183-x; Nguyen QT, 2002, VIROLOGY, V301, P374, DOI 10.1006/viro.2002.1585; Norja P, 2006, P NATL ACAD SCI USA, V103, P7450, DOI 10.1073/pnas.0602259103; Panning M, 2010, EMERG INFECT DIS, V16, P1143, DOI 10.3201/eid1607.100025; Parrish CR, 1999, VET MICROBIOL, V69, P29, DOI 10.1016/S0378-1135(99)00084-X; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Qiu J, 2007, J VIROL, V81, P12080, DOI 10.1128/JVI.00815-07; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schmidt M, 2004, J VIROL, V78, P6509, DOI 10.1128/JVI.78.12.6509-6516.2004; Schneider B, 2008, HAEMOPHILIA, V14, P978, DOI 10.1111/j.1365-2516.2008.01800.x; Servant A, 2002, J VIROL, V76, P9124, DOI 10.1128/JVI.76.18.9124-9134.2002; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Simmonds P, 2008, J GEN VIROL, V89, P2299, DOI 10.1099/vir.0.2008/001180-0; Simmonds P, 2007, EMERG INFECT DIS, V13, P1386, DOI 10.3201/eid1309.070428; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Soderlund M, 1997, LANCET, V349, P1063, DOI 10.1016/S0140-6736(96)09110-6; Szelei J, 2010, EMERG INFECT DIS, V16, P561, DOI [10.3210/eid1603.090746, 10.3201/eid1603.090746]; Touinssi M, 2011, J MED VIROL, V83, P717, DOI 10.1002/jmv.22003; Tuke PW, 2010, J GEN VIROL, V91, P541, DOI 10.1099/vir.0.014852-0; YANG SJ, 2011, J CLIN VIROL; Zehender G, 2010, INFECT GENET EVOL, V10, P215, DOI 10.1016/j.meegid.2009.11.011; Zuo J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-124	60	31	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25619	10.1371/journal.pone.0025619	http://dx.doi.org/10.1371/journal.pone.0025619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980506	Green Submitted, Green Published, gold			2022-12-27	WOS:000295933700047
J	Cheng, LH; Jin, CM; Lv, W; Ding, QP; Han, X				Cheng, Lihua; Jin, Chengmeng; Lv, Wen; Ding, Qiuping; Han, Xu			Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer	PLOS ONE			English	Article							SOLID LIPID NANOPARTICLES; TOXICITY; RELEASE; DRUGS; CIS-DICHLORODIAMMINEPLATINUM(II); FORMULATION; LIPOSOMES; CARCINOMA; CELLS	Background: Cisplatin is a potent anticancer drug, but its clinical application has been limited due to its undesirable physicochemical characteristics and severe side effects. Better drug formulations for cisplatin are highly desired. Methodology/Principal Findings: Herein, we have developed a nanoparticle formulation for cisplatin with high encapsulation efficiency and reduced toxicity by using cisplatin-crosslinked carboxymethyl cellulose (CMC) core nanoparticles made from poly(lactide-co-glycolide)-monomethoxy-poly(polyethylene glycol) copolymers (PLGA-mPEG). The nanoparticles have an average diameter of approximately 80 nm measured by transmission electron microscope (TEM). The encapsulation efficiency of cisplatin in the nanoparticles is up to 72%. Meanwhile, we have also observed a controlled release of cisplatin in a sustained manner and dose-dependent treatment efficacy of cisplatin-loaded nanoparticles against IGROV1-CP cells. Moreover, the median lethal dose (LD50) of the cisplatin-loaded nanoparticles was more than 100 mg/kg by intravenous administration, which was much higher than that of free cisplatin. Conclusion: This developed cisplatin-loaded nanoparticle is a promising formulation for the delivery of cisplatin, which will be an effective therapeutic regimen of ovarian cancer without severe side effects and cumulative toxicity.	[Cheng, Lihua; Jin, Chengmeng; Ding, Qiuping; Han, Xu] Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou, Zhejiang, Peoples R China; [Lv, Wen] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cheng, LH (corresponding author), Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou, Zhejiang, Peoples R China.	chenglihua75@gmail.com			China International Science and Technology Cooperation Foundation [2007DFC30306]; Zhejiang Province Technology Project Foundation [2009C11122]	China International Science and Technology Cooperation Foundation; Zhejiang Province Technology Project Foundation	The authors acknowledge support from the China International Science and Technology Cooperation Foundation (2007DFC30306, http://www.cistc.gov.cn/), and the Zhejiang Province Technology Project Foundation (2009C11122, http://www.zjkjt.gov.cn/html/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avgoustakis K, 2002, J CONTROL RELEASE, V79, P123, DOI 10.1016/S0168-3659(01)00530-2; Boulikas T, 2004, ONCOL REP, V11, P559; Boulikas T, 2009, EXPERT OPIN INV DRUG, V18, P1197, DOI 10.1517/13543780903114168; Cuong NV, 2009, CURR DRUG METAB, V10, P842, DOI 10.2174/138920009790274586; Doijad RC, 2008, INDIAN J PHARM SCI, V70, P203, DOI 10.4103/0250-474X.41456; Elvira C, 1997, J MATER SCI-MATER M, V8, P743, DOI 10.1023/A:1018504410878; Bosch ME, 2008, J PHARMACEUT BIOMED, V47, P451, DOI 10.1016/j.jpba.2008.01.047; Fujiyama J, 2003, J CONTROL RELEASE, V89, P397, DOI 10.1016/S0168-3659(03)00131-7; Gryparis EC, 2007, EUR J PHARM BIOPHARM, V67, P1, DOI 10.1016/j.ejpb.2006.12.017; Hirai M, 2010, INT J PHARMACEUT, V391, P274, DOI 10.1016/j.ijpharm.2010.02.030; Iseri S, 2007, TOXICOLOGY, V230, P256, DOI 10.1016/j.tox.2006.11.073; Jakupec MA, 2003, REV PHYSIOL BIOCH P, V146, P1, DOI 10.1007/s10254-002-0001-x; Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9; LAMBERT HE, 1985, BRIT MED J, V290, P889, DOI 10.1136/bmj.290.6472.889; Marsh S, 2007, J CLIN ONCOL, V25, P4528, DOI 10.1200/JCO.2006.10.4752; Miyamoto Yohei, 2007, J Toxicol Sci, V32, P311, DOI 10.2131/jts.32.311; Moreno D, 2008, EUR J PHARM BIOPHARM, V68, P503, DOI 10.1016/j.ejpb.2007.08.006; Nishiyama N, 2001, J CONTROL RELEASE, V74, P83, DOI 10.1016/S0168-3659(01)00314-5; Nosko M. M., 2010, Experimental Oncology, V32, P40; Sahin K, 2010, NUTR CANCER, V62, P988, DOI 10.1080/01635581.2010.509838; Takei T, 2005, J NUCL MED, V46, P794; Tian J, 2008, PHARMAZIE, V63, P593, DOI 10.1691/ph.2008.8017; Verma Anita K., 2008, Current Drug Delivery, V5, P120, DOI 10.2174/156720108783954806; WILTSHAW E, 1976, CANCER TREAT REP, V60, P55; Xiao CJ, 2004, J PHARM SCI-US, V93, P1718, DOI 10.1002/jps.20086	25	43	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25433	10.1371/journal.pone.0025433	http://dx.doi.org/10.1371/journal.pone.0025433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966528	Green Published, Green Submitted, gold			2022-12-27	WOS:000295932100040
J	Roper, J; Richardson, MP; Wang, WV; Richard, LG; Chen, W; Coffee, EM; Sinnamon, MJ; Lee, L; Chen, PC; Bronson, RT; Martin, ES; Hung, KE				Roper, Jatin; Richardson, Michael P.; Wang, Wei Vivian; Richard, Larissa Georgeon; Chen, Wei; Coffee, Erin M.; Sinnamon, Mark J.; Lee, Lydia; Chen, Peng-Chieh; Bronson, Roderick T.; Martin, Eric S.; Hung, Kenneth E.			The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; MAMMALIAN TARGET; MTORC1 PATHWAY; PI3K; GROWTH; CELLS; APOPTOSIS; PROLIFERATION; COMBINATION	Purpose: To examine the in vitro and in vivo efficacy of the dual PI3K/mTOR inhibitor NVP-BEZ235 in treatment of PIK3CA wild-type colorectal cancer (CRC). Experimental Design: PIK3CA mutant and wild-type human CRC cell lines were treated in vitro with NVP-BEZ235, and the resulting effects on proliferation, apoptosis, and signaling were assessed. Colonic tumors from a genetically engineered mouse (GEM) model for sporadic wild-type PIK3CA CRC were treated in vivo with NVP-BEZ235. The resulting effects on macroscopic tumor growth/regression, proliferation, apoptosis, angiogenesis, and signaling were examined. Results: In vitro treatment of CRC cell lines with NVP-BEZ235 resulted in transient PI3K blockade, sustained decreases in mTORC1/mTORC2 signaling, and a corresponding decrease in cell viability (median IC50 = 9.0-14.3 nM). Similar effects were seen in paired isogenic CRC cell lines that differed only in the presence or absence of an activating PIK3CA mutant allele. In vivo treatment of colonic tumor-bearing mice with NVP-BEZ235 resulted in transient PI3K inhibition and sustained blockade of mTORC1/mTORC2 signaling. Longitudinal tumor surveillance by optical colonoscopy demonstrated a 97% increase in tumor size in control mice (p = 0.01) vs. a 43% decrease (p = 0.008) in treated mice. Ex vivo analysis of the NVP-BEZ235-treated tumors demonstrated a 56% decrease in proliferation (p = 0.003), no effects on apoptosis, and a 75% reduction in angiogenesis (p = 0.013). Conclusions: These studies provide the preclinical rationale for studies examining the efficacy of the dual PI3K/mTOR inhibitor NVP-BEZ235 in treatment of PIK3CA wild-type CRC.	[Roper, Jatin; Richardson, Michael P.; Wang, Wei Vivian; Chen, Wei; Coffee, Erin M.; Sinnamon, Mark J.; Lee, Lydia; Hung, Kenneth E.] Tufts Med Ctr, Dept Med, Div Gastroenterol, Boston, MA USA; [Richard, Larissa Georgeon; Chen, Peng-Chieh] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Genet, Boston, MA 02115 USA; [Bronson, Roderick T.; Martin, Eric S.] Harvard Univ, Sch Med, Dana Farber Harvard Canc Ctr, Boston, MA USA	Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Roper, J (corresponding author), Tufts Med Ctr, Dept Med, Div Gastroenterol, Boston, MA USA.	khung@tuftsmedicalcenter.org		Roper, Jatin/0000-0002-8851-1352; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765	National Cancer Institute [2U01CA084301]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5K08DK7803325, R03DK088014, T32-DK07542]; NATIONAL CANCER INSTITUTE [U01CA084301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK088014, P30DK043351, T32DK007542, K08DK078033] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Cancer Institute (2U01CA084301) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(5K08DK7803325, R03DK088014, and T32-DK07542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Bhende PM, 2010, LEUKEMIA, V24, P1781, DOI 10.1038/leu.2010.154; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brunner-Kubath C, 2011, BREAST CANCER RES TR, V129, P387, DOI 10.1007/s10549-010-1232-1; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Cao P, 2009, BRIT J CANCER, V100, P1267, DOI 10.1038/sj.bjc.6604995; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang Q, 2009, CANCER BIOL THER, V8, P1893, DOI 10.4161/cbt.8.20.9430; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Fujishita T, 2009, CELL CYCLE, V8, P3684, DOI 10.4161/cc.8.22.9946; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Herrera VA, 2011, ANTICANCER RES, V31, P849; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Lang SA, 2007, INT J CANCER, V120, P1803, DOI 10.1002/ijc.22442; Lee M, 2011, MOL CANCER THER, V10, P1450, DOI 10.1158/1535-7163.MCT-11-0188; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mallon R, 2011, CLIN CANCER RES, V17, P3193, DOI 10.1158/1078-0432.CCR-10-1694; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Martin SK, 2010, J BONE MINER RES, V25, P2126, DOI 10.1002/jbmr.114; Martin-Fernandez C, 2009, MOL CANCER RES, V7, P955, DOI 10.1158/1541-7786.MCR-08-0445; MASUDA M, 2011, ONCOL REP; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Pollizzi K, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-38; Roccaro AM, 2010, BLOOD, V115, P559, DOI 10.1182/blood-2009-07-235747; Roulin D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-90; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santiskulvong C, 2011, CLIN CANCER RES, V17, P2373, DOI 10.1158/1078-0432.CCR-10-2289; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e; Sunayama J, 2010, NEURO-ONCOLOGY, V12, P1205, DOI 10.1093/neuonc/noq103; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tanaka H, 2011, CLIN CANCER RES, V17, P3272, DOI 10.1158/1078-0432.CCR-10-2882; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899; XU CX, 2011, CANC BIOL THER, V12; Zitzmann K, 2010, CANCER LETT, V295, P100, DOI 10.1016/j.canlet.2010.02.018; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	107	117	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25132	10.1371/journal.pone.0025132	http://dx.doi.org/10.1371/journal.pone.0025132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966435	Green Published, Green Submitted, gold			2022-12-27	WOS:000295932100020
J	Bin Ali, A; Nin, DS; Tam, J; Khan, M				Bin Ali, Azhar; Nin, Dawn Sijin; Tam, John; Khan, Matiullah			Role of Chaperone Mediated Autophagy (CMA) in the Degradation of Misfolded N-CoR Protein in Non-Small Cell Lung Cancer (NSCLC) Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREPRESSOR; PML-RAR-ALPHA; TRANSCRIPTIONAL REPRESSION; ENDOPLASMIC-RETICULUM; TUMOR-SUPPRESSOR; C/EBP-ALPHA; MSIN3; ACTIVATION; APOPTOSIS; SPECTRUM	Nuclear receptor co-repressor (N-CoR) plays important role in transcriptional control mediated by several tumor suppressor proteins. Recently, we reported a role of misfolded-conformation dependent loss (MCDL) of N-CoR in the activation of oncogenic survival pathway in acute promyelocytic leukemia (APL). Since N-CoR plays important role in cellular homeostasis in various tissues, therefore, we hypothesized that an APL like MCDL of N-CoR might also be involved in other malignancy. Indeed, our initial screening of N-CoR status in various leukemia and solid tumor cells revealed an APL like MCDL of N-CoR in primary and secondary tumor cells derived from non-small cell lung cancer (NSCLC). The NSCLC cell specific N-CoR loss could be blocked by Kaletra, a clinical grade protease inhibitor and by genistein, an inhibitor of N-CoR misfolding previously characterized by us. The misfolded N-CoR presented in NSCLC cells was linked to the amplification of ER stress and was subjected to degradation by NSCLC cell specific aberrant protease activity. In NSCLC cells, misfolded N-CoR was found to be associated with Hsc70, a molecular chaperone involved in chaperone mediated autophagy (CMA). Genetic and chemical inhibition of Lamp2A, a rate limiting factor of CMA, significantly blocked the loss of N-CoR in NSCLC cells, suggesting a crucial role of CMA in N-CoR degradation. These findings identify an important role of CMA-induced degradation of misfolded N-CoR in the neutralization of ER stress and suggest a possible role of misfolded N-CoR protein in the activation of oncogenic survival pathway in NSCLC cells.	[Bin Ali, Azhar; Nin, Dawn Sijin; Khan, Matiullah] Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst, Singapore 117595, Singapore; [Nin, Dawn Sijin; Khan, Matiullah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tam, John] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Tam, John] Natl Univ Singapore Hosp, Dept Cardiac, Singapore, Singapore; [Tam, John] Natl Univ Singapore Hosp, Dept Thorac, Singapore, Singapore; [Tam, John] Natl Univ Singapore Hosp, Dept Vasc Surg, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Bin Ali, A (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst, Singapore 117595, Singapore.	csimmk@nus.edu.sg	Tam, John/B-6048-2012; Ali, Azhar/J-3507-2019	Ali, Azhar/0000-0002-5895-9076	Singapore Stem Cell Consortium [SSCC-04-06]; National Medical Research Council of Singapore [NMRC/1213/2009]	Singapore Stem Cell Consortium; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by grants SSCC-04-06 and NMRC/1213/2009 to MK from Singapore Stem Cell Consortium and National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; CUERVO JAM, 1997, J BIOL CHEM, V272, P5606; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Furuya F, 2007, MOL CELL BIOL, V27, P6116, DOI 10.1128/MCB.00900-07; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Halmos B, 2002, CANCER RES, V62, P528; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Kaushik S., 2008, V445, P227, DOI 10.1007/978-1-59745-157-4_15; Khan MM, 2004, J BIOL CHEM, V279, P11814, DOI 10.1074/jbc.M312121200; Khan MM, 2001, J BIOL CHEM, V276, P43491, DOI 10.1074/jbc.C100532200; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Mallakin A, 2007, CANCER CELL, V12, P381, DOI 10.1016/j.ccr.2007.08.034; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Moran CA, 2006, ARCH PATHOL LAB MED, V130, P958; Ng APP, 2007, MOL CANCER THER, V6, P2240, DOI 10.1158/1535-7163.MCT-06-0705; Ng APP, 2006, CANCER RES, V66, P9903, DOI 10.1158/0008-5472.CAN-06-0002; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P3, DOI 10.1159/000055386; Sena-Esteves M, 1999, J VIROL, V73, P10426, DOI 10.1128/JVI.73.12.10426-10439.1999; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902	35	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25268	10.1371/journal.pone.0025268	http://dx.doi.org/10.1371/journal.pone.0025268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966475	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100036
J	Higashi, H; Barendregt, JJ				Higashi, Hideki; Barendregt, Jan J.			Cost-Effectiveness of Total Hip and Knee Replacements for the Australian Population with Osteoarthritis: Discrete-Event Simulation Model	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; OUTCOME MEASURES; NATIONAL-HEALTH; ARTHROPLASTY; MINIMUM; EPIDEMIOLOGY; PROGRESSION; PREVALENCE; SURGERY	Background: Osteoarthritis constitutes a major musculoskeletal burden for the aged Australians. Hip and knee replacement surgeries are effective interventions once all conservative therapies to manage the symptoms have been exhausted. This study aims to evaluate the cost-effectiveness of hip and knee replacements in Australia. To our best knowledge, the study is the first attempt to account for the dual nature of hip and knee osteoarthritis in modelling the severities of right and left joints separately. Methodology/Principal Findings: We developed a discrete-event simulation model that follows up the individuals with osteoarthritis over their lifetimes. The model defines separate attributes for right and left joints and accounts for several repeat replacements. The Australian population with osteoarthritis who were 40 years of age or older in 2003 were followed up until extinct. Intervention effects were modelled by means of disability-adjusted life-years (DALYs) averted. Both hip and knee replacements are highly cost effective (AUD 5,000 per DALY and AUD 12,000 per DALY respectively) under an AUD 50,000/DALY threshold level. The exclusion of cost offsets, and inclusion of future unrelated health care costs in extended years of life, did not change the findings that the interventions are cost-effective (AUD 17,000 per DALY and AUD 26,000 per DALY respectively). However, there was a substantial difference between hip and knee replacements where surgeries administered for hips were more cost-effective than for knees. Conclusions/Significance: Both hip and knee replacements are cost-effective interventions to improve the quality of life of people with osteoarthritis. It was also shown that the dual nature of hip and knee OA should be taken into account to provide more accurate estimation on the cost-effectiveness of hip and knee replacements.	[Higashi, Hideki; Barendregt, Jan J.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	University of Queensland	Higashi, H (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	h.higashi@uqconnect.edu.au	Higashi, Hideki/D-3797-2011; Barendregt, Jan J/F-6895-2010	Higashi, Hideki/0000-0002-5534-0905; 	Australian National Health and Medical Research Council [351558]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Financial support for this study was provided by a grant from the Australian National Health and Medical Research Council (Health Services Research grant no. 351558). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AUSTR BUR STAT, PERS NOT LAB FORC; *AUSTR BUR STAT, 2004, AV WEEKL EARN; *AUSTR GOV DEP HLT, 2005, NAT HOSP COST DAT CO; *AUSTR I HLTH WELF, 2005, AUSTR HOSP STAT 2003; *AUSTR I HTLH WELF, 2001, DIS COSTS IMP STUD 2; *AUSTR ORTH ASS NA, 2004, ANN REP; *AUSTR ORTH ASS NA, 2007, ANN REP; *AUSTR ORTH ASS NA, 2005, ANN REP S; Australian Bureau of Statistics, 2006, NAT HLTH SURV SUMM R; Australian Institute of Health and Welfare, 2005, HLTH EXP AUSTR 2003; Australian Institute of Health and Welfare, 2005, ARTHR MUSC COND AUST; Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; BAYLEY K, 1995, MEASURING SUCCESS TR; Begg S., 2007, BURDEN DIS INJURY AU; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennett KJ, 1997, J RHEUMATOL, V24, P1796; Brand C., 2009, GUIDELINE NONSURGICA; Brazier JE, 1999, RHEUMATOLOGY, V38, P870, DOI 10.1093/rheumatology/38.9.870; BRIGGS A, 2003, MODELLING COST EFFEC; Callaghan JJ, 2004, J BONE JOINT SURG AM, V86A, P690, DOI 10.2106/00004623-200404000-00004; Callaghan JJ, 2000, J BONE JOINT SURG AM, V82A, P487, DOI 10.2106/00004623-200004000-00004; *CAN I HTLH INF, 2007, CAN JOINT REPL REG R; CAO X, 2006, BIRMINGHAM, P1123; Chang RW, 1996, JAMA-J AM MED ASSOC, V275, P858, DOI 10.1001/jama.275.11.858; COMAS M, 2008, APPL DISCRETE EVENT; DAVIS MA, 1990, SEMIN ARTHRITIS RHEU, V20, P34, DOI 10.1016/0049-0172(90)90045-H; Dawson J, 2004, RHEUMATOLOGY, V43, P497, DOI 10.1093/rheumatology/keh086; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Dieppe P, 2000, OSTEOARTHR CARTILAGE, V8, P63, DOI 10.1053/joca.1999.0272; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; *EP INT PTY LTD, 2010, ERS 1 1; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GUCCIONE A, 1990, DEFINING ARTHRITIS M, P945; Gunal MM, 2010, J SIMUL, V4, P42, DOI 10.1057/jos.2009.25; Heck DA, 1998, CLIN ORTHOP RELAT R, P93, DOI 10.1097/00003086-199811000-00015; HOCHBERG MC, 1995, J RHEUMATOL, V22, P488; Hollocks BW, 2006, J OPER RES SOC, V57, P1383, DOI 10.1057/palgrave.jors.2602128; HOZACK WJ, 1997, CLIN ORTHOP RELAT R, V344, P88; Ingvarsson T, 1999, ANN RHEUM DIS, V58, P201, DOI 10.1136/ard.58.4.201; Jones CA, 2001, ARCH INTERN MED, V161, P454, DOI 10.1001/archinte.161.3.454; Jones CA, 2000, J RHEUMATOL, V27, P1745; Kiebzak G M, 1997, J South Orthop Assoc, V6, P169; Kiebzak GM, 2002, AM J MANAG CARE, V8, P463; Lacey RJ, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-82; Lavernia CJ, 1997, CLIN ORTHOP RELAT R, P134; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Madey SM, 1997, J BONE JOINT SURG AM, V79A, P53, DOI 10.2106/00004623-199701000-00006; Mannoni A, 2003, ANN RHEUM DIS, V62, P576, DOI 10.1136/ard.62.6.576; March L, 2002, J RHEUMATOL, V29, P1006; Mortimer D, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-33; *NAT ARTHR MUSC CO, 2005, NAT ACT PLAN OST RHE; RAND JA, 1991, J BONE JOINT SURG AM, V73A, P397, DOI 10.2106/00004623-199173030-00011; Rand JA, 2003, J BONE JOINT SURG AM, V85A, P259, DOI 10.2106/00004623-200302000-00012; Rissanen P, 1997, INT J TECHNOL ASSESS, V13, P575, DOI 10.1017/S0266462300010059; *ROYAL AUSTR COLL, 2007, REF JOINT REPL MAN G; Schreurs BW, 2004, J BONE JOINT SURG BR, V86B, P492, DOI 10.1302/0301-620X.86B4.14769; SCHULTE KR, 1993, J BONE JOINT SURG AM, V75A, P961, DOI 10.2106/00004623-199307000-00002; SEGAL L, 2004, PRIORITY SETTING OST; Shields RK, 1999, ARCH PHYS MED REHAB, V80, P572, DOI 10.1016/S0003-9993(99)90202-2; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Taylor SJE, 2006, J SIMUL, V1, P1, DOI 10.1057/palgrave.jos.4250002; Taylor SJE, 2009, J OPER RES SOC, V60, pS69, DOI 10.1057/jors.2008.196; TEPPER S, 1993, AM J EPIDEMIOL, V137, P1081, DOI 10.1093/oxfordjournals.aje.a116611; *UN, 2003, OP RAT EXCH; van Essen G J, 1998, J Qual Clin Pract, V18, P135; Veerman L., 2010, ASSESSING COST EFFEC; Viney RC, 2004, MED J AUSTRALIA, V181, P338, DOI 10.5694/j.1326-5377.2004.tb06305.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinstein MC, 2006, PHARMACOECONOMICS, V24, P1043, DOI 10.2165/00019053-200624110-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zhang YQ, 2001, ARTHRITIS RHEUM, V44, P2065, DOI 10.1002/1529-0131(200109)44:9<2065::AID-ART356>3.0.CO;2-Z	74	61	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25403	10.1371/journal.pone.0025403	http://dx.doi.org/10.1371/journal.pone.0025403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966520	Green Submitted, Green Published, gold			2022-12-27	WOS:000295267100056
J	Novensa, L; Novella, S; Medina, P; Segarra, G; Castillo, N; Heras, M; Hermenegildo, C; Dantas, AP				Novensa, Laura; Novella, Susana; Medina, Pascual; Segarra, Gloria; Castillo, Nadia; Heras, Magda; Hermenegildo, Carlos; Dantas, Ana Paula			Aging Negatively Affects Estrogens-Mediated Effects on Nitric Oxide Bioavailability by Shifting ER alpha/ER beta Balance in Female Mice	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE ENTERPRISES; SPONTANEOUSLY HYPERTENSIVE-RATS; POSTMENOPAUSAL HORMONE-THERAPY; CPG-ISLAND METHYLATION; CORONARY-HEART-DISEASE; ENDOTHELIAL FUNCTION; MAJOR SHAREHOLDERS; PLUS PROGESTIN; RECEPTOR GENE; MOUSE AORTA	Aims: Aging is among the major causes for the lack of cardiovascular protection by estrogen (E2) during postmenopause. Our study aims to determine the mechanisms whereby aging changes E2 effects on nitric oxide (NO) production in a mouse model of accelerated senescence (SAM). Methods and Results: Although we found no differences on NO production in females SAM prone (SAMP, aged) compared to SAM resistant (SAMR, young), by either DAF-2 fluorescence or plasmatic nitrite/nitrate (NO2/NO3), in both cases, E2 treatment increased NO production in SAMR but had no effect in SAMP. Those results are in agreement with changes of eNOS protein and gene expression. E2 up-regulated eNOS expression in SAMR but not in SAMP. E2 is also known to increase NO by decreasing its catabolism by superoxide anion (O-2(-)). Interestingly, E2 treatment decreased O-2(-) production in young females, while increased O-2(-) in aged ones. Furthermore, we observed that aging changed expression ratio of estrogen receptors (ER beta/ER alpha) and levels of DNA methylation. Increased ratio ER beta/ER alpha in aged females is associated to a lack of estrogen modulation of NO production and with a reversal in its antioxidant effect to a pro-oxidant profile. Conclusions: Together, our data suggest that aging has detrimental effects on E2-mediated benefits on NO bioavailability, partially by affecting the ability of E2 to induce up regulation of eNOS and decrease of O-2(-). These modifications may be associated to aging-mediated modifications on global DNA methylation status, but not to a specific methylation at 5'flanking region of ER alpha gene.	[Novensa, Laura; Castillo, Nadia; Heras, Magda; Dantas, Ana Paula] Inst dInvestigac Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain; [Novensa, Laura; Castillo, Nadia; Heras, Magda; Dantas, Ana Paula] Hosp Clin Barcelona, Inst Clin Torax, Barcelona, Spain; [Novella, Susana; Medina, Pascual; Segarra, Gloria; Hermenegildo, Carlos] Univ Valencia, Dept Physiol, Valencia, Spain; [Novella, Susana] Hosp Clin Univ, Res Fdn, Valencia, Spain; [Novella, Susana; Medina, Pascual; Segarra, Gloria; Hermenegildo, Carlos] Hosp Clini Univ, Inst Investigacion Sanitaria INCLIVA, Valencia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Valencia; Hospital Clinic Universitari de Valencia	Novensa, L (corresponding author), Inst dInvestigac Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain.	adantas@clinic.ub.es	Medina, Pascual/A-5461-2008; Hermenegildo, Carlos/C-5995-2008; Novella, Susana/A-7406-2017; Dantas, Ana Paula V/I-4100-2015; Segarra, Gloria/L-2495-2017	Medina, Pascual/0000-0002-0916-3311; Novella, Susana/0000-0001-8303-7252; Dantas, Ana Paula V/0000-0001-8514-4094; Segarra, Gloria/0000-0003-3069-2717; Hermenegildo, Carlos/0000-0002-4015-2645	Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III [FIS PI1000518, FIS PI080176, Red HERACLES RD06/0009]; Conselleria de Sanidad [AP-131/10, AP-117/10, GE-021/10]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Conselleria de Sanidad	This work was supported by a Spanish Grant from Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (grants FIS PI1000518, FIS PI080176 and Red HERACLES RD06/0009), and Conselleria de Sanidad (grants AP-131/10, AP-117/10, and GE-021/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavnani BR, 2008, ENDOCRINOLOGY, V149, P4857, DOI 10.1210/en.2008-0304; Chen YF, 2005, AM J PHYSIOL-RENAL, V289, pF749, DOI 10.1152/ajprenal.00115.2005; Darblade B, 2002, CIRC RES, V90, P413, DOI 10.1161/hh0402.105096; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; Fortepiani LA, 2003, HYPERTENSION, V41, P640, DOI 10.1161/01.HYP.0000046924.94886.EF; Fujiwara H, 2002, ANAL BIOCHEM, V307, P386, DOI 10.1016/S0003-2697(02)00053-2; Grodstein F, 2006, J WOMENS HEALTH, V15, P35, DOI 10.1089/jwh.2006.15.35; Harman S Mitchell, 2006, Gend Med, V3, P254, DOI 10.1016/S1550-8579(06)80214-7; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Issa JP, 2000, CURR TOP MICROBIOL, V249, P101; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; LeBlanc AJ, 2009, AM J PHYSIOL-REG I, V297, pR1713, DOI 10.1152/ajpregu.00178.2009; Lekontseva ON, 2010, MENOPAUSE, V17, P516, DOI 10.1097/gme.0b013e3181c91f04; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Meyer MR, 2009, CARDIOVASC RES, V83, P605, DOI 10.1093/cvr/cvp187; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Miro AM, 2011, J STEROID BIOCHEM, V123, P133, DOI 10.1016/j.jsbmb.2010.12.004; Moien-Afshari F, 2003, MATURITAS, V45, P213, DOI 10.1016/S0378-5122(03)00149-X; Novella S, 2010, EXP GERONTOL, V45, P868, DOI 10.1016/j.exger.2010.07.007; Novensa L, 2010, HYPERTENSION, V56, P405, DOI 10.1161/HYPERTENSIONAHA.110.151969; Oakes CC, 2006, EPIGENETICS-US, V1, P146, DOI 10.4161/epi.1.3.3392; Onetti Y, 2010, HYPERTENSION, V56, P1172; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Riazi S, 2006, KIDNEY INT, V69, P471, DOI 10.1038/sj.ki.5000140; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rubanyi GM, 1997, J CLIN INVEST, V99, P2429, DOI 10.1172/JCI119426; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Sherwood A, 2007, ARTERIOSCL THROM VAS, V27, P1782, DOI 10.1161/ATVBAHA.107.145383; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Sumi D, 2003, P NATL ACAD SCI USA, V100, P14451, DOI 10.1073/pnas.2235590100; Virdis A, 2000, CIRCULATION, V101, P2258, DOI 10.1161/01.CIR.101.19.2258; Wynne FL, 2004, HYPERTENSION, V43, P405, DOI 10.1161/01.HYP.0000111833.82664.0c; Yuan M, 2005, REPROD FERT DEVELOP, V17, P507, DOI 10.1071/RD04099; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009	40	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25335	10.1371/journal.pone.0025335	http://dx.doi.org/10.1371/journal.pone.0025335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966501	gold, Green Published, Green Submitted			2022-12-27	WOS:000295265100090
J	Charge, R; Sorci, G; Hingrat, Y; Lacroix, F; Saint Jalme, M				Charge, Remi; Sorci, Gabriele; Hingrat, Yves; Lacroix, Frederic; Saint Jalme, Michel			Immune-Mediated Change in the Expression of a Sexual Trait Predicts Offspring Survival in the Wild	PLOS ONE			English	Article							CHLAMYDOTIS-UNDULATA-UNDULATA; HOUBARA BUSTARD; INDIRECT SELECTION; JUVENILE SURVIVAL; HATCHING SUCCESS; GENETIC QUALITY; HEALTH-STATUS; MATE CHOICE; BENEFITS; FITNESS	Background: The "good genes'' theory of sexual selection postulates that females choose mates that will improve their offspring's fitness through the inheritance of paternal genes. In spite of the attention that this hypothesis has given rise to, the empirical evidence remains sparse, mostly because of the difficulties of controlling for the many environmental factors that may covary with both the paternal phenotype and offspring fitness. Here, we tested the hypothesis that offspring sired by males of a preferred phenotype should have better survival in an endangered bird, the houbara bustard (Chlamydotis undulata undulata). Methodology/Principal Findings: We tested if natural and experimentally-induced variation in courtship display (following an inflammatory challenge) predicts the survival of offspring. Chicks were produced by artificial insemination of females, ensuring that any effect on survival could only arise from the transfer of paternal genes. One hundred and twenty offspring were equipped with radio transmitters, and their survival monitored in the wild for a year. This allowed assessment of the potential benefits of paternal genes in a natural setting, where birds experience the whole range of environmental hazards. Although natural variation in sire courtship display did not predict offspring survival, sires that withstood the inflammatory insult and maintained their courtship activity sired offspring with the best survival upon release. Conclusions: This finding is relevant both to enlighten the debate on "good genes'' sexual selection and the management of supportive breeding programs.	[Charge, Remi; Saint Jalme, Michel] Museum Natl Hist Nat, F-75231 Paris, France; [Charge, Remi; Hingrat, Yves; Lacroix, Frederic] Emirates Ctr Wildlife Propagat, Missour, Morocco; [Sorci, Gabriele] Univ Bourgogne, Unite Mixte Rech, Ctr Natl Rech Sci, Dijon, France	Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Charge, R (corresponding author), Museum Natl Hist Nat, F-75231 Paris, France.	gabriele.sorci@u-bourgogne.fr	Hingrat, Yves/AAR-3275-2021	Sorci, Gabriele/0000-0002-0799-3995; Hingrat, Yves/0000-0003-2388-8826	Emirates Center for Wildlife Propagation; International Fund for Houbara Conservation (IFHC)	Emirates Center for Wildlife Propagation; International Fund for Houbara Conservation (IFHC)	The study has been funded by the Emirates Center for Wildlife Propagation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to H. H. Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the International Fund for Houbara Conservation (IFHC), and H. E. Mohammed Al Bowardi, Deputy Chairman of IFHC, for their support. We are very grateful to Gwenaelle Leveque, Pierre-Marie Beranger and Stephane Hemon for the breeding and rearing management and to Pierrick Rautureau and the Ecology staff involved in bird survey. Brian Preston greatly improved a previous version of the manuscript.	Anderson WW, 2007, P NATL ACAD SCI USA, V104, P4484, DOI 10.1073/pnas.0611152104; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Charge R, 2010, J ANIM ECOL, V79, P843, DOI 10.1111/j.1365-2656.2010.01696.x; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Evans JP, 2004, P ROY SOC B-BIOL SCI, V271, P2035, DOI 10.1098/rspb.2004.2815; Fiumera AC, 2000, CONSERV BIOL, V14, P886, DOI 10.1046/j.1523-1739.2000.97337.x; FOESTER K, 2003, NATURE, V425, P714; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; GARNETT MC, 1981, IBIS, V123, P31, DOI 10.1111/j.1474-919X.1981.tb00170.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grahn M, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P341; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; Hingrat Y, 2005, ARDEOLA, V52, P91; Hingrat Y, 2008, J AVIAN BIOL, V39, P393, DOI 10.1111/j.0908-8857.2008.03994.x; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; JALME MS, 1994, J REPROD FERTIL, V100, P93, DOI 10.1530/jrf.0.1000093; Jones TM, 1998, P ROY SOC B-BIOL SCI, V265, P1651, DOI 10.1098/rspb.1998.0484; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kotiaho JS, 2007, FUNCT ECOL, V21, P638, DOI 10.1111/j.1365-2435.2007.01286.x; Lesobre L, 2010, CONSERV GENET, V11, P1489, DOI 10.1007/s10592-009-9979-9; Loyau A, 2005, BEHAV ECOL SOCIOBIOL, V58, P552, DOI 10.1007/s00265-005-0958-y; Loyau A, 2010, P ROY SOC B-BIOL SCI, V277, P3453, DOI 10.1098/rspb.2010.0473; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; Maklakov AA, 2009, CURR BIOL, V19, P1903, DOI 10.1016/j.cub.2009.08.058; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Pitcher TE, 2007, CONSERV GENET, V8, P607, DOI 10.1007/s10592-006-9204-z; PRESTON BT, 2011, ECOL LETT IN PRESS; Puurtinen M, 2009, AM NAT, V174, P741, DOI 10.1086/606024; Quader S, 2005, CURR SCI INDIA, V89, P1220; SaintJalme M, 1996, GEN COMP ENDOCR, V102, P102, DOI 10.1006/gcen.1996.0051; Saura M, 2008, CONSERV BIOL, V22, P1277, DOI 10.1111/j.1523-1739.2008.00992.x; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Wedekind C, 2002, CONSERV BIOL, V16, P1204, DOI 10.1046/j.1523-1739.2002.01217.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	42	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25305	10.1371/journal.pone.0025305	http://dx.doi.org/10.1371/journal.pone.0025305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984912	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000023
J	Etcoff, NL; Stock, S; Haley, LE; Vickery, SA; House, DM				Etcoff, Nancy L.; Stock, Shannon; Haley, Lauren E.; Vickery, Sarah A.; House, David M.			Cosmetics as a Feature of the Extended Human Phenotype: Modulation of the Perception of Biologically Important Facial Signals	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; FACES; BEAUTY; COLOR; SEX; AGE; RATIONALITY; IMPRESSIONS; COMPETENCE; STEREOTYPE	Research on the perception of faces has focused on the size, shape, and configuration of inherited features or the biological phenotype, and largely ignored the effects of adornment, or the extended phenotype. Research on the evolution of signaling has shown that animals frequently alter visual features, including color cues, to attract, intimidate or protect themselves from conspecifics. Humans engage in conscious manipulation of visual signals using cultural tools in real time rather than genetic changes over evolutionary time. Here, we investigate one tool, the use of color cosmetics. In two studies, we asked viewers to rate the same female faces with or without color cosmetics, and we varied the style of makeup from minimal (natural), to moderate (professional), to dramatic (glamorous). Each look provided increasing luminance contrast between the facial features and surrounding skin. Faces were shown for 250 ms or for unlimited inspection time, and subjects rated them for attractiveness, competence, likeability and trustworthiness. At 250 ms, cosmetics had significant positive effects on all outcomes. Length of inspection time did not change the effect for competence or attractiveness. However, with longer inspection time, the effect of cosmetics on likability and trust varied by specific makeup looks, indicating that cosmetics could impact automatic and deliberative judgments differently. The results suggest that cosmetics can create supernormal facial stimuli, and that one way they may do so is by exaggerating cues to sexual dimorphism. Our results provide evidence that judgments of facial trustworthiness and attractiveness are at least partially separable, that beauty has a significant positive effect on judgment of competence, a universal dimension of social cognition, but has a more nuanced effect on the other universal dimension of social warmth, and that the extended phenotype significantly influences perception of biologically important signals at first glance and at longer inspection.	[Etcoff, Nancy L.; Haley, Lauren E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Etcoff, Nancy L.; Haley, Lauren E.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Stock, Shannon] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Vickery, Sarah A.] Procter & Gamble Cosmet, Procter & Gamble Beauty & Grooming, Hunt Valley, MD USA; [House, David M.] Boston Univ, Dept Comp Sci, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Dana-Farber Cancer Institute; Procter & Gamble; Boston University	Etcoff, NL (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	netcoff@partners.org			P&G Beauty and Grooming	P&G Beauty and Grooming	This study was funded by P&G Beauty and Grooming, where Sarah A. Vickery is employed as a Principal Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BERRY DS, 1986, PSYCHOL BULL, V100, P3, DOI 10.1037/0033-2909.100.1.3; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; CORSON R, 1972, FASHIONS MAKCUP ANCI; Dawkins R., 1989, EXTENDED PHENOTYPE; Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Etcoff N., 1999, SURVIVAL PRETTIEST S; ETCOFF NL, 1994, NATURE, V368, P186, DOI 10.1038/368186a0; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; FRIEZE IH, 1991, J APPL SOC PSYCHOL, V21, P1039, DOI 10.1111/j.1559-1816.1991.tb00458.x; FRIEZE IH, 1990, J APPL SOC PSYCHOL, V20, P46, DOI 10.1111/j.1559-1816.1990.tb00377.x; *GLOB IND AN INC, 2010, COL COSM GLOB STRAT; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Huguet P, 2004, J APPL SOC PSYCHOL, V34, P1752, DOI 10.1111/j.1559-1816.2004.tb02796.x; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kyle DJ, 1996, PSYCHOL WOMEN QUART, V20, P447, DOI 10.1111/j.1471-6402.1996.tb00311.x; Marlowe CM, 1996, J APPL PSYCHOL, V81, P11, DOI 10.1037/0021-9010.81.1.11; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Mobius MM, 2006, AM ECON REV, V96, P222, DOI 10.1257/000282806776157515; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Nash R, 2006, J APPL SOC PSYCHOL, V36, P493, DOI 10.1111/j.0021-9029.2006.00016.x; *NPD GROUP INC, 2010, MAK IN DEPTH CONS RE; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Riordan T., 2004, INVENTING BEAUTY; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Russell R, 2009, PERCEPTION, V38, P1211, DOI 10.1068/p6331; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Symons D., 1995, SEXUAL NATURE SEXUAL; Tinbergen N., 1953, HERRING GULLS WORLD; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Trivers R. L., 1985, SOCIAL EVOLUTION; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Walter P, 1999, NATURE, V397, P483, DOI 10.1038/17240; WEBSTER M, 1983, AM J SOCIOL, V89, P140, DOI 10.1086/227836; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	41	118	118	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25656	10.1371/journal.pone.0025656	http://dx.doi.org/10.1371/journal.pone.0025656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	21991328	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000052
J	Martel, V; Schlyter, F; Ignell, R; Hansson, BS; Anderson, P				Martel, Veronique; Schlyter, Fredrik; Ignell, Rickard; Hansson, Bill S.; Anderson, Peter			Mosquito Feeding Affects Larval Behaviour and Development in a Moth	PLOS ONE			English	Article							GNATHIID ISOPODS; AEDES-AEGYPTI; GROWTH; SIZE; FECUNDITY; SURVIVAL; MICROPREDATORS; PATTERNS; DEFENSES; INSECTS	Organisms are attacked by different natural enemies present in their habitat. While enemies such as parasitoids and predators will kill their hosts/preys when they successfully attack them, enemies such as micropredators will not entirely consume their prey. However, they can still have important consequences on the performance and ecology of the prey, such as reduced growth, increased emigration, disease transmission. In this paper, we investigated the impact of a terrestrial micropredator, the yellow fever mosquito Aedes aegypti, on its unusual invertebrate host, the Egyptian cotton leaf worm, Spodoptera littoralis. Larvae developing in presence of mosquitoes showed a slower development and reached a smaller pupal weight when compared to a control without mosquitoes, apparently because of a reduced feeding time for larvae. In addition, larvae tended to leave the plant in presence of mosquitoes. These results suggest that mosquitoes act as micropredators and affects lepidopteran larvae behaviour and development. Ecological impacts such as higher risks of food depletion and longer exposure to natural enemies are likely to be costly consequences. The importance of this phenomenon in nature - the possible function as last resort when vertebrates are unavailable - and the evolutionary aspects are discussed.	[Martel, Veronique; Schlyter, Fredrik; Ignell, Rickard; Anderson, Peter] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden; [Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Swedish University of Agricultural Sciences; Max Planck Society	Martel, V (corresponding author), Univ Rennes 1, UMR CNRS Ecobio 6553, Rennes, France.	veronique.martel@mail.mcgill.ca	Martel, Véronique/Q-5127-2019; Hansson, Bill S/G-2774-2013; Schlyter, Fredrik/F-8567-2015	Martel, Véronique/0000-0001-8111-5931; Hansson, Bill S/0000-0002-4811-1223; Schlyter, Fredrik/0000-0002-1244-0308	Formas; Fonds Quebecois de Recherche sur la Nature et les Technologies	Formas(Swedish Research Council Formas); Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT)	This research was funded as a part of the Linnaeus-program Insect Chemical Ecology, Ethology and Evolution IC-E3 funded by Formas. VM was supported by a postdoctoral fellowship from the Fonds Quebecois de Recherche sur la Nature et les Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashov YS., 2006, ENTOMOL REV, V86, P957, DOI [10.1134/S0013873806080112, DOI 10.1134/S0013873806080112]; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; BUTLIN RK, 1985, HEREDITY, V54, P107, DOI 10.1038/hdy.1985.14; CLANCY KM, 1987, ECOLOGY, V68, P733, DOI 10.2307/1938479; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; EDMAN JD, 1987, INSECT SCI APPL, V8, P617, DOI 10.1017/S1742758400022694; FOLSTAD I, 1991, CAN J ZOOL, V69, P2423, DOI 10.1139/z91-340; Gordon AS, 2005, HARMFUL ALGAE, V4, P423, DOI 10.1016/j.hal.2004.07.003; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Grutter AS, 2008, CORAL REEFS, V27, P655, DOI 10.1007/s00338-008-0377-4; Hagen H, 1883, ENTOMOL MON MAG, V19, P254; HARDY ICW, 1992, J ANIM ECOL, V61, P121, DOI 10.2307/5515; HARRIS P, 1969, SCIENCE, V164, P184, DOI 10.1126/science.164.3876.184; HARRIS P, 1969, NATURE, V222, P1264, DOI 10.1038/2221264a0; HINKS CF, 1976, CAN ENTOMOL, V108, P1345, DOI 10.4039/Ent1081345-12; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Howard L. O., 1912, MOSQUITOES N CENTRAL, V1; Jones CM, 2008, CORAL REEFS, V27, P677, DOI 10.1007/s00338-008-0383-6; Kuris AM, 2000, DEV AN VET, V32, P9; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Loxdale HD, 1999, PHILOS T R SOC B, V354, P1479, DOI 10.1098/rstb.1999.0492; MCIVER SB, 1968, J MED ENTOMOL, V5, P422, DOI 10.1093/jmedent/5.4.422; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; OSMAN RW, 1992, MAR ECOL PROG SER, V83, P35, DOI 10.3354/meps083035; Penfold R, 2008, MAR ECOL PROG SER, V357, P111, DOI 10.3354/meps07312; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Quicke D. L. J., 1997, PARASITIC WASPS; Ramos JA, 2001, AUK, V118, P709, DOI 10.1642/0004-8038(2001)118[0709:APAEOT]2.0.CO;2; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; *SERV MW, 1993, MOSQ EC FIELD SAMPL; STEELMAN CD, 1976, ANNU REV ENTOMOL, V21, P155, DOI 10.1146/annurev.en.21.010176.001103; WAAGE JK, 1979, BIOL J LINN SOC, V12, P187, DOI 10.1111/j.1095-8312.1979.tb00055.x; Weisser Wolfgang W., 2001, P180	35	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25658	10.1371/journal.pone.0025658	http://dx.doi.org/10.1371/journal.pone.0025658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991329	gold, Green Published			2022-12-27	WOS:000295943000053
J	Viscosi, V; Cardini, A				Viscosi, Vincenzo; Cardini, Andrea			Leaf Morphology, Taxonomy and Geometric Morphometrics: A Simplified Protocol for Beginners	PLOS ONE			English	Article							COROLLA SHAPE; QUERCUS; EVOLUTION; GROWTH; PLANT; HYBRIDIZATION; HETEROCHRONY; DIVERGENCE; SELECTION; PATTERNS	Taxonomy relies greatly on morphology to discriminate groups. Computerized geometric morphometric methods for quantitative shape analysis measure, test and visualize differences in form in a highly effective, reproducible, accurate and statistically powerful way. Plant leaves are commonly used in taxonomic analyses and are particularly suitable to landmark based geometric morphometrics. However, botanists do not yet seem to have taken advantage of this set of methods in their studies as much as zoologists have done. Using free software and an example dataset from two geographical populations of sessile oak leaves, we describe in detailed but simple terms how to: a) compute size and shape variables using Procrustes methods; b) test measurement error and the main levels of variation (population and trees) using a hierachical design; c) estimate the accuracy of group discrimination; d) repeat this estimate after controlling for the effect of size differences on shape (i.e., allometry). Measurement error was completely negligible; individual variation in leaf morphology was large and differences between trees were generally bigger than within trees; differences between the two geographic populations were small in both size and shape; despite a weak allometric trend, controlling for the effect of size on shape slighly increased discrimination accuracy. Procrustes based methods for the analysis of landmarks were highly efficient in measuring the hierarchical structure of differences in leaves and in revealing very small-scale variation. In taxonomy and many other fields of botany and biology, the application of geometric morphometrics contributes to increase scientific rigour in the description of important aspects of the phenotypic dimension of biodiversity. Easy to follow but detailed step by step example studies can promote a more extensive use of these numerical methods, as they provide an introduction to the discipline which, for many biologists, is less intimidating than the often inaccessible specialistic literature.	[Viscosi, Vincenzo] Univ Molise, Museo Erbario Molise, Dipartimento Sci & Tecnol Ambiente & Terr, Pesche, Italy; [Cardini, Andrea] Univ Modena & Reggio Emilia, Dipartimento Biol, Modena, Italy; [Cardini, Andrea] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Cardini, Andrea] Univ Western Australia, Ctr Forens Sci, Crawley, WA, Australia	University of Molise; Universita di Modena e Reggio Emilia; University of Hull; University of York - UK; University of Western Australia	Viscosi, V (corresponding author), Univ Molise, Museo Erbario Molise, Dipartimento Sci & Tecnol Ambiente & Terr, Pesche, Italy.	vincenzo.viscosi@unimol.it	cardini, andrea/G-9951-2011	cardini, andrea/0000-0003-2910-632X				Adams DC, 2011, J HUM EVOL, V60, P240, DOI 10.1016/j.jhevol.2010.02.003; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Albrecht G.H., 1992, Human Evolution, V7, P49, DOI 10.1007/BF02436412; ANTONECCHIA G, 2011, THESIS U MOLISE PESC; Bell A. D., 2008, PLANT FORM ILLUSTRAT; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Breuker CJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000007; Buchanan B, 2010, J ARCHAEOL SCI, V37, P350, DOI 10.1016/j.jas.2009.09.047; Cardini A, 2009, ETHOL ECOL EVOL, V21, P209, DOI 10.1080/08927014.2009.9522476; Cardini A, 2008, J HUM EVOL, V54, P615, DOI 10.1016/j.jhevol.2007.09.022; Cardini A, 2011, INT J PRIMATOL, V32, P377, DOI 10.1007/s10764-010-9475-6; Cardini A, 2009, GLOBAL ECOL BIOGEOGR, V18, P248, DOI 10.1111/j.1466-8238.2008.00432.x; Chickarmane V, 2010, ANNU REV PLANT BIOL, V61, P65, DOI 10.1146/annurev-arplant-042809-112213; Claude J, 2008, MORPHOMETRICS R; Debat V, 2009, EVOLUTION, V63, P2864, DOI 10.1111/j.1558-5646.2009.00774.x; deQueiroz K, 1997, Q REV BIOL, V72, P3, DOI 10.1086/419656; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Elton S, 2010, BIOL J LINN SOC, V101, P823, DOI 10.1111/j.1095-8312.2010.01504.x; Fadda C, 2001, J ZOOL SYST EVOL RES, V39, P235, DOI 10.1046/j.1439-0469.2001.00169.x; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Friess M, 2003, AM J PHYS ANTHROPOL, V122, P11, DOI 10.1002/ajpa.10286; Gomez JM, 2009, ECOL MONOGR, V79, P245, DOI 10.1890/08-0511.1; Gomez JM, 2008, P ROY SOC B-BIOL SCI, V275, P2241, DOI 10.1098/rspb.2008.0512; Gomez JM, 2009, EVOLUTION, V63, P1820, DOI 10.1111/j.1558-5646.2009.00667.x; GOULD SJ, 1971, AM NAT, V105, P113, DOI 10.1086/282710; Hammer O, 2011, PAST VER 2 09; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Howell D, 2002, STAT METHODS PSYCHOL; Huttegger SM, 2011, EVOL BIOL, V38, P335, DOI 10.1007/s11692-011-9123-x; JENSEN RJ, 1990, AM J BOT, V77, P1279, DOI 10.2307/2444589; Jensen RJ, 2003, TAXON, V52, P663, DOI 10.2307/3647340; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; JENSEN RJ, 1993, AM J BOT, V80, P1358, DOI 10.2307/2445721; Klingenberg CP, 2008, EVOL BIOL, V35, P186, DOI 10.1007/s11692-008-9029-4; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2002, EVOLUTION, V56, P1909; KOVAROVIC K, J ARCHAEOL IN PRESS; KOVAROVIC K, 2011, J ARCHAEOL IN PRESS; Legendre P., 2012, NUMERICAL ECOLOGY; Albarran-Lara AL, 2010, INT J PLANT SCI, V171, P310, DOI 10.1086/650317; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Manly BFJ, 1997, RANDOMISATION BOOTST; Penaloza-Ramirez JM, 2010, ANN BOT-LONDON, V105, P389, DOI 10.1093/aob/mcp301; Marcus Leslie F., 2000, Hystrix, V11, P27; MARCUS LF, 1990, P MICH MORPH WORKSH; McDonald J.H., 2009, HDB BIOL STAT; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Neff N. A., 1980, SURVEY MULTIVARIATE; OHIGGINS P, 2007, FOURIER DESCRIPTORS; Oxnard Charles, 2009, Biology Theory, V4, P84, DOI 10.1162/biot.2009.4.1.84; Rohlf F.J., 2010, TPS SERIES; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2003, J HUM EVOL, V44, P665, DOI 10.1016/S0047-2484(03)00047-2; Rohlf FJ, 1996, SYST BIOL, V45, P344, DOI 10.2307/2413569; Rohlf FJ, 2000, AM J PHYS ANTHROPOL, V111, P463, DOI 10.1002/(SICI)1096-8644(200004)111:4<463::AID-AJPA3>3.0.CO;2-B; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; ROHLF FJ, 1981, SYST ZOOL, V30, P459, DOI 10.2307/2413054; Rohlf FJ, 2000, HYSTRIX, V11, P8; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sanfilippo PG, 2009, PROG RETIN EYE RES, V28, P227, DOI 10.1016/j.preteyeres.2009.05.004; SHEETS HD, 2006, FRONT ZOOL, V3, P2; Sokal R.R., 2012, BIOMETRY; STANLEY SM, 1987, PALEOBIOLOGY, V13, P113; Stone GN, 2011, PHILOS T R SOC B, V366, P1410, DOI 10.1098/rstb.2010.0311; THOMPSON DW, 1917, GROWTH FORMS; Tsukaya H, 1995, J PLANT RES, V108, P407, DOI 10.1007/BF02344229; van der Niet T, 2010, TRENDS PLANT SCI, V15, P423, DOI 10.1016/j.tplants.2010.05.005; Viscosi V, 2009, PLANT BIOSYST, V143, P564, DOI 10.1080/11263500902723129; Viscosi V, 2009, PLANT BIOSYST, V143, P575, DOI 10.1080/11263500902775277; VISCOSI V, 2011, NORD J BOT IN PRESS; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; ZELDITCH ML, 1992, EVOLUTION, V46, P1164, DOI 10.1111/j.1558-5646.1992.tb00626.x	81	247	266	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25630	10.1371/journal.pone.0025630	http://dx.doi.org/10.1371/journal.pone.0025630			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991324	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000048
J	Engel, ME; Stander, R; Vogel, J; Adeyemo, AA; Mayosi, BM				Engel, Mark E.; Stander, Raphaella; Vogel, Jonathan; Adeyemo, Adebowale A.; Mayosi, Bongani M.			Genetic Susceptibility to Acute Rheumatic Fever: A Systematic Review and Meta-Analysis of Twin Studies	PLOS ONE			English	Review							DISEASE; CANCER	Background: Acute rheumatic fever is considered to be a heritable condition, but the magnitude of the genetic effect is unknown. The objective of this study was to conduct a systematic review and meta-analysis of twin studies of concordance of acute rheumatic fever in order to derive quantitative estimates of the size of the genetic effect. Methods: We searched PubMed/MEDLINE, ISI Web of Science, EMBASE, and Google Scholar from their inception to 31 January 2011, and bibliographies of retrieved articles, for twin studies of the concordance for acute rheumatic fever or rheumatic heart disease in monozygotic versus dizygotic twins that used accepted diagnostic criteria for acute rheumatic fever and zygosity without age, gender or language restrictions. Twin similarity was measured by probandwise concordance rate and odds ratio (OR), and aggregate probandwise concordance risk was calculated by combining raw data from each study. ORs from separate studies were combined by random-effects meta-analysis to evaluate association between zygosity status and concordance. Heritability was estimated by fitting a variance components model to the data. Results: 435 twin pairs from six independent studies met the inclusion criteria. The pooled probandwise concordance risk for acute rheumatic fever was 44% in monozygotic twins and 12% in dizygotic twins, and the association between zygosity and concordance was strong (OR 6.39; 95% confidence interval, 3.39 to 12.06; P<0.001), with no significant study heterogeneity (P = 0.768). The estimated heritability across all the studies was 60%. Conclusions: Acute rheumatic fever is an autoimmune disorder with a high heritability. The discovery of all genetic susceptibility loci through whole genome scanning may provide a clinically useful genetic risk prediction tool for acute rheumatic fever and its sequel, rheumatic heart disease.	[Engel, Mark E.; Stander, Raphaella; Vogel, Jonathan; Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Engel, Mark E.; Stander, Raphaella; Vogel, Jonathan; Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Adeyemo, Adebowale A.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA	University of Cape Town; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Engel, ME (corresponding author), Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa.	bongani.mayosi@uct.ac.za	Engel, Mark/AAP-6570-2020	Engel, Mark/0000-0002-1334-8829; Adeyemo, Adebowale/0000-0002-3105-3231; Mayosi, Bongani/0000-0001-6641-8950	South African Medical Research Council; National Research Foundation of South Africa; Lily and Hausmann Research Trust	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa); Lily and Hausmann Research Trust	Dr. A. A. Adeyemo was a Mellon Visiting Scholar to the University of Cape Town in July 2007 when the study was initiated. This study was funded in part by the South African Medical Research Council, National Research Foundation of South Africa, and Lily and Hausmann Research Trust. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; BENEVOLENSKAYA L I, 1973, Voprosy Revmatizma, V13, P33; BENEVOLENSKAYA L I, 1980, Voprosy Revmatizma, P26; Bobylev V Ia, 1972, Vopr Okhr Materin Det, V17, P20; Bryant PA, 2009, CIRCULATION, V119, P742, DOI 10.1161/CIRCULATIONAHA.108.792135; Denbow CE, 1999, W INDIAN MED J, V48, P242; Dixon A S, 1969, Bristol Med Chir J, V84, P125; Giannini G, 1967, G Mal Infett Parassit, V19, P105; HONEYMAN MS, 1971, ACTA GENET MED GEMEL, V20, P189, DOI 10.1017/S1120962300011616; Horne BD, 2004, CIRCULATION, V110, P3143, DOI 10.1161/01.CIR.0000147189.85636.C3; Irvine-Jones E, 1933, AM J DIS CHILD, V45, P1184; KAUFMAN O, 1938, Z MENSCHL VERERB KON, V21, P687; Mack TM, 2002, BRIT J CANCER, V87, P294, DOI 10.1038/sj.bjc.6600429; Paul JR, 1941, AM J PUBLIC HEALTH N, V31, P611, DOI 10.2105/AJPH.31.6.611; Paul JR, 1931, J CLIN INVEST, V10, P33, DOI 10.1172/JCI100340; PERRY CB, 1940, ARCH DIS CHILD, V15, P179; PHILLIPS DIW, 1993, LANCET, V342, P52, DOI 10.1016/0140-6736(93)91916-A; Prasad S, 1967, Indian Pediatr, V4, P290; QUINN RW, 1967, AM J EPIDEMIOL, V85, P120, DOI 10.1093/oxfordjournals.aje.a120669; REED S, 1964, PARENTHOOD HEREDITY; SPAGNUOLO M, 1968, NEW ENGL J MED, V278, P183, DOI 10.1056/NEJM196801252780403; Sterne JAC, 2001, SYSTEMATIC REV HLTH, P347, DOI [DOI 10.1002/9780470693926.CH18, 10.1002/9780470693926.ch18]; STEVENSON AC, 1953, ANN EUGENIC, V17, P177; Strusberg A M, 1968, Rev Fac Cienc Med Cordoba, V26, P219; TARANTA A, 1959, CIRCULATION, V20, P778; Uribarri G, 1965, Rev Clin Esp, V97, P410; Watkins DA, 2009, SCIENCE, V324, P37, DOI 10.1126/science.324.5923.37b; Wilson MG, 1937, J CLIN INVEST, V16, P555, DOI 10.1172/JCI100882; Zajicek M, 1966, Cesk Pediatr, V21, P250	29	72	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25326	10.1371/journal.pone.0025326	http://dx.doi.org/10.1371/journal.pone.0025326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980428	gold, Green Published, Green Submitted			2022-12-27	WOS:000295941300024
J	Gomes, CS; Izar, B; Pazan, F; Mohamed, W; Abu Mraheil, M; Mukherjee, K; Billion, A; Aharonowitz, Y; Chakraborty, T; Hain, T				Gomes, Christa Seifart; Izar, Benjamin; Pazan, Farhad; Mohamed, Walid; Abu Mraheil, Mobarak; Mukherjee, Krishnendu; Billion, Andre; Aharonowitz, Yair; Chakraborty, Trinad; Hain, Torsten			Universal Stress Proteins Are Important for Oxidative and Acid Stress Resistance and Growth of Listeria monocytogenes EGD-e In Vitro and In Vivo	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; GENE-EXPRESSION; VIRULENCE; SALMONELLA; SURVIVAL; SIGMA(B); REGULATOR; CLONING; USPA	Background: Pathogenic bacteria maintain a multifaceted apparatus to resist damage caused by external stimuli. As part of this, the universal stress protein A (UspA) and its homologues, initially discovered in Escherichia coli K-12 were shown to possess an important role in stress resistance and growth in several bacterial species. Methods and Findings: We conducted a study to assess the role of three homologous proteins containing the UspA domain in the facultative intracellular human pathogen Listeria monocytogenes under different stress conditions. The growth properties of three UspA deletion mutants (Delta lmo0515, Delta lmo1580 and Delta lmo2673) were examined either following challenge with a sublethal concentration of hydrogen peroxide or under acidic conditions. We also examined their ability for intracellular survival within murine macrophages. Virulence and growth of usp mutants were further characterized in invertebrate and vertebrate infection models. Tolerance to acidic stress was clearly reduced in Dlmo1580 and Dlmo0515, while oxidative stress dramatically diminished growth in all mutants. Survival within macrophages was significantly decreased in Dlmo1580 and Dlmo2673 as compared to the wild-type strain. Viability of infected Galleria mellonella larvae was markedly higher when injected with Dlmo1580 or Dlmo2673 as compared to wild-type strain inoculation, indicating impaired virulence of bacteria lacking these usp genes. Finally, we observed severely restricted growth of all chromosomal deletion mutants in mice livers and spleens as compared to the load of wild-type bacteria following infection. Conclusion: This work provides distinct evidence that universal stress proteins are strongly involved in listerial stress response and survival under both in vitro and in vivo growth conditions.	[Gomes, Christa Seifart; Izar, Benjamin; Pazan, Farhad; Mohamed, Walid; Abu Mraheil, Mobarak; Billion, Andre; Chakraborty, Trinad; Hain, Torsten] Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Mukherjee, Krishnendu] Univ Giessen, Inst Phytopathol & Appl Zool, Giessen, Germany; [Aharonowitz, Yair] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Justus Liebig University Giessen; Justus Liebig University Giessen; Tel Aviv University	Gomes, CS (corresponding author), Univ Giessen, Inst Med Microbiol, Giessen, Germany.	torsten.hain@mikrobio.med.uni-giessen.de	Mukherjee, Krishnendu/U-7159-2017; Mukherjee, Krishnendu/A-8186-2011	Mukherjee, Krishnendu/0000-0003-3470-9117; 	German Federal Ministry of Education and Research (BMBF, ERA-NET PathoGenomics Network) [sncRNAomics 0315437A, LISTRESS 0315907A]	German Federal Ministry of Education and Research (BMBF, ERA-NET PathoGenomics Network)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF, ERA-NET PathoGenomics Network projects sncRNAomics 0315437A to TH and LISTRESS 0315907A to TH and TC) and through the LOEWE program of the state Hessia by the collaborative research project Insect Biotechnology to TH and TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaha CAG, 2003, ANTON LEEUW INT J G, V83, P35, DOI 10.1023/A:1022937828186; Boes N, 2008, J BACTERIOL, V190, P7189, DOI 10.1128/JB.00600-08; Boes N, 2006, J BACTERIOL, V188, P6529, DOI 10.1128/JB.00308-06; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Chen J, 2007, J FOOD PROTECT, V70, P2392, DOI 10.4315/0362-028X-70.10.2392; Chen W, 2006, FEMS MICROBIOL LETT, V264, P15, DOI 10.1111/j.1574-6968.2006.00426.x; Cotter PD, 2000, INT J FOOD MICROBIOL, V60, P137, DOI 10.1016/S0168-1605(00)00305-6; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Ferreira A, 2003, APPL ENVIRON MICROB, V69, P2692, DOI 10.1128/AEM.69.5.2692-2698.2003; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Glaser P, 2001, SCIENCE, V294, P849; Gury J, 2009, APPL ENVIRON MICROB, V75, P5273, DOI 10.1128/AEM.00774-09; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kuenne CT, 2007, BIOINFORMATICS, V23, P125, DOI 10.1093/bioinformatics/btl556; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Licandro-Seraut H, 2008, J MOL MICROB BIOTECH, V14, P41, DOI 10.1159/000106081; Liu WT, 2007, MICROB PATHOGENESIS, V42, P2, DOI 10.1016/j.micpath.2006.09.002; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; O'Toole R, 2003, J BACTERIOL, V185, P1543, DOI 10.1128/JB.185.5.1543-1554.2003; Persson O, 2007, MOL MICROBIOL, V65, P968, DOI 10.1111/j.1365-2958.2007.05838.x; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Sagurthi SR, 2007, ACTA CRYSTALLOGR F, V63, P957, DOI 10.1107/S1744309107048610; SCHAFERKORDT S, 1995, BIOTECHNIQUES, V19, P720; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Sousa MC, 2001, STRUCTURE, V9, P1135, DOI 10.1016/S0969-2126(01)00680-3; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wemekamp-Kamphuis HH, 2004, APPL ENVIRON MICROB, V70, P3457, DOI 10.1128/AEM.70.6.3457-3466.2004; 2007, MICROBIOLOGY, V153, P3593	38	52	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24965	10.1371/journal.pone.0024965	http://dx.doi.org/10.1371/journal.pone.0024965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980369	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300015
J	Lackner, P; Beer, R; Broessner, G; Helbok, R; Dallago, K; Hess, MW; Pfaller, K; Bandtlow, C; Schmutzhard, E				Lackner, Peter; Beer, Ronny; Broessner, Gregor; Helbok, Raimund; Dallago, Karolin; Hess, Michael W.; Pfaller, Kristian; Bandtlow, Christine; Schmutzhard, Erich			Nogo-A Expression in the Brain of Mice with Cerebral Malaria	PLOS ONE			English	Article							NEURITE OUTGROWTH INHIBITOR; FALCIPARUM-MALARIA; INJURY; IDENTIFICATION; REGENERATION; APOPTOSIS; CHILDREN; SURVIVAL; SEQUELAE; PROFILE	Cerebral malaria (CM) is associated with a high rate of transient or persistent neurological sequelae. Nogo-A, a protein that is highly expressed in the endoplasmic reticulum (ER) of the mammalian central nervous system (CNS), is involved in neuronal regeneration and synaptic plasticity in the injured CNS. The current study investigates the role of Nogo-A in the course of experimental CM. C57BL/6J mice were infected with Plasmodium berghei ANKA blood stages. Brain homogenates of mice with different clinical severity levels of CM, infected animals without CM and control animals were analyzed for Nogo-A up-regulation by Western blotting and immunohistochemistry. Brain regions with Nogo-A upregulation were evaluated by tansmission electron microscopy. Densitometric analysis of Western blots yielded a statistically significant upregulation of Nogo-A in mice showing moderate to severe CM. The number of neurons and oligodendrocytes positive for Nogo-A did not differ significantly between the studied groups. However, mice with severe CM showed a significantly higher number of cells with intense Nogo-A staining in the brain stem. In this region ultrastructural alterations of the ER were regularly observed. Nogo-A is upregulated during the early course of experimental CM. In the brain stem of severely affected animals increased Nogo-A expression and ultrastructural changes of the ER were observed. These data indicate a role of Nogo-A in neuronal stress response during experimental CM.	[Lackner, Peter; Beer, Ronny; Broessner, Gregor; Helbok, Raimund; Dallago, Karolin; Schmutzhard, Erich] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Hess, Michael W.; Pfaller, Kristian] Innsbruck Med Univ, Div Histol & Embryol, Innsbruck, Austria; [Bandtlow, Christine] Innsbruck Med Univ, Div Neurobiochem, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Lackner, P (corresponding author), Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria.	peter.lackner@i-med.ac.at	Helbok, Raimund/AAA-8361-2021; Hess, Michael/AAE-1985-2019	Hess, Michael/0000-0002-5154-3553; Schmutzhard, Erich/0000-0003-3295-7491	Asia-European University Network	Asia-European University Network	This study was supported by the Asia-European University Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baka ID, 1996, MOL CELL NEUROSCI, V7, P289, DOI 10.1006/mcne.1996.0022; Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F; Bandtlow CE, 2004, EUR J NEUROSCI, V20, P195, DOI 10.1111/j.1460-9568.2004.03470.x; Buchli AD, 2007, NEURODEGENER DIS, V4, P51, DOI 10.1159/000100359; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Carter JA, 2003, BRAIN INJURY, V17, P217, DOI 10.1080/0269905021000038447; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Clark H, 1945, MALARIOLOGY, P874; Clausen F, 2010, J NEUROTRAUMA; Delekate A, 2011, P NATL ACAD SCI US; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hens J, 1998, CELL TISSUE RES, V292, P229, DOI 10.1007/s004410051054; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; Kampfl A, 1997, AM J TROP MED HYG, V56, P585, DOI 10.4269/ajtmh.1997.56.585; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Lackner P, 2007, NEUROPATH APPL NEURO, V33, P560, DOI 10.1111/j.1365-2990.2007.00833.x; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Lackner P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-116; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Liu HP, 2002, NEUROSCI LETT, V328, P257, DOI 10.1016/S0304-3940(02)00528-1; Ma N, 1997, J INFECT DIS, V175, P1480, DOI 10.1086/516483; Marchiafava E., 1894, MALARIA PARASITES MA, V15, P1; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Medana IM, 2007, NEUROPATH APPL NEURO, V33, P179, DOI 10.1111/j.1365-2990.2006.00777.x; Medana IM, 2007, J NEUROL SCI, V258, P93, DOI 10.1016/j.jns.2007.03.005; Meier S, 2003, FASEB J, V17, P1153, DOI 10.1096/fj.02-0453fje; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Oertle T, 2003, J NEUROSCI, V23, P5393; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Penet MF, 2005, J NEUROSCI, V25, P7352, DOI 10.1523/JNEUROSCI.1002-05.2005; Sasaki S, 2010, J NEUROPATH EXP NEUR, V69, P346, DOI 10.1097/NEN.0b013e3181d44992; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; SCHMUTZHARD E, 1984, T ROY SOC TROP MED H, V78, P351, DOI 10.1016/0035-9203(84)90118-4; Teng FYH, 2008, J CELL PHYSIOL, V216, P303, DOI 10.1002/jcp.21434; Villalobos V, 2009, BIOCELL, V33, P187; Wang H, 2006, BRAIN RES, V1114, P212, DOI 10.1016/j.brainres.2006.07.056; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3; Yang YS, 2009, J NEUROSCI, V29, P13850, DOI 10.1523/JNEUROSCI.2312-09.2009; Zhang F, 2006, J NEUROCHEM, V98, P102, DOI 10.1111/j.1471-4159.2006.03838.x	46	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25728	10.1371/journal.pone.0025728	http://dx.doi.org/10.1371/journal.pone.0025728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980529	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600050
J	Song, RR; Zou, L; Zhong, R; Zheng, XW; Zhu, BB; Chen, W; Liu, L; Miao, XP				Song, Ran-Ran; Zou, Li; Zhong, Rong; Zheng, Xia-Wen; Zhu, Bei-Bei; Chen, Wei; Liu, Li; Miao, Xiao-Ping			An Integrated Meta-Analysis of Two Variants in HOXA1/HOXB1 and Their Effect on the Risk of Autism Spectrum Disorders	PLOS ONE			English	Article							HOXA1 A218G POLYMORPHISM; ALLELIC VARIANTS; GENE VARIANTS; ASSOCIATION; HOXB1; PREVALENCE	Background: HOXA1 and HOXB1 have been strongly posed as candidate genes for autism spectrum disorders (ASD) given their important role in the development of hindbrain. The A218G (rs10951154) in HOXA1 and the insertion variant in HOXB1 (nINS/INS, rs72338773) were of special interest for ASD but with inconclusive results. Thus, we conducted a meta-analysis integrating case-control and transmission/disequilibrium test (TDT) studies to clearly discern the effect of these two variants in ASD. Methods and Findings:Multiple electronic databases were searched to identify studies assessing the A218G and/or nINS/INS variant in ASD. Data from case-control and TDT studies were analyzed in an allelic model using the Catmap software. A total of 10 and 7 reports were found to be eligible for meta-analyses of A218G and nINS/INS variant, respectively. In overall meta-analysis, the pooled OR for the 2186 allele and the INS allele was 0.97 (95% CI = 0.76-1.25, P-heterogeneity = 0.029) and 1.14(95% CI = 0.97-1.33, P-heterogeneity = 0.269), respectively. No significant association was also identified between these two variants and ASD risk in stratified analysis. Further, cumulative meta-analysis in chronologic order showed the inclination toward null-significant association for both variants with continual adding studies. Additionally, although the between study heterogeneity regarding the A218G is not explained by study design, ethnicity, and sample size, the sensitive analysis indicated the stability of the result. Conclusions: This meta-analysis suggests the HOXA1 A218G and HOXB1 nINS/INS variants may not contribute significantly to ASD risk.	[Song, Ran-Ran] Huangzhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan, Peoples R China; [Zou, Li; Zhong, Rong; Zheng, Xia-Wen; Zhu, Bei-Bei; Chen, Wei; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zou, Li; Zhong, Rong; Zheng, Xia-Wen; Zhu, Bei-Bei; Chen, Wei; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangdong Pharmaceutical University; Guangdong Pharmaceutical University	Song, RR (corresponding author), Huangzhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan, Peoples R China.	pupuliu919@gmail.com; miaoxp@mail.hust.edu.cn	miao, xiaoping/C-4336-2011; Song, Ranran/Z-3997-2019	miao, xiaoping/0000-0002-6818-9722; Song, Ranran/0000-0002-8354-7698	fundamental research funds for the central universities [2010MS124, 2010QN005]; Program for New Century Excellent Talents in University [NCET-10-0388]	fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the fundamental research funds for the central universities (HUST: NO.2010MS124) to Ran-Ran Song and the fundamental research funds for the central universities (HUST: NO.2010QN005) and Program for New Century Excellent Talents in University (NCET-10-0388) to Xiao-Ping Miao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Butler MG, 2002, J MED GENET, V39, P202, DOI 10.1136/jmg.39.3.202; Collins JS, 2003, J AUTISM DEV DISORD, V33, P343, DOI 10.1023/A:1024414803151; Conciatori M, 2004, BIOL PSYCHIAT, V55, P413, DOI 10.1016/j.biopsych.2003.10.005; Courchesne E, 1997, CURR OPIN NEUROBIOL, V7, P269, DOI 10.1016/S0959-4388(97)80016-5; Devlin B, 2002, AM J MED GENET, V114, P667, DOI 10.1002/ajmg.10603; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faiella Antonio, 1998, Human Mutation, V12, P363; Fombonne E, 2003, JAMA-J AM MED ASSOC, V289, P87, DOI 10.1001/jama.289.1.87; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Gallagher L, 2004, AM J MED GENET B, V124B, P64, DOI 10.1002/ajmg.b.20094; Gong YG, 2009, SCHIZOPHR RES, V111, P109, DOI 10.1016/j.schres.2009.03.017; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Ingram JL, 2000, TERATOLOGY, V62, P393, DOI 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li J, 2002, AM J MED GENET, V114, P24, DOI 10.1002/ajmg.1618; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MURPHY P, 1991, DEVELOPMENT, V111, P61; Muscarella LA, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-9; Muscarella LA, 2007, AM J MED GENET B, V144B, P388, DOI 10.1002/ajmg.b.30469; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Romano V, 2003, MOL PSYCHIATR, V8, P716, DOI 10.1038/sj.mp.4001285; Rossel M, 1999, DEVELOPMENT, V126, P5027; Sen B, 2007, PSYCHIAT GENET, V17, P1, DOI 10.1097/YPG.0b013e328010de0d; Yu SY, 2004, J CHINESE MED RES, V4, P675	29	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25603	10.1371/journal.pone.0025603	http://dx.doi.org/10.1371/journal.pone.0025603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980499	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600038
J	Turnbaugh, JA; Westergard, L; Unterberger, U; Biasini, E; Harris, DA				Turnbaugh, Jessie A.; Westergard, Laura; Unterberger, Ursula; Biasini, Emiliano; Harris, David A.			The N-Terminal, Polybasic Region Is Critical for Prion Protein Neuroprotective Activity	PLOS ONE			English	Article							INDUCED CELL-DEATH; TRANSGENIC MICE; HUMAN NEURONS; PRP; STRESS; DOMAIN; IDENTIFICATION; ENDOCYTOSIS; ATAXIA; EXPRESSION	Several lines of evidence suggest that the normal form of the prion protein, PrP(C) exerts a neuroprotective activity against cellular stress or toxicity. One of the clearest examples of such activity is the ability of wild-type PrP(C) to suppress the spontaneous neurodegenerative phenotype of transgenic mice expressing a deleted form of PrP (Delta 32-134, called F35). To define domains of PrP involved in its neuroprotective activity, we have analyzed the ability of several deletion mutants of PrP (Delta 23-31, Delta 23-111, and Delta 23-134) to rescue the phenotype of Tg(F35) mice. Surprisingly, all of these mutants displayed greatly diminished rescue activity, although Delta 23-31 PrP partially suppressed neuronal loss when expressed at very high levels. Our results pinpoint the N-terminal, polybasic domain as a critical determinant of PrP(C) neuroprotective activity, and suggest that identification of molecules interacting with this region will provide important clues regarding the normal function of the protein. Small molecule ligands targeting this region may also represent useful therapeutic agents for treatment of prion diseases.	[Turnbaugh, Jessie A.; Unterberger, Ursula; Biasini, Emiliano; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Turnbaugh, Jessie A.; Westergard, Laura] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Boston University; Washington University (WUSTL)	Turnbaugh, JA (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	daharris@bu.edu	Biasini, Emiliano/A-3147-2011	Biasini, Emiliano/0000-0002-3927-6341; Harris, David/0000-0002-6985-5790	N.I.H [NS040975, NS052526]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040975, R01NS052526, R01NS065244] Funding Source: NIH RePORTER	N.I.H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the N.I.H. to D.A.H. (NS040975 and NS052526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Boland MP, 2010, J BIOL CHEM, V285, P32282, DOI 10.1074/jbc.M110.123398; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Christensen HM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-11; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haigh CL, 2009, J CELL SCI, V122, P1518, DOI 10.1242/jcs.043604; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Li AM, 2007, EMBO J, V26, P2777, DOI 10.1038/sj.emboj.7601726; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2005, J BIOL CHEM, V280, P17430, DOI 10.1074/jbc.C500058200; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Meyer RK, 2000, J BIOL CHEM, V275, P38081, DOI 10.1074/jbc.M007114200; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; Oglecka K, 2008, BBA-BIOMEMBRANES, V1778, P206, DOI 10.1016/j.bbamem.2007.09.034; Osiecka KM, 2009, PROTEINS, V77, P279, DOI 10.1002/prot.22435; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger U.K., 2011, EMBO J; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; SOLOMON IH, 2011, J BIOL CHEM; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Taubner LM, 2010, J MOL BIOL, V395, P475, DOI 10.1016/j.jmb.2009.10.075; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Vincent B, 2001, J BIOL CHEM, V276, P37743; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; Yoshikawa D, 2008, J BIOL CHEM, V283, P24202, DOI 10.1074/jbc.M804212200	49	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25675	10.1371/journal.pone.0025675	http://dx.doi.org/10.1371/journal.pone.0025675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980526	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600049
J	Suzuki, T; Kondo, C; Kanamori, T; Inouye, S				Suzuki, Takahiro; Kondo, Chihiro; Kanamori, Takao; Inouye, Satoshi			Video-Rate Bioluminescence Imaging of Matrix Metalloproteinase-2 Secreted from a Migrating Cell	PLOS ONE			English	Article							INVASIVE CELLS; SURFACE; MMP-2; ACTIVATION; CYTOSKELETON; LUCIFERASE; EXOCYTOSIS; EXPRESSION; MICROSCOPY; MOTILITY	Background: Matrix metalloproteinase-2 (MMP-2) plays an important role in cancer progression and metastasis. MMP-2 is secreted as a pro-enzyme, which is activated by the membrane-bound proteins, and the polarized distribution of secretory and the membrane-associated MMP-2 has been investigated. However, the real-time visualizations of both MMP-2 secretion from the front edge of a migration cell and its distribution on the cell surface have not been reported. Methodology/Principal Findings: The method of video-rate bioluminescence imaging was applied to visualize exocytosis of MMP-2 from a living cell using Gaussia luciferase (GLase) as a reporter. The luminescence signals of GLase were detected by a high speed electron-multiplying charge-coupled device camera (EM-CCD camera) with a time resolution within 500 ms per image. The fusion protein of MMP-2 to GLase was expressed in a HeLa cell and exocytosis of MMP-2 was detected in a few seconds along the leading edge of a migrating HeLa cell. The membrane-associated MMP-2 was observed at the specific sites on the bottom side of the cells, suggesting that the sites of MMP-2 secretion are different from that of MMP-2 binding. Conclusions: We were the first to successfully demonstrate secretory dynamics of MMP-2 and the specific sites for polarized distribution of MMP-2 on the cell surface. The video-rate bioluminescence imaging using GLase is a useful method to investigate distribution and dynamics of secreted proteins on the whole surface of polarized cells in real time.	[Suzuki, Takahiro; Kondo, Chihiro; Kanamori, Takao] Aichi Gakuin Univ, Sch Dent, Dept Biochem, Nagoya, Aichi 464, Japan; [Inouye, Satoshi] JNC Corp, Yokohama Res Ctr, Yokohama, Kanagawa, Japan	Aichi Gakuin University	Suzuki, T (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Biochem, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	tsuzuki@dpc.agu.ac.jp; sinouye@jnc-corp.co.jp		Inouye, Satoshi/0000-0001-8732-7839	Japan Society for the Promotion of Science (JSPS); Strategic Research AGU-Platform Formation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research AGU-Platform Formation	This work was supported in part by Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (JSPS) and by Strategic Research AGU-Platform Formation (2008-2012). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chen WT, 1999, ANN NY ACAD SCI, V878, P361, DOI 10.1111/j.1749-6632.1999.tb07695.x; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; INOUYE S, 1992, P NATL ACAD SCI USA, V89, P9584, DOI 10.1073/pnas.89.20.9584; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628; Ma ZD, 2004, J BIOL CHEM, V279, P46326, DOI 10.1074/jbc.M405438200; Miesenbock G, 1997, P NATL ACAD SCI USA, V94, P3402, DOI 10.1073/pnas.94.7.3402; Nabeshima K, 2000, CANCER RES, V60, P3364; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Oheim M, 1999, PHILOS T R SOC B, V354, P307, DOI 10.1098/rstb.1999.0382; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suzuki T, 2007, FEBS LETT, V581, P4551, DOI 10.1016/j.febslet.2007.08.036; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; THOMPSON EM, 1995, P NATL ACAD SCI USA, V92, P1317, DOI 10.1073/pnas.92.5.1317; Tonti GA, 2009, INT J DEV BIOL, V53, P1, DOI 10.1387/ijdb.082573gt; VanSaun Michael N., 2006, Birth Defects Research, V78, P69, DOI 10.1002/bdrc.20061; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	34	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25243	10.1371/journal.pone.0025243	http://dx.doi.org/10.1371/journal.pone.0025243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969874	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900038
J	van Beilen, M; Bult, H; Renken, R; Stieger, M; Thumfart, S; Cornelissen, F; Kooijman, V				van Beilen, Marije; Bult, Harold; Renken, Remco; Stieger, Markus; Thumfart, Stefan; Cornelissen, Frans; Kooijman, Valesca			Effects of Visual Priming on Taste-Odor Interaction	PLOS ONE			English	Article							OLFACTORY PERCEPTION; SUCROSE SOLUTIONS; PERCEIVED FLAVOR; COLOR; SWEETNESS; DISCRIMINATION; INTENSITY; MIXTURES; TEXTURE; VISION	Little is known about the influence of visual characteristics other than colour on flavor perception, and the complex interactions between more than two sensory modalities. This study focused on the effects of recognizability of visual (texture) information on flavor perception of odorized sweet beverages. Participants rated the perceived sweetness of odorized sucrose solutions in the presence or absence of either a congruent or incongruent visual context. Odors were qualitatively reminiscent of sweet foods (strawberry and caramel) or not (savoury). Visual context was either an image of the same sweet foods (figurative context) or a visual texture derived from this product (non-figurative context). Textures were created using a texture synthesis method that preserved perceived food qualities while removing object information. Odor-taste combinations were rated sweeter within a figurative than a non-figurative context. This behaviour was exhibited for all odor-taste combinations, even in trials without images, indicating sustained priming by figurative visual context. A non-figurative context showed a transient sweetening effect. Sweetness was generally enhanced most by the strawberry odor. We conclude that the degree of recognizability of visual information (figurative versus non-figurative), influences flavor perception differently. Our results suggest that this visual context priming is mediated by separate sustained and transient processes that are differently evoked by figurative and non-figurative visual contexts. These components operate independent of the congruency of the image-odor-taste combinations.	[van Beilen, Marije; Renken, Remco; Cornelissen, Frans] Univ Groningen, Univ Med Ctr, Lab Expt Ophthalmol, Groningen, Netherlands; [Kooijman, Valesca] Top Inst Food & Nutr, Wageningen, Netherlands; [Bult, Harold; Stieger, Markus] Ctr Innovat Consumer Studies, Ede, Netherlands; [van Beilen, Marije; Renken, Remco; Cornelissen, Frans] Univ Groningen, Univ Med Ctr, Sch Behav & Cognit Neurosci, NeuroImaging Ctr, Groningen, Netherlands; [Thumfart, Stefan] Profactor GmbH, Steyr Gleink, Austria; [van Beilen, Marije] Univ Groningen, Univ Med Ctr, Dept Neurol, Groningen, Netherlands; [Stieger, Markus] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands	University of Groningen; Top Institute Food & Nutrition; University of Groningen; Upper Austrian Research GmbH; PROFACTOR; University of Groningen; Wageningen University & Research	van Beilen, M (corresponding author), Univ Groningen, Univ Med Ctr, Lab Expt Ophthalmol, Groningen, Netherlands.	m.van.beilen@umcg.nl	van Beilen, Marije/A-7435-2011; Stieger, Markus/O-7727-2014	Renken, Remco Jan/0000-0002-7777-9484; Stieger, Markus/0000-0002-8736-6026				Bult JHF, 2007, NEUROSCI LETT, V411, P6, DOI 10.1016/j.neulet.2006.09.036; CHRISTENSEN CM, 1977, CEREAL FOOD WORLD, V22, P243; CLARK CC, 1994, CHEM SENSES, V19, P583, DOI 10.1093/chemse/19.6.583; CLYDESDALE FM, 1993, CRIT REV FOOD SCI, V33, P83, DOI 10.1080/10408399309527614; Dalton P, 2000, NAT NEUROSCI, V3, P431, DOI 10.1038/74797; De Bonet J. S., 1997, SIGGRAPH 97, P361, DOI [10.1145/258734.258882, DOI 10.1145/258734.258882]; Delwiche J, 2004, FOOD QUAL PREFER, V15, P137, DOI 10.1016/S0950-3293(03)00041-7; Dematte ML, 2009, CHEM SENSES, V34, P103, DOI 10.1093/chemse/bjn055; DUBOSE CN, 1980, J FOOD SCI, V45, P1393, DOI 10.1111/j.1365-2621.1980.tb06562.x; FRANK RA, 1989, CHEM SENSES, V14, P371, DOI 10.1093/chemse/14.3.371; FRANK RA, 1993, PERCEPT PSYCHOPHYS, V54, P343, DOI 10.3758/BF03205269; Gilbert AN, 1996, AM J PSYCHOL, V109, P335, DOI 10.2307/1423010; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; JOHNSON J, 1982, J FOOD SCI, V47, P747, DOI 10.1111/j.1365-2621.1982.tb12706.x; JOHNSON JL, 1983, J FOOD PROTECT, V46, P21, DOI 10.4315/0362-028X-46.1.21; Koster EP, 2005, CHEM SENSES, V30, pI236, DOI 10.1093/chemse/bjh201; Labbe D, 2007, CHEM SENSES, V32, P205, DOI 10.1093/chemse/bjl040; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LAWRENCE JF, 1987, J CHROMATOGR SCI, V25, P444, DOI 10.1093/chromsci/25.10.444; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Livermore A, 1998, PHYSIOL BEHAV, V65, P311, DOI 10.1016/S0031-9384(98)00168-1; Livermore A, 1998, PERCEPT PSYCHOPHYS, V60, P650, DOI 10.3758/BF03206052; MACKAY A, 1956, FOOD TECHNOL, P238; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; Osterbauer RA, 2005, J NEUROPHYSIOL, V93, P3434, DOI 10.1152/jn.00555.2004; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; PHILIPSEN DH, 1995, J FOOD SCI, V60, P364, DOI 10.1111/j.1365-2621.1995.tb05674.x; Sakai N, 2005, CHEM SENSES, V30, pI244, DOI 10.1093/chemse/bjh205; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; Schifferstein HNJ, 2006, ACTA PSYCHOL, V121, P41, DOI 10.1016/j.actpsy.2005.06.004; Schifferstein HNJ, 2005, ACTA PSYCHOL, V118, P293, DOI 10.1016/j.actpsy.2004.10.009; Schifferstein HNJ, 1996, ACTA PSYCHOL, V94, P87, DOI 10.1016/0001-6918(95)00040-2; Stevenson RJ, 2007, PERCEPTION, V36, P1821, DOI 10.1068/p5563; Stevenson RJ, 2007, PSYCHOL BULL, V133, P294, DOI 10.1037/0033-2909.133.2.294; Stevenson RJ, 1999, CHEM SENSES, V24, P627, DOI 10.1093/chemse/24.6.627; Weel KGC, 2002, J AGR FOOD CHEM, V50, P5149, DOI 10.1021/jf0202786; Wei LY, 2000, COMP GRAPH, P479, DOI 10.1145/344779.345009; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Zampini M, 2007, FOOD QUAL PREFER, V18, P975, DOI 10.1016/j.foodqual.2007.04.001; ZELLNER DA, 1990, J EXP PSYCHOL HUMAN, V16, P391, DOI 10.1037/0096-1523.16.2.391	40	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e23857	10.1371/journal.pone.0023857	http://dx.doi.org/10.1371/journal.pone.0023857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969852	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900003
J	Dupont, YL; Damgaard, C; Simonsen, V				Dupont, Yoko L.; Damgaard, Christian; Simonsen, Vibeke			Quantitative Historical Change in Bumblebee (Bombus spp.) Assemblages of Red Clover Fields	PLOS ONE			English	Article							POLLINATION; DECLINE; BEES; CONSERVATION; HYMENOPTERA; RARITY; APIDAE; VULNERABILITY; DISTANCES; IMPACTS	Background: Flower visiting insects provide a vitally important pollination service for many crops and wild plants. Recent decline of pollinating insects due to anthropogenic modification of habitats and climate, in particular from 1950's onwards, is a major and widespread concern. However, few studies document the extent of declines in species diversity, and no studies have previously quantified local abundance declines. We here make a quantitative assessment of recent historical changes in bumblebee assemblages by comparing contemporary and historical survey data. Methodology/Principal Findings: We take advantage of detailed, quantitative historical survey data from the 1930's on bumblebee (Bombus spp.) abundances and species composition in red clover (Trifolium pratense) fields, an important floral resource and an attractant of all bumblebee species. We used the historical survey data as a pre-industrialization baseline, and repeated the same sampling protocol at nearly the same localities at present, hence setting up a historical experiment. We detected historical changes in abundances (bees/m(2)) of both workers (the "pollinatory units") and queens (effective population size), in addition to species composition. In particular, long-tongued bumblebee species showed consistent and dramatic declines in species richness and abundances throughout the flowering season of red clover, while short-tongued species were largely unaffected. Of 12 Bombus species observed in the 1930's, five species were not observed at present. The latter were all long-tongued, late-emerging species. Conclusions/Significance: Because bumblebees are important pollinators, historical changes in local bumblebee assemblages are expected to severely affect plant reproduction, in particular long-tubed species, which are pollinated by long-tongued bumblebees.	[Dupont, Yoko L.] Aarhus Univ, Dept Biosci, Sect Ecol & Genet, Aarhus, Denmark; [Damgaard, Christian; Simonsen, Vibeke] Aarhus Univ, Dept Biosci, Sect Terr Ecol NERI, Silkeborg, Denmark	Aarhus University; Aarhus University	Dupont, YL (corresponding author), Aarhus Univ, Dept Biosci, Sect Ecol & Genet, Aarhus, Denmark.	yoko.dupont@biology.au.dk	Dupont, Yoko/GOE-4804-2022; Damgaard, Christian/G-2441-2010	Damgaard, Christian/0000-0003-3932-4312	Aarhus University Research Foundation [AUFF-F-2009-FLS-5-7]; Danish Natural Sciences Research Council [09-063874]	Aarhus University Research Foundation; Danish Natural Sciences Research Council(Danish Natural Science Research Council)	The project was financed by the Aarhus University Research Foundation (AUFF-F-2009-FLS-5-7). During the writing of the manuscript, YLD was supported by the Danish Natural Sciences Research Council (grant number 09-063874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Benton T., 2006, BUMBLEBEES NATURAL H; Bertsch Andreas, 2004, Beitraege zur Entomologie, V54, P365; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; BRODSGAARD CJ, 2002, 71 DIAS MIN FOOD AGR, P3; BUCHMANN SL, 1985, J KANSAS ENTOMOL SOC, V58, P517; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; CORBET SA, 1993, ECOL ENTOMOL, V18, P17, DOI 10.1111/j.1365-2311.1993.tb01075.x; Corbet SA, 2000, CONSERV BIOL, V14, P1229, DOI 10.1046/j.1523-1739.2000.00014.x; DUPONT YL, 2010, NAT MUS, V1, P1; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Free JB, 1959, BUMBLEBEES; FUSSELL M, 1992, J APPL ECOL, V29, P451, DOI 10.2307/2404513; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; GOULSON D, 2005, NZ J ECOL, V28, P225; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; Hammer K., 1970, NATUR MUSEUM POPULAE, V14, P3; Heinrich B., 1979, BUMBLEBEE EC; HOLM SN, 1966, ANNU REV ENTOMOL, V11, P155, DOI 10.1146/annurev.en.11.010166.001103; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kells AR, 2003, BIOL CONSERV, V109, P165, DOI 10.1016/S0006-3207(02)00131-3; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Kosior A, 2007, ORYX, V41, P79, DOI 10.1017/S0030605307001597; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; MADSEN HB, 2009, DANISH RED LIST; Marletto Franco, 2003, Bulletin of Insectology, V56, P155; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Murray TE, 2009, APIDOLOGIE, V40, P211, DOI 10.1051/apido/2009015; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; RASMONT P, 1988, ANN SOC ROY ZOOL BEL, V118, P141; SKOVGAARD OS, 1936, DET KONGELIGE DANSKE, V96, P1; SKOVGAARD OS, 1943, TIDSSKRIFT PLANTEAVL, V47, P287; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Wermuth KH, 2010, APIDOLOGIE, V41, P657, DOI 10.1051/apido/2010038; Williams P, 2005, BIOL CONSERV, V122, P33, DOI 10.1016/j.biocon.2004.06.019; Williams P, 2009, CONSERV BIOL, V23, P931, DOI 10.1111/j.1523-1739.2009.01176.x; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2008, CURR BIOL, V18, pR968, DOI 10.1016/j.cub.2008.09.010	52	76	79	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25172	10.1371/journal.pone.0025172	http://dx.doi.org/10.1371/journal.pone.0025172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966445	Green Published, gold, Green Submitted			2022-12-27	WOS:000295932100021
J	Di Palma, T; Conti, A; de Cristofaro, T; Scala, S; Nitsch, L; Zannini, M				Di Palma, Tina; Conti, Anna; de Cristofaro, Tiziana; Scala, Serena; Nitsch, Lucio; Zannini, Mariastella			Identification of Novel Pax8 Targets in FRTL-5 Thyroid Cells by Gene Silencing and Expression Microarray Analysis	PLOS ONE			English	Article							CATENIN-INDEPENDENT PATHWAY; TRANSCRIPTION FACTORS; CONGENITAL HYPOTHYROIDISM; GLAND DEVELOPMENT; DEVELOPING KIDNEY; FOLLICULAR CELLS; EPITHELIAL-CELLS; BINDING-PROTEIN; TAZ INTERACTS; CADHERIN GENE	Background: The differentiation program of thyroid follicular cells (TFCs), by far the most abundant cell population of the thyroid gland, relies on the interplay between sequence-specific transcription factors and transcriptional coregulators with the basal transcriptional machinery of the cell. However, the molecular mechanisms leading to the fully differentiated thyrocyte are still the object of intense study. The transcription factor Pax8, a member of the Paired-box gene family, has been demonstrated to be a critical regulator required for proper development and differentiation of thyroid follicular cells. Despite being Pax8 well-characterized with respect to its role in regulating genes involved in thyroid differentiation, genomics approaches aiming at the identification of additional Pax8 targets are lacking and the biological pathways controlled by this transcription factor are largely unknown. Methodology/Principal Findings: To identify unique downstream targets of Pax8, we investigated the genome-wide effect of Pax8 silencing comparing the transcriptome of silenced versus normal differentiated FRTL-5 thyroid cells. In total, 2815 genes were found modulated 72 h after Pax8 RNAi, induced or repressed. Genes previously reported to be regulated by Pax8 in FRTL-5 cells were confirmed. In addition, novel targets genes involved in functional processes such as DNA replication, anion transport, kinase activity, apoptosis and cellular processes were newly identified. Transcriptome analysis highlighted that Pax8 is a key molecule for thyroid morphogenesis and differentiation. Conclusions/Significance: This is the first large-scale study aimed at the identification of new genes regulated by Pax8, a master regulator of thyroid development and differentiation. The biological pathways and target genes controlled by Pax8 will have considerable importance to understand thyroid disease progression as well as to set up novel therapeutic strategies.	[Di Palma, Tina; de Cristofaro, Tiziana; Scala, Serena; Zannini, Mariastella] CNR, Inst Expt Endocrinol & Oncol G Salvatore IEOS, Naples, Italy; [Conti, Anna; Nitsch, Lucio] Univ Naples Federico 2, Dept Cellular & Mol Biol & Pathol, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Di Palma, T (corresponding author), CNR, Inst Expt Endocrinol & Oncol G Salvatore IEOS, Naples, Italy.	s.zannini@ieos.cnr.it	Scala, Serena/Y-6756-2019; De+Cristofaro, Tiziana/AAX-4405-2020; Conti, Anna/G-5130-2012; Di+Palma, Tina/AAN-6853-2021; Zannini, Mariastella/I-1735-2012	Scala, Serena/0000-0002-8579-3809; Conti, Anna/0000-0002-2054-7375; DECRISTOFARO, TIZIANA/0000-0003-0121-0002	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Economy and Finance	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Economy and Finance	This work was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to M.Z. and by a grant from the Italian Ministry of Economy and Finance to the CNR for the Project FaReBio di Qualita. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambesi-Impiombato F. S., 1979, INT REV CYTOL S, P163; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Brisken C, 2000, GENE DEV, V14, P650; Cali G, 2007, ENDOCRINOLOGY, V148, P2737, DOI 10.1210/en.2006-1344; Chen YJ, 2008, CANCER RES, V68, P5724, DOI 10.1158/0008-5472.CAN-08-0058; Chia WK, 2010, CANCER GENET CYTOGEN, V196, P7, DOI 10.1016/j.cancergencyto.2009.08.001; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; D'Adamo MC, 2011, J BIOL CHEM, V286, P192, DOI 10.1074/jbc.M110.189290; D'Andrea B, 2006, MOL ENDOCRINOL, V20, P1810, DOI 10.1210/me.2005-0463; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Di Palma T, 2003, J BIOL CHEM, V278, P3395, DOI 10.1074/jbc.M205977200; Di Palma T, 2010, CLIN ENDOCRINOL, V73, P808, DOI 10.1111/j.1365-2265.2010.03851.x; Di Palma T, 2009, EXP CELL RES, V315, P162, DOI 10.1016/j.yexcr.2008.10.016; Di Palma T, 2008, J MOL ENDOCRINOL, V41, P379, DOI 10.1677/JME-08-0056; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Endo T, 2008, J CLIN ENDOCR METAB, V93, P2409, DOI 10.1210/jc.2007-2805; Endo T, 2010, MOL ENDOCRINOL, V24, P1267, DOI 10.1210/me.2010-0056; Gonzalez YR, 2008, J NEUROSCI, V28, P5559, DOI 10.1523/JNEUROSCI.1014-08.2008; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Marques AR, 2002, J CLIN ENDOCR METAB, V87, P3947, DOI 10.1210/jc.87.8.3947; Miyakoshi T, 2008, ENDOCR PATHOL, V19, P261, DOI 10.1007/s12022-008-9048-9; Mok SC, 1996, ONCOGENE, V12, P1895; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Provenzano C, 2010, MOL CELL ENDOCRINOL, V323, P215, DOI 10.1016/j.mce.2010.02.038; Puppin C, 2004, MOL CELL ENDOCRINOL, V214, P117, DOI 10.1016/j.mce.2003.10.061; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Torban E, 2006, J BIOL CHEM, V281, P12705, DOI 10.1074/jbc.M513181200; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Whyte DA, 1999, AM J PHYSIOL-RENAL, V277, pF587, DOI 10.1152/ajprenal.1999.277.4.F587; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; WU ZZ, 2010, J CELL PHYSL; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16	57	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25162	10.1371/journal.pone.0025162	http://dx.doi.org/10.1371/journal.pone.0025162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966443	Green Submitted, Green Published, gold			2022-12-27	WOS:000295267100021
J	Klijs, B; Nusselder, WJ; Looman, CW; Mackenbach, JP				Klijs, Bart; Nusselder, Wilma J.; Looman, Caspar W.; Mackenbach, Johan P.			Contribution of Chronic Disease to the Burden of Disability	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-BACK-PAIN; FUNCTIONAL DECLINE; RISK-FACTORS; HEALTH EXPECTANCY; DUTCH POPULATION; ELDERLY-PEOPLE; OLDER PERSONS; FREE LIFE; WOMEN	Background: Population ageing is expected to lead to strong increases in the number of persons with one or more disabilities, which may result in substantial declines in the quality of life. To reduce the burden of disability and to prevent concomitant declines in the quality of life, one of the first steps is to establish which diseases contribute most to the burden. Therefore, this paper aims to determine the contribution of specific diseases to the prevalence of disability and to years lived with disability, and to assess whether large contributions are due to a high disease prevalence or a high disabling impact. Methodology/Principal Findings: Data from the Dutch POLS-survey (Permanent Onderzoek Leefsituatie, 2001-2007) were analyzed. Using additive regression and accounting for co-morbidity, the disabling impact of selected chronic diseases was calculated, and the prevalence and years lived with ADL and mobility disabilities were partitioned into contributions of specific disease. Musculoskeletal and cardiovascular disease contributed most to the burden of disability, but chronic nonspecific lung disease (males) and diabetes (females) also contributed much. Within the musculoskeletal and cardiovascular disease groups, back pain, peripheral vascular disease and stroke contributed particularly by their high disabling impact. Arthritis and heart disease were less disabling but contributed substantially because of their high prevalence. The disabling impact of diseases was particularly high among persons older than 80. Conclusions/Significance: To reduce the burden of disability, the extent diseases such as back pain, peripheral vascular disease and stroke lead to disability should be reduced, particularly among the oldest old. But also moderately disabling diseases with a high prevalence, such as arthritis and heart disease, should be targeted.	[Klijs, Bart; Nusselder, Wilma J.; Looman, Caspar W.; Mackenbach, Johan P.] Univ Med Ctr, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Klijs, B (corresponding author), Univ Med Ctr, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands.	b.klijs@erasmusmc.nl	Klijs, Bart/B-3330-2013	Klijs, Bart/0000-0001-7543-2287	Netspar; European Public Health Programme [2006109]; Erasmus MC, University Medical Centre	Netspar; European Public Health Programme; Erasmus MC, University Medical Centre	This study was part of the project "Living longer in good health," which was financially supported by Netspar, an independent network for research, education and knowledge exchange in the field of pensions, aging and retirement. This work was supported by the European Public Health Programme (2006109) and the Erasmus MC, University Medical Centre. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; DAVIES PT, 1982, J R STAT SOC C-APPL, V31, P244; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; European health expectancy monitoring unit (EHEMU), 2010, EHEMU DAT INF SYST; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Freedman VA, 2000, AM J PUBLIC HEALTH, V90, P1755, DOI 10.2105/AJPH.90.11.1755; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Hills, 1993, STAT MODELS EPIDEMIO; Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Jagger C, 2007, J GERONTOL A-BIOL, V62, P408, DOI 10.1093/gerona/62.4.408; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Kattainen A, 2004, J CLIN EPIDEMIOL, V57, P513, DOI 10.1016/j.jclinepi.2003.10.004; Klerk M, 2005, LANDELIJK OVERZICHT; Kovacs FM, 2004, SPINE, V29, P206, DOI 10.1097/01.BRS.0000107235.47465.08; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Manton K. G., 1984, RECENT TRENDS MORTAL; Mathers CD, 1999, DISABIL REHABIL, V21, P211, DOI 10.1080/096382899297639; Nusselder WJ, 2005, AM J PUBLIC HEALTH, V95, P2035, DOI 10.2105/AJPH.2004.054700; Nusselder WJ, 2004, DEMOGRAPHY, V41, P315, DOI 10.1353/dem.2004.0017; Nusselder WJ, 1996, AM J PUBLIC HEALTH, V86, P187, DOI 10.2105/AJPH.86.2.187; Picavet HSJ, 1997, AM J PUBLIC HEALTH, V87, P1680, DOI 10.2105/AJPH.87.10.1680; Poos M, 2009, DEMENTIE OMVANG PROB; Puts MTE, 2008, AGE AGEING, V37, P187, DOI 10.1093/ageing/afm185; Rejeski WJ, 2009, J GERONTOL A-BIOL, V64, P462, DOI 10.1093/gerona/gln041; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Spiers NA, 2005, J GERONTOL A-BIOL, V60, P248, DOI 10.1093/gerona/60.2.248; Stam S, 2009, LANGE TIJDREEKSEN GE; Statistics Netherlands, 2010, STATL DAT BEV PROGN; Statistics Netherlands, 2007, GEZ ZORG CIJF 2007; Steinberg HO, 2000, CIRCULATION, V101, P2040, DOI 10.1161/01.CIR.101.17.2040; Stel VS, 2004, AGE AGEING, V33, P58, DOI 10.1093/ageing/afh028; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; The Netherlands Institute for Social Research, 2006, RAPP OUD 2006 VER LE; Truchon M, 2001, DISABIL REHABIL, V23, P758, DOI 10.1080/09638280110061744; van Gool CH, 2005, SOC SCI MED, V60, P25, DOI 10.1016/j.socscimed.2004.04.021; VERBRUGGE LM, 1995, AM J PUBLIC HEALTH, V85, P173, DOI 10.2105/AJPH.85.2.173; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yee TW, 2003, STAT MODEL, V3, P15, DOI 10.1191/1471082X03st045oa	45	74	77	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25325	10.1371/journal.pone.0025325	http://dx.doi.org/10.1371/journal.pone.0025325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IJ	21966497	Green Published, gold			2022-12-27	WOS:000295265100088
J	Labay, B; Cohen, AE; Sissel, B; Hendrickson, DA; Martin, FD; Sarkar, S				Labay, Ben; Cohen, Adam E.; Sissel, Blake; Hendrickson, Dean A.; Martin, F. Douglas; Sarkar, Sahotra			Assessing Historical Fish Community Composition Using Surveys, Historical Collection Data, and Species Distribution Models	PLOS ONE			English	Article							CLIMATE-CHANGE; NICHE MODELS; GEOGRAPHIC DISTRIBUTIONS; REFERENCE SITES; SAMPLE-SIZE; CONSERVATION; ASSEMBLAGES; PERFORMANCE; CHALLENGES; INTEGRITY	Accurate establishment of baseline conditions is critical to successful management and habitat restoration. We demonstrate the ability to robustly estimate historical fish community composition and assess the current status of the urbanized Barton Creek watershed in central Texas, U. S. A. Fish species were surveyed in 2008 and the resulting data compared to three sources of fish occurrence information: (i) historical records from a museum specimen database and literature searches; (ii) a nearly identical survey conducted 15 years earlier; and (iii) a modeled historical community constructed with species distribution models (SDMs). This holistic approach, and especially the application of SDMs, allowed us to discover that the fish community in Barton Creek was more diverse than the historical data and survey methods alone indicated. Sixteen native species with high modeled probability of occurrence within the watershed were not found in the 2008 survey, seven of these were not found in either survey or in any of the historical collection records. Our approach allowed us to more rigorously establish the true baseline for the pre-development fish fauna and then to more accurately assess trends and develop hypotheses regarding factors driving current fish community composition to better inform management decisions and future restoration efforts. Smaller, urbanized freshwater systems, like Barton Creek, typically have a relatively poor historical biodiversity inventory coupled with long histories of alteration, and thus there is a propensity for land managers and researchers to apply inaccurate baseline standards. Our methods provide a way around that limitation by using SDMs derived from larger and richer biodiversity databases of a broader geographic scope. Broadly applied, we propose that this technique has potential to overcome limitations of popular bioassessment metrics (e. g., IBI) to become a versatile and robust management tool for determining status of freshwater biotic communities.	[Labay, Ben; Cohen, Adam E.; Hendrickson, Dean A.; Martin, F. Douglas] Univ Texas Austin, Austin, TX 78712 USA; [Sissel, Blake; Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Labay, B (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	benlabay@mail.utexas.edu	Hendrickson, Dean A./G-9451-2018	Hendrickson, Dean A./0000-0001-7835-0295; Martin, F. Douglas/0000-0002-3421-4408	Texas Parks and Wildlife Department [T-27-P]; Texas Natural Science Center, University of Texas at Austin	Texas Parks and Wildlife Department; Texas Natural Science Center, University of Texas at Austin	This work was funded by the Texas Parks and Wildlife Department's State Wildlife Grant "Data Standardization and Georeferencing of the Fishes of Texas Database (T-27-P)" (http://www.tpwd.state.tx.us). The Texas Natural Science Center, University of Texas at Austin (http://www.utexas.edu/tmm/) provided support through the use of the laboratory at the Texas Natural History Collection and the salary of Dean Hendrickson, Curator of Ichthyology at the Texas Natural History Collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bailey RC, 2004, BIOASSESSMENT FRESHW; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; Chapman AD, 2006, GLOBAL BIODIVERSITY; Chessman BC, 2004, J N AM BENTHOL SOC, V23, P599, DOI 10.1899/0887-3593(2004)023&lt;0599:BWRSUO&gt;2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Freeman MC, 2007, J AM WATER RESOUR AS, V43, P5, DOI 10.1111/j.1752-1688.2007.00002.x; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hendrickson DA, 2010, FISHES TEXAS PROJECT; Herlihy AT, 2008, J N AM BENTHOL SOC, V27, P860, DOI 10.1899/08-081.1; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; HUBBS C, 1991, TEX J SCI, V43, P1; HUGHES RM, 1986, ENVIRON MANAGE, V10, P629, DOI 10.1007/BF01866767; Jordan DS, 1886, P US NATL MUSEUM, P9; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; KARR JR, 1991, ECOL APPL, V1, P66, DOI 10.2307/1941848; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Love JW, 2008, AM MIDL NAT, V160, P265, DOI 10.1674/0003-0031(2008)160[265:EOSDOF]2.0.CO;2; Meyer JL, 2007, J AM WATER RESOUR AS, V43, P86, DOI 10.1111/j.1752-1688.2007.00008.x; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Murienne J, 2009, BIOL J LINN SOC, V97, P177, DOI 10.1111/j.1095-8312.2008.01184.x; Nadeau TL, 2007, J AM WATER RESOUR AS, V43, P118, DOI 10.1111/j.1752-1688.2007.00010.x; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Norris RH, 2000, HYDROBIOLOGIA, V435, P5, DOI 10.1023/A:1004176507184; Page L.M., 1983, HDB DARTERS; Page L.M., 1998, FIELD GUIDE FRESHWAT; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, J VECTOR ECOL, V33, P342, DOI 10.3376/1081-1710-33.2.342; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; ROSS ST, 1985, AM NAT, V126, P24, DOI 10.1086/284393; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Scanlon BR, 2002, GROUNDWATER AVAILABI; Scardi M, 2008, ECOL INFORM, V3, P55, DOI 10.1016/j.ecoinf.2007.10.001; Stoddard JL, 2006, ECOL APPL, V16, P1267, DOI 10.1890/1051-0761(2006)016[1267:SEFTEC]2.0.CO;2; Suter GW, 2002, ENVIRON TOXICOL CHEM, V21, P1101, DOI 10.1897/1551-5028(2002)021<1101:AMFITC>2.0.CO;2; Thompson FD, 1943, TEXAS GAME FISH, V1, P8; Thorpe AS, 2011, J APPL ECOL, V48, P275, DOI 10.1111/j.1365-2664.2011.01972.x; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Williams SE, 2009, P NATL ACAD SCI USA, V106, P19737, DOI 10.1073/pnas.0901640106; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; [No title captured]	59	33	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25145	10.1371/journal.pone.0025145	http://dx.doi.org/10.1371/journal.pone.0025145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966438	Green Published, Green Submitted, gold			2022-12-27	WOS:000295265100066
J	Tian, J; Dang, H; Kaufman, DL				Tian, Jide; Dang, Hoa; Kaufman, Daniel L.			Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted beta-Cells in Diabetic NOD Mice	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; INFLAMMATORY RESPONSES; COMBINATION THERAPY; INSULIN-SECRETION; CHLORIDE CHANNELS; PRONE MICE; TYPE-1; IMMUNOTHERAPY; LYMPHOCYTES; INHIBITION	Antigen-based therapies (ABTs) very effectively prevent the development of type 1 diabetes (T1D) when given to young nonobese diabetic (NOD) mice, however, they have little or no ability to reverse hyperglycemia in newly diabetic NOD mice. More importantly, ABTs have not yet demonstrated an ability to effectively preserve residual beta-cells in individuals newly diagnosed with type 1 diabetes (T1D). Accordingly, there is great interest in identifying new treatments that can be combined with ABTs to safely protect beta-cells in diabetic animals. The activation of gamma-aminobutyric acid (GABA) receptors (GABA-Rs) on immune cells has been shown to prevent T1D, experimental autoimmune encephalomyelitis (EAE) and rheumatoid arthritis in mouse models. Based on GABA's ability to inhibit different autoimmune diseases and its safety profile, we tested whether the combination of ABT with GABA treatment could prolong the survival of transplanted beta-cells in newly diabetic NOD mice. Newly diabetic NOD mice were untreated, or given GAD/alum (20 or 100 mu g) and placed on plain drinking water, or water containing GABA (2 or 6 mg/ml). Twenty-eight days later, they received syngenic pancreas grafts and were monitored for the recurrence of hyperglycemia. Hyperglycemia reoccurred in the recipients given plain water, GAD monotherapy, GABA monotherapy, GAD (20 mu g)+GABA (2 mg/ml), GAD (20 mu g)+GABA (6 mg/ml) and GAD (100 mu g)+GABA (6 mg/ml) about 1, 2-3, 3, 2-3, 3-8 and 10-11 weeks post-transplantation, respectively. Thus, combined GABA and ABT treatment had a synergistic effect in a dose-dependent fashion. These findings suggest that co-treatment with GABA (or other GABA-R agonists) may provide a new strategy to safely enhance the efficacy of other therapeutics designed to prevent or reverse T1D, as well as other T cell-mediated autoimmune diseases.	[Tian, Jide; Dang, Hoa; Kaufman, Daniel L.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Tian, J (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	dkaufman@mednet.ucla.edu	Kaufman, Daniel/AAU-1228-2021	Kaufman, Daniel/0000-0002-9844-5918	National Institutes of Health [R21 DK075070, R21 DK080461]; Juvenile Diabetes Research Foundation International [17-2010-210]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075070, R21DK080461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health (R21 DK075070, R21 DK080461) and Juvenile Diabetes Research Foundation International (17-2010-210) to DLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh CD, 2005, J DIABETES COMPLICAT, V19, P238, DOI 10.1016/j.jdiacomp.2004.12.003; Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; CAHALAN MD, 1994, CURR TOP MEMBR, V42, P103, DOI 10.1016/S0070-2161(08)60820-5; GU XH, 1993, LIFE SCI, V52, P687, DOI 10.1016/0024-3205(93)90229-V; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Ligon B, 2007, DIABETOLOGIA, V50, P764, DOI 10.1007/s00125-007-0601-8; LOEB C, 1987, EPILEPSY RES, V1, P209, DOI 10.1016/0920-1211(87)90043-X; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Olcott AP, 2005, J IMMUNOL, V175, P1991, DOI 10.4049/jimmunol.175.3.1991; OTOMO E, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1511; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Pop SM, 2007, DIABETES, V56, P1395, DOI 10.2337/db06-0543; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Suarez-Pinzon WL, 2008, TRANSPL P, V40, P529, DOI 10.1016/j.transproceed.2008.01.005; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; TIAN J, 2011, PLOS ONE IN PRESS; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tian JD, 2011, AUTOIMMUNITY, V44, P465, DOI 10.3109/08916934.2011.571223; Tian J, 2009, DIABETES, V58, P1939, DOI 10.2337/db09-0451; Tower DB, 1960, INHIBITION NERVOUS S, P562; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Yip HC, 1999, J IMMUNOL, V162, P3942	27	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25337	10.1371/journal.pone.0025337	http://dx.doi.org/10.1371/journal.pone.0025337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966502	gold, Green Published			2022-12-27	WOS:000295265100091
J	Zahner, D; Gandhi, AR; Yi, H; Stephens, DS				Zaehner, Dorothea; Gandhi, Ashish R.; Yi, Hong; Stephens, David S.			Mitis Group Streptococci Express Variable Pilus Islet 2 Pili	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SURFACE-STRUCTURES; CRYSTAL-STRUCTURE; REVEALS PILI; S-MITIS; PNEUMONIAE; ORALIS; GENES; EVOLUTION; ADHERENCE	Background: Streptococcus oralis, Streptococcus mitis, and Streptococcus sanguinis are members of the Mitis group of streptococci and agents of oral biofilm, dental plaque and infective endocarditis, disease processes that involve bacteria-bacteria and bacteria-host interactions. Their close relative, the human pathogen S. pneumoniae uses pilus-islet 2 (PI-2)-encoded pili to facilitate adhesion to eukaryotic cells. Methodology/Principal Findings: PI-2 pilus-encoding genetic islets were identified in S. oralis, S. mitis, and S. sanguinis, but were absent from other isolates of these species. The PI-2 islets resembled the genetic organization of the PI-2 islet of S. pneumoniae, but differed in the genes encoding the structural pilus proteins PitA and PitB. Two and three variants of pitA (a pseudogene in S. pneumoniae) and pitB, respectively, were identified that showed approximate to 20% difference in nucleotide as well as corresponding protein sequence. Species-independent combinations of pitA and pitB variants indicated prior intra-and interspecies horizontal gene transfer events. Polyclonal antisera developed against PitA and PitB of S. oralis type strain ATCC35037 revealed that PI-2 pili in oral streptococci were composed of PitA and PitB. Electronmicrographs showed pilus structures radiating >700 nm from the bacterial surface in the wild type strain, but not in an isogenic PI-2 deletion mutant. Anti-PitB-antiserum only reacted with pili containing the same PitB variant, whereas anti-PitA antiserum was cross-reactive with the other PitA variant. Electronic multilocus sequence analysis revealed that all PI-2-encoding oral streptococci were closely-related and cluster with non-PI-2-encoding S. oralis strains. Conclusions/Significance: This is the first identification of PI-2 pili in Mitis group oral streptococci. The findings provide a striking example of intra-and interspecies horizontal gene transfer. The PI-2 pilus diversity provides a possible key to link strain-specific bacterial interactions and/or tissue tropisms with pathogenic traits in the Mitis group streptococci.	[Zaehner, Dorothea; Gandhi, Ashish R.; Stephens, David S.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Stephens, David S.] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA; [Zaehner, Dorothea; Stephens, David S.] Dept Vet Affairs Med Ctr Atlanta, Decatur, GA USA	Emory University; Emory University	Zahner, D (corresponding author), Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	dzahner@emory.edu	Stephens, David S/A-8788-2012		National Institutes of Health [R01AI070829]; Department of Veterans Affairs VA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs VA(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant #R01AI070829 (www.nih.gov) and Department of Veterans Affairs VA Merit Award (www.va.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; BRACCO RM, 1957, J EXP MED, V106, P247, DOI 10.1084/jem.106.2.247; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Chen P, 2007, INFECT IMMUN, V75, P4181, DOI 10.1128/IAI.01955-06; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; COLMAN G, 1969, J GEN MICROBIOL, V57, P247, DOI 10.1099/00221287-57-2-247; COLOMBATTI A, 1991, BLOOD, V77, P2305; COWAN MM, 1992, J GEN MICROBIOL, V138, P2707, DOI 10.1099/00221287-138-12-2707; Doern CD, 2010, J CLIN MICROBIOL, V48, P3829, DOI 10.1128/JCM.01563-10; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; DOWSON CG, 1993, MOL MICROBIOL, V9, P635, DOI 10.1111/j.1365-2958.1993.tb01723.x; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Elliott D, 2003, ORAL MICROBIOL IMMUN, V18, P114, DOI 10.1034/j.1399-302X.2003.00052.x; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Gong K, 1998, INFECT IMMUN, V66, P5388, DOI 10.1128/IAI.66.11.5388-5392.1998; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Handel PH, 1999, AIP CONF PROC, V466, P145; HANDLEY PS, 1985, INFECT IMMUN, V47, P217, DOI 10.1128/IAI.47.1.217-227.1985; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; JAMESON MW, 1995, MICROBIOL-UK, V141, P2729, DOI 10.1099/13500872-141-10-2729; Johnston C, 2010, J CLIN MICROBIOL, V48, P2762, DOI 10.1128/JCM.01746-09; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kilian M, 2005, TOPELY WILSONS MICRO; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; King SJ, 2005, J BACTERIOL, V187, P5376, DOI 10.1128/JB.187.15.5376-5386.2005; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; MCINTIRE FC, 1978, INFECT IMMUN, V21, P978, DOI 10.1128/IAI.21.3.978-988.1978; McNicol A, 2010, CAN J PHYSIOL PHARM, V88, P510, DOI [10.1139/Y10-029, 10.1139/y10-029]; Mishra A, 2010, MOL MICROBIOL, V77, P841, DOI 10.1111/j.1365-2958.2010.07252.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; NARIKAWA S, 1995, ARCH ORAL BIOL, V40, P685, DOI 10.1016/0003-9969(95)00042-N; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Reichmann P, 2011, J BACTERIOL, V193, P2888, DOI 10.1128/JB.00321-11; RONDA C, 1988, MOL GEN GENET, V215, P53, DOI 10.1007/BF00331302; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Sillanpaa J, 2009, J CLIN MICROBIOL, V47, P896, DOI 10.1128/JCM.02283-08; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Soriani M, 2010, FUTURE MICROBIOL, V5, P735, DOI [10.2217/fmb.10.37, 10.2217/FMB.10.37]; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WILLCOX MDP, 1989, MICROBIOS, V59, P19; Willcox MDP, 2001, INT J SYST EVOL MICR, V51, P1277, DOI 10.1099/00207713-51-4-1277; Yamaguchi T, 2009, RES MICROBIOL, V160, P809, DOI 10.1016/j.resmic.2009.09.014; Yi H, 2001, J HISTOCHEM CYTOCHEM, V49, P279, DOI 10.1177/002215540104900301; Yoshida Y, 2008, J BIOL CHEM, V283, P12654, DOI 10.1074/jbc.M801412200; Zahner D, 2011, BIOCHEM BIOPH RES CO, V409, P526, DOI 10.1016/j.bbrc.2011.05.038; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07; Zahner D, 2010, EMERG INFECT DIS, V16, P955, DOI 10.3201/eid1606.091820	70	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25124	10.1371/journal.pone.0025124	http://dx.doi.org/10.1371/journal.pone.0025124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966432	Green Submitted, Green Published, gold			2022-12-27	WOS:000295265100062
J	Boll, H; Nittka, S; Doyon, F; Neumaier, M; Marx, A; Kramer, M; Groden, C; Brockmann, MA				Boll, Hanne; Nittka, Stefanie; Doyon, Fabian; Neumaier, Michael; Marx, Alexander; Kramer, Martin; Groden, Christoph; Brockmann, Marc A.			Micro-CT Based Experimental Liver Imaging Using a Nanoparticulate Contrast Agent: A Longitudinal Study in Mice	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ENHANCEMENT; TUMORS; PHEOCHROMOCYTOMA; INTUBATION; RABBITS; TIME	Background: Micro-CT imaging of liver disease in mice relies on high soft tissue contrast to detect small lesions like liver metastases. Purpose of this study was to characterize the localization and time course of contrast enhancement of a nanoparticular alkaline earth metal-based contrast agent (VISCOVER ExiTron nano) developed for small animal liver CT imaging. Methodology: ExiTron nano 6000 and ExiTron nano 12000, formulated for liver/spleen imaging and angiography, respectively, were intravenously injected in C57BL/6J-mice. The distribution and time course of contrast enhancement were analysed by repeated micro-CT up to 6 months. Finally, mice developing liver metastases after intrasplenic injection of colon carcinoma cells underwent longitudinal micro-CT imaging after a single injection of ExiTron nano. Principal Findings: After a single injection of ExiTron nano the contrast of liver and spleen peaked after 4-8 hours, lasted up to several months and was tolerated well by all mice. In addition, strong contrast enhancement of abdominal and mediastinal lymph nodes and the adrenal glands was observed. Within the first two hours after injection, particularly ExiTron nano 12000 provided pronounced contrast for imaging of vascular structures. ExiTron nano facilitated detection of liver metastases and provided sufficient contrast for longitudinal observation of tumor development over weeks. Conclusions: The nanoparticulate contrast agents ExiTron nano 6000 and 12000 provide strong contrast of the liver, spleen, lymph nodes and adrenal glands up to weeks, hereby allowing longitudinal monitoring of pathological processes of these organs in small animals, with ExiTron nano 12000 being particularly optimized for angiography due to its very high initial vessel contrast.	[Boll, Hanne; Groden, Christoph; Brockmann, Marc A.] Univ Heidelberg, Dept Neuroradiol, Med Fac Mannheim, D-6800 Mannheim, Germany; [Nittka, Stefanie; Neumaier, Michael] Univ Heidelberg, Dept Clin Chem, Med Fac Mannheim, D-6800 Mannheim, Germany; [Doyon, Fabian] Univ Heidelberg, Dept Surg, Med Fac Mannheim, D-6800 Mannheim, Germany; [Marx, Alexander] Univ Heidelberg, Dept Pathol, Med Fac Mannheim, D-6800 Mannheim, Germany; [Kramer, Martin] Univ Giessen, Dept Vet Clin Sci, Small Anim Clin, Giessen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen	Boll, H (corresponding author), Univ Heidelberg, Dept Neuroradiol, Med Fac Mannheim, D-6800 Mannheim, Germany.	brockmann@gmx.de			Forschungsschwerpunkt Onkologie of the Medical Faculty Mannheim, University of Heidelberg; German Federal Ministry of Economics and Technology [KF2725101]; Federal Ministry of Education and Research; Land Baden-Wuerttemberg [125-648]	Forschungsschwerpunkt Onkologie of the Medical Faculty Mannheim, University of Heidelberg; German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Land Baden-Wuerttemberg	This work was supported by a fellowship granted to Hanne Boll by the Forschungsschwerpunkt Onkologie of the Medical Faculty Mannheim, University of Heidelberg and by the German Federal Ministry of Economics and Technology (ZIM-KOOP grant # KF2725101). The acquisition of the micro-CT (Yxlon Y. Fox) was funded by the Federal Ministry of Education and Research and the Land Baden-Wuerttemberg (HBFG grant # 125-648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almajdub M, 2007, CONTRAST MEDIA MOL I, V2, P88, DOI 10.1002/cmmi.130; Bakan D A, 2001, Am J Ther, V8, P359, DOI 10.1097/00045391-200109000-00009; Bakan DA, 1996, J PHARM SCI, V85, P908, DOI 10.1021/js960119z; Bakan DA, 2000, INVEST RADIOL, V35, P158, DOI 10.1097/00004424-200003000-00002; Boll H, 2011, INT J COLORECTAL DIS, V26, P721, DOI 10.1007/s00384-011-1181-0; Boll H, 2010, J COMPUT ASSIST TOMO, V34, P783, DOI 10.1097/RCT.0b013e3181e1050a; Chouker A, 2008, INVEST RADIOL, V43, P77, DOI 10.1097/RLI.0b013e318155aa2e; Ford NL, 2006, INVEST RADIOL, V41, P384, DOI 10.1097/01.rli.0000197981.66537.48; Graham KC, 2008, INVEST RADIOL, V43, P488, DOI 10.1097/RLI.0b013e318172f5b5; Kerl HU, 2011, J COMPUT ASSIST TOMO, V35, P517, DOI 10.1097/RCT.0b013e31821c662b; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; MacDonald KD, 2009, J APPL PHYSIOL, V106, P984, DOI 10.1152/japplphysiol.91376.2008; Martiniova L, 2010, METHODS, V50, P20, DOI 10.1016/j.ymeth.2009.05.016; Martiniova L, 2009, J MAGN RESON IMAGING, V29, P685, DOI 10.1002/jmri.21654; Montet X, 2007, INVEST RADIOL, V42, P652, DOI 10.1097/RLI.0b013e31805f445b; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Ohta S, 2006, INT J CANCER, V119, P2236, DOI 10.1002/ijc.22127; Rupp K, 2002, INVEST RADIOL, V37, P241; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003; Suckow CE, 2008, MOL IMAGING BIOL, V10, P114, DOI 10.1007/s11307-007-0128-x; Weber SM, 2004, J SURG RES, V119, P41, DOI 10.1016/S0022-4804(03)00357-3; WEICHERT JP, 1995, J MED CHEM, V38, P636, DOI 10.1021/jm00004a010; Weichert JP, 2000, RADIOLOGY, V216, P865, DOI 10.1148/radiology.216.3.r00se43865; Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7; Willekens I, 2009, MOL IMAGING BIOL, V11, P128, DOI 10.1007/s11307-008-0186-8	26	66	67	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25692	10.1371/journal.pone.0025692	http://dx.doi.org/10.1371/journal.pone.0025692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984939	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300049
J	Hoskins, ER; Hood, BL; Sun, M; Krivak, TC; Edwards, RP; Conrads, TP				Hoskins, Ebony R.; Hood, Brian L.; Sun, Mai; Krivak, Thomas C.; Edwards, Robert P.; Conrads, Thomas P.			Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; CARCINOMA; ABUNDANCE; RESOURCE; PROTEIN	Background: Epithelial ovarian cancer (EOC) is the deadliest gynecologic malignancy in the United States. Unfortunately, a validated protein biomarker-screening test to detect early stage disease from peripheral blood has not yet been developed. The present investigation assesses the ability to identify tumor relevant proteins from ovarian cancer proximal fluids, including tissue interstitial fluid (TIF) and corresponding ascites, from patients with papillary serous EOC and translates these findings to targeted blood-based immunoassays. Methodology/Principal Findings: Paired TIF and ascites collected from four papillary serous EOC patients at the time of surgery underwent immunodepletion, resolution by 1D gel electrophoresis and in-gel digestion for analysis by liquid chromatography-tandem mass spectrometry, which resulted in an aggregate identification of 569 and 171 proteins from TIF and ascites, respectively. Of these, peroxiredoxin I (PRDX1) was selected for validation in serum by ELISA and demonstrated to be present and significantly elevated (p = 0.0188) in 20 EOC patients with a mean level of 26.0 ng/mL (+/- 9.27 SEM) as compared to 4.19 ng/mL (+/- 2.58 SEM) from 16 patients with normal/benign ovarian pathology. Conclusions/Significance: We have utilized a workflow for harvesting EOC-relevant proximal biofluids, including TIF and ascites, for proteomic analysis. Among the differentially abundant proteins identified from these proximal fluids, PRDX1 was demonstrated to be present in serum and shown by ELISA to be elevated by nearly 6-fold in papillary serous EOC patients relative to normal/benign patients. Our findings demonstrate the facile ability to discover potential EOC-relevant proteins in proximal fluids and confirm their presence in peripheral blood serum. In addition, our finding of elevated levels of PRDX1 in the serum of EOC patients versus normal/benign patients warrants further evaluation as a tumor specific biomarker for EOC.	[Hoskins, Ebony R.; Krivak, Thomas C.; Edwards, Robert P.] Univ Pittsburgh, Magee Womens Hosp, Sch Med, Div Gynecol Oncol,Dept Obstet Gynecol & Reprod Sc, Pittsburgh, PA 15213 USA; [Hood, Brian L.; Conrads, Thomas P.] Inova Hlth Syst, Womens Hlth Integrated Res Ctr, Gynecol Canc Ctr Excellence, Annandale, VA USA; [Sun, Mai] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Inova Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoskins, ER (corresponding author), Univ Pittsburgh, Magee Womens Hosp, Sch Med, Div Gynecol Oncol,Dept Obstet Gynecol & Reprod Sc, Pittsburgh, PA 15213 USA.	conrads@whirc.org		Sun, Mai/0000-0003-0489-1616	Scaife Foundation	Scaife Foundation	Financial support was provided by The Scaife Foundation Pilot Project Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW JJ, 1983, CLIN OBSTET GYNAECOL, V10, P187; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Chung KH, 2010, J PROTEOME RES, V9, P451, DOI 10.1021/pr900811x; Davidson B, 2006, CLIN CANCER RES, V12, P791, DOI 10.1158/1078-0432.CCR-05-2516; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Gromov P, 2010, MOL ONCOL, V4, P65, DOI 10.1016/j.molonc.2009.11.003; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hoshino I, 2007, ONCOL REP, V18, P867; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; KOSARY C, 2007, CANC OVARY; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Maxwell GL, 2011, GYNECOL ONCOL, V121, P586, DOI 10.1016/j.ygyno.2011.02.031; OLIVER KE, 2011, GYNECOL ONCOL; Pylvas M, 2010, EUR J CANCER, V46, P1661, DOI 10.1016/j.ejca.2010.02.006; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Teng PN, 2011, J PROTEOME RES, V10, P1333, DOI 10.1021/pr101074p; Wu XY, 2010, HISTOL HISTOPATHOL, V25, P1297, DOI 10.14670/HH-25.1297	23	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25056	10.1371/journal.pone.0025056	http://dx.doi.org/10.1371/journal.pone.0025056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980378	gold, Green Accepted, Green Published			2022-12-27	WOS:000295941300017
J	Nakagawa, T; Suzuki, Y; Nagayasu, K; Kitaichi, M; Shirakawa, H; Kaneko, S				Nakagawa, Takayuki; Suzuki, Yuichi; Nagayasu, Kazuki; Kitaichi, Maiko; Shirakawa, Hisashi; Kaneko, Shuji			Repeated Exposure to Methamphetamine, Cocaine or Morphine Induces Augmentation of Dopamine Release in Rat Mesocorticolimbic Slice Co-Cultures	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; BEHAVIORAL SENSITIZATION; RECEPTOR ACTIVATION; SEROTONIN RELEASE; NUCLEUS ACCUMBENS; VENTRAL STRIATUM; D-AMPHETAMINE; NEUROTRANSMISSION; NEURONS; ADDICTION	Repeated intermittent exposure to psychostimulants and morphine leads to progressive augmentation of its locomotor activating effects in rodents. Accumulating evidence suggests the critical involvement of the mesocorticolimbic dopaminergic neurons, which project from the ventral tegmental area to the nucleus accumbens and the medial prefrontal cortex, in the behavioral sensitization. Here, we examined the acute and chronic effects of psychostimulants and morphine on dopamine release in a reconstructed mesocorticolimbic system comprised of a rat triple organotypic slice co-culture of the ventral tegmental area, nucleus accumbens and medial prefrontal cortex regions. Tyrosine hydroxylase-positive cell bodies were localized in the ventral tegmental area, and their neurites projected to the nucleus accumbens and medial prefrontal cortex regions. Acute treatment with methamphetamine (0.1-1000 mu M), cocaine (0.1-300 mu M) or morphine (0.1-100 mu M) for 30 min increased extracellular dopamine levels in a concentration-dependent manner, while 3,4-methylenedioxyamphetamine (0.1-1000 mu M) had little effect. Following repeated exposure to methamphetamine (10 mu M) for 30 min every day for 6 days, the dopamine release gradually increased during the 30-min treatment. The augmentation of dopamine release was maintained even after the withdrawal of methamphetamine for 7 days. Similar augmentation was observed by repeated exposure to cocaine (1-300 mu M) or morphine (10 and 100 mu M). Furthermore, methamphetamine-induced augmentation of dopamine release was prevented by an NMDA receptor antagonist, MK-801 (10 mu M), and was not observed in double slice co-cultures that excluded the medial prefrontal cortex slice. These results suggest that repeated psychostimulant-or morphine-induced augmentation of dopamine release, i.e. dopaminergic sensitization, was reproduced in a rat triple organotypic slice co-cultures. In addition, the slice co-culture system revealed that the NMDA receptors and the medial prefrontal cortex play an essential role in the dopaminergic sensitization. This in vitro sensitization model provides a unique approach for studying mechanisms underlying behavioral sensitization to drugs of abuse.	[Nakagawa, Takayuki; Suzuki, Yuichi; Nagayasu, Kazuki; Kitaichi, Maiko; Shirakawa, Hisashi; Kaneko, Shuji] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto, Japan	Kyoto University	Nakagawa, T (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto, Japan.	tnakaga@pharm.kyoto-u.ac.jp	Kaneko, Shuji/AAR-1005-2021; Nagayasu, Kazuki/B-4095-2014	Nakagawa, Takayuki/0000-0003-1890-0843; Kaneko, Shuji/0000-0001-5152-5809; Shirakawa, Hisashi/0000-0002-4129-0978	Ministry of Education, Culture, Sports, Science and Technology of Japan [20790062]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 20790062). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENMANSOUR S, 1992, PSYCHOPHARMACOLOGY, V106, P459, DOI 10.1007/BF02244815; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Cador M, 1999, NEUROSCIENCE, V94, P705, DOI 10.1016/S0306-4522(99)00361-9; Cass WA, 1998, NEUROSCI LETT, V248, P175, DOI 10.1016/S0304-3940(98)00374-7; Chefer VI, 2000, NEUROSCIENCE, V101, P619, DOI 10.1016/S0306-4522(00)00417-6; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; Gifford AN, 2000, N-S ARCH PHARMACOL, V362, P413, DOI 10.1007/s002100000293; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hedou G, 2001, NEUROPHARMACOLOGY, V40, P366, DOI 10.1016/S0028-3908(00)00174-X; Higuchi M, 2008, J NEUROCHEM, V106, P2410, DOI 10.1111/j.1471-4159.2008.05583.x; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; KALIVAS PW, 1989, J PHARMACOL EXP THER, V251, P378; KALIVAS PW, 1988, J NEUROCHEM, V50, P1498, DOI 10.1111/j.1471-4159.1988.tb03036.x; KARLER R, 1989, LIFE SCI, V45, P599, DOI 10.1016/0024-3205(89)90045-3; Kim S, 2000, J PHARMACOL EXP THER, V293, P625; Kita T, 2003, J PHARMACOL SCI, V92, P178; Kitai ST, 1999, CURR OPIN NEUROBIOL, V9, P690, DOI 10.1016/S0959-4388(99)00040-9; KOLTA MG, 1989, NEUROPHARMACOLOGY, V28, P9, DOI 10.1016/0028-3908(89)90060-9; Maeda T, 2004, BRAIN RES, V1015, P34, DOI 10.1016/j.brainres.2004.04.033; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; OHMORI T, 1994, PHARMACOL BIOCHEM BE, V48, P587, DOI 10.1016/0091-3057(94)90318-2; PAULSON PE, 1995, SYNAPSE, V19, P56, DOI 10.1002/syn.890190108; Paxinos G., 1991, ATLAS DEV RAT BRAIN; PERIS J, 1989, PHARMACOL BIOCHEM BE, V32, P71, DOI 10.1016/0091-3057(89)90212-8; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; ROBINSON TE, 1988, BRAIN RES, V462, P211, DOI 10.1016/0006-8993(88)90549-5; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rouge-Pont F, 1999, EUR J NEUROSCI, V11, P2343, DOI 10.1046/j.1460-9568.1999.00650.x; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; RYAN LJ, 1988, LIFE SCI, V43, P1403, DOI 10.1016/0024-3205(88)90307-4; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Sorg BA, 1997, J PHARMACOL EXP THER, V281, P54; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; White SR, 1996, PROG NEUROBIOL, V49, P455, DOI 10.1016/0301-0082(96)00027-5; Williams JM, 2005, NEUROPHARMACOLOGY, V48, P51, DOI 10.1016/j.neuropharm.2004.09.004; WOLF ME, 1995, NEUROSCIENCE, V69, P417, DOI 10.1016/0306-4522(95)00248-H; Wu WR, 2003, BRAIN RES, V991, P232, DOI 10.1016/j.brainres.2003.03.001	44	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24865	10.1371/journal.pone.0024865	http://dx.doi.org/10.1371/journal.pone.0024865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980362	gold, Green Submitted, Green Published			2022-12-27	WOS:000295941300013
J	Moroni, M; Lombardini, E; Salber, R; Kazemzedeh, M; Nagy, V; Olsen, C; Whitnall, MH				Moroni, Maria; Lombardini, Eric; Salber, Rudolph; Kazemzedeh, Mehdi; Nagy, Vitaly; Olsen, Cara; Whitnall, Mark H.			Hematological Changes as Prognostic Indicators of Survival: Similarities Between Gottingen Minipigs, Humans, and Other Large Animal Models	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NONHUMAN PRIMATE MODEL; INDUCED MARROW APLASIA; MULTILINEAGE HEMATOPOIETIC RECOVERY; RADIATION-INDUCED MYELOSUPPRESSION; G-CSF; HUMAN INTERLEUKIN-6; RECEPTOR AGONIST; COMBINATION; EXPOSURE	Background: The animal efficacy rule addressing development of drugs for selected disease categories has pointed out the need to develop alternative large animal models. Based on this rule, the pathophysiology of the disease in the animal model must be well characterized and must reflect that in humans. So far, manifestations of the acute radiation syndrome (ARS) have been extensively studied only in two large animal models, the non-human primate (NHP) and the canine. We are evaluating the suitability of the minipig as an additional large animal model for development of radiation countermeasures. We have previously shown that the Gottingen minipig manifests hematopoietic ARS phases and symptoms similar to those observed in canines, NHPs, and humans. Principal Findings: We establish here the LD50/30 dose (radiation dose at which 50% of the animals succumb within 30 days), and show that at this dose the time of nadir and the duration of cytopenia resemble those observed for NHP and canines, and mimic closely the kinetics of blood cell depletion and recovery in human patients with reversible hematopoietic damage (H3 category, METREPOL approach). No signs of GI damage in terms of diarrhea or shortening of villi were observed at doses up to 1.9 Gy. Platelet counts at days 10 and 14, number of days to reach critical platelet values, duration of thrombocytopenia, neutrophil stress response at 3 hours and count at 14 days, and CRP-to-platelet ratio were correlated with survival. The ratios between neutrophils, lymphocytes and platelets were significantly correlated with exposure to irradiation at different time intervals. Significance: As a non-rodent animal model, the minipig offers a useful alternative to NHP and canines, with attractive features including ARS resembling human ARS, cost, and regulatory acceptability. Use of the minipig may allow accelerated development of radiation countermeasures.	[Moroni, Maria; Salber, Rudolph; Kazemzedeh, Mehdi; Whitnall, Mark H.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Sci Res Dept, Bethesda, MD 20814 USA; [Lombardini, Eric] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Vet Sci, Bethesda, MD 20814 USA; [Nagy, Vitaly] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Radiat Sci, Bethesda, MD 20814 USA; [Olsen, Cara] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Biostat Consulting Ctr, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Moroni, M (corresponding author), Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Sci Res Dept, Bethesda, MD 20814 USA.	moroni@afrri.usuhs.mil			National Institute of Allergy and Infectious Diseases [OD-0505-01]; Armed Forced Radiobiology Research Institute [RBB2DG]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Armed Forced Radiobiology Research Institute	This work was supported by funding from National Institute of Allergy and Infectious Diseases OD-0505-01 and Armed Forced Radiobiology Research Institute RBB2DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizova TV, 2008, HEALTH PHYS, V94, P255, DOI 10.1097/01.HP.0000290833.66789.df; Belyi DA, 2009, RADIAT PROT DOSIM, V134, P159, DOI 10.1093/rpd/ncp077; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; BURSTEIN SA, 1992, BLOOD, V80, P420; Carsten AL., 1984, RESPONSE DIFFERENT S; CORASH L, 1978, BLOOD, V52, P726; Deeg HJ, 1997, ANN HEMATOL, V74, P117, DOI 10.1007/s002770050268; DEUBELBEISS KA, 1975, J CLIN INVEST, V55, P833, DOI 10.1172/JCI107994; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; ELTRINGHAM JR, 1967, RADIAT RES, V31, P533; FARESE AM, 1993, BLOOD, V82, P3012; Farese AM, 1996, J CLIN INVEST, V97, P2145, DOI 10.1172/JCI118652; Farese AM, 2001, STEM CELLS, V19, P522, DOI 10.1634/stemcells.19-6-522; Fliedner TM, 2007, EXP HEMATOL, V35, P8, DOI 10.1016/j.exphem.2007.01.006; Fliedner TM, 2001, MED MANAGEMENT RAD A, P18; Forster R, 2010, J PHARMACOL TOX MET, V62, P227, DOI 10.1016/j.vascn.2010.05.007; Goans RE, 1997, HEALTH PHYS, V72, P513, DOI 10.1097/00004032-199704000-00001; HERODIN F, 1992, BLOOD, V80, P688; Herodin F, 2007, EXP HEMATOL, V35, P1172, DOI 10.1016/j.exphem.2007.04.017; Jacobs A, 2006, EXPERT OPIN DRUG MET, V2, P345, DOI 10.1517/17425255.2.3.345; JAIN NC, 1993, ESSENTIALS VET HEMAT, P23; Larsen MH, 2001, COMPARATIVE MED, V51, P436; MacVittie TJ, 2005, HEALTH PHYS, V89, P546, DOI 10.1097/01.HP.0000173143.69659.5b; MACVITTIE TJ, 1994, BLOOD, V84, P2515; MacVittie TJ, 2000, BLOOD, V95, P837, DOI 10.1182/blood.V95.3.837.003k08_837_845; MacVittie TJ, 1996, BLOOD, V87, P4129, DOI 10.1182/blood.V87.10.4129.bloodjournal87104129; MANDEL L, 1980, Z VERSUCHSTIERKD, V22, P96; MOORE DM, 2006, SCHALMS VET HEMATOLO; Moroni M, 2011, RADIAT RES, V176, P89, DOI 10.1667/RR2481.1; Moroni M, 2011, J AM ASSOC LAB ANIM, V50, P65; NORRIS WP, 1968, RADIAT RES, V35, P681, DOI 10.2307/3572525; NOTHDURFT W, 1992, INT J RADIAT BIOL, V61, P519, DOI 10.1080/09553009214551281; ROTH JA, 2006, DIS SWINE; RUST JH, 1954, RADIOLOGY, V62, P569, DOI 10.1148/62.4.569; Simianer H, 2010, J PHARMACOL TOX MET, V62, P221, DOI 10.1016/j.vascn.2010.05.004; SMITH GS, 2006, SCHALMS VET HEMATOLO; SMITH RD, 1975, INFECT IMMUN, V11, P1216, DOI 10.1128/IAI.11.6.1216-1221.1975; Stickney DR, 2007, INT IMMUNOPHARMACOL, V7, P500, DOI 10.1016/j.intimp.2006.12.005; Stockham SL., 2008, FUNDAMENTALS VET CLI, V2nd; TULLIS JL, 1949, RADIOLOGY, V52, P396, DOI 10.1148/52.3.396; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1	41	55	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25210	10.1371/journal.pone.0025210	http://dx.doi.org/10.1371/journal.pone.0025210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969873	Green Submitted, gold, Green Published			2022-12-27	WOS:000295936900035
J	Tang, XL; Sanganalmath, SK; Sato, H; Bi, QL; Hunt, G; Vincent, RJ; Peng, Y; Shirk, G; Dawn, B; Bolli, R				Tang, Xian-Liang; Sanganalmath, Santosh K.; Sato, Hiroshi; Bi, Qiuli; Hunt, Greg; Vincent, Robert J.; Peng, Yong; Shirk, Gregg; Dawn, Buddhadeb; Bolli, Roberto			Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; NONISCHEMIC HEART-FAILURE; DILATED CARDIOMYOPATHY; ECHOCARDIOGRAPHIC-ASSESSMENT; DIASTOLIC DYSFUNCTION; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; REDUCTASE INHIBITOR; CARDIAC-HYPERTROPHY; CHOLESTEROL LEVELS	Although statins impart a number of cardiovascular benefits, whether statin therapy during the peri-infarct period improves subsequent myocardial structure and function remains unclear. Thus, we evaluated the effects of atorvastatin on cardiac function, remodeling, fibrosis, and apoptosis after myocardial infarction (MI). Two groups of rats were subjected to permanent coronary occlusion. Group II (n = 14) received oral atorvastatin (10 mg/kg/d) daily for 3 wk before and 4 wk after MI, while group I (n = 12) received equivalent doses of vehicle. Infarct size (Masson's trichrome-stained sections) was similar in both groups. Compared with group I, echocardiographic left ventricular ejection fraction (LVEF) and fractional area change (FAC) were higher while LV end-diastolic volume (LVEDV) and LV end-systolic and end-diastolic diameters (LVESD and LVEDD) were lower in treated rats. Hemodynamically, atorvastatin-treated rats exhibited significantly higher dP/dt(max), end-systolic elastance (Ees), and preload recruitable stroke work (PRSW) and lower LV end-diastolic pressure (LVEDP). Morphometrically, infarct wall thickness was greater in treated rats. The improvement of LV function by atorvastatin was associated with a decrease in hydroxyproline content and in the number of apoptotic cardiomyocyte nuclei. We conclude that atorvastatin therapy during the peri-infarct period significantly improves LV function and limits adverse LV remodeling following MI independent of a reduction in infarct size. These salubrious effects may be due in part to a decrease in myocardial fibrosis and apoptosis.	[Tang, Xian-Liang; Sanganalmath, Santosh K.; Sato, Hiroshi; Bi, Qiuli; Hunt, Greg; Peng, Yong; Shirk, Gregg; Bolli, Roberto] Univ Louisville, Div Cardiovasc Med, Louisville, KY 40292 USA; [Tang, Xian-Liang; Sanganalmath, Santosh K.; Sato, Hiroshi; Bi, Qiuli; Hunt, Greg; Peng, Yong; Shirk, Gregg; Bolli, Roberto] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [Vincent, Robert J.; Dawn, Buddhadeb] Univ Kansas, Med Ctr, Cardiovasc Res Inst, Kansas City, KS 66103 USA	University of Louisville; University of Louisville; University of Kansas; University of Kansas Medical Center	Tang, XL (corresponding author), Univ Louisville, Div Cardiovasc Med, Louisville, KY 40292 USA.	rbolli@louisville.edu	Peng, Yong/G-9270-2018; Tang, Xian-Liang/L-5703-2015; Bolli, Roberto/A-6870-2010; Stefanadis, Christodoulos/ABH-2232-2020	Peng, Yong/0000-0001-8390-7668; Tang, Xian-Liang/0000-0002-5987-340X; Stefanadis, Christodoulos/0000-0001-5974-6454	National Institutes of Health (NIH) [R0170897, HL-76794, HL-78825, HL-55757, HL-74351]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074351, R01HL076794, P01HL078825, R37HL055757, R01HL055757, R01HL070897] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by National Institutes of Health (NIH) Grants R0170897, HL-76794, HL-78825, HL-55757, and HL-74351. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT NR, 1979, ANNU REV PHYSIOL, V41, P521, DOI 10.1146/annurev.ph.41.030179.002513; ANVERSA P, 1985, AM J PHYSIOL, V248, pH883, DOI 10.1152/ajpheart.1985.248.6.H883; Aronow HD, 2008, AM J CARDIOL, V102, P1119, DOI 10.1016/j.amjcard.2008.06.032; Assayag P, 1997, CARDIOVASC RES, V34, P439, DOI 10.1016/S0008-6363(97)00073-4; Bauersachs J, 2001, CIRCULATION, V104, P982, DOI 10.1161/hc3401.095946; Birnbaum Y, 2003, CARDIOVASC DRUG THER, V17, P25, DOI 10.1023/A:1024251607923; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; COVELL JW, 1990, CIRCULATION, V81, P155; Didenko VV, 1999, BIOTECHNIQUES, V27, P1130, DOI 10.2144/99276bm09; Didenko VV, 1998, AM J PATHOL, V152, P897; Filusch A, 2008, ECHOCARDIOGR-J CARD, V25, P974, DOI 10.1111/j.1540-8175.2008.00724.x; Hayashidani S, 2002, CIRCULATION, V105, P868, DOI 10.1161/hc0702.104164; Herrmann J, 2002, CIRCULATION, V106, P2180, DOI 10.1161/01.CIR.0000037520.89770.5E; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Iliodromitis EK, 2010, BASIC RES CARDIOL, V105, P193, DOI 10.1007/s00395-009-0078-3; Kang L, 2007, PHARMACOLOGY, V80, P120, DOI 10.1159/000103251; Krum H, 2007, J CARD FAIL, V13, P1, DOI 10.1016/j.cardfail.2006.09.008; Laufs U, 2004, Z KARDIOL, V93, P103, DOI 10.1007/s00392-004-1005-0; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; Node K, 2003, CIRCULATION, V108, P839, DOI 10.1161/01.CIR.0000084539.58092.DE; Oi S, 1999, EUR J PHARMACOL, V376, P139, DOI 10.1016/S0014-2999(99)00282-4; PEDERSEN TR, 1994, LANCET, V344, P1383; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Plenge JK, 2002, CIRCULATION, V106, P1447, DOI 10.1161/01.CIR.0000029743.68247.31; Pliquett RU, 2003, CIRCULATION, V107, P2493, DOI 10.1161/01.CIR.0000065606.63163.B9; Rossi MA, 1998, J HYPERTENS, V16, P1031, DOI 10.1097/00004872-199816070-00018; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schmechel A, 2009, CARDIOVASC RES, V82, P100, DOI 10.1093/cvr/cvp005; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Stefanadi E, 2009, INT J CARDIOL, V133, P266, DOI 10.1016/j.ijcard.2007.11.025; Stein AB, 2007, BASIC RES CARDIOL, V102, P28, DOI 10.1007/s00395-006-0627-y; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; SWITZER BR, 1971, ANAL BIOCHEM, V39, P487, DOI 10.1016/0003-2697(71)90438-6; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Trochu JN, 2003, CARDIOVASC RES, V60, P250, DOI 10.1016/j.cardiores.2003.08.003; Van Linthout S, 2007, DIABETOLOGIA, V50, P1977, DOI 10.1007/s00125-007-0719-8; Vaughan CJ, 2000, J AM COLL CARDIOL, V35, P1, DOI 10.1016/S0735-1097(99)00525-2; Weber KT, 1997, CIRCULATION, V96, P4065; Weinberg EO, 2005, AM J PHYSIOL-HEART C, V288, pH1802, DOI 10.1152/ajpheart.00962.2004; Wojnicz R, 2006, AM J CARDIOL, V97, P899, DOI 10.1016/j.amjcard.2005.09.142; Wu YM, 2004, J MOL CELL CARDIOL, V37, P111, DOI 10.1016/j.yjmcc.2004.04.010; Yao L, 2009, BASIC RES CARDIOL, V104, P258, DOI 10.1007/s00395-008-0751-y; Ye YM, 2008, AM J PHYSIOL-HEART C, V295, pH343, DOI 10.1152/ajpheart.01350.2007; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	48	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25320	10.1371/journal.pone.0025320	http://dx.doi.org/10.1371/journal.pone.0025320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980426	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900053
J	Glennie, SJ; Sepako, E; Mzinza, D; Harawa, V; Miles, DJC; Jambo, KC; Gordon, SB; Williams, NA; Heyderman, RS				Glennie, Sarah J.; Sepako, Enoch; Mzinza, David; Harawa, Visopo; Miles, David J. C.; Jambo, Kondwani C.; Gordon, Stephen B.; Williams, Neil A.; Heyderman, Robert S.			Impaired CD4 T Cell Memory Response to Streptococcus pneumoniae Precedes CD4 T Cell Depletion in HIV-Infected Malawian Adults	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PNEUMOCOCCAL PROTEIN ANTIGENS; SURFACE ADHESIN-A; GAMMA-INTERFERON; OTITIS-MEDIA; B-CELL; DISEASE; CHILDREN; MUCOSAL; PNEUMOLYSIN	Objective: Invasive pneumococcal disease (IPD) is a leading cause of morbidity and mortality in HIV-infected African adults. CD4 T cell depletion may partially explain this high disease burden but those with relatively preserved T cell numbers are still at increased risk of IPD. This study evaluated the extent of pneumococcal-specific T cell memory dysfunction in asymptomatic HIV infection early on in the evolution of the disease. Methods: Peripheral blood mononuclear cells were isolated from asymptomatic HIV-infected and HIV-uninfected Malawian adults and stained to characterize the underlying degree of CD4 T cell immune activation, senescence and regulation. Pneumococcal-specific T cell proliferation, IFN-gamma, IL-17 production and CD154 expression was assessed using flow cytometry and ELISpot. Results: We find that in asymptomatic HIV-infected Malawian adults, there is considerable immune disruption with an increase in activated and senescent CD4(+) CD38(+) PD-1(+) and CD4(+) CD25(high)Foxp3(+) Treg cells. In the context of high pneumococcal exposure and therefore immune stimulation, show a failure in pneumococcal-specific memory T cell proliferation, skewing of T cell cytokine production with preservation of interleukin-17 but decreased interferon-gamma responses, and failure of activated T cells to express the co-stimulatory molecule CD154. Conclusion: Asymptomatic HIV-infected Malawian adults show early signs of pneumococcal-specific immune dysregulation with a shift in the balance of CD4 memory, T helper 17 cells and Treg. Together these data offer a mechanistic understanding of how antigen-specific T cell dysfunction occurs prior to T cell depletion and may explain the early susceptibility to IPD in those with relatively preserved CD4 T cell numbers.	[Glennie, Sarah J.; Sepako, Enoch; Mzinza, David; Harawa, Visopo; Miles, David J. C.; Jambo, Kondwani C.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Miles, David J. C.] Univ Cape Town, S African TB Vaccine Inst, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Jambo, Kondwani C.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Resp Infect Grp, Liverpool L3 5QA, Merseyside, England; [Williams, Neil A.; Heyderman, Robert S.] Univ Bristol, Sch Med Sci, Bristol BS8 1TD, Avon, England	University of Malawi; University of Cape Town; Liverpool School of Tropical Medicine; University of Liverpool; University of Bristol	Glennie, SJ (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	sarah.glennie@liverpool.ac.uk		Jambo, Kondwani/0000-0002-3195-2210; Mzinza, David/0000-0002-5999-8616; Gordon, Stephen/0000-0001-6576-1116	Wellcome Trust (United Kingdom) [083603/A/07/Z, 084679/Z/08/Z]; Commonwealth Scholarship Commission (United Kingdom) [MWCS-2007-477]	Wellcome Trust (United Kingdom)(Wellcome Trust); Commonwealth Scholarship Commission (United Kingdom)	This work was supported by a grant to NAW and RSH by the Wellcome Trust "083603/A/07/Z" (United Kingdom), a core programme grant to RSH by the Wellcome Trust "084679/Z/08/Z" (United Kingdom) and a grant to KCJ from the Commonwealth Scholarship Commission "MWCS-2007-477" (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHDAHL BM, 1995, AM J RESP CRIT CARE, V152, P2000, DOI 10.1164/ajrccm.152.6.8520768; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bentwich Z, 1998, CLIN EXP IMMUNOL, V111, P1; Berry AM, 1999, INFECT IMMUN, V67, P981, DOI 10.1128/IAI.67.2.981-985.1999; Beswick EJ, 2007, INFECT IMMUN, V75, P4334, DOI 10.1128/IAI.00553-07; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Cai GF, 2004, CELL IMMUNOL, V230, P89, DOI 10.1016/j.cellimm.2004.09.004; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; CLOT J, 1975, IMMUNOLOGY, V29, P445; Davenport V, 2007, CELL MICROBIOL, V9, P1050, DOI 10.1111/j.1462-5822.2006.00851.x; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Ford ES, 2009, CURR OPIN HIV AIDS, V4, P206, DOI 10.1097/COH.0b013e328329c68c; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Glennie SJ, 2010, TRENDS MICROBIOL, V18, P487, DOI 10.1016/j.tim.2010.08.002; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Kelly P, 2004, CLIN EXP IMMUNOL, V135, P303, DOI 10.1111/j.1365-2249.2004.02374.x; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Miga A., 2000, Immunological Investigations, V29, P111, DOI 10.3109/08820130009062292; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; PIDO J, 2010, TEL AVIV; Rapola S, 2001, PEDIATR INFECT DIS J, V20, P482, DOI 10.1097/00006454-200105000-00003; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; Rutjens E, 2008, EUR J IMMUNOL, V38, P1164, DOI 10.1002/eji.200737792; SAID EA, NAT MED; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Simell B, 2001, J INFECT DIS, V183, P887, DOI 10.1086/319246; Subauste CS, 2007, J IMMUNOL, V178, P1645, DOI 10.4049/jimmunol.178.3.1645; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; SUTHERLAND JS, J IMMUNOL, P6537; WHO, 2009, NEW HIV REC IMPR HLT; Zhang QB, 2006, INFECT IMMUN, V74, P4735, DOI 10.1128/IAI.00165-06; Zhang R, 2004, J IMMUNOL, V172, P2678, DOI 10.4049/jimmunol.172.4.2678	49	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25610	10.1371/journal.pone.0025610	http://dx.doi.org/10.1371/journal.pone.0025610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980502	Green Published, Green Accepted, gold			2022-12-27	WOS:000295933700046
J	Hu, MJ; Cox, KD; Schnabel, G; Luo, CX				Hu, Meng-Jun; Cox, Kerik D.; Schnabel, Guido; Luo, Chao-Xi			Monilinia Species Causing Brown Rot of Peach in China	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR PHYLOGENY; FRUIT CROPS; 1ST REPORT; FRUCTICOLA; IDENTIFICATION; FUNGI; LAXA; DNA; FRUCTIGENA	In this study, 145 peaches and nectarines displaying typical brown rot symptoms were collected from multiple provinces in China. A subsample of 26 single-spore isolates were characterized phylogenetically and morphologically to ascertain species. Phylogenetic analysis of internal transcribed spacer (ITS) regions 1 and 2, glyceraldehyde-3-phosphate dehydrogenase (G3PDH), b-tubulin (TUB2) revealed the presence of three distinct Monilinia species. These species included Monilinia fructicola, Monilia mumecola, and a previously undescribed species designated Monilia yunnanensis sp. nov. While M. fructicola is a well-documented pathogen of Prunus persica in China, M. mumecola had primarily only been isolated from mume fruit in Japan. Koch's postulates for M. mumecola and M. yunnanensis were fulfilled confirming pathogenicity of the two species on peach. Phylogenetic analysis of ITS, G3PDH, and TUB2 sequences indicated that M. yunnanensis is most closely related to M. fructigena, a species widely prevalent in Europe. Interestingly, there were considerable differences in the exon/intron structure of the cytochrome b (Cyt b) gene between the two species. Morphological characteristics, including spore size, colony morphology, lesion growth rate, and sporulation, support the phylogenetic evidence suggesting the designation of M. yunnanensis as a new species. A new multiplex PCR method was developed to facilitate the detection of M. yunnanensis and differentiation of Monilinia spp. causing brown rot of peach in China.	[Hu, Meng-Jun; Luo, Chao-Xi] Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Pathol, Wuhan, Peoples R China; [Hu, Meng-Jun; Luo, Chao-Xi] Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Peoples R China; [Cox, Kerik D.] Cornell Univ, New York State Agr Expt Stn, Dept Plant Pathol & Plant Microbe Biol, Geneva, NY 14456 USA; [Schnabel, Guido] Clemson Univ, Dept Entomol Soils & Plant Sci, Clemson, SC USA	Huazhong Agricultural University; Huazhong Agricultural University; Cornell University; Clemson University	Luo, CX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Pathol, Wuhan, Peoples R China.	cxluo@mail.hzau.edu.cn		Hu, Mengjun/0000-0003-1567-0843	Program for New Century Excellent Talents in University [NCET-08-0783]; Fundamental Research Funds for the Central Universities [2009PY010]; National Natural Science Foundation of China [31071703]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This material is based upon work supported by Program for New Century Excellent Talents in University (NCET-08-0783) and the Fundamental Research Funds for the Central Universities (Program No. 2009PY010), also partially sponsored by Project supported by the National Natural Science Foundation of China (Grant No. 31071703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Bryde RJ, 1977, BROWN ROT FUNGI FRUI; CABI, 2010, CROP PROT COMP; Chen YC, 2001, J CLIN MICROBIOL, V39, P4042, DOI 10.1128/JCM.39.11.4042-4051.2001; Cote MJ, 2004, PLANT DIS, V88, P1219, DOI 10.1094/PDIS.2004.88.11.1219; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; de Jong SN, 2001, MYCOL RES, V105, P658, DOI 10.1017/S0953756201003926; Fan JY, 2010, J EUKARYOT MICROBIOL, V57, P206, DOI 10.1111/j.1550-7408.2009.00467.x; Fan JinYan, 2007, Acta Phytophylacica Sinica, V34, P289; Fournier E, 2006 APS CPS MSA JOI, P195; Fournier E, 2005, MYCOLOGIA, V97, P1251, DOI 10.3852/mycologia.97.6.1251; Fulton CE, 1999, EUR J PLANT PATHOL, V105, P495, DOI 10.1023/A:1008711107347; Gell I, 2007, J APPL MICROBIOL, V103, P2629, DOI 10.1111/j.1365-2672.2007.03495.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harada Y, 1990, ANN PHYTOPATHOLOGICA, V59, P387; Harada Yukio, 2004, Journal of General Plant Pathology, V70, P297, DOI 10.1007/s10327-004-0137-4; Hily JM, 2011, PEST MANAG SCI, V67, P385, DOI 10.1002/ps.2074; HolstJensen A, 1997, AM J BOT, V84, P686, DOI 10.2307/2445905; Hu MJ, 2011, PLANT DIS, V95, P225, DOI 10.1094/PDIS-11-10-0779; Ioos R, 2000, EUR J PLANT PATHOL, V106, P373, DOI 10.1023/A:1008798520882; Iwen PC, 2002, MED MYCOL, V40, P87, DOI 10.1080/mmy.40.1.87.109; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KHOKHRIAKOVA TM, 1978, MIKOL FITOPATOL, V12, P154; Lane C. R., 2002, Bulletin OEPP, V32, P489, DOI 10.1046/j.1365-2338.2002.00595.x; Lehman JS, 2000, PHYTOPATHOLOGY, V90, P390, DOI 10.1094/PHYTO.2000.90.4.390; LI ZL, 1984, HORTSCIENCE, V19, P348; Luo Chao-Xi, 2002, Journal of General Plant Pathology, V68, P300, DOI 10.1007/PL00013095; Ma Z, 2003, J PHYTOPATHOL, V151, P312, DOI 10.1046/j.1439-0434.2003.00725.x; Ma ZH, 2005, PEST MANAG SCI, V61, P449, DOI 10.1002/ps.982; Miessner S, 2010, J PLANT DIS PROTECT, V117, P162, DOI 10.1007/BF03356354; Nakao S, 1992, KONGETSU NO NOYAKU, P92; O'Gorman DT, 2008, MYCOLOGIA, V100, P227, DOI 10.3852/mycologia.100.2.227; Shao W, 2009, ETIOLOGY OCCURRENCE; Sholberg PL, 2005, POSTHARVEST BIOL TEC, V36, P41, DOI 10.1016/j.postharvbio.2004.07.011; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Tai F. L., 1979, Sylloge fungorum Sinicorum.; Takahashi Yukiko, 2005, Mycoscience, V46, P106, DOI 10.1007/s10267-004-0219-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Q., 2007, DPS DATA PROCESSING; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Leeuwen GCM, 1998, CAN J BOT, V76, P2042, DOI 10.1139/cjb-76-12-2042; van Leeuwen GCM, 2002, MYCOL RES, V106, P444, DOI 10.1017/S0953756202005695; Wang YX, 1998, J YUNNAN AGR U, V13, P29; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WILLETTS HJ, 1984, MYCOLOGIA, V76, P314, DOI 10.2307/3793107; WILLETTS HJ, 1968, T BRIT MYCOL SOC, V51, P625, DOI 10.1016/S0007-1536(68)80082-8; Willetts HJ, 1968, T BRIT MYCOLOGICAL S, V51, pIN621; Wormald H, 1927, ANN BOT-LONDON, V41, P287, DOI 10.1093/oxfordjournals.aob.a090073; Xiang W. N., 1957, REFERENCE MYCOLOGY P; [薛伟 Xue Wei], 2010, [微生物学通报, Microbiology], V37, P71; Zhu XQ, 2010, PLANT DIS, V94, P478, DOI 10.1094/PDIS-94-4-0478A; Zhu XQ, 2005, PLANT PATHOL, V54, P575, DOI 10.1111/j.1365-3059.2005.01199.x; Zhuang WY, 1998, FLORA FUNGORUM SINIC, V8, P57	55	89	102	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24990	10.1371/journal.pone.0024990	http://dx.doi.org/10.1371/journal.pone.0024990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980371	Green Submitted, Green Published, gold			2022-12-27	WOS:000295933700013
J	Pineda, MC; Lopez-Legentil, S; Turon, X				Pineda, Mari Carmen; Lopez-Legentil, Susanna; Turon, Xavier			The Whereabouts of an Ancient Wanderer: Global Phylogeography of the Solitary Ascidian Styela plicata	PLOS ONE			English	Article							MICROCOSMUS-SQUAMIGER ASCIDIACEA; CYTOCHROME-C-OXIDASE; BIOLOGICAL INVASIONS; CIONA-INTESTINALIS; GENETIC-STRUCTURE; PHENOTYPIC ASSOCIATIONS; MULTIPLE INTRODUCTIONS; CLADISTIC-ANALYSIS; POPULATION-GROWTH; ATLANTIC-OCEAN	Genetic tools have greatly aided in tracing the sources and colonization history of introduced species. However, recurrent introductions and repeated shuffling of populations may have blurred some of the genetic signals left by ancient introductions. Styela plicata is a solitary ascidian distributed worldwide. Although its origin remains unclear, this species is believed to have spread worldwide by travelling on ship's hulls. The goals of this study were to infer the genetic structure and global phylogeography of S. plicata and to look for present-day and historical genetic patterns. Two genetic markers were used: a fragment of the mitochondrial gene Cytochrome Oxidase subunit I (COI) and a fragment of the nuclear gene Adenine Nucleotide Transporter/ADP-ATP Translocase (ANT). A total of 368 individuals for COI and 315 for ANT were sequenced from 17 locations worldwide. The levels of gene diversity were moderate for COI to high for ANT. The Mediterranean populations showed the least diversity and allelic richness for both markers, while the Indian, Atlantic and Pacific Oceans had the highest gene and nucleotide diversities. Network and phylogenetic analyses with COI and ANT revealed two groups of alleles separated by 15 and 4 mutational steps, respectively. The existence of different lineages suggested an ancient population split. However, the geographic distributions of these groups did not show any consistent pattern, indicating different phylogeographic histories for each gene. Genetic divergence was significant for many population-pairs irrespective of the geographic distance among them. Stochastic introduction events are reflected in the uneven distribution of COI and ANT allele frequencies and groups among many populations. Our results confirmed that S. plicata has been present in all studied oceans for a long time, and that recurrent colonization events and occasional shuffling among populations have determined the actual genetic structure of this species.	[Pineda, Mari Carmen; Lopez-Legentil, Susanna] Univ Barcelona, Dept Anim Biol Invertebrates, Barcelona, Spain; [Turon, Xavier] Consejo Super Invest Cient CEAB CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Pineda, MC (corresponding author), Univ Barcelona, Dept Anim Biol Invertebrates, Barcelona, Spain.	xturon@ceab.csic.es	Lopez-Legentil, Susanna/B-8194-2008; Turon, Xavier/J-9211-2012	Lopez-Legentil, Susanna/0000-0001-8737-6729; Turon, Xavier/0000-0002-9229-5541	European Community [FP7-PEOPLE-2010-RG 277038]; Spanish Government [CTM2010-22218, CTM2010-17755]; University of Barcelona	European Community(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); University of Barcelona	This study was funded by the Marie Curie International Reintegration Grant FP7-PEOPLE-2010-RG 277038 (within the 7th European Community Framework Program), by the Spanish Government projects CTM2010-22218 and CTM2010-17755, and by an APIF fellowship of the University of Barcelona to MCP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Donald P., 2007, P949; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barros R.C., 2009, AQUAT INVASIONS, V4, P45, DOI [http://dx.doi.org/10.3391/ai.2009.4.1.4, DOI 10.3391/AI.2009.4.1.4]; Bastrop R, 1998, MOL BIOL EVOL, V15, P97, DOI 10.1093/oxfordjournals.molbev.a025919; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Belkhir K, 2004, 5171 CNRS UMR LAB GE; Blakeslee AMH, 2010, DIVERS DISTRIB, V16, P879, DOI 10.1111/j.1472-4642.2010.00703.x; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Carlton James T., 2009, V204, P13; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carlton JT, 2003, HYDROBIOLOGIA, V503, P1, DOI 10.1023/B:HYDR.0000008479.90581.e1; CARLTON JT, 1989, CONSERV BIOL, V3, P265, DOI 10.1111/j.1523-1739.1989.tb00086.x; Carlton JT, 2006, BIOSCIENCE, V56, P694; Carman Mary R., 2009, Aquatic Invasions, V4, P65, DOI 10.3391/ai.2009.4.1.6; Castilla JC, 2004, P NATL ACAD SCI USA, V101, P8517, DOI 10.1073/pnas.0401921101; CHAO A., 2009, SPADE SPECIES PREDIC; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Dafforn KA, 2009, BIOFOULING, V25, P277, DOI 10.1080/08927010802710618; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; David GK, 2010, MAR BIOL, V157, P1955, DOI 10.1007/s00227-010-1464-y; Drew JA, 2010, CORAL REEFS, V29, P439, DOI 10.1007/s00338-010-0586-5; Dupont L, 2007, DIVERS DISTRIB, V13, P808, DOI 10.1111/j.1472-4642.2007.00405.x; Dupont L, 2010, BIOL INVASIONS, V12, P2707, DOI 10.1007/s10530-009-9676-0; Dupont L, 2009, MOL ECOL, V18, P442, DOI 10.1111/j.1365-294X.2008.04045.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feral JP, 2002, J EXP MAR BIOL ECOL, V268, P121, DOI 10.1016/S0022-0981(01)00382-3; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Galil Bella S., 2000, Biological Invasions, V2, P177, DOI 10.1023/A:1010057010476; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Goldstien SJ, 2010, MOL ECOL, V19, P874, DOI 10.1111/j.1365-294X.2010.04527.x; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Holland BS, 2000, HYDROBIOLOGIA, V420, P63, DOI 10.1023/A:1003929519809; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kelly DW, 2006, EVOLUTION, V60, P257; Lafferty KD, 1996, ECOLOGY, V77, P1989, DOI 10.2307/2265695; Lambert CC, 2003, MAR ECOL PROG SER, V259, P145, DOI 10.3354/meps259145; Lambert G, 2001, BIOLOGY OF ASCIDIANS, P249; Lambert G, 2007, J EXP MAR BIOL ECOL, V342, P3, DOI 10.1016/j.jembe.2006.10.009; Lejeusne C, 2011, BIOL INVASIONS, V13, P635, DOI 10.1007/s10530-010-9854-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Locke Andrea, 2009, Aquatic Invasions, V4, P249, DOI 10.3391/ai.2009.4.1.25; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lopez-Legentil S, 2006, MOL ECOL, V15, P3957, DOI 10.1111/j.1365-294X.2006.03087.x; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McDonald J, 2004, MAR POLLUT BULL, V49, P868, DOI 10.1016/j.marpolbul.2004.08.024; MCDONALD JH, 1991, NATURE, V354, P116, DOI 10.1038/354116a0; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Orensanz Jose Maria (Lobo), 2002, Biological Invasions, V4, P115; PAPACONSTANTINOU C, 1990, Scientia Marina, V54, P313; Perez-Portela R, 2009, MOL PHYLOGENET EVOL, V50, P560, DOI 10.1016/j.ympev.2008.11.014; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ramsay Aaron, 2009, Aquatic Invasions, V4, P169, DOI 10.3391/ai.2009.4.1.17; Rawson PD, 2002, P NATL ACAD SCI USA, V99, P12955, DOI 10.1073/pnas.202335899; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 1997, GENETICS, V145, P1219; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz GM, 1997, AM ZOOL, V37, P621; Sabbadin A, 1957, ARCH OCEANOGR LIMNOL, VXI, P1; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schizas NV, 2002, MAR BIOL, V140, P585, DOI 10.1007/s00227-001-0728-y; Sciscioli M., 1978, Memorie di Biologia Marina e di Oceanografia, V8, P65; Shaw PW, 2004, MOL ECOL, V13, P3293, DOI 10.1111/j.1365-294X.2004.02327.x; Simon-Bouhet B, 2006, MOL ECOL, V15, P1699, DOI 10.1111/j.1365-294X.2006.02881.x; SIMS LL, 1984, J EXP MAR BIOL ECOL, V82, P117, DOI 10.1016/0022-0981(84)90098-4; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1993, GENETICS, V134, P659; Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V290, P133, DOI 10.1016/S0022-0981(03)00071-6; Turon X, 2003, HYDROBIOLOGIA, V503, P29, DOI 10.1023/B:HYDR.0000008481.10705.c2; Turon X, 2007, J EXP MAR BIOL ECOL, V342, P185, DOI 10.1016/j.jembe.2006.10.040; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; VANNAME WG, 1945, B AM MUS NAT HIST, V84, P1; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Wasson K, 2001, BIOL CONSERV, V102, P143, DOI 10.1016/S0006-3207(01)00098-2; YAMAGUCHI M, 1975, MAR BIOL, V29, P253, DOI 10.1007/BF00391851; Zenetos A, 2010, BIOL INVASIONS, V12, P3379, DOI 10.1007/s10530-009-9679-x; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x; Zibrowius Helmut, 1991, Mesogee, V51, P83	106	65	65	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25495	10.1371/journal.pone.0025495	http://dx.doi.org/10.1371/journal.pone.0025495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966535	Green Published, gold			2022-12-27	WOS:000295267100063
J	Ruger, N; Berger, U; Hubbell, SP; Vieilledent, G; Condit, R				Rueger, Nadja; Berger, Uta; Hubbell, Stephen P.; Vieilledent, Ghislain; Condit, Richard			Growth Strategies of Tropical Tree Species: Disentangling Light and Size Effects	PLOS ONE			English	Article							RAIN-FOREST; NEIGHBORHOOD ANALYSIS; SAPLING GROWTH; MOIST FOREST; CANOPY; MORTALITY; RESPONSES; RECRUITMENT; SEEDLINGS; PERFORMANCE	An understanding of the drivers of tree growth at the species level is required to predict likely changes of carbon stocks and biodiversity when environmental conditions change. Especially in species-rich tropical forests, it is largely unknown how species differ in their response of growth to resource availability and individual size. We use a hierarchical Bayesian approach to quantify the impact of light availability and tree diameter on growth of 274 woody species in a 50-ha long-term forest census plot in Barro Colorado Island, Panama. Light reaching each individual tree was estimated from yearly vertical censuses of canopy density. The hierarchical Bayesian approach allowed accounting for different sources of error, such as negative growth observations, and including rare species correctly weighted by their abundance. All species grew faster at higher light. Exponents of a power function relating growth to light were mostly between 0 and 1. This indicates that nearly all species exhibit a decelerating increase of growth with light. In contrast, estimated growth rates at standardized conditions (5 cm dbh, 5% light) varied over a 9-fold range and reflect strong growth-strategy differentiation between the species. As a consequence, growth rankings of the species at low (2%) and high light (20%) were highly correlated. Rare species tended to grow faster and showed a greater sensitivity to light than abundant species. Overall, tree size was less important for growth than light and about half the species were predicted to grow faster in diameter when bigger or smaller, respectively. Together light availability and tree diameter only explained on average 12% of the variation in growth rates. Thus, other factors such as soil characteristics, herbivory, or pathogens may contribute considerably to shaping tree growth in the tropics.	[Rueger, Nadja] Univ Leipzig, Spezielle Botan & Funktionelle Biodiversitat, Leipzig, Germany; [Berger, Uta] Tech Univ Dresden, Inst Waldwachstum & Forstliche Informat, Dresden, Tharandt, Germany; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Hubbell, Stephen P.; Condit, Richard] Ctr Trop Forest Sci, Smithsonian Trop Res Inst, Washington, DE USA; [Vieilledent, Ghislain] Forest Ecosystem Goods & Serv, UR105, Montpellier, France; [Vieilledent, Ghislain] DRP Foret & Biodiversite, Antananarivo, Madagascar	Leipzig University; Technische Universitat Dresden; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian Tropical Research Institute	Ruger, N (corresponding author), Univ Leipzig, Spezielle Botan & Funktionelle Biodiversitat, Leipzig, Germany.	nadja.rueger@uni-leipzig.de	Rüger, Nadja/Q-6418-2019; Rüger, Nadja/J-6393-2015; Vieilledent, Ghislain/D-8323-2011	Rüger, Nadja/0000-0003-2371-4172; Rüger, Nadja/0000-0003-2371-4172; Vieilledent, Ghislain/0000-0002-1685-4997	Deutsche Forschungsgemeinschaft (DFG) [RU 1536/2-1]; Center for Tropical Forest Science (CTFS); United States National Science Foundation; John D. and Catherine T. McArthur Foundation; Smithsonian Tropical Research Institute	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for Tropical Forest Science (CTFS); United States National Science Foundation(National Science Foundation (NSF)); John D. and Catherine T. McArthur Foundation; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute)	NR was partially funded by research grants from Deutsche Forschungsgemeinschaft (DFG) (RU 1536/2-1) and the Center for Tropical Forest Science (CTFS). The Barro Colorado Island plot has been made possible through the support of the United States National Science Foundation, the John D. and Catherine T. McArthur Foundation and the Smithsonian Tropical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balderrama SIV, 2005, J TROP ECOL, V21, P383, DOI 10.1017/S026646740500235X; Baraloto C, 2006, J TROP ECOL, V22, P487, DOI 10.1017/S0266467406003439; Bloor JMG, 2003, J ECOL, V91, P77, DOI 10.1046/j.1365-2745.2003.00743.x; Brienen RJW, 2006, FOREST ECOL MANAG, V237, P179, DOI 10.1016/j.foreco.2006.09.042; BROWN ND, 1992, PHILOS T R SOC B, V335, P369, DOI 10.1098/rstb.1992.0028; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Clark DA, 1999, ECOL APPL, V9, P981, DOI 10.1890/1051-0761(1999)009[0981:ATGOTR]2.0.CO;2; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clark JS, 2007, ECOL APPL, V17, P1942, DOI 10.1890/06-1039.1; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONDIT R, 1993, FOREST ECOL MANAG, V62, P107, DOI 10.1016/0378-1127(93)90045-O; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Croat T.B., 1978, FLORA BARRO COLORADO; Dalling JW, 2004, FUNCT ECOL, V18, P725, DOI 10.1111/j.0269-8463.2004.00868.x; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; de Gouvenain RC, 2007, J TROP ECOL, V23, P569, DOI 10.1017/S0266467407004385; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; DENSLOW JS, 1990, ECOLOGY, V71, P165, DOI 10.2307/1940257; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Dent DH, 2009, BIOTROPICA, V41, P424, DOI 10.1111/j.1744-7429.2009.00505.x; Foster RB, 1982, ECOLOGY TROPICAL FOR, P67; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; Johnson SE, 2009, TREE PHYSIOL, V29, P1317, DOI 10.1093/treephys/tpp068; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; King DA, 2005, FUNCT ECOL, V19, P445, DOI 10.1111/j.1365-2435.2005.00982.x; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Kohyama T, 2003, J ECOL, V91, P797, DOI 10.1046/j.1365-2745.2003.00810.x; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Leigh E. G., 1996, ECOLOGY TROPICAL FOR; Leigh EG, 1999, TROPICAL FOREST ECOL; Lichstein JW, 2010, ECOL APPL, V20, P684, DOI 10.1890/08-2334.1; LIEBERMAN M, 1989, ECOLOGY, V70, P550, DOI 10.2307/1940201; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McMahon SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016253; Metcalf CJE, 2009, ECOLOGY, V90, P2766, DOI 10.1890/08-1645.1; Montgomery RA, 2002, OECOLOGIA, V131, P165, DOI 10.1007/s00442-002-0872-1; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Niklas K.., 1994, PLANT ALLOMETRY; PACALA SW, 1994, CAN J FOREST RES, V24, P2172, DOI 10.1139/x94-280; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Poorter L, 2003, PLANT ECOL, V166, P295, DOI 10.1023/A:1023295806147; Poorter L, 2005, J ECOL, V93, P256, DOI 10.1111/j.1365-2745.2004.00956.x; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Ruger N, 2011, OIKOS, V120, P1047, DOI 10.1111/j.1600-0706.2010.19021.x; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; Sack L, 2001, FUNCT ECOL, V15, P145, DOI 10.1046/j.1365-2435.2001.00507.x; Sheil D, 2006, J ECOL, V94, P494, DOI 10.1111/j.1365-2745.2006.01111.x; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; van der Meer PJ, 1998, J TROP ECOL, V14, P119, DOI 10.1017/S026646749800011X; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900; Windsor D.M., 1990, CLIMATE MOISTURE VAR; Windsor DM, 1990, ECOLOGIA BOSQUE TROP, P53; Wirth R, 2001, ACTA OECOL, V22, P235, DOI 10.1016/S1146-609X(01)01123-7; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wyckoff PH, 2005, CAN J FOREST RES, V35, P13, DOI 10.1139/x04-142; Yavitt JB, 2008, J TROP ECOL, V24, P19, DOI 10.1017/S0266467407004713; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	74	68	73	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25330	10.1371/journal.pone.0025330	http://dx.doi.org/10.1371/journal.pone.0025330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966498	gold, Green Submitted, Green Published			2022-12-27	WOS:000295265100089
J	Ahmad, F; Mani, J; Kumar, P; Haridas, S; Upadhyay, P; Bhaskar, S				Ahmad, Faiz; Mani, Jiju; Kumar, Pawan; Haridas, Seenu; Upadhyay, Pramod; Bhaskar, Sangeeta			Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BCG IMMUNOTHERAPY; CALMETTE-GUERIN; BLADDER-CANCER; NKT CELLS; CARCINOMA; PATHOGENICITY; TUBERCULOSIS; REJECTION; SURVIVAL	Background: Role of immune system in protecting the host from cancer is well established. Growing cancer however subverts immune response towards Th2 type and escape from antitumor mechanism of the host. Activation of both innate and Th1 type response is crucial for host antitumor activity. In our previous study it was found, that Mycobacterium indicus pranii (MIP) also known as M. w induces Th1 type response and activates macrophages in animal model of tuberculosis. Hence, we studied the immunotherapeutic potential of MIP in mouse tumor model and the underlying mechanisms for its antitumor activity. Methodology and Principal Findings: Tumors were implanted by injecting B16F10 melanoma cells subcutaneously into C57BL/6 mice. Using the optimized dose and treatment regimes, anti-tumor efficacy of heat killed MIP was evaluated. In MIP treated group, tumor appeared in only 50-60% of mice, tumor growth was delayed and tumor volume was less as compared to control. MIP mediated immune activation was analysed in the tumor microenvironment, tumor draining lymph node and spleen. Induction of Th1 response and higher infiltration of immune cells in the tumor microenvironment was observed in MIP treated mice. A large fraction of these immune cells were in activated state as confirmed by phenotypic and functional analysis. Interestingly, percentage of Treg cells in the tumor milieu of treated mice was less. We also evaluated efficacy of MIP along with chemotherapy and found a better response as compared to chemotherapy alone. Conclusion: MIP therapy is effective in protecting mice from tumor. It activates the immune cells, increases their infiltration in tumor, and abrogates tumor mediated immune suppression.	[Ahmad, Faiz; Mani, Jiju; Kumar, Pawan; Haridas, Seenu; Upadhyay, Pramod; Bhaskar, Sangeeta] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Ahmad, F (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	sangeeta@nii.res.in	Kumar, Pawan/GXF-7072-2022	Ahmad, Faiz/0000-0002-0450-042X; Bhaskar, Sangeeta/0000-0001-7902-5267	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR8239/Med/14/1243/2006]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by a research grant (BT/PR8239/Med/14/1243/2006) from the Department of Biotechnology, Ministry of Science and Technology, Government of India (FA, JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Baxevanis CN, 2003, J IMMUNOL, V171, P2953, DOI 10.4049/jimmunol.171.6.2953; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Cheadle EJ, 2005, INFECT IMMUN, V73, P784, DOI 10.1128/IAI.73.2.784-794.2005; CLEVENGER CV, 2001, CURRENT PROTOCOLS IM; Copier J, 2009, EUR J CANCER, V45, P1424, DOI 10.1016/j.ejca.2008.12.017; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dalgleish AG, 2006, CANCER IMMUNOL IMMUN, V55, P1025, DOI 10.1007/s00262-006-0128-8; Golgher D, 2002, EUR J IMMUNOL, V32, P3267, DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Hayashi A, 1998, P JPN ACAD B-PHYS, V74, P50, DOI 10.2183/pjab.74.50; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.3.CO;2-M; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Johns DG, 1998, AM J PHYSIOL-HEART C, V275, pH1592, DOI 10.1152/ajpheart.1998.275.5.H1592; Katoch K, 2008, VACCINE, V26, P1228, DOI 10.1016/j.vaccine.2007.12.025; LAMM DL, 1991, NEW ENGL J MED, V325, P1205, DOI 10.1056/NEJM199110243251703; LANEELLE G, 1991, RES MICROBIOL, V142, P433, DOI 10.1016/0923-2508(91)90116-R; Luo Y, 2000, MOL IMMUNOL, V37, P527, DOI 10.1016/S0161-5890(00)00077-8; Malmstrom PU, 2000, EUR UROL, V37, P16, DOI 10.1159/000052377; Park SH, 2003, J IMMUNOL, V170, P1197, DOI 10.4049/jimmunol.170.3.1197; Patel Naresh, 2003, J Indian Med Assoc, V101, P682; Patyar S, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-21; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; Stanford JL, 2008, EUR J CANCER, V44, P224, DOI 10.1016/j.ejca.2007.08.021; Sur Prabir Kumar, 2003, J Indian Med Assoc, V101, P120; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1016/S0022-5347(05)64273-5; TALWAR GP, 1990, VACCINE, V8, P121, DOI 10.1016/0264-410X(90)90134-8; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	32	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25424	10.1371/journal.pone.0025424	http://dx.doi.org/10.1371/journal.pone.0025424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984926	gold, Green Published, Green Submitted			2022-12-27	WOS:000295941300030
J	Hirbod, T; Kaldensjo, T; Broliden, K				Hirbod, Taha; Kaldensjo, Tove; Broliden, Kristina			In Situ Distribution of HIV-Binding CCR5 and C-Type Lectin Receptors in the Human Endocervical Mucosa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NORMAL UTERINE CERVIX; FEMALE GENITAL-TRACT; LANGERHANS CELLS; DENDRITIC CELLS; INTRAVAGINAL INOCULATION; NK CELLS; DC-SIGN; INFECTION; EXPRESSION	The endocervical mucosa is believed to be a primary site of HIV transmission. However, to date there is little known about the distribution of the HIV co-receptor CCR5 and the HIV-binding C-type lectin receptors, including Langerin, dendritic cell (DC)-specific intercellular adhesion molecule-grabbing non-integrin (DC-SIGN) and mannose receptor (MR) at this site. We therefore characterized the expression of these molecules in the endocervix of HIV seronegative women by computerized image analysis. Endocervical tissue biopsies were collected from women (n = 6) undergoing hysterectomy. All study individuals were diagnosed with benign and non-inflammatory diseases. CCR5+ CD4+ CD3+ T cells were found within or adjacent to the endocervical epithelium. The C-type lectin Langerin was expressed by intraepithelial CD1a+ CD4+ and CD11c+ CD4+ Langerhans cells, whereas DC-SIGN+ MR+ CD11c myeloid dendritic cells and MR+ CD68+ macrophages were localized in the submucosa of the endocervix. The previously defined immune effector cells including CD8+, CD56+, CD19+ and IgD+ cells were also found in the submucosa as well as occasional CD123+ BDCA-2+ plasmacytoid dendritic cells. Understanding the spatial distribution of potential HIV target cells and immune effector cells in relation to the endocervical canal forms a basis for deciphering the routes of HIV transmission events in humans as well as designing HIV-inhibiting compounds.	[Hirbod, Taha; Kaldensjo, Tove; Broliden, Kristina] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Div Infect Dis,Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Hirbod, T (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Div Infect Dis,Dept Med, Stockholm, Sweden.	tove.kaldensjo@ki.se			Vetenskapsradet; SIDA; Stiftelsen Lakare mot AIDS	Vetenskapsradet(Swedish Research Council); SIDA; Stiftelsen Lakare mot AIDS	This study was supported by grants from Vetenskapsradet, SIDA and Stiftelsen Lakare mot AIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel CE, 2007, INT IMMUNOL, V19, P1271, DOI 10.1093/intimm/dxm096; Bouhlal H, 2007, J IMMUNOL, V178, P1086, DOI 10.4049/jimmunol.178.2.1086; CROWLEYNOWICK PA, 1995, AM J REPROD IMMUNOL, V34, P241, DOI 10.1111/j.1600-0897.1995.tb00948.x; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Donaghy H, 2009, J VIROL, V83, P1952, DOI 10.1128/JVI.01578-08; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Harada H, 2007, EUR J IMMUNOL, V37, P2148, DOI 10.1002/eji.200737217; Hirbod T, 2006, JAIDS-J ACQ IMM DEF, V43, P137, DOI 10.1097/01.qai.0000229016.85192.60; Hirbod T, 2009, JAIDS-J ACQ IMM DEF, V51, P239, DOI 10.1097/QAI.0b013e3181a74f89; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Jacobson DL, 2000, SEX TRANSM DIS, V27, P252, DOI 10.1097/00007435-200005000-00003; Kaldensjo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021344; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; Kawamura T, 2005, J DERMATOL SCI, V40, P147, DOI 10.1016/j.jdermsci.2005.08.009; KUTTEH WH, 1994, AM J REPROD IMMUNOL, V31, P40, DOI 10.1111/j.1600-0897.1994.tb00845.x; LARKIN M, 1989, AIDS, V3, P793, DOI 10.1097/00002030-198912000-00003; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lore K., 2004, METH MOL B, V249, P201; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; MILLER CJ, 1992, LAB INVEST, V67, P628; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; MOSS GB, 1991, J INFECT DIS, V164, P588, DOI 10.1093/infdis/164.3.588; Mselle TF, 2007, CLIN IMMUNOL, V124, P69, DOI 10.1016/j.clim.2007.04.008; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Poonia B, 2006, J REPROD IMMUNOL, V72, P74, DOI 10.1016/j.jri.2006.02.004; Poppe WAJ, 1998, EUR J OBSTET GYN R B, V81, P277, DOI 10.1016/S0301-2115(98)00202-4; Prakash M, 2004, BJOG-INT J OBSTET GY, V111, P1468, DOI 10.1111/j.1471-0528.2004.00283.x; Prakash M, 2004, J INFECT DIS, V190, P246, DOI 10.1086/422034; Prakash M, 2001, J REPROD IMMUNOL, V52, P101, DOI 10.1016/S0165-0378(01)00114-0; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Quayle AJ, 2007, JAIDS-J ACQ IMM DEF, V44, P292, DOI 10.1097/QAI.0b013e31802c5b3a; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; Zhang LB, 1998, J SOC GYNECOL INVEST, V5, P72, DOI 10.1016/S1071-5576(97)00107-X; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	45	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25551	10.1371/journal.pone.0025551	http://dx.doi.org/10.1371/journal.pone.0025551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984929	Green Submitted, gold, Green Published			2022-12-27	WOS:000295941300039
J	Roy, S; Calcedo, R; Medina-Jaszek, A; Keough, M; Peng, H; Wilson, JM				Roy, Soumitra; Calcedo, Roberto; Medina-Jaszek, Angelica; Keough, Martin; Peng, Hui; Wilson, James M.			Adenoviruses in Lymphocytes of the Human Gastro-Intestinal Tract	PLOS ONE			English	Article							HUMAN LYMPHOID-CELLS; POLYMERASE-CHAIN-REACTION; NEUTRALIZING ANTIBODIES; VACCINE DEVELOPMENT; LATENT ADENOVIRUS; INFECTIOUS VIRUS; VIRAL-INFECTIONS; HUMAN TONSILS; T-CELLS; DNA	Objective: Persistent adenoviral shedding in stools is known to occur past convalescence following acute adenoviral infections. We wished to establish the frequency with which adenoviruses may colonize the gut in normal human subjects. Methods: The presence of adenoviral DNA in intestinal specimens obtained at surgery or autopsy was tested using a nested PCR method. The amplified adenoviral DNA sequences were compared to each other and to known adenoviral species. Lamina propria lymphocytes (LPLs) were isolated from the specimens and the adenoviral copy numbers in the CD4+ and CD8+ fractions were determined by quantitative PCR. Adenoviral gene expression was tested by amplification of adenoviral mRNA. Results: Intestinal tissue from 21 of 58 donors and LPLs from 21 of 24 donors were positive for the presence of adenoviral DNA. The majority of the sequences could be assigned to adenoviral species E, although species B and C sequences were also common. Multiple sequences were often present in the same sample. Forty-one non-identical sequences were identified from 39 different tissue donors. Quantitative PCR for adenoviral DNA in CD4+ and CD8+ fractions of LPLs showed adenoviral DNA to be present in both cell types and ranged from a few hundred to several million copies per million cells on average. Active adenoviral gene expression as evidenced by the presence of adenoviral messenger RNA in intestinal lymphocytes was demonstrated in 9 of the 11 donors tested. Conclusion: Adenoviral DNA is highly prevalent in lymphocytes from the gastro-intestinal tract indicating that adenoviruses may be part of the normal gut flora.	[Roy, Soumitra; Calcedo, Roberto; Medina-Jaszek, Angelica; Keough, Martin; Peng, Hui; Wilson, James M.] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Div Transfus Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Roy, S (corresponding author), Crucell Holland, Leiden, Netherlands.	wilsonjm@mail.med.upenn.edu	Wilson, James M/F-9220-2011; Roy, Soumitra/B-9113-2008	Wilson, James M/0000-0002-9630-3131; 	Bill and Melinda Gates Foundation; GlaxoSmithKline; National Institute of Diabetes and Digestive and Kidney Diseases [5P30DK047757-15]; National Heart, Lung, and Blood Institute [5P01HL059407-10]; Cystic Fibrosis Foundation [R881-CR07]; ReGenX Holdings; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047757] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); GlaxoSmithKline(GlaxoSmithKline); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); ReGenX Holdings; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was sponsored by grants from the Bill and Melinda Gates Foundation, GlaxoSmithKline, National Institute of Diabetes and Digestive and Kidney Diseases (5P30DK047757-15), National Heart, Lung, and Blood Institute (5P01HL059407-10), and the Cystic Fibrosis Foundation (R881-CR07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SR is an inventor on patents licensed to various biopharmaceutical companies. JMW is a consultant to ReGenX Holdings, and is a founder of, holds equity in, and receives a grant from affiliates of ReGenX Holdings; in addition, he is an inventor on patents licensed to various biopharmaceutical companies, including affiliates of ReGenX Holdings. This work was also partially funded by a commercial source (GlaxoSmithKline). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ADRIAN T, 1988, EPIDEMIOL INFECT, V101, P503, DOI 10.1017/S0950268800029393; Appaiahgari MB, 2007, CLIN VACCINE IMMUNOL, V14, P1053, DOI 10.1128/CVI.00173-07; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; Chen H, 2010, J VIROL, V84, P10522, DOI 10.1128/JVI.00450-10; CHU Y, 1992, VIROLOGY, V188, P793, DOI 10.1016/0042-6822(92)90534-V; CUNNINGHAM AL, 1988, J INFECT DIS, V158, P386, DOI 10.1093/infdis/158.2.386; Durepaire N, 1997, J ACQ IMMUN DEF SYND, V14, P189; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; EVANS AS, 1958, AM J HYG, V67, P256, DOI 10.1093/oxfordjournals.aje.a119932; Flomenberg P, 1997, J MED VIROL, V51, P182, DOI 10.1002/(SICI)1096-9071(199703)51:3<182::AID-JMV7>3.0.CO;2-2; FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; HORVATH J, 1986, J VIROL, V59, P189, DOI 10.1128/JVI.59.1.189-192.1986; Hutnick NA, 2010, VACCINE, V28, P1932, DOI 10.1016/j.vaccine.2009.10.091; LAVERY D, 1987, J VIROL, V61, P1466, DOI 10.1128/JVI.61.5.1466-1472.1987; Lu S, 2008, EXPERT REV VACCINES, V7, P151, DOI 10.1586/14760584.7.2.151; McManus TE, 2007, RESP MED, V101, P2084, DOI 10.1016/j.rmed.2007.05.015; McNees AL, 2004, J VIROL, V78, P6955, DOI 10.1128/JVI.78.13.6955-6966.2004; NEUMANN R, 1987, VIRUS RES, V7, P93, DOI 10.1016/0168-1702(87)90060-8; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; SILVER L, 1988, VIROLOGY, V165, P377, DOI 10.1016/0042-6822(88)90582-X; STROHL WA, 1965, VIROLOGY, V26, P199, DOI 10.1016/0042-6822(65)90047-4; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; TOP FH, 1971, J INFECT DIS, V124, P155, DOI 10.1093/infdis/124.2.155; Tucker SN, 2008, EXPERT REV VACCINES, V7, P25, DOI 10.1586/14760584.7.1.25; VANDERVE.J, 1973, INFECT IMMUN, V7, P604, DOI 10.1128/IAI.7.4.604-609.1973; WOLD WSM, 2007, FIELD VIROLOGY, P02395; Zhang YG, 2010, J VIROL, V84, P8799, DOI 10.1128/JVI.00562-10	37	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24859	10.1371/journal.pone.0024859	http://dx.doi.org/10.1371/journal.pone.0024859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980361	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300012
J	Russ, HA; Sintov, E; Anker-Kitai, L; Friedman, O; Lenz, A; Toren, G; Farhy, C; Pasmanik-Chor, M; Oron-Karni, V; Ravassard, P; Efrat, S				Russ, Holger A.; Sintov, Elad; Anker-Kitai, Leeat; Friedman, Orr; Lenz, Ayelet; Toren, Ginat; Farhy, Chen; Pasmanik-Chor, Metsada; Oron-Karni, Varda; Ravassard, Philippe; Efrat, Shimon			Insulin-Producing Cells Generated from Dedifferentiated Human Pancreatic Beta Cells Expanded In Vitro	PLOS ONE			English	Article							STEM-CELLS; MESENCHYMAL TRANSITION; PRECURSOR CELLS; PROLIFERATION; DIFFERENTIATION; EXPANSION; GROWTH; RATS; MASS; REDIFFERENTIATION	Background: Expansion of beta cells from the limited number of adult human islet donors is an attractive prospect for increasing cell availability for cell therapy of diabetes. However, attempts at expanding human islet cells in tissue culture result in loss of beta-cell phenotype. Using a lineage-tracing approach we provided evidence for massive proliferation of beta-cell-derived (BCD) cells within these cultures. Expansion involves dedifferentiation resembling epithelial-mesenchymal transition (EMT). Epigenetic analyses indicate that key beta-cell genes maintain open chromatin structure in expanded BCD cells, although they are not transcribed. Here we investigated whether BCD cells can be redifferentiated into beta-like cells. Methodology/Principal Finding: Redifferentiation conditions were screened by following activation of an insulin-DsRed2 reporter gene. Redifferentiated cells were characterized for gene expression, insulin content and secretion assays, and presence of secretory vesicles by electron microscopy. BCD cells were induced to redifferentiate by a combination of soluble factors. The redifferentiated cells expressed beta-cell genes, stored insulin in typical secretory vesicles, and released it in response to glucose. The redifferentiation process involved mesenchymal-epithelial transition, as judged by changes in gene expression. Moreover, inhibition of the EMT effector SLUG (SNAI2) using shRNA resulted in stimulation of redifferentiation. Lineage-traced cells also gave rise at a low rate to cells expressing other islet hormones, suggesting transition of BCD cells through an islet progenitor-like stage during redifferentiation. Conclusions/Significance: These findings demonstrate for the first time that expanded dedifferentiated beta cells can be induced to redifferentiate in culture. The findings suggest that ex-vivo expansion of adult human islet cells is a promising approach for generation of insulin-producing cells for transplantation, as well as basic research, toxicology studies, and drug screening.	[Russ, Holger A.; Sintov, Elad; Anker-Kitai, Leeat; Friedman, Orr; Lenz, Ayelet; Toren, Ginat; Farhy, Chen; Efrat, Shimon] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Pasmanik-Chor, Metsada; Oron-Karni, Varda] Tel Aviv Univ, George S Wise Fac Life Sci, Bioinformat Unit, IL-69978 Tel Aviv, Israel; [Ravassard, Philippe] Hop La Pitie Salpetriere, Dept Biotechnol & Biotherapy, Paris, France	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Russ, HA (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il		Efrat, Shimon/0000-0001-5987-232X; ravassard, philippe/0000-0002-0393-9262	Juvenile Diabetes Research Foundation [31-2008-413]; Israel Science Foundation; Integrated Islet Distribution Program	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); Integrated Islet Distribution Program	This work was funded by grants from the Juvenile Diabetes Research Foundation and the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Human islets were provided through the JDRF award 31-2008-413 (ECIT Islets for Basic Research Program) and the Integrated Islet Distribution Program. We thank Yael Bar, Tel Aviv University, for helpful discussions, Sarah Knoller, Tel Aviv University, for technical assistance, Palle Serup, Hagedorn Research Institute, for NKX6.1 antibody, Julie Kerr-Conte, University Lille-Nord de France, for human pancreas sections, Alberto Hayek, UC San Diego, and John Hutton, University of Colorado Health Sciences Center, for fetal pancreas sections, Ran Elkon, Tel Aviv University, for assistance with statistical analysis, and Yuval Dor, Hebrew University, for comments on the manuscript. This work was performed in partial fulfillment of the requirements for a Ph.D. degree of HAR.	Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Davani B, 2007, STEM CELLS, V25, P3215, DOI 10.1634/stemcells.2007-0323; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; NIELSEN JH, 1979, DIABETOLOGIA, V16, P97, DOI 10.1007/BF01225457; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; ROBERTSON RP, 1994, DIABETES, V43, P1085, DOI 10.2337/diabetes.43.9.1085; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311	26	60	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25566	10.1371/journal.pone.0025566	http://dx.doi.org/10.1371/journal.pone.0025566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984932	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300042
J	Watahiki, A; Wang, YW; Morris, J; Dennis, K; O'Dwyer, HM; Gleave, M; Gout, PW; Wang, YZ				Watahiki, Akira; Wang, Yuwei; Morris, James; Dennis, Kristopher; O'Dwyer, Helena M.; Gleave, Martin; Gout, Peter W.; Wang, Yuzhuo			MicroRNAs Associated with Metastatic Prostate Cancer	PLOS ONE			English	Article							SUBRENAL CAPSULE XENOGRAFTS; TUMOR-SUPPRESSOR; DOWN-REGULATION; CELL-GROWTH; SCID MICE; EXPRESSION; GENE; INVASION; PREDICTION; REVEALS	Objective: Metastasis is the most common cause of death of prostate cancer patients. Identification of specific metastasis biomarkers and novel therapeutic targets is considered essential for improved prognosis and management of the disease. MicroRNAs (miRNAs) form a class of non-coding small RNA molecules considered to be key regulators of gene expression. Their dysregulation has been shown to play a role in cancer onset, progression and metastasis, and miRNAs represent a promising new class of cancer biomarkers. The objective of this study was to identify down-and up-regulated miRNAs in prostate cancer that could provide potential biomarkers and/or therapeutic targets for prostate cancer metastasis. Methods: Next generation sequencing technology was applied to identify differentially expressed miRNAs in a transplantable metastatic versus a non-metastatic prostate cancer xenograft line, both derived from one patient's primary cancer. The xenografts were developed via subrenal capsule grafting of cancer tissue into NOD/SCID mice, a methodology that tends to preserve properties of the original cancers (e. g., tumor heterogeneity, genetic profiles). Results: Differentially expressed known miRNAs, isomiRs and 36 novel miRNAs were identified. A number of these miRNAs (21/104) have previously been reported to show similar down-or up-regulation in prostate cancers relative to normal prostate tissue, and some of them (e. g., miR-16, miR-34a, miR-126*, miR-145, miR-205) have been linked to prostate cancer metastasis, supporting the validity of the analytical approach. Conclusions: The use of metastatic and non-metastatic prostate cancer subrenal capsule xenografts derived from one patient's cancer makes it likely that the differentially expressed miRNAs identified in this study include potential biomarkers and/or therapeutic targets for human prostate cancer metastasis.	[Watahiki, Akira; Wang, Yuwei; Gout, Peter W.; Wang, Yuzhuo] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Morris, James; Dennis, Kristopher] British Columbia Canc Agcy, Dept Radiat Oncol, Vancouver, BC V5Z 4E6, Canada; [O'Dwyer, Helena M.] British Columbia Canc Agcy, Dept Diagnost Imaging, Vancouver, BC V5Z 4E6, Canada; [Gleave, Martin; Gout, Peter W.; Wang, Yuzhuo] Univ British Columbia, Fac Med, Dept Urol Sci, Vancouver, BC, Canada; [Watahiki, Akira; Gleave, Martin; Wang, Yuzhuo] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Watahiki, A (corresponding author), British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada.	ywang@bccrc.ca		Gleave, Martin/0000-0003-4235-0167; Wang, Yuzhuo/0000-0002-9749-8591	Canadian Institutes of Health Research; National Natural Science Foundation of China [30928027]; International Cancer Alliance for Cancer Research and Education; Fibrolamellar Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cancer Alliance for Cancer Research and Education; Fibrolamellar Cancer Foundation	This study was supported by the Canadian Institutes of Health Research (YZW/MG). YZW is a recipient of an Overseas Chinese Scholar Award from the National Natural Science Foundation of China (No 30928027), and a recipient of an Innovative Scholar Award from International Cancer Alliance for Cancer Research and Education and the Fibrolamellar Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bogner PN, 2009, BIOCHEM BIOPH RES CO, V386, P305, DOI 10.1016/j.bbrc.2009.06.021; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Cutz JC, 2006, CLIN CANCER RES, V12, P4043, DOI 10.1158/1078-0432.CCR-06-0252; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gandellini P, 2010, DISCOV MED, V9, P212; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kortmann U, 2011, CLIN CANCER RES, V17, P783, DOI 10.1158/1078-0432.CCR-10-1382; Kusters B, 2007, ONCOGENE, V26, P5808, DOI 10.1038/sj.onc.1210360; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; LEITE KR, 2009, UROL ONCOL      0415; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Makarov DV, 2009, ANNU REV MED, V60, P139, DOI 10.1146/annurev.med.60.042307.110714; Manzur M, 2009, CELL DEATH DIFFER, V16, P312, DOI 10.1038/cdd.2008.152; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pass HI, 2010, CANCER RES, V70, P1916, DOI 10.1158/0008-5472.CAN-09-3993; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Sato T, 2009, ONCOL REP, V21, P211, DOI 10.3892/or_00000210; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sethi S, 2011, AM J TRANSL RES, V3, P90; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Tsang WP, 2009, CARCINOGENESIS, V30, P953, DOI 10.1093/carcin/bgp094; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009; Zhang JJ, 2011, CANCER-AM CANCER SOC, V117, P86, DOI 10.1002/cncr.25522; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	81	166	204	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24950	10.1371/journal.pone.0024950	http://dx.doi.org/10.1371/journal.pone.0024950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980368	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300014
J	Chamberlain, G; Smith, H; Rainger, GE; Middleton, J				Chamberlain, Giselle; Smith, Helen; Rainger, G. Ed; Middleton, Jim			Mesenchymal Stem Cells Exhibit Firm Adhesion, Crawling, Spreading and Transmigration across Aortic Endothelial Cells: Effects of Chemokines and Shear	PLOS ONE			English	Article							HUMAN BONE-MARROW; INFARCTED MYOCARDIUM; T-CELLS; MIGRATION; RECEPTORS; EXPRESS; TRAFFICKING; MECHANISMS; CAPACITY; BEHAVIOR	Mesenchymal stem cells (MSCs) have anti-inflammatory and immunosuppressive properties and may be useful in the therapy of diseases such as arteriosclerosis. MSCs have some ability to traffic into inflamed tissues, however to exploit this therapeutically their migratory mechanisms need to be elucidated. This study examines the interaction of murine MSCs (mMSCs) with, and their migration across, murine aortic endothelial cells (MAECs), and the effects of chemokines and shear stress. The interaction of mMSCs with MAECs was examined under physiological flow conditions. mMSCs showed lack of interaction with MAECs under continuous flow. However, when the flow was stopped (for 10min) and then started, mMSCs adhered and crawled on the endothelial surface, extending fine microvillous processes (filopodia). They then spread extending pseudopodia in multiple directions. CXCL9 significantly enhanced the percentage of mMSCs adhering, crawling and spreading and shear forces markedly stimulated crawling and spreading. CXCL9, CXCL16, CCL20 and CCL25 significantly enhanced transendothelial migration across MAECs. The transmigrated mMSCs had down-regulated receptors CXCR3, CXCR6, CCR6 and CCR9. This study furthers the knowledge of MSC transendothelial migration and the effects of chemokines and shear stress which is of relevance to inflammatory diseases such as arteriosclerosis.	[Chamberlain, Giselle; Smith, Helen; Middleton, Jim] Keele Univ, Leopold Muller Arthrit Res Ctr, Sch Med, RJAH Orthopaed Hosp, Oswestry, Shrops, England; [Rainger, G. Ed] Univ Birmingham, Coll Med & Dent, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Middleton, Jim] Univ Bristol, Fac Med & Dent, Sch Oral & Dent Sci, Bristol, Avon, England	Keele University; University of Birmingham; University of Bristol	Chamberlain, G (corresponding author), Keele Univ, Leopold Muller Arthrit Res Ctr, Sch Med, RJAH Orthopaed Hosp, Oswestry, Shrops, England.	Jim.Middleton@bristol.ac.uk			Biotechnology and Biological Sciences Research Council (UK); Keele University; BBSRC [BB/D014905/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D014905/1] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Keele University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Biotechnology and Biological Sciences Research Council (UK) and Keele University funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bajada S, 2007, J BONE JOINT SURG BR, V89B, P1382, DOI 10.1302/0301-620X.89B10.19103; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2006.0037; Dewitt S, 2007, J LEUKOCYTE BIOL, V81, P1160, DOI 10.1189/jlb.1106710; GOETZ DJ, 1994, BIOPHYS J, V66, P2202, DOI 10.1016/S0006-3495(94)81016-1; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Janowska-Wieczorek A, 2000, EXP HEMATOL, V28, P1274, DOI 10.1016/S0301-472X(00)00532-4; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Koenen RR, 2010, NAT REV DRUG DISCOV, V9, P141, DOI 10.1038/nrd3048; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Luu NT, 1999, J VASC RES, V36, P477, DOI 10.1159/000025690; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Nishiyama T, 2007, J VASC RES, V44, P138, DOI 10.1159/000098520; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Price MJ, 2006, INT J CARDIOL, V111, P231, DOI 10.1016/j.ijcard.2005.07.036; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schmidt A, 2006, EUR J CELL BIOL, V85, P1179, DOI 10.1016/j.ejcb.2006.05.015; Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005; Semont A, 2006, ADV EXP MED BIOL, V585, P19; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Steingen C, 2008, J MOL CELL CARDIOL, V44, P1072, DOI 10.1016/j.yjmcc.2008.03.010; Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1; Tian Y, 2008, IMMUNOL INVEST, V37, P29, DOI 10.1080/08820130701410223; Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930; Xu YL, 2010, INT J CARDIOL, V138, P182, DOI 10.1016/j.ijcard.2009.03.071; Yu CR, 2000, J IMMUNOL, V164, P1293, DOI 10.4049/jimmunol.164.3.1293; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	50	80	85	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25663	10.1371/journal.pone.0025663	http://dx.doi.org/10.1371/journal.pone.0025663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980522	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900088
J	Charmandari, E; Chrousos, GP; Lambrou, GI; Pavlaki, A; Koide, H; Sinnie, SMN; Kino, T				Charmandari, Evangelia; Chrousos, George P.; Lambrou, George I.; Pavlaki, Aikaterini; Koide, Hisashi; Sinnie Sin Man Ng; Kino, Tomoshige			Peripheral CLOCK Regulates Target-Tissue Glucocorticoid Receptor Transcriptional Activity in a Circadian Fashion in Man	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATION; MONONUCLEAR; RHYTHMS; STRESS; SYSTEM; CELLS	Context and Objective: Circulating cortisol fluctuates diurnally under the control of the "master'' circadian CLOCK, while the peripheral "slave'' counterpart of the latter regulates the transcriptional activity of the glucocorticoid receptor (GR) at local glucocorticoid target tissues through acetylation. In this manuscript, we studied the effect of CLOCK-mediated GR acetylation on the sensitivity of peripheral tissues to glucocorticoids in humans. Design and Participants: We examined GR acetylation and mRNA expression of GR, CLOCK-related and glucocorticoid-responsive genes in peripheral blood mononuclear cells (PBMCs) obtained at 8 am and 8 pm from 10 healthy subjects, as well as in PBMCs obtained in the morning and cultured for 24 hours with exposure to 3-hour hydrocortisone pulses every 6 hours. We used EBV-transformed lymphocytes (EBVLs) as non-synchronized controls. Results: GR acetylation was higher in the morning than in the evening in PBMCs, mirroring the fluctuations of circulating cortisol in reverse phase. All known glucocorticoid-responsive genes tested responded as expected to hydrocortisone in non-synchronized EBVLs, however, some of these genes did not show the expected diurnal mRNA fluctuations in PBMCs in vivo. Instead, their mRNA oscillated in a Clock-and a GR acetylation-dependent fashion in naturally synchronized PBMCs cultured ex vivo in the absence of the endogenous glucocorticoid, suggesting that circulating cortisol might prevent circadian GR acetylation-dependent effects in some glucocorticoid-responsive genes in vivo. Conclusions: Peripheral CLOCK-mediated circadian acetylation of the human GR may function as a target-tissue, gene-specific counter regulatory mechanism to the actions of diurnally fluctuating cortisol, effectively decreasing tissue sensitivity to glucocorticoids in the morning and increasing it at night.	[Charmandari, Evangelia; Chrousos, George P.; Lambrou, George I.; Pavlaki, Aikaterini] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Dept Pediat 1, GR-11527 Athens, Greece; [Charmandari, Evangelia; Chrousos, George P.] Acad Athens, Div Endocrinol & Metab, Biomed Res Fdn, Athens, Greece; [Koide, Hisashi] Eunice Kennedy Shriver Inst Child Hlth & Human De, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Sinnie Sin Man Ng; Kino, Tomoshige] Eunice Kennedy Shriver Inst Child Hlth & Human De, Unit Mol Hormone Act, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Sinnie Sin Man Ng] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Academy of Athens; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong	Charmandari, E (corresponding author), Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Dept Pediat 1, GR-11527 Athens, Greece.	kinot@mail.nih.gov	Charmandari, Evangelia/B-6701-2011; Charmandari, Evangelia/AAF-2038-2019; Lambrou, George/F-9674-2011	Charmandari, Evangelia/0000-0002-0851-6998; Lambrou, George/0000-0001-8389-1360; Koide, Hisashi/0000-0002-8545-7530	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; National and Kapodistrian University of Athens; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000618, ZIAHD008732] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National and Kapodistrian University of Athens; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, and the National and Kapodistrian University of Athens. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Charmandari E, 2005, J CLIN ENDOCR METAB, V90, P3696, DOI 10.1210/jc.2004-1920; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Ekstrand K, 1996, ANGIOLOGY, V47, P1089, DOI 10.1177/000331979604701109; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Henley D. E., 2009, Journal of Medical Engineering & Technology, V33, P199, DOI 10.1080/03091900802185970; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kusanagi H, 2004, NEUROSCI LETT, V365, P124, DOI 10.1016/j.neulet.2004.04.065; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; RIVEST RW, 1989, J CLIN ENDOCR METAB, V68, P721, DOI 10.1210/jcem-68-4-721; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430	28	90	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25612	10.1371/journal.pone.0025612	http://dx.doi.org/10.1371/journal.pone.0025612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980503	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900080
J	Haddow, AD; Bixler, D; Schuh, AJ				Haddow, Andrew D.; Bixler, Danae; Schuh, Amy J.			The Demographic and Socioeconomic Factors Predictive for Populations at High-Risk for La Crosse Virus Infection in West Virginia	PLOS ONE			English	Article							CALIFORNIA ENCEPHALITIS GROUP; CENTRAL-NERVOUS-SYSTEM; NILE-VIRUS; AEDES-TRISERIATUS; LACROSSE VIRUS; EASTERN TENNESSEE; SPATIAL-ANALYSIS; SOCIAL IMPACTS; NORTH-CAROLINA; UNITED-STATES	Although a large body of literature exists for the environmental risk factors for La Crosse virus (LACV) transmission, the demographic and socioeconomic risk factors for developing LACV infection have not been investigated. Therefore, this study investigated the demographic and socioeconomic risk factors for LACV infection in West Virginia from 2003 to 2007, using two forward stepwise discriminant analyses. The discriminant analyses were used to evaluate a number of demographic and socioeconomic factors for their ability to predict: 1) those census tracts with at least one reported case of LACV infection versus those census tracts with no reported cases of LACV infection and 2) to evaluate significantly high-risk clusters for LACV infection versus significantly low-risk clusters for LACV infection. In the first model, a high school education diploma or a general education diploma or less and a lower housing density were found to be predictive of those census tracts with at least one case of LACV infection. A high school or a general education diploma or less, lower housing density, and housing built in 1969 and earlier were all found to be predictive of those census tracts displaying high-risk clusters versus census tracts displaying low-risk clusters in the second model. The cluster discriminant analysis was found to be more predictive than the census tract discriminant analysis as indicated by the Eigenvalues, canonical correlation, and grouping accuracy. The results of this study indicate that socioeconomically disadvantaged populations are at the highest risk for LACV infection and should be a focus of LACV infection prevention efforts.	[Haddow, Andrew D.; Schuh, Amy J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Schuh, Amy J.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX USA; [Haddow, Andrew D.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Bixler, Danae] W Virginia Bur Publ Hlth, Charleston, WV USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Haddow, AD (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	adhaddow@gmail.com	Haddow, Andrew/C-5902-2008	Haddow, Andrew/0000-0002-8957-2608				ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2003, GEODA VERSION 0 95I; BALFOUR HH, 1973, PEDIATRICS, V52, P680; Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403; BEATY BJ, 1991, CURR TOP MICROBIOL, V169, P27; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; CDC, 2011, NAT NOT INF DIS; *CDC, 2004, NEUR NONN DOM ARB DI; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P79; Chun R W, 1983, Prog Clin Biol Res, V123, P193; CHUN RWM, 1968, NEUROLOGY, V18, P369; DeGroote JP, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-19; Erwin PC, 2002, AM J EPIDEMIOL, V155, P1060, DOI 10.1093/aje/155.11.1060; ESRI, 2006, ARCVIEW GIS VERS 9 2; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Grimstad P. R., 1988, The arboviruses: epidemiology and ecology. Volume II., P99; Haddow AD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-29; Haddow AD, 2009, J VECTOR ECOL, V34, P70, DOI [10.1111/j.1948-7134.2009.00009.x, 10.3376/038.034.0109]; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006954; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145; Hardin SG, 2003, AM J INFECT CONTROL, V31, P508, DOI 10.1016/S0196-6553(03)00084-1; IBM, 2009, PASW STAT; JOHNSON KP, 1968, NEUROLOGY, V18, P250, DOI 10.1212/WNL.18.3.250; Jones TF, 1999, CLIN INFECT DIS, V28, P93, DOI 10.1086/515087; Kitron U, 1997, AM J TROP MED HYG, V57, P469, DOI 10.4269/ajtmh.1997.57.469; KSIAZEK TG, 1977, AM J TROP MED HYG, V26, P815, DOI 10.4269/ajtmh.1977.26.815; Kutz FW, 2003, J AM MOSQUITO CONTR, V19, P190; Lambert AJ, 2010, EMERG INFECT DIS, V16, P856, DOI 10.3201/eid1605.100170; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; MOULTON DW, 1971, AM J TROP MED HYG, V20, P474, DOI 10.4269/ajtmh.1971.20.474; Nasci RS, 2000, J MED ENTOMOL, V37, P559, DOI 10.1603/0022-2585-37.4.559; Odoi Agricola, 2003, Int J Health Geogr, V2, P5, DOI 10.1186/1476-072X-2-5; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; Parry J.E., 1983, Progress in Clinical and Biological Research, V123, P355; Rios J, 2006, J AM MOSQUITO CONTR, V22, P254, DOI 10.2987/8756-971X(2006)22[254:DASAOW]2.0.CO;2; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; Thompson W H, 1983, Prog Clin Biol Res, V123, P225; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P230, DOI 10.1093/oxfordjournals.aje.a120511; THOMPSON WH, 1977, SCIENCE, V196, P530, DOI 10.1126/science.850794; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; Tsai T F, 1991, Infect Dis Clin North Am, V5, P73; US Census Bureau, 2008, CART BOUND FIL; Utz JT, 2005, HUM ORGAN, V64, P135, DOI 10.17730/humo.64.2.xa6yqcmf13qnu2k9; Utz JT, 2003, AM J TROP MED HYG, V69, P509, DOI 10.4269/ajtmh.2003.69.509; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; WATTS DM, 1972, J MED ENTOMOL, V9, P125, DOI 10.1093/jmedent/9.2.125; Winters AM, 2010, AM J TROP MED HYG, V82, P945, DOI 10.4269/ajtmh.2010.09-0648; WOODRUFF BA, 1992, AM J EPIDEMIOL, V136, P320, DOI 10.1093/oxfordjournals.aje.a116497	52	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25739	10.1371/journal.pone.0025739	http://dx.doi.org/10.1371/journal.pone.0025739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980533	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900094
J	Krstic, G				Krstic, Goran			Apparent Temperature and Air Pollution vs. Elderly Population Mortality in Metro Vancouver	PLOS ONE			English	Article							DAILY RESPIRATORY MORTALITY; VITAMIN-D; AMBIENT-TEMPERATURE; PM10 POLLUTION; MEXICO-CITY; FINE; PARTICLES; WEATHER; ASSOCIATION; HEALTH	Background: Meteorological conditions and air pollution in urban environments have been associated with general population and elderly mortality, showing seasonal variation. Objectives: This study is designed to evaluate the relationship between apparent temperature (AT) and air pollution (PM2.5) vs. mortality in elderly population of Metro Vancouver. Methods: Statistical analyses are performed on moving sum daily mortality rates vs. moving average AT and PM2.5 in 1-, 2-, 3-, 5-, and 7-day models for all seasons, warm temperatures above 15 degrees C, and cold temperatures below 10 degrees C. Results: Approximately 37% of the variation in all-season mortality from circulatory and respiratory causes can be explained by the variation in 7-day moving average apparent temperature (r(2) = 0.37, p<0.001). Although the analytical results from air pollution models show increasingly better prediction ability of longer time-intervals (r(2) = 0.012, p<0.001 in a 7-day model), a very weak negative association between elderly mortality and air pollution is observed. Conclusions: Apparent temperature is associated with mortality from respiratory and circulatory causes in elderly population of Metro Vancouver. In a changing climate, one may anticipate to observe potential health impacts from the projected high- and particularly from the low-temperature extremes.	Fraser Hlth, Environm Hlth Serv, New Westminster, BC, Canada		Krstic, G (corresponding author), Fraser Hlth, Environm Hlth Serv, New Westminster, BC, Canada.	Goran.Krstic@fraserhealth.ca						Almeida SP, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-12; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Bernstein L., 2007, CLIMATE CHANGE SYNTH; Borja-Aburto VH, 1998, ENVIRON HEALTH PERSP, V106, P849, DOI 10.2307/3434129; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; BRISTOW KL, 1984, AGR FOREST METEOROL, V31, P159, DOI 10.1016/0168-1923(84)90017-0; Cakmak S, 2007, ENVIRON HEALTH PERSP, V115, P524, DOI 10.1289/ehp.9567; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Cutolo M, 2009, RHEUMATOLOGY, V48, P210, DOI 10.1093/rheumatology/ken394; Dabek-Zlotorzynska E, 2011, ATMOS ENVIRON, V45, P673, DOI 10.1016/j.atmosenv.2010.10.024; Daniels MJ, 2000, AM J EPIDEMIOL, V152, P397, DOI 10.1093/aje/152.5.397; Filleul L, 2001, EUR RESPIR J, V17, P1055; Fioletov VE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004820; Grass D, 2008, INT J CLIMATOL, V28, P1113, DOI 10.1002/joc.1592; Hughes DA, 2009, CLIN EXP IMMUNOL, V158, P20, DOI 10.1111/j.1365-2249.2009.04001.x; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P1738, DOI 10.2105/AJPH.84.11.1738; Laschewski G, 2002, CLIMATE RES, V21, P91, DOI 10.3354/cr021091; Mar TF, 2000, ENVIRON HEALTH PERSP, V108, P347, DOI 10.2307/3454354; Marris E, 2006, NATURE, V444, P248, DOI 10.1038/444248a; Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012; Mead MN, 2008, ENVIRON HEALTH PERSP, V116, pA160, DOI 10.1289/ehp.116-a160; Medina-Ramon M, 2006, ENVIRON HEALTH PERSP, V114, P1331, DOI 10.1289/ehp.9074; Moolgavkar S, 2007, NATURE, V445, P21, DOI 10.1038/445021c; Neuberger M, 2007, ATMOS ENVIRON, V41, P8549, DOI 10.1016/j.atmosenv.2007.07.013; Ostro B, 2006, ENVIRON HEALTH PERSP, V114, P29, DOI 10.1289/ehp.8335; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Rocklov J, 2010, INT J ENV RES PUB HE, V7, P2607, DOI 10.3390/ijerph7062607; Schwartz J, 2008, ENVIRON HEALTH PERSP, V116, P64, DOI 10.1289/ehp.9955; Spagnolo J, 2003, BUILD ENVIRON, V38, P721, DOI 10.1016/S0360-1323(02)00209-3; Steadman R. G., 1994, Australian Meteorological Magazine, V43, P1; Tellez-Rojo MM, 2000, EUR RESPIR J, V16, P391, DOI 10.1034/j.1399-3003.2000.016003391.x; Vedal S, 2003, ENVIRON HEALTH PERSP, V111, P45, DOI 10.1289/ehp.5276; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang XH, 2006, ENVIRON MONIT ASSESS, V119, P425, DOI 10.1007/s10661-005-9034-3	38	26	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25101	10.1371/journal.pone.0025101	http://dx.doi.org/10.1371/journal.pone.0025101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980381	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900023
J	Li, HY; Xi, QY; Xiong, YY; Cheng, X; Qi, Q; Yang, L; Shu, G; Wang, SB; Wang, LN; Gao, P; Zhu, XT; Jiang, QY; Zhang, YL; Yuan, L				Li, Hongyi; Xi, Qianyun; Xiong, Yuanyan; Cheng, Xiao; Qi, Qien; Yang, Lin; Shu, Gang; Wang, Songbo; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Jiang, Qingyan; Zhang, Yongliang; Yuan, Li			A Comprehensive Expression Profile of MicroRNAs in Porcine Pituitary	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; PROLIFERATION; DISCOVERY; TARGETS; IMPACT; GROWTH; TISSUE; CELLS	MicroRNAs (miRNAs) are an abundant class of small RNAs that regulate expressions of most genes. miRNAs play important roles in the pituitary, the "master" endocrine organ. However, we still don't know which role miRNAs play in the development of pituitary tissue or how much they contribute to the pituitary function. By applying a combination of microarray analysis and Solexa sequencing, we detected a total of 450 miRNAs in the porcine pituitary. Verification with RTPCR showed a high degree of confidence for the obtained data. According to the current miRBase release17.0, the detected miRNAs included 169 known porcine miRNAs, 163 conserved miRNAs not yet identified in the pig, and 12 potentially new miRNAs not yet identified in any species, three of which were revealed using Northern blot. The pituitary might contain about 80.17% miRNA types belonging to the animal. Analysis of 10 highly expressed miRNAs with the Kyoto Encyclopedia of Genes and Genomes (KEGG) indicated that the enriched miRNAs were involved not only in the development of the organ but also in a variety of inter-cell and inner cell processes or pathways that are involved in the function of the organ. We have revealed the existence of a large number of porcine miRNAs as well as some potentially new miRNAs and established for the first time a comprehensive miRNA expression profile of the pituitary. The pituitary gland contains unexpectedly many miRNA types and miRNA actions are involved in important processes for both the development and function of the organ.	[Li, Hongyi; Xi, Qianyun; Cheng, Xiao; Qi, Qien; Yang, Lin; Shu, Gang; Wang, Songbo; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Jiang, Qingyan; Zhang, Yongliang] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Yuan, Li] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen, Peoples R China; [Xiong, Yuanyan] Sun Yat Sen Univ, Coll Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China Agricultural University; Xiamen University; Sun Yat Sen University	Li, HY (corresponding author), S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	zhangyl@scau.edu.cn; yuanli@xmu.edu.cn			Chinese Key Basic Plan [2009CB941601]; National Natural Science Foundation of China [31072105, u0731004]; national Key project [2009ZX0890-024B]	Chinese Key Basic Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); national Key project	This work was supported by grants from the Chinese Key Basic Plan (No. 2009CB941601), the National Natural Science Foundation of China (31072105), the national Key project 2009ZX0890-024B, the Joint Funds of National Natural Science Foundation of China, u0731004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Harding CJ, 2008, PHYS CHEM CHEM PHYS, V10, P5875, DOI 10.1039/b805688a; Hawkins PG, 2008, CELL CYCLE, V7, P602, DOI 10.4161/cc.7.5.5522; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kim, 2006, PROQUEST BIOL J; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Nielsen M, 2009, ANIM GENET; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Rocha KM, 2003, MICROSC RES TECHNIQ, V61, P268, DOI 10.1002/jemt.10336; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sawera M, 2005, MAMM GENOME, V16, P594, DOI 10.1007/s00335-005-0013-3; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smrt RD, 2010, STEM CELLS; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Takeuchi Yasuhiro, 2009, Clin Calcium, V19, P977, DOI CliCa0907977983; Tan YL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-12; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; WEISS S, 1978, P SOC EXP BIOL MED, V159, P409; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Younger ST, 2011, NUCL ACIDS RES; Yousef M, 2009, FEBS J, V276, P2150, DOI 10.1111/j.1742-4658.2009.06933.x; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441	46	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24883	10.1371/journal.pone.0024883	http://dx.doi.org/10.1371/journal.pone.0024883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969866	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900017
J	Michels, KB; Harris, HR; Barault, L				Michels, Karin B.; Harris, Holly R.; Barault, Ludovic			Birthweight, Maternal Weight Trajectories and Global DNA Methylation of LINE-1 Repetitive Elements	PLOS ONE			English	Article							DEVELOPMENTAL ORIGINS; PLACENTAL EXPRESSION; PRENATAL EXPOSURE; IMPRINTED GENES; GROWTH; DISEASE; BIOMARKER; OBESITY; FAMINE; REGION	Low birthweight, premature birth, intrauterine growth retardation, and maternal malnutrition have been related to an increased risk of cardiovascular disease, type 2 diabetes mellitus, obesity, and neuropsychiatric disorders later in life. Conversely, high birthweight has been linked to future risk of cancer. Global DNA methylation estimated by the methylation of repetitive sequences in the genome is an indicator of susceptibility to chronic diseases. We used data and biospecimens from an epigenetic birth cohort to explore the association between trajectories of fetal and maternal weight and LINE-1 methylation in 319 mother-child dyads. Newborns with low or high birthweight had significantly lower LINE-1 methylation levels in their cord blood compared to normal weight infants after adjusting for gestational age, sex of the child, maternal age at delivery, and maternal smoking during pregnancy (p = 0.007 and p = 0.036, respectively), but the magnitude of the difference was small. Infants born prematurely also had lower LINE-1 methylation levels in cord blood compared to term infants, and this difference, though small, was statistically significant (p = 0.004). We did not find important associations between maternal prepregnancy BMI or gestational weight gain and global methylation of the cord blood or fetal placental tissue. In conclusion, we found significant differences in cord blood LINE-1 methylation among newborns with low and high birthweight as well as among prematurely born infants. Future studies may elucidate whether chromosomal instabilities or other functional consequences of these changes contribute to the increased risk of chronic diseases among individuals with these characteristics.	[Michels, Karin B.; Harris, Holly R.; Barault, Ludovic] Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr,Med Sch, Boston, MA 02115 USA; [Michels, Karin B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Michels, KB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr,Med Sch, Boston, MA 02115 USA.	kmichels@rics.bwh.harvard.edu	Barault, Ludovic/J-2472-2016; Harris, Holly/AAK-6844-2020	Barault, Ludovic/0000-0001-5227-5047; Harris, Holly/0000-0002-2572-6727	National Cancer Institute, National Institutes of Health [5R21CA128382]; NATIONAL CANCER INSTITUTE [R21CA128382] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Research Grant 5R21CA128382 from the National Cancer Institute, National Institutes of Health (to K. B. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams B, 2009, WEIGHT GAIN PREGNANC; Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; BARKER DJP, 1986, LANCET, V1, P1077; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Bourque DK, 2010, PLACENTA, V31, P197, DOI 10.1016/j.placenta.2009.12.003; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Hanson M, 2011, PROG BIOPHYS MOL BIO, V106, P272, DOI 10.1016/j.pbiomolbio.2010.12.008; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Michels KB, 2006, INT J CANCER, V119, P2007, DOI 10.1002/ijc.22004; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Schulz WA, 2006, CURR TOP MICROBIOL, V310, P211; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335	42	118	121	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25254	10.1371/journal.pone.0025254	http://dx.doi.org/10.1371/journal.pone.0025254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980406	gold, Green Submitted, Green Published			2022-12-27	WOS:000295936900041
J	Millet, JP; Orcau, A; Rius, C; Casals, M; de Olalla, PG; Moreno, A; Nelson, JL; Cayla, JA				Millet, Juan-Pablo; Orcau, Angels; Rius, Cristina; Casals, Marti; Garcia de Olalla, Patricia; Moreno, Antonio; Nelson, Jeanne L.; Cayla, Joan A.		Barcelona TB Working Grp	Predictors of Death among Patients Who Completed Tuberculosis Treatment: A Population-Based Cohort Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; RECURRENT TUBERCULOSIS; HIV-INFECTION; DRUG-USE; MORTALITY; DISEASE; FATALITY; RELAPSE	Background: Mortality among patients who complete tuberculosis (TB) treatment is still high among vulnerable populations. The objective of the study was to identify the probability of death and its predictive factors in a cohort of successfully treated TB patients. Methods: A population-based retrospective longitudinal study was performed in Barcelona, Spain. All patients who successfully completed TB treatment with culture-confirmation and available drug susceptibility testing between 1995-1997 were retrospectively followed-up until December 31, 2005 by the Barcelona TB Control Program. Socio-demographic, clinical, microbiological and treatment variables were examined. Mortality, TB Program and AIDS registries were reviewed. Kaplan-Meier and a Cox regression methods with time-dependent covariates were used for the survival analysis, calculating the hazard ratio (HR) with 95% confidence intervals (CI). Results: Among the 762 included patients, the median age was 36 years, 520 (68.2%) were male, 178 (23.4%) HIV-infected, and 208 (27.3%) were alcohol abusers. Of the 134 (17.6%) injecting drug users (IDU), 123 (91.8%) were HIV-infected. A total of 30 (3.9%) recurrences and 173 deaths (22.7%) occurred (mortality rate: 3.4/100 person-years of follow-up). The predictors of death were: age between 41-60 years old (HR: 3.5; CI: 2.1-5.7), age greater than 60 years (HR: 14.6; CI: 8.9-24), alcohol abuse (HR: 1.7; CI: 1.2-2.4) and HIV-infected IDU (HR: 7.9; CI: 4.7-13.3). Conclusions: The mortality rate among TB patients who completed treatment is associated with vulnerable populations such as the elderly, alcohol abusers, and HIV-infected IDU. We therefore need to fight against poverty, and promote and develop interventions and social policies directed towards these populations to improve their survival.	[Millet, Juan-Pablo; Orcau, Angels; Rius, Cristina; Casals, Marti; Garcia de Olalla, Patricia; Moreno, Antonio; Nelson, Jeanne L.; Cayla, Joan A.] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Millet, Juan-Pablo; Orcau, Angels; Casals, Marti; Garcia de Olalla, Patricia; Moreno, Antonio; Cayla, Joan A.] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Millet, Juan-Pablo; Cayla, Joan A.] Univ Autonoma Barcelona, Dept Pediat Ginecol & Med Prevent, E-08193 Barcelona, Spain; [Casals, Marti] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Casals, Marti] Univ Int Catalunya, Dept Ciencies Basiques, Barcelona, Spain	Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona; Universitat Internacional de Catalunya (UIC)	Millet, JP (corresponding author), Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain.	jmillet@aspb.es	Casals, Martí/M-8388-2019	Casals, Martí/0000-0002-1775-8331; Ocana, Inma/0000-0003-3699-0790; Millet, Joan Pau/0000-0003-0200-2459; Cayla, Joan A./0000-0003-3891-111X; de Souza Galvao, Maria Luiza/0000-0001-9703-989X	CIBER de Epidemiologia y Salud Publica (CIBERESP), Spain; Amsterdam Health Service/Academic Medical Center; Santiago Perez-Hoyos of the Barcelona Centre for International Health Research (CRESIB)	CIBER de Epidemiologia y Salud Publica (CIBERESP), Spain; Amsterdam Health Service/Academic Medical Center; Santiago Perez-Hoyos of the Barcelona Centre for International Health Research (CRESIB)	This work was supported by the CIBER de Epidemiologia y Salud Publica (CIBERESP), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to all the health and administrative personnel of the Epidemiology Service, Public Health Agency of Barcelona (PHAB), without whom this work would not have been possible. Thanks to Dr. Pablo Marcone for starting to study TB recurrences in Barcelona. Thanks to Dr. Anna Rodes and Elsa Plasencia (Generalitat de Catalunya), to Dr. Teresa Brugal and Dr. Josep M<SUP>a</SUP> Jansa (PHAB). Thank you also to Gloria Ribas of the Mortality Register of Catalonia, Servei d'Informacio i Estudis de la Direccio General de Recursos Sanitaris del Departament de Salut de la Generalitat de Catalunya. Thanks to Laia Fina and Lucia del Bano for their help with the translation. Finally, many thanks to Dr. Ronald Geskus of the Amsterdam Health Service/Academic Medical Center and Santiago Perez-Hoyos of the Barcelona Centre for International Health Research (CRESIB) for his support and help with the survival analysis.	Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; Cayla JA, 1996, AIDS, V10, P1446, DOI 10.1097/00002030-199610000-00029; Cayla JA, 2004, INT J TUBERC LUNG D, V8, P458; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; Centers for Disease Control and Prevention (CDC), 1996, TUB CAS DEF 1996; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P258; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; Girardi E, 2004, EUR RESPIR J, V24, P11, DOI 10.1183/09031936.04.00109303; Gordon S, 2009, THORAX, V64, P649, DOI 10.1136/thx.2009.116400; Institut Municipal de Salut Publica, SAL BARC AN 2000; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Manoff SB, 1996, J INFECT DIS, V174, P299, DOI 10.1093/infdis/174.2.299; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; Red Nacional de Vigilancia Epidemiologica, 2003, AMPL DEF CAS TUB RED; Rodger AJ, 2010, THORAX, V65, P63, DOI 10.1136/thx.2009.122754; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Tocque K, 2005, INT J TUBERC LUNG D, V9, P797; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; Veen J, 1998, EUR RESPIR J, V12, P505, DOI 10.1183/09031936.98.12020505; Vree M, 2007, INT J TUBERC LUNG D, V11, P392; Walpola HC, 2003, INT J TUBERC LUNG D, V7, P742; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2010, GLOB TUB CONTR SURV; Wu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010468; Yew WW, 2005, AM J RESP CRIT CARE, V171, P1324, DOI 10.1164/rccm.2502005; Zignol M, 2007, CLIN INFECT DIS, V44, P61, DOI 10.1086/509328	44	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25315	10.1371/journal.pone.0025315	http://dx.doi.org/10.1371/journal.pone.0025315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980423	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900051
J	Wolstenholme, JT; Taylor, JA; Shetty, SRJ; Edwards, M; Connelly, JJ; Rissman, EF				Wolstenholme, Jennifer T.; Taylor, Julia A.; Shetty, Savera R. J.; Edwards, Michelle; Connelly, Jessica J.; Rissman, Emilie F.			Gestational Exposure to Low Dose Bisphenol A Alters Social Behavior in Juvenile Mice	PLOS ONE			English	Article							TRANSPORTER GENE SLC1A1; PERINATAL EXPOSURE; SEXUAL-DIFFERENTIATION; OXYTOCIN RECEPTOR; ENVIRONMENTAL ESTROGENS; DEVELOPMENTAL EXPOSURE; SOCIOSEXUAL BEHAVIOR; SYNAPTIC PLASTICITY; GENOME-WIDE; IN-VITRO	Bisphenol A (BPA) is a man-made compound used to make polycarbonate plastics and epoxy resins; public health concerns have been fueled by findings that BPA exposure can reduce sex differences in brain and some behaviors. We asked if a low BPA dose, within the range measured in humans, ingested during pregnancy, would affect social behaviors in prepubertal mice. We noted sex differences in social interactions whereby females spent more time sitting side-by-side, while males engaged in more exploring and sitting alone. In addition BPA increased display of nose-to-nose contacts, play solicitations and approaches in both sexes. Interactions between sex and diet were found for self grooming, social interactions while sitting side-by-side and following the other mouse. In all these cases interactions were produced by differences between control and BPA females. We examined brains from embryos during late gestation to determine if gene expression differences might be correlated with some of the sexually dimorphic or BPA affected behaviors we observed. Because BPA treatments ended at birth we took the brains during embryogenesis to increase the probability of discovering BPA mediated effects. We also selected this embryonic age (E18.5) because it coincides with the onset of sexual differentiation of the brain. Interestingly, mRNA for the glutamate transporter, Slc1a1, was enhanced by exposure to BPA in female brains. Also we noted that BPA changed the expression of two of the three DNA methyltransferase genes, Dnmt1 and Dnmt3a. We propose that BPA affects DNA methylation of Sc1a1 during neural development. Sex differences in juvenile social interactions are affected by BPA and in particular this compound modifies behavior in females.	[Wolstenholme, Jennifer T.; Shetty, Savera R. J.; Edwards, Michelle; Rissman, Emilie F.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Taylor, Julia A.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Connelly, Jessica J.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA	University of Virginia; University of Missouri System; University of Missouri Columbia; University of Virginia	Wolstenholme, JT (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	Rissman@virginia.edu	WOLSTENHOLME, JENNIFER/GWV-6224-2022		National Institute of Mental Health (NIMH) [R01 MH086711]; Autism [4802]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [T32 DK007646]; National Research Service Award (NRSA) [F32ES01940]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES019404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086711] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by National Institute of Mental Health (NIMH) R01 MH086711 and Autism Speaks grant #4802 (EFR). JTW received 21 support from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) T32 DK007646 and is now supported by National Research Service Award (NRSA) F32ES01940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency USEP, 1993, 80057 CASRN AG USEP; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Bailey CG, 2011, J CLIN INVEST, V121, P446, DOI 10.1172/JCI44474; Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.025; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Cox KH, 2011, GENES BRAIN BEHAV; Cox KH, 2010, HORM BEHAV, V58, P754, DOI 10.1016/j.yhbeh.2010.07.008; Curley JP, 2010, BEHAV GENET, V40, P220, DOI 10.1007/s10519-010-9334-4; Dessi-Fulgheri F, 2002, ENVIRON HEALTH PERSP, V110, P403, DOI 10.1289/ehp.02110s3403; Dickel DE, 2006, ARCH GEN PSYCHIAT, V63, P778, DOI 10.1001/archpsyc.63.7.778; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Farabollino F, 2002, ENVIRON HEALTH PERSP, V110, P409, DOI 10.1289/ehp.02110s3409; Flynn KM, 2000, TOXICOL SCI, V55, P311, DOI 10.1093/toxsci/55.2.311; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; GANDELMAN R, 1977, NATURE, V266, P722, DOI 10.1038/266722a0; Gatewood JD, 2006, J NEUROSCI, V26, P2335, DOI 10.1523/JNEUROSCI.3743-05.2006; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Hajszan T, 2010, FRONT NEUROENDOCRIN, V31, P519, DOI 10.1016/j.yfrne.2010.06.004; Imwalle DB, 2005, PHYSIOL BEHAV, V84, P157, DOI 10.1016/j.physbeh.2004.11.002; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Kudwa AE, 2009, PHYSIOL BEHAV, V97, P146, DOI 10.1016/j.physbeh.2009.02.023; Kudwa AE, 2007, BEHAV NEUROSCI, V121, P356, DOI 10.1037/0735-7044.121.2.356; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kwon JS, 2009, ARCH GEN PSYCHIAT, V66, P1233, DOI 10.1001/archgenpsychiatry.2009.155; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lauritsen MB, 2006, MOL PSYCHIATR, V11, P37, DOI 10.1038/sj.mp.4001754; Laviola G, 2005, BRAIN RES BULL, V65, P235, DOI 10.1016/j.brainresbull.2004.11.015; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakagami A, 2009, PSYCHONEUROENDOCRINO, V34, P1189, DOI 10.1016/j.psyneuen.2009.03.005; Nakamura K, 2006, J NEUROSCI RES, V84, P1197, DOI 10.1002/jnr.21020; Negri-Cesi P, 2004, J Endocrinol Invest, V27, P120; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; Palanza P, 2002, ENVIRON HEALTH PERSP, V110, P415, DOI 10.1289/ehp.02110s3415; Pathak S, 2010, MOL CELL ENDOCRINOL, V314, P110, DOI 10.1016/j.mce.2009.08.005; Patisaul HB, 2006, NEUROTOXICOL TERATOL, V28, P111, DOI 10.1016/j.ntt.2005.11.004; Patisaul HB, 2008, BRAIN RES REV, V57, P352, DOI 10.1016/j.brainresrev.2007.06.008; Poimenova A, 2010, NEUROSCIENCE, V167, P741, DOI 10.1016/j.neuroscience.2010.02.051; Porrini S, 2005, BRAIN RES BULL, V65, P261, DOI 10.1016/j.brainresbull.2004.11.014; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Ruhlen RL, 2011, J DEV ORIG HLTH DIS, V2, P36, DOI 10.1017/S2040174410000711; Ruhlen RL, 2008, ENVIRON HEALTH PERSP, V116, P322, DOI 10.1289/ehp.10448; Ryan BC, 2006, HORM BEHAV, V50, P85, DOI 10.1016/j.yhbeh.2006.01.007; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Stewart SE, 2007, AM J MED GENET B, V144B, P1027, DOI 10.1002/ajmg.b.30533; Stichter JP, 2010, J AUTISM DEV DISORD, V40, P1067, DOI [10.1007/s10803-010-0959-1, 10.1007/s10803-010-0961-7]; Tian YH, 2010, SYNAPSE, V64, P432, DOI 10.1002/syn.20746; Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102; van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wilson ME, 2011, HORM BEHAV, V59, P353, DOI 10.1016/j.yhbeh.2010.08.004; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Xu LC, 2005, TOXICOLOGY, V216, P197, DOI 10.1016/j.tox.2005.08.006; Xu XH, 2010, HORM BEHAV, V58, P326, DOI 10.1016/j.yhbeh.2010.02.012; Xu XH, 2010, ENVIRON TOXICOL CHEM, V29, P176, DOI 10.1002/etc.18; Zhang J, 2011, J CHROMATOGR B, V879, P209, DOI 10.1016/j.jchromb.2010.11.031; Zhou R, 2009, NEUROSCIENCE, V159, P161, DOI 10.1016/j.neuroscience.2008.12.028	75	124	125	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25448	10.1371/journal.pone.0025448	http://dx.doi.org/10.1371/journal.pone.0025448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980460	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900066
J	Harjanto, D; Maffei, JS; Zaman, MH				Harjanto, Dewi; Maffei, Joseph S.; Zaman, Muhammad H.			Quantitative Analysis of the Effect of Cancer Invasiveness and Collagen Concentration on 3D Matrix Remodeling	PLOS ONE			English	Article							CONFOCAL REFLECTION MICROSCOPY; HUMAN PROSTATIC-CARCINOMA; MECHANICAL-PROPERTIES; CELL-MIGRATION; METALLOPROTEINASE INHIBITORS; EXTRACELLULAR-MATRIX; ELASTIC-MODULI; INVASION; GELS; CONTRACTION	Extracellular matrix (ECM) remodeling is a key component of cell migration and tumor metastasis, and has been associated with cancer progression. Despite the importance of matrix remodeling, systematic and quantitative studies on the process have largely been lacking. Furthermore, it remains unclear if the disrupted tensional homeostasis characteristic of malignancy is due to initially altered ECM and tissue properties, or to the alteration of the tissue by tumor cells. To explore these questions, we studied matrix remodeling by two different prostate cancer cell lines in a three-dimensional collagen system. Over one week, we monitored structural changes in gels of varying collagen content using confocal reflection microscopy and quantitative image analysis, tracking metrics of fibril fraction, pore size, and fiber length and diameter. Gels that were seeded with no cells (control), LNCaP cells, and DU-145 cells were quantitatively compared. Gels with higher collagen content initially had smaller pore sizes and higher fibril fractions, as expected. However, over time, LNCaP- and DU-145-populated matrices showed different structural properties compared both to each other and to the control gels, with LNCaP cells appearing to favor microenvironments with lower collagen fiber fractions and larger pores than DU-145 cells. We posit that the DU-145 cells' preference for denser matrices is due to their higher invasiveness and proteolytic capabilities. Inhibition of matrix proteases resulted in reduced fibril fractions for high concentration gels seeded with either cell type, supporting our hypothesis. Our novel quantitative results probe the dynamics of gel remodeling in three dimensions and suggest that prostate cancer cells remodel their ECM in a synergistic manner that is dependent on both initial matrix properties as well as their invasiveness.	[Harjanto, Dewi; Maffei, Joseph S.; Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University	Harjanto, D (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	zaman@bu.edu			National Institutes of Health [1R01CA132633]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA132633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support from National Institutes of Health (1R01CA132633). DH is supported by the National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin R. J., 2007, METASTASIS PROSTATE; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Burns-Cox N, 2001, J UROLOGY, V166, P1698, DOI 10.1016/S0022-5347(05)65656-X; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davis GE, 2001, J CELL SCI, V114, P917; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874; Fisher KE, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-69; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hoekstra R, 2001, ONCOLOGIST, V6, P415, DOI 10.1634/theoncologist.6-5-415; HOOSEIN NM, 1991, CANCER COMMUN, V3, P255, DOI 10.3727/095535491820873146; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jawerth LM, 2010, BIOPHYS J, V98, pL1, DOI 10.1016/j.bpj.2009.09.065; Kim HD, 2008, MOL BIOL CELL, V19, P4249, DOI 10.1091/mbc.E08-05-0501; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Li YY, 2002, AM J PHYSIOL-HEART C, V282, pH983, DOI 10.1152/ajpheart.00233.2001; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Morgia G, 2005, UROL RES, V33, P44, DOI 10.1007/s00240-004-0440-8; Nagakawa O, 1999, CANCER LETT, V147, P207, DOI 10.1016/S0304-3835(99)00309-2; Nagakawa O, 2000, CANCER LETT, V155, P173, DOI 10.1016/S0304-3835(00)00425-0; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roeder BA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005331; Scott KA, 1998, FEBS LETT, V441, P137, DOI 10.1016/S0014-5793(98)01542-7; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024; TOTH M, 2001, METASTASIS RES PROTO; Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P583; Witte MB, 1998, SURGERY, V124, P464, DOI 10.1016/S0039-6060(98)70154-0; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]	41	46	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24891	10.1371/journal.pone.0024891	http://dx.doi.org/10.1371/journal.pone.0024891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980363	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700010
J	Tian, YH; Huang, Y; Zhou, K; Humphreys, GW; Riddoch, MJ; Wang, K				Tian, Yanghua; Huang, Yan; Zhou, Ke; Humphreys, Glyn W.; Riddoch, M. Jane; Wang, Kai			When Connectedness Increases Hemispatial Neglect	PLOS ONE			English	Article							UNILATERAL SPATIAL NEGLECT; RIGHT-HEMISPHERE STROKE; VISUAL NEGLECT; VISUOSPATIAL NEGLECT; PERCEPTUAL ORGANIZATION; EGOCENTRIC NEGLECT; OBJECT; ATTENTION; SPACE; REPRESENTATION	Patients with left neglect were tested with "chimeric" figures composed of the right and left halves of two different objects. The connectivity relation was modulated between the two half figures. For some displays, the two chimeric halves were separated by a small gap, while in others, the separate halves were connected by a line segment. In line with previous reports, performance on reporting the left half improved when the chimera were separated; but when a line connected the two separated halves the advantage was lost. If the connecting line was broken, the performance was again enhanced. The results suggest an important role for connectedness in the representation of perceptual objects and in the distribution of attention in neglect.	[Tian, Yanghua; Wang, Kai] Anhui Med Univ, Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China; [Huang, Yan; Zhou, Ke] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Huang, Yan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Humphreys, Glyn W.; Riddoch, M. Jane] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	Anhui Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Birmingham	Tian, YH (corresponding author), Anhui Med Univ, Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	M.J.Riddoch@bham.ac.uk; wangkai1964@126.com		Tian, Yanghua/0000-0001-5038-0599	National Basic Research Program of China (973 Program) [2011CB707805]; Natural Science Foundation of Anhui province [KJ2010B395]; International Program of Anhui province [10080703040]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Anhui province(Natural Science Foundation of Anhui Province); International Program of Anhui province	This work was supported by grants from National Basic Research Program of China (973 Program) (Grant #2011CB707805; http://www.most.gov.cn/); the Natural Science Foundation of Anhui province (Grant #KJ2010B395; http://www.ahkjt.gov.cn/); International Program of Anhui province (Grant #10080703040; http://www.ahkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Bartolomeo P, 2002, NEUROSCI BIOBEHAV R, V26, P217, DOI 10.1016/S0149-7634(01)00065-3; Brooks JL, 2005, NEUROPSYCHOLOGIA, V43, P572, DOI 10.1016/j.neuropsychologia.2004.07.009; BUXBAUM LJ, 1994, NEUROPSYCHOLOGIA, V32, P275, DOI 10.1016/0028-3932(94)90131-7; Chechlacz M, 2010, COGN NEUROPSYCHOL, V27, P277, DOI 10.1080/02643294.2010.519699; Chen L, 2005, VIS COGN, V12, P553, DOI 10.1080/13506280444000256; CHEN L, 1982, SCIENCE, V218, P699, DOI 10.1126/science.7134969; COSTELLO AD, 1987, J NEUROL NEUROSUR PS, V50, P1110, DOI 10.1136/jnnp.50.9.1110; CUBELLI R, 1991, BRAIN COGNITION, V15, P139, DOI 10.1016/0278-2626(91)90023-2; Cubelli R, 2001, CORTEX, V37, P159, DOI 10.1016/S0010-9452(08)70565-3; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; DRIVER J, 1991, COGNITIVE NEUROPSYCH, V8, P475, DOI 10.1080/02643299108253384; Driver J, 2000, J COGNITIVE NEUROSCI, V12, P542, DOI 10.1162/089892900562192; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; FARAH MJ, 1990, NEUROPSYCHOLOGIA, V28, P335, DOI 10.1016/0028-3932(90)90060-2; Gilchrist ID, 1996, COGNITIVE NEUROPSYCH, V13, P1223, DOI 10.1080/026432996381737; GRABOWECKY M, 1993, J COGNITIVE NEUROSCI, V5, P288, DOI 10.1162/jocn.1993.5.3.288; Halligan P, 1990, Int Disabil Stud, V12, P95; HALLIGAN PW, 1994, NEUROREPORT, V5, P537, DOI 10.1097/00001756-199401000-00001; Heinke D, 2003, PSYCHOL REV, V110, P29, DOI 10.1037//0033-295X.110.1.29; HUMPHREYS G, 1992, ATTENTION PERFORM, V14, P143; Humphreys G. W., 1993, UNILATERAL NEGLECT C, P139; Humphreys GW, 1998, PHILOS T R SOC B, V353, P1341, DOI 10.1098/rstb.1998.0288; HUMPHREYS GW, 1993, ATTENTION PERFORM, V14, P143; MARK VW, 1988, NEUROLOGY, V38, P1207, DOI 10.1212/WNL.38.8.1207; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; PALMER S, 1994, PSYCHON B REV, V1, P29, DOI 10.3758/BF03200760; Pavlovskaya M, 1997, J COGNITIVE NEUROSCI, V9, P824, DOI 10.1162/jocn.1997.9.6.824; POSNER MI, 1984, J NEUROSCI, V4, P1863; RIDDOCH MJ, 1995, COGNITIVE NEUROPSYCH, V12, P569, DOI 10.1080/02643299508252008; Sarri M, 2009, NEUROPSYCHOLOGIA, V47, P91, DOI 10.1016/j.neuropsychologia.2008.08.020; SERON X, 1989, COGNITIVE NEUROPSYCH, V6, P475, DOI 10.1080/02643298908253427; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; Tipper SP, 1996, J EXP PSYCHOL HUMAN, V22, P1261, DOI 10.1037/0096-1523.22.5.1261; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Walker R, 1995, NEUROCASE, V1, P371; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; YOUNG AW, 1992, BRAIN, V115, P51, DOI 10.1093/brain/115.1.51	40	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24760	10.1371/journal.pone.0024760	http://dx.doi.org/10.1371/journal.pone.0024760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980355	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700008
J	Tomter, AB; Zoppellaro, G; Schmitzberger, F; Andersen, NH; Barra, AL; Engman, H; Nordlund, P; Andersson, KK				Tomter, Ane B.; Zoppellaro, Giorgio; Schmitzberger, Florian; Andersen, Niels H.; Barra, Anne-Laure; Engman, Henrik; Nordlund, Par; Andersson, K. Kristoffer			HF-EPR, Raman, UV/VIS Light Spectroscopic, and DFT Studies of the Ribonucleotide Reductase R2 Tyrosyl Radical from Epstein-Barr Virus	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HIGH-FIELD EPR; MAGNETIC CIRCULAR-DICHROISM; HIGH-FREQUENCY EPR; ESCHERICHIA-COLI; IRON CENTER; RESONANCE RAMAN; HYDROGEN-BOND; G-VALUES; ALLOSTERIC REGULATION	Epstein-Barr virus (EBV) belongs to the gamma subfamily of herpes viruses, among the most common pathogenic viruses in humans worldwide. The viral ribonucleotide reductase small subunit (RNR R2) is involved in the biosynthesis of nucleotides, the DNA precursors necessary for viral replication, and is an important drug target for EBV. RNR R2 generates a stable tyrosyl radical required for enzymatic turnover. Here, the electronic and magnetic properties of the tyrosyl radical in EBV R2 have been determined by X-band and high-field/high-frequency electron paramagnetic resonance (EPR) spectroscopy recorded at cryogenic temperatures. The radical exhibits an unusually low g(1)-tensor component at 2.0080, indicative of a positive charge in the vicinity of the radical. Consistent with these EPR results a relatively high C-O stretching frequency associated with the phenoxyl radical (at 1508 cm 21) is observed with resonance Raman spectroscopy. In contrast to mouse R2, EBV R2 does not show a deuterium shift in the resonance Raman spectra. Thus, the presence of a water molecule as a hydrogen bond donor moiety could not be identified unequivocally. Theoretical simulations showed that a water molecule placed at a distance of 2.6 angstrom from the tyrosyl-oxygen does not result in a detectable deuterium shift in the calculated Raman spectra. UV/VIS light spectroscopic studies with metal chelators and tyrosyl radical scavengers are consistent with a more accessible dimetal binding/radical site and a lower affinity for Fe2+ in EBV R2 than in Escherichia coli R2. Comparison with previous studies of RNR R2s from mouse, bacteria, and herpes viruses, demonstrates that finely tuned electronic properties of the radical exist within the same RNR R2 Ia class.	[Tomter, Ane B.; Zoppellaro, Giorgio; Andersen, Niels H.; Andersson, K. Kristoffer] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Schmitzberger, Florian; Engman, Henrik; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Barra, Anne-Laure] CNRS, Lab Natl Champs Magnet Intenses, LNCMI G, UPR 3228, Grenoble, France	University of Oslo; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Tomter, AB (corresponding author), Univ Oslo, Dept Mol Biosci, Oslo, Norway.	k.k.andersson@imbv.uio.no	Zoppellaro, Giorgio/F-8453-2012; Schmitzberger, Florian/B-4532-2013	Zoppellaro, Giorgio/0000-0003-2304-2564; Schmitzberger, Florian/0000-0001-9343-5561; Andersen, Niels Hojmark/0000-0003-3668-2800	European Community [PIEF-GA-2009-235237]; Research Council of Norway [177661/V30]; Cancer Foundation of Norway; Swedish Cancer Foundation; Swedish Research Council; Karolinska Institute Foundation; Howard Hughes Medical Institute	European Community(European Commission); Research Council of Norway(Research Council of Norway); Cancer Foundation of Norway; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute Foundation(Karolinska Institutet); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	GZ thanks the Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2009-235237) for financial support, KKA the Research Council of Norway (Grant 177661/V30) and The Cancer Foundation of Norway, PN the Swedish Cancer Foundation and the Swedish Research Council, FS a Karolinska Institute Foundation grant and a Howard Hughes Medical Institute fellowship. The Raman instrument and laser equipment was funded by a grant from the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 1996, J AM CHEM SOC, V118, P895, DOI 10.1021/ja9529192; Andersson K. K., 1995, ADV INORG CHEM, V43, P359; Andersson K.K., 2008, RIBONUCLEOTIDE REDUC; Andersson KK, 2003, J BIOL INORG CHEM, V8, P235, DOI 10.1007/s00775-002-0429-0; Andersson KK, 2002, SPECTROCHIM ACTA A, V58, P1101, DOI 10.1016/S1386-1425(01)00700-4; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; ATOR MA, 1986, J BIOL CHEM, V261, P3595; ATTA M, 1993, BIOCHEM J, V290, P807, DOI 10.1042/bj2900807; Atta M, 1996, J BIOL INORG CHEM, V1, P210, DOI 10.1007/s007750050045; ATTA M, 1994, J AM CHEM SOC, V116, P6429, DOI 10.1021/ja00093a051; Barra AL, 2004, BIO MAGN RE, V22, P145; Brynda M, 2007, RES CHEM INTERMEDIAT, V33, P863, DOI 10.1163/156856707782169426; Campbell KA, 1997, J AM CHEM SOC, V119, P4787, DOI 10.1021/ja9706155; Chodosh J, 1998, J INFECT DIS, V177, P1194, DOI 10.1086/515290; CONNER J, 1994, REV MED VIROL, V4, P25, DOI 10.1002/rmv.1980040107; Cornvik T, 2005, NAT METHODS, V2, P507, DOI 10.1038/NMETH767; Dahlroth SL, 2009, PROTEIN EXPRES PURIF, V68, P121, DOI 10.1016/j.pep.2009.07.010; Engstrom M, 2000, J PHYS CHEM A, V104, P5149, DOI 10.1021/jp0006633; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; GALLI C, 1995, J AM CHEM SOC, V117, P740, DOI 10.1021/ja00107a017; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; GLERUP J, 1991, ACTA CHEM SCAND, V45, P444, DOI 10.3891/acta.chem.scand.45-0444; Hanson MA, 1999, J AM CHEM SOC, V121, P6755, DOI 10.1021/ja990995p; Himo F, 1997, BIOPHYS J, V72, P1556, DOI 10.1016/S0006-3495(97)78803-9; Hoganson CW, 1996, J AM CHEM SOC, V118, P4672, DOI 10.1021/ja953979a; Ivancich A, 1999, J AM CHEM SOC, V121, P5743, DOI 10.1021/ja990562m; Jiang R, 2004, J MED VIROL, V73, P589, DOI 10.1002/jmv.20130; JOHNSON CR, 1986, J AM CHEM SOC, V108, P905, DOI 10.1021/ja00265a010; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Katterle B, 1997, J BIOL CHEM, V272, P10414; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lamarche N, 1996, BIOCHEM J, V320, P129, DOI 10.1042/bj3200129; Liu Xiyong, 2008, V477, P195, DOI 10.1007/978-1-60327-517-0_15; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; McCreery R.L., 2005, RAMAN SPECTROSCOPY C, VVolume 225; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; Offenbacher AR, 2009, J AM CHEM SOC, V131, P7496, DOI 10.1021/ja901908j; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; POTSCH S, 1995, FEBS LETT, V374, P95, DOI 10.1016/0014-5793(95)01082-P; Range K, 2006, J PHYS CHEM B, V110, P10970, DOI 10.1021/jp061503f; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; Schmidt PP, 1996, J BIOL CHEM, V271, P23615, DOI 10.1074/jbc.271.39.23615; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Smith P, 2009, BIOCHEMISTRY-US, V48, P11134, DOI 10.1021/bi9001425; Strand KR, 2004, J BIOL CHEM, V279, P46794, DOI 10.1074/jbc.M407346200; Strand KR, 2003, BIOCHEMISTRY-US, V42, P12223, DOI 10.1021/bi035248q; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Svistunenko DA, 2009, PHYS CHEM CHEM PHYS, V11, P6600, DOI 10.1039/b905522c; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Un S, 2005, MAGN RESON CHEM, V43, pS229, DOI 10.1002/mrc.1660; UN S, 1995, J AM CHEM SOC, V117, P10713, DOI 10.1021/ja00148a013; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; van Dam PJ, 1998, J AM CHEM SOC, V120, P5080, DOI 10.1021/ja9737127; Wakisaka N, 2005, INT J CANCER, V116, P640, DOI 10.1002/ijc.21096; Wei PP, 2006, BIOCHEMISTRY-US, V45, P14043, DOI 10.1021/bi061127p; Weihe H, SIM SOFTWARE; Wnuk SF, 2006, ANTIVIR RES, V71, P122, DOI 10.1016/j.antiviral.2006.03.002	63	20	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25022	10.1371/journal.pone.0025022	http://dx.doi.org/10.1371/journal.pone.0025022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980375	Green Published, gold, Green Submitted			2022-12-27	WOS:000295933700017
J	Esberg, A; Muller, LAH; McCusker, JH				Esberg, Anders; Muller, Ludo A. H.; McCusker, John H.			Genomic Structure of and Genome-Wide Recombination in the Saccharomyces cerevisiae S288C Progenitor Isolate EM93	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC GENE CONVERSION; HIS4 LOCUS; CROSSOVER INTERFERENCE; CHROMATIN-STRUCTURE; HOT-SPOT; YEAST; MEIOSIS; CHROMOSOMES; HOTSPOT	The diploid isolate EM93 is the main ancestor to the widely used Saccharomyces cerevisiae haploid laboratory strain, S288C. In this study, we generate a high-resolution overview of the genetic differences between EM93 and S288C. We show that EM93 is heterozygous for >45,000 polymorphisms, including large sequence polymorphisms, such as deletions and a Saccharomyces paradoxus introgression. We also find that many large sequence polymorphisms (LSPs) are associated with Ty-elements and sub-telomeric regions. We identified 2,965 genetic markers, which we then used to genotype 120 EM93 tetrads. In addition to deducing the structures of all EM93 chromosomes, we estimate that the average EM93 meiosis produces 144 detectable recombination events, consisting of 87 crossover and 31 non-crossover gene conversion events. Of the 50 polymorphisms showing the highest levels of non-crossover gene conversions, only three deviated from parity, all of which were near heterozygous LSPs. We find that non-telomeric heterozygous LSPs significantly reduce meiotic recombination in adjacent intervals, while sub-telomeric LSPs have no discernable effect on recombination. We identified 203 recombination hotspots, relatively few of which are hot for both non-crossover gene conversions and crossovers. Strikingly, we find that recombination hotspots show limited conservation. Some novel hotspots are found adjacent to heterozygous LSPs that eliminate other hotspots, suggesting that hotspots may appear and disappear relatively rapidly.	[Esberg, Anders; Muller, Ludo A. H.; McCusker, John H.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University	Esberg, A (corresponding author), Umea Univ, Fac Med, Dept Odontol, Umea, Sweden.	mccus001@mc.duke.edu		McCusker, John/0000-0002-8803-9131	Wenner-Gren Foundations; National Institutes of Health [GM02054, GM081690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081690] Funding Source: NIH RePORTER	Wenner-Gren Foundations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by Wenner-Gren Foundations (http://www.swgc.org/) (to AE) and the National Institutes of Health grants GM02054 and GM081690 (to JHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; Bengtsson H., 2008, 745 U CAL DEP STAT; Berchowitz LE, 2009, GENOME RES, V19, P2245, DOI 10.1101/gr.096297.109; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Bullard SA, 1996, P NATL ACAD SCI USA, V93, P13054, DOI 10.1073/pnas.93.23.13054; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Carvalho AB, 2003, NAT GENET, V34, P128, DOI 10.1038/ng0603-128; DETLOFF P, 1992, GENETICS, V132, P113; DICAPRIO L, 1976, GENETICS, V84, P697; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; FOGEL S, 1979, COLD SPRING HARB SYM, V43, P1325, DOI 10.1101/SQB.1979.043.01.152; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; HURST DD, 1972, P NATL ACAD SCI USA, V69, P101, DOI 10.1073/pnas.69.1.101; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kearney HM, 2001, GENETICS, V158, P1457; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keller PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000533; Kirkpatrick DT, 1999, MOL CELL BIOL, V19, P7661; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; LAMBIE EJ, 1988, CELL, V52, P863, DOI 10.1016/0092-8674(88)90428-X; LAMBIE EJ, 1986, GENETICS, V114, P769; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Liti G, 2005, ANNU REV MICROBIOL, V59, P135, DOI 10.1146/annurev.micro.59.030804.121400; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; MALONE RE, 1994, GENETICS, V137, P5; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; MORTIMER RK, 1986, GENETICS, V113, P35; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; PERKINS DD, 1949, GENETICS, V34, P607; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; PORTER SE, 1993, GENETICS, V134, P5; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Qi J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-475; R Development Core Team, 2007, R LANG ENV STAT COMP; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Ronald J, 2006, GENETICS, V174, P541, DOI 10.1534/genetics.106.060863; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SHERMAN F, 1991, METHOD ENZYMOL, P132; Sherman F., 1974, METHODS YEAST GENETI; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; ZENVIRTH D, 1992, EMBO J, V11, P3441, DOI 10.1002/j.1460-2075.1992.tb05423.x; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; [No title captured]	57	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25211	10.1371/journal.pone.0025211	http://dx.doi.org/10.1371/journal.pone.0025211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966457	Green Published, gold, Green Submitted			2022-12-27	WOS:000295932100025
J	Rossen, NS; Hansen, AJ; Selhuber-Unkel, C; Oddershede, LB				Rossen, Ninna Struck; Hansen, Anker Jon; Selhuber-Unkel, Christine; Oddershede, Lene Broeng			Arachidonic Acid Randomizes Endothelial Cell Motion and Regulates Adhesion and Migration	PLOS ONE			English	Article							ANGIOGENESIS; DYNAMICS; DISEASE; CANCER	Cell adhesion and migration are essential for the evolution, organization, and repair of living organisms. An example of a combination of these processes is the formation of new blood vessels (angiogenesis), which is mediated by a directed migration and adhesion of endothelial cells (ECs). Angiogenesis is an essential part of wound healing and a prerequisite of cancerous tumor growth. We investigated the effect of the amphiphilic compound arachidonic acid (AA) on EC adhesion and migration by combining live cell imaging with biophysical analysis methods. AA significantly influenced both EC adhesion and migration, in either a stimulating or inhibiting fashion depending on AA concentration. The temporal evolution of cell adhesion area was well described by a two-phase model. In the first phase, the spreading dynamics were independent of AA concentration. In the latter phase, the spreading dynamics increased at low AA concentrations and decreased at high AA concentrations. AA also affected EC migration; though the instantaneous speed of individual cells remained independent of AA concentration, the individual cells lost their sense of direction upon addition of AA, thus giving rise to an overall decrease in the collective motion of a confluent EC monolayer into vacant space. Addition of AA also caused ECs to become more elongated, this possibly being related to incorporation of AA in the EC membrane thus mediating a change in the viscosity of the membrane. Hence, AA is a promising non-receptor specific regulator of wound healing and angiogenesis.	[Rossen, Ninna Struck; Selhuber-Unkel, Christine; Oddershede, Lene Broeng] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Hansen, Anker Jon] Novo Nordisk AS, Malov, Denmark	University of Copenhagen; Niels Bohr Institute; Novo Nordisk	Rossen, NS (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	oddershede@nbi.dk	Selhuber-Unkel, Christine/D-9715-2016	Selhuber-Unkel, Christine/0000-0002-5051-4822	University of Copenhagen	University of Copenhagen	The work was supported by the University of Copenhagen Excellence Program. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AJH is employed at Novo Nordisk A/S and contributed to the design and analysis of the study.	Angelos MG, 2010, BIOPHYS J, V99, P3545, DOI 10.1016/j.bpj.2010.10.004; Barden A, 2011, FREE RADICAL RES, V45, P469, DOI 10.3109/10715762.2010.544730; Baynes J.W., 2005, MED BIOCH, VVolume 2; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Chamaraux F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158102; Chamaraux F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036009; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Dobereiner HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108105; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1994, J CLIN ONCOL, V12, P441, DOI 10.1200/JCO.1994.12.3.441; Ghosh PK, 2002, NAT CELL BIOL, V4, P894, DOI 10.1038/ncb873; Jensen Lasse D. E., 2007, Angiogenesis, V10, P13, DOI 10.1007/s10456-006-9060-y; Li Y, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3298361; Liu DQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003291; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2006, J PHYS-CONDENS MAT, V18, pS1305, DOI 10.1088/0953-8984/18/28/S13; Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306; MCGIFF JC, 1991, ANNU REV PHARMACOL, V31, P339, DOI 10.1146/annurev.pa.31.040191.002011; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Pozzi A, 2009, WIRES SYST BIOL MED, V1, P254, DOI 10.1002/wsbm.7; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001; Sengupta K, 2006, BIOPHYS J, V91, P4638, DOI [10.1529/biophysj.105.080382, 10.1529/biophysj.106.080382]; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510	29	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25196	10.1371/journal.pone.0025196	http://dx.doi.org/10.1371/journal.pone.0025196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966453	Green Submitted, Green Published, gold			2022-12-27	WOS:000295267100027
J	Sebastiani, G; Gkouvatsos, K; Maffettone, C; Busatto, G; Guido, M; Pantopoulos, K				Sebastiani, Giada; Gkouvatsos, Kostas; Maffettone, Carmen; Busatto, Graziella; Guido, Maria; Pantopoulos, Kostas			Accelerated CCl4-Induced Liver Fibrosis in Hjv-/- Mice, Associated with an Oxidative Burst and Precocious Profibrogenic Gene Expression	PLOS ONE			English	Article							DIETARY IRON OVERLOAD; NF-KAPPA-B; HEPATIC IRON; MEDICAL PROGRESS; RODENT MODEL; ANIMAL-MODEL; EXCESS IRON; LONG-TERM; HEMOCHROMATOSIS; ACTIVATION	Hereditary hemochromatosis is commonly associated with liver fibrosis. Likewise, hepatic iron overload secondary to chronic liver diseases aggravates liver injury. To uncover underlying molecular mechanisms, hemochromatotic hemojuvelin knockout (Hjv-/-) mice and wild type (wt) controls were intoxicated with CCl4. Hjv-/- mice developed earlier (by 2-4 weeks) and more acute liver damage, reflected in dramatic levels of serum transaminases and ferritin and the development of severe coagulative necrosis and fibrosis. These responses were associated with an oxidative burst and early upregulation of mRNAs encoding alpha 1-(I)-collagen, the profibrogenic cytokines TGF-beta 1, endothelin-1 and PDGF and, notably, the iron-regulatory hormone hepcidin. Hence, CCl4-induced liver fibrogenesis was exacerbated and progressed precociously in Hjv-/- animals. Even though livers of naive Hjv-/- mice were devoid of apparent pathology, they exhibited oxidative stress and immunoreactivity towards alpha-SMA antibodies, a marker of hepatic stellate cells activation. Furthermore, they expressed significantly higher (2-3 fold vs. wt, p<0.05) levels of alpha 1-(I)-collagen, TGF-beta 1, endothelin-1 and PDGF mRNAs, indicative of early fibrogenesis. Our data suggest that hepatic iron overload in parenchymal cells promotes oxidative stress and triggers premature profibrogenic gene expression, contributing to accelerated onset and precipitous progression of liver fibrogenesis.	[Sebastiani, Giada; Gkouvatsos, Kostas; Maffettone, Carmen; Pantopoulos, Kostas] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Sebastiani, Giada; Gkouvatsos, Kostas; Maffettone, Carmen; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Busatto, Graziella; Guido, Maria] Univ Padua, Dept Diagnost Sci & Special Therapies, Padua, Italy	Lady Davis Institute; McGill University; McGill University; University of Padua	Sebastiani, G (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	kostas.pantopoulos@mcgill.ca	Pantopoulos, Kostas/A-9668-2008	Pantopoulos, Kostas/0000-0002-2305-0057; Sebastiani, Giada/0000-0003-2655-8283	Canadian Institutes for Health Research (CIHR) [MOP-86515]; Fonds de la Recherche en Sante du Quebec (FRSQ); J. Latsis; A. Onassis; Government of Canada	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); J. Latsis; A. Onassis; Government of Canada(CGIAR)	This work was supported by a grant from the Canadian Institutes for Health Research: (CIHR; www.cihr-irsc.gc.ca); grant number: MOP-86515. KP holds a Chercheur National career award from the Fonds de la Recherche en Sante du Quebec (FRSQ; www.frsq.gouv.qc.ca). KG is supported by doctoral awards from the J. Latsis (www.latsis-foundation.org) and A. Onassis (www.onassis.gr) Public Benefit Foundations and CM was a recipient of a Government of Canada Post-Doctoral Research Fellowship (PDRF; www.scholarships.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla V, 2005, SEMIN LIVER DIS, V25, P461, DOI 10.1055/s-2005-923317; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Arezzini B, 2003, INT J BIOCHEM CELL B, V35, P486, DOI 10.1016/S1357-2725(02)00298-4; Asare GA, 2008, TOXICOLOGY, V254, P11, DOI 10.1016/j.tox.2008.08.024; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; CARTHEW P, 1993, LAB INVEST, V69, P217; Constandinou C, 2005, METH MOLEC MED, V117, P237; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fracanzani AL, 2010, HEPATOLOGY, V51, P501, DOI 10.1002/hep.23333; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; GUALDI R, 1994, GASTROENTEROLOGY, V107, P1118, DOI 10.1016/0016-5085(94)90237-2; Hider RC, 2002, EUR J CLIN INVEST, V32, P50, DOI 10.1046/j.1365-2362.2002.0320s1050.x; Houglum K, 1997, HEPATOLOGY, V26, P605, DOI 10.1002/hep.510260311; HOUGLUM K, 1990, J CLIN INVEST, V86, P1991, DOI 10.1172/JCI114934; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kowdley KV, 2004, GASTROENTEROLOGY, V127, pS79, DOI 10.1016/j.gastro.2004.09.019; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Lebeau A, 2002, EUR J CLIN INVEST, V32, P603, DOI 10.1046/j.1365-2362.2002.01026.x; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205; Lewis JH, 2006, MACSWEENS PATHOLOGY, P650; MACKINNON M, 1995, HEPATOLOGY, V21, P1083; Maffettone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010163; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; OLYNYK J, 1995, J HEPATOL, V22, P671, DOI 10.1016/0168-8278(95)80222-3; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; PARK CH, 1987, LAB INVEST, V57, P555; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; PIETRANGELO A, 1995, J CLIN INVEST, V95, P1824, DOI 10.1172/JCI117861; PIETRANGELO A, 1994, HEPATOLOGY, V19, P714, DOI 10.1002/hep.1840190325; PIETRANGELO A, 1990, HEPATOLOGY, V11, P798, DOI 10.1002/hep.1840110513; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Ramm GA, 1997, J HEPATOL, V26, P584, DOI 10.1016/S0168-8278(97)80424-2; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rippe RA, 2004, GASTROENTEROLOGY, V127, P1260, DOI 10.1053/j.gastro.2004.08.028; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Sebastiani G, 2006, J VIRAL HEPATITIS, V13, P199, DOI 10.1111/j.1365-2893.2005.00662.x; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P4673, DOI 10.3748/wjg.v13.i35.4673; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Ueberham E, 2003, HEPATOLOGY, V37, P1067, DOI 10.1053/jhep.2003.50196; Wang GS, 1999, J HEPATOL, V30, P689, DOI 10.1016/S0168-8278(99)80201-3; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Xiong SG, 2003, ALCOHOL, V30, P107, DOI 10.1016/S0741-8329(03)00100-9; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200	54	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25138	10.1371/journal.pone.0025138	http://dx.doi.org/10.1371/journal.pone.0025138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966437	gold, Green Published, Green Submitted			2022-12-27	WOS:000295265100065
J	Lussiana, C; Clemente, SVL; Tarquino, IAP; Paulo, I				Lussiana, Cristina; Loa Clemente, Sofia Vanda; Pulido Tarquino, Ivan Alejandro; Paulo, Isabel			Predictors of Bacterial Meningitis in Resource-Limited Contexts: An Angolan Case	PLOS ONE			English	Article							CRYPTOCOCCAL MENINGITIS; HAEMOPHILUS-INFLUENZAE; CLINICAL PRESENTATION; CHILDREN; CHILDHOOD; DIAGNOSIS; AFRICA; BURDEN	Background: Despite the great morbidity and mortality that childhood bacterial meningitis (BM) is experiencing in Africa, diagnosis of BM in resource-limited contexts is still a challenge. Several algorithms and clinical predictors have been proposed to help physicians in decision-making but a lot of these markers used variables that are calculable only in well-equipped laboratories. Predictors or algorithm based on parameters that can be easily performed in basic laboratories can help significantly in BM diagnosis, even in resource-limited settings, rural hospitals or health centers. Results: This retrospective study examined 145 cerebral-spinal fluid (CSF) specimens from children from 2 months to 14 years. CSF specimens were divided into two groups, according to the presence or not of a clinical diagnosis of BM. For each specimen, CSF aspect, CSF white blood cells (WBC) count, CSF glucose and protein concentration were analyzed and statistical analysis were performed. CSF WBC count >= 10/mu l is no more a valuable predictor of BM. CSF protein concentration >= 50 mg/dl has a better sensitivity for BM diagnosis and when used with CSF glucose concentration <= 40 mg/dl, can help to diagnose correctly almost all the BM cases. An algorithm including CSF protein concentration, glucose concentration and WBC count has been proposed to rule out BM and to correctly diagnose it. Conclusions: In resource-limited health centers, the availability of a combination of easy-to-obtain parameters can significantly help physicians in BM diagnosis. The prompt identification of a BM case can be rapid treated or transferred to adequate structures and can modify the outcome in the patient.	[Lussiana, Cristina; Pulido Tarquino, Ivan Alejandro] Hosp Divina Providencia, Infect Dis Lab, Luanda, Angola		Lussiana, C (corresponding author), Hosp Divina Providencia, Infect Dis Lab, Luanda, Angola.	cristinaelle@hotmail.it	Pulido Tarquino, Ivan Alejandro/GPS-7553-2022	Pulido Tarquino, Ivan Alejandro/0000-0002-1448-8268				Armitage P., 2001, STAT METHODS MED RES; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Bernardino L, 2003, LANCET, V361, P1564, DOI 10.1016/S0140-6736(03)13204-7; Bogaerts J, 1999, J INFECTION, V39, P32, DOI 10.1016/S0163-4453(99)90099-3; BURG F, 1996, CURRENT PEDIATR THER; Chavanet P, 2007, J INFECTION, V54, P328, DOI 10.1016/j.jinf.2006.06.009; Daoud AS, 1995, J TROP PEDIATRICS, V41, P308, DOI 10.1093/tropej/41.5.308; DONALD PR, 1983, J PEDIATR-US, V103, P413, DOI 10.1016/S0022-3476(83)80416-8; Forbes B. E., 2002, BAILEY SCOTTS DIAGNO; Freedman SB, 2001, ARCH PEDIAT ADOL MED, V155, P1301, DOI 10.1001/archpedi.155.12.1301; KACICA MA, 1994, PEDIATR ANN, V23, P69, DOI 10.3928/0090-4481-19940201-06; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; MURRAY CJ, 1996, GLOBAL HLTH STAT, V285; Mwaba P, 2001, POSTGRAD MED J, V77, P769, DOI 10.1136/pmj.77.914.769; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; Pelkonen T, 2008, SCAND J INFECT DIS, V40, P859, DOI 10.1080/00365540802262091; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Saez-Llorens X, 1990, Infect Dis Clin North Am, V4, P623; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; WALLACH J, 2000, INTERPRETATION DIAGN; WRIGHT JP, 1995, TROP DOCT, V25, P5, DOI 10.1177/004947559502500102	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25706	10.1371/journal.pone.0025706	http://dx.doi.org/10.1371/journal.pone.0025706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991337	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300018
J	Mech, LD; Cluff, HD				Mech, L. David; Cluff, H. Dean			Movements of Wolves at the Northern Extreme of the Species' Range, Including during Four Months of Darkness	PLOS ONE			English	Article							WOLF	Information about wolf (Canis lupus) movements anywhere near the northern extreme of the species' range in the High Arctic (>75 degrees N latitude) are lacking. There, wolves prey primarily on muskoxen (Ovibos moschatus) and must survive 4 months of 24 hr/day winter darkness and temperatures reaching -53 C. The extent to which wolves remain active and prey on muskoxen during the dark period are unknown, for the closest area where information is available about winter wolf movements is >2,250 km south. We studied a pack of >= 20 wolves on Ellesmere Island, Nunavut, Canada (80 degrees N latitude) from July 2009 through mid-April 2010 by collaring a lead wolf with a Global Positioning System (GPS)/Argos radio collar. The collar recorded the wolf's precise locations at 6:00 a.m. and 6:00 p.m. daily and transmitted the locations by satellite to our email. Straight-line distances between consecutive 12-hr locations varied between 0 and 76 km. Mean (SE) linear distance between consecutive locations (n = 554) was 11 (0.5) km. Total minimum distance traveled was 5,979 km, and total area covered was 6,640 km(2), the largest wolf range reported. The wolf and presumably his pack once made a 263-km (straight-line distance) foray to the southeast during 19-28 January 2010, returning 29 January to 1 February at an average of 41 km/day straight-line distances between 12-hr locations. This study produced the first detailed movement information about any large mammal in the High Arctic, and the average movements during the dark period did not differ from those afterwards. Wolf movements during the dark period in the highest latitudes match those of the other seasons and generally those of wolves in lower latitudes, and, at least with the gross movements measurable by our methods, the 4-month period without direct sunlight produced little change in movements.	[Mech, L. David] US Geol Survey, No Prairie Wildlife Res Ctr, Jamestown, ND USA; [Cluff, H. Dean] Govt NW Terr, Dept Environm & Nat Resources, Yellowknife, NT, Canada	United States Department of the Interior; United States Geological Survey	Mech, LD (corresponding author), Univ Minnesota, Raptor Ctr, St Paul, MN 55108 USA.	mechx002@umn.edu	Cluff, Howard D/B-3808-2009		U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	This work was supported by the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKHOLDER BOB L., 1959, JOUR WILDLIFE MANAGEMENT, V23, P1, DOI 10.2307/3797740; Fuller T.K, 2003, WOLVES BEHAV ECOLOGY; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; Goldman EA., 1944, WOLVES N AM 1; GRACE E S, 1976, Canadian Field-Naturalist, V90, P149; Gray DR, 1987, MUSKOXEN POLAR BEAR; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; Lau MK, 2011, DTK DUNNETT TUKEY KR; Mech D., 2003, WOLVES BEHAV ECOLOGY; Mech L. David, 2003, P1; Mech LD, 2005, ARCTIC, V58, P305; Mech LD, 2000, ARCTIC, V53, P69; MECH LD, 1993, J MAMMAL, V74, P485, DOI 10.2307/1382407; MECH LD, 1990, CAN FIELD NAT, V104, P484; Mech LD, 1995, ARCTIC, V48, P329; Mech LD, 1988, ARCTOC WOLF LIVING P; Mech LD, 2010, CAN FIELD NAT, V124; Musiani M, 1998, ACTA THERIOL, V43, P409, DOI 10.4098/AT.arch.98-51; Parmelee D.F, 1964, BEAVER, P4; PULLIAINEN ERKKI, 1965, ANN ZOOL FENNICI, V2, P215; R Development Core Team, 2010, R LANG ENV STAT COMP; Tener JS, 1954, WILDL MANAGE B 1, V1; Turchin Peter, 1998; Walton LR, 2001, J MAMMAL, V82, P867, DOI 10.1644/1545-1542(2001)082<0867:MPOBGW>2.0.CO;2	25	15	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25328	10.1371/journal.pone.0025328	http://dx.doi.org/10.1371/journal.pone.0025328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991308	Green Published, gold			2022-12-27	WOS:000295963300010
J	Uehara, S; Nambu, I; Tomatsu, S; Lee, J; Kakei, S; Naito, E				Uehara, Shintaro; Nambu, Isao; Tomatsu, Saeka; Lee, Jongho; Kakei, Shinji; Naito, Eiichi			Improving Human Plateaued Motor Skill with Somatic Stimulation	PLOS ONE			English	Article							MOVEMENTS; MUSCLE	Procedural motor learning includes a period when no substantial gain in performance improvement is obtained even with repeated, daily practice. Prompted by the potential benefit of high-frequency transcutaneous electrical stimulation, we examined if the stimulation to the hand reduces redundant motor activity that likely exists in an acquired hand motor skill, so as to further upgrade stable motor performance. Healthy participants were trained until their motor performance of continuously rotating two balls in the palm of their right hand became stable. In the series of experiments, they repeated a trial performing this cyclic rotation as many times as possible in 15 s. In trials where we applied the stimulation to the relaxed thumb before they initiated the task, most reported that their movements became smoother and they could perform the movements at a higher cycle compared to the control trials. This was not possible when the dorsal side of the wrist was stimulated. The performance improvement was associated with reduction of amplitude of finger displacement, which was consistently observed irrespective of the task demands. Importantly, this kinematic change occurred without being noticed by the participants, and their intentional changes of motor strategies (reducing amplitude of finger displacement) never improved the performance. Moreover, the performance never spontaneously improved during one-week training without stimulation, whereas the improvement in association with stimulation was consistently observed across days during training on another week combined with the stimulation. The improved effect obtained in stimulation trials on one day partially carried over to the next day, thereby promoting daily improvement of plateaued performance, which could not be unlocked by the first-week intensive training. This study demonstrated the possibility of effectively improving a plateaued motor skill, and pre-movement somatic stimulation driving this behavioral change.	[Uehara, Shintaro; Nambu, Isao; Naito, Eiichi] Natl Inst Informat & Commun Technol, Brain ICT Lab, Kyoto, Japan; [Uehara, Shintaro] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Uehara, Shintaro] Japan Soc Promot Sci, Tokyo, Japan; [Tomatsu, Saeka; Lee, Jongho; Kakei, Shinji] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Nambu, Isao; Naito, Eiichi] Ctr Informat & Neural Networks, Osaka, Japan; [Naito, Eiichi] Osaka Univ, Grad Sch Med, Osaka, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Kyoto University; Japan Society for the Promotion of Science; Tokyo Metropolitan Institute of Medical Science; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Uehara, S (corresponding author), Natl Inst Informat & Commun Technol, Brain ICT Lab, Kyoto, Japan.	eiichi.naito@nict.go.jp	Isao, Nambu/S-5963-2018	Isao, Nambu/0000-0002-1705-6268; Uehara, Shintaro/0000-0002-6255-1815; Kakei, Shinji/0000-0001-5111-5789	Japan Society for the Promotion of Science [22-4098]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was conducted as a pre-project for the Institute of Neural Systems and Information Networks. S.U. was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for JSPS fellows, 22-4098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYAN WL, 1897, PSYCHOL REV, V4, P27, DOI DOI 10.1037/H0073806; Dimitrijevic MM, 1996, SCI MED, V3, P54; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Kawashima R, 1998, EUR J NEUROSCI, V10, P2254, DOI 10.1046/j.1460-9568.1998.00237.x; Kline CE, 2007, J APPL PHYSIOL, V102, P641, DOI 10.1152/japplphysiol.00910.2006; Matsumura M, 2004, BRAIN RES BULL, V63, P471, DOI 10.1016/j.brainresbull.2004.04.008; McKay D, 2002, NEUROREPORT, V13, P1271, DOI 10.1097/00001756-200207190-00011; Meesen RLJ, 2011, HUM BRAIN MAPP, V32, P872, DOI 10.1002/hbm.21075; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Naito E, 2007, EUR J NEUROSCI, V25, P3476, DOI 10.1111/j.1460-9568.2007.05587.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; SCHIEBER MH, 1995, J NEUROSCI, V15, P284; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; VODOVNIK L, 1981, MED BIOL ENG COMPUT, V19, P470, DOI 10.1007/BF02441314; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	19	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25670	10.1371/journal.pone.0025670	http://dx.doi.org/10.1371/journal.pone.0025670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991331	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300015
J	Reis, M; Vieira, CP; Morales-Hojas, R; Aguiar, B; Rocha, H; Schlotterer, C; Vieira, J				Reis, Micael; Vieira, Cristina P.; Morales-Hojas, Ramiro; Aguiar, Bruno; Rocha, Helder; Schloetterer, Christian; Vieira, Jorge			A Comparative Study of the Short Term Cold Resistance Response in Distantly Related Drosophila Species: The Role of regucalcin and Frost	PLOS ONE			English	Article							CHILL-COMA RECOVERY; GENE-EXPRESSION; MELANOGASTER; THERMOTOLERANCE; TEMPERATURE; TOLERANCE; SELECTION; STRESS; HOST; ACCLIMATION	The molecular basis of short term cold resistance (indexed as chill-coma recovery time) has been mostly addressed in D. melanogaster, where candidate genes (Dca (also known as smp-30) and Frost (Fst)) have been identified. Nevertheless, in Drosophila, the ability to tolerate short term exposure to low temperatures evolved several times independently. Therefore, it is unclear whether variation in the same candidate genes is also responsible for short term cold resistance in distantly related Drosophila species. It should be noted that Dca is a candidate gene for cold resistance in the Sophophora subgenus only, since there is no orthologous gene copy in the Drosophila subgenus. Here we show that, in D. americana (Drosophila subgenus), there is a north-south gradient for a variant at the 59 non-coding region of regucalcin (a Dca-like gene; in D. melanogaster the proteins encoded by the two genes share 71.9% amino acid identities) but in our D. americana F2 association experiment there is no association between this polymorphism and chill-coma recovery times. Moreover, we found no convincing evidence that this gene is up-regulated after cold shock in both D. americana and D. melanogaster. Size variation in the Fst PEST domain (putatively involved in rapid protein degradation) is observed when comparing distantly related Drosophila species, and is associated with short term cold resistance differences in D. americana. Nevertheless, this effect is likely through body size variation. Moreover, we show that, even at two hours after cold shock, when up-regulation of this gene is maximal in D. melanogaster (about 48 fold expression change), in D. americana this gene is only moderately up-regulated (about 3 fold expression change). Our work thus shows that there are important differences regarding the molecular basis of cold resistance in distantly related Drosophila species.	[Reis, Micael; Vieira, Cristina P.; Morales-Hojas, Ramiro; Aguiar, Bruno; Rocha, Helder; Vieira, Jorge] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Schloetterer, Christian] Inst Populat Genet, Vienna, Austria	Universidade do Porto	Reis, M (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jbvieira@ibmc.up.pt	Vieira, Cristina P./K-1775-2013; Schlötterer, Christian/G-6326-2010; Vieira, Jorge/J-7477-2013; Schlötterer, Christian/Q-5264-2019	Vieira, Cristina P./0000-0002-7139-2107; Schlötterer, Christian/0000-0003-4710-6526; Vieira, Jorge/0000-0001-7032-5220; Schlötterer, Christian/0000-0003-4710-6526; Rocha, Helder/0000-0003-1062-2498; Reis, Micael/0000-0002-2601-0886; Morales Hojas, Ramiro/0000-0002-4120-5964	Programa Operacional para a Ciencia e Inovacao (POCI); Fundo Europeu para o Desenvolvimento Regional (FEDER); Programa Operacional para a Promocao da competividade (COMPETE [FCOMP-01-0124-FEDER-008923]; programme Ciencia; Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional(POPH - QREN); European Social Fund; Ministerio da Ciencia Tecnologia e Ensino Superior (MCTES); American Portuguese Biomedical Research Fund (APBRF);  [PTDC/BIA-BDE/66765/2006];  [PTDC/BIA-BEC/099933/2008 comp-01-0124-FEDER-008916]	Programa Operacional para a Ciencia e Inovacao (POCI); Fundo Europeu para o Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional para a Promocao da competividade (COMPETE; programme Ciencia; Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional(POPH - QREN); European Social Fund(European Social Fund (ESF)); Ministerio da Ciencia Tecnologia e Ensino Superior (MCTES); American Portuguese Biomedical Research Fund (APBRF); ; 	This work has been funded by the project PTDC/BIA-BDE/66765/2006 and PTDC/BIA-BEC/099933/2008 comp-01-0124-FEDER-008916, and through PhD grants attributed to Micael Reis and Bruno Aguiar, funded by Programa Operacional para a Ciencia e Inovacao (POCI) 2010, co-funded by Fundo Europeu para o Desenvolvimento Regional (FEDER) funds and Programa Operacional para a Promocao da competividade (COMPETE; FCOMP-01-0124-FEDER-008923). Ramiro Morales-Hojas is supported by the programme Ciencia 2007, financed by the Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional(POPH - QREN), cofinanced by the European Social Fund and Portuguese funds from the Ministerio da Ciencia Tecnologia e Ensino Superior (MCTES). The fly collection was funded by the American Portuguese Biomedical Research Fund (APBRF). We thank Sara Magalhaes for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck JG, 2006, TOXICOL SCI, V89, P495, DOI 10.1093/toxsci/kfj036; Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; ARBOLEDABUSTOS CE, 2011, MOL BIOL EVOL; Ayrinhac A, 2004, FUNCT ECOL, V18, P700, DOI 10.1111/j.0269-8463.2004.00904.x; Bubliy OA, 2002, J THERM BIOL, V27, P337, DOI 10.1016/S0306-4565(01)00098-5; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cabrero P, 2002, J EXP BIOL, V205, P3799; Carsten LD, 2005, MOL ECOL, V14, P3203, DOI 10.1111/j.1365-294X.2005.02654.x; Chamilos G, 2008, P NATL ACAD SCI USA, V105, P9367, DOI 10.1073/pnas.0709578105; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; Clowers KJ, 2010, GENET RES, V92, P103, DOI 10.1017/S0016672310000108; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; David JR, 2003, FUNCT ECOL, V17, P425, DOI 10.1046/j.1365-2435.2003.00750.x; David RJ, 1998, J THERM BIOL, V23, P291, DOI 10.1016/S0306-4565(98)00020-5; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Goto SG, 2001, GENE, V270, P259, DOI 10.1016/S0378-1119(01)00465-6; Goto SG, 2000, J INSECT PHYSIOL, V46, P1111, DOI 10.1016/S0022-1910(99)00221-8; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; James AC, 1997, GENETICS, V146, P881; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; LEE SF, 2011, MOL BIOL EVOL; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McAllister BF, 2002, GENOME, V45, P13, DOI 10.1139/g01-112; McAllister BF, 2008, EVOLUTION, V62, P1852, DOI 10.1111/j.1558-5646.2008.00435.x; McKechnie SW, 2010, MOL ECOL, V19, P775, DOI 10.1111/j.1365-294X.2009.04509.x; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Norry FM, 2008, MOL ECOL, V17, P4570, DOI 10.1111/j.1365-294X.2008.03945.x; Patterson J. T., 1952, EVOLUTION GENUS DROS; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rako L, 2006, J INSECT PHYSIOL, V52, P94, DOI 10.1016/j.jinsphys.2005.09.007; Rako L, 2007, MOL ECOL, V16, P2948, DOI 10.1111/j.1365-294X.2007.03332.x; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reis M, 2008, GENE, V425, P48, DOI 10.1016/j.gene.2008.08.010; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Telonis-Scott M, 2009, J INSECT PHYSIOL, V55, P549, DOI 10.1016/j.jinsphys.2009.01.010; van Heerwaarden B, 2011, EVOLUTION, V65, P1048, DOI 10.1111/j.1558-5646.2010.01196.x; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Vieira CP, 2006, GENET RES, V87, P163, DOI 10.1017/S0016672306008147; Vieira J, 2001, GENETICS, V158, P279; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	48	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25520	10.1371/journal.pone.0025520	http://dx.doi.org/10.1371/journal.pone.0025520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991316	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000035
J	Valentin-Acevedo, A; Sinquett, FL; Covey, LR				Valentin-Acevedo, Anibal; Sinquett, Frank L.; Covey, Lori R.			c-Rel Deficiency Increases Caspase-4 Expression and Leads to ER Stress and Necrosis in EBV-Transformed Cells	PLOS ONE			English	Article							NF-KAPPA-B; CHICKEN SPLEEN-CELLS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; LATENT MEMBRANE-PROTEIN-1; LYMPHOCYTE DEVELOPMENT; SURVIVAL PATHWAYS; CYCLE PROGRESSION; INDUCED APOPTOSIS; MARGINAL ZONE	LMP1-mediated activation of nuclear factor of kappaB (NF-kappa B) is critical for the ligand independent proliferation and cell survival of in vitro EBV-transformed lymphoblastoid cell lines (LCLs). Previous experiments revealed that a majority of LMP1-dependent responses are regulated by NF-kappa B. However, the extent that individual NF-kappa B family members are required for these responses, in particular, c-Rel, whose expression is restricted to mature hematopoietic cells, remains unclear. Here we report that low c-Rel expression in LCLs derived from a patient with hyper-IgM syndrome (Pt1), resulted in defects in proliferation and cell survival. In contrast to studies that associated loss of NF-kappa B with increased apoptosis, Pt1 LCLs failed to initiate apoptosis and alternatively underwent autophagy and necrotic cell death. Whereas the proliferation defect appeared linked to a c-Rel-associated decrease in c-myc expression, identified pro-survival and pro-apoptotic targets were expressed at or near control levels consistent with the absence of apoptosis. Ultrastructural examination of Pt1 LCLs revealed a high level of cellular and ER stress that was further supported by gene expression profiling showing the upregulation of several genes involved in stress and inflammation. Apoptosis-independent cell death was accompanied by increased expression of the inflammatory marker, caspase-4. Using gene overexpression and siRNA knockdown we demonstrated that levels of c-Rel directly modulated expression of caspase-4 as well as other ER stress genes. Overall, these findings reveal the importance of c-Rel in maintaining LCL viability and that decreased expression results in ER stress and a default response leading to necrotic cell death.	[Valentin-Acevedo, Anibal; Sinquett, Frank L.; Covey, Lori R.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Valentin-Acevedo, A (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	covey@biology.rutgers.edu			National Institutes of Health [R56AI037081]; New Jersey Commission on Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI037081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L. C. was supported by R56AI037081 from the National Institutes of Health and A. V-A. was supported by a pre-doctoral fellowship from the New Jersey Commission on Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Barth TFE, 2001, GENE CHROMOSOME CANC, V31, P316, DOI 10.1002/gcc.1150; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Bhushan A, 2000, J IMMUNOL, V164, P2871, DOI 10.4049/jimmunol.164.6.2871; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; CHAN MA, 1986, J IMMUNOL, V136, P106; Cheng SH, 2003, ONCOGENE, V22, P8472, DOI 10.1038/sj.onc.1206917; Darzynkiewicz Z, 2011, METHODS MOL BIOL, V682, P103, DOI 10.1007/978-1-60327-409-8_9; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Feuillard J, 2000, BLOOD, V95, P2068, DOI 10.1182/blood.V95.6.2068.2068; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; Grumont RJ, 2002, MOL CELL, V10, P1283, DOI 10.1016/S1097-2765(02)00779-7; HIBI T, 1986, J IMMUNOL, V136, P3211; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Houldsworth J, 1996, BLOOD, V87, P25; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Lu KT, 2006, BLOOD, V108, P3769, DOI 10.1182/blood-2006-03-008839; Lu KT, 2005, J LEUKOCYTE BIOL, V78, P620, DOI 10.1189/jlb.0305159; Luoto KR, 2010, CANCER RES, V70, P8748, DOI 10.1158/0008-5472.CAN-10-0944; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Moscat J, 2003, EMBO REP, V4, P31, DOI 10.1038/sj.embor.embor704; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Oh SH, 2009, J PHARMACOL EXP THER, V329, P112, DOI 10.1124/jpet.108.144113; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Paoluzzi L, 2010, ADV EXP MED BIOL, V687, P79; Pelletier N, 2006, J IMMUNOL, V176, P1340, DOI 10.4049/jimmunol.176.3.1340; Purchase H G, 1975, Curr Top Microbiol Immunol, V71, P103; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Starczynowski DT, 2003, ONCOGENE, V22, P6928, DOI 10.1038/sj.onc.1206801; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tian WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005028; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; WEIH F, 1994, ONCOGENE, V9, P3289; White E, 2008, AUTOPHAGY, V4, P399, DOI 10.4161/auto.5907; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	58	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25467	10.1371/journal.pone.0025467	http://dx.doi.org/10.1371/journal.pone.0025467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984918	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000031
J	Baran, J; Gerner, M; Haeussler, M; Nenadic, G; Bergman, CM				Baran, Joachim; Gerner, Martin; Haeussler, Maximilian; Nenadic, Goran; Bergman, Casey M.			pubmed2ensembl: A Resource for Mining the Biological Literature on Genes	PLOS ONE			English	Article							SEARCH ENGINE; DATABASE; BIOINFORMATICS; DROSOPHILA; TOOL; PUBLICATIONS; ANNOTATION; WAREHOUSE; SOFTWARE; QUERIES	Background: The last two decades have witnessed a dramatic acceleration in the production of genomic sequence information and publication of biomedical articles. Despite the fact that genome sequence data and publications are two of the most heavily relied-upon sources of information for many biologists, very little effort has been made to systematically integrate data from genomic sequences directly with the biological literature. For a limited number of model organisms dedicated teams manually curate publications about genes; however for species with no such dedicated staff many thousands of articles are never mapped to genes or genomic regions. Methodology/Principal Findings: To overcome the lack of integration between genomic data and biological literature, we have developed pubmed2ensembl (http://www.pubmed2ensembl.org), an extension to the BioMart system that links over 2,000,000 articles in PubMed to nearly 150,000 genes in Ensembl from 50 species. We use several sources of curated (e.g., Entrez Gene) and automatically generated (e.g., gene names extracted through text-mining on MEDLINE records) sources of gene-publication links, allowing users to filter and combine different data sources to suit their individual needs for information extraction and biological discovery. In addition to extending the Ensembl BioMart database to include published information on genes, we also implemented a scripting language for automated BioMart construction and a novel BioMart interface that allows text-based queries to be performed against PubMed and PubMed Central documents in conjunction with constraints on genomic features. Finally, we illustrate the potential of pubmed2ensembl through typical use cases that involve integrated queries across the biomedical literature and genomic data. Conclusion/Significance: By allowing biologists to find the relevant literature on specific genomic regions or sets of functionally related genes more easily, pubmed2ensembl offers a much-needed genome informatics inspired solution to accessing the ever-increasing biomedical literature.	[Baran, Joachim; Gerner, Martin; Haeussler, Maximilian; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Nenadic, Goran] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Baran, J (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	casey.bergman@manchester.ac.uk	Bergman, Casey/F-7854-2010; Haeussler, Maximilian/AAY-1649-2021	Bergman, Casey/0000-0002-5462-9854; Nenadic, Goran/0000-0003-0795-5363	BBSRC [BB/G000093/1]; BBSRC CASE in collaboration with BioMed Central; Biotechnology and Biological Sciences Research Council [BB/G000093/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC CASE in collaboration with BioMed Central(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by BBSRC grant BB/G000093/1 (to CMB and GN) and a BBSRC CASE studentship in collaboration with BioMed Central (to MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen LF, 2005, BIOINFORMATICS, V21, P248, DOI 10.1093/bioinformatics/bth496; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Dwight SS, 2004, BRIEF BIOINFORM, V5, P9, DOI 10.1093/bib/5.1.9; Eckman BA, 2001, BIOINFORMATICS, V17, P587, DOI 10.1093/bioinformatics/17.7.587; Fernandez JM, 2007, NUCLEIC ACIDS RES, V35, pW21, DOI 10.1093/nar/gkm298; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerner M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-85; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Haeussler M, 2011, BIOINFORMATICS, V27, P980, DOI 10.1093/bioinformatics/btr043; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hirschman J, 2010, MOL GENET GENOMICS, V283, P415, DOI 10.1007/s00438-010-0525-8; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Hull D, 2006, NUCLEIC ACIDS RES, V34, pW729, DOI 10.1093/nar/gkl320; Imanishi T, 2009, NUCLEIC ACIDS RES, V37, pW17, DOI 10.1093/nar/gkp355; Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3; Kersey P, 2006, NAT CELL BIOL, V8, P1183, DOI 10.1038/ncb1495; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s8, 10.1186/gb-2008-9-S2-S8]; Lee TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-170; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Makita Y, 2009, PLANT CELL PHYSIOL, V50, P1249, DOI 10.1093/pcp/pcp086; Matos S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-212; Miller Holly, 2009, BMC Res Notes, V2, P101, DOI 10.1186/1756-0500-2-101; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Plake C, 2009, NUCLEIC ACIDS RES, V37, pW300, DOI 10.1093/nar/gkp429; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Shah SP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-34; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Tamames J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-402; Xuan WJ, 2007, BIOINFORMATICS, V23, P2477, DOI 10.1093/bioinformatics/btm375; Yoshida Y, 2009, NUCLEIC ACIDS RES, V37, pW147, DOI 10.1093/nar/gkp384; Zdobnov EM, 2002, BIOINFORMATICS, V18, P1149, DOI 10.1093/bioinformatics/18.8.1149; Zhou GH, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-46	46	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24716	10.1371/journal.pone.0024716	http://dx.doi.org/10.1371/journal.pone.0024716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980353	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600005
J	Bottari, D; Caclin, A; Giard, MH; Pavani, F				Bottari, Davide; Caclin, Anne; Giard, Marie-Helene; Pavani, Francesco			Changes in Early Cortical Visual Processing Predict Enhanced Reactivity in Deaf Individuals	PLOS ONE			English	Article							CONGENITALLY DEAF; AUDITORY DEPRIVATION; EXOGENOUS ATTENTION; SIGN-LANGUAGE; HEARING; DISSOCIATION; POTENTIALS; COMPONENTS; STIMULI; MOTION	Individuals with profound deafness rely critically on vision to interact with their environment. Improvement of visual performance as a consequence of auditory deprivation is assumed to result from cross-model changes occurring in late stages of visual processing. Here we measured reaction times and event-related potentials (ERPs) in profoundly deaf adults and hearing controls during a speeded visual detection task, to assess to what extent the enhanced reactivity of deaf indivisuals could reflect plastic changes in the early cortical processing of the stimulus. We found that deaf subjects were faster than hearing controls at detecting the visual targets, regardless of their location in the visual field (peripheral or perifoveal). The behavioural facilitation was associated with ERP changes starting from the first detectable response in the striate cortex (C1 component) at about 80 ms after stimulus onset, in the P1 complex (100-150 ms). In addition, we found that P1 peak amplitudes predicted the response times in deaf subjects, whereas in hearing individuals visual reactivity and ERP amplitudes predicted the response times in deaf subjects, whereas in hearing individuals visual reactivity and ERP amplitudes correlated only at later stages of processing. These findings show that long-term auditory deprivation can profoundly alter visual processing from the earliest cortical stages. Furthermore, our results provide the first evidence of a co-variation between modified brain activity (cortical plasticity) and behavioural enhancement in this sensory deprived population.	[Bottari, Davide; Pavani, Francesco] Univ Trento, Dept Cognit Sci & Educ, Trento, Italy; [Bottari, Davide; Pavani, Francesco] Univ Trento, Ctr Mind Brain Sci, Trento, Italy; [Caclin, Anne; Giard, Marie-Helene] INSERM, U1028, F-69008 Lyon, France; [Caclin, Anne; Giard, Marie-Helene] CNRS, UMR5292, Lyon, France; [Caclin, Anne; Giard, Marie-Helene] Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, Lyon, France; [Caclin, Anne; Giard, Marie-Helene] Univ Lyon 1, F-69365 Lyon, France	University of Trento; University of Trento; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bottari, D (corresponding author), Univ Trento, Dept Cognit Sci & Educ, Trento, Italy.	davidebottari@gmail.com	Pavani, Francesco/B-4836-2010; Giard, Marie-Helene/AAH-1048-2019; Bottari, Davide/H-1694-2018; Caclin, Anne/K-1682-2017	Pavani, Francesco/0000-0003-0426-5578; Bottari, Davide/0000-0001-6843-1569; Caclin, Anne/0000-0003-1367-5923	MIUR (Italy) [Prot. 2006118540_004]; Italian University; French University; University of Trento (Italy)	MIUR (Italy)(Ministry of Education, Universities and Research (MIUR)); Italian University; French University; University of Trento (Italy)	This work was supported by a PRIN 2006 grant (Prot. 2006118540_004) from MIUR (Italy), a Galileo grant from Italian and French Universities, and a PAT-CRS grant from University of Trento (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; Armstrong BA, 2002, COGNITIVE BRAIN RES, V14, P422, DOI 10.1016/S0926-6410(02)00211-2; Bavelier D, 2000, PERCEPT PSYCHOPHYS, V62, P100, DOI 10.3758/BF03212064; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bottari D, 2010, RESTOR NEUROL NEUROS, V28, P167, DOI 10.3233/RNN-2010-0502; Chica AB, 2009, BRAIN RES, V1278, P75, DOI 10.1016/j.brainres.2009.04.011; Codina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020417; Colmenero JM, 2004, EUR J COGN PSYCHOL, V16, P791, DOI 10.1080/09541440340000312; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Emmorey K, 2003, P NATL ACAD SCI USA, V100, P10049, DOI 10.1073/pnas.1730169100; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Foxe JJ, 2008, BRAIN TOPOGR, V21, P11, DOI 10.1007/s10548-008-0063-4; Fu SM, 2010, BIOL PSYCHOL, V85, P171, DOI 10.1016/j.biopsycho.2010.06.008; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Hunt DL, 2005, ANAT REC PART A, V287A, P1051, DOI 10.1002/ar.a.20251; Karns CM, 2009, J COGNITIVE NEUROSCI, V21, P669, DOI 10.1162/jocn.2009.21037; Kim DJ, 2009, NEUROREPORT, V20, P1032, DOI 10.1097/WNR.0b013e32832e0cdd; LOKE WH, 1991, B PSYCHONOMIC SOC, V29, P437; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Mennes M, 2010, PSYCHOPHYSIOLOGY, V47, P1142, DOI 10.1111/j.1469-8986.2010.01015.x; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; PARASNIS I, 1985, BRAIN COGNITION, V4, P313, DOI 10.1016/0278-2626(85)90024-7; Pavani F., FRONTIERS N IN PRESS; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Proverbio AM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-59; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; REYNOLDS HN, 1993, AM J PSYCHOL, V106, P523, DOI 10.2307/1422967; SAARINEN J, 1989, INVEST OPHTH VIS SCI, V30, P293; Stivalet P, 1998, COGNITIVE BRAIN RES, V6, P227, DOI 10.1016/S0926-6410(97)00026-8; Talsma D, 2007, BRAIN RES, V1178, P92, DOI 10.1016/j.brainres.2007.07.099; Trillenberg P, 2000, CLIN NEUROPHYSIOL, V111, P1216, DOI 10.1016/S1388-2457(00)00274-1	38	56	57	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25607	10.1371/journal.pone.0025607	http://dx.doi.org/10.1371/journal.pone.0025607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834DM	21980501	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600039
J	Castilla-Ortega, E; Hoyo-Becerra, C; Pedraza, C; Chun, J; De Fonseca, FR; Estivill-Torrus, G; Santin, LJ				Castilla-Ortega, Estela; Hoyo-Becerra, Carolina; Pedraza, Carmen; Chun, Jerold; Rodriguez De Fonseca, Fernando; Estivill-Torrus, Guillermo; Santin, Luis J.			Aggravation of Chronic Stress Effects on Hippocampal Neurogenesis and Spatial Memory in LPA(1) Receptor Knockout Mice	PLOS ONE			English	Article							PRECURSOR CELL-PROLIFERATION; ANXIETY-RELATED BEHAVIORS; ADULT DENTATE GYRUS; LYSOPHOSPHATIDIC ACID; GRANULE CELLS; LYSOPHOSPHOLIPID RECEPTORS; NEURONAL DIFFERENTIATION; PREFRONTAL CORTEX; CHRONIC RESTRAINT; PROGENITOR CELLS	Background: The lysophosphatidic acid LPA(1), receptor regulates plasticity and neurogenesis in the adult hippocampus. Here, we studied whether absence of the LPA(1) receptor modulated the detrimental effects of chronic stress on hippocampal neurogenesis and spatial memory. Methodology/Principal Findings:Male LPA(1)-null (NULL) and wild-type (WT) mice were assigned to control or chronic stress conditions (21 days of restraint, 3 h/day). Immunohistochemistry for bromodeoxyuridine and endogenous markers was performed to examine hippocampal cell proliferation, survival, number and maturation of young neurons, hippocampal structure and apoptosis in the hippocampus. Corticosterone levels were measured in another a separate cohort of mice. Finally, the hole-board test assessed spatial reference and working memory. Under control conditions, NULL mice showed reduced cell proliferation, a defective population of young neurons, reduced hippocampal volume and moderate spatial memory deficits. However, the primary result is that chronic stress impaired hippocampal neurogenesis in NULLs more severely than in WT mice in terms of cell proliferation; apoptosis; the number and maturation of young neurons; and both the volume and neuronal density in the granular zone. Only stressed NULLs presented hypocortisolemia. Moreover, a dramatic deficit in spatial reference memory consolidation was observed in chronically stressed NULL mice, which was in contrast to the minor effect observed in stressed WT mice. Conclusions/Significance:These results reveal that the absence of the LPA(1), receptor aggravates the chronic stress-induced impairment to hippocampal neurogenesis and its dependent functions. Thus, modulation of the LPA(1) receptor pathway may be of interest with respect to the treatment of stress-induced hippocampal pathology.	[Castilla-Ortega, Estela; Pedraza, Carmen; Santin, Luis J.] Univ Malaga, Dept Psicobiol & Metodol CC, E-29071 Malaga, Spain; [Hoyo-Becerra, Carolina; Rodriguez De Fonseca, Fernando; Estivill-Torrus, Guillermo] Hosp Reg Univ Carlos Haya, Fdn IMABIS, Unidad Invest, Malaga, Spain; [Chun, Jerold] Scripps Res Inst, Dept Mol Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA	Universidad de Malaga; FIMABIS; Hospital Carlos Haya; Scripps Research Institute	Castilla-Ortega, E (corresponding author), Univ Malaga, Dept Psicobiol & Metodol CC, Campus Teatinos, E-29071 Malaga, Spain.	luis@uma.es	Benitez, Carmen Pedraza/K-2328-2017; Torrús, Guillermo Estivill/L-5157-2015; Chun, Jerold/Y-4670-2019; Santin, Luis Javier LJ/G-4364-2011; Castilla-Ortega, Estela/K-2811-2015; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Santin, Luis Javier/G-4364-2011	Benitez, Carmen Pedraza/0000-0002-0011-2817; Torrús, Guillermo Estivill/0000-0002-7124-2678; Santin, Luis Javier LJ/0000-0003-0894-8536; Castilla-Ortega, Estela/0000-0002-4496-1167; Santin, Luis Javier/0000-0003-1755-6497	Spanish Ministry of Education and Science [MEC SEJ2007-61187]; Programme for Stabilization of Researchers and Research Technician and Intensification of Research Activity in the National Health System; Human Frontier Science Programme; Carlos III Health Institute [FIS 02/1643, FIS PI07/0629]; Red de Trastornos Adictivos RTA [RD06/001]; Fund for Health Research; Andalusian Ministry of Health and of Innovation, Science and Enterprise [CTS065, CTS433]; National Institutes of Health (USA) [MH051699, MH01723]; Spanish Ministry of Education [AP-2006-02582]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001723, R01MH051699, R29MH051699] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); Programme for Stabilization of Researchers and Research Technician and Intensification of Research Activity in the National Health System; Human Frontier Science Programme(Human Frontier Science Program); Carlos III Health Institute(Instituto de Salud Carlos III); Red de Trastornos Adictivos RTA; Fund for Health Research; Andalusian Ministry of Health and of Innovation, Science and Enterprise; National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education(Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Spanish Ministry of Education and Science (MEC SEJ2007-61187; to US), Programme for Stabilization of Researchers and Research Technician and Intensification of Research Activity in the National Health System (I3SNS Programme; to GET), the Human Frontier Science Programme (to JC, FRDF), Fund for Health Research, Carlos III Health Institute (FIS 02/1643, FIS PI07/0629; to GET), Red de Trastornos Adictivos RTA (RD06/001; to FRDF), Andalusian Ministry of Health and of Innovation, Science and Enterprise (CTS065, to GET, and CTS433 to FRDF) and the National Institutes of Health (USA) MH051699 and MH01723 (to JC). The author E. Castilla-Ortega has a FPU Grant from the Spanish Ministry of Education (AP-2006-02582). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; ARMARIO A, 1990, PSYCHONEUROENDOCRINO, V15, P341, DOI 10.1016/0306-4530(90)90059-I; Bain MJ, 2004, NEUROSCI LETT, V368, P7, DOI 10.1016/j.neulet.2004.04.096; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Bland ST, 2006, NEUROREPORT, V17, P593, DOI 10.1097/00001756-200604240-00008; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Castilla-Ortega E, 2011, REV NEUROSCIENCE, V22, P267, DOI 10.1515/RNS.2011.027; Castilla-Ortega E, 2010, NEUROBIOL LEARN MEM, V94, P73, DOI 10.1016/j.nlm.2010.04.003; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chun J, 2005, PROSTAG OTH LIPID M, V77, P46, DOI 10.1016/j.prostaglandins.2004.09.009; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; Conrad CD, 2008, REV NEUROSCIENCE, V19, P395; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Douma BRK, 1998, PSYCHONEUROENDOCRINO, V23, P33, DOI 10.1016/S0306-4530(97)00091-7; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Dwivedi Y, 2005, NEUROPSYCHOPHARMACOL, V30, P473, DOI 10.1038/sj.npp.1300605; Egeland M, 2010, BIOL PSYCHIAT, V67, P1048, DOI 10.1016/j.biopsych.2010.01.024; Estivill-Torrus G, 2008, CEREB CORTEX, V18, P938, DOI 10.1093/cercor/bhm132; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Fujiwara Y, 2003, J NEUROCHEM, V87, P1272, DOI 10.1046/j.1471-4159.2003.02106.x; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hayashi F, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-22; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Inokuchi K, 2011, CURR OPIN NEUROBIOL, V21, P360, DOI 10.1016/j.conb.2011.02.006; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ito H, 2010, NEUROPHARMACOLOGY, V58, P746, DOI 10.1016/j.neuropharm.2009.12.011; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Joels M, 2007, FRONT NEUROENDOCRIN, V28, P72, DOI 10.1016/j.yfrne.2007.04.001; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; KORBO L, 1990, J NEUROSCI METH, V31, P93, DOI 10.1016/0165-0270(90)90153-7; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lee I, 2003, J NEUROSCI, V23, P1517, DOI 10.1523/JNEUROSCI.23-04-01517.2003; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Musazzi L, 2010, INT J NEUROPSYCHOPH, P1; Newport DJ, 2000, CURR OPIN NEUROBIOL, V10, P211, DOI 10.1016/S0959-4388(00)00080-5; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pilpel Y, 2006, J NEUROCHEM, V97, P1379, DOI 10.1111/j.1471-4159.2006.03825.x; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Rhee HJ, 2006, NEUROREPORT, V17, P523; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Roberts C, 2005, NEUROCHEM RES, V30, P371, DOI 10.1007/s11064-005-2611-6; Saitoh A, 2006, PSYCHOPHARMACOLOGY, V188, P1, DOI 10.1007/s00213-006-0466-4; Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Schloesser RJ, 2009, NEUROREPORT, V20, P553, DOI 10.1097/WNR.0b013e3283293e59; Schoenfeld T.J., 2011, EXP NEUROL IN PRESS; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Spohr TCDSE, 2008, J BIOL CHEM, V283, P7470, DOI 10.1074/jbc.M707758200; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Strekalova T, 2005, BEHAV PHARMACOL, V16, P171, DOI 10.1097/00008877-200505000-00006; Swinny JD, 2006, EUR J NEUROSCI, V24, P2481, DOI 10.1111/j.1460-9568.2006.05129.x; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; van der Beek EM, 2004, HIPPOCAMPUS, V14, P688, DOI 10.1002/hipo.10213; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Yu S, 2010, ANN NEUROL, V67, P21, DOI 10.1002/ana.21812; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x	104	60	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25522	10.1371/journal.pone.0025522	http://dx.doi.org/10.1371/journal.pone.0025522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980482	gold, Green Published			2022-12-27	WOS:000295939600033
J	Sen, S; Garcia-Ojalvo, J; Elowitz, MB				Sen, Shaunak; Garcia-Ojalvo, Jordi; Elowitz, Michael B.			Dynamical Consequences of Bandpass Feedback Loops in a Bacterial Phosphorelay	PLOS ONE			English	Article							BACILLUS-SUBTILIS; GENE-EXPRESSION; SPO0E GENE; SPORULATION; INITIATION; TRANSCRIPTION; DIFFERENTIATION; VARIABILITY; INTEGRATION; MECHANISM	Under conditions of nutrient limitation, Bacillus subtilis cells terminally differentiate into a dormant spore state. Progression to sporulation is controlled by a genetic circuit consisting of a phosphorelay embedded in multiple transcripional feedback loops, which is used to activate the master regulator Spo0A by phosphorylation. These transcriptional regulatory interactions are "bandpass"-like, in the sense that activation occurs within a limited band a Spo0A similar to P concentrations. Additionally, recent result show that the phosphorelay activation occurs in pulses, in a cell-cycle dependent fashion. However, the impact of these pulsed bandpass interactions on the circuit dynamics preceding sporulation remains unclear order to address this question, we measured key features of the bandpass interactions at the single-cell level and zed them in the context of a simple mathematical model. The model predicted the emergence of a delayed phase shift between the pulsing activity of the different sporulation genes, as well as the existence of a stable state, with elevated Spo0A activity but no sporulation embedded within the dynamical structure of the system. To test the model, we used time-lapse fluorescence microscopy to measure dynamics of single cells initiating sporulation. We obserbed the delayed phase shift emerging during the progression to sporulation, while a re-engineering of the sporulation circuit revealed behavior resembling the predicted additional state. These results show that periodically-driven bandpass feedback loops can give rise to complex dynamics in the progression towards sporulation.	[Sen, Shaunak] CALTECH, Div Engn & Appl Sci, Dept Control & Dynam Syst, Pasadena, CA 91125 USA; [Garcia-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Terrassa, Spain; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Div Biol, Dept Bioengn & Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; Universitat Politecnica de Catalunya; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sen, S (corresponding author), CALTECH, Div Engn & Appl Sci, Dept Control & Dynam Syst, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520	Betty and Gordon Moore Foundation; Ministerio de Ciencia e Innovacion (Spain) [FIS2009-13360]; Instituto de Salud Carlos III (Spain, REEM network); ICREA; NIH [R01GM079771]; US National Science Foundation [0644463]; Caltech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771] Funding Source: NIH RePORTER	Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (Spain, REEM network)(Instituto de Salud Carlos III); ICREA(ICREA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Caltech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.S. acknowledges financial support from the Betty and Gordon Moore Foundation, Caltech through the Poincare Fellowship. Funding for J.G.-O. is provided by the Ministerio de Ciencia e Innovacion (Spain, project FIS2009-13360), Instituto de Salud Carlos III (Spain, REEM network), and by the ICREA Academia Programme. Funding for M.B.E. is provided by NIH grant R01GM079771 and US National Science Foundation CAREER Award 0644463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bick MJ, 2009, J MOL BIOL, V386, P163, DOI 10.1016/j.jmb.2008.12.006; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; CHAPMAN JW, 1987, J GEN MICROBIOL, V133, P2079; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 1998, J BIOCHEM-TOKYO, V124, P98, DOI 10.1093/oxfordjournals.jbchem.a022103; Gilbert S.F., 2000, DEV BIOL; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; LEVINE JH, UNPUB; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; PEREGO M, 1994, CELL, V79, P1047, DOI 10.1016/0092-8674(94)90035-3; PEREGO M, 1987, MOL MICROBIOL, V1, P125, DOI 10.1111/j.1365-2958.1987.tb00536.x; PEREGO M, 1991, J BACTERIOL, V173, P2514, DOI 10.1128/jb.173.8.2514-2520.1991; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Ptashne M, 2004, GENETIC SWITCH PHAGE, Vxiv; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Veening JW, 2009, GENE DEV, V23, P1959, DOI 10.1101/gad.528209; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	28	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25102	10.1371/journal.pone.0025102	http://dx.doi.org/10.1371/journal.pone.0025102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980382	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000295939600010
J	Adams, VM; Segan, DB; Pressey, RL				Adams, Vanessa M.; Segan, Daniel B.; Pressey, Robert L.			How Much Does it Cost to Expand a Protected Area System? Some Critical Determining Factors and Ranges of Costs for Queensland	PLOS ONE			English	Article							CAPE FLORISTIC REGION; RESERVE SELECTION; CONSERVATION BENEFITS; EFFICIENCY; TARGETS; SCALE; REPRESENTATION; OPPORTUNITY; MANAGEMENT	Many governments have recently gone on record promising large-scale expansions of protected areas to meet global commitments such as the Convention on Biological Diversity. As systems of protected areas are expanded to be more comprehensive, they are more likely to be implemented if planners have realistic budget estimates so that appropriate funding can be requested. Estimating financial budgets a priori must acknowledge the inherent uncertainties and assumptions associated with key parameters, so planners should recognize these uncertainties by estimating ranges of potential costs. We explore the challenge of budgeting a priori for protected area expansion in the face of uncertainty, specifically considering the future expansion of protected areas in Queensland, Australia. The government has committed to adding,12 million ha to the reserve system, bringing the total area protected to 20 million ha by 2020. We used Marxan to estimate the costs of potential reserve designs with data on actual land value, market value, transaction costs, and land tenure. With scenarios, we explored three sources of budget variability: size of biodiversity objectives; subdivision of properties; and legal acquisition routes varying with tenure. Depending on the assumptions made, our budget estimates ranged from $214 million to $2.9 billion. Estimates were most sensitive to assumptions made about legal acquisition routes for leasehold land. Unexpected costs (costs encountered by planners when real-world costs deviate from assumed costs) responded non-linearly to inability to subdivide and percentage purchase of private land. A financially conservative approach - one that safeguards against large cost increases while allowing for potential financial windfalls - would involve less optimistic assumptions about acquisition and subdivision to allow Marxan to avoid expensive properties where possible while meeting conservation objectives. We demonstrate how a rigorous analysis can inform discussions about the expansion of systems of protected areas, including the identification of factors that influence budget variability.	[Adams, Vanessa M.; Pressey, Robert L.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Segan, Daniel B.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	James Cook University; University of Queensland	Adams, VM (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia.	vanessa.adams@jcu.edu.au	Adams, Vanessa M./A-3834-2012; Pressey, Bob/C-8370-2013	Adams, Vanessa M./0000-0002-3509-7901; Pressey, Bob/0000-0003-2740-0330				Adams VM, 2010, BIOL CONSERV, V143, P439, DOI 10.1016/j.biocon.2009.11.011; Anna Bligh Premier of Queensland, 2008, WITCH FALLS 100 BIRT; [Anonymous], 2001, NATL OBJECTIVE TARGE; ANZECC, 1997, NAT AGR CRIT EST COM; Babcock BA, 1997, LAND ECON, V73, P325, DOI 10.2307/3147171; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; Carwardine Josie, 2009, Conservation Letters, V2, P4, DOI 10.1111/j.1755-263X.2008.00042.x; CDB, 2002, CONTRIBUTION 6 NATL; Claassen R, 2008, ECOL ECON, V65, P737, DOI 10.1016/j.ecolecon.2007.07.032; DERM, 2007, DELB AGR STAT RUR LE; European Parliament, 2010, C BIOL DIV NAG 2010; Ferraro PJ, 2002, ECOL ECON, V43, P261, DOI 10.1016/S0921-8009(02)00219-7; Frazee SR, 2003, BIOL CONSERV, V112, P275, DOI 10.1016/S0006-3207(02)00400-7; Hajkowicz S, 2007, ECOL ECON, V61, P208, DOI 10.1016/j.ecolecon.2006.10.011; Herkenrath P, 2008, ORYX, V42, P483; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Justus J, 2008, CONSERV BIOL, V22, P673, DOI 10.1111/j.1523-1739.2008.00928.x; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Klein CJ, 2009, BIOL CONSERV, V142, P1282, DOI 10.1016/j.biocon.2009.01.035; Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x; Knoke T, 2008, CAN J FOREST RES, V38, P3033, DOI 10.1139/X08-137; Langford WT, 2009, ECOL INFORM, V4, P123, DOI 10.1016/j.ecoinf.2009.04.002; McCarthy MA, 2007, ENVIRON MANAGE, V39, P553, DOI 10.1007/s00267-006-0022-3; Messer KD, 2006, J ENVIRON MANAGE, V79, P305, DOI 10.1016/j.jenvman.2005.07.008; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; NELDNER VJ, 2005, METHODOLOGY SURVEY M; Newburn DA, 2006, AM J AGR ECON, V88, P28, DOI 10.1111/j.1467-8276.2006.00837.x; NICHOLLS AO, 1993, BIOL CONSERV, V64, P165, DOI 10.1016/0006-3207(93)90654-J; NRW, 2008, DIG CAD DAT QUEENSL; NRW, 2008, PROP SAL DAT VERS 01; NRW, 2008, PROP VAL DAT; Pressey RL, 1998, BIOL CONSERV, V85, P305, DOI 10.1016/S0006-3207(97)00146-8; Pressey RL, 1995, CONSERV BIOL, V9, P1506, DOI 10.1046/j.1523-1739.1995.09061506.x; Pressey RL, 2004, ECOL LETT, V7, P1035, DOI 10.1111/j.1461-0248.2004.00672.x; Pressey RL, 1999, J BIOGEOGR, V26, P179, DOI 10.1046/j.1365-2699.1999.00258.x; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; Rissman AR, 2007, CONSERV BIOL, V21, P709, DOI 10.1111/j.1523-1739.2007.00660.x; Rodrigues ASL, 2001, ECOL LETT, V4, P602, DOI 10.1046/j.1461-0248.2001.00275.x; Sattler P., 1999, CONSERVATION STATUS; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Stoneham G, 2003, AUST J AGR RESOUR EC, V47, P477, DOI 10.1111/j.1467-8489.2003.t01-1-00224.x; Warman LD, 2004, CONSERV BIOL, V18, P655, DOI 10.1111/j.1523-1739.2004.00538.x; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x	50	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25447	10.1371/journal.pone.0025447	http://dx.doi.org/10.1371/journal.pone.0025447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21980459	Green Published, gold, Green Accepted			2022-12-27	WOS:000295936900065
J	Smith, I; Broos, A; de Jong, C; Zeddeman, A; Smith, C; Smith, G; Moore, F; Barr, J; Crameri, G; Marsh, G; Tachedjian, M; Yu, M; Kung, YH; Wang, LF; Field, H				Smith, Ina; Broos, Alice; de Jong, Carol; Zeddeman, Anne; Smith, Craig; Smith, Greg; Moore, Fred; Barr, Jennifer; Crameri, Gary; Marsh, Glenn; Tachedjian, Mary; Yu, Meng; Kung, Yu Hsin; Wang, Lin-Fa; Field, Hume			Identifying Hendra Virus Diversity in Pteropid Bats	PLOS ONE			English	Article							EQUINE MORBILLIVIRUS; FRUIT BATS; INFECTION; HORSES; TRANSMISSION; OUTBREAK; GENOME	Hendra virus (HeV) causes a zoonotic disease with high mortality that is transmitted to humans from bats of the genus Pteropus (flying foxes) via an intermediary equine host. Factors promoting spillover from bats to horses are uncertain at this time, but plausibly encompass host and/or agent and/or environmental factors. There is a lack of HeV sequence information derived from the natural bat host, as previously sequences have only been obtained from horses or humans following spillover events. In order to obtain an insight into possible variants of HeV circulating in flying foxes, collection of urine was undertaken in multiple flying fox roosts in Queensland, Australia. HeV was found to be geographically widespread in flying foxes with a number of HeV variants circulating at the one time at multiple locations, while at times the same variant was found circulating at disparate locations. Sequence diversity within variants allowed differentiation on the basis of nucleotide changes, and hypervariable regions in the genome were identified that could be used to differentiate circulating variants. Further, during the study, HeV was isolated from the urine of flying foxes on four occasions from three different locations. The data indicates that spillover events do not correlate with particular HeV isolates, suggesting that host and/or environmental factors are the primary determinants of bat-horse spillover. Thus future spillover events are likely to occur, and there is an on-going need for effective risk management strategies for both human and animal health.	[Smith, Ina; Barr, Jennifer; Crameri, Gary; Marsh, Glenn; Tachedjian, Mary; Yu, Meng; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Smith, Ina; Broos, Alice; Smith, Greg; Moore, Fred] Queensland Hlth Forens & Sci Serv, Publ Hlth Virol, Coopers Plains, Qld, Australia; [de Jong, Carol; Zeddeman, Anne; Smith, Craig; Kung, Yu Hsin; Field, Hume] Queensland Ctr Emerging Infect Dis, Dept Employment Econ Dev & Innovat, Coopers Plains, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Health	Smith, I (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia.	ina.smith@csiro.au; hume.field@qld.gov.au	Smith, Ina/H-7225-2013; Crameri, Gary/H-8441-2013; Marsh, Glenn A/A-5418-2013; wang, lin/GSE-3040-2022; Barr, Jennifer A/H-9254-2013; Tachedjian, Mary/H-4572-2013	Smith, Ina/0000-0001-5807-3737; Marsh, Glenn A/0000-0002-3469-1837; Barr, Jennifer/0000-0001-5266-9142; Tachedjian, Mary/0000-0002-8936-6564; Broos, Alice/0000-0001-7593-1000; Wang, Lin-Fa/0000-0003-2752-0535	Wildlife and Exotic Disease Preparedness Program; Australian Biosecurity Collaborative Research Centre for Emerging Diseases	Wildlife and Exotic Disease Preparedness Program; Australian Biosecurity Collaborative Research Centre for Emerging Diseases	This work was supported in part by funding from the Wildlife and Exotic Disease Preparedness Program and Australian Biosecurity Collaborative Research Centre for Emerging Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HENDRA VIRUS EQUINE; [Anonymous], 2008, HENDRA VIRUS HUMAN E; [Anonymous], 2007, HENDRA VIRUS HUMAN E; [Anonymous], 2009, HENDRA VIRUS HUMAN E; [Anonymous], 2009, HENDRA VIRUS EQUINE; Arthur R, 2006, ANIMAL HLTH SURVEILL, V11, P8; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Eaton BT, 2006, FIELDS VIROLOGY, P1587; Field H, 2011, PLOS ONE UNPUB; Field HE, 2000, AUST VET J, V78, P279, DOI 10.1111/j.1751-0813.2000.tb11758.x; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hanna JN, 2006, MED J AUSTRALIA, V185, P562, DOI 10.5694/j.1326-5377.2006.tb00692.x; Hooper PT, 1996, AUST VET J, V74, P244, DOI 10.1111/j.1751-0813.1996.tb15414.x; Hyatt AD, 1996, VIRUS RES, V43, P1, DOI 10.1016/0168-1702(96)01307-X; Marsh GA, 2010, EMERG INFECT DIS, V16, P1767, DOI 10.3201/eid1611.100501; Murray G, 2005, DIS INFORM, V18, P66; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Murray K., 1998, EMERG INFECT DIS, V1, P43; OIE, 2010, MAN DIAGN TESTS VACC; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P BIOL SCI; Rogers RJ, 1996, AUST VET J, V74, P243, DOI 10.1111/j.1751-0813.1996.tb15413.x; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Smith IL, 2010, MOL DETECTION HUMAN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wang LF, 2000, J VIROL, V74, P9972, DOI 10.1128/JVI.74.21.9972-9979.2000; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	35	64	67	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25275	10.1371/journal.pone.0025275	http://dx.doi.org/10.1371/journal.pone.0025275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980413	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900046
J	Sasse, C; Schillig, R; Dierolf, F; Weyler, M; Schneider, S; Mogavero, S; Rogers, PD; Morschhauser, J				Sasse, Christoph; Schillig, Rebecca; Dierolf, Franziska; Weyler, Michael; Schneider, Sabrina; Mogavero, Selene; Rogers, P. David; Morschhaeuser, Joachim			The Transcription Factor Ndt80 Does Not Contribute to Mrr1-, Tac1-, and Upc2-Mediated Fluconazole Resistance in Candida albicans	PLOS ONE			English	Article							ANTIFUNGAL DRUG-RESISTANCE; ABC TRANSPORTERS CDR1; AZOLE RESISTANCE; STEROL-METABOLISM; EFFLUX PUMP; MULTIDRUG-RESISTANCE; CONFERS RESISTANCE; MAJOR FACILITATOR; REGULATING CDR1; UP-REGULATION	The pathogenic yeast Candida albicans can develop resistance to the widely used antifungal agent fluconazole, which inhibits ergosterol biosynthesis, by the overexpression of genes encoding multidrug efflux pumps or ergosterol biosynthesis enzymes. Zinc cluster transcription factors play a central role in the transcriptional regulation of drug resistance. Mrr1 regulates the expression of the major facilitator MDR1, Tac1 controls the expression of the ABC transporters CDR1 and CDR2, and Upc2 regulates ergosterol biosynthesis (ERG) genes. Gain-of-function mutations in these transcription factors result in constitutive overexpression of their target genes and are responsible for fluconazole resistance in many clinical C. albicans isolates. The transcription factor Ndt80 contributes to the drug-induced upregulation of CDR1 and ERG genes and also binds to the MDR1 and CDR2 promoters, suggesting that it is an important component of all major transcriptional mechanisms of fluconazole resistance. However, we found that Ndt80 is not required for the induction of MDR1 and CDR2 expression by inducing chemicals. CDR2 was even partially derepressed in ndt80D mutants, indicating that Ndt80 is a repressor of CDR2 expression. Hyperactive forms of Mrr1, Tac1, and Upc2 promoted overexpression of MDR1, CDR1/CDR2, and ERG11, respectively, with the same efficiency in the presence and absence of Ndt80. Mrr1- and Tac1-mediated fluconazole resistance was even slightly enhanced in ndt80D mutants compared to wild-type cells. These results demonstrate that Ndt80 is dispensable for the constitutive overexpression of Mrr1, Tac1, and Upc2 target genes and the increased fluconazole resistance of strains that have acquired activating mutations in these transcription factors.	[Sasse, Christoph; Schillig, Rebecca; Dierolf, Franziska; Weyler, Michael; Schneider, Sabrina; Mogavero, Selene; Morschhaeuser, Joachim] Univ Wurzburg, Inst Mol Infekt Biol, Wurzburg, Germany; [Mogavero, Selene] Univ Pisa, Dept Biol, Pisa, Italy; [Rogers, P. David] Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN USA; [Rogers, P. David] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Rogers, P. David] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Clin Pharm, Memphis, TN 38163 USA; [Rogers, P. David] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pediat, Memphis, TN 38163 USA	University of Wurzburg; University of Pisa; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Sasse, C (corresponding author), Univ Wurzburg, Inst Mol Infekt Biol, Wurzburg, Germany.	joachim.morschhaeuser@uni-wuerzburg.de	Morschhäuser, Joachim/AFS-2547-2022; Mogavero, Selene/L-8432-2017; Morschhäuser, Joachim/E-2918-2013	Morschhäuser, Joachim/0000-0003-4227-8687; Mogavero, Selene/0000-0003-0642-0068; Morschhäuser, Joachim/0000-0003-4227-8687	Deutsche Forschungsgemeinschaft (DFG) [MO 846/3, SFB 630]; National Institutes of Health (NIH) [AI058145]; University of Pisa; University of Wurzburg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058145, R21AI058145] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pisa; University of Wurzburg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG grant MO 846/3 and SFB 630) and the National Institutes of Health (NIH grant AI058145). Selene Mogavero was supported by the University of Pisa. Publication of the work was funded by the DFG and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Chen CG, 2004, ANTIMICROB AGENTS CH, V48, P4505, DOI 10.1128/AAC.48.12.4505-4512.2004; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Coste AT, 2009, EUKARYOT CELL, V8, P1250, DOI 10.1128/EC.00069-09; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; De Backer MD, 2001, ANTIMICROB AGENTS CH, V45, P1660, DOI 10.1128/AAC.45.6.1660-1670.2001; de Micheli M, 2002, MOL MICROBIOL, V43, P1197, DOI 10.1046/j.1365-2958.2002.02814.x; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; Goffeau A, 2008, NATURE, V452, P541, DOI 10.1038/452541a; Gupta V, 1998, CURR GENET, V34, P192, DOI 10.1007/s002940050385; Heilmann CJ, 2010, ANTIMICROB AGENTS CH, V54, P353, DOI 10.1128/AAC.01102-09; Holmes AR, 2008, ANTIMICROB AGENTS CH, V52, P3851, DOI 10.1128/AAC.00463-08; Hoot SJ, 2011, ANTIMICROB AGENTS CH, V55, P940, DOI 10.1128/AAC.00995-10; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; Kohler GA, 1997, J BACTERIOL, V179, P2331; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; MacPherson S, 2005, ANTIMICROB AGENTS CH, V49, P1745, DOI 10.1128/AAC.49.5.1745-1752.2005; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X; Morschhauser J, 1998, MOL GEN GENET, V257, P412, DOI 10.1007/s004380050665; Ramirez-Zavala B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000089; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Rognon B, 2006, MICROBIOL-SGM, V152, P3701, DOI 10.1099/mic.0.29277-0; RUHNKE M, 1994, J CLIN MICROBIOL, V32, P2092, DOI 10.1128/JCM.32.9.2092-2098.1994; Schubert S, 2008, ANTIMICROB AGENTS CH, V52, P4274, DOI 10.1128/AAC.00740-08; Schubert S, 2011, ANTIMICROB AGENTS CH, V55, P2212, DOI 10.1128/AAC.01343-10; Sellam A, 2010, EUKARYOT CELL, V9, P634, DOI 10.1128/EC.00325-09; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Silver PM, 2004, EUKARYOT CELL, V3, P1391, DOI 10.1128/EC.3.6.1391-1397.2004; Staib P, 2002, INFECT IMMUN, V70, P921, DOI 10.1128/IAI.70.2.921-927.2002; Tsao S, 2009, ANTIMICROB AGENTS CH, V53, P1344, DOI 10.1128/AAC.00926-08; Yang YL, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-22; Znaidi S, 2008, EUKARYOT CELL, V7, P836, DOI 10.1128/EC.00070-08; Znaidi S, 2007, MOL MICROBIOL, V66, P440, DOI 10.1111/j.1365-2958.2007.05931.x	36	43	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25623	10.1371/journal.pone.0025623	http://dx.doi.org/10.1371/journal.pone.0025623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980509	Green Submitted, Green Published, gold			2022-12-27	WOS:000295933700048
J	Jeffries, TC; Seymour, JR; Gilbert, JA; Dinsdale, EA; Newton, K; Leterme, SSC; Roudnew, B; Smith, RJ; Seuront, L; Mitchell, JG				Jeffries, Thomas C.; Seymour, Justin R.; Gilbert, Jack A.; Dinsdale, Elizabeth A.; Newton, Kelly; Leterme, Sophie S. C.; Roudnew, Ben; Smith, Renee J.; Seuront, Laurent; Mitchell, James G.			Substrate Type Determines Metagenomic Profiles from Diverse Chemical Habitats	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; BACTERIA; ENUMERATION; DYNAMICS; PATTERNS; PROJECT	Environmental parameters drive phenotypic and genotypic frequency variations in microbial communities and thus control the extent and structure of microbial diversity. We tested the extent to which microbial community composition changes are controlled by shifting physiochemical properties within a hypersaline lagoon. We sequenced four sediment metagenomes from the Coorong, South Australia from samples which varied in salinity by 99 Practical Salinity Units (PSU), an order of magnitude in ammonia concentration and two orders of magnitude in microbial abundance. Despite the marked divergence in environmental parameters observed between samples, hierarchical clustering of taxonomic and metabolic profiles of these metagenomes showed striking similarity between the samples (>89%). Comparison of these profiles to those derived from a wide variety of publically available datasets demonstrated that the Coorong sediment metagenomes were similar to other sediment, soil, biofilm and microbial mat samples regardless of salinity (>85% similarity). Overall, clustering of solid substrate and water metagenomes into discrete similarity groups based on functional potential indicated that the dichotomy between water and solid matrices is a fundamental determinant of community microbial metabolism that is not masked by salinity, nutrient concentration or microbial abundance.	[Jeffries, Thomas C.; Newton, Kelly; Leterme, Sophie S. C.; Roudnew, Ben; Smith, Renee J.; Seuront, Laurent; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Jeffries, Thomas C.; Seymour, Justin R.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Gilbert, Jack A.] Plymouth Marine Lab, Plymouth, Devon, England; [Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Gilbert, Jack A.] Argonne Natl Lab, Dept Biosci, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Dinsdale, Elizabeth A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Leterme, Sophie S. C.; Seuront, Laurent] S Australian Res & Dev Inst, Henley Beach, SA, Australia; [Seuront, Laurent] Ctr Natl Rech Sci, Paris, France	Flinders University South Australia; University of Technology Sydney; Plymouth Marine Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; California State University System; San Diego State University; Centre National de la Recherche Scientifique (CNRS)	Jeffries, TC (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	jeffries.thomas@gmail.com	Jeffries, Thomas/D-4270-2018; Gilbert, Jack/AAF-3270-2019; Jeffries, Thomas/E-8679-2013; Leterme, Sophie C/A-5013-2013	Leterme, Sophie C/0000-0001-8455-7049; Newton, Kelly/0000-0001-8405-7140; Jeffries, Thomas/0000-0001-6479-0353; Mitchell, Jim/0000-0002-8445-0935; Seuront, Laurent/0000-0002-0051-5202; dinsdale, elizabeth/0000-0002-2177-203X; Seymour, Justin/0000-0002-3745-6541	Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	This work was supported by an Australian Research Council (ARC) Discovery Grant (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Clarke A, 2006, PRIMER V6 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Delmont TO, 2011, ISME J; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Doolittle WF, 2010, BIOSCIENCE, V60, P102, DOI 10.1525/bio.2010.60.2.5; Drake LA, 1998, AQUAT MICROB ECOL, V16, P17, DOI 10.3354/ame016017; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Gasol JM, 2004, AQUAT MICROB ECOL, V34, P193, DOI 10.3354/ame034193; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Helton RR, 2006, APPL ENVIRON MICROB, V72, P4767, DOI 10.1128/AEM.00297-06; Hewson I, 2009, LIMNOL OCEANOGR, V54, P1981, DOI 10.4319/lo.2009.54.6.1981; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hugenholtz P, 2002, GENOME BIOL, V3; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Javor B, 1989, HYPERSALINE ENV MICR, Vviii; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Lester RE, 2009, ESTUAR COAST SHELF S, V85, P1, DOI 10.1016/j.ecss.2009.04.018; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2010, ISME J, V4, P1236, DOI 10.1038/ismej.2010.51; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schapira Mathilde, 2010, Saline Syst, V6, P2, DOI 10.1186/1746-1448-6-2; Schapira M, 2009, AQUAT MICROB ECOL, V54, P171, DOI 10.3354/ame01262; Segar DA, 1998, INTRO OCEAN SCI, Vxxiii, P497; Seymour JR, 2005, MAR ECOL PROG SER, V288, P1, DOI 10.3354/meps288001; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	51	24	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25173	10.1371/journal.pone.0025173	http://dx.doi.org/10.1371/journal.pone.0025173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966446	Green Submitted, gold, Green Published			2022-12-27	WOS:000295267100023
J	Huff, DD; Lindley, ST; Rankin, PS; Mora, EA				Huff, David D.; Lindley, Steven T.; Rankin, Polly S.; Mora, Ethan A.			Green Sturgeon Physical Habitat Use in the Coastal Pacific Ocean	PLOS ONE			English	Article							ACIPENSER-MEDIROSTRIS; SPATIAL AUTOCORRELATION; PARAMETER-ESTIMATION; MARINE DISTRIBUTION; MOVEMENT PATTERNS; RED HERRINGS; ROGUE RIVER; MIGRATION; CONSEQUENCES; CALIFORNIA	The green sturgeon (Acipenser medirostris) is a highly migratory, oceanic, anadromous species with a complex life history that makes it vulnerable to species-wide threats in both freshwater and at sea. Green sturgeon population declines have preceded legal protection and curtailment of activities in marine environments deemed to increase its extinction risk. Yet, its marine habitat is poorly understood. We built a statistical model to characterize green sturgeon marine habitat using data from a coastal tracking array located along the Siletz Reef near Newport, Oregon, USA that recorded the passage of 37 acoustically tagged green sturgeon. We classified seafloor physical habitat features with high-resolution bathymetric and backscatter data. We then described the distribution of habitat components and their relationship to green sturgeon presence using ordination and subsequently used generalized linear model selection to identify important habitat components. Finally, we summarized depth and temperature recordings from seven green sturgeon present off the Oregon coast that were fitted with pop-off archival geolocation tags. Our analyses indicated that green sturgeon, on average, spent a longer duration in areas with high seafloor complexity, especially where a greater proportion of the substrate consists of boulders. Green sturgeon in marine habitats are primarily found at depths of 20-60 meters and from 9.5-16.0 degrees C. Many sturgeon in this study were likely migrating in a northward direction, moving deeper, and may have been using complex seafloor habitat because it coincides with the distribution of benthic prey taxa or provides refuge from predators. Identifying important green sturgeon marine habitat is an essential step towards accurately defining the conditions that are necessary for its survival and will eventually yield range-wide, spatially explicit predictions of green sturgeon distribution.	[Huff, David D.; Lindley, Steven T.] Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Santa Cruz, CA USA; [Rankin, Polly S.] Oregon Dept Fish & Wildlife, Newport, OR USA; [Mora, Ethan A.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis	Huff, DD (corresponding author), Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Santa Cruz, CA USA.	david.huff@noaa.gov	Lindley, Steven T/G-3997-2014; Huff, David/A-8166-2008	Lindley, Steven T/0000-0001-9556-0411; Huff, David/0000-0001-9061-7685	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	The authors' research was supported by funds from the National Oceanic and Atmospheric Administration, California Current Integrated Ecosystem Assessment Program (http://www.st.nmfs.noaa.gov/iea/index.html) and a Species of Concern Program (http://www.nmfs.noaa.gov/pr/species/concern/grant.htm) grant to S. T. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2007, ENVIRON BIOL FISH, V79, P339, DOI 10.1007/s10641-006-9062-z; Afonso P, 2008, MAR ECOL PROG SER, V359, P215, DOI 10.3354/meps07272; [Anonymous], 2010, MAR POLLUT BULL, V60, P640; Barton K, 2011, MUM1 PACKAGE MULTIMO; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P167, DOI 10.1023/A:1007312524792; Benson RL, 2007, ENVIRON BIOL FISH, V79, P269, DOI 10.1007/s10641-006-9023-6; Berthold P., 1993, BIRD MIGRATION GEN S; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Comeau LA, 2002, CAN J FISH AQUAT SCI, V59, P1845, DOI 10.1139/F02-152; Commerce Do, 2008, END THREAT WILDL PLA, P52084; Cook RD, 1997, J AM STAT ASSOC, V92, P490, DOI 10.2307/2965698; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Donnellan M., 2009, RESOLVING SPATIAL SC; Edwards Randy E., 2003, Gulf of Mexico Science, V21, P59; Erdey-Heydorn MD, 2008, MAR GEOD, V31, P318, DOI 10.1080/01490410802466819; Erickson DL, 2007, AM FISH S S, V56, P197; Erickson DL, 2007, ENVIRON BIOL FISH, V79, P255, DOI 10.1007/s10641-006-9072-x; Erickson DL, 2002, J APPL ICHTHYOL, V18, P565, DOI 10.1046/j.1439-0426.2002.00403.x; Erickson DL, 2011, COMMUNICATION; Evans K, 2009, REV-METHODS TECHNOL, V9, P343, DOI 10.1007/978-1-4020-9640-2_21; Fairchild EA, 2009, REV-METHODS TECHNOL, V9, P5, DOI 10.1007/978-1-4020-9640-2_1; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fox DA, 2002, AM FISH S S, V28, P111; Fox J., 2011, CAR PACKAGE COMPANIO; GODAMBE VP, 1987, INT STAT REV, V55, P231, DOI 10.2307/1403403; Grothues TM, 2009, REV-METHODS TECHNOL, V9, P77, DOI 10.1007/978-1-4020-9640-2_5; Hannah RW, 2011, N AM J FISH MANAGE, V31, P483, DOI 10.1080/02755947.2011.591239; Hawkins BA, 2007, ECOGRAPHY, V30, P375, DOI 10.1111/j.2007.0906-7590.05117.x; Hayes Daniel B., 1996, P193; Heublein JC, 2009, ENVIRON BIOL FISH, V84, P245, DOI 10.1007/s10641-008-9432-9; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; IHAKA R., 1996, J COMPUTATIONAL GRAP, V5, P239; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kelly JT, 2007, ENVIRON BIOL FISH, V79, P281, DOI 10.1007/s10641-006-0036-y; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Laney RW, 2007, AM FISH S S, V56, P167; Lavenberg R. N., 1971, MARINE FOOD GAME FIS, V28; Lindley ST, 2008, T AM FISH SOC, V137, P182, DOI 10.1577/T07-055.1; Lindley ST, 2011, T AM FISH SOC, V140, P108, DOI 10.1080/00028487.2011.557017; Lowe CG, 2003, MAR ECOL PROG SER, V256, P205, DOI 10.3354/meps256205; Lundblad E., 2006, GEOD, V29, P89, DOI [10.1080/01490410600738021, DOI 10.1080/01490410600738021]; Mather P. M., 1976, COMPUTATIONAL METHOD; McCune B., 2006, PC ORD MULTIVARIATE; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Merems A, 2004, NEARSHORE ROCKY REEF, P15; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Moser ML, 2007, ENVIRON BIOL FISH, V79, P243, DOI 10.1007/s10641-006-9028-1; Moyle P.B., 2002, INLAND FISHES CALIFO; Munro J, 2007, AM FISH S S, V56, P1; Nasby-Lucas NM, 2002, FISH B-NOAA, V100, P739; [National Oceanic and Atmospheric Administration Commerce Do], 2007, NOAA FISH NAM PAN EX; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OKSANEN J, 2004, VEGAN COMMUNITY ECOL; Parauka FM, 2011, J APPL ICHTHYOL, V27, P343, DOI 10.1111/j.1439-0426.2011.01671.x; Parauka Frank M., 2001, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V55, P280; Parker SJ, 2007, LOW WAKE FI, V23, P39; ROBERTS DW, 1986, VEGETATIO, V66, P123, DOI 10.1007/BF00039905; Rochard E, 1997, AQUAT LIVING RESOUR, V10, P101, DOI 10.1051/alr:1997011; Ross ST, 2009, ESTUAR COAST, V32, P360, DOI 10.1007/s12237-008-9122-z; Salemaa M, 2008, BOREAL ENVIRON RES, V13, P48; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Semmens BX, 2008, CAN J FISH AQUAT SCI, V65, P2053, DOI 10.1139/F08-107; Stein AB, 2004, T AM FISH SOC, V133, P527, DOI 10.1577/T02-151.1; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; Sulak KJ, 2002, J APPL ICHTHYOL, V18, P519, DOI 10.1046/j.1439-0426.2002.00413.x; U. S. Geological Survey, 1986, ATL EXCL EC ZON W CO; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Virtanen R, 2006, J VEG SCI, V17, P519, DOI 10.1111/j.1654-1103.2006.tb02473.x; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; WINKER K, 1995, OECOLOGIA, V101, P211, DOI 10.1007/BF00317286; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; Wright D.J., 2005, BENTHIC TERRAIN MODE; Young MA, 2010, MAR ECOL PROG SER, V415, P247, DOI 10.3354/meps08760	77	14	14	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25156	10.1371/journal.pone.0025156	http://dx.doi.org/10.1371/journal.pone.0025156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966442	Green Published, Green Submitted, gold			2022-12-27	WOS:000295265100070
J	Shimba, S; Ogawa, T; Hitosugi, S; Ichihashi, Y; Nakadaira, Y; Kobayashi, M; Tezuka, M; Kosuge, Y; Ishige, K; Ito, Y; Komiyama, K; Okamatsu-Ogura, Y; Kimura, K; Saito, M				Shimba, Shigeki; Ogawa, Tomohiro; Hitosugi, Shunsuke; Ichihashi, Yuya; Nakadaira, Yuki; Kobayashi, Munehiro; Tezuka, Masakatsu; Kosuge, Yasuhiro; Ishige, Kumiko; Ito, Yoshihisa; Komiyama, Kazuo; Okamatsu-Ogura, Yuko; Kimura, Kazuhiro; Saito, Masayuki			Deficient of a Clock Gene, Brain and Muscle Arnt-Like Protein-1 (BMAL1), Induces Dyslipidemia and Ectopic Fat Formation	PLOS ONE			English	Article							SHIFT-WORK; CIRCADIAN-RHYTHM; METABOLIC SYNDROME; MESSENGER-RNA; HEART-DISEASE; LIPODYSTROPHY; COMPONENT; RISK; CATECHOLAMINES; CHOLESTEROL	A link between circadian rhythm and metabolism has long been discussed. Circadian rhythm is controlled by positive and negative transcriptional and translational feedback loops composed of several clock genes. Among clock genes, the brain and muscle Arnt-like protein-1 (BMAL1) and circadian locomotor output cycles kaput (CLOCK) play important roles in the regulation of the positive rhythmic transcription. In addition to control of circadian rhythm, we have previously shown that BMAL1 regulates adipogenesis. In metabolic syndrome patients, the function of BMAL1 is dysregulated in visceral adipose tissue. In addition, analysis of SNPs has revealed that BMAL1 is associated with susceptibility to hypertension and type II diabetes. Furthermore, the significant roles of BMAL1 in pancreatic beta cells proliferation and maturation were recently reported. These results suggest that BMAL1 regulates energy homeostasis. Therefore, in this study, we examined whether loss of BMAL1 function is capable of inducing metabolic syndrome. Deficient of the Bmal1 gene in mice resulted in elevation of the respiratory quotient value, indicating that BMAL1 is involved in the utilization of fat as an energy source. Indeed, lack of Bmal1 reduced the capacity of fat storage in adipose tissue, resulting in an increase in the levels of circulating fatty acids, including triglycerides, free fatty acids, and cholesterol. Elevation of the circulating fatty acids level induced the formation of ectopic fat in the liver and skeletal muscle in Bmal1 -/- mice. Interestingly, ectopic fat formation was not observed in tissue-specific (liver or skeletal muscle) Bmal1 -/- mice even under high fat diet feeding condition. Therefore, we were led to conclude that BMAL1 is a crucial factor in the regulation of energy homeostasis, and disorders of the functions of BMAL1 lead to the development of metabolic syndrome.	[Shimba, Shigeki; Ogawa, Tomohiro; Hitosugi, Shunsuke; Ichihashi, Yuya; Nakadaira, Yuki; Kobayashi, Munehiro; Tezuka, Masakatsu] Nihon Univ, Dept Hlth Sci, Sch Pharm, Chiba, Japan; [Kosuge, Yasuhiro; Ishige, Kumiko; Ito, Yoshihisa] Nihon Univ, Dept Pharmacol, Sch Pharm, Chiba, Japan; [Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan; [Okamatsu-Ogura, Yuko; Kimura, Kazuhiro] Hokkaido Univ, Dept Biomed Sci, Grad Sch Vet Med, Kita Ku, Sapporo, Hokkaido, Japan; [Saito, Masayuki] Tenshi Coll, Dept Nutr, Sch Nursing & Nutr, Sapporo, Hokkaido, Japan	Nihon University; Nihon University; Nihon University; Hokkaido University	Shimba, S (corresponding author), Nihon Univ, Dept Hlth Sci, Sch Pharm, Chiba, Japan.	shimba.shigeki@nihon-u.ac.jp	Kimura, Kazuhiro/A-5029-2012; Okamatsu-Ogura, Yuko/AAI-5602-2020	Kosuge, Yasuhiro/0000-0002-7513-5132	Ministry of Education, Sciences, Sports, and Culture of Japan; Nihon University; High-Tech Research Center from the Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Sciences, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University; High-Tech Research Center from the Ministry of Education, Culture, Sports, Science, and Technology	This work was supported in part by a grant from the Ministry of Education, Sciences, Sports, and Culture of Japan (to S. S.); a General Individual Research grant from Nihon University (to S. S.); an Interdisciplinary General Joint Research grant from Nihon University (to S. S.); and the "High-Tech Research Center'' Project for Private Universities, a matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen CP, 2004, J NEUROCHEM, V88, P1547, DOI 10.1046/j.1471-4159.2003.02300.x; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujino Y, 2006, AM J EPIDEMIOL, V164, P128, DOI 10.1093/aje/kwj185; FUJIWARA S, 1992, INT ARCH OCC ENV HEA, V63, P409, DOI 10.1007/BF00386937; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hemmeryckx B, 2011, ARTERIOSCLE IN PRESS; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kovac J, 2009, MOL CELLS, V28, P75, DOI 10.1007/s10059-009-0113-0; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; ORTHGOMER K, 1983, PSYCHOSOM MED, V45, P407, DOI 10.1097/00006842-198310000-00004; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; ROBBINS DC, 1979, METABOLISM, V28, P908, DOI 10.1016/0026-0495(79)90090-8; ROBBINS DC, 1982, METABOLISM, V31, P445, DOI 10.1016/0026-0495(82)90232-3; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Takahata S, 1988, BIOCHEM BIOPH RES CO, V248, P789; Tenkane L, 1977, SCAND J WORK ENV HEA, V23, P257; THEORELL T, 1976, ACTA MED SCAND, V200, P47; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Usui S, 2002, J LIPID RES, V43, P805; van Amelsvoort LGPM, 2001, OCCUP ENVIRON MED, V58, P678, DOI 10.1136/oem.58.10.678; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOKAC Z, 1980, SCAND J WORK ENV HEA, V6, P188, DOI 10.5271/sjweh.2617; WALDHAUSER F, 1986, NEW ENGL J MED, V315, P1614; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Yamasaki F, 1998, HYPERTENSION, V32, P417, DOI 10.1161/01.HYP.32.3.417; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	47	202	208	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25231	10.1371/journal.pone.0025231	http://dx.doi.org/10.1371/journal.pone.0025231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966465	gold, Green Published, Green Submitted			2022-12-27	WOS:000295265100075
J	Boeglin, E; Smulski, CR; Brun, S; Milosevic, S; Schneider, P; Fournel, S				Boeglin, Emmanuelle; Smulski, Cristian R.; Brun, Susana; Milosevic, Sara; Schneider, Pascal; Fournel, Sylvie			Toll-Like Receptor Agonists Synergize with CD40L to Induce Either Proliferation or Plasma Cell Differentiation of Mouse B Cells	PLOS ONE			English	Article							IMMUNE-RESPONSE MODIFIERS; DENDRITIC CELLS; INNATE IMMUNITY; INFECTED MICE; CUTTING EDGE; T-CELLS; IN-VIVO; ACTIVATION; LYMPHOCYTES; EXPRESSION	In a classical dogma, pathogens are sensed (via recognition of Pathogen Associated Molecular Patterns (PAMPs)) by innate immune cells that in turn activate adaptive immune cells. However, recent data showed that TLRs (Toll Like Receptors), the most characterized class of Pattern Recognition Receptors, are also expressed by adaptive immune B cells. B cells play an important role in protective immunity essentially by differentiating into antibody-secreting cells (ASC). This differentiation requires at least two signals: the recognition of an antigen by the B cell specific receptor (BCR) and a T cell co-stimulatory signal provided mainly by CD154/CD40L acting on CD40. In order to better understand interactions of innate and adaptive B cell stimulatory signals, we evaluated the outcome of combinations of TLRs, BCR and/or CD40 stimulation. For this purpose, mouse spleen B cells were activated with synthetic TLR agonists, recombinant mouse CD40L and agonist anti-BCR antibodies. As expected, TLR agonists induced mouse B cell proliferation and activation or differentiation into ASC. Interestingly, addition of CD40 signal to TLR agonists stimulated either B cell proliferation and activation (TLR3, TLR4, and TLR9) or differentiation into ASC (TLR1/2, TLR2/6, TLR4 and TLR7). Addition of a BCR signal to CD40L and either TLR3 or TLR9 agonists did not induce differentiation into ASC, which could be interpreted as an entrance into the memory pathway. In conclusion, our results suggest that PAMPs synergize with signals from adaptive immunity to regulate B lymphocyte fate during humoral immune response.	[Boeglin, Emmanuelle; Smulski, Cristian R.; Brun, Susana; Milosevic, Sara; Fournel, Sylvie] CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne	Boeglin, E (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France.	s.fournel@unistra.fr	Fournel, Sylvie/C-1195-2014; Brun, Susana/J-9865-2016	Fournel, Sylvie/0000-0003-3583-6548; Brun, Susana/0000-0002-7031-9733; Schneider, Pascal/0000-0003-0677-9409; Smulski, Cristian/0000-0003-4186-8116	Centre National de la Recherche Scientifique; Swiss National Research Fundation; French "Ministere de la Recherche"; Agence Nationale Recherche; Strasbourg University; foundation "Fundayacucho"; Fondation de la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Swiss National Research Fundation; French "Ministere de la Recherche"(Ministry of Research, France); Agence Nationale Recherche(French National Research Agency (ANR)); Strasbourg University; foundation "Fundayacucho"; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale)	The authors gratefully acknowledge financial support from Centre National de la Recherche Scientifique (to SF) and of the Swiss National Research Fundation (to PS). EB was granted by the French "Ministere de la Recherche", CS by Agence Nationale Recherche and Strasbourg University and SB by the foundation "Fundayacucho" and by Fondation de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Casadevall A, 2006, ADV IMMUNOL, V91, P1, DOI 10.1016/S0065-2776(06)91001-3; COUTELIER JP, 1990, J VIROL, V64, P5383, DOI 10.1128/JVI.64.11.5383-5388.1990; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Durandy A, 2003, EUR J IMMUNOL, V33, P2069, DOI 10.1002/eji.200324133; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Gantner F, 2003, EUR J IMMUNOL, V33, P1576, DOI 10.1002/eji.200323444; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Knodel M, 2001, EUR J IMMUNOL, V31, P1972; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Marshall JD, 2005, DNA CELL BIOL, V24, P63, DOI 10.1089/dna.2005.24.63; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; OLDSTONE MB, 1969, J EXP MED, V129, P483, DOI 10.1084/jem.129.3.483; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Poovassery JS, 2009, J IMMUNOL, V183, P2974, DOI 10.4049/jimmunol.0900495; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Schaniel C, 1998, J EXP MED, V188, P451, DOI 10.1084/jem.188.3.451; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Silverstein AM, 2003, NAT IMMUNOL, V4, P931, DOI 10.1038/ni1003-931; Soulas P, 2005, J CLIN INVEST, V115, P2257, DOI 10.1172/JCI24646; Spanedda MV, 2010, BIOORG MED CHEM LETT, V20, P1869, DOI 10.1016/j.bmcl.2010.01.146; Tomai MA, 2000, CELL IMMUNOL, V203, P55, DOI 10.1006/cimm.2000.1673; Underhill GH, 2002, BLOOD, V99, P2905, DOI 10.1182/blood.V99.8.2905; YANG LM, 1992, INFECT IMMUN, V60, P3033, DOI 10.1128/IAI.60.8.3033-3041.1992	49	38	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25542	10.1371/journal.pone.0025542	http://dx.doi.org/10.1371/journal.pone.0025542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991317	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000036
J	Kay, P; Schlossmacher, G; Matthews, L; Sommer, P; Singh, D; White, A; Ray, D				Kay, Paul; Schlossmacher, George; Matthews, Laura; Sommer, Paula; Singh, Dave; White, Anne; Ray, David			Loss of Glucocorticoid Receptor Expression by DNA Methylation Prevents Glucocorticoid Induced Apoptosis in Human Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GENE; CARCINOMA; LINES; SENSITIVITY; MECHANISMS	Human small cell lung cancer (SCLC) is highly aggressive, and quickly develops resistance to therapy. SCLC cells are typically insensitive to glucocorticoids due to impaired glucocorticoid receptor (GR) expression. This is important as we have previously shown that expression of a GR transgene induces cell death in-vitro, and inhibits tumor growth in-vivo. However, the underlying mechanism for loss of GR expression is unknown. The SCLC cell line, DMS79, has low GR expression, compared to non-SCLC cell lines and normal bronchial epithelial cells. Retroviral GR expression in DMS79 cells caused activation of the apoptotic pathway as evidenced by marked induction of caspase-3 activity. Methylation analysis of the GR promoter revealed some methylation in the 1D, and 1E promoters of the GR gene, however the ubiquitous constitutively active 1C promoter was heavily methylated. In the 1C promoter there was a highly significant increase in DNA methylation in a panel of 14 human SCLC cell lines compared to a mixed panel of GR expressing, and non-expressing cell lines, and to peripheral blood mononuclear cells. Furthermore, within the panel of SCLC cell lines there was a significant negative correlation seen between methylation of the 1C promoter, and GR protein expression. Reversal of GR gene methylation with DNA methyltransferase inhibition caused increased GR mRNA and protein expression in SCLC but not non-SCLC cells. This resulted in increased Gc sensitivity, decreased Bcl-2 expression and increased caspase-3 activity in SCLC cells. These data suggest that DNA methylation decreases GR gene expression in human SCLC cells, in a similar manner to that for conventional tumor suppressor genes.	[Kay, Paul; Matthews, Laura; Sommer, Paula; Singh, Dave; White, Anne; Ray, David] Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Schlossmacher, George; White, Anne] Univ Manchester, Fac Life Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Sommer, Paula] Univ KwaZulu Natal, Sch Biol Sci, Durban, South Africa	University of Manchester; University of Manchester; University of Kwazulu Natal	Kay, P (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	awhite@manchester.ac.uk; david.w.ray@manchester.ac.uk	Singh, Dave/AAH-4342-2020; Sommer, Paula/E-9454-2010; White, Anne/G-7717-2015	Singh, Dave/0000-0001-8918-7075; White, Anne/0000-0002-7686-2884; Ray, David/0000-0002-4739-6773; Sommer, Paula/0000-0001-6810-5587; Schlossmacher, George/0000-0001-7713-5729	NIHR Manchester Biomedical Research Centre; University of Manchester Alumni association; BBSRC; Barbara Mawer endowed studentship	NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); University of Manchester Alumni association; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Barbara Mawer endowed studentship	This work was supported by the NIHR Manchester Biomedical Research Centre and University of Manchester Alumni association. PK and GS have received a BBSRC studentship award (http://www.bbsrc.ac.uk). GS also has a Barbara Mawer endowed studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLIEJOHNSON H, 1985, BRIT J CANCER, V52, P495, DOI 10.1038/bjc.1985.220; Berry A, 2010, FASEB J, V24, P1700, DOI 10.1096/fj.09-139998; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Kayahara M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1047, DOI 10.1152/ajpendo.90429.2008; Kim JS, 2004, CARCINOGENESIS, V25, P2165, DOI 10.1093/carcin/bgh217; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Matthews L, 2009, ENDOCRINOLOGY, V150, P75, DOI 10.1210/en.2008-0196; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; PETTENGILL OS, 1980, CANCER-AM CANCER SOC, V45, P906, DOI 10.1002/1097-0142(19800301)45:5<906::AID-CNCR2820450513>3.0.CO;2-H; Piperi C, 2008, J CELL MOL MED, V12, P1495, DOI 10.1111/j.1582-4934.2008.00309.x; RAY DW, 1994, J CLIN INVEST, V93, P1625, DOI 10.1172/JCI117143; Ray DW, 1996, CANCER RES, V56, P3276; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Sommer P, 2007, ONCOGENE, V26, P7111, DOI 10.1038/sj.onc.1210524; Sommer P, 2010, ENDOCR-RELAT CANCER, V17, P203, DOI 10.1677/ERC-09-0241; Stevens A, 2004, J CLIN ENDOCR METAB, V89, P892, DOI 10.1210/jc.2003-031235; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	24	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24839	10.1371/journal.pone.0024839	http://dx.doi.org/10.1371/journal.pone.0024839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984896	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000006
J	Rajakannan, V; Lee, HS; Chong, SH; Ryu, HB; Bae, JY; Whang, EY; Huh, JW; Cho, SW; Kang, LW; Choe, H; Robinson, RC				Rajakannan, Venkatachalam; Lee, Hui-Sun; Chong, Seon-Ha; Ryu, Han-Bong; Bae, Ji-Young; Whang, Eun-Young; Huh, Jae-Wan; Cho, Sung-Woo; Kang, Lin-Woo; Choe, Han; Robinson, Robert C.			Structural Basis of Cooperativity in Human UDP-Glucose Dehydrogenase	PLOS ONE			English	Article							URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; GROUP-A STREPTOCOCCI; BOVINE LIVER; MOLECULAR CHARACTERIZATION; CDNA CLONING; EXPRESSION; HYALURONAN; BINDING; GENE; PURIFICATION	Background: UDP-glucose dehydrogenase (UGDH) is the sole enzyme that catalyzes the conversion of UDP-glucose to UDP-glucuronic acid. The product is used in xenobiotic glucuronidation in hepatocytes and in the production of proteoglycans that are involved in promoting normal cellular growth and migration. Overproduction of proteoglycans has been implicated in the progression of certain epithelial cancers, while inhibition of UGDH diminished tumor angiogenesis in vivo. A better understanding of the conformational changes occurring during the UGDH reaction cycle will pave the way for inhibitor design and potential cancer therapeutics. Methodology: Previously, the substrate-bound of UGDH was determined to be a symmetrical hexamer and this regular symmetry is disrupted on binding the inhibitor, UDP-alpha-D-xylose. Here, we have solved an alternate crystal structure of human UGDH (hUGDH) in complex with UDP-glucose at 2.8 angstrom resolution. Surprisingly, the quaternary structure of this substrate-bound protein complex consists of the open homohexamer that was previously observed for inhibitor-bound hUGDH, indicating that this conformation is relevant for deciphering elements of the normal reaction cycle. Conclusion: In all subunits of the present open structure, Thr131 has translocated into the active site occupying the volume vacated by the absent active water and partially disordered NAD(+) molecule. This conformation suggests a mechanism by which the enzyme may exchange NADH for NAD(+) and repolarize the catalytic water bound to Asp280 while protecting the reaction intermediates. The structure also indicates how the subunits may communicate with each other through two reaction state sensors in this highly cooperative enzyme.	[Rajakannan, Venkatachalam; Robinson, Robert C.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Lee, Hui-Sun; Chong, Seon-Ha; Ryu, Han-Bong; Bae, Ji-Young; Choe, Han] Univ Ulsan, Dept Physiol, Coll Med, Seoul, South Korea; [Lee, Hui-Sun; Chong, Seon-Ha; Ryu, Han-Bong; Bae, Ji-Young; Choe, Han] Univ Ulsan, Biomed Inst Technol, Coll Med, Seoul, South Korea; [Whang, Eun-Young; Huh, Jae-Wan; Cho, Sung-Woo] Univ Ulsan, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Kang, Lin-Woo] Kunkuk Univ, Dept Adv Technol Fus, Seoul, South Korea	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Ulsan; University of Ulsan; University of Ulsan; Konkuk University	Rajakannan, V (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.	hchoe@amc.seoul.kr	VENKATACHALAM, RAJAKANNAN/G-3684-2017; choe, han/A-5679-2010; Robinson, Robert/G-9702-2011	VENKATACHALAM, RAJAKANNAN/0000-0002-4129-9227; choe, han/0000-0003-4604-647X; Robinson, Robert/0000-0001-6367-6903	Korea Research Foundation [NRF-2010-R13-0029522]; Brain Research Center of the 21st Century Frontier Research Program [2011K000279]; Biomedical Research Council of A*STAR	Korea Research Foundation(National Research Foundation of Korea); Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR))	This work was funded by the Korea Research Foundation (http://www.krf.or.kr/KHPapp/eng/mainc.jsp) (NRF-2010-R13-0029522), the Brain Research Center of the 21st Century Frontier Research Program (http://english.mest.go.kr/enMain.do) (2011K000279), and the Biomedical Research Council of A*STAR (http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 2002, UROL INT, V69, P266, DOI 10.1159/000066123; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARRECUBIETA C, 1994, J BACTERIOL, V176, P6375, DOI 10.1128/jb.176.20.6375-6383.1994; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; CHEN A, 1974, CARBOHYD RES, V37, P155, DOI 10.1016/S0008-6215(00)87071-8; DOUGHERTY BA, 1993, J BIOL CHEM, V268, P7118; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2011, J BIOL CHEM IN PRESS; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEINGOLD DS, 1981, TRENDS BIOCHEM SCI, V6, P103, DOI 10.1016/0968-0004(81)90038-4; FRANZEN JS, 1973, BIOCHEM BIOPH RES CO, V50, P517, DOI 10.1016/0006-291X(73)90870-X; FRANZEN JS, 1980, BIOCHIM BIOPHYS ACTA, V614, P242, DOI 10.1016/0005-2744(80)90214-4; FRANZEN JS, 1980, BIOCHEMISTRY-US, V19, P6080, DOI 10.1021/bi00567a021; Ge X, 1998, J AM CHEM SOC, V120, P6613, DOI 10.1021/ja9805977; HEMPEL J, 1994, PROTEIN SCI, V3, P1074, DOI 10.1002/pro.5560030710; Huh JW, 2006, PROTEIN PEPTIDE LETT, V13, P859; Huh JW, 2007, J BIOCHEM MOL BIOL, V40, P690; Huh JW, 2004, J BIOL CHEM, V279, P37491, DOI 10.1074/jbc.M404234200; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; JAENICKE R, 1986, BIOCHEMISTRY-US, V25, P7283, DOI 10.1021/bi00371a006; JANSEN PLM, 1992, HEPATOLOGY, V15, P532, DOI 10.1002/hep.1840150328; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; Lind T, 1999, GLYCOBIOLOGY, V9, P595, DOI 10.1093/glycob/9.6.595; Lokeshwar VB, 1996, CANCER RES, V56, P651; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLZ RJ, 1971, BIOCHIM BIOPHYS ACTA, V250, P6, DOI 10.1016/0005-2744(71)90114-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada H, 1996, INT J CANCER, V66, P255, DOI 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A; ORDMAN AB, 1977, J BIOL CHEM, V252, P1320; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; RIDLEY WP, 1975, J BIOL CHEM, V250, P8761; Ropponen K, 1998, CANCER RES, V58, P342; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wegrowski Y, 1998, BIOCHEM BIOPH RES CO, V250, P206, DOI 10.1006/bbrc.1998.9262; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I; ZALITIS J, 1969, ARCH BIOCHEM BIOPHYS, V132, P457, DOI 10.1016/0003-9861(69)90389-0; ZEMEL E, 1989, J RHEUMATOL, V16, P825	49	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25226	10.1371/journal.pone.0025226	http://dx.doi.org/10.1371/journal.pone.0025226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984906	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000017
J	Taneja, N; Nato, F; Dartevelle, S; Sire, JM; Garin, B; Lan, NTP; Diep, TT; Shako, JC; Bimet, F; Filliol, I; Muyembe, JJ; Ungeheuer, MN; Ottone, C; Sansonetti, P; Germani, Y				Taneja, Neelam; Nato, Faridabano; Dartevelle, Sylvie; Sire, Jean Marie; Garin, Benoit; Lan Nguyen Thi Phuong; Tai The Diep; Shako, Jean Christophe; Bimet, Francois; Filliol, Ingrid; Muyembe, Jean-Jacques; Ungeheuer, Marie Noelle; Ottone, Catherine; Sansonetti, Philippe; Germani, Yves			Dipstick Test for Rapid Diagnosis of Shigella dysenteriae 1 in Bacterial Cultures and Its Potential Use on Stool Samples	PLOS ONE			English	Article							ENTEROINVASIVE ESCHERICHIA-COLI; SHIGA-BACILLUS DYSENTERY; ANTIMICROBIAL RESISTANCE; CONJUGATE VACCINES; VIBRIO-CHOLERAE; CENTRAL-AMERICA; EPIDEMIC; TYPE-1; IDENTIFICATION; INVASION	Background: We describe a test for rapid detection of S. dysenteriae 1 in bacterial cultures and in stools, at the bedside of patients. Methodology/Principal Findings: The test is based on the detection of S. dysenteriae 1 lipopolysaccharide (LPS) using serotype 1-specific monoclonal antibodies coupled to gold particles and displayed on a one-step immunochromatographic dipstick. A concentration as low as 15 ng/ml of LPS was detected in distilled water and in reconstituted stools in 10 minutes. In distilled water and in reconstituted stools, an unequivocal positive reaction was obtained with 1.6x10(6) CFU/ml and 4.9x10(6) CFU/ml of S. dysenteriae 1, respectively. Optimal conditions to read the test have been determined to limit the risk of ambiguous results due to appearance of a faint yellow test band in some negative samples. The specificity was 100% when tested with a battery of Shigella and unrelated strains in culture. When tested on 328 clinical samples in India, Vietnam, Senegal and France by laboratory technicians and in Democratic Republic of Congo by a field technician, the specificity (312/316) was 98.7% (95% CI: 96.6-99.6%) and the sensitivity (11/12) was 91.7% (95% CI: 59.8-99.6%). Stool cultures and the immunochromatographic test showed concordant results in 98.4 % of cases (323/328) in comparative studies. Positive and negative predictive values were 73.3% (95% CI: 44.8-91.1%) and 99.7% (95% CI: 98-100%). Conclusion: The initial findings presented here for a simple dipstick-based test to diagnose S. dysenteriae 1 demonstrates its promising potential to become a powerful tool for case management and epidemiological surveys.	[Taneja, Neelam] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India; [Sire, Jean Marie; Garin, Benoit] Inst Pasteur, Med Biol Lab, Dakar, Senegal; [Lan Nguyen Thi Phuong; Tai The Diep] Pasteur Inst Ho Chi Minh City, Dept Immunol & Microbiol, Ho Chi Minh City, Vietnam; [Bimet, Francois] Inst Pasteur, Ctr Ressources Biol, Paris, France; [Shako, Jean Christophe] Antenne Med Bunia, Bunia, DEM REP CONGO; [Filliol, Ingrid] Inst Pasteur, Ctr Natl Reference Escherichia Coli & Shigella, Unite Rech & Expertise Bacteries Pathogenes Enter, Paris, France; [Muyembe, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Sansonetti, Philippe; Germani, Yves] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Germani, Yves] BioSpeedia Soc Act Simplifee, Orsay, France	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institute Nacional de Recherche Biomedical; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Taneja, N (corresponding author), Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India.	ygermani@pasteur.fr	Diep, Tai/ABG-9477-2021	Diep, Tai/0000-0001-7166-6369; TANEJA, NEELAM/0000-0003-1198-6138	Institute Pasteur [PTR 179]; TOTAL Societe Anonyme	Institute Pasteur; TOTAL Societe Anonyme	This work was supported by the Institute Pasteur (grant PTR 179). Additionally, part of the work was supported by a grant from TOTAL Societe Anonyme (http://www.total.com/en/home-page-940596.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agtini MD, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-89; [Anonymous], 1995, Lancet, V345, P339; BARZU S, 1993, INFECT IMMUN, V61, P3825, DOI 10.1128/IAI.61.9.3825-3831.1993; BENNISH ML, 1990, NEW ENGL J MED, V322, P1357, DOI 10.1056/NEJM199005103221905; BENNISH ML, 1992, CLIN INFECT DIS, V14, P1055, DOI 10.1093/clinids/14.5.1055; BENNISH ML, 1991, REV INFECT DIS, V13, pS245; BLACK RE, 1986, DEV VACCINES DRUGS D, P23; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; BRENNER DJ, 1984, INT J SYST BACTERIOL, V34, P87, DOI 10.1099/00207713-34-1-87; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dutta P, 1995, Indian Pediatr, V32, P313; Dykman LA, 2000, FEMS IMMUNOL MED MIC, V27, P135, DOI 10.1111/j.1574-695X.2000.tb01423.x; ECHEVERRIA P, 1991, REV INFECT DIS, V13, pS220; Engels D, 1995, B WORLD HEALTH ORGAN, V73, P787; Feng L, 2007, MICROBIOL-SGM, V153, P139, DOI 10.1099/mic.0.2006/001107-0; Germani Y, 1998, AM J TROP MED HYG, V59, P1008, DOI 10.4269/ajtmh.1998.59.1008; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Guerin PJ, 2003, LANCET, V362, P705, DOI 10.1016/S0140-6736(03)14227-4; IIJIMA Y, 1995, LANCET, V345, P69, DOI 10.1016/S0140-6736(95)91197-9; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legros D, 1999, TROP MED INT HEALTH, V4, P428, DOI 10.1046/j.1365-3156.1999.00413.x; LINDBERG AA, 1999, REV INFECT DIS S4, V13, pS279; MATA LJ, 1970, J INFECT DIS, V122, P170, DOI 10.1093/infdis/122.3.170; MENDIZAB.CA, 1971, AM J TROP MED HYG, V20, P927, DOI 10.4269/ajtmh.1971.20.927; Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003; Nato F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000361; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Niyogi SK, 2003, JPN J INFECT DIS, V56, P33; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Passwell JH, 2001, INFECT IMMUN, V69, P1351, DOI 10.1128/IAI.69.3.1351-1357.2001; Pazhani GP, 2004, ANTIMICROB AGENTS CH, V48, P681, DOI 10.1128/AAC.48.2.681-684.2004; Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; POLLARD DR, 1990, J CLIN MICROBIOL, V28, P540, DOI 10.1128/JCM.28.3.540-545.1990; RICCI KA, 2006, NATURE S1, V23, P29; RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035; Rollins NC, 1995, J TROP PEDIATRICS, V41, P281, DOI 10.1093/tropej/41.5.281; RONSMANS C, 1988, LANCET, V2, P552; Sansonetti PJ, 1999, CLIN INFECT DIS, V28, P466, DOI 10.1086/515150; SETHABUTR O, 1993, J INFECT DIS, V167, P458, DOI 10.1093/infdis/167.2.458; Szakal D, 2003, DIAGN MICR INFEC DIS, V45, P165, DOI 10.1016/S0732-8893(02)00512-6; Taneja N, 2007, J CLIN MICROBIOL, V45, P678, DOI 10.1128/JCM.02247-06; TAYLOR DN, 1993, INFECT IMMUN, V61, P3678, DOI 10.1128/IAI.61.9.3678-3687.1993; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Wang XY, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-17; Wang XY, 2005, AM J TROP MED HYG, V73, P416, DOI 10.4269/ajtmh.2005.73.416; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; 2005, WHO WEEKLY EPIDEMIOL, V80, P93; 1994, MMWR MORB MORTAL WKL, V43, P701	55	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24830	10.1371/journal.pone.0024830	http://dx.doi.org/10.1371/journal.pone.0024830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984895	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000005
J	Yahata, N; Asai, M; Kitaoka, S; Takahashi, K; Asaka, I; Hioki, H; Kaneko, T; Maruyama, K; Saido, TC; Nakahata, T; Asada, T; Yamanaka, S; Iwata, N; Inoue, H				Yahata, Naoki; Asai, Masashi; Kitaoka, Shiho; Takahashi, Kazutoshi; Asaka, Isao; Hioki, Hiroyuki; Kaneko, Takeshi; Maruyama, Kei; Saido, Takaomi C.; Nakahata, Tatsutoshi; Asada, Takashi; Yamanaka, Shinya; Iwata, Nobuhisa; Inoue, Haruhisa			Anti-A beta Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TRANSGENIC MOUSE MODEL; AMYLOID-BETA; GAMMA-SECRETASE; A-BETA-42; PROTEIN; DIFFERENTIATION; FIBROBLASTS; GLUTAMINASE; DEPOSITION	Background: Alzheimer's disease (AD) is a neurodegenerative disorder that causes progressive memory and cognitive decline during middle to late adult life. The AD brain is characterized by deposition of amyloid beta peptide (A beta), which is produced from amyloid precursor protein by beta- and gamma-secretase (presenilin complex)-mediated sequential cleavage. Induced pluripotent stem (iPS) cells potentially provide an opportunity to generate a human cell-based model of AD that would be crucial for drug discovery as well as for investigating mechanisms of the disease. Methodology/Principal Findings: We differentiated human iPS (hiPS) cells into neuronal cells expressing the forebrain marker, Foxg1, and the neocortical markers, Cux1, Satb2, Ctip2, and Tbr1. The iPS cell-derived neuronal cells also expressed amyloid precursor protein, beta-secretase, and gamma-secretase components, and were capable of secreting A beta into the conditioned media. A beta production was inhibited by beta-secretase inhibitor, gamma-secretase inhibitor (GSI), and an NSAID; however, there were different susceptibilities to all three drugs between early and late differentiation stages. At the early differentiation stage, GSI treatment caused a fast increase at lower dose (A beta surge) and drastic decline of A beta production. Conclusions/Significance: These results indicate that the hiPS cell-derived neuronal cells express functional beta- and gamma-secretases involved in A beta production; however, anti-A beta drug screening using these hiPS cell-derived neuronal cells requires sufficient neuronal differentiation.	[Yahata, Naoki; Kitaoka, Shiho; Takahashi, Kazutoshi; Asaka, Isao; Nakahata, Tatsutoshi; Yamanaka, Shinya; Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Yamanaka, Shinya; Inoue, Haruhisa] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Saitama, Japan; [Asai, Masashi; Maruyama, Kei] Saitama Med Univ, Fac Med, Dept Pharmacol, Saitama, Japan; [Asai, Masashi; Saido, Takaomi C.; Iwata, Nobuhisa] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Saitama, Japan; [Hioki, Hiroyuki; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto, Japan; [Asada, Takashi] Univ Tsukuba, Inst Clin Med, Dept Neuropsychiat, Tsukuba, Ibaraki 305, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Kyoto University; Japan Science & Technology Agency (JST); Saitama Medical University; RIKEN; Kyoto University; University of Tsukuba; Nagasaki University	Yahata, N (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan.	iwata-n@nagasaki-u.ac.jp; haruhisa@cira.kyoto-u.ac.jp	Asai, Masashi/AAB-7672-2022; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Takahashi, Kazutoshi/ABE-5504-2020; Hioki, Hiroyuki/J-9412-2017	Asai, Masashi/0000-0001-6392-0910; Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Takahashi, Kazutoshi/0000-0002-5329-8395; Hioki, Hiroyuki/0000-0002-0152-7854; Inoue, Haruhisa/0000-0003-4736-9537	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; NOVARTIS Foundation for Gerontological Research	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NOVARTIS Foundation for Gerontological Research(Novartis Foundation for Gerontological Research)	This study was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (HI & NI), and a research grant from the NOVARTIS Foundation for Gerontological Research (HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J COMP NEUROL, V297, P239, DOI 10.1002/cne.902970207; Asai M, 2010, J NEUROSCI RES, V88, P3588, DOI 10.1002/jnr.22503; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; KANEKO T, 1987, J NEUROSCI, V7, P302; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lazarov O, 2002, J NEUROSCI, V22, P9785; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; Saito T, 2011, CEREB CORTEX, V21, P588, DOI 10.1093/cercor/bhq125; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006722; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853	47	126	145	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25788	10.1371/journal.pone.0025788	http://dx.doi.org/10.1371/journal.pone.0025788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984949	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300059
J	Andalman, AS; Foerster, JN; Fee, MS				Andalman, Aaron S.; Foerster, Jakob N.; Fee, Michale S.			Control of Vocal and Respiratory Patterns in Birdsong: Dissection of Forebrain and Brainstem Mechanisms Using Temperature	PLOS ONE			English	Article							ZEBRA FINCH SONG; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; INSPIRATORY PREMOTOR NEURONS; SEQUENCE GENERATION; SYRINGEAL MUSCLES; NEURAL ACTIVITY; CONTROL-SYSTEM; AIR-FLOW; CANARY; MODEL	Learned motor behaviors require descending forebrain control to be coordinated with midbrain and brainstem motor systems. In songbirds, such as the zebra finch, regular breathing is controlled by brainstem centers, but when the adult songbird begins to sing, its breathing becomes tightly coordinated with forebrain-controlled vocalizations. The periods of silence (gaps) between song syllables are typically filled with brief breaths, allowing the bird to sing uninterrupted for many seconds. While substantial progress has been made in identifying the brain areas and pathways involved in vocal and respiratory control, it is not understood how respiratory and vocal control is coordinated by forebrain motor circuits. Here we combine a recently developed technique for localized brain cooling, together with recordings of thoracic air sac pressure, to examine the role of cortical premotor nucleus HVC (proper name) in respiratory-vocal coordination. We found that HVC cooling, in addition to slowing all song timescales as previously reported, also increased the duration of expiratory pulses (EPs) and inspiratory pulses (IPs). Expiratory pulses, like song syllables, were stretched uniformly by HVC cooling, but most inspiratory pulses exhibited non-uniform stretch of pressure waveform such that the majority of stretch occurred late in the IP. Indeed, some IPs appeared to change duration by the earlier or later truncation of an underlying inspiratory event. These findings are consistent with the idea that during singing the temporal structure of EPs is under the direct control of forebrain circuits, whereas that of IPs can be strongly influenced by circuits downstream of HVC, likely in the brainstem. An analysis of the temporal jitter of respiratory and vocal structure suggests that IPs may be initiated by HVC at the end of each syllable and terminated by HVC immediately before the onset of the next syllable.	[Andalman, Aaron S.; Foerster, Jakob N.; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Andalman, AS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	fee@mit.edu	Andalman, Aaron S/C-7694-2011	Fee, Michale/0000-0001-7539-1745	National Institutes of Health [R01 DC009183, R01 MH067105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institutes of Health (Grants R01 DC009183 and R01 MH067105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov D, 2007, SOC NEUR ABSTR, V430, P5; Aronov D, 2011, J NEUROSCI METH, V197, P32, DOI 10.1016/j.jneumeth.2011.01.024; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Ashmore RC, 2008, J NEUROSCI, V28, P2613, DOI 10.1523/JNEUROSCI.4547-07.2008; CALDER WA, 1970, COMP BIOCHEM PHYSIOL, V32, P251, DOI 10.1016/0010-406X(70)90938-2; Chein R, 2004, APPL THERM ENG, V24, P2207, DOI 10.1016/j.applthermaleng.2004.03.001; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; CYNX J, 1990, J COMP PSYCHOL, V104, P3, DOI 10.1037/0735-7036.104.1.3; Fee MS, 2010, ILAR J, V51, P362, DOI 10.1093/ilar.51.4.362; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fee MS, 2011, CURR OPIN N IN PRESS, V21; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Franz M, 2003, J EXP BIOL, V206, P967, DOI 10.1242/jeb.00196; Franz M, 2002, J NEUROBIOL, V51, P129, DOI 10.1002/neu.10043; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Guillery RW, 2002, PHILOS T R SOC B, V357, P1809, DOI 10.1098/rstb.2002.1171; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HARTLEY RS, 1989, J COMP PHYSIOL A, V165, P15, DOI 10.1007/BF00613795; HARTLEY RS, 1990, RESP PHYSIOL, V81, P177, DOI 10.1016/0034-5687(90)90044-Y; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubke MF, 2005, J NEUROPHYSIOL, V94, P2379, DOI 10.1152/jn.00257.2005; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Levelt W.J., 1993, SPEAKING INTENTION A; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Moody SL, 1998, J COGNITIVE NEUROSCI, V10, P35, DOI 10.1162/089892998563761; Northcutt RG, 2002, INTEGR COMP BIOL, V42, P743, DOI 10.1093/icb/42.4.743; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Reinke H, 1998, J COMP NEUROL, V391, P147; Reinke H, 1997, J COMP NEUROL, V379, P347; Riede T, 2010, BRAIN LANG, V115, P69, DOI 10.1016/j.bandl.2009.11.003; Rubin JE, 2009, J NEUROPHYSIOL, V101, P2146, DOI 10.1152/jn.90958.2008; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 2008, PLOS BIOL, V6, P2089, DOI 10.1371/journal.pbio.0060269; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Schwartz AB, 2000, EUR J NEUROSCI, V12, P1851, DOI 10.1046/j.1460-9568.2000.00097.x; SELLER TJ, 1981, TRENDS NEUROSCI, V4, P301, DOI 10.1016/0166-2236(81)90094-1; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; Suthers RA, 1997, J NEUROBIOL, V33, P632, DOI 10.1002/(SICI)1097-4695(19971105)33:5<632::AID-NEU10>3.0.CO;2-B; SUTHERS RA, 1994, J NEUROBIOL, V25, P917, DOI 10.1002/neu.480250803; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; VICARIO DS, 1988, J COMP NEUROL, V271, P346, DOI 10.1002/cne.902710305; VICARIO DS, 1993, NEUROREPORT, V4, P983, DOI 10.1097/00001756-199307000-00037; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; Vu ET, 1998, J NEUROSCI, V18, P9088; VU ET, 1994, J NEUROSCI, V14, P6924; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; WILD JM, 1993, BRAIN RES, V606, P319, DOI 10.1016/0006-8993(93)91001-9; Wild JM, 1998, J NEUROBIOL, V36, P441, DOI 10.1002/(SICI)1097-4695(19980905)36:3<441::AID-NEU11>3.0.CO;2-E; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZANN R, 1996, ZEBRA FINCH	65	49	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25461	10.1371/journal.pone.0025461	http://dx.doi.org/10.1371/journal.pone.0025461			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980466	gold, Green Submitted, Green Published			2022-12-27	WOS:000295936900067
J	Anton, PA; Saunders, T; Elliott, J; Khanukhova, E; Dennis, R; Adler, A; Cortina, G; Tanner, K; Boscardin, J; Cumberland, WG; Zhou, Y; Ventuneac, A; Carballo-Dieguez, A; Rabe, L; McCormick, T; Gabelnick, H; Mauck, C; McGowan, I				Anton, Peter A.; Saunders, Terry; Elliott, Julie; Khanukhova, Elena; Dennis, Robert; Adler, Amy; Cortina, Galen; Tanner, Karen; Boscardin, John; Cumberland, William G.; Zhou, Ying; Ventuneac, Ana; Carballo-Dieguez, Alex; Rabe, Lorna; McCormick, Timothy; Gabelnick, Henry; Mauck, Christine; McGowan, Ian			First Phase 1 Double-Blind, Placebo-Controlled, Randomized Rectal Microbicide Trial Using UC781 Gel with a Novel Index of Ex Vivo Efficacy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HETEROSEXUAL ANAL INTERCOURSE; HIV-INFECTION; SEXUAL TRANSMISSION; BLOOD-PLASMA; RISK-FACTORS; VAGINAL GEL; MUCOSAL; PREVENTION; TISSUE	Objectives: Successful control of the HIV/AIDS pandemic requires reduction of HIV-1 transmission at sexually-exposed mucosae. No prevention studies of the higher-risk rectal compartment exist. We report the first-in-field Phase 1 trial of a rectally-applied, vaginally-formulated microbicide gel with the RT-inhibitor UC781 measuring clinical and mucosal safety, acceptability and plasma drug levels. A first-in-Phase 1 assessment of preliminary pharmacodynamics was included by measuring changes in ex vivo HIV-1 suppression in rectal biopsy tissue after exposure to product in vivo. Methods: HIV-1 seronegative, sexually-abstinent men and women (N = 36) were randomized in a double-blind, placebo-controlled trial comparing UC781 gel at two concentrations (0.1%, 0.25%) with placebo gel (1:1:1). Baseline, single-dose exposure and a separate, 7-day at-home dosing were assessed. Safety and acceptability were primary endpoints. Changes in colorectal mucosal markers and UC781 plasma drug levels were secondary endpoints; ex vivo biopsy infectibility was an ancillary endpoint. Results: All 36 subjects enrolled completed the 7-14 week trial (100% retention) including 3 flexible sigmoidoscopies, each with 28 biopsies (14 at 10 cm; 14 at 30 cm). There were 81 Grade 1 adverse events (AEs) and 8 Grade 2; no Grade 3, 4 or procedure-related AEs were reported. Acceptability was high, including likelihood of future use. No changes in mucosal immunoinflammatory markers were identified. Plasma levels of UC781 were not detected. Ex vivo infection of biopsies using two titers of HIV-1(BaL) showed marked suppression of p24 in tissues exposed in vivo to 0.25% UC781; strong trends of suppression were seen with the lower 0.1% UC781 concentration. Conclusions: Single and 7-day topical rectal exposure to both concentrations of UC781 were safe with no significant AEs, high acceptability, no detected plasma drug levels and no significant mucosal changes. Ex vivo biopsy infections demonstrated marked suppression of HIV infectibility, identifying a potential early biomarker of efficacy. (Registered at ClinicalTrials.gov; #NCT00408538)	[Anton, Peter A.; Saunders, Terry; Elliott, Julie; Khanukhova, Elena; Dennis, Robert; Adler, Amy; Cortina, Galen; Tanner, Karen; Boscardin, John] Univ Calif Los Angeles, David Geffen Sch Med, Ctr HIV Prevent Res, UCLA AIDS Inst,Dept Med, Los Angeles, CA 90095 USA; [Cumberland, William G.; Zhou, Ying] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Rabe, Lorna; McGowan, Ian] Univ Pittsburgh, Magee Womens Res Inst, Sch Med, Pittsburgh, PA USA; [Ventuneac, Ana; Carballo-Dieguez, Alex] Columbia Univ, Dept Psychiat, New York, NY USA; [McCormick, Timothy; Gabelnick, Henry; Mauck, Christine] CONRAD, Arlington, VA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Columbia University	Anton, PA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr HIV Prevent Res, UCLA AIDS Inst,Dept Med, Los Angeles, CA 90095 USA.	panton@mednet.ucla.edu	M, Ian/AAP-1032-2021; M, i/HCI-9242-2022	M, Ian/0000-0002-6470-8476; , Amy/0000-0002-1854-6613	Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM) [U19]; Division of AIDS (DAIDS); National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [AI060614]; University of California, Los Angeles (UCLA) Center for AIDS Research (CFAR) [AI28697]; CONRAD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI060614, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM); Division of AIDS (DAIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Los Angeles (UCLA) Center for AIDS Research (CFAR)(University of California System); CONRAD(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a U19 grant under the Integrated Preclinical-Clinical Program for HIV Topical Microbicides (IPCP-HTM), Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (AI060614) with additional support from the University of California, Los Angeles (UCLA) Center for AIDS Research (CFAR) (AI28697) Cores of Mucosal Immunology, Flow Cytometry and Biostatistics (http://grants.nih.gov/grants/guide/pa-files/PAR-09-103.html). CONRAD provided extensive additional support for animal toxicity studies, Investigational New Drug (IND) support and pharmacokinetics measurements(http://www.conrad.org). The opinions expressed herein do not represent opinions or statements made or expressed by the US Department of Health and Human Services. As stipulated in the RFA for these sponsored research efforts, the sponsors (both the IPCP Team Leadership within DAIDS/NIAID and at CONRAD) participated in study design, data collection and analysis, decision to publish, preparation and review of the manuscript.	Abdool Karim Quarraisha, 2010, Science, V329, P1168, DOI 10.1126/science.1193748; Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Anema A, 2008, CAN MED ASSOC J, V179, P13, DOI 10.1503/cmaj.071809; Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Anton PA, 2003, AIDS, V17, P53, DOI 10.1097/00002030-200301030-00008; Anton PA, 2008, VACCINE, V26, P4617, DOI 10.1016/j.vaccine.2008.05.084; *AVAC GLOB ADV HIV, 2009, UND RES TRIALS PRO 2; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baldwin JI, 2000, ARCH SEX BEHAV, V29, P357, DOI 10.1023/A:1001918504344; Balzarini J, 1996, MOL PHARMACOL, V50, P394; Barnard J, 1997, BIOCHEMISTRY-US, V36, P7786, DOI 10.1021/bi970140u; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; BRUN JG, 1994, SCAND J IMMUNOL, V40, P675, DOI 10.1111/j.1365-3083.1994.tb03523.x; BURADDAD LJ, 2008, PLOS ONE, V3, pE2230; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chan DJ, 2008, CURR HIV RES, V6, P182, DOI 10.2174/157016208784324949; Chan DJ, 2008, CURR HIV RES, V6, P138, DOI 10.2174/157016208783885074; Clarke JG, 2002, SEX TRANSM DIS, V29, P288, DOI 10.1097/00007435-200205000-00007; *CONRAD, 2006, INV BROCH UN PLAC GE; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Erickson PI, 1995, AIDS EDUC PREV, V7, P477; EVANS BA, 1988, GENITOURIN MED, V64, P43; Fletcher P, 2005, J VIROL, V79, P11179, DOI 10.1128/JVI.79.17.11179-11186.2005; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; Gates GJ, 2000, FAM PLANN PERSPECT, V32, P295, DOI 10.2307/2648198; Goddeeris C, 2008, EUR J PHARM SCI, V35, P104, DOI 10.1016/j.ejps.2008.06.010; GRANT RM, 2010, N ENGL J MED; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Gross M, 2000, J ACQ IMMUN DEF SYND, V24, P393, DOI 10.1097/00126334-200008010-00015; GUIMARAES MDC, 1995, AM J EPIDEMIOL, V142, P538, DOI 10.1093/oxfordjournals.aje.a117672; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Hendrix C, 2008, CLIN PHARMACOL THER, V83, P97, DOI 10.1038/sj.clpt.6100236; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; *HPTN 035, 2010, HPTN 035 PHAS 2 2B S; Ibarrondo FJ, 2005, J VIROL, V79, P4289, DOI 10.1128/JVI.79.7.4289-4297.2005; Kalichman SC, 2008, SEX TRANSM DIS, V35, P55, DOI 10.1097/OLQ.0b013e318141fe9b; Kamali A, 2010, SEX TRANSM INFECT, V86, P222, DOI 10.1136/sti.2009.038372; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lapenta C, 1999, EUR J IMMUNOL, V29, P1202, DOI 10.1002/(SICI)1521-4141(199904)29:04<1202::AID-IMMU1202>3.0.CO;2-O; Leichliter JS, 2007, J INFECT DIS, V196, P1852, DOI 10.1086/522867; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; McGowan I, 2004, JAIDS-J ACQ IMM DEF, V37, P1228, DOI 10.1097/01.qai.0000131846.12453.29; MCGOWAN I, 1994, AIDS, V8, P1569, DOI 10.1097/00002030-199411000-00008; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; Misegades L, 2001, AIDS, V15, P534, DOI 10.1097/00002030-200103090-00017; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; MOSHER WD, 2005, SEXUAL BEHAV SELECTE, P1; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; *NEW YORK CIT DEP, 2010, NYC VITAL SIGNS, V9; Olsson J, 2000, J INFECT DIS, V182, P1625, DOI 10.1086/317625; PADIAN N, 1987, JAMA-J AM MED ASSOC, V258, P788, DOI 10.1001/jama.258.6.788; Patterson BK, 1998, AM J PATHOL, V153, P481, DOI 10.1016/S0002-9440(10)65591-5; Patton DL, 2007, ANTIMICROB AGENTS CH, V51, P1608, DOI 10.1128/AAC.00984-06; Patton DL, 2002, SEX TRANSM DIS, V29, P581, DOI 10.1097/00007435-200210000-00004; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Poles MA, 2001, J VIROL, V75, P8390, DOI 10.1128/JVI.75.18.8390-8399.2001; Richardson-Harman N, 2009, J CLIN MICROBIOL, V47, P3530, DOI 10.1128/JCM.00673-09; RODRIGUES JJ, 1995, BRIT MED J, V311, P283, DOI 10.1136/bmj.311.7000.283; Roseth AG, 1997, DIGESTION, V58, P176, DOI 10.1159/000201441; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Saba E, 2010, MUCOSAL IMMUNOL, V3, P280, DOI 10.1038/mi.2010.2; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Schwartz JL, 2009, INT J STD AIDS, V20, P384, DOI 10.1258/ijsa.2008.008309; Schwartz JL, 2008, SEX TRANSM DIS, V35, P414, DOI 10.1097/OLQ.0b013e318162c4d8; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; Skurnick JH, 1998, CLIN INFECT DIS, V26, P855, DOI 10.1086/513929; STRANG J, 1994, INT J STD AIDS, V5, P133, DOI 10.1177/095646249400500211; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tabet SR, 1999, SEX TRANSM DIS, V26, P564, DOI 10.1097/00007435-199911000-00005; Terrazas-Aranda K, 2008, ANTIMICROB AGENTS CH, V52, P2544, DOI 10.1128/AAC.01627-07; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Ventuneac A, 2010, AIDS BEHAV, V14, P618, DOI 10.1007/s10461-009-9611-5; Yui S, 1995, J LEUKOCYTE BIOL, V58, P650, DOI 10.1002/jlb.58.6.650; Zhang LB, 1998, J SOC GYNECOL INVEST, V5, P72, DOI 10.1016/S1071-5576(97)00107-X; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	84	75	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e23243	10.1371/journal.pone.0023243	http://dx.doi.org/10.1371/journal.pone.0023243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969851	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900002
J	Sun, HY; Ou, NY; Wang, SW; Liu, WC; Cheng, TF; Shr, SJ; Sun, KT; Chang, TT; Young, KC				Sun, Hung-Yu; Ou, Nai-Ying; Wang, Shainn-Wei; Liu, Wen-Chun; Cheng, Ting-Fang; Shr, Shiou-Jiuan; Sun, Koun-Tem; Chang, Ting-Tsung; Young, Kung-Chia			Novel Nucleotide and Amino Acid Covariation between the 5 ' UTR and the NS2/NS3 Proteins of Hepatitis C Virus: Bioinformatic and Functional Analyses	PLOS ONE			English	Article							5' NONTRANSLATED REGION; RIBOSOME ENTRY SITE; STEM-LOOP STRUCTURE; RNA-RNA INTERACTION; ANTIVIRAL THERAPY; CRYSTAL-STRUCTURE; REPLICATION; NS2; TRANSLATION; MUTATIONS	Molecular covariation of highly polymorphic viruses is thought to have crucial effects on viral replication and fitness. This study employs association rule data mining of hepatitis C virus (HCV) sequences to search for specific evolutionary covariation and then tests functional relevance on HCV replication. Data mining is performed between nucleotides in the untranslated regions 5' and 3'UTR, and the amino acid residues in the non-structural proteins NS2, NS3 and NS5B. Results indicate covariance of the 243(rd) nucleotide of the 5'UTR with the 14(th), 41(st), 76(th), 110(th), 211(th) and 212(th) residues of NS2 and with the 71(st), 175(th) and 621(st) residues of NS3. Real-time experiments using an HCV subgenomic system to quantify viral replication confirm replication regulation for each covariant pair between 5'UTR243 and NS2-41, -76, -110, -211, and NS3-71, -175. The HCV subgenomic system with/without the NS2 region shows that regulatory effects vanish without NS2, so replicative modulation mediated by HCV 5'UTR243 depends on NS2. Strong binding of the NS2 variants to HCV RNA correlates with reduced HCV replication whereas weak binding correlates with restoration of HCV replication efficiency, as determined by RNA-protein immunoprecipitation assay band intensity. The dominant haplotype 5'UTR243-NS2-41-76-110-211-NS3-71-175 differs according to the HCV genotype: G-Ile-Ile-Ile-Gly-Ile-Met for genotype 1b and A-Leu-Val-Leu-Ser-Val-Leu for genotypes 1a, 2a and 2b. In conclusion, 5'UTR243 co-varies with specific NS2/3 protein amino acid residues, which may have significant structural and functional consequences for HCV replication. This unreported mechanism involving HCV replication possibly can be exploited in the development of advanced anti-HCV medication.	[Sun, Hung-Yu; Young, Kung-Chia] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Ou, Nai-Ying; Young, Kung-Chia] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Wang, Shainn-Wei; Cheng, Ting-Fang] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Liu, Wen-Chun] MingDao Univ, Coll Appl Sci, Dept Biotechnol, Changhua, Taiwan; [Shr, Shiou-Jiuan; Sun, Koun-Tem] Natl Univ Tainan, Dept Informat & Learning Technol, Sci & Engn Coll, Tainan, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan; [Chang, Ting-Tsung; Young, Kung-Chia] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Mingdao University; National University Tainan; National Cheng Kung University; National Cheng Kung University	Sun, HY (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	t7908077@mail.ncku.edu.tw	Wang, Shainn-Wei/B-9644-2009; Young, Kung-Chia/G-1529-2011		National Science Council of Taiwan [NSC 96-2628-B-006-007-MY3, NSC 99-2320-B-006-015-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council of Taiwan under grant numbers NSC 96-2628-B-006-007-MY3 and NSC 99-2320-B-006-015MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Campo DS, 2008, P NATL ACAD SCI USA, V105, P9685, DOI 10.1073/pnas.0801774105; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; Chang LL, 2007, ANTIVIR RES, V75, P43, DOI 10.1016/j.antiviral.2006.11.009; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; Diviney S, 2008, J VIROL, V82, P9008, DOI 10.1128/JVI.02326-07; Dutkiewicz M, 2008, BIOCHEMISTRY-US, V47, P12197, DOI 10.1021/bi800348g; Edelstein HA, 1999, INTRO DATA MINING KN; El Awady MK, 2009, WORLD J GASTROENTERO, V15, P1480, DOI 10.3748/wjg.15.1480; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Hngtyszyn HJ, 2005, ANTIVIR THER, V10, P1; Honda M, 1999, J VIROL, V73, P4941, DOI 10.1128/JVI.73.6.4941-4951.1999; Honda M, 1999, J VIROL, V73, P1165, DOI 10.1128/JVI.73.2.1165-1174.1999; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Kato T, 2008, HEPATOLOGY, V48, P732, DOI 10.1002/hep.22422; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Laporte J, 2003, BLOOD, V101, P52, DOI 10.1182/blood-2002-03-0818; Lerat H, 2000, J VIROL, V74, P7024, DOI 10.1128/JVI.74.15.7024-7031.2000; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Luo GX, 2003, J VIROL, V77, P3312, DOI 10.1128/JVI.77.5.3312-3318.2003; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Nakajima N, 1996, J VIROL, V70, P3325, DOI 10.1128/JVI.70.5.3325-3329.1996; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Paul S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-62; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Pelemans H, 2001, VIROLOGY, V287, P143, DOI 10.1006/viro.2001.1032; She YL, 2008, ARCH VIROL, V153, P1991, DOI 10.1007/s00705-008-0198-3; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Spangberg K, 2000, VIROLOGY, V274, P378, DOI 10.1006/viro.2000.0461; Tan SH, 2004, NUCLEIC ACIDS RES, V32, pW69, DOI 10.1093/nar/gkh471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Welbourn S, 2005, J BIOL CHEM, V280, P29604, DOI 10.1074/jbc.M505019200; Witten I. H., 2005, DATA MINING PRACTICA; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Xu ZK, 2008, J VIROL, V82, P9417, DOI 10.1128/JVI.00896-08; Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584	53	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25530	10.1371/journal.pone.0025530	http://dx.doi.org/10.1371/journal.pone.0025530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980483	Green Published, gold			2022-12-27	WOS:000295936900075
J	Lutz, R; Pataky, K; Gadhari, N; Marelli, M; Brugger, J; Chiquet, M				Lutz, Roman; Pataky, Kristopher; Gadhari, Neha; Marelli, Mattia; Brugger, Juergen; Chiquet, Matthias			Nano-Stenciled RGD-Gold Patterns That Inhibit Focal Contact Maturation Induce Lamellipodia Formation in Fibroblasts	PLOS ONE			English	Article							CELL-MATRIX ADHESIONS; EXTRACELLULAR-MATRIX; FIBRONECTIN FIBRILLOGENESIS; DYNAMICS; RHO; RAC; ACTIVATION; GTPASES; SHAPE; ALPHA-5-BETA-1	Cultured fibroblasts adhere to extracellular substrates by means of cell-matrix adhesions that are assembled in a hierarchical way, thereby gaining in protein complexity and size. Here we asked how restricting the size of cell-matrix adhesions affects cell morphology and behavior. Using a nanostencil technique, culture substrates were patterned with gold squares of a width and spacing between 250 nm and 2 mu m. The gold was functionalized with RGD peptide as ligand for cellular integrins, and mouse embryo fibroblasts were plated. Limiting the length of cell-matrix adhesions to 500 nm or less disturbed the maturation of vinculin-positive focal complexes into focal contacts and fibrillar adhesions, as indicated by poor recruitment of alpha 5-integrin. We found that on sub-micrometer patterns, fibroblasts spread extensively, but did not polarize. Instead, they formed excessive numbers of lamellipodia and a fine actin meshwork without stress fibers. Moreover, these cells showed aberrant fibronectin fibrillogenesis, and their speed of directed migration was reduced significantly compared to fibroblasts on 2 mu m square patterns. Interference with RhoA/ROCK signaling eliminated the pattern-dependent differences in cell morphology. Our results indicate that manipulating the maturation of cell-matrix adhesions by nanopatterned surfaces allows to influence morphology, actin dynamics, migration and ECM assembly of adhering fibroblasts.	[Lutz, Roman] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Pataky, Kristopher; Marelli, Mattia; Brugger, Juergen] Ecole Polytech Fed Lausanne, Microsyst Lab, Lausanne, Switzerland; [Gadhari, Neha; Chiquet, Matthias] Univ Bern, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bern	Lutz, R (corresponding author), CLS Behring AG, Bern, Switzerland.	matthias.chiquet@zmk.unibe.ch	Brugger, Juergen/C-5357-2009	Brugger, Juergen/0000-0002-7710-5930; Gadhari, Neha/0000-0003-1443-3088; Pataky, Kristopher/0000-0002-9059-9111; Chiquet, Matthias/0000-0001-7812-4853	Swiss National Science Foundation [CR2312_125290/1]; Novartis Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Research Foundation	This work was funded by grant CR2312_125290/1 from the Swiss National Science Foundation ( http://www.snf.ch/E/Pages/default.aspx) and by the Novartis Research Foundation (http://www.fmi.ch/About/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Fernandez-Sauze S, 2009, EXP CELL RES, V315, P2092, DOI 10.1016/j.yexcr.2009.03.017; Gallant ND, 2007, J NANOSCI NANOTECHNO, V7, P803, DOI 10.1166/jnn.2007.507; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Graness A, 2006, CELL SIGNAL, V18, P433, DOI 10.1016/j.cellsig.2005.05.011; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harjanto D, 2010, ORG BIOMOL CHEM, V8, P299, DOI 10.1039/b913064k; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kim GM, 2003, MICROELECTRON ENG, V67-8, P609, DOI 10.1016/S0167-9317(03)00121-7; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Lutz R, 2010, J CELL SCI, V123, P1511, DOI 10.1242/jcs.060905; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; May T, 2005, J BIOTECHNOL, V120, P99, DOI 10.1016/j.jbiotec.2005.03.027; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sarasa-Renedo A, 2006, EXP CELL RES, V312, P1361, DOI 10.1016/j.yexcr.2005.12.025; Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754; Thery M., 2019, COLD SPRING HARB PRO, V2009; Vazquez-Mena O, 2008, NANO LETT, V8, P3675, DOI 10.1021/nl801778t; WEHRLE B, 1990, DEVELOPMENT, V110, P401; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583	37	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25459	10.1371/journal.pone.0025459	http://dx.doi.org/10.1371/journal.pone.0025459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980465	gold, Green Submitted, Green Published			2022-12-27	WOS:000295933700038
J	Oliveira-Maia, AJ; Roberts, CD; Walker, QD; Luo, B; Kuhn, C; Simon, SA; Nicolelis, MAL				Oliveira-Maia, Albino J.; Roberts, Craig D.; Walker, Q. David; Luo, Brooke; Kuhn, Cynthia; Simon, Sidney A.; Nicolelis, Miguel A. L.			Intravascular Food Reward	PLOS ONE			English	Article							CONDITIONED FLAVOR PREFERENCES; NUCLEUS-ACCUMBENS SHELL; BLOOD-GLUCOSE LEVELS; INTRAVENOUS GLUCOSE; DOPAMINE RELEASE; INTESTINAL NUTRIENTS; VENTRAL STRIATUM; PLACE PREFERENCE; PLASMA-GLUCOSE; RATS	Consumption of caloriecontaining sugars elicits appetitive behavioral responses and dopamine release in the ventral striatum, even in the absence of sweet-taste transduction machinery. However, it is unclear if such reward-related postingestive effects reflect preabsorptive or postabsorptive events. In support of the importance of postabsorptive glucose detection, we found that, in rat behavioral tests, high concentration glucose solutions administered in the jugular vein were sufficient to condition a side-bias. Additionally, a lower concentration glucose solution conditioned robust behavioral responses when administered in the hepatic-portal, but not the jugular vein. Furthermore, enteric administration of glucose at a concentration that is sufficient to elicit behavioral conditioning resulted in a glycemic profile similar to that observed after administration of the low concentration glucose solution in the hepatic-portal, but not jugular vein. Finally using fast-scan cyclic voltammetry we found that, in accordance with behavioral findings, a low concentration glucose solution caused an increase in spontaneous dopamine release events in the nucleus accumbens shell when administered in the hepatic-portal, but not the jugular vein. These findings demonstrate that the postabsorptive effects of glucose are sufficient for the postingestive behavioral and dopaminergic reward-related responses that result from sugar consumption. Furthermore, glycemia levels in the hepatic-portal venous system contribute more significantly for this effect than systemic glycemia, arguing for the participation of an intra-abdominal visceral sensor for glucose.	[Oliveira-Maia, Albino J.; Roberts, Craig D.; Luo, Brooke; Simon, Sidney A.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Walker, Q. David; Kuhn, Cynthia] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Simon, Sidney A.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA; [Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Psychol & Neurosci, Durham, NC USA; [Simon, Sidney A.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Ctr Neuroengn, Durham, NC USA; [Nicolelis, Miguel A. L.] Edmond & Lily Safra Int, Inst Neurosci Natal, Natal, RN, Brazil	Duke University; Duke University; Duke University; Duke University; Duke University	Oliveira-Maia, AJ (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Program, Lisbon, Portugal.	albinojorgemai@gmail.com	Oliveira-Maia, AJ/B-7976-2009	Oliveira-Maia, AJ/0000-0001-5071-3007	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01DC001065]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001065] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Grant Number R01DC001065 to Sidney Simon from the National Institute on Deafness and Other Communication Disorders (NIDCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDCD or the National Institutes of Health.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Ackroff K, 2010, PHYSIOL BEHAV, V99, P402, DOI 10.1016/j.physbeh.2009.12.012; ADKINS BA, 1987, J CLIN INVEST, V79, P557, DOI 10.1172/JCI112847; Agmo A, 1997, APPETITE, V29, P269, DOI 10.1006/appe.1997.0101; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Aragona BJ, 2009, EUR J NEUROSCI, V30, P1889, DOI 10.1111/j.1460-9568.2009.07027.x; Baird JP, 1999, AM J PHYSIOL-REG I, V277, pR1136, DOI 10.1152/ajpregu.1999.277.4.R1136; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Bello NT, 2006, PHYSIOL BEHAV, V88, P138, DOI 10.1016/j.physbeh.2006.03.027; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; BRADLEY RM, 1971, J COMP PHYSIOL PSYCH, V75, P186, DOI 10.1037/h0030813; Cahill PS, 1996, ANAL CHEM, V68, P3180, DOI 10.1021/ac960347d; CHAMBERS RM, 1956, J COMP PHYSIOL PSYCH, V49, P558, DOI 10.1037/h0047138; Cheer JF, 2004, J NEUROSCI, V24, P4393, DOI 10.1523/JNEUROSCI.0529-04.2004; COPPOCK HW, 1954, J COMP PHYSIOL PSYCH, V47, P355, DOI 10.1037/h0061319; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; EPSTEIN AN, 1962, J COMP PHYSIOL PSYCH, V55, P753, DOI 10.1037/h0040455; Friedman MI, 2005, CHEM SENSES, V30, pI182, DOI 10.1093/chemse/bjh174; GOWANS SE, 1991, AM J PHYSIOL, V261, pR1409, DOI 10.1152/ajpregu.1991.261.6.R1409; GREEN JH, 1981, Q J EXP PHYSIOL CMS, V66, P465, DOI 10.1113/expphysiol.1981.sp002588; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hajnal A, 2001, BRAIN RES, V904, P76, DOI 10.1016/S0006-8993(01)02451-9; Haltia LT, 2007, SYNAPSE, V61, P748, DOI 10.1002/syn.20418; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; HOLM S, 1979, SCAND J STAT, V6, P65; HOLMAN GL, 1969, J COMP PHYSIOL PSYCH, V69, P432, DOI 10.1037/h0028233; JOUHANEAU J, 1982, PHYSIOL BEHAV, V29, P241, DOI 10.1016/0031-9384(82)90010-5; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; le Magnen J, 1999, APPETITE, V33, P14, DOI 10.1006/appe.1999.0252; le Magnen J, 1999, APPETITE, V33, P8, DOI 10.1006/appe.1999.0251; Levin BE, 2000, BRAIN RES, V874, P158, DOI 10.1016/S0006-8993(00)02573-7; Lucas F, 1996, AM J PHYSIOL-REG I, V270, pR1059, DOI 10.1152/ajpregu.1996.270.5.R1059; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; MATHER P, 1978, NATURE, V273, P461, DOI 10.1038/273461a0; MILLER NE, 1952, J COMP PHYSIOL PSYCH, V45, P555, DOI 10.1037/h0060113; Miras AD, 2010, CURR OPIN GASTROEN, V26, P140, DOI 10.1097/MOG.0b013e328333e94a; MYERS SR, 1991, J CLIN INVEST, V87, P930, DOI 10.1172/JCI115100; NIIJIMA A, 1982, J PHYSIOL-LONDON, V332, P315, DOI 10.1113/jphysiol.1982.sp014415; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; PUERTO A, 1976, SCIENCE, V192, P485, DOI 10.1126/science.1257784; RAWSON NE, 1994, AM J PHYSIOL, V266, pR112, DOI 10.1152/ajpregu.1994.266.1.R112; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; REVUSKY SH, 1971, PHYSIOL BEHAV, V6, P341, DOI 10.1016/0031-9384(71)90165-X; Robinson DL, 2004, J NEUROCHEM, V90, P894, DOI 10.1111/j.1471-4159.2004.02559.x; Robinson DL, 2002, J NEUROSCI, V22, P10477; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schultes B, 2010, AM J CLIN NUTR, V92, P277, DOI 10.3945/ajcn.2009.29007; Sclafani A, 1996, PHYSIOL BEHAV, V60, P447, DOI 10.1016/S0031-9384(96)80018-7; Sclafani A, 2004, PHYSIOL BEHAV, V81, P773, DOI 10.1016/j.physbeh.2004.04.031; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Sclafani A, 2003, PHYSIOL BEHAV, V78, P285, DOI 10.1016/S0031-9384(02)00968-X; SCLAFANI A, 1988, AM J PHYSIOL, V255, pR672, DOI 10.1152/ajpregu.1988.255.4.R672; Sclafani A, 2010, AM J PHYSIOL-REG I, V299, pR1643, DOI 10.1152/ajpregu.00495.2010; SHERMAN JE, 1983, ANIM LEARN BEHAV, V11, P101, DOI 10.3758/BF03212315; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; STRUBBE JH, 1977, PHYSIOL BEHAV, V19, P303, DOI 10.1016/0031-9384(77)90342-0; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; TORDOFF MG, 1986, AM J PHYSIOL, V251, pR192, DOI 10.1152/ajpregu.1986.251.1.R192; Touzani K, 2008, EUR J NEUROSCI, V27, P1525, DOI 10.1111/j.1460-9568.2008.06127.x; Venton BJ, 2007, SYNAPSE, V61, P37, DOI 10.1002/syn.20343; Wheeler RA, 2011, BIOL PSYCHIAT, V69, P1067, DOI 10.1016/j.biopsych.2011.02.014; WHITE NM, 1985, PHARMACOL BIOCHEM BE, V23, P37, DOI 10.1016/0091-3057(85)90127-3; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Zuurbier CJ, 2008, ANESTH ANALG, V106, P135, DOI 10.1213/01.ane.0000297299.91527.74	67	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24992	10.1371/journal.pone.0024992	http://dx.doi.org/10.1371/journal.pone.0024992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980372	Green Published, gold, Green Submitted			2022-12-27	WOS:000295933700014
J	Fung, SJ; Joshi, D; Allen, KM; Sivagnanasundaram, S; Rothmond, DA; Saunders, R; Noble, PL; Webster, MJ; Weickert, CS				Fung, Samantha J.; Joshi, Dipesh; Allen, Katherine M.; Sivagnanasundaram, Sinthuja; Rothmond, Debora A.; Saunders, Richard; Noble, Pamela L.; Webster, Maree J.; Weickert, Cynthia Shannon			Developmental Patterns of Doublecortin Expression and White Matter Neuron Density in the Postnatal Primate Prefrontal Cortex and Schizophrenia	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEWLY GENERATED NEURONS; CELL-ADHESION MOLECULE; PSA-NCAM EXPRESSION; CEREBRAL-CORTEX; HUMAN BRAIN; CORTICAL DEVELOPMENT; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; GABAERGIC NEURONS	Postnatal neurogenesis occurs in the subventricular zone and dentate gyrus, and evidence suggests that new neurons may be present in additional regions of the mature primate brain, including the prefrontal cortex (PFC). Addition of new neurons to the PFC implies local generation of neurons or migration from areas such as the subventricular zone. We examined the putative contribution of new, migrating neurons to postnatal cortical development by determining the density of neurons in white matter subjacent to the cortex and measuring expression of doublecortin (DCX), a microtubule-associated protein involved in neuronal migration, in humans and rhesus macaques. We found a striking decline in DCX expression (human and macaque) and density of white matter neurons (humans) during infancy, consistent with the arrival of new neurons in the early postnatal cortex. Considering the expansion of the brain during this time, the decline in white matter neuron density does not necessarily indicate reduced total numbers of white matter neurons in early postnatal life. Furthermore, numerous cells in the white matter and deep grey matter were positive for the migration-associated glycoprotein polysialiated-neuronal cell adhesion molecule and GAD65/67, suggesting that immature migrating neurons in the adult may be GABAergic. We also examined DCX mRNA in the PFC of adult schizophrenia patients (n = 37) and matched controls (n = 37) and did not find any difference in DCX mRNA expression. However, we report a negative correlation between DCX mRNA expression and white matter neuron density in adult schizophrenia patients, in contrast to a positive correlation in human development where DCX mRNA and white matter neuron density are higher earlier in life. Accumulation of neurons in the white matter in schizophrenia would be congruent with a negative correlation between DCX mRNA and white matter neuron density and support the hypothesis of a migration deficit in schizophrenia.	[Fung, Samantha J.; Joshi, Dipesh; Allen, Katherine M.; Sivagnanasundaram, Sinthuja; Rothmond, Debora A.; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Sydney, NSW, Australia; [Fung, Samantha J.; Joshi, Dipesh; Allen, Katherine M.; Sivagnanasundaram, Sinthuja; Rothmond, Debora A.; Weickert, Cynthia Shannon] Neurosci Res Australia, Sydney, NSW, Australia; [Fung, Samantha J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Allen, Katherine M.; Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Saunders, Richard] NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; [Noble, Pamela L.] Natl Inst Mental Hlth NIMH IRP Nonhuman Primate C, Poolesville, MD USA; [Webster, Maree J.] Stanley Med Res Inst, Rockville, MD USA	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Fung, SJ (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	s.fung@neura.edu.au	Joshi, Dipesh/I-2918-2012; Fung, Samantha/C-9660-2011; Weickert, Cynthia Shannon/G-3171-2011	Shannon Weickert, Cynthia/0000-0002-4560-0259	Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia [630452]; University of Sydney; National Institute of Alcohol Abuse and Alcoholism [R24AA012725]; NSW Department of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725] Funding Source: NIH RePORTER	Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NSW Department of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Schizophrenia Research Institute, utilizing funding from NSW Health and the Macquarie Group Foundation; Neuroscience Research Australia; the University of New South Wales; and National Health and Medical Research Council of Australia (grant number 630452). Tissues were received from the Australian Brain Donor Programs NSW Tissue Resource Centre, which is supported by the University of Sydney, National Health and Medical Research Council of Australia, Schizophrenia Research Institute, National Institute of Alcohol Abuse and Alcoholism (grant number R24AA012725) and NSW Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Anderson SA, 1996, SCHIZOPHR RES, V19, P111, DOI 10.1016/0920-9964(96)88521-5; Gomez-Climent MA, 2008, CEREB CORTEX, V18, P2229, DOI 10.1093/cercor/bhm255; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bartkowska K, 2010, BRAIN BEHAV EVOLUT, V76, P128, DOI 10.1159/000320944; Beltaifa S, 2005, EUR J NEUROSCI, V21, P2433, DOI 10.1111/j.1460-9568.2005.04074.x; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cai Y, 2009, EXP NEUROL, V216, P342, DOI 10.1016/j.expneurol.2008.12.008; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; Chong VZ, 2008, INT J DEV NEUROSCI, V26, P791, DOI 10.1016/j.ijdevneu.2008.06.004; Corbo JC, 2002, J NEUROSCI, V22, P7548; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Cox ET, 2009, NEUROSCIENCE, V162, P96, DOI 10.1016/j.neuroscience.2009.04.037; Cruz DA, 2003, J COMP NEUROL, V465, P385, DOI 10.1002/cne.10833; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; des Portes V, 1998, CELL, V92, P51; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Eastwood SL, 2005, SCHIZOPHR RES, V79, P181, DOI 10.1016/j.schres.2005.07.001; Eastwood SL, 2003, MOL PSYCHIATR, V8, P821, DOI 10.1038/sj.mp.4001371; Erickson SL, 2002, J COMP NEUROL, V448, P186, DOI 10.1002/cne.10249; ESTRADA C, 1993, J CEREBR BLOOD F MET, V13, P978, DOI 10.1038/jcbfm.1993.122; Estrada C, 1998, CEREB CORTEX, V8, P193, DOI 10.1093/cercor/8.3.193; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gomez-Climent MA, 2010, ARCH ITAL BIOL, V148, P159; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Grateron L, 2003, J CHEM NEUROANAT, V26, P311, DOI 10.1016/j.jchemneu.2003.09.005; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Iwasaki N, 1997, NEURORADIOLOGY, V39, P841, DOI 10.1007/s002340050517; Kalkman HO, 2009, PHARMACOL THERAPEUT, V121, P115, DOI 10.1016/j.pharmthera.2008.11.002; Kanold PO, 2006, NEURON, V51, P627, DOI 10.1016/j.neuron.2006.07.008; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kirkpatrick B, 2003, J NERV MENT DIS, V191, P563, DOI 10.1097/01.nmd.0000087181.61164.e1; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; KOSTOVIC I, 1980, J NEUROCYTOL, V9, P219, DOI 10.1007/BF01205159; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Suarez-Sola ML, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.007.2009; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Luzzati F, 2009, CEREB CORTEX, V19, P1028, DOI 10.1093/cercor/bhn145; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MEYER G, 1992, EXP BRAIN RES, V88, P204, DOI 10.1007/BF02259143; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Ohira K, 2011, CELL MOL LIFE SCI, V68, P1645, DOI 10.1007/s00018-010-0552-y; Petanjek Z, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.026.2009; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Reep RL, 2000, BRAIN BEHAV EVOLUT, V56, P212, DOI 10.1159/000047206; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Shankle WR, 1998, J THEOR BIOL, V191, P115, DOI 10.1006/jtbi.1997.0570; Shapiro LA, 2007, BRAIN STRUCT FUNCT, V212, P133, DOI 10.1007/s00429-007-0151-3; Shapiro LA, 2009, EPILEPSY BEHAV, V14, P74, DOI 10.1016/j.yebeh.2008.09.011; Varea E, 2007, J CHEM NEUROANAT, V33, P202, DOI 10.1016/j.jchemneu.2007.03.006; Varea E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00017; WAHLE P, 1987, J COMP NEUROL, V261, P165, DOI 10.1002/cne.902610202; Wang C., 2011, CELL RES; Webster MJ, 2011, INT J DEV NEUROSCI, V29, P225, DOI 10.1016/j.ijdevneu.2010.09.006; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Xiong K, 2008, EXP NEUROL, V211, P271, DOI 10.1016/j.expneurol.2008.02.003; Yang HKC, 2004, J NEUROSCI RES, V76, P282, DOI 10.1002/jnr.20071; Yang Y, 2011, BIOL PSYCHIAT, V69, P63, DOI 10.1016/j.biopsych.2010.08.020; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812; Zhang XM, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.017.2009	84	32	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25194	10.1371/journal.pone.0025194	http://dx.doi.org/10.1371/journal.pone.0025194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966452	Green Published, gold, Green Submitted			2022-12-27	WOS:000295932100023
J	Gao, W; Gilmore, JH; Giovanello, KS; Smith, JK; Shen, DG; Zhu, HT; Lin, WL				Gao, Wei; Gilmore, John H.; Giovanello, Kelly S.; Smith, Jeffery Keith; Shen, Dinggang; Zhu, Hongtu; Lin, Weili			Temporal and Spatial Evolution of Brain Network Topology during the First Two Years of Life	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE; CORTEX; ORGANIZATION; EMERGENCE; ANATOMY; MATTER	The mature brain features high wiring efficiency for information transfer. However, the emerging process of such an efficient topology remains elusive. With resting state functional MRI and a large cohort of normal pediatric subjects (n = 147) imaged during a critical time period of brain development, 3 wk- to 2 yr-old, the temporal and spatial evolution of brain network topology is revealed. The brain possesses the small world topology immediately after birth, followed by a remarkable improvement in whole brain wiring efficiency in 1 yr olds and becomes more stable in 2 yr olds. Regional developments of brain wiring efficiency and the evolution of functional hubs suggest differential development trend for primary and higher order cognitive functions during the first two years of life. Simulations of random errors and targeted attacks reveal an age-dependent improvement of resilience. The lower resilience to targeted attack observed in 3 wk old group is likely due to the fact that there are fewer well-established long-distance functional connections at this age whose elimination might have more profound implications in the overall efficiency of information transfer. Overall, our results offer new insights into the temporal and spatial evolution of brain topology during early brain development.	[Gao, Wei; Smith, Jeffery Keith; Shen, Dinggang; Lin, Weili] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27514 USA; [Gao, Wei; Giovanello, Kelly S.; Shen, Dinggang; Zhu, Hongtu; Lin, Weili] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; [Gilmore, John H.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Giovanello, Kelly S.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Zhu, Hongtu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gao, W (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27514 USA.	weili_lin@med.unc.edu	Gilmore, John H./AAE-1398-2019; Gao, Wei/F-2777-2013; Shen, Dinggang/ABF-6812-2020; Smith, J Keith/AAD-3968-2021	Gilmore, John H./0000-0002-0939-6764; Shen, Dinggang/0000-0002-7934-5698; Smith, J Keith/0000-0001-7588-3520	National Institutes of Health [MH064065, HD053000, NS055754]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064065, R01MH070890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from National Institutes of Health, including MH064065, HD053000, and NS055754. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Afif A, 2007, BRAIN STRUCT FUNCT, V212, P335, DOI 10.1007/s00429-007-0161-1; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Benjamini Y, 2001, ANN STAT, V29, P1165; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; Conel J.L., 1939, POSTNATAL DEV HUMAN; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gao W, 2008, AM J NEURORADIOL; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Goursaud APS, 2007, BEHAV BRAIN RES, V176, P75, DOI 10.1016/j.bbr.2006.09.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Grossmann T, 2010, BIOL LETTERS, V6, P540, DOI 10.1098/rsbl.2009.1069; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haynes RL, 2005, J COMP NEUROL, V484, P156, DOI 10.1002/cne.20453; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; KELLEHER JF, 1990, MED HYPOTHESES, V31, P55, DOI 10.1016/0306-9877(90)90055-J; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; POTEGAL M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P479; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ross-Sheehy S, 2003, CHILD DEV, V74, P1807, DOI 10.1046/j.1467-8624.2003.00639.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Streeter GL., 1912, DEV NERVOUS SYSTEM; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	50	158	159	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25278	10.1371/journal.pone.0025278	http://dx.doi.org/10.1371/journal.pone.0025278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966479	gold, Green Submitted, Green Published			2022-12-27	WOS:000295267100039
J	Marques-da-Silva, C; Chaves, MM; Rodrigues, JC; Corte-Real, S; Coutinho-Silva, R; Persechini, PM				Marques-da-Silva, Camila; Chaves, Mariana Martins; Rodrigues, Juliany Cola; Corte-Real, Suzana; Coutinho-Silva, Robson; Persechini, Pedro Muanis			Differential Modulation of ATP-Induced P2X7-Associated Permeabilities to Cations and Anions of Macrophages by Infection with Leishmania amazonensis	PLOS ONE			English	Article							P2X(7) RECEPTOR; TOXOPLASMA-GONDII; TRYPANOSOMA-CRUZI; EXTRACELLULAR ATP; INDUCED APOPTOSIS; DENDRITIC CELLS; INNATE IMMUNITY; PARASITE; INFLAMMATION; AMASTIGOTES	Leishmania and other parasites display several mechanisms to subvert host immune cell function in order to achieve successful infection. The ATP receptor P2X7, an agonist-gated cation channel widely expressed in macrophages and other cells of the immune system, is also coupled to inflammasome activation, IL-1 beta secretion, production of reactive oxygen species, cell death and the induction of the permeabilization of the plasma membrane to molecules of up to 900 Da. P2X7 receptors can function as an effective microbicidal triggering receptor in macrophages infected with several microorganisms including Mycobacteria tuberculosis, Chlamydia and Leishmania. We have previously shown that its expression is up-regulated in macrophages infected with L. amazonensis and that infected cells also display an increase in P2X7-induced apoptosis and membrane permeabilization to some anionic fluorescent dyes. In an independent study we recently showed that the phenomenon of macrophage membrane permeabilization can involve at least two distinct pathways for cations and anions respectively. Here, we re-addressed the effects of ATP-induced P2X7-associated phenomena in macrophages infected with L. amazonensis and demonstrated that the P2X7-associated dye uptake mechanisms are differentially modulated. While the membrane permeabilization for anionic dyes is up-modulated, as previously described, the uptake of cationic dyes is strongly down-modulated. These results unveil new characteristics of two distinct permeabilization mechanisms associated with P2X7 receptors in macrophages and provide the first evidence indicating that these pathways can be differentially modulated in an immunologically relevant situation. The possible importance of these results to the L. amazonensis escape mechanism is discussed.	[Marques-da-Silva, Camila; Chaves, Mariana Martins; Rodrigues, Juliany Cola; Coutinho-Silva, Robson; Persechini, Pedro Muanis] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Corte-Real, Suzana] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Marques-da-Silva, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	rcsilva@biof.ufrj.br	Coutinho-Silva, Robson/M-4690-2013; Marques-da-Silva, Camila/B-9284-2014; Fisiologia, Ciencias Biologicas/C-2407-2012; Chaves, Mariana/H-2333-2015; Rodrigues, Juliany Cola Fernandes/X-4977-2019; Chaves, Mariana Martins/F-2663-2014; Rodrigues, Juliany Cola Fernandes/H-2836-2012; Persechini, Pedro/A-9477-2009	Coutinho-Silva, Robson/0000-0002-7318-0204; Rodrigues, Juliany Cola Fernandes/0000-0001-6807-8101; Persechini, Pedro/0000-0002-3278-1951; M Chaves, Mariana/0000-0002-7515-3461; Silva, Camila/0000-0003-1132-1793	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Nucleos de Excelencia (PRONEX-CNPq); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/MCT (INCT-INPeTAm/CNPq/MCT), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia (PRONEX-CNPq); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/MCT (INCT-INPeTAm/CNPq/MCT), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(www.cnpq.br), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(www.faperj.br), Programa de Nucleos de Excelencia (PRONEX-CNPq) and Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/MCT (INCT-INPeTAm/CNPq/MCT), Brazil.(http://www.cnpq.br/programas/inct/_apresentacao/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Barcinski MA, 1999, BRAZ J MED BIOL RES, V32, P395, DOI 10.1590/S0100-879X1999000400003; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bhardwaj S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/109189; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; Burnstock G, 2010, ACTA PHYSIOL, V199, P93, DOI 10.1111/j.1748-1716.2010.02114.x; Cankurtaran-Sayar S, 2009, MOL PHARMACOL, V76, P1323, DOI 10.1124/mol.109.059923; Cassol E, 2010, J LEUKOCYTE BIOL, V87, P599, DOI 10.1189/jlb.1009673; Chaves SP, 2009, MICROBES INFECT, V11, P842, DOI 10.1016/j.micinf.2009.05.001; Correa G, 2010, MICROBES INFECT, V12, P497, DOI 10.1016/j.micinf.2010.03.004; Costa HM, 2009, PROSTAG OTH LIPID M, V88, P51, DOI 10.1016/j.prostaglandins.2008.09.004; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Coutinho-Silva R, 1997, AM J PHYSIOL-CELL PH, V273, pC1793, DOI 10.1152/ajpcell.1997.273.6.C1793; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Coutinho-Silva R, 2009, PURINERG SIGNAL, V5, P197, DOI 10.1007/s11302-009-9130-x; DARDANONI L., 1956, RIV 1ST SIEROTERAP ITAL, V31, P1; de Souza MC, 2010, ACTA TROP, V115, P262, DOI 10.1016/j.actatropica.2010.04.007; Denkers EY, 2005, TRENDS PARASITOL, V21, P35, DOI 10.1016/j.pt.2004.10.004; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Donovan MJ, 2009, EXP PARASITOL, V123, P58, DOI 10.1016/j.exppara.2009.05.012; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Forero ME, 1999, J MEMBRANE BIOL, V170, P173, DOI 10.1007/s002329900547; Fortea JOY, 2007, IMMUNOL REV, V219, P66, DOI 10.1111/j.1600-065X.2007.00559.x; Fortes FSA, 2004, J CELL SCI, V117, P4717, DOI 10.1242/jcs.01345; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Heussler VT, 2001, INT J PARASITOL, V31, P1166, DOI 10.1016/S0020-7519(01)00271-5; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; LAMY L, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P964; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; MAUEL J, 1990, J LEUKOCYTE BIOL, V47, P187, DOI 10.1002/jlb.47.2.187; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Monteiro-da-Cruz C, 2006, BRIT J PHARMACOL, V147, P324; NOGUEIRA N, 1976, J EXP MED, V143, P1402, DOI 10.1084/jem.143.6.1402; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2008, DRUG NEWS PERSPECT, V21, P424, DOI 10.1358/dnp.2008.21.8.1265800; Persechini PM, 1998, BRAZ J MED BIOL RES, V31, P25, DOI 10.1590/S0100-879X1998000100004; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; POPOVIC M, 1987, LANCET, V2, P916; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; RUSSELL DG, 1992, J CELL SCI, V103, P1193; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Schachter J, 2008, J CELL SCI, V121, P3261, DOI 10.1242/jcs.029991; Sharma U, 2009, INDIAN J EXP BIOL, V47, P412; Sikora A, 1999, J IMMUNOL, V163, P558; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Valdes-Reyes L, 2009, EXP PARASITOL, V121, P199, DOI 10.1016/j.exppara.2008.10.020; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Wanderley JLM, 2005, BRAZ J MED BIOL RES, V38, P807, DOI 10.1590/S0100-879X2005000600001	64	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25356	10.1371/journal.pone.0025356	http://dx.doi.org/10.1371/journal.pone.0025356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966508	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100048
J	Balabanova, Y; Gilsdorf, A; Buda, S; Burger, R; Eckmanns, T; Gartner, B; Gross, U; Haas, W; Hamouda, O; Hubner, J; Janisch, T; Kist, M; Kramer, MH; Ledig, T; Mielke, M; Pulz, M; Stark, K; Suttorp, N; Ulbrich, U; Wichmann, O; Krause, G				Balabanova, Yanina; Gilsdorf, Andreas; Buda, Silke; Burger, Reinhard; Eckmanns, Tim; Gaertner, Barbara; Gross, Uwe; Haas, Walter; Hamouda, Osamah; Huebner, Johannes; Jaenisch, Thomas; Kist, Manfred; Kramer, Michael H.; Ledig, Thomas; Mielke, Martin; Pulz, Matthias; Stark, Klaus; Suttorp, Norbert; Ulbrich, Uta; Wichmann, Ole; Krause, Gerard			Communicable Diseases Prioritized for Surveillance and Epidemiological Research: Results of a Standardized Prioritization Procedure in Germany, 2011	PLOS ONE			English	Article							HEALTH-SERVICES RESEARCH; SETTING PRIORITIES; HELICOBACTER-PYLORI; MATRIX	Introduction: To establish strategic priorities for the German national public health institute (RKI) and guide the institute's mid-term strategic decisions, we prioritized infectious pathogens in accordance with their importance for national surveillance and epidemiological research. Methods: We used the Delphi process with internal (RKI) and external experts and a metric-consensus approach to score pathogens according to ten three-tiered criteria. Additional experts were invited to weight each criterion, leading to the calculation of a median weight by which each score was multiplied. We ranked the pathogens according to the total weighted score and divided them into four priority groups. Results: 127 pathogens were scored. Eighty-six experts participated in the weighting; "Case fatality rate" was rated as the most important criterion. Twenty-six pathogens were ranked in the highest priority group; among those were pathogens with internationally recognised importance (e.g., Human Immunodeficiency Virus, Mycobacterium tuberculosis, Influenza virus, Hepatitis C virus, Neisseria meningitides), pathogens frequently causing large outbreaks (e. g., Campylobacter spp.), and nosocomial pathogens associated with antimicrobial resistance. Other pathogens in the highest priority group included Helicobacter pylori, Respiratory Syncytial Virus, Varicella zoster virus and Hantavirus. Discussion: While several pathogens from the highest priority group already have a high profile in national and international health policy documents, high scores for other pathogens (e.g., Helicobacter pylori, Respiratory syncytial virus or Hantavirus) indicate a possible under-recognised importance within the current German public health framework. A process to strengthen respective surveillance systems and research has been started. The prioritization methodology has worked well; its modular structure makes it potentially useful for other settings.	[Balabanova, Yanina; Gilsdorf, Andreas; Buda, Silke; Burger, Reinhard; Eckmanns, Tim; Haas, Walter; Hamouda, Osamah; Mielke, Martin; Stark, Klaus; Wichmann, Ole; Krause, Gerard] Robert Koch Inst, D-1000 Berlin, Germany; [Gaertner, Barbara] Univ Saarland, Inst Microbiol & Hyg, D-6650 Homburg, Germany; [Gross, Uwe] Univ Gottingen, Dept Med Microbiol, Gottingen, Germany; [Huebner, Johannes] Univ Med Ctr Freiburg, Div Infect Dis, Freiburg, Germany; [Jaenisch, Thomas] Univ Heidelberg, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany; [Kist, Manfred] Univ Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany; [Kramer, Michael H.] Fed Minist Hlth, Div Communicable Dis AIDS & Prevent Epidem, Berlin, Germany; [Pulz, Matthias] Govt Inst Publ Hlth Lower Saxony, Hannover, Germany; [Suttorp, Norbert] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany; [Ulbrich, Uta] Dortmund Reg Hlth Author, Dortmund, Germany	Robert Koch Institute; Saarland University; University of Gottingen; University of Freiburg; Ruprecht Karls University Heidelberg; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Balabanova, Y (corresponding author), Robert Koch Inst, D-1000 Berlin, Germany.	lenzy@rki.de	Jaenisch, Thomas/H-3473-2017	Suttorp, Norbert/0000-0002-3958-1151; Krause, Gerard/0000-0003-3328-8808; Wichmann, Ole/0000-0003-2353-7188; Gilsdorf, Andreas/0000-0001-8572-2798; Huebner, Johannes/0000-0003-1232-4646	Robert Koch Institute	Robert Koch Institute	The study was funded internally by Robert Koch Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MILL DEV GOALS REP; [Anonymous], 2008, INT HLTH REG; Berra S, 2010, INT J TECHNOL ASSESS, V26, P217, DOI 10.1017/S0266462310000012; Carter Anne O., 1992, Morbidity and Mortality Weekly Report, V41, P79; *COMM EUR COMM, 2009, OFF J EUR UN; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Doherty J A, 2000, Can J Infect Dis, V11, P21; *ECDC, 2011, ECEDC ANN WORK PROGR, V2011; Fleurence RL, 2004, HEALTH POLICY, V69, P1, DOI 10.1016/j.healthpol.2003.11.002; Ghaffar A, 2009, INDIAN J MED RES, V129, P368; Gilsdorf A, 2011, EURO SURVEILL, V16; Gooberman-Hill R, 2008, HEALTH EXPECT, V11, P272, DOI 10.1111/j.1369-7625.2008.00502.x; Heymann DL, 2008, CONTROL COMMUNICABLE; Kapiriri L, 2007, CROAT MED J, V48, P618; Krause G, 2008, EURO SURVEILL, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lomas J, 2003, MILBANK Q, V81, P363, DOI 10.1111/1468-0009.t01-1-00060; Miller S, 2010, J PEDIATR NURS, V25, P551, DOI 10.1016/j.pedn.2010.06.011; Nuyens Y, 2007, B WORLD HEALTH ORGAN, V85, P319, DOI 10.2471/BLT.06.032375; Remme JHF, 2002, TRENDS MICROBIOL, V10, P435, DOI 10.1016/S0966-842X(02)02431-9; Sibbald SL, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-43; Siedler A, 2010, EURO SURVEILL, V15, P19530; Tan VPY, 2011, J GASTROEN HEPATOL, V26, P42, DOI 10.1111/j.1440-1746.2010.06593.x; Tegnell A, 2006, CELL MOL LIFE SCI, V63, P2223, DOI 10.1007/s00018-006-6310-5; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; World Health Organization, 2010, WHOHTMTB20107; Wueppenhorst N, 2009, J ANTIMICROB CHEMOTH, V63, P648, DOI 10.1093/jac/dkp003; 2008, PRIOR SETT METH HLTH; 2008, GERM STRAT ANT RES; 2010, MED TERM STAT PLAN 2; 2000, BUNDESGEZETZBLATT, V33, P1045	31	65	71	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25691	10.1371/journal.pone.0025691	http://dx.doi.org/10.1371/journal.pone.0025691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991334	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300017
J	Bourgeois, MA; Denslow, ND; Seino, KS; Barber, DS; Long, MT				Bourgeois, Melissa A.; Denslow, Nancy D.; Seino, Kathy S.; Barber, David S.; Long, Maureen T.			Gene Expression Analysis in the Thalamus and Cerebrum of Horses Experimentally Infected with West Nile Virus	PLOS ONE			English	Article							LIVE FLAVIVIRUS CHIMERA; DENGUE VIRUS; MICROARRAY; IDENTIFICATION; MECHANISMS; DURATION; VACCINES; STRAINS; BRAIN; DEATH	Gene expression associated with West Nile virus (WNV) infection was profiled in the central nervous system of horses. Pyrosequencing and library annotation was performed on pooled RNA from the CNS and lymphoid tissues on horses experimentally infected with WNV (vaccinated and naive) and non-exposed controls. These sequences were used to create a custom microarray enriched for neurological and immunological sequences to quantitate gene expression in the thalamus and cerebrum of three experimentally infected groups of horses (naive/WNV exposed, vaccinated/WNV exposed, and normal). From the sequenced transcriptome, 41,040 sequences were identified by alignment against five databases. 31,357 good sequence hits (e < 10(-4)) were obtained with 3.1% of the sequences novel to the equine genome project. Sequences were compared to human expressed sequence tag database, with 31,473 equine sequences aligning to human sequences (69.27% contigs, 78.13% seed contigs, 80.17% singlets). This indicated a high degree of sequence homology between human and equine transcriptome (average identity 90.17%). Significant differences (p < 0.05) in gene expression were seen due to virus exposure (9,020), survival (7,395), and location (7,649). Pathways analysis revealed many genes that mapped to neurological and immunological categories. Involvement of both innate and adaptive components of immunity was seen, with higher levels of expression correlating with survival. This was highlighted by increased expression of suppressor of cytokine signaling 3 in horses exposed to WNV which functions to suppress innate immunity. Pentraxin 3 was most increased in expression for all horses exposed to WNV. Neurological pathways that demonstrated the greatest changes in gene expression included neurotransmitter and signaling pathways. Decreased expression of transcripts in both the glutamate and dopamine signaling pathways was seen in horses exposed to WNV, providing evidence of possible glutamate excitotoxicity and clinical signs associated with decreased dopamine. Many transcripts mapped to non-infectious neurological disease functions, including mental disorders and degenerative neuropathies.	[Bourgeois, Melissa A.; Long, Maureen T.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Denslow, Nancy D.; Barber, David S.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Seino, Kathy S.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington State University	Bourgeois, MA (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	MBourgeois@cdc.gov			University of South Florida Centers for Biological Defense	University of South Florida Centers for Biological Defense	This work was supported by the University of South Florida Centers for Biological Defense research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Bene R, 2009, ACTA CLIN CROAT, V48, P377; Blakely PK, 2009, J NEUROPATH EXP NEUR, V68, P1061, DOI 10.1097/NEN.0b013e3181b8ba14; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; Center for Disease Control and Prevention (CDC), 2011, CDC W NIL VIR STAT S; Darman J, 2004, J NEUROSCI, V24, P7566, DOI 10.1523/JNEUROSCI.2002-04.2004; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Erdmann NB, 2006, CLIN NEUROSCI RES, V6, P315, DOI 10.1016/j.cnr.2006.09.009; Glaser KE, 2009, EQUINE VET J, V41, P663, DOI 10.2746/042516409X412381; Grinev A, 2008, J VIROL METHODS, V154, P27, DOI 10.1016/j.jviromet.2008.09.015; Gupta N, 2010, VIRUS RES, V147, P107, DOI 10.1016/j.virusres.2009.10.018; Kaul M, 2008, FRONT BIOSCI-LANDMRK, V13, P2484, DOI 10.2741/2860; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076; Korimbocus J, 2005, J CLIN MICROBIOL, V43, P3779, DOI 10.1128/JCM.43.8.3779-3787.2005; Lefeuvre A, 2006, MICROBES INFECT, V8, P1530, DOI 10.1016/j.micinf.2006.01.013; Liew KJL, 2006, J VIROL METHODS, V131, P47, DOI 10.1016/j.jviromet.2005.07.003; Long MT, 2007, EQUINE VET J, V39, P491, DOI 10.2746/042516407X217416; Long MT, 2007, EQUINE VET J, V39, P486, DOI 10.2746/042516407X214473; Mansfield KL, 2010, VECTOR-BORNE ZOONOT, V10, P649, DOI 10.1089/vbz.2009.0259; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Moreno-Altamirano MMB, 2004, SCAND J IMMUNOL, V60, P631, DOI 10.1111/j.0300-9475.2004.01519.x; Nasirudeen AMA, 2009, J MED VIROL, V81, P1069, DOI 10.1002/jmv.21486; Nordstrom H, 2005, J MED VIROL, V77, P528, DOI 10.1002/jmv.20489; Porter MB, 2003, J AM VET MED ASSOC, V222, P1241, DOI 10.2460/javma.2003.222.1241; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Rodrigues L, 2009, EXPERT REV VACCINES, V8, P167, DOI 10.1586/14760584.8.2.167; Rodrigues L, 2009, MOL IMMUNOL, V46, P1494, DOI 10.1016/j.molimm.2008.12.033; Seino KK, 2007, CLIN VACCINE IMMUNOL, V14, P1465, DOI 10.1128/CVI.00249-07; Sellon D, EQUINE INFECT DIS; U.S. Department of Agriculture (USDA), 2011, USDA APHIS AN HLTH M; Ubol S, 2008, VIROLOGY, V376, P290, DOI 10.1016/j.virol.2008.03.030; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Venter M, 2005, VIROLOGY, V342, P119, DOI 10.1016/j.virol.2005.07.013; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Xiao Wei-wei, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P905; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633	39	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e24371	10.1371/journal.pone.0024371	http://dx.doi.org/10.1371/journal.pone.0024371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991302	gold, Green Published, Green Submitted			2022-12-27	WOS:000295963300003
J	Broderick, MP; Hansen, CJ; Russell, KL; Kaplan, EL; Blumer, JL; Faix, DJ				Broderick, Michael P.; Hansen, Christian J.; Russell, Kevin L.; Kaplan, Edward L.; Blumer, Jeffrey L.; Faix, Dennis J.			Serum Penicillin G Levels Are Lower Than Expected in Adults within Two Weeks of Administration of 1.2 Million Units	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; RHEUMATIC-FEVER; BENZATHINE; PHARYNGITIS; PREVENTION	When introduced in the 1950s, benzathine penicillin G (BPG) was shown to be effective in eradicating group A beta-hemolytic streptococcus (GAS) for at least 3 weeks after administration. Several studies since the 1990s suggest that at 3-4 weeks serum penicillin G levels are less than adequate (below MIC 90 of 0.016 mg/ml). We studied these levels for 4 weeks after the recommended dose of BPG in military recruits, for whom it is used as prophylaxis against GAS. The 329 subjects (mean age 20 years) each received 1.2 million units BPG IM and gave sera 1 day post injection and twice more at staggered time points over 4 weeks. Serum penicillin G levels were measured by liquid chromatography/tandem mass spectometry. The half-life of serum penicillin G was 4.1 days. By day 11, mean levels were, <0.02 mu g/ml, and by day 15<0.01 mu g/ml. Levels in more than 50% of the subjects were below 0.02 mu g/ml on day 9, and, <.01 mg/ml on day 16. There was no demonstrable effect of subject body-surface area nor of the four different lots of BPG used. These data indicate that in healthy young adults serum penicillin G levels become less than protective <21/2 weeks after injection of 1.2 million units of BPG. The findings require serious consideration in future medical and public health recommendations for treatment and prophylaxis of GAS upper respiratory tract infections.	[Broderick, Michael P.; Hansen, Christian J.] USN, Henry M Jackson Fdn Adv Mil Med, Hlth Res Ctr, San Diego, CA 92152 USA; [Russell, Kevin L.] US Dept Def Global Emerging Infect Surveillance &, Silver Spring, MD USA; [Kaplan, Edward L.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Blumer, Jeffrey L.] Case Western Reserve Univ, Sch Med, Dept Pediat & Pharmacol, Cleveland, OH USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University	Broderick, MP (corresponding author), USN, Henry M Jackson Fdn Adv Mil Med, Hlth Res Ctr, San Diego, CA 92152 USA.	michael.broderick@med.navy.mil			Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center [60501]	Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center(United States Department of Defense)	This work was supported by the Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center, WU# 60501, http://afhsc.mil/geis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass JW, 1996, CLIN INFECT DIS, V22, P727, DOI 10.1093/clinids/22.4.727; Carapetis JR, 2006, DIAGNOSIS MANAGEMENT; Crum NF, 2005, CLIN INFECT DIS, V40, P511, DOI 10.1086/427502; CURRIE BJ, 1994, ANTIMICROB AGENTS CH, V38, P1203, DOI 10.1128/AAC.38.5.1203; Decourt L V, 1983, Arq Bras Cardiol, V40, P3; ELIAS W, 1951, ANTIBIOT CHEMOTHER, V1, P491; Gerber MA, 2009, CIRCULATION, V119, P1541, DOI 10.1161/CIRCULATIONAHA.109.191959; Kaplan EL, 2006, CLIN INFECT DIS, V43, P1398, DOI 10.1086/508773; Kaplan EL, 1999, PEDIATR INFECT DIS J, V18, P1069, DOI 10.1097/00006454-199912000-00008; Kaplan EL, 2001, PEDIATRICS, V108, P1180, DOI 10.1542/peds.108.5.1180; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Ndiaye AG, 2009, J INFECT DEV COUNTR, V3, P660, DOI 10.3855/jidc.20; Raghuram T C, 1979, Indian Heart J, V31, P333; STOLLERMAN GH, 1952, JAMA-J AM MED ASSOC, V150, P1571, DOI 10.1001/jama.1952.03680160021005; WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease, 2001, WHO TECHN REP SER, V923; WRIGHT WILLIAM W., 1959, ANTIBIOT MED AND CLIN THER, V6, P232; ZAHER SR, 1992, J PHARM MED, V2, P17	17	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25308	10.1371/journal.pone.0025308	http://dx.doi.org/10.1371/journal.pone.0025308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991307	Green Published, gold, Green Submitted			2022-12-27	WOS:000295963300009
J	Pavan, G; Dalmaso, M; Galfano, G; Castelli, L				Pavan, Giulia; Dalmaso, Mario; Galfano, Giovanni; Castelli, Luigi			Racial Group Membership Is Associated to Gaze-Mediated Orienting in Italy	PLOS ONE			English	Article							STEREOTYPE CONTENT; VISUAL-ATTENTION; SOCIAL ATTENTION; REFLEXIVE; ATTITUDES; MONKEYS; COMPETENCE; PERCEPTION; ACTIVATION; COGNITION	Viewing a face with averted gaze results in a spatial shift of attention in the corresponding direction, a phenomenon defined as gaze-mediated orienting. In the present paper, we investigated whether this effect is influenced by social factors. Across three experiments, White and Black participants were presented with faces of White and Black individuals. A modified spatial cueing paradigm was used in which a peripheral target stimulus requiring a discrimination response was preceded by a noninformative gaze cue. Results showed that Black participants shifted attention to the averted gaze of both ingroup and outgroup faces, whereas White participants selectively shifted attention only in response to individuals of their same group. Interestingly, the modulatory effect of social factors was context-dependent and emerged only when group membership was situationally salient to participants. It was hypothesized that differences in the relative social status of the two groups might account for the observed asymmetry between White and Black participants. A final experiment ruled out an alternative explanation based on differences in perceptual familiarity with the face stimuli. Overall, these findings strengthen the idea that gaze-mediated orienting is a socially-connoted phenomenon.	[Pavan, Giulia; Dalmaso, Mario; Galfano, Giovanni; Castelli, Luigi] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy	University of Padua	Pavan, G (corresponding author), Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy.	giovanni.galfano@unipd.it	Galfano, Giovanni/B-7582-2008; GALFANO, GIOVANNI/AAI-6142-2020; Dalmaso, Mario/F-6507-2011	GALFANO, GIOVANNI/0000-0001-5327-4062; Dalmaso, Mario/0000-0003-0199-7861; Castelli, Luigi/0000-0002-1472-4507	University of Padova [60A17-8231, 60A17-1159]	University of Padova	The research was funded by the University of Padova (grants 60A17-8231 and 60A17-1159 awarded to GG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GLI STRAN NEL MERC L; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Castelli L, 2008, J EXP SOC PSYCHOL, V44, P679, DOI 10.1016/j.jesp.2007.04.006; Castelli L, 2011, J EXP SOC PSYCHOL, V47, P1013, DOI 10.1016/j.jesp.2011.03.016; Castelli L, 2009, DEV PSYCHOL, V45, P586, DOI 10.1037/a0014619; CHANCE MRA, 1967, MAN, V2, P503, DOI 10.2307/2799336; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Deaner RO, 2007, BIOL LETTERS, V3, P64, DOI 10.1098/rsbl.2006.0564; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DEVINE PG, 1995, PERS SOC PSYCHOL B, V21, P1139, DOI 10.1177/01461672952111002; Dovidio J. F., 2006, SAGE HDB NONVERBAL C, V25, P481, DOI DOI 10.4135/9781412976152.N25; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Dunham Y, 2006, CHILD DEV, V77, P1268, DOI 10.1111/j.1467-8624.2006.00933.x; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Friesen CK, 2004, J EXP PSYCHOL HUMAN, V30, P319, DOI 10.1037/0096-1523.30.2.319; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Holmes A, 2006, BRAIN COGNITION, V60, P282, DOI 10.1016/j.bandc.2005.05.002; Hosie JA, 1996, MEMORY, V4, P175, DOI 10.1080/096582196389031; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; KEVERNE EB, 1978, ANIM BEHAV, V26, P933, DOI 10.1016/0003-3472(78)90157-4; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Macrae CN, 2009, J EXP SOC PSYCHOL, V45, P1012, DOI 10.1016/j.jesp.2009.04.021; McNelis Nicole L., 1998, Animal Cognition, V1, P65, DOI 10.1007/s100710050008; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Pannozzo PL, 2007, ETHOLOGY, V113, P881, DOI 10.1111/j.1439-0310.2007.01392.x; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Ristic J, 2007, PSYCHON B REV, V14, P964, DOI 10.3758/BF03194129; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004930; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Sidanius J., 1999, SOCIAL DOMINANCE INT; Sniderman Paul M., 2000, OUTSIDER PREJUDICE P; Stevens SA, 2008, PSYCHON B REV, V15, P1148, DOI 10.3758/PBR.15.6.1148; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	45	70	70	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25608	10.1371/journal.pone.0025608	http://dx.doi.org/10.1371/journal.pone.0025608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834MB	21991323	Green Published, gold, Green Submitted			2022-12-27	WOS:000295963300014
J	Chassot, AA; Gregoire, EP; Lavery, R; Taketo, MM; de Rooij, DG; Adams, IR; Chaboissier, MC				Chassot, Anne-Amandine; Gregoire, Elodie P.; Lavery, Rowena; Taketo, Makoto M.; de Rooij, Dirk G.; Adams, Ian R.; Chaboissier, Marie-Christine			RSPO1/beta-Catenin Signaling Pathway Regulates Oogonia Differentiation and Entry into Meiosis in the Mouse Fetal Ovary	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; RETINOIC ACID; BETA-CATENIN; SEX DETERMINATION; SUPPRESSES MEIOSIS; MEIOTIC INITIATION; CONSERVED ROLE; ENTER MEIOSIS; R-SPONDIN1; EXPRESSION	Differentiation of germ cells into male gonocytes or female oocytes is a central event in sexual reproduction. Proliferation and differentiation of fetal germ cells depend on the sex of the embryo. In male mouse embryos, germ cell proliferation is regulated by the RNA helicase Mouse Vasa homolog gene and factors synthesized by the somatic Sertoli cells promote gonocyte differentiation. In the female, ovarian differentiation requires activation of the WNT/beta-catenin signaling pathway in the somatic cells by the secreted protein RSPO1. Using mouse models, we now show that Rspo1 also activates the WNT/beta-catenin signaling pathway in germ cells. In XX Rspo1(-/-) gonads, germ cell proliferation, expression of the early meiotic marker Stra8, and entry into meiosis are all impaired. In these gonads, impaired entry into meiosis and germ cell sex reversal occur prior to detectable Sertoli cell differentiation, suggesting that beta-catenin signaling acts within the germ cells to promote oogonial differentiation and entry into meiosis. Our results demonstrate that RSPO1/beta-catenin signaling is involved in meiosis in fetal germ cells and contributes to the cellular decision of germ cells to differentiate into oocyte or sperm.	[Chassot, Anne-Amandine; Gregoire, Elodie P.; Lavery, Rowena; Chaboissier, Marie-Christine] Fac Med Nice, INSERM, U636, F-06034 Nice, France; [Chassot, Anne-Amandine; Gregoire, Elodie P.; Lavery, Rowena; Chaboissier, Marie-Christine] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, Nice, France; [Taketo, Makoto M.] Kyoto Univ Yoshida Konoe Cho, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto, Japan; [de Rooij, Dirk G.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [de Rooij, Dirk G.] Univ Utrecht, Dept Endocrinol & Metab, Fac Sci, Utrecht, Netherlands; [Adams, Ian R.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Kyoto University; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; University of Edinburgh	Chassot, AA (corresponding author), Fac Med Nice, INSERM, U636, U210, F-06034 Nice, France.	Marie-Christine.Chaboissier@unice.fr	Adams, Ian R/AAU-1231-2021; CHABOISSIER, Marie-Christine/F-6166-2019; Chassot, Anne-Amandine/O-2102-2016; CHABOISSIER, Marie-Christine/AAZ-5905-2021; de Rooij, D.G./AAW-1195-2021; Grégoire, Elodie P./CAG-7541-2022; Adams, Ian/P-9862-2016	Adams, Ian R/0000-0001-8838-1271; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Chassot, Anne-Amandine/0000-0003-1242-9456; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Grégoire, Elodie P./0000-0001-7614-4754; Adams, Ian/0000-0001-8838-1271; de Rooij, Dirk/0000-0003-3932-4419	Association pour la Recherche sur le Cancer, Agence Nationale pour la Recherche [ANR-09-GENM-009-03, ANR-10-Blanc]; La Fondation pour la Recherche Medicale; MRC [MC_U127580973] Funding Source: UKRI; Medical Research Council [MC_U127580973] Funding Source: researchfish	Association pour la Recherche sur le Cancer, Agence Nationale pour la Recherche(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Association pour la Recherche sur le Cancer, Agence Nationale pour la Recherche (ANR-09-GENM-009-03 and ANR-10-Blanc SVSE2-Molmechmeiosis). A.A.C. was financed by La Fondation pour la Recherche Medicale (post-doctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Allard S, 2000, DEVELOPMENT, V127, P3349; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bingham NC, 2006, GENESIS, V44, P419, DOI 10.1002/dvg.20231; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brault V, 2001, DEVELOPMENT, V128, P1253; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Di Carlo A, 2000, DEV BIOL, V226, P209, DOI 10.1006/dbio.2000.9861; DiNapoli L, 2006, DEVELOPMENT, V133, P1519, DOI 10.1242/dev.02303; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Gregoire EP, 2011, DEV BIOL, V349, P65, DOI 10.1016/j.ydbio.2010.10.006; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim B, 2011, DEV BIOL, V349, P417, DOI 10.1016/j.ydbio.2010.10.010; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kimble J, 2007, SCIENCE, V316, P400, DOI 10.1126/science.1142109; Kocer A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-36; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; Li H, 2004, BIOL REPROD, V70, P687, DOI 10.1095/biolreprod.103.023135; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Li H, 2009, BIOL REPROD, V81, P996, DOI 10.1095/biolreprod.109.078808; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Morita Y, 1999, ENDOCRINOLOGY, V140, P2696, DOI 10.1210/en.140.6.2696; Nagamine CM, 1996, DEVELOPMENT, V122, P3597; Naillat F, 2010, HUM MOL GENET; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Tanaka SS, 2000, GENE DEV, V14, P841; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622	73	91	93	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25641	10.1371/journal.pone.0025641	http://dx.doi.org/10.1371/journal.pone.0025641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991325	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000049
J	Frenzel, J; Gessner, C; Sandvoss, T; Hammerschmidt, S; Schellenberger, W; Sack, U; Eschrich, K; Wirtz, H				Frenzel, Jochen; Gessner, Christian; Sandvoss, Torsten; Hammerschmidt, Stefan; Schellenberger, Wolfgang; Sack, Ulrich; Eschrich, Klaus; Wirtz, Hubert			Outcome Prediction in Pneumonia Induced ALI/ARDS by Clinical Features and Peptide Patterns of BALF Determined by Mass Spectrometry	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; BRONCHOALVEOLAR LAVAGE FLUID; OBSTRUCTIVE PULMONARY-DISEASE; SUPPORT VECTOR MACHINES; PROTEOMIC ANALYSIS; SAMPLE PREPARATION; CANCER-PATIENTS; TIDAL VOLUME; CLASSIFICATION	Background: Peptide patterns of bronchoalveolar lavage fluid (BALF) were assumed to reflect the complex pathology of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) better than clinical and inflammatory parameters and may be superior for outcome prediction. Methodology/Principal Findings: A training group of patients suffering from ALI/ARDS was compiled from equal numbers of survivors and nonsurvivors. Clinical history, ventilation parameters, Murray's lung injury severity score (Murray's LISS) and interleukins in BALF were gathered. In addition, samples of bronchoalveolar lavage fluid were analyzed by means of hydrophobic chromatography and MALDI-ToF mass spectrometry (MALDI-ToF MS). Receiver operating characteristic (ROC) analysis for each clinical and cytokine parameter revealed interleukin-6>interleukin-8>diabetes mellitus>Murray's LISS as the best outcome predictors. Outcome predicted on the basis of BALF levels of interleukin-6 resulted in 79.4% accuracy, 82.7% sensitivity and 76.1% specificity (area under the ROC curve, AUC, 0.853). Both clinical parameters and cytokines as well as peptide patterns determined by MALDI-ToF MS were analyzed by classification and regression tree (CART) analysis and support vector machine (SVM) algorithms. CART analysis including Murray's LISS, interleukin-6 and interleukin-8 in combination was correct in 78.0%. MALDI-ToF MS of BALF peptides did not reveal a single identifiable biomarker for ARDS. However, classification of patients was successfully achieved based on the entire peptide pattern analyzed using SVM. This method resulted in 90% accuracy, 93.3% sensitivity and 86.7% specificity following a 10-fold cross validation (AUC = 0.953). Subsequent validation of the optimized SVM algorithm with a test group of patients with unknown prognosis yielded 87.5% accuracy, 83.3% sensitivity and 90.0% specificity. Conclusions/Significance: MALDI-ToF MS peptide patterns of BALF, evaluated by appropriate mathematical methods can be of value in predicting outcome in pneumonia induced ALI/ARDS.	[Frenzel, Jochen; Schellenberger, Wolfgang; Eschrich, Klaus] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Gessner, Christian; Sandvoss, Torsten; Hammerschmidt, Stefan; Wirtz, Hubert] Univ Leipzig, Dept Resp Med, Leipzig, Germany; [Sack, Ulrich] Univ Leipzig, Inst Clin Immunol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Frenzel, J (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany.	Jochen.Frenzel@medizin.uni-leipzig.de	Sack, Ulrich/J-6301-2015	Sack, Ulrich/0000-0002-7813-0492	University of Leipzig	University of Leipzig	This work was supported by the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JH, 2008, STAT APPL GENET MOL, V7; Ben-David A, 2008, ENG APPL ARTIF INTEL, V21, P874, DOI 10.1016/j.engappai.2007.09.009; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bowler RP, 2004, AM J PHYSIOL-LUNG C, V286, pL1095, DOI 10.1152/ajplung.00304.2003; Bowler RP, 2006, CHEST, V130, P567, DOI 10.1378/chest.130.2.567; Bowler Russell P, 2006, COPD, V3, P41, DOI 10.1080/15412550500493394; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Candiano G, 2007, AM J PHYSIOL-LUNG C, V292, pL185, DOI 10.1152/ajplung.00085.2006; Chang DW, 2008, AM J RESP CRIT CARE, V178, P701, DOI 10.1164/rccm.200712-1895OC; Chaurand P, 2004, J PROTEOME RES, V3, P245, DOI 10.1021/pr0341282; Craig TR, 2010, CRIT CARE MED, V38, P114, DOI 10.1097/CCM.0b013e3181b43050; de Torre C, 2006, PROTEOMICS, V6, P3949, DOI 10.1002/pmic.200500693; Diaz JV, 2010, CRIT CARE MED, V38, P1644, DOI 10.1097/CCM.0b013e3181e795ee; Esme H, 2007, THORAC CARDIOV SURG, V55, P190, DOI 10.1055/s-2006-955883; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; Gamez-Pozo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007731; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Gessner C, 2003, CHEST, V124, P1046, DOI 10.1378/chest.124.3.1046; Girard TD, 2007, CHEST, V131, P921, DOI 10.1378/chest.06-1515; Grassi M, 2001, EUR J EPIDEMIOL, V17, P19, DOI 10.1023/A:1010987521885; Hirsch J, 2004, AM J PHYSIOL-LUNG C, V287, pL1, DOI 10.1152/ajplung.00301.2003; HUNNINGHAKE GW, 1979, AM J PATHOL, V97, P149; Ichikado K, 2006, RADIOLOGY, V238, P321, DOI 10.1148/radiol.2373041515; Jayasurya K, 2010, MED PHYS, V37, P1401, DOI 10.1118/1.3352709; KIPNIS E, 2009, INTENS CARE MED, P23; Kriegova E, 2006, AM J RESP CRIT CARE, V173, P1145, DOI 10.1164/rccm.200507-1126OC; Lee KS, 2008, RESP MED, V102, P464, DOI 10.1016/j.rmed.2007.10.001; Lee Y, 2009, COMPUT METH PROG BIO, V93, P206, DOI 10.1016/j.cmpb.2008.10.008; Leroy Baptiste, 2008, V425, P67, DOI 10.1007/978-1-60327-210-0_6; Lin WC, 2010, EXP BIOL MED, V235, P57, DOI 10.1258/ebm.2009.009256; Markey MK, 2003, PROTEOMICS, V3, P1678, DOI 10.1002/pmic.200300521; Merkel D, 2005, PROTEOMICS, V5, P2972, DOI 10.1002/pmic.200401180; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Noel-Georis I, 2002, J CHROMATOGR B, V771, P221, DOI 10.1016/S1570-0232(02)00114-9; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Plymoth A, 2003, PROTEOMICS, V3, P962, DOI 10.1002/pmic.200300387; Rocco TR, 2001, ANN SURG, V233, P414, DOI 10.1097/00000658-200103000-00017; Rose AS, 2007, SEMIN RESP CRIT CARE, V28, P561, DOI 10.1055/s-2007-991528; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Rupf S, 2005, ORAL MICROBIOL IMMUN, V20, P267, DOI 10.1111/j.1399-302X.2005.00223.x; Seeley E, 2008, THORAX, V63, P994, DOI 10.1136/thx.2007.093658; Stingu CS, 2008, J MED MICROBIOL, V57, P495, DOI 10.1099/jmm.0.47649-0; Tibshirani R, 2004, BIOINFORMATICS, V20, P3034, DOI 10.1093/bioinformatics/bth357; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware Lorraine B, 2005, Crit Care Med, V33, pS217, DOI 10.1097/01.CCM.0000155788.39101.7E; Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484; Wattiez R, 2005, J CHROMATOGR B, V815, P169, DOI 10.1016/j.jchromb.2004.10.029; WESTON J, MATLAB MACHINE LEARN; Wu J, 2005, MOL CELL PROTEOMICS, V4, P1251, DOI 10.1074/mcp.M500041-MCP200; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134; Zhu ZH, 2009, J CLIN ONCOL, V27, P1091, DOI 10.1200/JCO.2008.16.6991	56	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25544	10.1371/journal.pone.0025544	http://dx.doi.org/10.1371/journal.pone.0025544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991318	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000038
J	Baarsma, HA; Spanjer, AIR; Haitsma, G; Engelbertink, LHJM; Meurs, H; Jonker, MR; Timens, W; Postma, DS; Kerstjens, HAM; Gosens, R				Baarsma, Hoeke A.; Spanjer, Anita I. R.; Haitsma, Gertruud; Engelbertink, Lilian H. J. M.; Meurs, Herman; Jonker, Marnix R.; Timens, Wim; Postma, Dirkje S.; Kerstjens, Huib A. M.; Gosens, Reinoud			Activation of WNT/beta-Catenin Signaling in Pulmonary Fibroblasts by TGF-beta(1) Is Increased in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AIRWAY SMOOTH-MUSCLE; BETA-CATENIN; GENE-EXPRESSION; TGF-BETA; TRANSCRIPTIONAL ACTIVATION; LUNG FIBROBLASTS; WNT PATHWAY; MOLECULE; VERSICAN	Background: Chronic obstructive pulmonary disease (COPD) is characterized by abnormal extracellular matrix (ECM) turnover. Recently, activation of the WNT/beta-catenin pathway has been associated with abnormal ECM turnover in various chronic diseases. We determined WNT-pathway gene expression in pulmonary fibroblasts of individuals with and without COPD and disentangled the role of beta-catenin in fibroblast phenotype and function. Methods: We assessed the expression of WNT-pathway genes and the functional role of beta-catenin, using MRC-5 human lung fibroblasts and primary pulmonary fibroblasts of individuals with and without COPD. Results: Pulmonary fibroblasts expressed mRNA of genes required for WNT signaling. Stimulation of fibroblasts with TGF-beta(1), a growth factor important in COPD pathogenesis, induced WNT-5B, FZD(8), DVL3 and beta-catenin mRNA expression. The induction of WNT-5B, FZD(6), FZD(8) and DVL3 mRNA by TGF-beta(1) was higher in fibroblasts of individuals with COPD than without COPD, whilst basal expression was similar. Accordingly, TGF-beta(1) activated beta-catenin signaling, as shown by an increase in transcriptionally active and total beta-catenin protein expression. Furthermore, TGF-beta(1) induced the expression of collagen1 alpha 1, alpha-sm-actin and fibronectin, which was attenuated by beta-catenin specific siRNA and by pharmacological inhibition of beta-catenin, whereas the TGF-beta(1)-induced expression of PAI-1 was not affected. The induction of transcriptionally active beta-catenin and subsequent fibronectin deposition induced by TGF-beta(1) were enhanced in pulmonary fibroblasts from individuals with COPD. Conclusions: beta-catenin signaling contributes to ECM production by pulmonary fibroblasts and contributes to myofibroblasts differentiation. WNT/beta-catenin pathway expression and activation by TGF-beta(1) is enhanced in pulmonary fibroblasts from individuals with COPD. This suggests an important role of the WNT/beta-catenin pathway in regulating fibroblast phenotype and function in COPD.	[Baarsma, Hoeke A.; Spanjer, Anita I. R.; Haitsma, Gertruud; Engelbertink, Lilian H. J. M.; Meurs, Herman; Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Jonker, Marnix R.; Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Postma, Dirkje S.; Kerstjens, Huib A. M.] Univ Groningen, Dept Pulmonol, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Baarsma, HA (corresponding author), Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands.	H.A.Baarsma@rug.nl	Timens, Wim/K-5570-2013; Kerstjens, Huib/N-4754-2017	Timens, Wim/0000-0002-4146-6363; Kerstjens, Huib/0000-0001-7705-7927; Baarsma, Hoeke/0000-0002-0792-0374; Jonker, Marnix R./0000-0001-6309-871X; Gosens, Reinoud/0000-0002-5595-152X	Netherlands Asthma Foundation [3.2.07.23]; Dutch Organization for Scientific Research (NWO) [916.86.036]	Netherlands Asthma Foundation; Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the Netherlands Asthma Foundation (Grant 3.2.07.23). Reinoud Gosens is supported by a Veni fellowship from the Dutch Organization for Scientific Research (NWO Veni 916.86.036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chung K.F., 2001, EUR RESPIR J, V34, P50, DOI DOI 10.1183/09031936.01.00229701; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doyle JL, 2009, J CELL BIOCHEM, V107, P272, DOI 10.1002/jcb.22123; Gosens R, 2007, AM J PHYSIOL-LUNG C, V293, pL1348, DOI 10.1152/ajplung.00346.2007; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hallgren O, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-55; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Howe LR, 1999, CANCER RES, V59, P1572; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; Konigshoff M, 2009, SWISS MED WKLY, V139, P554, DOI smw-12528; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Laeremans H, 2010, CARDIOVASC RES, V87, P514, DOI 10.1093/cvr/cvq067; Lam AP, 2011, AM J RESP CELL MOL, V45, P915, DOI 10.1165/rcmb.2010-0113OC; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Letamendia A, 2001, J BONE JOINT SURG AM, V83A, pS31; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Minke KS, 2009, EUR J HAEMATOL, V82, P165, DOI 10.1111/j.1600-0609.2008.01188.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140303789; Noordhoek Jacobien A, 2005, COPD, V2, P17; Nunes RO, 2008, AM J PHYSIOL-LUNG C, V294, pL1110, DOI 10.1152/ajplung.00500.2007; Pauwels R A, 2001, Respir Care, V46, P798; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Plantier Laurent, 2007, Int J Chron Obstruct Pulmon Dis, V2, P463; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Shafer SL, 2009, J MOL CELL CARDIOL, V46, P621, DOI 10.1016/j.yjmcc.2009.01.005; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83; Zhang XB, 2001, CANCER RES, V61, P6050	58	113	123	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25450	10.1371/journal.pone.0025450	http://dx.doi.org/10.1371/journal.pone.0025450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980461	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300032
J	Fox, AA; Pretorius, M; Liu, KY; Collard, CD; Perry, TE; Shernan, SK; De Jager, PL; Hafler, DA; Herman, DS; DePalma, SR; Roden, DM; Muehlschlegel, JD; Donahue, BS; Darbar, D; Seidman, JG; Body, SC; Seidman, CE				Fox, Amanda A.; Pretorius, Mias; Liu, Kuang-Yu; Collard, Charles D.; Perry, Tjorvi E.; Shernan, Stanton K.; De Jager, Philip L.; Hafler, David A.; Herman, Daniel S.; DePalma, Steven R.; Roden, Dan M.; Muehlschlegel, Jochen D.; Donahue, Brian S.; Darbar, Dawood; Seidman, J. G.; Body, Simon C.; Seidman, Christine E.			Genome-Wide Assessment for Genetic Variants Associated with Ventricular Dysfunction after Primary Coronary Artery Bypass Graft Surgery	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; HEART-FAILURE; MORTALITY	Background: Postoperative ventricular dysfunction (VnD) occurs in 9-20% of coronary artery bypass graft (CABG) surgical patients and is associated with increased postoperative morbidity and mortality. Understanding genetic causes of postoperative VnD should enhance patient risk stratification and improve treatment and prevention strategies. We aimed to determine if genetic variants associate with occurrence of in-hospital VnD after CABG surgery. Methods: A genome-wide association study identified single nucleotide polymorphisms (SNPs) associated with postoperative VnD in male subjects of European ancestry undergoing isolated primary CABG surgery with cardiopulmonary bypass. VnD was defined as the need for >= 2 inotropes or mechanical ventricular support after CABG surgery. Validated SNPs were assessed further in two replication CABG cohorts and meta-analysis was performed. Results: Over 100 SNPs were associated with VnD (P<10(-4)), with one SNP (rs17691914) encoded at 3p22.3 reaching genome-wide significance (P-additive (model) = 2.14 x 10(-8)). Meta-analysis of validation and replication study data for 17 SNPs identified three SNPs associated with increased risk for developing postoperative VnD after adjusting for clinical risk factors. These SNPs are located at 3p22.3 (rs17691914, ORadditive model = 2.01, P = 0.0002), 3p14.2 (rs17061085, ORadditive model = 1.70, P = 0.0001) and 11q23.2 (rs12279572, ORrecessive (model) = 2.19, P = 0.001). Conclusions: No SNPs were consistently associated with strong risk (ORadditive model >2.1) of developing in-hospital VnD after CABG surgery. However, three genetic loci identified by meta-analysis were more modestly associated with development of postoperative VnD. Studies of larger cohorts to assess these loci as well as to define other genetic mechanisms and related biology that link genetic variants to postoperative ventricular dysfunction are warranted.	[Fox, Amanda A.; Liu, Kuang-Yu; Shernan, Stanton K.; Muehlschlegel, Jochen D.; Body, Simon C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Pretorius, Mias; Donahue, Brian S.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Collard, Charles D.] St Lukes Episcopal Hosp, Texas Heart Inst, Div Cardiovasc Anesthesia, Houston, TX USA; [Perry, Tjorvi E.] NW Anesthesia PA, Minneapolis, MN USA; [De Jager, Philip L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Herman, Daniel S.; DePalma, Steven R.; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Herman, Daniel S.; DePalma, Steven R.; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Partners HealthCare Ctr Genet & Genom, Boston, MA 02115 USA; [Roden, Dan M.; Darbar, Dawood] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Seidman, Christine E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiol, Boston, MA 02115 USA; [Seidman, Christine E.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Vanderbilt University; Saint Lukes Episcopal Hospital; Texas Heart Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Partners Healthcare System; Vanderbilt University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Fox, AA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.	afox@partners.org	Body, Simon C/O-2605-2013; Roden, Dan/ABD-5412-2021; Body, Simon/AAQ-7572-2020; Muehlschlegel, Danny/A-2993-2011; Perry, Tjorvi E/ABB-2736-2020; Darbar, Dawood/C-9079-2015	Body, Simon C/0000-0001-6721-7050; Body, Simon/0000-0001-6721-7050; Darbar, Dawood/0000-0002-4103-5977; Muehlschlegel, Jochen/0000-0002-6209-7253; DePalma, Steven/0000-0002-0381-5016; Donahue, Brian/0000-0001-9195-7374; Fox, Amanda/0000-0002-7027-5806; Pretorius, Mias/0000-0002-8777-3940	Foundation for Anesthesia, Research and Education, Rochester, Minnesota; American Geriatrics Society, New York, New York; National Inistitutes of Health National Heart, Lung, and Blood Institute, Bethesda, Maryland [K23 HL068774, RO1 098601, U19 HL065962, RO1 HL092217]; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Division of Cardiovascular Anesthesia at the Texas Heart Institute, Saint Luke's Episcopal Hospital, Houston, Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092217, U19HL065962, K23HL068774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Foundation for Anesthesia, Research and Education, Rochester, Minnesota; American Geriatrics Society, New York, New York; National Inistitutes of Health National Heart, Lung, and Blood Institute, Bethesda, Maryland; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Division of Cardiovascular Anesthesia at the Texas Heart Institute, Saint Luke's Episcopal Hospital, Houston, Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Foundation for Anesthesia, Research and Education, Rochester, Minnesota (Principal Investigator: AF; URL http://www.faer.org/programs/grants/index.html); Dennis W. Jahnigen Career Development Scholars Award, American Geriatrics Society, New York, New York (Principal Investigator: AF; URL http://specialists.americangeriatrics.org/jahnigen/apply/about_dennis.php); the National Inistitutes of Health National Heart, Lung, and Blood Institute, Bethesda, Maryland (K23 HL068774 and RO1 098601 Principal Investigator: SB; U19 HL065962 and RO1 HL092217 Principal Investigator: DD), and Funding from the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts and Division of Cardiovascular Anesthesia at the Texas Heart Institute, Saint Luke's Episcopal Hospital, Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; *CA UOS, 2009, QUANT; Fox AA, 2008, J THORAC CARDIOV SUR, V136, P452, DOI 10.1016/j.jtcvs.2007.12.036; Fox AA, 2010, ANESTHESIOLOGY, V112, P842, DOI 10.1097/ALN.0b013e3181d23168; Fox AA, 2009, ANESTHESIOLOGY, V110, P738, DOI 10.1097/ALN.0b013e31819c7496; Haddad GE, 2008, PHYSIOL GENOMICS, V33, P267, DOI 10.1152/physiolgenomics.00265.2007; Hutfless R, 2004, J AM COLL CARDIOL, V43, P1873, DOI 10.1016/j.jacc.2003.12.048; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Li MY, 2008, EUR J HUM GENET, V16, P635, DOI 10.1038/sj.ejhg.5202007; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Morrison AC, 2010, CIRC-CARDIOVASC GENE, V3, P248, DOI 10.1161/CIRCGENETICS.109.895995; Nieminen MS, 2008, EUR J HEART FAIL, V10, P140, DOI 10.1016/j.ejheart.2007.12.012; Ohki-Kaneda R, 2004, BIOCHEM BIOPH RES CO, V320, P1328, DOI 10.1016/j.bbrc.2004.06.090; Okumura H, 2009, CANCER SCI, V100, P1145, DOI 10.1111/j.1349-7006.2009.01168.x; Provenchere S, 2006, CRIT CARE MED, V34, P995, DOI 10.1097/01.CCM.0000206110.94385.C4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao V, 1996, J THORAC CARDIOV SUR, V112, P38, DOI 10.1016/S0022-5223(96)70176-9; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24593	10.1371/journal.pone.0024593	http://dx.doi.org/10.1371/journal.pone.0024593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980348	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300006
J	Otsuka, A; Kubo, M; Honda, T; Egawa, G; Nakajima, S; Tanizaki, H; Kim, B; Matsuoka, S; Watanabe, T; Nakae, S; Miyachi, Y; Kabashima, K				Otsuka, Atsushi; Kubo, Masato; Honda, Tetsuya; Egawa, Gyohei; Nakajima, Saeko; Tanizaki, Hideaki; Kim, Bongju; Matsuoka, Satoshi; Watanabe, Takeshi; Nakae, Susumu; Miyachi, Yoshiki; Kabashima, Kenji			Requirement of Interaction between Mast Cells and Skin Dendritic Cells to Establish Contact Hypersensitivity	PLOS ONE			English	Article							CUTANEOUS IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; T-CELLS; ACTIVATION; MIGRATION; MICE; TNF; IGE; EXPRESSION; RECEPTOR	The role of mast cells (MCs) in contact hypersensitivity (CHS) remains controversial. This is due in part to the use of the MC-deficient Kit(W/Wv) mouse model, since Kit(W/Wv) mice congenitally lack other types of cells as a result of a point mutation in c-kit. A recent study indicated that the intronic enhancer (IE) for Il4 gene transcription is essential for MCs but not in other cell types. The aim of this study is to re-evaluate the roles of MCs in CHS using mice in which MCs can be conditionally and specifically depleted. Transgenic Mas-TRECK mice in which MCs are depleted conditionally were newly generated using cell-type specific gene regulation by IE. Using this mouse, CHS and FITC-induced cutaneous DC migration were analyzed. Chemotaxis assay and cytoplasmic Ca(2+) imaging were performed by co-culture of bone marrow-derived MCs (BMMCs) and bone marrow-derived dendritic cells (BMDCs). In Mas-TRECK mice, CHS was attenuated when MCs were depleted during the sensitization phase. In addition, both maturation and migration of skin DCs were abrogated by MC depletion. Consistently, BMMCs enhanced maturation and chemotaxis of BMDC in ICAM-1 and TNF-alpha dependent manners Furthermore, stimulated BMDCs increased intracellular Ca(2+) of MC upon direct interaction and up-regulated membrane-bound TNF-alpha on BMMCs. These results suggest that MCs enhance DC functions by interacting with DCs in the skin to establish the sensitization phase of CHS.	[Otsuka, Atsushi; Honda, Tetsuya; Egawa, Gyohei; Nakajima, Saeko; Tanizaki, Hideaki; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Otsuka, Atsushi; Kim, Bongju; Matsuoka, Satoshi; Watanabe, Takeshi] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Kanagawa, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Frontier Res Initiat, Minato Ku, Tokyo, Japan	Kyoto University; Kyoto University; RIKEN; University of Tokyo	Otsuka, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.	kaba@kuhp.kyoto-u.ac.jp	matsuoka, satoshi/GWD-0440-2022; Nakajima, Saeko/AAB-1577-2021; Kim, Bongju/M-2016-2019; Kubo, Masato/A-5918-2016; Kabashima, Kenji/G-2521-2014	matsuoka, satoshi/0000-0003-3321-9749; Kim, Bongju/0000-0001-7309-5977; Egawa, Gyohei/0000-0002-6101-4719; Otsuka, Atsushi/0000-0001-7365-947X; Nakajima, Saeko/0000-0003-0831-1447; Kabashima, Kenji/0000-0002-0773-0554	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23650258] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; EGAWA G, 2011, J INVEST DERMATOL; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hammad H, 2003, J IMMUNOL, V171, P3936, DOI 10.4049/jimmunol.171.8.3936; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Inamura N, 1998, J IMMUNOL, V160, P4026; Jawdat DM, 2004, J IMMUNOL, V173, P5275, DOI 10.4049/jimmunol.173.8.5275; Kabashima K, 2004, J DERMATOL SCI, V34, P177, DOI 10.1016/j.jdermsci.2003.11.008; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Kitawaki T, 2006, INT IMMUNOL, V18, P1789, DOI 10.1093/intimm/dxl113; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Maurer M, 1997, LAB INVEST, V77, P319; Nakajima S, 2010, J IMMUNOL, V184, P5595, DOI 10.4049/jimmunol.0903260; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; RA CS, 1994, J ALLERGY CLIN IMMUN, V94, P625, DOI 10.1016/0091-6749(94)90139-2; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; SWOPE VB, 1994, J INVEST DERMATOL, V102, P749, DOI 10.1111/1523-1747.ep12376970; Tanizaki H, 2010, BLOOD, V116, P5875, DOI 10.1182/blood-2010-01-264150; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07; Yu N, 2009, J DERMATOL SCI, V56, P113, DOI 10.1016/j.jdermsci.2009.08.003	30	102	107	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25538	10.1371/journal.pone.0025538	http://dx.doi.org/10.1371/journal.pone.0025538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980488	gold, Green Submitted, Green Published			2022-12-27	WOS:000295941300038
J	Yin, JK; Lu, KR; Lin, J; Wu, L; Hildebrandt, MAT; Chang, DW; Meyer, L; Wu, XF; Liang, D				Yin, Jikai; Lu, Karen; Lin, Jie; Wu, Lei; Hildebrandt, Michelle A. T.; Chang, David W.; Meyer, Larissa; Wu, Xifeng; Liang, Dong			Genetic Variants in TGF-beta Pathway Are Associated with Ovarian Cancer Risk	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SUSCEPTIBILITY; EXPRESSION; HYPOTHESIS; MUTATIONS; RECEPTORS; CELLS	The transforming growth factor-beta (TGF-beta) signaling pathway is involved in a diverse array of cellular processes responsible for tumorigenesis. In this case-control study, we applied a pathway-based approach to evaluate single-nucleotide polymorphisms (SNPs) in the TGF-beta signaling pathway as predictors of ovarian cancer risk. We systematically genotyped 218 SNPs from 21 genes in the TGF-beta signaling pathway in 417 ovarian cancer cases and 417 matched control subjects. We analyzed the associations of these SNPs with ovarian cancer risk, performed haplotype analysis and identified potential cumulative effects of genetic variants. We also performed analysis to identify higher-order gene-gene interactions influencing ovarian cancer risk. Individual SNP analysis showed that the most significant SNP was SMAD6:rs4147407, with an adjusted odds ratio (OR) of 1.60 (95% confidence interval [CI], 1.14-2.24, P = 0.0066). Cumulative genotype analysis of 13 SNPs with significant main effects exhibited a clear dose-response trend of escalating risk with increasing number of unfavorable genotypes. In gene-based analysis, SMAD6 was identified as the most significant gene associated with ovarian cancer risk. Haplotype analysis further revealed that two haplotype blocks within SMAD6 were significantly associated with decreased ovarian cancer risk, as compared to the most common haplotype. Gene-gene interaction analysis further categorized the study population into subgroups with different ovarian cancer risk. Our findings suggest that genetic variants in the TGF-beta signaling pathway are associated with ovarian cancer risk and may facilitate the identification of high-risk subgroups in the general population.	[Yin, Jikai; Lin, Jie; Hildebrandt, Michelle A. T.; Chang, David W.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lu, Karen; Meyer, Larissa] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Wu, Lei] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX USA; [Liang, Dong] Texas So Univ, Coll Pharm, Houston, TX 77004 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; Texas Southern University	Yin, JK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	liang_dx@tsu.edu			Department of Defense [W81XWH-07-0449]; National Institutes of Health/National Center for Research Resources/Research Centers in Minority Institutions [5G12RR003045-21]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003045] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health/National Center for Research Resources/Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported in part by the Department of Defense Ovarian Cancer Research Program under award number W81XWH-07-0449, and National Institutes of Health/National Center for Research Resources/Research Centers in Minority Institutions grant 5G12RR003045-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony ML, 2010, J CANCER RES CLIN, V136, P351, DOI 10.1007/s00432-009-0703-4; Bai ST, 2002, J BIOL CHEM, V277, P4176, DOI 10.1074/jbc.M105105200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERCHUCK A, 1992, AM J OBSTET GYNECOL, V166, P676, DOI 10.1016/0002-9378(92)91697-9; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Bowen NJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-71; Chen T, 2001, CANCER RES, V61, P4679; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hu W, 2000, ANTICANCER RES, V20, P729; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Martinek I, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007929.pub2; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Notaridou M, 2011, INT J CANCER, V128, P2063, DOI 10.1002/ijc.25554; Ramus SJ, 2007, HUM MUTAT, V28, P1207, DOI 10.1002/humu.20599; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Stenvers KL, 2010, TRENDS ENDOCRIN MET, V21, P174, DOI 10.1016/j.tem.2009.11.009; Wang D, 2000, INT J ONCOL, V17, P1087; Wu XF, 2009, CANCER PREV RES, V2, P617, DOI 10.1158/1940-6207.CAPR-09-0025; Yamada SD, 1999, GYNECOL ONCOL, V75, P72, DOI 10.1006/gyno.1999.5535	30	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25559	10.1371/journal.pone.0025559	http://dx.doi.org/10.1371/journal.pone.0025559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984931	gold, Green Submitted, Green Published			2022-12-27	WOS:000295941300041
J	Darmanis, S; Nong, RY; Vanelid, J; Siegbahn, A; Ericsson, O; Fredriksson, S; Backlin, C; Gut, M; Heath, S; Gut, IG; Wallentin, L; Gustafsson, MG; Kamali-Moghaddam, M; Landegren, U				Darmanis, Spyros; Nong, Rachel Yuan; Vanelid, Johan; Siegbahn, Agneta; Ericsson, Olle; Fredriksson, Simon; Backlin, Christofer; Gut, Marta; Heath, Simon; Gut, Ivo Glynne; Wallentin, Lars; Gustafsson, Mats G.; Kamali-Moghaddam, Masood; Landegren, Ulf			ProteinSeq: High-Performance Proteomic Analyses by Proximity Ligation and Next Generation Sequencing	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SOLUBLE P-SELECTIN; PLASMA PROTEOME; MICROARRAYS; ENRICHMENT; ASSAYS	Despite intense interest, methods that provide enhanced sensitivity and specificity in parallel measurements of candidate protein biomarkers in numerous samples have been lacking. We present herein a multiplex proximity ligation assay with readout via realtime PCR or DNA sequencing (ProteinSeq). We demonstrate improved sensitivity over conventional sandwich assays for simultaneous analysis of sets of proteins in 5 mu l of blood plasma. Importantly, we observe a minimal tendency increased background with multiplexing, compared to a sandwich assay, suggesting that higher levels of multiplexing are possible. We used ProteinSeq to analyze proteins in plasma samples from cardiovascular disease (CVD) patient cohorts and matched controls. Three proteins, namely P-selectin, Cystatin-B and Kallikrein-6 were identified as putative diagnostic biomarkers for CVD. The latter two have not been previously reported in the literature and their potential roles must be validated in larger patient cohorts. We conclude that ProteinSeq is promising or screening large numbers of proteins and samples while the technology can provide a much-needed platform for validation of diagnostic markers in biabank samples and in clinical use.	[Darmanis, Spyros; Nong, Rachel Yuan; Vanelid, Johan; Kamali-Moghaddam, Masood; Landegren, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Siegbahn, Agneta; Wallentin, Lars] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Ericsson, Olle] Halo Genom AB, Uppsala, Sweden; [Fredriksson, Simon] Olink Biosci, Uppsala, Sweden; [Backlin, Christofer; Gustafsson, Mats G.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Gut, Marta; Heath, Simon; Gut, Ivo Glynne] Ctr Nacl Anal Genom, Barcelona, Spain; [Darmanis, Spyros; Nong, Rachel Yuan; Vanelid, Johan; Kamali-Moghaddam, Masood; Landegren, Ulf] Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University	Darmanis, S (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Ulf.Landegren@igp.uu.se	Heath, Simon C/J-4138-2012; Darmanis, Spyros/ABG-4670-2020; Landegren, Ulf D/A-8197-2019; Gut, Ivo/ABF-3188-2020; Nong, Rachel Yuan/AAM-1591-2020	Heath, Simon C/0000-0002-9550-0897; Darmanis, Spyros/0000-0003-4002-8158; Gut, Ivo/0000-0001-7219-632X; Ericsson, Olle/0000-0003-0652-1969; Backlin, Christofer/0000-0002-9615-5079	Knut and Alice Wallenberg Foundation; Swedish Research Council; Vinnova/Uppsala Bio; Uppsala Berzelii Center; European Community [FP7/2007-2013, Health-F4-2008-201418]; DiaTools [259796]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova/Uppsala Bio(Vinnova); Uppsala Berzelii Center; European Community(European Commission); DiaTools	This project was supported by funding from the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/), as well as by the Swedish Research Council (http://www.vr.se/), Vinnova/Uppsala Bio (http://www.vinnova.se/), Uppsala Berzelii Center (http://www.berzelii.uu.se/), the European Community's 6th and 7th Framework Programs and European Community's Seventh Framework Program (http://cordis.europa.eu/fp7/home_en.html) (FP7/2007-2013) under grant agreement no Health-F4-2008-201418 - READNA (REvolutionary Approaches and Devices for Nucleic Acid analysis) and grant agreement n 259796 (DiaTools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P995, DOI 10.1074/mcp.M800446-MCP200; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Carlsson A, 2010, PROTEOM CLIN APPL, V4, P591, DOI 10.1002/prca.200900173; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; Eggers KM, 2004, AM HEART J, V148, P574, DOI 10.1016/j.ahj.2004.04.030; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fredriksson S, 2008, CLIN CHEM, V54, P582, DOI 10.1373/clinchem.2007.093195; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Futh R, 2009, EXP CLIN CARDIOL, V14, pE76; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hoofnagle AN, 2009, J IMMUNOL METHODS, V347, P3, DOI 10.1016/j.jim.2009.06.003; Hsu HY, 2008, MED ENG PHYS, V30, P976, DOI 10.1016/j.medengphy.2008.01.003; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Johnston N, 2004, CLIN BIOCHEM, V37, P210, DOI 10.1016/j.clinbiochem.2003.11.002; Lundberg M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004978; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mishra Alok, 2010, Cancers (Basel), V2, P190, DOI 10.3390/cancers2010190; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Poetz O, 2010, MOL CELL PROTEOMICS, V9, P2474, DOI 10.1074/mcp.M110.002709; R Development Core Team, 2010, LANG ENV STAT COMP; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Schwenk JM, 2010, MOL CELL PROTEOMICS, V9, P2497, DOI 10.1074/mcp.M110.001560; Schwenk JM, 2010, PROTEOMICS, V10, P532, DOI 10.1002/pmic.200900657; Shao WP, 2003, J BIOMED BIOTECHNOL, P299, DOI 10.1155/S1110724303209268; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tavoosidana G, 2011, P NATL ACAD SCI US; Wallentin L, 1999, LANCET, V354, P701; Wallentin L, 2003, EUR HEART J, V24, P897, DOI 10.1016/S0195-668X(03)00006-X; Whiteaker JR, 2010, MOL CELL PROTEOMICS, V9, P184, DOI 10.1074/mcp.M900254-MCP200; Xu DY, 1998, INT J CARDIOL, V64, P253, DOI 10.1016/S0167-5273(98)00075-8	33	58	86	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25583	10.1371/journal.pone.0025583	http://dx.doi.org/10.1371/journal.pone.0025583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980495	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600036
J	Schutz, SV; Schrader, AJ; Zengerling, F; Genze, F; Cronauer, MV; Schrader, M				Schuetz, Stefanie V.; Schrader, Andres J.; Zengerling, Friedemann; Genze, Felicitas; Cronauer, Marcus V.; Schrader, Mark			Inhibition of Glycogen Synthase Kinase-3 beta Counteracts Ligand-Independent Activity of the Androgen Receptor in Castration Resistant Prostate Cancer	PLOS ONE			English	Article							NUCLEAR EXPORT; GLUCOCORTICOID-RECEPTOR; GROWTH-INHIBITION; BINDING DOMAIN; LNCAP CELLS; ACTIVATION; PROTEIN; PROGRESSION; EXPRESSION; APOPTOSIS	In order to generate genomic signals, the androgen receptor (AR) has to be transported into the nucleus upon androgenic stimuli. However, there is evidence from in vitro experiments that in castration-resistant prostate cancer (CRPC) cells the AR is able to translocate into the nucleus in a ligand-independent manner. The recent finding that inhibition of the glycogen-synthase-kinase 3 beta (GSK-3 beta) induces a rapid nuclear export of the AR in androgen stimulated prostate cancer cells prompted us to analyze the effects of a GSK-3 beta inhibition in the castration-resistant LNCaP sublines C4-2 and LNCaP-SSR. Both cell lines exhibit high levels of nuclear AR in the absence of androgenic stimuli. Exposure of these cells to the maleimide SB216763, a potent GSK-3 beta inhibitor, resulted in a rapid nuclear export of the AR even under androgen-deprived conditions. Moreover, the ability of C4-2 and LNCaP-SSR cells to grow in the absence of androgens was diminished after pharmacological inhibition of GSK-3 beta in vitro. The ability of SB216763 to modulate AR signalling and function in CRPC in vivo was additionally demonstrated in a modified chick chorioallantoic membrane xenograft assay after systemic delivery of SB216763. Our data suggest that inhibition of GSK-3 beta helps target the AR for export from the nucleus thereby diminishing the effects of mislocated AR in CRPC cells. Therefore inhibition of GSK-3 beta could be an interesting new strategy for the treatment of CRPC.	[Schuetz, Stefanie V.; Schrader, Andres J.; Zengerling, Friedemann; Genze, Felicitas; Cronauer, Marcus V.; Schrader, Mark] Univ Ulm, Dept Urol, Ulm, Germany	Ulm University	Schutz, SV (corresponding author), Univ Ulm, Dept Urol, Ulm, Germany.	marcus.cronauer@uni-ulm.de	Cronauer, Marcus/AAG-7457-2021		Action Lions Vaincre le Cancer, Luxembourg	Action Lions Vaincre le Cancer, Luxembourg	Funding was provided by the Action Lions Vaincre le Cancer, Luxembourg (to MVC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; Chang CY, 2001, CANCER RES, V61, P8712; Chen MW, 2002, ONCOGENE, V21, P7861, DOI 10.1038/sj.onc.1205991; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P2892; Hobisch A, 1996, PROSTATE, V28, P129; HOBISCH A, 1995, CANCER RES, V55, P3068; JENSTER G, 1992, J STEROID BIOCHEM, V41, P671, DOI 10.1016/0960-0760(92)90402-5; JIN F, 2009, NUCLEIC ACIDS RES, V37; Jones JO, 2008, ACS CHEM BIOL, V3, P412, DOI 10.1021/cb800054w; Koivisto P, 1997, CANCER RES, V57, P314; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Kunzi-Rapp K, 2001, J UROLOGY, V166, P1502, DOI 10.1016/S0022-5347(05)65820-X; Li R, 2009, ANTICANCER RES, V29, P2077; Liao XB, 2004, ENDOCRINOLOGY, V145, P2941, DOI 10.1210/en.2003-1519; Liao XB, 2003, MOL CANCER THER, V2, P1215; Liu S, 2008, ONCOGENE, V27, P499, DOI 10.1038/sj.onc.1210671; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Mazor M, 2004, ONCOGENE, V23, P7882, DOI 10.1038/sj.onc.1208068; Molina A, 2011, J UROLOGY, V185, P787, DOI 10.1016/j.juro.2010.10.042; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nguyen MM, 2009, MOL CELL ENDOCRINOL, V302, P65, DOI 10.1016/j.mce.2008.12.010; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Poukka H, 2000, J CELL SCI, V113, P2991; Rinnab L, 2008, NEOPLASIA, V10, P624, DOI 10.1593/neo.08248; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Saporita AJ, 2007, PROSTATE, V67, P509, DOI 10.1002/pros.20541; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Schutz SV, 2010, J CELL BIOCHEM, V109, P1192, DOI 10.1002/jcb.22500; Shank LC, 2008, J BIOL CHEM, V283, P10568, DOI 10.1074/jbc.M800810200; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; THALMANN GN, 1994, CANCER RES, V54, P2577; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	47	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25341	10.1371/journal.pone.0025341	http://dx.doi.org/10.1371/journal.pone.0025341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980429	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600020
J	Schofer, MD; Roessler, PP; Schaefer, J; Theisen, C; Schlimme, S; Heverhagen, JT; Voelker, M; Dersch, R; Agarwal, S; Fuchs-Winkelmann, S; Paletta, JRJ				Schofer, Markus D.; Roessler, Philip P.; Schaefer, Jan; Theisen, Christina; Schlimme, Sonja; Heverhagen, Johannes T.; Voelker, Maximilian; Dersch, Roland; Agarwal, Seema; Fuchs-Winkelmann, Susanne; Paletta, Juergen R. J.			Electrospun PLLA Nanofiber Scaffolds and Their Use in Combination with BMP-2 for Reconstruction of Bone Defects	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SIZE CALVARIAL DEFECT; OSTEOGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; HYBRID SCAFFOLD; DUAL DELIVERY; STROMAL CELLS; GROWTH-FACTOR; ECTOPIC BONE; GENE-THERAPY	Introduction: Adequate migration and differentiation of mesenchymal stem cells is essential for regeneration of large bone defects. To achieve this, modern graft materials are becoming increasingly important. Among them, electrospun nanofiber scaffolds are a promising approach, because of their high physical porosity and potential to mimic the extracellular matrix (ECM). Materials and Methods: The objective of the present study was to examine the impact of electrospun PLLA nanofiber scaffolds on bone formation in vivo, using a critical size rat calvarial defect model. In addition we analyzed whether direct incorporation of bone morphogenetic protein 2 (BMP-2) into nanofibers could enhance the osteoinductivity of the scaffolds. Two critical size calvarial defects (5 mm) were created in the parietal bones of adult male Sprague-Dawley rats. Defects were either (1) left unfilled, or treated with (2) bovine spongiosa, (3) PLLA scaffolds alone or (4) PLLA/BMP-2 scaffolds. Cranial CT-scans were taken at fixed intervals in vivo. Specimens obtained after euthanasia were processed for histology, histomorphometry and immunostaining (Osteocalcin, BMP-2 and Smad5). Results: PLLA scaffolds were well colonized with cells after implantation, but only showed marginal ossification. PLLA/BMP-2 scaffolds showed much better bone regeneration and several ossification foci were observed throughout the defect. PLLA/BMP-2 scaffolds also stimulated significantly faster bone regeneration during the first eight weeks compared to bovine spongiosa. However, no significant differences between these two scaffolds could be observed after twelve weeks. Expression of osteogenic marker proteins in PLLA/BMP-2 scaffolds continuously increased throughout the observation period. After twelve weeks osteocalcin, BMP-2 and Smad5 were all significantly higher in the PLLA/BMP-2 group than in all other groups. Conclusion: Electrospun PLLA nanofibers facilitate colonization of bone defects, while their use in combination with BMP-2 also increases bone regeneration in vivo and thus combines osteoconductivity of the scaffold with the ability to maintain an adequate osteogenic stimulus.	[Schofer, Markus D.; Roessler, Philip P.; Schaefer, Jan; Theisen, Christina; Schlimme, Sonja; Fuchs-Winkelmann, Susanne; Paletta, Juergen R. J.] Univ Hosp Marburg, Dept Orthoped & Rheumatol, Marburg, Germany; [Heverhagen, Johannes T.; Voelker, Maximilian] Univ Hosp Marburg, Dept Diagnost Radiol, Marburg, Germany; [Dersch, Roland; Agarwal, Seema] Univ Marburg, Dept Macromol Chem, Marburg, Germany	University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; Philipps University Marburg	Schofer, MD (corresponding author), Univ Hosp Marburg, Dept Orthoped & Rheumatol, Marburg, Germany.	paletta@med.uni-marburg.de	Agarwal, Seema/O-3307-2014; Roessler, Philip P./H-4342-2013	Agarwal, Seema/0000-0002-3174-3152; Roessler, Philip P./0000-0002-1574-0111; Heverhagen, Johannes/0000-0002-5416-6650; Volker, Maximilian/0000-0002-8792-4462	Deutsche Forschungsgemeinschaft DFG [BO 3065/1-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG (Grant No. BO 3065/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014; Akita S, 2004, WOUND REPAIR REGEN, V12, P252, DOI 10.1111/j.1067-1927.2004.012118.x; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Ashammakhi N, 2009, J BIOMED NANOTECHNOL, V5, P1, DOI 10.1166/jbn.2009.1003; Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719; Boyne PJ, 1996, BONE, V19, pS83, DOI 10.1016/S8756-3282(96)00144-5; Chen VJ, 2006, BIOMATERIALS, V27, P3708, DOI 10.1016/j.biomaterials.2006.02.020; Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004; Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029; Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020; DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307; Dersch R, 2003, J POLYM SCI POL CHEM, V41, P545, DOI 10.1002/pola.10609; DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8; Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.0.CO;2-U; Formhals A., 1934, U.S. Patent, Patent No. [1975504, 1,975,504]; Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648; Giavaresi G, 2004, BIOMED PHARMACOTHER, V58, P411, DOI 10.1016/j.biopha.2004.08.001; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Greiner A., 2007, ANGEW CHEM, V119, P5770, DOI DOI 10.1002/ANGE.200604646; Gysin R, 2002, GENE THER, V9, P991, DOI 10.1038/sj.gt.3301772; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383; Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002; Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018; Hosseinkhani H, 2007, TISSUE ENG, V13, P11, DOI 10.1089/ten.2006.0120; Hosseinkhani H, 2006, BIOMATERIALS, V27, P5089, DOI 10.1016/j.biomaterials.2006.05.050; Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030; Inoda H, 2007, INT J ORAL MAX SURG, V36, P39, DOI 10.1016/j.ijom.2006.07.011; Jager M, 2008, J ORTHOP RES, V26, P1440, DOI 10.1002/jor.20565; Jun Z, 2003, E-POLYMERS; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; Lane JM, 1999, CLIN ORTHOP RELAT R, pS107; Levengood SKL, 2010, ACTA BIOMATER, V6, P3283, DOI 10.1016/j.actbio.2010.02.026; Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005; Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009; Nie H, 2008, BIOTECHNOL BIOENG, V99, P223, DOI 10.1002/bit.21517; Paletta J R J, 2011, Eur Cell Mater, V21, P384; Paletta JRJ, 2009, THESCIENTIFICWORLDJO, V9, P1382, DOI 10.1100/tsw.2009.149; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047; Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611; Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009; Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168; Schofer MD, 2008, THESCIENTIFICWORLDJO, V8, P1269, DOI 10.1100/tsw.2008.163; Schofer MD, 2009, THESCIENTIFICWORLDJO, V9, P118, DOI 10.1100/tsw.2009.13; SCHOFER MD, 2008, J MAT SCI MAT MED; Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006; SRINIVASAN G, 1995, POLYM INT, V36, P195, DOI 10.1002/pi.1995.210360210; Srouji S, 2008, J MATER SCI-MATER M, V19, P1249, DOI 10.1007/s10856-007-3218-z; Suzuki A, 2008, EUR POLYM J, V44, P2499, DOI 10.1016/j.eurpolymj.2008.05.021; Theisen C, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-9; Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304; Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2; Waris E, 2004, J HAND SURG-BRIT EUR, V29B, P590, DOI 10.1016/j.jhsb.2004.02.005; Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013; Woo KM, 2009, TISSUE ENG PT A, V15, P2155, DOI 10.1089/ten.tea.2008.0433; Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656; Zhang R, 2002, PROCESSING POLYM SCA, P715; Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L; Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x	64	116	120	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25462	10.1371/journal.pone.0025462	http://dx.doi.org/10.1371/journal.pone.0025462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980467	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900068
J	Stolc, V; Shmygelska, A; Griko, Y				Stolc, Viktor; Shmygelska, Alena; Griko, Yuri			Adaptation of Organisms by Resonance of RNA Transcription with the Cellular Redox Cycle	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; DNA-DAMAGE; METABOLIC CYCLE; YEAST-CELLS; CODON USAGE; MECHANISM; ORIGIN; PHASE; STATE	Sequence variation in organisms differs across the genome and the majority of mutations are caused by oxidation, yet its origin is not fully understood. It has also been shown that the reduction-oxidation reaction cycle is the fundamental biochemical cycle that coordinates the timing of all biochemical processes in the cell, including energy production, DNA replication, and RNA transcription. We show that the temporal resonance of transcriptome biosynthesis with the oscillating binary state of the reduction-oxidation reaction cycle serves as a basis for non-random sequence variation at specific genome-wide coordinates that change faster than by accumulation of chance mutations. This work demonstrates evidence for a universal, persistent and iterative feedback mechanism between the environment and heredity, whereby acquired variation between cell divisions can outweigh inherited variation.	[Stolc, Viktor; Griko, Yuri] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Shmygelska, Alena] Carnegie Mellon Univ, Moffett Field, CA USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Carnegie Mellon University	Stolc, V (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	vstolc@mail.arc.nasa.gov			NASA [NNX08BA52A]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Human Research Program, and NASA contract to the Carnegie Mellon University Silicon Valley #NNX08BA52A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Boole R. G., 1848, CAMBRIDGE DUBLIN MAT, V3, P183; Bridges BA, 1997, NATURE, V387, P557, DOI 10.1038/42370; Burkhardt RW, 1984, ZOOLOGICAL PHILOS JB; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Chambers JM, GRAPHICAL METHODS DA; CHARLESWORTH D, 1988, NATURE, V336, P525, DOI 10.1038/336525a0; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; DAVIS BD, 1989, P NATL ACAD SCI USA, V86, P5005, DOI 10.1073/pnas.86.13.5005; Degtyareva NP, 2008, MOL CELL BIOL, V28, P5432, DOI 10.1128/MCB.00307-08; Demasi APD, 2006, FEBS J, V273, P805, DOI 10.1111/j.1742-4658.2006.05116.x; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Eide L, 1996, P NATL ACAD SCI USA, V93, P10735, DOI 10.1073/pnas.93.20.10735; Eldredge N., 1972, P82; Evans DJ, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051105; Evert BA, 2004, J BIOL CHEM, V279, P22585, DOI 10.1074/jbc.M400468200; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Fehrenbach E, 2001, EXERC IMMUNOL REV, V7, P66; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Georgiou G, 2002, CELL, V111, P607, DOI 10.1016/S0092-8674(02)01165-0; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; Iraqui I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000524; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; KOROGODIN VI, 1991, YEAST, V7, P105, DOI 10.1002/yea.320070204; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Kwak WJ, 2003, FEMS MICROBIOL LETT, V219, P99, DOI 10.1016/S0378-1097(02)01198-9; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Li CM, 2006, P NATL ACAD SCI USA, V103, P16254, DOI 10.1073/pnas.0604860103; Lloyd D, 2007, BIOESSAYS, V29, P465, DOI 10.1002/bies.20575; Lloyd D, 2006, FEBS LETT, V580, P2830, DOI 10.1016/j.febslet.2006.02.066; Mayr E, 1979, ORIGIN SPECIES FACSI, p[11, 43, 134, 135, 136, 137, 447, 454, 455, 472, 479, 480]; Mendel JG., 1865, VERHANDLUNGEN NATURF, V4, P3, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A106151; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Samanta MP, 2006, P NATL ACAD SCI USA, V103, P4192, DOI 10.1073/pnas.0507669103; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Selpi, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-451; *SGD PROJ, SACCH GEN DAT; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Trefil J, 2009, AM SCI, V97, P206, DOI 10.1511/2009.78.206; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2009, P NATL ACAD SCI USA, V106, P14293, DOI 10.1073/pnas.0907786106; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Ward P., 2006, OUT THIN AIR DINOSAU; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wright BE, 2000, J BACTERIOL, V182, P2993, DOI 10.1128/JB.182.11.2993-3001.2000	60	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25270	10.1371/journal.pone.0025270	http://dx.doi.org/10.1371/journal.pone.0025270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980411	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900044
J	Zhou, YH; Tang, JY; Wu, MJ; Lu, J; Wei, X; Qin, YY; Wang, C; Xu, JF; He, J				Zhou, Yu-Hao; Tang, Jian-Yuan; Wu, Mei-Jing; Lu, Jian; Wei, Xin; Qin, Ying-Yi; Wang, Chao; Xu, Jin-Fang; He, Jia			Effect of Folic Acid Supplementation on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							LOWERING HOMOCYSTEINE; STROKE PREVENTION; RISK; DISEASE; INTERVENTION; MORTALITY; TRIALS	Background: Folic acid is widely used to lower homocysteine concentrations and prevent adverse cardiovascular outcomes. However, the effect of folic acid on cardiovascular events is not clear at the present time. We carried out a comprehensive systematic review and meta-analysis to assess the effects of folic acid supplementation on cardiovascular outcomes. Methodology and Principal Findings: We systematically searched Medline, EmBase, the Cochrane Central Register of Controlled Trials, reference lists of articles, and proceedings of major meetings for relevant literature. We included randomized placebo-controlled trials that reported on the effects of folic acid on cardiovascular events compared to placebo. Of 1594 identified studies, we included 16 trials reporting data on 44841 patients. These studies reported 8238 major cardiovascular events, 2001 strokes, 2917 myocardial infarctions, and 6314 deaths. Folic acid supplementation as compared to placebo had no effect on major cardiovascular events (RR, 0.98; 95% CI, 0.93-1.04), stroke (RR, 0.89; 95% CI, 0.78-1.01), myocardial infarction (RR, 1.00; 95% CI, 0.93-1.07), or deaths from any cause (RR, 1.00; 95% CI, 0.96-1.05). Moreover, folic acid as compared to placebo also had no effect on the following secondary outcomes: risk of revascularization (RR, 1.05; 95% CI, 0.95-1.16), acute coronary syndrome (RR, 1.06; 95% CI, 0.97-1.15), cancer (RR, 1.08; 95% CI, 0.98-1.21), vascular death (RR, 0.94; 95% CI, 0.88-1.02), or non-vascular death (RR, 1.06; 95% CI, 0.97-1.15). Conclusion/Significance: Folic acid supplementation does not effect on the incidence of major cardiovascular events, stroke, myocardial infarction or all cause mortality.	[Zhou, Yu-Hao; Wu, Mei-Jing; Lu, Jian; Qin, Ying-Yi; Wang, Chao; Xu, Jin-Fang; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Tang, Jian-Yuan] SFDA, Ctr Drug Evaluat, Off Compliance & Dev, Beijing, Peoples R China; [Wei, Xin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Zhou, YH (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com		He, Jia/0000-0002-2338-9501	National Nature Science Foundation of China [30872186, 81072388]; leading talents of science in Shanghai [022]; Program of Shanghai Subject Chief Scientist [09XD1405500]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); leading talents of science in Shanghai; Program of Shanghai Subject Chief Scientist	Funding was provided by the National Nature Science Foundation of China (30872186, 81072388), a grant from the leading talents of science in Shanghai 2010 (022) and a grant sponsored by the Program of Shanghai Subject Chief Scientist (09XD1405500). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Baker F, 2002, CIRCULATION, V106, P741; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Carlsson CM, 2007, LANCET, V369, P1841, DOI 10.1016/S0140-6736(07)60830-7; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Hodis HN, 2009, STROKE, V40, P730, DOI 10.1161/STROKEAHA.108.526798; House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Liem A, 2005, HEART, V91, P1213, DOI 10.1136/hrt.2004.035030; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Loscalzo J, 2006, NEW ENGL J MED, V354, P1629, DOI 10.1056/NEJMe068060; Mark SD, 1996, AM J EPIDEMIOL, V143, P658, DOI 10.1093/oxfordjournals.aje.a008798; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; McNulty H, 2008, P NUTR SOC, V67, P232, DOI 10.1017/S0029665108007076; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Potter K, 2008, ARTERIOSCL THROM VAS, V28, P1158, DOI 10.1161/ATVBAHA.108.162743; Righetti M, 2006, BLOOD PURIFICAT, V24, P379, DOI 10.1159/000093680; Schnyder G, 2002, JAMA-J AM MED ASSOC, V288, P973, DOI 10.1001/jama.288.8.973; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Spence JD, 2007, LANCET NEUROL, V6, P830, DOI 10.1016/S1474-4422(07)70219-3; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Vianna Areuza C A, 2007, Hemodial Int, V11, P210, DOI 10.1111/j.1542-4758.2007.00171.x; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	38	48	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25142	10.1371/journal.pone.0025142	http://dx.doi.org/10.1371/journal.pone.0025142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980387	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900027
J	Song, LB; Lin, CY; Wu, ZQ; Gong, H; Zeng, Y; Wu, JH; Li, MF; Li, J				Song, Libing; Lin, Chuyong; Wu, Zhiqiang; Gong, Hui; Zeng, Yong; Wu, Jueheng; Li, Mengfeng; Li, Jun			miR-18a Impairs DNA Damage Response through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MICRORNA EXPRESSION; GENE; MUTATIONS; PROTEIN; REPAIR; CELLS; METHYLATION; CHECKPOINTS	The DNA damage response (DDR) encompasses multi-step processes by which cells evolve to sense DNA damage, transduce the signal and initiate the repair of damaged DNA. Ataxia Telangiectasia Mutated (ATM) Kinase, which functions as the primary sensor and transducer of DNA damage signal, has been demonstrated to play an important role in the DDR and cancer prevention. Hence, understanding the molecular mechanisms underlying the regulation of ATM has received much attention. Here, we found that miR-18a was upregulated in both cell lines and patients' tissue samples of breast cancer. Furthermore, we demonstrated that ectopically expressing miR-18a downregulated ATM expression by directly targeting the ATM-39-UTR and abrogated the IR-induced cell cycle arrest. Similar to the effect of ATM siRNA, overexpressing miR-18a in breast cancer cells reduced the DNA damage repair ability and the efficiency of homologous recombination-based DNA repair (HRR) and sensitized cells to c-irradiation (IR) treatment. However, inhibition of miR-18a led to augmentation of DNA damage repair, increase of HRR efficiency and reduced cellular radiosensitivity. Moreover, we showed that the phorsphorylation level and nuclear foci formation of H2AX and 53BP1, the downstream substrates of ATM kinase, were significantly deceased in miR-18a overexpressing cells. Taken together, our results uncover a new regulatory mechanism of ATM expression and suggest that miR-18a might be a novel therapeutic target.	[Song, Libing; Zeng, Yong] Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Chuyong; Wu, Zhiqiang; Gong, Hui; Li, Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Song, LB (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	junli99@gmail.com	Lin, Chuyong/AAA-9931-2020; meng, li/GVT-2063-2022; Song, LB/AAL-1968-2020	Lin, Chuyong/0000-0003-4887-5386; 	Natural Science Foundation of China [81030048, 30870963, 30831160517, 81071647, 81071762, 30872930, 81071780]; Program for New Century Excellent Talents in Universities [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [8251008901000006, 2008A030201006]; Ministry of Education of China [(2008)890, 200805580047, 20100171110080]; Fundamental Research Funds for the Central Universities [10ykzd03]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Science and Technology Department of Guangdong Province, China; Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was funded by The Natural Science Foundation of China (No. 81030048, 30870963, 30831160517, 81071647, 81071762, 30872930, 81071780); Program for New Century Excellent Talents in Universities (No. NCET-07-0877); The Science and Technology Department of Guangdong Province, China (No. 8251008901000006, 2008A030201006); Ministry of Education of China (No.(2008)890, No. 200805580047 and No. 20100171110080); The Fundamental Research Funds for the Central Universities (No. 10ykzd03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Al-Nakhle H, 2010, CANCER RES, V70, P4778, DOI 10.1158/0008-5472.CAN-09-4104; Appleby JM, 1997, BRIT J CANCER, V76, P1546, DOI 10.1038/bjc.1997.593; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Boultwood J, 2001, J CLIN PATHOL, V54, P512, DOI 10.1136/jcp.54.7.512; Bullrich F, 1999, CANCER RES, V59, P24; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gonzalez MB, 2004, HAEMATOLOGICA, V89, P1213; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ji M, 2011, AM J PATHOL; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim K, 2011, ONCOGENE; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lawrie CH, 2007, EXPERT OPIN BIOL TH, V7, P1363, DOI 10.1517/14712598.7.9.1363; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Mavrou A, 2008, ANTICANCER RES, V28, P401; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Ota A, 2004, IDENTIFICATION CHARA; Patry C, 2003, CANCER RES, V63, P7679; Roy K, 2006, BIOCHEM BIOPH RES CO, V344, P821, DOI 10.1016/j.bbrc.2006.03.222; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Taghian DG, 1997, MOL CELL BIOL, V17, P6386, DOI 10.1128/MCB.17.11.6386; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; WEINERT T, 1993, SEMIN CANCER BIOL, V4, P129; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yu GZ, 2004, PANCREAS, V28, P421, DOI 10.1097/00006676-200405000-00011; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	49	101	109	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25454	10.1371/journal.pone.0025454	http://dx.doi.org/10.1371/journal.pone.0025454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980462	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700036
J	Tadavarty, R; Rajput, PS; Wong, JM; Kumar, U; Sastry, BR				Tadavarty, Ramakrishna; Rajput, Padmesh S.; Wong, Jennifer M.; Kumar, Ujendra; Sastry, Bhagavatula R.			Sleep-Deprivation Induces Changes in GABA(B) and mGlu Receptor Expression and Has Consequences for Synaptic Long-Term Depression	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; HIPPOCAMPAL CA1 NEURONS; RAT HIPPOCAMPUS; INCREASED SUSCEPTIBILITY; SOMATOSTATIN RECEPTORS; PYRAMIDAL NEURONS; OPIOID RECEPTORS; MEMORY; INDUCTION; POTENTIATION	Long term depression (LTD) in the CA1 region of the hippocampus, induced with a 20-Hz, 30 s tetanus to Schaffer collaterals, is enhanced in sleep-deprived (SD) rats. In the present study, we investigated the role of metabotropic glutamate receptors (mGluRs), gamma-Aminobutyric acid (GABA) B receptors (GABA(B)-Rs) and N-methyl-D-aspartic acid receptors (NMDARs) in the LTD of the population excitatory postsynaptic potential (pEPSP). The requirement of Ca2+ from L-and T-type voltage-gated calcium channels (VGCCs) and intracellular stores was also studied. Results indicate that mGluRs, a release of Ca2+ from intracellular stores and GABAB-Rs are required for LTD. Interestingly, while mGlu1Rs seem to be involved in both short-term depression and LTD, mGlu5Rs appear to participate mostly in LTD. CGP 55845, a GABA(B)-R antagonist, partially suppressed LTD in normally sleeping (NS) rats, while completely blocking LTD in SD rats. Moreover, GS-39783, a positive allosteric modulator for GABA(B)-R, suppressed the pEPSP in SD, but not NS rats. Since both mGluRs and GABA(B)-Rs seem to be involved in the LTD, especially in SD rats, we examined if the receptor expression pattern and/or dimerization changed, using immunohistochemical, co-localization and co-immunoprecipitation techniques. Sleep-deprivation induced an increase in the expression of GABA(B)-R1 and mGlu1 alpha R in the CA1 region of the hippocampus. In addition, co-localization and heterodimerization between mGlu1aR/GABA(B)-R1 and mGlu1aR/GABA(B)-R2 is enhanced in SD rats. Taken together, our findings present a novel form of LTD sensitive to the activation of mGluRs and GABA(B)-Rs, and reveal, for the first time, that sleep-deprivation induces alterations in the expression and dimerization of these receptors.	[Tadavarty, Ramakrishna; Wong, Jennifer M.; Sastry, Bhagavatula R.] Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Neurosci Res Lab, Vancouver, BC, Canada; [Rajput, Padmesh S.; Kumar, Ujendra] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Tadavarty, R (corresponding author), Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Neurosci Res Lab, Vancouver, BC, Canada.	sastry@interchange.ubc.ca			Canadian Institutes of Health Research [TGS-109219, MOP-10268]; Dept. of Anesthesiology, Pharmacology and Therapeutics at The University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dept. of Anesthesiology, Pharmacology and Therapeutics at The University of British Columbia	This work was supported by a Canadian Institutes of Health Research Grant (TGS-109219) to Dr. Sastry and Canadian Institutes of Health Research Grant (MOP-10268) to Dr. Kumar. Dr. Tadavarty was supported by the Dept. of Anesthesiology, Pharmacology and Therapeutics at The University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Billinton A, 2001, TRENDS NEUROSCI, V24, P277, DOI 10.1016/S0166-2236(00)01815-4; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Congar P, 1997, J NEUROSCI, V17, P5366; Cozzi A, 2002, NEUROPHARMACOLOGY, V43, P119, DOI 10.1016/S0028-3908(02)00080-1; Davis CJ, 2003, BRAIN RES, V973, P293, DOI 10.1016/S0006-8993(03)02508-3; DAYAN P, 1991, BIOL CYBERN, V65, P253, DOI 10.1007/BF00206223; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Fagni L, 2004, SEMIN CELL DEV BIOL, V15, P289, DOI 10.1016/j.semcdb.2003.12.018; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Grant M, 2004, J BIOL CHEM, V279, P38636, DOI 10.1074/jbc.M406276200; GUERINEAU NC, 1994, J PHYSIOL-LONDON, V474, P27, DOI 10.1113/jphysiol.1994.sp019999; Hanson JE, 1999, J NEUROSCI, V19, P6488; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kornau HC, 2006, CELL TISSUE RES, V326, P517, DOI 10.1007/s00441-006-0264-7; Kulik A, 2003, J NEUROSCI, V23, P11026; Kumar A, 2005, BRAIN RES, V1031, P125, DOI 10.1016/j.brainres.2004.10.023; Kumar U, 2010, RESULTS PROBL CELL D, V50, P137, DOI 10.1007/400_2009_29; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Manahan-Vaughan D, 2000, CEREB CORTEX, V10, P482, DOI 10.1093/cercor/10.5.482; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McDermott CM, 2003, J NEUROSCI, V23, P9687; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; MORISHITA W, 1993, NEUROREPORT, V4, P719, DOI 10.1097/00001756-199306000-00030; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Norris CM, 1996, J NEUROSCI, V16, P5382; PITLER TA, 1992, J NEUROSCI, V12, P4122; Rajput PS, 2009, NEUROSCI RES, V65, P53, DOI 10.1016/j.neures.2009.05.005; Rajput PS, 2009, J CHEM NEUROANAT, V38, P20, DOI 10.1016/j.jchemneu.2009.05.004; Ray K, 2000, J BIOL CHEM, V275, P34245, DOI 10.1074/jbc.M005581200; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; SASTRY BR, 1984, LIFE SCI, V34, P1075, DOI 10.1016/0024-3205(84)90021-3; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SOLIS JM, 1992, J NEUROSCI, V12, P3466; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; STELZER A, 1992, INT REV NEUROBIOL, V33, P195, DOI 10.1016/S0074-7742(08)60693-5; STERN WC, 1971, PHYSIOL BEHAV, V7, P345, DOI 10.1016/0031-9384(71)90312-X; Stickgold R, 2005, TRENDS NEUROSCI, V28, P408, DOI 10.1016/j.tins.2005.06.004; Sullivan R, 2000, J PHARMACOL EXP THER, V293, P460; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; Tabata T, 2004, P NATL ACAD SCI USA, V101, P16952, DOI 10.1073/pnas.0405387101; Tadavarty R, 2009, EXP NEUROL, V216, P239, DOI 10.1016/j.expneurol.2008.11.012; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Urwyler S, 2003, J PHARMACOL EXP THER, V307, P322, DOI 10.1124/jpet.103.053074; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xie Z, 1995, CAN J PHYSIOL PHARM, V73, P1706, DOI 10.1139/y95-734	68	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24933	10.1371/journal.pone.0024933	http://dx.doi.org/10.1371/journal.pone.0024933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980366	Green Submitted, gold, Green Published			2022-12-27	WOS:000295933700011
J	Davis, LMG; Martinez, I; Walter, J; Goin, C; Hutkins, RW				Davis, Lauren M. G.; Martinez, Ines; Walter, Jens; Goin, Caitlin; Hutkins, Robert W.			Barcoded Pyrosequencing Reveals That Consumption of Galactooligosaccharides Results in a Highly Specific Bifidogenic Response in Humans	PLOS ONE			English	Article							GUT MICROBIOTA; DOUBLE-BLIND; FRUCTOOLIGOSACCHARIDE UTILIZATION; BACTERIAL-POPULATIONS; FECAL MICROBIOTA; GENOME SEQUENCE; HEALTHY HUMANS; LACTOBACILLUS; INULIN; DIET	Prebiotics are selectively fermented ingredients that allow specific changes in the gastrointestinal microbiota that confer health benefits to the host. However, the effects of prebiotics on the human gut microbiota are incomplete as most studies have relied on methods that fail to cover the breadth of the bacterial community. The goal of this research was to use high throughput multiplex community sequencing of 16S rDNA tags to gain a community wide perspective of the impact of prebiotic galactooligosaccharide (GOS) on the fecal microbiota of healthy human subjects. Fecal samples from eighteen healthy adults were previously obtained during a feeding trial in which each subject consumed a GOS-containing product for twelve weeks, with four increasing dosages (0, 2.5, 5, and 10 gram) of GOS. Multiplex sequencing of the 16S rDNA tags revealed that GOS induced significant compositional alterations in the fecal microbiota, principally by increasing the abundance of organisms within the Actinobacteria. Specifically, several distinct lineages of Bifidobacterium were enriched. Consumption of GOS led to five-to ten-fold increases in bifidobacteria in half of the subjects. Increases in Firmicutes were also observed, however, these changes were detectable in only a few individuals. The enrichment of bifidobacteria was generally at the expense of one group of bacteria, the Bacteroides. The responses to GOS and the magnitude of the response varied between individuals, were reversible, and were in accordance with dosage. The bifidobacteria were the only bacteria that were consistently and significantly enriched by GOS, although this substrate supported the growth of diverse colonic bacteria in mono-culture experiments. These results suggest that GOS can be used to enrich bifidobacteria in the human gastrointestinal tract with remarkable specificity, and that the bifidogenic properties of GOS that occur in vivo are caused by selective fermentation as well as by competitive interactions within the intestinal environment.	[Davis, Lauren M. G.; Martinez, Ines; Walter, Jens; Hutkins, Robert W.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Goin, Caitlin; Hutkins, Robert W.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Davis, LMG (corresponding author), Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA.	rhutkins1@unl.edu	Walter, Jens/AAA-7636-2020	Walter, Jens/0000-0003-1754-172X	United States Department of Agriculture; Midwest Advanced Food Manufacturing Alliance program; GTC Nutrition (Golden, CO)	United States Department of Agriculture(United States Department of Agriculture (USDA)); Midwest Advanced Food Manufacturing Alliance program; GTC Nutrition (Golden, CO)	This project was funded by a grant from the United States Department of Agriculture, Midwest Advanced Food Manufacturing Alliance program and a partnership grant from GTC Nutrition (Golden, CO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alles MS, 1999, AM J CLIN NUTR, V69, P980; Apajalahti JHA, 2002, APPL ENVIRON MICROB, V68, P4986, DOI 10.1128/AEM.68.10.4986-4995.2002; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; Barrangou R, 2003, P NATL ACAD SCI USA, V100, P8957, DOI 10.1073/pnas.1332765100; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costabile A, 2010, BRIT J NUTR, V104, P1007, DOI 10.1017/S0007114510001571; Cummings J H, 2003, Curr Issues Intest Microbiol, V4, P9; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; Depeint F, 2008, AM J CLIN NUTR, V87, P785, DOI 10.1093/ajcn/87.3.785; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRICH SD, 2011, METAGENOMICS HUMAN B, P307; Falony G, 2009, APPL ENVIRON MICROB, V75, P2312, DOI 10.1128/AEM.02649-08; Fava F, 2006, CURR MED CHEM, V13, P3005, DOI 10.2174/092986706778521814; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; GAHAN CGM, 2011, GUT MICROBIOTA PROBI, P113; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Goh YJ, 2007, APPL ENVIRON MICROB, V73, P5716, DOI 10.1128/AEM.00805-07; Hopkins MJ, 1998, J APPL MICROBIOL, V85, P381; ITO M, 1993, J NUTR SCI VITAMINOL, V39, P635, DOI 10.3177/jnsv.39.635; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; Kleessen B, 2007, BRIT J NUTR, V98, P540, DOI 10.1017/S0007114507730751; Kneifel Wolfgang, 2000, Microbial Ecology in Health and Disease, V12, P27, DOI 10.1080/089106000435563; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x; Macfarlane S, 2004, CLIN INFECT DIS, V38, P1690, DOI 10.1086/420823; Makelainen H, 2010, BENEF MICROBES, V1, P139, DOI 10.3920/BM2009.0029; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Maukonen J, 2008, INT DAIRY J, V18, P386, DOI 10.1016/j.idairyj.2007.10.003; Ordovas JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.mol.0000217897.75068.ba; Pallen MJ, 2011, METAGENOMICS OF THE HUMAN BODY, P43, DOI 10.1007/978-1-4419-7089-3_3; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saulnier DAA, 2007, APPL ENVIRON MICROB, V73, P1753, DOI 10.1128/AEM.01151-06; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P2129, DOI 10.1128/AEM.70.4.2129-2136.2004; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tzortzis G., 2009, PREBIOTICS PROBIOTIC, P207, DOI DOI 10.1007/978-0-387-79058-9_1; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z	52	195	199	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25200	10.1371/journal.pone.0025200	http://dx.doi.org/10.1371/journal.pone.0025200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966454	gold, Green Published			2022-12-27	WOS:000295932100024
J	Bally, J; Job, C; Belghazi, M; Job, D				Bally, Julia; Job, Claudette; Belghazi, Maya; Job, Dominique			Metabolic Adaptation in Transplastomic Plants Massively Accumulating Recombinant Proteins	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE-OXYGENASE; TRANSGENIC TOBACCO; RUBISCO ACTIVASE; PLASTID TRANSFORMATION; ANTISENSE RNA; CHLOROPLASTS; EXPRESSION; PHOTOSYNTHESIS; NUCLEAR; REDUCTION	Background: Recombinant chloroplasts are endowed with an astonishing capacity to accumulate foreign proteins. However, knowledge about the impact on resident proteins of such high levels of recombinant protein accumulation is lacking. Methodology/Principal Findings: Here we used proteomics to characterize tobacco (Nicotiana tabacum) plastid transformants massively accumulating a p-hydroxyphenyl pyruvate dioxygenase (HPPD) or a green fluorescent protein (GFP). While under the conditions used no obvious modifications in plant phenotype could be observed, these proteins accumulated to even higher levels than ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco), the most abundant protein on the planet. This accumulation occurred at the expense of a limited number of leaf proteins including Rubisco. In particular, enzymes involved in CO2 metabolism such as nuclear-encoded plastidial Calvin cycle enzymes and mitochondrial glycine decarboxylase were found to adjust their accumulation level to these novel physiological conditions. Conclusions/Significance: The results document how protein synthetic capacity is limited in plant cells. They may provide new avenues to evaluate possible bottlenecks in recombinant protein technology and to maintain plant fitness in future studies aiming at producing recombinant proteins of interest through chloroplast transformation.	[Bally, Julia; Job, Claudette; Job, Dominique] Ctr Natl Rech Scientif Bayer, CropSci Joint Lab, UMR5240, Lyon, France; [Belghazi, Maya] Ctr Anal Proteomique Marseille, Federatif Rech Jean Roche, Marseille, France	Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Bally, J (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	julia.bally@sydney.edu.au; dominique.job@bayer.com		Bally, Julia/0000-0003-0692-280X				Bally J, 2008, PLANT BIOTECHNOL J, V6, P46, DOI 10.1111/j.1467-7652.2007.00298.x; Bally J, 2009, PLANT PHYSIOL, V150, P1474, DOI 10.1104/pp.109.139816; Bauwe H, 2003, J EXP BOT, V54, P1523, DOI 10.1093/jxb/erg171; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai B, 2010, J PLANT PHYSIOL, V167, P1457, DOI 10.1016/j.jplph.2010.05.004; Catusse J, 2008, P NATL ACAD SCI USA, V105, P10262, DOI 10.1073/pnas.0800585105; Coragliotti AT, 2011, MOL BIOTECHNOL, V48, P60, DOI 10.1007/s12033-010-9348-4; Diaz-Vivancos P, 2008, J EXP BOT, V59, P2147, DOI 10.1093/jxb/ern082; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Garcia I, 2000, BIOCHEMISTRY-US, V39, P7501, DOI 10.1021/bi000135h; Garcia-Canas V, 2011, MASS SPECTROM REV, V30, P396, DOI 10.1002/mas.20286; GONTERO B, 1988, EUR J BIOCHEM, V173, P437, DOI 10.1111/j.1432-1033.1988.tb14018.x; Goossens A, 1999, FEBS LETT, V456, P160, DOI 10.1016/S0014-5793(99)00943-6; Han MJ, 2001, J BACTERIOL, V183, P301, DOI 10.1128/JB.183.1.301-308.2001; Harder A, 1999, ELECTROPHORESIS, V20, P826, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<826::AID-ELPS826>3.0.CO;2-A; Herrero M, 2011, MASS SPECTROM REV; Hirel B, 2006, NEW PHYTOL, V169, P445, DOI 10.1111/j.1469-8137.2006.01641.x; HUDSON GS, 1992, PLANT PHYSIOL, V98, P294, DOI 10.1104/pp.98.1.294; Iurina N P, 2008, Genetika, V44, P1445; Kebeish R, 2007, NAT BIOTECHNOL, V25, P593, DOI 10.1038/nbt1299; Leister D, 2005, GENE, V354, P110, DOI 10.1016/j.gene.2005.03.039; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Luo JL, 2009, J PROTEOME RES, V8, P829, DOI 10.1021/pr8002968; Maliga P, 2004, ANNU REV PLANT BIOL, V55, P289, DOI 10.1146/annurev.arplant.55.031903.141633; Mechin Valerie, 2007, V355, P1; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OECD, 1993, SAF EV FOODS DER MOD; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; PAUL MJ, 1995, PLANT J, V7, P535, DOI 10.1046/j.1365-313X.1995.7040535.x; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Prins A, 2008, J EXP BOT, V59, P1935, DOI 10.1093/jxb/ern086; QUICK WP, 1991, PLANTA, V183, P542, DOI 10.1007/BF00194276; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Ricroch AE, 2011, PLANT PHYSIOL, V155, P1752, DOI 10.1104/pp.111.173609; Rokka A, 2001, PLANT J, V25, P463, DOI 10.1046/j.1365-313x.2001.00981.x; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Schiltz S, 2004, PLANT PHYSIOL, V135, P2241, DOI 10.1104/pp.104.041947; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; TAYLOR WC, 1989, ANNU REV PLANT PHYS, V40, P211, DOI 10.1146/annurev.pp.40.060189.001235; Vargas-Suarez M, 2004, J EXP BOT, V55, P2533, DOI 10.1093/jxb/erh268; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Wright AF, 2009, TRENDS GENET, V25, P253, DOI 10.1016/j.tig.2009.04.006; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x; Zhou YH, 2006, PLANT CELL PHYSIOL, V47, P192, DOI 10.1093/pcp/pci234; ZOUBENKO OV, 1994, NUCLEIC ACIDS RES, V22, P3819, DOI 10.1093/nar/22.19.3819	53	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25289	10.1371/journal.pone.0025289	http://dx.doi.org/10.1371/journal.pone.0025289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966485	gold, Green Submitted, Green Published			2022-12-27	WOS:000295265100082
J	Coultrap, SJ; Bayer, KU				Coultrap, Steven J.; Bayer, K. Ulrich			Improving a Natural CaMKII Inhibitor by Random and Rational Design	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; NR2B SUBUNIT; CALMODULIN; CALCIUM/CALMODULIN; AUTOPHOSPHORYLATION; RECEPTOR; EXPRESSION; BINDING	Background: CaM-KIIN has evolved to inhibit stimulated and autonomous activity of the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) efficiently, selectively, and potently (IC50 similar to 100 nM). The CN class of peptides, derived from the inhibitory region of CaM-KIIN, provides powerful new tools to study CaMKII functions. The goal of this study was to identify the residues required for CaMKII inhibition, and to assess if artificial mutations could further improve the potency achieved during evolution. Methodology/Principal Findings: First, the minimal region with full inhibitory potency was identified (CN19) by determining the effect of truncated peptides on CaMKII activity in biochemical assays. Then, individual residues of CN19 were mutated. Most individual Ala substitutions decreased potency of CaMKII inhibition, however, P3A, K13A, and R14A increased potency. Importantly, this initial Ala scan suggested a specific interaction of the region around R11 with the CaMKII substrate binding site, which was exploited for further rational mutagenesis to generate an optimized pseudo-substrate sequence. Indeed, the potency of the optimized peptide CN19o was >250fold improved (IC50 <0.4 nM), and CN19o has characteristics of a tight-binding inhibitor. The selectivity for CaMKII versus CaMKI was similarly improved (to almost 100,000fold for CN19o). A phospho-mimetic S12D mutation decreased potency, indicating potential for regulation by cellular signaling. Consistent with importance of this residue in inhibition, most other S12 mutations also significantly decreased potency, however, mutation to V or Q did not. Conlusions/Significance: These results provide improved research tools for studying CaMKII function, and indicate that evolution fine-tuned CaM-KIIN not for maximal potency of CaMKII inhibition, but for lower potency that may be optimal for dynamic regulation of signal transduction.	[Coultrap, Steven J.; Bayer, K. Ulrich] Univ Colorado Denver, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Coultrap, SJ (corresponding author), Univ Colorado Denver, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu			National Institutes of Health [R01NS052644]; State of Colorado/University of Colorado; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Colorado/University of Colorado; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by National Institutes of Health grant R01NS052644 and by a State of Colorado/University of Colorado TTO Bioscience Discovery and Evaluation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; ILLARIO M, 2003, J BIOL CHEM; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Lepicard EM, 2006, EUR J NEUROSCI, V23, P3063, DOI 10.1111/j.1460-9568.2006.04830.x; LI GD, 1992, MOL PHARMACOL, V42, P489; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Radwanska K, 2010, GENES BRAIN BEHAV, V9, P648, DOI 10.1111/j.1601-183X.2010.00595.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	57	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25245	10.1371/journal.pone.0025245	http://dx.doi.org/10.1371/journal.pone.0025245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984908	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000019
J	Eacker, SM; Keuss, MJ; Berezikov, E; Dawson, VL; Dawson, TM				Eacker, Stephen M.; Keuss, Matthew J.; Berezikov, Eugene; Dawson, Valina L.; Dawson, Ted M.			Neuronal Activity Regulates Hippocampal miRNA Expression	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; INDUCED MICRORNA; IN-VIVO; PROTEIN; CREB; IDENTIFICATION; TRANSCRIPTION; DROSOPHILA; REVEALS; MEMORY	Neuronal activity regulates a broad range of processes in the hippocampus, including the precise regulation of translation. Disruptions in proper translational control in the nervous system are associated with a variety of disorders that fall in the autistic spectrum. MicroRNA (miRNA) represent a relatively recently discovered player in the regulation of translation in the nervous system. We have conducted an in depth analysis of how neuronal activity regulates miRNA expression in the hippocampus. Using deep sequencing we exhaustively identify all miRNAs, including 15 novel miRNAs, expressed in hippocampus of the adult mouse. We identified 119 miRNAs documented in miRBase but less than half of these miRNA were expressed at a level greater than 0.1% of total miRNA. Expression profiling following induction of neuronal activity by electroconvulsive shock demonstrates that most miRNA show a biphasic pattern of expression: rapid induction of specific mature miRNA expression followed by a decline in expression. These results have important implications into how miRNAs influence activity-dependent translational control.	[Eacker, Stephen M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA; [Eacker, Stephen M.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Keuss, Matthew J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Berezikov, Eugene] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Berezikov, Eugene] Univ Med Ctr, Utrecht, Netherlands; [Berezikov, Eugene] InteRNA Genom BV, Bilthoven, Netherlands; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins University	Eacker, SM (corresponding author), Johns Hopkins Univ, Sch Med, Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Berezikov, Eugene/D-3363-2013	Berezikov, Eugene/0000-0002-1145-2884; Dawson, Valina/0000-0002-2915-3970	National Institute for Drug Abuse [DA00266]; Foundation for Advance Research in the Medical Sciences; Howard Hughes Medical Institute; National Science Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Foundation for Advance Research in the Medical Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by a grant from the National Institute for Drug Abuse (DA00266). SME was supported by a fellowship from the Foundation for Advance Research in the Medical Sciences. MJK was supported by the Howard Hughes Medical Institute training grant for nanotechnology for biology and medicine and an IGERT Fellowship from the National Science Foundation. TMD is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; BEREZIKOV E, 2006, NAT GENET; Berezikov E, 2010, NAT GENET, V42, P6, DOI 10.1038/ng0110-6; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Osokine I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040034; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x	31	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25068	10.1371/journal.pone.0025068	http://dx.doi.org/10.1371/journal.pone.0025068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984899	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000010
J	Freche, D; Pannasch, U; Rouach, N; Holcman, D				Freche, Dominik; Pannasch, Ulrike; Rouach, Nathalie; Holcman, David			Synapse Geometry and Receptor Dynamics Modulate Synaptic Strength	PLOS ONE			English	Article							CENTRAL GLUTAMATERGIC SYNAPSES; MAGUK SCAFFOLDING PROTEINS; AMPA RECEPTORS; EXCITATORY SYNAPSES; DENDRITIC SPINES; HIPPOCAMPAL SYNAPSES; QUANTAL TRANSMISSION; RECYCLING ENDOSOMES; LATERAL DIFFUSION; VESICLE CYCLE	Synaptic transmission relies on several processes, such as the location of a released vesicle, the number and type of receptors, trafficking between the postsynaptic density (PSD) and extrasynaptic compartment, as well as the synapse organization. To study the impact of these parameters on excitatory synaptic transmission, we present a computational model for the fast AMPA-receptor mediated synaptic current. We show that in addition to the vesicular release probability, due to variations in their release locations and the AMPAR distribution, the postsynaptic current amplitude has a large variance, making a synapse an intrinsic unreliable device. We use our model to examine our experimental data recorded from CA1 mice hippocampal slices to study the differences between mEPSC and evoked EPSC variance. The synaptic current but not the coefficient of variation is maximal when the active zone where vesicles are released is apposed to the PSD. Moreover, we find that for certain type of synapses, receptor trafficking can affect the magnitude of synaptic depression. Finally, we demonstrate that perisynaptic microdomains located outside the PSD impacts synaptic transmission by regulating the number of desensitized receptors and their trafficking to the PSD. We conclude that geometrical modifications, reorganization of the PSD or perisynaptic microdomains modulate synaptic strength, as the mechanisms underlying long-term plasticity.	[Freche, Dominik] Weizmann Inst Sci, Dept Math, IL-76100 Rehovot, Israel; [Freche, Dominik] Weizmann Inst Sci, Dept Neurosci, IL-76100 Rehovot, Israel; [Pannasch, Ulrike; Rouach, Nathalie] CIRB CNRS UMR 7241 INSERM U1050 Coll France, Team Neuroglial Interact Cerebral Physiopathol, Paris, France; [Holcman, David] IBENS Ecole Normale Super, Dept Math & Computat Biol, Paris, France; [Holcman, David] Tel Aviv Univ, Dept Appl Math, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Tel Aviv University	Freche, D (corresponding author), Weizmann Inst Sci, Dept Math, IL-76100 Rehovot, Israel.	david.holcman@ens.fr	Rouach, Nathalie/L-4767-2017; Holcman, David/L-9243-2013	Rouach, Nathalie/0000-0002-5574-888X; holcman, david/0000-0001-9854-5014	Max Planck Society; Deutsche Forschungsgemeinschaft; Human Frontier Science Program CDA; Human Frontier Science Program	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program CDA(Human Frontier Science Program); Human Frontier Science Program(Human Frontier Science Program)	DF was supported by a Minerva fellowship of the Max Planck Society, UP by a Deutsche Forschungsgemeinschaft fellowship of Deutsche Forschungsgemeinschaft, NR by a Human Frontier Science Program CDA grant, DH by a Human Frontier Science Program research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Biess A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021922; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Franks KM, 2003, J NEUROSCI, V23, P3186; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Gerrow K., 2007, SCI STKE, V2007, P56; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Holmes WR, 1995, BIOPHYS J, V69, P1734, DOI 10.1016/S0006-3495(95)80043-3; Jiang Ma-Li, 2003, Shengli Xuebao, V55, P705; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Korkotian E, 2004, EUR J NEUROSCI, V20, P2649, DOI 10.1111/j.1460-9568.2004.03691.x; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARKUS EJ, 1987, DEV BRAIN RES, V35, P239, DOI 10.1016/0165-3806(87)90048-4; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Melone M, 2009, GLIA, V57, P108, DOI 10.1002/glia.20744; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taia A, 2007, J CHEM PHYS, V126; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ventriglia F, 2002, BIOSYSTEMS, V67, P287, DOI 10.1016/S0303-2647(02)00086-2; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2005, NEURON, V45, P482, DOI 10.1016/j.neuron.2005.02.003	62	51	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25122	10.1371/journal.pone.0025122	http://dx.doi.org/10.1371/journal.pone.0025122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984900	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000011
J	Maatallah, M; Cheriaa, J; Backhrouf, A; Iversen, A; Grundmann, H; Do, T; Lanotte, P; Mastouri, M; Elghmati, MS; Rojo, F; Mejdi, S; Giske, CG				Maatallah, Makaoui; Cheriaa, Jihane; Backhrouf, Amina; Iversen, Aina; Grundmann, Hajo; Thuy Do; Lanotte, Philippe; Mastouri, Maha; Elghmati, Mohamed Salem; Rojo, Fernando; Mejdi, Snoussi; Giske, Christian G.			Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; FIELD GEL-ELECTROPHORESIS; CYSTIC-FIBROSIS PATIENTS; SINGLE-NUCLEOTIDE-POLYMORPHISM; III PROTEIN SECRETION; ESCHERICHIA-COLI; GENOME SEQUENCE; VIRULENCE; INFECTIONS; RESISTANCE	Several studies in recent years have provided evidence that Pseudomonas aeruginosa has a non-clonal population structure punctuated by highly successful epidemic clones or clonal complexes. The role of recombination in the diversification of P. aeruginosa clones has been suggested, but not yet demonstrated using multi-locus sequence typing (MLST). Isolates of P. aeruginosa from five Mediterranean countries (n = 141) were subjected to pulsed-field gel electrophoresis (PFGE), serotyping and PCR targeting the virulence genes exoS and exoU. The occurrence of multi-resistance (>= 3 antipseudomonal drugs) was analyzed with disk diffusion according to EUCAST. MLST was performed on a subset of strains (n = 110) most of them had a distinct PFGE variant. MLST data were analyzed with Bionumerics 6.0, using minimal spanning tree (MST) as well as eBURST. Measurement of clonality was assessed by the standardized index of association (IAS). Evidence of recombination was estimated by ClonalFrame as well as SplitsTree4.0. The MST analysis connected 70 sequence types, among which ST235 was by far the most common. ST235 was very frequently associated with the O11 serotype, and frequently displayed multiresistance and the virulence genotype exoS(-)/exoU(+). ClonalFrame linked several groups previously identified by eBURST and MST, and provided insight to the evolutionary events occurring in the population; the recombination/mutation ratio was found to be 8.4. A Neighbor-Net analysis based on the concatenated sequences revealed a complex network, providing evidence of frequent recombination. The index of association when all the strains were considered indicated a freely recombining population. P. aeruginosa isolates from the Mediterranean countries display an epidemic population structure, particularly dominated by ST235-O11, which has earlier also been coupled to the spread of beta-lactamases in many countries.	[Maatallah, Makaoui; Cheriaa, Jihane; Backhrouf, Amina; Mejdi, Snoussi] Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia; [Iversen, Aina; Giske, Christian G.] Karolinska Inst, Karolinska Univ Hosp Solna, MTC, Stockholm, Sweden; [Grundmann, Hajo] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Grundmann, Hajo] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Thuy Do] Kings Coll London, Infect Res Grp, Inst Dent, London WC2R 2LS, England; [Thuy Do] Guys & St Thomas NHS & Fdn Trust, Biomed Res Ctr, London, England; [Lanotte, Philippe] Hop Bretonneau, CHRU Tours, Serv Bacteriol Virol, Tours, France; [Lanotte, Philippe] Univ Tours, Tours, France; [Mastouri, Maha] Lab Microbiol CHU Fattouma Bourguiba, Monastir, Tunisia; [Elghmati, Mohamed Salem] Univ Alfateh Tripoli, Fac Pharm, Dept Microbiol & Immunol, Tripoli, Libya; [Rojo, Fernando] CSIC, Dept Biotecnol Microbiana, Ctr Nacl Biotecnol, Madrid, Spain	Universite de Monastir; Karolinska Institutet; Karolinska University Hospital; University of Groningen; Netherlands National Institute for Public Health & the Environment; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; CHU Tours; Universite de Tours; Universite de Monastir; Hopital Fattouma Bourguiba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Maatallah, M (corresponding author), Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia.	christian.giske@karolinska.se	Snoussi, Mejdi/AAR-7495-2021; Snoussi, Mejdi/AAE-4486-2020; Rojo, Fernando/A-7038-2008	Snoussi, Mejdi/0000-0002-2309-2601; Snoussi, Mejdi/0000-0002-2309-2601; Rojo, Fernando/0000-0003-1848-7745	Karolinska University Hospital; Ministry of Higher Education and Scientific Research in Tunisia	Karolinska University Hospital(Karolinska Institutet); Ministry of Higher Education and Scientific Research in Tunisia	Internal funding at the Karolinska University Hospital and funding from the Ministry of Higher Education and Scientific Research in Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Ajayi T, 2003, J CLIN MICROBIOL, V41, P3526, DOI 10.1128/JCM.41.8.3526-3531.2003; Bergmans DCJJ, 1997, J ANTIMICROB CHEMOTH, V39, P527, DOI 10.1093/jac/39.4.527; Berthelot P, 2003, J INFECT DIS, V188, P512, DOI 10.1086/377000; Bingen E, 1996, J CLIN MICROBIOL, V34, P3226, DOI 10.1128/JCM.34.12.3226-3229.1996; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; DENAMUR E, 1993, FEMS MICROBIOL LETT, V110, P275, DOI 10.1111/j.1574-6968.1993.tb06334.x; Deplano A, 2005, J CLIN MICROBIOL, V43, P1198, DOI 10.1128/JCM.43.3.1198-1204.2005; DeVos D, 1997, J CLIN MICROBIOL, V35, P1295, DOI 10.1128/JCM.35.6.1295-1299.1997; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Doring G, 1987, Antibiot Chemother (1971), V39, P136; Duljasz W, 2009, ANTIMICROB AGENTS CH, V53, P2221, DOI 10.1128/AAC.01573-08; Edalucci E, 2008, CLIN MICROBIOL INFEC, V14, P88, DOI 10.1111/j.1469-0691.2007.01874.x; Empel J, 2007, J CLIN MICROBIOL, V45, P2829, DOI 10.1128/JCM.00997-07; Ernst RK, 2003, ENVIRON MICROBIOL, V5, P1341, DOI 10.1111/j.1462-2920.2003.00518.x; Faure K, 2003, J CLIN MICROBIOL, V41, P2158, DOI 10.1128/JCM.41.5.2158-2160.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Foght JM, 1996, MICROBIOL-UK, V142, P2333, DOI 10.1099/00221287-142-9-2333; FONSECA EL, ANTIMICROB AGENTS CH, V54, P2743; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Giske CG, 2006, J CLIN MICROBIOL, V44, P4309, DOI 10.1128/JCM.00817-06; Glupczynski Y, 2010, J ANTIMICROB CHEMOTH, V65, P866, DOI 10.1093/jac/dkq048; GRATTARD F, 1993, EUR J CLIN MICROBIOL, V12, P57, DOI 10.1007/BF01997061; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Holder IA, 2001, BURNS, V27, P129, DOI 10.1016/S0305-4179(00)00142-X; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson JK, 2007, J CLIN MICROBIOL, V45, P3707, DOI 10.1128/JCM.00560-07; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Juan C, 2010, J ANTIMICROB CHEMOTH, V65, P474, DOI 10.1093/jac/dkp491; Kettner M, 1995, INFECTION, V23, P380, DOI 10.1007/BF01713571; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; Koh TH, 2010, J CLIN MICROBIOL, V48, P2563, DOI 10.1128/JCM.01905-09; Kouda S, 2009, J ANTIMICROB CHEMOTH, V64, P46, DOI 10.1093/jac/dkp142; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Lepsanovic Z, 2008, ACTA MICROBIOL IMM H, V55, P447, DOI 10.1556/AMicr.55.2008.4.9; Libisch B, 2008, RES MICROBIOL, V159, P162, DOI 10.1016/j.resmic.2007.12.008; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIU PV, 1983, INT J SYST BACTERIOL, V33, P256, DOI 10.1099/00207713-33-2-256; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Magiorakos AP, 2011, CLIN MICROBIOL INFEC; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martin C, 1999, MICROBIOL-UK, V145, P2587, DOI 10.1099/00221287-145-9-2587; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Morales G, 2004, J BACTERIOL, V186, P4228, DOI 10.1128/JB.186.13.4228-4237.2004; MUSSER JM, 1987, J BACTERIOL, V169, P2793, DOI 10.1128/jb.169.6.2793-2803.1987; MUSSER JM, 1988, INFECT IMMUN, V56, P1837, DOI 10.1128/IAI.56.8.1837-1845.1988; Nemec A, 2010, RES MICROBIOL, V161, P234, DOI 10.1016/j.resmic.2010.02.002; Obritsch MD, 2004, ANTIMICROB AGENTS CH, V48, P4606, DOI 10.1128/AAC.48.12.4606-4610.2004; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; PICARD B, 1994, J MED MICROBIOL, V40, P313, DOI 10.1099/00222615-40-5-313; PIFFARETTI JC, 1989, P NATL ACAD SCI USA, V86, P3818, DOI 10.1073/pnas.86.10.3818; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; PITT TL, 1989, EPIDEMIOL INFECT, V103, P565, DOI 10.1017/S095026880003096X; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; Schmidt KD, 1996, J BACTERIOL, V178, P85, DOI 10.1128/jb.178.1.85-93.1996; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P979, DOI 10.1128/JCM.01772-06; SELANDER RK, 1985, J BACTERIOL, V163, P1021, DOI 10.1128/JB.163.3.1021-1037.1985; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873, DOI 10.1128/AEM.51.5.873-884.1986; SELANDER RK, 1987, MICROB PATHOGENESIS, V3, P1, DOI 10.1016/0882-4010(87)90032-5; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Silva FM, 2011, MICROB DRUG RESIST, V17, P215, DOI 10.1089/mdr.2010.0140; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Spratt Brian G, 2004, Methods Mol Biol, V266, P323; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Viedma E, 2009, ANTIMICROB AGENTS CH, V53, P4930, DOI 10.1128/AAC.00900-09; Waine DJ, 2009, J CLIN MICROBIOL, V47, P3444, DOI 10.1128/JCM.00459-09; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	97	98	105	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25617	10.1371/journal.pone.0025617	http://dx.doi.org/10.1371/journal.pone.0025617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984923	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000047
J	Martinic, M; Hoare, A; Contreras, I; Alvarez, SA				Martinic, Mara; Hoare, Anilei; Contreras, Ines; Alvarez, Sergio A.			Contribution of the Lipopolysaccharide to Resistance of Shigella flexneri 2a to Extreme Acidity	PLOS ONE			English	Article							ANTIGEN CHAIN-LENGTH; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; LIPID-A; PHOSPHOETHANOLAMINE MODIFICATION; TOLERANCE RESPONSE; GENOME SEQUENCE; GENE-EXPRESSION; REGULATED LOCUS; PH	Shigella flexneri is endemic in most underdeveloped countries, causing diarrheal disease and dysentery among young children. In order to reach its target site, the colon, Shigella must overcome the acid environment of the stomach. Shigella is able to persist in this stressful environment and, because of this ability it can initiate infection following the ingestion of very small inocula. Thus, acid resistance is considered an important virulence trait of this bacterium. It has been reported that moderate acid conditions regulate the expression of numerous components of the bacterial envelope. Because the lipopolysaccharide (LPS) is the major component of the bacterial surface, here we have addressed the role of LPS in acid resistance of S. flexneri 2a. Defined deletion mutants in genes encoding proteins involved in the synthesis, assembly and length regulation of the LPS O antigen were constructed and assayed for resistance to pH 2.5 after adaptation to pH 5.5. The results showed that a mutant lacking O antigen was significantly more sensitive to extreme acid conditions than the wild type. Not only the presence of polymerized O antigen, but also a particular polymer length (S-OAg) was required for acid resistance. Glucosylation of the O antigen also contributed to this property. In addition, a moderate acidic pH induced changes in the composition of the lipid A domain of LPS. The main modification was the addition of phosphoethanolamine to the 19 phosphate of lipid A. This modification increased resistance of S. flexneri to extreme acid conditions, provide that O antigen was produced. Overall, the results of this work point out to an important role of LPS in resistance of Shigella flexneri to acid stress.	[Martinic, Mara; Hoare, Anilei; Contreras, Ines; Alvarez, Sergio A.] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile	Universidad de Chile	Martinic, M (corresponding author), Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile.	salvarez@uchile.cl	Álvarez, Sergio A/J-6814-2017		Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Chile) [ADI-08/2006]; World Bank; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100092]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); World Bank(The World Bank India); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grant ADI-08/2006 from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT; www.conicyt.cl)(Chile) and The World Bank and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grant 1100092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Barua S, 2002, MOL MICROBIOL, V43, P629, DOI 10.1046/j.1365-2958.2002.02768.x; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; BATCHELOR RA, 1992, J BACTERIOL, V174, P5228, DOI 10.1128/JB.174.16.5228-5236.1992; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; BLASER MJ, 1982, REV INFECT DIS, V4, P1096; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Budin-Verneuil A, 2007, PROTEOMICS, V7, P2038, DOI 10.1002/pmic.200600773; Carter JA, 2007, MICROBIOL-SGM, V153, P3499, DOI 10.1099/mic.0.2007/010066-0; Carter JA, 2009, MICROBIOL-SGM, V155, P3260, DOI 10.1099/mic.0.028944-0; CHEN HC, 1993, APPL ENVIRON MICROB, V59, P1058, DOI 10.1128/AEM.59.4.1058-1064.1993; Cheng F, 2007, FEMS MICROBIOL LETT, V270, P12, DOI 10.1111/j.1574-6968.2007.00647.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delgado MA, 2006, MOL MICROBIOL, V60, P39, DOI 10.1111/j.1365-2958.2006.05069.x; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Gibbons HS, 2005, MOL MICROBIOL, V55, P425, DOI 10.1111/j.1365-2958.2004.04409.x; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Herrera CM, 2010, MOL MICROBIOL, V76, P1444, DOI 10.1111/j.1365-2958.2010.07150.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Huang YJ, 2007, J AGR FOOD CHEM, V55, P7182, DOI 10.1021/jf071014s; Jennison AV, 2007, MICROBIOL-SGM, V153, P2593, DOI 10.1099/mic.0.2007/006718-0; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kaniuk NA, 2004, J BIOL CHEM, V279, P31237, DOI 10.1074/jbc.M401879200; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; Merrell DS, 2001, J BACTERIOL, V183, P2746, DOI 10.1128/JB.183.9.2746-2754.2001; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Quivey RG, 2000, FEMS MICROBIOL LETT, V189, P89, DOI 10.1111/j.1574-6968.2000.tb09211.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1598, DOI 10.1128/AEM.01508-07; Sandlin RC, 1996, MOL MICROBIOL, V22, P63, DOI 10.1111/j.1365-2958.1996.tb02656.x; Sato M, 2000, APPL ENVIRON MICROB, V66, P943, DOI 10.1128/AEM.66.3.943-947.2000; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Sinnott ML, 2007, CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY: STRUCTURE AND MECHANISM, pV; STEVENSON G, 1995, FEMS MICROBIOL LETT, V125, P23, DOI 10.1016/0378-1097(94)00485-A; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Thomsen LE, 2003, FEMS MICROBIOL LETT, V228, P225, DOI 10.1016/S0378-1097(03)00762-6; Touze T, 2008, MOL MICROBIOL, V67, P264, DOI 10.1111/j.1365-2958.2007.06044.x; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503	64	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25557	10.1371/journal.pone.0025557	http://dx.doi.org/10.1371/journal.pone.0025557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984920	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000039
J	Restrepo-Montoya, D; Becerra, D; Carvajal-Patino, JG; Mongui, A; Nino, LF; Patarroyo, ME; Patarroyo, MA				Restrepo-Montoya, Daniel; Becerra, David; Carvajal-Patino, Juan G.; Mongui, Alvaro; Nino, Luis F.; Patarroyo, Manuel E.; Patarroyo, Manuel A.			Identification of Plasmodium vivax Proteins with Potential Role in Invasion Using Sequence Redundancy Reduction and Profile Hidden Markov Models	PLOS ONE			English	Article							IN-SILICO; SUBCELLULAR-LOCALIZATION; APICOMPLEXAN PARASITES; AOTUS MONKEYS; PREDICTION; FALCIPARUM; MEMBRANES; PEPTIDES; HOMOLOGY; DATABASE	Background: This study describes a bioinformatics approach designed to identify Plasmodium vivax proteins potentially involved in reticulocyte invasion. Specifically, different protein training sets were built and tuned based on different biological parameters, such as experimental evidence of secretion and/or involvement in invasion-related processes. A profile-based sequence method supported by hidden Markov models (HMMs) was then used to build classifiers to search for biologically-related proteins. The transcriptional profile of the P. vivax intra-erythrocyte developmental cycle was then screened using these classifiers. Results: A bioinformatics methodology for identifying potentially secreted P. vivax proteins was designed using sequence redundancy reduction and probabilistic profiles. This methodology led to identifying a set of 45 proteins that are potentially secreted during the P. vivax intra-erythrocyte development cycle and could be involved in cell invasion. Thirteen of the 45 proteins have already been described as vaccine candidates; there is experimental evidence of protein expression for 7 of the 32 remaining ones, while no previous studies of expression, function or immunology have been carried out for the additional 25. Conclusions: The results support the idea that probabilistic techniques like profile HMMs improve similarity searches. Also, different adjustments such as sequence redundancy reduction using Pisces or Cd-Hit allowed data clustering based on rational reproducible measurements. This kind of approach for selecting proteins with specific functions is highly important for supporting large-scale analyses that could aid in the identification of genes encoding potential new target antigens for vaccine development and drug design. The present study has led to targeting 32 proteins for further testing regarding their ability to induce protective immune responses against P. vivax malaria.	[Restrepo-Montoya, Daniel; Becerra, David; Carvajal-Patino, Juan G.; Nino, Luis F.] Univ Nacl Colombia, Bioinformat & Intelligent Syst Res Lab BIOLISI, Bogota, Colombia; [Restrepo-Montoya, Daniel; Becerra, David; Nino, Luis F.] Univ Nacl Colombia, Res Grp Combinatorial Algorithms ALGOS UN, Bogota, Colombia; [Restrepo-Montoya, Daniel; Carvajal-Patino, Juan G.; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Restrepo-Montoya, Daniel; Carvajal-Patino, Juan G.; Mongui, Alvaro; Patarroyo, Manuel E.; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Patarroyo, Manuel E.] Univ Nacl Colombia, Sch Med, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad del Rosario; Universidad Nacional de Colombia	Restrepo-Montoya, D (corresponding author), Univ Nacl Colombia, Bioinformat & Intelligent Syst Res Lab BIOLISI, Bogota, Colombia.	mapatarr.fidic@gmail.com	Patarroyo, Manuel A/I-8046-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017	Patarroyo, Manuel A/0000-0002-4751-2500; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Mongui, Alvaro/0000-0002-4834-2865; Restrepo-Montoya, Daniel/0000-0003-4910-7880	Asociacion de Investigacion Solidaria (SADAR); Caja Navarra (Navarra, Spain); Agencia Espanola de Cooperacion Internacional para el Desarrollo	Asociacion de Investigacion Solidaria (SADAR); Caja Navarra (Navarra, Spain); Agencia Espanola de Cooperacion Internacional para el Desarrollo	The authors would like to extend their sincerest gratitude to Asociacion de Investigacion Solidaria (SADAR), Caja Navarra (Navarra, Spain) and Agencia Espanola de Cooperacion Internacional para el Desarrollo for supporting and financing this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari FA, 2008, PROTEINS, V70, P659, DOI 10.1002/prot.21568; Arevalo-Pinzon G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-60; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bischoff E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-34; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; Chen YJ, 2003, MAMM GENOME, V14, P859, DOI 10.1007/s00335-003-2296-6; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; De Fonzo V, 2007, CURR BIOINFORM, V2, P49, DOI 10.2174/157489307779314348; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Farid Arenas Aylan, 2010, Genomics Proteomics & Bioinformatics, V8, P103, DOI 10.1016/S1672-0229(10)60011-3; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-503; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Ghouila A, 2011, INFECT GENET EVOL, V11, P698, DOI 10.1016/j.meegid.2010.09.008; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Isokpehi RD, 2007, METHODS OF MICROARRAY DATA ANALYSIS V, P1, DOI 10.1007/978-0-387-34569-7_1; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Llinas M, 2005, TRENDS PARASITOL, V21, P350, DOI 10.1016/j.pt.2005.06.009; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Mittra P, 2010, MICROBES INFECT, V12, P1019, DOI 10.1016/j.micinf.2010.07.004; Mongui A, 2006, BIOCHEM BIOPH RES CO, V351, P639, DOI 10.1016/j.bbrc.2006.10.082; Perez-Leal O, 2006, BIOCHEM BIOPH RES CO, V341, P1053, DOI 10.1016/j.bbrc.2006.01.061; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; Rojas-Caraballo J, 2009, VACCINE, V27, P2870, DOI 10.1016/j.vaccine.2009.02.083; ROOBSOONG W, 2011, J PROTEOMICS; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sierra AY, 2003, VACCINE, V21, P4133, DOI 10.1016/S0264-410X(03)00455-9; Son Eui-Sun, 2001, Korean Journal of Parasitology, V39, P171, DOI 10.3347/kjp.2001.39.2.171; Sugiyama T, 1996, VACCINE, V14, P1069, DOI 10.1016/0264-410X(95)00238-V; Terrapon N, 2009, BIOINFORMATICS, V25, P3077, DOI 10.1093/bioinformatics/btp560; Tonhosolo R, 2009, J BIOL CHEM, V284, P9974, DOI 10.1074/jbc.M807464200; Urquiza M, 2002, PEPTIDES, V23, P2265, DOI 10.1016/S0196-9781(02)00267-X; Wakaguri H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-312; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224	59	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25189	10.1371/journal.pone.0025189	http://dx.doi.org/10.1371/journal.pone.0025189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984903	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000014
J	Knowlton, WM; Daniels, RL; Palkar, R; Mccoy, DD; McKemy, DD				Knowlton, Wendy M.; Daniels, Richard L.; Palkar, Radhika; McCoy, Daniel D.; McKemy, David D.			Pharmacological Blockade of TRPM8 Ion Channels Alters Cold and Cold Pain Responses in Mice	PLOS ONE			English	Article							MENTHOL RECEPTOR TRPM8; BODY-TEMPERATURE; SENSORY NEURONS; HEAT; CAPSAZEPINE; ANTAGONIST; ACTIVATION; CALCIUM; VOLTAGE; TRPV1	TRPM8 (Transient Receptor Potential Melastatin-8) is a cold-and menthol-gated ion channel necessary for the detection of cold temperatures in the mammalian peripheral nervous system. Functioning TRPM8 channels are required for behavioral responses to innocuous cool, noxious cold, injury-evoked cold hypersensitivity, cooling-mediated analgesia, and thermoregulation. Because of these various roles, the ability to pharmacologically manipulate TRPM8 function to alter the excitability of cold-sensing neurons may have broad impact clinically. Here we examined a novel compound, PBMC (1-phenylethyl-4-(benzyloxy)-3-methoxybenzyl(2-aminoethyl) carbamate) which robustly and selectively inhibited TRPM8 channels in vitro with sub-nanomolar affinity, as determined by calcium microfluorimetry and electrophysiology. The actions of PBMC were selective for TRPM8, with no functional effects observed for the sensory ion channels TRPV1 and TRPA1. PBMC altered TRPM8 gating by shifting the voltage-dependence of menthol-evoked currents towards positive membrane potentials. When administered systemically to mice, PBMC treatment produced a dose-dependent hypothermia in wildtype animals while TRPM8-knockout mice remained unaffected. This hypothermic response was reduced at lower doses, whereas responses to evaporative cooling were still significantly attenuated. Lastly, systemic PBMC also diminished cold hypersensitivity in inflammatory and nerve-injury pain models, but was ineffective against oxaliplatin-induced neuropathic cold hypersensitivity, despite our findings that TRPM8 is required for the cold-related symptoms of this pathology. Thus PBMC is an attractive compound that serves as a template for the formulation of highly specific and potent TRPM8 antagonists that will have utility both in vitro and in vivo.	[Knowlton, Wendy M.; Daniels, Richard L.; Palkar, Radhika; McCoy, Daniel D.; McKemy, David D.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA; [McCoy, Daniel D.; McKemy, David D.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Knowlton, Wendy M.; Daniels, Richard L.; Palkar, Radhika; McKemy, David D.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Knowlton, WM (corresponding author), Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA.	mckemy@usc.edu		Daniels, Richard/0000-0003-2477-6025	National Institutes of Health [NS054069]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health Grant NS054069 to DDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal N, 2009, PAIN, V144, P245, DOI 10.1016/j.pain.2009.03.024; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Benedikt J, 2007, J NEUROCHEM, V100, P211, DOI 10.1111/j.1471-4159.2006.04192.x; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; DeFalco J, 2010, BIOORG MED CHEM LETT, V20, P7076, DOI 10.1016/j.bmcl.2010.09.099; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Ding Z, 2008, EUR J PHARMACOL, V578, P201, DOI 10.1016/j.ejphar.2007.09.030; Docherty RJ, 1997, BRIT J PHARMACOL, V121, P1461, DOI 10.1038/sj.bjp.0701272; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gavva NR, 2008, TRENDS PHARMACOL SCI, V29, P550, DOI 10.1016/j.tips.2008.08.003; Iida T, 2005, NEUROSCI LETT, V378, P28, DOI 10.1016/j.neulet.2004.12.007; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Knowlton WM, 2011, CURR PHARM BIOTECHNO, V12, P68; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Liu L, 1997, NEUROSCI LETT, V228, P29, DOI 10.1016/S0304-3940(97)00358-3; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; McCoy DD, 2011, AM J PHYSIOL-REG I, V300, pR1278, DOI 10.1152/ajpregu.00631.2010; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Montell C, 2007, CURR BIOL, V17, pR885, DOI 10.1016/j.cub.2007.08.016; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Nomoto S, 2004, INT J BIOMETEOROL, V49, P67, DOI 10.1007/s00484-004-0220-8; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Ruskin DN, 2007, EUR J PHARMACOL, V559, P161, DOI 10.1016/j.ejphar.2007.01.006; SCHWARZ G, 1994, CELL CALCIUM, V15, P45, DOI 10.1016/0143-4160(94)90103-1; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tajino K, 2007, AM J PHYSIOL-REG I, V293, pR2128, DOI 10.1152/ajpregu.00377.2007; Tajino K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017504; Valenzano KJ, 2004, CURR MED CHEM, V11, P3185, DOI 10.2174/0929867043363686; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; WALPOLE CSJ, 1994, J MED CHEM, V37, P1942, DOI 10.1021/jm00039a006; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007	48	140	144	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25894	10.1371/journal.pone.0025894	http://dx.doi.org/10.1371/journal.pone.0025894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984952	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300063
J	Mellor, KM; Bell, JR; Wendt, IR; Davidoff, AJ; Ritchie, RH; Delbridge, LMD				Mellor, Kimberley M.; Bell, James R.; Wendt, Igor R.; Davidoff, Amy J.; Ritchie, Rebecca H.; Delbridge, Lea M. D.			Fructose Modulates Cardiomyocyte Excitation-Contraction Coupling and Ca2+ Handling In Vitro	PLOS ONE			English	Article							TRANSPORTER; DYSFUNCTION; GLYCOLYSIS; EXPRESSION; GLUT5; GENE; ATP	Background-High dietary fructose has structural and metabolic cardiac impact, but the potential for fructose to exert direct myocardial action is uncertain. Cardiomyocyte functional responsiveness to fructose, and capacity to transport fructose has not been previously demonstrated. Objective:The aim of the present study was to seek evidence of fructos-induced modulation of cardiomyocyte excitation-contraction coupling in an acute, in vitro setting. Methods and Results: The functional effects of fructose on isolated adult rat cardiomyocyte contractility and Ca2+ handling were evaluated under physiological conditions (37 degrees C, 2 mM Ca2+, HEPES buffer, 4 Hz stimulation) using video edge detection and microfluorimetry (Fura2) methods. Compared with control glucose (11 mM) superfusate, 2-deoxyglucose (2 DG, 11 mM) substitution prolonged both the contraction and relaxation phases of the twitch (by 16 and 36% respectively, p<0.05) and this effect was completely abrogated with fructose supplementation (11 mM). Similarly, fructose prevented the Ca2+ transient delay induced by exposure to 2 DG (time to peak Ca2+ transient: 2 DG: 29.0 +/- 2.1 ms vs. glucose: 23.6 +/- 1.1 ms vs. fructose +2 DG: 23.7 +/- 1.0 ms; p<0.05). The presence of the fructose transporter, GLUT5 (Slc2a5) was demonstrated in ventricular cardiomyocytes using real time RT-PCR and this was confirmed by conventional RT-PCR. Conclusion: This is the first demonstration of an acute influence of fructose on cardiomyocyte excitation-contraction coupling. The findings indicate cardiomyocyte capacity to transport and functionally utilize exogenously supplied fructose. This study provides the impetus for future research directed towards characterizing myocardial fructose metabolism and understanding how long term high fructose intake may contribute to modulating cardiac function.	[Mellor, Kimberley M.; Bell, James R.; Delbridge, Lea M. D.] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [Ritchie, Rebecca H.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia; [Wendt, Igor R.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Davidoff, Amy J.] Univ New England, Coll Osteopath Med, Dept Pharmacol, Biddeford, ME USA; [Ritchie, Rebecca H.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Monash University; University of New England - Maine; Baker Heart and Diabetes Institute	Mellor, KM (corresponding author), Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia.	kimberley.mellor@unimelb.edu.au	Ritchie, Rebecca H/E-7392-2011	Ritchie, Rebecca/0000-0002-8610-0058; Mellor, Kimberley/0000-0002-8443-9365	National Heart Foundation of Australia	National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by the National Heart Foundation of Australia (www.heartfoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1990, J APPL PHYSIOL, V69, P1244, DOI 10.1152/jappl.1990.69.4.1244; BAIS R, 1985, BIOCHEM J, V230, P53, DOI 10.1042/bj2300053; CASTELLO A, 1995, BIOCHEM J, V309, P271, DOI 10.1042/bj3090271; Chess DJ, 2008, AM J PHYSIOL-HEART C, V295, pH2223, DOI 10.1152/ajpheart.00563.2008; Corpe CP, 2002, BBA-GENE STRUCT EXPR, V1576, P191, DOI 10.1016/S0167-4781(02)00284-1; Davidoff AJ, 2006, CLIN EXP PHARMACOL P, V33, P152, DOI 10.1111/j.1440-1681.2006.04343.x; Delbridge LMD, 2000, CLIN SCI, V98, P401, DOI 10.1042/CS19990230; GIBBS CL, 1979, ANNU REV PHYSIOL, V41, P507, DOI 10.1146/annurev.ph.41.030179.002451; Goldhaber J, 1997, MYOCARDIUM; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALL JL, 1995, J APPL PHYSIOL, V78, P76, DOI 10.1152/jappl.1995.78.1.76; HENRY RR, 1991, ANNU REV NUTR, V11, P21, DOI 10.1146/annurev.nu.11.070191.000321; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Kockskamper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; Mellor K, 2010, NUTRITION, V26, P842, DOI 10.1016/j.nut.2009.08.017; Mellor KM, 2011, J MOL CELL CARDIOL, V50, P1035, DOI 10.1016/j.yjmcc.2011.03.002; Mellor KM, 2010, CAN J PHYSIOL PHARM, V88, P525, DOI [10.1139/Y10-005, 10.1139/y10-005]; Mellor KM, 2010, CLIN EXP PHARMACOL P, V37, P222, DOI 10.1111/j.1440-1681.2009.05274.x; Noh HL, 2009, J PHARMACOL EXP THER, V328, P496, DOI 10.1124/jpet.108.136283; PIERCE GN, 1985, J BIOL CHEM, V260, P6862; Ren J, 1997, AM J PHYSIOL-HEART C, V273, pH2876, DOI 10.1152/ajpheart.1997.273.6.H2876; Ren J, 2009, CLIN EXP PHARMACOL P, V36, P141, DOI 10.1111/j.1440-1681.2008.05034.x; Rogers S, 2003, BIOCHEM BIOPH RES CO, V308, P422, DOI 10.1016/S0006-291X(03)01417-7; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Scheepers A, 2005, MOL MEMBR BIOL, V22, P339, DOI 10.1080/09687860500166143; Schwanke ML, 2006, DIABETOLOGIA, V49, P1097, DOI 10.1007/s00125-006-0184-9; SHEPHERD PR, 1992, DIABETES, V41, P1360, DOI 10.2337/diabetes.41.10.1360; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; TAVAZZI B, 1992, BASIC RES CARDIOL, V87, P280, DOI 10.1007/BF00804337; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Van Emous JG, 2001, AM J PHYSIOL-HEART C, V280, pH2189, DOI 10.1152/ajpheart.2001.280.5.H2189; WEISS JN, 1993, CARDIOVASC DRUG THER, V7, P499, DOI 10.1007/BF00877614; XU KY, 1995, CIRC RES, V77, P88, DOI 10.1161/01.RES.77.1.88	35	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25204	10.1371/journal.pone.0025204	http://dx.doi.org/10.1371/journal.pone.0025204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980397	Green Submitted, Green Published, gold			2022-12-27	WOS:000295939600015
J	Dziallas, C; Grossart, HP				Dziallas, Claudia; Grossart, Hans-Peter			Increasing Oxygen Radicals and Water Temperature Select for Toxic Microcystis sp.	PLOS ONE			English	Article							CYANOBACTERIAL BLOOMS; BACTERIA; GROWTH; LAKE; QUANTIFICATION; EXTRACTION; CLIMATE; SAMPLES; LIGHT	Pronounced rises in frequency of toxic cyanobacterial blooms are recently observed worldwide, particularly when temperatures increase. Different strains of cyanobacterial species vary in their potential to produce toxins but driving forces are still obscure. Our study examines effects of hydrogen peroxide on toxic and non-toxic (including a non-toxic mutant) strains of M. aeruginosa. Here we show that hydrogen peroxide diminishes chlorophyll a content and growth of cyanobacteria and that this reduction is significantly lower for toxic than for non-toxic strains. This indicates that microcystins protect from detrimental effects of oxygen radicals. Incubation of toxic and non-toxic strains of M. aeruginosa with other bacteria or without (axenic) at three temperatures (20, 26 and 32 degrees C) reveals a shift toward toxic strains at higher temperatures. In parallel to increases in abundance of toxic (i.e. toxin gene possessing) strains and their actual toxin expression, concentrations of microcystins rise with temperature, when amounts of radicals are expected to be enhanced. Field samples from three continents support the influence of radicals and temperature on toxic potential of M. aeruginosa. Our results imply that global warming will significantly increase toxic potential and toxicity of cyanobacterial blooms which has strong implications for socio-economical assessments of global change.	[Dziallas, Claudia; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Limnol Stratified Lakes, Stechlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Dziallas, C (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Limnol Stratified Lakes, Stechlin, Germany.	hgrossart@igb-berlin.de			German Science Foundation (DFG) [GR1540/11-1, GR1540/11-2]	German Science Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Science Foundation (DFG, grant GR1540/11-1,2 to HPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom JF, 2005, TOXICON, V46, P465, DOI 10.1016/j.toxicon.2005.06.013; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; DeStasio BT, 1996, LIMNOL OCEANOGR, V41, P1136, DOI 10.4319/lo.1996.41.5.1136; Dittmann E, 2001, MICROBIOL-SGM, V147, P3113, DOI 10.1099/00221287-147-11-3113; Dziallas C, 2011, ENVIRON MICROBIOL, V13, P1632, DOI 10.1111/j.1462-2920.2011.02479.x; Dziallas C, 2011, LIMNOL OCEANOGR-METH, V9, P67, DOI 10.4319/lom.2011.9.67; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Erhard M, 1997, NAT BIOTECHNOL, V15, P906, DOI 10.1038/nbt0997-906; Fastner J, 1998, WATER RES, V32, P3177, DOI 10.1016/S0043-1354(98)00073-6; Garcia-Pichel F, 1998, ORIGINS LIFE EVOL B, V28, P321, DOI 10.1023/A:1006545303412; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Gupta N, 2003, TOXICOLOGY, V188, P285, DOI 10.1016/S0300-483X(03)00112-4; Ho LN, 2007, TOXICON, V50, P438, DOI 10.1016/j.toxicon.2007.03.021; Hudnell H.K., 2008, CYANOBACTERIAL HARMF; Kieber D, 2003, UV EFFECTS AQUATIC O, V575; Kolmonen E, 2004, AQUAT MICROB ECOL, V36, P201, DOI 10.3354/ame036201; Kononen K, 1996, LIMNOL OCEANOGR, V41, P98, DOI 10.4319/lo.1996.41.1.0098; LAWTON LA, 1994, ANALYST, V119, P1525, DOI 10.1039/an9941901525; Lehtimaki J, 1997, APPL ENVIRON MICROB, V63, P1647, DOI 10.1128/AEM.63.5.1647-1656.1997; Lindstrom ES, 2005, AQUAT SCI, V67, P210, DOI 10.1007/s00027-005-0769-2; Mooij WM, 2005, AQUAT ECOL, V39, P381, DOI 10.1007/s10452-005-9008-0; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Schone K, 2010, HARMFUL ALGAE, V9, P494, DOI 10.1016/j.hal.2010.03.005; Shen PP, 2003, ENVIRON INT, V29, P641, DOI 10.1016/S0160-4120(03)00047-3; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2658, DOI 10.1128/AEM.56.9.2658-2666.1990; Surono IS, 2008, FOOD CHEM TOXICOL, V46, P502, DOI 10.1016/j.fct.2007.08.017; ZEHNDER A, 1960, CAN J MICROBIOL, V6, P645, DOI 10.1139/m60-077; Zhou J., 1996, APPL ENVIRON MICROB, V62, P695; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	33	98	100	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25569	10.1371/journal.pone.0025569	http://dx.doi.org/10.1371/journal.pone.0025569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980492	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900076
J	Kunst, M; Pfortner, R; Aschenbrenner, K; Heinrich, R				Kunst, Michael; Pfoertner, Ramona; Aschenbrenner, Katja; Heinrich, Ralf			Neurochemical Architecture of the Central Complex Related to Its Function in the Control of Grasshopper Acoustic Communication	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; MUSCARINIC ACETYLCHOLINE-RECEPTOR; GABA-LIKE IMMUNOREACTIVITY; NITRIC-OXIDE; STRIDULATORY BEHAVIOR; NERVOUS-SYSTEM; CYCLIC-GMP; GUANOSINE-MONOPHOSPHATE; BRAIN; INSECT	The central complex selects and coordinates the species-and situation-specific song production in acoustically communicating grasshoppers. Control of sound production is mediated by several neurotransmitters and modulators, their receptors and intracellular signaling pathways. It has previously been shown that muscarinic cholinergic excitation in the central complex promotes sound production whereas both GABA and nitric oxide/cyclic GMP signaling suppress its performance. The present immunocytochemical and pharmacological study investigates the question whether GABA and nitric oxide mediate inhibition of sound production independently. Muscarinic ACh receptors are expressed by columnar output neurons of the central complex that innervate the lower division of the central body and terminate in the lateral accessory lobes. GABAergic tangential neurons that innervate the lower division of the central body arborize in close proximity of columnar neurons and thus may directly inhibit these central complex output neurons. A subset of these GABAergic tangential neurons accumulates cyclic GMP following the release of nitric oxide from neurites in the upper division of the central body. While sound production stimulated by muscarine injection into the central complex is suppressed by co-application of sodium nitroprusside, picrotoxin-stimulated singing was not affected by co-application of this nitric oxide donor, indicating that nitric oxide mediated inhibition requires functional GABA signaling. Hence, grasshopper sound production is controlled by processing of information in the lower division of the central body which is subject to modulation by nitric oxide released from neurons in the upper division.	[Kunst, Michael; Pfoertner, Ramona; Aschenbrenner, Katja; Heinrich, Ralf] Univ Gottingen, Dept Cellular Neurobiol, Inst Zool, Gottingen, Germany	University of Gottingen	Kunst, M (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	rheinri1@gwdg.de		Kunst, Michael/0000-0003-4159-8056	Deutsche Forschungsgemeinschaft [HE 33301]; Georg-Christoph-Lichtenberg scholarship; Hertie PostDoc scholarship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-Christoph-Lichtenberg scholarship; Hertie PostDoc scholarship	This work was supported by Deutsche Forschungsgemeinschaft, Grant HE 33301 (to RH) and a Georg-Christoph-Lichtenberg scholarship and a Hertie PostDoc scholarship (both to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonuma H, 2004, ACTA BIOL HUNG, V55, P65, DOI 10.1556/ABiol.55.2004.1-4.8; Becker M, 1993, GENE BRAIN BEHAV; Bicker G, 1996, EUR J NEUROSCI, V8, P2635, DOI 10.1111/j.1460-9568.1996.tb01558.x; Bicker G, 1997, EUR J NEUROSCI, V9, P189, DOI 10.1111/j.1460-9568.1997.tb01366.x; Bicker G, 2001, CELL TISSUE RES, V303, P137, DOI 10.1007/s004410000321; BLAKE AD, 1993, MOL PHARMACOL, V44, P716; BLECHSCHMIDT K, 1990, J CHEM NEUROANAT, V3, P323; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOYAN G, 1993, J COMP NEUROL, V332, P358, DOI 10.1002/cne.903320308; Cayre M, 2005, EUR J NEUROSCI, V21, P2893, DOI 10.1111/j.1460-9568.2005.04153.x; CLEMENTS AN, 1974, J EXP BIOL, V60, P673; Collmann C, 2004, J NEUROSCI, V24, P6070, DOI 10.1523/JNEUROSCI.0710-04.2004; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; Elsner Norbert, 1994, Progress in Zoology, V39, P167; Gonzalez-Zulueta M, 1997, BIF FUTURA, V12, P1; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Heck C, 2009, J NEUROSCI METH, V183, P202, DOI 10.1016/j.jneumeth.2009.06.032; HEDWIG B, 1994, J NEUROPHYSIOL, V72, P2015, DOI 10.1152/jn.1994.72.4.2015; Hedwig B, 1997, J COMP PHYSIOL A, V180, P285, DOI 10.1007/s003590050048; HEDWIG B, 1992, J NEUROSCI METH, V45, P135, DOI 10.1016/0165-0270(92)90051-E; Hedwig B, 1995, VERH DT ZOOL GES, V72, P2015; Heinrich R, 1997, J EXP BIOL, V200, P1327; Heinrich R, 1998, J COMP PHYSIOL A, V183, P389, DOI 10.1007/s003590050265; Heinrich R, 2001, P NATL ACAD SCI USA, V98, P9919, DOI 10.1073/pnas.151131998; Heinrich R, 2001, J COMP PHYSIOL A, V187, P155, DOI 10.1007/s003590100188; Heinrich R, 2007, ADV EXP BIOL, V1, P107, DOI 10.1016/S1872-2423(07)01005-8; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Helversen Dvon, 1983, NEUROETHOLOGY BEHAV, P9; Hoffmann K, 2007, ZOOL SCI, V24, P1028, DOI 10.2108/zsj.24.1028; Homberg U, 2004, NATURWISSENSCHAFTEN, V91, P199, DOI 10.1007/s00114-004-0525-9; Homberg U, 1999, J COMP NEUROL, V409, P495, DOI 10.1002/(SICI)1096-9861(19990705)409:3<495::AID-CNE12>3.0.CO;2-F; HOMBERG U, 1991, J COMP NEUROL, V303, P245, DOI 10.1002/cne.903030207; Homberg U., 1987, P347; HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481; Jones IW, 1999, P ROY SOC B-BIOL SCI, V266, P413, DOI 10.1098/rspb.1999.0653; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; KNIPPER M, 1989, COMP BIOCHEM PHYS C, V93, P287, DOI 10.1016/0742-8413(89)90235-1; Kurylas AE, 2005, J COMP NEUROL, V484, P206, DOI 10.1002/cne.20467; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Madison D V, 1995, Curr Top Microbiol Immunol, V196, P5; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; Martinelli GPT, 2002, NEUROSCIENCE, V114, P111, DOI 10.1016/S0306-4522(02)00238-5; McLean DL, 2002, J NEUROSCI, V22, P4175, DOI 10.1523/JNEUROSCI.22-10-04175.2002; MEYER EP, 1986, HISTOCHEMISTRY, V84, P207, DOI 10.1007/BF00495784; MILLAR NS, 1995, J EXP BIOL, V198, P1843; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nugent FS, 2009, NEUROPSYCHOPHARMACOL, V34, P1829, DOI 10.1038/npp.2009.5; Ott SR, 2004, EUR J NEUROSCI, V20, P1231, DOI 10.1111/j.1460-9568.2004.03588.x; Ott SR, 2007, EUR J NEUROSCI, V25, P181, DOI 10.1111/j.1460-9568.2006.05271.x; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Popov A V, 2005, Neurosci Behav Physiol, V35, P741, DOI 10.1007/s11055-005-0118-x; Ridgel AL, 2007, J COMP PHYSIOL A, V193, P385, DOI 10.1007/s00359-006-0193-7; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Seki Y, 2005, J COMP NEUROL, V481, P340, DOI 10.1002/cne.20392; Siegl T, 2009, CELL TISSUE RES, V337, P327, DOI 10.1007/s00441-009-0820-z; Stern M, 2008, DEV NEUROBIOL, V68, P295, DOI 10.1002/dneu.20585; Stern M, 2010, J COMP NEUROL, V518, P1157, DOI 10.1002/cne.22303; Strambi C, 1998, LEARN MEMORY, V5, P78; Strausfeld NJ, 1999, PROG BRAIN RES, V123, P273, DOI 10.1016/S0079-6123(08)62863-0; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tanaka J, 1997, GLIA, V19, P286; Vitzthum H, 1996, J COMP NEUROL, V369, P419, DOI 10.1002/(SICI)1096-9861(19960603)369:3&lt;419::AID-CNE7&gt;3.0.CO;2-8; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; von Helversen D., 1972, Journal Comp Physiol, V81, P381; Wang S, 2006, FASEB J, V20, P1537, DOI 10.1096/fj.05-5547fje; WEGERHOFF R, 1992, CELL TISSUE RES, V268, P341, DOI 10.1007/BF00318803; Weinrich A, 2008, J COMP PHYSIOL A, V194, P763, DOI 10.1007/s00359-008-0347-x; Wenzel B, 2005, J COMP NEUROL, V488, P129, DOI 10.1002/cne.20600; Wenzel B, 2002, J NEUROPHYSIOL, V87, P876, DOI 10.1152/jn.00312.2001; Wessnitzer J, 2006, BIOINSPIR BIOMIM, V1, P63, DOI 10.1088/1748-3182/1/3/001; Wicher D, 2004, J BIOL CHEM, V279, P50410, DOI 10.1074/jbc.M405800200; WILLIAMS JLD, 1975, J ZOOL, V176, P67; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Xing JH, 2008, NEUROPHARMACOLOGY, V54, P734, DOI 10.1016/j.neuropharm.2007.12.008; Yu D, 2005, J COMP NEUROL, V483, P278, DOI 10.1002/cne.20416	79	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25613	10.1371/journal.pone.0025613	http://dx.doi.org/10.1371/journal.pone.0025613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980504	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900081
J	Martin, M; Vanichseni, S; Suntharasamai, P; Sangkum, U; Chuachoowong, R; Mock, PA; Leethochawalit, M; Chiamwongpaet, S; Kittimunkong, S; van Griensven, F; McNicholl, JM; Paxton, L; Choopanya, K				Martin, Michael; Vanichseni, Suphak; Suntharasamai, Pravan; Sangkum, Udomsak; Chuachoowong, Rutt; Mock, Philip A.; Leethochawalit, Manoj; Chiamwongpaet, Sithisat; Kittimunkong, Somyot; van Griensven, Frits; McNicholl, Janet M.; Paxton, Lynn; Choopanya, Kachit		Bangkok Tenofovir Study Grp	Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand	PLOS ONE			English	Article							HIV VACCINE TRIAL; HUMAN-IMMUNODEFICIENCY-VIRUS; DISOPROXIL FUMARATE; INFECTION; MACAQUES; EMTRICITABINE; PREVENTION; INCARCERATION; EFAVIRENZ; EFFICACY	Background: The Bangkok Tenofovir Study was launched in 2005 to determine if pre-exposure prophylaxis with tenofovir will reduce the risk of HIV infection among injecting drug users (IDUs). We describe recruitment, screening, enrollment, and baseline characteristics of study participants and contrast risk behavior of Tenofovir Study participants with participants in the 1999-2003 AIDSVAX B/E Vaccine Trial. Methods: The Bangkok Tenofovir Study is an ongoing, phase-3, randomized, double-blind, placebo-controlled, HIV pre-exposure prophylaxis trial of daily oral tenofovir. The Tenofovir Study and the Vaccine Trial were conducted among IDUs at 17 drug-treatment clinics in Bangkok. Tenofovir Study sample size was based on HIV incidence in the Vaccine Trial. Standardized questionnaires were used to collect demographic, risk behavior, and incarceration data. The Tenofovir Study is registered with ClinicalTrials.gov, number-NCT00119106. Results: From June 2005 through July 2010, 4094 IDUs were screened and 2413 enrolled in the Bangkok Tenofovir Study. The median age of enrolled participants was 31 years (range, 20-59), 80% were male, and 63% reported they injected drugs during the 3 months before enrollment. Among those who injected, 53% injected methamphetamine, 37% midazolam, and 35% heroin. Tenofovir Study participants were less likely to inject drugs, inject daily, or share needles (all, p<0.001) than Vaccine Trial participants. Discussion: The Bangkok Tenofovir Study has been successfully launched and is fully enrolled. Study participants are significantly less likely to report injecting drugs and sharing needles than participants in the 1999-2003 AIDSVAX B/E Vaccine Trial suggesting HIV incidence will be lower than expected. In response, the Bangkok Tenofovir Study enrollment was increased from 1600 to 2400 and the study design was changed from a defined 1-year follow-up period to an endpoint-driven design. Trial results demonstrating whether or not daily oral tenofovir reduces the risk of HIV infection among IDUs are expected in 2012.	[Martin, Michael; Chuachoowong, Rutt; Mock, Philip A.; van Griensven, Frits; McNicholl, Janet M.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Martin, Michael; McNicholl, Janet M.; Paxton, Lynn] Ctr Dis Control & Prevent, Atlanta, GA USA; [Vanichseni, Suphak; Suntharasamai, Pravan; Sangkum, Udomsak; Choopanya, Kachit] Bangkok Tenofovir Study Grp, Bangkok, Thailand; [Leethochawalit, Manoj; Chiamwongpaet, Sithisat] Bangkok Metropolitan Adm, Bangkok, Thailand	Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Martin, M (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand.	Znd9@cdc.gov	van Griensven, Frits/G-4719-2013	van Griensven, Frits/0000-0002-0971-2843; Cherdtrakulkiat, Thitima/0000-0001-5006-6145	US Centers for Disease Control and Prevention	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Sponsor (US Centers for Disease Control and Prevention) staff had a role in study design, the collection, analysis, and interpretation of data, writing the report, and in the decision to submit the paper for publication.	Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1; Baeten J, 2011, 6 INT AIDS SOC C; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Choopanya K, 2002, J ACQ IMMUN DEF SYND, V29, P86, DOI 10.1097/00126334-200201010-00012; Chuachoowong R, 2008, 17 INT AIDS C 2008 M; Daniell HW, 2002, J ADDICT DIS, V21, P47, DOI 10.1300/J069v21n04_05; De Clercq E, 2003, CLIN MICROBIOL REV, V16, P569, DOI 10.1128/CMR.16.4.569-596.2003; DECLERCQ E, 1987, ANTIVIR RES, V8, P261; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; FHI, FEM PREP PROJ; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2003, CLIN INFECT DIS, V37, P944, DOI 10.1086/378068; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Gilead Sciences, 2010, VIR TEN DIS FUM TABL; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Human Rights Watch, 2004, 8C HUM RIGHTS WATCH; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kearney BP, 2003, INT C ANT AG CHEM; KONINGS E, 1995, AIDS, V9, P375, DOI 10.1097/00002030-199509040-00009; Margot NA, 2009, JAIDS-J ACQ IMM DEF, V52, P209, DOI 10.1097/QAI.0b013e3181b05f7c; Martin M, 2010, INT J DRUG POLICY, V21, P296, DOI 10.1016/j.drugpo.2009.12.002; MASTRO TD, 1994, AM J PUBLIC HEALTH, V84, P1094, DOI 10.2105/AJPH.84.7.1094; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; MIRIN SM, 1980, AM J PSYCHIAT, V137, P909; National AIDS Prevention and Alleviation Committee, UNGASS COUNTR PROGR; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2018, RECOMMENDATIONS USE; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Smith PF, 2004, PHARMACOTHERAPY, V24, P970, DOI 10.1592/phco.24.11.970.36141; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Suntharasamai P, 2009, ADDICTION, V104, P235, DOI 10.1111/j.1360-0443.2008.02436.x; Thigpen MC, 2011, 6 INT AIDS SOC C; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; van Griensven F, 2006, AM J EPIDEMIOL, V163, P271, DOI 10.1093/aje/kwj038; Van Griensven F, 2005, INT J DRUG POLICY, V16, P171, DOI 10.1016/j.drugpo.2005.02.003; van Griensven F, 2004, AIDS, V18, P295, DOI 10.1097/00002030-200401230-00020; Van Rompay KKA, 2006, JAIDS-J ACQ IMM DEF, V43, P6, DOI 10.1097/01.qai.0000224972.60339.7c; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vanichseni S, 2004, AIDS, V18, P311, DOI 10.1097/00002030-200401230-00022; Vongchak T, 2005, INT J DRUG POLICY, V16, P115, DOI 10.1016/j.drugpo.2004.11.003; Wainberg MA, 1999, ANTIVIR THER, V4, P87; Wattana W, 2007, DRUG ALCOHOL DEPEN, V90, P228, DOI 10.1016/j.drugalcdep.2007.03.013; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; *WHO, EP FACT SHEET HIV AI	44	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25127	10.1371/journal.pone.0025127	http://dx.doi.org/10.1371/journal.pone.0025127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21969870	Green Published, gold			2022-12-27	WOS:000295936900026
J	Speed, N; Saunders, C; Davis, AR; Owens, WA; Matthies, HJG; Saadat, S; Kennedy, JP; Vaughan, RA; Neve, RL; Lindsley, CW; Russo, SJ; Daws, LC; Niswender, KD; Galli, A				Speed, Nicole; Saunders, Christine; Davis, Adeola R.; Owens, W. Anthony; Matthies, Heinrich J. G.; Saadat, Sanaz; Kennedy, Jack P.; Vaughan, Roxanne A.; Neve, Rachael L.; Lindsley, Craig W.; Russo, Scott J.; Daws, Lynette C.; Niswender, Kevin D.; Galli, Aurelio			Impaired Striatal Akt Signaling Disrupts Dopamine Homeostasis and Increases Feeding	PLOS ONE			English	Article							HIGH-FAT DIET; NOREPINEPHRINE TRANSPORTER TRAFFICKING; INSULIN-RESISTANCE; DORSAL STRIATUM; INDUCED OBESITY; FOOD REWARD; MICE PRONE; AMPHETAMINE; EXPRESSION; LEPTIN	Background: The prevalence of obesity has increased dramatically worldwide. The obesity epidemic begs for novel concepts and therapeutic targets that cohesively address "food-abuse" disorders. We demonstrate a molecular link between impairment of a central kinase (Akt) involved in insulin signaling induced by exposure to a high-fat (HF) diet and dysregulation of higher order circuitry involved in feeding. Dopamine (DA) rich brain structures, such as striatum, provide motivation stimuli for feeding. In these central circuitries, DA dysfunction is posited to contribute to obesity pathogenesis. We identified a mechanistic link between metabolic dysregulation and the maladaptive behaviors that potentiate weight gain. Insulin, a hormone in the periphery, also acts centrally to regulate both homeostatic and reward-based HF feeding. It regulates DA homeostasis, in part, by controlling a key element in DA clearance, the DA transporter (DAT). Upon HF feeding, nigro-striatal neurons rapidly develop insulin signaling deficiencies, causing increased HF calorie intake. Methodology/Principal Findings: We show that consumption of fat-rich food impairs striatal activation of the insulin-activated signaling kinase, Akt. HF-induced Akt impairment, in turn, reduces DAT cell surface expression and function, thereby decreasing DA homeostasis and amphetamine (AMPH)-induced DA efflux. In addition, HF-mediated dysregulation of Akt signaling impairs DA-related behaviors such as (AMPH)-induced locomotion and increased caloric intake. We restored nigro-striatal Akt phosphorylation using recombinant viral vector expression technology. We observed a rescue of DAT expression in HF fed rats, which was associated with a return of locomotor responses to AMPH and normalization of HF diet-induced hyperphagia. Conclusions/Significance: Acquired disruption of brain insulin action may confer risk for and/or underlie "food-abuse" disorders and the recalcitrance of obesity. This molecular model, thus, explains how even short-term exposure to "the fast food lifestyle" creates a cycle of disordered eating that cements pathological changes in DA signaling leading to weight gain and obesity.	[Davis, Adeola R.; Matthies, Heinrich J. G.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Speed, Nicole; Saunders, Christine; Kennedy, Jack P.; Lindsley, Craig W.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Galli, Aurelio] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37212 USA; [Owens, W. Anthony; Daws, Lynette C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Russo, Scott J.] Mt Sinai Med Ctr, Dept Neurosci, New York, NY 10029 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Saadat, Sanaz; Niswender, Kevin D.] Tennessee Valley Healthcare Syst, Nashville, TN USA; [Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Health San Antonio; University of North Dakota Grand Forks; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Speed, N (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	aurelio.galli@vanderbilt.edu	Russo, Scott/R-7107-2019; Matthies, Heinrich/B-7284-2017; Matthies, Heinrich/AAD-2375-2019	Russo, Scott/0000-0002-6470-1805; Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571	National Institutes of Health [DA14684, DK085712]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the National Institutes of Health grants DA14684 given to AG and LCD and by the DK085712 grant given to AG and KDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Doolen S, 2001, J PHARMACOL EXP THER, V296, P931; Figlewicz DP, 2010, PHARMACOL BIOCHEM BE, V97, P15, DOI 10.1016/j.pbb.2010.03.002; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Gochenauer GE, 2001, J NEUROCHEM, V78, P276, DOI 10.1046/j.1471-4159.2001.00385.x; Grueter BA, 2005, NEUROPSYCHOPHARMACOL, V30, P1302, DOI 10.1038/sj.npp.1300672; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; Huang XF, 2005, MOL BRAIN RES, V135, P150, DOI 10.1016/j.molbrainres.2004.12.013; Huang XF, 2006, BEHAV BRAIN RES, V175, P415, DOI 10.1016/j.bbr.2006.08.034; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Konner AC, 2011, CELL METAB, V13, P720, DOI 10.1016/j.cmet.2011.03.021; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Niswender KD, 2003, J HISTOCHEM CYTOCHEM, V51, P275, DOI 10.1177/002215540305100302; Niswender KD, 2011, NEUROPSYCHOPHARMACOL, V36, P359, DOI 10.1038/npp.2010.167; Owens WA, 2005, J NEUROCHEM, V94, P1402, DOI 10.1111/j.1471-4159.2005.03289.x; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Robertson SD, 2010, J NEUROSCI, V30, P11305, DOI 10.1523/JNEUROSCI.0126-10.2010; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Sotak BN, 2005, BRAIN RES, V1061, P88, DOI 10.1016/j.brainres.2005.08.053; Speed NK, 2010, ACS CHEM NEUROSCI, V1, P476, DOI 10.1021/cn100031t; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; Williams J, 2007, PLOS BIOL, V5, P2369, DOI 10.1371/journal.pbio.0050274	41	84	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25169	10.1371/journal.pone.0025169	http://dx.doi.org/10.1371/journal.pone.0025169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969871	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900028
J	Yu, QB; Sui, J; Rachakonda, S; He, H; Gruner, W; Pearlson, G; Kiehl, KA; Calhoun, VD				Yu, Qingbao; Sui, Jing; Rachakonda, Srinivas; He, Hao; Gruner, William; Pearlson, Godfrey; Kiehl, Kent A.; Calhoun, Vince D.			Altered Topological Properties of Functional Network Connectivity in Schizophrenia during Resting State: A Small-World Brain Network Study	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; GRAPH-THEORETICAL ANALYSIS; CORTICAL NETWORKS; BLIND SEPARATION; LOW-FREQUENCY; SCALE-FREE; FMRI DATA; MRI DATA; ORGANIZATION; DYSCONNECTIVITY	Aberrant topological properties of small-world human brain networks in patients with schizophrenia (SZ) have been documented in previous neuroimaging studies. Aberrant functional network connectivity (FNC, temporal relationships among independent component time courses) has also been found in SZ by a previous resting state functional magnetic resonance imaging (fMRI) study. However, no study has yet determined if topological properties of FNC are also altered in SZ. In this study, small-world network metrics of FNC during the resting state were examined in both healthy controls (HCs) and SZ subjects. FMRI data were obtained from 19 HCs and 19 SZ. Brain images were decomposed into independent components (ICs) by group independent component analysis (ICA). FNC maps were constructed via a partial correlation analysis of ICA time courses. A set of undirected graphs were built by thresholding the FNC maps and the small-world network metrics of these maps were evaluated. Our results demonstrated significantly altered topological properties of FNC in SZ relative to controls. In addition, topological measures of many ICs involving frontal, parietal, occipital and cerebellar areas were altered in SZ relative to controls. Specifically, topological measures of whole network and specific components in SZ were correlated with scores on the negative symptom scale of the Positive and Negative Symptom Scale (PANSS). These findings suggest that aberrant architecture of small-world brain topology in SZ consists of ICA temporally coherent brain networks.	[Yu, Qingbao; Sui, Jing; Rachakonda, Srinivas; He, Hao; Gruner, William; Kiehl, Kent A.; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [He, Hao; Gruner, William; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Pearlson, Godfrey; Calhoun, Vince D.] Olin Neuropsychiat Res Ctr, Hartford, CT USA; [Pearlson, Godfrey; Calhoun, Vince D.] Yale Univ, Dept Psychiat, New Haven, CT USA; [Kiehl, Kent A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; Yale University; University of New Mexico	Yu, QB (corresponding author), Mind Res Network, Albuquerque, NM USA.	qyu@mrn.org; vcalhoun@unm.edu	Calhoun, Vince D./ACN-9399-2022; Yu, Qingbao/I-2244-2013; He, Hao/H-9618-2014; Sui, Jing/B-3455-2018; Kiehl, Kent A./AAK-3290-2020	Calhoun, Vince D./0000-0001-9058-0747; Yu, Qingbao/0000-0003-4166-3102; He, Hao/0000-0002-9382-998X; Sui, Jing/0000-0001-6837-5966; 	NIH [R01 EB000840, R37 MH43775, R01 MH072681-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072681, R37MH043775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants R01 EB000840 (PI: Calhoun), R37 MH43775 (PI: Pearlson) and R01 MH072681-01 (PI: Kiehl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Adcock RA, 2009, SCHIZOPHRENIA BULL, V35, P1132, DOI 10.1093/schbul/sbp068; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bor J, SCHIZOPHR R IN PRESS; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1997, SCHIZOPHR RES, V28, P143, DOI 10.1016/S0920-9964(97)00114-X; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Danckert J, 2004, SCHIZOPHR RES, V70, P241, DOI 10.1016/j.schres.2003.12.007; Danielyan A, 2009, PSYCHIAT CLIN N AM, V32, P719, DOI 10.1016/j.psc.2009.08.004; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Erhardt EB, HUM BRAIN M IN PRESS; First M.B., 2016, STRUCTURED CLIN INTE; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Fisher RA, 1914, BIOMETRIKA, V10, P507; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 2005, AM J PSYCHIAT, V162, P429, DOI 10.1176/appi.ajp.162.3.429; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gillig Paulette Marie, 2010, Psychiatry (Edgmont), V7, P38; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hendler T, 2009, CURR OPIN PSYCHIATR, V22, P300, DOI 10.1097/YCO.0b013e32832a16f0; Honey GD, 2005, BRAIN, V128, P2597, DOI 10.1093/brain/awh632; Hugdahl Kenneth, 2010, Front Hum Neurosci, V4, P4, DOI 10.3389/neuro.09.004.2010; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iritani S, 2007, NEUROPATHOLOGY, V27, P604, DOI 10.1111/j.1440-1789.2007.00798.x; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Li XB, 2009, CURR OPIN PSYCHIATR, V22, P131, DOI 10.1097/YCO.0b013e328324bc43; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P368, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<368::AID-HBM7>3.3.CO;2-5; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Palmer BW, 2009, NEUROPSYCHOL REV, V19, P365, DOI 10.1007/s11065-009-9109-y; Park S, 2010, AM J PSYCHIAT, V167, P366, DOI 10.1176/appi.ajp.2010.10010089; Pearlson GD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.037.2009; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sava Simona, 2008, Top Magn Reson Imaging, V19, P71, DOI 10.1097/RMR.0b013e318184187c; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Swanson N, 2011, HUM BRAIN MAPP, V32, P654, DOI 10.1002/hbm.21055; Tan HY, 2006, AM J PSYCHIAT, V163, P1969, DOI 10.1176/appi.ajp.163.11.1969; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Van Snellenberg JX, 2009, PSYCHIAT RES-NEUROIM, V174, P89, DOI 10.1016/j.pscychresns.2009.04.001; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wang Y, 2009, SCHIZOPHR RES, V114, P64, DOI 10.1016/j.schres.2009.07.009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	93	103	107	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25423	10.1371/journal.pone.0025423	http://dx.doi.org/10.1371/journal.pone.0025423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980454	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900064
J	Armata, HL; Shroff, P; Garlick, DE; Penta, K; Tapper, AR; Sluss, HK				Armata, Heather L.; Shroff, Punita; Garlick, David E.; Penta, Krista; Tapper, Andrew R.; Sluss, Hayla K.			Loss of p53 Ser18 and Atm Results in Embryonic Lethality without Cooperation in Tumorigenesis	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; MUTATIONS; MICE; DEFICIENT; RADIATION; LYMPHOMA; GENE; DEFECTS; PHOSPHORYLATION; SUSCEPTIBILITY	Phosphorylation at murine Serine 18 (human Serine 15) is a critical regulatory process for the tumor suppressor function of p53. p53Ser18 residue is a substrate for ataxia-telangiectasia mutated (ATM) and ATM-related (ATR) protein kinases. Studies of mice with a germ-line mutation that replaces Ser18 with Ala (p53(S18A) mice) have demonstrated that loss of phosphorylation of p53Ser18 leads to the development of tumors, including lymphomas, fibrosarcomas, leukemia and leiomyosarcomas. The predominant lymphoma is B-cell lymphoma, which is in contrast to the lymphomas observed in Atm(-/-) animals. This observation and the fact that multiple kinases phosphorylate p53Ser18 suggest Atm-independent tumor suppressive functions of p53Ser18. Therefore, in order to examine p53Ser18 function in relationship to ATM, we analyzed the lifespan and tumorigenesis of mice with combined mutations in p53Ser18 and Atm. Surprisingly, we observed no cooperation in survival and tumorigenesis in compound p53(S18A) and Atm(-/-) animals. However, we observed embryonic lethality in the compound mutant animals. In addition, the homozygous p53Ser18 mutant allele impacted the weight of Atm(-/-) animals. These studies examine the genetic interaction of p53Ser18 and Atm in vivo. Furthermore, these studies demonstrate a role of p53Ser18 in regulating embryonic survival and motor coordination.	[Armata, Heather L.; Shroff, Punita; Sluss, Hayla K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol, Worcester, MA 01605 USA; [Garlick, David E.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Penta, Krista; Tapper, Andrew R.] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Armata, HL (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol, Worcester, MA 01605 USA.	hayla.sluss@umassmed.edu			American Cancer Society; Diabetes and Endocrinology Research grant [DK32520]; National Ataxia Foundation; National Institute on Alcohol Abuse and Alcoholism [5R01AA017656]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017656] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Diabetes and Endocrinology Research grant; National Ataxia Foundation; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	PS was funded by an American Cancer Society Fuller Fellow Award. HS is a member of the Universtiy of Massachusetts Diabetes and Endocrinology Research Center (DK32520). Core resources supported by the Diabetes and Endocrinology Research grant DK32520 were also used. This research was supported by a grant from the National Ataxia Foundation to HS and the National Institute on Alcohol Abuse and Alcoholism to AT (Grant 5R01AA017656). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Armata HL, 2007, CANCER RES, V67, P11696, DOI 10.1158/0008-5472.CAN-07-1610; Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; Bailey SL, 2008, MOL CANCER RES, V6, P1185, DOI 10.1158/1541-7786.MCR-07-2009; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barlow C, 1999, NATURE, V4, P359; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bullrich F, 1999, CANCER RES, V59, P24; Chao C, 2003, J BIOL CHEM IN PRESS; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mao JH, 2008, ONCOGENE, V27, P6596, DOI 10.1038/onc.2008.280; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Reliene R, 2007, J NUTR, V137, p229S, DOI 10.1093/jn/137.1.229S; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Sluss HK, 2010, MOL CANCER RES, V8, P216, DOI 10.1158/1541-7786.MCR-09-0324; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Smilenov LB, 2001, CANCER RES, V61, P5710; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Spring K, 2001, CANCER RES, V61, P4561; Stankovic T, 2002, LEUKEMIA LYMPHOMA, V43, P1563, DOI 10.1080/1042819021000002884; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Stilgenbauer S, 1997, NAT MED, V3, P1155, DOI 10.1038/nm1097-1155; Stoppa-Lyonnet D, 1998, BLOOD, V91, P3920, DOI 10.1182/blood.V91.10.3920.3920_3920_3926; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Taylor AMR, 2005, J CLIN PATHOL, V58, P1009, DOI 10.1136/jcp.2005.026062; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Worgul BV, 2002, P NATL ACAD SCI USA, V99, P9836, DOI 10.1073/pnas.162349699; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	40	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24813	10.1371/journal.pone.0024813	http://dx.doi.org/10.1371/journal.pone.0024813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980358	Green Published, gold, Green Submitted			2022-12-27	WOS:000295933700009
J	Cook, J; Kleinschmidt, I; Schwabe, C; Nseng, G; Bousema, T; Corran, PH; Riley, EM; Drakeley, CJ				Cook, Jackie; Kleinschmidt, Immo; Schwabe, Christopher; Nseng, Gloria; Bousema, Teun; Corran, Patrick H.; Riley, Eleanor M.; Drakeley, Chris J.			Serological Markers Suggest Heterogeneity of Effectiveness of Malaria Control Interventions on Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; VECTOR CONTROL; TRANSMISSION; SURVEILLANCE; ELIMINATION; COMBINATION; ANTIBODIES; MORBIDITY; INFECTION; EXPOSURE	Background: In order to control and eliminate malaria, areas of on-going transmission need to be identified and targeted for malaria control interventions. Immediately following intense interventions, malaria transmission can become more heterogeneous if interventions are more successful in some areas than others. Bioko Island, Equatorial Guinea, has been subject to comprehensive malaria control interventions since 2004. This has resulted in substantial reductions in the parasite burden, although this drop has not been uniform across the island. Methods/Principal Findings: In 2008, filter paper blood samples were collected from 7387 people in a cross-sectional study incorporating 18 sentinel sites across Bioko, Equatorial Guinea. Antibodies were measured to P. falciparum Apical Membrane Antigen-1 (AMA-1) by Enzyme Linked Immunosorbent Assay (ELISA). Age-specific seropositivity rates were used to estimate seroconversion rates (SCR). Analysis indicated there had been at least a 60% decline in SCR in four out of five regions on the island. Changes in SCR showed a high degree of congruence with changes in parasite rate (PR) and with regional reductions in all cause child mortality. The mean age adjusted concentration of anti-AMA-1 antibodies was mapped to identify areas where individual antibody responses were higher than expected. This approach confirmed the North West of the island as a major focus of continuing infection and an area where control interventions need to be concentrated or re-evaluated. Conclusion/Interpretation: Both SCR and PR revealed heterogeneity in malaria transmission and demonstrated the variable effectiveness of malaria control measures. This work confirms the utility of serological analysis as an adjunct measure for monitoring transmission. Age-specific seroprevalence based evidence of changes in transmission over time will be of particular value when no baseline data are available. Importantly, SCR data provide additional evidence to link malaria control activities to contemporaneous reductions in all-cause child mortality.	[Cook, Jackie; Bousema, Teun; Corran, Patrick H.; Riley, Eleanor M.; Drakeley, Chris J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Schwabe, Christopher] Med Care Dev Int, Silver Spring, MD USA; [Nseng, Gloria] Minist Hlth & Social Welf, Malabo, Equat Guinea	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Cook, J (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.	Chris.Drakeley@lshtm.ac.uk	Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013; Bousema, Teun/N-3574-2014	Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Bousema, Teun/0000-0003-2666-094X	Wellcome Trust [078925]; Marathon Oil Company; Government of Equatorial Guinea; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Marathon Oil Company; Government of Equatorial Guinea; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The malariometric surveys and serological analysis were funded by Marathon Oil and Government of Equatorial Guinea. Addtional funding was provided by by a grant from the Wellcome Trust (078925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported with funds from the Marathon Oil Company. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; BRUCECHWATT LJ, 1975, J TROP MED HYG, V78, P194; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Bukirwa H, 2009, AM J TROP MED HYG, V81, P611, DOI 10.4269/ajtmh.2009.09-0126; Cano J, 2004, J MED ENTOMOL, V41, P158, DOI 10.1603/0022-2585-41.2.158; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; COLLINS WE, 1964, AM J TROP MED HYG, V13, P256, DOI 10.4269/ajtmh.1964.13.256; CORNILLEBROGGER R, 1978, B WORLD HEALTH ORGAN, V56, P579; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; DRAPER CC, 1972, T ROY SOC TROP MED H, V66, P905, DOI 10.1016/0035-9203(72)90126-5; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Tseng LF, 2008, AM J TROP MED HYG, V78, P248, DOI 10.4269/ajtmh.2008.78.248; Vega JC, 2007, TROP MED INT HEALTH, V12, P1524, DOI 10.1111/j.1365-3156.2007.01961.x; WILLIAMS BG, 1994, PARASITOL TODAY, V10, P489, DOI 10.1016/0169-4758(94)90163-5; Williams GS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-168; Wilson S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-67	29	93	94	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25137	10.1371/journal.pone.0025137	http://dx.doi.org/10.1371/journal.pone.0025137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980386	gold, Green Published, Green Accepted			2022-12-27	WOS:000295933700018
J	Deblon, N; Veyrat-Durebex, C; Bourgoin, L; Caillon, A; Bussier, AL; Petrosino, S; Piscitelli, F; Legros, JJ; Geenen, V; Foti, M; Wahli, W; Di Marzo, V; Rohner-Jeanrenaud, F				Deblon, Nicolas; Veyrat-Durebex, Christelle; Bourgoin, Lucie; Caillon, Aurelie; Bussier, Anne-Lise; Petrosino, Stefania; Piscitelli, Fabiana; Legros, Jean-Jacques; Geenen, Vincent; Foti, Michelangelo; Wahli, Walter; Di Marzo, Vincenzo; Rohner-Jeanrenaud, Francoise			Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese Rats	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; BODY-WEIGHT; TARGETED DISRUPTION; MAMMARY-GLAND; PPAR-ALPHA; PLASMA; FAT; OLEOYLETHANOLAMIDE; GLUCOSE; BRAIN	Apart from its role during labor and lactation, oxytocin is involved in several other functions. Interestingly, oxytocin-and oxytocin receptor-deficient mice develop late-onset obesity with normal food intake, suggesting that the hormone might exert a series of beneficial metabolic effects. This was recently confirmed by data showing that central oxytocin infusion causes weight loss in diet-induced obese mice. The aim of the present study was to unravel the mechanisms underlying such beneficial effects of oxytocin. Chronic central oxytocin infusion was carried out in high fat diet-induced obese rats. Its impact on body weight, lipid metabolism and insulin sensitivity was determined. We observed a dose-dependent decrease in body weight gain, increased adipose tissue lipolysis and fatty acid beta-oxidation, as well as reduced glucose intolerance and insulin resistance. The additional observation that plasma oxytocin levels increased upon central infusion suggested that the hormone might affect adipose tissue metabolism by direct action. This was demonstrated using in vitro, ex vivo, as well as in vivo experiments. With regard to its mechanism of action in adipose tissue, oxytocin increased the expression of stearoyl-coenzyme A desaturase 1, as well as the tissue content of the phospholipid precursor, N-oleoyl-phosphatidyl-ethanolamine, the biosynthetic precursor of the oleic acid-derived PPAR-alpha activator, oleoylethanolamide. Because PPAR-alpha regulates fatty acid beta-oxidation, we hypothesized that this transcription factor might mediate the oxytocin effects. This was substantiated by the observation that, in contrast to its effects in wild-type mice, oxytocin infusion failed to induce weight loss and fat oxidation in PPAR-alpha-deficient animals. Altogether, these results suggest that oxytocin administration could represent a promising therapeutic approach for the treatment of human obesity and type 2 diabetes.	[Deblon, Nicolas; Veyrat-Durebex, Christelle; Caillon, Aurelie; Bussier, Anne-Lise; Rohner-Jeanrenaud, Francoise] Univ Geneva, Fac Med, Dept Internal Med, Div Endocrinol Diabetol & Nutr, Geneva, Switzerland; [Bourgoin, Lucie; Foti, Michelangelo] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland; [Petrosino, Stefania; Piscitelli, Fabiana; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, I-80125 Naples, Italy; [Legros, Jean-Jacques] Univ Liege, Ctr Hosp Reg Citadelle, Liege, Belgium; [Di Marzo, Vincenzo] Univ Liege, Ctr Immunol, CHU B23, Liege, Belgium; [Wahli, Walter] Univ Lausanne, Ctr Integrat Genom, Natl Res Ctr Frontiers Genet, Lausanne, Switzerland	University of Geneva; University of Geneva; Consiglio Nazionale delle Ricerche (CNR); University of Liege; University of Liege; University of Lausanne	Deblon, N (corresponding author), Univ Geneva, Fac Med, Dept Internal Med, Div Endocrinol Diabetol & Nutr, Geneva, Switzerland.	francoise.jeanrenaud@unige.ch	Di Marzo, Vincenzo/AAD-7742-2019; Wahli, Walter/B-1398-2009; Wahli, Walter/I-3194-2019; Piscitelli, Fabiana/A-7100-2014	Di Marzo, Vincenzo/0000-0002-1490-3070; Wahli, Walter/0000-0002-5966-9089; Piscitelli, Fabiana/0000-0001-9343-4622; Veyrat-Durebex, Christelle/0000-0001-5301-6493; Geenen, Vincent/0000-0002-8733-7284; Foti, Michelangelo/0000-0001-7199-4135	Swiss National Science Foundation, Bern, Switzerland [310000-120147/1, 31003A-134919/1, 310030-135727, 3100A0-128660/1]; National Institutes of Health (NIH) [DA009789]	Swiss National Science Foundation, Bern, Switzerland(Swiss National Science Foundation (SNSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants N<SUP>o</SUP> 310000-120147/1 (Dr. Rohner-Jeanrenaud), N<SUP>o</SUP> 31003A-134919/1 (Dr. Rohner-Jeanrenaud), N<SUP>o</SUP> 310030-135727 (Dr. Foti) and N<SUP>o</SUP> 3100A0-128660/1 (Dr. Wahli) from the Swiss National Science Foundation, Bern, Switzerland. Dr. Petrosino, Dr. Piscitelli and Dr. Di Marzo are grateful to the National Institutes of Health (NIH) for partly funding this study (grant N<SUP>o</SUP> DA009789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyama H, 2010, J BIOL CHEM; ARLETTI R, 1989, PEPTIDES, V10, P89, DOI 10.1016/0196-9781(89)90082-X; BJORKSTRAND E, 1992, ACTA PHYSIOL SCAND, V144, P355, DOI 10.1111/j.1748-1716.1992.tb09305.x; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Collins JM, 2010, J BIOL CHEM, V285, P6044, DOI 10.1074/jbc.M109.053280; Dobrzyn P, 2010, J APPL PHYSL; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; Gaetani S, 2010, J NEUROSCI, V30, P8096, DOI 10.1523/JNEUROSCI.0036-10.2010; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gonzalez-Yanes C, 2005, AM J PHYSIOL-ENDOC M, V289, pE923, DOI 10.1152/ajpendo.00555.2004; Gould BR, 2003, NEUROSCIENCE, V122, P155, DOI 10.1016/S0306-4522(03)00283-5; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; JENSEN DR, 1994, BIOCHEM J, V298, P321, DOI 10.1042/bj2980321; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Kusui C, 2001, BIOCHEM BIOPH RES CO, V289, P681, DOI 10.1006/bbrc.2001.6024; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; MUCHMORE DB, 1981, J BIOL CHEM, V256, P365; Murata T, 2000, J ENDOCRINOL, V166, P45, DOI 10.1677/joe.0.1660045; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pequeux C, 2001, SCAND J CLIN LAB INV, V61, P407, DOI 10.1080/003655101316911468; Popeijus HE, 2008, INT J OBESITY, V32, P1076, DOI 10.1038/ijo.2008.55; ROHNERJEANRENAUD F, 1989, ENDOCRINOLOGY, V124, P733, DOI 10.1210/endo-124-2-733; Schaffler A, 2005, NEUROPEPTIDES, V39, P363, DOI 10.1016/j.npep.2005.06.003; SWAAB DF, 1995, J CLIN ENDOCR METAB, V80, P573, DOI 10.1210/jc.80.2.573; TAKAGI T, 1985, HORM METAB RES, V17, P308, DOI 10.1055/s-2007-1013526; Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9; Tsuda T, 2006, BIOCHEM PHARMACOL, V71, P1184, DOI 10.1016/j.bcp.2005.12.042; VETTOR R, 1994, DIABETOLOGIA, V37, P1202, DOI 10.1007/s001250050236; Yogev Y, 2009, SEMIN FETAL NEONAT M, V14, P77, DOI 10.1016/j.siny.2008.09.002; Zhang G, 2011, NEURON, V69, P523, DOI 10.1016/j.neuron.2010.12.036	42	183	193	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25565	10.1371/journal.pone.0025565	http://dx.doi.org/10.1371/journal.pone.0025565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980491	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700043
J	MacNeil, D; Eliasmith, C				MacNeil, David; Eliasmith, Chris			Fine-Tuning and the Stability of Recurrent Neural Networks	PLOS ONE			English	Article							VESTIBULOOCULAR REFLEX; EYE-MOVEMENTS; CONTINUOUS ATTRACTORS; WORKING-MEMORY; MODEL; INTEGRATOR; PLASTICITY; NEURONS; MECHANISM; DYNAMICS	A central criticism of standard theoretical approaches to constructing stable, recurrent model networks is that the synaptic connection weights need to be finely-tuned. This criticism is severe because proposed rules for learning these weights have been shown to have various limitations to their biological plausibility. Hence it is unlikely that such rules are used to continuously fine-tune the network in vivo. We describe a learning rule that is able to tune synaptic weights in a biologically plausible manner. We demonstrate and test this rule in the context of the oculomotor integrator, showing that only known neural signals are needed to tune the weights. We demonstrate that the rule appropriately accounts for a wide variety of experimental results, and is robust under several kinds of perturbation. Furthermore, we show that the rule is able to achieve stability as good as or better than that provided by the linearly optimal weights often used in recurrent models of the integrator. Finally, we discuss how this rule can be generalized to tune a wide variety of recurrent attractor networks, such as those found in head direction and path integration systems, suggesting that it may be used to tune a wide variety of stable neural systems.	[MacNeil, David; Eliasmith, Chris] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	MacNeil, D (corresponding author), Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada.	celiasmith@uwaterloo.ca			National Science and Engineering Research Council of Canada (NSERC); NSERC; Canada Research Chair program; Canadian Foundation for Innovation (CFI); Ontario Innovation Trust (OIT)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Innovation Trust (OIT)	This research was supported by a National Science and Engineering Research Council of Canada (NSERC) Discovery grant, an NSERC Student Research Award (USRA), the Canada Research Chair program, and the Canadian Foundation for Innovation (CFI) and Ontario Innovation Trust (OIT) Leaders Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; [Anonymous], 1999, COGNITIVE MAP; [Anonymous], 2003, NEURAL ENG COMPUTATI; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; ARNOLD DB, 1991, BIOL CYBERN, V64, P447, DOI 10.1007/BF00202608; ARNOLD DB, 1992, PHILOS T ROY SOC B, V337, P327, DOI 10.1098/rstb.1992.0110; Bekolay T., 2010, CTNTR20101217010; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; COLLEWIJN H, 1977, EXP BRAIN RES, V27, P287; Conklin J, 2005, J COMPUTATIONAL NEUR, V18; De No RL, 1938, J NEUROPHYSIOL, V1, P207; Dell'Osso L, 2008, 070108 OMLAB; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Eliasmith C, 2005, NEURAL COMPUT, V17, P1276, DOI 10.1162/0899766053630332; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Georgopoulos AP, 1986, SCIENCE, V243; Glasser J, 1999, NEUROOPHTHAMALMOLOGY, P327; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Goodridge JP, 2000, J NEUROPHYSIOL, V83, P3402, DOI 10.1152/jn.2000.83.6.3402; Hardie J, 2009, J NEUROSCI, V29, P3233, DOI 10.1523/JNEUROSCI.6000-08.2009; HARRIS LR, 1981, EXP BRAIN RES, V44, P41; Hebb Donald O., 1949, ORG BEHAV; Henneman E, 1981, HDB PHYSL NERVOUS SY, V2; HESS K, 1985, NEURO-OPHTHALMOLOGY, V5, P247, DOI 10.3109/01658108509004937; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Ikezu T, 2008, NEUROIMMUNE PHARM; Jacobs JB, 2004, J VISION, V4, P604, DOI 10.1167/4.7.7; KAPOULA Z, 1989, J NEUROPHYSIOL, V61, P879, DOI 10.1152/jn.1989.61.5.879; KOMPF D, 1987, J NEUROL, V234, P337, DOI 10.1007/BF00314291; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; LASS Y, 1975, BIOL CYBERN, V19, P61, DOI 10.1007/BF00364102; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, P241; LEWIS RF, 1994, J NEUROPHYSIOL, V72, P1028, DOI 10.1152/jn.1994.72.2.1028; Major G, 2004, P NATL ACAD SCI USA, V101, P7739, DOI 10.1073/pnas.0401970101; Major G, 2004, CURRENT OPINION NEUR; McCrea R, 1992, RESPONSES VESTIBULAR, P379; Mensh BD, 2004, VISION RES, V44, P711, DOI 10.1016/j.visres.2003.10.015; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nikitchenko M, 2008, NEURAL COMPUT, V20, P2379, DOI 10.1162/neco.2008.12-06-416; Park J, 2007, J VISION, V7, P142; Porrill J, 2004, P ROY SOC B-BIOL SCI, V271, P789, DOI 10.1098/rspb.2003.2658; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Rao RPN, 2001, NEURAL COMPUT, V13, P2221, DOI 10.1162/089976601750541787; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Seung HS, 1998, NEURAL NETWORKS, V11, P1253, DOI 10.1016/S0893-6080(98)00064-1; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Turaga SC, 2006, COSYNE; Vasilaki E., 2009, PLOS COMPUTATIONAL B, V5; Wang ZI, 2009, VISION RES, V49, P182, DOI 10.1016/j.visres.2008.10.007; WEBER RB, 1972, VISION RES, V12, P467, DOI 10.1016/0042-6989(72)90090-9; WEISSMAN BM, 1989, NEUROLOGY, V39, P534, DOI 10.1212/WNL.39.4.534; Williams R.J., 1995, BACKPROPAGATION THEO, V1, P433; Zhang K, 1996, J NEUROSCI, V16, P2112	62	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e22885	10.1371/journal.pone.0022885	http://dx.doi.org/10.1371/journal.pone.0022885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980334	Green Published, gold			2022-12-27	WOS:000295933700002
J	Yan, SJ; Chen, YM; Dong, M; Song, WZ; Belcher, SM; Wang, HS				Yan, Sujuan; Chen, Yamei; Dong, Min; Song, Weizhong; Belcher, Scott M.; Wang, Hong-Sheng			Bisphenol A and 17 beta-Estradiol Promote Arrhythmia in the Female Heart via Alteration of Calcium Handling	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ISOLATED CARDIAC MYOCYTES; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; GENDER-DIFFERENCES; CELLULAR BASIS; GUINEA-PIG; CHEMICALS; RAT; CONTRACTION	Background: There is wide-spread human exposure to bisphenol A (BPA), a ubiquitous estrogenic endocrine disruptor that has been implicated as having potentially harmful effects on human heart health. Higher urine BPA concentrations have been shown to be associated with cardiovascular diseases in humans. However, neither the nature nor the mechanism(s) of BPA action on the heart are understood. Methodology/Principal Findings: The rapid (<7 min) effects of BPA and 17 beta-estradiol (E2) in the heart and ventricular myocytes from rodents were investigated in the present study. In isolated ventricular myocytes from young adult females, but not males, physiological concentrations of BPA or E2 (10(-9) M) rapidly induced arrhythmogenic triggered activities. The effects of BPA were particularly pronounced when combined with estradiol. Under conditions of catecholamine stimulation, E2 and BPA promoted ventricular arrhythmias in female, but not male, hearts. The cellular mechanism of the female-specific pro-arrhythmic effects of BPA and E2 were investigated. Exposure to E2 and/or BPA rapidly altered myocyte Ca2+ handling; in particular, estrogens markedly increased sarcoplasmic reticulum (SR) Ca2+ leak, and increased SR Ca2+ load. Ryanodine (10(-7) M) inhibition of SR Ca2+ leak suppressed estrogen-induced triggered activities. The rapid response of female myocytes to estrogens was abolished in an estrogen receptor (ER) beta knockout mouse model. Conclusions/Significance: Physiologically-relevant concentrations of BPA and E2 promote arrhythmias in a female-specific manner in rat hearts; the pro-arrhythmic actions of estrogens are mediated by ER beta-signaling through alterations of myocyte Ca2+ handling, particularly increases in SR Ca2+ leak. Our study provides the first experimental evidence suggesting that exposure to estrogenic endocrine disrupting chemicals and the unique sensitivity of female hearts to estrogens may play a role in arrhythmogenesis in the female heart.	[Yan, Sujuan; Chen, Yamei; Dong, Min; Song, Weizhong; Belcher, Scott M.; Wang, Hong-Sheng] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Yan, SJ (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China.	wanghs@uc.edu		Belcher, Scott/0000-0002-1196-3705	National Institute of Health [R01-ES017262, R21-HL084539, R01-ES05145, RC2 ES018765]; University of Cincinnati Center for Environmental Genetics [P30-ES06096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, RC2ES018765, R01ES017263] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Center for Environmental Genetics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health grants R01-ES017262, R21-HL084539 (HSW), R01-ES05145, RC2 ES018765 (SMB), and University of Cincinnati Center for Environmental Genetics (P30-ES06096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Loza PA, 2008, GENDER MED, V5, pS34, DOI 10.1016/j.genm.2008.03.005; Babiker FA, 2002, CARDIOVASC RES, V53, P709, DOI 10.1016/S0008-6363(01)00526-0; Barakat K, 2000, AM HEART J, V140, P740, DOI 10.1067/mhj.2000.110089; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bhupathy P, 2010, WOMENS HEALTH, V6, P77, DOI [10.2217/whe.09.80, 10.2217/WHE.09.80]; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Chung TH, 2004, J MOL CELL CARDIOL, V37, P1013, DOI 10.1016/j.yjmcc.2004.08.003; Czubryt MP, 2006, CAN J PHYSIOL PHARM, V84, P93, DOI 10.1139/Y05-151; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Du XJ, 2006, PHARMACOL THERAPEUT, V111, P434, DOI 10.1016/j.pharmthera.2005.10.016; Forster C, 2004, P NATL ACAD SCI USA, V101, P14234, DOI 10.1073/pnas.0405571101; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; JIANG C, 1992, BRIT J PHARMACOL, V106, P739, DOI 10.1111/j.1476-5381.1992.tb14403.x; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; Le HH, 2010, ENDOCRINOLOGY, V151, P5689, DOI 10.1210/en.2010-0710; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; Marks A. R., 2006, NOVART FDN SYMP, V274, P147; Marks A. R., 2006, NOVART FDN SYMP, V274, P272; Marks Andrew R, 2006, Novartis Found Symp, V274, P132; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Meyer R, 1998, EXP PHYSIOL, V83, P305, DOI 10.1113/expphysiol.1998.sp004115; Nakajima T, 1999, BRIT J PHARMACOL, V127, P429, DOI 10.1038/sj.bjp.0702576; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Rajapakse N, 2001, TOXICOL SCI, V60, P296, DOI 10.1093/toxsci/60.2.296; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Silva E, 2002, ENVIRON SCI TECHNOL, V36, P1751, DOI 10.1021/es0101227; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239, DOI 10.1177/074823379801400115; Wehrens XHT, 2005, ANN NY ACAD SCI, V1047, P366, DOI 10.1196/annals.1341.032; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wolbrette D, 2002, CLIN CARDIOL, V25, P49, DOI 10.1002/clc.4950250203; Xiao Y, 2011, TOXICOL IN VITRO, V25, P153, DOI 10.1016/j.tiv.2010.10.010; Xing LN, 2010, TOXICOL SCI, V115, P577, DOI 10.1093/toxsci/kfq081; Yap YG, 2005, EUR HEART J, V26, P1385, DOI 10.1093/eurheartj/ehi268; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565	43	105	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25455	10.1371/journal.pone.0025455	http://dx.doi.org/10.1371/journal.pone.0025455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980463	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700037
J	Houston, MA; Augenlicht, LH; Heerdt, BG				Houston, Michele A.; Augenlicht, Leonard H.; Heerdt, Barbara G.			Intrinsic Mitochondrial Membrane Potential and Associated Tumor Phenotype Are Independent of MUC1 Over-Expression	PLOS ONE			English	Article							COLONIC-CARCINOMA CELLS; CHAIN FATTY-ACIDS; CANCER-CELLS; SURVIVAL RESPONSE; INDUCED APOPTOSIS; RHODACYANINE DYE; OXIDATIVE STRESS; BARTH-SYNDROME; BETA-CATENIN; GROWTH	We have established previously that minor subpopulations of cells with stable differences in their intrinsic mitochondrial membrane potential (Delta psi m) exist within populations of mammary and colonic carcinoma cells and that these differences in Delta psi m are linked to tumorigenic phenotypes consistent with increased probability of participating in tumor progression. However, the mechanism(s) involved in generating and maintaining stable differences in intrinsic Delta psi m and how they are linked to phenotype are unclear. Because the mucin 1 (MUC1) oncoprotein is over-expressed in many cancers, with the cytoplasmic C-terminal fragment (MUC1 C-ter) and its integration into the outer mitochondrial membrane linked to tumorigenic phenotypes similar to those of cells with elevated intrinsic Delta psi m, we investigated whether endogenous differences in MUC1 levels were linked to stable differences in intrinsic Delta psi m and/or to the tumor phenotypes associated with the intrinsic Delta psi m. We report that levels of MUC1 are significantly higher in subpopulations of cells with elevated intrinsic Delta psi m derived from both mammary and colonic carcinoma cell lines. However, using siRNA we found that down-regulation of MUC1 failed to significantly affect either the intrinsic Delta psi m or the tumor phenotypes associated with increased intrinsic Delta psi m. Moreover, whereas pharmacologically mediated disruption of the Delta psi m was accompanied by attenuation of tumor phenotype, it had no impact on MUC1 levels. Therefore, while MUC1 over-expression is associated with subpopulations of cells with elevated intrinsic Delta psi m, it is not directly linked to the generation or maintenance of stable alterations in intrinsic Delta psi m, or to intrinsic Delta psi m associated tumor phenotypes. Since the Delta psi m is the focus of chemotherapeutic strategies, these data have important clinical implications in regard to effectively targeting those cells within a tumor cell population that exhibit stable elevations in intrinsic Delta psi m and are most likely to contribute to tumor progression.	[Houston, Michele A.; Augenlicht, Leonard H.; Heerdt, Barbara G.] Montefiore Med Ctr, Dept Oncol, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Houston, MA (corresponding author), Montefiore Med Ctr, Dept Oncol, Albert Einstein Canc Ctr, 111 E 210Th St, Bronx, NY 10467 USA.	barbara.heerdt@einstein.yu.edu			National Cancer Institute [CA93697]; NATIONAL CANCER INSTITUTE [R01CA093697] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by CA93697 from the National Cancer Institute. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; AZZONE GF, 1984, BIOCHEM SOC T, V12, P414, DOI 10.1042/bst0120414; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Barth PG, 1999, J PEDIATR-US, V135, P273, DOI 10.1016/S0022-3476(99)70118-6; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; Britten CD, 2000, CLIN CANCER RES, V6, P42; Chaturvedi R, 2005, INT J ONCOL, V26, P1169; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; CHRISTMAN JE, 1990, GYNECOL ONCOL, V39, P72, DOI 10.1016/0090-8258(90)90402-7; Cullen PJ, 2007, CRIT REV EUKAR GENE, V17, P241, DOI 10.1615/CritRevEukarGeneExpr.v17.i3.50; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; DAIRKEE SH, 1991, BREAST CANCER RES TR, V18, P57, DOI 10.1007/BF01975444; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Heerdt BG, 2005, CANCER RES, V65, P9861, DOI 10.1158/0008-5472.CAN-05-2444; Heerdt BG, 1998, CANCER RES, V58, P2869; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Heerdt BG, 1999, CANCER RES, V59, P1584; HEERDT BG, 1991, J BIOL CHEM, V266, P19120; Heerdt BG, 2000, CANCER RES, V60, P6704; Hong MY, 2002, CARCINOGENESIS, V23, P1919, DOI 10.1093/carcin/23.11.1919; Horobin RW, 2007, J CONTROL RELEASE, V121, P125, DOI 10.1016/j.jconrel.2007.05.040; Houston Michele A, 2011, Int J Cell Biol, V2011, P978583, DOI 10.1155/2011/978583; Huang L, 2003, CANCER BIOL THER, V2, P702; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Koya K, 1996, CANCER RES, V56, P538; Kufe DW, 2009, CANCER BIOL THER, V8, P1197, DOI 10.4161/cbt.8.13.8844; Liang BC, 2011, INT J MOL MED, V27, P159, DOI 10.3892/ijmm.2010.579; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; Mariadason JM, 2000, CANCER RES, V60, P4561; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Medina V, 1998, JPEN-PARENTER ENTER, V22, P14, DOI 10.1177/014860719802200114; MODICANAPOLITANO JS, 1987, CANCER RES, V47, P4361; ModicaNapolitano JS, 1996, CANCER RES, V56, P544; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; Paliwal Rishi, 2007, Current Drug Delivery, V4, P211; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; SCHULZ H, 1985, BIOCH LIPIDS MEMBRAN, P116; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; Terasaki M, 2007, MOL CELL BIOCHEM, V300, P227, DOI 10.1007/s11010-006-9387-0; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Weissig V., 2000, Current Pharmaceutical Biotechnology, V1, P325, DOI 10.2174/1389201003378870; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Yin L, 2004, J BIOL CHEM, V279, P45721, DOI 10.1074/jbc.M408027200; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25207	10.1371/journal.pone.0025207	http://dx.doi.org/10.1371/journal.pone.0025207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966455	Green Submitted, Green Published, gold			2022-12-27	WOS:000295267100028
J	Wong, AL; Shelhamer, M				Wong, Aaron L.; Shelhamer, Mark			Exploring the Fundamental Dynamics of Error-Based Motor Learning Using a Stationary Predictive-Saccade Task	PLOS ONE			English	Article							PROLONGED OPTICAL REVERSAL; VISUAL ERROR; ADAPTIVE-CONTROL; LONG MEMORY; POWER-LAW; ADAPTATION; GAIN; EYE; SEQUENCES; MODEL	The maintenance of movement accuracy uses prior performance errors to correct future motor plans; this motor-learning process ensures that movements remain quick and accurate. The control of predictive saccades, in which anticipatory movements are made to future targets before visual stimulus information becomes available, serves as an ideal paradigm to analyze how the motor system utilizes prior errors to drive movements to a desired goal. Predictive saccades constitute a stationary process (the mean and to a rough approximation the variability of the data do not vary over time, unlike a typical motor adaptation paradigm). This enables us to study inter-trial correlations, both on a trial-by-trial basis and across long blocks of trials. Saccade errors are found to be corrected on a trial-by-trial basis in a direction-specific manner (the next saccade made in the same direction will reflect a correction for errors made on the current saccade). Additionally, there is evidence for a second, modulating process that exhibits long memory. That is, performance information, as measured via inter-trial correlations, is strongly retained across a large number of saccades (about 100 trials). Together, this evidence indicates that the dynamics of motor learning exhibit complexities that must be carefully considered, as they cannot be fully described with current state-space (ARMA) modeling efforts.	[Wong, Aaron L.; Shelhamer, Mark] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Shelhamer, Mark] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	aaron.wong@jhu.edu		Wong, Aaron/0000-0001-7211-0653	National Science Foundation [BCS-0615106]; National Institutes of Health [T32-DC000023, R21 EY019713]; NATIONAL EYE INSTITUTE [R21EY019713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000023] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Science Foundation Grant BCS-0615106 and by the National Institutes of Health Grants T32-DC000023 and R21 EY019713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassingthwaighte J. B., 1994, FRACTAL PHYSL; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; BECKER W, 1973, VISION RES, V13, P1021, DOI 10.1016/0042-6989(73)90141-7; Becker W., 1989, NEUROBIOLOGY SACCADI, P13; Beran J., 1994, STAT LONG MEMORY PRO; Box G. E. P., 1970, Time series analysis, forecasting and control; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; DAVIES P, 1976, BRAIN RES, V103, P546, DOI 10.1016/0006-8993(76)90453-4; Doornik JA, 2003, COMPUT STAT DATA AN, V42, P333, DOI 10.1016/S0167-9473(02)00212-8; Doornik JA, 2001, INTRO OX VERSION 3 O; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; French AS, 2008, ANN BIOMED ENG, V36, P153, DOI 10.1007/s10439-007-9392-9; Gagnon D, 2002, BRAIN, V125, P123, DOI 10.1093/brain/awf005; Gaymard B, 2001, EUR J NEUROSCI, V14, P554, DOI 10.1046/j.0953-816x.2001.01669.x; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Giraitis L, 2001, J APPL PROBAB, V38, P1033, DOI 10.1017/S0021900200019215; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; GONSHOR A, 1976, J PHYSIOL-LONDON, V256, P381, DOI 10.1113/jphysiol.1976.sp011330; Granger C. W. J., 1980, Journal of Time Series Analysis, V1, P15, DOI 10.1111/j.1467-9892.1980.tb00297.x; Hausdorff JM, 1996, PHYS REV E, V54, P2154, DOI 10.1103/PhysRevE.54.2154; HOSKING JRM, 1981, BIOMETRIKA, V68, P165, DOI 10.1093/biomet/68.1.165; Joiner WM, 2005, ANN NY ACAD SCI, V1039, P536, DOI 10.1196/annals.1325.062; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; Kording KP, 2007, ADV NEURAL INFORM PR, P745; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lowen SB, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471754722; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; Mandelbrot B. B., 1982, FRACTAL GEOMETRY NAT, DOI DOI 10.1002/ESP3290080415; MANDL G, 1981, BRAIN RES, V209, P35, DOI 10.1016/0006-8993(81)91170-7; Miall RC, 1998, NOVART FDN SYMP, V218, P272; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Morel P, 2011, J NEUROSCI, V31, P10039, DOI 10.1523/JNEUROSCI.0492-11.2011; Nagel M, 2008, EUR NEUROL, V60, P179, DOI 10.1159/000148245; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Ooms M, 1999, INFERENCE FORECASTIN; Panouilleres M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017329; Papoulis A., 2002, PROBABILITY RANDOM V; Peng CK, 1995, J ELECTROCARDIOL, V28, P59, DOI 10.1016/S0022-0736(95)80017-4; Rangarajan G, 2000, PHYS REV E, V61, P4991, DOI 10.1103/PhysRevE.61.4991; Roberts S, 2000, PHYS REV E, V62, P2597, DOI 10.1103/PhysRevE.62.2597; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; ROSS SM, 1987, VISION RES, V27, P2177, DOI 10.1016/0042-6989(87)90131-3; Salvucci D.D., 2000, P EYE TRACKING RES A, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; Shelhamer M, 2005, J NEUROPHYSIOL, V93, P2002, DOI 10.1152/jn.00800.2004; Shelhamer M, 2002, NEUROSCI LETT, V332, P200, DOI 10.1016/S0304-3940(02)00951-5; Shelhamer M, 2007, NONLINEAR DYNAMICS IN PHYSIOLOGY: A STATE-SPACE APPROACH, P1; Shelhamer M, 2003, J NEUROPHYSIOL, V90, P2763, DOI 10.1152/jn.00478.2003; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Srimal R, 2008, J NEUROPHYSIOL, V99, P1554, DOI 10.1152/jn.01024.2007; STARK L, 1962, IRE T HUM FACT ELECT, VHFE3, P52, DOI 10.1109/THFE2.1962.4503342; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Straube A, 2001, NEUROLOGY, V57, P2105, DOI 10.1212/WNL.57.11.2105; Sulzenbruck S, 2009, CONSCIOUS COGN, V18, P145, DOI 10.1016/j.concog.2008.12.001; Takeichi N, 2007, J NEUROPHYSIOL, V97, P4096, DOI 10.1152/jn.01278.2006; Taylor JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002485; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; TREISMAN M, 1984, PSYCHOL REV, V91, P68, DOI 10.1037/0033-295X.91.1.68; Wagenmakers EJ, 2005, J EXP PSYCHOL GEN, V134, P108, DOI 10.1037/0096-3445.134.1.108; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Wang GD, 2000, PHYS PLASMAS, V7, P1181, DOI 10.1063/1.873927; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Zambarbieri D, 1987, EYE MOVEMENTS PHYSL, P131; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	70	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25225	10.1371/journal.pone.0025225	http://dx.doi.org/10.1371/journal.pone.0025225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IZ	21966462	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100030
J	Marchini, FK; de Godoy, LMF; Rampazzo, RCP; Pavoni, DP; Probst, CM; Gnad, F; Mann, M; Krieger, MA				Marchini, Fabricio K.; de Godoy, Lyris M. F.; Rampazzo, Rita C. P.; Pavoni, Daniela P.; Probst, Christian M.; Gnad, Florian; Mann, Matthias; Krieger, Marco A.			Profiling the Trypanosoma cruzi Phosphoproteome	PLOS ONE			English	Article							HIGHLY SELECTIVE ENRICHMENT; PROTEIN-KINASES; PHOSPHORYLATED PEPTIDES; MASS-SPECTROMETRY; SEQUENCE-ANALYSIS; TITANIUM-DIOXIDE; FLAGELLAR-LENGTH; LEISHMANIA-MAJOR; CELL-CYCLE; BRUCEI	Protein phosphorylation is a reversible post-translational modification essential for the regulation of several signal transduction pathways and biological processes in the living cell. Therefore, the identification of protein phosphorylation sites is crucial to understand cell signaling control at the molecular level. Based on mass spectrometry, recent studies have reported the large-scale mapping of phosphorylation sites in various eukaryotes and prokaryotes. However, little is known about the impact of phosphorylation in protozoan parasites. To in depth characterize the phosphoproteome of Trypanosoma cruzi, a parasite of the Kinetoplastida class, protein samples from cells at different phases of the metacyclogenesis - differentiation process of the parasites from non-infective epimastigotes to infective metacyclic trypomastigotes - were enriched for phosphopeptides using TiO2 chromatography and analyzed on an LTQ-Orbitrap mass spectrometer. In total, 1,671 proteins were identified, including 753 phosphoproteins, containing a total of 2,572 phosphorylation sites. The distribution of phosphorylated residues was 2,162 (84.1%) on serine, 384 (14.9%) on threonine and 26 (1.0%) on tyrosine. Here, we also report several consensus phosphorylation sequence motifs and as some of these conserved groups have enriched biological functions, we can infer the regulation by protein kinases of this functions. To our knowledge, our phosphoproteome is the most comprehensive dataset identified until now for Kinetoplastida species. Here we also were able to extract biological information and infer groups of sites phosphorylated by the same protein kinase. To make our data accessible to the scientific community, we uploaded our study to the data repositories PHOSIDA, Proteome Commons and TriTrypDB enabling researchers to access information about the phosphorylation sites identified here.	[Marchini, Fabricio K.; de Godoy, Lyris M. F.; Rampazzo, Rita C. P.; Pavoni, Daniela P.; Probst, Christian M.; Krieger, Marco A.] Inst Carios Chagas, Curitiba, Parana, Brazil; [de Godoy, Lyris M. F.; Gnad, Florian; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society	Marchini, FK (corresponding author), Inst Carios Chagas, Curitiba, Parana, Brazil.	mkrieger@fiocruz.br	Rampazzo, Rita/AAA-4590-2020; Marchini, Fabricio/ABE-4613-2020; Pavoni, Daniela P/L-3302-2014; Publica, Inct Saude/J-9544-2013; P, CM/B-1358-2013; Probst, Christian/B-8678-2009; Marchini, Fabricio K/A-4775-2009; Krieger, Marco/AAE-8611-2020; de Godoy, Lyris/C-4256-2008; Marchini, Fabricio/AAA-1027-2019; Mann, Matthias/A-3454-2013	Rampazzo, Rita/0000-0002-8367-999X; Pavoni, Daniela P/0000-0001-6776-4345; Probst, Christian/0000-0001-9993-6375; Marchini, Fabricio K/0000-0001-5695-2746; Marchini, Fabricio/0000-0001-5695-2746; Mann, Matthias/0000-0003-1292-4799; Krieger, Marco Aurelio/0000-0003-0030-3952; Gnad, Florian/0000-0002-2287-2251	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Oswaldo Cruz (FIOCRUZ); National Council for Scientific and Technological Development (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz (FIOCRUZ); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MAK has a research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This work was supported by grant Papes V from Fundacao Oswaldo Cruz (FIOCRUZ) and National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009; BATISTA JAN, 1994, MOL BIOCHEM PARASIT, V67, P301, DOI 10.1016/0166-6851(94)00133-2; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CHAPMAN AB, 1994, J BIOL CHEM, V269, P4754; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Orso I, 2003, TRENDS PARASITOL, V19, P151, DOI 10.1016/S1471-4922(03)00035-7; da Cunha JPC, 2005, MOL BIOCHEM PARASIT, V140, P75, DOI 10.1016/j.molbiopara.2004.12.007; Dallagiovanna B, 2005, EXP PARASITOL, V109, P260, DOI 10.1016/j.exppara.2005.01.003; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Erdmann M, 2006, MOL BIOL CELL, V17, P2035, DOI 10.1091/mbc.E05-10-0976; Espinosa JM, 2003, MOL BIOCHEM PARASIT, V131, P35, DOI 10.1016/S0166-6851(03)00187-7; GNAD F, 2009, PROTEOMICS; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gomez EB, 2001, INT J PARASITOL, V31, P1032, DOI 10.1016/S0020-7519(01)00219-3; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Morales MA, 2008, PROTEOMICS, V8, P350, DOI 10.1002/pmic.200700697; Nakayasu ES, 2009, PROTEOMICS, V9, P3489, DOI 10.1002/pmic.200800874; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SCANFF P, 1991, J CHROMATOGR, V539, P425, DOI 10.1016/S0021-9673(01)83951-0; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; TEIXEIRA SMR, 1995, J BIOL CHEM, V270, P22586, DOI 10.1074/jbc.270.38.22586; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; Wiese M, 2003, EUKARYOT CELL, V2, P769, DOI 10.1128/EC.2.4.769-777.2003; Xu P, 2001, MOL BIOCHEM PARASIT, V112, P39, DOI 10.1016/S0166-6851(00)00341-8	52	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25381	10.1371/journal.pone.0025381	http://dx.doi.org/10.1371/journal.pone.0025381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966514	Green Published, gold			2022-12-27	WOS:000295265100096
J	Kraehling, JR; Busker, M; Haase, T; Haase, N; Koglin, M; Linnenbaum, M; Behrends, S				Kraehling, Jan R.; Busker, Mareike; Haase, Tobias; Haase, Nadine; Koglin, Markus; Linnenbaum, Monika; Behrends, Soenke			The Amino-Terminus of Nitric Oxide Sensitive Guanylyl Cyclase alpha(1) Does Not Affect Dimerization but Influences Subcellular Localization	PLOS ONE			English	Article							PROTEASOMAL DEGRADATION; IN-VIVO; ACTIVATION; GLUTATHIONE; SUBUNIT; DOMAINS	Background: Nitric oxide sensitive guanylyl cyclase (NOsGC) is a heterodimeric enzyme formed by an alpha- and a beta(1)-subunit. A splice variant (C-alpha(1)) of the alpha(1)-subunit, lacking at least the first 236 amino acids has been described by Sharina et al. 2008 and has been shown to be expressed in differentiating human embryonic cells. Wagner et al. 2005 have shown that the amino acids 61-128 of the alpha(1)-subunit are mandatory for quantitative heterodimerization implying that the C-alpha(1)-splice variant should lose its capacity to dimerize quantitatively. Methodology/Principal Findings: In the current study we demonstrate preserved quantitative dimerization of the C-alpha(1)-splice by co-purification with the beta(1)-subunit. In addition we used fluorescence resonance energy transfer (FRET) based on fluorescence lifetime imaging (FLIM) using fusion proteins of the beta(1)-subunit and the alpha(1)-subunit or the C-alpha(1) variant with ECFP or EYFP. Analysis of the respective combinations in HEK-293 cells showed that the fluorescence lifetime was significantly shorter (approximate to 0.3 ns) for alpha(1)/beta(1) and C-alpha(1)/beta(1) than the negative control. In addition we show that lack of the amino-terminus in the alpha(1) splice variant directs it to a more oxidized subcellular compartment. Significance: We conclude that the amino-terminus of the alpha(1)-subunit is dispensable for dimerization in-vivo and ex-vivo, but influences the subcellular trafficking.	[Kraehling, Jan R.; Busker, Mareike; Linnenbaum, Monika; Behrends, Soenke] Univ Brunswick, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany; [Haase, Tobias] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Haase, Nadine] Expt & Clin Res Ctr, Berlin, Germany; [Haase, Nadine] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kraehling, JR (corresponding author), Univ Brunswick, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Behrends, Sönke/A-2551-2010; Kraehling, Jan/D-5327-2009	Behrends, Sönke/0000-0002-9068-0729; Kraehling, Jan/0000-0002-0979-2900; Haase, Nadine/0000-0003-0727-1738; Haase, Tobias/0000-0002-7220-602X	Deutsche Forschungsgemeinschaft [INST 188/286-1, BE 1865/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (INST 188/286-1; BE 1865/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2011, J CELL SCI, V124, P847, DOI 10.1242/jcs.080895; Baltrons MA, 2008, MOL CELL NEUROSCI, V37, P494, DOI 10.1016/j.mcn.2007.11.004; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Haase N, 2010, BIOCHEM PHARMACOL, V80, P1676, DOI 10.1016/j.bcp.2010.08.007; Haase T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011617; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Koglin M, 2003, J BIOL CHEM, V278, P12590, DOI 10.1074/jbc.M212740200; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Pifarre P, 2009, INT J BIOCHEM CELL B, V41, P1719, DOI 10.1016/j.biocel.2009.02.022; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schrammel A, 1996, MOL PHARMACOL, V50, P1; Schultz G., 1984, METHOD ENZYMAT AN, P379; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; SEEANNER M, 2010, BASIC CLIN PHARMACOL, V107, P162; Sharin VG, 2011, STEM CELLS DEV, V20, P1287, DOI 10.1089/scd.2010.0411; SHARINA IG, 2011, NITRIC OXIDE; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; Shiga T, 2005, ZOOL SCI, V22, P735, DOI 10.2108/zsj.22.735; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Wagner C, 2005, J BIOL CHEM, V280, P17687, DOI 10.1074/jbc.M412099200; Warburg O, 1942, BIOCHEM Z, V310, P384; WEDEL B, 1995, J BIOL CHEM, V270, P24871, DOI 10.1074/jbc.270.42.24871; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; ZHONG F, 2011, J BIOL INORG CHEM	34	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25772	10.1371/journal.pone.0025772	http://dx.doi.org/10.1371/journal.pone.0025772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984946	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000295941300056
J	Malone, BM; Tan, F; Bridges, SM; Peng, ZH				Malone, Brandon M.; Tan, Feng; Bridges, Susan M.; Peng, Zhaohua			Comparison of Four ChIP-Seq Analytical Algorithms Using Rice Endosperm H3K27 Trimethylation Profiling Data	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; POLYCOMB GROUP; DEVELOPMENTAL REGULATORS; SEED DEVELOPMENT; GENOME; ARABIDOPSIS; MEDEA; PROTEINS; SEQUENCE; BINDING	Chromatin immunoprecipitation coupled with high throughput DNA Sequencing (ChIP-Seq) has emerged as a powerful tool for genome wide profiling of the binding sites of proteins associated with DNA such as histones and transcription factors. However, no peak calling program has gained consensus acceptance by the scientific community as the preferred tool for ChIP-Seq data analysis. Analyzing the large data sets generated by ChIP-Seq studies remains highly challenging for most molecular biology laboratories. Here we profile H3K27me3 enrichment sites in rice young endospermusing the ChIP-Seq approach and analyze the data using four peak calling algorithms (FindPeaks, PeakSeq, USeq, and MACS). Comparison of the four algorithms reveals that these programs produce very different peaks in terms of peak size, number, and position relative to genes. We verify the peak predictions using ChIP-PCR to evaluate the accuracy of peak prediction of the four algorithms. We discuss the approach of each algorithm and compare similarities and differences in the results. Despite their differences in the peaks identified, all of the programs reach similar conclusions about the effect of H3K27me3 on gene expression. Its presence either upstream or downstream of a gene is predominately associated with repression of the gene. Additionally, GO analysis finds that a substantially higher ratio of genes associated with H3K27me3 were involved in multicellular organism development, signal transduction, response to external and endogenous stimuli, and secondary metabolic pathways than the rest of the rice genome.	[Malone, Brandon M.; Bridges, Susan M.] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA; [Malone, Brandon M.; Bridges, Susan M.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Tan, Feng; Peng, Zhaohua] Mississippi State Univ, Dept Biochem & Mol Biol, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University	Malone, BM (corresponding author), Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA.	bridges@cse.msstate.edu; zp7@BCH.msstate.edu			USDA [2005-35604-15357, 2011-67013-30125]; DOE [DE-FG02-07ER64459]; National Science Foundation [EPS 0903787]	USDA(United States Department of Agriculture (USDA)); DOE(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This project is supported by USDA Grants (2005-35604-15357 and 2011-67013-30125) and DOE grant (DE-FG02-07ER64459) to Zhaohua Peng, and by the National Science Foundation under award number EPS 0903787 to Susan Bridges. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 2001, CONTROL FALSE DISCOV, P29; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; COX A, 2001, ELAND EFFICIENT LOCA; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; FELLER W, 1968, HYPERGEOMETRIC SERIE; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Huh JH, 2007, CURR OPIN GENET DEV, V17, P480, DOI 10.1016/j.gde.2007.08.011; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li H., 2008, MAQ MAPPING ASSEMBLY; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; PAPOULIS A, 1984, CONDITIONAL PROBABIL, P33; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; R Development Core Team, 2006, R LANG ENV STAT COMP; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537	37	46	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25260	10.1371/journal.pone.0025260	http://dx.doi.org/10.1371/journal.pone.0025260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984925	gold, Green Submitted, Green Published			2022-12-27	WOS:000295941300022
J	Morris, L; Chen, X; Alam, M; Tomaras, G; Zhang, RJ; Marshall, DJ; Chen, B; Parks, R; Foulger, A; Jaeger, F; Donathan, M; Bilska, M; Gray, ES; Karim, SSA; Kepler, TB; Whitesides, J; Montefiori, D; Moody, MA; Liao, HX; Haynes, BF				Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Chen, Bing; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Gray, Elin S.; Karim, Salim S. Abdool; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.			Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; EXTERNAL REGION; SUBTYPE-B; ANTI-GP41 ANTIBODIES; MOLECULAR-FEATURES; GLYCOPROTEIN GP41; ACUTE INFECTION; VACCINE TARGET; ENV CLONES	Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by experimental HIV-1 vaccines. When these antibodies do occur, it is important to be able to isolate and characterize them to provide clues for vaccine design. CAP206 is a South African subtype C HIV-1-infected individual previously shown to have broadly neutralizing plasma antibodies targeting the envelope gp41 distal membrane proximal external region (MPER). We have now used a fluoresceinated peptide tetramer antigen with specific cell sorting to isolate a human neutralizing monoclonal antibody (mAb) against the HIV-1 envelope gp41 MPER. The isolated recombinant mAb, CAP206-CH12, utilized a portion of the distal MPER (HXB2 amino acid residues, 673-680) and neutralized a subset of HIV-1 pseudoviruses sensitive to CAP206 plasma antibodies. Interestingly, this mAb was polyreactive and used the same germ-line variable heavy (V(H)1-69) and variable kappa light chain (V(K)3-20) gene families as the prototype broadly neutralizing anti-MPER mAb, 4E10 (residues 672-680). These data indicate that there are multiple immunogenic targets in the C-terminus of the MPER of HIV-1 gp41 envelope and suggests that gp41 neutralizing epitopes may interact with a restricted set of naive B cells during HIV-1 infection.	[Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Dept Surg, Durham, NC USA; [Morris, Lynn; Chen, Xi; Alam, Munir; Tomaras, Georgia; Zhang, Ruijun; Marshall, Dawn J.; Parks, Robert; Foulger, Andrew; Jaeger, Frederick; Donathan, Michele; Bilska, Mira; Kepler, Thomas B.; Whitesides, John; Montefiori, David; Moody, M. Anthony; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; [Morris, Lynn; Gray, Elin S.] Natl Inst Communicable Dis, Johannesburg, South Africa; [Karim, Salim S. Abdool] Univ KwaZulu Natal, CAPRISA, Durban, South Africa; [Chen, Bing] Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, Boston, MA 02115 USA	Duke University; Duke University; Duke University; Duke University; National Institute for Communicable Diseases (NICD); University of Kwazulu Natal; Harvard University; Boston Children's Hospital; Harvard Medical School	Morris, L (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA.	lynnm@nicd.ac.za	Moody, M/AAB-6947-2020; Gray, Elin/V-6707-2019; Tomaras, Georgia/J-5041-2016; Alam, S. Munir/AAC-6711-2019; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Morris, Lynn/V-3941-2018; Karim, Salim Safurdeen Abdool/N-5947-2013; Zhang, RUIJUN/AAD-6887-2021; Abdool Karim, Quarraisha/GVS-1160-2022	Moody, M/0000-0002-3890-5855; Gray, Elin/0000-0002-8613-3570; Karim, Salim Abdool/0000-0002-4986-2133; Morris, Lynn/0000-0003-3961-7828; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Zhang, RUIJUN/0000-0001-6785-9619; Abdool Karim, Quarraisha/0000-0002-0985-477X; Kepler, Thomas/0000-0002-1383-6865	Center for HIV/AIDS Vaccine Immunology (CHAVI), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health [U54-AI057157]; US National Institutes of Health's Comprehensive International Program of Research on AIDS (CIPRA) [AI51794]; Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP) [D43TW00231, CAPRISA 002]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, T32AI007392, U19AI051794] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology (CHAVI), Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health's Comprehensive International Program of Research on AIDS (CIPRA); Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Center for HIV/AIDS Vaccine Immunology (CHAVI) grant U54-AI057157 from the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The authors thank the US National Institutes of Health's Comprehensive International Program of Research on AIDS (CIPRA grant # AI51794) and the Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP grant # D43TW00231) for the research infrastructure and training that made the CAPRISA 002 Acute Infection study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Alam SM, 2004, AIDS RES HUM RETROV, V20, P836, DOI 10.1089/0889222041725181; Blish CA, 2007, AIDS, V21, P693, DOI 10.1097/QAD.0b013e32805e8727; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Gray ES, 2006, PLOS MED, V3, P1023, DOI 10.1371/journal.pmed.0030255; HARRIS EN, 1987, LANCET, V1, P277; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Johnson TA, 1997, J IMMUNOL, V158, P235; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Perez LG, 2009, J VIROL, V83, P7397, DOI 10.1128/JVI.00656-09; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Sharma A, 2003, RHEUMATOLOGY, V42, P453, DOI 10.1093/rheumatology/keg161; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Verkoczy L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007215; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Xu HY, 2010, J VIROL, V84, P1076, DOI 10.1128/JVI.02113-09; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	50	121	138	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e23532	10.1371/journal.pone.0023532	http://dx.doi.org/10.1371/journal.pone.0023532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980336	gold, Green Published, Green Submitted			2022-12-27	WOS:000295941300001
J	Fulop, L; Szanda, G; Enyedi, B; Varnai, P; Spat, A				Fueloep, Laszlo; Szanda, Gergoe; Enyedi, Balazs; Varnai, Peter; Spaet, Andras			The Effect of OPA1 on Mitochondrial Ca2+ Signaling	PLOS ONE			English	Article							DYNAMIN-RELATED GTPASE; DOMINANT OPTIC ATROPHY; CYTOCHROME-C; PROTEOLYTIC CLEAVAGE; CALCIUM-UPTAKE; PROTEIN OPA1; FUSION; APOPTOSIS; TRANSPORT; MEMBRANE	The dynamin-related GTPase protein OPA1, localized in the intermembrane space and tethered to the inner membrane of mitochondria, participates in the fusion of these organelles. Its mutation is the most prevalent cause of Autosomal Dominant Optic Atrophy. OPA1 controls the diameter of the junctions between the boundary part of the inner membrane and the membrane of cristae and reduces the diffusibility of cytochrome c through these junctions. We postulated that if significant Ca2+ uptake into the matrix occurs from the lumen of the cristae, reduced expression of OPA1 would increase the access Ca2+ to the transporters in the crista membrane and thus would enhance Ca2+ uptake. In intact H295R adrenocortical and HeLa cells cytosolic Ca2+ signals evoked with K+ and histamine, respectively, were transferred into the mitochondria. The rate and amplitude of mitochandrial [Ca2+] rise (followed with confocal laser scanning microscopy and FRET measurements with fluorescent wide-field microscopy) were increased after knockdown of OPA1, as compared with cells transfected with control RNA or mitofusin1 siRNA. Ca2+ uptake was enhanced despite reduced nlitochondrial membrane potential. In permeablilized cells the rate of Ca2+ uptake by depolarized mitochondria was also increased in OPA1-silenced cells. The participation of Na+/Ca2+ and Ca2+/H+ antiporters in this transport process is indicate by pharmacological data. Altogether, our observations reveal the significance of OPA1 in the control of mitochondrial Ca2+ metabolism.	[Fueloep, Laszlo; Szanda, Gergoe; Enyedi, Balazs; Varnai, Peter; Spaet, Andras] Semmelweis Univ, Hungarian Acad Sci, Fac Med, Dept Physiol, Budapest, Hungary; [Spaet, Andras] Hungarian Acad Sci, Lab Neurobiochem & Mol Physiol, Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences	Fulop, L (corresponding author), Semmelweis Univ, Hungarian Acad Sci, Fac Med, Dept Physiol, Budapest, Hungary.	spat@eok.sote.hu	Enyedi, Balázs/I-9320-2017; Spat, Andras/AAE-9981-2019	Enyedi, Balázs/0000-0001-5713-3785; 	Hungarian Council for Medical Research [ETT 008-09]	Hungarian Council for Medical Research	Hungarian Council for Medical Research (ETT 008-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amutha B, 2004, BIOCHEM J, V381, P19, DOI 10.1042/BJ20040566; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Dayanithi G, 2010, OPHTHALMIC GENET, V31, P53, DOI 10.3109/13816811003698117; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; JUNG DW, 1995, J BIOL CHEM, V270, P672, DOI 10.1074/jbc.270.2.672; KAPUS A, 1991, FEBS LETT, V282, P61, DOI 10.1016/0014-5793(91)80444-8; Kim B, 2008, J PHYSIOL-LONDON, V586, P1683, DOI 10.1113/jphysiol.2007.148726; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lenaers G, 2009, INT J BIOCHEM CELL B, V41, P1866, DOI 10.1016/j.biocel.2009.04.013; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu X, 2011, CELL DEATH DIFFER; LONCAR D, 1990, J STRUCT BIOL, V105, P133, DOI 10.1016/1047-8477(90)90107-N; Malli R, 2010, FEBS LETT, V584, P1942, DOI 10.1016/j.febslet.2010.01.010; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mannella CA, 2000, J BIOENERG BIOMEMBR, V32, P1, DOI 10.1023/A:1005562109678; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; PEROTTI ME, 1983, J HISTOCHEM CYTOCHEM, V31, P351, DOI 10.1177/31.3.6186730; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Schaaf CP, 2011, MOL GENET METAB; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Smets I, 2004, AM J PHYSIOL-RENAL, V286, pF784, DOI 10.1152/ajprenal.00284.2003; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szanda G, 2010, CELL CALCIUM, V48, P168, DOI 10.1016/j.ceca.2010.08.005; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Twig G, 2010, AM J PHYSIOL-CELL PH, V299, pC477, DOI 10.1152/ajpcell.00427.2009; van der Bliek AM, 2003, DEV CELL, V4, P769, DOI 10.1016/S1534-5807(03)00167-9; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209	72	40	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25199	10.1371/journal.pone.0025199	http://dx.doi.org/10.1371/journal.pone.0025199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980395	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600014
J	Stackley, KD; Beeson, CC; Rahn, JJ; Chan, SSL				Stackley, Krista D.; Beeson, Craig C.; Rahn, Jennifer J.; Chan, Sherine S. L.			Bioenergetic Profiling of Zebrafish Embryonic Development	PLOS ONE			English	Article							MITOCHONDRIAL TOXICITY; MIDBLASTULA TRANSITION; OXYGEN-CONSUMPTION; ENERGY-METABOLISM; MODEL; EMBRYOGENESIS; CELLS; ASSAY; EFFICIENCY; DISCOVERY	Many debilitating conditions are linked to bioenergetic defects. Developing screens to probe the genetic and/or chemical basic for such links has proved intractable. Furthermore, there is a need for a physiologically relevant assay of bioenergetics in whole organisms, especially for early stages in life where perturbations could increase disease susceptibility with aging. Thus, we asked whether we could screen bioenergetics and mitochondrial function in the developing zebrafish embryo. We present a multiplexed method to assay bioenergetics in zebrafish embryos from the blastula period (3 hours post-fertilization, hpf) through to hatching (48 hpf). In proof of principle experiments, we measured respiration and acid extrusion of developing zebrafish embryos. We quantified respiratory coupling to various bioenergetic functions by using specific pharmacological inhibitors of bioenergetic pathways. We demonstrate that change in the coupling to ATP turnover and proton leak are correlated with developmental stage. The multiwell format of this assay enables the user to screen for the effects of drugs and environmental agents on bioenergetics in the zebrafish embryo with high sensitivity and reproducibility.	[Stackley, Krista D.; Beeson, Craig C.; Rahn, Jennifer J.; Chan, Sherine S. L.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina	Stackley, KD (corresponding author), Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA.	chans@musc.edu			National Institutes of Health [R00ES015555, P20RR024485]; MUSC; South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, NIH/NCRR [UL1RR029882]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882, P20RR024485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MUSC; South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Chan lab is supported by National Institutes of Health awards R00ES015555 and P20RR024485, startup funds provided by MUSC, and the South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, NIH/NCRR Grant Number UL1RR029882. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bang A, 2004, J FISH BIOL, V64, P1285, DOI 10.1111/j.0022-1112.2004.00391.x; Barker DJP, 1992, FETAL INFANT ORIGINS; Beeson CC, 2010, ANAL BIOCHEM, V404, P75, DOI 10.1016/j.ab.2010.04.040; Bishop T, 2000, J EXP BIOL, V203, P3603; BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; BRANDT RB, 1980, ANAL BIOCHEM, V102, P39, DOI 10.1016/0003-2697(80)90314-0; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Brownlie A, 2003, DEV BIOL, V255, P48, DOI 10.1016/S0012-1606(02)00041-6; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; DAWID IB, 1985, J EMBRYOL EXP MORPH, V89, P113; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Dykens JA, 2007, EXPERT REV MOL DIAGN, V7, P161, DOI 10.1586/14737159.7.2.161; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; FINN RN, 1993, FISH FARMING TECHNOLOGY, P117; Finn RN, 2010, AQUAC RES, V41, P684, DOI 10.1111/j.1365-2109.2009.02220.x; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Guderley H, 2004, BIOL REV, V79, P409, DOI 10.1017/S1464793103006328; HEMING TA, 1988, YOLK ABSORPTION EMBR, P407; Herst PM, 2004, BBA-BIOENERGETICS, V1656, P79, DOI 10.1016/j.bbabio.2004.01.008; Holtta-Vuori M., BIOCH J, V429, P235; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; Kamler E., 1992, EARLY LIFE HIST FISH; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lahnsteiner F, 2005, COMP BIOCHEM PHYS B, V142, P46, DOI 10.1016/j.cbpc.2005.05.015; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Mendelsohn BA, 2008, DEV DYNAM, V237, P1789, DOI 10.1002/dvdy.21584; Moran D, 2007, AQUACULTURE, V265, P359, DOI 10.1016/j.aquaculture.2007.02.003; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957; Rolfe VE, 1997, J PHYSIOL-LONDON, V503, P347, DOI 10.1111/j.1469-7793.1997.347bh.x; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schnellmann Rick G., 1994, V1 PART B, P128; Schuh RA, 2011, J NEUROSCI RES; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zamir E, 1997, MOL CELL BIOL, V17, P529, DOI 10.1128/MCB.17.2.529; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	48	92	92	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25652	10.1371/journal.pone.0025652	http://dx.doi.org/10.1371/journal.pone.0025652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980518	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600045
J	Yan, TZ; Mo, QH; Cai, R; Chen, X; Zhang, CM; Liu, YH; Chen, YJ; Zhou, WJ; Xiong, F; Xu, XM				Yan, Ti-Zhen; Mo, Qiu-Hua; Cai, Ren; Chen, Xue; Zhang, Cui-Mei; Liu, Yan-Hui; Chen, Ya-Jun; Zhou, Wan-Jun; Xiong, Fu; Xu, Xiang-Min			Reliable Detection of Paternal SNPs within Deletion Breakpoints for Non-Invasive Prenatal Exclusion of Homozygous alpha(0)-Thalassemia in Maternal Plasma	PLOS ONE			English	Article							CELL-FREE DNA; FREE FETAL DNA; NUCLEIC-ACIDS; DIAGNOSIS; THALASSEMIA; POINT; BLOOD; MUTATION; DISEASE; PCR	Reliable detection of large deletions from cell-free fetal DNA (cffDNA) in maternal plasma is challenging, especially when both parents have the same deletion owing to a lack of specific markers for fetal genotyping. In order to evaluate the efficacy of a non-invasive prenatal diagnosis (NIPD) test to exclude alpha-thalassemia major that uses SNPs linked to the normal paternal alpha-globin allele, we established a novel protocol to reliably detect paternal SNPs within the ((_ _SEA)) breakpoints and performed evaluation of the diagnostic potential of the protocol in a total of 67 pregnancies, in whom plasma samples were collected prior to invasive obstetrics procedures in southern China. A group of nine SNPs identified within the deletion breakpoints were scanned to select the informative SNPs in each of the 67 couples DNA by multiplex PCR based mini-sequencing technique. The paternally inherited SNP allele from cffDNA was detected by allele specific real-time PCR. A protocol for reliable detection of paternal SNPs within the ((_ _ SEA)) breakpoints was established and evaluation of the diagnostic potential of the protocol was performed in a total of 67 pregnancies. In 97% of the couples one or more different SNPs within the deletion breakpoint occurred between paternal and maternal alleles. Homozygosity for the ((_ _ SEA)) deletion was accurately excluded in 33 out of 67 (49.3%, 95% CI, 25.4-78.6%) pregnancies through the implementation of the protocol. Protocol was completely concordant with the traditional reference methods, except for two cases that exhibited uncertain results due to sample hemolysis. This method could be used as a routine NIPD test to exclude gross fetal deletions in alpha-thalassemia major, and could further be employed to test for other diseases due to gene deletion.	[Yan, Ti-Zhen; Mo, Qiu-Hua; Chen, Xue; Zhou, Wan-Jun; Xiong, Fu; Xu, Xiang-Min] So Med Univ, Sch Basic Med Sci, Dept Med Genet, Guangzhou, Guangdong, Peoples R China; [Yan, Ti-Zhen; Cai, Ren] Liuzhou Municipal Matern & Child Healthcare Hosp, Ctr Prenatal Diag, Liuzhou, Guangxi, Peoples R China; [Zhang, Cui-Mei] So Med Univ, Affiliated Zhongshan Boai Hosp, Ctr Prenatal Diag, Zhongshan, Guangdong, Peoples R China; [Liu, Yan-Hui] Sun Yat Sen Univ, Affiliated Donghua Hosp, Dept Lab Med, Dongguan, Guangdong, Peoples R China; [Chen, Ya-Jun] Shaoguan Municipal Matern & Child Healthcare Hosp, Ctr Prenatal Diag, Shaoguan, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Sun Yat Sen University	Yan, TZ (corresponding author), So Med Univ, Sch Basic Med Sci, Dept Med Genet, Guangzhou, Guangdong, Peoples R China.	gzxuxm@pub.guangzhou.gd.cn	Yan, Tizhen/AAY-7423-2021		National Natural Science Fund of China (NSFC) [30771192]; National Natural Science Foundation of China (NSFC) [U0632005]; Dongguan Medical Health Institutions [200910515024]	National Natural Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Dongguan Medical Health Institutions	This work was funded by a programme grant from the National Natural Science Fund of China (NSFC, No. 30771192), the National Natural Science Foundation of China (NSFC)-Guangdong Joint Fund (NO. U0632005) and the National Key Scientific Research Project of Dongguan Medical Health Institutions (No. 200910515024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amicucci P, 2000, CLIN CHEM, V46, P301; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Bischoff FZ, 2003, LANCET, V361, P139, DOI 10.1016/S0140-6736(03)12191-5; Chiu RWK, 2002, LANCET, V360, P998, DOI 10.1016/S0140-6736(02)11086-5; Chiu RWK, 2002, CLIN CHEM, V48, P778; Chui DHK, 2005, ANN NY ACAD SCI, V1054, P25, DOI 10.1196/annals.1345.004; Ding CM, 2004, P NATL ACAD SCI USA, V101, P10762, DOI 10.1073/pnas.0403962101; Galbiati S, 2008, HAEMATOLOGICA, V93, P610, DOI 10.3324/haematol.11895; Hahn S, 2002, CLIN OBSTET GYNECOL, V45, P649, DOI 10.1097/00003081-200209000-00008; Ho SSY, 2010, PRENATAL DIAG, V30, P65, DOI 10.1002/pd.2413; Ho SSY, 2007, CLIN CHEM, V53, P173, DOI 10.1373/clinchem.2006.075085; Hung ECW, 2009, J CLIN PATHOL, V62, P308, DOI 10.1136/jcp.2007.048470; JACKSON LG, 1992, NEW ENGL J MED, V327, P594, DOI 10.1056/NEJM199208273270903; Lau ET, 2005, PRENATAL DIAG, V25, P123, DOI 10.1002/pd.1096; Legler Tobias J., 2008, V444, P209, DOI 10.1007/978-1-59745-066-9_16; Li Y, 2005, JAMA-J AM MED ASSOC, V293, P843, DOI 10.1001/jama.293.7.843; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Li Y, 2007, PRENATAL DIAG, V27, P11, DOI 10.1002/pd.1608; Li Y, 2009, FETAL DIAGN THER, V25, P246, DOI 10.1159/000223442; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Nasis O, 2004, CLIN CHEM, V50, P694, DOI 10.1373/clinchem.2003.025981; Simpson JL, 2004, JAMA-J AM MED ASSOC, V291, P1135, DOI 10.1001/jama.291.9.1135; Tungwiwat W, 2006, ANN NY ACAD SCI, V1075, P103, DOI 10.1196/annals.1368.013; Vichinsky Elliott P, 2009, Hematology Am Soc Hematol Educ Program, P35, DOI 10.1182/asheducation-2009.1.35; Weatherall DJ, 2001, THALASSEMIA SYNDROME, P27; Winichagoon P, 2005, INT J HEMATOL, V81, P396, DOI 10.1532/IJH97.A20501; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Xiao W, 2000, Zhonghua Xue Ye Xue Za Zhi, V21, P192	30	10	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24779	10.1371/journal.pone.0024779	http://dx.doi.org/10.1371/journal.pone.0024779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980356	Green Submitted, gold, Green Published			2022-12-27	WOS:000295939600006
J	Liu, YJ; Testa, JS; Philip, R; Block, TM; Mehta, AS				Liu, Yuanjie; Testa, James S.; Philip, Ramila; Block, Timothy M.; Mehta, Anand S.			A Ubiquitin Independent Degradation Pathway Utilized by a Hepatitis B Virus Envelope Protein to Limit Antigen Presentation	PLOS ONE			English	Article							MHC CLASS-I; ENDOPLASMIC-RETICULUM STRESS; PRE-S MUTANTS; PEPTIDE-N-GLYCANASE; HEPATOCELLULAR-CARCINOMA; AAA-ATPASE; MISFOLDED GLYCOPROTEINS; AVIAN HEPADNAVIRUS; PROTEASOME PATHWAY; T-CELLS	Hepatitis B virus envelope glycoproteins Large (L), Middle (M) and Small (S) are targets of the host cellular immune system. The extent to which the host recognizes viral antigens presented by infected cells is believed to play a decisive role in determining if an infection will be resolved or become chronic. As with other antigens, HBV envelope polypeptides must be degraded, presumably by cellular proteasomes, to be presented by the MHC I pathway. We have used M as a model to study this process and determine how ER quality control monitors these foreign polymeric proteins and disposes of them through the ER-associated degradation (ERAD) pathway. Using both wild type and mutant HBV M protein, we found that unlike most ERAD substrates, which require ubiquitination for retrotranslocation and degradation, the HBV M protein, which only contains two lysine residues, can undergo rapid and complete, ubiquitin independent, proteasome dependent degradation. The utilization of this pathway had a functional consequence, since proteins degraded through it, were poorly presented via MHC I. To test the hypothesis that the level of ubiquitination, independent of protein degradation, controls the level of antigen presentation, we inserted two additional lysines into both the wild type and mutant M protein. Amazingly, while the addition of the lysine residues dramatically increased the level of ubiquitination, it did not alter the rate of degradation. However and remarkably, the increased ubiquitination was associated with a dramatic increase in the level of antigen presentation. In conclusion, using the HBV surface protein as a model, we have identified a novel ubiquitin independent degradation pathway and determined that this pathway can have implications for antigen presentation and potentially viral pathogenesis.	[Liu, Yuanjie; Block, Timothy M.; Mehta, Anand S.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA; [Testa, James S.; Philip, Ramila] Immunotope Inc, Doylestown, PA USA	Drexel University	Liu, YJ (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA.	Anand.Mehta@drexelmed.edu			National Cancer Institute (NCI) [R01 CA120206-01]; NCI Early Research Detection Network (EDRN) [UO1 CA084951-06]; National Institute of Allergy and Infectious Diseases (NIAID) [U01AI054763]; NATIONAL CANCER INSTITUTE [U01CA084951, R01CA120206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI054763] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Research Detection Network (EDRN); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01 CA120206-01 from the National Cancer Institute (NCI), grant UO1 CA084951-06 from the NCI Early Research Detection Network (EDRN), and grant U01AI054763 from the National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe K, 2009, CANCER SCI, V100, P2249, DOI 10.1111/j.1349-7006.2009.01309.x; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Eisenlohr LC, 2007, NAT REV IMMUNOL, V7, P403, DOI 10.1038/nri2077; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Fang ZL, 2008, J GEN VIROL, V89, P2882, DOI 10.1099/vir.0.2008/002824-0; Feldman M, 2009, TRENDS CELL BIOL, V19, P357, DOI 10.1016/j.tcb.2009.05.005; GERLICH WH, 1992, ARCH VIROL, P129; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Golovina TN, 2005, J IMMUNOL, V174, P2763, DOI 10.4049/jimmunol.174.5.2763; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRANT EP, 1995, J IMMUNOL, V155, P3750; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huang HP, 2010, PEDIATR RES, V67, P90, DOI 10.1203/PDR.0b013e3181c1b0b7; Huang L, 2011, J IMMUNOL, V186, P1904, DOI 10.4049/jimmunol.1003411; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kikkert M, 2001, BIOCHEM J, V358, P369, DOI 10.1042/0264-6021:3580369; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; LENHOFF RJ, 1994, J VIROL, V68, P4565, DOI 10.1128/JVI.68.7.4565-4571.1994; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Liu YJ, 2007, VIROLOGY, V365, P10, DOI 10.1016/j.virol.2007.03.042; Lord JM, 2003, BIOCHEM SOC T, V31, P1260; MANGOLD CMT, 1993, J VIROL, V67, P4588, DOI 10.1128/JVI.67.8.4588-4597.1993; Mellman I, 2010, CURR OPIN IMMUNOL, V22, P78, DOI 10.1016/j.coi.2010.01.013; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Norton PA, 2010, HEPATOLOGY, V52, P1242, DOI 10.1002/hep.23806; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Sifers RN, 2009, CELL CYCLE, V8, P4026; Simsek E, 2009, VIROLOGY, V384, P12, DOI 10.1016/j.virol.2008.11.027; Sinnathamby G, 2009, J IMMUNOTHER, V32, P856, DOI 10.1097/CJI.0b013e3181b0b125; SUMMERS J, 1991, J VIROL, V65, P1310, DOI 10.1128/JVI.65.3.1310-1317.1991; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; THUNG SN, 1986, HEPATOLOGY, V6, P1315, DOI 10.1002/hep.1840060615; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wang JG, 2006, J VIROL, V80, P8541, DOI 10.1128/JVI.00830-06; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096; Yewdell J, 1999, IMMUNOL REV, V172, P97, DOI 10.1111/j.1600-065X.1999.tb01359.x; Yoshida Y, 2010, BBA-GEN SUBJECTS, V1800, P172, DOI 10.1016/j.bbagen.2009.07.029; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24477	10.1371/journal.pone.0024477	http://dx.doi.org/10.1371/journal.pone.0024477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969857	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900008
J	Takamiya, M; Haider, KH; Ashraf, M				Takamiya, Michitaka; Haider, Khawaja H.; Ashraf, Muhammad			Identification and Characterization of a Novel Multipotent Sub-Population of Sca-1(+) Cardiac Progenitor Cells for Myocardial Regeneration	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MAMMALIAN HEART; SMOOTH-MUSCLE; CARDIOVASCULAR REGENERATION; EXPRESSION; POPULATION; DIFFERENTIATION; CARDIOMYOCYTES; GENERATION; LINEAGES	Methods and Results: The cardiac stem/progenitor cells from adult mice were seeded at low density in serum-free medium. The colonies thus obtained were expanded separately and assessed for expression of stem cell antigen-1 (Sca-1). Two colonies each with high Sca-1 (CSH1; 95.9%; CSH2; 90.6%) and low Sca-1 (CSL1; 37.1%; CSL2; 17.4%) expressing cells were selected for further studies. Sca-1(+) cells (98.4%) isolated using Magnetic Cell Sorting System (MACS) from the hearts were used as a control. Although the selected populations were similar in surface marker expression (low in c-kit, CD45, CD34, CD31 and high in CD29), these cells exhibited diverse differentiation potential. Unlike CSH1, CSH2 expressed Nanog, TERT, Bcrp1, Nestin, Musashi1 and Isl-1, and also showed differentiation into osteogenic, chondrogenic, smooth muscle, endothelial and cardiac lineages. MACS sorted cells exhibited similar tendency albeit with relatively weaker differentiation potential. Transplantation of CSH2 cells into infarcted heart showed attenuated infarction size, significantly preserved left ventricular function and anterior wall thickness, and increased capillary density. We also observed direct differentiation of transplanted cells into endothelium and cardiomyocytes. Conclusions: The cardiac stem/progenitor cells isolated by a combined clonal selection and surface marker approach possessed multiple stem cell features important for cardiac regeneration.	[Takamiya, Michitaka; Haider, Khawaja H.; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Takamiya, M (corresponding author), Univ Cincinnati, Dept Pathol, Cincinnati, OH 45221 USA.	muhammad.ashraf@uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health (NIH) [R37-HL074272, HL-080686, HL-087246, HL-087288, HL-089535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087288, R01HL089535, R01HL080686, R01HL087246, R37HL074272] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) Grants # R37-HL074272, HL-080686, HL-087246 to MA and HL-087288, HL-089535 to KHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jiang SJ, 2006, CIRC RES, V99, P776, DOI 10.1161/01.RES.0000244687.97719.4f; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Lai L, 1998, J IMMUNOL, V160, P3861; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leri A, 2001, P NATL ACAD SCI USA, V98, P8626, DOI 10.1073/pnas.151013298; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tateishi K, 2007, J CELL SCI, V120, P1791, DOI 10.1242/jcs.006122; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; WILSON R, 2007, CARDIOVASCULAR REGEN, P77; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yi BA, 2010, J CLIN INVEST, V120, P20, DOI 10.1172/JCI40820	32	55	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25265	10.1371/journal.pone.0025265	http://dx.doi.org/10.1371/journal.pone.0025265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980409	Green Submitted, gold, Green Published			2022-12-27	WOS:000295936900043
J	Tan, XJ; Huang, XY; Zhu, SL; Chen, H; Yu, QL; Wang, HY; Huo, XX; Zhou, JH; Wu, Y; Yan, DM; Zhang, Y; Wang, DY; Cui, AL; An, HQ; Xu, WB				Tan, Xiaojuan; Huang, Xueyong; Zhu, Shuangli; Chen, Hui; Yu, Qiuli; Wang, Haiyan; Huo, Xixiang; Zhou, Jianhui; Wu, Yan; Yan, Dongmei; Zhang, Yong; Wang, Dongyan; Cui, Aili; An, Hongqiu; Xu, Wenbo			The Persistent Circulation of Enterovirus 71 in People's Republic of China: Causing Emerging Nationwide Epidemics Since 2008	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; PACIFIC REGION; EVOLUTION; TAIWAN; HAND; FOOT; INFECTION; OUTBREAK	Emerging epidemics of hand-foot-and-mouth disease (HFMD) associated with enterovirus 71 (EV71) has become a serious concern in mainland China. It caused 126 and 353 fatalities in 2008 and 2009, respectively. The epidemiologic and pathogenic data of the outbreak collected from national laboratory network and notifiable disease surveillance system. To understand the virological evolution of this emerging outbreak, 326 VP1 gene sequences of EV71 detected in China from 1987 to 2009 were collected for genetic analyses. Evidence from both traditional and molecular epidemiology confirmed that the recent HFMD outbreak was an emerging one caused by EV71 of subgenotype C4. This emerging HFMD outbreak is associated with EV71 of subgenotype C4, circulating persistently in mainland China since 1998, but not attributed to the importation of new genotype. Originating from 1992, subgenotype C4 has been the predominant genotype since 1998 in mainland China, with an evolutionary rate of 4.6 similar to 4.8 x 10(-3) nucleotide substitutions/site/year. The phylogenetic analysis revealed that the majority of the virus during this epidemic was the most recent descendant of subgenotype C4 (clade C4a). It suggests that the evolution might be one of the potential reasons for this native virus to cause the emerging outbreak in China. However, strong negative selective pressure on VP1 protein of EV71 suggested that immune escape might not be the evolving strategy of EV71, predicting a light future for vaccine development. Nonetheless, long-term antigenic and genetic surveillance is still necessary for further understanding.	[Tan, Xiaojuan; Zhu, Shuangli; Yan, Dongmei; Zhang, Yong; Wang, Dongyan; Cui, Aili; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Huang, Xueyong] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Chen, Hui] Ningxia Prov Ctr Dis Control & Prevent, Ningxia, Peoples R China; [Yu, Qiuli] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Wang, Haiyan] Shandong Prov Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Huo, Xixiang] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Zhou, Jianhui] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China; [Wu, Yan] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Tan, XJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	Ministry of Science and Technology of the People's Republic of China [2011CB504902, 2009ZX10004-201, 2008BAI69D00, 2009ZX10004-202]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the Ministry of Science and Technology of the People's Republic of China, grant number 2011CB504902, 2009ZX10004-201, 2008BAI69D00, and 2009ZX10004-202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; BLOMBERG J, 1974, LANCET, V2, P112; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; CRAINIC R, 1993, BIOLOGICALS, V21, P379, DOI 10.1006/biol.1993.1099; daSilva EE, 1996, EMERG INFECT DIS, V2, P231, DOI 10.3201/eid0203.960312; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kung SH, 2007, CLIN MICROBIOL INFEC, V13, P782, DOI 10.1111/j.1469-0691.2007.01745.x; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; MATEU MG, 1995, VIRUS RES, V38, P1, DOI 10.1016/0168-1702(95)00048-U; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; MELNICK JL, 1979, INTERVIROLOGY, V12, P297, DOI 10.1159/000149088; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi Wei-feng, 2009, Virologica Sinica, V24, P59, DOI 10.1007/s12250-009-2976-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang Qi, 2010, Disease Surveillance, V25, P181; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; ZHENG Z-M, 1989, Virologica Sinica, V4, P375; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	49	128	161	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25662	10.1371/journal.pone.0025662	http://dx.doi.org/10.1371/journal.pone.0025662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980521	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900087
J	Kent, R; Bar-Massada, A; Carmel, Y				Kent, Rafi; Bar-Massada, Avi; Carmel, Yohay			Multiscale Analyses of Mammal Species Composition - Environment Relationship in the Contiguous USA	PLOS ONE			English	Article							CANONICAL CORRESPONDENCE-ANALYSIS; LATITUDINAL GRADIENTS; COMMUNITY COMPOSITION; SPATIAL VARIATION; BIODIVERSITY; RICHNESS; DISTRIBUTIONS; PATTERNS; DIVERSITY; SCALE	Relationships between species composition and its environmental determinants are a basic objective of ecology. Such relationships are scale dependent, and predictors of species composition typically include variables such as climate, topographic, historical legacies, land uses, human population levels, and random processes. Our objective was to quantify the effect of environmental determinants on U. S. mammal composition at various spatial scales. We found that climate was the predominant factor affecting species composition, and its relative impact increased in correlation with the increase of the spatial scale. Another factor affecting species composition is land-use-land-cover. Our findings showed that its impact decreased as the spatial scale increased. We provide quantitative indication of highly significant effect of climate and land-use-land-cover variables on mammal composition at multiple scales.	[Kent, Rafi; Carmel, Yohay] Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel; [Bar-Massada, Avi] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	Technion Israel Institute of Technology; University of Wisconsin System; University of Wisconsin Madison	Kent, R (corresponding author), Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel.	rkent@technion.ac.il	Carmel, Yohay/G-4362-2011	Carmel, Yohay/0000-0002-5883-0184	Israel Science Foundation [486-2010]	Israel Science Foundation(Israel Science Foundation)	This project was funded by the Israel Science Foundation, www.isf.org.il (grant number 486-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Allen TFH, 1992, UNIFIED ECOLOGY; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Cushman SA, 2002, LANDSCAPE ECOL, V17, P637, DOI 10.1023/A:1021571603605; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESRI, 1999, ARCVIEW GIS; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; GBIF, 2008, GBIF TRAIN MAN 1 DIG; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Grand J, 2004, BIOL CONSERV, V119, P495, DOI 10.1016/j.biocon.2004.01.012; Grand J, 2003, BIOL CONSERV, V112, P307, DOI 10.1016/S0006-3207(02)00323-3; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Jones MM, 2008, OECOLOGIA, V155, P593, DOI 10.1007/s00442-007-0923-8; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Kadmon R, 1999, J VEG SCI, V10, P421, DOI 10.2307/3237071; Kent R, 2011, DIVERS DISTRIB, V17, P474, DOI 10.1111/j.1472-4642.2011.00755.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Levin SA, 2000, ECOSYSTEMS, V3, P498, DOI 10.1007/s100210000044; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; MacArthur R.H., 1972, pvii; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; May R, 1984, OVERVIEW REAL APPARE, P3; Oksanen J., 2016, R PACKAG; PATRICK R, 1963, ANN NY ACAD SCI, V108, P359, DOI 10.1111/j.1749-6632.1963.tb13389.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pyron RA, 2009, GLOBAL ECOL BIOGEOGR, V18, P406, DOI 10.1111/j.1466-8238.2009.00462.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rodriguez J, 2006, J BIOGEOGR, V33, P291, DOI 10.1111/j.1365-2699.2005.01397.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Svenning JC, 2005, J BIOGEOGR, V32, P1019, DOI 10.1111/j.1365-2699.2005.01219.x; Team R. D. C, 2011, R LANG ENV STAT COMP; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031	41	13	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25440	10.1371/journal.pone.0025440	http://dx.doi.org/10.1371/journal.pone.0025440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980457	Green Submitted, Green Published, gold			2022-12-27	WOS:000295933700034
J	Ladeira, A; Fregni, F; Campanha, C; Valasek, CA; De Ridder, D; Brunoni, AR; Boggio, PS				Ladeira, Andrea; Fregni, Felipe; Campanha, Camila; Valasek, Claudia Aparecida; De Ridder, Dirk; Brunoni, Andre Russwsky; Boggio, Paulo Sergio			Polarity-Dependent Transcranial Direct Current Stimulation Effects on Central Auditory Processing	PLOS ONE			English	Article							MOTOR CORTEX; PHOSPHENE THRESHOLDS; PREFRONTAL CORTEX; DC STIMULATION; PURE-TONES; MODULATION; LOUDNESS; HUMANS; MEMORY; FACILITATION	Given the polarity dependent effects of transcranial direct current stimulation (tDCS) in facilitating or inhibiting neuronal processing, and tDCS effects on pitch perception, we tested the effects of tDCS on temporal aspects of auditory processing. We aimed to change baseline activity of the auditory cortex using tDCS as to modulate temporal aspects of auditory processing in healthy subjects without hearing impairment. Eleven subjects received 2mA bilateral anodal, cathodal and sham tDCS over auditory cortex in a randomized and counterbalanced order. Subjects were evaluated by the Random Gap Detection Test (RGDT), a test measuring temporal processing abilities in the auditory domain, before and during the stimulation. Statistical analysis revealed a significant interaction effect of time vs. tDCS condition for 4000 Hz and for clicks. Post-hoc tests showed significant differences according to stimulation polarity on RGDT performance: anodal improved 22.5% and cathodal decreased 54.5% subjects' performance, as compared to baseline. For clicks, anodal also increased performance in 29.4% when compared to baseline. tDCS presented polarity-dependent effects on the activity of the auditory cortex, which results in a positive or negative impact in a temporal resolution task performance. These results encourage further studies exploring tDCS in central auditory processing disorders.	[Ladeira, Andrea; Campanha, Camila; Valasek, Claudia Aparecida; Boggio, Paulo Sergio] Univ Prebiteriana Mackenzie, Social & Cognit Neurosci Lab, Sao Paulo, Brazil; [Ladeira, Andrea; Campanha, Camila; Valasek, Claudia Aparecida; Boggio, Paulo Sergio] Univ Prebiteriana Mackenzie, Dev Disorders Program, Ctr Hlth & Biol Sci, Sao Paulo, Brazil; [Fregni, Felipe] Spaulding Rehabil Hosp, Lab Neuromodulat, Boston, MA USA; [Fregni, Felipe] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Fregni, Felipe] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [De Ridder, Dirk] Univ Antwerp Hosp, BRAI2N TRI, Antwerp, Belgium; [De Ridder, Dirk] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Brunoni, Andre Russwsky] Univ Sao Paulo, Inst Psicol, Nucleo Neurociencias & Comportamento, Sao Paulo, Brazil	Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Antwerp; University of Antwerp; Universidade de Sao Paulo	Ladeira, A (corresponding author), Univ Prebiteriana Mackenzie, Social & Cognit Neurosci Lab, Sao Paulo, Brazil.	boggio@mackenzie.br	Boggio, Paulo S/K-6272-2012; Brunoni, Andre R./H-8394-2012	Boggio, Paulo S/0000-0002-6109-0447; Brunoni, Andre R./0000-0002-6310-3571; Fregni, Felipe/0000-0001-9359-8643	MackPesquisa; CNPq [305718/2009-6]; FAPESP	MackPesquisa; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by MackPesquisa. PSB is supported by a CNPq researcher grant (305718/2009-6). AL was supported by a Master grant (MackPesquisa). CC is supported by a PhD grant (FAPESP). CAV is supported by a Master grant (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2004, NEUROREPORT, V15, P2491, DOI 10.1097/00001756-200411150-00012; Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Antal A, 2003, NEUROPSYCHOLOGIA, V41, P1802, DOI 10.1016/S0028-3932(03)00181-7; Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Antal A, 2004, EUR J NEUROSCI, V19, P2888, DOI 10.1111/j.1460-9568.2004.03367.x; Bamiou DE, 2006, NEUROLOGY, V67, P614, DOI 10.1212/01.wnl.0000230197.40410.db; Bhatgnagar S, 2002, NEUROCIENCIAS ESTUDO; Boggio PS, 2011, BRAIN STIMUL; Ceponiene R, 2009, BRAIN LANG, V110, P107, DOI 10.1016/j.bandl.2009.04.003; Cohen-Mimran R, 2007, DYSLEXIA, V13, P175, DOI 10.1002/dys.323; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Fletcher H, 1933, J ACOUST SOC AM, V5, P82, DOI 10.1121/1.1915637; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Keith R W, 2000, J Am Acad Audiol, V11, P438; Kuhl P, 2008, ANNU REV NEUROSCI, V31, P511, DOI 10.1146/annurev.neuro.30.051606.094321; Langers DRM, 2007, NEUROIMAGE, V34, P264, DOI 10.1016/j.neuroimage.2006.09.002; Liasis A, 2006, J NEURAL TRANSM, V113, P939, DOI 10.1007/s00702-005-0357-6; Martin DM, 2011, J AFFECT DISORD; Mathys C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00193; Mendonca ME, 2011, J PAIN, V12, P610, DOI 10.1016/j.jpain.2010.12.015; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Okamoto H, 2008, NEUROSCIENCE, V151, P913, DOI 10.1016/j.neuroscience.2007.11.038; Paul-Brown D, 1996, AM J AUDIOL, V5, P41, DOI DOI 10.1044/POLICY.TR1996-00241; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; ROBINSON DW, 1956, BRIT J APPL PHYS, V7, P166, DOI 10.1088/0508-3443/7/5/302; Ruytjens L, 2007, EUR J NUCL MED MOL I, V34, P2073, DOI 10.1007/s00259-007-0517-z; Samelli A, 2005, TESTE GIN LIMIARES D; Schonwiesner M, 2009, P NATL ACAD SCI USA, V106, P14611, DOI 10.1073/pnas.0907682106; Shinn JB, 2009, J AM ACAD AUDIOL, V20, P229, DOI 10.3766/jaaa.20.4.3; Soros P, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-34; Suzuki Y, 2004, J ACOUST SOC AM, V116, P918, DOI 10.1121/1.1763601; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Uy J, 2003, J NEUROSCI METH, V127, P193, DOI 10.1016/S0165-0270(03)00142-0; Vines BW, 2006, NEUROREPORT, V17, P1047, DOI 10.1097/01.wnr.0000223396.05070.a2; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Yalcinkaya F, 2009, INT J PEDIATR OTORHI, V73, P1558, DOI 10.1016/j.ijporl.2009.07.024; Zaidan Elena, 2008, Pró-Fono R. Atual. Cient., V20, P19, DOI 10.1590/S0104-56872008000100004	45	57	58	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25399	10.1371/journal.pone.0025399	http://dx.doi.org/10.1371/journal.pone.0025399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966519	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100055
J	Folcher, L; Bourguet, D; Thiery, D; Pelozuelo, L; Phalip, M; Weissenberger, A; Eychenne, N; Regnault-Roger, C; Delos, M				Folcher, Laurent; Bourguet, Denis; Thiery, Denis; Pelozuelo, Laurent; Phalip, Michel; Weissenberger, Alain; Eychenne, Nathalie; Regnault-Roger, Catherine; Delos, Marc			Changes in Parasitoid Communities Over Time and Space: A Historical Case Study of the Maize Pest Ostrinia nubilalis	PLOS ONE			English	Article							PHYLLOCNISTIS-CITRELLA LEPIDOPTERA; MUGWORT ARTEMISIA-VULGARIS; ENEMY-FREE SPACE; NATURAL ENEMIES; NATIVE PARASITOIDS; HABITAT FRAGMENTATION; LANDSCAPE STRUCTURE; INSECT COMMUNITIES; SPECIES RICHNESS; CLIMATE-CHANGE	Understanding the ways in which human environmental modifications affect biodiversity is a key challenge in conservation planning, pest control and evolutionary ecology. Parasitoid communities, particularly those associated with agricultural pests, may be susceptible to such modifications. We document here changes in the larval parasitoid communities of Ostrinia nubilalis - the main pest of maize - and its sibling species O. scapulalis, based on two historical datasets, one collected from 1921-1928 and the other from 2001-2005. Each of these datasets encompasses several years and large geographical areas and was based on several thousands/millions of host larvae. The 80-year interval between the two datasets was marked by a decrease in O. nubilalis parasitism to about two thirds its initial level, mostly due to a decrease in the rate of parasitism by hymenopterans. However, a well balanced loss and gain of species ensured that species richness remained stable. Conversely, O. scapulalis displayed stable rates of parasitism over this period, with a decline in the species richness of its parasitoid community. Rates of parasitism and species richness in regions colonized by O. nubilalis during the 1950s were one half to one third those in regions displaying long-term colonisation by this pest. During the recent human activity-driven expansion of its range, O. nubilalis has neither captured native parasitoids nor triggered parasite spill back or spill over.	[Folcher, Laurent; Regnault-Roger, Catherine] Univ Pau & Pays Adour, Inst Pluridisciplinaire Environm & Mat, Equipe Environm & Microbiol, CNRS,UMR 5254, Pau, France; [Bourguet, Denis] INRA, Unite Mixte Rech, Ctr Biol Gest Populat, Montferrier Sur Lez, France; [Thiery, Denis] INRA, Unite Mixte Rech Sante & Agroecol Vignoble 1065, Inst Sci Vigne & Vin, Villenave Dornon, France; [Pelozuelo, Laurent] Univ Toulouse, Lab Ecol Fonct & Environm, UMR 5245, Toulouse, France; [Phalip, Michel] Direct Reg Agr & Foret Poitou Charentes, Serv Reg Alimentat, Biard, France; [Weissenberger, Alain] Chambre Agr Bas Rhin, Strasbourg, France; [Eychenne, Nathalie] Federat Reg Def Organismes Nuisibles Midi Pyrenee, Castanet Tolosan, France; [Delos, Marc] Direct Reg Agr & Foret Midi Pyrenees, Serv Reg Alimentat, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour; INRAE; Institut de Recherche pour le Developpement (IRD); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse	Folcher, L (corresponding author), Univ Pau & Pays Adour, Inst Pluridisciplinaire Environm & Mat, Equipe Environm & Microbiol, CNRS,UMR 5254, Pau, France.	laurent.folcher@anses.fr		Bourguet, Denis/0000-0002-2109-5323	French Ministry of Agriculture	French Ministry of Agriculture	Funding for this study was provided by the French Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AGR, 2010, OV AGR AGR IND FOR F; Amalin DM, 2002, BIOCONTROL, V47, P327, DOI 10.1023/A:1014815000826; ASKEW RR, 1979, ZOOL J LINN SOC-LOND, V67, P51, DOI 10.1111/j.1096-3642.1979.tb01104.x; ASKEW RR, 1980, J ANIM ECOL, V49, P817, DOI 10.2307/4229; BAKER W. A., 1949, U S DEPT AGRIC TECH BULL, V983, P1; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Belshaw R., 1993, HDB IDENT BR INSECTS, V10, P1; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Crispo E, 2010, EVOL ECOL RES, V12, P47; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; De Nardo EAB, 2004, BIOL CONTROL, V31, P280, DOI 10.1016/j.biocontrol.2004.07.003; Denys C, 1998, OECOLOGIA, V113, P269, DOI 10.1007/s004420050378; DiBattista JD, 2011, EVOL APPL, V4, P1, DOI 10.1111/j.1752-4571.2010.00125.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Faucher D, 1931, ANN GEOGR, V40, P113, DOI 10.3406/geo.1931.11287; Fenoglio MS, 2009, ACTA OECOL, V35, P318, DOI 10.1016/j.actao.2008.12.001; FOLCHER L, 2005, 7 INT C PESTS AGR 26; Fonseca CR, 2005, ECOL ENTOMOL, V30, P36, DOI 10.1111/j.0307-6946.2005.00664.x; FRANKIE GW, 1978, ANNU REV ENTOMOL, V23, P367, DOI 10.1146/annurev.en.23.010178.002055; Fried G., 2008, INNOVATIONS AGRONOMI, V3, P15; Frolov AN, 2007, BIOL J LINN SOC, V91, P49, DOI 10.1111/j.1095-8312.2007.00779.x; GALICHET PF, 1985, AGROMAIS, V25, P169; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Girardoz S, 2006, AGR FOREST ENTOMOL, V8, P49, DOI 10.1111/j.1461-9555.2006.00281.x; GODFRAY HCJ, 1995, J ANIM ECOL, V64, P393, DOI 10.2307/5899; GRENIER S, 1990, ENTOMOPHAGA, V35, P485, DOI 10.1007/BF02375274; Grobler BC, 2008, ECOL ENTOMOL, V33, P453, DOI 10.1111/j.1365-2311.2008.00990.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hawkins B. A., 1994, PATTERN PROCESS HOST; Heard SB, 2006, OECOLOGIA, V150, P421, DOI 10.1007/s00442-006-0529-6; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Herting B., 1984, STUTTGARTER BEITRA A, V369, P1; Ishitani M, 2003, ECOGRAPHY, V26, P481, DOI 10.1034/j.1600-0587.2003.03436.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Kruess A, 2003, ECOGRAPHY, V26, P283, DOI 10.1034/j.1600-0587.2003.03402.x; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; LANDIS DA, 1992, ENVIRON ENTOMOL, V21, P409, DOI 10.1093/ee/21.2.409; Mailafiya DM, 2009, J APPL ENTOMOL, V133, P416, DOI 10.1111/j.1439-0418.2009.01381.x; Marino PC, 1996, ECOL APPL, V6, P276, DOI 10.2307/2269571; Martel C, 2003, HEREDITY, V90, P141, DOI 10.1038/sj.hdy.6800186; MARTINEZ M, 1991, ENTOMOPHAGA, V36, P227, DOI 10.1007/BF02374558; Mastitsky SE, 2010, DIVERS DISTRIB, V16, P798, DOI 10.1111/j.1472-4642.2010.00693.x; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McGeoch MA, 1997, BIODIVERS CONSERV, V6, P979, DOI 10.1023/A:1018315614085; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Niemel? J., 1999, URBAN ECOSYST, V3, P57, DOI [10.1023/A:1009595932440, DOI 10.1023/A:1009595932440]; Norris RF, 2000, WEED SCI, V48, P94, DOI 10.1614/0043-1745(2000)048[0094:IBWAPA]2.0.CO;2; Parker HL, 1929, J ECON ENTOMOL, V22, P688, DOI 10.1093/jee/22.4.688; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pavuk DM, 1992, BIOL CONTROL, V2, P312, DOI 10.1016/1049-9644(92)90024-8; Pelissie B, 2010, J EVOLUTION BIOL, V23, P350, DOI 10.1111/j.1420-9101.2009.01903.x; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Development Core Team, 2010, LANG ENV STAT COMP; Rango JJ, 2005, BIODIVERS CONSERV, V14, P2185, DOI 10.1007/s10531-004-4669-x; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; Rott AS, 2000, J ANIM ECOL, V69, P274, DOI 10.1046/j.1365-2656.2000.00390.x; Salvo A, 2005, AGR ECOSYST ENVIRON, V109, P213, DOI 10.1016/j.agee.2005.03.014; Schonrogge K, 1996, ECOL ENTOMOL, V21, P71, DOI 10.1111/j.1365-2311.1996.tb00268.x; Schonrogge K, 1996, OIKOS, V77, P507, DOI 10.2307/3545940; Schonrogge K, 1998, P ROY SOC B-BIOL SCI, V265, P1643, DOI 10.1098/rspb.1998.0483; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shaw MR, 2006, J INSECT CONSERV, V10, P117, DOI 10.1007/s10841-006-6288-1; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Sugiura S, 2007, BASIC APPL ECOL, V8, P544, DOI 10.1016/j.baae.2006.09.006; Sumoski SE, 2009, FLA ENTOMOL, V92, P582, DOI 10.1653/024.092.0408; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thompson W.R., 1928, TECHN B USDA, V59, P1; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Urbaneja A, 2000, BIOL CONTROL, V18, P199, DOI 10.1006/bcon.2000.0830; van Achterberg C, 1993, ZOOLOGISCHE VERHANDE, V286, P1; Van Nouhuys S, 1999, J ANIM ECOL, V68, P1248, DOI 10.1046/j.1365-2656.1999.00365.x; Venables W.N., 2002, MODERN APPL STAT S, P183, DOI [10.1007/978-0-387-21706-2_7, DOI 10.1007/978-0-387-21706-2_7, DOI 10.1198/TECH.2003.S33]; Vercher R, 2005, ENVIRON ENTOMOL, V34, P1129, DOI 10.1603/0046-225X(2005)034[1129:RONPSB]2.0.CO;2; Vinal S. C., 1917, MASS AGR EXP STN B, V178, P147; WALDE SJ, 1988, ANNU REV ENTOMOL, V33, P441, DOI 10.1146/annurev.en.33.010188.002301; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weller B, 2004, BASIC APPL ECOL, V5, P193, DOI 10.1078/1439-1791-00220; Weston LA, 2005, PLANT SOIL, V277, P53, DOI 10.1007/s11104-005-3102-x; WILSON PJ, 1995, J APPL ECOL, V32, P295, DOI 10.2307/2405097; Yamaguchi T, 2004, ECOL RES, V19, P209, DOI 10.1111/j.1440-1703.2003.00625.x	91	11	11	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25374	10.1371/journal.pone.0025374	http://dx.doi.org/10.1371/journal.pone.0025374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980436	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300027
J	Guan, JS; Su, SC; Gao, J; Joseph, N; Xie, ZG; Zhou, Y; Durak, O; Zhang, L; Zhu, JJ; Clauser, KR; Carr, SA; Tsai, LH				Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Xie, Zhigang; Zhou, Ying; Durak, Omer; Zhang, Lei; Zhu, J. Julius; Clauser, Karl R.; Carr, Steven A.; Tsai, Li-Huei			Cdk5 Is Required for Memory Function and Hippocampal Plasticity via the cAMP Signaling Pathway	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; LONG-TERM-MEMORY; BIDIRECTIONAL SYNAPTIC PLASTICITY; RUBINSTEIN-TAYBI-SYNDROME; RESTRICTED GENE KNOCKOUT; CA3 NMDA RECEPTORS; ADENYLYL-CYCLASE; MOUSE-BRAIN; PHOSPHORYLATION SITES; TRANSGENIC MICE	Memory formation is modulated by pre- and post-synaptic signaling events in neurons. The neuronal protein kinase Cyclin-Dependent Kinase 5 (Cdk5) phosphorylates a variety of synaptic substrates and is implicated in memory formation. It has also been shown to play a role in homeostatic regulation of synaptic plasticity in cultured neurons. Surprisingly, we found that Cdk5 loss of function in hippocampal circuits results in severe impairments in memory formation and retrieval. Moreover, Cdk5 loss of function in the hippocampus disrupts cAMP signaling due to an aberrant increase in phosphodiesterase (PDE) proteins. Dysregulation of cAMP is associated with defective CREB phosphorylation and disrupted composition of synaptic proteins in Cdk5-deficient mice. Rolipram, a PDE4 inhibitor that prevents cAMP depletion, restores synaptic plasticity and memory formation in Cdk5-deficient mice. Collectively, our results demonstrate a critical role for Cdk5 in the regulation of cAMP-mediated hippocampal functions essential for synaptic plasticity and memory formation.	[Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Xie, Zhigang; Zhou, Ying; Durak, Omer; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Xie, Zhigang; Zhou, Ying; Durak, Omer; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Zhou, Ying; Durak, Omer; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Zhou, Ying; Durak, Omer; Clauser, Karl R.; Carr, Steven A.; Tsai, Li-Huei] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Zhang, Lei; Zhu, J. Julius] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Virginia	Guan, JS (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	lhtsai@mit.edu	Zhang, Lei/F-2603-2011; Carr, Steven A./AAH-8366-2019	Durak, Omer/0000-0001-8426-6188; Clauser, Karl/0000-0002-1052-9456; Guan, Ji-Song/0000-0001-5219-0289; Xie, Zhigang/0000-0002-5794-2977	NIH [T32 MH074249, RO1 NS051874]; Norman B. Leventhal fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH074249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman B. Leventhal fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	S.C.S. was supported by NIH T32 MH074249 and a Norman B. Leventhal fellowship. This work is supported by NIH RO1 NS051874 (L.-H.T.). L.-H.T. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Bao JX, 1997, SCIENCE, V275, P969, DOI 10.1126/science.275.5302.969; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Boy J, 2006, NEUROIMAGE, V33, P449, DOI 10.1016/j.neuroimage.2006.05.055; Calabresi P, 1999, J NEUROSCI, V19, P2489; Chergui K, 2004, P NATL ACAD SCI USA, V101, P2191, DOI 10.1073/pnas.0308652100; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hawasli AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005808; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Mozzachiodi R, 2008, NAT NEUROSCI, V11, P1146, DOI 10.1038/nn.2184; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Radulovic J, 1999, J NEUROSCI, V19, P5016; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Squire L. R., 1987, MEMORY BRAIN; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1998, PATHOL BIOL, V46, P699; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; WACHTEL H, 1983, NEUROPHARMACOLOGY, V22, P267, DOI 10.1016/0028-3908(83)90239-3; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	67	47	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25735	10.1371/journal.pone.0025735	http://dx.doi.org/10.1371/journal.pone.0025735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984943	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300053
J	Chen, M; Zeng, GM; Tan, ZY; Jiang, M; Li, H; Liu, LF; Zhu, Y; Yu, Z; Wei, Z; Liu, YY; Xie, GX				Chen, Ming; Zeng, Guangming; Tan, Zhongyang; Jiang, Min; Li, Hui; Liu, Lifeng; Zhu, Yi; Yu, Zhen; Wei, Zhen; Liu, Yuanyuan; Xie, Gengxin			Understanding Lignin-Degrading Reactions of Ligninolytic Enzymes: Binding Affinity and Interactional Profile	PLOS ONE			English	Article							PHANEROCHAETE-CHRYSOSPORIUM; MANGANESE PEROXIDASE; CRYSTAL-STRUCTURE; MOLECULAR DOCKING; LIGNOCELLULOSIC WASTE; RESOLUTION; SYSTEMS; DEGRADATION; COMPLEXES; SEQUENCE	Previous works have demonstrated that ligninolytic enzymes mediated effective degradation of ligand wastes. The degrading ability greatly relied on the interactions of ligninolytic enzymes with lignin. Ligninolytic enzymes mainly contain laccase (Lac), lignin peroxidase (LiP) and manganese peroxidase (MnP). In the present study, the binding modes of lignin to Lac, LiP and MnP were systematically determined, respectively. Robustness of these modes was further verified by molecular dynamics (MD) simulations. Residues GLU460, PRO346 and SER113 in Lac, residues ARG43, ALA180 and ASP183 in LiP and residues ARG42, HIS173 and ARG177 in MnP were most crucial in binding of lignin, respectively. Interactional analyses showed hydrophobic contacts were most abundant, playing an important role in the determination of substrate specificity. This information is an important contribution to the details of enzyme-catalyzed reactions in the process of lignin biodegradation, which can be used as references for designing enzyme mutants with a better lignin-degrading activity	[Chen, Ming; Zeng, Guangming; Jiang, Min; Li, Hui; Liu, Lifeng; Zhu, Yi; Yu, Zhen; Wei, Zhen; Liu, Yuanyuan; Xie, Gengxin] Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China; [Chen, Ming; Zeng, Guangming; Jiang, Min; Li, Hui; Liu, Lifeng; Zhu, Yi; Yu, Zhen; Wei, Zhen; Liu, Yuanyuan; Xie, Gengxin] Hunan Univ, Minist Educ, Key Lab Environm Biol & Pollut Control, Changsha 410082, Hunan, Peoples R China; [Tan, Zhongyang] Hunan Univ, Coll Biol, State Key Lab Chem Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China	Hunan University; Hunan University; Hunan University	Chen, M (corresponding author), Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China.	zgming@hnu.cn	WEI, ZHEN/K-4123-2015	Wei, Zhen/0000-0002-9625-6574	National Natural Science Foundation of China [50608029, 50978088, 50808073, 51039001]; Hunan Provincial Natural Science Foundation of China [10JJ7005]; Hunan Key Scientific Research Project [2009FJ1010]; Hunan Provincial Innovation Foundation For Postgraduate [CX2009B078, CX2010B157]; Program for New Century Excellent Talents in University [NCET-08-0181]; Research Fund for the Doctoral Program of Higher Education of China [20100161110012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Hunan Key Scientific Research Project; Hunan Provincial Innovation Foundation For Postgraduate; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The study was financially supported by the National Natural Science Foundation of China (No. 50608029, No. 50978088, No. 50808073, No. 51039001), the Hunan Provincial Natural Science Foundation of China (10JJ7005), the Hunan Key Scientific Research Project (2009FJ1010), the Hunan Provincial Innovation Foundation For Postgraduate (CX2009B078, CX2010B157), the Program for New Century Excellent Talents in University (NCET-08-0181) and the Research Fund for the Doctoral Program of Higher Education of China (20100161110012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha CM, 2010, J MOL MODEL, V16, P77, DOI 10.1007/s00894-009-0521-2; Araujo JQ, 2011, J MOL MODEL, V17, P1401, DOI 10.1007/s00894-010-0841-2; Aristilde L, 2010, ENVIRON SCI TECHNOL, V44, P7839, DOI 10.1021/es102136y; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bonagura CA, 2003, BIOCHEMISTRY-US, V42, P5600, DOI 10.1021/bi034058c; Cassidy CE, 2010, J MOL MODEL, V16, P311, DOI 10.1007/s00894-009-0547-5; Chen M, 2010, MOL BIOL EVOL, V27, P2227, DOI 10.1093/molbev/msq100; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Christenson A, 2004, ELECTROANAL, V16, P1074, DOI 10.1002/elan.200403004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong BL, 2011, J MOL MODEL, V17, P1727, DOI 10.1007/s00894-010-0881-7; Gelpke MDS, 1999, BIOCHEMISTRY-US, V38, P11482, DOI 10.1021/bi990943c; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Huang DL, 2008, ENVIRON SCI TECHNOL, V42, P4946, DOI 10.1021/es800072c; Huang DL, 2010, BIORESOURCE TECHNOL, V101, P4062, DOI 10.1016/j.biortech.2009.12.145; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Park JC, 2011, BIORESOURCE TECHNOL, V102, P4901, DOI 10.1016/j.biortech.2010.12.021; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shleev S, 2006, ENZYME MICROB TECH, V39, P841, DOI 10.1016/j.enzmictec.2006.01.010; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sundaramoorthy M, 2005, BIOCHEMISTRY-US, V44, P6463, DOI 10.1021/bi047318e; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Sundaramoorthy M, 2010, J INORG BIOCHEM, V104, P683, DOI 10.1016/j.jinorgbio.2010.02.011; Tang L, 2005, ENZYME MICROB TECH, V36, P960, DOI 10.1016/j.enzmictec.2005.02.009; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wu B, 2010, CHEMOSPHERE, V80, P535, DOI 10.1016/j.chemosphere.2010.04.043; Zeng GM, 2010, BIORESOURCE TECHNOL, V101, P222, DOI 10.1016/j.biortech.2009.08.013	35	21	22	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25647	10.1371/journal.pone.0025647	http://dx.doi.org/10.1371/journal.pone.0025647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980516	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600044
J	Vesterlund, M; Zadjali, F; Persson, T; Nielsen, ML; Kessler, BM; Norstedt, G; Flores-Morales, A				Vesterlund, Mattias; Zadjali, Fahad; Persson, Torbjorn; Nielsen, Michael Lund; Kessler, Benedikt M.; Norstedt, Gunnar; Flores-Morales, Amilcar			The SOCS2 Ubiquitin Ligase Complex Regulates Growth Hormone Receptor Levels	PLOS ONE			English	Article							CYTOKINE SIGNALING 2; SUPPRESSOR; BOX; DEGRADATION; ELONGIN; PROTEIN; INHIBITION; RECONSTITUTE; TRANSDUCER; ACTIVATOR	Growth Hormone is essential for the regulation of growth and the homeostatic control of intermediary metabolism. GH actions are mediated by the Growth Hormone Receptor; a member of the cytokine receptor super family that signals chiefly though the JAK2/STAT5 pathway. Target tissue responsiveness to GH is under regulatory control to avoid excessive and off-target effects upon GHR activation. The suppressor of cytokine signalling 2 (SOCS) is a key regulator of GHR sensitivity. This is clearly shown in mice where the SOCS2 gene has been inactivated, which show 30-40% increase in body length, a phenotype that is dependent on endogenous GH secretion. SOCS2 is a GH-stimulated, STAT5b-regulated gene that acts in a negative feedback loop to downregulate GHR signalling. Since the biochemical basis for these actions is poorly understood, we studied the molecular function of SOCS2. We demonstrated that SOCS2 is part of a multimeric complex with intrinsic ubiquitin ligase activity. Mutational analysis shows that the interaction with Elongin B/C controls SOCS2 protein turnover and affects its molecular activity. Increased GHR levels were observed in livers from SOCS2(-/-) mice and in the absence of SOCS2 in in vitro experiments. We showed that SOCS2 regulates cellular GHR level through direct ubiquitination and in a proteasomally dependent manner. We also confirmed the importance of the SOCS-box for the proper function of SOCS2. Finally, we identified two phosphotyrosine residues in the GHR to be responsible for the interaction with SOCS2, but only Y487 to account for the effects of SOCS2. The demonstration that SOCS2 is an ubiquitin ligase for the GHR unveils the molecular basis for its physiological actions.	[Vesterlund, Mattias; Zadjali, Fahad; Norstedt, Gunnar] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Zadjali, Fahad] Sultan Qaboos Univ, Coll Med & Hlth Sci, Muscat, Oman; [Persson, Torbjorn] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Nielsen, Michael Lund; Flores-Morales, Amilcar] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Oxford, England	Karolinska Institutet; Sultan Qaboos University; Karolinska Institutet; University of Copenhagen; University of Oxford	Vesterlund, M (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	Amilcar.Flores@cpr.ku.dk	Kessler, Benedikt/AAY-8614-2021; ZADJALI, FAHAD/B-5091-2019; Persson, Torbjörn/K-3229-2012; Vesterlund, Mattias/AAX-8014-2021	Kessler, Benedikt/0000-0002-8160-2446; ZADJALI, FAHAD/0000-0001-5891-4700; Nielsen, Michael/0000-0002-0067-9039; Norstedt, Gunnar/0000-0002-7759-3241; Vesterlund, Mattias/0000-0001-9471-6592	Vetenskapsradet [2009-3738]; Novo Nordisk Foundation Center for Protein Research; Cancerfonden; Biomedical Research Centre (NIHR), Oxford, United Kingdom; Karolinska Institutet; Sultan Qaboos University; MRC [G0501068] Funding Source: UKRI; Medical Research Council [G0501068] Funding Source: researchfish	Vetenskapsradet(Swedish Research Council); Novo Nordisk Foundation Center for Protein Research; Cancerfonden(Swedish Cancer Society); Biomedical Research Centre (NIHR), Oxford, United Kingdom(National Institute for Health Research (NIHR)); Karolinska Institutet(Karolinska Institutet); Sultan Qaboos University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grant 2009-3738 from Vetenskapsradet to Dr. Norstedt, and from grants from the Novo Nordisk Foundation Center for Protein Research, and Cancerfonden to Dr. Flores-Morales. Dr. Kessler is supported by the Biomedical Research Centre (NIHR), Oxford, United Kingdom. Dr. Vesterlund is supported by a fellowship from Karolinska Institutet. Dr. Zadjali is supported by a scholarship from Sultan Qaboos University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Botuyan MV, 1999, P NATL ACAD SCI USA, V96, P9033, DOI 10.1073/pnas.96.16.9033; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Choi YB, 2010, J BIOL CHEM, V285, P7271, DOI 10.1074/jbc.M109.073726; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Hu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007178; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Lee SH, 2010, J IMMUNOL, V185, P917, DOI 10.4049/jimmunol.1000784; Machado FS, 2008, J EXP MED, V205, P1077, DOI 10.1084/jem.20072416; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Rico-Bautista E, 2005, MOL ENDOCRINOL, V19, P781, DOI 10.1210/me.2004-0040; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Ridderstrale M, 2003, HORM METAB RES, V35, P169, DOI 10.1055/s-2003-39077; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Strous GJ, 2004, CURR TOP MICROBIOL, V286, P81; Tritos NA, 2009, CURR OPIN ENDOCRINOL, V16, P415, DOI 10.1097/MED.0b013e3283319e6d; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Uyttendaele I, 2007, MOL ENDOCRINOL, V21, P2821, DOI 10.1210/me.2006-0541; van den Eijnden MJ, 2007, MOL ENDOCRINOL, V21, P2832, DOI 10.1210/me.2007-0092; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Zadjali F, 2011, J BIOL CHEM, V286, P480, DOI 10.1074/jbc.M110.173526; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	45	52	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25358	10.1371/journal.pone.0025358	http://dx.doi.org/10.1371/journal.pone.0025358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980433	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600022
J	Chan, QWT; Mutti, NS; Foster, LJ; Kocher, SD; Amdam, GV; Wolschin, F				Chan, Queenie W. T.; Mutti, Navdeep S.; Foster, Leonard J.; Kocher, Sarah D.; Amdam, Gro V.; Wolschin, Florian			The Worker Honeybee Fat Body Proteome Is Extensively Remodeled Preceding a Major Life-History Transition	PLOS ONE			English	Article							QUANTITATIVE MASS-SPECTROMETRY; INSULIN-RECEPTOR SUBSTRATE-1; COLONY-LEVEL SELECTION; BEE APIS-MELLIFERA; DIVISION-OF-LABOR; JUVENILE-HORMONE; BEHAVIORAL-DEVELOPMENT; GLUCOSE-HOMEOSTASIS; VITELLOGENIN; METABOLISM	Honeybee workers are essentially sterile female helpers that make up the majority of individuals in a colony. Workers display a marked change in physiology when they transition from in-nest tasks to foraging. Recent technological advances have made it possible to unravel the metabolic modifications associated with this transition. Previous studies have revealed extensive remodeling of brain, thorax, and hypopharyngeal gland biochemistry. However, data on changes in the abdomen is scarce. To narrow this gap we investigated the proteomic composition of abdominal tissue in the days typically preceding the onset of foraging in honeybee workers. In order to get a broader representation of possible protein dynamics, we used workers of two genotypes with differences in the age at which they initiate foraging. This approach was combined with RNA interference-mediated downregulation of an insulin/insulin-like signaling component that is central to foraging behavior, the insulin receptor substrate (irs), and with measurements of glucose and lipid levels. Our data provide new insight into the molecular underpinnings of phenotypic plasticity in the honeybee, invoke parallels with vertebrate metabolism, and support an integrated and irs-dependent association of carbohydrate and lipid metabolism with the transition from in-nest tasks to foraging.	[Chan, Queenie W. T.; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Chan, Queenie W. T.; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Mutti, Navdeep S.; Amdam, Gro V.; Wolschin, Florian] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Kocher, Sarah D.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Amdam, Gro V.; Wolschin, Florian] Norwegian Univ Life Sci, Dept Biotechnol Chem & Food Sci, As, Norway	University of British Columbia; University of British Columbia; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Norwegian University of Life Sciences	Chan, QWT (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada.	f.wolschin@gmail.com			Alexander-von-Humboldt foundation; Research Council of Norway [180504, 185306, 191699]; National Institute on Aging [P01 AG22500]; Pew Charitable Trust; Natural Sciences and Engineering Research Council (NSERC) of Canada [F09-05648]; Michael Smith Foundation (MSF); Canada Foundation for Innovation; British Columbia Knowledge Development Fund; British Columbia Proteomics Network via the MSF; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	Alexander-von-Humboldt foundation(Alexander von Humboldt Foundation); Research Council of Norway(Research Council of Norway); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pew Charitable Trust; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation (MSF)(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; British Columbia Proteomics Network via the MSF; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	FW was supported by a Feodor-Lynen stipend of the Alexander-von-Humboldt foundation (http://www.humboldt-foundation.de/). GVA was supported by the Research Council of Norway (http://www.forskningsradet.no/) #180504 (to FW), 185306, and 191699, the National Institute on Aging (http://www.nia.nih.gov/), NIA P01 AG22500 (to NM), and the Pew Charitable Trust (http://www.pewtrusts.org/). QWTC has been supported by a PGS-D award from the Natural Sciences and Engineering Research Council (NSERC) of Canada and a Michael Smith Foundation (MSF) Graduate Fellowship. LJF is the Canada Research Chair in Quantitative Proteomics (http://www.chairs-chaires.gc.ca/) and a MSF Scholar (http://www.msfhr.org/). Mass spectrometry infrastructure used in this work is supported by the Canada Foundation for Innovation (http://innovation.ca/en), the British Columbia Knowledge Development Fund and the British Columbia Proteomics Network (http://www.bcproteomicsnetwork.ca/) via the MSF. This work was supported in part by an NSERC (http://www.nserc.gc.ca/index.htm) Discovery Grant #F09-05648 to LJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1998, J CLIN INVEST, V101, P1784, DOI 10.1172/JCI1594; Amdam GV, 2007, AM NAT, V170, P37, DOI 10.1086/518183; Amdam GV, 2005, INSECT SOC, V52, P316, DOI 10.1007/s00040-005-0812-2; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2010, EVOLUTION D IN PRESS; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Ayroles JF, 2006, METHOD ENZYMOL, V411, P214, DOI 10.1016/S0076-6879(06)11011-3; BALLARD FJ, 1967, J LIPID RES, V8, P73; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; Bitondi MMG, 2006, ARCH INSECT BIOCHEM, V63, P57, DOI 10.1002/arch.20142; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Craparo A, 1997, J BIOL CHEM, V272, P11663; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; DEKORT CAD, 1981, ANNU REV ENTOMOL, V26, P1, DOI 10.1146/annurev.en.26.010181.000245; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Elekonich MM, 2005, COMP BIOCHEM PHYS A, V141, P362, DOI 10.1016/j.cbpb.2005.04.014; ENGELMANN F, 1978, INSECT BIOCHEM, V8, P149, DOI 10.1016/0020-1790(78)90066-5; Fahrbach SE, 1996, DEV NEUROSCI-BASEL, V18, P102, DOI 10.1159/000111474; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; FOERSTER EC, 1981, BIOCHEM J, V196, P705, DOI 10.1042/bj1960705; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; HOELLDOBLER B, 1990, ANTS; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; HUANG ZY, 1989, INSECT SOC, V36, P264, DOI 10.1007/BF02224880; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; KETTERER B, 1989, MUTAT RES, V214, P33, DOI 10.1016/0027-5107(89)90195-4; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kubota M, 2004, BIOSCI BIOTECH BIOCH, V68, P2346, DOI 10.1271/bbb.68.2346; LAW JH, 1989, J BIOL CHEM, V264, P16335; Liu SCH, 1999, J BIOL CHEM, V274, P18093, DOI 10.1074/jbc.274.25.18093; Liu Y, 2009, ARCH INSECT BIOCHEM, V71, P16, DOI 10.1002/arch.20290; Mackert A, 2010, J INSECT PHYSIOL, V56, P1139, DOI 10.1016/j.jinsphys.2010.03.007; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Memon RA, 1995, BIOCHEM MOL BIOL INT, V37, P1079; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; Piper M. D. W., 2005, DRUG DISCOV TODAY DI, V2, P249; POLICANSKY D, 1982, ANNU REV ECOL SYST, V13, P471, DOI 10.1146/annurev.es.13.110182.002351; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Roberts SP, 2005, J EXP BIOL, V208, P4193, DOI 10.1242/jeb.01862; Schulz DJ, 2004, ANN ENTOMOL SOC AM, V97, P1313, DOI 10.1603/0013-8746(2004)097[1313:COJHHA]2.0.CO;2; Seed, 2001, PARASITISM DIVERSITY; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Souza JA, 2007, COMP BIOCHEM PHYS A, V147, P993, DOI 10.1016/j.cbpa.2007.03.008; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stow J L, 1995, Curr Opin Nephrol Hypertens, V4, P421, DOI 10.1097/00041552-199509000-00009; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Tchorzewski M, 2002, INT J BIOCHEM CELL B, V34, P911, DOI 10.1016/S1357-2725(02)00012-2; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Ueno T, 2009, ZOOL SCI, V26, P557, DOI 10.2108/zsj.26.557; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vargas L, 1998, HORM METAB RES, V30, P113, DOI 10.1055/s-2007-978847; Veech RL, 2003, P NATL ACAD SCI USA, V100, P5578, DOI 10.1073/pnas.1132039100; Wang Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000896; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winston M.L., 1991, BIOL HONEY BEE; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wolschin F, 2009, J EXP BIOL, V212, P4027, DOI 10.1242/jeb.033845; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5; Wolschin F, 2011, BIOL LETTERS, V7, P112, DOI 10.1098/rsbl.2010.0463; Woodcroft KJ, 2002, HEPATOLOGY, V35, P263, DOI 10.1053/jhep.2002.30691; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103; Zhang SC, 2008, ANAL BIOCHEM, V383, P76, DOI 10.1016/j.ab.2008.07.041	87	33	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24794	10.1371/journal.pone.0024794	http://dx.doi.org/10.1371/journal.pone.0024794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969861	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900012
J	Wang, HL; Zhang, GQ; Wen, YJ; Yang, ST; Xia, XZ; Fu, ZF				Wang, Hualei; Zhang, Guoqing; Wen, Yongjun; Yang, Songtao; Xia, Xianzhu; Fu, Zhen F.			Intracerebral Administration of Recombinant Rabies Virus Expressing GM-CSF Prevents the Development of Rabies after Infection with Street Virus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; POSTEXPOSURE PROPHYLAXIS; ATTENUATED RABIES; UNITED-STATES; B-CELLS; PERMEABILITY; ANIMALS; VACCINE; INTERFERON	Recently it was found that prior immunization with recombinant rabies virus (RABV) expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) (LBNSE-GM-CSF) resulted in high innate/adaptive immune responses and protection against challenge with virulent RABV (Wen et al., JVI, 2011). In this study, the ability of LBNSE-GM-CSF to prevent animals from developing rabies was investigated in mice after infection with lethal doses of street RABV. It was found that intracerebral administration of LBNSE-GM-CSF protected more mice from developing rabies than sham-treated mice as late as day 5 after infection with street RABV. Intracerebral administration of LBNSE-GM-CSF resulted in significantly higher levels of chemokine/cytokine expression and more infiltration of inflammatory and immune cells into the central nervous system (CNS) than sham-administration or administration with UV-inactivated LBNSE-GM-CSF. Enhancement of blood-brain barrier (BBB) permeability and increases in virus neutralizing antibodies (VNA) were also observed in mice treated with LBNSE-GM-CSF. On the other hand, intracerebral administration with UV-inactivated LBNSE-GM-CSF did not increase protection despite the fact that VNA were induced in the periphery. However, intracerebral administration with chemoattractant protein-1 (MCP-1, also termed CCL2) increased significantly the protective efficacy of UV-inactivated LBNSE-GM-CSF. Together these studies confirm that direct administration of LBNSE-GM-CSF can enhance the innate and adaptive immunity as well as the BBB permeability, thus allowing infiltration of inflammatory cells and other immune effectors enter into the CNS to clear the virus and prevent the development of rabies.	[Wang, Hualei; Zhang, Guoqing; Wen, Yongjun; Fu, Zhen F.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA; [Wang, Hualei; Yang, Songtao; Xia, Xianzhu] Chinese Acad Mil Med Sci, Inst Vet Med, Changchun, Jilin, Peoples R China; [Wang, Hualei] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China; [Fu, Zhen F.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Fu, Zhen F.] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China	University System of Georgia; University of Georgia; Jilin University; University System of Georgia; University of Georgia; Huazhong Agricultural University	Wang, HL (corresponding author), Univ Georgia, Dept Pathol, Athens, GA 30602 USA.	zhenfu@uga.edu	Wang, Hualei/S-7920-2018; zhang, guoqing/GXG-4800-2022	Wang, Hualei/0000-0001-8008-3878; 	National Institute of Allergy and Infectious Disease [AI-051560]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051560] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported partially by Public Health Service grant AI-051560 from the National Institute of Allergy and Infectious Disease. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MMWR; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Blanton JD, 2010, JAVMA-J AM VET MED A, V237, P646, DOI 10.2460/javma.237.6.646; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; Dietzschold B, 2000, J HUMAN VIROL, V3, P50; Dietzschold B, 1998, VACCINE, V16, P1656, DOI 10.1016/S0264-410X(98)00064-4; Faber M, 2009, P NATL ACAD SCI USA, V106, P11300, DOI 10.1073/pnas.0905640106; Fu ZF, 1997, VACCINE, V15, pS20, DOI 10.1016/S0264-410X(96)00312-X; Hanlon CA, 1998, J WILDLIFE DIS, V34, P228, DOI 10.7589/0090-3558-34.2.228; HATTWICK MA, 1972, J AMER MED ASSOC, V222, P44, DOI 10.1001/jama.222.1.44; HEMACHUDHA T, 1988, AM J MED, V84, P673, DOI 10.1016/0002-9343(88)90103-9; Hooper DC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000535; Hosking MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000937; Johnson N, 2006, J GEN VIROL, V87, P2663, DOI 10.1099/vir.0.82024-0; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kuang Y, 2009, VIRUS RES, V144, P18, DOI 10.1016/j.virusres.2009.03.014; Lackay SN, 2008, VET CLIN N AM-SMALL, V38, P851, DOI 10.1016/j.cvsm.2008.03.003; Li XQ, 2005, J VIROL, V79, P10063, DOI 10.1128/JVI.79.15.10063-10068.2005; Merrill JE, 1997, BRAIN BEHAV IMMUN, V11, P245, DOI 10.1006/brbi.1997.0496; Meslin F X, 1994, Curr Top Microbiol Immunol, V187, P1; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nigg AJ, 2009, PHARMACOTHERAPY, V29, P1182, DOI 10.1592/phco.29.10.1182; Phares TW, 2007, J IMMUNOL, V178, P7334, DOI 10.4049/jimmunol.178.11.7334; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roy A, 2007, J VIROL, V81, P7993, DOI 10.1128/JVI.00710-07; Roy A, 2007, J VIROL, V81, P1110, DOI 10.1128/JVI.01964-06; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Rupprecht CE, 1997, J NEUROVIROL, V3, pS52; Sampath G, 2005, VACCINE, V23, P1102, DOI 10.1016/j.vaccine.2004.08.036; Sarmento L, 2005, J NEUROVIROL, V11, P571, DOI 10.1080/13550280500385310; SCHUMACHER CL, 1993, ONDERSTEPOORT J VET, V60, P459; Smith J. S., 1996, P181; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Sudarshan M. K., 1999, Journal of Communicable Diseases, V31, P229; Wang ZW, 2005, J VIROL, V79, P12554, DOI 10.1128/JVI.79.19.12554-12565.2005; Wen YJ, 2011, J VIROL, V85, P1634, DOI 10.1128/JVI.01552-10; *WHO, 2010, FACT SHEET 99; Wu XF, 2011, VACCINE, V29, P4195, DOI 10.1016/j.vaccine.2011.03.104; Zhao L, 2010, J VIROL, V84, P9642, DOI 10.1128/JVI.00326-10; Zhao L, 2009, J VIROL, V83, P11808, DOI 10.1128/JVI.01346-09	43	59	64	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25414	10.1371/journal.pone.0025414	http://dx.doi.org/10.1371/journal.pone.0025414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980450	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900062
J	Zhu, WL; Yang, L; Du, ZM				Zhu, Wenliang; Yang, Lei; Du, Zhimin			MicroRNA Regulation and Tissue-Specific Protein Interaction Network	PLOS ONE			English	Article							EXPRESSION; RESOURCE; TARGET	Background: 'Fine-tuning' of protein abundance makes microRNAs (miRNAs) pervasively implicated in human biology. Although targeting many mRNAs endows the power of single miRNA to regulate complex biological processes, its functional roles in a particular tissue will be inevitably restricted because only a subset of its target genes is expressed. Methods: Here, we analyze the characteristics of miRNA regulation upon target genes according to tissue-specific gene expression by constructing tissue-specific protein interaction networks for ten main types of tissues in the human body. Results: Commonly expressed proteins are under more intensive but lower-cost miRNAs control than proteins with the tissue-specific expression. MiRNAs that target more commonly expressed genes usually regulate more tissue-specific genes. This is consistent with the previous finding that tissue-specific proteins tend to be functionally connected with commonly expressed proteins. But to a particular miRNA such a balance is not invariable among different tissues implying diverse tissue regulation modes executed by miRNAs. Conclusion: These results suggest miRNAs that interact with more commonly expressed genes can be expected to play important tissue-specific roles.	[Zhu, Wenliang; Du, Zhimin] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China; [Yang, Lei] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Du, ZM (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China.	dzm1956@126.com						Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun LL, 2011, DIABETES RES CLIN PR, V91, P94, DOI 10.1016/j.diabres.2010.11.006; Yang BF, 2008, CARDIOVASC RES, V79, P571, DOI 10.1093/cvr/cvn181; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032	26	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25394	10.1371/journal.pone.0025394	http://dx.doi.org/10.1371/journal.pone.0025394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980443	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700031
J	Azimi, M; Jamali, Y; Mofrad, MRK				Azimi, Mohammad; Jamali, Yousef; Mofrad, Mohammad R. K.			Accounting for Diffusion in Agent Based Models of Reaction-Diffusion Systems with Application to Cytoskeletal Diffusion	PLOS ONE			English	Article							ACTIN-FILAMENTS; ORGANIZATION; LAMELLIPODIUM; SIMULATION; MOTILITY; BIOLOGY; SPACE	Diffusion plays a key role in many biochemical reaction systems seen in nature. Scenarios where diffusion behavior is critical can be seen in the cell and subcellular compartments where molecular crowding limits the interaction between particles. We investigate the application of a computational method for modeling the diffusion of molecules and macromolecules in three-dimensional solutions using agent based modeling. This method allows for realistic modeling of a system of particles with different properties such as size, diffusion coefficients, and affinity as well as the environment properties such as viscosity and geometry. Simulations using these movement probabilities yield behavior that mimics natural diffusion. Using this modeling framework, we simulate the effects of molecular crowding on effective diffusion and have validated the results of our model using Langevin dynamics simulations and note that they are in good agreement with previous experimental data. Furthermore, we investigate an extension of this framework where single discrete cells can contain multiple particles of varying size in an effort to highlight errors that can arise from discretization that lead to the unnatural behavior of particles undergoing diffusion. Subsequently, we explore various algorithms that differ in how they handle the movement of multiple particles per cell and suggest an algorithm that properly accommodates multiple particles of various sizes per cell that can replicate the natural behavior of these particles diffusing. Finally, we use the present modeling framework to investigate the effect of structural geometry on the directionality of diffusion in the cell cytoskeleton with the observation that parallel orientation in the structural geometry of actin filaments of filopodia and the branched structure of lamellipodia can give directionality to diffusion at the filopodia-lamellipodia interface.	[Azimi, Mohammad; Jamali, Yousef; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Azimi, M (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019; Jamali, Yousef/V-5156-2019	/0000-0001-7004-4859; Jamali, Yousef/0000-0002-5709-3821				Atilgan E, 2005, BIOPHYS J, V89, P3589, DOI 10.1529/biophysj.105.065383; Berry BJL, 2002, P NATL ACAD SCI USA, V99, P7187, DOI 10.1073/pnas.092078899; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonchev D, 2010, SAR QSAR ENVIRON RES, V21, P77, DOI 10.1080/10629360903568580; Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072; Devillers J, 2010, SAR QSAR ENVIRON RES, V21, P337, DOI 10.1080/10629361003773963; Dobrzynski M, 2007, BIOINFORMATICS, V23, P1969, DOI 10.1093/bioinformatics/btm278; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; FICK A, 1995, J MEMBRANE SCI, V100, P33, DOI 10.1016/0376-7388(94)00230-V; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; HAN JN, 1993, BIOPHYS J, V65, P1155, DOI 10.1016/S0006-3495(93)81145-7; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Ihle T, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.020201; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Miller J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009454; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridgway D, 2006, CURR OPIN BIOTECH, V17, P493, DOI 10.1016/j.copbio.2006.08.004; Rivas German, 2004, EMBO Reports, V5, P23, DOI 10.1038/sj.embor.7400056; Schafer DA, 2004, NATURE, V430, P734, DOI 10.1038/430734a; Schaub S, 2007, J CELL SCI, V120, P1491, DOI 10.1242/jcs.03379; Scheutz M, 2006, J PARALLEL DISTR COM, V66, P1037, DOI 10.1016/j.jpdc.2005.09.004; Small JV, 2008, J MICROSC-OXFORD, V231, P479, DOI 10.1111/j.1365-2818.2008.02060.x; Strating P, 1999, PHYS REV E, V59, P2175, DOI 10.1103/PhysRevE.59.2175; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Tesfatsion L, 2006, HANDB ECON, V13, P831; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	35	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25306	10.1371/journal.pone.0025306	http://dx.doi.org/10.1371/journal.pone.0025306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966493	gold, Green Published, Green Submitted			2022-12-27	WOS:000295267100044
J	Kelly, S; Wickstead, B; Maini, PK; Gull, K				Kelly, Steven; Wickstead, Bill; Maini, Philip K.; Gull, Keith			Ab Initio Identification of Novel Regulatory Elements in the Genome of Trypanosoma brucei by Bayesian Inference on Sequence Segmentation	PLOS ONE			English	Article							3 UNTRANSLATED REGION; PROTEIN-CODING GENES; FACTOR-BINDING SITES; SPLICED LEADER RNA; PRE-MESSENGER-RNA; LEISHMANIA-MAJOR; DISCONTINUOUS TRANSCRIPTION; ANTIGENIC VARIATION; RIBOSOMAL-RNA; POLYMERASE-I	Background: The rapid increase in the availability of genome information has created considerable demand for both comparative and ab initio predictive bioinformatic analyses. The biology laid bare in the genomes of many organisms is often novel, presenting new challenges for bioinformatic interrogation. A paradigm for this is the collected genomes of the kinetoplastid parasites, a group which includes Trypanosoma brucei the causative agent of human African trypanosomiasis. These genomes, though outwardly simple in organisation and gene content, have historically challenged many theories for gene expression regulation in eukaryotes. Methodology/Principle Findings: Here we utilise a Bayesian approach to identify local changes in nucleotide composition in the genome of T. brucei. We show that there are several elements which are found at the starts and ends of multicopy gene arrays and that there are compositional elements that are common to all intergenic regions. We also show that there is a composition-inversion element that occurs at the position of the trans-splice site. Conclusions/Significance: The nature of the elements discovered reinforces the hypothesis that context dependant RNA secondary structure has an important influence on gene expression regulation in Trypanosoma brucei.	[Kelly, Steven] Univ Oxford, Dept Plant Sci, Oxford, England; [Kelly, Steven; Maini, Philip K.] Univ Oxford, Inst Math, Ctr Math Biol, Oxford OX1 3LB, England; [Kelly, Steven; Maini, Philip K.; Gull, Keith] Univ Oxford, Dept Biochem, Oxford Ctr Interact Syst Biol, Oxford OX1 3QU, England; [Wickstead, Bill; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Wickstead, Bill] Univ Nottingham, Ctr Genet & Genom, Queens Med Ctr, Nottingham NG7 2RD, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Nottingham	Kelly, S (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	steven.kelly@plants.ox.ac.uk	Kelly, Steven/F-7237-2011	Kelly, Steven/0000-0001-8583-5362; Wickstead, Bill/0000-0002-4620-9091	Biotechnology and Biological Sciences Research Council; Wellcome Trust; Royal Society	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), the Wellcome Trust (http://www.wellcome.ac.uk/) and the Royal Society (http://royalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Benz C, 2005, MOL BIOCHEM PARASIT, V143, P125, DOI 10.1016/j.molbiopara.2005.05.008; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BOOTHROYD JC, 1985, ANNU REV MICROBIOL, V39, P475, DOI 10.1146/annurev.mi.39.100185.002355; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; Boys RJ, 2004, BIOMETRICS, V60, P585; Boys RJ, 2004, BIOMETRICS, V60, P573, DOI 10.1111/j.0006-341X.2004.00206.x; BROWN SD, 1992, MOL CELL BIOL, V12, P2644, DOI 10.1128/MCB.12.6.2644; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Cora D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-57; DEFLORIN J, 1994, J BIOL CHEM, V269, P28745; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; Gopal S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r95; Gupta M, 2005, P NATL ACAD SCI USA, V102, P7079, DOI 10.1073/pnas.0408743102; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hoare CA, 1929, T ROY SOC TROP MED H, V23, P18; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; HUG M, 1994, MOL CELL BIOL, V14, P7428, DOI 10.1128/MCB.14.11.7428; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JANZ L, 1994, MOL CELL BIOL, V14, P5804, DOI 10.1128/MCB.14.9.5804; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lee MGS, 1997, ANNU REV MICROBIOL, V51, P463, DOI 10.1146/annurev.micro.51.1.463; Liu JS, 1999, BIOINFORMATICS, V15, P38, DOI 10.1093/bioinformatics/15.1.38; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; McDonagh PD, 2000, NUCLEIC ACIDS RES, V28, P2800, DOI 10.1093/nar/28.14.2800; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Pham VP, 1996, MOL BIOCHEM PARASIT, V75, P241, DOI 10.1016/0166-6851(95)02513-8; RUDENKO G, 1989, EMBO J, V8, P4259, DOI 10.1002/j.1460-2075.1989.tb08611.x; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schurch N, 1997, MOL BIOCHEM PARASIT, V89, P109, DOI 10.1016/S0166-6851(97)00107-2; SHERMAN DR, 1991, EMBO J, V10, P3379, DOI 10.1002/j.1460-2075.1991.tb04902.x; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Siegel TN, 2004, MOL BIOCHEM PARASIT, V172, P141; Siegel TN, 2010, NUCL ACIDS RES; Simpson AGB, 2004, PROTIST, V155, P407, DOI 10.1078/1434461042650389; Sturm NR, 1999, MOL CELL BIOL, V19, P1595; Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; VANDERPLOEG LHT, 1986, CELL, V47, P479, DOI 10.1016/0092-8674(86)90608-2; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; VANHAMME L, 1995, MOL CELL BIOL, V15, P5598; Walrad P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000317; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25666	10.1371/journal.pone.0025666	http://dx.doi.org/10.1371/journal.pone.0025666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991330	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000054
J	Lewis, DJ; Fraser, CA; Mahmoud, AN; Wiggins, RC; Woodrow, M; Cope, A; Cai, C; Giemza, R; Jeffs, SA; Manoussaka, M; Cole, T; Cranage, MP; Shattock, RJ; Lacey, CJ				Lewis, David J.; Fraser, Carol A.; Mahmoud, Abdel N.; Wiggins, Rebecca C.; Woodrow, Maria; Cope, Alethea; Cai, Chun; Giemza, Rafaela; Jeffs, Simon A.; Manoussaka, Maria; Cole, Tom; Cranage, Martin P.; Shattock, Robin J.; Lacey, Charles J.			Phase I Randomised Clinical Trial of an HIV-1(CN54), Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally	PLOS ONE			English	Article							GENITAL-TRACT; IMMUNODEFICIENCY-VIRUS; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; MUCOSAL; TRANSMISSION; IMMUNIZATION; INFECTION; IGA; SECRETIONS	We conducted a phase 1 double-blind randomised controlled trial (RCT) of a HIV-1 envelope protein (CN54 gp140) candidate vaccine delivered vaginally to assess immunogenicity and safety. It was hypothesised that repeated delivery of gp140 may facilitate antigen uptake and presentation at this mucosal surface. Twenty two healthy female volunteers aged 18-45 years were entered into the trial, the first receiving open-label active product. Subsequently, 16 women were randomised to receive 9 doses of 100 mu g of gp140 in 3 ml of a Carbopol 974P based gel, 5 were randomised to placebo solution in the same gel, delivered vaginally via an applicator. Participants delivered the vaccine three times a week over three weeks during one menstrual cycle, and were followed up for two further months. There were no serious adverse events, and the vaccine was well tolerated. No sustained systemic or local IgG, IgA, or T cell responses to the gp140 were detected following vaginal immunisations. Repeated vaginal immunisation with a HIV-1 envelope protein alone formulated in Carbopol gel was safe, but did not induce local or systemic immune responses in healthy women.	[Lewis, David J.; Fraser, Carol A.; Mahmoud, Abdel N.; Woodrow, Maria; Cope, Alethea; Giemza, Rafaela; Manoussaka, Maria; Cole, Tom; Cranage, Martin P.; Shattock, Robin J.] Univ London, Ctr Infect & Immun, Div Clin Sci, London WC1E 7HU, England; [Wiggins, Rebecca C.; Cai, Chun; Lacey, Charles J.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Wiggins, Rebecca C.; Cai, Chun; Lacey, Charles J.] Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Jeffs, Simon A.] Univ London Imperial Coll Sci Technol & Med, Jefferiss Trust Res Labs, London, England	University of London; University of Hull; University of York - UK; University of York - UK; Imperial College London	Lewis, DJ (corresponding author), Univ London, Ctr Infect & Immun, Div Clin Sci, London WC1E 7HU, England.	charles.lacey@hyms.ac.uk		Lewis, David JM/0000-0003-3105-9075	Bill and Melinda Gates Foundation; Wellcome Trust under Grand Challenges in Global Health initiative; International AIDS Vaccine Initiative; Sir Joseph Hotung Trust (United Kingdom) [1082710]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust under Grand Challenges in Global Health initiative(Wellcome Trust); International AIDS Vaccine Initiative; Sir Joseph Hotung Trust (United Kingdom)	This trial was part of a research programme funded by a grant to St George's University of London by the Bill and Melinda Gates Foundation www.grandchallenges.org/ and the Wellcome Trust www.wellcome.ac.uk/ under the Grand Challenges in Global Health initiative. Studies on cervical T cell assay development were supported by the International AIDS Vaccine Initiative www.iavi.org/. MPC is supported by the Sir Joseph Hotung Trust (United Kingdom Registered Charity Number: 1082710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBERINI F, 1991, ARCH HISTOL CYTOL, V54, P365, DOI 10.1679/aohc.54.365; Bere A, 2010, IMMUNOLOGY, V130, P23, DOI 10.1111/j.1365-2567.2009.03172.x; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110; Cranage MP, 2011, VACCINE, V29, P1421, DOI 10.1016/j.vaccine.2010.12.034; Curran RM, 2009, VACCINE, V27, P6791, DOI 10.1016/j.vaccine.2009.08.088; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Johansson EL, 2001, INFECT IMMUN, V69, P7481, DOI 10.1128/IAI.69.12.7481-7486.2001; Kaul R, 2003, AIDS, V17, P1139, DOI 10.1097/00002030-200305230-00004; Klavinskis LS, 1996, J IMMUNOL, V157, P2521; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Krashias G, 2010, VACCINE, V28, P2482, DOI 10.1016/j.vaccine.2010.01.046; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Mestecky J, 2011, AIDS RES HUM RETROV, V27, P469, DOI 10.1089/aid.2010.0169; Mestecky J, 2009, J REPROD IMMUNOL, V83, P196, DOI 10.1016/j.jri.2009.07.005; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; OGRA PL, 1973, J IMMUNOL, V110, P1307; Pialoux G, 2008, VACCINE, V26, P2657, DOI 10.1016/j.vaccine.2007.11.002; Raux M, 1999, AIDS RES HUM RETROV, V15, P1365, DOI 10.1089/088922299310070; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Safaeian M, 2009, CANCER EPIDEM BIOMAR, V18, P2672, DOI 10.1158/1055-9965.EPI-09-0348; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wassen L, 1996, SCAND J IMMUNOL, V44, P408, DOI 10.1046/j.1365-3083.1996.d01-320.x	27	46	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25165	10.1371/journal.pone.0025165	http://dx.doi.org/10.1371/journal.pone.0025165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984924	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000295941300020
J	van Damme, P; Kafeja, F; Anemona, A; Basile, V; Hilbert, AK; De Coster, I; Rondini, S; Micoli, F; Khan, RMQ; Marchetti, E; Di Cioccio, V; Saul, A; Martin, LB; Podda, A				van Damme, Pierre; Kafeja, Froukje; Anemona, Alessandra; Basile, Venere; Hilbert, Anne Katrin; De Coster, Ilse; Rondini, Simona; Micoli, Francesca; Khan, Rana M. Qasim; Marchetti, Elisa; Di Cioccio, Vito; Saul, Allan; Martin, Laura B.; Podda, Audino			Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults	PLOS ONE			English	Article							VI CAPSULAR POLYSACCHARIDE; SALMONELLA-TYPHI; CHILDREN; INDIA; BANGLADESH; EFFICACY; BURDEN	Background: Typhoid fever causes more than 21 million cases of disease and 200,000 deaths yearly worldwide, with more than 90% of the disease burden being reported from Asia. Epidemiological data show high disease incidence in young children and suggest that immunization programs should target children below two years of age: this is not possible with available vaccines. The Novartis Vaccines Institute for Global Health developed a conjugate vaccine (Vi-CRM197) for infant vaccination concomitantly with EPI vaccines, either starting at 6 weeks with DTP or at 9 months with measles vaccine. We report the results from a Phase 1 and a Phase 2 dose ranging trial with Vi-CRM197 in European adults. Methodology: Following randomized blinded comparison of single vaccination with either Vi-CRM197 or licensed polysaccharide vaccines (both containing 25.0 mu g of Vi antigen), a randomised observer blinded dose ranging trial was performed in the same center to compare three concentrations of Vi-CRM197 (1.25 mu g, 5.0 mu g and 12.5 mu g of Vi antigen) with the polysaccharide vaccine. Principal Findings: All vaccines were well tolerated. Compared to the polysaccharide vaccine, Vi-CRM197 induced a higher incidence of mild to moderate short lasting local pain. All Vi-CRM197 formulations induced higher Vi antibody levels compared to licensed control, with clear dose response relationship. Conclusions: Vi-CRM197 did not elicit safety concerns, was highly immunogenic and is therefore suitable for further clinical testing in endemic populations of South Asia.	[van Damme, Pierre; Kafeja, Froukje; De Coster, Ilse] Univ Antwerp, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Anemona, Alessandra; Basile, Venere; Rondini, Simona; Micoli, Francesca; Khan, Rana M. Qasim; Marchetti, Elisa; Di Cioccio, Vito; Saul, Allan; Martin, Laura B.; Podda, Audino] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Hilbert, Anne Katrin] Novartis Vaccines & Diagnost, Clin Serol Labs, Marburg, Germany	University of Antwerp; Novartis; Novartis	van Damme, P (corresponding author), Univ Antwerp, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium.	audino.podda@novartis.com	Di Cioccio, Vito/N-1296-2013; Saul, Allan J/I-6968-2013; Martin, Laura/N-1789-2013; Saul, Allan/ABH-2091-2020; van damme, pierre/I-4846-2013; Rondini, Simona/N-1780-2013	Di Cioccio, Vito/0000-0002-8063-9650; Saul, Allan J/0000-0003-0665-4091; Martin, Laura/0000-0002-4431-4381; Saul, Allan/0000-0003-0665-4091; Rondini, Simona/0000-0002-7993-9656; van damme, pierre/0000-0002-8642-1249	Regione Toscana; Fondazione Monte Dei Paschi di Siena; Center for the Evaluation of Vaccination - Vaccine & Infectious Disease Institute in Antwerp	Regione Toscana(Regione Toscana); Fondazione Monte Dei Paschi di Siena; Center for the Evaluation of Vaccination - Vaccine & Infectious Disease Institute in Antwerp	This work was conducted in collaboration with Sclavo Vaccines Association with grants from Regione Toscana and Fondazione Monte Dei Paschi di Siena which partially funded the trials. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; We thank all study participants for their time and support. We thank all NVGH staff who contributed with their work to make the clinical trials possible, the entire staff at the Center for the Evaluation of Vaccination -Vaccine & Infectious Disease Institute in Antwerp for their support and dedication, the staff at GenIbet Biopharmaceuticals (Portugal), Areta International (Italy) and B&C Group (Belgium) for the preparation, release and shipment of the clinical lot.	ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; Bhutta ZA, 2011, ADV EXP MED BIOL, V697, P17, DOI 10.1007/978-1-4419-7185-2_3; Brooks WA, 2005, EMERG INFECT DIS, V11, P326, DOI 10.3201/eid1102.040422; Canh DG, 2004, INFECT IMMUN, V72, P6586, DOI 10.1128/IAI.72.11.6586-6588.2004; Cooper B, 2011, EXPERT REV VACCINES, V10, P21, DOI 10.1586/ERV.10.147; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Ghosh S, 2010, JPN J INFECT DIS, V63, P219; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; Micoli F, 2011, VACCINE, V29, P712, DOI 10.1016/j.vaccine.2010.11.022; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Overbosch D, 2005, J TRAVEL MED, V12, P319, DOI 10.2310/7060.2005.12604; Podda A, 2010, PROCEDIA VACCINOL, V2, P124, DOI 10.1016/j.provac.2010.07.003; Podda A, 2010, J INFECT DEV COUNTR, V4, P404, DOI 10.3855/jidc.1048; Rondini S, 2011, CLIN VACCINE IMMUNOL, V18, P460, DOI 10.1128/CVI.00387-10; Saha SK, 2001, PEDIATR INFECT DIS J, V20, P521, DOI 10.1097/00006454-200105000-00010; Siddiqui FJ, 2006, INT J INFECT DIS, V10, P215, DOI 10.1016/j.ijid.2005.03.010; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Thiem VD, 2011, CLIN VACCINE IMMUNOL, V18, P730, DOI 10.1128/CVI.00532-10	21	50	50	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25398	10.1371/journal.pone.0025398	http://dx.doi.org/10.1371/journal.pone.0025398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980445	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300028
J	Dong, YL; Li, JL; Zhang, FX; Li, YQ				Dong, Yulin; Li, Jinlian; Zhang, Fuxing; Li, Yunqing			Nociceptive Afferents to the Premotor Neurons That Send Axons Simultaneously to the Facial and Hypoglossal Motoneurons by Means of Axon Collaterals	PLOS ONE			English	Article							BRAIN-STEM PROJECTIONS; MEDULLARY DORSAL-HORN; ORAL MOTOR NUCLEI; SUBSTANCE-P; RETICULAR-FORMATION; TRIGEMINAL MOTOR; TONGUE MOVEMENT; REFLEX; RAT; STIMULATION	It is well known that the brainstem premotor neurons of the facial nucleus and hypoglossal nucleus coordinate orofacial nociceptive reflex (ONR) responses. However, whether the brainstem PNs receive the nociceptive projection directly from the caudal spinal trigeminal nucleus is still kept unclear. Our present study focuses on the distribution of premotor neurons in the ONR pathways of rats and the collateral projection of the premotor neurons which are involved in the brainstem local pathways of the orofacial nociceptive reflexes of rat. Retrograde tracer Fluoro-gold (FG) or FG/tetramethylrhodamine-dextran amine (TMR-DA) were injected into the VII or/and XII, and anterograde tracer biotinylated dextran amine (BDA) was injected into the caudal spinal trigeminal nucleus (Vc). The tracing studies indicated that FG-labeled neurons receiving BDA-labeled fibers from the Vc were mainly distributed bilaterally in the parvicellular reticular formation (PCRt), dorsal and ventral medullary reticular formation (MdD, MdV), supratrigeminal nucleus (Vsup) and parabrachial nucleus (PBN) with an ipsilateral dominance. Some FG/TMR-DA double-labeled premotor neurons, which were observed bilaterally in the PCRt, MdD, dorsal part of the MdV, peri-motor nucleus regions, contacted with BDA-labeled axonal terminals and expressed c-fos protein-like immunoreactivity which induced by subcutaneous injection of formalin into the lip. After retrograde tracer wheat germ agglutinated horseradish peroxidase (WGA-HRP) was injected into VII or XII and BDA into Vc, electron microscopic study revealed that some BDA-labeled axonal terminals made mainly asymmetric synapses on the dendritic and somatic profiles of WGA-HRP-labeled premotor neurons. These data indicate that some premotor neurons could integrate the orofacial nociceptive input from the Vc and transfer these signals simultaneously to different brainstem motonuclei by axonal collaterals.	[Dong, Yulin] Fourth Mil Med Univ, Dept Anat & Histol & Embryol, Xian 710032, Peoples R China; Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Dong, YL (corresponding author), Fourth Mil Med Univ, Dept Anat & Histol & Embryol, Xian 710032, Peoples R China.	jinlian@fmmu.edu.cn; deptanat@fmmu.edu.cn			Nature Science Foundation of China [31010103909, 81070900, 81171050]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Grants-in-Aid from the Nature Science Foundation of China (Grant Nos: 31010103909, 81070900, 81171050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDES LD, 1990, J COMP NEUROL, V302, P643, DOI 10.1002/cne.903020318; ANDERSEN OK, 1995, ACTA PHYSIOL SCAND, V155, P87, DOI 10.1111/j.1748-1716.1995.tb09951.x; Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; BORKE RC, 1983, BRAIN RES, V269, P47, DOI 10.1016/0006-8993(83)90961-7; CLARKE RW, 1985, BRAIN RES, V332, P231, DOI 10.1016/0006-8993(85)90592-X; CONNAUGHTON M, 1986, NEUROSCIENCE, V17, P205, DOI 10.1016/0306-4522(86)90237-X; Dauvergne C, 2001, NEUROSCI LETT, V311, P109, DOI 10.1016/S0304-3940(01)02150-4; Ellrich J, 1999, PAIN, V82, P229, DOI 10.1016/S0304-3959(99)00063-9; Ellrich J, 2002, MOVEMENT DISORD, V17, pS41, DOI 10.1002/mds.10057; Esser MJ, 1998, J COMP NEUROL, V391, P526, DOI 10.1002/(SICI)1096-9861(19980222)391:4<526::AID-CNE8>3.0.CO;2-2; Fay RA, 1997, BRAIN RES REV, V25, P255, DOI 10.1016/S0165-0173(97)00026-X; Gatti PJ, 1996, EXP BRAIN RES, V110, P175; GERMAN RZ, 1991, J EXP ZOOL, V257, P34, DOI 10.1002/jez.1402570105; GU YM, 1992, J NEUROSCI METH, V42, P1, DOI 10.1016/0165-0270(92)90129-2; Henriquez VM, 2005, EXP BRAIN RES, V163, P445, DOI 10.1007/s00221-004-2200-y; HINRICHSEN CFL, 1983, BRAIN BEHAV EVOLUT, V22, P153, DOI 10.1159/000121514; ISOKAWAAKESSON M, 1987, EXP BRAIN RES, V65, P385; Kaneko T, 1996, J NEUROSCI METH, V65, P157, DOI 10.1016/0165-0270(95)00162-X; KATOH ME, 1982, NEUROSCI LETT, V33, P141, DOI 10.1016/0304-3940(82)90241-5; Li JL, 2005, NEUROSCI RES, V51, P81, DOI 10.1016/j.neures.2004.10.005; Li JL, 2000, J COMP NEUROL, V418, P156; LI YQ, 1993, BRAIN RES, V611, P160, DOI 10.1016/0006-8993(93)91789-U; LI YQ, 1995, J COMP NEUROL, V356, P563, DOI 10.1002/cne.903560407; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; LI YQ, 1993, NEUROSCI LETT, V152, P29, DOI 10.1016/0304-3940(93)90475-Z; LOWE AA, 1984, BRAIN BEHAV EVOLUT, V25, P128, DOI 10.1159/000118858; Luccarini P, 1998, BRAIN RES, V803, P79, DOI 10.1016/S0006-8993(98)00624-6; MARTIN MR, 1977, Q J EXP PHYSIOL CMS, V62, P209, DOI 10.1113/expphysiol.1977.sp002393; NOZAKI S, 1993, J NEUROPHYSIOL, V69, P595, DOI 10.1152/jn.1993.69.2.595; PANNETON WM, 1983, BRAIN RES, V267, P19, DOI 10.1016/0006-8993(83)91036-3; Pellegrini JJ, 1995, EXP BRAIN RES, V107, P166, DOI 10.1007/BF00230039; Popratiloff AS, 2001, J COMP NEUROL, V433, P364, DOI 10.1002/cne.1145; RYE DB, 1984, J HISTOCHEM CYTOCHEM, V32, P1145, DOI 10.1177/32.11.6548485; Streppel M, 2000, HNO, V48, P911, DOI 10.1007/s001060050687; TAKASU N, 1988, J COMP NEUROL, V271, P461, DOI 10.1002/cne.902710313; THEXTON AJ, 1989, ARCH ORAL BIOL, V34, P239, DOI 10.1016/0003-9969(89)90064-2; THEXTON AJ, 1988, ARCH ORAL BIOL, V33, P331, DOI 10.1016/0003-9969(88)90066-0; TRAVERS JB, 1983, J COMP NEUROL, V220, P280, DOI 10.1002/cne.902200303; Tsai CM, 1999, PAIN, V81, P115, DOI 10.1016/S0304-3959(99)00009-3; Tsai CM, 1999, BRAIN RES, V826, P293, DOI 10.1016/S0006-8993(99)01248-2; Westberg KG, 1997, PAIN, V73, P295, DOI 10.1016/S0304-3959(97)00103-6; Zerari-Mailly F, 2001, J COMP NEUROL, V429, P80, DOI 10.1002/1096-9861(20000101)429:1<80::AID-CNE7>3.0.CO;2-L; ZHANG GX, 1990, BRAIN RES BULL, V24, P221, DOI 10.1016/0361-9230(90)90209-I	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25615	10.1371/journal.pone.0025615	http://dx.doi.org/10.1371/journal.pone.0025615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980505	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600040
J	Hsieh, JY; Chen, MC; Hung, HC				Hsieh, Ju-Yi; Chen, Meng-Chun; Hung, Hui-Chih			Determinants of Nucleotide-Binding Selectivity of Malic Enzyme	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; FUNCTIONAL ROLES; CRYSTAL-STRUCTURE; CDNA CLONING; ATP; PURIFICATION; EXPRESSION; MECHANISM; SITE; INHIBITION	Malic enzymes have high cofactor selectivity. An isoform-specific distribution of residues 314, 346, 347 and 362 implies that they may play key roles in determining the cofactor specificity. Currently, Glu314, Ser346, Lys347 and Lys362 in human c-NADP-ME were changed to the corresponding residues of human m-NAD(P)-ME (Glu, Lys, Tyr and Gln, respectively) or Ascaris suum m-NAD-ME (Ala, Ile, Asp and His, respectively). Kinetic data demonstrated that the S346K/K347Y/K362Q c-NADP-ME was transformed into a debilitated NAD(+)-utilizing enzyme, as shown by a severe decrease in catalytic efficiency using NADP(+) as the cofactor without a significant increase in catalysis using NAD(+) as the cofactor. However, the S346K/K347Y/K362H enzyme displayed an enhanced value for k(cat,NAD), suggesting that His at residue 362 may be more beneficial than Gln for NAD(+) binding. Furthermore, the S3461/K347D/K362H mutant had a very large K-m,K-NADP value compared to other mutants, suggesting that this mutant exclusively utilizes NAD(+) as its cofactor. Since the S346K/K347Y/K362Q, S346K1K347Y/K362H and S346I/K347D/K362H c-NADP-ME mutants did not show significant reductions in their K-m,K-NAD values, the E314A mutation was then introduced into these triple mutants. Comparison of the kinetic parameters of each triple-quadruple mutant pair (for example, S346K/K347Y/K362Q versus E314A/S346K/K347Y/K362Q) revealed that all of the K-m values for NAD(+) and NADP(+) of the quadruple mutants were significantly decreased, while either k(cat,NAD) or k(cat,NADP) was substantially increased. By adding the E314A mutation to these triple mutant enzymes, the E314A/S346K/K347Y/K362Q, E314A/S346K/K347Y/K362H and E314A/S3461/K347D/K362H c-NADP-ME variants are no longer debilitated but become mainly NAD utilizing enzymes by a considerable increase in catalysis using NAD(+) as the cofactor. These results suggest that abolishing the repulsive effect of Glu314 in these quadruple mutants increases the binding affinity of NAD(+) Here, we demonstrate that a series of E314A-containing c-NADP-ME quadruple mutants have been changed to NAD(+)-Utilizing enzymes by abrogating NADP(+) binding and increasing NAD(+) binding.	[Hsieh, Ju-Yi; Chen, Meng-Chun; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hsieh, JY (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, ROC [NSC-99-2113-M-005-010]; Ministry of Education, Taiwan	National Science Council, ROC(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the National Science Council, ROC (NSC-99-2113-M-005-010) and the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas DF, 2008, BIOCHEMISTRY-US, V47, P2539, DOI 10.1021/bi702261m; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BAKER PJ, 1987, J MOL BIOL, V193, P233, DOI 10.1016/0022-2836(87)90643-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG GG, 1991, EUR J BIOCHEM, V202, P681, DOI 10.1111/j.1432-1033.1991.tb16423.x; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Coleman DE, 2002, BIOCHEMISTRY-US, V41, P6928, DOI 10.1021/bi0255120; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; FRENKEL R, 1972, BIOCHEM BIOPH RES CO, V47, P931, DOI 10.1016/0006-291X(72)90582-7; Goodridge AG, 1996, PROG NUCLEIC ACID RE, V52, P89, DOI 10.1016/S0079-6603(08)60965-4; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hsieh JY, 2008, FEBS J, V275, P5383, DOI 10.1111/j.1742-4658.2008.06668.x; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; Hsieh JY, 2009, J BIOL CHEM, V284, P4536, DOI 10.1074/jbc.M807008200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Hsu WC, 2004, BIOCHEMISTRY-US, V43, P7382, DOI 10.1021/bi049600r; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Karsten WE, 2005, BIOCHEMISTRY-US, V44, P3626, DOI 10.1021/bi047826o; KIICK DM, 1986, BIOCHEMISTRY-US, V25, P227, DOI 10.1021/bi00349a032; Kuo CC, 2000, BIOCHEM BIOPH RES CO, V270, P821, DOI 10.1006/bbrc.2000.2502; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; LOEBER G, 1991, J BIOL CHEM, V266, P3016; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MCKEEHAN WL, 1982, J CELL PHYSIOL, V110, P142, DOI 10.1002/jcp.1041100206; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; SAUER LA, 1973, FEBS LETT, V33, P251, DOI 10.1016/0014-5793(73)80205-4; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, BIOCHEM BIOPH RES CO, V274, P440, DOI 10.1006/bbrc.2000.3163; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25312	10.1371/journal.pone.0025312	http://dx.doi.org/10.1371/journal.pone.0025312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980421	Green Published, gold			2022-12-27	WOS:000295939600018
J	Zeng, T; Gao, HY; Yu, P; He, H; Ouyang, XM; Deng, LJ; Zhang, Y				Zeng, Tao; Gao, Hongyi; Yu, Pei; He, Heng; Ouyang, Xiaoming; Deng, Lijuan; Zhang, Yan			Up-Regulation of Kin17 Is Essential for Proliferation of Breast Cancer	PLOS ONE			English	Article							DNA-DAMAGE; RNA-BINDING; COMET ASSAY; CYCLIN D1; PROTEIN; REPAIR; EXPRESSION; COMPLEX; MARKERS; LINES	Background: Kin17 is ubiquitously expressed at low levels in human tissue and participates in DNA replication, DNA repair and cell cycle control. Breast cancer cells are characterized by enabling replicative immortality and accumulated DNA damage. However, whether kin17 contributes to breast carcinogenesis remains unknown. Methodology/Principal Findings: In this study, we show for the first time that kin17 is an important molecule related to breast cancer. Our results show that kin17 expression was markedly increased in clinical breast tumors and was associated with tumor grade, Ki-67 expression, p53 mutation status and progesterone receptor expression, which were assessed in a clinicopathologic characteristics review. Knockdown of kin17 inhibited DNA replication and repair, blocked cell cycle progression and inhibited anchorage-independent growth, while increasing sensitivity to chemotherapy in breast cancer cells. Moreover, kin17 silencing decreased EGF-stimulated cell growth. Furthermore, overexpression of kin17 promoted DNA replication and cell proliferation in MCF-10A. Conclusions/Significance:Our findings indicate that up-regulation of kin17 is strongly associated with cellular proliferation, DNA replication, DNA damage response and breast cancer development. The increased level of kin17 was not only a consequence of immortalization but also associated with tumorigenesis. Therefore, kin17 could be a novel therapeutic target for inhibiting cell growth in breast cancer.	[Zeng, Tao; Yu, Pei; He, Heng; Deng, Lijuan; Zhang, Yan] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, State Key Lab Biocontrol,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Hongyi] Guangdong Women & Childrens Hosp & Hlth Inst, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Ouyang, Xiaoming] Guangzhou Med Univ, Affiliated Hosp 2, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Zeng, T (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Minist Educ, State Key Lab Biocontrol,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.	zhang39@mail.sysu.edu.cn	Gao, Hongyi/AAE-3460-2020	Zeng, Tao/0000-0001-8896-0361	Guangdong Planning Project of Science and Technology [2008B030301342, 2009B030803037]	Guangdong Planning Project of Science and Technology	This work was supported by the Guangdong Planning Project of Science and Technology (No. 2008B030301342 and No. 2009B030803037) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Biard DSF, 1997, RADIAT RES, V147, P442, DOI 10.2307/3579501; Biard DSF, 2002, J BIOL CHEM, V277, P19156, DOI 10.1074/jbc.M200321200; Boccardo F, 2007, LANCET, V369, P533, DOI 10.1016/S0140-6736(07)60201-3; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Montero JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005565; Chen ZJ, 2010, MUTAT RES-GEN TOX EN, V695, P16, DOI 10.1016/j.mrgentox.2009.10.001; Collins Andrew R, 2004, Mol Biotechnol, V26, P249; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hussain SA, 2007, BIODRUGS, V21, P215, DOI 10.2165/00063030-200721040-00002; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kannouche P, 2000, CARCINOGENESIS, V21, P1701, DOI 10.1093/carcin/21.9.1701; Kannouche P, 1998, CARCINOGENESIS, V19, P781, DOI 10.1093/carcin/19.5.781; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; le Maire A, 2006, J MOL BIOL, V364, P764, DOI 10.1016/j.jmb.2006.09.033; Lu Jing, 2009, Cancer Res, V69, P4951, DOI 10.1158/0008-5472.CAN-09-0099; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Masson C, 2003, P NATL ACAD SCI USA, V100, P616, DOI 10.1073/pnas.0236176100; MAZIN A, 1994, MOL GEN GENET, V244, P435, DOI 10.1007/BF00286696; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Miccoli L, 2005, MOL CELL BIOL, V25, P3814, DOI 10.1128/MCB.25.9.3814-3830.2005; Miccoli L, 2002, CANCER RES, V62, P5425; Milanezi F, 2008, EXPERT REV MOL DIAGN, V8, P417, DOI 10.1586/14737159.8.4.417; Pinon-Lataillade G, 2004, J CELL SCI, V117, P3691, DOI 10.1242/jcs.01226; Price JT, 1999, CANCER RES, V59, P5475; Reddy TK, 2008, PHYTOTHER RES, V22, P1188, DOI 10.1002/ptr.2428; Salti GI, 2000, ANTICANCER RES, V20, P3189; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Venkatesha VA, 2010, TOXICOL LETT, V196, P110, DOI 10.1016/j.toxlet.2010.04.005	39	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25343	10.1371/journal.pone.0025343	http://dx.doi.org/10.1371/journal.pone.0025343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980430	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600021
J	Chiam, K; Centenera, MM; Butler, LM; Tilley, WD; Bianco-Miotto, T				Chiam, Karen; Centenera, Margaret M.; Butler, Lisa M.; Tilley, Wayne D.; Bianco-Miotto, Tina			GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2 '-Deoxycytidine Efficacy in Human Prostate Cancer Cells	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; RISK MYELODYSPLASTIC SYNDROME; PROMOTER METHYLATION; BREAST-CANCER; GENE-EXPRESSION; PHASE-I; HYPOMETHYLATING AGENT; ANTINEOPLASTIC ACTION; L1210 LEUKEMIA; MOUSE MODEL	DNA methylation plays an important role in carcinogenesis and the reversibility of this epigenetic modification makes it a potential therapeutic target. To date, DNA methyltransferase inhibitors (DNMTi) have not demonstrated clinical efficacy in prostate cancer, with one of the major obstacles being the inability to monitor drug activity during the trial. Given the high frequency and specificity of GSTP1 DNA methylation in prostate cancer, we investigated whether GSTP1 is a useful marker of DNMTi treatment efficacy. LNCaP prostate cancer cells were treated with 5-aza-2'-deoxycytidine (5-aza-CdR) either with a single high dose (5-20 mu M), every alternate day (0.1-10 mu M) or daily (0.005-2.5 mu M). A daily treatment regimen with 5-aza-CdR was optimal, with significant suppression of cell proliferation achieved with doses of 0.05 mu M or greater (p<0.0001) and induction of cell death from 0.5 mu M (p<0.0001). In contrast, treatment with a single high dose of 20 mu M 5-aza-CdR inhibited cell proliferation but was not able to induce cell death. Demethylation of GSTP1 was observed with doses of 5-aza-CdR that induced significant suppression of cell proliferation (>= 0.05 mu M). Re-expression of the GSTP1 protein was observed only at doses of 5-aza-CdR (>= 0.5 mu M) associated with induction of cell death. Treatment of LNCaP cells with a more stable DNMTi, Zebularine required at least a 100-fold higher dose (>= 50 mu M) to inhibit proliferation and was less potent in inducing cell death, which corresponded to a lack of GSTP1 protein re-expression. We have shown that GSTP1 DNA methylation and protein expression status is correlated with DNMTi treatment response in prostate cancer cells. Since GSTP1 is methylated in nearly all prostate cancers, our results warrant its testing as a marker of epigenetic therapy response in future clinical trials. We conclude that the DNA methylation and protein expression status of GSTP1 are good indicators of DNMTi efficacy.	[Chiam, Karen; Centenera, Margaret M.; Butler, Lisa M.; Tilley, Wayne D.; Bianco-Miotto, Tina] Univ Adelaide, Dame Roma Mitchell Canc Res Labs, Discipline Med, Hanson Inst, Adelaide, SA, Australia	Hanson Institute; University of Adelaide	Chiam, K (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	tina.bianco@adelaide.edu.au	Butler, Lisa/AAP-9088-2020; Butler, Lisa M/C-9843-2010; Bianco-Miotto, Tina/C-4808-2008	Butler, Lisa/0000-0003-2698-3220; Bianco-Miotto, Tina/0000-0002-8431-5338; centenera, margaret/0000-0002-2206-0632; Chiam, Karen/0000-0001-8154-6731; Tilley, Wayne/0000-0003-1893-2626	National Health and Medical Research Council [627185]; U.S. Department of Defense [W81XWH-04-1-0017]; Cancer Australia/Prostate Cancer Foundation of Australia [627229]; Prostate Cancer Foundation of Australia [EG0809]; W. Bruce Hall Cancer Council of SA; Cancer Council SA	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); U.S. Department of Defense(United States Department of Defense); Cancer Australia/Prostate Cancer Foundation of Australia; Prostate Cancer Foundation of Australia; W. Bruce Hall Cancer Council of SA; Cancer Council SA(Cancer Council South Australia)	This work was supported by grants from the National Health and Medical Research Council (627185; WDT, LMB, TBM), the U.S. Department of Defense (W81XWH-04-1-0017; WDT, LMB), Cancer Australia/Prostate Cancer Foundation of Australia (627229; LMB, WDT), Prostate Cancer Foundation of Australia Equipment Grant (EG0809; WDT, LMB, TBM), W. Bruce Hall Cancer Council of SA Research Fellowship (TBM), and a Cancer Council SA Senior Research Fellowship (LMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian PJ, 2005, CLIN CANCER RES, V11, P4037, DOI 10.1158/1078-0432.CCR-04-2446; Bender CM, 1999, MOL CELL BIOL, V19, P6690; Bender CM, 1998, CANCER RES, V58, P95; Bianco-Miotto T, 2010, CANCER EPIDEM BIOMAR, V19, P2611, DOI 10.1158/1055-9965.EPI-10-0555; Bott SRJ, 2005, PROSTATE CANCER P D, V8, P321, DOI 10.1038/sj.pcan.4500822; Brothman AR, 2005, CANCER GENET CYTOGEN, V156, P31, DOI 10.1016/j.cancergencyto.2004.04.004; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; de Vos D, 2005, ANN HEMATOL, V84, P3, DOI 10.1007/s00277-005-0008-x; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Festuccia C, 2008, INT J ONCOL, V33, P381, DOI 10.3892/ijo_00000019; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Hurtubise A, 2004, ANTI-CANCER DRUG, V15, P161, DOI 10.1097/01.cad.0000113334.52071.97; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones RL, 2009, BREAST CANCER RES TR, V116, P53, DOI 10.1007/s10549-008-0081-7; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; Lemaire M, 2005, ANTI-CANCER DRUG, V16, P301, DOI 10.1097/00001813-200503000-00009; Lin XH, 2001, CANCER RES, V61, P8611; Lin XH, 2001, AM J PATHOL, V159, P1815, DOI 10.1016/S0002-9440(10)63028-3; Lubbert M, 2001, BRIT J HAEMATOL, V114, P349, DOI 10.1046/j.1365-2141.2001.02933.x; Marrocco DL, 2007, MOL CANCER THER, V6, P51, DOI 10.1158/1535-7163.MCT-06-0144; McCabe MT, 2006, CANCER RES, V66, P385, DOI 10.1158/0008-5472.CAN-05-2020; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P277, DOI 10.1016/0163-7258(85)90052-X; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; MOMPARLER RL, 1984, LEUKEMIA RES, V8, P1043, DOI 10.1016/0145-2126(84)90059-6; Nakayama T, 2000, LAB INVEST, V80, P1789, DOI 10.1038/labinvest.3780190; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Patra SK, 2001, BIOCHEM BIOPH RES CO, V287, P705, DOI 10.1006/bbrc.2001.5639; Perry AS, 2006, ENDOCR-RELAT CANCER, V13, P357, DOI 10.1677/erc.1.01184; Pulukuri SMK, 2005, INT J ONCOL, V26, P863; Richter E, 2007, EPIGENETICS-US, V2, P100, DOI 10.4161/epi.2.2.4611; RIVARD GE, 1981, LEUKEMIA RES, V5, P453, DOI 10.1016/0145-2126(81)90116-8; Santourlidis S, 1999, PROSTATE, V39, P166; Shang DH, 2009, CANCER LETT, V278, P82, DOI 10.1016/j.canlet.2008.12.034; Sigalotti L, 2007, J CELL PHYSIOL, V212, P330, DOI 10.1002/jcp.21066; Singal R, 2001, CANCER RES, V61, P4820; SORM F, 1968, NEOPLASMA, V15, P339; Steiner MS, 2000, ONCOGENE, V19, P1297, DOI 10.1038/sj.onc.1203428; Stewart DJ, 2009, CLIN CANCER RES, V15, P3881, DOI 10.1158/1078-0432.CCR-08-2196; Tan LW, 2002, CARCINOGENESIS, V23, P231, DOI 10.1093/carcin/23.2.231; Thibault A, 1998, TUMORI, V84, P87, DOI 10.1177/030089169808400120; VANGROENINGEN CJ, 1986, CANCER RES, V46, P4831; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956; XIANG N, 2008, CARCINOGENESIS; Xiong JB, 2009, MOL CANCER THER, V8, P779, DOI 10.1158/1535-7163.MCT-08-0926; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhang Q, 2005, MOL ENDOCRINOL, V19, P2390, DOI 10.1210/me.2005-0096; Zorn CS, 2007, CLIN CANCER RES, V13, P2136, DOI 10.1158/1078-0432.CCR-06-2381	60	34	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25634	10.1371/journal.pone.0025634	http://dx.doi.org/10.1371/journal.pone.0025634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980513	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900085
J	Naudin, C; Joulin-Giet, A; Couetdic, G; Plesiat, P; Szymanska, A; Gorna, E; Gauthier, F; Kasprzykowski, F; Lecaille, F; Lalmanach, G				Naudin, Clement; Joulin-Giet, Alix; Couetdic, Gerard; Plesiat, Patrick; Szymanska, Aneta; Gorna, Emilia; Gauthier, Francis; Kasprzykowski, Franciszek; Lecaille, Fabien; Lalmanach, Gilles			Human Cysteine Cathepsins Are Not Reliable Markers of Infection by Pseudomonas aeruginosa in Cystic Fibrosis	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUIDS; NEUTROPHIL ELASTASE; LUNG-DISEASE; HYDROGEN-PEROXIDE; HUMAN SPUTUM; CYSTATIN-C; PROTEASES; INFLAMMATION; PROTEINASES; INHIBITORS	Cysteine cathepsins have emerged as new players in inflammatory lung disorders. Their activities are dramatically increased in the sputum of cystic fibrosis (CF) patients, suggesting that they are involved in the pathophysiology of CF. We have characterized the cathepsins in CF expectorations and evaluated their use as markers of colonization by Pseudomonas aeruginosa. The concentrations of active cathepsins B, H, K, L and S were the same in P. aeruginosa-positive (19 Ps+) and P. aeruginosa-negative (6 Ps-) samples, unlike those of human neutrophil elastase. Also the cathepsin inhibitory potential and the cathepsins/cathepsin inhibitors imbalance remained unchanged and similar (similar to 2-fold) in the Ps+ and Ps- groups (p<0.001), which correlated with the breakdown of their circulating cystatin-like inhibitors (kininogens). Procathepsins, which may be activated autocatalytically, are a potential proteolytic reservoir. Immunoblotting and active-site labeling identified the double-chain cathepsin B, the major cathepsin in CF sputum, as the main molecular form in both Ps+ and Ps- samples, despite the possible release of the similar to 31 kDa single-chain form from procathepsin B by sputum elastase. Thus, the hydrolytic activity of cysteine cathepsins was not correlated with bacterial colonization, indicating that cathepsins, unlike human neutrophil elastase, are not suitable markers of P. aeruginosa infection.	[Naudin, Clement; Joulin-Giet, Alix; Gauthier, Francis; Lecaille, Fabien; Lalmanach, Gilles] Univ Tours, INSERM, U618, Tours, France; [Couetdic, Gerard; Plesiat, Patrick] CHU Jean Minjoz, Bacteriol Lab, Besancon, France; [Szymanska, Aneta; Gorna, Emilia; Kasprzykowski, Franciszek] Univ Gdansk, Dept Med Chem, Fac Chem, PL-80952 Gdansk, Poland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Universite de Franche-Comte; CHU Besancon; Fahrenheit Universities; University of Gdansk	Naudin, C (corresponding author), Univ Tours, INSERM, U618, Tours, France.	gilles.lalmanach@univ-tours.fr	Lecaille, Fabien/GRY-5313-2022; Szymanska, Aneta/AAZ-2783-2021	Szymanska, Aneta/0000-0002-8664-2041; Lecaille, Fabien/0000-0003-1060-4222; Lalmanach, Gilles/0000-0001-8562-4821; Ilowska, Emilia/0000-0002-5774-3644	French cystic fibrosis association "Vaincre la Mucoviscidose'' (VLM, France) [IC0810]; VLM; Institut National de la Sante et de la Recherche Medicale (INSERM)	French cystic fibrosis association "Vaincre la Mucoviscidose'' (VLM, France); VLM; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The French cystic fibrosis association "Vaincre la Mucoviscidose'' provided financial support (VLM, France, Grant IC0810). CN is a recipient of a doctoral fellowship from VLM. This work was also supported by institutional funding from the Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assfalg-Machleidt I, 1992, Agents Actions Suppl, V38 ( Pt 1), P312; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BROMME D, 1993, J BIOL CHEM, V268, P4832; Buhling F, 2004, EUR RESPIR J, V23, P620, DOI 10.1183/09031936.04.00105304; BUTTLE DJ, 1990, SCAND J CLIN LAB INV, V50, P509, DOI 10.3109/00365519009089165; BUTTLE DJ, 1991, BIOCHEM J, V276, P325, DOI 10.1042/bj2760325; Florent I, 2005, BIOL CHEM, V386, P401, DOI 10.1515/BC.2005.048; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gilligan PH, 2006, CYSTIC FIBROSIS MICR; Godat E, 2008, BIOL CHEM, V389, P1123, DOI 10.1515/BC.2008.109; Grasemann H, 2010, EXPERT OPIN EMERG DR, V15, P653, DOI 10.1517/14728214.2010.517746; Grasemann H, 2010, PEDIATR PULM, V45, P845, DOI 10.1002/ppul.21298; Herve-Grepinet V, 2008, FEBS LETT, V582, P1307, DOI 10.1016/j.febslet.2008.03.007; Kasabova M, 2011, CLIN REV BONE MINER, V9, P148, DOI 10.1007/s12018-011-9094-6; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; LALMANACH G, 1992, J IMMUNOL METHODS, V149, P197, DOI 10.1016/0022-1759(92)90251-N; Lalmanach G, 1996, BIOCHEM J, V318, P395, DOI 10.1042/bj3180395; Lalmanach G, 2006, BIOL CHEM, V387, P863, DOI 10.1515/BC.2006.109; Lalmanach G, 2010, BIOCHIMIE, V92, P1568, DOI 10.1016/j.biochi.2010.03.011; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; MACH L, 1994, J BIOL CHEM, V269, P13036; Majerle A, 2003, ARCH BIOCHEM BIOPHYS, V417, P53, DOI 10.1016/S0003-9861(03)00319-9; Martin SL, 2010, PEDIATR PULM, V45, P860, DOI 10.1002/ppul.21274; MAY TB, 1991, CLIN MICROBIOL REV, V4, P191, DOI 10.1128/CMR.4.2.191-206.1991; Naudin C, 2010, J MOL BIOL, V400, P1022, DOI 10.1016/j.jmb.2010.06.006; Owen Caroline A, 2005, Proc Am Thorac Soc, V2, P373, DOI 10.1513/pats.200504-029SR; Perdereau C, 2006, BBA-MOL BASIS DIS, V1762, P351, DOI 10.1016/j.bbadis.2005.10.005; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Quinn Derek J, 2010, Open Respir Med J, V4, P20, DOI 10.2174/1874306401004020020; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; Serveau-Avesque C, 2006, BIOL CELL, V98, P15, DOI 10.1042/BC20040512; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Takeyabu K, 1998, EUR RESPIR J, V12, P1033, DOI 10.1183/09031936.98.12051033; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Veillard F, 2008, INT J BIOCHEM CELL B, V40, P1079, DOI 10.1016/j.biocel.2007.10.030; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691	44	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25577	10.1371/journal.pone.0025577	http://dx.doi.org/10.1371/journal.pone.0025577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980493	Green Submitted, gold, Green Published			2022-12-27	WOS:000295936900077
J	Petrovan, SO; Ward, AI; Wheeler, P				Petrovan, Silviu O.; Ward, Alastair I.; Wheeler, Philip			Detectability Counts when Assessing Populations for Biodiversity Targets	PLOS ONE			English	Article							HARES LEPUS-EUROPAEUS; BROWN HARES; ABUNDANCE; CONSERVATION; LANDSCAPE; FARMLAND; BRITAIN; DESIGN	Efficient, practical and accurate estimates of population parameters are a necessary basis for effective conservation action to meet biodiversity targets. The brown hare is representative of many European farmland species: historically widespread and abundant but having undergone rapid declines as a result of agricultural intensification. As a priority species in the UK Biodiversity Action Plan, it has national targets for population increase that are part of wider national environmental indicators. Previous research has indicated that brown hare declines have been greatest in pastural landscapes and that gains might be made by focussing conservation effort there. We therefore used hares in pastural landscapes to examine how basic changes in survey methodology can affect the precision of population density estimates and related these to national targets for biodiversity conservation in the UK. Line transects for hares carried out at night resulted in higher numbers of detections, had better-fitting detection functions and provided more robust density estimates with lower effort than those during the day, due primarily to the increased probability of detection of hares at night and the nature of hare responses to the observer. Hare spring densities varied widely within a single region, with a pooled mean of 20.6 hares km 22, significantly higher than the reported national average of hares in pastures of 3.3 hares km(-2). The high number of encounters allowed us to resolve hare densities at site, season and year scales. We demonstrate how survey conduct can impact on data quantity and quality with implications for setting and monitoring biodiversity targets. Our case study of the brown hare provides evidence that for wildlife species with low detectability, large scale volunteer-based monitoring programmes, either species specific or generalist, might be more successfully and efficiently carried out by a small number of trained personnel able to employ methods that maximise detectability.	[Petrovan, Silviu O.; Wheeler, Philip] Univ Hull, Ctr Environm & Marine Sci, Scarborough, N Yorkshire, England; [Petrovan, Silviu O.; Ward, Alastair I.] Food & Environm Res Agcy, York, N Yorkshire, England	University of Hull; Food & Environment Research Agency	Petrovan, SO (corresponding author), Univ Hull, Ctr Environm & Marine Sci, Scarborough Campus, Scarborough, N Yorkshire, England.	s.petrovan@hull.ac.uk	Ward, Alastair/J-5616-2014; Petrovan, Silviu/AAZ-9299-2021; Petrovan, Silviu/ADM-9976-2022	Petrovan, Silviu/0000-0002-3984-2403; Petrovan, Silviu/0000-0002-3984-2403; Wheeler, Philip/0000-0002-2056-6605; Ward, Alastair/0000-0002-3305-3323	University of Hull, United Kingdom	University of Hull, United Kingdom	The sole funder of this work was the University of Hull, United Kingdom, through a research studentship to SP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES RFW, 1985, J ZOOL, V206, P273, DOI 10.1111/j.1469-7998.1985.tb05653.x; Battersby, 2005, UK MAMMALS SPECIES S; BROWNE SJ, 2003, ARABLE STEWARDSHIP I; Buckland S.T., 2001, pi; Cowan D., 2004, OVERVIEW CURRENT STA; Fewster RM, 2009, BIOMETRICS, V65, P225, DOI 10.1111/j.1541-0420.2008.01018.x; Field SA, 2007, AUSTRAL ECOL, V32, P485, DOI 10.1111/j.1442-9993.2007.01715.x; Heydon MJ, 2000, J ZOOL, V251, P253, DOI 10.1111/j.1469-7998.2000.tb00608.x; HOLLEY AJF, 2001, MAMM BIOL, V66, P1; Hutchings MR, 1995, J ZOOL, V237, P663, DOI 10.1111/j.1469-7998.1995.tb05023.x; Hutchings MR, 1996, CURRENT STATUS BROWN; Jackson AL, 2008, BIOL CONSERV, V141, P2932, DOI 10.1016/j.biocon.2008.09.002; Jensen C., 2017, VELFAERD; Langbein J, 1999, MAMMAL REV, V29, P93, DOI 10.1046/j.1365-2907.1999.00040.x; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Marboutin E, 1995, J APPL ECOL, V32, P809, DOI 10.2307/2404820; Marques TA, 2010, BIOMETRICS, V66, P1247, DOI 10.1111/j.1541-0420.2009.01381.x; McLaren G. W., 1997, Gibier Faune Sauvage, V14, P335; MONAGHAN P, 1985, ANIM BEHAV, V33, P993, DOI 10.1016/S0003-3472(85)80033-6; Newey S, 2003, WILDLIFE BIOL, V9, P185, DOI 10.2981/wlb.2003.049; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Petrovan SO, 2011, EUR J WILDLIFE RES, V57, P27, DOI 10.1007/s10344-010-0394-9; Reid N, 2007, IRISH WILDLIFE MANUA, V30; Reid N, 2007, J APPL ECOL, V44, P1200, DOI 10.1111/j.1365-2664.2007.01336.x; Reynolds JC, 2010, EUR J WILDLIFE RES, V56, P541, DOI 10.1007/s10344-009-0355-3; Risely K., 2009, 537 BTO; Sauer J.R., 2008, N AM BREEDING BIRD S; Smith RK, 2005, MAMMAL REV, V35, P1, DOI 10.1111/j.1365-2907.2005.00057.x; Smith RK, 2004, J APPL ECOL, V41, P1092, DOI 10.1111/j.0021-8901.2004.00976.x; TAPPER S, 1984, MAMMAL REV, V14, P57, DOI 10.1111/j.1365-2907.1984.tb00339.x; TAPPER SC, 1986, J APPL ECOL, V23, P39, DOI 10.2307/2403079; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; *UK BAP, 1995, BIOD UK ACT PLAN; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Vaughan N, 2003, J APPL ECOL, V40, P163, DOI 10.1046/j.1365-2664.2003.00784.x	35	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24206	10.1371/journal.pone.0024206	http://dx.doi.org/10.1371/journal.pone.0024206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980343	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700004
J	Roy, SK; Chen, QH; Fu, JS; Shankar, S; Srivastava, RK				Roy, Sanjit K.; Chen, Qinghe; Fu, Junsheng; Shankar, Sharmila; Srivastava, Rakesh K.			Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors	PLOS ONE			English	Article							CELL-SURVIVAL; KINASE; ANGIOGENESIS; CANCER; AKT; SULFORAPHANE; POLYPHENOLS; MECHANISMS; PATHWAY; GENES	Background: The forkhead transcription factors of the O class (FOXO) play a direct role in cellular proliferation, oxidative stress response, and tumorigenesis. The objectives of this study were to examine whether FOXOs regulate antitumor activities of resveratrol in pancreatic cancer cells in vitro and in vivo. Methodology/Principal Findings: Pancreatic cancer cell lines were treated with resveratrol. Cell viability, colony formation, apoptosis and cell cycle were measured by XTT, soft agar, TUNEL and flow cytometry assays, respectively. FOXO nuclear translocation, DNA binding and transcriptional activities were measured by fluorescence technique, gelshift and luciferase assay, respectively. Mice were orthotopically implanted with PANC1 cells and orally gavaged with resveratrol. The components of PI3K and ERK pathways, FOXOs and their target gene expressions were measured by the Western blot analysis. Resveratrol inhibited cell viability and colony formations, and induced apoptosis through caspase-3 activation in four pancreatic cancer cell lines (PANC-1, MIA PaCa-2, Hs766T, and AsPC-1). Resveratrol induced cell cycle arrest by up-regulating the expression of p21/CIP1, p27/KIP1 and inhibiting the expression of cyclin D1. Resveratrol induced apoptosis by up-regulating Bim and activating caspase-3. Resveratrol inhibited phosphorylation of FOXOs, and enhanced their nuclear translocation, FOXO-DNA binding and transcriptional activities. The inhibition of PI3K/AKT and MEK/ERK pathways induced FOXO transcriptional activity and apoptosis. Furthermore, deletion of FOXO genes abrogated resveratrol-induced cell cycle arrest and apoptosis. Finally, resveratrol-treated mice showed significant inhibition in tumor growth which was associated with reduced phosphorylation of ERK, PI3K, AKT, FOXO1 and FOXO3a, and induction of apoptosis and FOXO target genes. Conclusions: These data suggest that inhibition of ERK and AKT pathways act together to activate FOXO transcription factors which are involved in resveratrol-mediated pancreatic tumor growth suppression.	[Roy, Sanjit K.; Chen, Qinghe; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut & Med, Ctr Canc, Kansas City, KS 66103 USA; [Fu, Junsheng; Shankar, Sharmila] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Ctr Canc, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Roy, SK (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut & Med, Ctr Canc, Kansas City, KS 66103 USA.	rsrivastava@kumc.edu						Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cappellini A, 2003, LEUKEMIA, V17, P2157, DOI 10.1038/sj.leu.2403111; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis R, 2009, ONCOL REP, V22, P1473, DOI 10.3892/or_00000589; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Boer VCJ, 2006, MECH AGEING DEV, V127, P618, DOI 10.1016/j.mad.2006.02.007; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Harikumar Kuzhuvelil B, 2010, Int J Cancer, V127, P257, DOI 10.1002/ijc.25041; Hruban RH, 2001, J GASTROINTEST SURG, V5, P583, DOI 10.1016/S1091-255X(01)80099-8; Hutzen B, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-24; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kallifatidis G, 2008, GUT; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Li DH, 2001, CANCER J, V7, P259; LUBINUS M, 1994, J BIOL CHEM, V269, P9822; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; McKenna S, 2003, ONCOLOGIST, V8, P149, DOI 10.1634/theoncologist.8-2-149; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Shankar S, 2008, CLIN CANCER RES, V14, P1; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4881, DOI 10.2741/2435; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Srivastava Rakesh K., 2000, Molecular Cell Biology Research Communications, V4, P67, DOI 10.1006/mcbr.2001.0265; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167	44	102	107	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25166	10.1371/journal.pone.0025166	http://dx.doi.org/10.1371/journal.pone.0025166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980390	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700019
J	Midkiff, J; Borochoff-Porte, N; White, D; Johnson, DI				Midkiff, John; Borochoff-Porte, Nathan; White, Dylan; Johnson, Douglas I.			Small Molecule Inhibitors of the Candida albicans Budded-to-Hyphal Transition Act through Multiple Signaling Pathways	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; FILAMENTOUS GROWTH; GENE-EXPRESSION; FATTY-ACIDS; KINASE; MORPHOGENESIS; ACTIVATION; VIRULENCE; EFG1; TRANSDUCTION	The ability of the pathogenic yeast Candida albicans to interconvert between budded and hyphal growth states, herein termed the budded-to-hyphal transition (BHT), is important for C. albicans development and virulence. The BHT is under the control of multiple cell signaling pathways that respond to external stimuli, including nutrient availability, high temperature, and pH. Previous studies identified 21 small molecules that could inhibit the C. albicans BHT in response to carbon limitation in Spider media. However, the studies herein show that the BHT inhibitors had varying efficacies in other hyphal-inducing media, reflecting their varying abilities to block signaling pathways associated with the different media. Chemical epistasis analyses suggest that most, but not all, of the BHT inhibitors were acting through either the Efg1 or Cph1 signaling pathways. Notably, the BHT inhibitor clozapine, a FDA-approved drug used to treat atypical schizophrenia by inhibiting G-protein-coupled dopamine receptors in the brain, and several of its functional analogs were shown to act at the level of the Gpr1 G-protein-coupled receptor. These studies are the first step in determining the target and mechanism of action of these BHT inhibitors, which may have therapeutic anti-fungal utility in the future.	[Midkiff, John; Borochoff-Porte, Nathan; White, Dylan; Johnson, Douglas I.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Midkiff, J (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	Douglas.Johnson@uvm.edu			Vermont Experiment Station [VT-H01308]	Vermont Experiment Station	This research was supported by USDA-Hatch grant VT-H01308 from the Vermont Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Barrington RE, 1998, MOL CELL BIOL, V18, P85, DOI 10.1128/MCB.18.1.85; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Bockmuhl DP, 2001, GENETICS, V157, P1523; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Brown Alistair J. P., 2002, P87; Brown Alistair J. P., 2002, P95; CHIOU CY, 1975, BRIT J PHARMACOL, V53, P279, DOI 10.1111/j.1476-5381.1975.tb07359.x; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Cottier F, 2009, FEMS MICROBIOL LETT, V295, P1, DOI 10.1111/j.1574-6968.2009.01564.x; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis-Hanna A, 2008, MOL MICROBIOL, V67, P47, DOI 10.1111/j.1365-2958.2007.06013.x; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Han TL, 2011, FUNGAL GENET BIOL, V48, P747, DOI 10.1016/j.fgb.2011.04.002; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; INAGAKI M, 1986, MOL PHARMACOL, V29, P577; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V125, P258, DOI 10.1016/S0006-291X(84)80362-9; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; Kumamoto CA, 2008, CURR OPIN MICROBIOL, V11, P325, DOI 10.1016/j.mib.2008.05.008; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Maccarrone M, 2000, EUR J BIOCHEM, V267, P5078, DOI 10.1046/j.1432-1327.2000.01564.x; Maidan MM, 2005, BIOCHEM SOC T, V33, P291, DOI 10.1042/BST0330291; Maidan MM, 2005, MOL BIOL CELL, V16, P1971, DOI 10.1091/mbc.E04-09-0780; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; Sanchez-Martinez C, 2002, EUKARYOT CELL, V1, P865, DOI 10.1128/EC.1.6.865-874.2002; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; Sherman F., 1986, METHODS YEAST GENETI; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Singh P, 2001, INFECT IMMUN, V69, P7898, DOI 10.1128/IAI.69.12.7898-7903.2001; Sonneborn A, 2000, MOL MICROBIOL, V35, P386, DOI 10.1046/j.1365-2958.2000.01705.x; Staab JF, 2003, MICROBIOL-SGM, V149, P2977, DOI 10.1099/mic.0.26445-0; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Takami M, 2000, AM J PHYSIOL-CELL PH, V278, pC646, DOI 10.1152/ajpcell.2000.278.4.C646; Toenjes KA, 2005, ANTIMICROB AGENTS CH, V49, P963, DOI 10.1128/AAC.49.3.963-972.2005; Toenjes KA, 2009, J MED MICROBIOL, V58, P779, DOI 10.1099/jmm.0.006841-0; VERCESI AE, 1993, J BIOL CHEM, V268, P8564; Warnock David W, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P1, DOI 10.3314/jjmm.48.1; YECIES LD, 1979, J IMMUNOL, V122, P2083	66	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25395	10.1371/journal.pone.0025395	http://dx.doi.org/10.1371/journal.pone.0025395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966518	gold, Green Submitted, Green Published			2022-12-27	WOS:000295932100037
J	Singh, B; Bhat, NK; Bhat, HK				Singh, Bhupendra; Bhat, Nimee K.; Bhat, Hari K.			Partial Inhibition of Estrogen-Induced Mammary Carcinogenesis in Rats by Tamoxifen: Balance between Oxidant Stress and Estrogen Responsiveness	PLOS ONE			English	Article							FEMALE ACI RATS; DNA-FRAGMENTATION-FACTOR; CONTAINING MONOOXYGENASE FMO; HUMAN LIVER-MICROSOMES; DUCTAL BREAST-CANCER; OXIDATIVE STRESS; ANTIESTROGEN RESISTANCE; RECEPTOR MODULATORS; CATECHOL QUINONES; SYRIAN-HAMSTERS	Epidemiological and experimental evidences strongly support the role of estrogens in breast tumor development. Both estrogen receptor (ER)-dependent and ER-independent mechanisms are implicated in estrogen-induced breast carcinogenesis. Tamoxifen, a selective estrogen receptor modulator is widely used as chemoprotectant in human breast cancer. It binds to ERs and interferes with normal binding of estrogen to ERs. In the present study, we examined the effect of long-term tamoxifen treatment in the prevention of estrogen-induced breast cancer. Female ACI rats were treated with 17 beta-estradiol (E2), tamoxifen or with a combination of E2 and tamoxifen for eight months. Tissue levels of oxidative stress markers 8-iso-Prostane F-2 alpha (8-isoPGF(2 alpha)), superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase, and oxidative DNA damage marker 8-hydroxydeoxyguanosine (8-OHdG) were quantified in the mammary tissues of all the treatment groups and compared with age-matched controls. Levels of tamoxifen metabolizing enzymes cytochrome P450s as well as estrogen responsive genes were also quantified. At necropsy, breast tumors were detected in 44% of rats co-treated with tamoxifen+E2. No tumors were detected in the sham or tamoxifen only treatment groups whereas in the E2 only treatment group, the tumor incidence was 82%. Co-treatment with tamoxifen decreased GPx and catalase levels; did not completely inhibit E2-mediated oxidative DNA damage and estrogen-responsive genes monoamine oxygenase B1 (MaoB1) and cell death inducing DFF45 like effector C (Cidec) but differentially affected the levels of tamoxifen metabolizing enzymes. In summary, our studies suggest that although tamoxifen treatment inhibits estrogen-induced breast tumor development and increases the latency of tumor development, it does not completely abrogate breast tumor development in a rat model of estrogen-induced breast cancer. The inability of tamoxifen to completely inhibit E2-induced breast carcinogenesis may be because of increased estrogen-mediated oxidant burden.	[Singh, Bhupendra; Bhat, Nimee K.; Bhat, Hari K.] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Singh, B (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	bhath@umkc.edu	Singh, Bhupendra/E-7691-2013		National Institutes of Health [CA 109551]; NATIONAL CANCER INSTITUTE [R01CA109551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant CA 109551 to HKB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnerlov C, 2001, ANAL CELL PATHOL, V23, P21, DOI 10.1155/2001/430674; Bhat HK, 2004, J STEROID BIOCHEM, V92, P391, DOI 10.1016/j.jsbmb.2004.07.009; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; BHAT HK, 1993, CANCER RES, V53, P5447; Boocock DJ, 2002, CARCINOGENESIS, V23, P1897, DOI 10.1093/carcin/23.11.1897; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CARTHEW P, 1995, CANCER RES, V55, P544; Cavalieri EL, 2004, ANN NY ACAD SCI, V1028, P247, DOI 10.1196/annals.1322.029; Cavalieri E, 2006, ANN NY ACAD SCI, V1089, P286, DOI 10.1196/annals.1386.042; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Clark AS, 2002, MOL CANCER THER, V1, P707; Clarke M, 1998, LANCET, V351, P1451; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; CRESPI CL, 1991, CHEM RES TOXICOL, V4, P566, DOI 10.1021/tx00023a013; Dehal SS, 1997, CANCER RES, V57, P3402; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; HAN XL, 1992, CANCER RES, V52, P1360; HAN XL, 1994, CARCINOGENESIS, V15, P997, DOI 10.1093/carcin/15.5.997; Harvell DME, 2000, P NATL ACAD SCI USA, V97, P2779, DOI 10.1073/pnas.050569097; Hu Y, 2003, XENOBIOTICA, V33, P141, DOI 10.1080/0049825021000042733; Huang X, 2001, FREE RADICAL BIO MED, V31, P1341, DOI 10.1016/S0891-5849(01)00681-5; *IARC, 1999, IARC MON EV CARC RIS, V72, P474; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Kariagina Anastasia, 2010, Hormones & Cancer, V1, P229, DOI 10.1007/s12672-010-0048-0; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Krueger SK, 2006, DRUG METAB REV, V38, P139, DOI 10.1080/03602530600569919; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Li JJ, 2002, MOL CARCINOGEN, V33, P56, DOI 10.1002/mc.10022; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; LI JJ, 1987, FED PROC, V46, P1858; Li SA, 2002, J ENDOCRINOL, V175, P297, DOI 10.1677/joe.0.1750297; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; LIEHR JG, 1986, J STEROID BIOCHEM, V24, P353, DOI 10.1016/0022-4731(86)90080-4; LIEHR JG, 1990, FREE RADICAL BIO MED, V8, P415, DOI 10.1016/0891-5849(90)90108-U; LIM CK, 1994, CARCINOGENESIS, V15, P589, DOI 10.1093/carcin/15.4.589; Lundholm L, 2008, J ENDOCRINOL, V196, P547, DOI 10.1677/JOE-07-0277; Makris A, 1997, BREAST CANCER RES TR, V44, P65, DOI 10.1023/A:1005717924761; MARKLUND S, 1980, ACTA PHYSIOL SCAND, P19; Mense SM, 2008, TOXICOL APPL PHARM, V232, P78, DOI 10.1016/j.taap.2008.06.007; Mense SM, 2009, CARCINOGENESIS, V30, P1202, DOI 10.1093/carcin/bgp093; Mobley JA, 2004, CARCINOGENESIS, V25, P3, DOI 10.1093/carcin/bgg175; Montano MM, 2007, ONCOGENE, V26, P3587, DOI 10.1038/sj.onc.1210144; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; Parte P, 2005, DRUG METAB DISPOS, V33, P1446, DOI 10.1124/dmd.104.000802; Patel MM, 2004, J BIOCHEM MOL TOXIC, V18, P37, DOI 10.1002/jbt.20005; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; PHILLIPS DH, 1994, CANCER RES, V54, P5518; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; SEOUD MAF, 1993, OBSTET GYNECOL, V82, P165; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Shull JD, 1997, CARCINOGENESIS, V18, P1595, DOI 10.1093/carcin/18.8.1595; Singh B, 2010, TOXICOL APPL PHARM, V247, P83, DOI 10.1016/j.taap.2010.06.011; Singh B, 2009, J BIOCHEM MOL TOXIC, V23, P202, DOI 10.1002/jbt.20281; STYLES JA, 1994, CARCINOGENESIS, V15, P5, DOI 10.1093/carcin/15.1.5; Umemoto A, 2000, CARCINOGENESIS, V21, P1737, DOI 10.1093/carcin/21.9.1737; Vitseva O, 2005, J PHARMACOL EXP THER, V312, P1144, DOI 10.1124/jpet.104.076315; von Mach-Szczypinski J, 2009, METABOLISM, V58, P867, DOI 10.1016/j.metabol.2009.02.011; Weroha SJ, 2006, CARCINOGENESIS, V27, P491, DOI 10.1093/carcin/bgi278; WILSON AJ, 1985, WORLD J SURG, V9, P756, DOI 10.1007/BF01655191; Yager J D, 2000, J Natl Cancer Inst Monogr, P67; Zhang ZP, 2006, MOL ENDOCRINOL, V20, P1547, DOI 10.1210/me.2005-0252	68	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25125	10.1371/journal.pone.0025125	http://dx.doi.org/10.1371/journal.pone.0025125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966433	gold, Green Published, Green Submitted			2022-12-27	WOS:000295932100019
J	Meshki, J; Douglas, SD; Hu, MY; Leeman, SE; Tuluc, F				Meshki, John; Douglas, Steven D.; Hu, Mingyue; Leeman, Susan E.; Tuluc, Florin			Substance P Induces Rapid and Transient Membrane Blebbing in U373MG Cells in a p21-Activated Kinase-Dependent Manner	PLOS ONE			English	Article							NEUROKININ-1 RECEPTOR; TACHYKININ RECEPTOR; PAK; NEUROPEPTIDES; INFLAMMATION; ACTIVATION; EXPRESSION; DISORDERS; MECHANISM; GEF-H1	U373MG astrocytoma cells endogenously express the full-length neurokinin 1 receptor (NK1R). Substance P (SP), the natural ligand for NK1R, triggers rapid and transient membrane blebbing and we report that these morphological changes have different dynamics and intracellular signaling as compared to the changes that we have previously described in HEK293-NK1R cells. In both cell lines, the SP-induced morphological changes are Gq-independent, and they require the Rho, Rho-associated coiled-coil kinase (ROCK) signaling pathway. Using confocal microscopy we have demonstrated that tubulin is phosphorylated subsequent to cell stimulation with SP and that tubulin accumulates inside the blebs. Colchicine, a tubulin polymerization inhibitor, blocked SP-induced blebbing in U373MG but not in HEK293-NK1R cells. Although p21-activated kinase (PAK) is expressed in both cell lines, SP induced rapid phosphorylation of PAK in U373MG, but failed to phosphorylate PAK in HEK293-NK1R cells. The cell-permeable Rho inhibitor C3 transferase inhibited SP-induced PAK phosphorylation, but the ROCK inhibitor Y27632 had no effect on PAK phosphorylation, suggesting that Rho activates PAK in a ROCK-independent manner. Our study demonstrates that SP triggers rapid changes in cell morphology mediated by distinct intracellular signaling mechanisms in U373MG versus HEK293-NK1R cells.	[Meshki, John; Douglas, Steven D.; Hu, Mingyue; Tuluc, Florin] Childrens Hosp Philadelphia, Res Inst, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Douglas, Steven D.; Tuluc, Florin] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Tuluc, Florin] Childrens Hosp Philadelphia, Res Inst, Flow Cytometry Core Lab, Philadelphia, PA 19104 USA; [Leeman, Susan E.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Boston University	Meshki, J (corresponding author), Childrens Hosp Philadelphia, Res Inst, Div Allergy & Immunol, Philadelphia, PA 19104 USA.	tuluc@email.chop.edu	Tuluc, Petronel/C-2527-2011	Douglas, Steven/0000-0002-3748-3603; Leeman, Susan/0000-0002-0951-5364	National Institutes of Health [U01MH090325, R01-MH049981, P01-MH076388]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049981, P01MH076388, U01MH090325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants U01MH090325, R01-MH049981 and P01-MH076388 (to SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Bahri S, 2010, DEVELOPMENT, V137, P2023, DOI 10.1242/dev.045088; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bost KL, 2004, FRONT BIOSCI-LANDMRK, V9, P3331, DOI 10.2741/1484; Brain SD, 1997, IMMUNOPHARMACOLOGY, V37, P133, DOI 10.1016/S0162-3109(97)00055-6; Chahl LA, 2006, CURR DRUG TARGETS, V7, P993, DOI 10.2174/138945006778019309; CHANG MM, 1970, J BIOL CHEM, V245, P4784; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Ebner K, 2006, AMINO ACIDS, V31, P251, DOI 10.1007/s00726-006-0335-9; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; FONG TM, 1992, MOL PHARMACOL, V41, P24; Goode T, 2000, CLIN DIAGN LAB IMMUN, V7, P371, DOI 10.1128/CDLI.7.3.371-376.2000; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEUILLET E, 1993, J NEUROCHEM, V60, P868, DOI 10.1111/j.1471-4159.1993.tb03231.x; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Huebert RC, 2010, HEPATOLOGY, V52, P238, DOI 10.1002/hep.23628; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; KAGE R, 1993, J NEUROCHEM, V60, P347, DOI 10.1111/j.1471-4159.1993.tb05857.x; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Lai JP, 2006, P NATL ACAD SCI USA, V103, P7771, DOI 10.1073/pnas.0602563103; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; LANIYONU A, 1988, FEBS LETT, V240, P186, DOI 10.1016/0014-5793(88)80365-X; Meshki J, 2009, J BIOL CHEM, V284, P9280, DOI 10.1074/jbc.M808825200; NICOLL RA, 1980, ANNU REV NEUROSCI, V3, P227, DOI 10.1146/annurev.ne.03.030180.001303; OBLAS B, 1990, BIOCHEM BIOPH RES CO, V166, P978, DOI 10.1016/0006-291X(90)90907-5; Palma C, 2006, CURR DRUG TARGETS, V7, P1043, DOI 10.2174/138945006778019282; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Rosenkranz MA, 2007, PSYCHOL BULL, V133, P1007, DOI 10.1037/0033-2909.133.6.1007; Satake H, 2006, CURR DRUG TARGETS, V7, P963, DOI 10.2174/138945006778019273; Svensson A, 2005, J IMMUNOL, V175, P6802, DOI 10.4049/jimmunol.175.10.6802; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Thorley JA, 2010, PROTOPLASMA, V244, P15, DOI 10.1007/s00709-010-0152-6; Tuluc F, 2009, TRENDS IMMUNOL, V30, P271, DOI 10.1016/j.it.2009.03.006; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	47	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25332	10.1371/journal.pone.0025332	http://dx.doi.org/10.1371/journal.pone.0025332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966499	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100045
J	Singer, E; Emerson, D; Webb, EA; Barco, RA; Kuenen, JG; Nelson, WC; Chan, CS; Comolli, LR; Ferriera, S; Johnson, J; Heidelberg, JF; Edwards, KJ				singer, Esther; Emerson, David; Webb, Eric A.; Barco, Roman A.; Kuenen, J. Gijs; Nelson, William C.; Chan, Clara S.; Comolli, Luis R.; Ferriera, Steve; Johnson, Justin; Heidelberg, John F.; Edwards, Katrina J.			Mariprofundus ferrooxydans PV-1 the First Genome of a Marine Fe(II) Oxidizing Zetaproteobacterium	PLOS ONE			English	Article							CHEMOLITHOTROPH THIOBACILLUS-NEAPOLITANUS; GREEN-SULFUR BACTERIUM; DE-FUCA RIDGE; HYDROTHERMAL VENTS; ACIDITHIOBACILLUS-FERROOXIDANS; FERROUS IRON; INTRACELLULAR POLYGLUCOSE; MICROBIAL GENOMES; ELECTRON-TRANSFER; PURPLE BACTERIA	Mariprofundus ferrooxydans PV-1 has provided the first genome of the recently discovered Zetaproteobacteria subdivision. Genome analysis reveals a complete TCA cycle, the ability to fix CO2, carbon-storage proteins and a sugar phosphotransferase system (PTS). The latter could facilitate the transport of carbohydrates across the cell membrane and possibly aid in stalk formation, a matrix composed of exopolymers and/or exopolysaccharides, which is used to store oxidized iron minerals outside the cell. Two-component signal transduction system genes, including histidine kinases, GGDEF domain genes, and response regulators containing CheY-like receivers, are abundant and widely distributed across the genome. Most of these are located in close proximity to genes required for cell division, phosphate uptake and transport, exopolymer and heavy metal secretion, flagellar biosynthesis and pilus assembly suggesting that these functions are highly regulated. Similar to many other motile, microaerophilic bacteria, genes encoding aerotaxis as well as antioxidant functionality (e.g., superoxide dismutases and peroxidases) are predicted to sense and respond to oxygen gradients, as would be required to maintain cellular redox balance in the specialized habitat where M. ferrooxydans resides. Comparative genomics with other Fe(II) oxidizing bacteria residing in freshwater and marine environments revealed similar content, synteny, and amino acid similarity of coding sequences potentially involved in Fe( II) oxidation, signal transduction and response regulation, oxygen sensation and detoxification, and heavy metal resistance. This study has provided novel insights into the molecular nature of Zetaproteobacteria.	[singer, Esther; Edwards, Katrina J.] Univ So Calif, Geomicrobiol Grp, Dept Earth Sci, Los Angeles, CA 90095 USA; [Emerson, David] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Webb, Eric A.; Barco, Roman A.; Nelson, William C.; Heidelberg, John F.; Edwards, Katrina J.] Univ So Calif, Dept Biol Sci, Marine Environm Biol Sect, Los Angeles, CA 90089 USA; [Kuenen, J. Gijs] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands; [Chan, Clara S.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Comolli, Luis R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Ferriera, Steve; Johnson, Justin] J Craig Venter Inst, San Diego, CA USA	University of Southern California; Bigelow Laboratory for Ocean Sciences; University of Southern California; Delft University of Technology; Woods Hole Oceanographic Institution; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; J. Craig Venter Institute	Singer, E (corresponding author), Univ So Calif, Geomicrobiol Grp, Dept Earth Sci, Los Angeles, CA 90095 USA.	kje@usc.edu	Chan, Clara S/B-6420-2011; Nelson, William C/E-9263-2016; Comolli, Luis Raul/C-5907-2017	Chan, Clara S/0000-0003-1810-4994; Nelson, William C/0000-0002-1873-3929; Singer, Esther/0000-0002-3126-2199; Comolli, Luis Raul/0000-0002-9313-6550; Heidelberg, John/0000-0003-0673-3224	NSF; Gordon and Betty Moore Foundation; College of Letters, Arts, and Sciences at the University of Southern California; NASA Astrobiology Institute; Office of Science, Basic Energy Sciences, Division of Materials Science of the United States Department of Energy [DE-AC02-05CH11231]	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); College of Letters, Arts, and Sciences at the University of Southern California; NASA Astrobiology Institute; Office of Science, Basic Energy Sciences, Division of Materials Science of the United States Department of Energy(United States Department of Energy (DOE))	Funding has been provided by the NSF Microbial Observatories Program (KJE, DE), NSF's Science and Technology Program, by the Gordon and Betty Moore Foundation (KJE), the College of Letters, Arts, and Sciences at the University of Southern California (KJE), and by the NASA Astrobiology Institute (KJE, DE). Advanced Light Source analyses at the Lawrence Berkeley National Lab are supported by the Office of Science, Basic Energy Sciences, Division of Materials Science of the United States Department of Energy (DE-AC02-05CH11231). This is the Center for Dark Energy Biosphere Investigations contribution #110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; BEUDEKER RF, 1981, ARCH MICROBIOL, V129, P221, DOI 10.1007/BF00425255; BEUDEKER RF, 1981, FEMS MICROBIOL LETT, V12, P337; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Chang C.-C., 2010, P 2010 INT JOINT C N, P1, DOI DOI 10.1109/ICC.2010.5502361; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Comolli LR, 2006, J MICROSC-OXFORD, V223, P40, DOI 10.1111/j.1365-2818.2006.01597.x; Croal LR, 2007, J BACTERIOL, V189, P1774, DOI 10.1128/JB.01395-06; Croal LR, 2004, ANNU REV GENET, V38, P175, DOI 10.1146/annurev.genet.38.072902.091138; Davis R, 2005, AGU FALL M SAN FRANC; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; Drummond AJ, 2010, GENEIOUS; Druschel GK, 2008, GEOCHIM COSMOCHIM AC, V72, P3358, DOI 10.1016/j.gca.2008.04.035; Eder W, 2001, APPL ENVIRON MICROB, V67, P3077, DOI 10.1128/AEM.67.7.3077-3085.2001; Edwards KJ, 2011, ISME J; EHRENREICH A, 1994, APPL ENVIRON MICROB, V60, P4517, DOI 10.1128/AEM.60.12.4517-4526.1994; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Elbehti A, 2000, J BACTERIOL, V182, P3602, DOI 10.1128/JB.182.12.3602-3606.2000; Emerson D, 2005, METHOD ENZYMOL, V397, P112, DOI 10.1016/S0076-6879(05)97006-7; Emerson D, 1997, APPL ENVIRON MICROB, V63, P4784, DOI 10.1128/AEM.63.12.4784-4792.1997; Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Emerson D, 2010, OCEANOGRAPHY, V23, P148, DOI 10.5670/oceanog.2010.67; Forget NL, 2010, GEOBIOLOGY, V8, P417, DOI 10.1111/j.1472-4669.2010.00247.x; FRANCIS RT, 1984, ANAL BIOCHEM, V136, P509, DOI 10.1016/0003-2697(84)90253-7; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Glazer BT, 2009, GEOMICROBIOL J, V26, P606, DOI 10.1080/01490450903263392; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; GOMMERS PJF, 1988, ARCH MICROBIOL, V150, P117, DOI 10.1007/BF00425150; GORBY YA, 1991, APPL ENVIRON MICROB, V57, P867, DOI 10.1128/AEM.57.3.867-870.1991; Gottschalk G., 1986, BACTERIAL METABOLISM; GUAY R, 1977, BIOTECHNOL BIOENG, V19, P727, DOI 10.1002/bit.260190509; Haber F, 1932, NATURWISSENSCHAFTEN, V20, P948, DOI 10.1007/BF01504715; Heising S, 1999, ARCH MICROBIOL, V172, P116, DOI 10.1007/s002030050748; Hernandez JM, 1996, J BACTERIOL, V178, P347, DOI 10.1128/jb.178.2.347-356.1996; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Kappler A, 2004, GEOCHIM COSMOCHIM AC, V68, P1217, DOI 10.1016/j.gca.2003.09.006; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kennedy CB, 2003, GEOMICROBIOL J, V20, P199, DOI 10.1080/01490450303873; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; LANDER E S, 1988, Genomics, V2, P231; LAZAROFF N, 1982, APPL ENVIRON MICROB, V43, P924, DOI 10.1128/AEM.43.4.924-938.1982; Li XZ, 2009, J BACTERIOL, V191, P2675, DOI 10.1128/JB.01814-08; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Mahmoud KK, 2005, J MICROBIOL METH, V61, P33, DOI 10.1016/j.mimet.2004.10.022; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; MCFADDEN BA, 1973, BACTERIOL REV, V37, P289, DOI 10.1128/MMBR.37.3.289-319.1973; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Omata T, 1999, P NATL ACAD SCI USA, V96, P13571, DOI 10.1073/pnas.96.23.13571; OREN A, 1979, ARCH MICROBIOL, V122, P77, DOI 10.1007/BF00408049; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rassa AC, 2009, GEOMICROBIOL J, V26, P623, DOI 10.1080/01490450903263350; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Shi L, 2008, J BACTERIOLOGY; Shi LA, 2009, ENV MICROBIOL REP, V1, P220, DOI 10.1111/j.1758-2229.2009.00035.x; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Staudigel H, 2006, P NATL ACAD SCI USA, V103, P6448, DOI 10.1073/pnas.0600830103; Straub K, 2001, FEMS MICROBIOLOGY EC; TABITA FR, 1995, ADV PHOTOSYNTH, V2, P885; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Toner BM, 2009, GEOCHIM COSMOCHIM AC, V73, P388, DOI 10.1016/j.gca.2008.09.035; Weber KA, 2006, APPL ENVIRON MICROB, V72, P686, DOI 10.1128/AEM.72.1.686-694.2006; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l; Yarzabal A, 2002, FEMS MICROBIOL LETT, V209, P189, DOI 10.1016/S0378-1097(02)00514-1; Yarzabal A, 2002, J BACTERIOL, V184, P313, DOI 10.1128/JB.184.1.313-317.2002; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114	76	104	107	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25386	10.1371/journal.pone.0025386	http://dx.doi.org/10.1371/journal.pone.0025386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966516	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100053
J	Walther, B; Hossin, S; Townend, J; Abernethy, N; Parker, D; Jeffries, D				Walther, Brigitte; Hossin, Safayet; Townend, John; Abernethy, Neil; Parker, David; Jeffries, David			Comparison of Electronic Data Capture (EDC) with the Standard Data Capture Method for Clinical Trial Data	PLOS ONE			English	Article							HAND-HELD COMPUTERS; SKILL; ENTRY; AGE	Background: Traditionally, clinical research studies rely on collecting data with case report forms, which are subsequently entered into a database to create electronic records. Although well established, this method is time-consuming and error-prone. This study compares four electronic data capture (EDC) methods with the conventional approach with respect to duration of data capture and accuracy. It was performed in a West African setting, where clinical trials involve data collection from urban, rural and often remote locations. Methodology/Principal Findings: Three types of commonly available EDC tools were assessed in face-to-face interviews; netbook, PDA, and tablet PC. EDC performance during telephone interviews via mobile phone was evaluated as a fourth method. The Graeco Latin square study design allowed comparison of all four methods to standard paper-based recording followed by data double entry while controlling simultaneously for possible confounding factors such as interview order, interviewer and interviewee. Over a study period of three weeks the error rates decreased considerably for all EDC methods. In the last week of the study the data accuracy for the netbook (5.1%, CI95%: 3.5-7.2%) and the tablet PC (5.2%, CI95%: 3.7-7.4%) was not significantly different from the accuracy of the conventional paper-based method (3.6%, CI95%: 2.2-5.5%), but error rates for the PDA (7.9%, CI95%: 6.0-10.5%) and telephone (6.3%, CI95% 4.6-8.6%) remained significantly higher. While EDC-interviews take slightly longer, data become readily available after download, making EDC more time effective. Free text and date fields were associated with higher error rates than numerical, single select and skip fields. Conclusions: EDC solutions have the potential to produce similar data accuracy compared to paper-based methods. Given the considerable reduction in the time from data collection to database lock, EDC holds the promise to reduce research-associated costs. However, the successful implementation of EDC requires adjustment of work processes and reallocation of resources.	[Walther, Brigitte; Hossin, Safayet; Townend, John; Parker, David; Jeffries, David] MRC, Stat & Data Management Dept, Fajara, Gambia; [Abernethy, Neil] Univ Washington, Dept Bioinformat, Seattle, WA 98195 USA; [Jeffries, David] Populat Serv Int, Washington, DC USA	University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of Washington Seattle	Walther, B (corresponding author), MRC, Stat & Data Management Dept, Fajara, Gambia.	waltherbrigitte@t-online.de			Medical Research Council (UK), The Gambia	Medical Research Council (UK), The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (UK), The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza, 2011, OPENCLINICA 3 1; Akaza Research, 2003, AK RES; Bosman E. A., 1996, PERSPECTIVES COGNITI, P428; BOSMAN EA, 1993, PSYCHOL AGING, V8, P87, DOI 10.1037/0882-7974.8.1.87; Congress.gov, 1996, HLTH INSURANCE PORTA; Eng JLV, 2007, AM J TROP MED HYG, V77, P393, DOI 10.4269/ajtmh.2007.77.393; Franklin JD, 2011, J BIOMED INFORM, DOI [101016/jjbi201105008, DOI 10.1016/JJBI201105008]; Gamtel, 2009, GAMT CREAT BRIGHT FU; Garritty C, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e7; Health Decisions, 2009, SMARTPEN ADV EDC SYS; International Telecommunication Union, 2009, INT TEL UN MEAS INF, P33; Kayiwa D, 2010, MOBILE DATA ENTRY US; Lane Shannon J, 2006, BMC Med Inform Decis Mak, V6, P23, DOI 10.1186/1472-6947-6-23; MEASURE DHS, 2010, DEM HLTH SURV; Meunier PNS, 2002, P 11 IEEE INT WORKSH; Netpage, 2008, NETPAGE TECHNOLOGY S; Ocran CQ, 2007, GENERIC ADJUDICATED, P9; QuantumNET, 2008, QUANTUMNET GROUP SET; SALTHOUSE TA, 1984, J EXP PSYCHOL GEN, V113, P345, DOI 10.1037/0096-3445.113.3.345; SEARS A, 1993, BEHAV INFORM TECHNOL, V12, P17, DOI 10.1080/01449299308924362; Seebregts CJ, 2009, INT J MED INFORM, V78, P721, DOI 10.1016/j.ijmedinf.2008.10.006; Shelby-James TM, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-5; SMITH DC, 1982, BYTE, V7, P242; Snap Surveys, 2010, SNAP SURV SOFTW; Tesler L., 1981, BYTE, V6, P90; Tomlinson M, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-51; U.S. Department of Health & Human Services, 2005, PAT SAF QUAL IMPR AC; UNICEF, 2010, MULT IND CLUST SURV; US FDA, 2007, GUID IND COMP SYST U; World Health Organization, 2002, WORLD HLTH SURV 2002; Wright P, 2000, ERGONOMICS, V43, P702, DOI 10.1080/001401300404689	31	83	85	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25348	10.1371/journal.pone.0025348	http://dx.doi.org/10.1371/journal.pone.0025348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966505	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100047
J	Drwal, MN; Agama, K; Wakelin, LPG; Pommier, Y; Griffith, R				Drwal, Malgorzata N.; Agama, Keli; Wakelin, Laurence P. G.; Pommier, Yves; Griffith, Renate			Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents	PLOS ONE			English	Article							PLANT ANTITUMOR AGENTS; CAMPTOTHECIN RESISTANCE; DRUG DISCOVERY; INHIBITORS; NORINDENOISOQUINOLINE; DERIVATIVES; MECHANISM; DESIGN; ORIENTATION; FLAVONOIDS	DNA topoisomerase I (Top1) is over-expressed in tumour cells and is an important target in cancer chemotherapy. It relaxes DNA torsional strain generated during DNA processing by introducing transient single-strand breaks and allowing the broken strand to rotate around the intermediate Top1 -DNA covalent complex. This complex can be trapped by a group of anticancer agents interacting with the DNA bases and the enzyme at the cleavage site, preventing further topoisomerase activity. Here we have identified novel Top1 inhibitors as potential anticancer agents by using a combination of structure- and ligand-based molecular modelling methods. Pharmacophore models have been developed based on the molecular characteristics of derivatives of the alkaloid camptothecin (CPT), which represent potent antitumour agents and the main group of Top1 inhibitors. The models generated were used for in silico screening of the National Cancer Institute (NCI, USA) compound database, leading to the identification of a set of structurally diverse molecules. The strategy is validated by the observation that amongst these molecules are several known Top1 inhibitors and agents cytotoxic against human tumour cell lines. The potential of the untested hits to inhibit Top1 activity was further evaluated by docking into the binding site of a Top1 -DNA complex, resulting in a selection of 10 compounds for biological testing. Limited by the compound availability, 7 compounds have been tested in vitro for their Top1 inhibitory activity, 5 of which display mild to moderate Top1 inhibition. A further compound, found by similarity search to the active compounds, also shows mild activity. Although the tested compounds display only low in vitro antitumour activity, our approach has been successful in the identification of structurally novel Top1 inhibitors worthy of further investigation as potential anticancer agents.	[Drwal, Malgorzata N.; Wakelin, Laurence P. G.; Griffith, Renate] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia; [Agama, Keli; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	University of New South Wales Sydney; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Drwal, MN (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia.	r.griffith@unsw.edu.au	Drwal, Malgorzata/B-6461-2015; Griffith, Renate/A-3584-2015	Griffith, Renate/0000-0001-7739-5686	University of New South Wales; National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	University of New South Wales; National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for the computer-aided design work was provided by internal University of New South Wales funding (Faculty grant to RG, scholarship to MD). The biological assays were supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andricopulo AD, 2009, CURR TOP MED CHEM, V9, P771, DOI 10.2174/156802609789207127; Bailly C, 2003, CRIT REV ONCOL HEMAT, V45, P91, DOI 10.1016/S1040-8428(02)00090-2; Brangi M, 1999, CANCER RES, V59, P5938; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; CREAVEN PJ, 1973, CANCER CHEMOTH REP 1, V57, P175; Dexheimer TS, 2008, NAT PROTOC, V3, P1736, DOI 10.1038/nprot.2008.174; Dong G, 2010, J MED CHEM; Gao QZ, 2010, CURR COMPUT-AID DRUG, V6, P37, DOI 10.2174/157340910790980151; GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461; Hein M., 2010, DRUG DISCOV TODAY-TE, V7, pe229, DOI [10.1016/j.ddtec.2010.12.003, DOI 10.1016/J.DDTEC.2010.12.003]; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KIKUCHI Y, 1991, CHEM PHARM BULL, V39, P1466, DOI 10.1248/cpb.39.1466; Kiselev E, 2010, J MED CHEM, V53, P8716, DOI 10.1021/jm101048k; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; LACKEY K, 1995, J MED CHEM, V38, P906, DOI 10.1021/jm00006a008; Lackey K, 1996, J MED CHEM, V39, P713, DOI 10.1021/jm950507y; Lansiaux A, 2007, MOL PHARMACOL, V72, P311, DOI 10.1124/mol.107.034637; Li HS., 2000, PRINCIPLES TECHNIQUE; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lloyd DG, 2006, DRUG DISCOV TODAY, V11, P149, DOI 10.1016/S1359-6446(05)03688-3; LUZZIO MJ, 1995, J MED CHEM, V38, P395, DOI 10.1021/jm00003a001; Marchand C, 2006, MOL CANCER THER, V5, P287, DOI 10.1158/1535-7163.MCT-05-0456; Meng LH, 2003, CURR TOP MED CHEM, V3, P305; Oprea TI, 2002, J COMPUT AID MOL DES, V16, P325, DOI 10.1023/A:1020877402759; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Pommier Y, 2009, MOL CANCER THER, V8, P1008, DOI 10.1158/1535-7163.MCT-08-0706; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Song YL, 2008, J PHYS CHEM B, V112, P9484, DOI 10.1021/jp8005603; Song YL, 2010, J MED CHEM, V53, P1979, DOI 10.1021/jm901649x; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Talevi A, 2009, CURR COMPUT-AID DRUG, V5, P23, DOI 10.2174/157340909787580854; UEHLING DE, 1995, J MED CHEM, V38, P1106, DOI 10.1021/jm00007a008; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; WALL ME, 1993, J MED CHEM, V36, P2689, DOI 10.1021/jm00070a013; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Webb MR, 2004, BIOCHEM J, V384, P527, DOI 10.1042/BJ20040474; WILLETT P, 1986, QUANT STRUCT-ACT REL, V5, P18, DOI 10.1002/qsar.19860050105; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013; Zhang XW, 1999, ANTI-CANCER DRUG, V10, P569, DOI 10.1097/00001813-199907000-00009	47	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25150	10.1371/journal.pone.0025150	http://dx.doi.org/10.1371/journal.pone.0025150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966440	gold, Green Submitted, Green Published			2022-12-27	WOS:000295265100068
J	Marathe, A; Lewis, B; Barrett, C; Chen, JZ; Marathe, M; Eubank, S; Ma, YF				Marathe, Achla; Lewis, Bryan; Barrett, Christopher; Chen, Jiangzhuo; Marathe, Madhav; Eubank, Stephen; Ma, Yifei			Comparing Effectiveness of Top-Down and Bottom-Up Strategies in Containing Influenza	PLOS ONE			English	Article								This research compares the performance of bottom-up, self-motivated behavioral interventions with top-down interventions targeted at controlling an "Influenza-like-illness''. Both types of interventions use a variant of the ring strategy. In the first case, when the fraction of a person's direct contacts who are diagnosed exceeds a threshold, that person decides to seek prophylaxis, e. g. vaccine or antivirals; in the second case, we consider two intervention protocols, denoted Block and School: when a fraction of people who are diagnosed in a Census Block (resp., School) exceeds the threshold, prophylax the entire Block (resp., School). Results show that the bottom-up strategy outperforms the top-down strategies under our parameter settings. Even in situations where the Block strategy reduces the overall attack rate well, it incurs a much higher cost. These findings lend credence to the notion that if people used antivirals effectively, making them available quickly on demand to private citizens could be a very effective way to control an outbreak.	[Marathe, Achla; Lewis, Bryan; Barrett, Christopher; Chen, Jiangzhuo; Marathe, Madhav; Eubank, Stephen; Ma, Yifei] Virginia Tech, Network Dynam & Simulat Sci Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Marathe, Achla] Virginia Tech, Dept Agr & Appl Econ, Blacksburg, VA USA; [Barrett, Christopher; Marathe, Madhav] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Eubank, Stephen] Virginia Tech, Dept Phys, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Marathe, A (corresponding author), Virginia Tech, Network Dynam & Simulat Sci Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	amarathe@vbi.vt.edu	Eubank, Stephen/AAD-5089-2021; Eubank, Stephen/D-7497-2011	Chen, Jiangzhuo/0000-0002-2729-3881; Eubank, Stephen/0000-0002-7177-309X	National Science Foundation [CNS-0626964, SES-0729441, OCI-0904844, CNS-0831633, CNS-0845700, CNS-1011769, OCI-1032677]; Defense Threat Reduction Agency [HDTRA1-0901-0017, HDTRA1-07-C-0113]; Department of Energy [DE-SC0003957]; United States Naval Surface Warfare Center [N00178-09-D-3017 DEL ORDER 13]; National Institutes of Health [2U01GM070694-7]; National Institute of Allergy and Infectious Disease & National Institute of Health [HHSN272201000056C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Department of Energy(United States Department of Energy (DOE)); United States Naval Surface Warfare Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease & National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been partially supported by National Science Foundation Networking Technology and Systems Grant CNS-0626964, National Science Foundation Human and Social Dynamics Grant SES-0729441, National Science Foundation Accelerating Discovery in Science and Engineering Through PetaScale Simulations and Analysis Grant OCI-0904844, National Science Foundation Networking Technology and Systems Grant CNS-0831633, National Science Foundation Research Experiences for Undergraduates Supplement Grant CNS-0845700, National Science Foundation Network Science and Engineering Grant CNS-1011769, National Science Foundation Software Development for Cyberinfrastructure Grant OCI-1032677, Defense Threat Reduction Agency Research & Development Grant HDTRA1-0901-0017, Defense Threat Reduction Agency Comprehensive National Incident Management System Grant HDTRA1-07-C-0113, Department of Energy Grant DE-SC0003957, United States Naval Surface Warfare Center Grant N00178-09-D-3017 DEL ORDER 13, National Institutes of Health Models of Infectious Disease Agent Study project 2U01GM070694-7 and National Institute of Allergy and Infectious Disease & National Institute of Health project HHSN272201000056C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey NTJ, 1975, MATH THEORY INFECT D; Balicer RD, 2005, EMERGING INFECT DIS, P11; Barrett C., 2001, LAUR001725; Barrett C.L., 2008, SC 2008 P 2008 ACMIE, P1, DOI DOI 10.1109/SC.2008.5214892; Barrett C, 2010, AI MAG, V31, P75, DOI 10.1609/aimag.v31i1.2283; Beckman RJ, 1996, TRANSPORT RES A-POL, V30, P415, DOI 10.1016/0965-8564(96)00004-3; Bisset K., 2009, DOE SCIDAC MAG, V66, P36; Bisset KR, 2009, ICS'09: PROCEEDINGS OF THE 2009 ACM SIGARCH INTERNATIONAL CONFERENCE ON SUPERCOMPUTING, P430, DOI 10.1145/1542275.1542336; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson N, 2005, NATURE; KUZNETSOV YA, 1994, J MATH BIOL, V32, P109, DOI 10.1007/BF00163027; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Murray J., 2002, BIOMATHEMATICS, V19	13	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25149	10.1371/journal.pone.0025149	http://dx.doi.org/10.1371/journal.pone.0025149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966439	gold, Green Published, Green Submitted			2022-12-27	WOS:000295265100067
J	Necchi, F; Nardi-Dei, V; Biagini, M; Assfalg, M; Nuccitelli, A; Cozzi, R; Norais, N; Telford, JL; Rinaudo, CD; Grandi, G; Maione, D				Necchi, Francesca; Nardi-Dei, Vincenzo; Biagini, Massimiliano; Assfalg, Michael; Nuccitelli, Annalisa; Cozzi, Roberta; Norais, Nathalie; Telford, John L.; Rinaudo, C. Daniela; Grandi, Guido; Maione, Domenico			Sortase A Substrate Specificity in GBS Pilus 2a Cell Wall Anchoring	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; ACTINOMYCES-NAESLUNDII; EPITHELIAL-CELLS; SURFACE-PROTEINS; LPXTG MOTIF; TRANSPEPTIDASE; COLONIZATION; INVOLVEMENT	Streptococcus agalactiae, also referred to as Group B Streptococcus (GBS), is one of the most common causes of life-threatening bacterial infections in infants. In recent years cell surface pili have been identified in several Gram-positive bacteria, including GBS, as important virulence factors and promising vaccine candidates. In GBS, three structurally distinct types of pili have been discovered (pilus 1, 2a and 2b), whose structural subunits are assembled in high-molecular weight polymers by specific class C sortases. In addition, the highly conserved housekeeping sortase A (SrtA), whose main role is to link surface proteins to bacterial cell wall peptidoglycan by a transpeptidation reaction, is also involved in pili cell wall anchoring in many bacteria. Through in vivo mutagenesis, we demonstrate that the LPXTG sorting signal of the minor ancillary protein (AP2) is essential for pilus 2a anchoring. We successfully produced a highly purified recombinant SrtA (SrtA(Delta N40)) able to specifically hydrolyze the sorting signal of pilus 2a minor ancillary protein (AP2-2a) and catalyze in vitro the transpeptidation reaction between peptidoglycan analogues and the LPXTG motif, using both synthetic fluorescent peptides and recombinant proteins. By contrast, SrtADN40 does not catalyze the transpeptidation reaction with substrate-peptides mimicking sorting signals of the other pilus 2a subunits (the backbone protein and the major ancillary protein). Thus, our results add further insight into the proposed model of GBS pilus 2a assembly, in which SrtA is required for pili cell wall covalent attachment, acting exclusively on the minor accessory pilin, representing the terminal subunit located at the base of the pilus.	[Necchi, Francesca; Nardi-Dei, Vincenzo; Biagini, Massimiliano; Nuccitelli, Annalisa; Cozzi, Roberta; Norais, Nathalie; Telford, John L.; Rinaudo, C. Daniela; Grandi, Guido; Maione, Domenico] Novartis Vaccines & Diagnost, Siena, Italy; [Assfalg, Michael] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy	Novartis; University of Verona	Necchi, F (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020	Grandi, Guido/0000-0001-9724-2185; Assfalg, Michael/0000-0001-9331-3169	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was supported by internal funding from Novartis Vaccines and Diagnostics, whose role, through the employment of Francesca Necchi, Vincenzo Nardi-Dei, Massimiliano Biagini, Annalisa Nuccitelli, Roberta Cozzi, Nathalie Norais, John L. Telford, C. Daniela Rinaudo, Guido Grandi and Domenico Maione, involved conceiving, designing and performing the experiments and analyzing the data.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; CHANG C, 2001, MOL MICROBIOL, V79, P1236; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cozzi R, 2011, FASEB J, V25, P1874, DOI 10.1096/fj.10-174797; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Reinscheid DJ, 2003, FEMS MICROBIOL LETT, V221, P73, DOI 10.1016/S0378-1097(03)00167-8; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yeung MK, 1997, INFECT IMMUN, V65, P2629, DOI 10.1128/IAI.65.7.2629-2639.1997	37	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25300	10.1371/journal.pone.0025300	http://dx.doi.org/10.1371/journal.pone.0025300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991306	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300008
J	Conte, E; Fruciano, M; Fagone, E; Gili, E; Caraci, F; Iemmolo, M; Crimi, N; Vancheri, C				Conte, Enrico; Fruciano, Mary; Fagone, Evelina; Gili, Elisa; Caraci, Filippo; Iemmolo, Maria; Crimi, Nunzio; Vancheri, Carlo			Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 Isoforms	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-PROLIFERATION; PULMONARY-FIBROSIS; P38 MAPK; PHOSPHOINOSITIDE; ACTIVATION; EXPRESSION	Idiopathic pulmonary fibrosis (IPF) is a progressive fibroproliferative disease characterized by an accumulation of fibroblasts and myofibroblasts in the alveolar wall. Even though the pathogenesis of this fatal disorder remains unclear, transforming growth factor-beta (TGF-beta)-induced differentiation and proliferation of myofibroblasts is recognized as a primary event. The molecular pathways involved in TGF-beta signalling are generally Smad-dependent yet Smad-independent pathways, including phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), have been recently proposed. In this research we established ex-vivo cultures of human lung fibroblasts and we investigated the role of the PI3K/Akt pathway in two critical stages of the fibrotic process induced by TGF-beta: fibroblast proliferation and differentiation into myofibroblasts. Here we show that the pan-inhibitor of PI3Ks LY294002 is able to abrogate the TGF-beta-induced increase in cell proliferation, in alpha-smooth muscle actin expression and in collagen production besides inhibiting Akt phosphorylation, thus demonstrating the centrality of the PI3K/Akt pathway in lung fibroblast proliferation and differentiation. Moreover, for the first time we show that PI3K p110 delta and p110 gamma are functionally expressed in human lung fibroblasts, in addition to the ubiquitously expressed p110 alpha and beta. Finally, results obtained with both selective inhibitors and gene knocking-down experiments demonstrate a major role of p110 gamma and p110 alpha in both TGF-beta-induced fibroblast proliferation and differentiation. This finding suggests that specific PI3K isoforms can be pharmacological targets in IPF.	[Conte, Enrico; Fruciano, Mary; Fagone, Evelina; Gili, Elisa; Caraci, Filippo; Iemmolo, Maria; Crimi, Nunzio; Vancheri, Carlo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy	University of Catania	Conte, E (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	econte@unict.it	Fruciano, Mary/K-8102-2016; Crimi, Nunzio/AAL-2994-2020; Caraci, Filippo/K-2262-2016; Conte, Enrico/AAD-4597-2019; VANCHERI, Carlo/K-9417-2016	Fruciano, Mary/0000-0002-6201-8092; Crimi, Nunzio/0000-0002-8591-4535; Caraci, Filippo/0000-0002-9867-6054; Conte, Enrico/0000-0002-5780-8735; Fagone, Evelina/0000-0001-8413-7300; VANCHERI, Carlo/0000-0002-5120-9926	European Community [HEALTH-F2-2007-202224 eurIPFnet]	European Community(European Commission)	The research has been funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n<SUP>o</SUP> HEALTH-F2-2007-202224 eurIPFnet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Fagone E, 2011, EXP LUNG RES, V37, P162, DOI 10.3109/01902148.2010.524722; FINE A, 1987, J BIOL CHEM, V262, P3897; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Ito K, 2007, J PHARMACOL EXP THER, V321, P1, DOI 10.1124/jpet.106.111674; JORDANA M, 1988, AM REV RESPIR DIS, V137, P579, DOI 10.1164/ajrccm/137.3.579; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Martin MM, 2007, AM J PHYSIOL-LUNG C, V293, pL790, DOI 10.1152/ajplung.00099.2007; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; RAGHU G, 1989, AM REV RESPIR DIS, V140, P95, DOI 10.1164/ajrccm/140.1.95; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Wei X, 2010, BIOCHEM BIOPH RES CO, V397, P311, DOI 10.1016/j.bbrc.2010.05.109; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117	23	89	104	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24663	10.1371/journal.pone.0024663	http://dx.doi.org/10.1371/journal.pone.0024663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984893	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000003
J	Clemens, B; Zvyagintsev, M; Sack, A; Heinecke, A; Willmes, K; Sturm, W				Clemens, Benjamin; Zvyagintsev, Mikhail; Sack, Alexander; Heinecke, Armin; Willmes, Klaus; Sturm, Walter			Revealing the Functional Neuroanatomy of Intrinsic Alertness Using fMRI: Methodological Peculiarities	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; NEURAL MECHANISMS; ATTENTION; TIME; ACTIVATION; NETWORK; SYSTEMS; INNERVATION; ANATOMY; DEFICIT	Clinical observations and neuroimaging data revealed a right-hemisphere fronto-parietal-thalamic-brainstem network for intrinsic alertness, and additional left fronto-parietal activity during phasic alertness. The primary objective of this fMRI study was to map the functional neuroanatomy of intrinsic alertness as precisely as possible in healthy participants, using a novel assessment paradigm already employed in clinical settings. Both the paradigm and the experimental design were optimized to specifically assess intrinsic alertness, while at the same time controlling for sensory-motor processing. The present results suggest that the processing of intrinsic alertness is accompanied by increased activity within the brainstem, thalamus, anterior cingulate gyrus, right insula, and right parietal cortex. Additionally, we found increased activation in the left hemisphere around the middle frontal gyrus (BA 9), the insula, the supplementary motor area, and the cerebellum. Our results further suggest that rather minute aspects of the experimental design may induce aspects of phasic alertness, which in turn might lead to additional brain activation in left-frontal areas not normally involved in intrinsic alertness. Accordingly, left BA 9 activation may be related to co-activation of the phasic alertness network due to the switch between rest and task conditions functioning as an external warning cue triggering the phasic alertness network. Furthermore, activation of the intrinsic alertness network during fixation blocks due to enhanced expectancy shortly before the switch to the task block might, when subtracted from the task block, lead to diminished activation in the typical right hemisphere intrinsic alertness network. Thus, we cautiously suggest that - as a methodological artifact - left frontal activations might show up due to phasic alertness involvement and intrinsic alertness activations might be weakened due to contrasting with fixation blocks, when assessing the functional neuroanatomy of intrinsic alertness with a block design in fMRI studies.	[Clemens, Benjamin; Willmes, Klaus] Univ Hosp RWTH Aachen, Sect Neuropsychol, Neurol Clin, Aachen, Germany; [Clemens, Benjamin; Zvyagintsev, Mikhail; Willmes, Klaus] Univ Hosp RWTH Aachen, Neurofunct Imaging Lab, Interdisciplinary Ctr Clin Res, Aachen, Germany; [Sack, Alexander; Heinecke, Armin] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Sturm, Walter] Univ Hosp RWTH Aachen, Neurol Clin, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University; RWTH Aachen University; RWTH Aachen University Hospital	Clemens, B (corresponding author), Univ Hosp RWTH Aachen, Sect Neuropsychol, Neurol Clin, Aachen, Germany.	clemens@neuropsych.rwth-aachen.de	Willmes, Klaus F/A-1268-2014	Willmes, Klaus F/0000-0002-9012-0553; Sack, Alexander/0000-0002-1471-0885; Zvyagintsev, Mikhail/0000-0001-9521-042X	IZKF Aachen (Interdisciplinary Centre for Clinical Research) [520806]; European Research Council under the European Union [263472]	IZKF Aachen (Interdisciplinary Centre for Clinical Research); European Research Council under the European Union(European Research Council (ERC))	B.C. was funded by a grant from the IZKF Aachen (Interdisciplinary Centre for Clinical Research, grant number 520806). A. S. received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement number 263472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Chica A. B., 2011, CORTEX IN PRESS; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Coull JT, 1998, J NEUROSCI, V18, P7426; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; FernandezDuque D, 1997, NEUROPSYCHOLOGIA, V35, P477, DOI 10.1016/S0028-3932(96)00103-0; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; GASPAR P, 1989, J COMP NEUROL, V279, P249, DOI 10.1002/cne.902790208; Geiser E, 2008, J COGNITIVE NEUROSCI, V20, P541, DOI 10.1162/jocn.2008.20029; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Hausler J, 2009, Z NEUROPSYCHOL, V20, P327, DOI 10.1024/1016-264X.20.4.327; HOWES D, 1975, BRAIN, V98, P317, DOI 10.1093/brain/98.2.317; James W, 1890, PRINCIPLES PSYCHOL, V1; Kiebel SJ, 2000, NEUROIMAGE, V11, P656, DOI 10.1006/nimg.1999.0542; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; LABERGE D, 1990, J NEUROSCI, V10, P613; LADAVAS E, 1987, BRAIN, V110, P167, DOI 10.1093/brain/110.1.167; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; LUU P, 2004, COGNITIVE NEUROSCIEN, P232; Marois R, 2000, NEURON, V25, P717, DOI 10.1016/S0896-6273(00)81073-9; MESULAM MM, 1992, J COMP NEUROL, V318, P316, DOI 10.1002/cne.903180308; Mottaghy FM, 2006, NEUROIMAGE, V29, P225, DOI 10.1016/j.neuroimage.2005.07.034; Murtha S, 1996, HUM BRAIN MAPP, V4, P103, DOI 10.1002/(SICI)1097-0193(1996)4:2<103::AID-HBM2>3.0.CO;2-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Perin B, 2010, BRAIN COGNITION, V72, P271, DOI 10.1016/j.bandc.2009.09.010; Posner M.I., 1987, NEUROPSYCHOL REHABIL, P182; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; POSNER MI, 1975, HDB PSYCHOBIOLOGY; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; ROBINSON RG, 1980, BRAIN RES, V188, P63, DOI 10.1016/0006-8993(80)90557-0; Schubotz RI, 2003, NEUROIMAGE, V20, P173, DOI 10.1016/S1053-8119(03)00218-0; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P563, DOI 10.1016/j.neuropsychologia.2003.11.004; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; STURM W, 1989, NEUROPSYCHOLOGIA, V27, P747, DOI 10.1016/0028-3932(89)90121-8; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Sturm W., 2009, LEHRBUCH KLIN NEUROP, P421; Sturm W, 2007, TESTBATTERIE WAHRNEH; Stuss D.T., 1986, FRONTAL LOBES; Talairach J., 1988, COPLANAR STEREOTAXIC; Thiel CM, 2007, J NEUROPHYSIOL, V97, P2758, DOI 10.1152/jn.00017.2007; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Van Zomeren A.H., 1994, CLIN NEUROPSYCHOLOGY, V1st ed.; Yanaka HT, 2010, NEUROSCI RES, V68, P51, DOI 10.1016/j.neures.2010.05.005	65	33	34	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25453	10.1371/journal.pone.0025453	http://dx.doi.org/10.1371/journal.pone.0025453			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984928	gold, Green Published, Green Submitted			2022-12-27	WOS:000295941300033
J	Paul, AG; Sharma-Walia, N; Chandran, B				Paul, Arun George; Sharma-Walia, Neelam; Chandran, Bala			Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; KAPOSIS-SARCOMA; CYCLOOXYGENASE-2 COX-2; GROWTH-FACTOR; CANCER-CELLS; IN-VITRO; APOPTOSIS; EXPRESSION; INDUCTION; INFECTION	The significance of inflammation in KSHV biology and tumorigenesis prompted us to examine the role of COX-2 in primary effusion lymphoma (PEL), an aggressive AIDS-linked KSHV-associated non-Hodgkin's lymphoma (NHL) using nimesulide, a well-known COX-2 specific NSAID. We demonstrate that (1) nimesulide is efficacious in inducing proliferation arrest in PEL (KSHV+/EBV-; BCBL-1 and BC-3, KSHV+/EBV+; JSC-1), EBV-infected (KSHV-/EBV+; Raji) and non-infected (KSHV-/EBV-; Akata, Loukes, Ramos, BJAB) high malignancy human Burkitt's lymphoma (BL) as well as KSHV-/EBV+ lymphoblastoid (LCL) cell lines; (2) nimesulide is selectively toxic to KSHV infected endothelial cells (TIVE-LTC) compared to TIVE and primary endothelial cells (HMVEC-d); (3) nimesulide reduced KSHV latent gene expression, disrupted p53-LANA-1 protein complexes, and activated the p53/p21 tumor-suppressor pathway; (4) COX-2 inhibition down-regulated cell survival kinases (p-Akt and p-GSK-3b), an angiogenic factor (VEGF-C), PEL defining genes (syndecan-1, aquaporin-3, and vitamin-D3 receptor) and cell cycle proteins such as cyclins E/A and cdc25C; (5) nimesulide induced sustained cell death and G1 arrest in BCBL-1 cells; (6) nimesulide substantially reduced the colony forming capacity of BCBL-1 cells. Overall, our studies provide a comprehensive molecular framework linking COX-2 with PEL pathogenesis and identify the chemotherapeutic potential of nimesulide in treating PEL.	[Paul, Arun George; Sharma-Walia, Neelam; Chandran, Bala] Rosalind Franklin Univ Med & Sci, HM Bligh Canc Res Labs, Dept Microbiol & Immunol, Chicago Med Sch, N Chicago, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Paul, AG (corresponding author), Rosalind Franklin Univ Med & Sci, HM Bligh Canc Res Labs, Dept Microbiol & Immunol, Chicago Med Sch, N Chicago, IL USA.	neelam.sharma-walia@rosalindfranklin.edu		Paul, Arun/0000-0002-4643-2568	Public Health Service [CA128560]; RFUMS H. M. Bligh Cancer Research Fund;  [G2009101428];  [CA 099925]; NATIONAL CANCER INSTITUTE [R01CA099925, R21CA128560] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); RFUMS H. M. Bligh Cancer Research Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by Sigma Xi Grant-in-aid grant G2009101428 to AGP, Public Health Service grant CA128560 to NSW, and CA 099925 and RFUMS H. M. Bligh Cancer Research Fund to B. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2004, LEUKEMIA, V18, P1699, DOI 10.1038/sj.leu.2403460; Aoki M, 2001, TUMOR BIOL, V22, P239, DOI 10.1159/000050622; Bakhle YS, 2001, BRIT J PHARMACOL, V134, P1137, DOI 10.1038/sj.bjp.0704365; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Bernard MP, 2008, CURR PHARM DESIGN, V14, P2051, DOI 10.2174/138161208785294654; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Blumenthal RD, 2001, CLIN CANCER RES, V7, P3178; Campbell FC, 2010, BIOCHEM PHARMACOL, V79, P1, DOI 10.1016/j.bcp.2009.09.005; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; Curreli F, 2005, J CLIN INVEST, V115, P642, DOI 10.1172/JCI200523334; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; DAVIS R, 1994, DRUGS, V48, P431, DOI 10.2165/00003495-199448030-00008; de Groot DJA, 2007, BRIT J CANCER, V97, P1077, DOI 10.1038/sj.bjc.6604010; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; Halfdanarson TR, 2006, ANN ONCOL, V17, P1849, DOI 10.1093/annonc/mdl139; Hocqueloux L, 2001, AIDS, V15, P280, DOI 10.1097/00002030-200101260-00023; Hull MA, 2005, EUR J CANCER, V41, P1854, DOI 10.1016/j.ejca.2005.04.013; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Jones MK, 1999, NAT MED, V5, P1418; Kardosh A, 2005, CANCER BIOL THER, V4, P571, DOI 10.4161/cbt.4.5.1699; Klass CM, 2005, CURR OPIN ONCOL, V17, P447, DOI 10.1097/01.cco.0000172823.01190.6c; Klein U, 2003, BLOOD, V101, P4115, DOI 10.1182/blood-2002-10-3090; Kobayashi M, 2005, EUR J HAEMATOL, V75, P212, DOI 10.1111/j.1600-0609.2005.00498.x; Ladetto M, 2005, BLOOD, V105, P4784, DOI 10.1182/blood-2004-11-4201; Li JY, 2003, WORLD J GASTROENTERO, V9, P915; Liu JF, 2009, CANCER INVEST, V27, P17, DOI 10.1080/07357900801992913; Luppi M, 2005, LEUKEMIA, V19, P473, DOI 10.1038/sj.leu.2403646; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Nun TK, 2007, MOL CANCER THER, V6, P2360, DOI 10.1158/1535-7163.MCT-07-0108; Paul AG, 2010, CANCER RES, V70, P3697, DOI 10.1158/0008-5472.CAN-09-3934; Renard Jean-Francois, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P233, DOI 10.2174/187152006776930855; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Saini AK, 2009, NUTR HOSP, V24, P717, DOI 10.3305/nh.2009.24.6.4557; Sarek G, 2007, J CLIN INVEST, V117, P1019, DOI 10.1172/JCI30945; Sharma-Walia N, 2006, J VIROL, V80, P6534, DOI 10.1128/JVI.00231-06; SHARMAWALIA N, 2010, PLOS PATHOG, V0006; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Sinha-Datta U, 2008, APOPTOSIS, V13, P33, DOI 10.1007/s10495-007-0148-7; Su B, 2009, BIOORG MED CHEM LETT, V19, P6733, DOI 10.1016/j.bmcl.2009.09.109; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Toomey NL, 2001, ONCOGENE, V20, P7029, DOI 10.1038/sj.onc.1204895; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wen KW, 2010, CANCER LETT, V289, P140, DOI 10.1016/j.canlet.2009.07.004; Wun T, 2004, LEUKEMIA RES, V28, P179, DOI 10.1016/S0145-2126(03)00183-8; Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014	53	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24379	10.1371/journal.pone.0024379	http://dx.doi.org/10.1371/journal.pone.0024379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980345	gold, Green Published, Green Submitted			2022-12-27	WOS:000295941300005
J	Wulfken, LM; Moritz, R; Ohlmann, C; Holdenrieder, S; Jung, V; Becker, F; Herrmann, E; Walgenbach-Brunagel, G; von Ruecker, A; Muller, SC; Ellinger, J				Wulfken, Lena M.; Moritz, Rudolf; Ohlmann, Carsten; Holdenrieder, Stefan; Jung, Volker; Becker, Frank; Herrmann, Edwin; Walgenbach-Bruenagel, Gisela; von Ruecker, Alexander; Mueller, Stefan C.; Ellinger, Joerg			MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CANCER; BIOMARKERS; EXPRESSION; KIDNEY; PLASMA; HYPERMETHYLATION; IDENTIFICATION	Background: MicroRNA expression is altered in cancer cells, and microRNAs could serve as diagnostic/prognostic biomarker for cancer patients. Our study was designed to analyze circulating serum microRNAs in patients with renal cell carcinoma (RCC). Methodology/Principal Findings: We first explored microRNA expression profiles in tissue and serum using TaqMan Low Density Arrays in each six malignant and benign samples: Although 109 microRNAs were circulating at higher levels in cancer patients' serum, we identified only 36 microRNAs with up-regulation in RCC tissue and serum of RCC patients. Seven candidate microRNAs were selected for verification based on the finding of up-regulation in serum and tissue of RCC patients: miR-7-1*, miR-93, miR-106b*, miR-210, miR-320b, miR-1233 and miR-1290 levels in serum of healthy controls (n = 30) and RCC (n = 33) patients were determined using quantitative real-time PCR (TaqMan MicroRNA Assays). miR-1233 was increased in RCC patients, and thus validated in a multicentre cohort of 84 RCC patients and 93 healthy controls using quantitative real-time PCR (sensitivity 77.4%, specificity 37.6%, AUC 0.588). We also studied 13 samples of patients with angiomyolipoma or oncocytoma, whose serum miR-1233 levels were similar to RCC patients. Circulating microRNAs were not correlated with clinical-pathological parameters. Conclusions/Significance: MicroRNA levels are distinctly increased in cancer patients, although only a small subset of circulating microRNAs has a tumor-specific origin. We identify circulating miR-1233 as a potential biomarker for RCC patients. Larger-scaled studies are warranted to fully explore the role of circulating microRNAs in RCC.	[Wulfken, Lena M.; Mueller, Stefan C.; Ellinger, Joerg] Univ Klinikum Bonn, Klin & Poliklin Urol & Kinderurol, Bonn, Germany; [Moritz, Rudolf; Herrmann, Edwin] Univ Klinikum Munster, Klin & Poliklin Urol, Munster, Germany; [Ohlmann, Carsten; Jung, Volker; Becker, Frank] Univ Klinikum Saarlandes, Klin & Poliklin Urol, Homburg, Germany; [Holdenrieder, Stefan] Univ Klinikum Bonn, Inst Klin Chem & Klin Pharmakol, Bonn, Germany; [von Ruecker, Alexander] Univ Klinikum Bonn, Inst Pathol, Bonn, Germany	University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Universitatsklinikum des Saarlandes; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; University of Bonn	Wulfken, LM (corresponding author), Univ Klinikum Bonn, Klin & Poliklin Urol & Kinderurol, Bonn, Germany.	joerg.ellinger@ukb.uni-bonn.de	Ellinger, Jörg/D-8389-2011	Ellinger, Jörg/0000-0002-7526-0857	Deutsche Forschungsgemeinschaft [EL-623/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by a research grant to Jorg Ellinger from the Deutsche Forschungsgemeinschaft (EL-623/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; DWEEP H, 2011, J BIOMED INFORM; Ellinger J, 2008, PROSTATE, V68, P42, DOI 10.1002/pros.20651; Ellinger J, 2008, J UROLOGY, V179, P346, DOI 10.1016/j.juro.2007.08.091; Ellinger J, 2008, INT J CANCER, V122, P138, DOI 10.1002/ijc.23057; Ellinger J, 2009, J UROLOGY, V182, P324, DOI 10.1016/j.juro.2009.02.106; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moreira JMA, 2010, MOL CELL PROTEOMICS, V9, P161, DOI 10.1074/mcp.M900294-MCP200; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004	32	185	192	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25787	10.1371/journal.pone.0025787	http://dx.doi.org/10.1371/journal.pone.0025787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984948	Green Submitted, gold, Green Published			2022-12-27	WOS:000295941300058
J	Wu, XH; Chen, S; He, YZ; Rhodes, SD; Mohammad, KS; Li, XH; Yang, XL; Jiang, L; Nalepa, G; Snider, P; Robling, AG; Clapp, DW; Conway, SJ; Guise, TA; Yang, FC				Wu, Xiaohua; Chen, Shi; He, Yongzheng; Rhodes, Steven D.; Mohammad, Khalid S.; Li, Xiaohong; Yang, Xianlin; Jiang, Li; Nalepa, Grzegorz; Snider, Paige; Robling, Alexander G.; Clapp, D. Wade; Conway, Simon J.; Guise, Theresa A.; Yang, Feng-Chun			The Haploinsufficient Hematopoietic Microenvironment Is Critical to the Pathological Fracture Repair in Murine Models of Neurofibromatosis Type 1	PLOS ONE			English	Article							NF1 TUMOR-SUPPRESSOR; BONE-MINERAL-DENSITY; STEM-CELL NICHE; TIBIAL PSEUDOARTHROSIS; SPINAL DEFORMITIES; SKELETAL TISSUES; MICE; GENE; IDENTIFICATION; OSTEOBLAST	Germline mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1 (NF1), a complex genetic disorder with a high predisposition of numerous skeletal dysplasias including short stature, osteoporosis, kyphoscoliosis, and facture non-union (pseudoarthrosis). We have developed rnurine models that phenocopy many of the skeletal dysplasias observed in NF1 patients, including reduced bone mass and fracture non-union. We also show that the development of these skeletal manifestations requires an Nf1 haploinsufficient background in addition to nullizygous loss of Nf1 in mesenchymal stem/progenitor cells (MSCs) and/or their progenies. This is replicated in two animal models of NF1, PeriCre(+);Nf1(flox/-) and Col2.3Cre(+);Nf1(flox/-) mice. Adoptive transfer experiments demonstrate a critical role of the Nf1(+/-) marrow microenvironment in the impaired fracture healing in both models and adoptive transfer of WT bone marrow cells improves fracture healing in these mice. To our knowledge, this is the first demonstration of a non-cell autonomous mechanism in non-malignant NF1 manifestations. Collectively, these data provide evidence of a combinatory effect between nullizygous loss Nf1 in osteoblast progenitors and haploinsufficiency in hematoietic cells in the develpment of non-malignant NF1 manifestations.	[Wu, Xiaohua; Chen, Shi; He, Yongzheng; Li, Xiaohong; Yang, Xianlin; Jiang, Li; Nalepa, Grzegorz; Snider, Paige; Clapp, D. Wade; Conway, Simon J.; Yang, Feng-Chun] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Wu, Xiaohua; Chen, Shi; He, Yongzheng; Rhodes, Steven D.; Li, Xiaohong; Yang, Xianlin; Jiang, Li; Nalepa, Grzegorz; Snider, Paige; Clapp, D. Wade; Conway, Simon J.; Yang, Feng-Chun] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Mohammad, Khalid S.; Guise, Theresa A.] Indiana Univ Sch Med, Dept Internal Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wu, XH (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	fyang@iupui.edu	Mohammad, Khalid/AAE-9569-2022; Mohammad, Khalid/AFE-4205-2022	Lab, Nalepa/0000-0002-7560-1906; Nalepa, Grzegorz/0000-0002-5779-9103	Department of Defense (DOD) [NF043032, NF073112]; March of Dimes [YF08-246]; National Institute of Neurological Disorders and Stroke [NS052606]; Indiana Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS052606] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); March of Dimes(March of Dimes); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Indiana Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Department of Defense (DOD) grant no. NF043032 to FCY and grant no. NF073112 to FCY; March of Dimes grant no. YF08-246 to FCY; National Institute of Neurological Disorders and Stroke grant no. NS052606 to WC, SJC and FCY; and the Indiana Clinical and Translational Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2001, J IMMUNOL, V166, P552, DOI 10.4049/jimmunol.166.1.552; Atit RP, 1999, J INVEST DERMATOL, V112, P835, DOI 10.1046/j.1523-1747.1999.00609.x; Atit RP, 2000, J INVEST DERMATOL, V114, P1093, DOI 10.1046/j.1523-1747.2000.00994.x; Bajenaru ML, 2003, CANCER RES, V63, P8573; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Cecchini MG, 1997, MOL REPROD DEV, V46, P75; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; CRAWFORD AH, 1986, J PEDIATR ORTHOPED, V6, P72, DOI 10.1097/01241398-198601000-00015; CRAWFORD AH, 1989, CLIN ORTHOP RELAT R, P29; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Heuze Y, 2002, Rev Stomatol Chir Maxillofac, V103, P105; Illes T, 2001, OSTEOPOROSIS INT, V12, P823, DOI 10.1007/s001980170032; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jacques C, 2005, J NEURORADIOLOGY, V32, P180, DOI 10.1016/S0150-9861(05)83136-0; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kolanczyk M, 2007, HUM MOL GENET, V16, P874, DOI 10.1093/hmg/ddm032; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; Kruzynska-Frejtag A, 2004, DEV DYNAM, V229, P857, DOI 10.1002/dvdy.10453; Kuorilehto T, 2004, J BONE MINER RES, V19, P983, DOI 10.1359/JBMR.040130; Kuorilehto T, 2005, OSTEOPOROSIS INT, V16, P928, DOI 10.1007/s00198-004-1801-4; Kuorilehto T, 2006, PATHOL RES PRACT, V202, P687, DOI 10.1016/j.prp.2006.03.006; Lammert M, 2005, OSTEOPOROSIS INT, V16, P1161, DOI 10.1007/s00198-005-1940-2; Lindsley A, 2007, DEV BIOL, V307, P340, DOI 10.1016/j.ydbio.2007.04.041; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; MARQUES P, 1951, J Radiol Electrol Arch Electr Medicale, V32, P608; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rasmussen SA, 2000, GENE CHROMOSOME CANC, V28, P425, DOI 10.1002/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rutkowski JL, 2000, HUM MOL GENET, V9, P1059, DOI 10.1093/hmg/9.7.1059; Sawada S, 1996, NAT GENET, V14, P110, DOI 10.1038/ng0996-110; Sbihi A, 1980, Maroc Med, V2, P393; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; Stevenson DA, 2006, AM J HUM GENET, V79, P143, DOI 10.1086/504441; Stevenson DA, 1999, AM J MED GENET, V84, P413, DOI 10.1002/(SICI)1096-8628(19990611)84:5<413::AID-AJMG5>3.0.CO;2-1; Stevenson DA, 2007, J PEDIATR-US, V150, P83, DOI 10.1016/j.jpeds.2006.10.048; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wang W, 2010, J BONE MINER RES; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Warden SJ, 2009, BONE, V44, P485, DOI 10.1016/j.bone.2008.11.007; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang FC, 2006, J CLIN INVEST, V116, P2880, DOI 10.1172/JCI29092; Yu X, 2005, BONE; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang W, 2011, BONE; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	58	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24917	10.1371/journal.pone.0024917	http://dx.doi.org/10.1371/journal.pone.0024917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980365	Green Submitted, Green Published, gold			2022-12-27	WOS:000295939600009
J	Garvin, MR; Bielawski, JP; Gharrett, AJ				Garvin, Michael R.; Bielawski, Joseph P.; Gharrett, Anthony J.			Positive Darwinian Selection in the Piston That Powers Proton Pumps in Complex I of the Mitochondria of Pacific Salmon	PLOS ONE			English	Article							MOLECULAR ADAPTATION; ADAPTIVE SELECTION; NATURAL-SELECTION; DNA; EVOLUTION; MTDNA; ONCORHYNCHUS; HUMANS; SUBSTITUTION; MODELS	The mechanism of oxidative phosphorylation is well understood, but evolution of the proteins involved is not. We combined phylogenetic, genomic, and structural biology analyses to examine the evolution of twelve mitochondrial encoded proteins of closely related, yet phenotypically diverse, Pacific salmon. Two separate analyses identified the same seven positively selected sites in ND5. A strong signal was also detected at three sites of ND2. An energetic coupling analysis revealed several structures in the ND5 protein that may have co-evolved with the selected sites. These data implicate Complex I, specifically the piston arm of ND5 where it connects the proton pumps, as important in the evolution of Pacific salmon. Lastly, the lineage to Chinook experienced rapid evolution at the piston arm.	[Garvin, Michael R.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Div Fisheries, Juneau, AK USA; [Bielawski, Joseph P.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Gharrett, Anthony J.] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	University of Alaska System; University of Alaska Fairbanks; Dalhousie University; Dalhousie University	Garvin, MR (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Div Fisheries, Juneau, AK USA.	mrgarvin@alaska.edu		Garvin, Michael/0000-0002-2204-7569; Bielawski, Joseph/0000-0002-1621-1772	Arctic-Yukon-Kuskokwim-Sustainable-Salmon-Initiative; Alaska Sustainable Salmon Fund	Arctic-Yukon-Kuskokwim-Sustainable-Salmon-Initiative; Alaska Sustainable Salmon Fund	M. Garvin's PhD thesis is being supported by the Arctic-Yukon-Kuskokwim-Sustainable-Salmon-Initiative (www.aykssi.org) and the Alaska Sustainable Salmon Fund (www.akssf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barrowclough GF, 2009, MOL ECOL, V18, P2934, DOI 10.1111/j.1365-294X.2009.04271.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Behnke RJ, 2002, TROUT SALMON N AM; Bielawski JP, 2005, LIKELIHOOD METHODS D; BLIER PU, 1993, J EXP BIOL, V176, P145; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Efremov R.G., 2011, NATURE; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FRIEDBERG EC, 2005, DNA REPAIR MUTATGENE; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Garvin MR, 2010, GENOME, V53, P501, DOI [10.1139/G10-026, 10.1139/g10-026]; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Glemet H, 1998, MOL ECOL, V7, P1655, DOI 10.1046/j.1365-294x.1998.00494.x; GLEMET HC, 1997, MITOCHONDRIAL DNA IN; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hendry A. P., 2004, EVOLUTION ILLUMINATE; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lio P, 2005, GENE, V345, P55, DOI 10.1016/j.gene.2004.11.033; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lodish H, 2000, MOL CELL BIOL; Mathews C.K., 2000, BIOCHEMISTRY-US; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; MCCUSKER MR, 2010, MOL ECOLOGY; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nachman MW, 1996, GENETICS, V142, P953; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; Pabijan M, 2008, J MOL EVOL, V67, P246, DOI 10.1007/s00239-008-9123-3; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; STEARLEY RF, 1993, T AM FISH SOC, V122, P1, DOI 10.1577/1548-8659(1993)122<0001:POTPTA>2.3.CO;2; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; THOMAS WK, 1986, CAN J ZOOL, V64, P1058, DOI 10.1139/z86-158; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; UTTER FM, 1994, CONSERV BIOL, V8, P864, DOI 10.1046/j.1523-1739.1994.08030863-2.x; Wise CA, 1998, GENETICS, V148, P409; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zink RM, 2005, P ROY SOC B-BIOL SCI, V272, P71, DOI 10.1098/rspb.2004.2908; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	76	78	80	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24127	10.1371/journal.pone.0024127	http://dx.doi.org/10.1371/journal.pone.0024127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969854	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900005
J	Bakshi, K; Kosciuk, M; Nagele, RG; Friedman, E; Wang, HY				Bakshi, Kalindi; Kosciuk, Mary; Nagele, Robert G.; Friedman, Eitan; Wang, Hoau-Yan			Prenatal Cocaine Exposure Increases Synaptic Localization of a Neuronal RasGEF, GRASP-1 via Hyperphosphorylation of AMPAR Anchoring Protein, GRIP	PLOS ONE			English	Article							ACETYLCHOLINE-RELEASE; SMALL GTPASES; RECEPTOR; ACTIVATION; ACTIN	Prenatal cocaine exposure causes sustained phosphorylation of the synaptic anchoring protein, glutamate receptor interacting protein (GRIP1/2), preventing synaptic targeting of the GluR2/3-containing alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors (AMPARs; J. Neurosci. 29: 6308-6319, 2009). Because overexpression of GRIP-associated neuronal rasGEF protein (GRASP-1) specifically reduces the synaptic targeting of AMPARs, we hypothesized that prenatal cocaine exposure enhances GRASP-1 synaptic membrane localization leading to hyper-activation of ras family proteins and heightened actin polymerization. Our results show a markedly increased GRIP1-associated GRASP-1 content with approximately 40% reduction in its rasGEF activity in frontal cortices (FCX) of 21-day-old (P21) prenatal cocaine-exposed rats. This cocaine effect is the result of a persistent protein kinase C (PKC)- and downstream Src tyrosine kinase-mediated GRIP phosphorylation. The hyperactivated PKC also increased membrane-associated GRASP-1 and activated small G-proteins RhoA, cdc42/Rac1 and Rap1 as well as filamentous actin (F-actin) levels without an effect on the phosphorylation state of actin. Since increased F-actin facilitates protein transport, our results suggest that increased GRASP-1 synaptic localization in prenatal cocaine-exposed brains is an adaptive response to restoring the synaptic expression of AMPA-GluR2/3. Our earlier data demonstrated that persistent PKC-mediated GRIP phosphorylation reduces GluR2/3 synaptic targeting in prenatal cocaine-exposed brains, we now show that the increased GRIP-associated GRASP-1 may contribute to the reduction in GluR2/3 synaptic expression and AMPAR signaling defects.	[Bakshi, Kalindi; Friedman, Eitan; Wang, Hoau-Yan] CUNY, Sophie Davis Sch Biomed Educ, Dept Physiol, New York, NY 10021 USA; [Bakshi, Kalindi; Friedman, Eitan; Wang, Hoau-Yan] CUNY, Sophie Davis Sch Biomed Educ, Dept Pharmacol & Neurosci, New York, NY 10021 USA; [Bakshi, Kalindi; Friedman, Eitan; Wang, Hoau-Yan] CUNY, Grad Ctr, Dept Biol & Neurosci, New York, NY USA; [Bakshi, Kalindi] CUNY, Grad Sch, Inst Basic Res, Ctr Dev Neurosci, Staten Isl, NY USA; [Kosciuk, Mary; Nagele, Robert G.] Univ Med & Dent New Jersey, Sch Osteopath Med, New Jersey Inst Successful Aging, Stratford, NJ 08084 USA	City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; City University of New York (CUNY) System; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Bakshi, K (corresponding author), CUNY, Sophie Davis Sch Biomed Educ, Dept Physiol, New York, NY 10021 USA.	hywang@med.cuny.edu			National Institute on Drug Abuse [R24-DA018055]; City University of New York (CUNY); NATIONAL INSTITUTE ON DRUG ABUSE [R24DA018055] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); City University of New York (CUNY); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by public service grant, Minority Institutions' Drug Abuse Research Program R24-DA018055 from the National Institute on Drug Abuse (EF, H-YW), The City University of New York (CUNY) collaborative grant (H-YW) and CUNY Doctoral Student Research Grant (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DW, 1998, J NEUROSCI, V18, P2423; Bakshi K, 2009, J NEUROSCI, V29, P6308, DOI 10.1523/JNEUROSCI.5485-08.2009; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Brennan AR, 2009, NEUROBIOL AGING, V30, P782, DOI 10.1016/j.neurobiolaging.2007.08.020; Fontainhas AM, 2008, INVEST OPHTH VIS SCI, V49, P4177, DOI 10.1167/iovs.07-1580; Frankfurt M, 2009, DEV NEUROSCI-BASEL, V31, P71, DOI 10.1159/000207495; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Garavan H, 2000, BEHAV NEUROSCI, V114, P725, DOI 10.1037//0735-7044.114.4.725; Ghasemzadeh MB, 2009, PHARMACOL BIOCHEM BE, V92, P383, DOI 10.1016/j.pbb.2008.12.004; Ghasemzadeh MB, 2003, EUR J NEUROSCI, V18, P1645, DOI 10.1046/j.1460-9568.2003.02880.x; Haditsch U, 2009, MOL CELL NEUROSCI, V41, P409, DOI 10.1016/j.mcn.2009.04.005; Hahn CG, 2005, J PSYCHIATR RES, V39, P355, DOI 10.1016/j.jpsychires.2004.10.007; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; Harvey JA, 2001, NEUROTOX RES, V3, P117, DOI 10.1007/BF03033234; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Huentelman MJ, 2009, BEHAV NEUROSCI, V123, P218, DOI 10.1037/a0014260; Jones LB, 2000, J NEUROSCI, V20, P4606, DOI 10.1523/JNEUROSCI.20-12-04606.2000; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lee CT, 2009, J ADDICT MED, V3, P218, DOI 10.1097/ADM.0b013e318199d863; Lloyd SA, 2003, DEV BRAIN RES, V147, P59, DOI 10.1016/j.devbrainres.2003.09.008; Lu H, 2009, J NEUROSCI, V29, P12664, DOI 10.1523/JNEUROSCI.1984-09.2009; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Morrow CE, 2006, DEV NEUROPSYCHOL, V30, P905, DOI 10.1207/s15326942dn3003_8; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Okvist A, 2011, BIOL PSYCHIAT, V69, P245, DOI 10.1016/j.biopsych.2010.09.037; Pilpel Y, 2004, EUR J NEUROSCI, V19, P3151, DOI 10.1111/j.0953-816X.2004.03380.x; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Richardson GA, 1996, NEUROTOXICOL TERATOL, V18, P627, DOI 10.1016/S0892-0362(96)00121-3; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Romano AG, 1996, PHARMACOL BIOCHEM BE, V53, P617, DOI 10.1016/0091-3057(95)02061-6; ROMANO AG, 1995, PHARMACOL BIOCHEM BE, V52, P415, DOI 10.1016/0091-3057(95)00129-K; Salas-Ramirez KY, 2010, NEUROSCIENCE, V169, P1287, DOI 10.1016/j.neuroscience.2010.04.067; Schubert V, 2006, J CELL BIOL, V172, P453, DOI 10.1083/jcb.200506136; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Stanwood GD, 2003, NEUROSCIENCE, V122, P579, DOI 10.1016/j.neuroscience.2003.08.029; Thompson BL, 2005, BEHAV BRAIN RES, V164, P107, DOI 10.1016/j.bbr.2005.06.010; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Troca-Marin JA, 2010, MOL CELL NEUROSCI, V43, P308, DOI 10.1016/j.mcn.2009.12.004; Wang HY, 2010, BIOL PSYCHIAT, V67, P522, DOI 10.1016/j.biopsych.2009.09.031; Wang HY, 1999, NEUROPEPTIDES, V33, P197, DOI 10.1054/npep.1999.0024; WANG HY, 1995, J PHARMACOL EXP THER, V273, P492; WANG HY, 1994, J NEUROCHEM, V63, P1720; Wang HY, 1993, SOC NEUR ABSTR, V19; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yablonsky-Alter E, 2005, J PHARMACOL EXP THER, V312, P297, DOI 10.1124/jpet.104.074062; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Ye B, 2007, FEBS LETT, V581, P4403, DOI 10.1016/j.febslet.2007.08.008; ZHU JJ, 2002, NEURON, V4, P443	55	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25019	10.1371/journal.pone.0025019	http://dx.doi.org/10.1371/journal.pone.0025019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980374	Green Published, gold			2022-12-27	WOS:000295933700016
J	Mereuta, L; Asandei, A; Luchian, T				Mereuta, Loredana; Asandei, Alina; Luchian, Tudor			Meet Me on the Other Side: Trans-Bilayer Modulation of a Model Voltage-Gated Ion Channel Activity by Membrane Electrostatics Asymmetry	PLOS ONE			English	Article							HP(2-20) ANTIMICROBIAL PEPTIDE; LIPID-MEMBRANES; BIOLOGICAL-MEMBRANES; GRAMICIDIN CHANNEL; ALAMETHICIN; CONDUCTANCE; PHOSPHOLIPIDS; PROBABILITY; PHLORETIN; BEHAVIOR	While it is accepted that biomembrane asymmetry is generated by proteins and phospholipids distribution, little is known about how electric changes manifested in a monolayer influence functional properties of proteins localized on the opposite leaflet. Herein we used single-molecule electrophysiology and investigated how asymmetric changes in the electrostatics of an artificial lipid membrane monolayer, generated oppositely from where alamethicin - a model voltage-gated ion channel was added, altered peptide activity. We found that phlorizin, a membrane dipole potential lowering amphiphile, augmented alamethicin activity and transport features, whereas the opposite occurred with RH-421, which enhances the monolayer dipole potential. Further, the monolayer surface potential was decreased via adsorption of sodium dodecyl sulfate, and demonstrated that vectorial modification of it also affected the alamethicin activity in a predictive manner. A new paradigm is suggested according to which asymmetric changes in the monolayer dipole and surface potential extend their effects spatially by altering the intramembrane potential, whose gradient is sensed by distantly located peptides.	[Mereuta, Loredana; Asandei, Alina; Luchian, Tudor] Alexandru I Cuza Univ, Dept Phys, Lab Mol Biophys & Med Phys, Iasi, Romania	Alexandru Ioan Cuza University	Luchian, T (corresponding author), Alexandru I Cuza Univ, Dept Phys, Lab Mol Biophys & Med Phys, Iasi, Romania.	luchian@uaic.ro	Asandei, Alina/ABA-2912-2021	Luchian, Tudor/0000-0002-9388-7266	 [POSDRU/89/1.5/S/49944];  [POSDRU/89/1.5/S/63663]	; 	The authors' acknowledge the financial support offered by post-doctoral grants POSDRU/89/1.5/S/49944 (Development of the innovation capacity and growth of the research impact through post-doctoral programs) and POSDRU/89/1.5/S/63663 (Communicating Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen O S, 1999, Methods Enzymol, V294, P208; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Apetrei A, 2009, BBA-GEN SUBJECTS, V1790, P809, DOI 10.1016/j.bbagen.2009.04.002; Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Bezrukov SM, 1998, FARADAY DISCUSS, V111, P173; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; CAFISO DS, 1994, ANNU REV BIOPH BIOM, V23, P141, DOI 10.1146/annurev.bb.23.060194.001041; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 1999, J BIOL CHEM, V274, P29951, DOI 10.1074/jbc.274.42.29951; Duclohier H, 2001, J MEMBRANE BIOL, V184, P1, DOI 10.1007/s00232-001-0077-2; Duffin RL, 2003, LANGMUIR, V19, P1439, DOI 10.1021/la025892q; FLEWELLING RF, 1986, BIOPHYS J, V49, P541, DOI 10.1016/S0006-3495(86)83664-5; FRANKLIN JC, 1993, BIOPHYS J, V65, P289, DOI 10.1016/S0006-3495(93)81051-8; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Gurtovenko AA, 2007, J AM CHEM SOC, V129, P5358, DOI 10.1021/ja070949m; HALL JE, 1984, BIOPHYS J, V45, P233, DOI 10.1016/S0006-3495(84)84151-X; Jackson M. B., 2006, MOL CELLULAR BIOPHYS; KELLER SL, 1993, BIOPHYS J, V65, P23, DOI 10.1016/S0006-3495(93)81040-3; Lewis JR, 1999, BIOCHEMISTRY-US, V38, P5932, DOI 10.1021/bi9828167; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Luchian T, 2006, LANGMUIR, V22, P8452, DOI 10.1021/la0613777; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Maggio B, 1999, J LIPID RES, V40, P930; Malkov DY, 1996, BBA-BIOMEMBRANES, V1278, P197, DOI 10.1016/0005-2736(95)00197-2; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Mereuta L, 2008, BIOCHEM BIOPH RES CO, V373, P467, DOI 10.1016/j.bbrc.2008.04.046; Mereuta L, 2009, J BIOENERG BIOMEMBR, V41, P79, DOI 10.1007/s10863-009-9204-z; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; O'Shea P, 2005, PHILOS T R SOC A, V363, P575, DOI 10.1098/rsta.2004.1509; Ostroumova OS, 2008, LANGMUIR, V24, P2987, DOI 10.1021/la800206v; Ostroumova OS, 2010, LANGMUIR, V26, P15092, DOI 10.1021/la102691y; Petrache HI, 2006, P NATL ACAD SCI USA, V103, P7982, DOI 10.1073/pnas.0509967103; Pohl P, 1997, BBA-BIOMEMBRANES, V1323, P163, DOI 10.1016/S0005-2736(96)00185-X; Raychaudhuri P, 2011, BIOCHEMISTRY-US, V50, P1599, DOI 10.1021/bi1012386; Rokitskaya TI, 2002, BIOPHYS J, V82, P865, DOI 10.1016/S0006-3495(02)75448-9; SANSOM MSP, 1991, EUR BIOPHYS J, V20, P229, DOI 10.1007/BF00183460; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sudbrack TP, 2011, J PHYS CHEM B, V115, P269, DOI 10.1021/jp108653e; Tan AM, 2002, BIOPHYS J, V83, P1547, DOI 10.1016/S0006-3495(02)73924-6; Tour O, 1998, BIOPHYS J, V74, P1767, DOI 10.1016/S0006-3495(98)77887-7; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Wiese A, 1996, BIOPHYS J, V70, P321, DOI 10.1016/S0006-3495(96)79573-5; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	51	17	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25276	10.1371/journal.pone.0025276	http://dx.doi.org/10.1371/journal.pone.0025276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980414	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700024
J	Subathra, M; Qureshi, A; Luberto, C				Subathra, Marimuthu; Qureshi, Asfia; Luberto, Chiara			Sphingomyelin Synthases Regulate Protein Trafficking and Secretion	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; D-MEDIATED PHOSPHORYLATION; CERAMIDE TRANSFER PROTEIN; CYSTEINE-RICH DOMAIN/; KINASE-C-MU; PLASMA-MEMBRANE; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; MOLECULAR-CLONING; PHOSPHOLIPASE-C	Sphingomyelin synthases (SMS1 and 2) represent a class of enzymes that transfer a phosphocholine moiety from phosphatidylcholine onto ceramide thus producing sphingomyelin and diacylglycerol (DAG). SMS1 localizes at the Golgi while SMS2 localizes both at the Golgi and the plasma membrane. Previous studies from our laboratory showed that modulation of SMS1 and, to a lesser extent, of SMS2 affected the formation of DAG at the Golgi apparatus. As a consequence, down-regulation of SMS1 and SMS2 reduced the localization of the DAG-binding protein, protein kinase D (PKD), to the Golgi. Since PKD recruitment to the Golgi has been implicated in cellular secretion through the trans golgi network (TGN), the effect of down-regulation of SMSs on TGN-to-plasma membrane trafficking was studied. Down regulation of either SMS1 or SMS2 significantly retarded trafficking of the reporter protein vesicular stomatitis virus G protein tagged with GFP (VSVG-GFP) from the TGN to the cell surface. Inhibition of SMSs also induced tubular protrusions from the trans Golgi network reminiscent of inhibited TGN membrane fission. Since a recent study demonstrated the requirement of PKD activity for insulin secretion in beta cells, we tested the function of SMS in this model. Inhibition of SMS significantly reduced insulin secretion in rat INS-1 cells. Taken together these results provide the first direct evidence that both enzymes (SMS1 and 2) are capable of regulating TGN-mediated protein trafficking and secretion, functions that are compatible with PKD being a down-stream target for SMSs in the Golgi.	[Subathra, Marimuthu; Qureshi, Asfia; Luberto, Chiara] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Subathra, M (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	luberto@musc.edu			Hollings Cancer Center/Medical University of South Carolina Department of Defense [GC-3319-05-4498CM]; Nation Institutes of Health (NIH), National Center for Research Resources [P20 RR-017677]; American Cancer Society [IRG 97-219-08]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER	Hollings Cancer Center/Medical University of South Carolina Department of Defense; Nation Institutes of Health (NIH), National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a Hollings Cancer Center/Medical University of South Carolina Department of Defense grant "Translational Research on Cancer Control and Related Therapy" (Subcontract GC-3319-05-4498CM), by the Nation Institutes of Health (NIH) Grant # P20 RR-017677 from the National Center for Research Resources, and by Grant # IRG 97-219-08 from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John R. Raymond for the use of the velocity 3 software (obtained through the Department of Veterans Affairs Shared Equipment and Research Enhancement Award Program Grants to the Ralph H. Johnson VA Medical Center) and Drs. Aleksander Baldys and Jolanta Katarzyna Idkowiak- Baldys for their help with the 3D analysis of the images. We are grateful to Mrs. Katherine Robinson for the precious guidance in handling of INS- 1 cells and insulin measurements. We are deeply grateful to Dr. Paola Giussani (University of Milan, Italy) for the siRNA transfection protocol for INS- 1 cells. We thank Dr. Julie Chao for the use of the Gamma Counter. We are very appreciative of Drs. Yusuf Hannun, Lina Obeid and Maurizio Del Poeta for their enthusiastic support and critical discussion. We thank the Cell and Molecular Imaging Core at the Hollings Cancer Center (Medical University of South Carolina) for assistance with imaging analysis.	Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chen J, 2008, BIOCHEM J, V411, P333, DOI 10.1042/BJ20071334; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; DIRINGER H, 1972, BIOCHEM BIOPH RES CO, V47, P1345, DOI 10.1016/0006-291X(72)90220-3; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; HAN S, 2010, CELL RES; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Huwiler A, 2009, PHARMACOL THERAPEUT, V124, P96, DOI 10.1016/j.pharmthera.2009.06.008; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jin ZX, 2008, INT IMMUNOL, V20, P1427, DOI 10.1093/intimm/dxn100; Lafont E, 2010, CELL DEATH DIFFER, V17, P642, DOI 10.1038/cdd.2009.130; LEFRANCOIS L, 1982, VIROLOGY, V121, P168, DOI 10.1016/0042-6822(82)90126-X; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Qureshi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015587; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Rey O, 2001, BIOCHEM BIOPH RES CO, V287, P21, DOI 10.1006/bbrc.2001.5530; Schultz A, 2004, J BIOL CHEM, V279, P31750, DOI 10.1074/jbc.M313017200; Separovic D, 2008, EXP CELL RES, V314, P1860, DOI 10.1016/j.yexcr.2008.02.008; Separovic D, 2007, BIOCHEM BIOPH RES CO, V358, P196, DOI 10.1016/j.bbrc.2007.04.095; Speight P, 2005, TRAFFIC, V6, P858, DOI 10.1111/j.1600-0854.2005.00321.x; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tani M, 2009, BIOCHEM BIOPH RES CO, V381, P328, DOI 10.1016/j.bbrc.2009.02.063; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; Toomre D, 1999, J CELL SCI, V112, P21; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	60	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e23644	10.1371/journal.pone.0023644	http://dx.doi.org/10.1371/journal.pone.0023644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980337	Green Submitted, gold, Green Published			2022-12-27	WOS:000295933700003
J	Varady, G; Sarkadi, B; Fatyol, K				Varady, Gyoergy; Sarkadi, Balazs; Fatyol, Karoly			TTRAP Is a Novel Component of the Non-Canonical TRAF6-TAK1 TGF-beta Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; 5'-TYROSYL DNA PHOSPHODIESTERASE; RECEPTOR-ASSOCIATED FACTORS; BREAST-CANCER PROGRESSION; P38 MAP KINASE; ACTIVATED KINASE-1; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSIENT ACTIVATION; CELL-PROLIFERATION; INDUCED APOPTOSIS	Transforming growth factor-beta (TGF-beta) principally relays its effects through the Smad pathway however, accumulating evidence indicate that alternative signaling routes are also employed by this pleiotropic cytokine. For instance recently, we have demonstrated that ligand occupied TGF-beta receptors can directly trigger the TRAF6-TAK1 signaling module, resulting in MAP kinase activation. Here we report identification of the adaptor molecule T TRAP as a novel component of this non-canonical TGF-beta pathway. We show that the protein associates with TGF-beta receptors and components of the TRAF6-TAK1 signaling module, resulting in differential regulation of TGF-beta activated p38 and NF-kappa B responses. Modulation of cellular TTRAP level affects cell viability in the presence of TGF-beta, suggesting that the protein is an important component of the TGF-beta induced apoptotic process.	[Varady, Gyoergy; Sarkadi, Balazs; Fatyol, Karoly] Hungarian Acad Sci, Membrane Res Grp, Budapest, Hungary	Hungarian Academy of Sciences	Varady, G (corresponding author), Hungarian Acad Sci, Membrane Res Grp, Budapest, Hungary.	kfatyol@gmail.com	Sarkadi, Balazs/I-5024-2013; György, Várady/J-8118-2017		Hungarian Science Foundation (OTKA)/Norwegian Financial Mechanism [NNF78805]; Janos Bolyai fellowship	Hungarian Science Foundation (OTKA)/Norwegian Financial Mechanism(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai fellowship(Hungarian Academy of Sciences)	This research was supported by a Hungarian Science Foundation (OTKA)/Norwegian Financial Mechanism joint grant (NNF78805). KF was supported by a Janos Bolyai fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Arsura M, 1997, CELL GROWTH DIFFER, V8, P1049; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Davies CC, 2005, MOL CELL BIOL, V25, P9806, DOI 10.1128/MCB.25.22.9806-9819.2005; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Fatyol K, 2001, J BIOL CHEM, V276, P28421, DOI 10.1074/jbc.M102847200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Sung I, 2009, J BIOL CHEM, V284, P22285, DOI 10.1074/jbc.M109.007146; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P112, DOI 10.1161/ATVBAHA.107.153304; Li C., 2011, ONCOGENE IN PRESS; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; Neil JR, 2009, J BIOL CHEM, V284, P21209, DOI 10.1074/jbc.M109.018374; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; PARVANI JG, 2011, J MAMMARY G IN PRESS; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Resch U, 2009, J CELL SCI, V122, P2651, DOI 10.1242/jcs.049940; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Xu GL, 2008, BIOCHEM BIOPH RES CO, V375, P395, DOI 10.1016/j.bbrc.2008.08.023; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	61	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25548	10.1371/journal.pone.0025548	http://dx.doi.org/10.1371/journal.pone.0025548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980489	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700042
J	Gonzalez, NH; Felsner, G; Schramm, FD; Klingl, A; Maier, UG; Bolte, K				Gonzalez, Nicola H.; Felsner, Gregor; Schramm, Frederic D.; Klingl, Andreas; Maier, Uwe-G.; Bolte, Kathrin			A Single Peroxisomal Targeting Signal Mediates Matrix Protein Import in Diatoms	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PHAEODACTYLUM-TRICORNUTUM; MEMBRANE-PROTEINS; CARBOXY-TERMINUS; RECEPTOR; ARABIDOPSIS; EVOLUTION; THIOLASE; PLASTIDS; PATHWAY	Peroxisomes are single membrane bound compartments. They are thought to be present in almost all eukaryotic cells, although the bulk of our knowledge about peroxisomes has been generated from only a handful of model organisms. Peroxisomal matrix proteins are synthesized cytosolically and posttranslationally imported into the peroxisomal matrix. The import is generally thought to be mediated by two different targeting signals. These are respectively recognized by the two import receptor proteins Pex5 and Pex7, which facilitate transport across the peroxisomal membrane. Here, we show the first in vivo localization studies of peroxisomes in a representative organism of the ecologically relevant group of diatoms using fluorescence and transmission electron microscopy. By expression of various homologous and heterologous fusion proteins we demonstrate that targeting of Phaeodactylum tricornutum peroxisomal matrix proteins is mediated only by PTS1 targeting signals, also for proteins that are in other systems imported via a PTS2 mode of action. Additional in silico analyses suggest this surprising finding may also apply to further diatoms. Our data suggest that loss of the PTS2 peroxisomal import signal is not reserved to Caenorhabditis elegans as a single exception, but has also occurred in evolutionary divergent organisms. Obviously, targeting switching from PTS2 to PTS1 across different major eukaryotic groups might have occurred for different reasons. Thus, our findings question the widespread assumption that import of peroxisomal matrix proteins is generally mediated by two different targeting signals. Our results implicate that there apparently must have been an event causing the loss of one targeting signal even in the group of diatoms. Different possibilities are discussed that indicate multiple reasons for the detected targeting switching from PTS2 to PTS1.	[Gonzalez, Nicola H.; Felsner, Gregor; Schramm, Frederic D.; Maier, Uwe-G.; Bolte, Kathrin] Univ Marburg, Cell Biol Lab, Marburg, Germany; [Klingl, Andreas; Maier, Uwe-G.] LOEWE Zent Synthet Mikrobiol SynMikro, Marburg, Germany	Philipps University Marburg	Gonzalez, NH (corresponding author), Univ Marburg, Cell Biol Lab, Marburg, Germany.	kathrin.bolte@biologie.uni-marburg.de	Klingl, Andreas/K-6675-2014	Schramm, Frederic Dominique/0000-0003-1858-7770; Klingl, Andreas/0000-0001-8414-8317	German Research Foundation [SFB593]; LOEWE program of the State of Hessen (Germany)	German Research Foundation(German Research Foundation (DFG)); LOEWE program of the State of Hessen (Germany)	The authors' work is supported by the German Research Foundation (SFB593) and the LOEWE program of the State of Hessen (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bolte K, 2011, BIOESSAYS, V33, P368, DOI 10.1002/bies.201100007; Bolte K, 2009, J EUKARYOT MICROBIOL, V56, P9, DOI 10.1111/j.1550-7408.2008.00370.x; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Carrie C, 2007, PLANT MOL BIOL, V63, P97, DOI 10.1007/s11103-006-9075-1; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Hempel F, 2007, BIOL CHEM, V388, P899, DOI 10.1515/BC.2007.119; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Junglas B, 2008, ARCH MICROBIOL, V190, P395, DOI 10.1007/s00203-008-0402-6; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Klingl A, 2011, ARCH MICROBIOL; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Motley AM, 2000, EMBO REP, V1, P40, DOI 10.1093/embo-reports/kvd010; MULLER M, 1973, J HISTOCHEM CYTOCHEM, V21, P955; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Peterhansel C, 2011, PLANT PHYSIOL, V155, P49, DOI 10.1104/pp.110.165019; PHILIPPI ML, 1975, ARCH MICROBIOL, V103, P127, DOI 10.1007/BF00436339; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Purdue PE, 1998, J CELL BIOL, V143, P1859; Rachel R, 2010, METHOD CELL BIOL, V96, P47, DOI 10.1016/S0091-679X(10)96003-2; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Rucktaschel R, 2010, BIOCHIM BIOPHYS ACTA, V1808, P892; Sambrook J., 2002, MOL CLONING LAB MANU; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schluter A, 2006, MOL BIOL EVOL, V23, P838, DOI 10.1093/molbev/msj103; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Shinozaki A, 2009, PROTOPLASMA, V235, P57, DOI 10.1007/s00709-009-0031-1; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; STELLY N, 1975, J HISTOCHEM CYTOCHEM, V23, P686, DOI 10.1177/23.9.170331; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; Titorenko VI, 1998, J CELL BIOL, V142, P403, DOI 10.1083/jcb.142.2.403; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; WINKLER U, 1995, PLANTA, V195, P403; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65	60	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25316	10.1371/journal.pone.0025316	http://dx.doi.org/10.1371/journal.pone.0025316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966495	Green Published, Green Submitted, gold			2022-12-27	WOS:000295265100086
J	Rohling, JHT; Vanderleest, HT; Michel, S; Vansteensel, MJ; Meijer, JH				Rohling, Jos H. T.; Vanderleest, Henk Tjebbe; Michel, Stephan; Vansteensel, Mariska J.; Meijer, Johanna H.			Phase Resetting of the Mammalian Circadian Clock Relies on a Rapid Shift of a Small Population of Pacemaker Neurons	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; ELECTRICAL-ACTIVITY; IMMUNOREACTIVE NEURONS; GENE-EXPRESSION; OSCILLATORS; CELLS; LIGHT; PER1; SYNCHRONIZATION; HETEROGENEITY	The circadian pacemaker of the suprachiasmatic nuclei (SCN) contains a major pacemaker for 24 h rhythms that is synchronized to the external light-dark cycle. In response to a shift in the external cycle, neurons of the SCN resynchronize with different pace. We performed electrical activity recordings of the SCN of rats in vitro following a 6 hour delay of the light-dark cycle and observed a bimodal electrical activity pattern with a shifted and an unshifted component. The shifted component was relatively narrow as compared to the unshifted component (2.2 h and 5.7 h, respectively). Curve fitting and simulations predicted that less than 30% of the neurons contribute to the shifted component and that their phase distribution is small. This prediction was confirmed by electrophysiological recordings of neuronal subpopulations. Only 25% of the neurons exhibited an immediate shift in the phase of the electrical activity rhythms, and the phases of the shifted subpopulations appeared significantly more synchronized as compared to the phases of the unshifted subpopulations (p<0.05). We also performed electrical activity recordings of the SCN following a 9 hour advance of the light-dark cycle. The phase advances induced a large desynchrony among the neurons, but consistent with the delays, only 19% of the neurons peaked at the mid of the new light phase. The data suggest that resetting of the central circadian pacemaker to both delays and advances is brought about by an initial shift of a relatively small group of neurons that becomes highly synchronized following a shift in the external cycle. The high degree of synchronization of the shifted neurons may add to the ability of this group to reset the pacemaker. The large desynchronization observed following advances may contribute to the relative difficulty of the circadian system to respond to advanced light cycles.	[Rohling, Jos H. T.; Vanderleest, Henk Tjebbe; Michel, Stephan; Meijer, Johanna H.] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands; [Vansteensel, Mariska J.] Univ Med Ctr Utrecht, Sect Brain Funct & Plast, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Rohling, JHT (corresponding author), Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands.	J.H.Meijer@lumc.nl	Rohling, Jos/AAC-3516-2022; Michel, Stephan/ABC-4211-2021; Vansteensel, Mariska/K-8015-2019	Vansteensel, Mariska/0000-0002-9252-5116; Rohling, Jos H T/0000-0001-5721-2715	Netherlands Organization for Scientific Research (NWO) [805.47.212]; EU	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	This research was supported by Netherlands Organization for Scientific Research (NWO), program grant nr 805.47.212 "From Molecule to Cell" (http://www.nwo.nl/nwohome.nsf/pages/NWOP_5BQDBD_Eng), and by "Entrainment of the circadian clock" - EUCLOCK program of the EU (http://www.euclock.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Antle MC, 2009, REV ENDOCR METAB DIS, V10, P279, DOI 10.1007/s11154-009-9116-6; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; CARD JP, 1981, J NEUROSCI, V1, P1289; Colwell CS, 2005, NAT NEUROSCI, V8, P10, DOI 10.1038/nn0105-10; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Engelund A, 2010, CELL TISSUE RES, V340, P243, DOI 10.1007/s00441-010-0950-3; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; GROOS GA, 1980, J COMP PHYSIOL, V135, P349, DOI 10.1007/BF00657651; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; IBATA Y, 1989, NEUROSCI LETT, V97, P1, DOI 10.1016/0304-3940(89)90129-8; Kawamoto K, 2003, J NEUROSCI RES, V74, P852, DOI 10.1002/jnr.10751; Kiss J, 2008, EUR J NEUROSCI, V28, P1760, DOI 10.1111/j.1460-9568.2008.06463.x; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rohling J, 2006, J PHYSIOL-PARIS, V100, P261, DOI 10.1016/j.jphysparis.2007.05.005; Romijn HJ, 1997, EUR J NEUROSCI, V9, P2613, DOI 10.1111/j.1460-9568.1997.tb01691.x; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Sharma L, 2007, J R SOC PROMO HEALTH, V127, P268, DOI 10.1177/1466424006064305; van Esseveldt LKE, 2000, BRAIN RES REV, V33, P34, DOI 10.1016/S0165-0173(00)00025-4; van Oosterhout F, 2008, ANN NEUROL, V64, P315, DOI 10.1002/ana.21418; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Watanabe K, 2000, BRAIN RES, V877, P361, DOI 10.1016/S0006-8993(00)02724-4; Waterhouse J, 2007, LANCET, V369, P1117, DOI 10.1016/S0140-6736(07)60529-7; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Winfree T., 2000, GEOMETRY BIOL TIME; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x	41	49	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25437	10.1371/journal.pone.0025437	http://dx.doi.org/10.1371/journal.pone.0025437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966529	gold, Green Published, Green Submitted			2022-12-27	WOS:000295265100098
J	Ljungdahl, A; Hanrieder, J; Falth, M; Bergquist, J; Andersson, M				Ljungdahl, Anna; Hanrieder, Jorg; Faelth, Maria; Bergquist, Jonas; Andersson, Malin			Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIAS; KAPPA-OPIOID RECEPTOR; LONG-DURATION RESPONSE; MESSENGER-RNA; DOPAMINERGIC AGENTS; BASAL GANGLIA; IMMUNOHISTOCHEMICAL DISTRIBUTION; ENDOGENOUS LIGANDS; SUBSTANTIA-NIGRA; PRIMATE MODEL	L-DOPA-induced dyskinesia is a troublesome complication of L-DOPA pharmacotherapy of Parkinson's disease and has been associated with disturbed brain opioid transmission. However, so far the results of clinical and preclinical studies on the effects of opioids agonists and antagonists have been contradictory at best. Prodynorphin mRNA levels correlate well with the severity of dyskinesia in animal models of Parkinson's disease; however the identities of the actual neuroactive opioid effectors in their target basal ganglia output structures have not yet been determined. For the first time MALDI-TOF imaging mass spectrometry (IMS) was used for unbiased assessment and topographical elucidation of prodynorphin-derived peptides in the substantia nigra of a unilateral rat model of Parkinson's disease and L-DOPA induced dyskinesia. Nigral levels of dynorphin B and alpha-neoendorphin strongly correlated with the severity of dyskinesia. Even if dynorphin peptide levels were elevated in both the medial and lateral part of the substantia nigra, MALDI IMS analysis revealed that the most prominent changes were localized to the lateral part of the substantia nigra. MALDI IMS is advantageous compared with traditional molecular methods, such as radioimmunoassay, in that neither the molecular identity analyzed, nor the specific localization needs to be predetermined. Indeed, MALDI IMS revealed that the bioconverted metabolite leu-enkephalin-arg also correlated positively with severity of dyskinesia. Multiplexing DynB and leu-enkephalin-arg ion images revealed small (0.25 by 0.5 mm) nigral subregions with complementing ion intensities, indicating localized peptide release followed by bioconversion. The nigral dynorphins associated with L-DOPA-induced dyskinesia were not those with high affinity to kappa opioid receptors, but consisted of shorter peptides, mainly dynorphin B and alpha-neoendorphin that are known to bind and activate mu and delta opioid receptors. This suggests that mu and/or delta subtype-selective opioid receptor antagonists may be clinically relevant for reducing L-DOPA-induced dyskinesia in Parkinson's disease.	[Ljungdahl, Anna; Hanrieder, Jorg; Andersson, Malin] Uppsala Univ, Dept Pharmaceut Biosci Drug Safety & Toxicol, Uppsala, Sweden; [Hanrieder, Jorg; Bergquist, Jonas] Uppsala Univ, Dept Phys & Analyt Chem, Uppsala, Sweden; [Faelth, Maria] German Canc Res Ctr, Div Mol Genet, Unit Canc Genome Res, Heidelberg, Germany	Uppsala University; Uppsala University; Helmholtz Association; German Cancer Research Center (DKFZ)	Ljungdahl, A (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci Drug Safety & Toxicol, Uppsala, Sweden.	malin.andersson@farmbio.uu.se	Andersson, Malin/A-9930-2009; Bergquist, Jonas/C-5894-2015; Hanrieder, Jörg/E-9706-2011	Andersson, Malin/0000-0002-1450-8046; Bergquist, Jonas/0000-0002-4597-041X	Swedish Research Council [522-2006-6414, 521-2007-5407, 342-2004-3944, 621-2008-3562]; Swedish Parkinson Foundation; Swedish Royal Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; Swedish Royal Academy of Sciences	This work was funded by the Swedish Research Council grant #522-2006-6414 (MA), 521-2007-5407 (MA), Swedish Parkinson Foundation (MA), Swedish Royal Academy of Sciences (MA), Swedish Research Council grant #342-2004-3944 (JB), 621-2008-3562 (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; Andersson M, 2008, NAT METHODS, V5, P101, DOI [10.1038/nmeth1145, 10.1038/NMETH1145]; Aubert I, 2007, BIOL PSYCHIAT, V61, P836, DOI 10.1016/j.biopsych.2006.06.038; BENJAMINI Y, 1995, J R STAT SOC B, V57, P125; BERGSTROM L, 1983, LIFE SCI, V33, P1613, DOI 10.1016/0024-3205(83)90703-8; Brotchie J, 2009, NEUROLOGY, V72, pS32, DOI 10.1212/WNL.0b013e318198e0e9; Calon F, 2002, J NEUROPATH EXP NEUR, V61, P186, DOI 10.1093/jnen/61.2.186; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Chan PLS, 2007, PHARM RES-DORDR, V24, P791, DOI 10.1007/s11095-006-9202-3; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; CHRISTENSSONNYLANDER I, 1986, EXP BRAIN RES, V64, P169; CHRISTENSSONNYLANDER I, 1985, NEUROPEPTIDES, V6, P391, DOI 10.1016/0143-4179(85)90137-4; Cox H, 2007, EXP NEUROL, V205, P101, DOI 10.1016/j.expneurol.2007.01.024; El Atifi-Borel M, 2009, NEUROBIOL DIS, V34, P340, DOI 10.1016/j.nbd.2009.02.002; Fox S, 2004, MOVEMENT DISORD, V19, P554, DOI 10.1002/mds.10693; FOX SH, 2009, EFFECTS OPIOID ANTAG, P569; Fox Susan H., 2009, P569, DOI 10.1007/978-1-59745-197-0_30; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; HANRIEDER J, 2011, MOL CELL PR IN PRESS; Henry B, 2003, EXP NEUROL, V183, P458, DOI 10.1016/S0014-4886(03)00064-5; Henry B, 2001, EXP NEUROL, V171, P139, DOI 10.1006/exnr.2001.7727; Johansson PA, 2001, NEUROBIOL DIS, V8, P220, DOI 10.1006/nbdi.2000.0372; Klintenberg R, 2005, J MASS SPECTROM, V40, P261, DOI 10.1002/jms.754; Klintenberg R, 2002, J NEURAL TRANSM, V109, P1295, DOI 10.1007/s00702-002-0715-6; LI H, MASS SPECTROMETRY BI; Liu B, 2001, J PHARMACOL EXP THER, V298, P1133; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; Marin C, 2003, EXP NEUROL, V183, P66, DOI 10.1016/S0014-4886(03)00107-9; Merg F, 2006, J NEUROCHEM, V97, P292, DOI 10.1111/j.1471-4159.2006.03732.x; NISBET AP, 1995, NEUROSCIENCE, V66, P361, DOI 10.1016/0306-4522(94)00606-6; Norris JL, 2007, INT J MASS SPECTROM, V260, P212, DOI 10.1016/j.ijms.2006.10.005; NUTT JG, 1995, NEUROLOGY, V45, P1613, DOI 10.1212/WNL.45.8.1613; Nyberg F, 2007, CURR DRUG TARGETS, V8, P147, DOI 10.2174/138945007779315597; Nylander I, 1997, NEUROPEPTIDES, V31, P357, DOI 10.1016/S0143-4179(97)90072-X; Obeso JA, 2000, ANN NEUROL, V47, pS22; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Piccini P, 1997, ANN NEUROL, V42, P720, DOI 10.1002/ana.410420508; QUATTRONE A, 1995, ANN NEUROL, V38, P389, DOI 10.1002/ana.410380308; RASCOL O, 1994, MOVEMENT DISORD, V9, P437, DOI 10.1002/mds.870090410; Samadi P, 2004, NEUROBIOL DIS, V16, P246, DOI 10.1016/j.nbd.2004.02.002; Samadi P, 2003, NEUROPHARMACOLOGY, V45, P954, DOI 10.1016/S0028-3908(03)00249-1; Sandin J, 1997, PEPTIDES, V18, P949, DOI 10.1016/S0196-9781(97)00025-9; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schapira AHV, 2009, EUR J NEUROL, V16, P982, DOI 10.1111/j.1468-1331.2009.02697.x; SCHULZ R, 1982, PEPTIDES, V3, P973, DOI 10.1016/0196-9781(82)90067-5; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Sharifi N, 2001, MOL BRAIN RES, V86, P70, DOI 10.1016/S0169-328X(00)00264-3; SILBERRING J, 1989, J BIOL CHEM, V264, P11082; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stocchi F, 2010, EUR NEUROL, V63, P257, DOI 10.1159/000300647; Team RDC, 2008, LANGUAGE ENV STAT CO; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; TRUJILLO KA, 1990, BRAIN RES, V518, P244, DOI 10.1016/0006-8993(90)90977-J; VINCENT S, 1982, EUR J PHARMACOL, V85, P251, DOI 10.1016/0014-2999(82)90477-0; WALKER JM, 1982, EUR J PHARMACOL, V85, P121, DOI 10.1016/0014-2999(82)90433-2; WEBER E, 1982, P NATL ACAD SCI-BIOL, V79, P3062, DOI 10.1073/pnas.79.9.3062; WEBER E, 1983, P NATL ACAD SCI-BIOL, V80, P1125, DOI 10.1073/pnas.80.4.1125; ZAMIR N, 1984, BRAIN RES, V322, P356, DOI 10.1016/0006-8993(84)90133-1	59	49	49	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25653	10.1371/journal.pone.0025653	http://dx.doi.org/10.1371/journal.pone.0025653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984936	Green Published, gold			2022-12-27	WOS:000295941300046
J	Ding, YY; Zhang, L; Wang, YH; Huang, W; Tang, Y; Bai, L; Ross, CJD; Hayden, MR; Liu, G				Ding, Yinyuan; Zhang, Ling; Wang, Yuhui; Huang, Wei; Tang, Yin; Bai, Lu; Ross, Colin J. D.; Hayden, Michael R.; Liu, George			Amelioration of Hypertriglyceridemia with Hypo-Alpha-Cholesterolemia in LPL Deficient Mice by Hematopoietic Cell-Derived LPL	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; LPLS447X BENEFICIAL MUTATION; PLASMA TRIGLYCERIDE; KNOCKOUT MICE; GENE-TRANSFER; BONE-MARROW; LIPASE; ATHEROSCLEROSIS; EXPRESSION; METABOLISM	Background: Macrophage-derived lipoprotein lipase (LPL) has been shown uniformly to promote atherosclerotic lesion formation while the extent to which it affects plasma lipid and lipoprotein levels varies in wild-type and hypercholesterolemic mice. It is known that high levels of LPL in the bulk of adipose tissue and skeletal muscle would certainly mask the contribution of macrophage LPL to metabolism of plasma lipoprotein. Therefore, we chose LPL deficient (LPL(-/-)) mice with severe hypertriglyceridemia as an alternative model to assess the role of macrophage LPL in plasma lipoprotein metabolism via bone marrow transplant, through which LPL will be produced mainly by hematopoietic cell-derived macrophages. Methods and Results: Hypertriglyceridemic LPL(-/-) mice were lethally irradiated, then transplanted with bone marrow from wild-type (LPL(+/+)) or LPL(-/-) mice, respectively. Sixteen weeks later, LPL(+/+) -> LPL(-/-) mice displayed significant reduction in plasma levels of triglyceride and cholesterol (408 +/- 44.9 vs. 2.7 +/- 0.5 x10(3) and 82.9 +/- 7.1 vs. 229.1 +/- 30.6 mg/dl, p<0.05, respectively), while a 2.7-fold increase in plasma high density lipoprotein-cholesterol (p<0.01) was observed, compared with LPL(-/-) -> LPL(-/-) control mice. The clearance rate for the oral fat load test in LPL(+/+) -> LPL(-/-) mice was faster than that in LPL(-/-) -> LPL(-/-) mice, but slower than that in wild-type mice. Liver triglyceride content in LPL(+/+) -> LPL(-/-) mice was also significantly increased, compared with LPL(-/-) -> LPL(-/-) mice (6.8 +/- 0.7 vs. 4.6 +/- 0.5 mg/g wet tissue, p<0.05, n = 6). However, no significant change was observed in the expression levels of genes involved in hepatic lipid metabolism between the two groups. Conclusions: Hematopoietic cell-derived LPL could efficiently ameliorate severe hypertriglyceridemia and hypo-alpha-cholesterolemia at the compensation of increased triglyceride content of liver in LPL(-/-) mice.	[Ding, Yinyuan; Zhang, Ling; Wang, Yuhui; Huang, Wei; Tang, Yin; Bai, Lu; Liu, George] Peking Univ, Inst Cardiovasc Sci, Beijing 100871, Peoples R China; [Ding, Yinyuan; Zhang, Ling; Wang, Yuhui; Huang, Wei; Tang, Yin; Bai, Lu; Liu, George] Peking Univ, Key Lab Mol Cardiovasc Sci, Beijing 100871, Peoples R China; [Ross, Colin J. D.; Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada	Peking University; Peking University; University of British Columbia	Ding, YY (corresponding author), Peking Univ, Inst Cardiovasc Sci, Beijing 100871, Peoples R China.	vangeorgeliu@gmail.com	Hayden, Michael R/D-8581-2011; 王, 宇慧/GXZ-7548-2022	Hayden, Michael R/0000-0001-5159-1419; Ross, Colin/0000-0003-1476-7037	Major National Basic Research Program of the People's Republic of China [2011CB503900]; National Natural Science Foundation of the People's Republic of China [30821001, 30870994, 30930037]	Major National Basic Research Program of the People's Republic of China(National Basic Research Program of China); National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	This project was supported in part by Major National Basic Research Program of the People's Republic of China (2011CB503900) (http://www.nsfc.gov. cn/Portal0/default124.htm), grants from the National Natural Science Foundation of the People's Republic of China (No. 30821001; No. 30870994 and No. 30930037) (http://www.nsfc.gov.cn/Portal0/default124.htm) awarded to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; Del Bas JM, 2005, FASEB J, V19, P479, DOI 10.1096/fj.04-3095fje; EISENBERG S, 1984, J LIPID RES, V25, P1017; Huang W, 2006, BIOCHEM BIOPH RES CO, V346, P14, DOI 10.1016/j.bbrc.2006.05.072; HUSSAIN MM, 1989, J BIOL CHEM, V264, P9571; HUSSAIN MM, 1989, J BIOL CHEM, V264, P17931; Levak-Frank S, 1999, P NATL ACAD SCI USA, V96, P3165, DOI 10.1073/pnas.96.6.3165; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; MATTSSON L, 1993, J CLIN INVEST, V92, P1759, DOI 10.1172/JCI116764; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Nordestgaard Borge G, 2007, Ugeskr Laeger, V169, P3865; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; Ross CJD, 2005, ARTERIOSCL THROM VAS, V25, P2143, DOI 10.1161/01.ATV.0000176971.27302.b0; Ross CJD, 2004, HUM GENE THER, V15, P906, DOI 10.1089/hum.2004.15.906; Strauss JG, 2001, J BIOL CHEM, V276, P36083, DOI 10.1074/jbc.M104430200; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Wang Y, 2009, GUT, V58, P422, DOI 10.1136/gut.2007.146258; Weinstein MM, 2010, ARTERIOSCL THROM VAS, V30, P20, DOI 10.1161/ATVBAHA.109.196329; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Wilson K, 2001, ARTERIOSCL THROM VAS, V21, P1809, DOI 10.1161/hq1101.097805; Wu XJ, 2006, ATHEROSCLEROSIS, V187, P65, DOI 10.1016/j.atherosclerosis.2005.08.032; Xian XD, 2009, J NEUROSCI, V29, P4681, DOI 10.1523/JNEUROSCI.0297-09.2009; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P10143, DOI 10.1073/pnas.88.22.10143; Zhang XH, 2008, CIRC RES, V102, P250, DOI 10.1161/CIRCRESAHA.107.156554	27	4	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25620	10.1371/journal.pone.0025620	http://dx.doi.org/10.1371/journal.pone.0025620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980507	Green Submitted, Green Published, gold			2022-12-27	WOS:000295939600041
J	Herman, AB; Savage, VM; West, GB				Herman, Alexander B.; Savage, Van M.; West, Geoffrey B.			A Quantitative Theory of Solid Tumor Growth, Metabolic Rate and Vascularization	PLOS ONE			English	Article							BLOOD-FLOW; FRACTAL CHARACTERISTICS; GEOMETRIC RESISTANCE; GENERAL-MODEL; SCALING LAWS; ARCHITECTURE; PATTERNS; VASCULATURE; EVOLUTION; DYNAMICS	The relationships between cellular, structural and dynamical properties tumors have traditionally been studied separately. Here, we construct a quantitative, predictive theory of solid tumor growth, metabolic ate, vascularization and necrosis that the relationships between these properties. To accomplish this, we develop a comprehensive theory that the interface and integration of the tumor vascular network and resource supply with the cardiovascular system of Our theory enables a quantitative understanding of how cells, tissues, and vascular networks act together across pie scales by building on recent theoretical advances in modeling both healthy vasculature and the detailed processes angiogenesis and tumor growth. The theory explicitly relates tumor vascularization and growth to metabolic rate, and extensive predictions four or properties, inclucling growth rates, metabolic rates, degree of necrosis, blood flow rates and vessel sizes. Besides these quantitative predictions, we explain how growth rates depend on capillary density and metabolic rate and why similar tumors grow slower and occur less frequently in larger animals, shedding light on Peto's paradox. Various implications for potential therapeutic strategies and further research are discussed.	[Herman, Alexander B.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Savage, Van M.] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA; [Herman, Alexander B.; Savage, Van M.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Herman, Alexander B.; Savage, Van M.; West, Geoffrey B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; The Santa Fe Institute; United States Department of Energy (DOE); Los Alamos National Laboratory	Herman, AB (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	alexander.herman@ucsf.edu			National Science Foundation [PHY 0750037, PHY-0946635]; Thaw Charitable Trust; Zwan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; Division Of Physics [0750037] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Thaw Charitable Trust; Zwan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation Award #PHY 0750037, NSF Grant #PHY-0946635, the Thaw Charitable Trust and the Zwan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; BAKER GM, 1990, GROWTH DEVELOP AGING, V54, P85; BASSUKAS ID, 1993, NATURWISSENSCHAFTEN, V80, P366, DOI 10.1007/BF01138793; BAXTER LT, 1995, CANCER RES, V55, P4611; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; BRUNTON GF, 1978, CELL TISSUE KINET, V11, P161, DOI 10.1111/j.1365-2184.1978.tb00884.x; Castorina P, 2009, CANCER RES, V69, P8507, DOI 10.1158/0008-5472.CAN-09-0653; Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chaplain MAJ, 2000, J NEURO-ONCOL, V50, P37, DOI 10.1023/A:1006446020377; Craciunescu OI, 1999, J BIOMECH ENG-T ASME, V121, P480, DOI 10.1115/1.2835076; DeGregori J, 2011, CANCER RES, V71, P3739, DOI 10.1158/0008-5472.CAN-11-0342; Friebores B, 2006, CANCER RES, V66, P1597; Gatenby RA, 2003, NATURE, V421, P321, DOI 10.1038/421321a; Gazit Y, 1997, MICROCIRCULATION-LON, V4, P395, DOI 10.3109/10739689709146803; Gevertz J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051910; Gevertz JL, 2006, J THEOR BIOL, V243, P517, DOI 10.1016/j.jtbi.2006.07.002; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Guiot C, 2003, J THEOR BIOL, V225, P147, DOI 10.1016/S0022-5193(03)00221-2; Guiot C, 2006, J THEOR BIOL, V240, P459, DOI 10.1016/j.jtbi.2005.10.006; GULLINO PM, 1964, CANCER RES, V24, P1727; GULLINO PM, 1961, J NATL CANCER I, V27, P1465; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hilmas DE, 1973, CANCER, V33, P103; HORI K, 1991, JPN J CANCER RES, V82, P109, DOI 10.1111/j.1349-7006.1991.tb01753.x; Huo YL, 2006, AM J PHYSIOL-HEART C, V291, pH1074, DOI 10.1152/ajpheart.00200.2006; Jain RK, 1996, SCIENCE, V271, P1079, DOI 10.1126/science.271.5252.1079; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kallinowsk F, 1984, CANCER RES, V49, P3759; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; LESS JR, 1991, CANCER RES, V51, P265; Leu AJ, 2000, CANCER RES, V60, P4324; LYNG H, 1992, CANCER RES, V52, P584; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Rogers W, 1967, THESIS U MINNESOTA; Sabo E, 2001, CLIN CANCER RES, V7, P533; Savage VM, 2010, P NATL ACAD SCI USA, V107, P22722, DOI 10.1073/pnas.1012194108; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SEVICK EM, 1989, CANCER RES, V49, P3506; SKEHAN P, 1986, GROWTH, V50, P496; SPENCER RP, 1970, YALE J BIOL MED, V43, P22; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; STEEL GG, 1980, CELL TISSUE KINET, V13, P451, DOI 10.1111/j.1365-2184.1980.tb00485.x; Steel GG, 1977, GROWTH KINETICS TUMO; Tannock I, 1998, BASIC SCI ONCOLOGY; van Leeuwen IMM, 2003, BRIT J CANCER, V89, P2254, DOI 10.1038/sj.bjc.6601394; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; Zamir M, 2000, SFI S SCI C, P129; Zimmer C, MERE EXISTENCE WHALE	57	59	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e22973	10.1371/journal.pone.0022973	http://dx.doi.org/10.1371/journal.pone.0022973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980335	Green Submitted, gold, Green Published			2022-12-27	WOS:000295939600001
J	Sangsuriya, P; Senapin, S; Huang, WP; Lo, CF; Flegel, TW				Sangsuriya, Pakkakul; Senapin, Saengchan; Huang, Wei-Pang; Lo, Chu-Fang; Flegel, Timothy W.			Co-Interactive DNA-Binding between a Novel, Immunophilin-Like Shrimp Protein and VP15 Nucleocapsid Protein of White Spot Syndrome Virus	PLOS ONE			English	Article							VIRAL-PROTEINS; IDENTIFICATION; GENE; WSSV; GLYCOSYLATION; LOCALIZATION; SEQUENCE; RECEPTOR; FK-506; FKBPS	White spot syndrome virus (WSSV) is one of the most serious pathogens of penaeid shrimp. Although its genome has been completely characterized, the functions of most of its putative proteins are not yet known. It has been suggested that the major nucleocapsid protein VP15 is involved in packaging of the WSSV genome during virion formation. However, little is known in its relationship with shrimp host cells. Using the yeast two-hybrid approach to screen a shrimp lymphoid organ (LO) cDNA library for proteins that might interact with VP15, a protein named PmFKBP46 was identified. It had high sequence similarity to a 46 kDa-immunophilin called FKBP46 from the lepidopteran Spodoptera frugiperda (the fall armyworm). The full length PmFKBP46 consisted of a 1,257-nucleotide open reading frame with a deduced amino acid sequence of 418 residues containing a putative FKBP-PPlase domain in the C-terminal region. Results from a GST pull-down assay and histological co-localization revealed that VP15 physically interacted with PmFKBP46 and that both proteins shared the same subcellular location in the nucleus. An electrophoretic mobility shift assay indicated that PmFKBP46 possessed DNA-binding activity and functionally co-interacted with VP15 in DNA binding. The overall results suggested that host PmFKBP46 might be involved in genome packaging by viral VP15 during virion assembly.	[Sangsuriya, Pakkakul; Flegel, Timothy W.] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Senapin, Saengchan] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Huang, Wei-Pang; Lo, Chu-Fang] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Academia Sinica - Taiwan; National Taiwan University	Sangsuriya, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand.	sctwf@mahidol.ac.th	Lo, Chu-Fang/G-3088-2014; Senapin, Saengchan/F-1323-2011	Lo, Chu-Fang/0000-0001-5136-8129; Senapin, Saengchan/0000-0002-5599-4343; Sangsuriya, Panpanga/0000-0002-5522-0620; Flegel, Timothy W./0000-0002-1913-213X; Sangsuriya, Pakkakul/0000-0001-5978-7977; HUANG, WEI-PANG/0000-0001-8410-6555	Mahidol University; Taiwan National Science Council; Thailand Research Fund [PHD/0231/2548]	Mahidol University; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by research grants from Mahidol University and a Taiwan National Science Council grant. P.S. has been supported by a Royal Golden Jubilee Ph.D. program (PHD/0231/2548) from the Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALNEMRI ES, 1994, J BIOL CHEM, V269, P30828; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; BIERER BE, 1990, SCIENCE, V250, P556, DOI 10.1126/science.1700475; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Breiman A, 2002, TRANSGENIC RES, V11, P321, DOI 10.1023/A:1016331814412; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; Chen KY, 2009, FISH SHELLFISH IMMUN, V27, P460, DOI 10.1016/j.fsi.2009.06.018; Chen LL, 2007, DIS AQUAT ORGAN, V74, P171, DOI 10.3354/dao074171; Chen LL, 2002, VIROLOGY, V301, P136, DOI 10.1006/viro.2002.1536; Flegel TW, 2011, MAR BIOTECHNOL, V13, P587, DOI 10.1007/s10126-010-9287-x; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; GALAT A, 1992, BIOCHEMISTRY-US, V31, P2427, DOI 10.1021/bi00123a031; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gollan PJ, 2010, PLANT MOL BIOL, V72, P1, DOI 10.1007/s11103-009-9547-1; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Huang CH, 2002, MOL CELL PROTEOMICS, V1, P223, DOI 10.1074/mcp.M100035-MCP200; Kang CB, 2005, BIOCHEM BIOPH RES CO, V337, P30, DOI 10.1016/j.bbrc.2005.09.023; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kuzuhara T, 2004, NAT STRUCT MOL BIOL, V11, P275, DOI 10.1038/nsmb733; Leu JH, 2009, CURR TOP MICROBIOL, V328, P197; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Li Li-juan, 2009, Virologica Sinica, V24, P71, DOI 10.1007/s12250-009-3013-8; Liang Y, 2005, DIS AQUAT ORGAN, V66, P81, DOI 10.3354/dao066081; Lightner D.V, 1996, HDB SHRIMP PATHOLOGY; Liu YJ, 2010, VIROLOGY, V408, P197, DOI 10.1016/j.virol.2010.09.008; Lu LQ, 2004, FEBS LETT, V577, P141, DOI 10.1016/j.febslet.2004.08.087; Nyanguile O, 1997, P NATL ACAD SCI USA, V94, P13402, DOI 10.1073/pnas.94.25.13402; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; RIVIERE S, 1993, FEBS LETT, V315, P247, DOI 10.1016/0014-5793(93)81173-W; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Somarelli JA, 2007, ARCH INSECT BIOCHEM, V65, P195, DOI 10.1002/arch.20177; Sriphaijit T, 2007, DEV COMP IMMUNOL, V31, P1145, DOI 10.1016/j.dci.2007.03.005; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tonganunt M, 2009, FISH SHELLFISH IMMUN, V26, P509, DOI 10.1016/j.fsi.2009.02.002; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; van Hulten MCW, 2002, J GEN VIROL, V83, P257, DOI 10.1099/0022-1317-83-1-257; Vlak J.M., 2005, VIRUS TAXONOMY, P187; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Wang ZL, 2005, J VIROL, V79, P8764, DOI 10.1128/JVI.79.14.8764-8772.2005; Witteveldt J, 2005, ARCH VIROL, V150, P1121, DOI 10.1007/s00705-004-0483-8; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Yao YL, 2011, CURR OPIN PHARMACOL, V11, P301, DOI 10.1016/j.coph.2011.03.005; Zhang XB, 2001, VIRUS RES, V79, P137, DOI 10.1016/S0168-1702(01)00340-9	52	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25420	10.1371/journal.pone.0025420	http://dx.doi.org/10.1371/journal.pone.0025420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980453	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600025
J	Takeuchi, H; Taki, Y; Hashizume, H; Sassa, Y; Nagase, T; Nouchi, R; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Nagase, Tomomi; Nouchi, Rui; Kawashima, Ryuta			Cerebral Blood Flow during Rest Associates with General Intelligence and Creativity	PLOS ONE			English	Article							SUBCORTICAL VASCULAR ENCEPHALOPATHY; POSITRON-EMISSION-TOMOGRAPHY; VOXEL-BASED MORPHOMETRY; WHITE-MATTER; DEFAULT NETWORK; SEX-DIFFERENCES; BINSWANGER TYPE; BRAIN; FMRI; MRI	Recently, much scientific attention has been focused on resting brain activity and its investigation through such methods as the analysis of functional connectivity during rest (the temporal correlation of brain activities in different regions). However, investigation of the magnitude of brain activity during rest has focused on the relative decrease of brain activity during a task, rather than on the absolute resting brain activity. It is thus necessary to investigate the association between cognitive factors and measures of absolute resting brain activity, such as cerebral blood flow (CBF), during rest (rest-CBF). In this study, we examined this association using multiple regression analyses. Rest-CBF was the dependent variable and the independent variables included two essential components of cognitive functions, psychometric general intelligence and creativity. CBF was measured using arterial spin labeling and there were three analyses for rest-CBF; namely mean gray matter rest-CBF, mean white matter rest-CBF, and regional rest-CBF. The results showed that mean gray and white matter rest-CBF were significantly and positively correlated with individual psychometric intelligence. Furthermore, mean white matter rest-CBF was significantly and positively correlated with creativity. After correcting the effect of mean gray matter rest-CBF the significant and positive correlation between regional rest-CBF in the perisylvian anatomical cluster that includes the left superior temporal gyrus and insula and individual psychometric intelligence was found. Also, regional rest-CBF in the precuneus was significantly and negatively correlated with individual creativity. Significance of these results of regional rest-CBF did not change when the effect of regional gray matter density was corrected. The findings showed mean and regional rest-CBF in healthy young subjects to be correlated with cognitive functions. The findings also suggest that, even in young cognitively intact subjects, resting brain activity (possibly underlain by default cognitive activity or metabolic demand from developed brain structures) is associated with cognitive functions.	[Takeuchi, Hikaru; Nouchi, Rui; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Nagase, Tomomi; Kawashima, Ryuta] Tohoku Univ, Fac Med, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Takeuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan.	takehi@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011; Nouchi, Rui/GQH-1608-2022	Takeuchi, Hikaru/0000-0002-8022-9694; Nouchi, Rui/0000-0002-2078-9518	JST/RISTEX, JST/CREST	JST/RISTEX, JST/CREST(Core Research for Evolutional Science and Technology (CREST))	This study was supported by JST/RISTEX, JST/CREST (there are no particular numbers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Colom R, 2007, INTELLIGENCE, V35, P183, DOI 10.1016/j.intell.2006.06.003; Colom R, 2006, NEUROIMAGE, V31, P1359, DOI 10.1016/j.neuroimage.2006.01.006; Fisher JE, 2004, J RES PERS, V38, P24, DOI 10.1016/j.jrp.2003.09.014; Flaherty AW, 2005, J COMP NEUROL, V493, P147, DOI 10.1002/cne.20768; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; GUILFORD JP, 1973, J CREATIVE BEHAV, V7, P247, DOI 10.1002/j.2162-6057.1973.tb01096.x; Guilford JP, 1967, NAT HUM INTELL; HAGBERG BO, 1976, BRIT J PSYCHIAT, V128, P209, DOI 10.1192/bjp.128.3.209; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; HEAUSLER NL, 1988, EDUC PSYCHOL MEAS, V48, P463, DOI 10.1177/0013164488482021; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; HSU YY, 2007, P INT SOC MAGN RESON, V15, P1860; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McNair D. M, 1992, PROFILE MOOD STATES; Minds Society For Creative, 1969, MAN S A CREAT TEST; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peiffer AM, 2009, HUM BRAIN MAPP, V30, P228, DOI 10.1002/hbm.20497; Petersen ET, 2006, BRIT J RADIOL, V79, P688, DOI 10.1259/bjr/67705974; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raven J.C., 1998, ADV PROGR MATRICES; RUSHTON JP, 1983, SCIENTOMETRICS, V5, P93, DOI 10.1007/BF02072856; Sabri O, 1999, STROKE, V30, P556, DOI 10.1161/01.STR.30.3.556; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schmithorst VJ, 2006, NEUROIMAGE, V31, P1366, DOI 10.1016/j.neuroimage.2006.01.010; SCHNEIDER F, 1994, PSYCHIAT RES, V52, P215, DOI 10.1016/0165-1781(94)90089-2; Shen S, 2007, MAGN RESON IMAGING, V25, P1385, DOI 10.1016/j.mri.2007.03.025; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Takeuchi H, 2011, J NEUROSCI, V31, P12139, DOI 10.1523/JNEUROSCI.2948-11.2011; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; TAKI Y, 2011, HUMAN BRAIN MAPPING; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Torrance E. P., 1966, TORRANCE TESTS CREAT; Treffinger D. J., 1985, 9 MENTAL MEASUREMENT, P1632; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; YAMANOUCHI H, 1989, J NEUROL, V236, P382, DOI 10.1007/BF00314894; YAMANOUCHI H, 1991, ACTA NEUROL SCAND, V83, P301, DOI 10.1111/j.1600-0404.1991.tb04706.x; Yokoyama K., 2005, POMS SHORTENED VERSI; Yoshiura T, 2009, AM J NEURORADIOL, V30, P1388, DOI 10.3174/ajnr.A1562	58	46	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25532	10.1371/journal.pone.0025532	http://dx.doi.org/10.1371/journal.pone.0025532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980485	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600034
J	Alkema, L; Ann, WL				Alkema, Leontine; Ann, Wei Ling			Estimating the Under-Five Mortality Rate Using a Bayesian Hierarchical Time Series Model	PLOS ONE			English	Article								Background: Millennium Development Goal 4 calls for a reduction in the under-five mortality rate by two-thirds between 1990 and 2015, which corresponds to an annual rate of decline of 4.4%. The United Nations Inter-Agency Group for Child Mortality Estimation estimates under-five mortality in every country to measure progress. For the majority of countries, the estimates within a country are based on the assumption of a piece-wise constant rate of decline. Methods and Findings: This paper proposes an alternative method to estimate under-five mortality, such that the underlying rate of change is allowed to vary smoothly over time using a time series model. Information about the average rate of decline and changes therein is exchanged between countries using a Bayesian hierarchical model. Cross-validation exercises suggest that the proposed model provides credible bounds for the under-five mortality rate that are reasonably well calibrated during the observation period. The alternative estimates suggest smoother trends in under-five mortality and give new insights into changes in the rate of decline within countries. Conclusions: The proposed model offers an alternative modeling approach for obtaining estimates of under-five mortality which removes the restriction of a piece-wise linear rate of decline and introduces hierarchy to exchange information between countries. The newly proposed estimates of the rate of decline in under-5 mortality and the uncertainty assessments would help to monitor progress towards Millennium Development Goal 4.	[Alkema, Leontine; Ann, Wei Ling] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore	National University of Singapore	Alkema, L (corresponding author), Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore.	alkema@nus.edu.sg	Alkema, Leontine/K-1585-2013	Alkema, Leontine/0000-0001-8806-5957	National University of Singapore	National University of Singapore(National University of Singapore)	This work was funded by the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cleveland W.S., 1991, STAT MODELS S; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelman A., 2004, BAYESIAN DATA ANAL; Hill K ., 1998, TRENDS CHILD MORTALI; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Raftery AE, 1996, MARKOV CHAIN MONTE C; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; *UN INT GROUP CHIL, 2010, EST METH US UN INT G; UNICEF the World Health Organization (WHO) World Bank and United Nation Population Division (UNPD), 2007, LEV TRENDS CHILD MOR; United Nations Interagency Group for Child Mortality Estimations, 2010, LEV TRENDS CHILD MOR	14	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e23954	10.1371/journal.pone.0023954	http://dx.doi.org/10.1371/journal.pone.0023954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969853	gold, Green Submitted, Green Published			2022-12-27	WOS:000295936900004
J	Yu, DC; Parlitz, U				Yu, Dongchuan; Parlitz, Ulrich			Inferring Network Connectivity by Delayed Feedback Control	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; STEADY-STATES; FUNCTIONAL NETWORKS; DYNAMICAL-SYSTEMS; PERIODIC-ORBITS; COMPLEX; REVEALS	We suggest a control based approach to topology estimation of networks with N elements. This method first drives the network to steady states by a delayed feedback control; then performs structural perturbations for shifting the steady states M times; and finally infers the connection topology from the steady states' shifts by matrix inverse algorithm ( M = N) or l(1-)norm convex optimization strategy applicable to estimate the topology of sparse networks from M << N perturbations. We discuss as well some aspects important for applications, such as the topology reconstruction quality and error sources, advantages and disadvantages of the suggested method, and the influence of ( control) perturbations, inhomegenity, sparsity, coupling functions, and measurement noise. Some examples of networks with Chua's oscillators are presented to illustrate the reliability of the suggested technique.	[Yu, Dongchuan] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Yu, Dongchuan] Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China; [Parlitz, Ulrich] Max Planck Inst Dynam & Self Org, Biomed Phys Grp, Gottingen, Germany	Southeast University - China; Southeast University - China; Max Planck Society	Yu, DC (corresponding author), Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China.	dongchuanyu@yahoo.com			National Basic Research Program (973 Program) of China [2011CB707803]; National Natural Science Foundation of China [61074126, 10602026, 60934002]; Outstanding Youth Foundation of Sichuan Province [2010JQ0001]; Federal Ministry of Education and Research (BMBF) Germany [01GQ1005A]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Foundation of Sichuan Province; Federal Ministry of Education and Research (BMBF) Germany(Federal Ministry of Education & Research (BMBF))	The work was supported by the National Basic Research Program (973 Program) of China under Grant No. 2011CB707803, by the National Natural Science Foundation of China under Grant Nos. 61074126, 10602026 and 60934002, by the Outstanding Youth Foundation of Sichuan Province under Grant No. 2010JQ0001, and by the Federal Ministry of Education and Research (BMBF) Germany under Grant No. 01GQ1005A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Ahlborn A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016206; Ahlborn A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.264101; Ahlborn A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.065202; Baba N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.074101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bleich ME, 1996, PHYS LETT A, V210, P87, DOI 10.1016/0375-9601(95)00827-6; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cecchi GA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S5; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fiedler B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.114101; Friston KJ, 2002, NEUROIMAGE, V16, P513, DOI 10.1006/nimg.2001.1044; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; GERSTEIN GL, 1985, J NEUROPHYSIOL, V54, P1513, DOI 10.1152/jn.1985.54.6.1513; HJELMFELT A, 1994, J PHYS CHEM-US, V98, P1176, DOI 10.1021/j100055a022; Just W, 2004, PHYSICA D, V199, P33, DOI 10.1016/j.physd.2004.08.002; Just W, 1997, PHYS REV LETT, V78, P203, DOI 10.1103/PhysRevLett.78.203; Kim M, 2001, SCIENCE, V292, P1357, DOI 10.1126/science.1059478; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Kiss IZ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238301; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Kudryavtsev L. D., 2001, ENCY MATH; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Osipov G.V., SYNCHRONIZATION OSCI; Pajevic S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000271; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Pyragas K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.244103; PYRAGAS K, 1992, PHYS LETT A, V170, P421, DOI 10.1016/0375-9601(92)90745-8; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shandilya SG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013004; SOCOLAR JES, 1994, PHYS REV E, V50, P3245, DOI 10.1103/PhysRevE.50.3245; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Timme M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.224101; Van Bussel F, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00003; van Geert PLC, 2010, BEHAV BRAIN SCI, V33, P174, DOI 10.1017/S0140525X10000828; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang W, 2001, PHYS REV LETT, V86, P4954, DOI 10.1103/PhysRevLett.86.4954; Wang WX, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/48006; Wang WX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.154101; Yu D, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48007; Yu DC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188701; Yu DC, 2010, AUTOMATICA, V46, P2035, DOI 10.1016/j.automatica.2010.08.010; Yu DC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026108; Zykov VS, 1997, PHYS REV LETT, V78, P3398, DOI 10.1103/PhysRevLett.78.3398	50	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24333	10.1371/journal.pone.0024333	http://dx.doi.org/10.1371/journal.pone.0024333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969856	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900007
J	de Meijer, VE; Le, HD; Meisel, JA; Sharma, AK; Popov, Y; Puder, M				de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Sharma, Anisha K.; Popov, Yury; Puder, Mark			Tumor Necrosis Factor alpha-Converting Enzyme Inhibition Reverses Hepatic Steatosis and Improves Insulin Sensitivity Markers and Surgical Outcome in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; RESISTANCE; INFLAMMATION; METALLOPROTEINASE; CANCER; TRANSPLANTATION; PATHOGENESIS; DISINTEGRIN; PROGRESSION	Background: Hepatic steatosis is an established risk factor for complications following major hepatic resection. Pharmacological options to reverse steatosis prior to surgery, however, are lacking. We hypothesized that treatment with the pharmacologic tumor necrosis factor-alpha converting enzyme (TACE)-inhibitor Marimastat would reverse established steatosis, leading to improved outcome following hepatectomy. Methodology/Principal Findings: C57BL/6 male mice were fed a high fat diet for 9 weeks to establish obesity, hepatic steatosis and insulin resistance, and were administered either Marimastat or vehicle for an additional 2 or 4 weeks. Leptin deficient, hyperinsulinemic ob/ob mice were treated with Marimastat for 4 weeks. Hepatic steatosis was quantified by magnetic resonance spectroscopy and confirmed by histology. After two weeks, Marimastat-treated animals significantly improved surrogate markers for insulin sensitivity and liver histology, and experienced a 66% decrease in steatosis (P = 0.010). These findings were confirmed in ob/ob mice. Transcripts related to fatty acid synthesis were significantly downregulated in Marimastat-treated animals. Following pre-treatment with Marimastat or vehicle for two weeks, high fat fed C57BL/6 mice were subjected to two-thirds hepatectomy. Post-operative liver injury as quantified by serum aspartate aminotransferase levels and alanine aminotransferase levels was significantly decreased by 57% (P = 0.020) and 44% (P = 0.032) respectively, compared to controls. Conclusion/Significance: Treatment with the TACE-inhibitor Marimastat improved surrogate markers for insulin sensitivity and reversed steatosis in mouse models of diet-induced obesity and leptin deficiency, thereby attenuating post-operative injury following hepatectomy. This may suggest a potential therapeutic role in patients with fatty liver disease; especially those who need to undergo hepatic resection.	[de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Puder, Mark] Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA; [de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Puder, Mark] Harvard Univ, Sch Med, Vasc Biol Program, Childrens Hosp Boston, Boston, MA 02115 USA; [de Meijer, Vincent E.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Surg, Rotterdam, Netherlands; [Le, Hau D.; Meisel, Jonathan A.] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Sharma, Anisha K.; Popov, Yury] Harvard Univ, Sch Med, Div Gastroenterol & Hepatol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	de Meijer, VE (corresponding author), Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA.	vdemeijer@hotmail.com	Popov, Yury V./A-7781-2008; de Meijer, Vincent Erwin/H-6610-2019	Popov, Yury V./0000-0001-7973-942X; de Meijer, Vincent Erwin/0000-0002-7900-5917	Stichting Profesor Michael-van Vloten Fonds (Venray, The Netherlands); VSBfonds (Utrecht, The Netherlands); Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands); Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands); Dr Saal van Zwanenberg Stichting (Oss, The Netherlands); Children's Hospital Boston Surgical Foundation; Vascular Biology Program (Boston, Massachusetts); National Institutes of Health [DK069621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK069621] Funding Source: NIH RePORTER	Stichting Profesor Michael-van Vloten Fonds (Venray, The Netherlands)(Netherlands Government); VSBfonds (Utrecht, The Netherlands)(Netherlands Government); Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands)(Netherlands Government); Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands)(Netherlands Government); Dr Saal van Zwanenberg Stichting (Oss, The Netherlands)(Netherlands Government); Children's Hospital Boston Surgical Foundation; Vascular Biology Program (Boston, Massachusetts); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	VdM was recipient of fellowships from the foundations Stichting Profesor Michael-van Vloten Fonds (Venray, The Netherlands), VSBfonds (Utrecht, The Netherlands), Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands), Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands), and Dr Saal van Zwanenberg Stichting (Oss, The Netherlands). MP was supported by the Children's Hospital Boston Surgical Foundation and The Vascular Biology Program (Boston, Massachusetts), and the National Institutes of Health (grant DK069621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2009, SEMIN LIVER DIS, V29, P3, DOI 10.1055/s-0029-1192052; Alwayn IPJ, 2008, J SURG RES, V145, P192, DOI 10.1016/j.jss.2007.04.002; Alwayn IPJ, 2006, AM J PHYSIOL-GASTR L, V291, pG1011, DOI 10.1152/ajpgi.00047.2006; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bramhall SR, 2002, BRIT J CANCER, V86, P1864, DOI 10.1038/sj.bjc.6600310; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; de Meijer VE, 2010, BRIT J SURG, V97, P1331, DOI 10.1002/bjs.7194; de Meijer VE, 2010, METABOLISM, V59, P1092, DOI 10.1016/j.metabol.2009.11.006; de Meijer VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011256; de Meijer VE, 2010, PHYSIOL BEHAV, V100, P387, DOI 10.1016/j.physbeh.2010.04.001; Doggrell SA, 2002, EXPERT OPIN INV DRUG, V11, P1003, DOI 10.1517/13543784.11.7.1003; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; OTWAY S, 1967, J PHYSIOL-LONDON, V190, P321, DOI 10.1113/jphysiol.1967.sp008211; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rosenbaum E, 2005, CLIN CANCER RES, V11, P4437, DOI 10.1158/1078-0432.CCR-04-2252; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Togashi N, 2002, HYPERTENSION, V39, P578, DOI 10.1161/hy0202.103290; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25587	10.1371/journal.pone.0025587	http://dx.doi.org/10.1371/journal.pone.0025587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980496	Green Published, gold, Green Submitted			2022-12-27	WOS:000295933700045
J	Hines, CS; Liow, JS; Zanotti-Fregonara, P; Hirvonen, J; Morse, C; Pike, VW; Innis, RB				Hines, Christina S.; Liow, Jeih-San; Zanotti-Fregonara, Paolo; Hirvonen, Jussi; Morse, Cheryl; Pike, Victor W.; Innis, Robert B.			Human Biodistribution and Dosimetry of C-11-CUMI-101, an Agonist Radioligand for Serotonin-1A Receptors in Brain	PLOS ONE			English	Article							ANTERIOR-PITUITARY; DOPAMINE-RECEPTOR; BINDING; PET	As a reported agonist, C-11-CUMI-101 is believed to selectively bind the G-protein-coupled state of the serotonin-1A (5-HT1A) receptor, thereby providing a measure of the active subset of all 5-HT1A receptors in brain. Although C-11-CUMI-101 has been successfully used to quantify 5-HT1A receptors in human and monkey brain, its radiation exposure has not previously been reported. The purpose of this study was to calculate the radiation exposure to organs of the body based on serial whole-body imaging with positron emission tomography (PET) in human subjects. Methods: Nine healthy volunteers were injected with 428 +/- 84 MBq (mean +/- SD) C-11-CUMI-101 and then imaged with a PET-only device for two hours from head to mid-thigh. Eleven source organs (brain, heart, liver, pancreas, stomach, spleen, lungs, kidneys, lumbar spine L1-5, thyroid, and urinary bladder) were identified on whole body images and used to calculate radiation doses using the software program OLINDA/EXM 1.1. To confirm that we had correctly identified the pancreas, a tenth subject was imaged on a PET/CT device. Results: Brain had high uptake (similar to 11% of injected activity (IA)) at 10 min. Although liver had the highest uptake (similar to 35% IA at 120 min), excretion of this activity was not visible in gall bladder or intestine during the scanning session. Organs which received the highest doses (microSv/MBq) were pancreas (32.0), liver (18.4), and spleen (14.5). The effective dose of 11-CCUMI-101 was 5.3 +/- 0.5 microSv/MBq. Conclusion: The peak brain uptake (similar to 11% IA) of C-11-CUMI-101 is the highest among more than twenty C-11-labeled ligands reported in the literature and provides good counting statistics from relatively low injected activities. Similar to that of other C-11-labeled ligands for brain imaging, the effective dose of C-11-CUMI-101 is 5.3 +/- 0.5 microSv/MBq, a value that can now be used to estimate the radiation risks in future research studies.	[Hines, Christina S.; Liow, Jeih-San; Zanotti-Fregonara, Paolo; Hirvonen, Jussi; Morse, Cheryl; Pike, Victor W.; Innis, Robert B.] NIMH, Mol Imaging Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Hines, CS (corresponding author), NIMH, Mol Imaging Branch, Bethesda, MD 20892 USA.	robert.innis@nih.gov	Hirvonen, Jussi/H-2521-2012; Pike, Victor/AAJ-4139-2020; Hirvonen, Jussi/AAC-1864-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002795, ZIAMH002793, ZIAMH002852] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 2002, Ann ICRP, V32, P5; GEORGE SR, 1985, ENDOCRINOLOGY, V117, P690, DOI 10.1210/endo-117-2-690; Kumar JSD, 2007, EUR J NUCL MED MOL I, V34, P1050, DOI 10.1007/s00259-006-0324-y; Milak MS, 2011, J CEREBR BLOOD F MET, V31, P243, DOI 10.1038/jcbfm.2010.83; Milak MS, 2010, J NUCL MED, V51, P1892, DOI 10.2967/jnumed.110.076257; Milak MS, 2008, NEUR ABSTR, V41, pT58; Narendran R, 2004, SYNAPSE, V52, P188, DOI 10.1002/syn.20013; SIBLEY DR, 1982, J BIOL CHEM, V257, P6351; Skinbjerg M, 2010, NEUROIMAGE, V50, P1402, DOI 10.1016/j.neuroimage.2010.01.055; Sprague DR, 2008, NUCL MED BIOL, V35, P493, DOI 10.1016/j.nucmedbio.2008.02.004; Stabin MG, 2005, J NUCL MED, V46, P1023	11	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25309	10.1371/journal.pone.0025309	http://dx.doi.org/10.1371/journal.pone.0025309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980419	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700026
J	Pradel, A; Tafforeau, P; Maisey, JG; Janvier, P				Pradel, Alan; Tafforeau, Paul; Maisey, John G.; Janvier, Philippe			A New Paleozoic Symmoriiformes (Chondrichthyes) from the Late Carboniferous of Kansas (USA) and Cladistic Analysis of Early Chondrichthyans	PLOS ONE			English	Article							BEAR GULCH LIMESTONE; ELEPHANT SHARK; BRAINCASE; MICROTOMOGRAPHY; INIOPTERYGIA; PHYLOGENY; EVOLUTION; INSIGHTS; MONTANA; SKULL	Background: The relationships of cartilaginous fishes are discussed in the light of well preserved three-dimensional Paleozoic specimens. There is no consensus to date on the interrelationship of Paleozoic chondrichthyans, although three main phylogenetic hypotheses exist in the current literature: 1. the Paleozoic shark-like chondrichthyans, such as the Symmoriiformes, are grouped along with the modern sharks (neoselachians) into a clade which is sister group of holocephalans; 2. the Symmoriiformes are related to holocephalans, whereas the other Paleozoic shark-like chondrichthyans are related to neoselachians; 3. many Paleozoic shark-like chondrichthyans, such as the Symmoriiformes, are stem chondrichthyans, whereas stem and crown holocephalans are sister group to the stem and crown neoselachians in a crown-chondrichthyan clade. This third hypothesis was proposed recently, based mainly on dental characters. Methodology/Principal Findings: On the basis of two well preserved chondrichthyan neurocrania from the Late Carboniferous of Kansas, USA, we describe here a new species of Symmoriiformes, Kawichthys moodiei gen. et sp. nov., which was investigated by means of computerized X-ray synchrotron microtomography. We present a new phylogenetic analysis based on neurocranial characters, which supports the third hypothesis and corroborates the hypothesis that crown-group chondrichthyans (Holocephali+Neoselachii) form a tightly-knit group within the chondrichthyan total group, by providing additional, non dental characters. Conclusions/Significance: Our results highlight the importance of new well preserved Paleozoic fossils and new techniques of observation, and suggest that a new look at the synapomorphies of the crown-group chondrichthyans would be worthwhile in terms of understanding the adaptive significance of phylogenetically important characters.	[Pradel, Alan; Maisey, John G.] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Janvier, Philippe] Museum Natl Hist Nat, CNRS, Ctr Rech Paleobiodivers & Paleoenvironm CRP2, UMR 7207,Dept Hist Terre, Paris, France	American Museum of Natural History (AMNH); European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Pradel, A (corresponding author), Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA.	apradel@amnh.org	Janvier, Philippe/Q-5268-2019	Tafforeau, Paul/0000-0002-5962-1683				Allis E. P., 1914, Anatomischer Anzeiger, V46; Coates MI, 2001, SYST ASSOC SPEC VOL, V61, P241; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; Coates MI, 2007, PALAEONTOLOGY, V50, P1421, DOI 10.1111/j.1475-4983.2007.00719.x; COLE FJ, 1896, T ROY SOC EDINBURGH, V38, P49; de Beer G., 1937, DEV VERTEBRATE SKULL; de Beer GR, 1934, PHILOS T ROY SOC B, V224, P287; DICK J R F, 1978, Transactions of the Royal Society of Edinburgh, V70, P63; Didier DA, 1995, AM MUS NOVIT, V3119, P1; Duffin CJ, 1996, NEUES JB GEOLOGIE PA, V1996, P232; Fritsch A., 1880, FAUNA GASKOHLE KALKS, V1, P93, DOI [10.5962/bhl.title.14775, DOI 10.5962/BHL.TITLE.14775]; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Ginter M, 2004, ACTA PALAEONTOL POL, V49, P409; Ginter M., 2004, RECENT ADV ORIGIN EA, P473; Ginter M, 2010, HDB PALEOICHTHYOLO V, V3D; Ginter M., 2005, ICHTHYOLITH ISSUES S, V8, P11; GOLOBOFF PA, TREE ANAL USING NEW; Grogan ED, 2000, J MORPHOL, V243, P219, DOI 10.1002/(SICI)1097-4687(200003)243:3<219::AID-JMOR1>3.0.CO;2-1; Grogan ED, 2009, ACTA ZOOL-STOCKHOLM, V90, P134, DOI 10.1111/j.1463-6395.2008.00371.x; Holmgren Nils, 1940, ACTA ZOOL [STOCKHOLM], V21, P51; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Janvier P., 1996, EARLY VERTEBRATES; Klug S, 2010, ZOOL SCR, V39, P37, DOI 10.1111/j.1463-6409.2009.00399.x; Labiche JC, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2783112; Lane JA, 2010, AM MUS NOVIT, P1, DOI 10.1206/681.1; Larsson TA, 2009, GENOMICS, V93, P254, DOI 10.1016/j.ygeno.2008.10.001; Lisney TJ, 2010, REV FISH BIOL FISHER, V20, P571, DOI 10.1007/s11160-010-9162-x; Long John A., 1995, Records of the Western Australian Museum, V17, P287; Lund R., 1977, Annals of Carnegie Museum, V46, P195; Lund R., 1986, Journal of Vertebrate Paleontology, V6, P12; Lund R, 1997, REV FISH BIOL FISHER, V7, P65, DOI 10.1023/A:1018471324332; Lund R., 1985, Journal of Vertebrate Paleontology, V5, P1; Maddison WP, 2004, MESQUIT MODULAR SYST; Mader H., 1986, Goettinger Arbeiten zur Geologie und Palaeontologie, P1; Maisey J.G., 1986, American Museum Novitates, P1; MAISEY J G, 1985, American Museum Novitates, P1; MAISEY J G, 1983, American Museum Novitates, P1; Maisey J.G., 2004, RECENT ADV ORIGIN EA, P139; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)429<0001:MOTBIT>2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Maisey JG, 2007, B AM MUS NAT HIST, P4; Maisey JG, 2011, PALAEONTOLOGY, V54, P417, DOI 10.1111/j.1475-4983.2011.01035.x; Maisey JG, 2010, CR PALEVOL, V9, P289, DOI 10.1016/j.crpv.2010.07.021; Maisey JG, 2009, J VERTEBR PALEONTOL, V29, P14, DOI 10.1671/039.029.0130; Marinelli W, 1959, VERGLEICHENDE ANAT 2, P179; Moy-Thomas J.A., 1936, GEOL MAG, V73, P488, DOI [10.1017/S0016756800095212, DOI 10.1017/S0016756800095212]; Nixon KC, 2002, WINCLADIA VERSION 1; Oelofsen B.W., 1986, P107; ORVIG T, 1972, Zoologica Scripta, V1, P139, DOI 10.1111/j.1463-6409.1972.tb00672.x; PATTERSO.C, 1965, PHILOS T ROY SOC B, V249, P101, DOI 10.1098/rstb.1965.0010; Pradel A, 2010, GEODIVERSITAS, V32, P595, DOI 10.5252/g2010n4a2; Pradel A, 2010, CR PALEVOL, V9, P377, DOI 10.1016/j.crpv.2010.07.015; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; Ravi V, 2009, P NATL ACAD SCI USA, V106, P16327, DOI 10.1073/pnas.0907914106; Schaeffer B., 1967, P3; Schaeffer B., 1981, B AM MUS NAT HIST, V169, P3; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Williams M.E., 1985, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V190, P83; Woodward A.S., 1889, CATALOGUE FOSSIL F 1, P1; Woodward AS, 1919, ZOOL SOC P, V13, P231; Yu WP, 2008, P NATL ACAD SCI USA, V105, P3819, DOI 10.1073/pnas.0800398105; Zangere R., 1976, Palaeontographica Abt A, V154, P107; ZANGERL R, 1973, Fieldiana Geology Memoirs, V6, P1; ZANGERL R, 1990, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V213, P115; ZANGERL R, 1981, HDB PALEOICHTHYOLO A, V3; Zangerl R, 1997, US FIELDIANA GEOL, V35, P1	71	48	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24938	10.1371/journal.pone.0024938	http://dx.doi.org/10.1371/journal.pone.0024938			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980367	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700012
J	Valdez, CD; Davis, JN; Odeh, HM; Layfield, TL; Cousineau, CS; Berton, TR; Johnson, DG; Wojno, KJ; Day, ML				Valdez, Conrad David; Davis, Joanne N.; Odeh, Hana M.; Layfield, Tristan L.; Cousineau, Craig S.; Berton, Thomas R.; Johnson, David G.; Wojno, Kirk J.; Day, Mark L.			Repression of Androgen Receptor Transcription through the E2F1/DNMT1 Axis	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; EPITHELIAL-CELL LINE; HEAT-SHOCK-PROTEIN; CHIP-SEQ DATA; DNA METHYLATION; GENE-EXPRESSION; DEREGULATED EXPRESSION; E2F1 ACTIVATION; BINDING-SITES; CYCLE ARREST	Although androgen receptor (AR) function has been extensively studied, regulation of the AR gene itself has been much less characterized. In this study, we observed a dramatic reduction in the expression of androgen receptor mRNA and protein in hyperproliferative prostate epithelium of keratin 5 promoter driven E2F1 transgenic mice. To confirm an inhibitory function for E2F1 on AR transcription, we showed that E2F1 inhibited the transcription of endogenous AR mRNA, subsequent AR protein, and AR promoter activity in both human and mouse epithelial cells. E2F1 also inhibited androgen-stimulated activation of two AR target gene promoters. To elucidate the molecular mechanism of E2F-mediated inhibition of AR, we evaluated the effects of two functional E2F1 mutants on AR promoter activity and found that the transactivation domain appears to mediate E2F1 repression of the AR promoter. Because DNMT1 is a functional intermediate of E2F1 we examined DNMT1 function in AR repression. Repression of endogenous AR in normal human prostate epithelial cells was relieved by DNMT1 shRNA knock down. DNMT1 was shown to be physically associated within the AR minimal promoter located 22 bps from the transcription start site; however, methylation remained unchanged at the promoter regardless of DNMT1 expression. Taken together, our results suggest that DNMT1 operates either as a functional intermediary or in cooperation with E2F1 inhibiting AR gene expression in a methylation independent manner.	[Valdez, Conrad David; Davis, Joanne N.; Odeh, Hana M.; Layfield, Tristan L.; Cousineau, Craig S.; Wojno, Kirk J.; Day, Mark L.] Univ Michigan, Dept Urol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Berton, Thomas R.; Johnson, David G.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA	University of Michigan System; University of Michigan; University of Texas System; UTMD Anderson Cancer Center	Valdez, CD (corresponding author), Univ Michigan, Dept Urol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	mday@umich.edu		Johnson, David/0000-0002-6223-1790	National Institutes of Health [R01 DK-056137, R01 DK-066610]; Department of Defense; American Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056137, R01DK066610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health grants (R01 DK-056137 and R01 DK-066610) (to MLD), Department of Defense prostate cancer training grant (to CDV), and the American Cancer Society Clyde-Dixon Postdoctoral Fellowship (to JND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Boily G, 2004, BRIT J CANCER, V90, P1606, DOI 10.1038/sj.bjc.6601716; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; CUNHA GR, 1992, J ANDROL, V13, P465; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; Day KC, 2002, J BIOL CHEM, V277, P44475, DOI 10.1074/jbc.M205361200; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; FABER PW, 1991, J BIOL CHEM, V266, P10743; FABER PW, 1993, J BIOL CHEM, V268, P9296; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Heinlein CA, 1999, J BIOL CHEM, V274, P16147, DOI 10.1074/jbc.274.23.16147; Hobisch A, 1996, PROSTATE, V28, P129; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jarrard DF, 1998, CANCER RES, V58, P5310; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Keller ET, 1996, FRONT BIOSCI, V1, pd59, DOI DOI 10.2741/A116; Kinoshita H, 2000, CANCER RES, V60, P3623; Koziczak M, 2000, MOL CELL BIOL, V20, P2014, DOI 10.1128/MCB.20.6.2014-2022.2000; KUMAR MV, 1994, NUCLEIC ACIDS RES, V22, P3693, DOI 10.1093/nar/22.18.3693; Lin XH, 2003, CANCER RES, V63, P498; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; Marker PC, 2008, DIFFERENTIATION, V76, P736, DOI 10.1111/j.1432-0436.2008.00297.x; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Milutinovic S, 2004, J BIOL CHEM, V279, P27915, DOI 10.1074/jbc.M312823200; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; Pierce AM, 1998, ONCOGENE, V16, P1267, DOI 10.1038/sj.onc.1201666; Pierce AM, 1999, MOL CELL BIOL, V19, P6408; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Seelan RS, 2002, NEOPLASIA, V4, P195, DOI 10.1038/sj.neo.7900237; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; SENSIBAR JA, 1995, MICROSC RES TECHNIQ, V30, P342, DOI 10.1002/jemt.1070300409; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Sobel RE, 2006, IN VITRO CELL DEV-AN, V42, P33; SONG CS, 1995, ANN NY ACAD SCI, V761, P97, DOI 10.1111/j.1749-6632.1995.tb31372.x; Song CS, 1999, MOL ENDOCRINOL, V13, P1487, DOI 10.1210/me.13.9.1487; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400; TAKEDA H, 1991, BIOCHEM BIOPH RES CO, V177, P488, DOI 10.1016/0006-291X(91)92010-H; TAM CW, 2011, J PINEAL RES; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; TILLEY WD, 1990, J BIOL CHEM, V265, P13776; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Waltregny D, 2001, MOL ENDOCRINOL, V15, P765, DOI 10.1210/me.15.5.765; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Yakabe S, 2008, GENES GENET SYST, V83, P199, DOI 10.1266/ggs.83.199; Yan L, 2003, CANCER BIOL THER, V2, P552, DOI 10.4161/cbt.2.5.469; Yeh Shuyuan, 1999, Keio Journal of Medicine, V48, P87; Yu S, 2009, BIOCHEM BIOPH RES CO, V382, P756, DOI 10.1016/j.bbrc.2009.03.110; YUAN SX, 1993, CANCER RES, V53, P1304; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	83	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25187	10.1371/journal.pone.0025187	http://dx.doi.org/10.1371/journal.pone.0025187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966451	gold, Green Published, Green Submitted			2022-12-27	WOS:000295932100022
J	Martin, J; Jenkins, RH; Bennagi, R; Krupa, A; Phillips, AO; Bowen, T; Fraser, DJ				Martin, John; Jenkins, Robert H.; Bennagi, Rasha; Krupa, Aleksandra; Phillips, Aled O.; Bowen, Timothy; Fraser, Donald J.			Post-Transcriptional Regulation of Transforming Growth Factor Beta-1 by MicroRNA-744	PLOS ONE			English	Article							SIGNALING PATHWAYS; GROWTH-FACTOR-BETA-1; TRANSLATION; CELLS; EXPRESSION; CLEAVAGE; GLUCOSE; RNA	Transforming Growth Factor Beta-1 (TGF-beta 1) is a pleiotropic cytokine that is of central importance in wound healing, inflammation, and in key pathological processes including cancer and progressive tissue fibrosis. TGF-beta 1 is post-transcriptionally regulated, but the underlying mechanisms remain incompletely defined. Previously, we have extensively delineated post-transcriptional regulation of TGF-beta 1 synthesis in the kidney, with evidence for relief of translational repression in proximal tubular cells in the context of diabetic nephropathy. In this study, we have investigated the role of the TGF-beta 1 3'Untranslated Region (3'UTR). Two different 3'UTR lengths have been reported for TGF-beta 1, of 543 and 137 nucleotides. Absolute quantification showed that, while both UTR lengths were detectable in various human cell types and in a broad range of tissues, the short form predominated in the kidney and elsewhere. Expression of both forms was up-regulated following auto-induction by TGF-beta 1, but the short: long UTR ratio remained constant. Incorporation of the short UTR into a luciferase reporter vector significantly reduced reporter protein synthesis without major effect on RNA amount, suggesting post-transcriptional inhibition. In silico approaches identified multiple binding sites for miR-744 located in the proximal TGF-beta 1 3'UTR. A screen in RNA from human tissues showed widespread miR-744 expression. miR-744 transfection inhibited endogenous TGF-beta 1 synthesis, while direct targeting of TGF-beta 1 was shown in separate experiments, in which miR-744 decreased TGF-beta 1 3'UTR reporter activity. This work identifies miR-744-directed post-transcriptional regulation of TGF-beta 1 which, given the pleiotropic nature of cellular responses to TGF-beta 1, is potentially widely significant.	[Martin, John; Jenkins, Robert H.; Bennagi, Rasha; Krupa, Aleksandra; Phillips, Aled O.; Bowen, Timothy; Fraser, Donald J.] Cardiff Univ, Sch Med, Inst Nephrol, Cardiff, S Glam, Wales	Cardiff University	Martin, J (corresponding author), Cardiff Univ, Sch Med, Inst Nephrol, Cardiff, S Glam, Wales.	fraserdj@cf.ac.uk		Fraser, Donald/0000-0003-0102-9342; Jenkins, Robert/0000-0001-8500-9044	Kidney Research UK [RP24/2009]	Kidney Research UK(Kidney Research UK (KRUK))	This study was funded by Kidney Research UK, grant number RP24/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RSH, 1998, GROWTH FACTORS, V16, P89, DOI 10.3109/08977199809002120; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; Fraser D, 2003, AM J PATHOL, V163, P2565, DOI 10.1016/S0002-9440(10)63611-5; Fraser D, 2002, AM J PATHOL, V161, P1039, DOI 10.1016/S0002-9440(10)64265-4; Fraser D, 2008, KIDNEY INT, V73, P724, DOI 10.1038/sj.ki.5002719; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jenkins RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012283; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Mangone M, 2010, SCIENCE; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; ROMEO DS, 1993, MOL ENDOCRINOL, V7, P759, DOI 10.1210/me.7.6.759; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SCOTTO L, 1993, MOL CELL BIOL, V13, P3588, DOI 10.1128/MCB.13.6.3588; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wilusz JE, 2010, RNA, V16, P259, DOI 10.1261/rna.1907510; Zhang M, 2006, AM J PATHOL, V169, P1282, DOI 10.2353/ajpath.2006.050921	27	54	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25044	10.1371/journal.pone.0025044	http://dx.doi.org/10.1371/journal.pone.0025044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991303	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300004
J	Aguzzi, MS; D'Arcangelo, D; Giampietri, C; Capogrossi, MC; Facchiano, A				Aguzzi, Maria Simona; D'Arcangelo, Daniela; Giampietri, Claudia; Capogrossi, Maurizio C.; Facchiano, Antonio			RAM, an RGDS Analog, Exerts Potent Anti-Melanoma Effects In Vitro and In Vivo	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; MELANOMA-CELLS; CASPASE-3 ACTIVATION; EXTRACELLULAR-MATRIX; INDUCE APOPTOSIS; TUMOR-CELLS; PEPTIDE; INTEGRIN; ANGIOGENESIS; METASTASIS	Peptides containing the RGD sequence are under continuous investigation given their ability to control cell adhesion and apoptosis. Since small peptides are quickly metabolized and degraded in vivo, developing analogs resistant to serum-induced degradation is a challenging task. RGD analogs developed so far are known as molecules mostly inhibiting cell adhesion; this feature may reduce cell proliferation and tumor development but may not induce regression of tumors or metastases already formed. In the current study, carried out in melanoma in vitro and in vivo models, we show that RAM, an RGD-non-peptide Analog-Molecule, strongly inhibits cells adhesion onto plastic, vitronectin, fibronectin, laminin and von Willebrand Factor while it does not inhibit cell adhesion onto collagen IV, similarly to the RGDS template peptide. It also strongly inhibits in vitro cell proliferation, migration and DNA-synthesis, increases melanoma cells apoptosis and reduces survivin expression. All such effects were observed in collagen IV seeded cells, therefore are most likely independent from the anti adhesive properties. Further, RAM is more stable than the template RGDS; in fact it maintains its anti-proliferation and anti-adhesion effects after long serum exposure while RGDS almost completely loses its effects upon serum exposure. In a mouse metastatic melanoma in vivo model, increasing doses of RAM significantly reduce up to about 80% lung metastases development, while comparable doses of RGDS are less potent. In conclusion these data show that RAM is a potent inhibitor of melanoma growth in vitro, strongly reduces melanoma metastases development in vivo and represents a novel candidate for further in vivo investigations in the cancer treatment field.	[Aguzzi, Maria Simona; D'Arcangelo, Daniela; Capogrossi, Maurizio C.; Facchiano, Antonio] IDI IRCCS, Lab Patol Vascolare, Ist Dermopat Immacolata, Rome, Italy; [Giampietri, Claudia] Univ Roma La Sapienza, DAHFMO Sect Histol & Med Embryol, Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome	Aguzzi, MS (corresponding author), IDI IRCCS, Lab Patol Vascolare, Ist Dermopat Immacolata, Rome, Italy.	a.facchiano@idi.it	D'Arcangelo, Daniela/K-6533-2016; Facchiano, Antonio/J-4744-2012; Facchiano, Antonio/K-5984-2016	D'Arcangelo, Daniela/0000-0002-7862-3289; Facchiano, Antonio/0000-0002-4243-2392; Facchiano, Antonio/0000-0002-4243-2392; Giampietri, Claudia/0000-0002-5025-5365	Italian Ministry of Health [RF07 Onc-25/3, RC2008-2009]; Progetto Oncoproteomica Italia-USA [527B/2A/5]; Progetto Oncologico Ordinario Ministero della salute [Onc_ord 25/07]; Progetto integrato-Ministero della salute, Ricerca oncologica [RFPS-2006-7-342220]	Italian Ministry of Health(Ministry of Health, Italy); Progetto Oncoproteomica Italia-USA; Progetto Oncologico Ordinario Ministero della salute; Progetto integrato-Ministero della salute, Ricerca oncologica	This study was supported in part by grants from the Italian Ministry of Health Contract (RF07 Onc-25/3; RC2008-2009 to AF), by Progetto Oncoproteomica Italia-USA 527B/2A/5 to AF, by Progetto Oncologico Ordinario Ministero della salute (Onc_ord 25/07) to AF, and by Progetto integrato-Ministero della salute, Ricerca oncologica (RFPS-2006-7-342220) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SR, 2000, J BIOL CHEM, V275, P5760, DOI 10.1074/jbc.275.8.5760; Aguzzi MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-84; Aguzzi MS, 2004, BLOOD, V103, P4180, DOI 10.1182/blood-2003-06-2144; Aguzzi MS, 2004, BIOCHEM BIOPH RES CO, V321, P809, DOI 10.1016/j.bbrc.2004.07.036; AHMADI M, 2008, CANCER BIOTHER RADI, V27, P27; Bruck R, 2000, ISRAEL MED ASSOC J, V2, P74; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Casadio R, 2002, SAR QSAR ENVIRON RES, V13, P473, DOI 10.1080/10629360290015961; CHEN W, 2010, FASEB J; Eble JA, 2006, CURR CANCER DRUG TAR, V6, P89, DOI 10.2174/156800906776056518; Faraone D, 2009, NEOPLASIA, V11, P732, DOI 10.1593/neo.09408; Fujii H, 1998, CLIN EXP METASTAS, V16, P94; Garanger E, 2007, ANTI-CANCER AGENT ME, V7, P552, DOI 10.2174/187152007781668706; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; GUARNIERI D, 2010, ACTA BIOMATER; Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529; Haubner R, 2009, FRONT BIOSCI-LANDMRK, V14, P872, DOI 10.2741/3283; Huang GF, 2008, BIOMATERIALS, V29, P1676, DOI 10.1016/j.biomaterials.2007.12.015; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kurihara H, 2005, J BIOSCI BIOENG, V100, P82, DOI 10.1263/jbb.100.82; Kurohane K, 2000, LIFE SCI, V68, P273, DOI 10.1016/S0024-3205(00)00938-3; Laurens N, 2009, ANGIOGENESIS, V12, P275, DOI 10.1007/s10456-009-9150-8; Li PC, 2010, MOL THER, V18, P921, DOI 10.1038/mt.2010.5; Li ZB, 2007, J NUCL MED, V48, P1162, DOI 10.2967/jnumed.107.039859; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P947, DOI 10.1007/s00259-008-1045-1; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Matsuki K, 2008, J ORTHOP SCI, V13, P524, DOI 10.1007/s00776-008-1281-z; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Oku N, 1996, LIFE SCI, V58, P2263, DOI 10.1016/0024-3205(96)00221-4; Perlot RL, 2002, J BONE MINER RES, V17, P66, DOI 10.1359/jbmr.2002.17.1.66; Plow EF, 2001, THROMB HAEMOSTASIS, V86, P34; Popkov M, 2006, INT J CANCER, V119, P1194, DOI 10.1002/ijc.21924; Ramos OHP, 2008, CLIN EXP METASTAS, V25, P53, DOI 10.1007/s10585-007-9101-y; Rerat V, 2009, J MED CHEM, V52, P7029, DOI 10.1021/jm901133z; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; SRINIVASAN R, 2009, J BIOMED MAT RES A; Strieth S, 2006, INT J CANCER, V119, P423, DOI 10.1002/ijc.21838; Susuki Y, 2002, CHEM PHARM BULL, V50, P1229, DOI 10.1248/cpb.50.1229; Tai BCU, 2010, BIOMATERIALS, V31, P48, DOI 10.1016/j.biomaterials.2009.09.022; Wang YG, 2009, J DRUG TARGET, V17, P459, DOI 10.1080/10611860902974085; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25352	10.1371/journal.pone.0025352	http://dx.doi.org/10.1371/journal.pone.0025352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984914	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000025
J	Dumortier, O; Theys, N; Ahn, MT; Remacle, C; Reusens, B				Dumortier, Olivier; Theys, Nicolas; Ahn, Marie-Therese; Remacle, Claude; Reusens, Brigitte			Impairment of Rat Fetal Beta-Cell Development by Maternal Exposure to Dexamethasone during Different Time-Windows	PLOS ONE			English	Article							GLUCOCORTICOIDS INHIBIT PROLIFERATION; GENE-EXPRESSION; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; PRENATAL EXPOSURE; LOW-PROTEIN; GROWTH; RECEPTOR; ISLETS; PANCREAS; GLUCOSE	Aim: Glucocorticoids (GCs) take part in the direct control of cell lineage during the late phase of pancreas development when endocrine and exocrine cell differentiation occurs. However, other tissues such as the vasculature exert a critical role before that phase. This study aims to investigate the consequences of overexposure to exogenous glucocorticoids during different time-windows of gestation for the development of the fetal endocrine pancreas. Methods: Pregnant Wistar rats received dexamethasone acetate in their drinking water (1 mg/ml) during the last week or throughout gestation. Fetuses and their pancreases were analyzed at day 15 and 21 of gestation. Morphometrical analysis was performed on pancreatic sections after immunohistochemistry techniques and insulin secretion was evaluated on fetal islets collected in vitro. Results: Dexamethasone given the last week or throughout gestation reduced the beta-cell mass in 21-day-old fetuses by respectively 18% or 62%. This was accompanied by a defect in insulin secretion. The alpha-cell mass was reduced similarly. Neither islet vascularization nor beta-cell proliferation was affected when dexamethasone was administered during the last week, which was however the case when given throughout gestation. When given from the beginning of gestation, dexamethasone reduced the number of cells expressing the early marker of endocrine lineage neurogenin-3 when analyzed at 15 days of fetal age. Conclusions: GCs reduce the beta-and alpha-cell mass by different mechanisms according to the stage of development during which the treatment was applied. In fetuses exposed to glucocorticoids the last week of gestation only, beta-cell mass is reduced due to impairment of beta-cell commitment, whereas in fetuses exposed throughout gestation, islet vascularization and lower beta-cell proliferation are involved as well, amplifying the reduction of the endocrine mass.	[Dumortier, Olivier; Theys, Nicolas; Ahn, Marie-Therese; Remacle, Claude; Reusens, Brigitte] Catholic Univ Louvain, Inst Sci Vie, Biol Cellulaire Lab, B-3000 Louvain, Belgium	Universite Catholique Louvain	Dumortier, O (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Biol Cellulaire Lab, B-3000 Louvain, Belgium.	brigitte.reusens@uclouvain.be			European Commission [NUTRIX/QLK1-200-00083, EARNEST/FOOD-CT-2005-007036]; Parthenon Trust (London, UK); Belgian Fonds National de la Recherche Scientifique; Fonds pour la Recherche dans l'Industrie et l'Agriculture fellowship	European Commission(European CommissionEuropean Commission Joint Research Centre); Parthenon Trust (London, UK); Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Recherche dans l'Industrie et l'Agriculture fellowship(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the European Commission (NUTRIX/QLK1-200-00083, 5th FP and EARNEST/FOOD-CT-2005-007036, 6th FP), the Parthenon Trust (London, UK), and the Belgian Fonds National de la Recherche Scientifique. O. Dumortier was a recipient of a Fonds pour la Recherche dans l'Industrie et l'Agriculture fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain R, 2005, J ENDOCRINOL, V185, P253, DOI 10.1677/joe.1.06039; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Boujendar S, 2002, DIABETOLOGIA, V45, P856, DOI 10.1007/s00125-002-0833-6; Crocker IC, 1998, ANN ALLERG ASTHMA IM, V80, P509, DOI 10.1016/S1081-1206(10)63075-X; Dumortier O, 2007, DIABETOLOGIA, V50, P2495, DOI 10.1007/s00125-007-0811-0; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Gesina E, 2006, DIABETOLOGIA, V49, P2939, DOI 10.1007/s00125-006-0449-3; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Ham JN, 2009, PEDIATR RES, V66, P42, DOI 10.1203/PDR.0b013e3181a282a5; HAMAMDZIC D, 1995, AM J PHYSIOL-ENDOC M, V269, pE162, DOI 10.1152/ajpendo.1995.269.1.E162; Hewitt DP, 2006, ENDOCRINOLOGY, V147, P5568, DOI 10.1210/en.2006-0825; Jacquemin P, 2006, DEV BIOL, V290, P189, DOI 10.1016/j.ydbio.2005.11.023; JAMAL H, 1991, ENDOCRINOLOGY, V129, P3372, DOI 10.1210/endo-129-6-3372; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; KHAN A, 1995, ENDOCRINOLOGY, V136, P1934, DOI 10.1210/en.136.5.1934; KHAN A, 1992, AM J PHYSIOL, V263, pE663, DOI 10.1152/ajpendo.1992.263.4.E663; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Komatsu S, 1998, J ANAT, V193, P551, DOI 10.1046/j.1469-7580.1998.19340551.x; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Langdown ML, 2001, MOL CELL ENDOCRINOL, V185, P109, DOI 10.1016/S0303-7207(01)00629-3; Langley-Evans SC, 2009, J ANAT, V215, P36, DOI 10.1111/j.1469-7580.2008.00977.x; Li MQ, 2007, IMMUNOL LETT, V109, P129, DOI 10.1016/j.imlet.2007.02.002; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; MOURMEAUX JL, 1985, MOL CELL ENDOCRINOL, V39, P237, DOI 10.1016/0303-7207(85)90067-X; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; NOVY MJ, 1983, AM J OBSTET GYNECOL, V145, P920, DOI 10.1016/0002-9378(83)90841-4; Nyirenda MJ, 2001, J ENDOCRINOL, V170, P653, DOI 10.1677/joe.0.1700653; PRICE WA, 1992, ENDOCRINOLOGY, V130, P1424, DOI 10.1210/en.130.3.1424; REINISCH JM, 1978, SCIENCE, V202, P436, DOI 10.1126/science.705336; Rojas A, 2010, ADV EXP MED BIOL, V654, P59, DOI 10.1007/978-90-481-3271-3_4; *ROYAL COLL OBST G, 2010, ANT CORT RED NEON MO, V7; Sakai H, 1999, ARCH DERMATOL RES, V291, P224, DOI 10.1007/s004030050398; Scutt N, 2006, J ORTHOP RES, V24, P173, DOI 10.1002/jor.20030; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Seckl JR, 2000, KIDNEY INT, V57, P1412, DOI 10.1046/j.1523-1755.2000.00984.x; Shen CN, 2003, BIOCHEM J, V375, P41, DOI 10.1042/BJ20030140; Smith JT, 2003, ENDOCRINOLOGY, V144, P3024, DOI 10.1210/en.2003-0145; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; Vinukonda G, 2010, STROKE, V41, P1766, DOI 10.1161/STROKEAHA.110.588400; Ward JW, 2002, PLACENTA, V23, P451, DOI 10.1053/plac.2002.0834; Weinhaus AJ, 2000, ENDOCRINOLOGY, V141, P1384, DOI 10.1210/en.141.4.1384; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x	51	29	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25576	10.1371/journal.pone.0025576	http://dx.doi.org/10.1371/journal.pone.0025576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991320	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000041
J	Lippolis, JD; Reinhardt, TA; Sacco, RA; Nonnecke, BJ; Nelson, CD				Lippolis, John D.; Reinhardt, Timothy A.; Sacco, Randy A.; Nonnecke, Brian J.; Nelson, Corwin D.			Treatment of an Intramammary Bacterial Infection with 25-Hydroxyvitamin D-3	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; INNATE IMMUNE-RESPONSE; VITAMIN-D; MYCOBACTERIUM-TUBERCULOSIS; MULTIPLE-SCLEROSIS; MONOCYTES; 1-ALPHA,25-DIHYDROXYVITAMIN-D3; 1,25-DIHYDROXYVITAMIN-D3; PROLIFERATION; SARCOIDOSIS	Deficiency of serum levels of 25-hydroxyvitamin D-3 has been correlated with increased risk of infectious diseases such as tuberculosis and influenza. A plausible reason for this association is that expression of genes encoding important antimicrobial proteins depends on concentrations of 1,25-dihydroxyvitamin D-3 produced by activated immune cells at sites of infection, and that synthesis of 1,25-dihydroxyvitamin D-3 is dependent on the availability of 25-hydroxyvitamin D-3. Thus, increasing the availability of 25(OH) D-3 for immune cell synthesis of 1,25-dihydroxyvitamin D-3 at sites of infection has been hypothesized to aid in clearance of the infection. This report details the treatment of an acute intramammary infection with infusion of 25-hydroxyvitamin D-3 to the site of infection. Ten lactating cows were infected with in one quarter of their mammary glands. Half of the animals were treated intramammary with 25-hydroxyvitamin D-3. The 25-hydroxyvitamin D-3 treated animal showed significantly lower bacterial counts in milk and showed reduced symptomatic affects of the mastitis. It is significant that treatment with 25-hydroxyvitamin D-3 reduced the severity of an acute bacterial infection. This finding suggested a significant non-antibiotic complimentary role for 25-hydroxyvitamin D-3 in the treatment of infections in compartments naturally low in 25-hydroxyvitamin D-3 such as the mammary gland and by extension, possibly upper respiratory tract infections.	[Lippolis, John D.; Reinhardt, Timothy A.; Sacco, Randy A.; Nonnecke, Brian J.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA; [Nelson, Corwin D.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Lippolis, JD (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	john.lippolis@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509; Lippolis, John/0000-0003-2314-4384; Nelson, Corwin/0000-0003-0195-5610	United States Department of Agriculture (USDA)	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	United States Department of Agriculture (USDA) was the sole funder for this research. USDA determines the research priorities of all research that it funds. Publication of research is subject to review of USDA officials. Specific study design, data collection, data analysis, and preparation of the manuscript is under the control of the individual researchers.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; ADAMS JS, 1983, J CLIN INVEST, V72, P1856, DOI 10.1172/JCI111147; Bannerman DD, 2004, VET RES, V35, P681, DOI 10.1051/vetres:2004040; BARBOUR GL, 1981, NEW ENGL J MED, V305, P440, DOI 10.1056/NEJM198108203050807; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Chocano-Bedoya P, 2009, NUTR REV, V67, P289, DOI 10.1111/j.1753-4887.2009.00195.x; Ginde AA, 2009, CURR ALLERGY ASTHM R, V9, P81, DOI 10.1007/s11882-009-0012-7; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; GIRASOLE G, 1990, J IMMUNOL, V145, P2459; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; HOLLIS BW, 1981, J NUTR, V111, P1240, DOI 10.1093/jn/111.7.1240; HOLLIS BW, 1993, CLIN CHEM, V39, P529; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Nelson CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021674; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; REINHARDT TA, 1982, BIOCHEM BIOPH RES CO, V106, P1012, DOI 10.1016/0006-291X(82)91812-5; Reinhardt TA, 1999, J DAIRY SCI, V82, P1904, DOI 10.3168/jds.S0022-0302(99)75425-1; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Sordillo LM, 1997, J DAIRY SCI, V80, P1851, DOI 10.3168/jds.S0022-0302(97)76121-6; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094	32	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25479	10.1371/journal.pone.0025479	http://dx.doi.org/10.1371/journal.pone.0025479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991312	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000032
J	Martinez, O; Ecochard, V; Maheo, S; Gross, G; Bodin, P; Teissie, J; Escudier, JM; Paquereau, L				Martinez, Olivier; Ecochard, Vincent; Maheo, Sabrina; Gross, Gregori; Bodin, Pierre; Teissie, Justin; Escudier, Jean-Marc; Paquereau, Laurent			alpha,beta-D-Constrained Nucleic Acids Are Strong Terminators of Thermostable DNA Polymerases in Polymerase Chain Reaction	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; CONFORMATIONALLY RESTRICTED DINUCLEOTIDE; ENZYMATIC INCORPORATION; REPLICATION SLIPPAGE; TEMPLATES; SITE; PCR; FIDELITY; POLYMERIZATION; NUCLEOTIDES	(S-C5', R-P) alpha,beta-D-Constrained Nucleic Acids (CNA) are dinucleotide building blocks that can feature either B-type torsional angle values or non-canonical values, depending on their 5'C and P absolute stereochemistry. These CNA are modified neither on the nucleobase nor on the sugar structure and therefore represent a new class of nucleotide with specific chemical and structural characteristics. They promote marked bending in a single stranded DNA so as to preorganize it into a loop-like structure, and they have been shown to induce rigidity within oligonucleotides. Following their synthesis, studies performed on CNA have only focused on the constraints that this family of nucleotides introduced into DNA. On the assumption that bending in a DNA template may produce a terminator structure, we investigated whether CNA could be used as a new strong terminator of polymerization in PCR. We therefore assessed the efficiency of CNA as a terminator in PCR, using triethylene glycol phosphate units as a control. Analyses were performed by denaturing gel electrophoresis and several PCR products were further analysed by sequencing. The results showed that the incorporation of only one CNA was always skipped by the polymerases tested. On the other hand, two CNA units always stopped proofreading polymerases, such as Pfu DNA polymerase, as expected for a strong replication terminator. Non-proofreading enzymes, e.g. Taq DNA polymerase, did not recognize this modification as a strong terminator although it was predominantly stopped by this structure. In conclusion, this first functional use of CNA units shows that these modified nucleotides can be used as novel polymerization terminators of proofreading polymerases. Furthermore, our results lead us to propose that CNA and their derivatives could be useful tools for investigating the behaviour of different classes of polymerases.	[Martinez, Olivier; Ecochard, Vincent; Maheo, Sabrina; Gross, Gregori; Bodin, Pierre; Teissie, Justin; Paquereau, Laurent] CNRS, Unite Mixte Rech 5089, Inst Pharmacol & Biol Struct, Toulouse, France; [Martinez, Olivier; Ecochard, Vincent; Maheo, Sabrina; Gross, Gregori; Bodin, Pierre; Teissie, Justin; Paquereau, Laurent] Univ Toulouse 3, Fac Sci & Ingn, F-31062 Toulouse, France; [Escudier, Jean-Marc] CNRS, Unite Mixte Rech 5068, Lab Synth & Physicochim Mol Interet Biol, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Martinez, O (corresponding author), CNRS, Unite Mixte Rech 5089, Inst Pharmacol & Biol Struct, Toulouse, France.	Laurent.Paquereau@ipbs.fr	Teissie, Justin/AAA-5697-2019	Teissie, Justin/0000-0002-7588-8062; PAQUEREAU, Laurent/0000-0002-6158-0155; MARTINEZ, OLIVIER/0000-0002-3950-5458	Conseil Regional de la Region Midi-Pyrenees [08004695]	Conseil Regional de la Region Midi-Pyrenees(Region Occitanie)	Financial support for this project was provided by the Conseil Regional de la Region Midi-Pyrenees under grant number 08004695. The authors are grateful to Plateforme de synthese d oligonucleotides modifies de l'Interface Chimie Biologie de l'ITAV de Toulouse for providing facilities for oligonucleotides synthesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMERMAN N, 1976, J MOL BIOL, V107, P601, DOI 10.1016/S0022-2836(76)80086-1; CARIELLO NF, 1991, GENE, V99, P105, DOI 10.1016/0378-1119(91)90040-I; Chen JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004949; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; COSTA GL, 1994, NUCLEIC ACIDS RES, V22, P2423, DOI 10.1093/nar/22.12.2423; Dupouy C, 2008, ORG BIOMOL CHEM, V6, P2849, DOI 10.1039/b809775e; Dupouy C, 2006, ANGEW CHEM INT EDIT, V45, P3623, DOI 10.1002/anie.200504475; Dupouy C, 2010, CHEM COMMUN, V46, P5142, DOI 10.1039/c0cc00244e; Dupouy C, 2006, EUR J ORG CHEM, V2006, P5515, DOI 10.1002/ejoc.200600593; Dupouy C, 2008, TARG HETEROCYCL SYST, V12, P185; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ESPELUND M, 1990, NUCLEIC ACIDS RES, V18, P6157, DOI 10.1093/nar/18.20.6157; Feschenko VV, 1998, J MOL BIOL, V276, P559, DOI 10.1006/jmbi.1997.1566; Garcia-Diaz M, 2006, TRENDS BIOCHEM SCI, V31, P206, DOI 10.1016/j.tibs.2006.02.004; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; Horhota A, 2005, J AM CHEM SOC, V127, P7427, DOI 10.1021/ja0428255; Kempeneers V, 2005, NUCLEIC ACIDS RES, V33, P3828, DOI 10.1093/nar/gki695; Kempeneers V, 2003, NUCLEIC ACIDS RES, V31, P6221, DOI 10.1093/nar/gkg833; Kim TW, 2006, J BIOL CHEM, V281, P2289, DOI 10.1074/jbc.M510744200; Kuwahara M, 2008, NUCLEIC ACIDS RES, V36, P4257, DOI 10.1093/nar/gkn404; Kuwahara M, 2009, BIOORG MED CHEM LETT, V19, P2941, DOI 10.1016/j.bmcl.2009.04.064; Le Clezio I, 2005, J ORG CHEM, V70, P1620, DOI 10.1021/jo048136t; Le Clezio I, 2003, ORG LETT, V5, P161, DOI 10.1021/ol027222h; Le Clezio I, 2007, EUR J ORG CHEM, V2007, P3894, DOI 10.1002/ejoc.200700229; Marx A, 1999, CHEM BIOL, V6, P111, DOI 10.1016/S1074-5521(99)80007-6; Potapova O, 2006, BIOCHEMISTRY-US, V45, P890, DOI 10.1021/bi051792i; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tanaka K, 2008, CHEMBIOCHEM, V9, P2120, DOI 10.1002/cbic.200800285; Tanaka K, 2008, CHEM LETT, V37, P584, DOI 10.1246/cl.2008.584; TRAN HT, 1995, MOL CELL BIOL, V15, P5607; Tsai CH, 2007, P NATL ACAD SCI USA, V104, P14598, DOI 10.1073/pnas.0704211104; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vastmans K, 2000, BIOCHEMISTRY-US, V39, P12757, DOI 10.1021/bi001297g; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Viguera E, 2001, J MOL BIOL, V312, P323, DOI 10.1006/jmbi.2001.4943; WILLIAMS KP, 1995, NUCLEIC ACIDS RES, V23, P4220, DOI 10.1093/nar/23.20.4220	40	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25510	10.1371/journal.pone.0025510	http://dx.doi.org/10.1371/journal.pone.0025510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991314	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000033
J	Phua, SLC; Sivakamasundari, V; Shao, Y; Cai, XH; Zhang, LF; Lufkin, T; Featherstone, M				Phua, Sze Lynn Calista; Sivakamasundari, V.; Shao, Yu; Cai, Xiaohan; Zhang, Li-Feng; Lufkin, Thomas; Featherstone, Mark			Nuclear Accumulation of an Uncapped RNA Produced by Drosha Cleavage of a Transcript Encoding miR-10b and HOXD4	PLOS ONE			English	Article							ACID RESPONSE ELEMENT; EXPRESSION PATTERNS; MICRORNA EXPRESSION; HOMEOTIC TRANSFORMATIONS; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; AXIAL SKELETON; BREAST-CANCER; HOST GENES; MOUSE	Patterning of the animal embryo's antero-posterior (AP) axis is dependent on spatially and temporally regulated Hox gene expression. The murine Hoxd4 gene has been proposed to harbour two promoters, an upstream promoter P2, and a downstream promoter P1, that lie 5.2 and 1.1 kilobase pairs (kb) upstream of the coding region respectively. The evolutionarily conserved microRNA-10b (miR-10b) gene lies in the Hoxd4 genomic locus in the intron separating the non-coding exons 4 and 5 of the P2 transcript and directly adjacent to the proposed P1 promoter. Hoxd4 transcription is regulated by a 3' neural enhancer that harbours a retinoic acid response element (RARE). Here, we show that the expression profiles of Hoxd4 and miR-10b transcripts during neural differentiation of mouse embryonal carcinoma (EC) P19 cells are coordinately regulated, suggesting that both Hoxd4 and miR-10b expression is governed by the neural enhancer. Our observation that P1 transcripts are uncapped, together with the mapping of their 5' ends, strongly suggests that they are generated by Drosha cleavage of P2 transcripts rather than by transcriptional initiation. This is supported by the colocalization of P1 and P2 transcripts to the same posterior expression domain in the mouse embryo. These uncapped P1 transcripts do not appear to possess an Internal Ribosomal Entry Site (IRES), but accumulate within multiple punctate bodies within the nucleus suggesting that they play a functional role. Finally, similar uncapped Drosha-cleaved P1-like transcripts originating from the paralogous Hoxb4/miR-10a locus were also identified. We propose that these transcripts may belong to a novel class of regulatory RNAs.	[Phua, Sze Lynn Calista; Shao, Yu; Cai, Xiaohan; Zhang, Li-Feng; Featherstone, Mark] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Sivakamasundari, V.; Lufkin, Thomas] Genome Inst Singapore, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Phua, SLC (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	msfeatherstone@ntu.edu.sg	Featherstone, Mark/E-8057-2010; Lufkin, Thomas/B-5352-2011; Lufkin, Thomas/AAG-7476-2019; Zhang, Li-Feng/A-2209-2011	Featherstone, Mark/0000-0003-1576-046X; Lufkin, Thomas/0000-0002-7902-4771; Lufkin, Thomas/0000-0002-7902-4771; Zhang, Li-Feng/0000-0003-0917-0017	Biomedical Research Council (Singapore) [07/1/22/19/5]; Agency for Science, Technology and Research (A*STAR) of Singapore; Singapore Stem Cell Consortium [SSCC-09-015]	Biomedical Research Council (Singapore)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium	This work was supported by Biomedical Research Council (Singapore) grant number 07/1/22/19/5 (MF), the Agency for Science, Technology and Research (A*STAR) of Singapore (TL), and Singapore Stem Cell Consortium grant number SSCC-09-015 (LFZ). The Biomedical Research Council (BMRC, Singapore) vetted the manuscript for potentially patentable material. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON A, 1987, EMBO J, V6, P2977, DOI 10.1002/j.1460-2075.1987.tb02603.x; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; CIANETTI L, 1990, NUCLEIC ACIDS RES, V18, P4361, DOI 10.1093/nar/18.15.4361; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Durston AJ, 2010, GENOMICS, V95, P250, DOI 10.1016/j.ygeno.2009.11.002; FEATHERSTONE MS, 1988, P NATL ACAD SCI USA, V85, P4760, DOI 10.1073/pnas.85.13.4760; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Folberg A, 1997, J BIOL CHEM, V272, P29151, DOI 10.1074/jbc.272.46.29151; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; GAUNT SJ, 1989, DEVELOPMENT, V107, P131; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hadrys T, 2004, J EXP ZOOL PART B, V302B, P147, DOI 10.1002/jez.b.20012; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; HORAN GSB, 1995, DEV BIOL, V169, P359, DOI 10.1006/dbio.1995.1150; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LAROSA GJ, 1988, MOL CELL BIOL, V8, P3906, DOI 10.1128/MCB.8.9.3906; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Morrison A, 1996, DEVELOPMENT, V122, P1895; Morrison A, 1997, DEVELOPMENT, V124, P3135; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nolte C, 2003, MECH DEVELOP, V120, P325, DOI 10.1016/S0925-4773(02)00442-2; Nolte C, 2006, DEV BIOL, V299, P582, DOI 10.1016/j.ydbio.2006.08.061; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; SIMEONE A, 1988, NUCLEIC ACIDS RES, V16, P5379, DOI 10.1093/nar/16.12.5379; Tan YL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-12; Thim VV, 2005, HUM MUTAT, V25, P384, DOI 10.1002/humu.20155; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang WD, 2001, DEVELOPMENT, V128, P5017; Wei Y, 2002, DIFFERENTIATION, V70, P204, DOI 10.1046/j.1432-0436.2002.700409.x; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Zhang F, 2000, MECH DEVELOP, V96, P79, DOI 10.1016/S0925-4773(00)00377-4; Zhang F, 1997, MECH DEVELOP, V67, P49, DOI 10.1016/S0925-4773(97)00104-4	60	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25689	10.1371/journal.pone.0025689	http://dx.doi.org/10.1371/journal.pone.0025689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991333	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000055
J	Venkov, C; Plieth, D; Ni, T; Karmaker, A; Bian, AH; George, AL; Neilson, EG				Venkov, Christo; Plieth, David; Ni, Terri; Karmaker, Amitava; Bian, Aihua; George, Alfred L., Jr.; Neilson, Eric G.			Transcriptional Networks in Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; GROWTH-FACTOR-BETA; CONFERS RESISTANCE; TGF-BETA; EXPRESSION; FIBROSIS; DISEASE; CANCER; KIDNEY; QUANTIFICATION	Backround: Epithelial-mesenchymal transition (EMT) changes polarized epithelial cells into migratory phenotypes associated with loss of cell-cell adhesion molecules and cytoskeletal rearrangements. This form of plasticity is seen in mesodermal development, fibroblast formation, and cancer metastasis. Methods and Findings: Here we identify prominent transcriptional networks active during three time points of this transitional process, as epithelial cells become fibroblasts. DNA microarray in cultured epithelia undergoing EMT, validated in vivo, were used to detect various patterns of gene expression. In particular, the promoter sequences of differentially expressed genes and their transcription factors were analyzed to identify potential binding sites and partners. The four most frequent cis-regulatory elements (CREs) in up-regulated genes were SRY, FTS-1, Evi-1, and GC-Box, and RNA inhibition of the four transcription factors, Atf2, Klf10, Sox11, and SP1, most frequently binding these CREs, establish their importance in the initiation and propagation of EMT. Oligonucleotides that block the most frequent CREs restrain EMT at early and intermediate stages through apoptosis of the cells. Conclusions: Our results identify new transcriptional interactions with high frequency CREs that modulate the stability of cellular plasticity, and may serve as targets for modulating these transitional states in fibroblasts.	[Venkov, Christo; Plieth, David; Ni, Terri; George, Alfred L., Jr.; Neilson, Eric G.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Neilson, Eric G.] Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37212 USA; [Bian, Aihua] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Karmaker, Amitava] Univ Wisconsin Stout, Menomonie, WI USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Stout	Venkov, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	eric.neilson@vanderbilt.edu			National Institutes of Health [DK-46282]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK-46282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Defrance M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-396; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; GOTEA V, 2010, GENOME RES; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Iwano Masayuki, 2010, Front Biosci (Schol Ed), V2, P229; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kubo A, 2010, DEVELOPMENT, V137, P1613, DOI 10.1242/dev.046789; Kuhn H, 2001, ANTISENSE NUCLEIC A, V11, P149, DOI 10.1089/108729001300338672; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lok CN, 2008, J CELL BIOCHEM, V103, P1066, DOI 10.1002/jcb.21477; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Morishita R, 1998, CIRC RES, V82, P1023, DOI 10.1161/01.RES.82.10.1023; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Ni TT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-505; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Penolazzi L, 2003, BIOCHEM PHARMACOL, V66, P1189, DOI 10.1016/S0006-2952(03)00470-2; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Plisov SY, 2000, GENESIS, V27, P22, DOI 10.1002/1526-968X(200005)27:1<22::AID-GENE40>3.3.CO;2-M; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; PRYOR JL, 1992, ANAL BIOCHEM, V202, P100, DOI 10.1016/0003-2697(92)90213-Q; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; Ross KR, 2007, CELL SIGNAL, V19, P923, DOI 10.1016/j.cellsig.2006.11.008; Shoval O, 2010, CELL, V143, P326, DOI 10.1016/j.cell.2010.09.050; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Subramaniam M, 2010, BIOFACTORS, V36, P8, DOI 10.1002/biof.67; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tomita Naruya, 2007, Clin Exp Nephrol, V11, P7, DOI 10.1007/s10157-007-0459-6; Uhl JD, 2010, DEV BIOL, V343, P154, DOI 10.1016/j.ydbio.2010.04.004; Valdes F, 2002, MOL CANCER RES, V1, P68; Vavouri T, 2009, BIOESSAYS, V31, P727, DOI 10.1002/bies.200900014; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Xue CS, 2003, CANCER RES, V63, P3386; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003	71	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25354	10.1371/journal.pone.0025354	http://dx.doi.org/10.1371/journal.pone.0025354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980432	Green Submitted, gold, Green Published			2022-12-27	WOS:000295941300025
J	Rajasekaran, M; Abirami, S; Chen, CP				Rajasekaran, M.; Abirami, Santhanam; Chen, Chinpan			Effects of Single Nucleotide Polymorphisms on Human N-Acetyltransferase 2 Structure and Dynamics by Molecular Dynamics Simulation	PLOS ONE			English	Article							HAMSTER ARYLAMINE N-ACETYLTRANSFERASE-2; SLOW ACETYLATOR PHENOTYPE; SITE-DIRECTED MUTAGENESIS; BREAST-CANCER RISK; FUNCTIONAL-CHARACTERIZATION; METABOLIC-ACTIVATION; CATALYTIC MECHANISM; COLORECTAL-CANCER; NAT2 ALLOZYMES; O-ACETYLATION	Background: Arylamine N-acetyltransferase 2 (NAT2) is an important catalytic enzyme that metabolizes the carcinogenic arylamines, hydrazine drugs and chemicals. This enzyme is highly polymorphic in different human populations. Several polymorphisms of NAT2, including the single amino acid substitutions R64Q, 1114T, D122N, L137F, Q145P, R197Q, and G286E, are classified as slow acetylators, whereas the wild-type NAT2 is classified as a fast acetylator. The slow acetylators are often associated with drug toxicity and efficacy as well as cancer susceptibility. The biological functions of these 7 mutations have previously been characterized, but the structural basis behind the reduced catalytic activity and reduced protein level is not clear. Methodology/Principal Findings: We performed multiple molecular dynamics simulations of these mutants as well as NAT2 to investigate the structural and dynamical effects throughout the protein structure, specifically the catalytic triad, cofactor binding site, and the substrate binding pocket. None of these mutations induced unfolding; instead, their effects were confined to the inter-domain, domain 3 and 17-residue insert region, where the flexibility was significantly reduced relative to the wild-type. Structural effects of these mutations propagate through space and cause a change in catalytic triad conformation, cofactor binding site, substrate binding pocket size/shape and electrostatic potential. Conclusions/Significance: Our results showed that the dynamical properties of all the mutant structures, especially in inter-domain, domain 3 and 17-residue insert region were affected in the same manner. Similarly, the electrostatic potential of all the mutants were altered and also the functionally important regions such as catalytic triad, cofactor binding site, and substrate binding pocket adopted different orientation and/or conformation relative to the wild-type that may affect the functions of the mutants. Overall, our study may provide the structural basis for reduced catalytic activity and protein level, as was experimentally observed for these polymorphisms.	[Rajasekaran, M.; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Rajasekaran, M.] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Rajasekaran, M.; Abirami, Santhanam] Acad Sinica, Inst Biol Chem, Taiwan Int Grad Program, Taipei, Taiwan; [Abirami, Santhanam] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; Academia Sinica - Taiwan; National Taiwan University	Rajasekaran, M (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	bmchinp@ibms.sinica.edu.tw	Santhanam, Abirami/J-6314-2019; Chen, Chinpan/O-4202-2018; Mahalingam, Rajasekaran/E-2065-2013	Santhanam, Abirami/0000-0002-1952-431X; Mahalingam, Rajasekaran/0000-0003-2228-5628				Achary MS, 2006, BIOPHYS J, V91, P4329, DOI 10.1529/biophysj.106.085498; Alberg AJ, 2004, CANCER DETECT PREV, V28, P187, DOI 10.1016/j.cdp.2004.04.001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boukouvala S, 2005, DRUG METAB REV, V37, P511, DOI 10.1080/03602530500251204; Brockton N, 2000, AM J EPIDEMIOL, V151, P846; Cascorbi I, 1996, PHARMACOGENETICS, V6, P257, DOI 10.1097/00008571-199606000-00009; Costa I, 2005, PROSTATE, V64, P246, DOI 10.1002/pros.20241; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEGUCHI T, 1992, J BIOL CHEM, V267, P18140; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; EVANS DAP, 1964, J LAB CLIN MED, V63, P394; Fretland AJ, 2001, PHARMACOGENETICS, V11, P207, DOI 10.1097/00008571-200104000-00004; Goodfellow GH, 2000, BIOCHEM J, V348, P159, DOI 10.1042/0264-6021:3480159; Grant DM, 1997, MUTAT RES-FUND MOL M, V376, P61, DOI 10.1016/S0027-5107(97)00026-2; Hein DW, 2006, INT J CANCER, V119, P1208, DOI 10.1002/ijc.21957; Hein DW, 2009, EXPERT OPIN DRUG MET, V5, P353, DOI [10.1517/17425250902877698, 10.1517/17425250902877698 ]; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; HEIN DW, 1994, HUM MOL GENET, V3, P729; HEIN DW, 1995, CANCER RES, V55, P3531; Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29; Hein DW, 2002, ENVIRON MOL MUTAGEN, V40, P161, DOI 10.1002/em.10103; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HODGKIN EE, 1987, INT J QUANTUM CHEM, P105; Hubbard S. J., 1993, NACCESS; Lau EY, 2006, CHEM RES TOXICOL, V19, P1182, DOI 10.1021/tx0600999; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P1259; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Oda A, 2010, BIOL PHARM BULL, V33, P1639, DOI 10.1248/bpb.33.1639; Pompeo F, 2002, PHARMACOGENOMICS, V3, P19, DOI 10.1517/14622416.3.1.19; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; RIDDLE B, 1971, J BIOL CHEM, V246, P3250; RISCH A, 1995, HUM MOL GENET, V4, P231, DOI 10.1093/hmg/4.2.231; Rodrigues-Lima F, 2002, BIOCHEM BIOPH RES CO, V291, P116, DOI 10.1006/bbrc.2002.6414; Sillanpaa P, 2005, INT J CANCER, V114, P579, DOI 10.1002/ijc.20677; Teixeira RLF, 2010, MUTAT RES-FUND MOL M, V683, P43, DOI 10.1016/j.mrfmmm.2009.10.009; van der Hel OL, 2003, PHARMACOGENETICS, V13, P399, DOI 10.1097/00008571-200307000-00005; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; Walraven JM, 2008, CURR DRUG METAB, V9, P471, DOI 10.2174/138920008784892065; Walraven JM, 2007, DRUG METAB DISPOS, V35, P1001, DOI 10.1124/dmd.107.015040; Wang HQ, 2005, BIOCHEMISTRY-US, V44, P11295, DOI 10.1021/bi047564q; Wang HQ, 2004, BIOCHEMISTRY-US, V43, P8234, DOI 10.1021/bi0497244; WEBER WW, 1985, PHARMACOL REV, V37, P25; Windmill KF, 2000, TOXICOL SCI, V54, P19, DOI 10.1093/toxsci/54.1.19; Wu H, 2007, J BIOL CHEM, V282, P30189, DOI 10.1074/jbc.M704138200; Zang Y, 2004, PHARMACOGENETICS, V14, P717, DOI 10.1097/00008571-200411000-00002; Zang Y, 2007, CARCINOGENESIS, V28, P1665, DOI 10.1093/carcin/bgm085; Zang Y, 2007, PHARMACOGENET GENOM, V17, P37, DOI 10.1097/01.fpc.0000236325.73186.2c; Zhu JJ, 2003, CANCER EPIDEM BIOMAR, V12, P830	50	27	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25801	10.1371/journal.pone.0025801	http://dx.doi.org/10.1371/journal.pone.0025801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980537	Green Submitted, Green Published, gold			2022-12-27	WOS:000295939600055
J	Tran, HT; Sanchez, L; Esparza, TJ; Brody, DL				Tran, Hien T.; Sanchez, Laura; Esparza, Thomas J.; Brody, David L.			Distinct Temporal and Anatomical Distributions of Amyloid-beta and Tau Abnormalities following Controlled Cortical Impact in Transgenic Mice	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRANEURONAL A-BETA-42 ACCUMULATION; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR-PROTEIN; HEAD-INJURY; PLAQUE-FORMATION; GAMMA-SECRETASE; DOWN-SYNDROME; MOUSE MODEL	Traumatic brain injury TBI is a major environmental risk factor for Alzheimer's disease. Intracellular accumulations of amyloid-beta and tau proteins have been observed within hours following severe TBI in humans. Similar abnormalities have been recapitulated in young 3xTg-AD mice subjected to the controlled cortical impact model (CCI) of TBI and sacrificed at 24 h and 7 days post injury. This study investigated the temporal and anatomical distributions of amyloid-beta and tau abnormalities from 1 h to 24 h post injury in the same model. Intra-axonal amyloid-beta accumulation in the fimbria was detected as early as 1 hour and increased monotonically over 24 hours following injury. Tau immunoreactivity in the fimbria and amygdala had a biphasic time course with peaks at 1 hour and 24 hours, while tau immunoreactivity in the contralateral CA1 rose in a delayed fashion starting at 12 hours after Injury Furthermore, rapid intra-axonal amyloid-beta accumulation was similarly observed post controlled cortical injury in APP/PS1 mice, another transgenic Alzheimer's disease mouse model. Acute increases in total and phospho-tau imunoreactivity were also evident in single transgenic Tau(p301L) mice subjected to controlled cortical injury. These data provide further evidence for the causal effects of moderately severe contusional TBI on acceleration of acute Alzheimer-related abnormalities and the independent la on hip between a amyloid-beta and tau in this setting.	[Tran, Hien T.; Sanchez, Laura; Esparza, Thomas J.; Brody, David L.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Brody, David L.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Tran, HT (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63130 USA.	brodyd@neuro.wustl.edu			NIH [R01 NS065069 (Brody), K08 NS049237 (Brody)]; Burroughs Wellcome Career Award; Biomedical Sciences (Brody); Thrasher Research Fund (Brody); Washington University Office of Undergraduate Research Award (Sanchez); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065069, K08NS049237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); Biomedical Sciences (Brody); Thrasher Research Fund (Brody); Washington University Office of Undergraduate Research Award (Sanchez); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 NS065069 (Brody), NIH K08 NS049237 (Brody), a Burroughs Wellcome Career Award in the Biomedical Sciences (Brody), the Thrasher Research Fund (Brody), and a Washington University Office of Undergraduate Research Award (Sanchez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wirths O, 2006, ACTA NEUROPATHOL, V111, P312, DOI 10.1007/s00401-006-0041-4; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	46	71	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25475	10.1371/journal.pone.0025475	http://dx.doi.org/10.1371/journal.pone.0025475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980472	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600028
J	Proppe, DS; Sturdy, CB; St Clair, CC				Proppe, Darren S.; Sturdy, Christopher B.; St Clair, Colleen Cassady			Flexibility in Animal Signals Facilitates Adaptation to Rapidly Changing Environments	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; SONG STRUCTURE; URBAN NOISE; GREAT TITS; BIRDS; CALLS; MECHANISM; CONTESTS; BEHAVIOR; QUALITY	Charles Darwin posited that secondary sexual characteristics result from competition to attract mates. In male songbirds, specialized vocalizations represent secondary sexual characteristics of particular importance because females prefer songs at specific frequencies, amplitudes, and duration. For birds living in human-dominated landscapes, historic selection for song characteristics that convey fitness may compete with novel selective pressures from anthropogenic noise. Here we show that black-capped chickadees (Poecile atricapillus) use shorter, higher-frequency songs when traffic noise is high, and longer, lower-frequency songs when noise abates. We suggest that chickadees balance opposing selective pressures by use low-frequency songs to preserve vocal characteristics of dominance that repel competitors and attract females, and high frequency songs to increase song transmission when their environment is noisy. The remarkable vocal flexibility exhibited by chickadees may be one reason that they thrive in urban environments, and such flexibility may also support subsequent genetic adaptation to an increasingly urbanized world.	[Proppe, Darren S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Sturdy, Christopher B.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [St Clair, Colleen Cassady] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Proppe, DS (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	dproppe@montreat.edu	St. Clair, Colleen Cassady/A-2953-2016; Sturdy, Christopher B/A-4407-2009	St. Clair, Colleen Cassady/0000-0002-3378-795X; Sturdy, Christopher/0000-0003-2721-3770; Proppe, Darren/0000-0001-7741-6504	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; University of Alberta; Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks, and Wildlife Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); University of Alberta(University of Alberta); Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks, and Wildlife Foundation	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (CBS and CCS), the Canada Foundation for Innovation (CBS and CCS), partner funding from the University of Alberta (CBS), Alberta Ingenuity Fund (CBS) and the Alberta Sport, Recreation, Parks, and Wildlife Foundation (DSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; Brumm H, 2011, BEHAV ECOL, V22, P310, DOI 10.1093/beheco/arq205; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caro SP, 2010, BEHAV ECOL, V21, P562, DOI 10.1093/beheco/arq022; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; Christie PJ, 2004, BEHAVIOUR, V141, P101, DOI 10.1163/156853904772746628; Darwin C., 1981, DESCENT MAN SELECTIO; Foote JR, 2008, BEHAV ECOL, V19, P1192, DOI 10.1093/beheco/arn087; Franz M, 2003, J EXP BIOL, V206, P967, DOI 10.1242/jeb.00196; Hall DW, 2000, EVOLUTION, V54, P1862, DOI 10.1111/j.0014-3820.2000.tb01233.x; Hoeschele M, 2010, ANIM BEHAV, V79, P657, DOI 10.1016/j.anbehav.2009.12.015; Hof D, 2010, ANIM BEHAV, V80, P821, DOI 10.1016/j.anbehav.2010.07.017; HORN AG, 1992, AUK, V109, P847; Horn AG, 1992, FREQUENCY VARIATION; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mennill DJ, 2004, ANIM BEHAV, V67, P441, DOI 10.1016/j.anbehav.2003.04.010; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Proppe DS, 2009, J EXP BIOL, V212, P3016, DOI 10.1242/jeb.031724; Proppe DS, 2010, EFFECT ANTHROPOGENIC; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; RATCLIFFE L, 1985, CONDOR, V87, P555, DOI 10.2307/1367963; Reijnen R, 2006, ENVIRONM POLLUT SER, V10, P255, DOI 10.1007/1-4020-4504-2_12; Sharbaugh SM, 2001, PHYSIOL BIOCHEM ZOOL, V74, P568, DOI 10.1086/322170; Slabbekoom H, 2004, J ACOUST SOC AM, V116, P3727, DOI 10.1121/1.1811121; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Smith S.M., 1991, BLACK CAPPED CHICKAD; Weisman R, 1990, CONDOR, V92, P188; Wiley R. H., 1982, ACOUSTIC COMMUNICATI, P131, DOI DOI 10.1016/B978-0-08-092416-8.50014-0; Zahavi A, 1999, HANDICAP PRINCIPLE M	33	21	21	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25413	10.1371/journal.pone.0025413	http://dx.doi.org/10.1371/journal.pone.0025413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980449	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900061
J	Valcarcel, B; Wurtz, P; al Basatena, NKS; Tukiainen, T; Kangas, AJ; Soininen, P; Jarvelin, MR; Ala-Korpela, M; Ebbels, TM; de Iorio, M				Valcarcel, Beatriz; Wurtz, Peter; al Basatena, Nafisa-Katrin Seich; Tukiainen, Taru; Kangas, Antti J.; Soininen, Pasi; Jarvelin, Marjo-Riitta; Ala-Korpela, Mika; Ebbels, Timothy M.; de Iorio, Maria			A Differential Network Approach to Exploring Differences between Biological States: An Application to Prediabetes	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; VLDL	Background: Variations in the pattern of molecular associations are observed during disease development. The comprehensive analysis of molecular association patterns and their changes in relation to different physiological conditions can yield insight into the biological basis of disease-specific phenotype variation. Methodology: Here, we introduce a formal statistical method for the differential analysis of molecular associations via network representation. We illustrate our approach with extensive data on lipoprotein subclasses measured by NMR spectroscopy in 4,406 individuals with normal fasting glucose, and 531 subjects with impaired fasting glucose (prediabetes). We estimate the pair-wise association between measures using shrinkage estimates of partial correlations and build the differential network based on this measure of association. We explore the topological properties of the inferred network to gain insight into important metabolic differences between individuals with normal fasting glucose and prediabetes. Conclusions/Significance: Differential networks provide new insights characterizing differences in biological states. Based on conventional statistical methods, few differences in concentration levels of lipoprotein subclasses were found between individuals with normal fasting glucose and individuals with prediabetes. By performing the differential analysis of networks, several characteristic changes in lipoprotein metabolism known to be related to diabetic dyslipidemias were identified. The results demonstrate the applicability of the new approach to identify key molecular changes inaccessible to standard approaches.	[Valcarcel, Beatriz; al Basatena, Nafisa-Katrin Seich] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Wurtz, Peter; Tukiainen, Taru; Kangas, Antti J.; Soininen, Pasi; Ala-Korpela, Mika] Univ Oulu, Inst Clin Med, Oulu, Finland; [Wurtz, Peter; Tukiainen, Taru; Kangas, Antti J.; Soininen, Pasi; Jarvelin, Marjo-Riitta; Ala-Korpela, Mika] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Soininen, Pasi; Ala-Korpela, Mika] Univ Eastern Finland, Dept Biosci, NMR Metabon Lab, Kuopio, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Wellbeing, Dept Child & Adolescent Hlth, Oulu, Finland; [Jarvelin, Marjo-Riitta] Inst Hlth Sci, Oulu, Finland; [Ala-Korpela, Mika] Univ Oulu, Dept Internal Med, Clin Res Ctr, SF-90220 Oulu, Finland; [Ebbels, Timothy M.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Imperial College London; University of Oulu; University of Oulu; University of Eastern Finland; University of Oulu; Imperial College London	Valcarcel, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England.	t.ebbels@imperial.ac.uk; m.deiorio@imperial.ac.uk	Ebbels, Tim/ABB-2627-2021; Soininen, Pasi/B-9716-2008	Ebbels, Tim/0000-0002-3372-8423; Ala-Korpela, Mika/0000-0001-5905-1206; De Iorio, Maria/0000-0003-3109-0478; Wurtz, Peter/0000-0002-5832-0221; Kangas, Antti/0000-0001-7492-1732; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Tukiainen, Taru/0000-0002-5404-8398	Biotechnology and Biological Sciences Research Council [BB/E20372/1]; Academy of Finland [137870, 129429, 104781, 120315, 1114194, 129269 (SALVE), 139900S]; Finnish Cardiovascular Research Foundation; Jenny and Antti Wihuri Foundation; Instrumentarium Science Foundation; University Hospital Oulu, Biocenter, University of Oulu, Finland; Medical Research Council (PrevMetSyn), UK; ENGAGE project [HEALTH-F4-2007-201413]; BBSRC [BB/E020372/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020372/1] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Academy of Finland(Academy of Finland); Finnish Cardiovascular Research Foundation; Jenny and Antti Wihuri Foundation; Instrumentarium Science Foundation; University Hospital Oulu, Biocenter, University of Oulu, Finland; Medical Research Council (PrevMetSyn), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ENGAGE project(General Electric); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by: Biotechnology and Biological Sciences Research Council (Grant Ref. BB/E20372/1); Academy of Finland (grant number 137870); Responding to Public Health Challenges Research Programme of the Academy of Finland (grant number 129429); The Finnish Cardiovascular Research Foundation; The Jenny and Antti Wihuri Foundation; Academy of Finland and the Instrumentarium Science Foundation; The Academy of Finland (project grants 104781, 120315, 1114194, 129269 (SALVE), 139900S); University Hospital Oulu, Biocenter, University of Oulu, Finland; The Medical Research Council (PrevMetSyn), UK and the ENGAGE project and grant agreement HEALTH-F4-2007-201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bertram HC, 2009, METABOLISM, V58, P1039, DOI 10.1016/j.metabol.2009.03.011; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; de Silva E, 2005, J R SOC INTERFACE, V2, P419, DOI 10.1098/rsif.2005.0067; Festa A, 2005, CIRCULATION, V111, P3465, DOI 10.1161/CIRCULATIONAHA.104.512079; Fuite J, 2008, GENOMICS, V92, P393, DOI 10.1016/j.ygeno.2008.08.008; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gill R, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-427, 10.1186/1471-2105-11-95]; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hodge AM, 2009, DIABETES RES CLIN PR, V83, P132, DOI 10.1016/j.diabres.2008.11.007; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Ledoit O., 2003, J EMPIR FINANCE, V10, P603, DOI [10.1016/S0927-5398(03)00007-0, DOI 10.1016/S0927-5398(03)00007-0]; Mora S, 2010, DIABETES, V59, P1153, DOI 10.2337/db09-1114; Niemi J, 2009, ANN MED, V41, P451, DOI 10.1080/07853890902893392; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Ursem R, 2008, EUPHYTICA, V161, P181, DOI 10.1007/s10681-008-9672-y; Vehtari A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S8; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; World Health Organization, 2003, WHONMHMN031	30	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24702	10.1371/journal.pone.0024702	http://dx.doi.org/10.1371/journal.pone.0024702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980352	Green Published, gold, Green Submitted			2022-12-27	WOS:000295933700007
J	Wang, QL; Zhang, M; Liang, B; Shirwany, N; Zhu, Y; Zou, MH				Wang, Qilong; Zhang, Miao; Liang, Bin; Shirwany, Najeeb; Zhu, Yi; Zou, Ming-Hui			Activation of AMP-Activated Protein Kinase Is Required for Berberine-Induced Reduction of Atherosclerosis in Mice: The Role of Uncoupling Protein 2	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; TRADITIONAL CHINESE MEDICINE; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; INSULIN SENSITIVITY; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; IN-VIVO; MITOCHONDRIAL BIOGENESIS; HYDROGEN-PEROXIDE	Aims: Berberine, a botanical alkaloid purified from Coptidis rhizoma, is reported to activate the AMP-activated protein kinase (AMPK). Whether AMPK is required for the protective effects of berberine in cardiovascular diseases remains unknown. This study was designed to determine whether AMPK is required for berberine-induced reduction of oxidative stress and atherosclerosis in vivo. Methods: ApoE (ApoE(-/-)) mice and ApoE(-/-)/AMPK alpha 2(-/-) mice that were fed Western diets were treated with berberine for 8 weeks. Atherosclerotic aortic lesions, expression of uncoupling protein 2 (UCP2), and markers of oxidative stress were evaluated in isolated aortas. Results: In ApoE(-/-) mice, chronic administration of berberine significantly reduced aortic lesions, markedly reduced oxidative stress and expression of adhesion molecules in aorta, and significantly increased UCP2 levels. In contrast, in ApoE(-/-)/AMPK alpha 2(-/-) mice, berberine had little effect on those endpoints. In cultured human umbilical vein endothelial cells (HUVECs), berberine significantly increased UCP2 mRNA and protein expression in an AMPK-dependent manner. Transfection of HUVECs with nuclear respiratory factor 1 (NRF1)-specific siRNA attenuated berberine-induced expression of UCP2, whereas transfection with control siRNA did not. Finally, berberine promoted mitochondrial biogenesis that contributed to up-regulation of UCP2 expression. Conclusion: We conclude that berberine reduces oxidative stress and vascular inflammation, and suppresses atherogenesis via a mechanism that includes stimulation of AMPK-dependent UCP2 expression.	[Wang, Qilong; Zhang, Miao; Liang, Bin; Shirwany, Najeeb; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73190 USA; [Zhu, Yi] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Peking University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wang, QL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	wang, qilong/O-1962-2013	wang, qilong/0000-0002-4375-991X	National Institutes of Health; American Diabetes Association; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health, American Diabetes Association, and American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arayne MS, 2007, PAK J PHARM SCI, V20, P83; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Beall C, 2010, BIOCHEM J, V429, P323, DOI 10.1042/BJ20100231; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Cho BJ, 2005, MOL CELLS, V20, P429; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Cicero AEG, 2007, ARZNEIMITTELFORSCH, V57, P26; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; DONG Y, 2002, CIRCULATION, V121, P792; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Fulop P, 2006, HEPATOLOGY, V44, P592, DOI 10.1002/hep.21310; Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127; Guo Y, 2008, CHINESE MED J-PEKING, V121, P1197, DOI 10.1097/00029330-200807010-00009; Han YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015420; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Horimoto M, 2004, HEPATOLOGY, V39, P386, DOI 10.1002/hep.20047; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Jo SH, 2006, J IMMUNOL, V177, P3737, DOI 10.4049/jimmunol.177.6.3737; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Liang KW, 2006, BIOCHEM PHARMACOL, V71, P806, DOI 10.1016/j.bcp.2005.12.028; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Moukdar F, 2009, J LIPID RES, V50, P59, DOI 10.1194/jlr.M800273-JLR200; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Palanivel R, 2008, J ENDOCRINOL, V199, P389, DOI 10.1677/JOE-08-0336; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Ruzicka M, 2005, INT J BIOCHEM CELL B, V37, P809, DOI 10.1016/j.biocel.2004.10.016; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Shirwany NA, 2010, ACTA PHARMACOL SIN, V31, P1075, DOI 10.1038/aps.2010.139; Tsai JS, 2010, J CELL BIOCHEM, V110, P1410, DOI 10.1002/jcb.22657; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Vieira O, 2000, FASEB J, V14, P532, DOI 10.1096/fasebj.14.3.532; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang HY, 2009, SPECTROCHIM ACTA A, V73, P682, DOI 10.1016/j.saa.2009.03.017; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang YQ, 2009, CARDIOVASC RES, V82, P484, DOI 10.1093/cvr/cvp078; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; WUTHRICH RP, 1990, AM J PATHOL, V136, P441; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Ye JM, 2006, DIABETES, V55, P2797, DOI 10.2337/db05-1315; Yin HQ, 2008, J ETHNOPHARMACOL, V118, P133, DOI 10.1016/j.jep.2008.03.022; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Yu L, 2010, NEUROSCIENCE, V169, P23, DOI 10.1016/j.neuroscience.2010.04.063; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253	63	102	111	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25436	10.1371/journal.pone.0025436	http://dx.doi.org/10.1371/journal.pone.0025436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980456	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700033
J	Scoma, HD; Humby, M; Yadav, G; Zhang, QJ; Fogerty, J; Besharse, JC				Scoma, Heather Dehlin; Humby, Monica; Yadav, Geetha; Zhang, Qingjiong; Fogerty, Joseph; Besharse, Joseph C.			The De-Ubiquitinylating Enzyme, USP2, Is Associated with the Circadian Clockwork and Regulates Its Sensitivity to Light	PLOS ONE			English	Article							GENE-EXPRESSION; DEUBIQUITINATING ENZYMES; DEGRADATION; TRANSCRIPTION; ACTIVATION; COACTIVATOR; PHYSIOLOGY; TURNOVER; PROTEIN; BMAL1	We have identified a novel component of the circadian clock that regulates its sensitivity to light at the evening light to dark transition. USP2 (Ubiquitin Specific Protease 2), which de-ubiquitinylates and stabilizes target proteins, is rhythmically expressed in multiple tissues including the SCN. We have developed a knockout model of USP2 and found that exposure to low irradiance light at ZT12 increases phase delays of USP2(-/-) mice compared to wildtype. We additionally show that USP2b is in a complex with several clock components and regulates the stability and turnover of BMAL1, which in turn alters the expression of several CLOCK/BMAL1 controlled genes. Rhythmic expression of USP2 in the SCN and other tissues offers a new level of control of the clock machinery through de-ubiqutinylation and suggests a role for USP2 during circadian adaptation to environmental day length changes.	[Scoma, Heather Dehlin; Humby, Monica; Yadav, Geetha; Zhang, Qingjiong; Fogerty, Joseph; Besharse, Joseph C.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Scoma, HD (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	jbeshars@mcw.edu	Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X; Fogerty, Joseph/0000-0003-0028-1861	NIH [EY02414, EY03222, P30-EY01931, T32-EY014537]; NATIONAL EYE INSTITUTE [P30EY001931, T32EY014537, R01EY002414, R01EY003222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by NIH research grants EY02414 (JCB) and EY03222 (JCB) and by NIH Core Grant for Vision Research P30-EY01931. HDS and JF were supported by training grant NIH T32-EY014537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hurst WJ, 2002, BIOCHEM BIOPH RES CO, V298, P133, DOI 10.1016/S0006-291X(02)02346-X; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kondratov RV, 2007, CURR TOP DEV BIOL, V78, P173, DOI 10.1016/S0070-2153(06)78005-X; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Liu S, 2007, CHRONOBIOL INT, V24, P793, DOI 10.1080/07420520701672556; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Parviz F, 2002, GENESIS, V32, P130, DOI 10.1002/gene.10058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeffer M, 2009, J NEUROSCI, V29, P6114, DOI 10.1523/JNEUROSCI.0275-09.2009; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Sehgal A, 2008, NEURON, V57, P8, DOI 10.1016/j.neuron.2007.12.018; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Tischkau SA, 2005, METHOD ENZYMOL, V393, P593, DOI 10.1016/S0076-6879(05)93031-0; Verrey F, 2008, KIDNEY INT, V73, P691, DOI 10.1038/sj.ki.5002737; von Gall C, 2003, EUR J NEUROSCI, V18, P125, DOI 10.1046/j.1460-9568.2003.02735.x; Wu M, 2000, GENE DEV, V14, P301; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	40	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25382	10.1371/journal.pone.0025382	http://dx.doi.org/10.1371/journal.pone.0025382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966515	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100052
J	Zor, R; Szechtman, H; Hermesh, H; Fineberg, NA; Eilam, D				Zor, Rama; Szechtman, Henry; Hermesh, Haggai; Fineberg, Naomi A.; Eilam, David			Manifestation of Incompleteness in Obsessive-Compulsive Disorder (OCD) as Reduced Functionality and Extended Activity beyond Task Completion	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL ANALYSIS; SECURITY MOTIVATION SYSTEM; RIGHT EXPERIENCES; POTENTIAL THREAT; RESPONSIBILITY; PERFECTIONISM; PSYCHOPATHOLOGY; CHECKING; FEATURES	Background: This study focused on hypotheses regarding the source of incompleteness in obsessive-compulsive disorder (OCD). For this, we had to document the behavioral manifestation of incompleteness in compulsive rituals, predicting that an exaggerated focus on acts that are appropriate for the task will support the hypothesis on heightened responsibility/perfectionism. In contrast, activity past the expected terminal act for the motor task would support the "stop signal deficiency" hypothesis. Methodology and Principal Findings: We employed video-telemetry to analyze 39 motor OCD rituals and compared each with a similar task performed by a non-OCD individual, in order to objectively and explicitly determine the functional end of the activity. We found that 75% of OCD rituals comprised a "tail ," which is a section that follows the functional end of the task that the patients ascribed to their activity. The other 25% tailless rituals comprised a relatively high number and higher rate of repetition of non-functional acts. Thus, in rituals with tail, incompleteness was manifested by the mere presence of the tail whereas in tailless rituals, incompleteness was manifested by the reduced functionality of the task due to an inflated execution and repetition of non-functional acts. Conclusions: The prevalence of activity after the functional end ("tail") and the elevated non-functionality in OCD motor rituals support the "lack of stop signal" theories as the underlying mechanism in OCD. Furthermore, the presence and content of the tail might have a therapeutic potential in cognitive-behavior therapy.	[Zor, Rama; Eilam, David] Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel; [Szechtman, Henry] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Hermesh, Haggai] Tel Aviv Univ, Adult Outpatient Dept & Anxiety Disorders, Ramat Aviv, Israel; [Hermesh, Haggai] Tel Aviv Univ, Behav Therapy Unit, Geha Mental Hlth Ctr, Rabin Med Ctr, Ramat Aviv, Israel; [Hermesh, Haggai] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Fineberg, Naomi A.] Hertfordshire Partnership NHS Fdn Trust, Queen Elizabeth II Hosp, Natl OCD Treatment Serv, Welwyn Garden City, Herts, England	Tel Aviv University; McMaster University; Tel Aviv University; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Zor, R (corresponding author), Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel.	eilam@post.tau.ac.il	Eilam, David/GOV-6655-2022; Fineberg, Naomi/ABI-5522-2020; Szechtman, Henry/A-4706-2009	Eilam, David/0000-0002-4494-6928; Szechtman, Henry/0000-0003-3986-4482	Tel-Aviv University; Lundbeck; Glaxo-SmithKline; Astra Zeneca; Wellcome; Cephalon; ECNP; Servier; Janssen; Bristol Myers Squibb; Jazz; Wyeth; International College of OC Spectrum Disorders	Tel-Aviv University; Lundbeck(Lundbeck Corporation); Glaxo-SmithKline(GlaxoSmithKline); Astra Zeneca(AstraZeneca); Wellcome; Cephalon; ECNP; Servier(Servier); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol Myers Squibb(Bristol-Myers Squibb); Jazz(Jazz Pharmaceuticals); Wyeth(Wyeth); International College of OC Spectrum Disorders	This study was supported by an internal grant to D.E., provided by the vice president for Research and Development in Tel-Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Fineberg has consulted for Lundbeck, Glaxo-Smith Kline, Servier, and Bristol Myers Squibb; has received research grants/support from Lundbeck, Glaxo-SmithKline, Astra Zeneca, Wellcome, Cephalon, ECNP, and Servier; has received honoraria for lectures at scientific meetings from Janssen, Jazz, Lundbeck, Servier, Astra Zeneca, and Wyeth; has received financial support to attend scientific meetings from Janssen, Bristol Myers Squibb, Jazz, Lundbeck, Servier, Astra Zeneca, Wyeth, Cephalon, and International College of OC Spectrum Disorders. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Rama Zor, Henry Szechtman, Haggai Hermesh and David Eilam declare that no competing interests exist.	Antony MM, 1998, BEHAV RES THER, V36, P1143, DOI 10.1016/S0005-7967(98)00083-7; APA, 2000, DIAGN STAT MAN, P456; Arntz A, 2007, BEHAV RES THER, V45, P425, DOI 10.1016/j.brat.2006.03.016; BERRIOS GE, 1989, COMPR PSYCHIAT, V30, P283, DOI 10.1016/0010-440X(89)90052-7; Berrios GE, 2002, BIOL PSYCHIAT, P3; Boyer P, 2006, BEHAV BRAIN SCI, V29, P595, DOI 10.1017/S0140525X06009332; BURNS DD, 1980, PSYCHOL TODAY, V14, P34; Coles ME, 2005, BEHAV RES THER, V43, P153, DOI 10.1016/j.brat.2004.01.002; Coles ME, 2003, BEHAV RES THER, V41, P681, DOI 10.1016/S0005-7967(02)00044-X; Cougle JR, 2007, J ANXIETY DISORD, V21, P153, DOI 10.1016/j.janxdis.2006.03.012; Eilam D, 2011, BEHAV BRAIN IN PRESS; Frost RO, 1997, BEHAV RES THER, V35, P291, DOI 10.1016/S0005-7967(96)00108-8; Gillan CM, 2011, AM J PSYCHI IN PRESS; HAMACHEK DE, 1978, PSYCHOLOGY, V15, P27; Hinds AL, 2010, BIOL PSYCHOL, V85, P331, DOI 10.1016/j.biopsycho.2010.08.003; LADOUCEUR R, 1995, BEHAV RES THER, V33, P937, DOI 10.1016/0005-7967(95)00024-R; LECKMAN JF, 1994, ANXIETY, V1, P208; Lee JC, 2009, COMPR PSYCHIAT, V50, P431, DOI 10.1016/j.comppsych.2008.11.007; RACHMAN S, 1993, BEHAV RES THER, V31, P149, DOI 10.1016/0005-7967(93)90066-4; Rachman S, 2002, BEHAV RES THER, V40, P625, DOI 10.1016/S0005-7967(01)00028-6; Rapoport J.L., 1989, BOY WHO COULD NOT ST; RASMUSSEN SA, 1992, J CLIN PSYCHIAT, V53, P4; Reed G.F., 1985, OBSESSIONAL EXPERIEN; RHEAUME J, 1995, BEHAV RES THER, V33, P785, DOI 10.1016/0005-7967(95)00017-R; Rheaume J, 2000, BEHAV RES THER, V38, P119, DOI 10.1016/S0005-7967(98)00203-4; SALKOVSKIS PM, 1989, BEHAV RES THER, V27, P677, DOI 10.1016/0005-7967(89)90152-6; SALKOVSKIS PM, 1985, BEHAV RES THER, V23, P571, DOI 10.1016/0005-7967(85)90105-6; Salkovskis PM, 1999, BEHAV RES THER, V37, pS29, DOI 10.1016/S0005-7967(99)00049-2; Summerfeldt LJ, 2004, J CLIN PSYCHOL, V60, P1155, DOI 10.1002/jclp.20080; Szechtman H, 2004, PSYCHOL REV, V111, P111, DOI 10.1037/0033-295X.111.1.111; Szechtman H, 2004, BEHAV LAB RAT HDB TE, P462; Taylor S, 2011, J ABNORM PSYCHOL, V120, P174, DOI 10.1037/a0021403; Wahl K, 2008, J ANXIETY DISORD, V22, P143, DOI 10.1016/j.janxdis.2007.02.009; Woody EZ, 2011, NEUROSCI BIOBEHAV R, V35, P1019, DOI 10.1016/j.neubiorev.2010.08.003; Zor R, 2009, ACTA PSYCHIAT SCAND, V120, P288, DOI 10.1111/j.1600-0447.2009.01370.x; Zor R, 2011, EUR NEUROPS IN PRESS; Zor R, 2010, CNS SPECTRUMS, V15, P445, DOI 10.1017/S1092852900000377; Zor R, 2009, WORLD J BIOL PSYCHIA, V10, P480, DOI 10.1080/15622970701416539	38	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25217	10.1371/journal.pone.0025217	http://dx.doi.org/10.1371/journal.pone.0025217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IZ	21966460	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100029
J	Rossi, S; Toigo, C; Hars, J; Pol, F; Hamann, JL; Depner, K; Le Potier, MF				Rossi, Sophie; Toigo, Carole; Hars, Jean; Pol, Francoise; Hamann, Jean-Luc; Depner, Klaus; Le Potier, Marie-Frederique			New Insights on the Management of Wildlife Diseases Using Multi-State Recapture Models: The Case of Classical Swine Fever in Wild Boar	PLOS ONE			English	Article							ORAL IMMUNIZATION; LONG-TERM; PERSISTENCE; VACCINATION; CSF; EPIDEMIOLOGY; DIAGNOSIS; SURVIVAL; ANIMALS; BAITS	Background: The understanding of host-parasite systems in wildlife is of increasing interest in relation to the risk of emerging diseases in livestock and humans. In this respect, many efforts have been dedicated to controlling classical swine fever (CSF) in the European Wild Boar. But CSF eradication has not always been achieved even though vaccination has been implemented at a large-scale. Piglets have been assumed to be the main cause of CSF persistence in the wild since they appeared to be more often infected and less often immune than older animals. However, this assumption emerged from laboratory trials or cross-sectional surveys based on the hunting bags. Methodology/Principal Findings: In the present paper we conducted a capture-mark-recapture study in free-ranging wild boar piglets that experienced both CSF infection and vaccination under natural conditions. We used multi-state capture recapture models to estimate the immunization and infection rates, and their variations according to the periods with or without vaccination. According to the model prediction, 80% of the infected piglets did not survive more than two weeks, while the other 20% quickly recovered. The probability of becoming immune did not increase significantly during the summer vaccination sessions, and the proportion of immune piglets was not higher after the autumn vaccination. Conclusions/Significance: Given the high lethality of CSF in piglets highlighted in our study, we consider unlikely that piglets could maintain the chain of CSF virus transmission. Our study also revealed the low efficacy of vaccination in piglets in summer and autumn, possibly due to the low palatability of baits to that age class, but also to the competition between baits and alternative food sources. Based on this new information, we discuss the prospects for the improvement of CSF control and the interest of the capture-recapture approach for improving the understanding of wildlife diseases.	[Rossi, Sophie; Hars, Jean] Off Natl Chasse & Faune Sauvage, Unite Sanit Faune, Gap, France; [Toigo, Carole] Off Natl Chasse & Faune Sauvage, CNERA Faune Montagne, Gieres, France; [Pol, Francoise; Le Potier, Marie-Frederique] French Agcy Food Envionmental & Occupat Hlth & Sa, Lab Natl Reference Pestes Porcines, Ploufragan, France; [Hamann, Jean-Luc] Off Natl Chasse & Faune Sauvage, CNERA Cervides Sanglier, Petite Pierre, France; [Depner, Klaus] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	Friedrich Loeffler Institute	Rossi, S (corresponding author), Off Natl Chasse & Faune Sauvage, Unite Sanit Faune, Gap, France.	sophie.rossi@oncfs.gouv.fr		Pol, Francoise/0000-0003-1696-8959	French Ministry of Agriculture	French Ministry of Agriculture	This study has been funded by the French Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artois M, 2002, REV SCI TECH OIE, V21, P287, DOI 10.20506/rst.21.2.1332; Ballesteros C, 2009, RES VET SCI, V86, P388, DOI 10.1016/j.rvsc.2008.09.003; Bonenfant C, 2002, ECOGRAPHY, V25, P446, DOI 10.1034/j.1600-0587.2002.250407.x; Brauer A, 2006, EUR J WILDLIFE RES, V52, P271, DOI 10.1007/s10344-006-0048-0; Burnham K. P., 1998, MODEL SELECTION INFE; Choquet R, 2005, MSURGE 1 7 USERS MAN; CHOQUET R, 2005, UCARE 2 2 USERS MANU; Conn PB, 2009, J APPL ECOL, V46, P486, DOI 10.1111/j.1365-2664.2008.01597.x; Depner K.R, 2000, DTSCH TIERARZTL WSCH, V107, P41; Depner K, 2007, VET MICROBIOL, V121, P338, DOI 10.1016/j.vetmic.2006.12.027; Depner KR, 1995, VET REC, V140, P506; Dewulf J, 2004, J VIROL METHODS, V119, P137, DOI 10.1016/j.jviromet.2004.03.010; EFSA, 2008, ANN EFSA J, V932, P1; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; GAILLARD JM, 1992, OECOLOGIA, V90, P167, DOI 10.1007/BF00317173; Guberti V, 1998, P M MEAS CONTR CLASS, P54; Hars J., 2004, Game & Wildlife Science, V21, P513; Hebeisen C., 2007, POPULATION SIZE DENS; HONE J, 1992, EPIDEMIOL INFECT, V108, P377, DOI 10.1017/S0950268800049840; HUGGETT AS, 1951, J PHYSIOL-LONDON, V114, P306, DOI 10.1113/jphysiol.1951.sp004622; Jennelle CS, 2007, ECOL APPL, V17, P154, DOI 10.1890/1051-0761(2007)017[0154:SDPADP]2.0.CO;2; Jullien JM, 1988, B MENSUEL OFFICE NAT, V122, P28; Kaden V, 2006, J VET MED B, V53, P455, DOI 10.1111/j.1439-0450.2006.00993.x; Kaden V, 2004, DEUT TIERARZTL WOCH, V111, P63; Kaden V, 2002, BERL MUNCH TIERARZTL, V115, P179; Kern B, 1999, J VET MED B, V46, P63, DOI 10.1046/j.1439-0450.1999.00214.x; KLEIN F, 2004, GESTION SANGLIER PIS; Klein F., 1984, S INT SANGL TOUL, P58; Kramer-Schadt S, 2007, MAMMAL REV, V37, P1, DOI 10.1111/j.1365-2907.2007.00097.x; Kramer-Schadt S, 2009, OIKOS, V118, P199, DOI 10.1111/j.1600-0706.2008.16582.x; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Laddomada A, 2000, VET MICROBIOL, V73, P121, DOI 10.1016/S0378-1135(00)00139-5; Le Dimna M, 2008, J VIROL METHODS, V147, P136, DOI 10.1016/j.jviromet.2007.08.013; Le Potier M. F., 2006, DIS SWINE, V9th, P309; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Louguet Y, 2005, B EPIDEMIOLOGIQUE AG, V19, P3; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; Muller T, 2005, J VET MED B, V52, P432, DOI 10.1111/j.1439-0450.2005.00896.x; Oli MK, 2006, ECOL MODEL, V198, P183, DOI 10.1016/j.ecolmodel.2006.04.007; Pol F, 2008, VET REC, V162, P811, DOI 10.1136/vr.162.25.811; Pradel R, 2003, BIOMETRICS, V59, P43, DOI 10.1111/1541-0420.00006; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Rossi S, 2005, EPIDEMIOL INFECT, V133, P559, DOI 10.1017/S0950268804003553; Rossi S, 2005, VET RES, V36, P27, DOI 10.1051/vetres:2004050; Rossi S, 2010, VET MICROBIOL, V142, P99, DOI 10.1016/j.vetmic.2009.09.050; Rossi S, 2006, B ACAD VET FRANCE, V159, P389; Rossi S, 2008, P EWDA S ROV 5 9 OCT; Ruiz-Fons F, 2008, VET J, V176, P158, DOI 10.1016/j.tvjl.2007.02.017; Toigo C, 2008, J WILDLIFE MANAGE, V72, P1532, DOI 10.2193/2007-378; von Ruden S, 2008, VET MICROBIOL, V132, P29, DOI 10.1016/j.vetmic.2008.04.022	51	24	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e24257	10.1371/journal.pone.0024257	http://dx.doi.org/10.1371/journal.pone.0024257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21977225	Green Submitted, Green Published, gold			2022-12-27	WOS:000295265100007
J	Stratton, P; Milford, M; Wyeth, G; Wiles, J				Stratton, Peter; Milford, Michael; Wyeth, Gordon; Wiles, Janet			Using Strategic Movement to Calibrate a Neural Compass: A Spiking Network for Tracking Head Direction in Rats and Robots	PLOS ONE			English	Article							PATH-INTEGRATION; RECURRENT EXCITATION; MODEL; MOTOR; CELLS; MAP	The head direction (HD) system in mammals contains neurons that fire to represent the direction the animal is facing in its environment. The ability of these cells to reliably track head direction even after the removal of external sensory cues implies that the HD system is calibrated to function effectively using just internal (proprioceptive and vestibular) inputs. Rat pups and other infant mammals display stereotypical warm-up movements prior to locomotion in novel environments, and similar warm-up movements are seen in adult mammals with certain brain lesion-induced motor impairments. In this study we propose that synaptic learning mechanisms, in conjunction with appropriate movement strategies based on warm-up movements, can calibrate the HD system so that it functions effectively even in darkness. To examine the link between physical embodiment and neural control, and to determine that the system is robust to real-world phenomena, we implemented the synaptic mechanisms in a spiking neural network and tested it on a mobile robot platform. Results show that the combination of the synaptic learning mechanisms and warm-up movements are able to reliably calibrate the HD system so that it accurately tracks real-world head direction, and that calibration breaks down in systematic ways if certain movements are omitted. This work confirms that targeted, embodied behaviour can be used to calibrate neural systems, demonstrates that 'grounding' of modelled biological processes in the real world can reveal underlying functional principles (supporting the importance of robotics to biology), and proposes a functional role for stereotypical behaviours seen in infant mammals and those animals with certain motor deficits. We conjecture that these calibration principles may extend to the calibration of other neural systems involved in motion tracking and the representation of space, such as grid cells in entorhinal cortex.	[Stratton, Peter] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Stratton, Peter; Wiles, Janet] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia; [Milford, Michael; Wyeth, Gordon] Queensland Univ Technol, Sch Engn Syst, Brisbane, Qld 4001, Australia	University of Queensland; University of Queensland; Queensland University of Technology (QUT)	Stratton, P (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	stratton@itee.uq.edu.au	Milford, Michael/J-1304-2012; Wiles, Janet/C-1989-2008	Milford, Michael/0000-0002-5162-1793; Stratton, Peter/0000-0002-3312-7505; Wiles, Janet/0000-0002-4051-4116; Wyeth, Gordon/0000-0002-4996-3612	Australian Research Council; National Health and Medical Research Council [TS0669699]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council (www.arc.gov.au) and National Health and Medical Research Council (www.nhmrc.gov.au) Thinking Systems Grant (Special Research Initiative: Thinking Systems; grant number: TS0669699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Arleo A, 2001, NEUROCOMPUTING, V38, P1059, DOI 10.1016/S0925-2312(01)00572-0; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Beer RD, 2009, ADAPT BEHAV, V17, P296, DOI 10.1177/1059712309340844; Boucheny C, 2005, J COMPUT NEUROSCI, V18, P205, DOI 10.1007/s10827-005-6559-y; Brunner D, 1999, BEHAV NEUROSCI, V113, P587; Daney D, 2005, INT J ROBOT RES, V24, P501, DOI 10.1177/0278364905053185; Daney D, 2001, ROBUST PARALLEL ROBO, P3262; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; GOLANI I, 1981, P NATL ACAD SCI-BIOL, V78, P7226, DOI 10.1073/pnas.78.11.7226; GOLANI I, 1979, BRAIN RES, V164, P237, DOI 10.1016/0006-8993(79)90019-2; Goodridge JP, 1998, BEHAV NEUROSCI, V112, P749, DOI 10.1037/0735-7044.112.4.749; Goodridge JP, 2000, J NEUROPHYSIOL, V83, P3402, DOI 10.1152/jn.2000.83.6.3402; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hahnloser RHR, 2003, NEUROSCIENCE, V120, P877, DOI 10.1016/S0306-4522(03)00201-X; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Korner AF, 1972, P 3 S OR SENS PERC, P335; Lackner JR, 2005, CURR OPIN NEUROBIOL, V15, P653, DOI 10.1016/j.conb.2005.10.012; LORDEN JF, 1984, J NEUROSCI, V4, P1925; Meng Y, 2007, ROBOT CIM-INT MANUF, V23, P436, DOI 10.1016/j.rcim.2006.05.002; Milford M, ROBOT NAVIGATION NAT; Milford M, 2010, INT J ROBOT RES, V29, P1131, DOI 10.1177/0278364909340592; Milford MJ, 2008, IEEE T ROBOT, V24, P1038, DOI 10.1109/TRO.2008.2004520; Milford MJ, 2004, IEEE INT CONF ROBOT, P403, DOI 10.1109/ROBOT.2004.1307183; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Olsson LA, 2006, CONNECT SCI, V18, P121, DOI 10.1080/09540090600768542; Piaget J., 1952, ORIGINS INTELLIGENCE; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Roy N, 1999, ONLINE SELF CALIBRAT, P2292; Schouenborg J, 2004, CURR OPIN NEUROBIOL, V14, P693, DOI 10.1016/j.conb.2004.10.009; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Skaggs WE, 1995, ADV NEURAL INFORM PR, V7, P51; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; STEIN RB, 1967, PROC R SOC SER B-BIO, V167, P64, DOI 10.1098/rspb.1967.0013; Stratton P, 2010, J COMPUT NEUROSCI, V28, P527, DOI 10.1007/s10827-010-0234-7; Stringer SM, 2002, NETWORK-COMP NEURAL, V13, P217, DOI 10.1088/0954-898X/13/2/304; Takeichi N, 2005, J NEUROPHYSIOL, V94, P1938, DOI 10.1152/jn.00113.2005; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; TAUBE JS, 1990, J NEUROSCI, V10, P420; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; Walters DM, 2010, BIOL CYBERN, V103, P21, DOI 10.1007/s00422-009-0355-0; Webb B, 2001, BEHAV BRAIN SCI, V24, P1033, DOI 10.1017/S0140525X01220123; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Xie XH, 2002, PHYS REV E, V66, DOI 10.1003/PhysRevE.66.041902; Zugaro MB, 2003, J NEUROSCI, V23, P3478	49	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25687	10.1371/journal.pone.0025687	http://dx.doi.org/10.1371/journal.pone.0025687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991332	Green Published, gold, Green Submitted			2022-12-27	WOS:000295963300016
J	Cai, W; Kramarova, TV; Berg, P; Korbonits, M; Pongratz, I				Cai, Wen; Kramarova, Tatiana V.; Berg, Petra; Korbonits, Marta; Pongratz, Ingemar			The Immunophilin-Like Protein XAP2 Is a Negative Regulator of Estrogen Signaling through Interaction with Estrogen Receptor alpha	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; RESPONSIVE BREAST-CANCER; INDUCED PITUITARY-TUMOR; X-ASSOCIATED PROTEIN-2; HEAT-SHOCK-PROTEIN; CORE COMPLEX; AH RECEPTOR; IN-VIVO; BETA; TRANSCRIPTION	XAP2 (also known as aryl hydrocarbon receptor interacting protein, AIP) is originally identified as a negative regulator of the hepatitis B virus X-associated protein. Recent studies have expanded the range of XAP2 client proteins to include the nuclear receptor family of transcription factors. In this study, we show that XAP2 is recruited to the promoter of ER alpha regulated genes like the breast cancer marker gene pS2 or GREB1 and negatively regulate the expression of these genes in MCF-7 cells. Interestingly, we show that XAP2 downregulates the E(2)-dependent transcriptional activation in an estrogen receptor (ER) isoform-specific manner: XAP2 inhibits ER alpha but not ER beta-mediated transcription. Thus, knockdown of intracellular XAP2 levels leads to increased ER alpha activity. XAP2 proteins, carrying mutations in their primary structures, loose the ability of interacting with ER alpha and can no longer regulate ER target gene transcription. Taken together, this study shows that XAP2 exerts a negative effect on ER alpha transcriptional activity and may thus prevent ER alpha-dependent events.	[Cai, Wen; Kramarova, Tatiana V.; Berg, Petra; Pongratz, Ingemar] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med, London, England	Karolinska Institutet; University of London; Queen Mary University London	Cai, W (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	Ingemar.Pongratz@ki.se		Korbonits, Marta/0000-0002-4101-9432	Consortorium for Research into Nuclear Receptors in Development and Aging Integrated Project [LSHM-CT-2005-018652]; CASCADE Network of Excellence [FOOD-CT-2004-506319 CASCADE]	Consortorium for Research into Nuclear Receptors in Development and Aging Integrated Project; CASCADE Network of Excellence	This work is supported by the Consortorium for Research into Nuclear Receptors in Development and Aging Integrated Project (LSHM-CT-2005-018652) and the CASCADE Network of Excellence (FOOD-CT-2004-506319 CASCADE). URL: www.cordis.lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Berg P, 2002, J BIOL CHEM, V277, P32310, DOI 10.1074/jbc.M203351200; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Cai W, 2008, MOL CELL BIOL, V28, P784, DOI 10.1128/MCB.00233-07; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Faulds MH, 2004, MOL ENDOCRINOL, V18, P412, DOI 10.1210/me.2003-0290; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Froidevaux MSC, 2006, EMBO REP, V7, P1035, DOI 10.1038/sj.embor.7400778; FUJIMOTO M, 1987, J NEURO-ONCOL, V5, P151, DOI 10.1007/BF02571303; Ghosh MG, 2000, CANCER RES, V60, P6367; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Greiser CM, 2007, HUM REPROD UPDATE, V13, P453, DOI 10.1093/humupd/dmm012; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Heaney AP, 2007, HORM RES, V68, P132, DOI 10.1159/000110608; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Kang BH, 2011, J BIOL CHEM, V286, P16758, DOI 10.1074/jbc.M110.210120; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Levenson AS, 1997, CANCER RES, V57, P3071; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Nakata A, 2009, EMBO REP, V10, P622, DOI 10.1038/embor.2009.35; Naves LA, 2007, EUR J ENDOCRINOL, V157, P383, DOI 10.1530/EJE-07-0533; Persson I, 1999, CANCER CAUSE CONTROL, V10, P253, DOI 10.1023/A:1008909128110; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pravettoni A, 2007, MOL CELL ENDOCRINOL, V263, P46, DOI 10.1016/j.mce.2006.08.008; Ruegg J, 2008, MOL ENDOCRINOL, V22, P304, DOI 10.1210/me.2007-0128; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Swedenborg E, 2008, MOL PHARMACOL, V73, P575, DOI 10.1124/mol.107.036384; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Swedenborg E, 2009, J MOL ENDOCRINOL, V43, P1, DOI 10.1677/JME-08-0132; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Zeng Q, 2008, J PATHOL, V214, P425, DOI 10.1002/path.2297	44	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25201	10.1371/journal.pone.0025201	http://dx.doi.org/10.1371/journal.pone.0025201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984905	Green Submitted, gold, Green Published			2022-12-27	WOS:000295943000016
J	Li, TS; Ikeda, S; Kubo, M; Ohshima, M; Kurazumi, H; Takemoto, Y; Ueda, K; Hamano, K				Li, Tao-Sheng; Ikeda, Satoshi; Kubo, Masayuki; Ohshima, Mako; Kurazumi, Hiroshi; Takemoto, Yoshihiro; Ueda, Kazuhiro; Hamano, Kimikazu			Diabetic Impairment of C-Kit(+) Bone Marrow Stem Cells Involves the Disorders of Inflammatory Factors, Cell Adhesion and Extracellular Matrix Molecules	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ISCHEMIC-HEART-DISEASE; PROGENITOR CELLS; THERAPEUTIC ANGIOGENESIS; MONONUCLEAR-CELLS; REPAIR; NEOVASCULARIZATION; IMPLANTATION; TRANSPLANTATION; COMPLICATIONS	Bone marrow stem cells from diabetes mellitus patients exhibit functional impairment, but the relative molecular mechanisms responsible for this impairment are poorly understood. We investigated the mechanisms responsible for diabetes-related functional impairment of bone marrow stem cells by extensively screening the expression levels of inflammatory factors, cell cycle regulating molecules, extracellular matrix molecules and adhesion molecules. Bone marrow cells were collected from type 2 diabetic (db/db) and healthy control (db/m+) mice, and c-kit(+) stem cells were purified (purity>85%) for experiments. Compared with the healthy control mice, diabetic mice had significantly fewer c-kit(+) stem cells, and these cells had a lower potency of endothelial differentiation; however, the production of the angiogenic growth factor VEGF did not differ between groups. A pathway-focused array showed that the c-kit(+) stem cells from diabetic mice had up-regulated expression levels of many inflammatory factors, including Tlr4, Cxcl9, Il9, Tgfb1, Il4, and Tnfsf5, but no obvious change in the expression levels of cell cycle molecules. Interestingly, diabetes-related alterations of the extracellular matrix and adhesion molecules were varied; Pecam, Mmp10, Lamc1, Itgb7, Mmp9, and Timp4 were up-regulated, but Col11a1, Fn1, Admts2, and Itgav were down-regulated. Some of these changes were also confirmed at the protein level by flow cytometry analysis. In conclusion, c-kit(+) bone marrow stem cells from diabetic mice exhibited an extensive enhancement of inflammatory factors and disorders of the extracellular matrix and adhesion molecules. Further intervention studies are required to determine the precise role of each molecule in the diabetes-related functional impairment of c-kit(+) bone marrow stem cells.	[Li, Tao-Sheng] Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Li, Tao-Sheng; Ikeda, Satoshi; Kubo, Masayuki; Ohshima, Mako; Kurazumi, Hiroshi; Takemoto, Yoshihiro; Ueda, Kazuhiro; Hamano, Kimikazu] Yamaguchi Univ, Dept Surg & Clin Sci, Grad Sch Med, Yamaguchi, Japan	Nagasaki University; Yamaguchi University	Li, TS (corresponding author), Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	litaoshe@nagasaki-u.ac.jp		Li, Tao-Sheng/0000-0002-7653-8873	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Baxter MA, 2009, STEM CELL RES, V3, P28, DOI 10.1016/j.scr.2009.03.002; Benigni A, 2010, LANCET, V375, P1310, DOI 10.1016/S0140-6736(10)60237-1; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; CLARK CM, 1995, NEW ENGL J MED, V332, P1210, DOI 10.1056/NEJM199505043321807; Di Santo S, 2008, BIOCHEM BIOPH RES CO, V373, P528, DOI 10.1016/j.bbrc.2008.06.066; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Esato K, 2002, CELL TRANSPLANT, V11, P747; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fuchs S, 2003, J AM COLL CARDIOL, V41, P1721, DOI 10.1016/S0735-1097(03)00328-0; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Kempf K, 2006, ANN NY ACAD SCI, V1084, P30, DOI 10.1196/annals.1372.012; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Li TS, 2008, BIOCHEM BIOPH RES CO, V366, P1074, DOI 10.1016/j.bbrc.2007.12.095; Li TS, 2007, J THORAC CARDIOV SUR, V134, P1347, DOI 10.1016/j.jtcvs.2007.07.016; Li TS, 2007, STEM CELLS, V25, P911, DOI 10.1634/stemcells.2006-0497; Li TS, 2010, J THORAC CARDIOV SUR, V139, P459, DOI 10.1016/j.jtcvs.2009.07.053; Li TS, 2009, CIRCULATION, V120, pS255, DOI 10.1161/CIRCULATIONAHA.108.837039; Li TS, 2006, AM J PHYSIOL-HEART C, V290, pH1362, DOI 10.1152/ajpheart.00766.2005; Li TS, 2005, CARDIOVASC RES, V65, P64, DOI 10.1016/j.cardiores.2004.08.019; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; McClellan KA, 2009, MOL CELL BIOL, V29, P4701, DOI 10.1128/MCB.01767-08; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Ohshima M, 2009, CIRC J, V73, P162, DOI 10.1253/circj.CJ-08-0123; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Sheng T, 2005, CIRCULATION, V111, P2438, DOI 10.1161/01.CIR.0000167553.49133.81; Spees JL, 2008, FASEB J, V22, P1226, DOI 10.1096/fj.07-8076com; Tamarat R, 2004, AM J PATHOL, V164, P457, DOI 10.1016/S0002-9440(10)63136-7; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25543	10.1371/journal.pone.0025543	http://dx.doi.org/10.1371/journal.pone.0025543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984919	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000037
J	Kataoka, K; Fujihashi, K; Terao, Y; Gilbert, RS; Sekine, S; Kobayashi, R; Fukuyama, Y; Kawabata, S; Fujihashi, K				Kataoka, Kosuke; Fujihashi, Keiko; Terao, Yutaka; Gilbert, Rebekah S.; Sekine, Shinichi; Kobayashi, Ryoki; Fukuyama, Yoshiko; Kawabata, Shigetada; Fujihashi, Kohtaro			Oral-Nasopharyngeal Dendritic Cells Mediate T Cell-Independent IgA Class Switching on B-1 B Cells	PLOS ONE			English	Article							MUCOSAL IMMUNE-SYSTEM; FLT3 LIGAND CDNA; CHOLERA-TOXIN; LAMINA PROPRIA; LYMPHOID-TISSUE; TH2 CELLS; GUT; ADJUVANT; RESPONSES; EXPRESSION	Native cholera toxin (nCT) as a nasal adjuvant was shown to elicit increased levels of T-independent S-IgA antibody (Ab) responses through IL-5- IL-5 receptor interactions between CD4(+) T cells and IgA(+) B-1 B cells in murine submandibular glands (SMGs) and nasal passages (NPs). Here, we further investigate whether oral-nasopharyngeal dendritic cells (DCs) play a central role in the induction of B-1 B cell IgA class switch recombination (CSR) for the enhancement of T cell-independent (TI) mucosal S-IgA Ab responses. High expression levels of activation-induced cytidine deaminase, I alpha-C mu circulation transcripts and I mu-C alpha transcripts were seen on B-1 B cells purified from SMGs and NPs of both TCR beta(-/-) mice and wild-type mice given nasal trinitrophenyl (TNP)-LPS plus nCT, than in the same tissues of mice given nCT or TNP-LPS alone. Further, DCs from SMGs, NPs and NALT of mice given nasal TNP-LPS plus nCT expressed significantly higher levels of a proliferation-inducing ligand (APRIL) than those in mice given TNP-LPS or nCT alone, whereas the B-1 B cells in SMGs and NPs showed elevated levels of transmembrane activator and calcium modulator cyclophilin ligand interactor (TACI) expression. Interestingly, high frequencies of IgA(+) B-1 B cells were induced when peritoneal IgA(-) IgM(+) B cells were stimulated with mucosal DCs from mice given nasal TNP-LPS plus nCT. Taken together, these findings show nasal nCT plays a key role in the enhancement of mucosal DC-mediated TI IgA CSR by B-1 B cells through their interactions with APRIL and TACI.	[Kataoka, Kosuke] Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Prevent Dent, Tokushima, Japan; [Kataoka, Kosuke; Fujihashi, Keiko; Gilbert, Rebekah S.; Kobayashi, Ryoki; Fukuyama, Yoshiko; Fujihashi, Kohtaro] Univ Alabama Birmingham, Immunobiol Vaccine Ctr, Dept Pediat Dent, Birmingham, AL USA; [Kataoka, Kosuke; Fujihashi, Keiko; Gilbert, Rebekah S.; Kobayashi, Ryoki; Fukuyama, Yoshiko; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Microbiol, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA; [Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Osaka, Japan; [Sekine, Shinichi] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Osaka, Japan	Tokushima University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Osaka University; Osaka University	Kataoka, K (corresponding author), Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Prevent Dent, Tokushima, Japan.	kohtarof@uab.edu	KATAOKA, KOSUKE/AAD-7003-2022; Sekine, Shinichi/AGT-1514-2022	Sekine, Shinichi/0000-0003-4160-5578; Kobayashi, Ryoki/0000-0002-7909-8981; Terao, Yutaka/0000-0002-4450-5583	National Institutes of Health (NIH) [DE 12242, AG 025873]; Ministry of Education, Culture, Sports, Science and Technology of Japan [B-23390481, C-19592403, 22659383]; Fujii-Otsuka Foundation for International Research; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE012242, R01DE012242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025873] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fujii-Otsuka Foundation for International Research; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health (NIH) grants DE 12242 and AG 025873 to Dr. Fujihashi, as well as by Grants-in-Aid (B-23390481, C-19592403, Challenging Exploratory Research 22659383) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Scholarship of the Fujii-Otsuka Foundation for International Research to Dr. Kataoka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone F, 2009, MUCOSAL IMMUNOL, V2, P495, DOI 10.1038/mi.2009.106; Boyaka PN, 1999, J IMMUNOL, V162, P122; Bracci L, 2008, EXPERT REV VACCINES, V7, P373, DOI 10.1586/14760584.7.3.373; Brandt LE, 2009, P NATL ACAD SCI USA, V106, P5773; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Fukuiwa T, 2008, VACCINE, V26, P4849, DOI 10.1016/j.vaccine.2008.06.091; Hagiwara Y, 2006, J IMMUNOL, V177, P3045, DOI 10.4049/jimmunol.177.5.3045; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hiroi T, 1999, J IMMUNOL, V162, P821; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; Kataoka K, 2004, J IMMUNOL, V172, P3612, DOI 10.4049/jimmunol.172.6.3612; Kataoka K, 2007, J IMMUNOL, V178, P6058, DOI 10.4049/jimmunol.178.10.6058; Kataoka K, 2009, EXPERT REV VACCINES, V8, P1183, DOI [10.1586/erv.09.80, 10.1586/ERV.09.80]; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kroese F G, 1996, Semin Immunol, V8, P11, DOI 10.1006/smim.1996.0003; KROESE FGM, 1993, INT IMMUNOL, V5, P1317, DOI 10.1093/intimm/5.10.1317; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lillard JW, 2003, BLOOD, V101, P807, DOI 10.1182/blood-2002-07-2305; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2002, NAT IMMUNOL, V3, P798, DOI 10.1038/ni0902-798; MARINARO M, 1995, J IMMUNOL, V155, P4621; Mestecky J, 2003, FUNDAMENTAL IMMUNOLO, P965; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111; MURAKAMI M, 1995, IMMUNOL TODAY, V16, P534, DOI 10.1016/0167-5699(95)80047-6; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Savage DC, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P19, DOI 10.1016/B978-012491543-5/50006-1; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Sekine S, 2008, J IMMUNOL, V180, P8126, DOI 10.4049/jimmunol.180.12.8126; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25396	10.1371/journal.pone.0025396	http://dx.doi.org/10.1371/journal.pone.0025396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980444	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600023
J	Kotas, ME; Lee, HY; Gillum, MP; Annicelli, C; Guigni, BA; Shulman, GI; Medzhitov, R				Kotas, Maya E.; Lee, Hui-Young; Gillum, Matthew P.; Annicelli, Charles; Guigni, Blas A.; Shulman, Gerald I.; Medzhitov, Ruslan			Impact of CD1d Deficiency on Metabolism	PLOS ONE			English	Article							KILLER T-CELLS; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; NKT CELLS; IMMUNE-SYSTEM; GLUCOSE-INTOLERANCE; INKT CELLS; MICE; OBESITY; ACTIVATION	Invariant natural killer T cells (iNKTs) are innate-like T cells that are highly concentrated in the liver and recognize lipids presented on the MHC-like molecule CD1d. Although capable of a myriad of responses, few essential functions have been described for iNKTs. Among the many cell types of the immune system implicated in metabolic control and disease, iNKTs seem ideally poised for such a role, yet little has been done to elucidate such a possible function. We hypothesized that lipid presentation by CD1d could report on metabolic status and engage iNKts to regulate cellular lipid content through their various effector mechanisms. To test this hypothesis, we examined CD1d deficient mice in a variety of metabolically stressed paradigms including high fat feeding, choline-deficient feeding, fasting, and acute inflammation. CD1d deficiency led to a mild exacerbation of steatosis during high fat or choline-deficient feeding, accompained by impaired hepatic glucose tolerance. Surprisingly, however, this phenotype was not observed in J alpha 18(-/-) mice, which are deficient in iNKTs but express CD1d. Thus, CD1d appears to modulate some metabolic functions through an iNKT-independent mechanism.	[Kotas, Maya E.; Annicelli, Charles; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lee, Hui-Young; Guigni, Blas A.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Lee, Hui-Young; Shulman, Gerald I.; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Gillum, Matthew P.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Iowa	Kotas, ME (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	maya.kotas@gmail.com	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Guigni, Blas/0000-0002-9667-8195; Gillum, Matthew/0000-0003-4893-012X; Lee, Hui-Young/0000-0002-3464-6382	National stitutes of Health [AI046688, AI055502, AI089771, DK 045735, DK R01 40936, U24 DK 059635, NIH MSTP TG 2T32GM07205]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089771, R01AI046688, R37AI046688, R01AI055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK059635, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National stitutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National stitutes of Health (AI046688, AI055502, AI089771 and DK 045735 to Dr. Medzhitov; DK R01 40936, U24 DK 059635 to Dr. Shulman; and NIH MSTP TG 2T32GM07205 for Dr. Kotas). Dr. Medzhitov and Dr. Sulman are investigators of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.In	Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bezbradica JS, 2006, CURR PROTOC IMMUNOL; Chang WS, 2008, J IMMUNOL, V181, P6707, DOI 10.4049/jimmunol.181.10.6707; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Mark Manuel, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29b04s78; Matarese G, 2004, TRENDS IMMUNOL, V25, P193, DOI 10.1016/j.it.2004.02.009; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; TO K, 2009, ARTERIOSCLER THROMB; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Wang JX, 2009, J IMMUNOL, V182, P6644, DOI 10.4049/jimmunol.0804050; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Yue SC, 2010, J IMMUNOL, V184, P268, DOI 10.4049/jimmunol.0800924; Zeng J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-142	55	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25478	10.1371/journal.pone.0025478	http://dx.doi.org/10.1371/journal.pone.0025478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980475	gold, Green Submitted, Green Published			2022-12-27	WOS:000295939600030
J	Kormelink, TG; Pardo, A; Knipping, K; Buendia-Roldan, I; Garcia-de-Alba, C; Blokhuis, BR; Selman, M; Redegeld, FA				Kormelink, Tom Groot; Pardo, Annie; Knipping, Karen; Buendia-Roldan, Ivette; Garcia-de-Alba, Carolina; Blokhuis, Bart R.; Selman, Moises; Redegeld, Frank A.			Immunoglobulin Free Light Chains Are Increased in Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; FIBROBLAST-GROWTH-FACTOR; MAST-CELL TRYPTASE; FARMERS LUNG; TISSUE; PATHOGENESIS; SUBACUTE; SERUM; DNA	Background: Idiopathic pulmonary fibrosis (IPF), a devastating lung disorder of unknown aetiology, and chronic hypersensitivity pneumonitis (HP), a disease provoked by an immunopathologic reaction to inhaled antigens, are two common interstitial lung diseases with uncertain pathogenic mechanisms. Previously, we have shown in other upper and lower airway diseases that immunoglobulin free light chains (FLCs) are increased and may be involved in initiating a local inflammation. In this study we explored if such a mechanism may also apply to HP and IPF. Methods: In this study we examined the presence of FLC in serum and BAL fluid from 21 IPF and 22 HP patients and controls. IgG, IgE and tryptase concentrations were measured in BAL fluid only. The presence of FLCs, plasma cells, B cells and mast cells in lung tissue of 3 HP and 3 IPF patients and 1 control was analyzed using immunohistochemistry. Results: FLC concentrations in serum and BAL fluid were increased in IPF and HP patients as compared to control subjects. IgG concentrations were only increased in HP patients, whereas IgE concentrations were comparable to controls in both patient groups. FLC-positive cells, B cells, plasma cells, and large numbers of activated mast cells were all detected in the lungs of HP and IPF patients, not in control lung. Conclusion: These results show that FLC concentrations are increased in serum and BAL fluid of IPF and HP patients and that FLCs are present within affected lung tissue. This suggests that FLCs may be involved in mediating pathology in both diseases.	[Kormelink, Tom Groot; Knipping, Karen; Blokhuis, Bart R.; Redegeld, Frank A.] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Sci, Mexico City 04510, DF, Mexico; [Knipping, Karen] Ctr Specialised Nutr, Wageningen, Netherlands; [Buendia-Roldan, Ivette; Garcia-de-Alba, Carolina; Selman, Moises] Inst Nacl Enfermedades Respiratorias Ismael Cosio, Mexico City, DF, Mexico	Utrecht University; Universidad Nacional Autonoma de Mexico	Kormelink, TG (corresponding author), Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands.	f.a.m.redegeld@uu.nl	Garcia-de-Alba, Carolina/AAJ-3924-2021; Redegeld, Frank A/O-6534-2016	Garcia-de-Alba, Carolina/0000-0001-9774-445X; Redegeld, Frank A/0000-0001-8830-7960; Buendia, Ivette/0000-0002-8230-0749				Akashi T, 2009, AM J CLIN PATHOL, V131, P405, DOI 10.1309/AJCPNWX4SLZRP9SW; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Araya J, 2010, ANNU REV PATHOL-MECH, V5, P77, DOI 10.1146/annurev.pathol.4.110807.092217; Barrera L, 2008, AM J RESP CRIT CARE, V177, P44, DOI 10.1164/rccm.200701-093OC; BJERMER L, 1988, ARCH INTERN MED, V148, P1362, DOI 10.1001/archinte.148.6.1362; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Churg A, 2006, AM J SURG PATHOL, V30, P201, DOI 10.1097/01.pas.0000184806.38037.3c; Cohen G, 2002, NEPHROL DIAL TRANSPL, V17, P879, DOI 10.1093/ndt/17.5.879; DRENT M, 1993, THORAX, V48, P835, DOI 10.1136/thx.48.8.835; Fink JN, 2005, AM J RESP CRIT CARE, V171, P792, DOI 10.1164/rccm.200409-1205WS; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Gotway MB, 2007, THORAX, V62, P546, DOI 10.1136/thx.2004.040022; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; HUNT LW, 1992, MAYO CLIN PROC, V67, P941, DOI 10.1016/S0025-6196(12)60924-0; Inoue Y, 1996, AM J PATHOL, V149, P2037; Inoue Y, 2002, AM J RESP CRIT CARE, V166, P765, DOI 10.1164/rccm.2010014; ISHIDA T, 1995, INTERNAL MED, V34, P357, DOI 10.2169/internalmedicine.34.357; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Kormelink TG, 2010, ANN RHEUM DIS, V69, P2137, DOI 10.1136/ard.2009.126441; Kraneveld AD, 2005, P NATL ACAD SCI USA, V102, P1578, DOI 10.1073/pnas.0406808102; Matsumori A, 2010, CIRC RES, V106, P1533, DOI 10.1161/CIRCRESAHA.110.218438; McSharry C, 2003, CLIN EXP ALLERGY, V33, P159, DOI 10.1046/j.1365-2222.2003.01603.x; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; PESCI A, 1991, CHEST, V100, P1197, DOI 10.1378/chest.100.5.1197; PESCI A, 1993, CHEST, V103, P989, DOI 10.1378/chest.103.4.989; Powe DG, 2010, J ALLERGY CLIN IMMUN, V125, P139, DOI 10.1016/j.jaci.2009.07.025; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Redegeld FA, 2002, NAT MED, V8, P694, DOI 10.1038/nm722; Rijnierse A, 2010, J IMMUNOL, V185, P653, DOI 10.4049/jimmunol.0901129; Selman M, 2004, CLIN CHEST MED, V25, P531, DOI 10.1016/j.ccm.2004.04.001; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2010, MURRAY NADELS TXB RE, P1356, DOI DOI 10.1016/B978-1-4160-4710-0.00057-2; SOLER P, 1987, THORAX, V42, P565, DOI 10.1136/thx.42.8.565; SOLLING K, 1977, SCAND J CLIN LAB INV, V37, P21; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Vannella KM, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-2; WALLS AF, 1991, CLIN SCI, V81, P183, DOI 10.1042/cs0810183; Wolff F, 2007, CLIN BIOCHEM, V40, P351, DOI 10.1016/j.clinbiochem.2006.11.011	42	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25392	10.1371/journal.pone.0025392	http://dx.doi.org/10.1371/journal.pone.0025392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980441	gold, Green Submitted, Green Published			2022-12-27	WOS:000295936900058
J	Bekkers, MBM; Brunekreef, B; Smit, HA; Kerkhof, M; Koppelman, GH; Oldenwening, M; Wijga, AH				Bekkers, Marga B. M.; Brunekreef, Bert; Smit, Henriette A.; Kerkhof, Marjan; Koppelman, Gerard H.; Oldenwening, Marieke; Wijga, Alet H.			Early-Life Determinants of Total and HDL Cholesterol Concentrations in 8-Year-Old Children; The PIAMA Birth Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BLOOD CHOLESTEROL; SERUM-CHOLESTEROL; EARLY ADULTHOOD; IN-UTERO; GROWTH; WEIGHT; RISK; AGE; BORN	Background: Adult cholesterol concentrations might be influenced by early-life factors, such as breastfeeding and birth weight, referred to as "early programming". How such early factors exert their influence over the life course is still poorly understood. Evidence from studies in children and adolescents is scarce and conflicting. We investigated the influence of 6 different perinatal risk factors on childhood total and HDL cholesterol concentrations and total-to-HDL cholesterol ratio measured at 8 years of age, and additionally we studied the role of the child's current Body Mass Index (BMI). Methods: Anthropometric measures and blood plasma samples were collected during a medical examination in 751 8-year-old children participating in the prospective Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort study. Linear and logistic regression were performed to estimate associations of total and HDL cholesterol concentrations with breastfeeding, birth weight, infant weight gain, maternal overweight before pregnancy, gestational diabetes and maternal smoking during pregnancy, taking into account the child's current BMI. Results: Linear regressions showed an association between total-to-HDL cholesterol ratio and maternal pre-pregnancy overweight (beta = 0.15, Confidence Interval 95% (CI): 0.02, 0.28), rapid infant weight gain (beta = 0.13, 95% CI: 0.01, 0.26), and maternal smoking during pregnancy (beta = 0.14, 95% CI: 0.00, 0.29). These associations were partly mediated by the child's BMI. Conclusion: Total-to-HDL cholesterol ratio in 8-year-old children was positively associated with maternal pre-pregnancy overweight, maternal smoking during pregnancy and rapid infant weight gain.	[Bekkers, Marga B. M.; Brunekreef, Bert; Oldenwening, Marieke] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Bekkers, Marga B. M.; Wijga, Alet H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kerkhof, Marjan] Univ Groningen, Dept Epidemiol & Bioinformat, Groningen, Netherlands; [Koppelman, Gerard H.] Beatrix Childrens Hosp, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen	Bekkers, MBM (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.	marga.bekkers@rivm.nl	Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252; brunekreef, bert/0000-0001-9908-0060	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing, and the Environment; Netherlands Ministry of Health, Welfare and Sport	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing, and the Environment; Netherlands Ministry of Health, Welfare and Sport	Research relating to this manuscript was funded by The Netherlands Organization for Health Research and Development; The Netherlands Organization for Scientific Research; The Netherlands Asthma Fund, The Netherlands Ministry of Spatial Planning Housing, and the Environment; and The Netherlands Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Bell R., 1986, CHILDREN EXERCISE, P19; BERGSTROM E, 1995, ATHEROSCLEROSIS, V117, P1, DOI 10.1016/0021-9150(95)05549-C; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; CLOEY T, 1990, JAMA-J AM MED ASSOC, V263, P2788, DOI 10.1001/jama.263.20.2788; Davies AA, 2004, CIRCULATION, V110, P1258, DOI 10.1161/01.CIR.0000140980.61294.4D; FOMON SJ, 1984, PEDIATR RES, V18, P1233, DOI 10.1203/00006450-198412000-00001; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Frontini Maria G, 2004, BMC Pediatr, V4, P22, DOI 10.1186/1471-2431-4-22; Gardner DSL, 2009, PEDIATRICS, V123, pE67, DOI 10.1542/peds.2008-1292; Huxley R, 2004, JAMA-J AM MED ASSOC, V292, P2755, DOI 10.1001/jama.292.22.2755; Lawlor DA, 2006, ANN EPIDEMIOL, V16, P19, DOI 10.1016/j.annepidem.2005.04.006; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P4307, DOI 10.1210/jc.2008-0621; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Manderson JG, 2002, DIABETOLOGIA, V45, P991, DOI 10.1007/s00125-002-0865-y; Martyn CN, 1998, LANCET, V352, P173, DOI 10.1016/S0140-6736(97)10404-4; Mogren I, 2001, INT J EPIDEMIOL, V30, P853, DOI 10.1093/ije/30.4.853; Mortaz M, 2001, ARCH DIS CHILD, V84, P212, DOI 10.1136/adc.84.3.212; Owen CG, 2003, PEDIATRICS, V111, P1081, DOI 10.1542/peds.111.5.1081; Owen CG, 2008, AM J CLIN NUTR, V88, P305, DOI 10.1093/ajcn/88.2.305; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; Schack-Nielsen L, 2006, CURR OPIN CLIN NUTR, V9, P289, DOI 10.1097/01.mco.0000222114.84159.79; Tam WH, 2008, PEDIATRICS, V122, P1229, DOI 10.1542/peds.2008-0158; Tenhola S, 2000, PEDIATR RES, V48, P623, DOI 10.1203/00006450-200011000-00012; Thorsdottir I, 2003, NUTR METAB CARDIOVAS, V13, P267, DOI 10.1016/S0939-4753(03)80030-3; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25533	10.1371/journal.pone.0025533	http://dx.doi.org/10.1371/journal.pone.0025533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980486	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700041
J	Bourseau-Guilmain, E; Griveau, A; Benoit, JP; Garcion, E				Bourseau-Guilmain, Erika; Griveau, Audrey; Benoit, Jean-Pierre; Garcion, Emmanuel			The Importance of the Stem Cell Marker Prominin-1/CD133 in the Uptake of Transferrin and in Iron Metabolism in Human Colon Cancer Caco-2 Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTRUSIONS; BLOOD-BRAIN-BARRIER; HEMATOPOIETIC STEM; SIGNALING PATHWAY; EPITHELIAL-CELLS; RETINAL DEGENERATION; RESPONSIVE ELEMENTS; 3T3-L1 ADIPOCYTES; OXIDATIVE STRESS; BINDING PROTEIN	As the pentaspan stem cell marker CD133 was shown to bind cholesterol and to localize in plasma membrane protrusions, we investigated a possible function for CD133 in endocytosis. Using the CD133 siRNA knockdown strategy and non-differentiated human colon cancer Caco-2 cells that constitutively over-expressed CD133, we provide for the first time direct evidence for a role of CD133 in the intracellular accumulation of fluorescently labeled extracellular compounds. Assessed using AC133 monoclonal antibody, CD133 knockdown was shown to improve Alexa488-transferrin (Tf) uptake in Caco-2 cells but had no impact on FITC-dextran or FITC-cholera-toxin. Absence of effect of the CD133 knockdown on Tf recycling established a role for CD133 in inhibiting Tf endocytosis rather than in stimulating Tf exocytosis. Use of previously identified inhibitors of known endocytic pathways and the positive impact of CD133 knockdown on cellular uptake of clathrin-endocytosed synthetic lipid nanocapsules supported that CD133 impact on endocytosis was primarily ascribed to the clathrin pathway. Also, cholesterol extraction with methyl-beta-cyclodextrine up regulated Tf uptake at greater intensity in the CD133(high) situation than in the CD133(low) situation, thus suggesting a role for cholesterol in the inhibitory effect of CD133 on endocytosis. Interestingly, cell treatment with the AC133 antibody down regulated Tf uptake, thus demonstrating that direct extracellular binding to CD133 could affect endocytosis. Moreover, flow cytometry and confocal microscopy established that down regulation of CD133 improved the accessibility to the TfR from the extracellular space, providing a mechanism by which CD133 inhibited Tf uptake. As Tf is involved in supplying iron to the cell, effects of iron supplementation and deprivation on CD133/AC133 expression were investigated. Both demonstrated a dose-dependent down regulation here discussed to the light of transcriptional and post-transciptional effects. Taken together, these data extend our knowledge of the function of CD133 and underline the interest of further exploring the CD133-Tf-iron network.	[Bourseau-Guilmain, Erika; Griveau, Audrey; Benoit, Jean-Pierre; Garcion, Emmanuel] Univ Angers, Lab Ingn Vectorisat Particulaire, INSERM, UMR S 646, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Bourseau-Guilmain, E (corresponding author), Univ Angers, Lab Ingn Vectorisat Particulaire, INSERM, UMR S 646, Angers, France.	emmanuel.garcion@univ-angers.fr	GARCION, Emmanuel/K-5417-2015; Benoit, Jean-Pierre/K-4387-2015	GARCION, Emmanuel/0000-0003-0887-272X; BENOIT, Jean-Pierre/0000-0002-6178-7199; GRIVEAU, Audrey/0000-0002-5928-6328	Institut National de la Sante et de la Recherche Medicale; Canceropole Grand-Ouest; "La Ligue Contre le Cancer" through an "Equipe Labellisee"	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canceropole Grand-Ouest; "La Ligue Contre le Cancer" through an "Equipe Labellisee"	This work was supported by the "Institut National de la Sante et de la Recherche Medicale", the "Axe Cellules Souches et Cancer" at the "Canceropole Grand-Ouest" and by "La Ligue Contre le Cancer" through an "Equipe Labellisee 2007" grant. Erika Bourseau was initially a PhD fellow with the "Conseil General de Maine-et-Loire" and then a PhD fellow with the "Comite Departemental de Maine-et-Loire de La Ligue Contre le Cancer". Audrey Griveau was a PhD fellow with the "Conseil General de Maine-et-Loire". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Bedrine-Ferran H, 2004, GENOMICS, V83, P772, DOI 10.1016/j.ygeno.2003.11.014; Bhatt L, 2010, FEBS J, V277, P3219, DOI 10.1111/j.1742-4658.2010.07727.x; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chang J, 2009, INT J PHARMACEUT, V379, P285, DOI 10.1016/j.ijpharm.2009.04.035; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Cmejla R, 2006, BIOCHEM BIOPH RES CO, V341, P158, DOI 10.1016/j.bbrc.2005.12.155; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Eckard J, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-28; Enns CA, 2001, TRAFFIC, V2, P167, DOI 10.1034/j.1600-0854.2001.020303.x; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Garcion E, 2001, DEVELOPMENT, V128, P2485; Garcion E, 2006, MOL CANCER THER, V5, P1710, DOI 10.1158/1535-7163.MCT-06-0289; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; He WL, 2008, J ZHEJIANG UNIV-SC B, V9, P707, DOI 10.1631/jzus.B0820023; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; INMAN RS, 1993, J BIOL CHEM, V268, P8521; Jacolot S, 2008, BLOOD CELL MOL DIS, V41, P100, DOI 10.1016/j.bcmd.2008.01.006; Jiang DL, 2009, BIOCHEMISTRY-US, V48, P7939, DOI 10.1021/bi900907a; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Knowles HJ, 2006, CANCER RES, V66, P2600, DOI 10.1158/0008-5472.CAN-05-2351; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lin E, 2001, J BIOL CHEM, V276, P27685, DOI 10.1074/jbc.M100941200; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Martini LA, 2002, J NUTR, V132, P693, DOI 10.1093/jn/132.4.693; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Mastroberardino PG, 2009, NEUROBIOL DIS, V34, P417, DOI 10.1016/j.nbd.2009.02.009; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mole DR, 2010, ANTIOXID REDOX SIGN, V12, P445, DOI 10.1089/ars.2009.2790; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; NUNEZ MT, 1982, BIOCHEMISTRY-US, V21, P4139, DOI 10.1021/bi00260a034; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Paillard A, 2010, BIOMATERIALS, V31, P7542, DOI 10.1016/j.biomaterials.2010.06.024; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Roger E, 2009, J CONTROL RELEASE, V140, P174, DOI 10.1016/j.jconrel.2009.08.010; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Stehling O, 2009, METHOD ENZYMOL, V456, P209, DOI 10.1016/S0076-6879(08)04412-1; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Taieb N, 2009, CANCER LETT, V278, P164, DOI 10.1016/j.canlet.2009.01.013; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; TEICHMANN R, 1990, J CLIN INVEST, V86, P2145, DOI 10.1172/JCI114953; THEIL EC, 1994, BIOCHEM J, V304, P1; Torgersen ML, 2001, J CELL SCI, V114, P3737; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WARBURG O, 1956, SCIENCE, V124, P269; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Woo KJ, 2006, BIOCHEM BIOPH RES CO, V343, P8, DOI 10.1016/j.bbrc.2006.02.116; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Yang C, 2007, BIOCHEMISTRY-MOSCOW+, V72, P854, DOI 10.1134/S000629790708007X; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang ZH, 2003, EUR J PHARMACOL, V467, P41, DOI 10.1016/S0014-2999(03)01597-8; Zhu L, 2006, J AGR FOOD CHEM, V54, P7924, DOI 10.1021/jf061036z	87	54	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25515	10.1371/journal.pone.0025515	http://dx.doi.org/10.1371/journal.pone.0025515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966538	gold, Green Published, Green Submitted			2022-12-27	WOS:000295932100046
J	Freeman, JB; Penner, AM; Saperstein, A; Scheutz, M; Ambady, N				Freeman, Jonathan B.; Penner, Andrew M.; Saperstein, Aliya; Scheutz, Matthias; Ambady, Nalini			Looking the Part: Social Status Cues Shape Race Perception	PLOS ONE			English	Article							CATEGORIZATION; BLACK; FACES; AUTOMATICITY; INFORMATION; ACTIVATION; PREJUDICE; COGNITION; MEMORY; MODEL	It is commonly believed that race is perceived through another's facial features, such as skin color. In the present research, we demonstrate that cues to social status that often surround a face systematically change the perception of its race. Participants categorized the race of faces that varied along White-Black morph continua and that were presented with high-status or low-status attire. Low-status attire increased the likelihood of categorization as Black, whereas high-status attire increased the likelihood of categorization as White; and this influence grew stronger as race became more ambiguous (Experiment 1). When faces with high-status attire were categorized as Black or faces with low-status attire were categorized as White, participants' hand movements nevertheless revealed a simultaneous attraction to select the other race-category response (stereotypically tied to the status cue) before arriving at a final categorization. Further, this attraction effect grew as race became more ambiguous (Experiment 2). Computational simulations then demonstrated that these effects may be accounted for by a neurally plausible person categorization system, in which contextual cues come to trigger stereotypes that in turn influence race perception. Together, the findings show how stereotypes interact with physical cues to shape person categorization, and suggest that social and contextual factors guide the perception of race.	[Freeman, Jonathan B.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Penner, Andrew M.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA; [Saperstein, Aliya] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Scheutz, Matthias] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Ambady, Nalini] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Tufts University; University of California System; University of California Irvine; Stanford University; Tufts University; Stanford University	Freeman, JB (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	jon.freeman@tufts.edu	Penner, Andrew/A-5128-2010; Saperstein, Aliya/E-8403-2013	Saperstein, Aliya/0000-0002-6429-1172; Scheutz, Matthias/0000-0002-0064-2789	National Institutes of Health (NIH) NRSA [F31-MH092000]; National Science Foundation (NSF) [BCS-0435547]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH092000] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a National Institutes of Health (NIH) NRSA fellowship (F31-MH092000) to Dr. Freeman and National Science Foundation (NSF) research grant (BCS-0435547) to Dr. Ambady. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.B., 2010, SCI SOCIAL VISION; Allport G. W., 1954, NATURE PREJUDICE; [Anonymous], 1997, NEW AM; Balcetis E, 2010, SOCIAL PSYCHOL VISUA; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Blair IV, 2004, J PERS SOC PSYCHOL, V87, P763, DOI 10.1037/0022-3514.87.6.763; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; Castano E, 2002, J EXP SOC PSYCHOL, V38, P315, DOI 10.1006/jesp.2001.1512; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; Eberhardt JL, 2003, PERS SOC PSYCHOL B, V29, P360, DOI 10.1177/0146167202250215; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Freeman JB, 2008, J EXP PSYCHOL GEN, V137, P673, DOI 10.1037/a0013875; Freeman JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00059; Freeman JB, 2011, PSYCHOL REV, V118, P247, DOI 10.1037/a0022327; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Freeman JB, 2010, J EXP SOC PSYCHOL, V46, P179, DOI 10.1016/j.jesp.2009.10.002; Gilens Martin, 1999, WHY AM HATE WELFARE; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Halberstadt J, 2011, PSYCHOL SCI, V22, P29, DOI 10.1177/0956797610390383; Hane Mikiso, 1982, PEASANTS REBELS OUTC; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; HIRSCHFELD LA, 1995, CHILD DEV, V66, P1418, DOI 10.1111/j.1467-8624.1995.tb00943.x; Ho AK, 2011, J PERS SOC PSYCHOL, V100, P492, DOI 10.1037/a0021562; Hugenberg K, 2004, PSYCHOL SCI, V15, P342, DOI 10.1111/j.0956-7976.2004.00680.x; Hurwitz J, 2005, J POLIT, V67, P762, DOI 10.1111/j.1468-2508.2005.00338.x; Levin DT, 2002, PERCEPTION, V31, P567, DOI 10.1068/p3315; MacLin OH, 2001, PSYCHOL PUBLIC POL L, V7, P98, DOI 10.1037//1076-8971.7.1.98; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; MCCLELLAND JL, 1991, COGNITIVE PSYCHOL, V23, P1, DOI 10.1016/0010-0285(91)90002-6; Noymer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015812; Omi Michael., 1994, RACIAL FORMATIONS US; Pauker K, 2009, J PERS SOC PSYCHOL, V96, P795, DOI 10.1037/a0013265; Peery D, 2008, PSYCHOL SCI, V19, P973, DOI 10.1111/j.1467-9280.2008.02185.x; Penner AM, 2008, P NATL ACAD SCI USA, V105, P19628, DOI 10.1073/pnas.0805762105; Ratcliff NJ, 2011, PERS SOC PSYCHOL B, V37, P1003, DOI 10.1177/0146167211407210; Rogers T. T., 2004, SEMANTIC COGNITION P; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, P517; Schyns PG, 1998, COGNITION, V67, P147, DOI 10.1016/S0010-0277(98)00016-X; SEXTON K, 1993, TOXICOL IND HEALTH, V9, P843, DOI 10.1177/074823379300900509; SMITH ER, 1992, PSYCHOL REV, V99, P3, DOI 10.1037/0033-295X.99.1.3; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; SMOLENSKY P, 1989, NEURAL CONNECTIONS M; Spivey M. J., 2007, CONTINUITY MIND; Spivey MJ, 2006, CURR DIR PSYCHOL SCI, V15, P207, DOI 10.1111/j.1467-8721.2006.00437.x; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	48	164	166	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25107	10.1371/journal.pone.0025107	http://dx.doi.org/10.1371/journal.pone.0025107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834BK	21977227	Green Published, gold, Green Submitted			2022-12-27	WOS:000295932100018
J	Hopf, PS; Ford, RS; Zebian, N; Merkx-Jacques, A; Vijayakumar, S; Ratnayake, D; Hayworth, J; Creuzenet, C				Hopf, Patrick S.; Ford, Rachel S.; Zebian, Najwa; Merkx-Jacques, Alexandra; Vijayakumar, Somalinga; Ratnayake, Dinath; Hayworth, Jacqueline; Creuzenet, Carole			Protein Glycosylation in Helicobacter pylori: Beyond the Flagellins?	PLOS ONE			English	Article							ANION-EXCHANGE CHROMATOGRAPHY; OUTER-MEMBRANE PROTEIN; HUMAN EPITHELIAL-CELLS; CAMPYLOBACTER-JEJUNI; FUNCTIONAL-CHARACTERIZATION; POSTTRANSLATIONAL MODIFICATION; GENETIC-CHARACTERIZATION; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; POLYACRYLAMIDE GELS	Glycosylation of flagellins by pseudaminic acid is required for virulence in Helicobacter pylori. We demonstrate that, in H. pylori, glycosylation extends to proteins other than flagellins and to sugars other than pseudaminic acid. Several candidate glycoproteins distinct from the flagellins were detected via ProQ-emerald staining and DIG-or biotin-hydrazide labeling of the soluble and outer membrane fractions of wild-type H. pylori, suggesting that protein glycosylation is not limited to the flagellins. DIG-hydrazide labeling of proteins from pseudaminic acid biosynthesis pathway mutants showed that the glycosylation of some glycoproteins is not dependent on the pseudaminic acid glycosylation pathway, indicating the existence of a novel glycosylation pathway. Fractions enriched in glycoprotein candidates by ion exchange chromatography were used to extract the sugars by acid hydrolysis. High performance anion exchange chromatography with pulsed amperometric detection revealed characteristic monosaccharide peaks in these extracts. The monosaccharides were then identified by LC-ESI-MS/MS. The spectra are consistent with sugars such as 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (Pse5Ac7Ac) previously described on flagellins, 5-acetamidino-7-acetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (Pse5Am7Ac), bacillosamine derivatives and a potential legionaminic acid derivative (Leg5AmNMe7Ac) which were not previously identified in H. pylori. These data open the way to the study of the mechanism and role of protein glycosylation on protein function and virulence in H. pylori.	[Hopf, Patrick S.; Ford, Rachel S.; Zebian, Najwa; Merkx-Jacques, Alexandra; Vijayakumar, Somalinga; Ratnayake, Dinath; Hayworth, Jacqueline; Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, London, ON, Canada	Western University (University of Western Ontario)	Hopf, PS (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, London, ON, Canada.	ccreuzen@uwo.ca			Canadian Institutes of Health Research (CIHR) [MOP-62775]; Schulich School of Medicine and Dentistry of the University of Western Ontario; Natural Sciences and Engineering Research Council of Canada; Canadian Association of Gastroenterologists; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Schulich School of Medicine and Dentistry of the University of Western Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Association of Gastroenterologists; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported in part by operating grant MOP-62775 from the Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca) and in part by funding from the Schulich School of Medicine and Dentistry of the University of Western Ontario (http://www.schulich.uwo.ca/) to Dr. Creuzenet. Dr. Creuzenet was the recipient of a University Faculty Award from the Natural Sciences and Engineering Research Council of Canada, and of a Premier's Research Excellence Award (Ontario). A. Merkx-Jacques was the recipient of a Canadian Digestive Health Foundation/CIHR Doctoral Research Award. J. Hayworth was the recipient of a summer scholarship from the Canadian Association of Gastroenterologists, and P. Hopf was the recipient of an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Baik SC, 2004, J BACTERIOL, V186, P949, DOI 10.1128/JB.186.4.949-955.2004; Carlsohn E, 2006, J PROTEOME RES, V5, P3197, DOI 10.1021/pr060181p; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Censini S, 2001, CURR OPIN MICROBIOL, V4, P41, DOI 10.1016/S1369-5274(00)00162-4; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLYNE M, 1995, INFECT IMMUN, V63, P1669, DOI 10.1128/IAI.63.5.1669-1673.1995; COOPER GA, 1995, ANAL BIOCHEM, V226, P182, DOI 10.1006/abio.1995.1207; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Creuzenet C, 2004, FEBS LETT, V559, P136, DOI 10.1016/S0014-5793(04)00057-2; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Demendi M, 2009, BIOCHEM CELL BIOL, V87, P469, DOI [10.1139/O09-002, 10.1139/o09-002]; Doig P, 1996, MOL MICROBIOL, V19, P379, DOI 10.1046/j.1365-2958.1996.370890.x; DOIG P, 1994, INFECT IMMUN, V62, P4526, DOI 10.1128/IAI.62.10.4526-4533.1994; EGGERT FM, 1985, J CHROMATOGR, V333, P123; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; Fischer W, 2004, J BACTERIOL, V186, P777, DOI 10.1128/JB.186.3.777-784.2004; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; FLETCHER CM, 2010, J BIOL CHEM; FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627, DOI 10.1128/JCM.28.12.2627-2631.1990; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; GEIS G, 1993, J MED MICROBIOL, V38, P371, DOI 10.1099/00222615-38-5-371; GOODWIN CS, 1989, INT J SYST BACTERIOL, V39, P397, DOI 10.1099/00207713-39-4-397; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Guerry P, 1996, MOL MICROBIOL, V19, P369, DOI 10.1046/j.1365-2958.1996.369895.x; Heuermann D, 1998, MOL GEN GENET, V257, P519, DOI 10.1007/s004380050677; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Josenhans C, 1999, MOL MICROBIOL, V33, P350, DOI 10.1046/j.1365-2958.1999.01478.x; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Kakuda T, 2006, INFECT IMMUN, V74, P4715, DOI 10.1128/IAI.00033-06; Karlyshev AV, 2004, MICROBIOL-SGM, V150, P1957, DOI 10.1099/mic.0.26721-0; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Koenigs MB, 2009, MOL BIOSYST, V5, P909, DOI 10.1039/b902178g; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Kwon DH, 1998, CURR MICROBIOL, V37, P144, DOI 10.1007/s002849900354; Lindhout T, 2009, MICROBIOL-SGM, V155, P3449, DOI 10.1099/mic.0.030510-0; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; Logan SM, 2002, MOL MICROBIOL, V46, P587, DOI 10.1046/j.1365-2958.2002.03185.x; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MARSHALL B J, 1984, Microbios Letters, V25, P83; McGee DJ, 2002, J MED MICROBIOL, V51, P958, DOI 10.1099/0022-1317-51-11-958; McGee DJ, 1999, J BACTERIOL, V181, P2477, DOI 10.1128/JB.181.8.2477-2484.1999; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; McNally DJ, 2006, J BIOL CHEM, V281, P18489, DOI 10.1074/jbc.M603777200; Merkx-Jacques A, 2004, J BACTERIOL, V186, P2253, DOI 10.1128/JB.186.8.2253-2265.2004; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; NEESER JR, 1984, ANAL BIOCHEM, V142, P58, DOI 10.1016/0003-2697(84)90516-5; Newton DT, 1999, BIOCHEM J, V339, P63, DOI 10.1042/0264-6021:3390063; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Obhi RK, 2005, J BIOL CHEM, V280, P20902, DOI 10.1074/jbc.M413832200; Odenbreit S, 1996, J BACTERIOL, V178, P6960, DOI 10.1128/jb.178.23.6960-6967.1996; Odenbreit S, 1999, MOL MICROBIOL, V31, P1537, DOI 10.1046/j.1365-2958.1999.01300.x; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Raymond J, 2010, HELICOBACTER, V15, P21, DOI 10.1111/j.1523-5378.2009.00737.x; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; SCHOENHOFEN IC, 2006, GLYCOBIOLOGY; SOMALINGA V, 2005, P 105 GEN M AM SOC M, P53; Stead C, 2005, J BACTERIOL, V187, P3374, DOI 10.1128/JB.187.10.3374-3383.2005; STEAD CM, 2010, MOL MICROBIOL; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; SUERBAUM S, 1993, J BACTERIOL, V175, P3278, DOI 10.1128/jb.175.11.3278-3288.1993; Tabei SMB, 2009, J BACTERIOL, V191, P2851, DOI 10.1128/JB.01406-08; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vijayakumar S, 2006, J BIOL CHEM, V281, P27733, DOI 10.1074/jbc.M511714200; Wang G, 1999, MICROBIOL-SGM, V145, P3245, DOI 10.1099/00221287-145-11-3245; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; WARREN JR, 1983, LANCET, V1, P1273; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; Zhang CJ, 2004, PHYTOCHEMISTRY, V65, P1575, DOI 10.1016/j.phytochem.2004.03.031	92	39	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25722	10.1371/journal.pone.0025722	http://dx.doi.org/10.1371/journal.pone.0025722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984942	Green Submitted, gold, Green Published			2022-12-27	WOS:000295941300052
J	Jesse, M; Mazzucco, R; Dieckmann, U; Heesterbeek, H; Metz, JAJ				Jesse, Marieke; Mazzucco, Rupert; Dieckmann, Ulf; Heesterbeek, Hans; Metz, Johan A. J.			Invasion and Persistence of Infectious Agents in Fragmented Host Populations	PLOS ONE			English	Article							STRUCTURED POPULATIONS; HABITAT FRAGMENTATION; METAPOPULATION MODELS; DISEASE DYNAMICS; EPIDEMIC SPREAD; MOUTH-DISEASE; WATER VOLE; TRANSMISSION; HOUSEHOLDS; FITNESS	One of the important questions in understanding infectious diseases and their prevention and control is how infectious agents can invade and become endemic in a host population. A ubiquitous feature of natural populations is that they are spatially fragmented, resulting in relatively homogeneous local populations inhabiting patches connected by the migration of hosts. Such fragmented population structures are studied extensively with metapopulation models. Being able to define and calculate an indicator for the success of invasion and persistence of an infectious agent is essential for obtaining general qualitative insights into infection dynamics, for the comparison of prevention and control scenarios, and for quantitative insights into specific systems. For homogeneous populations, the basic reproduction ratio R(0) plays this role. For metapopulations, defining such an 'invasion indicator' is not straightforward. Some indicators have been defined for specific situations, e. g., the household reproduction number R(*). However, these existing indicators often fail to account for host demography and especially host migration. Here we show how to calculate a more broadly applicable indicator R(m) for the invasion and persistence of infectious agents in a host metapopulation of equally connected patches, for a wide range of possible epidemiological models. A strong feature of our method is that it explicitly accounts for host demography and host migration. Using a simple compartmental system as an example, we illustrate how Rm can be calculated and expressed in terms of the key determinants of epidemiological dynamics.	[Jesse, Marieke; Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Mazzucco, Rupert; Dieckmann, Ulf; Metz, Johan A. J.] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Metz, Johan A. J.] Inst Biol, Leiden, Netherlands; [Metz, Johan A. J.] Math Inst, Leiden, Netherlands	Utrecht University; International Institute for Applied Systems Analysis (IIASA)	Jesse, M (corresponding author), Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.	m.jesse@uu.nl	Dieckmann, Ulf/E-1424-2011	Dieckmann, Ulf/0000-0001-7089-0393; Mazzucco, Rupert/0000-0002-7608-0196; Heesterbeek, Hans/0000-0001-8537-6418	Chair Modelisation Mathematique et biodiversite VEOLIA-Ecole Polytechnique-MNHN-F.X; Netherlands Organisation for Scientific Research (NWO) [918.56.620]; European Commission; European Science Foundation; Austrian Science Fund; Austrian Ministry of Science and Research; Vienna Science and Technology Fund	Chair Modelisation Mathematique et biodiversite VEOLIA-Ecole Polytechnique-MNHN-F.X; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Vienna Science and Technology Fund	This research benefited from the support of the Chair Modelisation Mathematique et biodiversite VEOLIA-Ecole Polytechnique-MNHN-F.X to JAJM. The research carried out by MJ and HH is supported by The Netherlands Organisation for Scientific Research (NWO grant 918.56.620). UD gratefully acknowledges financial support by the European Commission, the European Science Foundation, the Austrian Science Fund, the Austrian Ministry of Science and Research, and the Vienna Science and Technology Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball F, 1999, MATH BIOSCI, V156, P41, DOI 10.1016/S0025-5564(98)10060-3; Ball F, 1997, ANN APPL PROBAB, V7, P46; Ball F, 2010, MATH BIOSCI, V224, P53, DOI 10.1016/j.mbs.2009.12.003; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; CHESSON PL, 1984, Z WAHRSCHEINLICHKEIT, V66, P97, DOI 10.1007/BF00532798; Coops NC, 2010, FOREST ECOL MANAG, V259, P2355, DOI 10.1016/j.foreco.2010.03.008; Cross PC, 2007, J R SOC INTERFACE, V4, P315, DOI 10.1098/rsif.2006.0185; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Fulford GR, 2002, THEOR POPUL BIOL, V61, P15, DOI 10.1006/tpbi.2001.1553; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Gourbiere S, 2002, J THEOR BIOL, V217, P351, DOI 10.1006/jtbi.2002.3033; Grenfell B T, 1995, Stat Methods Med Res, V4, P160, DOI 10.1177/096228029500400205; Gyllenberg M, 2001, J MATH BIOL, V43, P545, DOI 10.1007/s002850100113; Hall IM, 2007, EPIDEMIOL INFECT, V135, P1133, DOI 10.1017/S0950268806007783; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Hanski I., 1999, METAPOPULATION ECOLO; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kinezaki N, 2010, THEOR POPUL BIOL, V78, P298, DOI 10.1016/j.tpb.2010.09.002; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Le Menach A, 2005, VET RES, V36, P699, DOI 10.1051/vetres:2005025; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Li TA, 2010, LANDSCAPE ECOL, V25, P839, DOI 10.1007/s10980-010-9461-6; Massol F, 2009, THEOR POPUL BIOL, V75, P183, DOI 10.1016/j.tpb.2009.02.005; Metz JAJ, 2001, P ROY SOC B-BIOL SCI, V268, P499, DOI 10.1098/rspb.2000.1373; Olsson GE, 2010, VECTOR-BORNE ZOONOT, V10, P549, DOI 10.1089/vbz.2009.0138; Ostfeld RS, INFECT DIS ECOLOGY E; Parvinen K, 2008, THEOR POPUL BIOL, V73, P517, DOI 10.1016/j.tpb.2008.01.002; Pellis L, 2009, J R SOC INTERFACE, V6, P979, DOI 10.1098/rsif.2008.0493; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Ross JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009666; Rushton SP, 2000, J APPL ECOL, V37, P475, DOI 10.1046/j.1365-2664.2000.00504.x; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Telfer S, 2001, OIKOS, V95, P31, DOI 10.1034/j.1600-0706.2001.950104.x; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; Weisser WW, 1997, J THEOR BIOL, V189, P413, DOI 10.1006/jtbi.1997.0529	47	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24006	10.1371/journal.pone.0024006	http://dx.doi.org/10.1371/journal.pone.0024006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980339	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000295941300002
J	Shao, HY; Lin, YW; Yu, SL; Lin, HY; Chitra, E; Chang, YC; Sia, C; Chong, PL; Hsu, MT; Wei, OL; Chow, YH				Shao, Hsiao-Yun; Lin, Yi-Wen; Yu, Shu-Ling; Lin, Hsiang-Yin; Chitra, Ebenezer; Chang, Yung-Chen; Sia, Charles; Chong, Pele; Hsu, Ming-Tao; Wei, Olivia L.; Chow, Yen-Hung			Immunoprotectivity of HLA-A2 CTL Peptides Derived from Respiratory Syncytial Virus Fusion Protein in HLA-A2 Transgenic Mouse	PLOS ONE			English	Article							T-LYMPHOCYTE EPITOPE; VACCINE-ENHANCED DISEASE; PULMONARY EOSINOPHILIA; CELL RESPONSES; GLYCOPROTEIN-G; PRIMARY INFECTION; DENDRITIC CELLS; RSV INFECTION; IN-VIVO; MICE	Identification of HLA-restricted CD8(+) T cell epitopes is important to study RSV-induced immunity and illness. We algorthmically analyzed the sequence of the fusion protein (F) of respiratory syncytial virus (RSV) and generated synthetic peptides that can potentially bind to HLA-A*0201. Four out of the twenty-five 9-mer peptides tested: peptides 3 (F33-41), 13 (F214-222), 14 (F273-281), and 23 (F559-567), were found to bind to HLA-A*0201 with moderate to high affinity and were capable of inducing and IFN-gamma and IL-2 secretion in lymphocytes from HLA-A*0201 transgenic (HLA-Tg) mice pre-immunized with RSV or recombinant adenovirus expressing RSV F. HLA-Tg mice were immunized with these four peptides and were found to induce both Th1 and CD8(+) T cell responses in in vitro secondary recall. Effector responses induced by these peptides were observed to confer differential protection against live RSV challenge. These peptides also caused better recovery of body weight loss induced by RSV. A significant reduction of lung viral load was observed in mice immunized with peptide 23, which appeared to enhance the levels of inflammatory chemokines (CCL17, CCL22, and IL-18) but did not increase eosinophil infiltration in the lungs. Whereas significant reduction of infiltrated eosinophils induced by RSV infection was found in mice pre-immunized with peptide 13. Our results suggest that HLA-A2-restricted epitopes of RSV F protein could be useful for the development of epitope-based RSV vaccine.	[Shao, Hsiao-Yun; Lin, Yi-Wen; Yu, Shu-Ling; Lin, Hsiang-Yin; Chitra, Ebenezer; Chang, Yung-Chen; Sia, Charles; Chong, Pele; Hsu, Ming-Tao; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Wei, Olivia L.] Emory Univ, GDBBS, Atlanta, GA 30322 USA	National Health Research Institutes - Taiwan; National Tsing Hua University; Emory University	Shao, HY (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan.	choeyenh@nhri.org.tw	Chong, Pele/E-3855-2010; Chow, Yen-Hung/E-3863-2010; Sia, Dwo-Yuan/E-3860-2010; Chitra, Ebenezer/F-5984-2019	Chitra, Ebenezer/0000-0002-5818-6587	National Health Research Institutes [VC-99PP04]; National Science Council [99-2323-B-400-014-]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes' intramural funding, VC-99PP04 and National Science Council's funding, 99-2323-B-400-014-. (http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do) (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbach E, 2005, VIRUS GENES, V30, P267, DOI 10.1007/s11262-004-5633-2; ALWAN WH, 1993, J IMMUNOL, V150, P5211; Aung S, 1999, J VIROL, V73, P8944, DOI 10.1128/JVI.73.11.8944-8949.1999; BANGHAM CRM, 1986, J IMMUNOL, V137, P3973; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; Brandenburg AH, 2000, J VIROL, V74, P10240, DOI 10.1128/JVI.74.21.10240-10244.2000; Bukreyev A, 2005, J VIROL, V79, P9515, DOI 10.1128/JVI.79.15.9515-9526.2005; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Castilow EM, 2008, FUTURE VIROL, V3, P445, DOI 10.2217/17460794.3.5.445; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; Chang J, 2004, J IMMUNOL, V172, P503, DOI 10.4049/jimmunol.172.1.503; Chang J, 2001, J IMMUNOL, V167, P4254, DOI 10.4049/jimmunol.167.8.4254; CHANOCK R, 1957, AM J HYG, V66, P291, DOI 10.1093/oxfordjournals.aje.a119902; CHERRIE AH, 1992, J VIROL, V66, P2102, DOI 10.1128/JVI.66.4.2102-2110.1992; CHIBA Y, 1989, J MED VIROL, V28, P133, DOI 10.1002/jmv.1890280304; Colleton BA, 2009, J VIROL, V83, P6288, DOI 10.1128/JVI.02611-08; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; DING EX, 2009, HEPATOLOGY; Doherty P C, 1994, Trends Microbiol, V2, P148, DOI 10.1016/0966-842X(94)90662-9; DOHERTY PC, 1994, TRENDS MICROBIOL, V2, P149; EHLENFIELD DR, 2000, PEDIATRICS, V79, P83; Falsey A R, 2005, Exp Lung Res, V31 Suppl 1, P77; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Goulder PJR, 2000, J VIROL, V74, P7694, DOI 10.1128/JVI.74.16.7694-7697.2000; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Graham BS, 2002, VIROLOGY, V297, P1, DOI 10.1006/viro.2002.1431; Hancock GE, 2003, J MED VIROL, V70, P301, DOI 10.1002/jmv.10395; Harker JA, 2010, J VIROL, V84, P4073, DOI 10.1128/JVI.02014-09; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Heidema J, 2004, J GEN VIROL, V85, P2365, DOI 10.1099/vir.0.80131-0; HOLZEL A, 1963, LANCET, V1, P295; Huang YH, 2004, J GEN VIROL, V85, P3089, DOI 10.1099/vir.0.80183-0; Hussell T, 1997, EUR J IMMUNOL, V27, P3341, DOI 10.1002/eji.1830271233; Hussell T, 1998, J IMMUNOL, V161, P6215; ISAACS D, 1991, LANCET, V337, P1223, DOI 10.1016/0140-6736(91)92893-7; Jiang SS, 2002, J GEN VIROL, V83, P429, DOI 10.1099/0022-1317-83-2-429; Johnson TR, 2004, J VIROL, V78, P6024, DOI 10.1128/JVI.78.11.6024-6032.2004; Johnson TR, 2003, J IMMUNOL, V170, P2037, DOI 10.4049/jimmunol.170.4.2037; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Johnstone C, 2004, J GEN VIROL, V85, P3229, DOI 10.1099/vir.0.80219-0; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Krishnan A, 2008, IMMUNOL LETT, V120, P108, DOI 10.1016/j.imlet.2008.07.010; Kruijsen D, 2011, VACCINE, V29, P2730, DOI 10.1016/j.vaccine.2011.01.087; KULKARNI AB, 1993, J VIROL, V67, P1044, DOI 10.1128/JVI.67.2.1044-1049.1993; La Rosa C, 2002, BLOOD, V100, P3681, DOI 10.1182/blood-2002-03-0926; Matthews SP, 2005, J VIROL, V79, P2050, DOI 10.1128/JVI.79.4.2050-2057.2005; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Monick MM, 2007, J IMMUNOL, V179, P1648, DOI 10.4049/jimmunol.179.3.1648; MOTT KR, 2009, INVEST OPHTHALMOL VI; NICHOLAS JA, 1990, J VIROL, V64, P4232, DOI 10.1128/JVI.64.9.4232-4241.1990; Olson MR, 2008, EXPERT REV VACCINES, V7, P1239, DOI 10.1586/14760584.7.8.1239; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; OPENSHAW PJM, 1990, J VIROL, V64, P1683, DOI 10.1128/JVI.64.4.1683-1689.1990; Partidos CD, 1996, IMMUNOLOGY, V87, P179, DOI 10.1046/j.1365-2567.1996.462527.x; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; PEMBERTON RM, 1987, J GEN VIROL, V68, P2177, DOI 10.1099/0022-1317-68-8-2177; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Rock MT, 2003, IMMUNOLOGY, V108, P474, DOI 10.1046/j.1365-2567.2003.01619.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Rutigliano JA, 2005, VIROLOGY, V337, P335, DOI 10.1016/j.virol.2005.04.032; Shao H. Y., 2009, VACCINE; Srikiatkhachorn A, 1997, J VIROL, V71, P678, DOI 10.1128/JVI.71.1.678-685.1997; Tekkanat KK, 2002, EUR J IMMUNOL, V32, P3276, DOI 10.1002/1521-4141(200211)32:11<3276::AID-IMMU3276>3.0.CO;2-5; Terrosi C, 2007, VIRAL IMMUNOL, V20, P399, DOI 10.1089/vim.2007.0041; Tregoning JS, 2008, J VIROL, V82, P4115, DOI 10.1128/JVI.02313-07; Venter M, 2003, J VIROL, V77, P7319, DOI 10.1128/JVI.77.13.7319-7329.2003; Wahl A, 2009, P NATL ACAD SCI USA, V106, P540, DOI 10.1073/pnas.0811271106; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787	74	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25500	10.1371/journal.pone.0025500	http://dx.doi.org/10.1371/journal.pone.0025500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980478	Green Submitted, Green Published, gold			2022-12-27	WOS:000295939600031
J	Town, L; McGlinn, E; Davidson, TL; Browne, CM; Chawengsaksophak, K; Koopman, P; Richman, JM; Wicking, C				Town, Liam; McGlinn, Edwina; Davidson, Tara-Lynne; Browne, Catherine M.; Chawengsaksophak, Kallayanee; Koopman, Peter; Richman, Joy M.; Wicking, Carol			Tmem26 Is Dynamically Expressed during Palate and Limb Development but Is Not Required for Embryonic Survival	PLOS ONE			English	Article							EXHIBIT CLEFT-PALATE; CRANIOFACIAL DEVELOPMENT; VERTEBRATE LIMB; MICE; GENE; GLI3; CHONDROGENESIS; OSTEOGENESIS; TOPOLOGY; SEGMENTS	The Tmem26 gene encodes a novel protein that we have previously shown to be regulated by hedgehog signalling in the mouse limb. We now report that Tmem26 expression is spatially and temporally restricted in other regions of the mouse embryo, most notably the facial primordia. In particular, Tmem26 expression in the mesenchyme of the maxillary and nasal prominences is coincident with fusion of the primary palate. In the secondary palate, Tmem26 is expressed in the palatal shelves during their growth and fusion but is downregualted once fusion is complete. Expression was also detected at the midline of the expanding mandible and at the tips of the eyelids as they migrate across the cornea. Given the spatio-temporally restricted expression of Tmen26, we sought to uncover a functional role in embryonic development through targeted gene inactivation in the mouse. However, ubiquitous inactivation of Tmem26 led to no overt phenotype in the resulting embryos or adult mice, suggesting that TMEM26 function is dispensable for embryonic survival.	[Town, Liam; McGlinn, Edwina; Davidson, Tara-Lynne; Browne, Catherine M.; Chawengsaksophak, Kallayanee; Koopman, Peter; Wicking, Carol] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Richman, Joy M.] Univ British Columbia, Inst Life Sci, Dept Oral Hlth Sci, Vancouver, BC V5Z 1M9, Canada	University of Queensland; University of British Columbia	Town, L (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	c.wicking@imb.uq.edu.au	Richman, Joy M./C-3111-2018; Richman, Joy/AAD-9445-2020; Koopman, Peter A/C-9416-2009; Chawengsaksophak, Kallayanee/G-4427-2014; Wicking, Carol/J-1814-2014	Richman, Joy M./0000-0002-1409-8163; Richman, Joy/0000-0002-1409-8163; Koopman, Peter A/0000-0001-6939-0914; Chawengsaksophak, Kallayanee/0000-0001-9401-2122; Wicking, Carol/0000-0002-7225-3803; McGlinn, Edwina/0000-0002-1829-986X	Australian National Health and Medical Research Council (NHMRC) [401683]; Australian Postgraduate Award; Killam Research Fellowship; IMB	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Killam Research Fellowship; IMB	This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant (#401683). CW is an NHMRC Senior Research Fellow. EM was the recipient of an Australian Postgraduate Award, and LT was a recipient of an NHMRC Dora Lush Postgraduate Research Scholarship. JR was funded by a Killam Research Fellowship and an IMB visitor award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bancroft JD, 1990, THEORY PRACTICE HIST, Vxiv, P726; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Dixon J, 2004, DEV DYNAM, V229, P907, DOI 10.1002/dvdy.20004; Fowles LF, 2003, GENESIS, V35, P73, DOI 10.1002/gene.10165; Hogan B, 1994, MANIPULATING MOUSE E; Huang X, 2008, DEV DYNAM, V237, P3079, DOI 10.1002/dvdy.21714; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; JONES MC, 1988, CLEFT PALATE J, V25, P16; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Pauws E, 2009, HUM MOL GENET, V18, P4171, DOI 10.1093/hmg/ddp368; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sambrook J., 2001, MOL CLONING LAB MANU; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Schutte BC, 1999, HUM MOL GENET, V8, P1853, DOI 10.1093/hmg/8.10.1853; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	28	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25228	10.1371/journal.pone.0025228	http://dx.doi.org/10.1371/journal.pone.0025228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980401	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600016
J	Domingues, I; Rino, J; Demmers, JAA; de Lanerolle, P; Santos, SCR				Domingues, Ines; Rino, Jose; Demmers, Jeroen A. A.; de Lanerolle, Primal; Rosa Santos, Susana Constantino			VEGFR2 Translocates to the Nucleus to Regulate Its Own Transcription	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE PROGRESSION; FACTOR RECEPTOR-2; TUMOR ANGIOGENESIS; THERAPEUTIC IMPLICATIONS; PHOSPHORYLATED KDR; PANCREATIC-CANCER; EXPRESSION; PROTEINS; GENE	Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) is the major mediator of the angiogenic effects of VEGF. In addition to its well known role as a membrane receptor that activates multiple signaling pathways, VEGFR2 also has a nuclear localization. However, what VEGFR2 does in the nucleus is still unknown. In the present report we show that, in endothelial cells, nuclear VEGFR2 interacts with several nuclear proteins, including the Sp1, a transcription factor that has been implicated in the regulation of genes needed for angiogenesis. By in vivo chromatin immunoprecipitation (ChIP) assays, we found that VEGFR2 binds to the Sp1-responsive region of the VEGFR2 proximal promoter. These results were confirmed by EMSA assays, using the same region of the VEGFR2 promoter. Importantly, we show that the VEGFR2 DNA binding is directly linked to the transcriptional activation of the VEGFR2 promoter. By reporter assays, we found that the region between -300/-116 relative to the transcription start site is essential to confer VEGFR2-dependent transcriptional activity. It was previously described that nuclear translocation of the VEGFR2 is dependent on its activation by VEGF. In agreement, we observed that the binding of VEGFR2 to DNA requires VEGF activation, being blocked by Bevacizumab and Sunitinib, two anti-angiogenic agents that inhibit VEGFR2 activation. Our findings demonstrate a new mechanism by which VEGFR2 activates its own promoter that could be involved in amplifying the angiogenic response.	[Domingues, Ines; Rino, Jose; Rosa Santos, Susana Constantino] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Demmers, Jeroen A. A.] Erasmus Univ, Med Ctr, Prote Ctr, Rotterdam, Netherlands; [de Lanerolle, Primal] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA	Universidade de Lisboa; Erasmus University Rotterdam; Erasmus MC; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Domingues, I (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	sconstantino@fm.ul.pt	Demmers, Jeroen AA/F-4046-2016; Rino, José/I-2990-2013; Santos, Susana/AAM-8902-2021	Demmers, Jeroen AA/0000-0002-8757-9611; Rino, José/0000-0002-0637-4527; Constantino Rosa Santos, Susana/0000-0002-5711-1292; Domingues, Ines/0000-0002-5535-619X	Fundacao para a Ciencia e Tecnologia (FCT) [POCTI\BIA-BCM 58929\2004]; NIH [R01GM080587]; FCT [SFRH/BD/27505/2006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080587] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research project was founded by Fundacao para a Ciencia e Tecnologia (FCT) POCTI\BIA-BCM 58929\2004 to SCRS and NIH R01GM080587 to PdeL. I. D. is the recipient of FCT PhD Fellowship SFRH/BD/27505/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blazquez C, 2006, CELL RES, V16, P93, DOI 10.1038/sj.cr.7310012; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Chen DH, 2000, ARTERIOSCL THROM VAS, V20, P629, DOI 10.1161/01.ATV.20.3.629; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; de Nigris F, 2010, P NATL ACAD SCI USA, V107, P14484, DOI 10.1073/pnas.1008256107; DYER RB, 1995, NUCLEIC ACIDS RES, V23, P3345; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fernandez SL, 2007, BIOL PROCED ONLINE, V9, P84, DOI 10.1251/bpo136; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fox SB, 2004, J PATHOL, V202, P313, DOI 10.1002/path.1520; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Herbert SP, 2009, J BIOL CHEM, V284, P5784, DOI 10.1074/jbc.M807282200; Higgins KJ, 2006, BIOCHEM BIOPH RES CO, V345, P292, DOI 10.1016/j.bbrc.2006.04.111; Huang S, 2000, CANCER RES, V60, P5334; Huang S, 2000, CLIN CANCER RES, V6, P2573; KAPELLER R, 1993, MOL CELL BIOL, V13, P6052, DOI 10.1128/MCB.13.10.6052; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Li WL, 2000, J CELL SCI, V113, P1525; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Liu J, 2010, J IMMUNOL, V185, P1215, DOI 10.4049/jimmunol.0903660; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Patterson C, 1997, J BIOL CHEM, V272, P8410, DOI 10.1074/jbc.272.13.8410; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; Sassa Y, 2004, DIABETES, V53, P1222, DOI 10.2337/diabetes.53.5.1222; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shen BQ, 1998, J BIOL CHEM, V273, P29979, DOI 10.1074/jbc.273.45.29979; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Stewart M, 2003, HISTOPATHOLOGY, V43, P33, DOI 10.1046/j.1365-2559.2003.01644.x; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Urbich C, 2003, FEBS LETT, V535, P87, DOI 10.1016/S0014-5793(02)03879-6; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yu HG, 2004, INT J COLORECTAL DIS, V19, P18, DOI 10.1007/s00384-003-0494-z; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092; Zhang YY, 2005, HUM PATHOL, V36, P797, DOI 10.1016/j.humpath.2005.05.015	59	69	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25668	10.1371/journal.pone.0025668	http://dx.doi.org/10.1371/journal.pone.0025668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980525	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900090
J	Smits, J; Monden, C				Smits, Jeroen; Monden, Christiaan			Twinning across the Developing World	PLOS ONE			English	Article							MULTIPLE BIRTHS; RATES; RISK; CONSEQUENCES; PREGNANCIES; COUNTRIES; REGISTRY; NIGERIA; TRENDS; TWINS	Background: Until now, little was known about the variation in incidence of twin births across developing countries, because national representative data was lacking. This study provides the first comprehensive overview of national twinning rates across the developing world on the basis of reliable survey data. Methods: Data on incidence of twinning was extracted from birth histories of women aged 15-49 interviewed in 150 Demographic and Health Surveys, held between 1987 and 2010 in 75 low and middle income countries. During the interview, information on all live births experienced by the women was recorded, including whether it was a singleton or multiple birth. Information was available for 2.47 million births experienced by 1.38 million women in a period of ten years before the interview. Twinning incidence was measured as the number of twin births per thousand births. Data for China were computed on the basis of published figures from the 1990 census. Both natural and age-standardized twinning rates are presented. Results/Conclusions: The very low natural twinning rates of 6-9 per thousand births previously observed in some East Asian countries turn out to be the dominant pattern in the whole South and South-East Asian region. Very high twinning rates of above 18 per thousand are not restricted to Nigeria (until now seen as the world's twinning champion) but found in most Central-African countries. Twinning rates in Latin America turn out to be as low as those in Asia. Changes over time are small and not in a specific direction. Significance: We provide the most complete and comparable overview of twinning rates across the developing world currently possible.	[Smits, Jeroen] Radboud Univ Nijmegen, Inst Management Res, Nijmegen Ctr Econ, NL-6525 ED Nijmegen, Netherlands; [Monden, Christiaan] Univ Oxford, Dept Sociol, Oxford, England	Radboud University Nijmegen; University of Oxford	Smits, J (corresponding author), Radboud Univ Nijmegen, Inst Management Res, Nijmegen Ctr Econ, NL-6525 ED Nijmegen, Netherlands.	j.smits@fm.ru.nl	smits, jeroen pjm/D-3840-2012; Monden, Christiaan/F-2640-2014	smits, jeroen pjm/0000-0002-5802-975X; Monden, Christiaan/0000-0003-1642-1582				Astolfi P, 2003, HUM REPROD, V18, P207, DOI 10.1093/humrep/deg036; Basso O, 2004, JAMA-J AM MED ASSOC, V291, P1564, DOI 10.1001/jama.291.13.1564-c; Blickstein I., 2005, MULTIPLE PREGNANCY E; Blondel B, 2002, SEMIN PERINATOL, V26, P239, DOI 10.1053/sper.2002.34775; Bortolus R, 1999, HUM REPROD UPDATE, V5, P179, DOI 10.1093/humupd/5.2.179; Bulmer M. G., 1970, BIOL TWINNING MAN; CHEN CJ, 1992, ACTA GENET MED GEMEL, V41, P205, DOI 10.1017/S0001566000002415; Chia KS, 2004, ANN ACAD MED SINGAP, V33, P195; Choi SH, 2010, J KOREAN MED SCI, V25, P1191, DOI 10.3346/jkms.2010.25.8.1191; Eriksson AW, 2004, HUM BIOL, V76, P343, DOI 10.1353/hub.2004.0044; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Fellman J, 2009, TWIN RES HUM GENET, V12, P183, DOI 10.1375/twin.12.2.183; Gan JP, 2007, TWIN RES HUM GENET, V10, P633, DOI 10.1375/twin.10.4.633; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Hellin D., 1895, URSACHE MULTIPARITAT; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Igberase GO, 2008, J OBSTET GYNAECOL, V28, P586, DOI 10.1080/01443610802344308; Imaizumi Y, 2003, J BIOSOC SCI, V35, P287, DOI 10.1017/S0021932003002876; Imaizumi Y., 2005, MULTIPLE PREGNANCY, P33; Kallen K, 1998, Twin Res, V1, P206, DOI 10.1375/136905298320566177; Katz J, 2001, INT J EPIDEMIOL, V30, P802, DOI 10.1093/ije/30.4.802; Lichtenstein P, 1996, BRIT MED J, V312, P879; Little J., 1988, TWINNING TWINS, P37; MCGILLIVRAY I, 1988, TWINNING TWINS, P67; Morales-Suarez-Varela MM, 2007, TWIN RES HUM GENET, V10, P597, DOI 10.1375/twin.10.4.597; MUHEREE M, 2006, DEVELOPMENT, V49, P128; MURPHY MFG, 1989, J EPIDEMIOL COMMUN H, V43, P275, DOI 10.1136/jech.43.3.275; NYLANDER PP, 1971, J BIOSOC SCI, V3, P151, DOI 10.1017/S0021932000007896; Nylander PPS., 1983, OBSTET EPIDEMIOLOGY, P143; NYLANDER PPS, 1975, HUMAN MULTIPLE REPRO, P98; Nylander PPS, 1975, HUMAN MULTIPLE REPRO, P87; Oleszczuk JJ, 2001, J REPROD MED, V46, P550; Pison G, 2006, TWIN RES HUM GENET, V9, P250, DOI 10.1375/twin.9.2.250; Pison G., 1989, MORTALITE SOC AFRIQU, P245; POLLARD R, 1995, HUM BIOL, V67, P921; Rutstein SO, 1983, WFS COMP STUDIES; Segal N.L., 1999, ENTWINED LIVES TWINS; WEDSTROM KD, 1988, CLIN PERINATOL, V15, P1; Westergaard T, 1997, BMJ-BRIT MED J, V314, P775, DOI 10.1136/bmj.314.7083.775; WHITE C, 1964, NEW ENGL J MED, V271, P1003, DOI 10.1056/NEJM196411052711908	40	135	138	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25239	10.1371/journal.pone.0025239	http://dx.doi.org/10.1371/journal.pone.0025239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980404	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900037
J	Sigoillot, FD; Huckins, JF; Li, FH; Zhou, XB; Wong, STC; King, RW				Sigoillot, Frederic D.; Huckins, Jeremy F.; Li, Fuhai; Zhou, Xiaobo; Wong, Stephen T. C.; King, Randall W.			A Time-Series Method for Automated Measurement of Changes in Mitotic and Interphase Duration from Time-Lapse Movies	PLOS ONE			English	Article							MAMMALIAN-CELLS; FLUORESCENCE MICROSCOPY; PHASE IDENTIFICATION; ANTIMITOTIC DRUGS; DNA-DAMAGE; SEGMENTATION; CLASSIFICATION; DYNAMICS; SYSTEM	Background: Automated time-lapse microscopy can visualize proliferation of large numbers of individual cells, enabling accurate measurement of the frequency of cell division and the duration of interphase and mitosis. However, extraction of quantitative information by manual inspection of time-lapse movies is too time-consuming to be useful for analysis of large experiments. Methodology/Principal Findings: Here we present an automated time-series approach that can measure changes in the duration of mitosis and interphase in individual cells expressing fluorescent histone 2B. The approach requires analysis of only 2 features, nuclear area and average intensity. Compared to supervised learning approaches, this method reduces processing time and does not require generation of training data sets. We demonstrate that this method is as sensitive as manual analysis in identifying small changes in interphase or mitotic duration induced by drug or siRNA treatment. Conclusions/Significance: This approach should facilitate automated analysis of high-throughput time-lapse data sets to identify small molecules or gene products that influence timing of cell division.	[Sigoillot, Frederic D.; Huckins, Jeremy F.; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Li, Fuhai; Wong, Stephen T. C.] Weill Cornell Med Coll, Methodist Hosp, Res Inst, Dept Syst Med & Bioengn, Houston, TX USA; [Zhou, Xiaobo] Weill Cornell Med Coll, Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX USA	Harvard University; Harvard Medical School; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Sigoillot, FD (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	randy_king@hms.harvard.edu	Huckins, Jeremy/AAI-7446-2020	Huckins, Jeremy/0000-0003-0106-7808; Sigoillot, Frederic/0000-0002-8695-4838	NIH [GM66492]; Lynch Foundation; National Library of Medicine [R01LM008696]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066492, R01GM066492] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lynch Foundation; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants GM66492 from the NIH http://www.nih.gov/ and the Lynch Foundation http://www.thelynchfoundation.org/ to R.W.K. and a grant from National Library of Medicine http://www.nlm.nih.gov/ to S.W. (R01LM008696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Davis PJ, 2007, J MICROSC-OXFORD, V228, P296, DOI 10.1111/j.1365-2818.2007.01847.x; Debeir O, 2008, EXP CELL RES, V314, P2985, DOI 10.1016/j.yexcr.2008.06.010; DEWITH A, 1995, J PHOTOCH PHOTOBIO B, V30, P71, DOI 10.1016/1011-1344(95)07151-Q; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Gambe AE, 2007, CYTOM PART A, V71A, P286, DOI 10.1002/cyto.a.20378; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200; GUPTA RS, 1985, JNCI-J NATL CANCER I, V74, P159; Harder N, 2008, METHOD CELL BIOL, V85, P539, DOI 10.1016/S0091-679X(08)85023-6; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Jones JT, 2004, NAT BIOTECHNOL, V22, P306, DOI 10.1038/nbt941; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Li F, 2010, IEEE T MED IMAGING; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Nath SK, 2006, LECT NOTES COMPUT SC, V4190, P101; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Vogel C, 2007, CANCER RES, V67, P339, DOI 10.1158/0008-5472.CAN-06-2548; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; Wang M, 2008, BIOINFORMATICS, V24, P94, DOI 10.1093/bioinformatics/btm530; Yan PK, 2008, IEEE T INF TECHNOL B, V12, P109, DOI 10.1109/TITB.2007.898006	26	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25511	10.1371/journal.pone.0025511	http://dx.doi.org/10.1371/journal.pone.0025511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966537	gold, Green Published, Green Submitted			2022-12-27	WOS:000295932100045
J	Hayman, DTS; Wang, LF; Barr, J; Baker, KS; Suu-Ire, R; Broder, CC; Cunningham, AA; Wood, JLN				Hayman, David T. S.; Wang, Lin-Fa; Barr, Jennifer; Baker, Kate S.; Suu-Ire, Richard; Broder, Christopher C.; Cunningham, Andrew A.; Wood, James L. N.			Antibodies to Henipavirus or Henipa-Like Viruses in Domestic Pigs in Ghana, West Africa	PLOS ONE			English	Article							NIPAH-VIRUS; FRUIT BATS; HENDRA VIRUS; MORBILLIVIRUS; TRANSMISSION; ENCEPHALITIS; INFECTION; HORSES; CATS	Henipaviruses, Hendra virus (HeV) and Nipah virus (NiV), have Pteropid bats as their known natural reservoirs. Antibodies against henipaviruses have been found in Eidolon helvum, an old world fruit bat species, and henipavirus-like nucleic acid has been detected in faecal samples from E. helvum in Ghana. The initial outbreak of NiV in Malaysia led to over 265 human encephalitis cases, including 105 deaths, with infected pigs acting as amplifier hosts for NiV during the outbreak. We detected non-neutralizing antibodies against viruses of the genus Henipavirus in approximately 5% of pig sera (N = 97) tested in Ghana, but not in a small sample of other domestic species sampled under a E. helvum roost. Although we did not detect neutralizing antibody, our results suggest prior exposure of the Ghana pig population to henipavirus(es). Because a wide diversity of henipavirus-like nucleic acid sequences have been found in Ghanaian E. helvum, we hypothesise that these pigs might have been infected by henipavirus(es) sufficiently divergent enough from HeVor NiV to produce cross-reactive, but not cross-neutralizing antibodies to HeV or NiV.	[Hayman, David T. S.; Baker, Kate S.; Wood, James L. N.] Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England; [Hayman, David T. S.; Baker, Kate S.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hayman, David T. S.] Anim Hlth & Vet Labs Agcy, Weybridge, Surrey, England; [Hayman, David T. S.] Colorado State Univ, Ft Collins, CO 80523 USA; [Wang, Lin-Fa; Barr, Jennifer] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Suu-Ire, Richard] Ghana Forestry Commiss, Wildlife Div, Accra, Ghana; [Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	University of Cambridge; Zoological Society of London; Veterinary Laboratories Agency; Colorado State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Uniformed Services University of the Health Sciences - USA	Hayman, DTS (corresponding author), Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England.	dtsh2@cam.ac.uk	Barr, Jennifer A/H-9254-2013; wang, lin/GSE-3040-2022; Baker, Kate/P-2087-2016; Wood, James/A-1626-2008; Cunningham, Andrew A/E-7536-2010; Broder, Christopher/E-1169-2013	Baker, Kate/0000-0001-5850-1949; Wood, James/0000-0002-0258-3188; Wang, Lin-Fa/0000-0003-2752-0535; Hayman, David/0000-0003-0087-3015; Barr, Jennifer/0000-0001-5266-9142	Wellcome Trust [VT0105]; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health (NIH); NIH [AI077995]; MRC [G0902430] Funding Source: UKRI; Medical Research Council [G0902430] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077995] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the The Wellcome Trust (to DTSH, KSB), Defra grant VT0105, the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and Fogarty International Center, National Institutes of Health (NIH), and NIH grant AI077995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chen JM, 2006, J VIROL METHODS, V136, P273, DOI 10.1016/j.jviromet.2006.05.003; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; PULLIAM JR, 2011, J R SOC INT IN PRESS; Tamungang SA, 2008, AFR J ECOL, V46, P230, DOI 10.1111/j.1365-2028.2007.00825.x; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; PROMED PRO AH EDR HE	19	54	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25256	10.1371/journal.pone.0025256	http://dx.doi.org/10.1371/journal.pone.0025256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966471	gold, Green Submitted, Green Published			2022-12-27	WOS:000295265100076
J	Leblond, M; Fan, D; Brynildsen, JK; Yin, HH				Leblond, Mona; Fan, David; Brynildsen, Julia K.; Yin, Henry H.			Motivational State and Reward Content Determine Choice Behavior under Risk in Mice	PLOS ONE			English	Article							DECISION-MAKING; SENSITIVITY; RECEPTORS; STRIATUM	Risk is a ubiquitous feature of the environment for most organisms, who must often choose between a small and certain reward and a larger but less certain reward. To study choice behavior under risk in a genetically well characterized species, we trained mice (C57BL/6) on a discrete trial, concurrent-choice task in which they must choose between two levers. Pressing one lever (safe choice) is always followed by a small reward. Pressing the other lever (risky choice) is followed by a larger reward, but only on some of the trials. The overall payoff is the same on both levers. When mice were not food deprived, they were indifferent to risk, choosing both levers with equal probability regardless of the level of risk. In contrast, following food or water deprivation, mice earning 10% sucrose solution were risk-averse, though the addition of alcohol to the sucrose solution dose-dependently reduced risk aversion, even before the mice became intoxicated. Our results falsify the budget rule in optimal foraging theory often used to explain behavior under risk. Instead, they suggest that the overall demand or desired amount for a particular reward determines risk preference. Changes in motivational state or reward identity affect risk preference by changing demand. Any manipulation that increases the demand for a reward also increases risk aversion, by selectively increasing the frequency of safe choices without affecting frequency of risky choices.	[Leblond, Mona; Fan, David; Brynildsen, Julia K.; Yin, Henry H.] Duke Univ, Dept Psychol & Neuroscience, Dept Neurobiol, Ctr Cognit Neuroscience, Durham, NC 27708 USA	Duke University	Yin, HH (corresponding author), Duke Univ, Dept Psychol & Neuroscience, Dept Neurobiol, Ctr Cognit Neuroscience, Durham, NC 27708 USA.	hy43@duke.edu		Brynildsen, Julia Katherine (Kate)/0000-0002-1627-6576	National Institute of Alcohol Abuse and Alcoholism [018018, 016991]; National Science Foundation	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Institute of Alcohol Abuse and Alcoholism grants 018018 and 016991 to HHY and by a National Science Foundation Mechanisms of Behavior Summer Fellowship to JKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cagniard B, 2006, NEURON, V51, P541, DOI 10.1016/j.neuron.2006.07.026; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; Cardinal RN, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-37; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Glimcher PW, 2008, COGN AFFECT BEHAV NE, V8, P348, DOI 10.3758/CABN.8.4.348; Hayden BY, 2007, CURR BIOL, V17, P49, DOI 10.1016/j.cub.2006.10.055; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Innis, 1966, PSYCHON SCI, V4, P193; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Kacelnik A, 1997, TRENDS COGN SCI, V1, P304, DOI 10.1016/S1364-6613(97)01093-0; Knight, 1933, RISK UNCERTAINTY PRO; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; St Onge JR, 2011, J NEUROSCI, V31, P8625, DOI 10.1523/JNEUROSCI.1020-11.2011; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; Yin HH, 2010, J NEUROSCI, V30, P14719, DOI 10.1523/JNEUROSCI.3989-10.2010; Yin HH, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.023.2009; Yin HH, 2006, NEUROBIOL LEARN MEM, V85, P283, DOI 10.1016/j.nlm.2005.12.001; Yu CX, 2009, J NEUROSCI, V29, P15100, DOI 10.1523/JNEUROSCI.4215-09.2009	20	12	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25342	10.1371/journal.pone.0025342	http://dx.doi.org/10.1371/journal.pone.0025342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966504	Green Published, Green Submitted, gold			2022-12-27	WOS:000295265100093
J	Pan, LT; Wu, X; Zhao, D; Hessari, NM; Lee, I; Zhang, XZ; Xu, JJ				Pan, Leiting; Wu, Xian; Zhao, Dan; Hessari, Nason Ma'ani; Lee, Imshik; Zhang, Xinzheng; Xu, Jingjun			Sulfhydryl Modification Induces Calcium Entry through IP3-Sensitive Store-Operated Pathway in Activation-Dependent Human Neutrophils	PLOS ONE			English	Article							2-AMINOETHOXYDIPHENYL BORATE 2-APB; INOSITOL TRISPHOSPHATE RECEPTOR; STIMULATES CA2+ ENTRY; PROTEIN-KINASE-C; S-NITROSYLATION; RESPIRATORY BURST; NITRIC-OXIDE; N-ETHYLMALEIMIDE; RELEASE; INFLUX	As the first line of host defense, neutrophils are stimulated by pro-inflammatory cytokines from resting state, facilitating the execution of immunomodulatory functions in activation state. Sulfhydryl modification has a regulatory role in a wide variety of physiological functions through mediation of signaling transductions in various cell types. Recent research suggested that two kinds of sulfhydryl modification, S-nitrosylation by exogenous nitric oxide (NO) and alkylation by N-ethylmaleimide (NEM), could induce calcium entry through a non-store-operated pathway in resting rat neutrophils and DDT1MF-2 cells, while in active human neutrophils a different process has been observed by us. In the present work, data showed that NEM induced a sharp rising of cytosolic calcium concentration ([Ca2+](c)) without external calcium, followed by a second [Ca2+](c) increase with readdition of external calcium in phorbol 12-myristate 13-acetate (PMA)-activated human neutrophils. Meanwhile, addition of external calcium did not cause [Ca2+](c) change of Ca2+-free PMA-activated neutrophils before application of NEM. These data indicated that NEM could induce believable store-operated calcium entry (SOCE) in PMA-activated neutrophils. Besides, we found that sodium nitroprusside (SNP), a donor of exogenous NO, resulted in believable SOCE in PMA-activated human neutrophils via S-nitrosylation modification. In contrast, NEM and SNP have no effect on [Ca2+](c) of resting neutrophils which were performed in suspension. Furthermore, 2-Aminoethoxydiphenyl borate, a reliable blocker of SOCE and an inhibitor of inositol 1,4,5-trisphosphate (IP3) receptor, evidently abolished SNP and NEM-induced calcium entry at 75 mu M, while preventing calcium release in a concentration-dependent manner. Considered together, these results demonstrated that NEM and SNP induced calcium entry through an IP3-sensitive store-operated pathway of human neutrophils via sulfhydryl modification in a PMA-induced activation-dependent manner.	[Pan, Leiting] Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, TEDA Appl Phys Sch, Tianjin 300071, Peoples R China; Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Pan, LT (corresponding author), Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, TEDA Appl Phys Sch, Tianjin 300071, Peoples R China.	plt@nankai.edu.cn	Pan, Leiting/F-5001-2010; Lee, Imshik/G-6129-2010; xu, jing/GRR-8698-2022; Zhang, Xinzheng/C-5703-2009; Jingjun, Xu/A-1282-2010	Lee, Imshik/0000-0002-0098-392X; Zhang, Xinzheng/0000-0001-8128-3273; Maani, Nason/0000-0002-3398-0688	Fundamental Research Funds for the Central Universities [65010861]; National Basic Research Program of China [2007CB307002, 2010CB934101]; 111 Project [B07013]; National Natural Science Foundation of China [11074133]; Oversea Famous Teacher Project [MS2010NKDX023]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research Program of China(National Basic Research Program of China); 111 Project(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oversea Famous Teacher Project	This work was supported by the Fundamental Research Funds for the Central Universities (No. 65010861), the National Basic Research Program of China (Nos. 2007CB307002, 2010CB934101), 111 Project (No. B07013) and National Natural Science Foundation of China (No. 11074133), Oversea Famous Teacher Project (No. MS2010NKDX023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1997, CLIN EXP IMMUNOL, V110, P132, DOI 10.1046/j.1365-2249.1997.5051403.x; Anderson R, 2005, BIOCHEM PHARMACOL, V69, P1567, DOI 10.1016/j.bcp.2005.03.004; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Berton G, 1996, INT J CLIN LAB RES, V26, P160, DOI 10.1007/BF02592978; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; DIVIRGILIO F, 1984, NATURE, V310, P691, DOI 10.1038/310691a0; DIVIRGILIO F, 1985, BIOCHEM J, V229, P361, DOI 10.1042/bj2290361; Favre CJ, 1998, J BIOL CHEM, V273, P30855, DOI 10.1074/jbc.273.47.30855; FODER B, 1989, CELL CALCIUM, V10, P477, DOI 10.1016/0143-4160(89)90025-0; FRYER MW, 1992, NEUROSCI LETT, V146, P84, DOI 10.1016/0304-3940(92)90178-A; Gibon J, 2010, CELL CALCIUM, V48, P37, DOI 10.1016/j.ceca.2010.06.004; Granfeldt D, 2002, J LEUKOCYTE BIOL, V71, P611; Harfi I, 2005, J IMMUNOL, V175, P4091, DOI 10.4049/jimmunol.175.6.4091; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hsu MF, 2006, EUR J PHARMACOL, V535, P43, DOI 10.1016/j.ejphar.2006.02.013; Hsu MF, 2005, BIOCHEM PHARMACOL, V70, P1320, DOI 10.1016/j.bcp.2005.07.029; Itagaki K, 2002, J IMMUNOL, V168, P4063, DOI 10.4049/jimmunol.168.8.4063; Klink M, 2009, IMMUNOBIOLOGY, V214, P692, DOI 10.1016/j.imbio.2008.12.001; LEW DP, 1989, EUR J CLIN INVEST, V19, P338, DOI 10.1111/j.1365-2362.1989.tb00240.x; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 1999, J BIOL CHEM, V274, P35318, DOI 10.1074/jbc.274.50.35318; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; MONTERO M, 1993, J BIOL CHEM, V268, P13055; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pan LT, 2008, BIOCHEM BIOPH RES CO, V377, P1320, DOI 10.1016/j.bbrc.2008.11.001; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; Petty HR, 2000, PHYS REV LETT, V84, P2754, DOI 10.1103/PhysRevLett.84.2754; Petty HR, 2001, P NATL ACAD SCI USA, V98, P3145, DOI 10.1073/pnas.061014298; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; SAVAGE COS, 1992, AM J PATHOL, V141, P335; SEEDS MC, 1985, BLOOD, V65, P233; SHAAFI RI, 1983, BIOCHEM BIOPH RES CO, V114, P638, DOI 10.1016/0006-291X(83)90828-8; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Smith RJ, 1996, J PHARMACOL EXP THER, V278, P320; Smyth DG, 1960, J AM CHEM SOC, V82, P4600, DOI 10.1021/ja01502a039; Soulsby MD, 2002, CELL CALCIUM, V32, P175, DOI 10.1016/S0143416002001525; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Takei H, 1996, J LEUKOCYTE BIOL, V59, P229, DOI 10.1002/jlb.59.2.229; TAUBER AI, 1987, BLOOD, V69, P711; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Wang JP, 2003, EUR J PHARMACOL, V458, P243, DOI 10.1016/S0014-2999(02)02790-5; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; YULE DI, 1992, J BIOL CHEM, V267, P13830	55	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25262	10.1371/journal.pone.0025262	http://dx.doi.org/10.1371/journal.pone.0025262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984909	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000020
J	Facey, PD; Sevcikova, B; Novakova, R; Hitchings, MD; Crack, JC; Kormanec, J; Dyson, PJ; Del Sol, R				Facey, Paul D.; Sevcikova, Beatrica; Novakova, Renata; Hitchings, Matthew D.; Crack, Jason C.; Kormanec, Jan; Dyson, Paul J.; Del Sol, Ricardo			The dpsA Gene of Streptomyces coelicolor: Induction of Expression from a Single Promoter in Response to Environmental Stress or during Development	PLOS ONE			English	Article							SIGMA-FACTOR SIGMA(H); ESCHERICHIA-COLI; ANTIBIOTIC PRODUCTION; BACILLUS-SUBTILIS; NITRIC-OXIDE; A3(2); IDENTIFICATION; DIFFERENTIATION; TRANSCRIPTION; PROTEIN	The DpsA protein plays a dual role in Streptomyces coelicolor, both as part of the stress response and contributing to nucleoid condensation during sporulation. Promoter mapping experiments indicated that dpsA is transcribed from a single, sigB-like dependent promoter. Expression studies implicate SigH and SigB as the sigma factors responsible for dpsA expression while the contribution of other SigB-like factors is indirect by means of controlling sigH expression. The promoter is massively induced in response to osmotic stress, in part due to its sensitivity to changes in DNA supercoiling. In addition, we determined that WhiB is required for dpsA expression, particularly during development. Gel retardation experiments revealed direct interaction between apoWhiB and the dpsA promoter region, providing the first evidence for a direct WhiB target in S. coelicolor.	[Facey, Paul D.; Hitchings, Matthew D.; Dyson, Paul J.; Del Sol, Ricardo] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Sevcikova, Beatrica; Novakova, Renata; Kormanec, Jan] Slovak Acad Sci, Inst Mol Biol, Bratislava 84251, Slovakia; [Crack, Jason C.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	Swansea University; Slovak Academy of Sciences; University of East Anglia	Facey, PD (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	e.r.abascal@swansea.ac.uk	Facey, Paul/AAK-3265-2021; Kormanec, Jan/AAA-7446-2019; Del Sol, Ricardo/L-3171-2015; Dyson, Paul/S-7312-2019	Del Sol, Ricardo/0000-0003-0015-3843; Facey, Paul/0000-0002-3229-0255; Kormanec, Jan/0000-0003-0377-6413; Dyson, Paul/0000-0002-0558-2666; Hitchings, Matthew/0000-0002-5527-4709; Crack, Jason C./0000-0002-4979-1910	Slovak Academy of Sciences [2/0104/09]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/E019242/1] Funding Source: researchfish; BBSRC [BB/E019242/1] Funding Source: UKRI	Slovak Academy of Sciences(Slovak Academy of Sciences); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a VEGA grant 2/0104/09 from Slovak Academy of Sciences. MDH is supported by a Biotechnology and Biological Sciences Research Council Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; Bishop A, 2004, GENOME RES, V14, P893, DOI 10.1101/gr.1710304; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Cho YH, 2001, MOL MICROBIOL, V42, P205, DOI 10.1046/j.1365-2958.2001.02622.x; Crack JC, 2008, METHOD ENZYMOL, V437, P191, DOI 10.1016/S0076-6879(07)37011-0; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; Dalton KA, 2007, MOL MICROBIOL, V64, P719, DOI 10.1111/j.1365-2958.2007.05684.x; den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Fernandez-Martinez L, 2009, MOL MICROBIOL, V71, P1250, DOI 10.1111/j.1365-2958.2009.06599.x; Flardh K, 1999, MICROBIOL-SGM, V145, P2229, DOI 10.1099/00221287-145-9-2229; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Kang JG, 1997, NUCLEIC ACIDS RES, V25, P2566, DOI 10.1093/nar/25.13.2566; Karoonuthaisiri N, 2005, GENE, V353, P53, DOI 10.1016/j.gene.2005.03.042; Kelemen GH, 1998, J BACTERIOL, V180, P2515, DOI 10.1128/JB.180.9.2515-2521.1998; Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kormanec J, 2002, BBA-GENE STRUCT EXPR, V1577, P149, DOI 10.1016/S0167-4781(02)00409-8; Kormanec J, 2002, MOL GENET GENOMICS, V267, P536, DOI 10.1007/200438-002-0687-0; Kormanec J, 2000, FEMS MICROBIOL LETT, V189, P31, DOI 10.1111/j.1574-6968.2000.tb09202.x; Lee EJ, 2005, MOL MICROBIOL, V57, P1252, DOI 10.1111/j.1365-2958.2005.04761.x; Lee EJ, 2004, J MICROBIOL, V42, P147; Mao XM, 2009, J BACTERIOL, V191, P6473, DOI 10.1128/JB.00875-09; Maxam A M, 1980, Methods Enzymol, V65, P499; Mazurakova V, 2006, ARCH MICROBIOL, V186, P435, DOI 10.1007/s00203-006-0158-9; Paget MSB, 1999, MOL MICROBIOL, V33, P97, DOI 10.1046/j.1365-2958.1999.01452.x; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sevcikova B, 2001, ARCH MICROBIOL, V177, P98, DOI 10.1007/s00203-001-0367-1; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; SOLIVERI J, 1992, J BACTERIOL, V174, P6215, DOI 10.1128/JB.174.19.6215-6220.1992; Viollier PH, 2003, MOL MICROBIOL, V47, P699, DOI 10.1046/j.1365-2958.2003.03302.x; Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	39	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25593	10.1371/journal.pone.0025593	http://dx.doi.org/10.1371/journal.pone.0025593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984935	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300045
J	Hollister, JW; Milstead, WB; Urrutia, MA				Hollister, Jeffrey W.; Milstead, W. Bryan; Urrutia, M. Andrea			Predicting Maximum Lake Depth from Surrounding Topography	PLOS ONE			English	Article							MODELS	Information about lake morphometry (e. g., depth, volume, size, etc.) aids understanding of the physical and ecological dynamics of lakes, yet is often not readily available. The data needed to calculate measures of lake morphometry, particularly lake depth, are usually collected on a lake-by-lake basis and are difficult to obtain across broad regions. To span the gap between studies of individual lakes where detailed data exist and regional studies where access to useful data on lake depth is unavailable, we developed a method to predict maximum lake depth from the slope of the topography surrounding a lake. We use the National Elevation Dataset and the National Hydrography Dataset - Plus to estimate the percent slope of surrounding lakes and use this information to predict maximum lake depth. We also use field measured maximum lake depths from the US EPA's National Lakes Assessment to empirically adjust and cross-validate our predictions. We were able to predict maximum depth for similar to 28,000 lakes in the Northeastern United States with an average cross-validated RMSE of 5.95 m and 5.09 m and average correlation of 0.82 and 0.69 for Hydrological Unit Code Regions 01 and 02, respectively. The depth predictions and the scripts are openly available as supplements to this manuscript.	[Hollister, Jeffrey W.; Milstead, W. Bryan] US EPA, Off Res & Dev, Atlantic Ecol Div, Narragansett, RI USA; [Urrutia, M. Andrea] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	United States Environmental Protection Agency; University of Rhode Island	Hollister, JW (corresponding author), US EPA, Off Res & Dev, Atlantic Ecol Div, Narragansett, RI USA.	hollister.jeff@epa.gov	Hollister, Jeffrey/J-9920-2013	Hollister, Jeffrey/0000-0002-9254-9740	United States Environmental Protection Agency	United States Environmental Protection Agency(United States Environmental Protection Agency)	The research described in this paper has been funded by the United States Environmental Protection Agency. This paper has not been subjected to Agency review. Therefore, it does not necessarily reflect the views of the Agency. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. This is contribution number AED-11-013 of the Atlantic Ecology Division, Office of Research and Development, National Health and Environmental Effects Research Laboratory. The funding agency employs Dr. Hollister and Dr. Milstead, but beyond salary support for the authors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Arnold JG, 2005, HYDROL PROCESS, V19, P563, DOI 10.1002/hyp.5611; Carrara A, 1997, INT J GEOGR INF SCI, V11, P451, DOI 10.1080/136588197242257; Chaplot V, 2006, GEOMORPHOLOGY, V77, P126, DOI 10.1016/j.geomorph.2005.12.010; *ENV SYST RES INC, 2011, ARCGIS 10 0 ENV SYST; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Gesch D, 2009, NATL MAP ELEVATION; Hamilton L. C., 1992, REGRESSION GRAPHICS; Hollister J, 2010, LAKE RESERV MANAGE, V26, P194, DOI 10.1080/07438141.2010.504321; Hutchinson GE, 1957, TREATISE LIMNOLOGY, P1015; Kalff J, 2002, LIMNOLOGY INLAND WAT; Moore RB, 2011, J AM WATER RESOUR AS, V47, P965, DOI 10.1111/j.1752-1688.2011.00582.x; R Core Team, 2020, R LANG ENV STAT COMP; Shary P.A., 2008, ADV DIGITAL TERRAIN; Smith RA, 1997, WATER RESOUR RES, V33, P2781, DOI 10.1029/97WR02171; U.S. ENVIRONMENTAL PROTECTION AGENCY, 2009, 841R09001 US EPA OFF; *US EPA, 2009, EPA600R09091 US EPA	17	43	44	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25764	10.1371/journal.pone.0025764	http://dx.doi.org/10.1371/journal.pone.0025764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984945	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300055
J	Labeed, FH; Lu, JT; Mulhall, HJ; Marchenko, SA; Hoettges, KF; Estrada, LC; Lee, AP; Hughes, MP; Flanagan, LA				Labeed, Fatima H.; Lu, Jente; Mulhall, Hayley J.; Marchenko, Steve A.; Hoettges, Kai F.; Estrada, Laura C.; Lee, Abraham P.; Hughes, Michael P.; Flanagan, Lisa A.			Biophysical Characteristics Reveal Neural Stem Cell Differentiation Potential	PLOS ONE			English	Article							PROGENITOR CELLS; DIELECTRIC-PROPERTIES; SUBVENTRICULAR ZONE; RADIAL GLIA; REACTIVE ASTROCYTES; GROWTH-FACTORS; CANCER-CELLS; MEMBRANE; SEPARATION; NEURONS	Background: Distinguishing human neural stem/progenitor cell (huNSPC) populations that will predominantly generate neurons from those that produce glia is currently hampered by a lack of sufficient cell type-specific surface markers predictive of fate potential. This limits investigation of lineage-biased progenitors and their potential use as therapeutic agents. A live-cell biophysical and label-free measure of fate potential would solve this problem by obviating the need for specific cell surface markers. Methodology/Principal Findings: We used dielectrophoresis (DEP) to analyze the biophysical, specifically electrophysiological, properties of cortical human and mouse NSPCs that vary in differentiation potential. Our data demonstrate that the electrophysiological property membrane capacitance inversely correlates with the neurogenic potential of NSPCs. Furthermore, as huNSPCs are continually passaged they decrease neuron generation and increase membrane capacitance, confirming that this parameter dynamically predicts and negatively correlates with neurogenic potential. In contrast, differences in membrane conductance between NSPCs do not consistently correlate with the ability of the cells to generate neurons. DEP crossover frequency, which is a quantitative measure of cell behavior in DEP, directly correlates with neuron generation of NSPCs, indicating a potential mechanism to separate stem cells biased to particular differentiated cell fates. Conclusions/Significance: We show here that whole cell membrane capacitance, but not membrane conductance, reflects and predicts the neurogenic potential of human and mouse NSPCs. Stem cell biophysical characteristics therefore provide a completely novel and quantitative measure of stem cell fate potential and a label-free means to identify neuron- or glial-biased progenitors.	[Labeed, Fatima H.; Mulhall, Hayley J.; Hoettges, Kai F.; Hughes, Michael P.] Univ Surrey, Ctr Biomed Engn, Guildford GU2 5XH, Surrey, England; [Lu, Jente; Flanagan, Lisa A.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Lu, Jente; Estrada, Laura C.; Lee, Abraham P.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Marchenko, Steve A.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Estrada, Laura C.] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA USA	University of Surrey; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Labeed, FH (corresponding author), Univ Surrey, Ctr Biomed Engn, Guildford GU2 5XH, Surrey, England.	lflanaga@uci.edu	Lu, Jente/F-4189-2011; Hoettges, Kai/F-1613-2013; Hughes, Michael/H-6996-2016; Lee, Abraham/E-7401-2011	Lu, Jente/0000-0001-6951-290X; Hughes, Michael/0000-0001-7385-5876; Labeed, Fatima/0000-0002-0092-257X; Lee, Abraham/0000-0001-8378-6616	Roman Reed Spinal Cord Injury Research Fund of California; UK Foreign and Commonwealth Office Collaboration; SETsquared UK-US Science Bridge for Applied Collaborative Research; California Institute for Regenerative Medicine [RT1-01074, TG2-01152]; NIH [P41-RR003155, AG23583]; Engineering and Physical Sciences Research Council [EP/I500936/1] Funding Source: researchfish; EPSRC [EP/I500936/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG023583] Funding Source: NIH RePORTER	Roman Reed Spinal Cord Injury Research Fund of California; UK Foreign and Commonwealth Office Collaboration; SETsquared UK-US Science Bridge for Applied Collaborative Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded in part by the Roman Reed Spinal Cord Injury Research Fund of California (http://www.reeve.uci.edu/roman-reed-research-grants.html), the UK Foreign and Commonwealth Office Collaboration Development Award (http://ukinusa.fco.gov.uk/en/news/?view=News&id=22705563), the SETsquared UK-US Science Bridge for Applied Collaborative Research (http://www.setsquared.co.uk/), the California Institute for Regenerative Medicine RT1-01074 and TG2-01152 (http://www.cirm.ca.gov/), and grants NIH P41-RR003155 (http://www.ncrr.nih.gov/) and NIH AG23583 (http://www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare L, 2003, BIOTECHNOL BIOENG, V82, P474, DOI 10.1002/bit.10590; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; BECKER FF, 1994, J PHYS D APPL PHYS, V27, P2659, DOI 10.1088/0022-3727/27/12/030; Broche LM, 2005, PHYS MED BIOL, V50, P2267, DOI 10.1088/0031-9155/50/10/006; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Chin S, 2006, INT J NANOMED, V1, P333; Clowry G, 2010, J ANAT, V217, P276, DOI 10.1111/j.1469-7580.2010.01281.x; Desai SP, 2009, LANGMUIR, V25, P3867, DOI 10.1021/la803330c; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Duncan L, 2008, PHYS MED BIOL, V53, pN1, DOI 10.1088/0031-9155/53/2/N01; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Flanagan LA, 2008, STEM CELLS, V26, P656, DOI 10.1634/stemcells.2007-0810; Gascoyne PRC, 1997, IEEE T IND APPL, V33, P670, DOI 10.1109/28.585856; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; GHEORGHIU E, 1993, PHYS MED BIOL, V38, P979, DOI 10.1088/0031-9155/38/7/008; GROVE EA, 1993, DEVELOPMENT, V117, P553; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hoettges KF, 2008, ANAL CHEM, V80, P2063, DOI 10.1021/ac702083g; Howard B, 2006, GLIA, V53, P57, DOI 10.1002/glia.20259; IRIMAJIRI A, 1979, J THEOR BIOL, V78, P251, DOI 10.1016/0022-5193(79)90268-6; Labeed FH, 2006, BBA-GEN SUBJECTS, V1760, P922, DOI 10.1016/j.bbagen.2006.01.018; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Maric D, 2003, J NEUROSCI, V23, P240; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Mo ZC, 2007, J NEUROSCI, V27, P4132, DOI 10.1523/JNEUROSCI.0111-07.2007; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Patel P, 2008, ENZYME MICROB TECH, V43, P463, DOI 10.1016/j.enzmictec.2008.09.005; Pethig R, 1997, TRENDS BIOTECHNOL, V15, P426, DOI 10.1016/S0167-7799(97)01096-2; Pethig R, 2002, ELECTROPHORESIS, V23, P2057, DOI 10.1002/1522-2683(200207)23:13<2057::AID-ELPS2057>3.0.CO;2-X; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Pohl H., 1978, DIELECTROPHORESIS; Prasad S, 2004, J NEUROSCI METH, V135, P79, DOI 10.1016/j.jneumeth.2003.12.007; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sah DWY, 1997, J NEUROBIOL, V32, P95, DOI 10.1002/(SICI)1097-4695(199701)32:1<95::AID-NEU9>3.0.CO;2-9; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Smith DO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001604; Stoneman M, 2007, BIOELECTROCHEMISTRY, V70, P542, DOI 10.1016/j.bioelechem.2006.12.008; Suzuki M, 2006, EUR J NEUROSCI, V24, P645, DOI 10.1111/j.1460-9568.2006.04957.x; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wang XJ, 1999, BBA-GEN SUBJECTS, V1426, P53, DOI 10.1016/S0304-4165(98)00122-6; Wang XJ, 2002, BBA-BIOMEMBRANES, V1564, P412, DOI 10.1016/S0005-2736(02)00495-9; Wegner F, 2009, J NEUROCHEM, V111, P204, DOI 10.1111/j.1471-4159.2009.06315.x; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Yang J, 1999, BIOPHYS J, V76, P3307, DOI 10.1016/S0006-3495(99)77483-7; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044	56	60	62	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25458	10.1371/journal.pone.0025458	http://dx.doi.org/10.1371/journal.pone.0025458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980464	Green Published, gold			2022-12-27	WOS:000295941300034
J	Rosen, S; Wise, RJS; Chadha, S; Conway, EJ; Scott, SK				Rosen, Stuart; Wise, Richard J. S.; Chadha, Shabneet; Conway, Eleanor-Jayne; Scott, Sophie K.			Hemispheric Asymmetries in Speech Perception: Sense, Nonsense and Modulations	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TEMPORAL ENVELOPE; HUMAN BRAIN; CUES; LATERALIZATION; SENSITIVITY; ACTIVATION; AMPLITUDE; POSITION; FEATURES	Background: The well-established left hemisphere specialisation for language processing has long been claimed to be based on a low-level auditory specialization for specific acoustic features in speech, particularly regarding 'rapid temporal processing'. Methodology: A novel analysis/synthesis technique was used to construct a variety of sounds based on simple sentences which could be manipulated in spectro-temporal complexity, and whether they were intelligible or not. All sounds consisted of two noise-excited spectral prominences (based on the lower two formants in the original speech) which could be static or varying in frequency and/or amplitude independently. Dynamically varying both acoustic features based on the same sentence led to intelligible speech but when either or both acoustic features were static, the stimuli were not intelligible. Using the frequency dynamics from one sentence with the amplitude dynamics of another led to unintelligible sounds of comparable spectro-temporal complexity to the intelligible ones. Positron emission tomography (PET) was used to compare which brain regions were active when participants listened to the different sounds. Conclusions: Neural activity to spectral and amplitude modulations sufficient to support speech intelligibility (without actually being intelligible) was seen bilaterally, with a right temporal lobe dominance. A left dominant response was seen only to intelligible sounds. It thus appears that the left hemisphere specialisation for speech is based on the linguistic properties of utterances, not on particular acoustic features.	[Rosen, Stuart; Chadha, Shabneet; Conway, Eleanor-Jayne] UCL, Univ Coll London Speech Hearing & Phonet Sci, Div Psychol & Language Sci, London, England; [Wise, Richard J. S.] Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Mental Hlth, London, England; [Scott, Sophie K.] UCL, Univ Coll London Inst Cognit Neurosci, Div Psychol & Language Sci, London, England	University of London; University College London; Imperial College London; University of London; University College London	Rosen, S (corresponding author), UCL, Univ Coll London Speech Hearing & Phonet Sci, Div Psychol & Language Sci, London, England.	stuart@phon.ucl.ac.uk	Scott, Sophie K/A-1843-2010; Rosen, Stuart/A-7875-2008; Rosen, Stuart/A-7875-2008	Scott, Sophie K/0000-0001-7510-6297; Rosen, Stuart/0000-0002-9376-2148; Rosen, Stuart/0000-0002-4893-8669	Wellcome Trust [WT074414MA]; MRC [MC_U120064975] Funding Source: UKRI; Medical Research Council [MC_U120064975] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S. K. S. is funded by Grant No. WT074414MA from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bench J., 1979, SPEECH HEARING TESTS; Best CT, 1999, PSYCHOL SCI, V10, P65, DOI 10.1111/1467-9280.00108; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; DORMAN MF, 1980, J PHONETICS, V8, P397, DOI 10.1016/S0095-4470(19)31496-2; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; EFRON R, 1963, BRAIN, V86, P403, DOI 10.1093/brain/86.3.403; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433; Hart HC, 2003, CEREB CORTEX, V13, P773, DOI 10.1093/cercor/13.7.773; Langers DRM, 2003, NEUROIMAGE, V20, P265, DOI 10.1016/S1053-8119(03)00258-1; Obleser J, 2008, J NEUROSCI, V28, P8116, DOI 10.1523/JNEUROSCI.1290-08.2008; Overath T, 2008, J NEUROSCI, V28, P13268, DOI 10.1523/JNEUROSCI.4596-08.2008; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; REMEZ RE, 1981, SCIENCE, V212, P947, DOI 10.1126/science.7233191; Rosen S, 2007, DEVELOPMENTAL SCI, V10, P165, DOI 10.1111/j.1467-7687.2007.00550.x; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; Scott SK, 2004, J ACOUST SOC AM, V115, P813, DOI 10.1121/1.1639336; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sharp DJ, 2004, CEREB CORTEX, V14, P1, DOI 10.1093/cercor/bhg086; Thivard L, 2000, NEUROREPORT, V11, P2969, DOI 10.1097/00001756-200009110-00028; Warren JD, 2005, NEUROIMAGE, V24, P1052, DOI 10.1016/j.neuroimage.2004.10.031; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	32	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24672	10.1371/journal.pone.0024672	http://dx.doi.org/10.1371/journal.pone.0024672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980349	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300007
J	Sabari, J; Lax, D; Connors, D; Brotman, I; Mindrebo, E; Butler, C; Entersz, I; Jia, DX; Foty, RA				Sabari, Joshua; Lax, Daniel; Connors, Daniel; Brotman, Ian; Mindrebo, Eric; Butler, Christine; Entersz, Ildiko; Jia, Dongxuan; Foty, Ramsey A.			Fibronectin Matrix Assembly Suppresses Dispersal of Glioblastoma Cells	PLOS ONE			English	Article							HUMAN FIBROSARCOMA CELLS; EXTRACELLULAR-MATRIX; GENETIC ALTERATIONS; INVASION; GLIOMAS; COHESION; ADHESION; PROLIFERATION; EXPRESSION; CADHERIN	Glioblastoma (GBM), the most aggressive and most common form of primary brain tumor, has a median survival of 12-15 months. Surgical excision, radiation and chemotherapy are rarely curative since tumor cells broadly disperse within the brain. Preventing dispersal could be of therapeutic benefit. Previous studies have reported that increased cell-cell cohesion can markedly reduce invasion by discouraging cell detachment from the tumor mass. We have previously reported that alpha 5 beta 1 integrin-fibronectin interaction is a powerful mediator of indirect cell-cell cohesion and that the process of fibronectin matrix assembly (FNMA) is crucial to establishing strong bonds between cells in 3D tumor-like spheroids. Here, we explore a potential role for FNMA in preventing dispersal of GBM cells from a tumor-like mass. Using a series of GBM-derived cell lines we developed an in vitro assay to measure the dispersal velocity of aggregates on a solid substrate. Despite their similar pathologic grade, aggregates from these lines spread at markedly different rates. Spreading velocity is inversely proportional to capacity for FNMA and restoring FNMA in GBM cells markedly reduces spreading velocity by keeping cells more connected. Blocking FNMA using the 70 KDa fibronectin fragment in FNMA-restored cells rescues spreading velocity, establishing a functional role for FNMA in mediating dispersal. Collectively, the data support a functional causation between restoration of FNMA and decreased dispersal velocity. This is a first demonstration that FNMA can play a suppressive role in GBM dispersal.	[Sabari, Joshua; Lax, Daniel; Connors, Daniel; Brotman, Ian; Mindrebo, Eric; Butler, Christine; Entersz, Ildiko; Jia, Dongxuan; Foty, Ramsey A.] UMDNJ Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sabari, J (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA.	fotyra@umdnj.edu			National Institutes of Health/National Cancer Institute [R01CA118755]; NATIONAL CANCER INSTITUTE [R01CA118755] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by grant R01CA118755 from the National Institutes of Health/National Cancer Institute to RAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandes AA, 2008, CRIT REV ONCOL HEMAT, V67, P139, DOI 10.1016/j.critrevonc.2008.02.005; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Caicedo-Carvajal CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011830; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; CIFARELLI CP, 2010, J NEUROSURG; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; de Gennes P. G, 1994, SOFT INTERFACES; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fehlauer F, 2007, ONCOL REP, V17, P941; Foty RA, 2004, INT J DEV BIOL, V48, P397, DOI 10.1387/ijdb.041810rf; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Foty RA, 1997, CANCER RES, V57, P5033; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Foty RA, 1998, CANCER RES, V58, P3586; George J, 2010, INT J BIOCHEM CELL B, V42, P1164, DOI 10.1016/j.biocel.2010.04.002; Hagemann Carsten, 2010, BMC Res Notes, V3, P293, DOI 10.1186/1756-0500-3-293; Hamel W, 2000, ACTA NEUROCHIR, V142, P113, DOI 10.1007/s007010050015; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Jang HS, 2010, NEUROCHEM RES, V35, P1796, DOI 10.1007/s11064-010-0246-8; Knupfer MM, 1997, KLIN PADIATR, V209, P271, DOI 10.1055/s-2008-1043961; Kogiku M, 2008, J CLIN NEUROSCI, V15, P1198, DOI 10.1016/j.jocn.2007.11.012; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Li RH, 2010, ONCOL REP, V23, P1553, DOI 10.3892/or_00000795; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MCKEOWNLONGO PJ, 1987, J CELL BIOL, V104, P601, DOI 10.1083/jcb.104.3.601; NAGANE M, 2001, CANC LETT, V162, P17; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Riemenschneider MJ, 2010, TARGET ONCOL, V5, P161, DOI 10.1007/s11523-010-0153-6; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Robinson EE, 2004, MOL BIOL CELL, V12, P12; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Smith JS, 2000, FRONT BIOSCI-LANDMRK, V5, pD213, DOI 10.2741/Smith; Tabatabai G, 2010, TARGET ONCOL, V5, P175, DOI 10.1007/s11523-010-0156-3; Varga I, 2010, CENT EUR NEUROSURG, V71, P173, DOI 10.1055/s-0030-1249698; Winters BS, 2006, MOL BIOL CELL, V17, P3386, DOI 10.1091/mbc.E05-09-0849; Winters BS, 2005, INT J CANCER, V114, P371, DOI 10.1002/ijc.20722; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; YUAN L, 2010, J NEUROONCOL	46	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24810	10.1371/journal.pone.0024810	http://dx.doi.org/10.1371/journal.pone.0024810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980357	Green Published, gold			2022-12-27	WOS:000295941300010
J	Avinun, R; Israel, S; Shalev, I; Gritsenko, I; Bornstein, G; Ebstein, RP; Knafo, A				Avinun, Reut; Israel, Salomon; Shalev, Idan; Gritsenko, Inga; Bornstein, Gary; Ebstein, Richard P.; Knafo, Ariel			AVPR1A Variant Associated with Preschoolers' Lower Altruistic Behavior	PLOS ONE			English	Article							PROMOTER REGION; PROSOCIAL BEHAVIOR; GENETIC-VARIATION; VASOPRESSIN; POLYMORPHISMS; MICROSATELLITE; SUSCEPTIBILITY; HERITABILITY; CHILDHOOD	The genetic origins of altruism, defined here as a costly act aimed to benefit non-kin individuals, have not been examined in young children. However, previous findings concerning adults pointed at the arginine vasopressin receptor 1A (AVPR1A) gene as a possible candidate. AVPR1A has been associated with a range of behaviors including aggressive, affiliative and altruistic phenotypes, and recently a specific allele (327 bp) of one of its promoter region polymorphisms (RS3) has been singled out in particular. We modeled altruistic behavior in preschoolers using a laboratory-based economic paradigm, a modified dictator game (DG), and tested for association between DG allocations and the RS3 "target allele." Using both population and family-based analyses we show a significant link between lower allocations and the RS3 "target allele," associating it, for the first time, with a lower proclivity toward altruistic behavior in children. This finding helps further the understanding of the intricate mechanisms underlying early altruistic behavior.	[Avinun, Reut; Shalev, Idan] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel; [Israel, Salomon; Bornstein, Gary; Ebstein, Richard P.; Knafo, Ariel] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Gritsenko, Inga] S Herzog Mem Hosp, Jerusalem, Israel; [Bornstein, Gary] Ctr Study Rational & Interact Decis Theory, Jerusalem, Israel; [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Herzog Medical Center; National University of Singapore	Avinun, R (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel.	msarielk@huji.ac.il	Shalev, Idan/H-1943-2011; Knafo-Noam, Ariel/E-8067-2011	Knafo-Noam, Ariel/0000-0003-0613-1960; Israel, Salomon/0000-0003-3629-2466; Avinun, Reut/0000-0002-3281-1268; Ebstein, Richard/0000-0002-3626-541X	Israel Science Foundation [31/06]; Notre Dame Science of Generosity Project; National Institute for Psychobiology in Israel	Israel Science Foundation(Israel Science Foundation); Notre Dame Science of Generosity Project; National Institute for Psychobiology in Israel	The longitudinal Israeli study of twins is supported by grant No. 31/06 from the Israel Science Foundation to the last author and by a grant from the Notre Dame Science of Generosity Project. Genotyping was supported by a grant from the National Institute for Psychobiology in Israel to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachner-Melman R, 2005, MOL PSYCHIATR, V10, P333, DOI 10.1038/sj.mp.4001635; Bachner-Melman R, 2004, INT J EAT DISORDER, V36, P451, DOI 10.1002/eat.20049; Bachner-Melman R., 2005, J INDIVID DIFFER, V26, P2, DOI DOI 10.1027/1614-0001.26.1.2; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Ben-Ner A, 2004, J ECON PSYCHOL, V25, P581, DOI 10.1016/S0167-4870(03)00065-5; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Caprara GV, 2000, PSYCHOL SCI, V11, P302, DOI 10.1111/1467-9280.00260; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; DiLalla LF, 2009, DEV PSYCHOBIOL, V51, P451, DOI 10.1002/dev.20384; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gummerum M, 2009, J EC PSYCHOL; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Knafo A, 2006, TWIN RES HUM GENET, V9, P791, DOI 10.1375/twin.9.6.791; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Knafo A, 2009, ANN NY ACAD SCI, V1167, P103, DOI 10.1111/j.1749-6632.2009.04540.x; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Levin R, 2009, PSYCHONEUROENDOCRINO, V34, P901, DOI 10.1016/j.psyneuen.2008.12.014; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oakley BA, PATHOLOGICAL ALTRUIS; Reuter M, 2011, SOC COGN AFFECT NEUR, V6, P662, DOI 10.1093/scan/nsq083; RUSHTON JP, 1986, J PERS SOC PSYCHOL, V50, P1192, DOI 10.1037/0022-3514.50.6.1192; Skuse DH, 2009, TRENDS COGN SCI, V13, P27, DOI 10.1016/j.tics.2008.09.007; Smith Adam, 1966, THEORY MORAL SENTIME; Thibonnier M, 2000, J MOL CELL CARDIOL, V32, P557, DOI 10.1006/jmcc.2000.1108; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529	44	51	56	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25274	10.1371/journal.pone.0025274	http://dx.doi.org/10.1371/journal.pone.0025274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980412	gold, Green Published			2022-12-27	WOS:000295936900045
J	Gentile, LB; Piva, B; Diaz, BL				Gentile, Luciana B.; Piva, Bruno; Diaz, Bruno L.			Hypertonic Stress Induces VEGF Production in Human Colon Cancer Cell Line Caco-2: Inhibitory Role of Autocrine PGE(2)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR-KAPPA-B; FACTOR EXPRESSION; IN-VIVO; CYCLOOXYGENASE-2 EXPRESSION; TUMOR ANGIOGENESIS; COLORECTAL-CANCER; DESCENDING COLON; GENE-EXPRESSION; UP-REGULATION	Vascular Endothelial Growth Factor (VEGF) is a major regulator of angiogenesis. VEGF expression is up regulated in response to micro-environmental cues related to poor blood supply such as hypoxia. However, regulation of VEGF expression in cancer cells is not limited to the stress response due to increased volume of the tumor mass. Lipid mediators in particular arachidonic acid-derived prostaglandin (PG)E-2 are regulators of VEGF expression and angiogenesis in colon cancer. In addition, increased osmolarity that is generated during colonic water absorption and feces consolidation seems to activate colon cancer cells and promote PGE(2) generation. Such physiological stimulation may provide signaling for cancer promotion. Here we investigated the effect of exposure to a hypertonic medium, to emulate colonic environment, on VEGF production by colon cancer cells. The role of concomitant PGE(2) generation and MAPK activation was addressed by specific pharmacological inhibition. Human colon cancer cell line Caco-2 exposed to a hypertonic environment responded with marked VEGF and PGE(2) production. VEGF production was inhibited by selective inhibitors of ERK 1/2 and p38 MAPK pathways. To address the regulatory role of PGE(2) on VEGF production, Caco-2 cells were treated with cPLA(2) (ATK) and COX-2 (NS-398) inhibitors, that completely block PGE(2) generation. The Caco-2 cells were also treated with a non selective PGE(2) receptor antagonist. Each treatment significantly increased the hypertonic stress-induced VEGF production. Moreover, addition of PGE(2) or selective EP2 receptor agonist to activated Caco-2 cells inhibited VEGF production. The autocrine inhibitory role for PGE(2) appears to be selective to hypertonic environment since VEGF production induced by exposure to CoCl2 was decreased by inhibition of concomitant PGE(2) generation. Our results indicated that hypertonicity stimulates VEGF production in colon cancer cell lines. Also PGE(2) plays an inhibitory role on VEGF production by Caco-2 cells exposed to hyperosmotic stress through EP2 activation.	[Gentile, Luciana B.] Inst Nacl Canc, Div Biol Celular, Rio De Janeiro, Brazil; [Gentile, Luciana B.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Ciencias Morfol, Rio De Janeiro, Brazil; [Piva, Bruno; Diaz, Bruno L.] Univ Fed Rio de Janeiro, Inst Biofis, Programa Imunobiol, Rio De Janeiro, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gentile, LB (corresponding author), Inst Nacl Canc, Div Biol Celular, Rio De Janeiro, Brazil.	bldiaz@biof.ufrj.br	Gentile, Luciana/B-7151-2014; Diaz, Bruno L./A-5673-2009	Gentile, Luciana/0000-0002-5248-5789; Diaz, Bruno L./0000-0001-8393-3823	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil); Ministry of Health (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministry of Health (Brazil)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil) (to BLD) and a Ministry of Health (Brazil) PhD fellowship (to LBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Bermont L, 2000, INT J CANCER, V85, P117, DOI 10.1002/(SICI)1097-0215(20000101)85:1<117::AID-IJC21>3.3.CO;2-O; Bobrovnikova-Marjon EV, 2004, CANCER RES, V64, P4858, DOI 10.1158/0008-5472.CAN-04-0682; Brown NS, 2005, BRIT J CANCER, V92, P1696, DOI 10.1038/sj.bjc.6602522; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Chapple KS, 2002, J PATHOL, V198, P435, DOI 10.1002/path.1223; Chulada PC, 2000, CANCER RES, V60, P4705; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; DAngelo G, 1997, J CELL BIOCHEM, V67, P353, DOI 10.1002/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.3.CO;2-2; Feng WG, 2002, CELL RES, V12, P331, DOI 10.1038/sj.cr.7290135; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Fukuda R, 2003, CANCER RES, V63, P2330; Gentile LB, 2010, PROSTAG LEUKOTR ESS, V82, P131, DOI 10.1016/j.plefa.2009.11.005; Grader-Beck T, 2003, BLOOD, V101, P998, DOI 10.1182/blood-2002-06-1665; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; IJICHI A, 1995, GLIA, V14, P87, DOI 10.1002/glia.440140203; Jurek D, 2004, FASEB J, V18, P97, DOI 10.1096/fj.04-2111fje; Ko HM, 2002, CANCER RES, V62, P1809; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; Leahy KM, 2002, CANCER RES, V62, P625; Litz J, 2006, MOL CANCER THER, V5, P1415, DOI 10.1158/1535-7163.MCT-05-0503; Liu XH, 1999, CLIN EXP METASTAS, V17, P687, DOI 10.1023/A:1006728119549; Mezentsev A, 2002, J BIOL CHEM, V277, P18670, DOI 10.1074/jbc.M201143200; Moreira LS, 2009, BBA-MOL CELL BIOL L, V1791, P156, DOI 10.1016/j.bbalip.2009.01.003; NAFTALIN RJ, 1994, PHYSIOL RES, V43, P65; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Newcomb EW, 2006, INT J ONCOL, V28, P1121; Okita NT, 2009, JPN J CLIN ONCOL, V39, P595, DOI 10.1093/jjco/hyp066; Poulios E, 2006, ANTICANCER RES, V26, P2165; POWELL DW, 1995, J CLIN INVEST, V96, P2102, DOI 10.1172/JCI118261; Rao M, 2004, INT J COLORECTAL DIS, V19, P1, DOI 10.1007/s00384-003-0511-2; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shoji Y, 2004, GUT, V53, P1151, DOI 10.1136/gut.2003.028787; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; Takeda H, 2003, CANCER RES, V63, P4872; Thiagarajah JR, 2001, AM J PHYSIOL-CELL PH, V281, pC1898, DOI 10.1152/ajpcell.2001.281.6.C1898; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Zhong H, 2004, INT J CANCER, V112, P585, DOI 10.1002/ijc.20438	45	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25193	10.1371/journal.pone.0025193	http://dx.doi.org/10.1371/journal.pone.0025193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980393	Green Submitted, gold, Green Published			2022-12-27	WOS:000295936900031
J	Kim, HS; Cross, GAM				Kim, Hee-Sook; Cross, George A. M.			Identification of Trypanosoma brucei RMI1/BLAP75 Homologue and Its Roles in Antigenic Variation	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; TOPOISOMERASE-III-ALPHA; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; DNA-REPLICATION; RECQ HELICASE; ESSENTIAL COMPONENT; EXPRESSION SITES; SYNDROME PROTEIN; BLOOM HELICASE	At any time, each cell of the protozoan parasite Trypanosoma brucei expresses a single species of its major antigenic protein, the variant surface glycoprotein (VSG), from a repertoire of >2,000 VSG genes and pseudogenes. The potential to express different VSGs by transcription and recombination allows the parasite to escape the antibody-mediated host immune response, a mechanism known as antigenic variation. The active VSG is transcribed from a sub-telomeric polycistronic unit called the expression site (ES), whose promoter is 40-60 kb upstream of the VSG. While the mechanisms that initiate recombination remain unclear, the resolution phase of these reactions results in the recombinational replacement of the expressed VSG with a donor from one of three distinct chromosomal locations; sub-telomeric loci on the 11 essential chromosomes, on minichromosomes, or at telomere-distal loci. Depending on the type of recombinational replacement (single or double crossover, duplicative gene conversion, etc), several DNA-repair pathways have been thought to play a role. Here we show that VSG recombination relies on at least two distinct DNA-repair pathways, one of which requires RMI1-TOPO3 alpha to suppress recombination and one that is dependent on RAD51 and RMI1. These genetic interactions suggest that both RAD51-dependent and RAD51-independent recombination pathways operate in antigenic switching and that trypanosomes differentially utilize recombination factors for VSG switching, depending on currently unknown parameters within the ES.	[Kim, Hee-Sook; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA	Rockefeller University	Kim, HS (corresponding author), Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA.	george.cross@rockefeller.edu	Cross, George/B-7444-2011	Cross, George/0000-0003-1374-6955	Rockefeller University; National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) [R01AI021729]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729] Funding Source: NIH RePORTER	Rockefeller University; National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Rockefeller University Women in Science fellowship to HK and by grant no. R01AI021729 from the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitcheson N, 2005, MOL MICROBIOL, V57, P1608, DOI 10.1111/j.1365-2958.2005.04795.x; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; BERNARDS A, 1986, J MOL BIOL, V190, P1, DOI 10.1016/0022-2836(86)90070-7; Bernstein KA, 2009, EMBO J, V28, P915, DOI 10.1038/emboj.2009.28; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chelysheva L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000309; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Conway C, 2002, MOL MICROBIOL, V45, P1687, DOI 10.1046/j.1365-2958.2002.03122.x; CROSS GAM, 2002, MOL MED, P89; Cross M, 1998, MOL CELL BIOL, V18, P198, DOI 10.1128/MCB.18.1.198; DALGAARD JZ, 2004, SCI STKE, pRE17; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hartung F, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000285; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; Hoadley KA, 2010, STRUCTURE, V18, P1149, DOI 10.1016/j.str.2010.06.009; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kim HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000992; Kratz E, 2002, TRENDS GENET, V18, P29, DOI 10.1016/S0168-9525(01)02579-3; Le S, 1999, GENETICS, V152, P143; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Machado CR, 2006, MUTAT RES-REV MUTAT, V612, P40, DOI 10.1016/j.mrrev.2005.05.001; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Mankouri HW, 2006, MOL BIOL CELL, V17, P4473, DOI 10.1091/mbc.E06-06-0516; Marrero VA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; PAYS E, 1985, NATURE, V316, P562, DOI 10.1038/316562a0; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Rudenko G, 1996, MOL BIOCHEM PARASIT, V80, P65, DOI 10.1016/0166-6851(96)02669-2; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Seki Masayuki, 2006, Subcell Biochem, V40, P49; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shor E, 2002, GENETICS, V162, P647; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Watt PM, 1996, GENETICS, V144, P935; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	64	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25313	10.1371/journal.pone.0025313	http://dx.doi.org/10.1371/journal.pone.0025313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980422	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900050
J	Roffman, JL; Nitenson, AZ; Agam, Y; Isom, M; Friedman, JS; Dyckman, KA; Brohawn, DG; Smoller, JW; Goff, DC; Manoach, DS				Roffman, Joshua L.; Nitenson, Adam Z.; Agam, Yigal; Isom, Marlisa; Friedman, Jesse S.; Dyckman, Kara A.; Brohawn, David G.; Smoller, Jordan W.; Goff, Donald C.; Manoach, Dara S.			A Hypomethylating Variant of MTHFR, 677C > T, Blunts the Neural Response to Errors in Patients with Schizophrenia and Healthy Individuals	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; METHYLENETETRAHYDROFOLATE REDUCTASE; ANTERIOR CINGULATE; EXECUTIVE FUNCTION; DNA-METHYLATION; COMMON MUTATION; POLYMORPHISMS; PERFORMANCE; DISORDERS; NEURONS	Background: Responding to errors is a critical first step in learning from mistakes, a process that is abnormal in schizophrenia. To gain insight into the neural and molecular mechanisms of error processing, we used functional MRI to examine effects of a genetic variant in methylenetetrahydrofolate reductase (MTHFR 677C>T, rs1801133) that increases risk for schizophrenia and that has been specifically associated with increased perseverative errors among patients. MTHFR is a key regulator of the intracellular one-carbon milieu, including DNA methylation, and each copy of the 677T allele reduces MTHFR activity by 35%. Methodology/Principal Findings: Using an antisaccade paradigm, we found that the 677T allele induces a dose-dependent blunting of dorsal anterior cingulate cortex (dACC) activation in response to errors, a pattern that was identical in healthy individuals and patients with schizophrenia. Further, the normal relationship between dACC activation and error rate was disrupted among carriers of the 677T allele. Conclusions/Significance: These findings implicate an epigenetic mechanism in the neural response to errors, and provide insight into normal cognitive variation through a schizophrenia risk gene.	[Roffman, Joshua L.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; Harvard Univ, Sch Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Roffman, JL (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA.	jroffman@partners.org	Roffman, Joshua/G-8228-2012	Roffman, Joshua/0000-0003-4073-532X	National Institute of Mental Health [5R01MH067720]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067720] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This paper was funded by the National Institute of Mental Health (5R01MH067720) to DSM. and a Howard Hughes Medical Institute Physician-Scientist Early Career Award to JLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gilbody S, 2007, AM J EPIDEMIOL, V165, P1, DOI 10.1093/aje/kwj347; Graff J, 2009, EUR J NEUROSCI, V30, P1, DOI 10.1111/j.1460-9568.2009.06787.x; Hill M, 2011, SCHIZOPHR RES, V127, P41, DOI 10.1016/j.schres.2010.12.006; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Imamura K, 2007, NEUROREPORT, V18, P1319, DOI 10.1097/WNR.0b013e3282aaa0b4; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Levav-Rabkin T, 2011, BEHAV BRAIN RES, V216, P505, DOI 10.1016/j.bbr.2010.08.031; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; PEERBOOMS OL, 2010, BRAIN BEHAV IN PRESS; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Polli FE, 2008, BRAIN, V131, P971, DOI 10.1093/brain/awm307; Roffman JL, 2006, HARVARD REV PSYCHIAT, V14, P78, DOI 10.1080/10673220600642945; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Roffman JL, 2008, AM J MED GENET B, V147B, P990, DOI 10.1002/ajmg.b.30684; Roffman JL, 2008, BIOL PSYCHIAT, V63, P42, DOI 10.1016/j.biopsych.2006.12.017; Roffman JL, 2007, SCHIZOPHR RES, V92, P181, DOI 10.1016/j.schres.2007.01.003; Roffman JL, 2011, BRAIN IMAGING BEHAV, V5, P65, DOI 10.1007/s11682-010-9111-2; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI [10.1093/cercor/bhm069, 10.1093/cercor/hhm069]; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; ZHU Q, 2011, SCAND J GAS IN PRESS	35	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25253	10.1371/journal.pone.0025253	http://dx.doi.org/10.1371/journal.pone.0025253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980405	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900040
J	Cutfield, SW; Derraik, JGB; Reed, PW; Hofman, PL; Jefferies, C; Cutfield, WS				Cutfield, Samuel W.; Derraik, Jose G. B.; Reed, Peter W.; Hofman, Paul L.; Jefferies, Craig; Cutfield, Wayne S.			Early Markers of Glycaemic Control in Children with Type 1 Diabetes Mellitus	PLOS ONE			English	Article							METABOLIC-CONTROL; NEW-ZEALAND; SOCIOECONOMIC-STATUS; PARTIAL REMISSION; RISK-FACTORS; ADOLESCENTS; INSULIN; FAMILY; ETHNICITY; ADHERENCE	Background: Type 1 diabetes mellitus (T1DM) may lead to severe long-term health consequences. In a longitudinal study, we aimed to identify factors present at diagnosis and 6 months later that were associated with glycosylated haemoglobin (HbA(1c)) levels at 24 months after T1DM diagnosis, so that diabetic children at risk of poor glycaemic control may be identified. Methods: 229 children,15 years of age diagnosed with T1DM in the Auckland region were studied. Data collected at diagnosis were: age, sex, weight, height, ethnicity, family living arrangement, socio-economic status (SES), T1DM antibody titre, venous pH and bicarbonate. At 6 and 24 months after diagnosis we collected data on weight, height, HbA(1c) level, and Results: Factors at diagnosis that were associated with higher HbA(1c) levels at 6 months: female sex (p<0.05), lower SES (p<0.01), non-European ethnicity (p<0.01) and younger age (p<0.05). At 24 months, higher HbA1c was associated with lower SES (p<0.001), Pacific Island ethnicity (p<0.001), not living with both biological parents (p<0.05), and greater BMI SDS (p<0.05). A regression equation to predict HbA(1c) at 24 months was consequently developed. Conclusions: Deterioration in glycaemic control shortly after diagnosis in diabetic children is particularly marked in Pacific Island children and in those not living with both biological parents. Clinicians need to be aware of factors associated with poor glycaemic control beyond the remission phase, so that more effective measures can be implemented shortly after diagnosis to prevent deterioration in diabetes control.	[Cutfield, Samuel W.; Derraik, Jose G. B.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Reed, Peter W.; Jefferies, Craig] Auckland Dist Hlth Board, Starship Childrens Hosp, Auckland, New Zealand; [Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland; Auckland District Health Board; Starship Children's Hospital; University of Auckland	Cutfield, SW (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Jefferies, craig/ABA-1921-2021; Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Jefferies, Craig/0000-0002-0541-6094				Abdul-Rasoul M, 2006, PEDIATR DIABETES, V7, P101, DOI 10.1111/j.1399-543X.2006.00155.x; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x; AUSLANDER W F, 1990, Health and Social Work, V15, P133; Auslander WF, 1997, DIABETES CARE, V20, P1569, DOI 10.2337/diacare.20.10.1569; BAKER L, 1967, J PEDIATR-US, V71, P825, DOI 10.1016/S0022-3476(67)80007-6; Bober E, 2001, J PEDIATR ENDOCR MET, V14, P435; Cameron FJ, 2008, DIABETIC MED, V25, P463, DOI 10.1111/j.1464-5491.2008.02399.x; Campbell-Stokes PL, 2005, DIABETOLOGIA, V48, P643, DOI 10.1007/s00125-005-1697-3; Carter PJ, 2008, DIABETOLOGIA, V51, P1835, DOI 10.1007/s00125-008-1106-9; Chalew SA, 2000, J DIABETES COMPLICAT, V14, P71, DOI 10.1016/S1056-8727(00)00072-6; Chase HP, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00034.x; Davis CL, 2001, J PEDIATR PSYCHOL, V26, P123, DOI 10.1093/jpepsy/26.2.123; Delamater AM, 1999, DIABETES CARE, V22, P700, DOI 10.2337/diacare.22.5.700; DELAMATER AM, 1991, DIABETES CARE, V14, P20, DOI 10.2337/diacare.14.1.20; Delderfield M, 2005, SDS INDIVIDUAL CALCU; Dost A, 2007, EXP CLIN ENDOCR DIAB, V115, P33, DOI 10.1055/s-2007-948214; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; ELLIOTT RB, 1992, PEDIAT AD E, V21, P66; Frey MA, 2007, PEDIATR DIABETES, V8, P220, DOI 10.1111/j.1399-5448.2007.00260.x; Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x; Gerstl EM, 2008, EUR J PEDIATR, V167, P447, DOI 10.1007/s00431-007-0586-9; Hardy D, 2011, CANCER-AM CANCER SOC, V117, P1506, DOI 10.1002/cncr.25669; Hoey H, 2001, DIABETES CARE, V24, P1923, DOI 10.2337/diacare.24.11.1923; Hoffman RP, 2000, PEDIATR RES, V48, P384, DOI 10.1203/00006450-200009000-00022; Kaufman FR, 1999, PEDIATRICS, V103, P948, DOI 10.1542/peds.103.5.948; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; KNIP M, 1982, ACTA DIABETOL LAT, V19, P243, DOI 10.1007/BF02624684; Lee Rachel, 2010, Hawaii Med J, V69, P28; MIROUZE J, 1978, DIABETOLOGIA, V14, P223, DOI 10.1007/BF01219420; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; Muhammad J, 1999, ARCH DIS CHILD, V80, P367, DOI 10.1136/adc.80.4.367; New Zealand Health Information Service, 2010, DOM COD TABL; New Zealand. Ministry of Social Development, 2010, SOC REP; Overstreet S, 1997, DIABETIC MED, V14, P153, DOI 10.1002/(SICI)1096-9136(199702)14:2<153::AID-DIA318>3.0.CO;2-K; Povlsen L, 2005, J ADV NURS, V50, P576, DOI 10.1111/j.1365-2648.2005.03443.x; Salmond C, 2002, NZDEP2001 INDEX DEPR; Salmond C., 2007, NZDEP2006 INDEX DEPR; SHAH SC, 1989, NEW ENGL J MED, V320, P550, DOI 10.1056/NEJM198903023200902; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; Simmons D, 2004, DIABETES CARE, V27, P3002, DOI 10.2337/diacare.27.12.3002; Sopoaga F, 2010, J PRIM HEALTH CARE, V2, P105, DOI 10.1071/HC10105; Springer D, 2006, J PEDIATR-US, V149, P227, DOI 10.1016/j.jpeds.2006.03.052; Statistics New Zealand, 2006, 2006 CENS DAT QUICKS; Sundborn G, 2010, NZ MED J, V123, P4036; Swift EE, 2006, ANN BEHAV MED, V32, P39, DOI 10.1207/s15324796abm3201_5; Thompson SJ, 2001, DIABETES CARE, V24, P234, DOI 10.2337/diacare.24.2.234; Tomlin Andrew, 2006, N Z Med J, V119, pU2004; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tyrrell VJ, 2001, INT J OBESITY, V25, P164, DOI 10.1038/sj.ijo.0801532; Viswanathan V, 2011, DIABETES RES CLIN PR, V92, P65, DOI 10.1016/j.diabres.2010.12.032; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x	54	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25251	10.1371/journal.pone.0025251	http://dx.doi.org/10.1371/journal.pone.0025251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966469	gold, Green Submitted, Green Published			2022-12-27	WOS:000295932100029
J	Hudson, NJ; Gu, Q; Nagaraj, SH; Ding, YS; Dalrymple, BP; Reverter, A				Hudson, Nicholas J.; Gu, Quan; Nagaraj, Shivashankar H.; Ding, Yong-Sheng; Dalrymple, Brian P.; Reverter, Antonio			Eukaryotic Evolutionary Transitions Are Associated with Extreme Codon Bias in Functionally-Related Proteins	PLOS ONE			English	Article							SYNONYMOUS CODON; USAGE BIAS; ADAPTATION INDEX; GENE-EXPRESSION; TRANSFER-RNAS; QUANTIFICATION; FAMILY; SITES	Codon bias in the genome of an organism influences its phenome by changing the speed and efficiency of mRNA translation and hence protein abundance. We hypothesized that differences in codon bias, either between-species differences in orthologous genes, or within-species differences between genes, may play an evolutionary role. To explore this hypothesis, we compared the genome-wide codon bias in six species that occupy vital positions in the Eukaryotic Tree of Life. We acquired the entire protein coding sequences for these organisms, computed the codon bias for all genes in each organism and explored the output for relationships between codon bias and protein function, both within-and between-lineages. We discovered five notable coordinated patterns, with extreme codon bias most pronounced in traits considered highly characteristic of a given lineage. Firstly, the Homo sapiens genome had stronger codon bias for DNA-binding transcription factors than the Saccharomyces cerevisiae genome, whereas the opposite was true for ribosomal proteins - perhaps underscoring transcriptional regulation in the origin of complexity. Secondly, both mammalian species examined possessed extreme codon bias in genes relating to hair - a tissue unique to mammals. Thirdly, Arabidopsis thaliana showed extreme codon bias in genes implicated in cell wall formation and chloroplast function - which are unique to plants. Fourthly, Gallus gallus possessed strong codon bias in a subset of genes encoding mitochondrial proteins perhaps reflecting the enhanced bioenergetic efficiency in birds that co-evolved with flight. And lastly, the G. gallus genome had extreme codon bias for the Ciliary Neurotrophic Factor - which may help to explain their spontaneous recovery from deafness. We propose that extreme codon bias in groups of genes that encode functionally related proteins has a pathway-level energetic explanation.	[Hudson, Nicholas J.; Gu, Quan; Nagaraj, Shivashankar H.; Dalrymple, Brian P.; Reverter, Antonio] CSIRO Livestock Ind, Brisbane, Qld, Australia; [Gu, Quan; Ding, Yong-Sheng] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Donghua University	Hudson, NJ (corresponding author), CSIRO Livestock Ind, Brisbane, Qld, Australia.	nick.hudson@csiro.au	Reverter, Antonio/C-9699-2013; Hudson, Nick/AAF-5644-2020; Dalrymple, Brian P/F-8721-2010; Hudson, Nick/C-1201-2008; Hudson, Nicholas J/D-1606-2011	Reverter, Antonio/0000-0002-4681-9404; Hudson, Nick/0000-0002-3549-9396; Dalrymple, Brian P/0000-0003-3891-5233; Hudson, Nicholas J/0000-0002-3549-9396; Gu, Quan/0000-0002-1201-6734	National Nature Science Foundation of China [60975059, 60775052]; Ministry of Education of China [20090075110002]; Shanghai Committee of Science and Technology [10JC1400200, 10DZ0506500, 09JC1400900]; CSIRO; CSIRO Transformational Biology Capability Platform and Food Futures Flagship	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Transformational Biology Capability Platform and Food Futures Flagship	This work was supported by the National Nature Science Foundation of China (No. 60975059, 60775052), Specialized Research Fund for the Doctoral Program of Higher Education from Ministry of Education of China (No. 20090075110002), Project of the Shanghai Committee of Science and Technology (Nos. 10JC1400200, 10DZ0506500, 09JC1400900). Shivashankar H. Nagaraj is grateful to CSIRO for the award of an OCE Post-Doctoral Fellowship. The financial support of the CSIRO Transformational Biology Capability Platform and Food Futures Flagship is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg OG, 1999, J MOL EVOL, V48, P398, DOI 10.1007/PL00006484; Bracewell RN, 2000, FOURIER TRANSFORM IT; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Carlini DB, 2001, GENETICS, V159, P623; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Cutter AD, 2006, MOL BIOL EVOL, V23, P2303, DOI 10.1093/molbev/msl097; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Gregory TR, 2002, GENETICA, V115, P131, DOI 10.1023/A:1016032400147; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Hurst LD, 2011, NATURE, V471, P582, DOI 10.1038/471582a; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Itzkovitz S, 2010, GENOME RES, V20, P1582, DOI 10.1101/gr.105072.110; Lane N., 2002, OXYGEN MOL MADE WORL; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; Maderson PFA, 2003, EXP DERMATOL, V12, P233, DOI 10.1034/j.1600-0625.2003.00069.x; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; McPherson JD, 2004, PROPOSAL SEQUENCE GE; Pennisi E, 2010, SCIENCE, V329, P128, DOI 10.1126/science.329.5988.128-a; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1994, METHOD ENZYMOL, V240, P68; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Powell JR, 1997, P NATL ACAD SCI USA, V94, P7784, DOI 10.1073/pnas.94.15.7784; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Roux B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S12; Sau Keya, 2007, Journal of Microbiology Immunology and Infection, V40, P24; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; Takahashi A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-214; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan X, 2003, INTELLIGENT ENG SYST, P1101; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wu DD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-241; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Zhang F, SCIENCE, V329, P1534	43	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25457	10.1371/journal.pone.0025457	http://dx.doi.org/10.1371/journal.pone.0025457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966531	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000295267100062
J	Szabo, V; Muskotal, A; Toth, B; Mihovilovic, MD; Vonderviszt, F				Szabo, Veronika; Muskotal, Adel; Toth, Balazs; Mihovilovic, Marko D.; Vonderviszt, Ferenc			Construction of a Xylanase A Variant Capable of Polymerization	PLOS ONE			English	Article							BIOENGINEERED FLAGELLA; BACTERIAL FLAGELLA; FILAMENT FORMATION; TERMINAL REGIONS; NANOTUBES; DISPLAY; PROTEIN	The aim of our work is to furnish enzymes with polymerization ability by creating fusion constructs with the polymerizable protein, flagellin, the main component of bacterial flagellar filaments. The D3 domain of flagellin, exposed on the surface of flagellar filaments, is formed by the hypervariable central portion of the polypeptide chain. D3 is not essential for filament formation. The concept in this project is to replace the D3 domain with suitable monomeric enzymes without adversely affecting polymerization ability, and to assemble these chimeric flagellins into tubular nanostructures. To test the feasibility of this approach, xylanase A (XynA) from B. subtilis was chosen as a model enzyme for insertion into the central part of flagellin. With the help of genetic engineering, a fusion construct was created in which the D3 domain was replaced by XynA. The flagellin-XynA chimera exhibited catalytic activity as well as polymerization ability. These results demonstrate that polymerization ability can be introduced into various proteins, and building blocks for rationally designed assembly of filamentous nanostructures can be created.	[Szabo, Veronika; Muskotal, Adel; Toth, Balazs; Vonderviszt, Ferenc] Univ Pannonia, Bionanosyst Lab, Fac Informat Technol, Res Inst Chem & Proc Engn, Veszprem, Hungary; [Toth, Balazs] Hungarian Acad Sci, Agr Res Inst, H-2462 Martonvasar, Hungary; [Mihovilovic, Marko D.] Vienna Univ Technol, Inst Appl Synthet Chem, A-1040 Vienna, Austria; [Vonderviszt, Ferenc] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary	University of Pannonia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Technische Universitat Wien; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Szabo, V (corresponding author), Univ Pannonia, Bionanosyst Lab, Fac Informat Technol, Res Inst Chem & Proc Engn, Veszprem, Hungary.	von007@almos.vein.hu	Toth, Balazs/B-4252-2012; Vonderviszt, Ferenc/GLR-5618-2022	Vonderviszt, Ferenc/0000-0002-6498-8172; Mihovilovic, Marko D./0000-0002-5438-8368	Hungarian Scientific Research Fund (OTKA) [NK77978]; National Development Agency [CK77819, TAMOP-4.2.2/B-10/1-2010-0025]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The support of the Hungarian Scientific Research Fund (OTKA grant NK77978) and the National Development Agency (grants CK77819 and TAMOP-4.2.2/B-10/1-2010-0025) is gratefully acknowledged. BT was supported by the Bolyai Fellowship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Ezaki S, 1998, J FERMENT BIOENG, V86, P500, DOI 10.1016/S0922-338X(98)80159-1; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ge J, 2009, BIOCHEM ENG J, V44, P53, DOI 10.1016/j.bej.2009.01.002; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Kim JB, 2008, TRENDS BIOTECHNOL, V26, P639, DOI 10.1016/j.tibtech.2008.07.009; Kumara MT, 2007, BIOMACROMOLECULES, V8, P3718, DOI 10.1021/bm7005449; Kumara MT, 2007, J NANOSCI NANOTECHNO, V7, P2260, DOI 10.1166/jnn.2007.641; Kumara MT, 2007, J PHYS CHEM C, V111, P5276, DOI 10.1021/jp067479n; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; MimoriKiyosue Y, 1996, P NATL ACAD SCI USA, V93, P15108, DOI 10.1073/pnas.93.26.15108; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Murakami MT, 2005, FEBS LETT, V579, P6505, DOI 10.1016/j.febslet.2005.10.039; Muskotal A, 2010, J MOL BIOL, V403, P607, DOI 10.1016/j.jmb.2010.09.024; Saijo-Hamano Y, 2000, J STRUCT BIOL, V132, P142, DOI 10.1006/jsbi.2000.4311; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Stocker B A, 1994, Int Rev Immunol, V11, P167, DOI 10.3109/08830189409061724; VONDERVISZT F, 1991, J MOL BIOL, V221, P1461, DOI 10.1016/0022-2836(91)90946-4; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; Vonderviszt F., 2008, FIBROUS PROTEINS, P58; Westerlund-Wikstrom B, 2000, INT J MED MICROBIOL, V290, P223; Woods RD, 2007, NANO LETT, V7, P1809, DOI 10.1021/nl0702968; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	26	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25388	10.1371/journal.pone.0025388	http://dx.doi.org/10.1371/journal.pone.0025388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966517	Green Submitted, gold, Green Published			2022-12-27	WOS:000295267100054
J	Tamaki, H; Wright, CL; Li, XZ; Lin, QY; Hwang, CC; Wang, SP; Thimmapuram, J; Kamagata, Y; Liu, WT				Tamaki, Hideyuki; Wright, Chris L.; Li, Xiangzhen; Lin, Qiaoyan; Hwang, Chiachi; Wang, Shiping; Thimmapuram, Jyothi; Kamagata, Yoichi; Liu, Wen-Tso			Analysis of 16S rRNA Amplicon Sequencing Options on the Roche/454 Next-Generation Titanium Sequencing Platform	PLOS ONE			English	Article							SPECIES RICHNESS; RARE BIOSPHERE; GENE; COMMUNITY; FRAGMENTS; TAXONOMY; PCR	Background: 16S rRNA gene pyrosequencing approach has revolutionized studies in microbial ecology. While primer selection and short read length can affect the resulting microbial community profile, little is known about the influence of pyrosequencing methods on the sequencing throughput and the outcome of microbial community analyses. The aim of this study is to compare differences in output, ease, and cost among three different amplicon pyrosequencing methods for the Roche/454 Titanium platform Methodology/Principal Findings: The following three pyrosequencing methods for 16S rRNA genes were selected in this study: Method-1 (standard method) is the recommended method for bi-directional sequencing using the LIB-A kit; Method-2 is a new option designed in this study for unidirectional sequencing with the LIB-A kit; and Method-3 uses the LIB-L kit for unidirectional sequencing. In our comparison among these three methods using 10 different environmental samples, Method-2 and Method-3 produced 1.5-1.6 times more useable reads than the standard method (Method-1), after quality-based trimming, and did not compromise the outcome of microbial community analyses. Specifically, Method-3 is the most cost-effective unidirectional amplicon sequencing method as it provided the most reads and required the least effort in consumables management. Conclusions: Our findings clearly demonstrated that alternative pyrosequencing methods for 16S rRNA genes could drastically affect sequencing output (e. g. number of reads before and after trimming) but have little effect on the outcomes of microbial community analysis. This finding is important for both researchers and sequencing facilities utilizing 16S rRNA gene pyrosequencing for microbial ecological studies.	[Tamaki, Hideyuki; Li, Xiangzhen; Lin, Qiaoyan; Hwang, Chiachi; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Tamaki, Hideyuki; Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Wright, Chris L.; Thimmapuram, Jyothi] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Roy J Carver Biotechnol Ctr, Urbana, IL USA; [Lin, Qiaoyan; Wang, Shiping] Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, Haibei Alpine Meadow Ecosyst Res Stn, NW Inst Plateau Biol, Xining, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Advanced Industrial Science & Technology (AIST); University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences	Tamaki, H (corresponding author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.	wtliu@illinois.edu	Tamaki, Hideyuki/M-9863-2016; Liu, Wen-Tso/C-8788-2011; Tamaki, Hideyuki/C-9414-2009; Lin, Qiaoyan/H-1164-2011	Liu, Wen-Tso/0000-0002-8700-9803; 	University of Illinois; Grants-in-Aid for Scientific Research [23657069] Funding Source: KAKEN	University of Illinois; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a start-up account for WTL from the University of Illinois. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Hamp TJ, 2009, APPL ENVIRON MICROB, V75, P3263, DOI 10.1128/AEM.01931-08; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lykidis A, 2011, ISME J, V5, P122, DOI 10.1038/ismej.2010.125; Palatinszky M, 2011, J MICROBIOL METH, V85, P131, DOI 10.1016/j.mimet.2011.02.007; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	17	167	184	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25263	10.1371/journal.pone.0025263	http://dx.doi.org/10.1371/journal.pone.0025263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966473	Green Submitted, Green Published, gold			2022-12-27	WOS:000295267100034
J	Delivopoulos, E; Murray, AF				Delivopoulos, Evangelos; Murray, Alan F.			Controlled Adhesion and Growth of Long Term Glial and Neuronal Cultures on Parylene-C	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL; NEUROTROPHIC FACTOR; CELL-PROLIFERATION; NEURAL-NETWORKS; ASTROCYTES; PATTERNS; SURVIVAL; RELEASE; DENSITY; BDNF	This paper explores the long term development of networks of glia and neurons on patterns of Parylene-C on a SiO2 substrate. We harvested glia and neurons from the Sprague-Dawley (P1-P7) rat hippocampus and utilized an established cell patterning technique in order to investigate cellular migration, over the course of 3 weeks. This work demonstrates that uncontrolled glial mitosis gradually disrupts cellular patterns that are established early during culture. This effect is not attributed to a loss of protein from the Parylene-C surface, as nitrogen levels on the substrate remain stable over 3 weeks. The inclusion of the anti-mitotic cytarabine (Ara-C) in the culture medium moderates glial division and thus, adequately preserves initial glial and neuronal conformity to underlying patterns. Neuronal apoptosis, often associated with the use of Ara-C, is mitigated by the addition of brain derived neurotrophic factor (BDNF). We believe that with the right combination of glial inhibitors and neuronal promoters, the Parylene-C based cell patterning method can generate structured, active neural networks that can be sustained and investigated over extended periods of time. To our knowledge this is the first report on the concurrent application of Ara-C and BDNF on patterned cell cultures.	[Delivopoulos, Evangelos] Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB2 1PZ, Cambs, England; [Murray, Alan F.] Univ Edinburgh, Sch Engn & Elect, Inst Integrated Micro & Nano Syst, Edinburgh, Midlothian, Scotland	University of Cambridge; University of Edinburgh	Delivopoulos, E (corresponding author), Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB2 1PZ, Cambs, England.	ed369@cam.ac.uk			Engineering and Physical Sciences Research Council (EPSRC) [EP/G005508/1]; EPSRC [EP/H011242/1, EP/G005508/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G005508/1, EP/H011242/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Engineering and Physical Sciences Research Council (EPSRC), grant reference: EP/G005508/1 (http://gow.epsrc.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; Aguado F, 2002, J NEUROSCI, V22, P9430; Ahlemeyer B, 2003, NEUROCHEM INT, V42, P567, DOI 10.1016/S0197-0186(02)00164-X; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bartrup JT, 1997, NEUROREPORT, V8, P3791, DOI 10.1097/00001756-199712010-00027; Boehler MD, 2007, NEURON GLIA BIOL, V3, P127, DOI 10.1017/S1740925X07000440; Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4; Branch DW, 2000, IEEE T BIO-MED ENG, V47, P290, DOI 10.1109/10.827289; Brewer GJ, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/014001; Chang JC, 2000, BIOMED MICRODEVICES, V2, P245, DOI 10.1023/A:1009946920296; Delivopoulos E, 2010, J BIOMED MATER RES A, V94A, P47, DOI 10.1002/jbm.a.32662; Delivopoulos E, 2009, BIOMATERIALS, V30, P2048, DOI 10.1016/j.biomaterials.2008.12.049; Depboylu C, 2007, NEURODEGENER DIS, V4, P218, DOI 10.1159/000101846; Franks W, 2007, BIOSENS BIOELECTRON, V22, P1426, DOI 10.1016/j.bios.2006.06.031; Frimat JP, 2010, LAB CHIP, V10, P701, DOI 10.1039/b922193j; Hardelauf H, 2011, LAB CHIP, V11, P2763, DOI 10.1039/c1lc20257j; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; Jun SB, 2008, J NEURAL ENG, V5, P203, DOI 10.1088/1741-2560/5/2/011; Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; Millet LJ, 2010, LAB CHIP, V10, P1525, DOI 10.1039/c001552k; Musick K, 2009, LAB CHIP, V9, P2036, DOI 10.1039/b820596e; Nam Y, 2004, IEE Proc Nanobiotechnol, V151, P109, DOI 10.1049/ip-nbt:20040706; Nam Y, 2005, I IEEE EMBS C NEUR E, P325; Nam Y, 2007, J BIOMAT SCI-POLYM E, V18, P1091, DOI 10.1163/156856207781494430; Nam Y, 2006, BIOSENS BIOELECTRON, V22, P589, DOI 10.1016/j.bios.2006.01.027; Negishi T, 2003, J NEUROSCI METH, V131, P133, DOI 10.1016/j.jneumeth.2003.08.006; Pinzon-Duarte G, 2004, EUR J NEUROSCI, V19, P1475, DOI 10.1111/j.1460-9568.2004.03252.x; Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9; Sakai R, 2005, J NEURAL TRANSM, V112, P1005, DOI 10.1007/s00702-004-0246-4; Schmidt EM, 1995, J NEUROSCI METH, V62, P89, DOI 10.1016/0165-0270(95)00060-7; SHARMA A, 2010, APPL PHYS LETT, V96; Takeuchi S, 2005, LAB CHIP, V5, P519, DOI 10.1039/b417497f; Tooker A, 2005, IEEE ENG MED BIOL, V24, P30, DOI 10.1109/MEMB.2005.1549727; Unsworth CF, 2010, J NEUROSCI METH, V194, P154, DOI 10.1016/j.jneumeth.2010.09.022; Unsworth CP, 2011, BIOMATERIALS, V32, P6541, DOI 10.1016/j.biomaterials.2011.05.041; Unsworth CR, 2011, BIOMATERIALS, V32, P2566, DOI 10.1016/j.biomaterials.2010.12.017; WALLACE TL, 1989, J NEUROSCI, V9, P115; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Wright D, 2007, LAB CHIP, V7, P1272, DOI 10.1039/b706081e; Yu MR, 2011, ACS NANO, V5, P2447, DOI 10.1021/nn103618d; Zeng HC, 2007, J NEUROSCI METH, V165, P72, DOI 10.1016/j.jneumeth.2007.05.027; Zheng HP, 2004, LANGMUIR, V20, P7215, DOI 10.1021/la049856y	43	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25411	10.1371/journal.pone.0025411	http://dx.doi.org/10.1371/journal.pone.0025411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966523	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000295265100097
J	Singh, BK; Parham, PE; Hu, CK				Singh, Brajendra K.; Parham, Paul E.; Hu, Chin-Kun			Structural Perturbations to Population Skeletons: Transient Dynamics, Coexistence of Attractors and the Rarity of Chaos	PLOS ONE			English	Article							SIMPLE ECOLOGICAL MODELS; EARLY-WARNING SIGNALS; DENSITY-DEPENDENCE; STRANGE ATTRACTOR; INDUCE CHAOS; LOGISTIC MAP; NOISE; PERSISTENCE; EXTINCTION; EDGE	Background: Simple models of insect populations with non-overlapping generations have been instrumental in understanding the mechanisms behind population cycles, including wild (chaotic) fluctuations. The presence of deterministic chaos in natural populations, however, has never been unequivocally accepted. Recently, it has been proposed that the application of chaos control theory can be useful in unravelling the complexity observed in real population data. This approach is based on structural perturbations to simple population models (population skeletons). The mechanism behind such perturbations to control chaotic dynamics thus far is model dependent and constant (in size and direction) through time. In addition, the outcome of such structurally perturbed models is [almost] always equilibrium type, which fails to commensurate with the patterns observed in population data. Methodology/Principal Findings: We present a proportional feedback mechanism that is independent of model formulation and capable of perturbing population skeletons in an evolutionary way, as opposed to requiring constant feedbacks. We observe the same repertoire of patterns, from equilibrium states to non-chaotic aperiodic oscillations to chaotic behaviour, across different population models, in agreement with observations in real population data. Model outputs also indicate the existence of multiple attractors in some parameter regimes and this coexistence is found to depend on initial population densities or the duration of transient dynamics. Our results suggest that such a feedback mechanism may enable a better understanding of the regulatory processes in natural populations.	[Singh, Brajendra K.; Hu, Chin-Kun] Acad Sinica, Inst Phys, Taipei, Taiwan; [Singh, Brajendra K.] Univ Edinburgh, Interdisciplinary Ctr Human & Avian Influenza Res, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Parham, Paul E.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Grantham Inst Climate Change, London, England	Academia Sinica - Taiwan; University of Edinburgh; Imperial College London	Singh, BK (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	brajendra98@yahoo.com	Singh, Brajendra Kumar/C-3787-2012	Singh, Brajendra Kumar/0000-0001-5847-8750; Hu, Chin-Kun/0000-0002-3620-8319	National Science Council (NSC) of Taiwan [NSC 93-2811-M-001-050, NSC 96-2911-M-001-003-MY3]; Interdisciplinary Centre for Human and Avian Influenza Research; Epigroup, the University of Edinburgh, Edinburgh, United Kingdom; National Center for Theoretical Sciences (North) of Taiwan; Grantham Institute for Climate Change, Imperial College London	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan); Interdisciplinary Centre for Human and Avian Influenza Research; Epigroup, the University of Edinburgh, Edinburgh, United Kingdom; National Center for Theoretical Sciences (North) of Taiwan; Grantham Institute for Climate Change, Imperial College London	This work was supported in part by the following grants from the National Science Council (NSC) of Taiwan: NSC 93-2811-M-001-050 and NSC 96-2911-M-001-003-MY3. BKS also acknowledges the support from the Interdisciplinary Centre for Human and Avian Influenza Research and Epigroup, the University of Edinburgh, Edinburgh, United Kingdom, where the idea of analytical solutions presented in this paper was developed. CH also acknowledges funding support from National Center for Theoretical Sciences (North) of Taiwan. PEP is supported by the Grantham Institute for Climate Change, Imperial College London. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JC, 1993, NATURE, V364, P229, DOI 10.1038/364229a0; Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; BERRYMAN AA, 1989, TRENDS ECOL EVOL, V4, P26, DOI 10.1016/0169-5347(89)90014-1; CONSTANTINO RF, 1997, SCIENCE, V275, P389; Coulson T, 2004, TRENDS ECOL EVOL, V19, P359, DOI 10.1016/j.tree.2004.05.008; Dennis B, 2003, OIKOS, V102, P329, DOI 10.1034/j.1600-0706.2003.12387.x; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Edelstein-Keshet L, 2005, MATH MODELS BIOL; Edmunds JL, 2007, THEOR POPUL BIOL, V72, P379, DOI 10.1016/j.tpb.2007.07.004; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Gamarra JGP, 2001, CHAOS SOLITON FRACT, V12, P235, DOI 10.1016/S0960-0779(00)00110-7; Garvie MR, 2010, ECOL COMPLEX, V7, P55, DOI 10.1016/j.ecocom.2009.05.001; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; HASTINGS A, 1993, ANNU REV ECOL SYST, V24, P1, DOI 10.1146/annurev.es.24.110193.000245; HASTINGS A, 1994, SCIENCE, V263, P1133, DOI 10.1126/science.263.5150.1133; Jansen VAA, 1998, P NATL ACAD SCI USA, V95, P3696, DOI 10.1073/pnas.95.7.3696; Keeling, 2008, MODELLING INFECT DIS; KENDALL BE, IMPACT CHAOS SCI SOC, P190; Kibble T. W. B., 2004, CLASSICAL MECH; Lima M, 1999, AM NAT, V153, P476, DOI 10.1086/303191; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MAY RM, 1974, J ANIM ECOL, V43, P747, DOI 10.2307/3535; MAYRM, 1974, SCIENCE, V186, P645; MCCALLUM HI, 1992, J THEOR BIOL, V154, P277, DOI 10.1016/S0022-5193(05)80170-5; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Melby P, 2000, PHYS REV LETT, V84, P5991, DOI 10.1103/PhysRevLett.84.5991; Nandi A, 2005, CHAOS, V15, DOI 10.1063/1.1914755; PARTHASARATHY S, 1995, PHYS REV E, V51, P6239, DOI 10.1103/PhysRevE.51.6239; Pascual M, 2003, THEOR POPUL BIOL, V64, P385, DOI 10.1016/S0040-5809(03)00086-8; Perry JN, 1997, SCIENCE, V276, P1881, DOI 10.1126/science.276.5320.1881; ROHANI P, 1995, J THEOR BIOL, V175, P203, DOI 10.1006/jtbi.1995.0133; SCHAFFER WM, 1984, AM NAT, V124, P798, DOI 10.1086/284318; SCHAFFER WM, 1985, ECOLOGY, V66, P93, DOI 10.2307/1941309; SCHEFFER M, 1991, J PLANKTON RES, V13, P1291, DOI 10.1093/plankt/13.6.1291; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Scheuring I, 2007, OIKOS, V116, P361, DOI 10.1111/j.2006.0030-1299.15287.x; Sherratt T. N., 2009, BIG QUESTIONS ECOLOG; Singh BK, 2004, ECOL MODEL, V180, P435, DOI 10.1016/j.ecolmodel.2004.04.031; Singh BK, 2004, J THEOR BIOL, V231, P153, DOI 10.1016/j.jtbi.2004.06.010; Singh BK, 2008, CHAOS SOLITON FRACT, V38, P641, DOI 10.1016/j.chaos.2008.02.024; Sole RV, 1999, B MATH BIOL, V61, P1187, DOI 10.1006/bulm.1999.0141; STONE L, 1993, NATURE, V365, P617, DOI 10.1038/365617a0; Turchin P, 2000, ECOLOGY, V81, P3099, DOI 10.1890/0012-9658(2000)081[3099:LOTEOC]2.0.CO;2	45	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24200	10.1371/journal.pone.0024200	http://dx.doi.org/10.1371/journal.pone.0024200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21980342	Green Published, Green Submitted, gold			2022-12-27	WOS:000295257900007
J	Kershner, J; Samhouri, JF; James, CA; Levin, PS				Kershner, Jessi; Samhouri, Jameal F.; James, C. Andrew; Levin, Phillip S.			Selecting Indicator Portfolios for Marine Species and Food Webs: A Puget Sound Case Study	PLOS ONE			English	Article							MULTICRITERIA DECISION-ANALYSIS; ECOLOGICAL INDICATORS; ECOSYSTEM APPROACH; MANAGEMENT; FRAMEWORK; CONSERVATION; BIODIVERSITY; DIVERSITY; INDEXES; IMPACT	Ecosystem-based management (EBM) has emerged as a promising approach for maintaining the benefits humans want and need from the ocean, yet concrete approaches for implementing EBM remain scarce. A key challenge lies in the development of indicators that can provide useful information on ecosystem status and trends, and assess progress towards management goals. In this paper, we describe a generalized framework for the methodical and transparent selection of ecosystem indicators. We apply the framework to the second largest estuary in the United States - Puget Sound, Washington - where one of the most advanced EBM processes is currently underway. Rather than introduce a new method, this paper integrates a variety of familiar approaches into one step-by-step approach that will lead to more consistent and reliable reporting on ecosystem condition. Importantly, we demonstrate how a framework linking indicators to policy goals, as well as a clearly defined indicator evaluation and scoring process, can result in a portfolio of useful and complementary indicators based on the needs of different users (e. g., policy makers and scientists). Although the set of indicators described in this paper is specific to marine species and food webs, we provide a general approach that could be applied to any set of management objectives or ecological system.	[Kershner, Jessi] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Samhouri, Jameal F.; Levin, Phillip S.] NOAA, NW Fisheries Sci Ctr, Seattle, WA USA; [James, C. Andrew] Univ Washington, Ctr Urban Waters, Tacoma, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Tacoma	Kershner, J (corresponding author), EcoAdapt, Bainbridge Isl, WA USA.	jessikershner@gmail.com			Puget Sound Partnership; U.S. Environmental Protection Agency	Puget Sound Partnership; U.S. Environmental Protection Agency(United States Environmental Protection Agency)	We gratefully acknowledge funding from the Puget Sound Partnership and the U.S. Environmental Protection Agency (Dr. Samhouri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Caro T. M, 2010, CONSERVATION PROXY I; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Conservation Measures Partnership, 2007, OP STAND PRACT CONS; Cury PM, 2005, ICES J MAR SCI, V62, P577, DOI 10.1016/j.icesjms.2004.10.007; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Doren RF, 2009, ECOL INDIC, V9, pS2, DOI 10.1016/j.ecolind.2008.08.009; Essington T, 2010, BIOPHYSICAL CONDITIO; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harwell MA, 1999, BIOSCIENCE, V49, P543, DOI 10.2307/1313475; Heiman K, 2005, BIOSCIENCE, V55, P548, DOI 10.1641/0006-3568(2005)055[0548:SINS]2.0.CO;2; Heinz H.J, 2013, STATE NATIONS ECOSYS; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Jackson LE, 2000, EPA620R99005US OFF R; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Jorgensen S.E., 2005, HDB ECOLOGICAL INDIC; Kurtz Janis C., 2001, Ecological Indicators, V1, P49, DOI 10.1016/S1470-160X(01)00004-8; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Levin P. S., 2010, STANFORD J LAW SCI P, V2, P36; Levin PS, 2010, DEV EXECUTIVE DASHBO; Levin PS, 2010, PUGET SOUND SCI UPDA; Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Mardle S., 1999, MARINE RESOURCE EC, V1999, P41; McElhany P, 2000, NMFSNWFSC42 NOAA; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; OCONNOR JS, 1986, ENVIRON MANAGE, V10, P335, DOI 10.1007/BF01867257; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; ONeill T.K., 2008, ENV INDICATORS PUGET; Orians GH, 2009, ANNU REV ENV RESOUR, V34, P375, DOI 10.1146/annurev.environ.020608.151439; Pacala S, 2002, MG POP BIOL, V33, P169; Parsons M, 2008, ICES J MAR SCI, V65, P1520, DOI 10.1093/icesjms/fsn155; Patrick WS, 2010, FISH B-NOAA, V108, P305; *PEW OC COMM, 2003, AM LIV OC CHART COUR; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pirrone N, 2005, REG ENVIRON CHANGE, V5, P111, DOI 10.1007/s10113-004-0092-9; Powers JE, 2010, MAR POLICY, V34, P723, DOI 10.1016/j.marpol.2009.11.009; Puget Sound Action Team, 2007, 9 PUG SOUND ASS MON; Puget Sound Partnership, 2010, 2009 STAT SOUND REP; Puget Sound Partnership, 2010, STRAT SCI PLAN; Puget Sound Partnership, 2009, ID EC COMP THEIR IND; Puget Sound Partnership, 2008, PUG SOUND ACT AG PRO; RAPPORT D, 1990, ENVIRON MONIT ASSESS, V15, P273, DOI 10.1007/BF00394894; RAPPORT DJ, 1985, AM NAT, V125, P617, DOI 10.1086/284368; Recchia C, 2009, DRAFT N CENTRAL COAS; Rice J, 2003, OCEAN COAST MANAGE, V46, P235, DOI 10.1016/S0964-5691(03)00006-1; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rothaus DP, 2008, CAN J FISH AQUAT SCI, V65, P2703, DOI 10.1139/F08-168; Ruckelshaus M.H., 2007, SOUND SCI SYNTHESIZI; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Samhouri JF, 2009, ECOSYSTEMS, V12, P1283, DOI 10.1007/s10021-009-9286-9; Samhouri JF, MARINE POLI IN PRESS; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shin Y-J, 2010, ICES J MARINE SCI, V67; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Steele K, 2009, RISK ANAL, V29, P26, DOI 10.1111/j.1539-6924.2008.01130.x; U.S. Environmental Protection Agency, 2002, FRAM ASS REP EC COND; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429	72	80	81	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25248	10.1371/journal.pone.0025248	http://dx.doi.org/10.1371/journal.pone.0025248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991305	gold, Green Published, Green Submitted			2022-12-27	WOS:000295963300007
J	Kelly, AD; Breitkopf, SB; Yuan, M; Goldsmith, J; Spentzos, D; Asara, JM				Kelly, Andrew D.; Breitkopf, Susanne B.; Yuan, Min; Goldsmith, Jeffrey; Spentzos, Dimitrios; Asara, John M.			Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma	PLOS ONE			English	Article							MASS-SPECTROMETRY; CANCER; CELLS; METABOANALYST	The relatively new field of onco-metabolomics attempts to identify relationships between various cancer phenotypes and global metabolite content. Previous metabolomics studies utilized either nuclear magnetic resonance spectroscopy or gas chromatography/mass spectrometry, and analyzed metabolites present in urine and serum. However, direct metabolomic assessment of tumor tissues is important for determining altered metabolism in cancers. In this respect, the ability to obtain reliable data from archival specimens is desirable and has not been reported to date. In this feasibility study, we demonstrate the analysis of polar metabolites extracted directly from ten formalin-fixed, paraffin-embedded (FFPE) specimens, including five soft tissue sarcomas and five paired normal samples. Using targeted liquid chromatography-tandem mass spectrometry (LC/MS/MS) via selected reaction monitoring (SRM), we detect an average of 106 metabolites across the samples with excellent reproducibility and correlation between different sections of the same specimen. Unsupervised hierarchical clustering and principal components analysis reliably recovers a priori known tumor and normal tissue phenotypes, and supervised analysis identifies candidate metabolic markers supported by the literature. In addition, we find that diverse biochemical processes are well-represented in the list of detected metabolites. Our study supports the notion that reliable and broadly informative metabolomic data may be acquired from FFPE soft tissue sarcoma specimens, a finding that is likely to be extended to other malignancies.	[Kelly, Andrew D.; Spentzos, Dimitrios] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol,Sarcoma Program, Boston, MA 02215 USA; [Breitkopf, Susanne B.; Yuan, Min; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Goldsmith, Jeffrey] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Spentzos, Dimitrios; Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Kelly, AD (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol,Sarcoma Program, Boston, MA 02215 USA.	jasara@bidmc.harvard.edu		Kelly, Andrew/0000-0002-5338-7689	National Institutes of Health/National Cancer Institute [1 K22 CA138716-01A2, 5 P01 CA120964-05, 5 P30 CA006516-46]; Beth Israel Deaconess Medical Center; NATIONAL CANCER INSTITUTE [P30CA006516, K22CA138716, P01CA120964] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Beth Israel Deaconess Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute 1 K22 CA138716-01A2 Award (DS), 5 P01 CA120964-05 (JA), and 5 P30 CA006516-46 (JA). The authors would also like to acknowledge a donation by Dr. Richard and Virginia Clemmer to the sarcoma program at Beth Israel Deaconess Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen HN, 2003, J MOL DIAGN, V5, P34, DOI 10.1016/S1525-1578(10)60449-7; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Davis VW, 2011, J SURG ONCOL, V103, P451, DOI 10.1002/jso.21831; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Lei Z, 2011, J BIOL CHEM IN PRESS; Locasale JW, 2011, NAT GENET IN PRESS; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Mishur RJ, 2011, MASS SPECTR IN PRESS; Naderi EH, 2009, BLOOD, V114, P608, DOI 10.1182/blood-2009-02-204883; Naderi S, 2005, MOL BIOL CELL, V16, P1527, DOI 10.1091/mbc.E04-06-0501; Safa M, 2011, J RECEPT SIG TRANSD, V31, P256, DOI 10.3109/10799893.2011.578140; Sheikh Kathryn D, 2011, J Biomol Tech, V22, P1; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	19	57	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25357	10.1371/journal.pone.0025357	http://dx.doi.org/10.1371/journal.pone.0025357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984915	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000026
J	De Leeneer, K; De Schrijver, J; Clement, L; Baetens, M; Lefever, S; De Keulenaer, S; Van Criekinge, W; Deforce, D; Van Nieuwerburgh, F; Bekaert, S; Pattyn, F; De Wilde, B; Coucke, P; Vandesompele, J; Claes, K; Hellemans, J				De Leeneer, Kim; De Schrijver, Joachim; Clement, Lieven; Baetens, Machteld; Lefever, Steve; De Keulenaer, Sarah; Van Criekinge, Wim; Deforce, Dieter; Van Nieuwerburgh, Filip; Bekaert, Sofie; Pattyn, Filip; De Wilde, Bram; Coucke, Paul; Vandesompele, Jo; Claes, Kathleen; Hellemans, Jan			Practical Tools to Implement Massive Parallel Pyrosequencing of PCR Products in Next Generation Molecular Diagnostics	PLOS ONE			English	Article							MELTING ANALYSIS; DNA; IDENTIFICATION	Despite improvements in terms of sequence quality and price per basepair, Sanger sequencing remains restricted to screening of individual disease genes. The development of massively parallel sequencing (MPS) technologies heralded an era in which molecular diagnostics for multigenic disorders becomes reality. Here, we outline different PCR amplification based strategies for the screening of a multitude of genes in a patient cohort. We performed a thorough evaluation in terms of set-up, coverage and sequencing variants on the data of 10 GS-FLX experiments (over 200 patients). Crucially, we determined the actual coverage that is required for reliable diagnostic results using MPS, and provide a tool to calculate the number of patients that can be screened in a single run. Finally, we provide an overview of factors contributing to false negative or false positive mutation calls and suggest ways to maximize sensitivity and specificity, both important in a routine setting. By describing practical strategies for screening of multigenic disorders in a multitude of samples and providing answers to questions about minimum required coverage, the number of patients that can be screened in a single run and the factors that may affect sensitivity and specificity we hope to facilitate the implementation of MPS technology in molecular diagnostics. A	[De Leeneer, Kim; Baetens, Machteld; Lefever, Steve; Pattyn, Filip; De Wilde, Bram; Coucke, Paul; Vandesompele, Jo; Claes, Kathleen; Hellemans, Jan] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [De Keulenaer, Sarah; Van Criekinge, Wim; Deforce, Dieter; Van Nieuwerburgh, Filip; Bekaert, Sofie; Coucke, Paul; Vandesompele, Jo; Hellemans, Jan] Univ Ghent, NXTGNT, B-9000 Ghent, Belgium; [De Schrijver, Joachim; Van Criekinge, Wim] Univ Ghent, Lab Bioinformat & Computat Genom, B-9000 Ghent, Belgium; [Clement, Lieven] Univ Ghent, Dept Appl Math Biometr & Proc Control, B-9000 Ghent, Belgium; [Deforce, Dieter; Van Nieuwerburgh, Filip] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University	De Leeneer, K (corresponding author), Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium.	Kim.deleeneer@UGent.be	Pattyn, Filip/A-4164-2015; Vandesompele, Jo/W-3411-2018; Coucke, Paul J/AAO-2954-2020; Van Nieuwerburgh, Filip/H-9697-2015; De Leeneer, Kim/AFS-1595-2022; Deforce, Dieter LD/J-4725-2013; Claes, Kathleen/AFR-6830-2022; Clement, Lieven/G-5143-2012	Pattyn, Filip/0000-0003-0858-6651; Vandesompele, Jo/0000-0001-6274-0184; Coucke, Paul J/0000-0001-7119-586X; Van Nieuwerburgh, Filip/0000-0001-8815-5485; De Leeneer, Kim/0000-0002-9319-411X; Deforce, Dieter LD/0000-0002-0635-661X; Claes, Kathleen/0000-0003-0841-7372; De Wilde, Bram/0000-0003-0213-1322; clement, lieven/0000-0002-9050-4370	Fund for Scientific Research Flanders (FWO) [1.5.150.07]; Ghent University [BOF10/GOA/019]; EC; Vlaamse Liga tegen Kanker through Foundation Emmanuel van der Schueren; Hercules Foundation [AUGE/039]; Ghent University (UGent - IOF); NXTGNT consortium; Ake Wiberg Foundation; Swedish Royal Academy of Sciences	Fund for Scientific Research Flanders (FWO)(FWO); Ghent University(Ghent University); EC(European CommissionEuropean Commission Joint Research Centre); Vlaamse Liga tegen Kanker through Foundation Emmanuel van der Schueren; Hercules Foundation; Ghent University (UGent - IOF)(Ghent University); NXTGNT consortium; Ake Wiberg Foundation; Swedish Royal Academy of Sciences	This research was supported by grant 1.5.150.07 from the Fund for Scientific Research Flanders (FWO) to Kathleen Claes, by GOA grant BOF10/GOA/019 (Ghent University) and by Fighting Aneurysmal Disease [EC-FP7]. Kim De Leeneer is supported by the Vlaamse Liga tegen Kanker through a grant of the Foundation Emmanuel van der Schueren. Jan Hellemans is supported by a grant from the Fund for Scientific Research Flanders (FWO). This research has been made possible by funding from Hercules Foundation [AUGE/039] and industrieel onderzoeksfonds of Ghent University (UGent - IOF) StepStone and support of the NXTGNT consortium. Funding also received from Ake Wiberg Foundation (MA, JH) and The Swedish Royal Academy of Sciences also supported both MA and JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Baetens M, 2011, HUM MUTAT, V32, P1053, DOI 10.1002/humu.21525; CARR IM, 2011, GENOMICS IN PRESS; Chou LS, 2005, AM J CLIN PATHOL, V124, P330, DOI 10.1309/BF3MLJN8J527MWQY; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; De Leeneer K, 2008, CLIN CHEM, V54, P982, DOI 10.1373/clinchem.2007.098764; De Leeneer K, 2011, HUM MUTAT, V32, P335, DOI 10.1002/humu.21428; De Leeneer K, 2009, J MOL DIAGN, V11, P415, DOI 10.2353/jmoldx.2009.090032; De Schrijver JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-269; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Harismendy O, 2009, BIOTECHNIQUES, V46, P229, DOI 10.2144/000113082; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Morgan JE, 2010, HUM MUTAT, V31, P484, DOI 10.1002/humu.21216; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SHENDURE JA, 2008, OVERVIEW DNA SEQUENC; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951	18	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25531	10.1371/journal.pone.0025531	http://dx.doi.org/10.1371/journal.pone.0025531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980484	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300036
J	Srivastava, RK; Rahman, Q; Kashyap, MP; Lohani, M; Pant, AB				Srivastava, Ritesh Kumar; Rahman, Qamar; Kashyap, Mahendra Pratap; Lohani, Mohtashim; Pant, Aditya Bhushan			Ameliorative Effects of Dimetylthiourea and N-Acetylcysteine on Nanoparticles Induced Cyto-Genotoxicity in Human Lung Cancer Cells-A549	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; WALL CARBON NANOTUBES; OXIDATIVE STRESS; OXIDE NANOPARTICLES; MEDIATED APOPTOSIS; SURFACE-CHEMISTRY; ASBESTOS; TOXICITY; ACTIVATION; IMPACT	We study the ameliorative potential of dimetylhiourea (DMTU), an OH radical trapper and N-acetylcysteine (NAC), a glutathione precursor/H2O2 scavenger against titanium dioxide nanoparticles (TiO2-NPs) and multi-walled carbon nanotubes (MWCNTs) induced cyto-genotoxicity in cultured human lung cancer cells-A549. Cytogenotoxicity was induced by exposing the cells to selected concentrations (10 and 50 mu g/ml) of either of TiO2-NPs or MWCNTs for 24 h . Anti-cytogenotoxicity effects of DMTU and NAC were studied in two groups, i.e., treatment of 30 minutes prior to toxic insult (short term exposure), while the other group received DMTU and NAC treatment during nanoparticles, exposure, i.e., 24 h (long term exposure). Investigations were carried out for cell viability, generation of reactive oxygen specie (ROS), micronuclei (MN), and expression of markers of oxidative stress (HSP27, CYP2E1), genotoxicity (P-53) and CYP2E1 dependent n-nitrosodimethylamine-demethylase (NDMA-d) activity. In general, the treatment of both DMTU and NAC was found to be effective significantly against TiO2-NPs and MWCNTs induced cytogenotoxicity in A549 cells. Long-term treatment of DMTU and NAC during toxic insults has shown better prevention than short-term pretreatment. Although, cells responded significantly to both DMTU and NAC, but responses were chemical specific. In part, TiO(2-)NPs induced toxic responses were mediated through OH" radicals generation and reduction in the antioxidant defense system. While in the case of MWCNTs, adverse effects were primarily due to altering/hampering the enzymatic antioxidant system. Data indicate the applicability of human lung cancer cells-A549 as a pre-screening tool to identify he target specific prophylactic and therapeutic potential of drugs candidate molecules against nanoparticles induced cellular damages.	[Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap; Pant, Aditya Bhushan] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap; Pant, Aditya Bhushan] CSIR, New Delhi, India; [Rahman, Qamar; Lohani, Mohtashim] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; Integral University	Srivastava, RK (corresponding author), Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India.	abpant@rediffmail.com	Rahman, Qamar/AFJ-9953-2022; Kashyap, Mahendra/G-4305-2011; Lohani, Mohtashim/AAR-3394-2021; Rahman, Qamar/AAF-7026-2022; Srivastava, Ritesh/V-6029-2019	Kashyap, Mahendra/0000-0001-7924-4793; Lohani, Mohtashim/0000-0001-9414-4539	Council of Scientific & Industrial Research, New Delhi [SIP-08]	Council of Scientific & Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Financial support was received from the Council of Scientific & Industrial Research, New Delhi, (SIP-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Barillet S, 2010, TOXICOL LETT, V198, P324, DOI 10.1016/j.toxlet.2010.07.009; Bhattacharya K, 2005, MUTAT RES-FUND MOL M, V579, P6, DOI 10.1016/j.mrfmmm.2005.02.022; Bhattacharya K, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-17; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Dopp E, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-9; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Fubini B, 2010, NANOTOXICOLOGY, V4, P347, DOI 10.3109/17435390.2010.509519; Gillissen A, 1997, RESP MED, V91, P159, DOI 10.1016/S0954-6111(97)90052-4; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Jiang M, 2007, BIOCHEM PHARMACOL, V73, P1499, DOI 10.1016/j.bcp.2007.01.010; Kapoor N, 2006, LIFE SCI, V79, P1514, DOI 10.1016/j.lfs.2006.04.023; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; Kashyap MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017757; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kong SJ, 2008, ENVIRON MOL MUTAGEN, V49, P399, DOI 10.1002/em.20399; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; McVicker BL, 2009, WORLD J GASTROENTERO, V15, P2609, DOI 10.3748/wjg.15.2609; Mroz RM, 2008, EUR RESPIR J, V31, P241, DOI 10.1183/09031936.00006707; Muller J, 2008, CARCINOGENESIS, V29, P427, DOI 10.1093/carcin/bgm243; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Pacurari M, 2010, J TOXICOL ENV HEAL A, V73, P378, DOI 10.1080/15287390903486527; Pant AB, 2001, HUM EXP TOXICOL, V20, P412, DOI 10.1191/096032701682692919; Patlolla A, 2010, ETHNIC DIS, V20, P65; Patlolla AK, 2010, ENVIRON TOXICOL, V25, P608, DOI 10.1002/tox.20621; Poser I, 2004, MUTAT RES-GEN TOX EN, V559, P19, DOI 10.1016/j.mrgentox.2003.12.006; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Rahman Q, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110797; RAJU PA, 1994, AIDS RES HUM RETROV, V10, P961, DOI 10.1089/aid.1994.10.961; Sato Y, 2005, MOL BIOSYST, V1, P176, DOI 10.1039/b502429c; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Srivastava RK, 2011, NANOTOXICOLOGY, V5, P195, DOI 10.3109/17435390.2010.503944; Srivastava RK, 2010, TOXICOL IND HEALTH, V26, P575, DOI 10.1177/0748233710374464; Stoeger T, 2009, ENVIRON HEALTH PERSP, V117, P54, DOI 10.1289/ehp.11370; Thevenot P, 2008, NANOMED-NANOTECHNOL, V4, P226, DOI 10.1016/j.nano.2008.04.001; Tirmenstein MA, 2000, CHEM-BIOL INTERACT, V127, P201, DOI 10.1016/S0009-2797(00)00180-0; Trouiller B, 2009, CANCER RES, V69, P8784, DOI 10.1158/0008-5472.CAN-09-2496; Tsuji T, 2009, TOXICOL APPL PHARM, V234, P202, DOI 10.1016/j.taap.2008.09.031; Wang JJ, 2007, MUTAT RES-GEN TOX EN, V628, P99, DOI 10.1016/j.mrgentox.2006.12.003; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385; Yin H, 2010, LANGMUIR, V26, P15399, DOI 10.1021/la101033n	44	27	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25767	10.1371/journal.pone.0025767	http://dx.doi.org/10.1371/journal.pone.0025767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980536	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600054
J	Newmeyer, T; Tecimer, SN; Jaworsky, D; Chihrin, S; Gough, K; Rachlis, A; Martin, J; Mohammed, S; Loutfy, MR				Newmeyer, Trent; Tecimer, Sandy N.; Jaworsky, Denise; Chihrin, Steven; Gough, Kevin; Rachlis, Anita; Martin, James; Mohammed, Saira; Loutfy, Mona R.			Case Series of Fertility Treatment in HIV-Discordant Couples (Male Positive, Female Negative): The Ontario Experience	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; INTENTIONS; WOMEN; PREGNANCY; DESIRES; INDIVIDUALS; PEOPLE; MEN; DECISION; SERVICES	The success of combination antiretroviral therapies for the treatment of human immunodeficiency virus (HIV) has resulted in prolonged life expectancy (over 40 years from diagnosis) and an improved quality of life for people living with HIV. The risk of vertical HIV transmission during pregnancy has been reduced to less than 1%. As a result of these breakthroughs and as many of these individuals are of reproductive age, fertility issues are becoming increasingly important for this population. One population in which conception planning and reduction of horizontal HIV transmission warrants further research is HIV-discordant couples where the male partner is HIV-positive and the female partner is HIV-negative. Sperm washing is a technique carried out in a fertility clinic that separates HIV from the seminal fluid. Although sperm washing followed by intrauterine insemination significantly reduces the risk of horizontal HIV transmission, there has been limited access to the procedure in North America. Furthermore, little is known about the conception decision-making experiences of HIV-discordant couples who might benefit from sperm washing. Chart reviews and semi-structured interviews were completed with 12 HIV-discordant couples in Ontario, Canada. Couples were recruited through HIV clinics and one fertility clinic that offered sperm washing. Participants identified a number of factors that affected their decision-making around pregnancy planning. Access to sperm washing and other fertility services was an issue (cost, travel and few clinics). Participants identified a lack of information on the procedure (availability, safety). Sources of support (social networks, healthcare providers) were unevenly distributed, especially among those who did not disclose their HIV status to friends and family. Finally, the stigmatisation of HIV continues to have a negative affect on HIV-discordant couples and their intentions to conceive. Access to sperm washing and fertility service is significantly limited for this population and is accompanied with a number of challenges.	[Newmeyer, Trent] Brock Univ, St Catharines, ON L2S 3A1, Canada; [Tecimer, Sandy N.; Jaworsky, Denise; Mohammed, Saira; Loutfy, Mona R.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Tecimer, Sandy N.; Jaworsky, Denise; Gough, Kevin; Rachlis, Anita; Loutfy, Mona R.] Univ Toronto, Toronto, ON, Canada; [Chihrin, Steven] Univ Western Ontario, London, ON, Canada; [Gough, Kevin; Loutfy, Mona R.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Rachlis, Anita] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Martin, James] So Ontario Fertil Technol, London, ON, Canada	Brock University; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Newmeyer, T (corresponding author), Brock Univ, St Catharines, ON L2S 3A1, Canada.	trent.newmeyer@brocku.ca			Women's College Research Institute, Toronto, Ontario	Women's College Research Institute, Toronto, Ontario	The Women and HIV Research Program, Women's College Research Institute, Toronto, Ontario provided financial support for the transcriptions in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braverman A, 2010, FERTIL STERIL, V94, P11, DOI 10.1016/j.fertnstert.2010.01.077; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Gruskin S, 2008, AM J PUBLIC HEALTH, V98, P1746, DOI 10.2105/AJPH.2008.137232; Gruskin S, 2007, REPROD HEALTH MATTER, V15, P4, DOI 10.1016/S0968-8080(07)29028-7; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; Klein J, 2003, OBSTET GYNECOL, V101, P987, DOI 10.1016/S0029-7844(03)00012-7; Ko NY, 2005, J MIDWIFERY WOM HEAL, V50, P23, DOI 10.1016/j.jmwh.2004.08.003; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; Lurie M, 2008, JAIDS-J ACQ IMM DEF, V47, P484, DOI 10.1097/QAI.0b013e3181648de8; Margolese S, 2010, 18 INT AIDS C VIENN; Margolese S, 2011, 1 INT WORKSH HIV WOM; Myer L, 2006, AIDS CARE, V18, P772, DOI 10.1080/09540120500409283; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Oosterhoff P, 2008, CULT HEALTH SEX, V10, P403, DOI 10.1080/13691050801915192; Paiva V, 2003, REPROD HEALTH MATTER, V11, P91, DOI 10.1016/S0968-8080(03)02293-6; Panozzo L, 2003, SWISS MED WKLY, V133, P124; *PUBL HLTH AG CAN, 2009, HIV AIDS CAN SEL SUR; Scott S, J AM PHARM ASS, V49, P462; SEMPRINI AE, 1992, LANCET, V340, P1317, DOI 10.1016/0140-6736(92)92495-2; Sherr L, 2004, HIV MED, V5, P258, DOI 10.1111/j.1468-1293.2004.00218.x; Siegel K, 2001, PSYCHOL WOMEN QUART, V25, P112, DOI 10.1111/1471-6402.00013; Sunderam S, 2008, REPROD HEALTH MATTER, V16, P211, DOI 10.1016/S0968-8080(08)31342-1; Tecimer Sandy N, 2011, Open AIDS J, V5, P37, DOI 10.2174/1874613601105010037; VanDevanter N, 1999, AIDS CARE, V11, P181, DOI 10.1080/09540129948072; Vernazza P, 2008, B MED SUISSES, V89, P165; Yudin MH, 2011, J OBSTET GYNAECOL CA, V33, P269, DOI 10.1016/S1701-2163(16)34829-0; Yudin MH, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-7; Yudin MH, 2011, 20 CAN ASS HIV RES C	33	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24853	10.1371/journal.pone.0024853	http://dx.doi.org/10.1371/journal.pone.0024853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21969863	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900014
J	Racanelli, V; Brunetti, C; De Re, V; Caggiari, L; De Zorzi, M; Leone, P; Perosa, F; Vacca, A; Dammacco, F				Racanelli, Vito; Brunetti, Claudia; De Re, Valli; Caggiari, Laura; De Zorzi, Mariangela; Leone, Patrizia; Perosa, Federico; Vacca, Angelo; Dammacco, Franco			Antibody V-h Repertoire Differences between Resolving and Chronically Evolving Hepatitis C Virus Infections	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; B-CELLS; MIXED CRYOGLOBULINEMIA; ANTIGEN SELECTION; NEUTRALIZING ANTIBODIES; SOMATIC HYPERMUTATION; CLONAL EXPANSION; VIRAL CLEARANCE; HCV; RISK	Despite the production of neutralizing antibodies to hepatitis C virus (HCV), many patients fail to clear the virus and instead develop chronic infection and long-term complications. To understand how HCV infection perturbs the antibody repertoire and to identify molecular features of antibody genes associated with either viral clearance or chronic infection, we sequenced the V(D)J region of naive and memory B cells of 6 persons who spontaneously resolved an HCV infection (SR), 9 patients with a newly diagnosed chronically evolving infection (CE), and 7 healthy donors. In both naive and memory B cells, the frequency of use of particular antibody gene subfamilies and segments varied among the three clinical groups, especially between SR and CE. Compared to CE, SR antibody genes used fewer VH, D and JH gene segments in naive B cells and fewer VH segments in memory B cells. SR and CE groups significantly differed in the frequency of use of 7 gene segments in naive B cell clones and 3 gene segments in memory clones. The nucleotide mutation rates were similar among groups, but the pattern of replacement and silent mutations in memory B cell clones indicated greater antigen selection in SR than CE. Greater clonal evolution of SR than CE memory B cells was revealed by analysis of phylogenetic trees and CDR3 lengths. Pauciclonality of the peripheral memory B cell population is a distinguishing feature of persons who spontaneously resolved an HCV infection. This finding, previously considered characteristic only of patients with HCV-associated lymphoproliferative disorders, suggests that the B cell clones potentially involved in clearance of the virus may also be those susceptible to abnormal expansion.	[Racanelli, Vito; Brunetti, Claudia; Leone, Patrizia; Perosa, Federico; Vacca, Angelo; Dammacco, Franco] Univ Bari, Sch Med, Dept Internal Med & Clin Oncol, Bari, Italy; [De Re, Valli; Caggiari, Laura; De Zorzi, Mariangela] IRCCS Natl Canc Inst, Expt & Clin Pharmacol Unit, Ctr Riferimento Oncol, Aviano, PN, Italy	Universita degli Studi di Bari Aldo Moro; IRCCS Aviano (CRO)	Racanelli, V (corresponding author), Univ Bari, Sch Med, Dept Internal Med & Clin Oncol, Bari, Italy.	v.racanelli@dimo.uniba.it	DE RE, VALLI/AAA-1374-2019; Dammacco, Franco/ABG-5728-2020; Racanelli, Vito/J-8511-2018; De Re, Valli/K-4121-2016; CAGGIARI, LAURA/Q-6125-2019; Vacca, Angelo/AAC-9558-2022; De Zorzi, Mariangela/AAA-8832-2019	DE RE, VALLI/0000-0001-6100-9373; Dammacco, Franco/0000-0003-2149-5471; Racanelli, Vito/0000-0002-8639-1940; De Re, Valli/0000-0001-6100-9373; CAGGIARI, LAURA/0000-0003-1651-6653; Vacca, Angelo/0000-0002-4567-8216; De Zorzi, Mariangela/0000-0002-3794-270X; Perosa, Federico/0000-0002-4072-4244	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro)	The study was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro, Milan, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; BAHLER DW, 1992, CANCER RES, V52, pS5547; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Chapel HM, 2001, CLIN IMMUNOL, V99, P320, DOI 10.1006/clim.2001.5036; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; De Re V, 2006, RHEUMATOLOGY, V45, P685, DOI 10.1093/rheumatology/kei278; De Re V, 2000, INT J CANCER, V87, P211, DOI 10.1002/1097-0215(20000715)87:2&lt;211::AID-IJC9&gt;3.0.CO;2-8; De Re V, 2000, BLOOD, V96, P3578; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; FRANZIN F, 1995, BRIT J HAEMATOL, V90, P548, DOI 10.1111/j.1365-2141.1995.tb05582.x; Giordano TP, 2007, JAMA-J AM MED ASSOC, V297, P2010, DOI 10.1001/jama.297.18.2010; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Ivanovski M, 1998, BLOOD, V91, P2433, DOI 10.1182/blood.V91.7.2433.2433_2433_2442; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Libra M, 2005, J PATHOL, V206, P87, DOI 10.1002/path.1754; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; Magalini AR, 1998, J PATHOL, V185, P86; Matsuo K, 2004, CANCER SCI, V95, P745, DOI 10.1111/j.1349-7006.2004.tb03256.x; Meuleman P, 2011, HEPATOLOGY, V53, P755, DOI 10.1002/hep.24171; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Miqueu P, 2007, MOL IMMUNOL, V44, P1057, DOI 10.1016/j.molimm.2006.06.026; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Netski DM, 2005, CLIN INFECT DIS, V41, P667, DOI 10.1086/432478; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Racanelli V, 2006, J VIROL, V80, P3923, DOI 10.1128/JVI.80.8.3923-3934.2006; Racanelli V, 2003, TRENDS IMMUNOL, V24, P456, DOI 10.1016/S1471-4906(03)00178-9; Racanelli V, 2001, J IMMUNOL, V167, P21, DOI 10.4049/jimmunol.167.1.21; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rasul I, 1999, HEPATOLOGY, V29, P543, DOI 10.1002/hep.510290224; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Sansonno D, 2005, LANCET INFECT DIS, V5, P227, DOI 10.1016/S1473-3099(05)70053-0; Sansonno D, 1998, J IMMUNOL, V160, P3594; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; Strasak AM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-15; Uchiyama M, 2003, J CLIN PATHOL, V56, P778, DOI 10.1136/jcp.56.10.778; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Yu MYW, 2004, P NATL ACAD SCI USA, V101, P7705, DOI 10.1073/pnas.0402458101; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; Zhang JS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000800; Zuckerman E, 2001, BRIT J HAEMATOL, V112, P364, DOI 10.1046/j.1365-2141.2001.02573.x	48	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25606	10.1371/journal.pone.0025606	http://dx.doi.org/10.1371/journal.pone.0025606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980500	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900079
J	Comte, J; del Giorgio, PA				Comte, Jerome; del Giorgio, Paul A.			Composition Influences the Pathway but not the Outcome of the Metabolic Response of Bacterioplankton to Resource Shifts	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; BACTERIAL COMMUNITIES; PRODUCTIVITY; BIODIVERSITY; TEMPERATURE; REDUNDANCY; DIVERSITY; MORTALITY; SALINITY; DYNAMICS	Bacterioplankton community metabolism is central to the functioning of aquatic ecosystems, and strongly reactive to changes in the environment, yet the processes underlying this response remain unclear. Here we explore the role that community composition plays in shaping the bacterial metabolic response to resource gradients that occur along aquatic ecotones in a complex watershed in Quebec. Our results show that the response is mediated by complex shifts in community structure, and structural equation analysis confirmed two main pathways, one involving adjustments in the level of activity of existing phylotypes, and the other the replacement of the dominant phylotypes. These contrasting response pathways were not determined by the type or the intensity of the gradients involved, as we had hypothesized, but rather it would appear that some compositional configurations may be intrinsically more plastic than others. Our results suggest that community composition determines this overall level of community plasticity, but that composition itself may be driven by factors independent of the environmental gradients themselves, such that the response of bacterial communities to a given type of gradient may alternate between the adjustment and replacement pathways. We conclude that community composition influences the pathways of response in these bacterial communities, but not the metabolic outcome itself, which is driven by the environment, and which can be attained through multiple alternative configurations.	[Comte, Jerome; del Giorgio, Paul A.] Univ Quebec, Dept Sci Biol, GRIL, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Comte, J (corresponding author), Univ Quebec, Dept Sci Biol, GRIL, CP 8888, Montreal, PQ H3C 3P8, Canada.	comte.jerome@courrier.uqam.ca	del Giorgio, Paul/AAD-1315-2019	del Giorgio, Paul/0000-0003-1866-8159; Comte, Jerome/0000-0002-7936-4290	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL AA, 2001, SCIENCE, V12, P221; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Alonso-Saez L, 2007, AQUAT MICROB ECOL, V46, P43, DOI 10.3354/ame046043; [Anonymous], 2002, CAUSE CORRELATION BI; Apple JK, 2008, J COASTAL RES, P59, DOI 10.2112/SI55-005.1; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bertilsson S, 2007, ISME J, V1, P532, DOI 10.1038/ismej.2007.64; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Button DK, 2004, APPL ENVIRON MICROB, V70, P5511, DOI 10.1128/AEM.70.9.5511-5521.2004; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Comte J, 2010, ECOLOGY, V91, P1466, DOI 10.1890/09-0848.1; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; Corno G, 2008, ENVIRON MICROBIOL, V10, P2857, DOI 10.1111/j.1462-2920.2008.01713.x; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; del Giorgio P. A., 2008, MICROBIAL ECOLOGY OC, P243, DOI DOI 10.1002/9780470281840.CH8; del Giorgio PA, 2002, LIMNOL OCEANOGR, V47, P471, DOI 10.4319/lo.2002.47.2.0471; Ducklow H, 2008, AQUAT MICROB ECOL, V53, P13, DOI 10.3354/ame01220; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Findlay SEG, 2003, LIMNOL OCEANOGR, V48, P1608, DOI 10.4319/lo.2003.48.4.1608; Fisher MM, 2000, MICROBIAL ECOL, V40, P125, DOI 10.1007/s002480000049; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Kirchman DL, 2004, AQUAT MICROB ECOL, V35, P243, DOI 10.3354/ame035243; Kritzberg ES, 2006, FEMS MICROBIOL ECOL, V56, P406, DOI 10.1111/j.1574-6941.2006.00084.x; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Lennon JT, 2008, ECOLOGY, V89, P1001, DOI 10.1890/07-1380.1; Longnecker K, 2005, APPL ENVIRON MICROB, V71, P7737, DOI 10.1128/AEM.71.12.7737-7749.2005; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Meyer AF, 2004, APPL ENVIRON MICROB, V70, P483, DOI 10.1128/AEM.70.1.483-489.2004; Mills AL, 2003, 2003012509 SAE INT; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Nelson CE, 2009, ISME J, V3, P13, DOI 10.1038/ismej.2008.81; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 1998, GLOBAL CHANGE BIOL, V4, P745, DOI 10.1046/j.1365-2486.1998.00195.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vrede K, 2005, MICROB ECOL, V49, P245, DOI 10.1007/s00248-004-0259-4; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	49	52	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25266	10.1371/journal.pone.0025266	http://dx.doi.org/10.1371/journal.pone.0025266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980410	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700023
J	Soichot, M; Hennart, B; Al Saabi, A; Leloire, A; Froguel, P; Levy-Marchal, C; Poulain-Godefroy, O; Allorge, D				Soichot, Marion; Hennart, Benjamin; Al Saabi, Alaa; Leloire, Audrey; Froguel, Philippe; Levy-Marchal, Claire; Poulain-Godefroy, Odile; Allorge, Delphine			Identification of a Variable Number of Tandem Repeats Polymorphism and Characterization of LEF-1 Response Elements in the Promoter of the IDO1 Gene	PLOS ONE			English	Article							SERUM KYNURENINE/TRYPTOPHAN RATIO; INDOLEAMINE 2,3-DIOXYGENASE GENE; ALLOGENEIC FETAL REJECTION; INTERFERON-GAMMA; IFN-GAMMA; TRYPTOPHAN CATABOLITES; IMMUNE TOLERANCE; DENDRITIC CELLS; EXPRESSION; DIOXYGENASE	Background: Indoleamine 2,3-dioxygenase (IDO) catalyzes the first and rate-limiting step of the kynurenine pathway that is an important component of immunomodulatory and neuromodulatory processes. The IDO1 gene is highly inducible by IFN-gamma and TNF-alpha through interaction with cis-acting regulatory elements of the promoter region. Accordingly, functional polymorphisms in the IDO1 promoter could partly explain the interindividual variability in IDO expression that has been previously documented. Methodology/Principal Findings: A PCR-sequencing strategy, applied to DNA samples from healthy Caucasians, allowed us to identify a VNTR polymorphism in the IDO1 promoter, which correlates significantly with serum tryptophan concentration, controlled partially by IDO activity, in female subjects, but not in males. Although this VNTR does not appear to affect basal or cytokine-induced promoter activity in gene reporter assays, it contains novel cis-acting elements. Three putative LEF-1 binding sites, one being located within the VNTR repeat motif, were predicted in silico and confirmed by chromatin immunoprecipitation. Overexpression of LEF-1 in luciferase assays confirmed an interaction between LEF-1 and the predicted transcription factor binding sites, and modification of the LEF-1 core sequence within the VNTR repeat motif, by site-directed mutagenesis, resulted in an increase in promoter activity. Conclusions/Significance: The identification of a VNTR in the IDO1 promoter revealed a cis-acting element interacting with the most downstream factor of the Wnt signaling pathway, suggesting novel mechanisms of regulation of IDO1 expression. These data offer new insights, and suggest further studies, into the role of IDO in various pathological conditions, particularly in cancer where IDO and the Wnt pathway are strongly dysregulated.	[Soichot, Marion; Hennart, Benjamin; Al Saabi, Alaa; Allorge, Delphine] Univ Lille Nord France, UDSL, Fac Med Lille, Equipe Accueil 4483, Lille, France; [Leloire, Audrey; Froguel, Philippe; Poulain-Godefroy, Odile] Univ Lille 2, Inst Pasteur, CNRS Inst Biol 8199, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Levy-Marchal, Claire] Hop Robert Debre, CIC EC 05, Inst Natl Sante & Rech Med, F-75019 Paris, France	Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Soichot, M (corresponding author), Univ Lille Nord France, UDSL, Fac Med Lille, Equipe Accueil 4483, Lille, France.	dallorge@univ-lille2.fr	FROGUEL, Philippe/O-6799-2017; Poulain-Godefroy, Odile/AAF-5474-2021	FROGUEL, Philippe/0000-0003-2972-0784; POULAIN-GODEFROY, Odile/0000-0001-8805-9450; allorge, delphine/0000-0003-2356-3319; HENNART, Benjamin/0000-0003-0302-6049	Universite Lille-Nord de France; Centre Hospitalier et Universitaire de Lille; Conseil Regional Nord-Pas de Calais; CHRU de Lille; MRC [G0700342] Funding Source: UKRI; Medical Research Council [G0700342] Funding Source: researchfish	Universite Lille-Nord de France; Centre Hospitalier et Universitaire de Lille; Conseil Regional Nord-Pas de Calais(Region Hauts-de-France); CHRU de Lille; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Universite Lille-Nord de France, the Centre Hospitalier et Universitaire de Lille and the Conseil Regional Nord-Pas de Calais. This work is part of a research program of the Pole Interdisciplinaire sur les Conduites Addictives (PIRCad). Marion Soichot is co-funded by the CHRU de Lille and the Conseil Regional Nord-Pas de Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Arefayene M, 2009, PHARMACOGENET GENOM, V19, P464, DOI 10.1097/FPC.0b013e32832c005a; Bonaccorso S, 2002, J CLIN PSYCHOPHARM, V22, P86, DOI 10.1097/00004714-200202000-00014; Bouatia-Naji N, 2009, EUR J ENDOCRINOL, V160, P557, DOI 10.1530/EJE-08-0794; Carretti N, 2005, HUM REPROD, V20, P1548, DOI 10.1093/humrep/deh795; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247; Corm S, 2009, LEUKEMIA RES, V33, P490, DOI 10.1016/j.leukres.2008.06.014; Hebenstreit D, 2008, J BIOL CHEM, V283, P22490, DOI 10.1074/jbc.M804096200; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Jaquet D, 2004, HORM RES, V62, P92, DOI 10.1159/000079709; Kato A, 2010, HEMODIAL INT, V14, P418, DOI 10.1111/j.1542-4758.2010.00464.x; Kawaguchi R, 2008, J REPROD IMMUNOL, V77, P117, DOI 10.1016/j.jri.2007.08.003; Konan KV, 1996, J BIOL CHEM, V271, P19140, DOI 10.1074/jbc.271.32.19140; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; Logters TT, 2009, SHOCK, V32, P29, DOI 10.1097/SHK.0b013e31819714fa; Macchiarulo A, 2009, AMINO ACIDS, V37, P219, DOI 10.1007/s00726-008-0137-3; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Muller AJ, 2005, EXPERT OPIN THER TAR, V9, P831, DOI 10.1517/14728222.9.4.831; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Murray MF, 2007, CURR DRUG METAB, V8, P197, DOI 10.2174/138920007780362509; Myint AM, 2009, METAB BRAIN DIS, V24, P55, DOI 10.1007/s11011-008-9114-5; Nemeth H, 2006, J NEURAL TRANSM-SUPP, P285; Nemeth Hajnalka, 2007, Central Nervous System Agents in Medicinal Chemistry, V7, P45, DOI 10.2174/187152407780059240; Nishizawa H, 2007, AM J REPROD IMMUNOL, V58, P11, DOI 10.1111/j.1600-0897.2007.00484.x; Nishizawa H, 2010, AM J REPROD IMMUNOL, V64, P68, DOI 10.1111/j.1600-0897.2010.00820.x; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; Oxenkrug G, 2011, J NEURAL TRANSM, V118, P271, DOI 10.1007/s00702-010-0525-1; Oxenkrug GF, 2007, ANN NY ACAD SCI, V1122, P35, DOI 10.1196/annals.1403.003; Oxenkrug GF, 2011, J NEURAL TRANSM, V118, P75, DOI 10.1007/s00702-010-0475-7; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Pertovaara M, 2007, CLIN EXP IMMUNOL, V148, P106, DOI 10.1111/j.1365-2249.2007.03325.x; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Raitala A, 2005, SCAND J IMMUNOL, V61, P387, DOI 10.1111/j.1365-3083.2005.01586.x; Robinson CM, 2005, J INTERF CYTOK RES, V25, P20, DOI 10.1089/jir.2005.25.20; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Robinson CM, 2006, CYTOKINE, V35, P53, DOI 10.1016/j.cyto.2006.07.007; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Suzuki Y, 2010, LUNG CANCER, V67, P361, DOI 10.1016/j.lungcan.2009.05.001; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Ueno A, 2007, DIABETES, V56, P1686, DOI 10.2337/db06-1727; Vonica A, 2000, DEV BIOL, V217, P230, DOI 10.1006/dbio.1999.9551; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Zhu BT, 2010, INT J MOL MED, V25, P831, DOI 10.3892/ijmm_00000411; Zhu WH, 2007, MULT SCLER J, V13, P33, DOI 10.1177/1352458506071171	55	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25470	10.1371/journal.pone.0025470	http://dx.doi.org/10.1371/journal.pone.0025470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980470	Green Published, gold, Green Submitted			2022-12-27	WOS:000295933700039
J	Trotter, EW; Rolfe, MD; Hounslow, AM; Craven, CJ; Williamson, MP; Sanguinetti, G; Poole, RK; Green, J				Trotter, Eleanor W.; Rolfe, Matthew D.; Hounslow, Andrea M.; Craven, C. Jeremy; Williamson, Michael P.; Sanguinetti, Guido; Poole, Robert K.; Green, Jeffrey			Reprogramming of Escherichia coli K-12 Metabolism during the Initial Phase of Transition from an Anaerobic to a Micro-Aerobic Environment	PLOS ONE			English	Article							OXYGEN AVAILABILITY; TRANSCRIPTION; ACTIVATION; EXPRESSION; OPERON; PDHR	Background: Many bacteria undergo transitions between environments with differing O-2 availabilities as part of their natural lifestyles and during biotechnological processes. However, the dynamics of adaptation when bacteria experience changes in O-2 availability are understudied. The model bacterium and facultative anaerobe Escherichia coli K-12 provides an ideal system for exploring this process. Methods and Findings: Time-resolved transcript profiles of E. coli K-12 during the initial phase of transition from anaerobic to micro-aerobic conditions revealed a reprogramming of gene expression consistent with a switch from fermentative to respiratory metabolism. The changes in transcript abundance were matched by changes in the abundances of selected central metabolic proteins. A probabilistic state space model was used to infer the activities of two key regulators, FNR (O-2 sensing) and PdhR (pyruvate sensing). The model implied that both regulators were rapidly inactivated during the transition from an anaerobic to a micro-aerobic environment. Analysis of the external metabolome and protein levels suggested that the cultures transit through different physiological states during the process of adaptation, characterized by the rapid inactivation of pyruvate formate-lyase (PFL), a slower induction of pyruvate dehydrogenase complex (PDHC) activity and transient excretion of pyruvate, consistent with the predicted inactivation of PdhR and FNR. Conclusion: Perturbation of anaerobic steady-state cultures by introduction of a limited supply of O-2 combined with time-resolved transcript, protein and metabolite profiling, and probabilistic modeling has revealed that pyruvate (sensed by PdhR) is a key metabolic signal in coordinating the reprogramming of E. coli K-12 gene expression by working alongside the O-2 sensor FNR during transition from anaerobic to micro-aerobic conditions.	[Trotter, Eleanor W.; Rolfe, Matthew D.; Hounslow, Andrea M.; Craven, C. Jeremy; Williamson, Michael P.; Poole, Robert K.; Green, Jeffrey] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sanguinetti, Guido] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Sheffield; University of Edinburgh	Trotter, EW (corresponding author), Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	jeff.green@sheffield.ac.uk		Williamson, Mike/0000-0001-5572-1903	Biotechnology and Biological Sciences Research Council UK [BB/E019943/1]; SysMO initiative; BBSRC [BB/E019943/1, BB/F003463/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003463/1, BB/E019943/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SysMO initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Biotechnology and Biological Sciences Research Council UK (grant number BB/E019943/1, bbsrc.ac.uk) and the SysMO initiative (www.sysmo.net) for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Asif HMS, 2010, BIOINFORMATICS, V26, P2635, DOI 10.1093/bioinformatics/btq469; Bock A., 1996, ESCHERICHIA COLI SAL, V2, P262; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Evans CGT, 1970, METHOD MICROBIOL, V2, P278; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guest John R., 1996, P317; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; KESSLER D, 1992, J BIOL CHEM, V267, P18073; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marshall FA, 2001, MOL MICROBIOL, V39, P747, DOI 10.1046/j.1365-2958.2001.02262.x; Ogasawara H, 2007, J BACTERIOL, V189, P5534, DOI 10.1128/JB.00229-07; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; QUAIL MA, 1995, MOL MICROBIOL, V15, P519, DOI 10.1111/j.1365-2958.1995.tb02265.x; Reyes-Ramirez F, 2006, FEMS MICROBIOL LETT, V255, P262, DOI 10.1111/j.1574-6968.2005.00077.x; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sawers G, 1999, CURR OPIN MICROBIOL, V2, P181, DOI 10.1016/S1369-5274(99)80032-0; Taymaz-Nikerel H, 2010, BIOTECHNOL BIOENG, V107, P369, DOI 10.1002/bit.22802; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; Wyborn NR, 2002, MICROBIOL-SGM, V148, P1015, DOI 10.1099/00221287-148-4-1015	25	44	45	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25501	10.1371/journal.pone.0025501	http://dx.doi.org/10.1371/journal.pone.0025501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980479	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000295933700040
J	Amit, M; Collins, MT; FitzGibbon, EJ; Butman, JA; Fliss, DM; Gil, Z				Amit, Moran; Collins, Michael T.; FitzGibbon, Edmond J.; Butman, John A.; Fliss, Dan M.; Gil, Ziv			Surgery versus Watchful Waiting in Patients with Craniofacial Fibrous Dysplasia - a Meta-Analysis	PLOS ONE			English	Article							OPTIC-NERVE DECOMPRESSION; MCCUNE-ALBRIGHT-SYNDROME; STIMULATORY G-PROTEIN; SURGICAL-TREATMENT; PRECOCIOUS PUBERTY; VISUAL-LOSS; SKULL BASE; COMPLICATIONS; PIGMENTATION; BLINDNESS	Background: Fibrous dysplasia (FD) is a benign bone tumor which most commonly involves the craniofacial skeleton. The most devastating consequence of craniofacial FD (CFD) is loss of vision due to optic nerve compression (ONC). Radiological evidence of ONC is common, however the management of this condition is not well established. Our objective was to compare the long-term outcome of patients with optic nerve compression (ONC) due to craniofacial fibrous dysplasia (CFD) who either underwent surgery or were managed expectantly. Methodology/Principal Findings: We performed a meta-analysis of 27 studies along with analysis of the records of a cohort of patients enrolled in National Institutes of Health (NIH) protocol 98-D-0145, entitled Screening and Natural History of Fibrous Dysplasia, with a diagnosis of CFD. The study group consisted of 241 patients; 122 were enrolled in the NIH study and 119 were extracted from cases published in the literature. The median follow-up period was 54 months (range, 6-228 months). A total of 368 optic nerves were investigated. All clinically impaired optic nerves (n = 86, 23.3%) underwent therapeutic decompression. Of the 282 clinically intact nerves, 41 (15%) were surgically decompressed and 241 (85%) were followed expectantly. Improvement in visual function was reported in fifty-eight (67.4%) of the clinically impaired nerves after surgery. In the intact nerves group, long-term stable vision was achieved in 31/45 (75.6%) of the operated nerves, compared to 229/241 (95.1%) of the non-operated ones (p = 0.0003). Surgery in asymptomatic patients was associated with visual deterioration (RR 4.89; 95% CI 2.26-10.59). Conclusions: Most patients with CFD will remain asymptomatic during long-term follow-up. Expectant management is recommended in asymptomatic patients even in the presence of radiological evidence of ONC.	[Amit, Moran; Fliss, Dan M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Dept Otolaryngol Head & Neck Surg, IL-69978 Tel Aviv, Israel; [Collins, Michael T.] Natl Inst Dent & Craniofacial Res, Skeletal Clin Studies Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [FitzGibbon, Edmond J.] NEI, NIH, Bethesda, MD 20892 USA; [Butman, John A.] NIH, Dept Diagnost Radiol, Bethesda, MD 20892 USA; [Gil, Ziv] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Head & Neck Surg Unit, IL-69978 Tel Aviv, Israel; [Gil, Ziv] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Lab Appl Canc Res, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Amit, M (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Dept Otolaryngol Head & Neck Surg, IL-69978 Tel Aviv, Israel.	mc247k@nih.gov; ziv@baseofskull.org	Butman, John/J-2780-2013; Butman, John A/A-2694-2008	Butman, John/0000-0002-1547-9195; 	Israel Science Foundation [1680/08]; Israel Cancer Association [20090068]; Israeli Ministry of Health [3-7355]; Weizmann Institute - Sourasky Medical Center; Tel Aviv Sourasky Intramural Grant; US-Israel Binational Science Foundation [2007312]; Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA; NATIONAL EYE INSTITUTE [ZIAEY000388] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israeli Ministry of Health; Weizmann Institute - Sourasky Medical Center; Tel Aviv Sourasky Intramural Grant; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation (No. 1680/08), the Israel Cancer Association (grant donated by Ellan and Emanuel Kronitz in memory of Dr Leon Kronitz No. 20090068), the Israeli Ministry of Health (No. 3-7355), the Weizmann Institute - Sourasky Medical Center Joint Grant, the Tel Aviv Sourasky Intramural Grant (all to Z.G.) and by a grant from the US-Israel Binational Science Foundation (No. 2007312) to Z.G., R.J.W. and Y.F. This work was supported in part by funding from the Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, SKULL BASE-INTERD AP, V16, P145, DOI 10.1055/s-2006-949517; Albright F, 1937, NEW ENGL J MED, V216, P727, DOI 10.1056/NEJM193704292161701; BIBBY K, 1994, BRIT J OPHTHALMOL, V78, P266, DOI 10.1136/bjo.78.4.266; Bocca G, 1998, ACTA PAEDIATR, V87, P599, DOI 10.1080/08035259850158371; Chao K, 2008, J NEUROSURG, V109, P889, DOI 10.3171/JNS/2008/109/11/0889; Chen YR, 1997, PLAST RECONSTR SURG, V99, P22, DOI 10.1097/00006534-199701000-00004; Cruz AAV, 2007, OPHTHAL PLAST RECONS, V23, P450, DOI 10.1097/IOP.0b013e318158e9a8; Cutler CM, 2006, NEUROSURGERY, V59, P1011; DOWLER JGF, 1995, BRIT J OPHTHALMOL, V79, P503, DOI 10.1136/bjo.79.5.503; Edelstein C, 1998, AM J OPHTHALMOL, V126, P469, DOI 10.1016/S0002-9394(98)00118-4; EDGERTON MT, 1985, ANN SURG, V202, P459, DOI 10.1097/00000658-198510000-00007; Fujimoto A, 2004, J CLIN NEUROSCI, V11, P95, DOI 10.1016/j.jocn.2002.12.004; Glover M, 2010, ENDOCR REV, V31; Goisis M, 2006, OPHTHAL PLAST RECONS, V22, P383, DOI 10.1097/01.iop.0000229761.37416.3e; Horgan MA, 1999, BRIT J NEUROSURG, V13, P335; Kelly MH, 2008, OSTEOPOROSIS INT, V19, P57, DOI 10.1007/s00198-007-0425-x; Kurimoto Masanori, 1996, Neurologia Medico-Chirurgica, V36, P102, DOI 10.2176/nmc.36.102; KUROKAWA Y, 1989, SURG NEUROL, V32, P421, DOI 10.1016/0090-3019(89)90004-9; Lee JS, 2002, NEW ENGL J MED, V347, P1670, DOI 10.1056/NEJMoa020742; Lei P, 2009, SURG NEUROL, V72, pS17, DOI 10.1016/j.surneu.2008.03.041; LIAKOS GM, 1979, BRIT J OPHTHALMOL, V63, P611, DOI 10.1136/bjo.63.9.611; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lustig LR, 2001, ARCH OTOLARYNGOL, V127, P1239, DOI 10.1001/archotol.127.10.1239; Maher CO, 2002, PEDIATR NEUROSURG, V37, P87, DOI 10.1159/000065110; MCCLUSKEY P, 1993, BRIT J OPHTHALMOL, V77, P54, DOI 10.1136/bjo.77.1.54; McCune DJ, 1937, AM J DIS CHILD, V54, P806, DOI 10.1001/archpedi.1937.01980040110009; Michael CB, 2000, J NEUROSURG, V92, P350, DOI 10.3171/jns.2000.92.2.0350; MISRA M, 1990, Indian Journal of Ophthalmology, V38, P39; Movassaghi K, 2005, ANN PLAS SURG, V54, P331, DOI 10.1097/01.sap.0000139570.15897.79; OSGUTHORPE JD, 1987, OTOLARYNG HEAD NECK, V97, P403, DOI 10.1177/019459988709700412; Panda NK, 2007, OTOLARYNG HEAD NECK, V136, P928, DOI 10.1016/j.otohns.2007.01.031; PAPAY FA, 1995, J CRANIOFAC SURG, V6, P5, DOI 10.1097/00001665-199501000-00004; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Sharma RR, 2002, J CLIN NEUROSCI, V9, P381, DOI 10.1054/jocn.2002.1056; Tabrizi R, 2008, J CRANIOFAC SURG, V19, P1532, DOI 10.1097/SCS.0b013e31818ac270; Tajima T, 2008, ENDOCR J, V55, P595, DOI 10.1507/endocrj.K07E-042; Tan YC, 2007, PLAST RECONSTR SURG, V120, P1957, DOI 10.1097/01.prs.0000287338.28018.c7; Thomas C, 2001, J CRANIOFAC SURG, V12, P247, DOI 10.1097/00001665-200105000-00010; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Yang XX, 2009, J CRANIOFAC SURG, V20, P1831, DOI 10.1097/SCS.0b013e3181b6d82e	40	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25179	10.1371/journal.pone.0025179	http://dx.doi.org/10.1371/journal.pone.0025179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966448	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100025
J	Alessandri, AL; Duffin, R; Leitch, AE; Lucas, CD; Sheldrake, TA; Dorward, DA; Hirani, N; Pinho, V; de Sousa, LP; Teixeira, MM; Lyons, JF; Haslett, C; Rossi, AG				Alessandri, Ana L.; Duffin, Rodger; Leitch, Andrew E.; Lucas, Christopher D.; Sheldrake, Tara A.; Dorward, David A.; Hirani, Nik; Pinho, Vanessa; de Sousa, Lirlandia Pires; Teixeira, Mauro M.; Lyons, John F.; Haslett, Christopher; Rossi, Adriano G.			Induction of Eosinophil Apoptosis by the Cyclin-Dependent Kinase Inhibitor AT7519 Promotes the Resolution of Eosinophil-Dominant Allergic Inflammation	PLOS ONE			English	Article							KAPPA-B ACTIVATION; GRANULOCYTE APOPTOSIS; R-ROSCOVITINE; IN-VITRO; MACROPHAGE PHAGOCYTOSIS; NEUTROPHIL APOPTOSIS; AIRWAY INFLAMMATION; CASPASE INHIBITOR; CELL APOPTOSIS; TNF-ALPHA	Background: Eosinophils not only defend the body against parasitic infection but are also involved in pathological inflammatory allergic diseases such as asthma, allergic rhinitis and contact dermatitis. Clearance of apoptotic eosinophils by macrophages is a key process responsible for driving the resolution of eosinophilic inflammation and can be defective in allergic diseases. However, enhanced resolution of eosinophilic inflammation by deliberate induction of eosinophil apoptosis using pharmacological agents has not been previously demonstrated. Here we investigated the effect of a novel cyclin-dependent kinase inhibitor drug, AT7519, on human and mouse eosinophil apoptosis and examined whether it could enhance the resolution of a murine model of eosinophil-dominant inflammation in vivo. Methodology/Principal Findings: Eosinophils from blood of healthy donors were treated with AT7519 and apoptosis assessed morphologically and by flow-cytometric detection of annexin-V/propidium iodide staining. AT7519 induced eosinophil apoptosis in a concentration dependent manner. Therapeutic administration of AT7519 in eosinophil-dominant allergic inflammation was investigated using an established ovalbumin-sensitised mouse model of allergic pleurisy. Following ovalbumin challenge AT7519 was administered systemically at the peak of pleural inflammation and inflammatory cell infiltrate, apoptosis and evidence of macrophage phagocytosis of apoptotic eosinophils assessed at appropriate time points. Administration of AT7519 dramatically enhanced the resolution of allergic pleurisy via direct induction of eosinophil apoptosis without detriment to macrophage clearance of these cells. This enhanced resolution of inflammation was shown to be caspase-dependent as the effects of AT7519 were reduced by treatment with a broad spectrum caspase inhibitor (z-vad-fmk). Conclusions: Our data show that AT7519 induces human eosinophil apoptosis and enhances the resolution of a murine model of allergic pleurisy by inducing caspase-dependent eosinophil apoptosis and enhancing macrophage ingestion of apoptotic eosinophils. These findings demonstrate the utility of cyclin-dependent kinase inhibitors such as AT7519 as potential therapeutic agents for the treatment of eosinophil dominant allergic disorders.	[Alessandri, Ana L.; Duffin, Rodger; Leitch, Andrew E.; Lucas, Christopher D.; Sheldrake, Tara A.; Dorward, David A.; Hirani, Nik; Haslett, Christopher; Rossi, Adriano G.] Univ Edinburgh, Ctr Inflammat Res, Med Res Council, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Pinho, Vanessa; de Sousa, Lirlandia Pires; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Lyons, John F.] Astex Therapeut, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; Universidade Federal de Minas Gerais; Astex Pharmaceuticals	Alessandri, AL (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Med Res Council, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	rodger.duffin@ed.ac.uk	Dorward, David/K-8669-2012; Pinho, Vanessa/AAR-1686-2021; pinho, vanessa/AAC-8437-2020; Pinho, Vanessa/GXM-8532-2022; Teixeira, Mauro M/A-4587-2008	Dorward, David/0000-0002-4658-8829; pinho, vanessa/0000-0003-1038-2324; Teixeira, Mauro M/0000-0002-6944-3008; Sousa, Lirlandia/0000-0002-1042-9762; Duffin, Rodger/0000-0002-3425-9745; Lucas, Christopher/0000-0002-7523-0295	Medical Research Council [G0601481]; Wellcome Trust [WT082181, WT094415]; Chief Scientist Office (Scotland) [ETM/86]; MRC [G0901697, G0701740, G0601481] Funding Source: UKRI; Medical Research Council [G0701740, G9900991B, G0901697] Funding Source: researchfish; Chief Scientist Office [ETM/86] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office (Scotland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was funded by a Medical Research Council grant (G0601481) and Wellcome Trust grants (WT082181) and (WT094415). ALA is currently funded through a Chief Scientist Office (Scotland) awarded research grant: ETM/86. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; BRADLEY BL, 1991, J ALLERGY CLIN IMMUN, V88, P661, DOI 10.1016/0091-6749(91)90160-P; Brazil TJ, 2005, CLIN EXP ALLERGY, V35, P854, DOI 10.1111/j.1365-2222.2005.02231.x; Brode S, 2010, THORAX, V65, P1116, DOI 10.1136/thx.2009.124909; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Duffin R, 2009, FEBS LETT, V583, P2540, DOI 10.1016/j.febslet.2009.07.017; Duncan CJA, 2003, EUR RESPIR J, V22, P484, DOI 10.1183/09031936.03.00109803a; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Farahi N, 2011, CLIN EXP ALLERGY, V41, P673, DOI 10.1111/j.1365-2222.2010.03680.x; Fitzpatrick AM, 2008, J ALLERGY CLIN IMMUN, V121, P1372, DOI 10.1016/j.jaci.2008.03.008; Fujihara S, 2002, EUR J IMMUNOL, V32, P457, DOI 10.1002/1521-4141(200202)32:2<457::AID-IMMU457>3.0.CO;2-1; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Hallett JM, 2008, TRENDS PHARMACOL SCI, V29, P250, DOI 10.1016/j.tips.2008.03.002; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; HASLETT C, 1985, AM J PATHOL, V119, P101; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Kuwano K, 2001, AM J PHYSIOL-LUNG C, V280, pL316, DOI 10.1152/ajplung.2001.280.2.L316; Leitch AE, 2008, MUCOSAL IMMUNOL, V1, P350, DOI 10.1038/mi.2008.31; Leitch AE, 2009, BRIT J PHARMACOL, V158, P1004, DOI 10.1111/j.1476-5381.2009.00402.x; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; MAHADEVAN D, 2011, ANN ONCOL, V16; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Mersmann J, 2008, RESUSCITATION, V79, P468, DOI 10.1016/j.resuscitation.2008.07.008; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Persson C, 2010, THORAX, V65, P1111, DOI 10.1136/thx.2009.133363; Pinho V, 2005, J LEUKOCYTE BIOL, V77, P800, DOI 10.1189/jlb.0704386; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Santo L, 2010, ONCOGENE, V29, P2325, DOI 10.1038/onc.2009.510; Senderowicz AM, 2003, CANCER BIOL THER, V2, pS84; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Simon HU, 2001, IMMUNOL REV, V179, P156, DOI 10.1034/j.1600-065X.2001.790115.x; Sousa LP, 2010, J LEUKOCYTE BIOL, V87, P895, DOI 10.1189/jlb.0809540; Squires MS, 2010, MOL CANCER THER, V9, P920, DOI 10.1158/1535-7163.MCT-09-1071; Squires MS, 2009, MOL CANCER THER, V8, P324, DOI 10.1158/1535-7163.MCT-08-0890; Venge P, 2010, CLIN RESPIR J, V4, P15, DOI 10.1111/j.1752-699X.2010.00192.x; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; Woolley KL, 1996, AM J RESP CRIT CARE, V154, P237, DOI 10.1164/ajrccm.154.1.8680686; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h	52	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25683	10.1371/journal.pone.0025683	http://dx.doi.org/10.1371/journal.pone.0025683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984938	gold, Green Published, Green Submitted			2022-12-27	WOS:000295941300048
J	Olmedillas, H; Gonzalez-Aguero, A; Moreno, LA; Casajus, JA; Vicente-Rodriguez, G				Olmedillas, Hugo; Gonzalez-Agueero, Alejandro; Moreno, Luis A.; Casajus, Jose A.; Vicente-Rodriguez, German			Bone Related Health Status in Adolescent Cyclists	PLOS ONE			English	Article							MINERAL DENSITY; PHYSICAL-ACTIVITY; MASTER CYCLISTS; MUSCLE MASS; EXERCISE; ACQUISITION; GROWTH; WOMEN; GIRLS; RISK	Purpose: To describe bone status and analyse bone mass in adolescent cyclists. Methods: Male road cyclists (n = 22) who had been training for a minimum of 2 years and a maximum of 7 years with a volume of 10 h/w, were compared to age-matched controls (n = 22) involved in recreational sports activities. Subjects were divided in 2 groups based on age: adolescents under 17 yrs (cyclists, n = 11; controls, n = 13) and over 17 yrs (cyclists, n = 11; controls, n = 9). Peak oxygen uptake (VO(2)max) was measured on a cycloergometer. Whole body, lumbar spine, and hip bone mineral content (BMC), density (BMD) and bone area were assessed using dual x-ray absorptiometry (DXA). Volumetric BMD (vBMD) and bone mineral apparent density (BMAD) were also estimated. Results: The BMC of cyclists was lower for the whole body, pelvis, femoral neck and legs; BMD for the pelvis, hip, legs and whole body and legs bone area was lower but higher in the hip area (all, P <= 0.05) after adjusting by lean mass and height. The BMC of young cyclists was 10% lower in the leg and 8% higher in the hip area than young controls (P <= 0.05). The BMC of cyclists over 17 yrs was 26.5%, 15.8% and 14.4% lower BMC at the pelvis, femoral neck and legs respectively while the BMD was 8.9% to 24.5% lower for the whole body, pelvis, total hip, trochanter, intertrochanter, femoral neck and legs and 17.1% lower the vBMD at the femoral neck (all P <= 0.05). Grouped by age interaction was found in both pelvis and hip BMC and BMD and in femoral neck vBMD (all P <= 0.05). Conclusion: Cycling performed throughout adolescence may negatively affect bone health, then compromising the acquisition of peak bone mass.	[Olmedillas, Hugo; Gonzalez-Agueero, Alejandro; Moreno, Luis A.; Casajus, Jose A.; Vicente-Rodriguez, German] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Olmedillas, Hugo; Gonzalez-Agueero, Alejandro; Casajus, Jose A.; Vicente-Rodriguez, German] Univ Zaragoza, Dept Psychiat & Nursing, Fac Hlth & Sport Sci FCSD, Huesca, Spain; [Moreno, Luis A.] Univ Zaragoza, Sch Hlth Sci EUCS, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza	Olmedillas, H (corresponding author), Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain.	hugo.olmedillas@gmail.com	Moreno, Luis/S-1780-2019; Olmedillas, Hugo/F-4809-2015; Vicente-Rodriguez, German/J-9846-2016	Moreno, Luis/0000-0003-0454-653X; Olmedillas, Hugo/0000-0003-4625-2759; Vicente-Rodriguez, German/0000-0002-4303-4097; Casajus Mallen, Jose Antonio/0000-0002-7215-6931; Gonzalez-Aguero, Alex/0000-0002-1132-5906	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III [DPS2008-06999]; Presidencia del Gobierno de Espana, Consejo Superior de Deportes [21/UPB20/10]	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Presidencia del Gobierno de Espana, Consejo Superior de Deportes	This work has been funded by Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (DPS2008-06999) and Presidencia del Gobierno de Espana, Consejo Superior de Deportes (21/UPB20/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach LK, 1999, J CLIN ENDOCR METAB, V84, P4702, DOI 10.1210/jc.84.12.4702; BASSEY EJ, 1995, BONE, V16, P469; Beghin L, 2008, INT J OBESITY, V32, pS12, DOI 10.1038/ijo.2008.179; Calbet JAL, 2001, MED SCI SPORT EXER, V33, P1682, DOI 10.1097/00005768-200110000-00011; de Geus B, 2008, SCAND J MED SCI SPOR, V18, P498, DOI 10.1111/j.1600-0838.2007.00729.x; Dorado C, 2002, J SPORT SCI, V20, P591, DOI 10.1080/026404102320183149; Ducher G, 2009, MED SCI SPORT EXER, V41, P1975, DOI 10.1249/MSS.0b013e3181af2764; Duncan CS, 2002, MED SCI SPORT EXER, V34, P286, DOI 10.1097/00005768-200202000-00017; Duncan CS, 2002, MED SCI SPORT EXER, V34, P673, DOI 10.1097/00005768-200204000-00018; Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017; GOULET GC, 2011, CALCIF TISSUE INT; Gravholt CH, 2002, J CLIN ENDOCR METAB, V87, P2798, DOI 10.1210/jc.87.6.2798; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Lauritzen JB, 1996, BONE, V18, pS65, DOI 10.1016/8756-3282(95)00382-7; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Medelli J, 2009, J CLIN DENSITOM, V12, P28, DOI 10.1016/j.jocd.2008.07.057; Morel J, 2001, OSTEOPOROSIS INT, V12, P152, DOI 10.1007/s001980170148; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nevill AM, 2004, J SPORT SCI, V22, P645, DOI 10.1080/02640410310001655769; Nichols JF, 2003, OSTEOPOROSIS INT, V14, P644, DOI 10.1007/s00198-003-1418-z; NICHOLS JF, 2010, J STRENGTH COND RES; Rector RS, 2008, METABOLISM, V57, P226, DOI 10.1016/j.metabol.2007.09.005; RICO H, 1993, BONE, V14, P93, DOI 10.1016/8756-3282(93)90233-Z; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Sanchis-Moysi J, 2010, EUR J APPL PHYSIOL, V110, P83, DOI 10.1007/s00421-010-1470-2; SLEMENDA CW, 1994, J PEDIATR-US, V125, P201, DOI 10.1016/S0022-3476(94)70193-8; Vicente-Rodriguez G, 2007, INT J SPORTS MED, V28, P386, DOI 10.1055/s-2006-924397; Vicente-Rodriguez G, 2005, BRIT J SPORT MED, V39, P611, DOI 10.1136/bjsm.2004.014431; Vicente-Rodriguez G, 2004, BONE, V35, P1208, DOI 10.1016/j.bone.2004.06.012; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; Warner SE, 2002, BONE, V30, P281, DOI 10.1016/S8756-3282(01)00704-9; Wilks DC, 2009, MED SCI SPORT EXER, V41, P566, DOI 10.1249/MSS.0b013e31818a0ec8	34	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24841	10.1371/journal.pone.0024841	http://dx.doi.org/10.1371/journal.pone.0024841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980360	Green Published, gold			2022-12-27	WOS:000295941300011
J	Glaser, R; Andridge, R; Yang, EV; Shana'ah, AY; Di Gregorio, M; Chen, M; Johnson, SL; De Renne, LA; Lambert, DR; Jewell, SD; Bechtel, MA; Hearne, DW; Herron, JB; Kiecolt-Glaser, JK				Glaser, Ronald; Andridge, Rebecca; Yang, Eric V.; Shana'ah, Arwa Y.; Di Gregorio, Michael; Chen, Min; Johnson, Sheri L.; De Renne, Lawrence A.; Lambert, David R.; Jewell, Scott D.; Bechtel, Mark A.; Hearne, Dean W.; Herron, Joel Bain; Kiecolt-Glaser, Janice K.			Tumor Site Immune Markers Associated with Risk for Subsequent Basal Cell Carcinomas	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; ULTRAVIOLET-RADIATION; REGRESSION; MELANOMA; HISTORY; SUN	Background: Basal cell carcinoma (BCC) tumors are the most common skin cancer and are highly immunogenic. Objective:The goal of this study was to assess how immune-cell related gene expression in an initial BCC tumor biopsy was related to the appearance of subsequent BCC tumors. Materials and Methods: Levels of mRNA for CD3 epsilon; (a T-cell receptor marker), CD25 (the alpha chain of the interleukin (IL)-2 receptor expressed on activated T-cells and B-cells), CD68 (a marker for monocytes/macrophages), the cell surface glycoprotein intercellular adhesion molecule-1 (ICAM-1), the cytokine interferon-7 (IFN-gamma) and the anti-inflammatory cytokine IL-10 were measured in BCC tumor biopsies from 138 patients using real-time PCR. Results:The median follow-up was 26.6 months, and 61% of subjects were free of new BCCs two years post-initial biopsy. Patients with low CD3 epsilon CD25, CD68, and ICAM-1 mRNA levels had significantly shorter times before new tumors were detected (p = 0.03, p = 0.02, p = 0.003, and p = 0.08, respectively). Furthermore, older age diminished the association of mRNA levels with the appearance of subsequent tumors. Conclusions: Our results show that levels of CDR, CD25, CD68, and ICAM-1 mRNA in BCC biopsies may predict risk for new BCC tumors.	[Glaser, Ronald; Yang, Eric V.; Di Gregorio, Michael; Chen, Min; Kiecolt-Glaser, Janice K.] Ohio State Univ Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA; [Glaser, Ronald; Yang, Eric V.] Ohio State Univ Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH USA; [Glaser, Ronald; Lambert, David R.; Bechtel, Mark A.; Hearne, Dean W.; Herron, Joel Bain] Ohio State Univ Med Ctr, Dept Internal Med, Columbus, OH USA; [Glaser, Ronald; Yang, Eric V.] Ohio State Univ Med Ctr, Ctr Comprehens Canc, Columbus, OH USA; [Andridge, Rebecca] Ohio State Univ Coll Publ Hlth, Div Biostat, Columbus, OH USA; [Yang, Eric V.] Ohio State Univ Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH USA; [Shana'ah, Arwa Y.; De Renne, Lawrence A.; Jewell, Scott D.] Ohio State Univ Med Ctr, Dept Pathol, Columbus, OH USA; [Johnson, Sheri L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Lambert, David R.; Bechtel, Mark A.; Hearne, Dean W.; Herron, Joel Bain] Ohio State Univ Med Ctr, Div Dermatol, Columbus, OH USA; [Kiecolt-Glaser, Janice K.] Ohio State Univ Med Ctr, Dept Psychiat, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Berkeley; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Glaser, R (corresponding author), Ohio State Univ Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA.	Ronald.glaser@osumc.edu	Andridge, Rebecca Roberts/C-8457-2012; Kiecolt-Glaser, Janice K/A-3236-2009; Glaser, Ronald/E-3124-2011; Johnson, Sheri/D-8712-2014	Andridge, Rebecca Roberts/0000-0001-9991-9647; Kiecolt-Glaser, Janice K/0000-0003-4900-9578; Johnson, Sheri/0000-0002-9945-4816	National Cancer Institute [CA100243]; The Gilbert and Kathryn Mitchell Endowment; Ohio State University Comprehensive Cancer Center [CA16058]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA100243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Gilbert and Kathryn Mitchell Endowment; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a grant from the National Cancer Institute CA100243 (RG), The Gilbert and Kathryn Mitchell Endowment (RG), and in part by the Ohio State University Comprehensive Cancer Center, CA16058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2010, CANC FACTS FIG 2010; Barnes EA, 2005, ONCOGENE, V24, P902, DOI 10.1038/sj.onc.1208240; Cantwell MM, 2009, BRIT J CANCER, V100, P174, DOI 10.1038/sj.bjc.6604842; Carlson JA, 2002, J CUTAN PATHOL, V29, P268, DOI 10.1034/j.1600-0560.2002.290502.x; De Giorgi V, 2009, INT J DERMATOL, V48, P312, DOI 10.1111/j.1365-4632.2009.03916.x; Domingo DS, 2008, ADV EXP MED BIOL, V624, P187, DOI 10.1007/978-0-387-77574-6_15; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Fortina AB, 2004, ARCH DERMATOL, V140, P1079, DOI 10.1001/archderm.140.9.1079; Goppner D, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/650258; HALLIDAY GM, 1995, WORLD J SURG, V19, P352, DOI 10.1007/BF00299157; HUNT MJ, 1994, BRIT J DERMATOL, V130, P1, DOI 10.1111/j.1365-2133.1994.tb06873.x; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Kahn HS, 1998, JAMA-J AM MED ASSOC, V280, P910, DOI 10.1001/jama.280.10.910; Kaur P, 2006, AM J DERMATOPATH, V28, P293, DOI 10.1097/00000372-200608000-00002; Kiiski V, 2010, ARCH DERMATOL, V146, P848, DOI 10.1001/archdermatol.2010.155; KIM J, 1995, J IMMUNOL, V155, P2240; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; KRIPKE ML, 1994, CANCER RES, V54, P6102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcil I, 2000, ARCH DERMATOL, V136, P1524, DOI 10.1001/archderm.136.12.1524; Nugent Z, 2005, CANCER EPIDEM BIOMAR, V14, P2584, DOI 10.1158/1055-9965.EPI-05-0379; Paul J, 2011, AM J DERMATOPATH, V33, P152, DOI 10.1097/DAD.0b013e3181ef2d65; Rama I, 2010, NAT REV NEPHROL, V6, P511, DOI 10.1038/nrneph.2010.102; Rieger UM, 2009, TUMORI, V95, P258; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Rosenberg CA, 2004, CANCER, V100, P130, DOI 10.1002/cncr.11874; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schwarz A, 2004, J IMMUNOL, V172, P1036, DOI 10.4049/jimmunol.172.2.1036; Schwarz T, 1999, ALLERGY, V54, P1252, DOI 10.1034/j.1398-9995.1999.00105.x; Slominski A, 2007, J CLIN INVEST, V117, P3166, DOI 10.1172/JCI33508; Tessari G, 2010, ARCH DERMATOL, V146, P294, DOI 10.1001/archdermatol.2009.377; Uitto Jouni, 2008, J Drugs Dermatol, V7, ps12; Urosevic M, 2003, ARCH DERMATOL, V139, P1325, DOI 10.1001/archderm.139.10.1325; Wisgerhof HC, 2010, TRANSPLANTATION, V89, P1231, DOI 10.1097/TP.0b013e3181d84cdc; Wong DA, 2000, BRIT J DERMATOL, V143, P91, DOI 10.1046/j.1365-2133.2000.03596.x	35	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25160	10.1371/journal.pone.0025160	http://dx.doi.org/10.1371/journal.pone.0025160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980389	Green Published, gold			2022-12-27	WOS:000295939600013
J	Leache, AD				Leache, Adam D.			Multi-Locus Estimates of Population Structure and Migration in a Fence Lizard Hybrid Zone	PLOS ONE			English	Article							SCELOPORUS-UNDULATUS; GENUS SCELOPORUS; GENOTYPE DATA; DNA POLYMORPHISM; SPECIES GROUP; INFERENCE; GENETICS; MODEL	A hybrid zone between two species of lizards in the genus Sceloporus (S. cowlesi and S. tristichus) on the Mogollon Rim in Arizona provides a unique opportunity to study the processes of lineage divergence and merging. This hybrid zone involves complex interactions between 2 morphologically and ecologically divergent subspecies, 3 chromosomal groups, and 4 mitochondrial DNA (mtDNA) clades. The spatial patterns of divergence between morphology, chromosomes and mtDNA are discordant, and determining which of these character types (if any) reflects the underlying population-level lineages that are of interest has remained impeded by character conflict. The focus of this study is to estimate the number of populations interacting in the hybrid zone using multi-locus nuclear data, and to then estimate the migration rates and divergence time between the inferred populations. Multi-locus estimates of population structure and gene flow were obtained from 12 anonymous nuclear loci sequenced for 93 specimens of Sceloporus. Population structure estimates support two populations, and this result is robust to changes to the prior probability distribution used in the Bayesian analysis and the use of spatially-explicit or non-spatial models. A coalescent analysis of population divergence suggests that gene flow is high between the two populations, and that the timing of divergence is restricted to the Pleistocene. The hybrid zone is more accurately described as involving two populations belonging to S. tristichus, and the presence of S. cowlesi mtDNA haplotypes in the hybrid zone is an anomaly resulting from mitochondrial introgression.	[Leache, Adam D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Leache, Adam D.] Univ Washington, Burke Museum, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Leache, AD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	leache@uw.edu			National Science Foundation [DEB-0508929, DBI-0805455]; Chang-Lin Tien Graduate Fellowship in Biodiversity	National Science Foundation(National Science Foundation (NSF)); Chang-Lin Tien Graduate Fellowship in Biodiversity	Funding was provided by the National Science Foundation (DEB-0508929 and DBI-0805455) and the Chang-Lin Tien Graduate Fellowship in Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; COLE CJ, 1972, SYST ZOOL, V21, P357, DOI 10.2307/2412428; Falush D, 2003, GENETICS, V164, P1567; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Leache AD, 2009, CYTOGENET GENOME RES, V127, P166, DOI 10.1159/000293285; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Leache AD, 2007, MOL ECOL, V16, P5216, DOI 10.1111/j.1365-294X.2007.03556.x; Leache AD, 2007, MOL ECOL, V16, P1035, DOI 10.1111/j.1365-294X.2006.03194.x; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; Li N, 2003, GENETICS, V165, P2213; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; Pritchard JK, 2000, GENETICS, V155, P945; Rosenblum EB, 2007, MOL ECOL NOTES, V7, P113, DOI 10.1111/j.1471-8286.2006.01547.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SITES JW, 1992, B AM MUS NAT HIST, P1; Smith Hobart M., 1992, Bulletin of the Maryland Herpetological Society, V28, P123; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; TAJIMA F, 1989, GENETICS, V123, P597	23	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25827	10.1371/journal.pone.0025827	http://dx.doi.org/10.1371/journal.pone.0025827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980539	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600057
J	Lee, KH; Miller, CR; Nagel, AC; Wichman, HA; Joyce, P; Ytreberg, FM				Lee, Kuo Hao; Miller, Craig R.; Nagel, Anna C.; Wichman, Holly A.; Joyce, Paul; Ytreberg, F. Marty			First-Step Mutations for Adaptation at Elevated Temperature Increase Capsid Stability in a Virus	PLOS ONE			English	Article							PREDICTING PROTEIN STABILITY; INDUCED STRUCTURAL-CHANGES; STRANDED-DNA VIRUS; FREE-ENERGY; SCAFFOLDING PROTEINS; MOLECULAR-DYNAMICS; FUNCTIONAL IMPLICATIONS; ATOMIC-STRUCTURE; EVOLUTION; BACTERIOPHAGE-PHI-X174	The relationship between mutation, protein stability and protein function plays a central role in molecular evolution. Mutations tend to be destabilizing, including those that would confer novel functions such as host-switching or antibiotic resistance. Elevated temperature may play an important role in preadapting a protein for such novel functions by selecting for stabilizing mutations. In this study, we test the stability change conferred by single mutations that arise in a G4-like bacteriophage adapting to elevated temperature. The vast majority of these mutations map to interfaces between viral coat proteins suggesting they affect protein-protein interactions. We assess their effects by estimating thermodynamic stability using molecular dynamic simulations and measuring kinetic stability using experimental decay assays. The results indicate that most, though not all, of the observed mutations are stabilizing.	[Lee, Kuo Hao; Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID 83843 USA; [Miller, Craig R.; Nagel, Anna C.; Wichman, Holly A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Miller, Craig R.; Joyce, Paul] Univ Idaho, Dept Math, Moscow, ID 83843 USA; [Joyce, Paul] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Lee, Kuo Hao; Miller, Craig R.; Nagel, Anna C.; Wichman, Holly A.; Joyce, Paul; Ytreberg, F. Marty] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Lee, KH (corresponding author), Univ Idaho, Dept Phys, Moscow, ID 83843 USA.	ytreberg@uidaho.edu	Lee, Kuo Hao/H-9929-2019; Miller, Craig/GWQ-5012-2022		National Institutes of Health [P20RR016448-07S1, R01GM076040]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant P20RR016448-07S1 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Computational resources were provided by the Institute for Bioinformatics and Evolutionary Studies at University of Idaho. CRM and ACN were partially supported by grant R01GM076040 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Andricioaei I, 1996, PHYS REV E, V53, pR3055, DOI 10.1103/PhysRevE.53.R3055; Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bernal RA, 2003, J MOL BIOL, V325, P11, DOI 10.1016/S0022-2836(02)01201-9; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cherwa JE, 2008, J VIROL, V82, P5774, DOI 10.1128/JVI.02758-07; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; den Otter WK, 2000, J CHEM PHYS, V112, P7283, DOI 10.1063/1.481329; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dokland T, 1999, J MOL BIOL, V288, P595, DOI 10.1006/jmbi.1999.2699; EKECHUKWU MC, 1995, J BACTERIOL, V177, P829, DOI 10.1128/jb.177.3.829-830.1995; FANE BA, 1993, GENETICS, V134, P1003; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Huang LT, 2007, BIOINFORMATICS, V23, P1292, DOI 10.1093/bioinformatics/btm100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ILAG LL, 1994, J MOL BIOL, V244, P291, DOI 10.1006/jmbi.1994.1730; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; McKenna R, 1996, J MOL BIOL, V256, P736, DOI 10.1006/jmbi.1996.0121; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Michel J, 2008, J MED CHEM, V51, P6654, DOI 10.1021/jm800524s; Miller CR, 2011, GENETICS, V187, P185, DOI 10.1534/genetics.110.121400; Pearlman DA, 2001, J MED CHEM, V44, P3417, DOI 10.1021/jm0100279; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Rader AJ, 2005, STRUCTURE, V13, P413, DOI 10.1016/j.str.2004.12.015; Reddy VS, 1998, BIOPHYS J, V74, P546, DOI 10.1016/S0006-3495(98)77813-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schafer H, 2002, PROTEINS, V46, P215, DOI 10.1002/prot.1166; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; van Vlijmen HWT, 1998, J MOL BIOL, V275, P295, DOI 10.1006/jmbi.1997.1418; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Ytreberg FM, 2006, COMP FREE ENERGY MET, V125, P184114, DOI [10.1063/1.2378907, DOI 10.1063/1.2378907]; Zhou RH, 2008, J PHYS CHEM B, V112, P15813, DOI 10.1021/jp805529z; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005	55	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25640	10.1371/journal.pone.0025640	http://dx.doi.org/10.1371/journal.pone.0025640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980515	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600043
J	Sun, JP; Glass, NL				Sun, Jianping; Glass, N. Louise			Identification of the CRE-1 Cellulolytic Regulon in Neurospora crassa	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; SECRETORY PHOSPHOLIPASES A(2); JECORINA TRICHODERMA-REESEI; CELL WALL DEGRADATION; ASPERGILLUS-NIDULANS; HYPOCREA-JECORINA; ETHANOL REGULON; BINDING-SITES; SACCHAROMYCES-CEREVISIAE; DNA-BINDING	Background: In filamentous ascomycete fungi, the utilization of alternate carbon sources is influenced by the zinc finger transcription factor CreA/CRE-1, which encodes a carbon catabolite repressor protein homologous to Mig1 from Saccharomyces cerevisiae. In Neurospora crassa, deletion of cre-1 results in increased secretion of amylase and beta-galactosidase. Methodology/Principal Findings: Here we show that a strain carrying a deletion of cre-1 has increased cellulolytic activity and increased expression of cellulolytic genes during growth on crystalline cellulose (Avicel). Constitutive expression of cre-1 complements the phenotype of a N. crassa Delta cre-1 strain grown on Avicel, and also results in stronger repression of cellulolytic protein secretion and enzyme activity. We determined the CRE-1 regulon by investigating the secretome and transcriptome of a Delta cre-1 strain as compared to wild type when grown on Avicel versus minimal medium. Chromatin immunoprecipitation-PCR of putative target genes showed that (CRE-1 binds to only some adjacent 5'-SYGGRG-3' motifs, consistent with previous findings in other fungi, and suggests that unidentified additional regulatory factors affect CRE-1 binding to promoter regions. Characterization of 30 mutants containing deletions in genes whose expression level increased in a Delta cre-1 strain under cellulolytic conditions identified novel genes that affect cellulase activity and protein secretion. Conclusions/Significance:Our data provide comprehensive information on the CRE-1 regulon in N. crassa and contribute to deciphering the global role of carbon catabolite repression in filamentous ascomycete fungi during plant cell wall deconstruction.	[Sun, Jianping; Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sun, JP (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	Lglass@berkeley.edu	Glass, N. Louise/ABA-7303-2021		Energy Biosciences Institute to NLG	Energy Biosciences Institute to NLG	This work was supported by a grant from the Energy Biosciences Institute to NLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bruno KS, 1996, EMBO J, V15, P5772, DOI 10.1002/j.1460-2075.1996.tb00963.x; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chulkin AM, MOL BIOL MOSK, V44, P677; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; Cziferszky A, 2003, FUNGAL GENET BIOL, V40, P166, DOI 10.1016/S1087-1845(03)00082-3; Cziferszky A, 2002, J BIOL CHEM, V277, P14688, DOI 10.1074/jbc.M200744200; David H, 2005, MICROBIOL-SGM, V151, P2209, DOI 10.1099/mic.0.27787-0; de Vries RP, 1999, RES MICROBIOL, V150, P281; de Vries RP, 2002, MOL GENET GENOMICS, V268, P96, DOI 10.1007/s00438-002-0729-7; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Dementhon K, 2006, EUKARYOT CELL, V5, P2161, DOI 10.1128/EC.00253-06; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Ebbole DJ, 1998, FUNGAL GENET BIOL, V25, P15, DOI 10.1006/fgbi.1998.1088; ENTIAN KD, 1984, J BACTERIOL, V158, P29, DOI 10.1128/JB.158.1.29-35.1984; ESPESO EA, 1994, FEBS LETT, V342, P43, DOI 10.1016/0014-5793(94)80581-4; FELENBOK B, 1988, GENE, V73, P385, DOI 10.1016/0378-1119(88)90503-3; FILLINGER S, 1995, FEBS LETT, V368, P547, DOI 10.1016/0014-5793(95)00736-S; Forment JV, 2006, J BIOL CHEM, V281, P8339, DOI 10.1074/jbc.M508198200; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Granata F, 2003, INT ARCH ALLERGY IMM, V131, P153, DOI 10.1159/000071481; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Jonkers W, 2009, MOL MICROBIOL, V74, P1100, DOI 10.1111/j.1365-2958.2009.06922.x; Kasuga T, 2005, NUCLEIC ACIDS RES, V33, P6469, DOI 10.1093/nar/gki953; Kato M, 1996, BIOSCI BIOTECH BIOCH, V60, P1776, DOI 10.1271/bbb.60.1776; KOFOD LV, 1994, J BIOL CHEM, V269, P29182; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; KULMBURG P, 1993, MOL MICROBIOL, V7, P847, DOI 10.1111/j.1365-2958.1993.tb01175.x; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; Lorito M, 1996, P NATL ACAD SCI USA, V93, P14868, DOI 10.1073/pnas.93.25.14868; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Mach RL, 1996, MOL MICROBIOL, V21, P1273, DOI 10.1046/j.1365-2958.1996.00094.x; Mach-Aigner AR, 2008, APPL ENVIRON MICROB, V74, P6554, DOI 10.1128/AEM.01143-08; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Mathieu M, 2000, MOL MICROBIOL, V36, P123, DOI 10.1046/j.1365-2958.2000.01833.x; MATHIEU M, 1994, EMBO J, V13, P4022, DOI 10.1002/j.1460-2075.1994.tb06718.x; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; Mogensen J, 2006, FUNGAL GENET BIOL, V43, P593, DOI 10.1016/j.fgb.2006.03.003; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nakahama T, 2010, FUNGAL GENET BIOL, V47, P318, DOI 10.1016/j.fgb.2009.12.011; Nakamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P2363, DOI 10.1271/bbb.50694; Nakari-Setala T, 2009, APPL ENVIRON MICROB, V75, P4853, DOI 10.1128/AEM.00282-09; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Orejas M, 1999, MOL MICROBIOL, V31, P177, DOI 10.1046/j.1365-2958.1999.01157.x; PICKETT M, 1987, GENE, V51, P217, DOI 10.1016/0378-1119(87)90310-6; Portnoy T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-269; Roy P, 2008, FUNGAL GENET BIOL, V45, P657, DOI 10.1016/j.fgb.2007.10.016; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruijter GJG, 1996, FEMS MICROBIOL LETT, V139, P223, DOI 10.1111/j.1574-6968.1996.tb08206.x; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Ruijter GJG, 1997, MICROBIOL-UK, V143, P2991, DOI 10.1099/00221287-143-9-2991; SAKAGUCHI M, 1991, J BIOCHEM-TOKYO, V109, P799, DOI 10.1093/oxfordjournals.jbchem.a123460; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schroder K, 1999, EMBO J, V18, P4804, DOI 10.1093/emboj/18.17.4804; Seidl V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-327; Smith KM, EUKARYOT CELL, P1549; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Soragni E, 2001, EMBO J, V20, P5079, DOI 10.1093/emboj/20.18.5079; STRAUSS J, 1995, FEBS LETT, V376, P103, DOI 10.1016/0014-5793(95)01255-5; Strauss J, 1999, MOL MICROBIOL, V32, P169, DOI 10.1046/j.1365-2958.1999.01341.x; Sun JP, 2011, PROTEIN EXPRES PURIF, V75, P147, DOI 10.1016/j.pep.2010.08.016; Takashima S, 1996, FEMS MICROBIOL LETT, V145, P361, DOI 10.1016/S0378-1097(96)00432-6; Tamayo EN, 2008, FUNGAL GENET BIOL, V45, P984, DOI 10.1016/j.fgb.2008.03.002; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; Tian CG, 2007, EUKARYOT CELL, V6, P1018, DOI 10.1128/EC.00078-07; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Townsend JP, 2002, GENOME BIOL, V3; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; VANDERVEEN P, 1995, MICROBIOL-UK, V141, P2301, DOI 10.1099/13500872-141-9-2301; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3; Ziv C, 2008, FUNGAL GENET BIOL, V45, P103, DOI 10.1016/j.fgb.2007.05.005	85	151	158	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25654	10.1371/journal.pone.0025654	http://dx.doi.org/10.1371/journal.pone.0025654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980519	Green Submitted, Green Published, gold			2022-12-27	WOS:000295939600046
J	Kranzer, K; van Schaik, N; Karmue, U; Middelkoop, K; Sebastian, E; Lawn, SD; Wood, R; Bekker, LG				Kranzer, Katharina; van Schaik, Nienke; Karmue, Unice; Middelkoop, Keren; Sebastian, Elaine; Lawn, Stephen D.; Wood, Robin; Bekker, Linda-Gail			High Prevalence of Self-Reported Undiagnosed HIV despite High Coverage of HIV Testing: A Cross-Sectional Population Based Sero-Survey in South Africa	PLOS ONE			English	Article							DISCORDANT COUPLES; INFECTION; COMMUNITY; COUNTRIES; ATTITUDES; STIGMA; RATES	Objectives: To measure HIV prevalence and uptake of HIV counseling and testing (HCT) in a peri-urban South African community. To assess predictors for previous HIV testing and the association between the yield of previously undiagnosed HIV and time of last negative HIV test Methods: A random sample of 10% of the adult population (>= 15 years) were invited to attend a mobile HCT service. Study procedures included a questionnaire, HIV testing and CD4 counts. Predictors for previous testing were determined using a binominal model. Results: 1,144 (88.0%) of 1,300 randomly selected individuals participated in the study. 71.0% (68.3-73.6) had previously had an HIV test and 37.5% (34.6-40.5) had tested in the past 12 months. Men, migrants and older (>35 years) and younger (<20 years) individuals were less likely to have had a previous HIV test. Overall HIV prevalence was 22.7 (20.3-25.3) with peak prevalence of 41.8% (35.8-47.8) in women aged 25.1-35 years and 37.5% (26.7-48.3) in men aged 25.1-45 years. Prevalence of previously undiagnosed HIV was 10.3% (8.5-12.1) overall and 4.5% (2.3-6.6), 8.0% (CI 3.9-12.0) and 20.0% (13.2-26.8) in individuals who had their most recent HIV test within 1, 1-2 and more than 2 years prior to the survey. Conclusion: The high burden of undiagnosed HIV in individuals who had recently tested underscores the importance of frequent repeat testing at least annually. The high prevalence of previously undiagnosed HIV in individuals reporting a negative test in the 12 months preceding the survey indicates a very high incidence. Innovative prevention strategies are needed.	[Kranzer, Katharina; Lawn, Stephen D.] London Sch Hyg & Trop Med, Dept Clin Res Unit, London WC1, England; [Kranzer, Katharina; van Schaik, Nienke; Middelkoop, Keren; Sebastian, Elaine; Lawn, Stephen D.; Wood, Robin; Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Karmue, Unice] Northeastern Univ, Boston, MA 02115 USA; [Wood, Robin] Univ Stellenbosch, S African Ctr Epidemiol Modeling & Anal, ZA-7600 Stellenbosch, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; Northeastern University; Stellenbosch University	Kranzer, K (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res Unit, London WC1, England.	katharina.kranzer@lshtm.ac.uk	Bekker, Linda-Gail/AAZ-8929-2020; Kranzer, Katharina/O-8845-2014; Wood, Robin/G-8509-2011	Kranzer, Katharina/0000-0001-5691-7270; Middelkoop, Keren/0000-0001-9922-4263; BEKKER, LINDA-GAIL/0000-0002-0755-4386	Wellcome Trust, London, UK; IeDEAA [5U01AI069924-02]; NIH [1U19AI053217]; CEPAC (CostEffectiveness of Preventing AIDS Complications) [5 R01 AI058736-02]; USAID Right to Care [CA 674 A 00 08 0000 700]; CIPRA (Comprehensive International Program of Research on AIDS) [IU19AI53217-07]; Wellcome Trust; Desmond Tutu HIV Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, U01AI069924, U19AI053217] Funding Source: NIH RePORTER	Wellcome Trust, London, UK(Wellcome Trust); IeDEAA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CEPAC (CostEffectiveness of Preventing AIDS Complications); USAID Right to Care(United States Agency for International Development (USAID)); CIPRA (Comprehensive International Program of Research on AIDS); Wellcome Trust(Wellcome TrustEuropean Commission); Desmond Tutu HIV Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KK and SDL are funded by the Wellcome Trust, London, UK. RW is funded by IeDEAA (5U01AI069924-02, a global network of clinics funded in part by the NIH), CEPAC (5 R01 AI058736-02, CostEffectiveness of Preventing AIDS Complications), USAID Right to Care (CA 674 A 00 08 0000 700), CIPRA (IU19AI53217-07, Comprehensive International Program of Research on AIDS). KM and LGB are funded by the NIH CIPRA (1U19AI053217). The study was funded by the Wellcome Trust and the Desmond Tutu HIV Foundation. The HIV testing was made possible by the support of the American people through the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdool Karim Q, 2010, INT J EPIDEMIOL, P3; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; [Anonymous], NAT HIV COUNS TEST P; April MD, 2009, JAIDS-J ACQ IMM DEF, V51, P310, DOI 10.1097/QAI.0b013e3181a248e6; Bekker LG, CLIN INFECT DIS S3, V50, pS208; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Helleringer S, 2009, JAIDS-J ACQ IMM DEF, V51, P185, DOI 10.1097/QAI.0b013e31819c1726; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; Johnson LF, 2011, MODEL IMPACT HIV AID; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kranzer K, 2008, TROP MED INT HEALTH, V13, P1341, DOI 10.1111/j.1365-3156.2008.02148.x; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Middelkoop K, 2009, WIDESPREAD ART IS AS; Middelkoop K, 2008, J ADOLESCENT HEALTH, V43, P8, DOI 10.1016/j.jadohealth.2007.11.144; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Middelkoop K, 2010, AM J RESP CRIT CARE, V182, P1080, DOI 10.1164/rccm.201004-0598OC; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Sambisa W, 2010, AIDS CARE, V22, P170, DOI 10.1080/09540120903038374; Shisana O, 2009, S AFRICAN NATL HIV P; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; UNAIDS/WHO, UNAIDS WHO POL STAT; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Venkatesh KK, J ACQUIR IMMUNE DEFI, V56, P151; Walensky RP, J ACQUIR IMMUNE DEFI, V56, P26; Wand H, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-41; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Western Cape Department of Health, 2006, W CAP ANT PROGR; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2011, DEL HIV TEST RES MES; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73; Young SD, 2010, J ACQ IMMUN DEF SYND, P27; Ziraba AK, POPUL HLTH METR, V8, P22	40	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25244	10.1371/journal.pone.0025244	http://dx.doi.org/10.1371/journal.pone.0025244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21969875	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000295936900039
J	Pati, S; Gerber, MH; Menge, TD; Wataha, KA; Zhao, YH; Baumgartner, JA; Zhao, J; Letourneau, PA; Huby, MP; Baer, LA; Salsbury, JR; Kozar, RA; Wade, CE; Walker, PA; Dash, PK; Cox, CS; Doursout, MF; Holcomb, JB				Pati, Shibani; Gerber, Michael H.; Menge, Tyler D.; Wataha, Kathryn A.; Zhao, Yuhai; Baumgartner, John Adam; Zhao, Jing; Letourneau, Phillip A.; Huby, Maria P.; Baer, Lisa A.; Salsbury, John R.; Kozar, Rosemary A.; Wade, Charles E.; Walker, Peter A.; Dash, Pramod K.; Cox, Charles S., Jr.; Doursout, Marie-Francoise; Holcomb, John B.			Bone Marrow Derived Mesenchymal Stem Cells Inhibit Inflammation and Preserve Vascular Endothelial Integrity in the Lungs after Hemorrhagic Shock	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; STROMAL CELLS; ADHERENS JUNCTIONS; KAPOSIS-SARCOMA; GROWTH-FACTORS; VE-CADHERIN; INJURY; PERMEABILITY; DISEASE; SEPSIS	Hemorrhagic shock (HS) and trauma is currently the leading cause of death in young adults worldwide. Morbidity and mortality after HS and trauma is often the result of multi-organ failure such as acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), conditions with few therapeutic options. Bone marrow derived mesenchymal stem cells (MSCs) are a multipotent stem cell population that has shown therapeutic promise in numerous pre-clinical and clinical models of disease. In this paper, in vitro studies with pulmonary endothelial cells (PECs) reveal that conditioned media (CM) from MSCs and MSC-PEC co-cultures inhibits PEC permeability by preserving adherens junctions (VE-cadherin and beta-catenin). Leukocyte adhesion and adhesion molecule expression (VCAM-1 and ICAM-1) are inhibited in PECs treated with CM from MSC-PEC co-cultures. Further support for the modulatory effects of MSCs on pulmonary endothelial function and inflammation is demonstrated in our in vivo studies on HS in the rat. In a rat "fixed volume" model of mild HS, we show that MSCs administered IV potently inhibit systemic levels of inflammatory cytokines and chemokines in the serum of treated animals. In vivo MSCs also inhibit pulmonary endothelial permeability and lung edema with concurrent preservation of the vascular endothelial barrier proteins: VE-cadherin, Claudin-1, and Occludin-1. Leukocyte infiltrates (CD68 and MPO positive cells) are also decreased in lungs with MSC treatment. Taken together, these data suggest that MSCs, acting directly and through soluble factors, are potent stabilizers of the vascular endothelium and inflammation. These data are the first to demonstrate the therapeutic potential of MSCs in HS and have implications for the potential use of MSCs as a cellular therapy in HS-induced lung injury.	[Pati, Shibani; Gerber, Michael H.; Menge, Tyler D.; Wataha, Kathryn A.; Zhao, Yuhai; Baumgartner, John Adam; Letourneau, Phillip A.; Huby, Maria P.; Baer, Lisa A.; Salsbury, John R.; Kozar, Rosemary A.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA; [Pati, Shibani; Gerber, Michael H.; Menge, Tyler D.; Wataha, Kathryn A.; Zhao, Yuhai; Baumgartner, John Adam; Letourneau, Phillip A.; Huby, Maria P.; Baer, Lisa A.; Salsbury, John R.; Kozar, Rosemary A.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX USA; [Dash, Pramod K.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA; [Zhao, Jing; Walker, Peter A.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX USA; [Doursout, Marie-Francoise] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Pati, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA.	shibani.pati@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002; holcomb, john/0000-0001-8312-9157	Mission Connect: The Institute for Rehabilitation and Research; National Institutes of Health [T32GM008792-11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008792] Funding Source: NIH RePORTER	Mission Connect: The Institute for Rehabilitation and Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from Mission Connect: The Institute for Rehabilitation and Research and the National Institutes of Health T32GM008792-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aird WC, 2003, CRIT CARE MED, V31, pS221, DOI 10.1097/01.CCM.0000057847.32590.C1; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ball SG, 2007, J CELL MOL MED, V11, P1012, DOI 10.1111/j.1582-4934.2007.00120.x; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DIAZFLORES L, 1991, HISTOL HISTOPATHOL, V6, P269; Fang XH, 2010, J BIOL CHEM, V285, P26211, DOI 10.1074/jbc.M110.119917; Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; FLECK A, 1985, LANCET, V1, P781; GROTZ MRW, 1995, SHOCK, V3, P362; Guidot DM, 2006, AM J PHYSIOL-LUNG C, V291, pL301, DOI 10.1152/ajplung.00153.2006; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Kamouchi M, 2010, CELL MOL NEUROBIOL; Kerkar S, 2001, J TRAUMA, V51, P440, DOI 10.1097/00005373-200109000-00003; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Lampugnani MG, 2007, THROMB RES, V120, pS1, DOI 10.1016/S0049-3848(07)70124-X; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; Rocco TR, 2001, ANN SURG, V233, P414, DOI 10.1097/00000658-200103000-00017; SIMS DE, 1991, CAN J CARDIOL, V7, P431; SINCLAIR DG, 1994, CHEST, V106, P535, DOI 10.1378/chest.106.2.535; Sondeen JL, 2007, SHOCK, V28, P426, DOI 10.1097/shk.0b013e31804a5791; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7	47	108	118	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25171	10.1371/journal.pone.0025171	http://dx.doi.org/10.1371/journal.pone.0025171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980392	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900029
J	Nijwening, JH; Geutjes, EJ; Bernards, R; Beijersbergen, RL				Nijwening, Jeroen H.; Geutjes, Ernst-Jan; Bernards, Rene; Beijersbergen, Roderick L.			The Histone Demethylase Jarid1b (Kdm5b) Is a Novel Component of the Rb Pathway and Associates with E2f-Target Genes in MEFs during Senescence	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; TRANSCRIPTIONAL REPRESSION; INK4A-ARF LOCUS; HETEROCHROMATIN FORMATION; EMBRYONIC FIBROBLASTS; EPIGENETIC CONTROL; JMJD3 CONTRIBUTES; MELANOMA-CELLS	Senescence is a robust cell cycle arrest controlled by the p53 and Rb pathways that acts as an important barrier to tumorigenesis. Senescence is associated with profound alterations in gene expression, including stable suppression of E2f-target genes by heterochromatin formation. Some of these changes in chromatin composition are orchestrated by Rb. In complex with E2f, Rb recruits chromatin modifying enzymes to E2f target genes, leading to their transcriptional repression. To identify novel chromatin remodeling enzymes that specifically function in the Rb pathway, we used a functional genetic screening model for bypass of senescence in murine cells. We identified the H3K4-demethylase Jarid1b as novel component of the Rb pathway in this screening model. We find that depletion of Jarid1b phenocopies knockdown of Rb1 and that Jarid1b associates with E2f-target genes during cellular senescence. These results suggest a role for Jarid1b in Rb-mediated repression of cell cycle genes during senescence.	[Nijwening, Jeroen H.; Geutjes, Ernst-Jan; Bernards, Rene; Beijersbergen, Roderick L.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands	Netherlands Cancer Institute	Nijwening, JH (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands.	r.beijersbergen@nki.nl		Bernards, Rene/0000-0001-8677-3423; Beijersbergen, Roderick/0000-0003-0116-4130	Top Institute Pharma [T3-105]	Top Institute Pharma	This work has been supported by Top Institute Pharma (project T3-105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Epping MT, 2011, NAT CELL BIOL, V13, P102, DOI 10.1038/ncb2142; Ferreira R, 2001, ONCOGENE, V20, P3128, DOI 10.1038/sj.onc.1204337; Halaban R, 2005, CANCER METAST REV, V24, P339, DOI 10.1007/s10555-005-1582-z; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roesch A, 2006, J INVEST DERMATOL, V126, P1850, DOI 10.1038/sj.jid.5700324; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Talluri S, 2010, MOL CELL BIOL, V30, P948, DOI 10.1128/MCB.01168-09; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Vogt T, 1999, LAB INVEST, V79, P1615; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	54	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25235	10.1371/journal.pone.0025235	http://dx.doi.org/10.1371/journal.pone.0025235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980403	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700022
J	Tse, H; To, KKW; Wen, X; Chen, HL; Chan, KH; Tsoi, HW; Li, IWS; Yuen, KY				Tse, Herman; To, Kelvin K. W.; Wen, Xi; Chen, Honglin; Chan, Kwok-Hung; Tsoi, Hoi-Wah; Li, Iris W. S.; Yuen, Kwok-Yung			Clinical and Virological Factors Associated with Viremia in Pandemic Influenza A/H1N1/2009 Virus Infection	PLOS ONE			English	Article							H1N1 2009; DISEASE; HEMAGGLUTININ; CONCURRENT	Background: Positive detection of viral RNA in blood and other non-respiratory specimens occurs in severe human influenza A/H5N1 viral infection but is not known to occur commonly in seasonal human influenza infection. Recently, viral RNA was detected in the blood of patients suffering from severe pandemic influenza A/H1N1/2009 viral infection, although the significance of viremia had not been previously studied. Our study aims to explore the clinical and virological factors associated with pandemic influenza A/H1N1/2009 viremia and to determine its clinical significance. Methodology/Principal Findings: Clinical data of patients admitted to hospitals in Hong Kong between May 2009 and April 2010 and tested positive for pandemic influenza A/H1N1/2009 was collected. Viral RNA was detected by reverse-transcription polymerase chain reactions (RT-PCR) targeting the matrix (M) and HA genes of pandemic influenza A/H1N1/2009 virus from the following specimens: nasopharyngeal aspirate (NPA), endotracheal aspirate (ETA), blood, stool and rectal swab. Stool and/or rectal swab was obtained only if the patient complained of any gastrointestinal symptoms. A total of 139 patients were included in the study, with viral RNA being detected in the blood of 14 patients by RT-PCR. The occurrence of viremia was strongly associated with a severe clinical presentation and a higher mortality rate, although the latter association was not statistically significant. D222G/N quasispecies were observed in 90% of the blood samples. Conclusion: Presence of pandemic influenza A/H1N1/2009 viremia is an indicator of disease severity and strongly associated with D222G/N mutation in the viral hemagglutinin protein.	[Tse, Herman; To, Kelvin K. W.; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Wen, Xi; Tsoi, Hoi-Wah] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok-Hung; Li, Iris W. S.] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Tse, H (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; Chen, Honglin/C-4224-2009; To, Kelvin/AAV-7007-2020	Chen, Honglin/0000-0001-5108-8338; To, Kelvin/0000-0002-1921-5824; Wen, Xi/0000-0002-7103-9936; Yuen, Kwok-yung/0000-0002-2083-1552	Providence Foundation Limited; University Grants Council; Food and Health Bureau of the Hong Kong SAR Government	Providence Foundation Limited; University Grants Council; Food and Health Bureau of the Hong Kong SAR Government	We gratefully acknowledge funding support from the Providence Foundation Limited in memory of the late Dr Lui Hac Minh, the University Grants Council, and the Research Fund for the Control of Infectious Diseases (RFCID) of the Food and Health Bureau of the Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CDCP, 2007, 100705 CDCP; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Gordon CL, 2010, CLIN INFECT DIS, V50, P672, DOI 10.1086/650462; HERZBERG K, 1961, Z HYG INFEKTIONSKR, V147, P382, DOI 10.1007/BF02152067; Hung IFN, 2010, CLIN INFECT DIS, V51, P274, DOI 10.1086/653940; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kilander A, 2010, EURO SURVEILL, V15; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Likos AM, 2007, TRANSFUSION, V47, P1080, DOI 10.1111/j.1537-2995.2007.01264.x; Mak GC, 2010, EURO SURVEILL, V15; MILLER RR, 2010, EURO SURVEILL, V15; MINUSE E, 1962, J LAB CLIN MED, V59, P1016; NAFICY K, 1963, NEW ENGL J MED, V269, P964, DOI 10.1056/NEJM196310312691807; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Oughton M, 2011, DIAGN MICR INFEC DIS, V70, P213, DOI 10.1016/j.diagmicrobio.2010.12.013; Poliakova T G, 1970, Vopr Virusol, V15, P724; Rouphael NG, 2007, LANCET INFECT DIS, V7, P814, DOI 10.1016/S1473-3099(07)70290-6; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stanley E D, 1966, Trans Assoc Am Physicians, V79, P376; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; To KKW, 2010, POSTGRAD MED J, V86, P515, DOI 10.1136/pgmj.2009.096206; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tsuruoka H, 1997, Nihon Rinsho, V55, P2714; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P1541; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P21	27	55	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e22534	10.1371/journal.pone.0022534	http://dx.doi.org/10.1371/journal.pone.0022534			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980333	gold, Green Published			2022-12-27	WOS:000295933700001
J	Zhou, P; Cowled, C; Marsh, GA; Shi, ZL; Wang, LF; Baker, ML				Zhou, Peng; Cowled, Chris; Marsh, Glenn A.; Shi, Zhengli; Wang, Lin-Fa; Baker, Michelle L.			Type III IFN Receptor Expression and Functional Characterisation in the Pteropid Bat, Pteropus alecto	PLOS ONE			English	Article							IL-10 RECEPTOR-2; CYTOKINE; INTERLEUKIN-22; INTERFERONS; ALIGNMENT; IMMUNITY; COMPLEX; FAMILY; CELLS; CHAIN	Bats are rich reservoir hosts for a variety of viruses, many of which are capable of spillover to other susceptible mammals with lethal consequences. The ability of bats to remain asymptomatic to viral infection may be due to the rapid control of viral replication very early in the immune response through innate antiviral mechanisms. Type I and III interferons (IFNs) represent the first line of defence against viral infection in mammals, with both families of IFNs present in pteropid bats. To obtain further insight into the type III IFN system in bats, we describe the characterization of the type III IFN receptor (IFN lambda R) in the black flying fox, P. alecto with the characterization of IFN lambda R1 and IL10R2 genes that make up the type III IFN receptor complex. The bat IFN lambda R complex has a wide tissue distribution and at the cellular level, both epithelial and immune cells are responsive to IFN-lambda treatment. Furthermore, we demonstrate that the bat IFN lambda R1 chain acts as a functional receptor. To our knowledge, this report represents the first description of an IFN receptor in any species of bat. The responsiveness of bat cells to IFN-lambda support a role for the type III IFN system by epithelial and immune cells in bats.	[Zhou, Peng; Cowled, Chris; Marsh, Glenn A.; Wang, Lin-Fa; Baker, Michelle L.] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Zhou, Peng; Shi, Zhengli] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Wang, Lin-Fa] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Baker, Michelle L.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Melbourne; University of New Mexico	Zhou, P (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia.	Michelle.Baker@csiro.au	Marsh, Glenn A/A-5418-2013; Cowled, Christopher JE/H-5308-2013; Baker, Michelle L/C-9694-2013; Zhou, Peng/I-8578-2015; wang, lin/GSE-3040-2022; Baker, Michelle/AAX-9171-2020; Shi, Zheng-Li/A-1013-2013	Marsh, Glenn A/0000-0002-3469-1837; Cowled, Christopher JE/0000-0002-1969-9371; Baker, Michelle L/0000-0002-7993-9971; Zhou, Peng/0000-0003-1938-8255; Baker, Michelle/0000-0002-7993-9971; Shi, Zheng-Li/0000-0001-8089-163X; Wang, Lin-Fa/0000-0003-2752-0535	Commonwealth Scientific and Industrial Research Organisation; National Institutes of Health of the National Center for Research Resources [P20RR018754]; Chinese Academy of Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); National Institutes of Health of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Commonwealth Scientific and Industrial Research Organisation Chief Executive Officer Science Leaders award to L-F.W, a grant from the National Institutes of Health (grant no. P20RR018754) from the Institutional Development Award (IDeA) programme of the National Center for Research Resources to M. L. B., and a Scholarship from the Chinese Academy of Sciences to P.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Baker ML, 2010, IMMUNOGENETICS, V62, P173, DOI 10.1007/s00251-010-0425-4; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Li J, 2004, INT IMMUNOPHARMACOL, V4, P693, DOI 10.1016/j.intimp.2004.01.010; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Witte K, 2009, GENES IMMUN, V10, P702, DOI 10.1038/gene.2009.72; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115	25	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25385	10.1371/journal.pone.0025385	http://dx.doi.org/10.1371/journal.pone.0025385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980438	gold, Green Published			2022-12-27	WOS:000295933700029
J	Fidanboylu, M; Griffiths, LA; Flatters, SJL				Fidanboylu, Mehmet; Griffiths, Lisa A.; Flatters, Sarah J. L.			Global Inhibition of Reactive Oxygen Species (ROS) Inhibits Paclitaxel-Induced Painful Peripheral Neuropathy	PLOS ONE			English	Article							DORSAL-HORN NEURONS; ACETYL-L-CARNITINE; RADICAL SCAVENGER; LANGERHANS CELLS; DOUBLE-BLIND; RATS; HYPERALGESIA; TAXOL; SUPEROXIDE; TRIAL	Paclitaxel (Taxol (R)) is a widely used chemotherapeutic agent that has a major dose limiting side-effect of painful peripheral neuropathy. Currently there is no effective therapy for the prevention or treatment of chemotherapy-induced painful peripheral neuropathies. Evidence for mitochondrial dysfunction during paclitaxel-induced pain was previously indicated with the presence of swollen and vacuolated neuronal mitochondria. As mitochondria are a major source of reactive oxygen species (ROS), the aim of this study was to examine whether pharmacological inhibition of ROS could reverse established paclitaxel-induced pain or prevent the development of paclitaxel-induced pain. Using a rat model of paclitaxel-induced pain (intraperitoneal 2 mg/kg paclitaxel on days 0, 2, 4 & 6), the effects of a non-specific ROS scavenger, N-tert-Butyl-alpha-phenylnitrone (PBN) and a superoxide selective scavenger, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL) were compared. Systemic 100 mg/kg PBN administration markedly inhibited established paclitaxel-induced mechanical hypersensitivity to von Frey 8 g and 15 g stimulation and cold hypersensitivity to plantar acetone application. Daily systemic administration of 50 mg/kg PBN (days -1 to 13) completely prevented mechanical hypersensitivity to von Frey 4 g and 8 g stimulation and significantly attenuated mechanical hypersensitivity to von Frey 15 g. Systemic 100 mg/kg TEMPOL had no effect on established paclitaxel-induced mechanical or cold hypersensitivity. High dose (250 mg/kg) systemic TEMPOL significantly inhibited mechanical hypersensitivity to von Frey 8 g & 15 g, but to a lesser extent than PBN. Daily systemic administration of 100 mg/kg TEMPOL (day -1 to 12) did not affect the development of paclitaxel-induced mechanical hypersensitivity. These data suggest that ROS play a causal role in the development and maintenance of paclitaxel-induced pain, but such effects cannot be attributed to superoxide radicals alone.	[Fidanboylu, Mehmet] Kings Coll London, Ctr Integrat Biomed, Inst Pharmaceut Sci, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	University of London; King's College London	Fidanboylu, M (corresponding author), Kings Coll London, Ctr Integrat Biomed, Inst Pharmaceut Sci, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	sarah.flatters@kcl.ac.uk		Griffiths, Lisa/0000-0002-3676-1560; Flatters, Sarah Jane Louise/0000-0001-7129-3670	Capacity Building Award in Integrative Mammalian Biology; Biotechnology and Biological Sciences Research Council (BBSRC); British Pharmacological Society (BPS); Higher Education Funding Council for England (HEFCE); Medical Research Council (MRC); Scottish Funding Council (SFC); Department for Innovation, Universities and Skills (DIUS); Wellcome Trust; BBSRC [BB/E527098/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E527098/1] Funding Source: researchfish	Capacity Building Award in Integrative Mammalian Biology; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Pharmacological Society (BPS); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council (SFC); Department for Innovation, Universities and Skills (DIUS); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SJLF is an Academic Fellow and MF and LAG are postgraduate students in the Centre for Integrative Biomedicine. Their positions and these studies are supported by a Capacity Building Award in Integrative Mammalian Biology funded by the Biotechnology and Biological Sciences Research Council (BBSRC), British Pharmacological Society (BPS) Integrative Pharmacology Fund, Higher Education Funding Council for England (HEFCE), Medical Research Council (MRC), Scottish Funding Council (SFC) and the Department for Innovation, Universities and Skills (DIUS). These studies are also partly funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley W, 1998, J CLIN ONCOL, V16, P153, DOI 10.1200/JCO.1998.16.1.153; Authier N, 2000, BRAIN RES, V887, P239, DOI 10.1016/S0006-8993(00)02910-3; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Campana WM, 1998, NEUROTOXICOLOGY, V19, P237; Cata JP, 2008, BRAIN RES, V1229, P100, DOI 10.1016/j.brainres.2008.07.001; Cavaletti G, 1997, NEUROTOXICOLOGY, V18, P137; CAVALETTI G, 1995, EXP NEUROL, V133, P64, DOI 10.1006/exnr.1995.1008; Cliffer KD, 1998, ANN NEUROL, V43, P46, DOI 10.1002/ana.410430111; Dougherty PM, 2004, PAIN, V109, P132, DOI 10.1016/j.pain.2004.01.021; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Flatters SJL, 2006, NEUROSCI LETT, V397, P219, DOI 10.1016/j.neulet.2005.12.013; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Forsyth PA, 1997, J NEURO-ONCOL, V35, P47, DOI 10.1023/A:1005805907311; Gao X, 2007, PAIN, V131, P262, DOI 10.1016/j.pain.2007.01.011; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Kautio AL, 2008, J PAIN SYMPTOM MANAG, V35, P31, DOI 10.1016/j.jpainsymman.2007.02.043; Kautio AL, 2009, ANTICANCER RES, V29, P2601; Khalil Z, 1999, PAIN, V79, P31, DOI 10.1016/S0304-3959(98)00143-2; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kim HK, 2010, ANESTHESIOLOGY, V112, P432, DOI 10.1097/ALN.0b013e3181ca31bd; Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Park ES, 2006, NEUROSCI LETT, V391, P108, DOI 10.1016/j.neulet.2005.08.055; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; POSTMA TJ, 1995, ANN ONCOL, V6, P489, DOI 10.1093/oxfordjournals.annonc.a059220; Rao RD, 2008, CANCER, V112, P2802, DOI 10.1002/cncr.23482; Rao RD, 2007, CANCER-AM CANCER SOC, V110, P2110, DOI 10.1002/cncr.23008; Rosenfeld J, 1997, EXP NEUROL, V147, P37, DOI 10.1006/exnr.1997.6604; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Schwartz E.S., 2008, PAIN; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Tal M, 1996, NEUROREPORT, V7, P1382, DOI 10.1097/00001756-199605310-00010; Tanabe M, 2009, NEUROPHARMACOLOGY, V56, P702, DOI 10.1016/j.neuropharm.2008.12.003; vandenBent MJ, 1997, MUSCLE NERVE, V20, P750; Wagner R, 1998, PAIN, V77, P173, DOI 10.1016/S0304-3959(98)00091-8; Wang J, 2008, NEUROSCI LETT, V439, P216, DOI 10.1016/j.neulet.2008.05.018; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	42	102	106	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25212	10.1371/journal.pone.0025212	http://dx.doi.org/10.1371/journal.pone.0025212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966458	Green Published, Green Submitted, gold			2022-12-27	WOS:000295932100026
J	Thibodeau, V; Lajoie, J; Labbe, AC; Zannou, MD; Fowke, KR; Alary, M; Poudrier, J; Roger, M				Thibodeau, Valerie; Lajoie, Julie; Labbe, Annie-Claude; Zannou, Marcel D.; Fowke, Keith R.; Alary, Michel; Poudrier, Johanne; Roger, Michel			High Level of Soluble HLA-G in the Female Genital Tract of Beninese Commercial Sex Workers Is Associated with HIV-1 Infection	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; LEUKOCYTE ANTIGEN-G; CLASS-I; BACTERIAL VAGINOSIS; T-CELLS; AFRICAN WOMEN; G GENOTYPE; NK CELLS; ACQUISITION; EXPRESSION	Background: Most HIV infections are transmitted across mucosal epithelium. Understanding the role of innate and specific mucosal immunity in susceptibility or protection against HIV infection, as well as the effect of HIV infection on mucosal immunity, are of fundamental importance. HLA-G is a powerful modulator of the immune response. The aim of this study was to investigate whether soluble HLA-G (sHLA-G) expression in the female genital tract is associated with HIV-1 infection. Methods and Findings: Genital levels of sHLA-G were determined in 52 HIV-1-uninfected and 44 antiretroviral naive HIV-1-infected female commercial sex workers (CSWs), as well as 71 HIV-1-uninfected non-CSW women at low risk of exposure, recruited in Cotonou, Benin. HIV-1-infected CSWs had higher genital levels of sHLA-G compared with those in both the HIV-1-uninfected CSW (P = 0.009) and non-CSW groups (P = 0.0006). The presence of bacterial vaginosis (P = 0.008), and HLA-G*01:01:02 genotype (P = 0.002) were associated with higher genital levels of sHLA-G in the HIV-1-infected CSWs, whereas the HLA-G*01: 04: 04 genotype was also associated with higher genital level of sHLA-G in the overall population (P = 0.038). When adjustment was made for all significant variables, the increased expression of sHLA-G in the genital mucosa remained significantly associated with both HIV-1 infection (P = 0.02) and bacterial vaginosis (P = 0.03). Conclusion: This study demonstrates that high level of sHLA-G in the genital mucosa is independently associated with both HIV-1 infection and bacterial vaginosis.	[Thibodeau, Valerie; Poudrier, Johanne; Roger, Michel] CRCHUM, Immunogenet Lab, Montreal, PQ, Canada; [Thibodeau, Valerie; Labbe, Annie-Claude; Poudrier, Johanne; Roger, Michel] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Lajoie, Julie; Fowke, Keith R.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Labbe, Annie-Claude] Hop Maison Neuve Rosemont, Dept Med Microbiol, Montreal, PQ H1T 2M4, Canada; [Zannou, Marcel D.] Univ Abomey Calavi, Natl Ctr, Hosp Univ Hubert K Maga, Cotonou, Benin; [Alary, Michel] Affilie Univ Quebec, Unite Rech Sante Populat, Ctr Hosp, Quebec City, PQ, Canada; [Alary, Michel] Univ Laval, Quebec City, PQ, Canada; [Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Manitoba; Universite de Montreal; University of Abomey Calavi; Laval University; Laval University; Laval University	Thibodeau, V (corresponding author), CRCHUM, Immunogenet Lab, Montreal, PQ, Canada.	michel.roger.chum@ssss.gouv.qc.ca		Lajoie, Julie/0000-0003-0262-8005; Fowke, Keith/0000-0001-8227-6649	Canadian Institutes of Health Research (CIHR) [HOP-79213]; Reseau SIDA from the Fonds de la Recherche en Sante du Quebec (FRSQ); FRSQ	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau SIDA from the Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grant HOP-79213 from the Canadian Institutes of Health Research (CIHR) and by the Reseau SIDA from the Fonds de la Recherche en Sante du Quebec (FRSQ) to MR. JL holds a Student Research award from the CIHR. MR is recipient of a Research Scholar award from the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Cabello A, 2003, HUM IMMUNOL, V64, P1045, DOI 10.1016/j.humimm.2003.08.353; Cohen CR, 1999, AIDS, V13, P327, DOI 10.1097/00002030-199902250-00004; Fabris A, 2009, AIDS, V23, P177, DOI 10.1097/QAD.0b013e32832027bf; Ferguson R, 2011, HUM IMMUNOL, V72, P337, DOI 10.1016/j.humimm.2011.01.010; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; Hackmon R, 2004, FETAL DIAGN THER, V19, P404, DOI 10.1159/000078992; Haynes BF, 2008, IMMUNITY, V28, P10, DOI 10.1016/j.immuni.2007.12.005; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Huang JH, 2010, J VIROL, V84, P10784, DOI 10.1128/JVI.01292-10; Hviid TVF, 2004, IMMUNOGENETICS, V56, P135, DOI 10.1007/s00251-004-0673-2; Hviid TVF, 2004, TISSUE ANTIGENS, V64, P66, DOI 10.1111/j.1399-0039.2004.00239.x; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; Kanai T, 2001, MOL HUM REPROD, V7, P195, DOI 10.1093/molehr/7.2.195; Lajoie J, 2008, MUCOSAL IMMUNOL, V1, P309, DOI 10.1038/mi.2008.18; Lajoie J, 2006, J INFECT DIS, V193, P298, DOI 10.1086/498877; Lajoie J, 2010, J CLIN IMMUNOL, V30, P90, DOI 10.1007/s10875-009-9343-3; Lajoie J, 2010, HUM IMMUNOL, V71, P182, DOI 10.1016/j.humimm.2009.11.007; Lajoie J, 2009, AIDS, V23, P1437, DOI 10.1097/QAD.0b013e32832d0825; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Le Rond S, 2006, J IMMUNOL, V176, P3266, DOI 10.4049/jimmunol.176.5.3266; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Lila N, 2001, P NATL ACAD SCI USA, V98, P12150, DOI 10.1073/pnas.201407398; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Matte C, 2004, AIDS, V18, P427, DOI 10.1097/00002030-200402200-00008; McIntire RH, 2004, J LEUKOCYTE BIOL, V76, P1220, DOI 10.1189/jlb.0604337; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803; Morel E, 2008, J IMMUNOL, V181, P2368, DOI 10.4049/jimmunol.181.4.2368; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Park GM, 2004, BIOCHEM BIOPH RES CO, V313, P606, DOI 10.1016/j.bbrc.2003.11.153; Pistoia V, 2007, SEMIN CANCER BIOL, V17, P469, DOI 10.1016/j.semcancer.2007.07.004; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Riteau B, 2001, INT IMMUNOL, V13, P193, DOI 10.1093/intimm/13.2.193; Rivero A, 2007, HUM IMMUNOL, V68, P303, DOI 10.1016/j.humimm.2006.10.014; Rudstein-Svetlicky N, 2007, TISSUE ANTIGENS, V69, P140, DOI 10.1111/j.1399-0039.2006.763_4.x; Segat L, 2010, AIDS, V24, P1961, DOI 10.1097/QAD.0b013e32833c3324; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100; Yasodhara P, 2006, J REPROD IMMUNOL, V70, P133, DOI 10.1016/j.jri.2005.11.001; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059	46	23	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25185	10.1371/journal.pone.0025185	http://dx.doi.org/10.1371/journal.pone.0025185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966450	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100026
J	Dellagi, K; Rollot, O; Temmam, S; Salez, N; Guernier, V; Pascalis, H; Gerardin, P; Fianu, A; Lapidus, N; Naty, N; Tortosa, P; Boussaid, K; Jaffar-Banjee, MC; Filleul, L; Flahault, A; Carrat, F; Favier, F; de Lamballerie, X				Dellagi, Koussay; Rollot, Olivier; Temmam, Sarah; Salez, Nicolas; Guernier, Vanina; Pascalis, Herve; Gerardin, Patrick; Fianu, Adrian; Lapidus, Nathanael; Naty, Nadege; Tortosa, Pablo; Boussaid, Karim; Jaffar-Banjee, Marie-Christine; Filleul, Laurent; Flahault, Antoine; Carrat, Fabrice; Favier, Francois; de Lamballerie, Xavier			Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009	PLOS ONE			English	Article							ANTIBODY-RESPONSES; RISK-FACTORS; H1N1 VIRUS; SEROCONVERSION; SURVEILLANCE; EMERGENCE	Background: To date, there is little information that reflects the true extent of spread of the pH1N1/2009v influenza pandemic at the community level as infection often results in mild or no clinical symptoms. This study aimed at assessing through a prospective study, the attack rate of pH1N1/2009 virus in Reunion Island and risk factors of infection, during the 2009 season. Methodology/Principal Findings: A serosurvey was conducted during the 2009 austral winter, in the frame of a prospective population study. Pairs of sera were collected from 1687 individuals belonging to 772 households, during and after passage of the pandemic wave. Antibodies to pH1N1/2009v were titered using the hemagglutination inhibition assay (HIA) with titers >= 1/40 being considered positive. Seroprevalence during the first two weeks of detection of pH1N1/2009v in Reunion Island was 29.8% in people under 20 years of age, 35.6% in adults (20-59 years) and 73.3% in the elderly (>= 60 years) (P<0.0001). Baseline corrected cumulative incidence rates, were 42.9%, 13.9% and 0% in these age groups respectively (P<0.0001). A significant decline in antibody titers occurred soon after the passage of the epidemic wave. Seroconversion rates to pH1N1/2009 correlated negatively with age: 63.2%, 39.4% and 16.7%, in each age group respectively (P<0.0001). Seroconversion occurred in 65.2% of individuals who were seronegative at inclusion compared to 6.8% in those who were initially seropositive. Conclusions: Seroincidence of pH1N1/2009v infection was three times that estimated from clinical surveillance, indicating that almost two thirds of infections occurring at the community level have escaped medical detection. People under 20 years of age were the most affected group. Pre-epidemic titers >= 1/40 prevented seroconversion and are likely protective against infection. A concern was raised about the long term stability of the antibody responses.	[Dellagi, Koussay; Temmam, Sarah; Guernier, Vanina; Pascalis, Herve; Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien, GIS CRVOI, St Denis, Reunion, France; [Dellagi, Koussay; Guernier, Vanina; Pascalis, Herve] IRD, Marseille, France; [Rollot, Olivier; Gerardin, Patrick; Fianu, Adrian; Naty, Nadege; Boussaid, Karim; Favier, Francois] Ctr Hosp Reg, Ctr Invest Clin Epidemiol Clin CIC EC La Reunion, INSERM CHR Univ URMLR, St Pierre, Reunion, France; [Temmam, Sarah] Univ Lyon, CNRS, Ecol Microbienne UMR 5557, Lyon, France; [Salez, Nicolas; de Lamballerie, Xavier] Univ Mediterranee, IRD, Unite Virus Emergents, UMR S 190, Marseille, France; [Lapidus, Nathanael; Carrat, Fabrice] Univ Paris 06, INSERM, Epidemiol Malad Infect & Modelisat UMR S 70, Paris, France; [Tortosa, Pablo] Univ La Reunion, Chaire Mixte CNRS INEE, St Denis, Reunion, France; [Jaffar-Banjee, Marie-Christine] Ctr Hosp Reg, Dept Microbiol, St Denis, Reunion, France; [Filleul, Laurent] Cellule Interreg Epidemiol CIRE Reunion Mayotte I, St Denis, Reunion, France; [Flahault, Antoine] EHESP, Paris, France	Institut de Recherche pour le Developpement (IRD); Centre Hospitalier Annecy Genevois; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of La Reunion; Centre Hospitalier Annecy Genevois; CHU Reunion; Ecole des Hautes Etudes en Sante Publique (EHESP)	Dellagi, K (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien, GIS CRVOI, St Denis, Reunion, France.	koussay.dellagi@ird.fr	Lapidus, N./AAT-4479-2020; Pascalis, Herve/M-9410-2019; Guernier, Vanina/AAX-3772-2020; Carrat, Fabrice/AAU-8480-2020; Pascalis, Herve/F-5726-2014; TEMMAM, Sarah/AAX-3717-2021	Lapidus, N./0000-0002-4837-1068; Pascalis, Herve/0000-0002-6822-7311; Guernier, Vanina/0000-0002-0960-3874; Carrat, Fabrice/0000-0002-8672-7918; Pascalis, Herve/0000-0002-6822-7311; TEMMAM, Sarah/0000-0003-3655-9220; Abid, sayda/0000-0003-2488-1431; Tortosa, Pablo/0000-0002-7928-7264	CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI; CRVOI; CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI; CRVOI	CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI(Institut National de la Sante et de la Recherche Medicale (Inserm)); CRVOI; CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI(Institut National de la Sante et de la Recherche Medicale (Inserm)); CRVOI	This study was supported by funds from CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund), INSERM/IMMI and CRVOI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Booy R, 2011, MED J AUSTRALIA, V194, P19, DOI 10.5694/j.1326-5377.2011.tb04139.x; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chao DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014555; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Cire Ocean Indien, 2010, POINT EP; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Delangue J, 2012, CLIN MICROBIOL INFEC, V18, P177, DOI 10.1111/j.1469-0691.2011.03545.x; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; Gerardin P, 2011, BMC MED IN PRESS; Gerardin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010896; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Henderson AR, 2005, CLIN CHIM ACTA, V359, P1, DOI 10.1016/j.cccn.2005.04.002; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Huo XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017995; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Kumar S, 2010, VIRUSES-BASEL, V2, P782, DOI 10.3390/v2040782; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Lemaitre M, 2010, CLIN MICROBIOL INFEC, DOI [10.1111/11469-0691.2010.03352.x, DOI 10.1111/11469-0691.2010.03352.X]; Lim WY, 2011, EMERG INFECT DIS, V17, P1455, DOI 10.3201/eid1708.101270; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Renault Philippe, 2010, PLoS Curr, V2, pRRN1145; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Soonawala D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016496; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Waalen K, 2010, EUROSURVEILLANCE, V15, P2; Wang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016809; Xie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016650; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	46	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25738	10.1371/journal.pone.0025738	http://dx.doi.org/10.1371/journal.pone.0025738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980532	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000295939600052
J	Bhat, AA; Mahajan, G; Mehta, A				Bhat, Ajaz Ahmad; Mahajan, Gaurang; Mehta, Anita			Learning with a Network of Competing Synapses	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; MODELS; ADAPTATION; TIMESCALES	Competition between synapses arises in some forms of correlation-based plasticity. Here we propose a game theory-inspired model of synaptic interactions whose dynamics is driven by competition between synapses in their weak and strong states, which are characterized by different timescales. The learning of inputs and memory are meaningfully definable in an effective description of networked synaptic populations. We study, numerically and analytically, the dynamic responses of the effective system to various signal types, particularly with reference to an existing empirical motor adaptation model. The dependence of the system-level behavior on the synaptic parameters, and the signal strength, is brought out in a clear manner, thus illuminating issues such as those of optimal performance, and the functional role of multiple timescales.	[Bhat, Ajaz Ahmad; Mahajan, Gaurang; Mehta, Anita] SN Bose Natl Ctr Basic Sci, Kolkata 700064, W Bengal, India; [Mehta, Anita] CEA Saclay, Inst Phys Thor, F-91191 Gif Sur Yvette, France	Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS); CEA; UDICE-French Research Universities; Universite Paris Saclay	Bhat, AA (corresponding author), SN Bose Natl Ctr Basic Sci, Kolkata 700064, W Bengal, India.	anita@bose.res.in		Mahajan, Gaurang/0000-0002-6583-6269; Bhat, Ajaz/0000-0002-6992-8224	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was funded by the Department of Science and Technology, Government of India, under the project "Cognitive Science Initiative." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ACKLEY DH, 1985, COGNITIVE SCI, V9, P147; Babadi B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000961; Baldassi C, 2007, P NATL ACAD SCI USA, V104, P11079, DOI 10.1073/pnas.0700324104; Barrett AB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000230; Bhat AA, 2011, ARXIV11050523; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BOGARTZ RS, 1990, J EXP PSYCHOL LEARN, V16, P138, DOI 10.1037/0278-7393.16.1.138; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Dayan P, 2001, COMPUTATIONAL NEUROS; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Fairhall AL, 2000, P NIPS, P124; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P271, DOI 10.1088/0305-4470/21/1/031; Gerstner W, 2002, SPIKING NEURON MODEL; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Leibold C, 2008, CEREB CORTEX, V18, P67, DOI 10.1093/cercor/bhm037; Mahajan G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/48008; Mehta A, 1999, PHYS REV E, V60, P5218, DOI 10.1103/PhysRevE.60.5218; Mehta A, 2011, JSTAT IN PRESS; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103	40	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25048	10.1371/journal.pone.0025048	http://dx.doi.org/10.1371/journal.pone.0025048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980377	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900020
J	Biyani, N; Mandal, S; Seth, C; Saint, M; Natarajan, K; Ghosh, I; Madhubala, R				Biyani, Neha; Mandal, Swati; Seth, Chandan; Saint, Malika; Natarajan, Krishnamurthy; Ghosh, Indira; Madhubala, Rentala			Characterization of Leishmania donovani Aquaporins Shows Presence of Subcellular Aquaporins Similar to Tonoplast Intrinsic Proteins of Plants	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; PLASMODIUM-FALCIPARUM; CRYSTAL-STRUCTURE; WATER CHANNELS; DRUG UPTAKE; AQUAGLYCEROPORIN; GLYCEROL; PREDICTION; MEMBRANE	Leishmania donovani, a protozoan parasite, resides in the macrophages of the mammalian host. The aquaporin family of proteins form important components of the parasite-host interface. The parasite-host interface could be a potential target for chemotherapy. Analysis of L. major and L. infantum genomes showed the presence of five aquaporins (AQPs) annotated as AQP9 (230aa), AQP putative (294aa), AQP-like protein (279aa), AQP1 (314aa) and AQP-like protein (596aa). We report here the structural modeling, localization and functional characterization of the AQPs from L. donovani. LdAQP1, LdAQP9, LdAQP2860 and LdAQP2870 have the canonical NPA-NPA motifs, whereas LdAQP putative has a non-canonical NPM-NPA motif. In the carboxyl terminal to the second NPA box of all AQPs except AQP1, a valine/alanine residue was found instead of the arginine. In that respect these four AQPs are similar to tonoplast intrinsic proteins in plants, which are localized to intracellular organelles. Confocal microscopy of L. donovani expressing GFP-tagged AQPs showed an intracellular localization of LdAQP9 and LdAQP2870. Real-time PCR assays showed expression of all aquaporins except LdAQP2860, whose level was undetectable. Three-dimensional homology modeling of the AQPs showed that LdAQP1 structure bears greater topological similarity to the aquaglyceroporin than to aquaporin of E. coli. The pore of LdAQP1 was very different from the rest in shape and size. The cavity of LdAQP2860 was highly irregular and undefined in geometry. For functional characterization, four AQP proteins were heterologously expressed in yeast. In the fps1 Delta yeast cells, which lacked the key aquaglyceroporin, LdAQP1 alone displayed an osmosensitive phenotype indicating glycerol transport activity. However, expression of LdAQP1 and LdAQP putative in a yeast gpd1 Delta strain, deleted for glycerol production, conferred osmosensitive phenotype indicating water transport activity or aquaporin function. Our analysis for the first time shows the presence of subcellular aquaporins and provides structural and functional characterization of aquaporins in Leishmania donovani.	[Biyani, Neha; Saint, Malika; Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Regulat, New Delhi 110067, India; [Seth, Chandan; Ghosh, Indira] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Biyani, N (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Regulat, New Delhi 110067, India.	madhubala@mail.jnu.ac.in	biyani, neha/AAN-1860-2020; ghosh, indira/H-5008-2019	madhubala, rentala/0000-0002-0034-399X; Saint, Malika/0000-0001-7509-0619; Seth Nanda, Chandan/0000-0002-3955-8808	Department of Biotechnology, India; Department of Science and Technology, India; Council of Scientific and Industrial Research, India; University Grants Commission, Government of India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India)	This work is supported by a grant from the Department of Biotechnology, India to Rentala Madhubala. Rentala Madhubala is a JC Bose National Fellow supported by the Department of Science and Technology, India. Neha Biyani is supported by a Senior Research Fellowship from the Council of Scientific and Industrial Research, India, and Swati Mandal is supported by a fellowship from the University Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alconada A, 1996, EMBO J, V15, P6096, DOI 10.1002/j.1460-2075.1996.tb00998.x; Amiry-Moghaddam M, 2005, FASEB J, V19, P1459, DOI 10.1096/fj.04-3515com; [Anonymous], EMBOSS HMOMENT; Bates PA, 2001, PROTEINS, P39; Beitz E, 2005, BIOL CELL, V97, P373, DOI 10.1042/BC20040095; Bhattacharjee Hiranmoy, 2009, Handb Exp Pharmacol, P309, DOI 10.1007/978-3-540-79885-9_16; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Figarella K, 2007, MOL MICROBIOL, V65, P1006, DOI 10.1111/j.1365-2958.2007.05845.x; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ishibashi K, 2006, BBA-BIOMEMBRANES, V1758, P989, DOI 10.1016/j.bbamem.2006.02.024; Ishikawa Y, 2006, BBA-BIOMEMBRANES, V1758, P1053, DOI 10.1016/j.bbamem.2006.03.026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jiang JS, 2006, J BIOL CHEM, V281, P454, DOI 10.1074/jbc.M508926200; Kirk K, 2004, ACTA TROP, V89, P285, DOI 10.1016/j.actatropica.2003.10.002; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Ma S, 2004, PLANT J, V40, P845, DOI 10.1111/j.1365-313X.2004.02265.x; Maharjan M, 2008, AM J TROP MED HYG, V79, P69, DOI 10.4269/ajtmh.2008.79.69; Mandal S, 2010, J ANTIMICROB CHEMOTH, V65, P496, DOI 10.1093/jac/dkp468; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Newby ZER, 2008, NAT STRUCT MOL BIOL, V15, P619, DOI 10.1038/nsmb.1431; Oliveira EMM, 2005, FEMS YEAST RES, V5, P605, DOI 10.1016/j.femsyr.2004.11.011; Oliveira R, 2003, BBA-BIOMEMBRANES, V1613, P57, DOI 10.1016/S0005-2736(03)00138-X; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Pettersson N, 2006, CURR GENET, V50, P247, DOI 10.1007/s00294-006-0092-z; Pitt WR, 2001, BIOINFORMATICS, V17, P729, DOI 10.1093/bioinformatics/17.8.729; Prudent S, 2005, FEBS LETT, V579, P3872, DOI 10.1016/j.febslet.2005.05.076; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schrodinger L., PYMOL MOL GRAPHICS S; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Weig AR, 2000, FEBS LETT, V481, P293, DOI 10.1016/S0014-5793(00)02027-5; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wiwanitkit V, 2008, INDIAN J MED MICROBI, V26, P246, DOI 10.4103/0255-0857.42036	53	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24820	10.1371/journal.pone.0024820	http://dx.doi.org/10.1371/journal.pone.0024820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969862	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900013
J	Pradhan, AK; Das Mohapatra, A; Nayak, KB; Chakraborty, S				Pradhan, Anjan Kumar; Das Mohapatra, Alok; Nayak, Kasturi Bala; Chakraborty, Soumen			Acetylation of the Proto-Oncogene EVI1 Abrogates Bcl-xL Promoter Binding and Induces Apoptosis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CELL-DEATH; MYELODYSPLASTIC SYNDROMES; TRANSCRIPTION FACTORS; CARDIAC MYOCYTES; GENE-EXPRESSION; DNA-BINDING; BCL-X(L); DEACETYLASE; INDUCTION	EVI1 (Ecotropic Viral Integration site I), which was originally identified as a myeloid transforming gene by means of retroviral insertional mutagenesis in mouse leukemia, encodes a nuclear DNA binding zinc finger protein. The presence of zinc fingers that are able to bind to specific sequences of DNA suggests that EVI1 is a transcriptional regulator; however, except a few, target genes of EVI1 are poorly functionally identified thus far. In this study we provide evidence that EVI1 directly induces the expression of Bcl-xL through the first set of zinc finger and thereby inhibits apoptosis. ChIP analysis showed that EVI1 binds to the Bcl-xL promoter in HT-29 cells, a colon carcinoma cell line, which expresses EVI1. The observation is also supported by the fact that EVI1 siRNA treated HT-29 cells, shows a down regulation of Bcl-xL expression and that over expression of EVI1 results in the induction of the Bcl-xL reporter construct. A set of EVI1 positive chronic myeloid leukemia (CML) samples also showed higher Bcl-xL expression with respect to EVI1 negative samples. Interestingly, co-expression of EVI1 with wild type, but not with dominant-negative form of PCAF, abolishes the effect of EVI1 on Bcl-xL, indicating that acetylation of EVI1 abrogates its ability not only to bind Bcl-xL promoter but also alleviate Bcl-xL activity. Finally we have shown that EVI1 expression regulates apoptosis in HT-29 cells, which is abrogated when HT-29 cells are transfected with EVI1 siRNA or PCAF. The result for the first time shows a direct pathway by which EVI1 can protect cells from apoptosis and also demonstrates that the pathway can be reversed when EVI1 is acetylated.	[Pradhan, Anjan Kumar; Nayak, Kasturi Bala; Chakraborty, Soumen] Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Orissa, India; [Das Mohapatra, Alok] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Orissa, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Pradhan, AK (corresponding author), Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Orissa, India.	soumen_ils@yahoo.co.in	Pradhan, Anjan K/O-2555-2014	DAS MOHAPATRA, ALOK/0000-0001-6189-9118	Department of Science and Technology (DST) [SR/SO/BB-13/2006]; Council of Scientific and Industrial Research, India; Indian Council of Medical Research, India; Department of Science and Technology, India	Department of Science and Technology (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by a grant-in-aid from the Department of Science and Technology (DST) to SC (Grant No. SR/SO/BB-13/2006) and also partly by the Institutional core grant. AKP is supported by a fellowship from the Council of Scientific and Industrial Research, India. ADM is supported by fellowship from the Indian Council of Medical Research, India. KBN was supported by fellowship from Department of Science and Technology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, CANCER RES, V60, P6101; BARTHOLOMEW C, 1994, ONCOGENE, V9, P939; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buonamici S, 2005, J BIOL CHEM, V280, P428, DOI 10.1074/jbc.M410836200; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; CherbonnelLasserre C, 1996, ONCOGENE, V13, P1489; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DREYFUS F, 1995, LEUKEMIA, V9, P203; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; Kuo YY, 2007, MOL CELL BIOL, V27, P4261, DOI 10.1128/MCB.02212-06; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; MORISHITA K, 1990, ONCOGENE, V5, P963; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Ogawa S, 1996, LEUKEMIA, V10, P788; OHYASHIKI JH, 1995, BLOOD, V85, P3713, DOI 10.1182/blood.V85.12.3713.bloodjournal85123713; Qiu Y, 2008, BIOCHEMISTRY-US, V47, P3697, DOI 10.1021/bi702524v; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Roy P, 2010, FEBS J, V277, P441, DOI 10.1111/j.1742-4658.2009.07496.x; RUSSELL M, 1994, BLOOD, V84, P1243, DOI 10.1182/blood.V84.4.1243.bloodjournal8441243; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Valks DM, 2003, J BIOL CHEM, V278, P25542, DOI 10.1074/jbc.M303760200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679	42	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25370	10.1371/journal.pone.0025370	http://dx.doi.org/10.1371/journal.pone.0025370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980434	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900055
J	Wallace, BP; DiMatteo, AD; Bolten, AB; Chaloupka, MY; Hutchinson, BJ; Abreu-Grobois, FA; Mortimer, JA; Seminoff, JA; Amorocho, D; Bjorndal, KA; Bourjea, J; Bowen, BW; Duenas, RB; Casale, P; Choudhury, BC; Costa, A; Dutton, PH; Fallabrino, A; Finkbeiner, EM; Girard, A; Girondot, M; Hamann, M; Hurley, BJ; Lopez-Mendilaharsu, M; Marcovaldi, MA; Musick, JA; Nel, R; Pilcher, NJ; Troeng, S; Witherington, B; Mast, RB				Wallace, Bryan P.; DiMatteo, Andrew D.; Bolten, Alan B.; Chaloupka, Milani Y.; Hutchinson, Brian J.; Abreu-Grobois, F. Alberto; Mortimer, Jeanne A.; Seminoff, Jeffrey A.; Amorocho, Diego; Bjorndal, Karen A.; Bourjea, Jerome; Bowen, Brian W.; Briseno Duenas, Raquel; Casale, Paolo; Choudhury, B. C.; Costa, Alice; Dutton, Peter H.; Fallabrino, Alejandro; Finkbeiner, Elena M.; Girard, Alexandre; Girondot, Marc; Hamann, Mark; Hurley, Brendan J.; Lopez-Mendilaharsu, Milagros; Angela Marcovaldi, Maria; Musick, John A.; Nel, Ronel; Pilcher, Nicolas J.; Troeng, Sebastian; Witherington, Blair; Mast, Roderic B.			Global Conservation Priorities for Marine Turtles	PLOS ONE			English	Article							LEATHERBACK TURTLE; SEA-TURTLES; POPULATION; MANAGEMENT; PACIFIC; RECOVERY	Where conservation resources are limited and conservation targets are diverse, robust yet flexible priority-setting frameworks are vital. Priority-setting is especially important for geographically widespread species with distinct populations subject to multiple threats that operate on different spatial and temporal scales. Marine turtles are widely distributed and exhibit intra-specific variations in population sizes and trends, as well as reproduction and morphology. However, current global extinction risk assessment frameworks do not assess conservation status of spatially and biologically distinct marine turtle Regional Management Units (RMUs), and thus do not capture variations in population trends, impacts of threats, or necessary conservation actions across individual populations. To address this issue, we developed a new assessment framework that allowed us to evaluate, compare and organize marine turtle RMUs according to status and threats criteria. Because conservation priorities can vary widely (i.e. from avoiding imminent extinction to maintaining long-term monitoring efforts) we developed a "conservation priorities portfolio" system using categories of paired risk and threats scores for all RMUs (n = 58). We performed these assessments and rankings globally, by species, by ocean basin, and by recognized geopolitical bodies to identify patterns in risk, threats, and data gaps at different scales. This process resulted in characterization of risk and threats to all marine turtle RMUs, including identification of the world's 11 most endangered marine turtle RMUs based on highest risk and threats scores. This system also highlighted important gaps in available information that is crucial for accurate conservation assessments. Overall, this priority-setting framework can provide guidance for research and conservation priorities at multiple relevant scales, and should serve as a model for conservation status assessments and priority-setting for widespread, long-lived taxa.	[Wallace, Bryan P.; DiMatteo, Andrew D.; Bolten, Alan B.; Chaloupka, Milani Y.; Hutchinson, Brian J.; Abreu-Grobois, F. Alberto; Mortimer, Jeanne A.; Seminoff, Jeffrey A.; Amorocho, Diego; Bjorndal, Karen A.; Bourjea, Jerome; Bowen, Brian W.; Briseno Duenas, Raquel; Casale, Paolo; Choudhury, B. C.; Costa, Alice; Dutton, Peter H.; Fallabrino, Alejandro; Finkbeiner, Elena M.; Girard, Alexandre; Girondot, Marc; Hamann, Mark; Hurley, Brendan J.; Lopez-Mendilaharsu, Milagros; Angela Marcovaldi, Maria; Musick, John A.; Nel, Ronel; Pilcher, Nicolas J.; Troeng, Sebastian; Witherington, Blair; Mast, Roderic B.] Burning Issues Working Grp, IUCN SSC Marine Turtle Specialist Grp, Arlington, VA USA; [Wallace, Bryan P.; Hutchinson, Brian J.; Hurley, Brendan J.; Mast, Roderic B.] Conservat Int, Global Marine Div, Arlington, VA USA; [Wallace, Bryan P.; Finkbeiner, Elena M.] Duke Univ, Div Marine Sci & Conservat, Beaufort, NC USA; [DiMatteo, Andrew D.] Duke Univ, Marine Geospatial Ecol Lab, Durham, NC USA; [Bolten, Alan B.; Bjorndal, Karen A.] Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL USA; [Bolten, Alan B.; Mortimer, Jeanne A.; Bjorndal, Karen A.] Univ Florida, Dept Biol, Gainesville, FL USA; [Chaloupka, Milani Y.] Univ Queensland, Ecol Modelling Serv Pty Ltd, Brisbane, Qld, Australia; [Abreu-Grobois, F. Alberto] Univ Nacl Autonoma Mexico, Unidad Acad Mazatlan, Inst Ciencias Mar & Limnol, Mazatlan, Sinaloa, Mexico; [Mortimer, Jeanne A.] Isl Conservat Soc, Victoria, Mahe, Seychelles; [Amorocho, Diego] NOAA, Natl Marine Fisheries Serv, Marine Turtle Ecol & Assessment Program, SW Fisheries Sci Ctr, La Jolla, CA USA; [Amorocho, Diego] Ctr Invest Medio Ambiente & Desarrollo, Cali, Colombia; [Bourjea, Jerome] IFREMER, Lab Ressources Halieut, Ile De La Reunion, France; [Bowen, Brian W.] Hawaii Inst Marine Biol, Kaneohe, HI USA; [Briseno Duenas, Raquel] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Banco Informac Tortugas Marinas BITMAR, Unidad Mazatlan, Mazatlan, Sinaloa, Mexico; [Casale, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Casale, Paolo] World Wildlife Fund Italy, WWF Mediterranean Turtle Programme, Rome, Italy; [Choudhury, B. C.] Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India; [Costa, Alice] World Wildlife Fund Mozamb, Maputo, Mozambique; [Dutton, Peter H.] Natl Ocean & Atmospher Adm, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Fallabrino, Alejandro] Karumbe, Montevideo, Uruguay; [Girard, Alexandre] Assoc RENATURA, Albens, France; [Girard, Alexandre] Assoc RENATURA, Pointe Noire, Rep Congo; [Girondot, Marc] Univ Paris 11, Lab Ecol Syst & Evolut, Orsay, France; [Hamann, Mark] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld, Australia; [Lopez-Mendilaharsu, Milagros; Angela Marcovaldi, Maria] Fundacao Pro Tamar, Projeto Tamar ICMBio, Salvador, BA, Brazil; Univ Estado Rio de Janeiro, Dept Ecol, Inst Biol, BR-20550011 Rio De Janeiro, Brazil; [Musick, John A.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Nel, Ronel] Nelson Mandela Metropolitan Univ, Sch Environm Sci, Summerstrand Campus, South Africa; [Pilcher, Nicolas J.] Marine Res Fdn, Sabah, Malaysia; [Troeng, Sebastian] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Troeng, Sebastian] Sea Turtle Conservancy, Sci Advisory Comm, Gainesville, FL USA; [Witherington, Blair] Florida Fish & Wildlife Conservat Commiss, Melbourne Beach, FL USA	Conservation International; Duke University; Duke University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Queensland; Universidad Nacional Autonoma de Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; Ifremer; Universidad Nacional Autonoma de Mexico; Sapienza University Rome; Wildlife Institute of India; National Oceanic Atmospheric Admin (NOAA) - USA; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; James Cook University; Universidade do Estado do Rio de Janeiro; William & Mary; Virginia Institute of Marine Science; Nelson Mandela University; Lund University; Florida Fish & Wildlife Conservation Commission	Wallace, BP (corresponding author), Burning Issues Working Grp, IUCN SSC Marine Turtle Specialist Grp, Arlington, VA USA.	b.wallace@conservation.org	Grobois, Alberto Abreu/A-3560-2017; Girondot, Marc/A-7663-2010	Grobois, Alberto Abreu/0000-0002-7350-757X; Bjorndal, Karen/0000-0002-6286-1901; Bolten, Alan/0000-0002-4834-2742; Mortimer, Jeanne A./0000-0001-6318-2890; Girondot, Marc/0000-0001-6645-8530; Bourjea, Jerome/0000-0001-7149-3648; Girard, Alexandre/0000-0002-2973-5137; Hamann, Mark/0000-0003-4588-7955; CASALE, PAOLO/0000-0003-2534-6158	National Fish and Wildlife Foundation; Offield Family Foundation; Ecological Modelling Services, Pty Ltd	National Fish and Wildlife Foundation; Offield Family Foundation; Ecological Modelling Services, Pty Ltd	This study was funded by the National Fish and Wildlife Foundation and the Offield Family Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MYC is employed by a commercial company (Ecological Modelling Services, Pty Ltd) that provides ecological modeling services, and his involvement in all aspects of this study was partially supported by this company. However, this support in no way biased his contributions to all aspects of this study, the overall process or resulting products generated by this study.	Abreu-Grobois FA, 2007, IUCN RED LIST STATUS; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten A.B., 2003, LOGGERHEAD SEA TURTL, P63; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Calix M., 2018, EUROPEAN RED LIST SA; Casale P, SEA TURTLES MEDITERR; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Donlan CJ, 2010, CONSERV BIOL, V24, P1586, DOI 10.1111/j.1523-1739.2010.01541.x; Ehrhart L.M., 2003, LOGGERHEAD SEA TURTL, P157; Fowler SL, 2005, SHARKS RAYS CHIMAERA; Freeman Milton M. R., 2008, Endangered Species Research, V6, P173, DOI 10.3354/esr00102; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Gaos AR, 2010, ORYX, V44, P595, DOI 10.1017/S0030605310000773; Godfrey Matthew H., 2008, Endangered Species Research, V6, P155, DOI 10.3354/esr00071; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Lauret-Stepler M., 2007, Endangered Species Research, V3, P217, DOI 10.3354/esr003217; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Margaritoulis D., 2003, LOGGERHEAD SEA TURTL, P175; Marsh H, 2007, CONSERV BIOL, V21, P387, DOI 10.1111/j.1523-1739.2006.00589.x; Mast R., 2005, MARINE TURTLE NEWSLE, V110, P13; Mast Roderic B., 2009, Marine Turtle Newsletter, P17; Merkhofer M.W., 2012, DECISION SCI SOCIAL, V2; Meylan Anne B., 1999, Chelonian Conservation and Biology, V3, P200; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; Mortimer JA, 2008, TURTLE SPECIALIST GR; National Research Council (NRC), 2010, ASS SEA TURTL STAT T; Nel R, 2008, SEA TURTLES KWAZULU; Tomillo PS, 2007, CHELONIAN CONSERV BI, V6, P54; Martinez LS, 2007, CHELONIAN CONSERV BI, V6, P70, DOI 10.2744/1071-8443(2007)6[70:CABOTL]2.0.CO;2; SEMINOFF J, 2004, GLOBAL STATUS ASSESS; Seminoff JA, 2008, J EXP MAR BIOL ECOL, V356, P52, DOI 10.1016/j.jembe.2007.12.007; Shanker K, 2008, MARINE TURTLES INDIA; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Turtle Expert Working Group, 2007, NMFSSEFSC555 NOAA; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Wallace Bryan P., 2009, Endangered Species Research, V7, P11, DOI 10.3354/esr00177; Witt MJ, 2011, P ROY SOC B-BIOL SCI, V278, P2338, DOI 10.1098/rspb.2010.2467	43	327	350	2	190	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24510	10.1371/journal.pone.0024510	http://dx.doi.org/10.1371/journal.pone.0024510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969858	Green Published, Green Accepted, gold			2022-12-27	WOS:000295936900009
J	Zhu, XZ; Zhang, JT; Ma, KP				Zhu, Xunzhi; Zhang, Jintun; Ma, Keping			Soil Biota Reduce Allelopathic Effects of the Invasive Eupatorium adenophorum	PLOS ONE			English	Article							CENTAUREA-MACULOSA; ALLELOCHEMICAL (+/-)-CATECHIN; ROOT EXUDATE; WEAPONS; FACILITATE; COMMUNITY; MECHANISM; SUCCESS; FUNGI	Allelopathy has been hypothesized to play a role in exotic plant invasions, and study of this process can improve our understanding of how direct and indirect plant interactions influence plant community organization and ecosystem functioning. However, allelopathic effects can be highly conditional. For example allelopathic effects demonstrated in vivo can be difficult to demonstrate in field soils. Here we tested phytotoxicity of Eupatorium adenophorum (croftonweed), one of the most destructive exotic species in China, to a native plant species Brassica rapa both in sand and in native soil. Our results suggested that natural soils from different invaded habitats alleviated or eliminated the efficacy of potential allelochemicals relative to sand cultures. When that soil is sterilized, the allelopathic effects returned; suggesting that soil biota were responsible for the reduced phytotoxicity in natural soils. Neither of the two allelopathic compounds (9-Oxo-10,11-dehydroageraphorone and 9b-Hydroxyageraphorone) of E. adenophorum could be found in natural soils infested by the invader, and when those compounds were added to the soils as leachates, they showed substantial degradation after 24 hours in natural soils but not in sand. Our findings emphasize that soil biota can reduce the allelopathic effects of invaders on other plants, and therefore can reduce community invasibility. These results also suggest that soil biota may have stronger or weaker effects on allelopathic interactions depending on how allelochemicals are delivered.	[Zhu, Xunzhi; Ma, Keping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Jintun] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Beijing Normal University	Zhu, XZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	kpma@ibcas.ac.cn		Zhang, Jin-tun/0000-0002-3163-6808	Chinese Academy of Sciences [KSCX1-SW-13-03]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was financially supported with the Knowledge Innovation Project of Chinese Academy of Sciences (KSCX1-SW-13-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2000, PERSPECT PLANT ECOL, V3, P52, DOI DOI 10.1078/1433-8319-00004; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Barto EK, 2009, CHEMOSPHERE, V76, P71, DOI 10.1016/j.chemosphere.2009.02.020; BARUAH NC, 1994, J CHEM ECOL, V20, P1885, DOI 10.1007/BF02066230; Bertin C, 2009, J CHEM ECOL, V35, P1288, DOI 10.1007/s10886-009-9707-4; Blair AC, 2005, ECOL LETT, V8, P1039, DOI 10.1111/j.1461-0248.2005.00805.x; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Callaway RM, 2003, ECOLOGY, V84, P129, DOI 10.1890/0012-9658(2003)084[0129:SFATEO]2.0.CO;2; Cui QG, 2009, WEED RES, V49, P201, DOI 10.1111/j.1365-3180.2008.00679.x; D'Antonio CM, 2004, WEED TECHNOL, V18, P1572, DOI 10.1614/0890-037X(2004)018[1572:ERITAP]2.0.CO;2; Duke SO, 2009, J CHEM ECOL, V35, P141, DOI 10.1007/s10886-008-9587-z; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Gimsing AL, 2009, CHEMOSPHERE, V76, P1041, DOI 10.1016/j.chemosphere.2009.04.048; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Inderjit, 2003, PLANT SOIL, V256, P1, DOI 10.1023/A:1026242418333; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2000, J CHEM ECOL, V26, P2111, DOI 10.1023/A:1005516431969; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Lu Ping, 2005, Acta Phytoecologica Sinica, V29, P1029; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; Pollock JL, 2009, J ECOL, V97, P1234, DOI 10.1111/j.1365-2745.2009.01553.x; Reinhart KO, 2004, ECOL APPL, V14, P1737, DOI 10.1890/03-5204; SONG QS, 2000, ACTA PHYTOECOL SIN, V24, P362; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; TRIPATHI R S, 1981, Proceedings of the Indian National Science Academy Part B Biological Sciences, V47, P458; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; [王俊峰 WANG JunFeng], 2006, [生态学报, Acta Ecologica Sinica], V26, P1809; Yang GQ, 2006, ALLELOPATHY J, V18, P237; Yang GQ, 2008, ALLELOPATHY J, V21, P253; Yu XJ, 2006, WEED RES, V46, P319, DOI 10.1111/j.1365-3180.2006.00501.x; Yu XingJun, 2004, Acta Phytoecologica Sinica, V28, P773; Yu XJ, 2005, CHINESE SCI BULL, V50, P1105, DOI 10.1360/04WC0280; ZHANG XY, 2005, THESIS CHINESE ACAD; Zhang ZY, 2010, J APPL MICROBIOL, V108, P1839, DOI 10.1111/j.1365-2672.2009.04589.x; [郑丽 ZHENG Li], 2005, [生态学报, Acta Ecologica Sinica], V25, P2782	41	18	24	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25393	10.1371/journal.pone.0025393	http://dx.doi.org/10.1371/journal.pone.0025393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980442	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900059
J	Shephard, F; Adenle, AA; Jacobson, LA; Szewczyk, NJ				Shephard, Freya; Adenle, Ademola A.; Jacobson, Lewis A.; Szewczyk, Nathaniel J.			Identification and Functional Clustering of Genes Regulating Muscle Protein Degradation from amongst the Known C. elegans Muscle Mutants	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; HOMEOSTASIS; GENETICS; CELLS; RESISTANCE; EXERCISE; RNA	Loss of muscle mass via protein degradation is an important clinical problem but we know little of how muscle protein degradation is regulated genetically. To gain insight our labs developed C. elegans into a model for understanding the regulation of muscle protein degradation. Past studies uncovered novel functional roles for genes affecting muscle and/or involved in signalling in other cells or tissues. Here we examine most of the genes previously identified as the sites of mutations affecting muscle for novel roles in regulating degradation. We evaluate genomic (RNAi knockdown) approaches and combine them with our established genetic (mutant) and pharmacologic (drugs) approaches to examine these 159 genes. We find that RNAi usually recapitulates both organismal and sub-cellular mutant phenotypes but RNAi, unlike mutants, can frequently be used acutely to study gene function solely in differentiated muscle. In the majority of cases where RNAi does not produce organismal level phenotypes, sub-cellular defects can be detected; disrupted proteostasis is most commonly observed. We identify 48 genes in which mutation or RNAi knockdown causes excessive protein degradation; myofibrillar and/or mitochondrial morphologies are also disrupted in 19 of these 48 cases. These 48 genes appear to act via at least three sub-networks to control bulk degradation of protein in muscle cytosol. Attachment to the extracellular matrix regulates degradation via unidentified proteases and affects myofibrillar and mitochondrial morphology. Growth factor imbalance and calcium overload promote lysosome based degradation whereas calcium deficit promotes proteasome based degradation, in both cases myofibrillar and mitochondrial morphologies are largely unaffected. Our results provide a framework for effectively using RNAi to identify and functionally cluster novel regulators of degradation. This clustering allows prioritization of candidate genes/pathways for future mechanistic studies.	[Shephard, Freya; Adenle, Ademola A.; Szewczyk, Nathaniel J.] Univ Nottingham, Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby, England; [Jacobson, Lewis A.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shephard, F (corresponding author), Univ Nottingham, Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby, England.	nate@alumni.cmu.edu		Szewczyk, Nathaniel/0000-0003-4425-9746	United States National Institutes of Health (NIH) National Institute for Arthritis and Musculoskeletal and Skin Diseases [AR-054342]; US National Science Foundation [MCB-0542355]; US NIH National Center for Research Resources; US NIH National Human Genome Research Institute; British Medical Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054342] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH) National Institute for Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Science Foundation(National Science Foundation (NSF)); US NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US NIH National Human Genome Research Institute; British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the United States National Institutes of Health (NIH) National Institute for Arthritis and Musculoskeletal and Skin Diseases (AR-054342). Strains used for comparative analysis that were not specifically made for this work were constructed by past members of the Jacobson lab and funded by the US National Science Foundation (MCB-0542355). Almost all of the mutant alleles utilized in this work were obtained from the Caenorhabditis Genetics Center, which is funded by the US NIH National Center for Research Resources. All Bioinformatic work was conducted utilizing WormBase [27], which is funded by the US NIH National Human Genome Research Institute and the British Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1084, DOI 10.1016/j.biocel.2004.10.003; AVERY L, 1993, GENETICS, V133, P897; Avery L, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-69; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BRENNER S, 1974, GENETICS, V77, P71; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fostel JL, 2003, BIOCHEM BIOPH RES CO, V312, P173, DOI 10.1016/j.bbrc.2003.09.248; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lecroisey C, 2007, J MUSCLE RES CELL M, V28, P79, DOI 10.1007/s10974-007-9104-y; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Plenefisch JD, 2000, DEVELOPMENT, V127, P1197; REINER DJ, 1995, GENETICS, V141, P961; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schafer William R, 2005, WormBook, P1; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Szewczyk NJ, 2007, EMBO J, V26, P935, DOI 10.1038/sj.emboj.7601540; Szewczyk NJ, 2005, INT J BIOCHEM CELL B, V37, P1997, DOI 10.1016/j.biocel.2005.02.020; Szewczyk NJ, 2000, J CELL SCI, V113, P2003; Szewczyk NJ, 2003, EMBO J, V22, P5058, DOI 10.1093/emboj/cdg472; Szewczyk NJ, 2002, MOL CELL BIOL, V22, P4181, DOI 10.1128/MCB.22.12.4181-4188.2002; THOMAS JH, 1990, GENETICS, V124, P855; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Zdinak LA, 1997, J CELL BIOCHEM, V67, P143, DOI 10.1002/(SICI)1097-4644(19971001)67:1<143::AID-JCB15>3.3.CO;2-F	42	24	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24686	10.1371/journal.pone.0024686	http://dx.doi.org/10.1371/journal.pone.0024686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980350	Green Published, Green Accepted, gold			2022-12-27	WOS:000295933700006
J	Hresko, RC; Hruz, PW				Hresko, Richard C.; Hruz, Paul W.			HIV Protease Inhibitors Act as Competitive Inhibitors of the Cytoplasmic Glucose Binding Site of GLUTs with Differing Affinities for GLUT1 and GLUT4	PLOS ONE			English	Article							INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; IN-VITRO; TRANSPORTER; INFECTION; CELLS; LOPINAVIR/RITONAVIR; SENSITIVITY; TIPRANAVIR	The clinical use of several first generation HIV protease inhibitors (PIs) is associated with the development of insulin resistance. Indinavir has been shown to act as a potent reversible noncompetitive inhibitor of zero-trans glucose influx via direct interaction with the insulin responsive facilitative glucose transporter GLUT4. Newer drugs within this class have differing effects on insulin sensitivity in treated patients. GLUTs are known to contain two distinct glucose-binding sites that are located on opposite sides of the lipid bilayer. To determine whether interference with the cytoplasmic glucose binding site is responsible for differential effects of PIs on glucose transport, intact intracellular membrane vesicles containing GLUT1 and GLUT4, which have an inverted transporter orientation relative to the plasma membrane, were isolated from 3T3-L1 adipocytes. The binding of biotinylated ATB-BMPA, a membrane impermeable bis-mannose containing photolabel, was determined in the presence of indinavir, ritonavir, atazanavir, tipranavir, and cytochalasin b. Zero-trans 2-deoxyglucose transport was measured in both 3T3-L1 fibroblasts and primary rat adipocytes acutely exposed to these compounds. PI inhibition of glucose transport correlated strongly with the PI inhibition of ATB-BMPA/transporter binding. At therapeutically relevant concentrations, ritonavir was not selective for GLUT4 over GLUT1. Indinavir was found to act as a competitive inhibitor of the cytoplasmic glucose binding site of GLUT4 with a K-I of 8.2 mu M. These data establish biotinylated ATB-BMPA as an effective probe to quantify accessibility of the endofacial glucose-binding site in GLUTs and reveal that the ability of PIs to block this site differs among drugs within this class. This provides mechanistic insight into the basis for the clinical variation in drug-related metabolic toxicity.	[Hresko, Richard C.; Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hresko, RC (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	hruz_p@kids.wustl.edu		Hruz, Paul/0000-0002-1478-3355	National Institutes of Health [DK064572, HL092798]; March of Dimes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the National Institutes of Health (DK064572 and HL092798) and from the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; CLARK AE, 1990, BIOCHEM J, V269, P615, DOI 10.1042/bj2690615; Copeland R. A., 2005, EVALUATION ENZYME IN; Grinspoon Steven K, 2005, Am J Med, V118 Suppl 2, p23S; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; Hruz PW, 2006, JAIDS-J ACQ IMM DEF, V43, P624, DOI 10.1097/01.qai.0000245883.66509.b4; Hruz PW, 2011, BEST PRACT RES CL EN, V25, P459, DOI 10.1016/j.beem.2010.10.017; Hruz PW, 2008, CURR OPIN HIV AIDS, V3, P660, DOI 10.1097/COH.0b013e3283139134; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Kalla Vyas A, 2010, J BIOL CHEM; Koumanov F, 1998, BIOCHEM J, V330, P1209, DOI 10.1042/bj3301209; LANGE K, 1990, FEBS LETT, V261, P459, DOI 10.1016/0014-5793(90)80615-P; LOWE AG, 1989, BIOCHEM SOC T, V17, P435, DOI 10.1042/bst0170435; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Murata H, 2002, AIDS, V16, P859, DOI 10.1097/00002030-200204120-00005; Nolte LA, 2001, DIABETES, V50, P1397, DOI 10.2337/diabetes.50.6.1397; Noor MA, 2004, AIDS, V18, P2137, DOI 10.1097/00002030-200411050-00005; Noor MA, 2006, AIDS, V20, P1813, DOI 10.1097/01.aids.0000244200.11006.55; Orman JS, 2008, DRUGS, V68, P1435, DOI 10.2165/00003495-200868100-00006; Owen Andrew, 2004, J HIV Ther, V9, P97; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Tan QY, 2005, JAIDS-J ACQ IMM DEF, V40, P398, DOI 10.1097/01.qai.0000176654.97392.c7; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wang S, 2002, ANTIVIR THER, V7, pL6; Weber T. M., 1988, INSULIN RECEPTORS B, P171	31	60	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25237	10.1371/journal.pone.0025237	http://dx.doi.org/10.1371/journal.pone.0025237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966466	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100032
J	Coleman, JJ; Ghosh, S; Okoli, I; Mylonakis, E				Coleman, Jeffrey J.; Ghosh, Suman; Okoli, Ikechukwu; Mylonakis, Eleftherios			Antifungal Activity of Microbial Secondary Metabolites	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; CYTOCHROME BC(1) COMPLEX; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; CAENORHABDITIS-ELEGANS; GLIOTOXIN PRODUCTION; FUSARIUM-OXYSPORUM; ILICICOLIN-H; IN-VITRO; IDENTIFICATION	Secondary metabolites are well known for their ability to impede other microorganisms. Reanalysis of a screen of natural products using the Caenorhabditis elegans-Candida albicans infection model identified twelve microbial secondary metabolites capable of conferring an increase in survival to infected nematodes. In this screen, the two compound treatments conferring the highest survival rates were members of the epipolythiodioxopiperazine (ETP) family of fungal secondary metabolites, acetylgliotoxin and a derivative of hyalodendrin. The abundance of fungal secondary metabolites indentified in this screen prompted further studies investigating the interaction between opportunistic pathogenic fungi and Aspergillus fumigatus, because of the ability of the fungus to produce a plethora of secondary metabolites, including the well studied ETP gliotoxin. We found that cell-free supernatant of A. fumigatus was able to inhibit the growth of Candida albicans through the production of a secreted product. Comparative studies between a wild-type and an A. fumigatus Delta gliP strain unable to synthesize gliotoxin demonstrate that this secondary metabolite is the major factor responsible for the inhibition. Although toxic to organisms, gliotoxin conferred an increase in survival to C. albicans-infected C. elegans in a dose dependent manner. As A. fumigatus produces gliotoxin in vivo, we propose that in addition to being a virulence factor, gliotoxin may also provide an advantage to A. fumigatus when infecting a host that harbors other opportunistic fungi.	[Coleman, Jeffrey J.; Ghosh, Suman; Okoli, Ikechukwu; Mylonakis, Eleftherios] Massachusetts Gen Hosp, Harvard Med Sch, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Coleman, JJ (corresponding author), Massachusetts Gen Hosp, Harvard Med Sch, Div Infect Dis, Boston, MA 02114 USA.	emylonakis@partners.org	Ghosh, Suman/F-3453-2013; Coleman, Jeffrey J/E-2981-2015	Coleman, Jeffrey/0000-0001-8579-1996	National Institutes of Health [AI075286, AI070569, AI07061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075286, T32AI007061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health trough, an R01 award (AI075286), and an R21 award (AI070569) to EM, and a T32 (AI07061) to JJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo PH, 2003, J BIOL CHEM, V278, P46549, DOI 10.1074/jbc.M304825200; Berry EA, 2010, BBA-BIOENERGETICS, V1797, P360, DOI 10.1016/j.bbabio.2009.12.003; BOELAERT JR, 1993, J CLIN INVEST, V91, P1979, DOI 10.1172/JCI116419; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Coleman JJ, 2010, ACS CHEM BIOL, V5, P321, DOI 10.1021/cb900243b; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; EICHNER RD, 1988, J BIOL CHEM, V263, P3772; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; FREEMAN GG, 1948, NATURE, V162, P30, DOI 10.1038/162030a0; FREEMAN GG, 1949, J GEN MICROBIOL, V3, P60, DOI 10.1099/00221287-3-1-60; Frisvad JC, 2009, MED MYCOL, V47, pS53, DOI 10.1080/13693780802307720; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Gardiner DM, 2005, FUNGAL GENET BIOL, V42, P257, DOI 10.1016/j.fgb.2004.12.001; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Groll AH, 1996, J INFECTION, V33, P23, DOI 10.1016/S0163-4453(96)92700-0; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; Ibrahim AS, 2008, CURR OPIN INFECT DIS, V21, P620, DOI 10.1097/QCO.0b013e3283165fd1; Jayasinghe L, 2006, J NAT PROD, V69, P439, DOI 10.1021/np050487v; Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021; Johnson JR, 1943, J AM CHEM SOC, V65, P2005, DOI 10.1021/ja01250a051; KAMOGASHIRA T, 1988, AGR BIOL CHEM TOKYO, V52, P859; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kim B, 1999, CAN J BOT, V77, P850, DOI 10.1139/cjb-77-6-850; KONETSCHNYRAPP S, 1992, J AM CHEM SOC, V114, P2224, DOI 10.1021/ja00032a043; Kupfahl C, 2008, INT J MED MICROBIOL, V298, P319, DOI 10.1016/j.ijmm.2007.04.006; Kupfahl C, 2007, FEMS YEAST RES, V7, P986, DOI 10.1111/j.1567-1364.2007.00256.x; Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee KZ, 2010, VIRULENCE, V1, P113, DOI 10.4161/viru.1.3.10974; Lewis RE, 2005, J CLIN MICROBIOL, V43, P6120, DOI 10.1128/JCM.43.12.6120-6122.2005; Lewis RE, 2005, INFECT IMMUN, V73, P635, DOI 10.1128/IAI.73.1.635-637.2005; Lionakis MS, 2010, VIRULENCE, V1, P488, DOI 10.4161/viru.1.6.13311; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; MATSUMOTO M, 1976, TETRAHEDRON LETT, P3827; National Committee for Clinical Laboratory Standards, 1995, M27A NAT COMM CLIN L; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Nieminen SM, 2002, APPL ENVIRON MICROB, V68, P4871, DOI 10.1128/AEM.68.10.4871-4875.2002; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Patron NJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-174; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Pukkila-Worley R, 2010, VIRULENCE, V1, P111, DOI 10.4161/viru.1.3.11746; REILLY HC, 1945, J BACTERIOL, V49, P585, DOI 10.1128/JB.49.6.585-594.1945; ROHR J, 1992, NAT PROD REP, V9, P103, DOI 10.1039/np9920900103; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; SHAH DT, 1991, MYCOPATHOLOGIA, V116, P203, DOI 10.1007/BF00436836; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; STILLWELL MA, 1974, CAN J MICROBIOL, V20, P759, DOI 10.1139/m74-116; TAMURA G, 1968, J ANTIBIOT, V21, P539, DOI 10.7164/antibiotics.21.539; WINKELMANN G, 1992, MYCOL RES, V96, P529, DOI 10.1016/S0953-7562(09)80976-3; ZOCHER R, 1982, BIOCHEMISTRY-US, V21, P43, DOI 10.1021/bi00530a008	52	49	55	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25321	10.1371/journal.pone.0025321	http://dx.doi.org/10.1371/journal.pone.0025321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966496	Green Published, gold, Green Submitted			2022-12-27	WOS:000295265100087
J	James, PMA; Coltman, DW; Murray, BW; Hamelin, RC; Sperling, FAH				James, Patrick M. A.; Coltman, Dave W.; Murray, Brent W.; Hamelin, Richard C.; Sperling, Felix A. H.			Spatial Genetic Structure of a Symbiotic Beetle-Fungal System: Toward Multi-Taxa Integrated Landscape Genetics	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; DENDROCTONUS-PONDEROSAE HOPK; BARK BEETLES; MYCANGIAL FUNGI; RANGE EXPANSION; CLIMATE-CHANGE; COLEOPTERA; FOREST; COMMUNITY; ECOLOGY	Spatial patterns of genetic variation in interacting species can identify shared features that are important to gene flow and can elucidate co-evolutionary relationships. We assessed concordance in spatial genetic variation between the mountain pine beetle (Dendroctonus ponderosae) and one of its fungal symbionts, Grosmanniaclavigera, in western Canada using neutral genetic markers. We examined how spatial heterogeneity affects genetic variation within beetles and fungi and developed a novel integrated landscape genetics approach to assess reciprocal genetic influences between species using constrained ordination. We also compared landscape genetic models built using Euclidean distances based on allele frequencies to traditional pair-wise Fst. Both beetles and fungi exhibited moderate levels of genetic structure over the total study area, low levels of structure in the south, and more pronounced fungal structure in the north. Beetle genetic variation was associated with geographic location while that of the fungus was not. Pinevolume and climate explained beetle genetic variation in the northern region of recent outbreak expansion. Reciprocal genetic relationships were only detectedin the south where there has been alonger history of beetle infestations. The Euclidean distance and Fst-based analyses resulted in similar models in the north and over the entire study area, but differences between methods in the south suggest that genetic distances measures should be selected based on ecological and evolutionary contexts. The integrated landscape genetics framework we present is powerful, general, and can be applied to other systems to quantify the biotic and abiotic determinants of spatial genetic variation within and among taxa.	[James, Patrick M. A.; Coltman, Dave W.; Sperling, Felix A. H.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Murray, Brent W.] Univ No British Columbia, Nat Resources & Environm Studies Inst, Prince George, BC V2L 5P2, Canada; [Hamelin, Richard C.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Hamelin, Richard C.] Nat Resources Canada, Quebec City, PQ, Canada	University of Alberta; University of Northern British Columbia; University of British Columbia; Natural Resources Canada	James, PMA (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	patrick.ma.james@umontreal.ca	Lundquist, John/B-6433-2012; Coltman, David W/A-4453-2012; Sperling, Felix A.H./H-8376-2012; Murray, Brent/F-5031-2012; Hamelin, Richard/F-7006-2010	Coltman, David W/0000-0002-1268-2307; Sperling, Felix A.H./0000-0001-5148-4226; Hamelin, Richard/0000-0003-4006-532X	Government of Alberta [AAET/AFRI-859-G07]; Genome Canada; Genome Alberta; Genome British Columbia; University of Alberta	Government of Alberta; Genome Canada(Genome Canada); Genome Alberta; Genome British Columbia; University of Alberta(University of Alberta)	Funding for this research was provided through grants from the Government of Alberta (AAET/AFRI-859-G07) to DWC, and FAHS and from Genome Canada, Genome Alberta, and Genome British Columbia for the TRIA1 and TRIA2 Projects (http://www.thetriaproject.ca) to DWC, BM, RH and FAHS. PMAJ was also supported by a Killam Post-Doctoral Fellowship at the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 1999, EVOLUTION, V53, P818, DOI 10.1111/j.1558-5646.1999.tb05375.x; Amman GD, 1973, INT171 NAT RES CAN; Anderson B, 2004, EVOLUTION, V58, P1730, DOI 10.1111/j.0014-3820.2004.tb00457.x; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; BERRYMAN AA, 1972, BIOSCIENCE, V22, P598, DOI 10.2307/1296206; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; Bleiker KP, 2009, CAN ENTOMOL, V141, P503, DOI 10.4039/n09-034; Cardoza YJ, 2008, ENVIRON ENTOMOL, V37, P956, DOI 10.1603/0046-225X(2008)37[956:MSAFMN]2.0.CO;2; Carroll AL, 2004, PACIF FOR C, V399, P223; Davis CS, 2009, MOL ECOL RESOUR, V9, P1071, DOI 10.1111/j.1755-0998.2009.02579.x; Ecological Stratification Working Group, 1996, NATL ECOLOGICAL FRAM; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fall A, 2007, ECOSYSTEMS, V10, P448, DOI 10.1007/s10021-007-9038-7; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Hopping G. R., 1945, FOREST CHRON, V21, P1; Jackson PL, 2008, CAN J FOREST RES, V38, P2313, DOI 10.1139/X08-066; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Katoh H, 2002, MOL ECOL, V11, P1565, DOI 10.1046/j.1365-294X.2002.01535.x; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lieutier F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009066; Logan J, 1999, ENV ENTOMOLOGY, V28; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mock KE, 2007, MOL ECOL, V16, P553, DOI 10.1111/j.1365-294X.2006.03158.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Nealis V, 2008, BCX417 NAT RES CAN; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Roe AD, 2011, MICROB ECOL, V62, P347, DOI 10.1007/s00248-011-9841-8; Roe AD, 2011, MOL ECOL, V20, P584, DOI 10.1111/j.1365-294X.2010.04953.x; SAFRANYIK L, 1989, J APPL ENTOMOL, V108, P498, DOI 10.1111/j.1439-0418.1989.tb00484.x; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Six DL, 2007, MICROB ECOL, V54, P112, DOI 10.1007/s00248-006-9178-x; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Six DL, 2004, SYMBIOSIS, V37, P207; Six DL, 1999, ANN ENTOMOL SOC AM, V92, P159, DOI 10.1093/aesa/92.2.159; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; ter Braak CJF, 1987, DATA ANAL COMMUNITY; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Tsui CKM, 2009, MOL ECOL RESOUR, V9, P1501, DOI 10.1111/j.1755-0998.2009.02717.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wright S, 1943, GENETICS, V28, P114; Yemshanov D, ENV MONITOR IN PRESS	59	57	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25359	10.1371/journal.pone.0025359	http://dx.doi.org/10.1371/journal.pone.0025359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991309	gold, Green Submitted, Green Published			2022-12-27	WOS:000295963300011
J	Nogaro, SI; Hafalla, JC; Walther, B; Remarque, EJ; Tetteh, KKA; Conway, DJ; Riley, EM; Walther, M				Nogaro, Sarah I.; Hafalla, Julius C.; Walther, Brigitte; Remarque, Edmond J.; Tetteh, Kevin K. A.; Conway, David J.; Riley, Eleanor M.; Walther, Michael			The Breadth, but Not the Magnitude, of Circulating Memory B Cell Responses to P. falciparum Increases with Age/Exposure in an Area of Low Transmission	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; APICAL MEMBRANE ANTIGEN-1; MALARIA-ENDEMIC AREA; PLASMODIUM-FALCIPARUM; SERUM ANTIBODIES; ACQUIRED-IMMUNITY; NATURAL-SELECTION; GAMBIAN CHILDREN; INDIVIDUALS; RECOGNITION	Background: Malaria caused by Plasmodium falciparum remains a major cause of death in sub-Saharan Africa. Immunity against symptoms of malaria requires repeated exposure, suggesting either that the parasite is poorly immunogenic or that the development of effective immune responses to malaria may be impaired. Methods: We carried out two age-stratified cross-sectional surveys of anti-malarial humoral immune responses in a Gambian village where P. falciparum malaria transmission is low and sporadic. Circulating antibodies and memory B cells (MBC) to four malarial antigens were measured using ELISA and cultured B cell ELISpot. Findings and Conclusions: The proportion of individuals with malaria-specific MBC and antibodies, and the average number of antigens recognised by each individual, increased with age but the magnitude of these responses did not. Malaria-specific antibody levels did not correlate with either the prevalence or median number of MBC, indicating that these two assays are measuring different aspects of the humoral immune response. Among those with immunological evidence of malaria exposure (defined as a positive response to at least one malarial antigen either by ELISA or ELISPOT), the median number of malaria-specific MBC was similar to median numbers of diphtheria-specific MBC, suggesting that the circulating memory cell pool for malaria antigens is of similar size to that for other antigens.	[Nogaro, Sarah I.; Walther, Brigitte; Conway, David J.; Walther, Michael] MRC Labs, Banjul, Gambia; [Nogaro, Sarah I.; Hafalla, Julius C.; Riley, Eleanor M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England; [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Gj Rijswijk, Netherlands; [Tetteh, Kevin K. A.; Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Fac Infect & Trop Dis, London WC1, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Nogaro, SI (corresponding author), MRC Labs, Banjul, Gambia.	Michael.Walther@nih.gov	Riley, Eleanor M/C-8960-2013; Tetteh, Kevin/GYQ-9704-2022; Remarque, Ed/AAE-8643-2020; Riley, Eleanor/AAL-1382-2020	Riley, Eleanor M/0000-0003-3447-3570; Tetteh, Kevin/0000-0003-2733-0037; Riley, Eleanor/0000-0003-3447-3570; Conway, David/0000-0002-8711-3037	Medical Research Council (UK), The Gambia; Wellcome Trust [079920]; Royal Society (UK); MRC [MC_U190097907, MC_U190081993, MC_U190081986] Funding Source: UKRI; Medical Research Council [MC_U190081993, MC_U190097907, MC_U190081986] Funding Source: researchfish	Medical Research Council (UK), The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society (UK)(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK), The Gambia. J.C.H. was a recipient of a Wellcome Trust Visiting Fellowship (grant reference number 079920) and is currently supported by a University Research Fellowship from The Royal Society (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V67, P343, DOI 10.1016/0166-6851(94)90026-4; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chelimo K, 2005, PEDIATR INFECT DIS J, V24, P680, DOI 10.1097/01.inf.0000172151.28851.fd; Clarke SE, 2002, T ROY SOC TROP MED H, V96, P499, DOI 10.1016/S0035-9203(02)90419-0; Cockburn IA, 2007, CURR OPIN IMMUNOL, V19, P424, DOI 10.1016/j.coi.2007.05.008; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; EGAN AF, 1995, INFECT IMMUN, V63, P456, DOI 10.1128/IAI.63.2.456-466.1995; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gomez-Escobar N, 2010, J INFECT DIS, V201, P444, DOI 10.1086/649902; GREENWOOD BM, 1974, LANCET, V1, P435; GREENWOOD BM, 1975, NATURE, V257, P592, DOI 10.1038/257592a0; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; OSIER FH, 2011, INFECT IMMU IN PRESS, P1; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; RAMASAMY R, 1994, AM J TROP MED HYG, V50, P537, DOI 10.4269/ajtmh.1994.50.537; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; UNICEF, 2011, INF COUNTR; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; WHITTLE HC, 1990, CLIN EXP IMMUNOL, V80, P213, DOI 10.1111/j.1365-2249.1990.tb05236.x; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; World Health Organization/UNICEF, 2009, REV NAT IMM COV 1980	53	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25582	10.1371/journal.pone.0025582	http://dx.doi.org/10.1371/journal.pone.0025582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991321	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000295963300013
J	Mechtcheriakova, D; Sobanov, Y; Holtappels, G; Bajna, E; Svoboda, M; Jaritz, M; Bachert, C; Jensen-Jarolim, E				Mechtcheriakova, Diana; Sobanov, Yury; Holtappels, Gabriele; Bajna, Erika; Svoboda, Martin; Jaritz, Markus; Bachert, Claus; Jensen-Jarolim, Erika			Activation-Induced Cytidine Deaminase (AID)-Associated Multigene Signature to Assess Impact of AID in Etiology of Diseases with Inflammatory Component	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; LARGE B-CELLS; NASAL POLYPS; T-CELLS; MONOCLONAL-ANTIBODY; EXPRESSION; GENE; IGE; HYPERMUTATION; PAX5	Activation-induced cytidine deaminase (AID) is expressed in B cells within germinal centers and is critically involved in class switch recombination and somatic hypermutation of immunoglobulin loci. Functionally active AID can additionally be detected within ectopic follicular structures developed at sites of chronic inflammation. Furthermore, AID may target non-Ig genes in B-and non-B-cell background. Therefore, AID-associated effects are of increasing interest in disease areas such as allergy, inflammation, autoimmunity, and cancer. Pathway-or disease-relevant multigene signatures have attracted substantial attention for therapeutic target proposal, diagnostic tools, and monitoring of therapy response. To delineate the impact of AID in etiology of multifactorial diseases, we designed the AID-associated 25-gene signature. Chronic rhinosinusitis with nasal polyps was used as an inflammation-driven airway disease model; high levels of IgE have been previously shown to be present within polyp tissue. Expression levels of 16 genes were found to be modulated in polyps including AID, IgG and IgE mature transcripts which reflect AID activity; clustering algorithm revealed an AID-specific gene signature for the disease state with nasal polyp. Complementary, AID-positive ectopic lymphoid structures were detected within polyp tissues by in situ immunostaining. Our data demonstrate the class switch recombination and somatic hypermutation events likely taking place locally in the airways and in addition to the previously highlighted markers and/or targets as IL5 and IgE suggest novel candidate genes to be considered for treatment of nasal polyposis including among others IL13 and CD23. Thus, the algorithm presented herein including the multigene signature approach, analysis of co-regularities and creation of AID-associated functional network gives an integrated view of biological processes and might be further applied to assess role of altered AID expression in etiology of other diseases, in particular, aberrant immunity and cancer.	[Mechtcheriakova, Diana; Sobanov, Yury; Bajna, Erika; Svoboda, Martin; Jensen-Jarolim, Erika] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Holtappels, Gabriele; Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, B-9000 Ghent, Belgium; [Jaritz, Markus] Res Inst Mol Pathol, A-1030 Vienna, Austria	Medical University of Vienna; Ghent University; Ghent University Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Mechtcheriakova, D (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	diana.mechtcheriakova@meduniwien.ac.at	Jensen-Jarolim, Erika/C-5120-2018; Bachert, Claus/J-8825-2012	Jensen-Jarolim, Erika/0000-0003-4019-5765; Mechtcheriakova, Diana/0000-0002-8737-3592; Jaritz, Markus/0000-0002-9326-2047	Austrian Science Fund (FWF) [539, APP22441FW]; Flemish Scientific Research Board (FWO) [A12/5-HB-KH3, G.0436.04]; Austrian Science Fund (FWF) [P 22441] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Flemish Scientific Research Board (FWO)(FWO); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by The Austrian Science Fund (FWF;539 http://www.fwf.ac.at/) APP22441FW to DM, and by the Flemish Scientific Research Board (FWO) A12/5-HB-KH3 and G.0436.04 to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Bachert C, 1997, J ALLERGY CLIN IMMUN, V99, P837, DOI 10.1016/S0091-6749(97)80019-X; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2344; Bonnefoy J Y, 1997, Int Rev Immunol, V16, P113, DOI 10.3109/08830189709045705; Bornancin FR, 2005, BBA-MOL CELL BIOL L, V1687, P31, DOI 10.1016/j.bbalip.2004.11.012; Byrd JC, 2010, BLOOD, V115, P489, DOI 10.1182/blood-2009-08-237727; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Cotta CV, 2003, BLOOD, V101, P4342, DOI 10.1182/blood-2002-10-3139; Dinkel A, 1997, J IMMUNOL, V159, P2678; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ewart MA, 2002, GENES IMMUN, V3, P158, DOI 10.1038/sj.gene.6363848; Fokkens W, 2007, RHINOLOGY, V45, P97; Gevaert P, 2008, J ALLERGY CLIN IMMUN, V121, P797, DOI 10.1016/j.jaci.2008.01.062; Gevaert P, 2005, ALLERGY, V60, P71, DOI 10.1111/j.1398-9995.2004.00621.x; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Huvenne W, 2009, CURR ALLERGY ASTHM R, V9, P213, DOI 10.1007/s11882-009-0031-4; Iacobucci I, 2010, LEUKEMIA, V24, P66, DOI 10.1038/leu.2009.197; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kijimoto-Ochiai S, 2002, CELL MOL LIFE SCI, V59, P648, DOI 10.1007/s00018-002-8455-1; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kothapalli NR, 2011, CURR OPIN IMMUNOL, V23, P184, DOI 10.1016/j.coi.2010.12.009; Kowalski ML, 2011, ALLERGY, V66, P32, DOI 10.1111/j.1398-9995.2010.02379.x; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Lewis Christina C, 2009, J Allergy Clin Immunol, V123, P795, DOI 10.1016/j.jaci.2009.01.003; Liu T, 2011, CLIN EXP IMMUNOL, V163, P59, DOI 10.1111/j.1365-2249.2010.04278.x; Liu YJ, 1997, J EXP MED, V185, P165, DOI 10.1084/jem.185.1.165; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; Marafioti T, 2003, BLOOD, V102, P2868, DOI 10.1182/blood-2003-03-0692; McCloskey N, 2007, J BIOL CHEM, V282, P24083, DOI 10.1074/jbc.M703195200; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; MITTELSTADT PR, 1993, J IMMUNOL, V150, P4822; Moldenhauer G, 2006, BLOOD, V107, P2470, DOI 10.1182/blood-2005-06-2502; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Naclerio RM, 2010, INT J GEN MED, V3, P47; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Patadia M, 2010, AM J RHINOL ALLERGY, V24, P11, DOI 10.2500/ajra.2010.24.3386; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Poole JA, 2005, J ALLERGY CLIN IMMUN, V116, P780, DOI 10.1016/j.jaci.2005.07.007; Rawstron A., 2006, CURR PROTOC CYTOM, V23; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Shinmura K, 2011, ANN SURG ONCOL, V18, P2084, DOI 10.1245/s10434-011-1568-8; Silverman ES, 2001, AM J RESP CRIT CARE, V163, P778, DOI 10.1164/ajrccm.163.3.2003123; Simon HU, 1997, J IMMUNOL, V158, P3902; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Thomson CW, 2006, J IMMUNOL, V177, P2250, DOI 10.4049/jimmunol.177.4.2250; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Zele T, 2007, CLIN EXP ALLERGY, V37, P1840, DOI 10.1111/j.1365-2222.2007.02838.x; Van Zele T, 2009, LARYNGOSCOPE, V119, P1753, DOI 10.1002/lary.20484; Vicario M, 2010, GUT, V59, P12, DOI 10.1136/gut.2009.178020; Visan I, 2003, EUR J IMMUNOL, V33, P1163, DOI 10.1002/eji.200323747; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wu XS, 2008, BLOOD, V112, P4675, DOI 10.1182/blood-2008-03-145995; Xu ZM, 2007, CRIT REV IMMUNOL, V27, P367, DOI 10.1615/CritRevImmunol.v27.i4.60; YOKOTA A, 1988, CELL, V55, P611, DOI 10.1016/0092-8674(88)90219-X; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	80	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25611	10.1371/journal.pone.0025611	http://dx.doi.org/10.1371/journal.pone.0025611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984922	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000046
J	Shin, J; Epperson, K; Yanjanin, NM; Albus, J; Borgenheimer, L; Bott, N; Brennan, E; Castellanos, D; Cheng, M; Clark, M; Devany, M; Ensslin, C; Farivari, N; Fernando, S; Gabriel, L; Gallardo, R; Castleman, M; Gutierrez, O; Herschel, A; Hodge, S; Horst, A; Howard, M; James, E; Jones, L; Kearns, M; Kelly, M; Kim, C; Kiser, K; Klazura, G; Knoedler, C; Kolbus, E; Lange, L; Lee, J; Li, E; Lu, W; Luttrell, A; Ly, E; McKeough, K; McSorley, B; Miller, C; Mitchell, S; Moon, A; Moser, K; O'Brien, S; Olivieri, P; Patzwahl, A; Pereira, M; Pymento, C; Ramelb, E; Ramos, B; Raya, T; Riney, S; Roberts, G; Robertshaw, M; Rudolf, F; Rund, S; Sansone, S; Schwartz, L; Shay, R; Siu, E; Spear, T; Tan, C; Truong, M; Uddin, M; VanTrieste, J; Veloz, O; White, E; Porter, FD; Haldar, K				Shin, Jenny; Epperson, Katrina; Yanjanin, Nicole M.; Albus, Jennifer; Borgenheimer, Laura; Bott, Natalie; Brennan, Erin; Castellanos, Daniel; Cheng, Melissa; Clark, Michael; Devany, Margaret; Ensslin, Courtney; Farivari, Nina; Fernando, Shanik; Gabriel, Lauren; Gallardo, Rani; Castleman, Moriah; Gutierrez, Olimpia; Herschel, Allison; Hodge, Sarah; Horst, Anne; Howard, Mary; James, Evan; Jones, Lindsey; Kearns, Mary; Kelly, Mary; Kim, Christine; Kiser, Kinzie; Klazura, Gregory; Knoedler, Chris; Kolbus, Emily; Lange, Lauren; Lee, Joan; Li, Eileena; Lu, Wei; Luttrell, Andrew; Ly, Emily; McKeough, Katherine; McSorley, Brianna; Miller, Catherine; Mitchell, Sean; Moon, Abbey; Moser, Kevin; O'Brien, Shane; Olivieri, Paula; Patzwahl, Aaron; Pereira, Marie; Pymento, Craig; Ramelb, Erin; Ramos, Bryce; Raya, Teresa; Riney, Stephen; Roberts, Geoff; Robertshaw, Mark; Rudolf, Frannie; Rund, Samuel; Sansone, Stephanie; Schwartz, Lindsay; Shay, Ryan; Siu, Edwin; Spear, Timothy; Tan, Catherine; Marisa Truong; Uddin, Mairaj; VanTrieste, Jennifer; Veloz, Omar; White, Elizabeth; Porter, Forbes D.; Haldar, Kasturi			Defining Natural History: Assessment of the Ability of College Students to Aid in Characterizing Clinical Progression of Niemann-Pick Disease, Type C	PLOS ONE			English	Article								Niemann-Pick Disease, type C (NPC) is a fatal, neurodegenerative, lysosomal storage disorder. It is a rare disease with broad phenotypic spectrum and variable age of onset. These issues make it difficult to develop a universally accepted clinical outcome measure to assess urgently needed therapies. To this end, clinical investigators have defined emerging, disease severity scales. The average time from initial symptom to diagnosis is approximately 4 years. Further, some patients may not travel to specialized clinical centers even after diagnosis. We were therefore interested in investigating whether appropriately trained, community-based assessment of patient records could assist in defining disease progression using clinical severity scores. In this study we evolved a secure, step wise process to show that pre-existing medical records may be correctly assessed by non-clinical practitioners trained to quantify disease progression. Sixty-four undergraduate students at the University of Notre Dame were expertly trained in clinical disease assessment and recognition of major and minor symptoms of NPC. Seven clinical records, randomly selected from a total of thirty seven used to establish a leading clinical severity scale, were correctly assessed to show expected characteristics of linear disease progression. Student assessment of two new records donated by NPC families to our study also revealed linear progression of disease, but both showed accelerated disease progression, relative to the current severity scale, especially at the later stages. Together, these data suggest that college students may be trained in assessment of patient records, and thus provide insight into the natural history of a disease.	[Shin, Jenny; Epperson, Katrina; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Yanjanin, Nicole M.; Porter, Forbes D.] NICHD, Program Dev Endocrinol & Genet, NIH, DHHS, Bethesda, MD USA; [Albus, Jennifer; Borgenheimer, Laura; Bott, Natalie; Brennan, Erin; Castellanos, Daniel; Cheng, Melissa; Clark, Michael; Devany, Margaret; Ensslin, Courtney; Farivari, Nina; Fernando, Shanik; Gabriel, Lauren; Gallardo, Rani; Castleman, Moriah; Gutierrez, Olimpia; Herschel, Allison; Hodge, Sarah; Horst, Anne; Howard, Mary; James, Evan; Jones, Lindsey; Kearns, Mary; Kelly, Mary; Kim, Christine; Kiser, Kinzie; Klazura, Gregory; Knoedler, Chris; Kolbus, Emily; Lange, Lauren; Lee, Joan; Li, Eileena; Lu, Wei; Luttrell, Andrew; Ly, Emily; McKeough, Katherine; McSorley, Brianna; Miller, Catherine; Mitchell, Sean; Moon, Abbey; Moser, Kevin; O'Brien, Shane; Olivieri, Paula; Patzwahl, Aaron; Pereira, Marie; Pymento, Craig; Ramelb, Erin; Ramos, Bryce; Raya, Teresa; Riney, Stephen; Roberts, Geoff; Robertshaw, Mark; Rudolf, Frannie; Rund, Samuel; Sansone, Stephanie; Schwartz, Lindsay; Shay, Ryan; Siu, Edwin; Spear, Timothy; Tan, Catherine; Marisa Truong; Uddin, Mairaj; VanTrieste, Jennifer; Veloz, Omar; White, Elizabeth] NPC Consortium Community Based Assessment Patient, Cape Town, South Africa	University of Notre Dame; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shin, J (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014; Rund, Samuel SC/AAH-5724-2019; Mitchell, Sean M/AAJ-6000-2020	Rund, Samuel SC/0000-0002-1701-7787; Mitchell, Sean M/0000-0002-0584-3256; Siu, Edwin/0000-0003-1046-2279; , Helen Catherine (Miller) Wilbur/0000-0001-5330-5084; Castellanos, Daniel/0000-0003-1188-5257; Vater, Laura/0000-0002-5920-9576; Keenan, Anne/0000-0001-5601-2682; Shin, Jenny/0000-0002-5650-8044	University of Notre Dame; NICHD; Office of Rare Diseases; Dana's Angels Research Trust	University of Notre Dame; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Rare Diseases; Dana's Angels Research Trust	The work was supported in part by funds to KH (start-up funds from the University of Notre Dame), to FDP (intramural research program of NICHD and via a Bench to Bedside Grant from the Office of Rare Diseases), and to NY (Ara Parseghian Medical Research Foundation, http://www.parseghian.org/, and Dana's Angels Research Trust, www.DanasAngels.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Imrie J, 2007, J INHERIT METAB DIS, V30, P51, DOI 10.1007/s10545-006-0384-7; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Pineda M, 2009, MOL GENET METAB, V98, P243, DOI 10.1016/j.ymgme.2009.07.003; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969	6	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e23666	10.1371/journal.pone.0023666	http://dx.doi.org/10.1371/journal.pone.0023666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984891	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000001
J	Zhang, X; Ramirez, BE; Liao, XB; Diekwisch, TGH				Zhang, Xu; Ramirez, Benjamin E.; Liao, Xiubei; Diekwisch, Thomas G. H.			Amelogenin Supramolecular Assembly in Nanospheres Defined by a Complex Helix-Coil-PPII Helix 3D-Structure	PLOS ONE			English	Article							BOVINE TOOTH ENAMEL; TORSION ANGLE; PROTEINS; PH; HYDROXYAPATITE; MATRIX; AGGREGATION; DYNAMICS; PROGRAM; DISPLAY	Tooth enamel, the hardest material in the human body, is formed within a self-assembled matrix consisting mostly of amelogenin proteins. Here we have determined the complete mouse amelogenin structure under physiological conditions and defined interactions between individual domains. NMR spectroscopy revealed four major amelogenin structural motifs, including an N-terminal assembly of four alpha-helical segments (S9-V19, T21-P33, Y39-W45, V53-Q56), an elongated random coil region interrupted by two 3(10) helices (similar to P60-Q117), an extended proline-rich PPII-helical region (P118-L165), and a charged hydrophilic C-terminus (L165-D180). HSQC experiments demonstrated ipsilateral interactions between terminal domains of individual amelogenin molecules, i.e. N-terminal interactions with corresponding N-termini and C-terminal interactions with corresponding C-termini, while the central random coil domain did not engage in interactions. Our HSQC spectra of the full-length amelogenin central domain region completely overlapped with spectra of the monomeric Amel-M fragment, suggesting that the central amelogenin coil region did not involve in assembly, even in assembled nanospheres. This finding was confirmed by analytical ultracentrifugation experiments. We conclude that under conditions resembling those found in the developing enamel protein matrix, amelogenin molecules form complex 3D-structures with N-terminal alpha-helix-like segments and C-terminal PPII-helices, which self-assemble through ipsilateral interactions at the N-terminus of the molecule.	[Zhang, Xu; Diekwisch, Thomas G. H.] Univ Illinois, Brodie Lab Craniofacial Genet, Coll Dent, Chicago, IL 60607 USA; [Ramirez, Benjamin E.; Liao, Xiubei] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhang, X (corresponding author), Univ Illinois, Brodie Lab Craniofacial Genet, Coll Dent, Chicago, IL 60607 USA.	xiubei@uic.edu; tomdkw@uic.edu		Diekwisch, Thomas GH/0000-0003-3356-9677	NIDCR [DE13378, DE18900]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018900, R01DE013378] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding by NIDCR grants DE13378 and DE18900 to TD is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichmayer B, 2010, BIOMACROMOLECULES, V11, P369, DOI 10.1021/bm900983b; AOBA T, 1987, CALCIFIED TISSUE INT, V41, P281, DOI 10.1007/BF02555230; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Buchko GW, 2008, BIOCHEMISTRY-US, V47, P13215, DOI 10.1021/bi8018288; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; DIEKWISCH T, 1993, DEVELOPMENT, V117, P471; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin TQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000262; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Lakshminarayanan R, 2010, J BIOL CHEM, V285, P40593, DOI 10.1074/jbc.M110.131136; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Moradian-Oldak J, 1998, J STRUCT BIOL, V122, P320, DOI 10.1006/jsbi.1998.4008; Moradian-Oldak J, 2002, CONNECT TISSUE RES, V43, P450, DOI 10.1080/03008200290000835; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; NIKIFORUK G, 1965, J DENT RES, V44, P1119, DOI 10.1177/00220345650440061101; Paine ML, 2004, CELLS TISSUES ORGANS, V176, P7, DOI 10.1159/000075023; Renugopalakrishnan V, 2002, J PEPT SCI, V8, P139, DOI 10.1002/psc.378; RENUGOPALAKRISHNAN V, 1986, BIOCHEMISTRY-US, V25, P4879, DOI 10.1021/bi00365a023; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; SOGAH GDY, 1976, J AM CHEM SOC, V98, P3038; Tan J, 1998, CONNECT TISSUE RES, V38, P215, DOI 10.3109/03008209809017039; Vieira-Pires RS, 2010, J GEN PHYSIOL, V136, P585, DOI 10.1085/jgp.201010508; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; ZHENG SD, 1987, BIOPOLYMERS, V26, P1809, DOI 10.1002/bip.360261012	33	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24952	10.1371/journal.pone.0024952	http://dx.doi.org/10.1371/journal.pone.0024952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984897	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000007
J	Luzzati, F; De Marchis, S; Parlato, R; Gribaudo, S; Schutz, G; Fasolo, A; Peretto, P				Luzzati, Federico; De Marchis, Silvia; Parlato, Rosanna; Gribaudo, Simona; Schuetz, Guenther; Fasolo, Aldo; Peretto, Paolo			New Striatal Neurons in a Mouse Model of Progressive Striatal Degeneration Are Generated in both the Subventricular Zone and the Striatal Parenchyma	PLOS ONE			English	Article							NEURAL STEM-CELLS; ISCHEMIC BRAIN-INJURY; PROGENITOR CELLS; ADULT BRAIN; FOREBRAIN NEUROGENESIS; QUANTITATIVE-ANALYSIS; DIFFERENTIATION; MIGRATION; INTERNEURONS; MULTIPOTENT	Acute striatal lesions increase proliferation in the subventricular zone (SVZ) and induce migration of SVZ neuroblasts to the striatum. However, the potential of these cells to replace acutely degenerated neurons is controversial. The possible contribution of parenchymal progenitors to striatal lesion-induced neurogenesis has been poorly explored. Here, we present a detailed investigation of neurogenesis in the striatum of a mouse model showing slow progressive neurodegeneration of striatal neurons, the Creb1(Camkcre4) Crem(-/-) mutant mice (CBCM). By using BrdU time course analyses, intraventricular injections of a cell tracker and 3D reconstructions we showed that neurodegeneration in CBCM mice stimulates the migration of SVZ neuroblasts to the striatum without altering SVZ proliferation. SVZ-neuroblasts migrate as chains through the callosal striatal border and then enter within the striatal parenchyma as individual cells. In addition, a population of clustered neuroblasts showing high turnover rates were observed in the mutant striatum that had not migrated from the SVZ. Clustered neuroblasts might originate within the striatum itself because they are specifically associated with parenchymal proliferating cells showing features of intermediate neuronal progenitors such as clustering, expression of EGF receptor and multiple glial (SOX2, SOX9, BLBP) and neuronal (Dlx, Sp8, and to some extent DCX) markers. Newborn striatal neurons had a short lifespan and did not replace projection neurons nor expressed sets of transcription factors involved in their specification. The differentiation failure of endogenous neuroblasts likely occurred cell autonomously because transplanted wild type embryonic precursors correctly differentiated into striatal projection neurons. Thus, we propose that under progressive degeneration, neither SVZ derived nor intra-striatal generated neurons have the potential to differentiate into striatal projection neurons.	[Luzzati, Federico; De Marchis, Silvia; Gribaudo, Simona; Fasolo, Aldo; Peretto, Paolo] Univ Turin, Dept Anim & Human Biol, Turin, Italy; [Luzzati, Federico; Peretto, Paolo] Cavalieri Ottolenghi Fdn, Inst Sci, Orbassano, Italy; [Parlato, Rosanna; Schuetz, Guenther] German Canc Res Ctr, Heidelberg, Germany	University of Turin; Helmholtz Association; German Cancer Research Center (DKFZ)	Luzzati, F (corresponding author), Univ Turin, Dept Anim & Human Biol, Turin, Italy.	paolo.peretto@unito.it	De+Marchis, Silvia/ABH-8872-2020; Parlato, Rosanna/G-8768-2015; Parlato, Rosanna/AAH-4429-2020	Parlato, Rosanna/0000-0001-6682-9645; Gribaudo, Simona/0000-0002-9361-3855; de marchis, silvia/0000-0002-8096-7670; Peretto, Paolo Marcello/0000-0001-9747-6379; LUZZATI, FEDERICO/0000-0003-0648-9989	Compagnia di San Paolo [NEUROTRANSPLANT 2004.2019]; Universita di Torino; PRIN 2007; Regione Piemonte - Ricerca Sanitaria Finalizzata	Compagnia di San Paolo(Compagnia di San Paolo); Universita di Torino; PRIN 2007(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Piemonte - Ricerca Sanitaria Finalizzata(Regione Piemonte)	Support was contributed by Compagnia di San Paolo (NEUROTRANSPLANT 2004.2019); Universita di Torino 2007; PRIN 2007; Regione Piemonte - Ricerca Sanitaria Finalizzata (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Batista CMC, 2006, J NEUROSCI, V26, P10452, DOI 10.1523/JNEUROSCI.2850-06.2006; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Carletti B, 2004, J NEUROCYTOL, V33, P309, DOI 10.1023/B:NEUR.0000044192.20397.7e; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Collin T, 2005, EXP NEUROL, V195, P71, DOI 10.1016/j.expneurol.2005.03.017; Cong SY, 2005, MOL CELL NEUROSCI, V30, P560, DOI 10.1016/j.mcn.2005.10.015; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; De Marchis S, 2001, J NEUROBIOL, V49, P326, DOI 10.1002/neu.10012; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Eriksson C, 2003, EXP NEUROL, V184, P615, DOI 10.1016/S0014-4886(03)00271-1; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Gordon RJ, 2007, NEUROSCIENCE, V146, P1704, DOI 10.1016/j.neuroscience.2007.03.011; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Luzzati F, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00070; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marin O, 2000, J NEUROSCI, V20, P6063; Mason HA, 2005, DEVELOPMENT, V132, P4247, DOI 10.1242/dev.02008; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Palmer TD, 1999, J NEUROSCI, V19, P8487; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wei B, 2011, EUR J NEUROSCI, V33, P819, DOI 10.1111/j.1460-9568.2010.07570.x; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	54	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25088	10.1371/journal.pone.0025088	http://dx.doi.org/10.1371/journal.pone.0025088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980380	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300018
J	Yamaguchi, J; Mizoguchi, T; Fujiwara, H				Yamaguchi, Junichi; Mizoguchi, Takayuki; Fujiwara, Haruhiko			siRNAs Induce Efficient RNAi Response in Bombyx mori Embryos	PLOS ONE			English	Article							GENETIC INTERFERENCE; PROLEG DEVELOPMENT; MAMMALIAN-CELLS; SILKWORM; DROSOPHILA; SELECTION; DESIGN	Short interference RNA (siRNA) is widely used in mammalian cells. In insects, however, reports concerning the suitablility of siRNA in vivo is very limited compared with that of long dsRNA, which is thought to be more effective. There is insufficient information on the essential rules of siRNA design in insects, as very few siRNAs have been tested in this context. To establish an effective method of gene silencing using siRNA in vivo in insects, we determined the effects of siRNA on seven target genes. We designed siRNAs according to a new guideline and injected them into eggs of Bombyx mori. At the mRNA level, the expression of most of these genes was successfully silenced, down to less than half the constitutive level, which in some cases led to the development of distinctive phenotypes. In addition, we observed stronger effect of siRNA both on the mRNA level and the phenotype than that of long dsRNA under comparable conditions. These results indicate that direct injection of siRNA is an effective reverse-genetics tool for the analysis of embryogenesis in vivo in insects.	[Yamaguchi, Junichi; Mizoguchi, Takayuki; Fujiwara, Haruhiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan	University of Tokyo	Yamaguchi, J (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan.	haruh@k.u-tokyo.ac.jp			Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN);  [22128005]	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); 	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (22128005) of Japan and the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clemons A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016730; COULTER DE, 1988, GENE DEV, V2, P1812, DOI 10.1101/gad.2.12b.1812; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gong LA, 2011, PEST MANAG SCI, V67, P514, DOI 10.1002/ps.2086; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; KRAFT R, 1994, P NATL ACAD SCI USA, V91, P6634, DOI 10.1073/pnas.91.14.6634; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Luo KQ, 2004, BIOCHEM BIOPH RES CO, V318, P303, DOI 10.1016/j.bbrc.2004.04.027; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; Masumoto M, 2009, DEV GENES EVOL, V219, P437, DOI 10.1007/s00427-009-0305-9; NAGY L, 1994, DEV BIOL, V165, P137, DOI 10.1006/dbio.1994.1241; Nakao H, 2010, J EXP ZOOL PART B, V314B, P224, DOI 10.1002/jez.b.21328; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Svoboda P, 2000, DEVELOPMENT, V127, P4147; TAKESUE S, 1980, J EMBRYOL EXP MORPH, V60, P117; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tamura Toshiki, 2007, Journal of Insect Biotechnology and Sericology, V76, P155; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tomita S, 2009, DEV BIOL, V328, P403, DOI 10.1016/j.ydbio.2009.01.040; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Xiang H, 2011, ARCH INSECT BIOCHEM, V76, P1, DOI 10.1002/arch.20393; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	27	49	52	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25469	10.1371/journal.pone.0025469	http://dx.doi.org/10.1371/journal.pone.0025469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980469	gold, Green Submitted, Green Published			2022-12-27	WOS:000295941300035
J	Brannstrom, K; Ohman, A; Olofsson, A				Brannstrom, Kristoffer; Ohman, Anders; Olofsson, Anders			A beta Peptide Fibrillar Architectures Controlled by Conformational Constraints of the Monomer	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; SOLUTION NMR-SPECTROSCOPY; ALZHEIMERS-DISEASE; HYDROGEN/DEUTERIUM EXCHANGE; SOLVENT PROTECTION; KINETIC-ANALYSIS; AGGREGATION; MICE; MUTAGENESIS; FORM	Anomalous self-assembly of the A beta peptide into fibrillar amyloid deposits strongly correlated with the development of Alzheimer's disease. A beta fibril extension follows a template guided "dock and lock" mechanism where polymerisation is catalysed by the fibrillar ends. Using surface plasmon resonance (SPR) and quenched hydrogen-deuterium exchange NMR (H/D-exchange NMR), we have analysed the fibrillar structure and polymerisation properties of both the highly aggregation prone A beta 1-40 Glu22Gly (A beta(40Arc)) and wild type A beta 1-40 (A beta(40WT)). The solvent protection patterns from H/D exchange experiments suggest very similar structures of the fibrillar forms. However, through cross-seeding experiments monitored by SPR, we found that the monomeric form of A beta(40WT) is significantly impaired to acquire the fibrillar architecture of A beta(40Arc). A detailed characterisation demonstrated that A beta(40WT) has a restricted ability to dock and isomerise with high binding affinity onto A beta(40Arc) fibrils. These results have general implications for the process of fibril assembly, where the rate of polymerisation, and consequently the architecture of the formed fibrils, is restricted by conformational constraints of the monomers. Interestingly, we also found that the kinetic rate of fibril formation rather than the thermodynamically lowest energy state determines the overall fibrillar structure.	[Brannstrom, Kristoffer; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Ohman, Anders] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Umea University	Brannstrom, K (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.ohman@chem.umu.se; anders.olofsson@medchem.umu.se	Brännström, Kristoffer/AAC-1204-2020; Brännström, Kristoffer/D-3648-2009		J.C. Kempe Foundation; Swedish Research Council; O.E. och Edla Johanssons vetenskapliga stiftelse; FAMY; Medical Faculty of Umea University	J.C. Kempe Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); O.E. och Edla Johanssons vetenskapliga stiftelse; FAMY; Medical Faculty of Umea University	This work was supported by J.C. Kempe Foundation, the Swedish Research Council, O.E. och Edla Johanssons vetenskapliga stiftelse, FAMY and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2005, NEUROTOX RES, V7, P17, DOI 10.1007/BF03033773; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Codita A, 2010, BEHAV BRAIN RES, V215, P83, DOI 10.1016/j.bbr.2010.06.034; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Hu WP, 2006, J NEUROSCI METH, V154, P190, DOI 10.1016/j.jneumeth.2005.12.016; Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Mercy L, 2008, NEUROLOGY, V71, P1496, DOI 10.1212/01.wnl.0000334277.16896.fa; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; OLOFSSON A, 2007, BIOCH J; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Olofsson A, 2009, FEBS J, V276, P4051, DOI 10.1111/j.1742-4658.2009.07113.x; Olofsson A, 2009, ANAL BIOCHEM, V385, P374, DOI 10.1016/j.ab.2008.10.034; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Ryu J, 2008, ANAL CHEM, V80, P2400, DOI 10.1021/ac7019514; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; Williams AD, 2006, J MOL BIOL, V357, P1283, DOI 10.1016/j.jmb.2006.01.041; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x	30	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25157	10.1371/journal.pone.0025157	http://dx.doi.org/10.1371/journal.pone.0025157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980388	Green Submitted, Green Published, gold			2022-12-27	WOS:000295939600012
J	Benner, J; Daniel, H; Spanier, B				Benner, Jacqueline; Daniel, Hannelore; Spanier, Britta			A Glutathione Peroxidase, Intracellular Peptidases and the TOR Complexes Regulate Peptide Transporter PEPT-1 in C-elegans	PLOS ONE			English	Article							P70 S6 KINASE; CAENORHABDITIS-ELEGANS; MAMMALIAN TARGET; FAT STORAGE; LEUKOTRIENE-A(4) HYDROLASE; GENE-EXPRESSION; NA+/H+ EXCHANGE; RAPAMYCIN MTOR; LIFE-SPAN; HYDROPEROXIDE	The intestinal peptide transporter PEPT-1 in Caenorhabditis elegans is a rheogenic H+-dependent carrier responsible for the absorption of di- and tripeptides. Transporter-deficient pept-1(lg601) worms are characterized by impairments in growth, development and reproduction and develop a severe obesity like phenotype. The transport function of PEPT-1 as well as the influx of free fatty acids was shown to be dependent on the membrane potential and on the intracellular pH homeostasis, both of which are regulated by the sodium-proton exchanger NHX-2. Since many membrane proteins commonly function as complexes, there could be proteins that possibly modulate PEPT-1 expression and function. A systematic RNAi screening of 162 genes that are exclusively expressed in the intestine combined with a functional transport assay revealed four genes with homologues existing in mammals as predicted PEPT-1 modulators. While silencing of a glutathione peroxidase surprisingly caused an increase in PEPT-1 transport function, silencing of the ER to Golgi cargo transport protein and of two cytosolic peptidases reduced PEPT-1 transport activity and this even corresponded with lower PEPT-1 protein levels. These modifications of PEPT-1 function by gene silencing of homologous genes were also found to be conserved in the human epithelial cell line Caco-2/TC7 cells. Peptidase inhibition, amino acid supplementation and RNAi silencing of targets of rapamycin (TOR) components in C. elegans supports evidence that intracellular peptide hydrolysis and amino acid concentration are a part of a sensing system that controls PEPT-1 expression and function and that involves the TOR complexes TORC1 and TORC2.	[Benner, Jacqueline; Daniel, Hannelore; Spanier, Britta] Tech Univ Munich, Abt Biochem, ZIEL Res Ctr Nutr & Food Sci, D-8050 Freising Weihenstephan, Germany	Technical University of Munich	Benner, J (corresponding author), Tech Univ Munich, Abt Biochem, ZIEL Res Ctr Nutr & Food Sci, D-8050 Freising Weihenstephan, Germany.	spanier@wzw.tum.de	Daniel, Hannelore/B-8982-2009; Elgeti, Dana/H-8859-2015	Wallwitz, Jacqueline/0000-0002-7335-362X; Elgeti, Dana/0000-0002-4295-4983	Deutsche Forschungsgemeinschaft (DFG) [SP965/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the grant SP965/2-1 by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ban H, 2004, INT J MOL MED, V13, P537; Bao YP, 1997, FEBS LETT, V410, P210, DOI 10.1016/S0014-5793(97)00591-7; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P705, DOI 10.1159/000185554; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; DANIEL H, 1994, FASEB J, V8, P753, DOI 10.1096/fasebj.8.10.8050675; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Davies DR, 2009, J MED CHEM, V52, P4694, DOI 10.1021/jm900259h; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Fei YJ, 1998, BIOCHEM J, V332, P565, DOI 10.1042/bj3320565; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Gilbert ER, 2008, J ANIM SCI, V86, P2135, DOI 10.2527/jas.2007-0826; Girotti AW, 1998, J LIPID RES, V39, P1529; Goberdhan DCI, 2009, BIOCHEM SOC T, V37, P248, DOI 10.1042/BST0370248; Groneberg DA, 2001, AM J PHYSIOL-GASTR L, V281, pG697, DOI 10.1152/ajpgi.2001.281.3.G697; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kennedy DJ, 2002, PFLUG ARCH EUR J PHY, V445, P139, DOI 10.1007/s00424-002-0910-1; LENNEY JF, 1990, BIOL CHEM H-S, V371, P167, DOI 10.1515/bchm3.1990.371.1.167; Liu XM, 2004, FASEB J, V18, P768, DOI 10.1096/fj.03-0886fje; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Makky K, 2007, DEV BIOL, V303, P501, DOI 10.1016/j.ydbio.2006.11.030; Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Mertl M, 2008, AM J PHYSIOL-CELL PH, V295, pC1332, DOI 10.1152/ajpcell.00241.2008; Morgan EL, 2005, DEV COMP IMMUNOL, V29, P53, DOI 10.1016/j.dci.2004.05.001; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; ORNING L, 1994, J BIOL CHEM, V269, P11269; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; Rhoads JM, 2009, AMINO ACIDS, V37, P111, DOI 10.1007/s00726-008-0225-4; Rubio-Aliaga I, 2008, XENOBIOTICA, V38, P1022, DOI [10.1080/00498250701875254, 10.1080/00498250701875254 ]; Rubio-Aliaga I, 2002, TRENDS PHARMACOL SCI, V23, P434, DOI 10.1016/S0165-6147(02)02072-2; Rudberg PC, 2002, P NATL ACAD SCI USA, V99, P4215, DOI 10.1073/pnas.072090099; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Shiraga T, 1999, GASTROENTEROLOGY, V116, P354, DOI 10.1016/S0016-5085(99)70132-0; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Thwaites DT, 1999, J CLIN INVEST, V104, P629, DOI 10.1172/JCI7192; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Veljkovic E, 2004, J BIOL CHEM, V279, P7655, DOI 10.1074/jbc.M309528200; Wood W B, 1988, Dev Biol (N Y 1985), V5, P57	69	36	51	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25624	10.1371/journal.pone.0025624	http://dx.doi.org/10.1371/journal.pone.0025624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980510	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900082
J	Caruso, V; Chen, H; Morris, MJ				Caruso, Vanni; Chen, Hui; Morris, Margaret J.			Early Hypothalamic FTO Overexpression in Response to Maternal Obesity - Potential Contribution to Postweaning Hyperphagia	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; BODY-MASS INDEX; CHILDHOOD OBESITY; MITOCHONDRIAL DYSFUNCTION; APPETITE REGULATORS; ADULT OBESITY; ENERGY-INTAKE; FOOD-INTAKE; CHILDREN; VARIANTS	Background: Intrauterine and postnatal overnutrition program hyperphagia, adiposity and glucose intolerance in offspring. Single-nucleotide polymorphisms (SNPs) of the fat mass and obesity associated (FTO) gene have been linked to increased risk of obesity. FTO is highly expressed in hypothalamic regions critical for energy balance and hyperphagic phenotypes were linked with FTO SNPs. As nutrition during fetal development can influence the expression of genes involved in metabolic function, we investigated the impact of maternal obesity on FTO. Methods: Female Sprague Dawley rats were exposed to chow or high fat diet (HFD) for 5 weeks before mating, throughout gestation and lactation. On postnatal day 1 (PND1), some litters were adjusted to 3 pups (vs. 12 control) to induce postnatal overnutrition. At PND20, rats were weaned onto chow or HFD for 15 weeks. FTO mRNA expression in the hypothalamus and liver, as well as hepatic markers of lipid metabolism were measured. Results: At weaning, hypothalamic FTO mRNA expression was increased significantly in offspring of obese mothers and FTO was correlated with both visceral and epididymal fat mass (P<0.05); body weight approached significance (P = 0.07). Hepatic FTO and Fatty Acid Synthase mRNA expression were decreased by maternal obesity. At 18 weeks, FTO mRNA expression did not differ between groups; however body weight was significantly correlated with hypothalamic FTO. Postnatal HFD feeding significantly reduced hepatic Carnitine Palmitoyltransferase-1a but did not affect the expression of other hepatic markers investigated. FTO was not affected by chronic HFD feeding. Significance: Maternal obesity significantly impacted FTO expression in both hypothalamus and liver at weaning. Early overexpression of hypothalamic FTO correlated with increased adiposity and later food intake of siblings exposed to HFD suggesting upregulation of FTO may contribute to subsequent hyperphagia, in line with some human data. No effect of maternal obesity was observed on FTO in adulthood.	[Caruso, Vanni; Chen, Hui; Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia; [Chen, Hui] Univ Technol Sydney, Fac Sci, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia	University of New South Wales Sydney; University of Technology Sydney	Caruso, V (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia.	m.morris@unsw.edu.au	Morris, Margaret J/J-4285-2013; Chen, Hui/R-6137-2019; Chen, Hui/D-2005-2014	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Caruso, Vanni/0000-0002-0523-6149; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by project funding from the National Health and Medical Research Council of Australia to Margaret J Morris.	Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Fang HY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-136; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Jacobsson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020158; Keller MP, 2010, ANNU REV NUTR, V30, P341, DOI 10.1146/annurev.nutr.012809.104747; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mitchell GA, 2009, INT J OBESITY, V33, pS41, DOI 10.1038/ijo.2009.16; Morris MJ, 2009, INT J OBESITY, V33, P115, DOI 10.1038/ijo.2008.213; Morris Margaret J, 2009, Expert Rev Endocrinol Metab, V4, P625, DOI 10.1586/eem.09.45; Oben JA, J HEPATOLOGY, V52, P913; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; Okuda M, 2011, PEDIAT DIABETES; Poritsanos NJ, 2010, BIOCHEM BIOPH RES CO, V400, P713, DOI 10.1016/j.bbrc.2010.08.133; Rutters F, 2011, J CLIN ENDOCR METAB, V96, pE939, DOI 10.1210/jc.2010-2413; Ryu MH, 2005, NUTRITION, V21, P537, DOI 10.1016/j.nut.2004.08.015; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Skiba-Cassy S, 2007, COMP BIOCHEM PHYS B, V147, P278, DOI 10.1016/j.cbpb.2007.01.007; Soncini M, 1995, J BIOL CHEM, V270, P30339, DOI 10.1074/jbc.270.51.30339; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Sul HS, 1998, PROG NUCLEIC ACID RE, V60, P317, DOI 10.1016/S0079-6603(08)60896-X; THUMELIN S, 1994, BIOCHEM J, V300, P583, DOI 10.1042/bj3000583; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0; Zhang JH, 2001, FASEB J, V15, P1261, DOI 10.1096/fj.00-0717fje	53	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25261	10.1371/journal.pone.0025261	http://dx.doi.org/10.1371/journal.pone.0025261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980407	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900042
J	Corsi, DJ; Finlay, JE; Subramanian, SV				Corsi, Daniel J.; Finlay, Jocelyn E.; Subramanian, S. V.			Global Burden of Double Malnutrition: Has Anyone Seen It?	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; RISK-FACTORS; OVERWEIGHT; WOMEN; UNDERNUTRITION; OBESITY; OVERNUTRITION; UNDERWEIGHT	Background: Low-to middle-income countries (LMICs) are believed to be characterized by the coexistence of underweight and overweight. It has also been posited that such coexistence is appearing among the low socioeconomic status (SES) groups. Methods: We conducted a cross-sectional analysis of nationally representative samples of 451321 women aged 20-49 years drawn from 57 Demographic and Health Surveys conducted between 1994 and 2008. Body Mass Index (BMI in kg/m(2)), was used to define underweight and overweight following conventional cut-points. Covariates included age, household wealth, education, and residence. We estimated multinomial multilevel models to assess the extent to which underweight (BMI<18.5 kg/m(2)) and overweight (BMI >= 25.0 kg/m(2)) correlate at the country-level, and at the neighborhood-level within each country. Results: In age-adjusted models, there was a strong negative correlation between likelihood of being underweight and overweight at country- (r = -0.79, p<0.001), and at the neighborhood-level within countries (r = -0.51, P<0.001). Negative correlations ranging from -0.11 to -0.90 were observed in 46 of the 57 countries at the neighborhood-level and 29/57 were statistically significant (p <= 0.05). Similar negative correlations were observed in analyses restricted to low SES groups. Finally, the negative correlations across countries, and within-countries, appeared to be stable over time in a sub-set of 36 countries. Conclusion: The explicitly negative correlations between prevalence of underweight and overweight at the country-level and at neighborhood-level suggest that the hypothesized coexistence of underweight and overweight has not yet occurred in a substantial manner in a majority of LMICs.	[Corsi, Daniel J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Corsi, Daniel J.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Finlay, Jocelyn E.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	McMaster University; Population Health Research Institute; McMaster University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Corsi, DJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	svsubram@hsph.harvard.edu	Finlay, Jocelyn/AAS-9588-2021; Corsi, Daniel J/S-4689-2018	Finlay, Jocelyn/0000-0002-3077-5515; Corsi, Daniel J/0000-0001-7063-3354	Macro International Inc. (Washington, DC)	Macro International Inc. (Washington, DC)	The authors acknowledge the support of Macro International Inc. (Washington, DC) for providing access to the various Demographic and Health Surveys.	Ackerson LK, 2008, ECON HUM BIOL, V6, P264, DOI 10.1016/j.ehb.2008.05.002; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; Browne W., 2009, MCMC ESTIMATION MLWI; Corsi DJ, 2011, J NUTR, V141, P631, DOI 10.3945/jn.110.131599; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garrett James L., 2005, Food and Nutrition Bulletin, V26, P209; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Griffiths P, 2005, EUR J CLIN NUTR, V59, P1217, DOI 10.1038/sj.ejcn.1602228; Griffiths PL, 2001, J NUTR, V131, P2692, DOI 10.1093/jn/131.10.2692; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Kennedy G., 2006, DOUBLE BURDEN MALNUT; Lukito Widjaja, 2006, Asia Pac J Clin Nutr, V15 Suppl, P21; Macro International Inc, 1996, 6 DHS 3 MACR INT INC; *MEASURE DHS, 2009, DEM HLTH SURV; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2002, PUBLIC HEALTH NUTR, V5, P105, DOI 10.1079/PHN2001281; *ORC MACR, 2006, 2 ORC MACR MEASURE D; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Popkin BM, 2003, DEV POLICY REV, V21, P581, DOI DOI 10.1111/J.1467-8659.2003.00225.X; Pullum TW, 2008, ASSESSMENT QUALITY D; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Reddy KS, 1998, CIRCULATION, V97, P596; Rutstein SO, 2003, GUIDE DHS STAT; Rutstein SO, 2004, DHS WEALTH ASSET IND; Shafique S, 2007, INT J EPIDEMIOL, V36, P449, DOI 10.1093/ije/dyl306; Shukla HC, 2002, J EPIDEMIOL COMMUN H, V56, P876, DOI 10.1136/jech.56.11.876; Steyn K, 1998, E AFR MED J, V75, P35; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Subramanian S. V., 2003, Neighborhoods and health, P65; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Subramanian SV, 2009, AM J CLIN NUTR, V90, P369, DOI 10.3945/ajcn.2009.27487; Subramanian SV, 2004, SOC SCI MED, V58, P1961, DOI 10.1016/S0277-9536(03)00415-5; Usfar AA, 2010, OBES REV, V11, P924, DOI 10.1111/j.1467-789X.2010.00814.x; VAESSEN M, 1996, DEMOGRAPHIC EVALUATI; van der Sande MAB, 2001, AM J PUBLIC HEALTH, V91, P1641, DOI 10.2105/AJPH.91.10.1641; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; WHO, 2004, LANCET, V363, P902; WHO/FAO, 2002, REP JOINT WHO FAO EX; Wirth M., 2006, MONITORING HLTH EQUI; World Bank, 2009, WORLD DEV IND; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	47	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25120	10.1371/journal.pone.0025120	http://dx.doi.org/10.1371/journal.pone.0025120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21980384	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900025
J	Li, L; Eldredge, LC; Quach, DH; Honasoge, A; Gruner, K; Tourtellotte, WG				Li, Lin; Eldredge, Laurie C.; Quach, David H.; Honasoge, Avinash; Gruner, Katherine; Tourtellotte, Warren G.			Egr3 Dependent Sympathetic Target Tissue Innervation in the Absence of Neuron Death	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; MICE LACKING; IN-VIVO; SYSTEM; NGF; OVEREXPRESSION; SPECIFICATION; HYPERPLASIA; REQUIREMENT; MIGRATION	Nerve Growth Factor (NGF) is a target tissue derived neurotrophin required for normal sympathetic neuron survival and target tissue innervation. NGF signaling regulates gene expression in sympathetic neurons, which in turn mediates critical aspects of neuron survival, axon extension and terminal axon branching during sympathetic nervous system (SNS) development. Egr3 is a transcription factor regulated by NGF signaling in sympathetic neurons that is essential for normal SNS development. Germline Egr3-deficient mice have physiologic dysautonomia characterized by apoptotic sympathetic neuron death and abnormal innervation to many target tissues. The extent to which sympathetic innervation abnormalities in the absence of Egr3 is caused by altered innervation or by neuron death during development is unknown. Using Bax-deficient mice to abrogate apoptotic sympathetic neuron death in vivo, we show that Egr3 has an essential role in target tissue innervation in the absence of neuron death. Sympathetic target tissue innervation is abnormal in many target tissues in the absence of neuron death, and like NGF, Egr3 also appears to effect target tissue innervation heterogeneously. In some tissues, such as heart, spleen, bowel, kidney, pineal gland and the eye, Egr3 is essential for normal innervation, whereas in other tissues such as lung, stomach, pancreas and liver, Egr3 appears to have little role in innervation. Moreover, in salivary glands and heart, two tissues where Egr3 has an essential role in sympathetic innervation, NGF and NT-3 are expressed normally in the absence of Egr3 indicating that abnormal target tissue innervation is not due to deregulation of these neurotrophins in target tissues. Taken together, these results clearly demonstrate a role for Egr3 in mediating sympathetic target tissue innervation that is independent of neuron survival or neurotrophin deregulation.	[Li, Lin; Tourtellotte, Warren G.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Div Neuropathol, Chicago, IL 60611 USA; [Tourtellotte, Warren G.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Li, L (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Div Neuropathol, Chicago, IL 60611 USA.	warren@northwestern.edu			NIH [R01-NS040748, K02-NS046468, K26-RR026099, F30-NS047775, F31-NS066721]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741, K26RR026099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788, R01NS040748, K02NS046468, F31NS066721, F30NS047775] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD010945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R01-NS040748, K02-NS046468 and K26-RR026099 (WGT). LCE was supported by NIH grant F30-NS047775 and DHQ was supported by NIH grant F31-NS066721. http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERS KM, 1994, J NEUROSCI, V14, P1422, DOI 10.1523/JNEUROSCI.14-03-01422.1994; Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; HASSANKHANI A, 1995, DEV BIOL, V169, P309, DOI 10.1006/dbio.1995.1146; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huettl RE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001020; Kawasaki T, 2002, DEVELOPMENT, V129, P671; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1960, ANN NY ACAD SCI, V85, P324; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Rohrer H, 2003, DRUG NEWS PERSPECT, V16, P589, DOI 10.1358/dnp.2003.16.9.829341; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757	28	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25696	10.1371/journal.pone.0025696	http://dx.doi.org/10.1371/journal.pone.0025696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980528	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900092
J	Donze, A; Fanchon, E; Gattepaille, LM; Maler, O; Tracqui, P				Donze, Alexandre; Fanchon, Eric; Gattepaille, Lucie Martine; Maler, Oded; Tracqui, Philippe			Robustness Analysis and Behavior Discrimination in Enzymatic Reaction Networks	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; MODEL CHECKING	Characterizing the behavior and robustness of enzymatic networks with numerous variables and unknown parameter values is a major challenge in biology, especially when some enzymes have counter-intuitive properties or switch-like behavior between activation and inhibition. In this paper, we propose new methodological and tool-supported contributions, based on the intuitive formalism of temporal logic, to express in a rigorous manner arbitrarily complex dynamical properties. Our multi-step analysis allows efficient sampling of the parameter space in order to define feasible regions in which the model exhibits imposed or experimentally observed behaviors. In a first step, an algorithmic methodology involving sensitivity analysis is conducted to determine bifurcation thresholds for a limited number of model parameters or initial conditions. In a second step, this boundary detection is supplemented by a global robustness analysis, based on quasi-Monte Carlo approach that takes into account all model parameters. We apply this method to a well-documented enzymatic reaction network describing collagen proteolysis by matrix metalloproteinase MMP2 and membrane type 1 metalloproteinase (MT1-MMP) in the presence of tissue inhibitor of metalloproteinase TIMP2. For this model, our method provides an extended analysis and quantification of network robustness toward paradoxical TIMP2 switching activity between activation or inhibition of MMP2 production. Further implication of our approach is illustrated by demonstrating and analyzing the possible existence of oscillatory behaviors when considering an extended open configuration of the enzymatic network. Notably, we construct bifurcation diagrams that specify key parameters values controlling the co-existence of stable steady and non-steady oscillatory proteolytic dynamics.	[Donze, Alexandre; Maler, Oded] UJF Grenoble 1, CNRS, Lab VERIMAG, UMR 5104, Gieres, France; [Fanchon, Eric; Gattepaille, Lucie Martine; Tracqui, Philippe] UJF Grenoble 1, CNRS, Lab TIMC IMAG, UMR 5525,DyCTiM Team,Fac Med Grenoble, Grenoble, France; [Fanchon, Eric; Gattepaille, Lucie Martine; Tracqui, Philippe] UJF Grenoble 1, CNRS, Lab TIMC IMAG, UMR 5525,BCM Team,Fac Med Grenoble, Grenoble, France; [Fanchon, Eric; Gattepaille, Lucie Martine; Tracqui, Philippe] In3S, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Donze, A (corresponding author), UJF Grenoble 1, CNRS, Lab VERIMAG, UMR 5104, Gieres, France.	Alexandre.Donze@imag.fr; Philippe.Tracqui@imag.fr	Gattepaille, Lucie/V-3229-2019	Donze, Alexandre/0000-0002-1138-5458	IXXI (Institut Rhone-Alpin des Systemes Complexes); Syne2Arti ANR	IXXI (Institut Rhone-Alpin des Systemes Complexes)(Region Auvergne-Rhone-Alpes); Syne2Arti ANR(French National Research Agency (ANR))	This work is supported by a grant from IXXI (Institut Rhone-Alpin des Systemes Complexes, http://www.ixxi.fr/) and the Syne2Arti ANR Grant (http://www.agence-nationale-recherche.fr/programmes-de-recherche/projets-selectionnes/programme-conception-et-simulation-2010/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alur R, 1996, J ACM, V43, P116, DOI 10.1145/227595.227602; Antoniotti M, 2003, CELL BIOCHEM BIOPHYS, V38, P271, DOI 10.1385/CBB:38:3:271; Baier C, 2008, PRINCIPLES OF MODEL CHECKING, P1; Batt G, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P370; Chabrier N, 2003, LECT NOTES COMPUT SC, V2602, P149; Chaves M, 2006, IEE P SYST BIOL, V153, P154, DOI 10.1049/ip-syb:20050079; Coelho PMBM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000319; Cook B, 2011, LECT NOTES COMPUT SC, V6538, P134, DOI 10.1007/978-3-642-18275-4_11; Dang T, 2009, LECT N BIOINFORMAT, V5688, P126, DOI 10.1007/978-3-642-03845-7_9; Dayarian A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000256; Donze A, 2010, LECT NOTES COMPUT SC, V6246, P92, DOI 10.1007/978-3-642-15297-9_9; Donze A, 2010, LECT NOTES COMPUT SC, V6174, P167, DOI 10.1007/978-3-642-14295-6_17; Donze A, 2010, J COMPUT BIOL, V17, P325, DOI 10.1089/cmb.2009.0172; Fages F, 2009, LECT NOTES COMPUT SC, V5732, P319, DOI 10.1007/978-3-642-04244-7_26; Fainekos GE, 2009, THEOR COMPUT SCI, V410, P4262, DOI 10.1016/j.tcs.2009.06.021; Faure H, 2009, ACM T MODEL COMPUT S, V19, DOI 10.1145/1596519.1596520; Fisher J, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P1675, DOI 10.1109/WSC.2006.322942; Gattepaille Lucie Martine EF, 2009, CELLML MODEL COLLAGE; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Gruel J, 2009, BMC RES NOTES; GUNAWARDENA J, 2009, ELEMENTS COMPUTATION; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hafner M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000534; Hahn T, 2005, COMPUT PHYS COMMUN, V168, P78, DOI 10.1016/j.cpc.2005.01.010; Karagiannis ED, 2004, J BIOL CHEM, V279, P39105, DOI 10.1074/jbc.M403627200; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Kiparissides A, 2009, IND ENG CHEM RES, V48, P7168, DOI 10.1021/ie900139x; Kleinberg S, 2009, QUEUE, V7, P40; KOYMANS R, 1990, REAL-TIME SYST, V2, P255, DOI 10.1007/BF01995674; Kugler H, 2010, J R SOC INTERFACE, V7, P1015, DOI 10.1098/rsif.2009.0457; Lafleur MA, 2002, J CELL SCI, V115, P3427; Maler O, 2008, LECT NOTES COMPUT SC, V4800, P475, DOI 10.1007/978-3-540-78127-1_26; Manna Z., 1991, TEMPORAL LOGIC REACT; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Niederreiter H., 1992, RANDOM NUMBER GENERA; Pnueli A., 1977, 18th Annual Symposium on Foundations of Computer Science, P46, DOI 10.1109/SFCS.1977.32; Rizk A, 2009, BIOINFORMATICS, V25, pI169, DOI 10.1093/bioinformatics/btp200; Rizk A, 2008, LECT N BIOINFORMAT, V5307, P251, DOI 10.1007/978-3-540-88562-7_19; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Sobol IM, 2010, COMPUT PHYS COMMUN, V181, P1212, DOI 10.1016/j.cpc.2010.03.006; Stephanou A, 2007, MICROVASC RES, V73, P182, DOI 10.1016/j.mvr.2006.12.002; Voit E. O., 2000, COMPUTATIONAL ANAL B	42	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e24246	10.1371/journal.pone.0024246	http://dx.doi.org/10.1371/journal.pone.0024246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980344	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700005
J	Borcherding, DC; Hugo, ER; Idelman, G; De Silva, A; Richtand, NW; Loftus, J; Ben-Jonathan, N				Borcherding, Dana C.; Hugo, Eric R.; Idelman, Gila; De Silva, Anuradha; Richtand, Nathan W.; Loftus, Jean; Ben-Jonathan, Nira			Dopamine Receptors in Human Adipocytes: Expression and Functions	PLOS ONE			English	Article							BETA-ADRENERGIC REGULATION; ADIPOSE-TISSUE; METACHROMATIC LEUKODYSTROPHY; ARYLSULFATASE-A; WEIGHT-GAIN; IN-VIVO; PROLACTIN; RELEASE; SECRETION; BINDING	Introduction: Dopamine (DA) binds to five receptors (DAR), classified by their ability to increase (D1R-like) or decrease (D2R-like) cAMP. In humans, most DA circulates as dopamine sulfate (DA-S), which can be de-conjugated to bioactive DA by arylsulfatase A (ARSA). The objective was to examine expression of DAR and ARSA in human adipose tissue and determine whether DA regulates prolactin (PRL) and adipokine expression and release. Methods: DAR were analyzed by RT-PCR and Western blotting in explants, primary adipocytes and two human adipocyte cell lines, LS14 and SW872. ARSA expression and activity were determined by qPCR and enzymatic assay. PRL expression and release were determined by luciferase reporter and Nb2 bioassay. Analysis of cAMP, cGMP, leptin, adiponectin and interleukin 6 (IL-6) was done by ELISA. Activation of MAPK and PI3 kinase/Akt was determined by Western blotting. Results: DAR are variably expressed at the mRNA and protein levels in adipose tissue and adipocytes during adipogenesis. ARSA activity in adipocyte increases after differentiation. DA at nM concentrations suppresses cAMP, stimulates cGMP, and activates MAPK in adipocytes. Acting via D2R-like receptors, DA and DA-S inhibit PRL gene expression and release. Acting via D1R/D5R receptors, DA suppresses leptin and stimulates adiponectin and IL-6 release. Conclusions: This is the first report that human adipocytes express functional DAR and ARSA, suggesting a regulatory role for peripheral DA in adipose functions. We speculate that the propensity of some DAR-activating antipsychotics to increase weight and alter metabolic homeostasis is due, in part, to their direct action on adipose tissue.	[Borcherding, Dana C.; Hugo, Eric R.; Idelman, Gila; De Silva, Anuradha; Richtand, Nathan W.; Ben-Jonathan, Nira] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA; [Loftus, Jean] Christ Hosp, Cincinnati, OH 45219 USA	University System of Ohio; University of Cincinnati; Christ Hospital - Ohio	Borcherding, DC (corresponding author), Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	Nira.Ben-Jonathan@uc.edu	Hugo, Eric/ADA-3523-2022	Hugo, Eric/0000-0002-2990-6362; Borcherding, Dana/0000-0002-8849-2139	National Institutes of Health [S012212, CA096613]; Department of Defense [BC05725]; Susan G. Komen Breast Cancer Foundation [BCRT87406]; Elsa U. Pardee foundation; National Research Service Award (NRSA) [F31 DK761852]; NATIONAL CANCER INSTITUTE [R01CA096613, Z01BC005725, T32CA117846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Elsa U. Pardee foundation; National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants S012212 and CA096613, Department of Defense BC05725, Susan G. Komen Breast Cancer Foundation grant BCRT87406, and a grant from the Elsa U. Pardee foundation (to NBJ), and a National Research Service Award (NRSA) predoctoral fellowship F31 DK761852 (to DCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BENJONATHAN N, 1985, ENDOCR REV, V6, P564, DOI 10.1210/edrv-6-4-564; BENJONATHAN N, 1980, J CLIN ENDOCR METAB, V51, P1019; Biffi A, 2008, CLIN GENET, V74, P349, DOI 10.1111/j.1399-0004.2008.01058.x; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; CHANG PL, 1981, ANAL BIOCHEM, V117, P382, DOI 10.1016/0003-2697(81)90795-8; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; Dalla Valle L, 2006, J ENDOCRINOL, V190, P129, DOI 10.1677/joe.1.06811; Dixon TM, 2001, J BIOL CHEM, V276, P722, DOI 10.1074/jbc.M008440200; Eisenhofer G, 1999, CLIN EXP PHARMACOL P, V26, pS41; Eldrup E, 2004, DAN MED BULL, V51, P34; Fain JN, 2000, METABOLISM, V49, P804, DOI 10.1053/meta.2000.6244; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Ghosh D, 2007, CELL MOL LIFE SCI, V64, P2013, DOI 10.1007/s00018-007-7175-y; Gieselmann V, 2008, ACTA PAEDIATR, V97, P15, DOI 10.1111/j.1651-2227.2008.00648.x; GOLANDER A, 1979, J CLIN ENDOCR METAB, V49, P787, DOI 10.1210/jcem-49-5-787; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Goossens GH, 2008, DIABETES OBES METAB, V10, P1029, DOI 10.1111/j.1463-1326.2008.00856.x; GUEST SJ, 1990, J BIOL CHEM, V265, P5370; Hugo ER, 2006, ENDOCRINOLOGY, V147, P306, DOI 10.1210/en.2005-0989; Hugo ER, 2008, J CLIN ENDOCR METAB, V93, P4006, DOI 10.1210/jc.2008-1172; LaPensee CR, 2008, ENDOCRINOLOGY, V149, P5415, DOI 10.1210/en.2008-0549; Lee MY, 2006, J CELL PHYSIOL, V208, P399, DOI 10.1002/jcp.20674; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Matzner U, 2009, J BIOL CHEM, V284, P9372, DOI 10.1074/jbc.M809457200; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Mignini F, 2000, J AUTON PHARMACOL, V20, P325, DOI 10.1046/j.1365-2680.2000.00198.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mohamed-Ali V, 2001, J CLIN ENDOCR METAB, V86, P5864, DOI 10.1210/jc.86.12.5864; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; NISOLI E, 1992, J PHARMACOL EXP THER, V263, P823; Path G, 2001, J CLIN ENDOCR METAB, V86, P2281, DOI 10.1210/jc.86.5.2281; Pivonello R, 2007, EUR J ENDOCRINOL, V156, pS13, DOI 10.1530/eje.1.02353; Regis S, 2002, HUM GENET, V110, P351, DOI 10.1007/s00439-002-0701-y; Ricci A, 1997, NEUROSCI LETT, V229, P130, DOI 10.1016/S0304-3940(97)00413-8; Ricci A, 1999, J NEUROIMMUNOL, V96, P234, DOI 10.1016/S0165-5728(99)00042-9; Richtand NM, 2007, NEUROPSYCHOPHARMACOL, V32, P1715, DOI 10.1038/sj.npp.1301305; Rondinone CM, 2006, ENDOCRINE, V29, P81, DOI 10.1385/ENDO:29:1:81; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Sidhu A, 2000, INT J DEV NEUROSCI, V18, P669, DOI 10.1016/S0736-5748(00)00033-2; STROBEL G, 1990, BIOCHEM INT, V20, P343; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Than A, 2011, MOL CELL ENDOCRINOL, V332, P261, DOI 10.1016/j.mce.2010.11.002; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Zeigerer A, 2008, EXP CELL RES, V314, P2249, DOI 10.1016/j.yexcr.2008.04.003; Zimmermann U, 2003, J PSYCHIATR RES, V37, P193, DOI 10.1016/S0022-3956(03)00018-9; Zinger M, 2003, J CLIN ENDOCR METAB, V88, P689, DOI 10.1210/jc.2002-021255	55	67	70	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25537	10.1371/journal.pone.0025537	http://dx.doi.org/10.1371/journal.pone.0025537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966540	Green Submitted, Green Published, gold			2022-12-27	WOS:000295932100048
J	Liu, Q; Fan, JJ; Niu, C; Wang, DC; Wang, JP; Wang, X; Villaruz, AE; Li, M; Otto, M; Gao, Q				Liu, Qian; Fan, Jiajia; Niu, Chen; Wang, Decheng; Wang, Jianping; Wang, Xing; Villaruz, Amer E.; Li, Min; Otto, Michael; Gao, Qian			The Eukaryotic-Type Serine/Threonine Protein Kinase Stk Is Required for Biofilm Formation and Virulence in Staphylococcus epidermidis	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; SERINE THREONINE KINASE; SER/THR KINASE; STREPTOCOCCUS-PNEUMONIAE; BINDING PROTEIN; GENE; IDENTIFICATION; AUREUS; PHOSPHATASE; PHOSPHORYLATION	Background: Serine/threonine kinases are involved in gene regulation and signal transduction in prokaryotes and eukaryotes. Here, we investigated the role of the serine/threonine kinase Stk in the opportunistic pathogen Staphylococcus epidermidis. Methodology/Principal Findings: We constructed an isogenic stk mutant of a biofilm-forming clinical S. epidermidis isolate. Presence of stk was important for biofilm formation in vitro and virulence in a murine subcutaneous foreign body infection model. Furthermore, the stk mutant exhibited phenotypes indicating an impact of stk on metabolic pathways. Using different constructs for the genetic complementation of the stk mutant strain with full-length Stk or specific Stk domains, we determined that the Stk intracellular kinase domain is important for biofilm formation and regulation of purine metabolism. Site-specific inactivation of the Stk kinase domain led to defective biofilm formation, in further support of the notion that the kinase activity of Stk regulates biofilm formation of S. epidermidis. According to immunological detection of the biofilm exopolysaccharide PIA and real-time PCR of the PIA biosynthesis genes, the impact of stk on biofilm formation is mediated, at least in part, by a strong influence on PIA expression. Conclusions: Our study identifies Stk as an important regulator of biofilm formation and virulence of S. epidermidis, with additional involvement in purine metabolism and the bacterial stress response.	[Liu, Qian; Fan, Jiajia; Niu, Chen; Wang, Decheng; Wang, Jianping; Wang, Xing; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Liu, Qian; Fan, Jiajia; Niu, Chen; Wang, Decheng; Wang, Jianping; Wang, Xing; Gao, Qian] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Villaruz, Amer E.; Otto, Michael] NIAID, NIH, Bethesda, MD 20892 USA; [Li, Min] Fudan Univ, Dept Lab Med, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University	Liu, Q (corresponding author), Fudan Univ, Key Lab Med Mol Virol, Inst Biomed Sci, Shanghai 200433, Peoples R China.	qgao99@yahoo.com	WANG, DECHENG/AGO-5098-2022	WANG, DECHENG/0000-0002-1742-7460; Otto, Michael/0000-0002-2222-4115	National Natural Science Foundation of China [30670108, J0730860]; National Institute of Allergy and Infectious Diseases, The National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001080] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases, The National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Natural Science Foundation of China 30670108 and J0730860, and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, The National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; COZZONE AJ, 1993, J CELL BIOCHEM, V51, P7, DOI 10.1002/jcb.240510103; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Dias R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-121; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Fey PD, 2010, CURR OPIN MICROBIOL, V13, P610, DOI 10.1016/j.mib.2010.09.007; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hussain H, 2006, J BACTERIOL, V188, P1628, DOI 10.1128/JB.188.4.1628-1632.2006; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Knobloch JKM, 2003, APPL ENVIRON MICROB, V69, P5812, DOI 10.1128/AEM.69.10.5812-5818.2003; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Novakova L, 2005, FEBS J, V272, P1243, DOI 10.1111/j.1742-4658.2005.04560.x; Novakova L, 2010, J BACTERIOL; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pei L, 2001, MICROB PATHOGENESIS, V31, P185, DOI 10.1006/mpat.2001.0462; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005; Rupp ME, 1999, INFECT IMMUN, V67, P2656, DOI 10.1128/IAI.67.5.2656-2659.1999; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Wang CZ, 2007, MICROBES INFECT, V9, P1376, DOI 10.1016/j.micinf.2007.06.012; Wang CZ, 2010, FEMS IMMUNOL MED MIC, V59, P152, DOI 10.1111/j.1574-695X.2010.00673.x; Wang L, 2008, J INFECT DIS, V197, P1254, DOI 10.1086/586714; Wang X, 2010, INFECT IMMUN, V79, P1007; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002; Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	64	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25380	10.1371/journal.pone.0025380	http://dx.doi.org/10.1371/journal.pone.0025380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966513	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100051
J	Johnson, KL; Kibble, NAJ; Bacic, A; Schultz, CJ				Johnson, Kim L.; Kibble, Natalie A. J.; Bacic, Antony; Schultz, Carolyn J.			A Fasciclin-Like Arabinogalactan-Protein (FLA) Mutant of Arabidopsis thaliana, fla1, Shows Defects in Shoot Regeneration	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; GENE FAMILY; MEDIATED TRANSFORMATION; REVERSE GENETICS; GENOME-WIDE; ROOT; EXPRESSION; MUTATIONS; IDENTIFICATION; PERICYCLE	Background: The fasciclin-like arabinogalactan-proteins (FLAs) are an enigmatic class of 21 members within the larger family of arabinogalactan-proteins (AGPs) in Arabidopsis thaliana. Located at the cell surface, in the cell wall/plasma membrane, they are implicated in many developmental roles yet their function remains largely undefined. Fasciclin (FAS) domains are putative cell-adhesion domains found in extracellular matrix proteins of organisms from all kingdoms, but the juxtaposition of FAS domains with highly glycosylated AGP domains is unique to plants. Recent studies have started to elucidate the role of FLAs in Arabidopsis development. FLAs containing a single FAS domain are important for the integrity and elasticity of the plant cell wall matrix (FLA11 and FLA12) and FLA3 is involved in microspore development. FLA4/SOS5 with two FAS domains and two AGP domains has a role in maintaining proper cell expansion under salt stressed conditions. The role of other FLAs remains to be uncovered. Method/Principal Findings: Here we describe the characterisation of a T-DNA insertion mutant in the FLA1 gene (At5g55730). Under standard growth conditions fla1-1 mutants have no obvious phenotype. Based on gene expression studies, a putative role for FLA1 in callus induction was investigated and revealed that fla1-1 has a reduced ability to regenerate shoots in an in vitro shoot-induction assay. Analysis of FLA1p:GUS reporter lines show that FLA1 is expressed in several tissues including stomata, trichomes, the vasculature of leaves, the primary root tip and in lateral roots near the junction of the primary root. Conclusion: The results of the developmental expression of FLA1 and characterisation of the fla1 mutant support a role for FLA1 in the early events of lateral root development and shoot development in tissue culture, prior to cell-type specification.	[Johnson, Kim L.; Bacic, Antony] Univ Melbourne, Sch Bot, ARC Ctr Excellence Plant Cell Walls & Plant Cell, Melbourne, Vic, Australia; [Kibble, Natalie A. J.] Univ Adelaide, ARC Ctr Excellence Plant Cell Walls, Waite Res Inst, Glen Osmond, SA, Australia; [Kibble, Natalie A. J.; Schultz, Carolyn J.] Univ Adelaide, Sch Agr & Wine, Waite Res Inst, Glen Osmond, SA, Australia	University of Melbourne; University of Adelaide; University of Adelaide	Johnson, KL (corresponding author), John Innes Ctr, Colney Lane, Norwich, Norfolk, England.	carolyn.schultz@adelaide.edu.au	Johnson, Kim/AAB-5696-2022	Johnson, Kim/0000-0001-6917-7742; Bacic, Tony/0000-0001-7483-8605	Australian Research Council [DP034545]; University of Melbourne	Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne)	This work was funded by Australian Research Council grant (DP034545 to CJS and AB), and University of Melbourne, Albert Shimmins writing-up award (KLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Bouche N, 2001, CURR OPIN PLANT BIOL, V4, P111, DOI 10.1016/S1369-5266(00)00145-X; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Buechel S, 2010, EUR J CELL BIOL, V89, P279, DOI 10.1016/j.ejcb.2009.11.016; Candela M, 2001, IN VITRO CELL DEV-PL, V37, P638, DOI 10.1007/s11627-001-0111-1; Cary A, 2001, PLANTA, V213, P700, DOI 10.1007/s004250100565; Cary AJ, 2002, PLANT J, V32, P867, DOI 10.1046/j.1365-313X.2002.01479.x; Casero PJ, 1998, PLANTA, V204, P252, DOI 10.1007/s004250050254; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clout NJ, 2003, STRUCTURE, V11, P197, DOI 10.1016/S0969-2126(03)00002-9; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fischer U, 2004, CURR OPIN PLANT BIOL, V7, P670, DOI 10.1016/j.pbi.2004.09.007; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; Gaspar YM, 2004, PLANT PHYSIOL, V135, P2162, DOI 10.1104/pp.104.045542; Gens JS, 2000, PROTOPLASMA, V212, P115, DOI 10.1007/BF01279353; Harwood A, 2004, CURR OPIN CELL BIOL, V16, P470, DOI 10.1016/j.ceb.2004.07.011; HUBER O, 1994, EMBO J, V13, P4212, DOI 10.1002/j.1460-2075.1994.tb06741.x; Iwase A, 2011, CURR BIOL, V21, P508, DOI 10.1016/j.cub.2011.02.020; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; KNOX JP, 1995, FASEB J, V9, P1004, DOI 10.1096/fasebj.9.11.7544308; Lalanne E, 2004, PLANT CELL, V16, P229, DOI 10.1105/tpc.014407; Li J, 2010, PLANT J, V64, P482, DOI 10.1111/j.1365-313X.2010.04344.x; Liu TB, 2009, J ZHEJIANG UNIV-SC B, V10, P434, DOI 10.1631/jzus.B0920017; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Majewska-Sawka A, 2000, PLANT PHYSIOL, V122, P3, DOI 10.1104/pp.122.1.3; Matsuo N, 2011, PLANT SCI, V181, P39, DOI 10.1016/j.plantsci.2011.03.007; McCabe PF, 1997, PLANT CELL, V9, P2225, DOI 10.1105/tpc.9.12.2225; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; Meissner RC, 1999, PLANT CELL, V11, P1827, DOI 10.1105/tpc.11.10.1827; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02613; Nam J, 1999, MOL GEN GENET, V261, P429, DOI 10.1007/s004380050985; PENNELL RI, 1995, PHILOS T R SOC B, V350, P87, DOI 10.1098/rstb.1995.0142; PENNELL RI, 1991, PLANT CELL, V3, P1317, DOI 10.1105/tpc.3.12.1317; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Pickard BG, 2005, FUNCT PLANT BIOL, V32, P863, DOI 10.1071/FP05045; Schultz CJ, 1997, PLANT MOL BIOL, V35, P833, DOI 10.1023/A:1005816520060; Schultz CJ, 2002, PLANT PHYSIOL, V129, P1448, DOI 10.1104/pp.003459; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Serpe MD, 1999, ADV BOT RES, V30, P207; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; van Hengel AJ, 2003, PLANT J, V36, P256, DOI 10.1046/j.1365-313X.2003.01874.x; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; Winkler RG, 1998, PLANT PHYSIOL, V118, P743, DOI 10.1104/pp.118.3.743	59	51	57	7	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25154	10.1371/journal.pone.0025154	http://dx.doi.org/10.1371/journal.pone.0025154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966441	gold, Green Published			2022-12-27	WOS:000295265100069
J	Orlandi, C; La Via, L; Bonini, D; Mora, C; Russo, I; Barbon, A; Barlati, S				Orlandi, Cesare; La Via, Luca; Bonini, Daniela; Mora, Cristina; Russo, Isabella; Barbon, Alessandro; Barlati, Sergio			AMPA Receptor Regulation at the mRNA and Protein Level in Rat Primary Cortical Cultures	PLOS ONE			English	Article							GLUTAMATE-OPERATED CHANNELS; HIPPOCAMPAL-NEURONS; KINETIC-PROPERTIES; MOLECULAR DETERMINANT; RETINOIC ACID; GLUR2; TRAFFICKING; EXPRESSION; FLOP; TRANSLATION	Ionotropic glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors are the major mediators of fast synaptic neurotransmission. In this work, we used primary cortical cultures from rats as a model system to study AMPA receptor regulation during in vitro cell maturation and after synaptic activity modifications. The levels of AMPA receptor mRNA and protein, along with the alternative splicing and RNA editing of the AMPA receptor subunit (GluR1-4) mRNAs, were analyzed in immature (DIV5) and mature (DIV26) rat neuronal cultures. We observed an increase in the expression of all four AMPA receptor subunits during in vitro neuronal maturation. This finding might be due to the formation of new synapses between neurons during the development of a complex neuronal network. We also analyzed the effects of stimulation (KCl and glutamate) and inhibition (APV/TTX) on rat mature neuronal cultures (DIV26): stimulation with KCl led to an overall down-regulation of GluR1 and GluR3 AMPA receptor subunits and an up-regulation of the GluR2 subunit. Similarly, glutamate treatment induced a significant down-regulation of GluR1 together with an up-regulation of GluR2. In contrast, the chronic blockade of neuronal activity that resulted from APV/TTX treatment up-regulated GluR1 and GluR3 with a parallel down-regulation of GluR2 and GluR4. RNA editing at the R/G site increased during neuronal cell maturation for all AMPA receptors (from 8-39% at DIV5 to 28-67% at DIV26). Unexpectedly, all the treatments tested induced a marked reduction (ranging from -9% to -52%) of R/G editing levels in mature neurons, primarily for the mRNA flip variant. In summary, we showed that cultured rat cortical neurons are able to vary the stoichiometric ratios of the AMPA receptor subunits and to control post-transcriptional processes to adapt fast synaptic transmission under different environmental conditions.	[Orlandi, Cesare] Univ Brescia, Div Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy; Univ Brescia, Natl Inst Neurosci, Brescia, Italy	University of Brescia; University of Brescia	Orlandi, C (corresponding author), Univ Brescia, Div Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy.	barlati@med.unibs.it	Orlandi, Cesare/AAK-3180-2020; Russo, Isabella/AAB-4882-2020; Barbon, Alessandro/E-7037-2010; Mora, Cristina/K-1222-2018; Orlandi, Cesare/O-4332-2015	Orlandi, Cesare/0000-0002-4992-9350; Russo, Isabella/0000-0002-6151-2451; Barbon, Alessandro/0000-0002-1127-7764; Mora, Cristina/0000-0003-3896-7893; 	MIUR [2007YYL5J9]; Ricerca Finalizzata Min Sal. Conv. [42]	MIUR(Ministry of Education, Universities and Research (MIUR)); Ricerca Finalizzata Min Sal. Conv.	This work was supported by grants from MIUR (PRIN 2007YYL5J9) and by Ricerca Finalizzata 2007 Min Sal. Conv. N<SUP>o</SUP> 42. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2007, EUR J NEUROSCI, V25, P1641, DOI 10.1111/j.1460-9568.2007.05388.x; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Bai XT, 2003, J NEUROCYTOL, V32, P71, DOI 10.1023/A:1027380315902; Barbon A, 2003, MOL BRAIN RES, V117, P168, DOI 10.1016/S0169-328X(03)00317-6; Barbon A, 2010, J NEUROCHEM, V114, P397, DOI 10.1111/j.1471-4159.2010.06767.x; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Ben Fredj N, 2004, J CELL SCI, V117, P1079, DOI 10.1242/jcs.00927; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DeLima AD, 1997, J COMP NEUROL, V382, P230, DOI 10.1002/(SICI)1096-9861(19970602)382:2<230::AID-CNE7>3.0.CO;2-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Goslin K., 1991, CULTURING NERVE CELL, P251; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Ha JS, 2009, BRAIN RES, V1273, P138, DOI 10.1016/j.brainres.2009.03.050; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Howes JF, 2007, NEUROTHERAPEUTICS, V4, P126, DOI 10.1016/j.nurt.2006.11.001; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; KHATEB A, 1995, J PHYSIOL-LONDON, V487, P623, DOI 10.1113/jphysiol.1995.sp020905; King AE, 2006, J COMP NEUROL, V498, P277, DOI 10.1002/cne.21053; Koike M, 2000, J NEUROSCI, V20, P2166; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; KRIEGSTEIN AR, 1983, J NEUROSCI, V3, P1634; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maghsoodi B, 2008, P NATL ACAD SCI USA, V105, P16015, DOI 10.1073/pnas.0804801105; Mahajan SS, 2011, NEUROSCIENCE; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marenco S, 2006, CNS DRUGS, V20, P173, DOI 10.2165/00023210-200620030-00001; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Myers SJ, 2004, J NEUROSCI, V24, P3489, DOI 10.1523/JNEUROSCI.4127-03.2004; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pei WM, 2009, BIOCHEMISTRY-US, V48, P3767, DOI 10.1021/bi8015907; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Qian YS, 2011, EUR J PHARMACOL, V651, P59, DOI 10.1016/j.ejphar.2010.10.095; Rao A, 1998, J NEUROSCI, V18, P1217; Ryman K, 2007, RNA, V13, P1071, DOI 10.1261/rna.404407; Schoft VK, 2007, NUCLEIC ACIDS RES, V35, P3723, DOI 10.1093/nar/gkm314; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Sergeeva OA, 2007, CELL MOL NEUROBIOL, V27, P669, DOI 10.1007/s10571-007-9153-1; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sohya K, 2007, NEUROSCIENCE, V145, P232, DOI 10.1016/j.neuroscience.2006.11.045; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009	63	28	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25350	10.1371/journal.pone.0025350	http://dx.doi.org/10.1371/journal.pone.0025350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966506	Green Submitted, Green Published, gold			2022-12-27	WOS:000295265100094
J	Ma, HL; Zhao, HM; Liu, Z; Zhao, J				Ma, Haoli; Zhao, Heming; Liu, Zhi; Zhao, Jie			The Phytocyanin Gene Family in Rice (Oryza sativa L.): Genome-Wide Identification, Classification and Transcriptional Analysis	PLOS ONE			English	Article							ARABINOGALACTAN PROTEIN GENE; EXPRESSION ANALYSIS; EARLY NODULIN; ARABIDOPSIS; STRESS; GERMINATION; EVOLUTION; OXYGEN; PLANTS; MOTIFS	Background: Phytocyanins (PCs) are plant-specific blue copper proteins involved in electron transport, and a large number of known PCs are considered to be chimeric arabinogalactan proteins (AGPs). To date there has not been a genome-wide overview of the OsPC gene family. Therefore, as the first step and a useful strategy to elucidate the functions of OsPCs, there is an urgent need for a thorough genome-wide analysis of this gene family. Methodology/Principal Findings: In this study, a total of 62 OsPC genes were identified through a comprehensive bioinformatics analysis of the rice (Oryza sativa L.) genome. Based on phylogeny and motif constitution, the family of OsPCs was classified into three subclasses: uclacyanin-like proteins (OsUCLs), stellacyanin-like proteins (OsSCLs) and early nodulin-like proteins (OsENODLs). Structure and glycosylation prediction indicated that 46 OsPCs were glycosylphosphatigylinositolanchored proteins and 38 OsPCs were chimeric AGPs. Gene duplication analysis revealed that chromosomal segment and tandem duplications contributed almost equally to the expansion of this gene family, and duplication events were mostly happened in the OsUCL subfamily. The expression profiles of OsPC genes were analyzed at different stages of vegetative and reproductive development and under abiotic stresses. It revealed that a large number of OsPC genes were abundantly expressed in the various stages of development. Moreover, 17 genes were regulated under the treatments of abiotic stresses. Conclusions/Significance: The genome-wide identification and expression analysis of OsPC genes should facilitate research in this gene family and give new insights toward elucidating their functions in higher plants.	[Ma, Haoli; Zhao, Heming; Liu, Zhi; Zhao, Jie] Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Ma, HL (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China.	jzhao@whu.edu.cn			National Natural Science Foundation of China [30821064, 31170171]; Major State Basic Research Program of China [2007CB108704]; Ministry of Education of China [20090141110035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China)	This study was supported by the National Natural Science Foundation of China (30821064; 31170171, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), the Major State Basic Research Program of China (2007CB108704, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm) and the Special Doctoral Program Funds of the Ministry of Education of China (20090141110035, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Borner GHH, 2003, PLANT PHYSIOL, V132, P568, DOI 10.1104/pp.103.021170; Boutrot F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-86; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; DELRIO LA, 1992, FREE RADICAL BIO MED, V13, P557, DOI 10.1016/0891-5849(92)90150-F; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Estevez JM, 2006, PLANT PHYSIOL, V142, P458, DOI 10.1104/pp.106.084244; Ezaki B, 2005, J EXP BOT, V56, P2661, DOI 10.1093/jxb/eri259; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Ezaki B, 2001, PLANT PHYSIOL, V127, P918, DOI 10.1104/pp.010399; Fruhling M, 2000, PLANT SCI, V160, P67, DOI 10.1016/S0168-9452(00)00362-9; Greene EA, 1998, PLANT MOL BIOL, V36, P775, DOI 10.1023/A:1005916821224; Hene L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-333; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Khan JA, 2007, PLANT PHYSIOL, V143, P1576, DOI 10.1104/pp.106.092296; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Lalanne E, 2004, PLANT CELL, V16, P229, DOI 10.1105/tpc.014407; Levitin B, 2008, PLANT J, V56, P351, DOI 10.1111/j.1365-313X.2008.03607.x; Li J, 2010, PLANT J, V64, P482, DOI 10.1111/j.1365-313X.2010.04344.x; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Mashiguchi K, 2004, PLANT CELL PHYSIOL, V45, P1817, DOI 10.1093/pcp/pch208; Mashiguchi K, 2009, BIOSCI BIOTECH BIOCH, V73, P2452, DOI 10.1271/bbb.90407; Miller JD, 1999, PLANT PHYSIOL, V120, P1015, DOI 10.1104/pp.120.4.1015; Nersissian AM, 1998, PROTEIN SCI, V7, P1915, DOI 10.1002/pro.5560070907; Richards KD, 1998, PLANT PHYSIOL, V116, P409, DOI 10.1104/pp.116.1.409; RYDEN LG, 1993, J MOL EVOL, V36, P41, DOI 10.1007/BF02407305; Schultz CJ, 2004, J BIOL CHEM, V279, P45503, DOI 10.1074/jbc.M407594200; Schultz CJ, 2002, PLANT PHYSIOL, V129, P1448, DOI 10.1104/pp.003459; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Stears RL, 2000, PHYSIOL GENOMICS, V3, P93, DOI 10.1152/physiolgenomics.2000.3.2.93; Tan L, 2003, PLANT PHYSIOL, V132, P1362, DOI 10.1104/pp.103.021766; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yoshizaki M, 2000, BIOCHEM BIOPH RES CO, V268, P466, DOI 10.1006/bbrc.2000.2130; Yuan J, 2008, PLANT PHYSIOL, V146, P1637, DOI 10.1104/pp.107.110304	45	42	47	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25184	10.1371/journal.pone.0025184	http://dx.doi.org/10.1371/journal.pone.0025184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984902	Green Submitted, gold, Green Published			2022-12-27	WOS:000295943000013
J	Aberg, UWN; Saarinen, N; Abrahamsson, A; Nurmi, T; Engblom, S; Dabrosin, C				Aberg, Ulrika W. Nilsson; Saarinen, Niina; Abrahamsson, Annelie; Nurmi, Tarja; Engblom, Sofia; Dabrosin, Charlotta			Tamoxifen and Flaxseed Alter Angiogenesis Regulators in Normal Human Breast Tissue In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LIQUID-CHROMATOGRAPHY; POSTMENOPAUSAL WOMEN; CANCER; ESTRADIOL; ENDOSTATIN; MICRODIALYSIS; PREVENTION; LIGNANS; CELLS	The incidence of breast cancer is increasing in the Western world and there is an urgent need for studies of the mechanisms of sex steroids in order to develop novel preventive strategies. Diet modifications may be among the means for breast cancer prevention. Angiogenesis, key in tumor progression, is regulated by the balance between pro-and anti-angiogenic factors, which are controlled in the extracellular space. Sampling of these molecules at their bioactive compartment is therefore needed. The aims of this study were to explore if tamoxifen, one of the most used anti-estrogen treatments for breast cancer affected some of the most important endogenous angiogenesis regulators, vascular endothelial growth factor (VEGF), angiogenin, and endostatin in normal breast tissue in vivo and if a diet supplementation with flaxseed had similar effects as tamoxifen in the breast. Microdialysis was used for in situ sampling of extracellular proteins in normal breast tissue of women before and after six weeks of tamoxifen treatment or before and after addition of 25 g/day of ground flaxseed to the diet or in control women. We show significant correlations between estradiol and levels of VEGF, angiogenin, and endostatin in vivo, which was verified in ex vivo breast tissue culture. Moreover, tamoxifen decreased the levels of VEGF and angiogenin in the breast whereas endostatin increased significantly. Flaxseed did not alter VEGF or angiogenin levels but similar to tamoxifen the levels of endostatin increased significantly. We conclude that one of the mechanisms of tamoxifen in normal breast tissue include tipping of the angiogenic balance into an anti-angiogenic state and that flaxseed has limited effects on the pro-angiogenic factors whereas the anti-angiogenic endostatin may be modified by diet. Further studies of diet modifications for breast cancer prevention are warranted.	[Aberg, Ulrika W. Nilsson; Saarinen, Niina; Abrahamsson, Annelie; Engblom, Sofia; Dabrosin, Charlotta] Linkoping Univ, Fac Hlth Sci, Div Oncol, Dept Clin & Expt Med, Linkoping, Sweden; [Abrahamsson, Annelie; Engblom, Sofia; Dabrosin, Charlotta] Cty Council Ostergotland, Dept Oncol, Linkoping, Sweden; [Saarinen, Niina] Univ Turku, Turku, Finland; [Nurmi, Tarja] Univ Eastern Finland, Kuopio, Finland	Linkoping University; City Council Ostergotland; University of Turku; University of Eastern Finland	Aberg, UWN (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Oncol, Dept Clin & Expt Med, Linkoping, Sweden.	charlotta.dabrosin@liu.se		Saarinen, Niina/0000-0003-3531-378X	Swedish Cancer Society; Swedish Research Counsil; Ekhaga Foundation; Academy of Finland [114526, 115459]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Counsil; Ekhaga Foundation; Academy of Finland(Academy of Finland)	This study was supported by Swedish Cancer Society (CD); Swedish Research Counsil (CD); Ekhaga Foundation (CD); Academy of Finland #114526 (TN); Academy of Finland #115459 (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; Bendrik C, 2008, CANCER RES, V68, P3405, DOI 10.1158/0008-5472.CAN-08-0295; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Brooks JD, 2004, AM J CLIN NUTR, V79, P318; Clarke M, 1998, LANCET, V351, P1451; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Dabrosin C, 2005, CLIN CANCER RES, V11, P8036, DOI 10.1158/1078-0432.CCR-05-0977; Dabrosin C, 2005, FRONT BIOSCI-LANDMRK, V10, P1329, DOI 10.2741/1622; Dabrosin C, 2003, INT J CANCER, V107, P535, DOI 10.1002/ijc.11398; Dabrosin C, 2003, BREAST CANCER RES TR, V80, P193, DOI 10.1023/A:1024575103524; Dabrosin C, 2003, J CLIN ENDOCR METAB, V88, P2695, DOI 10.1210/jc.2002-021584; Dabrosin C, 2003, BREAST CANCER RES TR, V78, P1, DOI 10.1023/A:1022133219353; Dabrosin C, 2001, SCAND J CLIN LAB INV, V61, P269, DOI 10.1080/00365510152378987; Dabrosin C, 1997, J CLIN ENDOCR METAB, V82, P1382, DOI 10.1210/jc.82.5.1382; Dabrosin C, 1997, CLIN SCI, V92, P493, DOI 10.1042/cs0920493; Dabrosin C, 2005, J ENDOCRINOL, V187, P103, DOI 10.1677/joe.1.06163; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Folkman J, 1992, Semin Cancer Biol, V3, P65; Garvin S, 2003, CANCER RES, V63, P8742; Garvin S, 2006, CELL TISSUE RES, V325, P245, DOI 10.1007/s00441-006-0159-7; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; HOWE GR, 1990, JNCI-J NATL CANCER I, V82, P561, DOI 10.1093/jnci/82.7.561; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; Hyder SM, 2000, CANCER RES, V60, P3183; Jungestrom MB, 2007, CLIN CANCER RES, V13, P1061, DOI 10.1158/1078-0432.CCR-06-1651; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Kulke MH, 2006, J CLIN ONCOL, V24, P3555, DOI 10.1200/JCO.2006.05.6762; Lindahl G, 2011, CANCER RES, V71, P51, DOI 10.1158/0008-5472.CAN-10-2289; Nilsson UW, 2006, CANCER RES, V66, P4789, DOI 10.1158/0008-5472.CAN-05-4012; Nilsson UW, 2010, CLIN CANCER RES, V16, P3659, DOI 10.1158/1078-0432.CCR-10-0501; Nurmi T, 1999, ANAL BIOCHEM, V274, P110, DOI 10.1006/abio.1999.4247; Nurmi T, 2003, J CHROMATOGR B, V798, P101, DOI 10.1016/j.jchromb.2003.09.018; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Penalvo JL, 2004, ANAL BIOCHEM, V332, P384, DOI 10.1016/j.ab.2004.05.046; Penttinen-Damdimopoulou PE, 2009, MOL NUTR FOOD RES, V53, P996, DOI 10.1002/mnfr.200800487; Pike MC, 2004, ONCOGENE, V23, P6379, DOI 10.1038/sj.onc.1207899; Rosdahl H, 1998, AM J PHYSIOL-ENDOC M, V274, pE936, DOI 10.1152/ajpendo.1998.274.5.E936; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saarinen NM, 2010, INT J CANCER, V127, P737, DOI 10.1002/ijc.25052; SAARINEN NM, 2008, BROMACOLOGY PHARM FO, P1; Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996; Smeds AI, 2007, J AGR FOOD CHEM, V55, P1337, DOI 10.1021/jf0629134; Sund M, 2005, P NATL ACAD SCI USA, V102, P2934, DOI 10.1073/pnas.0500180102; Thompson LU, 2005, CLIN CANCER RES, V11, P3828, DOI 10.1158/1078-0432.CCR-04-2326; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Zorick TS, 2001, EUR J HUM GENET, V9, P811, DOI 10.1038/sj.ejhg.5200721	51	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25720	10.1371/journal.pone.0025720	http://dx.doi.org/10.1371/journal.pone.0025720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984941	Green Submitted, gold, Green Published			2022-12-27	WOS:000295941300051
J	Gervan, P; Berencsi, A; Kovacs, I				Gervan, Patricia; Berencsi, Andrea; Kovacs, Ilona			Vision First? The Development of Primary Visual Cortical Networks Is More Rapid Than the Development of Primary Motor Networks in Humans	PLOS ONE			English	Article							HORIZONTAL CONNECTIONS; CONTEXTUAL INTERACTIONS; INTRINSIC CONNECTIONS; MAGNETIC STIMULATION; CONTOUR INTEGRATION; GLOBAL SHAPES; CORTEX; ORGANIZATION; CAT; REPRESENTATION	The development of cortical functions and the capacity of the mature brain to learn are largely determined by the establishment and maintenance of neocortical networks. Here we address the human development of long-range connectivity in primary visual and motor cortices, using well-established behavioral measures - a Contour Integration test and a Finger-tapping task - that have been shown to be related to these specific primary areas, and the long-range neural connectivity within those. Possible confounding factors, such as different task requirements (complexity, cognitive load) are eliminated by using these tasks in a learning paradigm. We find that there is a temporal lag between the developmental timing of primary sensory vs. motor areas with an advantage of visual development; we also confirm that human development is very slow in both cases, and that there is a retained capacity for practice induced plastic changes in adults. This pattern of results seems to point to human-specific development of the "canonical circuits'' of primary sensory and motor cortices, probably reflecting the ecological requirements of human life.	[Gervan, Patricia; Kovacs, Ilona] Budapest Univ Technol & Econ, Fac Sci, Dept Cognit Sci, H-1117 Budapest, Hungary; [Gervan, Patricia; Berencsi, Andrea; Kovacs, Ilona] Budapest Univ Technol & Econ, Hungarian Natl Acad, Cognit Sci Res Grp, H-1117 Budapest, Hungary	Budapest University of Technology & Economics; Budapest University of Technology & Economics	Gervan, P (corresponding author), Budapest Univ Technol & Econ, Fac Sci, Dept Cognit Sci, H-1117 Budapest, Hungary.	ikovacs@cogsci.bme.hu	Berencsi, Andrea/I-8951-2017; Kovacs, Ilona/A-2372-2009	Berencsi, Andrea/0000-0002-2330-7895; Kovacs, Ilona/0000-0002-1772-2697; Gervan, Patricia/0000-0001-5603-1912	National Science Foundation, Hungary [OTKA NF60806]	National Science Foundation, Hungary(National Science Foundation (NSF))	Funding was provided by the National Science Foundation, Hungary OTKA NF60806. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; BURKHALTER A, 1993, J NEUROSCI, V13, P1916, DOI 10.1523/jneurosci.13-05-01916.1993; Butefisch CM, 2004, J NEUROPHYSIOL, V91, P2110, DOI 10.1152/jn.01038.2003; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; Capaday C, 1998, EXP BRAIN RES, V120, P223, DOI 10.1007/s002210050396; Capaday C, 2011, J PHYSIOL-LONDON, V589, P2515, DOI 10.1113/jphysiol.2011.206938; Chakrabarty S, 2005, J NEUROPHYSIOL, V94, P3192, DOI 10.1152/jn.00424.2005; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Coogan TA, 1996, J COMP NEUROL, V372, P327, DOI 10.1002/(SICI)1096-9861(19960826)372:3<327::AID-CNE1>3.0.CO;2-4; DENCKLA MB, 1973, DEV MED CHILD NEUROL, V15, P635; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; Dorffierger S, 2009, BEHAV BRAIN RES, V198, P165, DOI 10.1016/j.bbr.2008.10.033; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Eyre JA, 2000, BRAIN, V123, P51, DOI 10.1093/brain/123.1.51; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Gervan P, 2010, J VISION, V10, DOI 10.1167/10.6.24; Giersch A, 2000, COGNITIVE NEUROPSYCH, V17, P731, DOI 10.1080/026432900750038317; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GILBERT CD, 2009, J PHYSL, V587, P2243; HUMPHREY DR, 1986, FED PROC, V45, P2687; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JENKINS IH, 1994, J NEUROSCI, V14, P3775; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; Kinoshita M, 2009, J NEUROPHYSIOL, V102, P1930, DOI 10.1152/jn.90882.2008; KISVARDAY ZF, 1992, NEUROSCIENCE, V46, P275, DOI 10.1016/0306-4522(92)90050-C; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kovacs I, 1996, BEHAV BRAIN RES, V82, P1, DOI 10.1016/S0166-4328(97)81103-5; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; KOVACS I, 1994, NATURE, V370, P644, DOI 10.1038/370644a0; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Kovacs I, 2000, VISION RES, V40, P1301, DOI 10.1016/S0042-6989(00)00055-9; Kozma-Wiebe P, 2006, COMPUT HUM BEHAV, V22, P971, DOI 10.1016/j.chb.2004.03.017; KWAN HC, 1987, BRAIN RES, V400, P259, DOI 10.1016/0006-8993(87)90625-1; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Mathes B, 2007, VISION RES, V47, P818, DOI 10.1016/j.visres.2006.11.014; Matsuzaka Y, 2007, J NEUROPHYSIOL, V97, P1819, DOI 10.1152/jn.00784.2006; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; MULLER K, 1991, ELECTROEN CLIN NEURO, V81, P63, DOI 10.1016/0168-5597(91)90105-7; Nezu A, 1997, BRAIN DEV-JPN, V19, P176, DOI 10.1016/S0387-7604(96)00552-9; NIEDERMEYER E, 2005, ELECTROENCEPHALOGRAP, P209; Pinto JGA, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00016; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273; Zhu FF, 2010, BIOL PSYCHOL, V84, P221, DOI 10.1016/j.biopsycho.2010.01.015; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171	66	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25572	10.1371/journal.pone.0025572	http://dx.doi.org/10.1371/journal.pone.0025572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984933	gold, Green Published, Green Submitted			2022-12-27	WOS:000295941300043
J	Zhang, Q; Chen, L; Helfand, BT; Jang, TL; Sharma, V; Kozlowski, J; Kuzel, TM; Zhu, LJ; Yang, XJ; Javonovic, B; Guo, YL; Lonning, S; Harper, J; Teicher, BA; Brendler, C; Yu, NW; Catalona, WJ; Lee, C				Zhang, Qiang; Chen, Lin; Helfand, Brian T.; Jang, Thomas L.; Sharma, Vidit; Kozlowski, James; Kuzel, Timothy Michael; Zhu, Lihua J.; Yang, Ximing J.; Javonovic, Borko; Guo, Yinglu; Lonning, Scott; Harper, Jay; Teicher, Beverly A.; Brendler, Charles; Yu, Nengwang; Catalona, William J.; Lee, Chung			TGF-beta Regulates DNA Methyltransferase Expression in Prostate Cancer, Correlates with Aggressive Capabilities, and Predicts Disease Recurrence	PLOS ONE			English	Article							CD8(+) T-CELLS; GROWTH-FACTOR; PROTEIN EXPRESSION; METHYLATION; TUMOR; INHIBITION; PATHWAY; PROLIFERATION; MECHANISM; ERK	Background: DNA methyltransferase (DNMT) is one of the major factors mediating the methylation of cancer related genes such as TGF-beta receptors (T beta Rs). This in turn may result in a loss of sensitivity to physiologic levels of TGF-beta in aggressive prostate cancer (CaP). The specific mechanisms of DNMT's role in CaP remain undetermined. In this study, we describe the mechanism of TGF-beta-mediated DNMT in CaP and its association with clinical outcomes following radical prostatectomy. Methodology/Principal Findings: We used human CaP cell lines with varying degrees of invasive capability to describe how TGF-beta mediates the expression of DNMT in CaP, and its effects on methylation status of TGF-beta receptors and the invasive capability of CaP in vitro and in vivo. Furthermore, we determined the association between DNMT expression and clinical outcome after radical prostatectomy. We found that more aggressive CaP cells had significantly higher TGF-b levels, increased expression of DNMT, but reduced T beta Rs when compared to benign prostate cells and less aggressive prostate cancer cells. Blockade of TGF-beta signaling or ERK activation (p-ERK) was associated with a dramatic decrease in the expression of DNMT, which results in a coincident increase in the expression of T beta Rs. Blockade of either TGF-beta signaling or DNMT dramatically decreased the invasive capabilities of CaP. Inhibition of TGF-beta in an TRAMP-C2 CaP model in C57BL/6 mice using 1D11 was associated with downregulation of DNMTs and p-ERK and impairment in tumor growth. Finally, independent of Gleason grade, increased DNMT1 expression was associated with biochemical recurrence following surgical treatment for prostate cancer. Conclusions and Significance: Our findings demonstrate that CaP derived TGF-beta may induce the expression of DNMTs in CaP which is associated with methylation of its receptors and the aggressive potential of CaP. In addition, DNMTs is an independent predictor for disease recurrence after prostatectomy, and may have clinical implications for CaP prognostication and therapy.	[Zhang, Qiang; Chen, Lin; Helfand, Brian T.; Sharma, Vidit; Kozlowski, James; Yu, Nengwang; Catalona, William J.; Lee, Chung] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Zhang, Qiang; Kozlowski, James; Yang, Ximing J.; Javonovic, Borko; Catalona, William J.; Lee, Chung] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Jang, Thomas L.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Kuzel, Timothy Michael] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Zhu, Lihua J.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Boston, MA 02125 USA; [Yang, Ximing J.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Javonovic, Borko] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Guo, Yinglu] Peking Univ, Inst Urol, Dept Urol, Hosp 1, Beijing 100871, Peoples R China; [Lonning, Scott; Harper, Jay; Teicher, Beverly A.] Genzyme Corp, Framingham, MA 01701 USA; [Brendler, Charles] Northshore Univ Heathsyst, Dept Surg, Evanston, IL USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Northwestern University; Feinberg School of Medicine; University of Massachusetts System; University of Massachusetts Boston; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Peking University; Sanofi-Aventis; Genzyme Corporation; NorthShore University Health System	Zhang, Q (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	q-zhang2@northwestern.edu			National Cancer Institute, NIH [2 P50CA090386-06A2]; National Cancer Institute [U01 CA152738]; American Cancer Society, Illinois [08-22]; Department of Defense [W81XWH-09-1-0311]; Portes Center/Institute of Medicine of Chicago; American Cancer Society [ACS-IRG 93-037-12]; Genzyme Corporation; Northshore University Healthsystem; NATIONAL CANCER INSTITUTE [U01CA152738, P50CA090386] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society, Illinois(American Cancer Society); Department of Defense(United States Department of Defense); Portes Center/Institute of Medicine of Chicago; American Cancer Society(American Cancer Society); Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Northshore University Healthsystem; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by Grant Number 2 P50CA090386-06A2 from the National Cancer Institute, NIH, as well as grants from the National Cancer Institute (U01 CA152738), American Cancer Society, Illinois (#08-22), Department of Defense (W81XWH-09-1-0311), Portes Center/Institute of Medicine of Chicago (QZ), American Cancer Society Institutional Research Grant (ACS-IRG 93-037-12), a grant from the Genzyme Corporation, a grant from Northshore University Healthsystem, and a gift from Mr. Fred L. Turner. Through the employment of SL, JH and BT, Genzyme Corporation's role included: providing reagents, offering suggestions of experimental design and help with the preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Attwood John, 2004, Methods Mol Biol, V287, P273; Bacolla A, 1999, J BIOL CHEM, V274, P33011, DOI 10.1074/jbc.274.46.33011; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bender CM, 1998, CANCER RES, V58, P95; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Chan MF, 2000, CURR TOP MICROBIOL, V249, P75; Chen MF, 2010, J MOL MED, V88, P953, DOI 10.1007/s00109-010-0640-3; Deng C, 2003, ARTHRITIS RHEUM, V48, P746, DOI 10.1002/art.10833; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Ghoshal K, 2007, DRUG TODAY, V43, P395, DOI 10.1358/dot.2007.43.6.1062666; Giehl K, 2000, ONCOGENE, V19, P4531, DOI 10.1038/sj.onc.1203806; Gowher H, 2004, CANCER BIOL THER, V3, P1062, DOI 10.4161/cbt.3.11.1308; Grizzle WE, 1998, METH MOLEC MED, V14, P143; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim IY, 1996, CANCER RES, V56, P44; KOZLOWSKI JM, 1991, INNOVATIONS UROLOGIC, P13; KOZLOWSKI JM, 1988, TUMOR PROGR METASTAS, P189; LEE C, 1993, CANCER METAST REV, V12, P21, DOI 10.1007/BF00689787; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; LIN C, 2010, 101 AM UR ASS ANN M; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Lu QJ, 2005, J IMMUNOL, V174, P6212, DOI 10.4049/jimmunol.174.10.6212; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Perry K, 2008, UROLOGY, V72, P225, DOI 10.1016/j.urology.2007.11.091; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Serganova I, 2009, FASEB J, V23, P2662, DOI 10.1096/fj.08-126920; Sintich SM, 1999, ENDOCRINOLOGY, V140, P3411, DOI 10.1210/en.140.8.3411; Steg A, 2007, DIAGN MOL PATHOL, V16, P229, DOI 10.1097/PDM.0b013e31811edc7e; WU JC, 1987, J BIOL CHEM, V262, P4778; Xing J, 2008, BRIT J CANCER, V98, P1716, DOI 10.1038/sj.bjc.6604343; Yu NF, 2008, CURR MED CHEM, V15, P1350, DOI 10.2174/092986708784567653; Zhang Q, 2005, MOL ENDOCRINOL, V19, P2390, DOI 10.1210/me.2005-0096; Zhang Q, 2005, CANCER RES, V65, P1761, DOI 10.1158/0008-5472.CAN-04-3169; ZHANG Q, 2011, 102 AM ASS CANC RES; Zhang Q, 2006, MOL CANCER THER, V5, P1733, DOI 10.1158/1535-7163.MCT-06-0109; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656; Zhou W, 2003, ENDOCRINOLOGY, V144, P4280, DOI 10.1210/en.2003-0554	49	59	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25168	10.1371/journal.pone.0025168	http://dx.doi.org/10.1371/journal.pone.0025168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980391	Green Published, gold			2022-12-27	WOS:000295941300021
J	Nawata, H; Kashino, G; Tano, K; Daino, K; Shimada, Y; Kugoh, H; Oshimura, M; Watanabe, M				Nawata, Hisakatsu; Kashino, Genro; Tano, Keizo; Daino, Kazuhiro; Shimada, Yoshiya; Kugoh, Hiroyuki; Oshimura, Mitsuo; Watanabe, Masami			Dysregulation of Gene Expression in the Artificial Human Trisomy Cells of Chromosome 8 Associated with Transformed Cell Phenotypes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DNA METHYLATION; WILMS-TUMORS; TSLC1 GENE; LIFE-SPAN; WT1 GENE; ABERRATIONS; ANEUPLOIDY; IMMORTALIZATION; ARCHITECTURE	A change in chromosome number, known as aneuploidy is a common characteristic of cancer. Aneuploidy disrupts gene expression in human cancer cells and immortalized human epithelial cells, but not in normal human cells. However, the relationship between aneuploidy and cancer remains unclear. To study the effects of aneuploidy in normal human cells, we generated artificial cells of human primary fibroblast having three chromosome 8 (trisomy 8 cells) by using microcell- mediated chromosome transfer technique. In addition to decreased proliferation, the trisomy 8 cells lost contact inhibition and reproliferated after exhibiting senescence-like characteristics that are typical of transformed cells. Furthermore, the trisomy 8 cells exhibited chromosome instability, and the overall gene expression profile based on microarray analyses was significantly different from that of diploid human primary fibroblasts. Our data suggest that aneuploidy, even a single chromosome gain, can be introduced into normal human cells and causes, in some cases a partial cancer phenotype due to a disruption in overall gene expression.	[Nawata, Hisakatsu; Tano, Keizo; Watanabe, Masami] Kyoto Univ, Inst Res Reactor, Radiat Biol Lab, Osaka 59004, Japan; [Kashino, Genro] Oita Univ, Sch Med, Adv Mol Imaging Ctr, Oita 87011, Japan; [Daino, Kazuhiro; Shimada, Yoshiya] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Expt Radiobiol Childrens Hlth Res Grp, Chiba 260, Japan; [Kugoh, Hiroyuki; Oshimura, Mitsuo] Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Tottori 680, Japan	Kyoto University; Oita University; National Institutes for Quantum Science & Technology; Tottori University	Nawata, H (corresponding author), Kyoto Univ, Inst Res Reactor, Radiat Biol Lab, Osaka 59004, Japan.	msm@rri.kyoto-u.ac.jp	Nawata, Hisakatsu/F-5351-2011		Ministry of Education, Culture, Sports, Science and Technology of Japan [21310036]; Nuclear Safety Commission of Japan; Central Research Institute of Electric Power Industry; Grants-in-Aid for Scientific Research [22501012] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nuclear Safety Commission of Japan; Central Research Institute of Electric Power Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21310036) and for The Nuclear Safety Research Enhancement Actions from the Nuclear Safety Commission of Japan. A grant from the Central Research Institute of Electric Power Industry also supported part of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGAR EM, 1995, HUM MUTAT, V5, P221, DOI 10.1002/humu.1380050306; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boffetta P, 2007, AM J EPIDEMIOL, V165, P36, DOI 10.1093/aje/kwj367; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; COPPES MJ, 1993, FASEB J, V7, P886, DOI 10.1096/fasebj.7.10.8393819; Doherty AMO, 2003, MAMM GENOME, V14, P583, DOI 10.1007/s00335-003-4002-0; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; FLETCHER JA, 1995, CANCER GENET CYTOGEN, V79, P139, DOI 10.1016/0165-4608(94)00134-W; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fukami T, 2003, INT J CANCER, V107, P53, DOI 10.1002/ijc.11348; Ganmore I, 2009, HUM MOL GENET, V18, pR84, DOI 10.1093/hmg/ddp084; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Goto A, 2005, CANCER SCI, V96, P480, DOI 10.1111/j.1349-7006.2005.00075.x; HABER DA, 1993, SCIENCE, V262, P2057, DOI 10.1126/science.8266105; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heller G, 2006, ONCOGENE, V25, P959, DOI 10.1038/sj.onc.1209115; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Ito T, 2003, CANCER RES, V63, P6320; Kodama S, 2001, RADIAT RES, V155, P254, DOI 10.1667/0033-7587(2001)155[0254:CCDSLG]2.0.CO;2; Kugoh H, 1999, DNA Res, V6, P165, DOI 10.1093/dnares/6.3.165; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; Loeb DM, 2002, INT J HEMATOL, V76, P117, DOI 10.1007/BF02982573; Mao XL, 2004, ONCOGENE, V23, P5632, DOI 10.1038/sj.onc.1207756; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakurai-Yageta M, 2009, BIOCHEM BIOPH RES CO, V390, P977, DOI 10.1016/j.bbrc.2009.10.088; SANKARY S, 1993, CANCER GENET CYTOGEN, V65, P152, DOI 10.1016/0165-4608(93)90225-B; SCHOFIELD DE, 1994, AM J SURG PATHOL, V18, P14, DOI 10.1097/00000478-199401000-00002; SCHOFIELD DE, 1993, AM J PATHOL, V143, P714; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Shimizu K, 2007, BIOCHEM BIOPH RES CO, V353, P522, DOI 10.1016/j.bbrc.2006.12.048; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Suzuki M, 1998, J RADIAT RES, V39, P203, DOI 10.1269/jrr.39.203; Tsujiuchi T, 2007, CANCER SCI, V98, P943, DOI 10.1111/j.1349-7006.2007.00480.x; Upender MB, 2004, CANCER RES, V64, P6941, DOI 10.1158/0008-5472.CAN-04-0474; Virtaneva K, 2001, P NATL ACAD SCI USA, V98, P1124, DOI 10.1073/pnas.98.3.1124; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Yang Z, 1998, J RADIAT RES, V39, P35, DOI 10.1269/jrr.39.35	52	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25319	10.1371/journal.pone.0025319	http://dx.doi.org/10.1371/journal.pone.0025319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980425	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600019
J	Rodriguez, S; Eriksson, M				Rodriguez, Sofia; Eriksson, Maria			Low and High Expressing Alleles of the LMNA Gene: Implications for Laminopathy Disease Development	PLOS ONE			English	Article							LAMIN-A; MUTATIONS; MICE	Today, there are at least a dozen different genetic disorders caused by mutations within the LMNA gene, and collectively, they are named laminopathies. Interestingly, the same mutation can cause phenotypes with different seventies or even different disorders and might, in some cases, be asymptomatic. We hypothesized that one possible contributing mechanism this phenotypic variability could be the existence of high and low expressing alleles in the LMNA locus. To investigate this hypothesis, we developed an allele-specific absolute quantification method for lamin A and lamin C transcripts using he polymorphic rs4641(C/T) LMNA coding SNP. The contribution of each allele to the total transcript level was investigated in nine informative human primary dermal fibroblast cultures from Hutchinson-Gilford progeria syndrome (HGPS) and unaffected controls. Our results show differential expression of the two alleles. The C allele is more frequently expressed and accounts for similar to 70% of the lamin A and lamin C transcripts. Analysis of samples from six patients with Hutchinson-Gilford progeria syndrome showed that the c.1824C>T, p.G608G mutation is located in both the C and the T allele which might account for the variability in phenotype seen among HGPS patients. Our method should be useful for further studies of human samples with mutations in the LMNA gene and to increase the understanding of the link between genotype and phenotype in laminopathies.	[Rodriguez, Sofia; Eriksson, Maria] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet	Rodriguez, S (corresponding author), Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden.	Maria.Eriksson.2@ki.se			Swedish Medical Research Council; Gun and Bertil Stohne foundation; Torsten and Ragnar Soderberg foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Gun and Bertil Stohne foundation; Torsten and Ragnar Soderberg foundation	This study was supported by grants from the Swedish Medical Research Council, the Gun and Bertil Stohne foundation, and the Torsten and Ragnar Soderberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheimer M, 1996, EXP CELL RES, V228, P181, DOI 10.1006/excr.1996.0315; Becane HM, 2000, PACE, V23, P1661, DOI 10.1046/j.1460-9592.2000.01661.x; FURUKAWA K, 1994, EXP CELL RES, V212, P426, DOI 10.1006/excr.1994.1164; LIN F, 1993, J BIOL CHEM, V268, P16321; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Moulson CL, 2007, HUM MUTAT, V28, P882, DOI 10.1002/humu.20536; Muntoni F, 2006, BRAIN, V129, P1260, DOI 10.1093/brain/awl062; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Rankin J, 2008, AM J MED GENET A, V146A, P1530, DOI 10.1002/ajmg.a.32331; Rodriguez S, 2009, EUR J HUM GENET, V17, P928, DOI 10.1038/ejhg.2008.270; Rozen S, 2000, Methods Mol Biol, V132, P365; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; van der Kooi AJ, 2002, NEUROLOGY, V59, P620, DOI 10.1212/WNL.59.4.620; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wydner KL, 1996, GENOMICS, V32, P474, DOI 10.1006/geno.1996.0146; Yang SH, 2008, J BIOL CHEM, V283, P7094, DOI 10.1074/jbc.M708138200	18	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25472	10.1371/journal.pone.0025472	http://dx.doi.org/10.1371/journal.pone.0025472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980471	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600027
J	Wang, HG; Wang, C; Pitt, GS				Wang, Hong-Gang; Wang, Chuan; Pitt, Geoffrey S.			Rem2-Targeted shRNAs Reduce Frequency of Miniature Excitatory Postsynaptic Currents without Altering Voltage-Gated Ca2+ Currents	PLOS ONE			English	Article							SMALL G-PROTEIN; CALCIUM-CHANNELS; SYNAPSE DEVELOPMENT; RAS FAMILY; GEM; GTPASES; REM2; INACTIVATION; CALMODULIN; MODULATION	Ca2+ influx through voltage-gated Ca2+ channels (VGCCs) plays important roles in neuronal cell development and function. Rem2 is a member of the RGK ((R) under bar ad, (R) under bar em, (R) under bar em2, (G) under bar em/(K) under bar ir) subfamily of small GTPases that confers potent inhibition upon VGCCs. The physiologic roles of RGK proteins, particularly in the brain, are poorly r understood. Rem2 was implicated in synaptogenesis through an RNAi screen and proposed to regulate Ca2+ homeostasis in neurons. To test this hypothesis and uncover physiological roles for Rem2 in the brain, we investigated the molecular mechanisms by which Rem2 knockdown affected synaptogenesis and Ca2+ homeostasis in cultured rat hippocampal neurons. Expression of a cocktail of shRNAs targeting rat Rem2 (rRem2) reduced the frequency of miniature excitatory postsynaptic currents (mEPSCs) measured 10 d after transfection (14 d in vitro), but did not affect mEPSC amplitude. VGCC current amplitude, after rRem2-targeted knockdown was not different from that in control cells, however, a either 4 or 10 d Po transfection. Co-expression of a human Rem2 that was insensitive to the shRNAs targeting rRem2 was unable to prevent the reduction in mEPSC frequency after rRem2-targeted knockdown. Over-expression of rRem2 resulted in 50% reduction in VGCC current, but neither the mEPSC frequency nor amplitude was affected. Taken together, the observed effects upon synaptogenesis after shRNA treatment are more likely due to mechanisms other than modulation of VGCCs and Ca2+ homeostasis, and may be independent of Rem2. In addition, our results reveal a surprising lack of contribution of VGCCs to synaptogenesis during early development in cultured hippocampal neurons.	[Wang, Hong-Gang] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC USA	Duke University; Duke University	Wang, HG (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA.	geoffrey.pitt@duke.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	National Institutes of Health [R01 HL71165, R01 HL088089]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088089, R01HL071165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (R01 HL71165 and R01 HL088089). GSP is supported by an Established Investigator Award from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; BASARSKY TA, 1994, HIPPOCAMPAL SYNAPTOG, P6402; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Opatowsky Y, 2006, FEBS LETT, V580, P5959, DOI 10.1016/j.febslet.2006.09.067; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; van Daalen E, 2009, EUR CHILD ADOLES PSY, V18, P663, DOI 10.1007/s00787-009-0025-8; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Wang H., 2007, Autonomic & Autacoid Pharmacology, V27, P1, DOI 10.1111/j.1474-8673.2006.00381.x; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25741	10.1371/journal.pone.0025741	http://dx.doi.org/10.1371/journal.pone.0025741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980534	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600053
J	Iwasaki, H; Kawamoto, A; Tjwa, M; Horii, M; Hayashi, S; Oyamada, A; Matsumoto, T; Suehiro, S; Carmeliet, P; Asahara, T				Iwasaki, Hiroto; Kawamoto, Atsuhiko; Tjwa, Marc; Horii, Miki; Hayashi, Saeko; Oyamada, Akira; Matsumoto, Tomoyuki; Suehiro, Shigefumi; Carmeliet, Peter; Asahara, Takayuki			PlGF Repairs Myocardial Ischemia through Mechanisms of Angiogenesis, Cardioprotection and Recruitment of Myo-Angiogenic Competent Marrow Progenitors	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; GENE-TRANSFER; FACTOR-I; DOUBLE-BLIND; EXPRESSION; CELLS; REVASCULARIZATION; HEART; VEGF; IMPROVEMENT	Rationale: Despite preclinical success in regenerating and revascularizing the infarcted heart using angiogenic growth factors or bone marrow (BM) cells, recent clinical trials have revealed less benefit from these therapies than expected. Objective: We explored the therapeutic potential of myocardial gene therapy of placental growth factor (PlGF), a VEGF-related angiogenic growth factor, with progenitor-mobilizing activity. Methods and Results: Myocardial PlGF gene therapy improves cardiac performance after myocardial infarction, by inducing cardiac repair and reparative myoangiogenesis, via upregulation of paracrine anti-apoptotic and angiogenic factors. In addition, PlGF therapy stimulated Sca-1(+)/Lin(-) (SL) BM progenitor proliferation, enhanced their mobilization into peripheral blood, and promoted their recruitment into the peri-infarct borders. Moreover, PlGF enhanced endothelial progenitor colony formation of BM-derived SL cells, and induced a phenotypic switch of BM-SL cells, recruited in the infarct, to the endothelial, smooth muscle and cardiomyocyte lineage. Conclusions: Such pleiotropic effects of PlGF on cardiac repair and regeneration offer novel opportunities in the treatment of ischemic heart disease.	[Iwasaki, Hiroto; Kawamoto, Atsuhiko; Horii, Miki; Hayashi, Saeko; Oyamada, Akira; Matsumoto, Tomoyuki; Asahara, Takayuki] RIKEN, Ctr Dev Biol, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Iwasaki, Hiroto; Suehiro, Shigefumi] Osaka City Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka 558, Japan; [Tjwa, Marc; Carmeliet, Peter] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium; [Tjwa, Marc; Carmeliet, Peter] VIB, Dept Transgene Technol & Gene Therapy, Louvain, Belgium; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Osaka Metropolitan University; KU Leuven; Flanders Institute for Biotechnology (VIB); Tokai University	Iwasaki, H (corresponding author), RIKEN, Ctr Dev Biol, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan.	kawamoto@fbri.org; asa777@is.icc.u-tokai.ac.jp	Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821; Kawamoto, Atsuhiko/0000-0002-2733-8015; Matsumoto, Tomoyuki/0000-0003-4587-0029	Japanese Ministry of Health, Labour and Welfare [H14-trans-001, H17-trans-002]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) [G.0121.02]; Belgian Science Policy [IAP-P5/02]; Concerted Research Activities, Belgium [GOA2001/09, GOA2006/11]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Belgian Science Policy(Belgian Federal Science Policy Office); Concerted Research Activities, Belgium	This work was supported by a Health and Labour Sciences Research Grant (H14-trans-001, H17-trans-002) from the Japanese Ministry of Health, Labour and Welfare and by grants from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO G.0121.02), the Belgian Science Policy (project no. IAP-P5/02), from the Concerted Research Activities, Belgium (grants #GOA2001/09 and GOA2006/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 2002, CANCER RES, V62, P2749; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Fukuhara S, 2004, CELL TRANSPLANT, V13, P741, DOI 10.3727/000000004783983486; Horio T, 2005, REGUL PEPTIDES, V124, P65, DOI 10.1016/j.regpep.2004.06.029; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwama H, 2006, J AM COLL CARDIOL, V47, P1559, DOI 10.1016/j.jacc.2005.11.064; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kidoguchi K, 2006, STROKE, V37, P1856, DOI 10.1161/01.STR.0000226904.96059.a6; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Lenderink T, 2006, J AM COLL CARDIOL, V47, P307, DOI 10.1016/j.jacc.2005.08.063; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Mehrhof FB, 2001, CIRCULATION, V104, P2088, DOI 10.1161/hc4201.097133; Ninomiya M, 2003, GENE THER, V10, P1152, DOI 10.1038/sj.gt.3301984; Odorisio T, 2006, J DERMATOL SCI, V41, P11, DOI 10.1016/j.jdermsci.2005.08.008; Roy H, 2005, HUM GENE THER, V16, P1422, DOI 10.1089/hum.2005.16.1422; Szukiewicz D, 2005, GYNECOL OBSTET INVES, V59, P102, DOI 10.1159/000082622; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Wei SC, 2005, GUT, V54, P666, DOI 10.1136/gut.2004.050831	31	48	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24872	10.1371/journal.pone.0024872	http://dx.doi.org/10.1371/journal.pone.0024872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969865	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900016
J	Liu, MY; Liu, WY; Luo, J; Liu, YL; Zhu, Y; Berman, H; Wu, JG				Liu, Michelle Y.; Liu, Weiyong; Luo, Jun; Liu, Yingle; Zhu, Yang; Berman, Hillary; Wu, Jianguo			Characterization of an Outbreak of Hand, Foot, and Mouth Disease in Nanchang, China in 2010	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; MOLECULAR EPIDEMIOLOGY; RECOMBINATION; TAIWAN; CIRCULATION; PREVALENCE; CHILDREN; JAPAN	Recent outbreaks of human enterovirus 71 (EV71) infection and EV71-associated hand, foot, and mouth disease (HFMD) in China have affected millions and potentially lead to life-threatening complications in newborns. Furthermore, these outbreaks represent a significant global public health issue in the world. Understanding the epidemiology of HFMD and EV71 infection and their transmission patterns in China is essential for controlling outbreaks. However, no studies on the outbreaks of HFMD and EV71 infection in China during 2010 have been reported. In this report, we carried out an epidemiological analysis to study an outbreak of HFMD and EV71 infection in 2010 in the city of Nanchang in the Jiangxi province of People's Republic of China. From April 7 to May 11, 2010, a total of 109 HFMD cases were reported, and in this report the HFMD cases were studied by both epidemiological and laboratory analyses. The epidemiological study indicates that children aged younger than 8 years old represented more than 90% of the reported cases, with the age group of 1-3 years containing the highest number of cases. Laboratory studies detected a high prevalence of EV71 amongst the cases in our study, suggesting EV71 as a common enterovirus found in HFMD cases in Nanchang. Phylogenetic analysis of the sequence of the VP1 region of four EV71 isolates indicated that the Nanchang strains belong to the C4 subgenotype commonly found in China during outbreaks in 2008 but contain distinct variations from these strains. Our study for the first time characterizes the epidemiology of HFMD and EV71 infection in China in 2010 and furthermore, provides the first direct evidence of the genotype of EV71 circulating in Nanchang, China. Our study should facilitate the development of public health measures for the control and prevention of HFMD and EV71 infection in at-risk individuals in China.	[Liu, Michelle Y.; Liu, Weiyong; Luo, Jun; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Michelle Y.; Liu, Weiyong; Luo, Jun; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Zhongnan Hosp, Chinese French Liver Dis Res Inst, Wuhan 430072, Peoples R China; [Zhu, Yang] Jiangsu Affynigen Biotechnol Inc, Taizhou Inst Virol, Taizhou, Jiangsu, Peoples R China; [Berman, Hillary] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Liu, Weiyong; Liu, Yingle; Wu, Jianguo] Wuhan E Lake High Technol Dev Zone, Wuhan Inst Biotechnol, Wuhan, Peoples R China	Wuhan University; Wuhan University; University of California System; University of California Berkeley	Liu, MY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	jwu@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895	National Mega Project on Major Infectious Diseases Prevention [2008ZX10002-009, 2008ZX10204, 2009ZX10004-207]; National Mega Project on Major Drug Development [2009ZX09301-014, 2011ZX09401-302]; National Science Foundation of China [30730001, 30872491, 81030031]; Major State Basic Research Development Program [2007CB512803, 2009CB522506, 2011CB504800]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0745]; Chinese Ministry of Education [204114208]; Department of Science and Technology of Hubei Province [2005ABC003]; Fundamental Research Funds for the Central Universities [1102001]; Specialized Research Fund for the Doctoral Program of Higher Education [20090141110033]	National Mega Project on Major Infectious Diseases Prevention; National Mega Project on Major Drug Development; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education(Ministry of Education, China); Department of Science and Technology of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by research grants from the National Mega Project on Major Infectious Diseases Prevention (2008ZX10002-009, 2008ZX10204, and 2009ZX10004-207), the National Mega Project on Major Drug Development (2009ZX09301-014 and 2011ZX09401-302), the National Science Foundation of China (30730001 30872491, and 81030031), the Major State Basic Research Development Program (2007CB512803, 2009CB522506, and 2011CB504800), the Program for Changjiang Scholars and Innovative Research Team in University (IRT0745), the Key Project of the Chinese Ministry of Education (204114208), the Department of Science and Technology of Hubei Province (2005ABC003), Fundamental Research Funds for the Central Universities (1102001), and the Specialized Research Fund for the Doctoral Program of Higher Education (20090141110033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chen CH, 2008, J APPL MICROBIOL, V104, P817, DOI 10.1111/j.1365-2672.2007.03598.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Hsu BM, 2008, FEMS IMMUNOL MED MIC, V52, P253, DOI 10.1111/j.1574-695X.2008.00379.x; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Mao L. X., 2010, J CLIN VIRO IN PRESS; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Oberste MS, 2004, J VIROL, V78, P2948, DOI 10.1128/JVI.78.6.2948-2955.2004; Oprisan G, 2002, J GEN VIROL, V83, P2193, DOI 10.1099/0022-1317-83-9-2193; Ortner B, 2009, J MED VIROL, V81, P317, DOI 10.1002/jmv.21374; Pallansch, 2007, FIELDS VIROLOGY, P839; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Witso E, 2007, VIRUS RES, V123, P19, DOI 10.1016/j.virusres.2006.07.015; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	35	63	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25287	10.1371/journal.pone.0025287	http://dx.doi.org/10.1371/journal.pone.0025287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980416	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900047
J	Rosa, RD; Santini, A; Fievet, J; Bulet, P; Destoumieux-Garzon, D; Bachere, E				Rosa, Rafael D.; Santini, Adrien; Fievet, Julie; Bulet, Philippe; Destoumieux-Garzon, Delphine; Bachere, Evelyne			Big Defensins, a Diverse Family of Antimicrobial Peptides That Follows Different Patterns of Expression in Hemocytes of the Oyster Crassostrea gigas	PLOS ONE			English	Article							MOLECULAR-CLONING; GENE; INVERTEBRATE; CONVERTASE; RESISTANCE; SEQUENCE; PROTEIN; NOV.	Background: Big defensin is an antimicrobial peptide composed of a highly hydrophobic N-terminal region and a cationic C-terminal region containing six cysteine residues involved in three internal disulfide bridges. While big defensin sequences have been reported in various mollusk species, few studies have been devoted to their sequence diversity, gene organization and their expression in response to microbial infections. Findings: Using the high-throughput Digital Gene Expression approach, we have identified in Crassostrea gigas oysters several sequences coding for big defensins induced in response to a Vibrio infection. We showed that the oyster big defensin family is composed of three members (named Cg-BigDef1, Cg-BigDef2 and Cg-BigDef3) that are encoded by distinct genomic sequences. All Cg-BigDefs contain a hydrophobic N-terminal domain and a cationic C-terminal domain that resembles vertebrate beta-defensins. Both domains are encoded by separate exons. We found that big defensins form a group predominantly present in mollusks and closer to vertebrate defensins than to invertebrate and fungi CS alpha beta-containing defensins. Moreover, we showed that Cg-BigDefs are expressed in oyster hemocytes only and follow different patterns of gene expression. While Cg-BigDef3 is non-regulated, both Cg-BigDef1 and Cg-BigDef2 transcripts are strongly induced in response to bacterial challenge. Induction was dependent on pathogen associated molecular patterns but not damage-dependent. The inducibility of Cg-BigDef1 was confirmed by HPLC and mass spectrometry, since ions with a molecular mass compatible with mature Cg-BigDef1 (10.7 kDa) were present in immune-challenged oysters only. From our biochemical data, native Cg-BigDef1 would result from the elimination of a prepropeptide sequence and the cyclization of the resulting N-terminal glutamine residue into a pyroglutamic acid. Conclusions: We provide here the first report showing that big defensins form a family of antimicrobial peptides diverse not only in terms of sequences but also in terms of genomic organization and regulation of gene expression.	[Rosa, Rafael D.; Santini, Adrien; Fievet, Julie; Bachere, Evelyne] IFREMER, CNRS, Univ Montpellier 2, IRD, Montpellier, France; [Rosa, Rafael D.; Santini, Adrien; Destoumieux-Garzon, Delphine; Bachere, Evelyne] Univ Montpellier I, UMR Ecol Syst Marins Cotiers 5119, Montpellier, France; [Bulet, Philippe] UJF Grenoble, AGIM, FRE 3405, CNRS EPHE 1, La Tronche, France; AGIM, Plateforme BioPk Archamps, Archamps, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rosa, RD (corresponding author), IFREMER, CNRS, Univ Montpellier 2, IRD, Montpellier, France.	ebachere@ifremer.fr	Destoumieux-Garzón, Delphine/O-3328-2014; BUELT, PHILIPPE/C-8451-2014; BULET, Philippe/C-8557-2014; Rosa, Rafael Diego/L-6944-2019; Bachere, Evelyne/O-6117-2014	Destoumieux-Garzón, Delphine/0000-0002-8793-9138; BULET, Philippe/0000-0001-9016-265X; Rosa, Rafael Diego/0000-0002-4076-3163; 	IFREMER; CNRS; CNPq-Brazil	IFREMER; CNRS(Centre National de la Recherche Scientifique (CNRS)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study received financial support from IFREMER and CNRS. RDR was supported by a doctoral funding from CNPq-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Cuthbertson BJ, 2008, DEV COMP IMMUNOL, V32, P167, DOI 10.1016/j.dci.2007.06.009; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Garnier M, 2008, SYST APPL MICROBIOL, V31, P358, DOI 10.1016/j.syapm.2008.06.003; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kouno T, 2008, BIOCHEMISTRY-US, V47, P10611, DOI 10.1021/bi800957n; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; Munoz M, 2002, EUR J BIOCHEM, V269, P2678, DOI 10.1046/j.1432-1033.2002.02934.x; NAGLE GT, 1995, DNA CELL BIOL, V14, P431, DOI 10.1089/dna.1995.14.431; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Perrigault M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-377; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piquemal D, 2002, GENOMICS, V80, P361, DOI 10.1006/geno.2002.6836; Rabel D, 2004, J BIOL CHEM, V279, P14853, DOI 10.1074/jbc.M313608200; Rosa RD, 2010, ISJ-INVERT SURVIV J, V7, P262; SAITO T, 1995, J BIOCHEM-TOKYO, V117, P1131, DOI 10.1093/oxfordjournals.jbchem.a124818; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Spijker S, 1999, J NEUROBIOL, V41, P399, DOI 10.1002/(SICI)1097-4695(19991115)41:3<399::AID-NEU8>3.0.CO;2-Z; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thompson FL, 2003, SYST APPL MICROBIOL, V26, P65, DOI 10.1078/072320203322337326; VALORE EV, 1992, BLOOD, V79, P1538; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025; Zhao JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013480	43	84	86	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25594	10.1371/journal.pone.0025594	http://dx.doi.org/10.1371/journal.pone.0025594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980497	Green Published, gold			2022-12-27	WOS:000295936900078
J	Sartori, L; Straulino, E; Castiello, U				Sartori, Luisa; Straulino, Elisa; Castiello, Umberto			How Objects Are Grasped: The Interplay between Affordances and End-Goals	PLOS ONE			English	Article							OF-MASS PERCEPTION; MANIPULATIVE FORCES; SIZE; PREHENSION; MOVEMENT; SELECTION; HAND; INFORMATION; INTEGRATION; KINEMATICS	Background: Substantial literature has demonstrated that how the hand approaches an object depends on the manipulative action that will follow object contact. Little is known about how the placement of individual fingers on objects is affected by the end-goal of the action. Methodology/Principal Findings: Hand movement kinematics were measured during reaching for and grasping movements towards two objects (stimuli): a bottle with an ordinary cylindrical shape and a bottle with a concave constriction. The effects of the stimuli's weight (half full or completely full of water) and the end-goals (pouring, moving) of the action were also assessed. Analysis of key kinematic landmarks measured during reaching movements indicate that object affordance facilitates the end-goal of the action regardless of accuracy constraints. Furthermore, the placement of individual digits at contact is modulated by the shape of the object and the end-goal of the action. Conclusions/Significance: These findings offer a substantial contribution to the current debate about the role played by affordances and end-goals in determining the structure of reach-to-grasp movements.	[Sartori, Luisa; Straulino, Elisa; Castiello, Umberto] Univ Padua, Dipartimento Psicol Gen, Padua, Italy	University of Padua	Sartori, L (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	umberto.castiello@unipd.it		Sartori, Luisa/0000-0002-3838-8958; Castiello, Umberto/0000-0003-0629-1286	Italian Ministry of Research and Education [60A17-4387/11]	Italian Ministry of Research and Education(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Italian Ministry of Research and Education (60A17-4387/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2008, EXP BRAIN RES, V185, P111, DOI 10.1007/s00221-007-1136-4; Armbruster C, 2006, MOTOR CONTROL, V10, P311, DOI 10.1123/mcj.10.4.311; Baud-Bovy G, 2001, J NEUROPHYSIOL, V86, P604, DOI 10.1152/jn.2001.86.2.604; BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P617, DOI 10.3758/BF03211785; BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P633, DOI 10.3758/BF03211786; Bingham GP, 1995, GLOBAL PERSPECTIVES, V1; Brenner E, 1996, EXP BRAIN RES, V111, P473; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; Cohen RG, 2004, EXP BRAIN RES, V157, P486, DOI 10.1007/s00221-004-1862-9; Cole KJ, 2002, EXP BRAIN RES, V143, P35, DOI 10.1007/s00221-001-0965-9; Craighero L, 1998, VIS COGN, V5, P109, DOI 10.1080/713756780; Craje C, 2011, EXP BRAIN RES, V212, P119, DOI 10.1007/s00221-011-2704-1; DAMICO M, 1992, MED BIOL ENG COMPUT, V30, P193, DOI 10.1007/BF02446130; DAMICO M, 1990, MED BIOL ENG COMPUT, V28, P407, DOI 10.1007/BF02441963; Eastough D, 2007, EXP BRAIN RES, V176, P193, DOI 10.1007/s00221-006-0749-3; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Galea MP, 2001, NEUROREPORT, V12, P2185, DOI 10.1097/00001756-200107200-00028; Gibson J.J., 1977, PERCEIVING ACTING KN, P67; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GORDON AM, 1991, EXP BRAIN RES, V85, P226; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1991, EXP BRAIN RES, V83, P483; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Iberall T, 1986, GENERATION MODULATIO; Jackson SR, 2000, J EXP PSYCHOL HUMAN, V26, P418, DOI 10.1037/0096-1523.26.1.418; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johansson RS, 1996, HAND BRAIN NEUROPHYS; KINOSHITA H, 1995, ERGONOMICS, V38, P1212; Lederman SJ, 2003, EXP BRAIN RES, V152, P156, DOI 10.1007/s00221-003-1522-5; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; MARK LS, 1997, J EXPT PSYCHOL HUMAN, V23, P1; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Mon-Williams M, 2000, EXP BRAIN RES, V135, P405, DOI 10.1007/s002210000538; Mon-Williams M, 2011, EXP BRAIN RES, V211, P145, DOI 10.1007/s00221-011-2659-2; NEWELL KM, 1989, DEV PSYCHOBIOL, V22, P1, DOI 10.1002/dev.420220102; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Rumiati RI, 1998, J EXP PSYCHOL HUMAN, V24, P631, DOI 10.1037/0096-1523.24.2.631; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; Santello M, 1998, J NEUROPHYSIOL, V79, P1307, DOI 10.1152/jn.1998.79.3.1307; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Westwood DA, 2000, EXP BRAIN RES, V135, P535, DOI 10.1007/s002210000552; WING AM, 1983, Q J EXP PSYCHOL-A, V35, P297, DOI 10.1080/14640748308402135	47	79	79	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25203	10.1371/journal.pone.0025203	http://dx.doi.org/10.1371/journal.pone.0025203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21980396	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900032
J	Wang, DP; Calla, B; Vimolmangkang, S; Wu, X; Korban, SS; Huber, SC; Clough, SJ; Zhao, YF				Wang, Dongping; Calla, Bernarda; Vimolmangkang, Sornkanok; Wu, Xia; Korban, Schuyler S.; Huber, Steven C.; Clough, Steven J.; Zhao, Youfu			The Orphan Gene ybjN Conveys Pleiotropic Effects on Multicellular Behavior and Survival of Escherichia coli	PLOS ONE			English	Article							ANTIGEN-43-MEDIATED AUTOAGGREGATION; BIOFILM FORMATION; RCS PHOSPHORELAY; PERSISTER CELLS; ACID RESISTANCE; EXPRESSION; TOLERANCE; GENOMES; K-12; OVEREXPRESSION	YbjN, encoding an enterobacteria-specific protein, is a multicopy suppressor of temperature sensitivity in the ts9 mutant strain of Escherichia coli. In this study, we further explored the role(s) of ybjN. First, we demonstrated that the ybjN transcript was about 10-fold lower in the ts9 strain compared to that of E. coli strain BW25113 (BW). Introduction of multiple copies of ybjN in the ts9 strain resulted in over-expression of ybjN by about 10-fold as compared to that of BW. These results suggested that temperature sensitivity of the ts9 mutant of E. coli may be related to expression levels of ybjN. Characterization of E. coli ybjN mutant revealed that ybjN mutation resulted in pleiotropic phenotypes, including increased motility, fimbriation (auto-aggregation), exopolysaccharide production, and biofilm formation. In contrast, over-expression of ybjN (in terms of multiple copies) resulted in reduced motility, fimbriation, exopolysaccharide production, biofilm formation and acid resistance. In addition, our results indicate that a ybjN-homolog gene from Erwinia amylovora, a plant enterobacterial pathogen, is functionally conserved with that of E. coli, suggesting similar evolution of the YbjN family proteins in enterobacteria. A microarray study revealed that the expression level of ybjN was inversely correlated with the expression of flagellar, fimbrial and acid resistance genes. Over-expression of ybjN significantly down-regulated genes involved in citric acid cycle, glycolysis, the glyoxylate shunt, oxidative phosphorylation, amino acid and nucleotide metabolism. Furthermore, over-expression of ybjN up-regulated toxin-antitoxin modules, the SOS response pathway, cold shock and starvation induced transporter genes. Collectively, these results suggest that YbjN may play important roles in regulating bacterial multicellular behavior, metabolism, and survival under stress conditions in E. coli. These results also suggest that ybjN over-expression-related temperature rescue of the ts9 mutant may be due to down-regulation of metabolic activity and activation of stress response genes in the ts9 mutant.	[Wang, Dongping; Calla, Bernarda; Clough, Steven J.; Zhao, Youfu] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Vimolmangkang, Sornkanok; Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Wu, Xia; Huber, Steven C.; Zhao, Youfu] Univ Illinois, Program Physiol & Mol Plant Biol, Urbana, IL 61801 USA; [Huber, Steven C.; Clough, Steven J.] ARS, USDA, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Wang, DP (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	zhao888@illinois.edu	Wu, Xia/J-8690-2014; Wang, Dongping/L-2124-2013	Wu, Xia/0000-0002-0024-4481; 	USDA National Institute of Food and Agriculture [2010-65110-20497]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by the Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65110-20497 from the USDA National Institute of Food and Agriculture (Dr. Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Binnewies Tim T., 2006, Functional & Integrative Genomics, V6, P165, DOI 10.1007/s10142-006-0027-2; Bore E, 2007, MICROBIOL-SGM, V153, P935, DOI 10.1099/mic.0.29288-0; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chen XN, 2006, BIOCHEM BIOPH RES CO, V345, P834, DOI 10.1016/j.bbrc.2006.04.101; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; FLAKS JG, 1966, COLD SPRING HARB SYM, V31, P623, DOI 10.1101/SQB.1966.031.01.081; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Frazier ME, 2003, SCIENCE, V300, P290, DOI 10.1126/science.1084566; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Galperin MY, 2001, COMPAR FUNCT GENOM, V2, P14, DOI 10.1002/cfg.66; Hasman H, 1999, J BACTERIOL, V181, P4834, DOI 10.1128/JB.181.16.4834-4841.1999; Hayashi S, 2003, J BIOSCI BIOENG, V95, P379, DOI 10.1263/jbb.95.379; Itou J, 2009, BIOSCI BIOTECH BIOCH, V73, P870, DOI 10.1271/bbb.80795; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Keeney D, 2008, J ANTIMICROB CHEMOTH, V61, P46, DOI 10.1093/jac/dkm397; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Krin E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-273; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Narra HP, 2008, PROTEOMICS, V8, P4772, DOI 10.1002/pmic.200800061; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Sambrook J., 2001, MOL CLONING LAB MANU; Sayed AK, 2007, MICROBIOL-SGM, V153, P2584, DOI 10.1099/mic.0.2007/007005-0; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Thomas GH, 1999, BIOINFORMATICS, V15, P860, DOI 10.1093/bioinformatics/15.10.860; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang DP, 2011, PHYTOPATHOLOGY, V101, P710, DOI 10.1094/PHYTO-09-10-0258; Wang DP, 2010, PHYTOPATHOLOGY, V100, P192, DOI 10.1094/PHYTO-100-2-0192; Wang DP, 2009, MOL PLANT PATHOL, V10, P277, DOI 10.1111/j.1364-3703.2008.00531.x; Whitworth DE, 2008, TRENDS MICROBIOL, V16, P512, DOI 10.1016/j.tim.2008.08.001; Zhao YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-245	51	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25293	10.1371/journal.pone.0025293	http://dx.doi.org/10.1371/journal.pone.0025293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980417	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700025
J	Chan, LK; Ko, FCF; Sze, KMF; Ng, IOL; Yam, JWP				Chan, Lo-Kong; Ko, Frankie Chi Fat; Sze, Karen Man-Fong; Ng, Irene Oi-Lin; Yam, Judy Wai Ping			Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GTPASE-ACTIVATING PROTEIN; CELL-PROLIFERATION; DOWN-REGULATION; RHOA GTPASE; GENE; EXPRESSION; GROWTH; APOPTOSIS; TUMORIGENICITY	Background: Deleted in liver cancer 1 (DLC1) serves as an important RhoGTPase activating protein (RhoGAP) protein that terminates active RhoA signaling in human cancers. Increasing evidence has demonstrated that the tumor suppressive activity of DLC1 depends not only on RhoGAP activity, but also relies on proper focal adhesion localization through its interaction with tensin family proteins. Recently, there are reports showing that DLC1 can also be found in the nucleus; however, the existence and the relative tumor suppressive activity of nuclear DLC1 have never been clearly addressed. Methodology and Principal Findings: We herein provide new evidence that DLC1 protein, which predominantly associated with focal adhesions and localized in cytosol, dynamically shuttled between cytoplasm and nucleus. Treatment of cells with nuclear export blocker, Leptomycin B (LMB), retained DLC1 in the nucleus. To understand the nuclear entry of DLC1, we identified amino acids 600-700 of DLC1 as a novel region that is important for its nuclear localization. The tumor suppressive activity of nuclear DLC1 was directly assessed by employing a nuclear localization signal (NLS) fusion variant of DLC1 (NLS-DLC1) with preferential nuclear localization. In SMMC-7721 HCC cells, expression of NLS-DLC1 failed to suppress colony formation and actin stress fiber formation in vitro. The abrogated tumor suppressive activity of nuclear DLC1 was demonstrated for the first time in vivo by subcutaneously injecting p53(-/-) RasV12 hepatoblasts with stable NLS-DLC1 expression in nude mice. The injected hepatoblasts with NLS-DLC1 expression effectively formed tumors when compared with the non-nuclear targeted DLC1. Conclusions/Significance: Our study identified a novel region responsible for the nuclear entry of DLC1 and demonstrated the functional difference of DLC1 in different cellular compartments both in vitro and in vivo.	[Chan, Lo-Kong; Ko, Frankie Chi Fat; Sze, Karen Man-Fong; Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Lo-Kong; Ko, Frankie Chi Fat; Sze, Karen Man-Fong; Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Chan, Lo-Kong; Ko, Frankie Chi Fat; Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, LK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	iolng@hku.hk; judyyam@pathology.hku.hk	Ko, Frankie Chi Fat/AAZ-8112-2021; Ko, Frankie Chi Fat/C-4759-2009; Kong, Chan Lo/AAI-9300-2020; Yam, Judy Wai Ping/C-4454-2009	Ko, Frankie Chi Fat/0000-0002-0393-9668; Ko, Frankie Chi Fat/0000-0002-0393-9668; Kong, Chan Lo/0000-0003-3082-1013; Yam, Judy Wai Ping/0000-0002-5637-121X; Ng, Irene Oi-lin/0000-0001-7532-2029	Hong Kong Research Grants Council [HKU7798/07M, HKU 1/06C, HKU 7/CRG/09]; Outstanding Young Researcher Award	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Outstanding Young Researcher Award	This work was supported by the Hong Kong Research Grants Council (HKU7798/07M), Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09) and Outstanding Young Researcher Award (to J.W.P. Yam). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; Dubash AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017380; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Feng MH, 2011, MOL BIOL REP, V38, P1915, DOI 10.1007/s11033-010-0311-z; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Hers I, 2006, J BIOL CHEM, V281, P4762, DOI 10.1074/jbc.M511008200; Jang BC, 2004, BIOCHEM PHARMACOL, V68, P263, DOI 10.1016/j.bcp.2004.03.007; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kawai K, 2009, GENES CELLS, V14, P227, DOI 10.1111/j.1365-2443.2008.01265.x; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Kim TY, 2003, ONCOGENE, V22, P3943, DOI 10.1038/sj.onc.1206573; Ko FCF, 2010, GASTROENTEROLOGY, V139, P1397, DOI 10.1053/j.gastro.2010.06.051; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Ng IOL, 2000, CANCER RES, V60, P6581; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; Yuan BZ, 2007, EXP CELL RES, V313, P3868, DOI 10.1016/j.yexcr.2007.08.009; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhou X, 2008, INT J ONCOL, V32, P1285; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25547	10.1371/journal.pone.0025547	http://dx.doi.org/10.1371/journal.pone.0025547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966542	Green Published, gold, Green Submitted			2022-12-27	WOS:000295932100050
J	Favia, AD; Masetti, M; Recanatini, M; Cavalli, A				Favia, Angelo D.; Masetti, Matteo; Recanatini, Maurizio; Cavalli, Andrea			Substrate Binding Process and Mechanistic Functioning of Type 1 11 beta-Hydroxysteroid Dehydrogenase from Enhanced Sampling Methods	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; MOLECULAR-DYNAMICS; COENZYME SPECIFICITY; CRYSTAL-STRUCTURE; FREE-ENERGIES; FORCE-FIELD; INHIBITORS; ENZYMES; COMPLEX; DISCOVERY	In humans, type 1 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD-1) plays a key role in the regulation of the glucocorticoids balance by converting the inactive hormone cortisone into cortisol. Numerous functional aspects of 11 beta-HSD-1 have been understood thanks to the availability at the Worldwide Protein Data Bank of a number of X-ray structures of the enzyme either alone or in complex with inhibitors, and to several experimental data. However at present, a complete description of the dynamic behaviour of 11 beta-HSD-1 upon substrate binding is missing. To this aim we firstly docked cortisone into the catalytic site of 11 beta-HSD-1 (both wild type and Y177A mutant), and then we used steered molecular dynamics and metadynamics to simulate its undocking. This methodology helped shedding light at molecular level on the complex relationship between the enzyme and its natural substrate. In particular, the work highlights a) the reason behind the functional dimerisation of 11 beta-HSD-1, b) the key role of Y177 in the cortisone binding event, c) the fine tuning of the active site degree of solvation, and d) the role of the S228-P237 loop in ligand recognition.	[Favia, Angelo D.; Cavalli, Andrea] Ist Italiano Tecnol, Drug Discovery & Dev Dept, Genoa, Italy; [Masetti, Matteo; Recanatini, Maurizio; Cavalli, Andrea] Univ Bologna, Dipartimento Sci Farmaceut, I-40126 Bologna, Italy	Istituto Italiano di Tecnologia - IIT; University of Bologna	Favia, AD (corresponding author), Ist Italiano Tecnol, Drug Discovery & Dev Dept, Genoa, Italy.	angelo.favia@iit.it	Recanatini, Maurizio/AAU-3319-2021; Recanatini, Maurizio/GXH-1338-2022	Recanatini, Maurizio/0000-0002-0039-0518; Masetti, Matteo/0000-0002-3757-7802; CAVALLI, ANDREA/0000-0002-6370-1176	European Community [228398]	European Community(European Commission)	This work was partly carried out under the HPC-EUROPA2 project (project number 228398), with the support of the European Community - Research Infrastructure Action of the FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mezei M, 1986, Ann N Y Acad Sci, V482, P1, DOI 10.1111/j.1749-6632.1986.tb20933.x; [Anonymous], MAESTR VERS 8 5; [Anonymous], GLID VERS 5 0; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; Cieplak P, 2001, J COMPUT CHEM, V22, P1048, DOI 10.1002/jcc.1065; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Daggett V, 2000, CURR OPIN STRUC BIOL, V10, P160, DOI 10.1016/S0959-440X(00)00062-2; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; Favia A.D., COMPUTATION IN PRESS; Favia AD, 2008, J MOL BIOL, V375, P855, DOI 10.1016/j.jmb.2007.10.065; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fowler PW, 2007, BIOCHEMISTRY-US, V46, P3108, DOI 10.1021/bi602455n; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Frisch M.J., 2016, GAUSSIAN16 REV B01; Gervasio FL, 2005, J AM CHEM SOC, V127, P2600, DOI 10.1021/ja0445950; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hosfield DJ, 2005, J BIOL CHEM, V280, P4639, DOI 10.1074/jbc.M411104200; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iannuzzi M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238302; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Julian LD, 2008, J MED CHEM, V51, P3953, DOI 10.1021/jm800310g; Kaminski GA, 2002, J COMPUT CHEM, V23, P1515, DOI 10.1002/jcc.10125; KEARSLEY SK, 1989, ACTA CRYSTALLOGR A, V45, P208, DOI 10.1107/S0108767388010128; Kim KW, 2007, FEBS LETT, V581, P995, DOI 10.1016/j.febslet.2007.01.075; Kim KW, 2006, BBA-PROTEINS PROTEOM, V1764, P824, DOI 10.1016/j.bbapap.2006.02.008; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Limongelli V, 2010, P NATL ACAD SCI USA, V107, P5411, DOI 10.1073/pnas.0913377107; Maser E, 2002, BIOCHEMISTRY-US, V41, P2459, DOI 10.1021/bi015803t; Masetti M, 2009, J PHYS CHEM B, V113, P4807, DOI 10.1021/jp803936q; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Ogg D, 2005, J BIOL CHEM, V280, P3789, DOI 10.1074/jbc.M412463200; Oppermann UCT, 2001, CHEM-BIOL INTERACT, V130, P699, DOI 10.1016/S0009-2797(00)00301-X; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Procacci P, 1997, J COMPUT CHEM, V18, P1848, DOI 10.1002/(SICI)1096-987X(19971130)18:15<1848::AID-JCC2>3.0.CO;2-O; Provasi D, 2009, BIOCHEMISTRY-US, V48, P10020, DOI 10.1021/bi901494n; Ren PY, 2002, J COMPUT CHEM, V23, P1497, DOI 10.1002/jcc.10127; Rew Y, 2009, BIOORG MED CHEM LETT, V19, P1797, DOI 10.1016/j.bmcl.2009.01.058; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tu H, 2008, BIOORGAN MED CHEM, V16, P8922, DOI 10.1016/j.bmc.2008.08.065; Walker EA, 2001, J BIOL CHEM, V276, P21343, DOI 10.1074/jbc.M011142200; Wan ZK, 2009, J MED CHEM, V52, P5449, DOI 10.1021/jm900639u; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xie WS, 2007, J CHEM THEORY COMPUT, V3, P1878, DOI 10.1021/ct700146x	61	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25375	10.1371/journal.pone.0025375	http://dx.doi.org/10.1371/journal.pone.0025375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966510	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100049
J	Ibrahim, MM; Fjaere, E; Lock, EJ; Naville, D; Amlund, H; Meugnier, E; Battistoni, BL; Froyland, L; Madsen, L; Jessen, N; Lund, S; Vidal, H; Ruzzin, J				Ibrahim, Mohammad Madani; Fjaere, Even; Lock, Erik-Jan; Naville, Danielle; Amlund, Heidi; Meugnier, Emmanuelle; Battistoni, Brigitte Le Magueresse; Froyland, Livar; Madsen, Lise; Jessen, Niels; Lund, Sten; Vidal, Hubert; Ruzzin, Jerome			Chronic Consumption of Farmed Salmon Containing Persistent Organic Pollutants Causes Insulin Resistance and Obesity in Mice	PLOS ONE			English	Article							FISH-OIL SUPPLEMENTATION; POLYUNSATURATED FATTY-ACIDS; DIETARY COD PROTEIN; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; BLOOD-PRESSURE; SERUM-LIPIDS; RISK; OMEGA-3-FATTY-ACIDS; SENSITIVITY	Background: Dietary interventions are critical in the prevention of metabolic diseases. Yet, the effects of fatty fish consumption on type 2 diabetes remain unclear. The aim of this study was to investigate whether a diet containing farmed salmon prevents or contributes to insulin resistance in mice. Methodology/Principal Findings: Adult male C57BL/6J mice were fed control diet (C), a very high-fat diet without or with farmed Atlantic salmon fillet (VHF and VHF/S, respectively), and Western diet without or with farmed Atlantic salmon fillet (WD and WD/S, respectively). Other mice were fed VHF containing farmed salmon fillet with reduced concentrations of persistent organic pollutants (VHF/S-POPs). We assessed body weight gain, fat mass, insulin sensitivity, glucose tolerance, ex vivo muscle glucose uptake, performed histology and immunohistochemistry analysis, and investigated gene and protein expression. In comparison with animals fed VHF and WD, consumption of both VHF/S and WD/S exaggerated insulin resistance, visceral obesity, and glucose intolerance. In addition, the ability of insulin to stimulate Akt phosphorylation and muscle glucose uptake was impaired in mice fed farmed salmon. Relative to VHF/S-fed mice, animals fed VHF/S-POPs had less body burdens of POPs, accumulated less visceral fat, and had reduced mRNA levels of TNF alpha as well as macrophage infiltration in adipose tissue. VHF/S-POPs-fed mice further exhibited better insulin sensitivity and glucose tolerance than mice fed VHF/S. Conclusions/Significance: Our data indicate that intake of farmed salmon fillet contributes to several metabolic disorders linked to type 2 diabetes and obesity, and suggest a role of POPs in these deleterious effects. Overall, these findings may participate to improve nutritional strategies for the prevention and therapy of insulin resistance.	[Ibrahim, Mohammad Madani; Fjaere, Even; Lock, Erik-Jan; Amlund, Heidi; Froyland, Livar; Madsen, Lise; Ruzzin, Jerome] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Ibrahim, Mohammad Madani] Univ Bergen, Inst Biomed, Bergen, Norway; [Fjaere, Even; Madsen, Lise] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Naville, Danielle; Meugnier, Emmanuelle; Battistoni, Brigitte Le Magueresse; Vidal, Hubert] Univ Lyon 1, INSERM, INRA, CarMeN Lab,U 1060,U 1235, Oullins, France; [Jessen, Niels] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark; [Lund, Sten] Aarhus Univ Hosp, Dept Internal Med & Diabet, DK-8000 Aarhus, Denmark; [Lund, Sten] Aarhus Univ Hosp, Inst Expt Clin Res, DK-8000 Aarhus, Denmark; [Ruzzin, Jerome] Univ Bergen, Dept Biol, Bergen, Norway	University of Bergen; University of Copenhagen; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Aarhus University; Aarhus University; Aarhus University; University of Bergen	Ibrahim, MM (corresponding author), Natl Inst Nutr & Seafood Res, Bergen, Norway.	jerome.ruzzin@bio.uib.no	Madsen, Lise/C-6246-2012; Ruzzin, Jérôme/U-1688-2017; Le Magueresse-Battistoni, Brigitte/AAZ-5601-2021; Lock, Erik-Jan/AAM-9766-2020; Ruzzin, Jerome/AAA-5826-2020; Naville, Danielle/N-1200-2017; Lock, Erik-Jan/B-7523-2012; Jessen, Niels/E-1731-2011; Vidal, Hubert/M-6674-2017; Le Magueresse-Battistoni, Brigitte/M-6927-2017; Lock, Erik-Jan/F-3115-2012	Madsen, Lise/0000-0003-4468-1947; Ruzzin, Jérôme/0000-0003-3676-8145; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Naville, Danielle/0000-0003-2615-6161; Vidal, Hubert/0000-0002-9467-0317; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Lock, Erik-Jan/0000-0002-8157-5249; Jessen, Niels/0000-0001-5613-7274; Amlund, Heidi/0000-0002-2471-3676; Lund, Sten/0000-0002-3805-6267; meugnier, emmanuelle/0000-0002-2291-7691	Research Council of Norway [184783, 204473, 185567]; Danish Council for Strategic Research [2101-08-0053]	Research Council of Norway(Research Council of Norway); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by grants from the Research Council of Norway (no. 184783 and 204473 to J.R. and 185567 for M.M.I.). E.F. and L.M. were supported by a grant from the Danish Council for Strategic Research (no. 2101-08-0053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Berntssen MHG, 2010, CHEMOSPHERE, V81, P242, DOI 10.1016/j.chemosphere.2010.06.031; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BORKMAN M, 1989, DIABETES, V38, P1314, DOI 10.2337/diabetes.38.10.1314; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; ERITSLAND J, 1994, SCAND J CLIN LAB INV, V54, P273, DOI 10.3109/00365519409087522; FASCHING P, 1991, DIABETES, V40, P583, DOI 10.2337/diabetes.40.5.583; FESKENS EJM, 1995, DIABETES CARE, V18, P1104, DOI 10.2337/diacare.18.8.1104; Fisher BE, 1999, ENVIRON HEALTH PERSP, V107, pA18, DOI 10.2307/3434279; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Giacco R, 2007, NUTR METAB CARDIOVAS, V17, P572, DOI 10.1016/j.numecd.2006.06.006; GLAUBER H, 1988, ANN INTERN MED, V108, P663, DOI 10.7326/0003-4819-108-5-663; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; HENDRA TJ, 1990, DIABETES CARE, V13, P821, DOI 10.2337/diacare.13.8.821; Hites RA, 2004, SCIENCE, V303, P226, DOI 10.1126/science.1091447; Jessen N, 2008, HORM METAB RES, V40, P269, DOI 10.1055/s-2007-1022546; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Laaksonen DE, 2002, DIABETIC MED, V19, P456, DOI 10.1046/j.1464-5491.2002.00707.x; Lavigne C, 2001, AM J PHYSIOL-ENDOC M, V281, pE62, DOI 10.1152/ajpendo.2001.281.1.E62; Lee DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022360; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480; Li QQ, 2006, J TOXICOL ENV HEAL A, V69, P1927, DOI 10.1080/15287390600751306; LIM S, 2009, PLOS ONE, V4; Lordo RA, 1996, AM J PUBLIC HEALTH, V86, P1253, DOI 10.2105/AJPH.86.9.1253; Mann JI, 2002, LANCET, V360, P783, DOI 10.1016/S0140-6736(02)09901-4; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Mostad IL, 2006, AM J CLIN NUTR, V84, P540, DOI 10.1093/ajcn/84.3.540; OECD/EU, 2010, HLTH GLANC EUR 2010; Ouellet V, 2007, DIABETES CARE, V30, P2816, DOI 10.2337/dc07-0273; Pilon G, 2011, METABOLISM, V60, P1122, DOI 10.1016/j.metabol.2010.12.005; Ruzzin J, 2007, ANN NUTR METAB, V51, P347; Ruzzin J, 2005, DIABETOLOGIA, V48, P2119, DOI 10.1007/s00125-005-1886-0; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; TOFT I, 1995, ANN INTERN MED, V123, P911, DOI 10.7326/0003-4819-123-12-199512150-00003; Torstensen BE, 2008, AQUACULTURE, V285, P193, DOI 10.1016/j.aquaculture.2008.08.025; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; van Woudenbergh GJ, 2009, DIABETES CARE, V32, P2021, DOI 10.2337/dc09-1042; VESSBY B, 1992, DIABETIC MED, V9, P126, DOI 10.1111/j.1464-5491.1992.tb01748.x; *WHO, 2005, CHRON DIS VIT INV; Woodman RJ, 2002, AM J CLIN NUTR, V76, P1007, DOI 10.1093/ajcn/76.5.1007	50	115	119	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25170	10.1371/journal.pone.0025170	http://dx.doi.org/10.1371/journal.pone.0025170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966444	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000295267100022
J	Schlafer, S; Raarup, MK; Meyer, RL; Sutherland, DS; Dige, I; Nyengaard, JR; Nyvad, B				Schlafer, Sebastian; Raarup, Merete K.; Meyer, Rikke L.; Sutherland, Duncan S.; Dige, Irene; Nyengaard, Jens R.; Nyvad, Bente			pH Landscapes in a Novel Five-Species Model of Early Dental Biofilm	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; ACTINOMYCES-NAESLUNDII; ORAL STREPTOCOCCI; ARTIFICIAL MOUTH; ROOT SURFACES; MOLECULAR ANALYSIS; TOOTH SURFACES; CARIES; PLAQUE; ENAMEL	Background: Despite continued preventive efforts, dental caries remains the most common disease of man. Organic acids produced by microorganisms in dental plaque play a crucial role for the development of carious lesions. During early stages of the pathogenetic process, repeated pH drops induce changes in microbial composition and favour the establishment of an increasingly acidogenic and aciduric microflora. The complex structure of dental biofilms, allowing for a multitude of different ecological environments in close proximity, remains largely unexplored. In this study, we designed a laboratory biofilm model that mimics the bacterial community present during early acidogenic stages of the caries process. We then performed a time-resolved microscopic analysis of the extracellular pH landscape at the interface between bacterial biofilm and underlying substrate. Methodology/Principal Findings: Strains of Streptococcus oralis, Streptococcus sanguinis, Streptococcus mitis, Streptococcus downei and Actinomyces naeslundii were employed in the model. Biofilms were grown in flow channels that allowed for direct microscopic analysis of the biofilms in situ. The architecture and composition of the biofilms were analysed using fluorescence in situ hybridization and confocal laser scanning microscopy. Both biofilm structure and composition were highly reproducible and showed similarity to in-vivo-grown dental plaque. We employed the pH-sensitive ratiometric probe C-SNARF-4 to perform real-time microscopic analyses of the biofilm pH in response to salivary solutions containing glucose. Anaerobic glycolysis in the model biofilms created a mildly acidic environment. Decrease in pH in different areas of the biofilms varied, and distinct extracellular pH-microenvironments were conserved over several hours. Conclusions/Significance: The designed biofilm model represents a promising tool to determine the effect of potential therapeutic agents on biofilm growth, composition and extracellular pH. Ratiometric pH analysis using C-SNARF-4 gives detailed insight into the pH landscape of living biofilms and contributes to our general understanding of metabolic processes in in-vivo-grown bacterial biofilms.	[Schlafer, Sebastian; Meyer, Rikke L.; Sutherland, Duncan S.] Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, Fac Sci, Aarhus, Denmark; [Schlafer, Sebastian; Dige, Irene; Nyvad, Bente] Aarhus Univ, Dept Dent Pathol Operat Dent & Endodont, Sch Dent, Fac Hlth Sci, Aarhus, Denmark; [Raarup, Merete K.; Nyengaard, Jens R.] Aarhus Univ, Stereol & Elect Microscopy Res Lab, Ctr Stochast Geometry & Adv Bioimaging, Aarhus, Denmark; [Meyer, Rikke L.] Aarhus Univ, Dept Biol Sci, Fac Sci, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Schlafer, S (corresponding author), Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, Fac Sci, Aarhus, Denmark.	sebastian.schlafer@hotmail.de	Meyer, Rikke Louise/AAB-5377-2021; Sutherland, Duncan S/E-4385-2010; Schlafer, Sebastian/I-8788-2018	Meyer, Rikke Louise/0000-0002-6485-5134; Sutherland, Duncan S/0000-0002-5045-9915; Dige, Irene/0000-0003-0095-179X; Schlafer, Sebastian/0000-0003-2463-1926; Nyvad, Bente/0000-0002-9545-0447	Danish National Advanced Technology Foundation; Villum Foundation; Villum Fonden [00008721] Funding Source: researchfish	Danish National Advanced Technology Foundation; Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	This work was funded by the Danish National Advanced Technology Foundation through the ProSURF platform project (Protein-Based Functionalisation of Surfaces). The Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AamdalScheie A, 1996, J DENT RES, V75, P1901, DOI 10.1177/00220345960750111301; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Babaahmady KG, 1997, ARCH ORAL BIOL, V42, P101, DOI 10.1016/S0003-9969(96)00116-1; BOUE D, 1987, J DENT RES, V66, P23, DOI 10.1177/00220345870660010501; BOYAR RM, 1989, J DENT RES, V68, P1734, DOI 10.1177/00220345890680120301; BRADSHAW DJ, 1989, J DENT RES, V68, P1298, DOI 10.1177/00220345890680090101; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; BROWN LR, 1976, MICROBIAL ASPECTS DE, P275; CHESTNUTT IG, 1994, ARCH ORAL BIOL, V39, P589, DOI 10.1016/0003-9969(94)90134-1; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; DAWES C, 1989, J DENT RES, V68, P1479, DOI 10.1177/00220345890680110201; Dawes Colin, 2003, J Can Dent Assoc, V69, P722; de los Rios A, 2003, ENVIRON MICROBIOL, V5, P231; de Soet JJ, 2000, CARIES RES, V34, P486, DOI 10.1159/000016628; DEJONG MH, 1984, APPL ENVIRON MICROB, V47, P901, DOI 10.1128/AEM.47.5.901-904.1984; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hunter RC, 2005, APPL ENVIRON MICROB, V71, P2501, DOI 10.1128/AEM.71.5.2501-2510.2005; Kara D, 2006, EUR J ORAL SCI, V114, P58, DOI 10.1111/j.1600-0722.2006.00262.x; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Lima JPM, 2009, EUR J ORAL SCI, V117, P568, DOI 10.1111/j.1600-0722.2009.00662.x; LISTGARTEN MA, 1975, J PERIODONTOL, V46, P10, DOI 10.1902/jop.1975.46.1.10; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Lynch RJM, 2006, CARIES RES, V40, P142, DOI 10.1159/000091061; MACPHERSON LMD, 1991, CARIES RES, V25, P58, DOI 10.1159/000261343; Magitot E, 1878, TREATISE DENT CARIES; MARSH PD, 1989, J DENT RES, V68, P1151, DOI 10.1177/00220345890680070301; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Periasamy S, 2009, INFECT IMMUN, V77, P3542, DOI 10.1128/IAI.00345-09; PERRONS CJ, 1990, J DENT RES, V69, P483, DOI 10.1177/00220345900690021301; PIGMAN W, 1952, J DENT RES, V31, P627, DOI 10.1177/00220345520310050501; Ramberg P, 2003, J CLIN PERIODONTOL, V30, P990, DOI 10.1034/j.1600-051X.2003.00419.x; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; RUSSELL C, 1975, APPL MICROBIOL, V29, P141, DOI 10.1128/AEM.29.2.141-144.1975; SANSONE C, 1993, J DENT RES, V72, P508, DOI 10.1177/00220345930720020701; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; SEKSEK O, 1991, ANAL BIOCHEM, V193, P49, DOI 10.1016/0003-2697(91)90042-R; Shapiro S, 2002, CARIES RES, V36, P93, DOI 10.1159/000057866; Shen S, 2004, J DENT, V32, P667, DOI 10.1016/j.jdent.2004.07.002; Shu M, 2000, ARCH ORAL BIOL, V45, P27, DOI 10.1016/S0003-9969(99)00111-9; Sissons C H, 1997, Adv Dent Res, V11, P110; SISSONS CH, 1992, ARCH ORAL BIOL, V37, P913, DOI 10.1016/0003-9969(92)90062-D; Steinberg D, 2001, J ANTIMICROB CHEMOTH, V48, P241, DOI 10.1093/jac/48.2.241; Svensater G, 2003, CARIES RES, V37, P395, DOI 10.1159/000073390; Takahashi N, 1996, ORAL MICROBIOL IMMUN, V11, P193, DOI 10.1111/j.1399-302X.1996.tb00357.x; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Tang G, 2003, J DENT, V31, P161, DOI 10.1016/S0300-5712(03)00009-5; THEILADE E, 1982, J PERIODONTAL RES, V17, P12, DOI 10.1111/j.1600-0765.1982.tb01127.x; van Ruyven FOJ, 2000, J DENT RES, V79, P778, DOI 10.1177/00220345000790021201; Vecer J, 2001, PHOTOCHEM PHOTOBIOL, V74, P8, DOI 10.1562/0031-8655(2001)074<0008:FBOTPS>2.0.CO;2; von Ohle C, 2010, APPL ENVIRON MICROB, V76, P2326, DOI 10.1128/AEM.02090-09; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205	59	39	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25299	10.1371/journal.pone.0025299	http://dx.doi.org/10.1371/journal.pone.0025299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966490	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100042
J	Buntgen, U; Raible, CC; Frank, D; Helama, S; Cunningham, L; Hofer, D; Nievergelt, D; Verstege, A; Timonen, M; Stenseth, NC; Esper, J				Buentgen, Ulf; Raible, Christoph C.; Frank, David; Helama, Samuli; Cunningham, Laura; Hofer, Dominik; Nievergelt, Daniel; Verstege, Anne; Timonen, Mauri; Stenseth, Nils Chr.; Esper, Jan			Causes and Consequences of Past and Projected Scandinavian Summer Temperatures, 500-2100 AD	PLOS ONE			English	Article							TREE-RING WIDTH; NORTH-ATLANTIC; CLIMATE-CHANGE; DENSITY DATA; VARIABILITY; RECONSTRUCTION; OSCILLATION; CIRCULATION; SENSITIVITY; SIMULATIONS	Tree rings dominate millennium-long temperature reconstructions and many records originate from Scandinavia, an area for which the relative roles of external forcing and internal variation on climatic changes are, however, not yet fully understood. Here we compile 1,179 series of maximum latewood density measurements from 25 conifer sites in northern Scandinavia, establish a suite of 36 subset chronologies, and analyse their climate signal. A new reconstruction for the 1483-2006 period correlates at 0.80 with June-August temperatures back to 1860. Summer cooling during the early 17th century and peak warming in the 1930s translate into a decadal amplitude of 2.9 degrees C, which agrees with existing Scandinavian tree-ring proxies. Climate model simulations reveal similar amounts of mid to low frequency variability, suggesting that internal ocean-atmosphere feedbacks likely influenced Scandinavian temperatures more than external forcing. Projected 21st century warming under the SRES A2 scenario would, however, exceed the reconstructed temperature envelope of the past 1,500 years.	[Buentgen, Ulf; Frank, David; Nievergelt, Daniel; Verstege, Anne] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Buentgen, Ulf; Raible, Christoph C.; Frank, David; Hofer, Dominik] Oeschger Ctr Climate Change Res, Bern, Switzerland; [Raible, Christoph C.; Hofer, Dominik] Univ Bern, Inst Phys, Bern, Switzerland; [Helama, Samuli] Univ Lapland, Arctic Ctr, Rovaniemi, Finland; [Cunningham, Laura] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Timonen, Mauri] Finnish Forest Res Inst, Rovaniemi, Finland; [Stenseth, Nils Chr.] Univ Oslo, Ctr Ecol & Evolutionary Synth CEES, Blindern, Norway; [Esper, Jan] Johannes Gutenberg Univ Mainz, Dept Geog, Mainz, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; University of Bern; University of Lapland; University of St Andrews; Natural Resources Institute Finland (Luke); University of Oslo; Johannes Gutenberg University of Mainz	Buntgen, U (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	buentgen@wsl.ch	Raible, Christoph/M-8309-2016; Nievergelt, Daniel/J-7156-2012; buentgen, ulf/J-6952-2013; Stenseth, Nils Chr./G-5212-2016; Frank, David/C-7764-2013; Esper, Jan/O-3127-2018	Raible, Christoph/0000-0003-0176-0602; Nievergelt, Daniel/0000-0003-0402-9348; Stenseth, Nils Chr./0000-0002-1591-5399; Esper, Jan/0000-0003-3919-014X; Frank, David/0000-0001-5463-5640; Cunningham, Laura Kay/0000-0001-6591-4610	Swiss Federal Research Institute WSL	Swiss Federal Research Institute WSL	Funding was provided by the Swiss Federal Research Institute WSL (www.wsl.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battipaglia G, 2010, GLOBAL PLANET CHANGE, V72, P182, DOI 10.1016/j.gloplacha.2010.02.004; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Buntgen U, 2008, GLOBAL CHANGE BIOL, V14, P2443, DOI 10.1111/j.1365-2486.2008.01640.x; Buntgen U, 2010, TREES-STRUCT FUNCT, V24, P261, DOI 10.1007/s00468-009-0396-y; Buntgen U, 2006, J CLIMATE, V19, P5606, DOI 10.1175/JCLI3917.1; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; D'Arrigo R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006352; D'Arrigo RD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017250; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Eschbach W., 1995, Dendrochronologia, V13, P155; Esper J, 2005, QUATERNARY SCI REV, V24, P2164, DOI 10.1016/j.quascirev.2005.07.001; Esper J, 2003, TREE-RING RES, V59, P81; Esper J, 2010, GLOBAL CHANGE BIOL, V16, P386, DOI 10.1111/j.1365-2486.2009.01913.x; Fischer EM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027992; Frank D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030571; Frank D, 2010, WIRES CLIM CHANGE, V1, P507, DOI 10.1002/wcc.53; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; Helama S, 2007, MAR ENVIRON RES, V63, P185, DOI 10.1016/j.marenvres.2006.08.003; Helama S, 2011, J ARCHAEOL SCI, V38, P452, DOI 10.1016/j.jas.2010.09.029; Helama S, 2009, J QUATERNARY SCI, V24, P450, DOI 10.1002/jqs.1291; Hofer D, 2011, CLIM PAST, V7, P133, DOI 10.5194/cp-7-133-2011; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Jones PD, 1997, J CLIMATE, V10, P2548, DOI 10.1175/1520-0442(1997)010<2548:ESEILS>2.0.CO;2; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Klingbjer P, 2003, INT J CLIMATOL, V23, P1465, DOI 10.1002/joc.946; Kristensen DK, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000960; Luterbacher J, 2002, CLIM DYNAM, V18, P545, DOI 10.1007/s00382-001-0196-6; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Raible CC, 2005, J CLIMATE, V18, P3968, DOI 10.1175/JCLI3511.1; Raible CC, 2001, CLIM DYNAM, V18, P321, DOI 10.1007/s003820100176; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schone BR, 2003, GEOLOGY, V31, P1037, DOI 10.1130/G20013.1; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Yoshimori M, 2005, J CLIMATE, V18, P4253, DOI 10.1175/JCLI3537.1; Yoshimori M, 2010, CLIM DYNAM, V34, P101, DOI 10.1007/s00382-009-0540-9; Zorita E, 2010, CLIMATIC CHANGE, V101, P143, DOI 10.1007/s10584-010-9824-7	47	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25133	10.1371/journal.pone.0025133	http://dx.doi.org/10.1371/journal.pone.0025133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966436	Green Published, gold, Green Submitted			2022-12-27	WOS:000295265100064
J	Quille, ML; Carat, S; Quemener-Redon, S; Hirchaud, E; Baron, D; Benech, C; Guihot, J; Placet, M; Mignen, O; Ferec, C; Houlgatte, R; Friocourt, G				Quille, Marie-Lise; Carat, Solenne; Quemener-Redon, Sylvia; Hirchaud, Edouard; Baron, Daniel; Benech, Caroline; Guihot, Jeanne; Placet, Morgane; Mignen, Olivier; Ferec, Claude; Houlgatte, Remi; Friocourt, Gaelle			High-Throughput Analysis of Promoter Occupancy Reveals New Targets for Arx, a Gene Mutated in Mental Retardation and Interneuronopathies	PLOS ONE			English	Article							HOMEOBOX GENE; INTELLECTUAL DISABILITY; POLYALANINE EXPANSION; NEURONAL MIGRATION; ABNORMAL GENITALIA; INFANTILE SPASMS; EXPRESSION; TELENCEPHALON; FOREBRAIN; MUTATIONS	Genetic investigations of X-linked intellectual disabilities have implicated the ARX (Aristaless-related homeobox) gene in a wide spectrum of disorders extending from phenotypes characterised by severe neuronal migration defects such as lissencephaly, to mild or moderate forms of mental retardation without apparent brain abnormalities but with associated features of dystonia and epilepsy. Analysis of Arx spatio-temporal localisation profile in mouse revealed expression in telencephalic structures, mainly restricted to populations of GABAergic neurons at all stages of development. Furthermore, studies of the effects of ARX loss of function in humans and animal models revealed varying defects, suggesting multiple roles of this gene during brain development. However, to date, little is known about how ARX functions as a transcription factor and the nature of its targets. To better understand its role, we combined chromatin immunoprecipitation and mRNA expression with microarray analysis and identified a total of 1006 gene promoters bound by Arx in transfected neuroblastoma (N2a) cells and in mouse embryonic brain. Approximately 24% of Arx-bound genes were found to show expression changes following Arx overexpression or knock-down. Several of the Arx target genes we identified are known to be important for a variety of functions in brain development and some of them suggest new functions for Arx. Overall, these results identified multiple new candidate targets for Arx and should help to better understand the pathophysiological mechanisms of intellectual disability and epilepsy associated with ARX mutations.	[Quille, Marie-Lise; Quemener-Redon, Sylvia; Benech, Caroline; Guihot, Jeanne; Placet, Morgane; Mignen, Olivier; Ferec, Claude; Friocourt, Gaelle] INSERM, U613, Brest, France; [Quille, Marie-Lise; Quemener-Redon, Sylvia; Benech, Caroline; Guihot, Jeanne; Placet, Morgane; Mignen, Olivier; Ferec, Claude; Friocourt, Gaelle] Brest Univ, Fac Med & Sci Sante, Brest, France; [Quille, Marie-Lise; Quemener-Redon, Sylvia; Benech, Caroline; Guihot, Jeanne; Placet, Morgane; Mignen, Olivier; Ferec, Claude; Friocourt, Gaelle] Brest Univ Hosp, Lab Mol Genet & Histocompatibil, Brest, France; [Carat, Solenne; Hirchaud, Edouard; Baron, Daniel; Houlgatte, Remi] Univ Nantes, INSERM, Inst Thorax, U915, Nantes, France; [Benech, Caroline; Ferec, Claude] Etab Francais Sang EFS Bretagne, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Quille, ML (corresponding author), INSERM, U613, Brest, France.	gaelle.friocourt@univ-brest.fr	Dumont, Solenne/L-3023-2015; MIGNEN, Olivier/M-3258-2019; Ferec, Claude/ABG-9699-2020; Houlgatte, Remi/P-3020-2017; Friocourt-Masse, Gaelle/M-8916-2017	Dumont, Solenne/0000-0003-3237-7382; MIGNEN, Olivier/0000-0001-7913-6119; Ferec, Claude/0000-0002-2325-0710; Friocourt, Gaelle/0000-0001-6681-7644; REDON, Sylvia/0000-0001-7310-1142	la Fondation Jerome Lejeune; le Fonds Europeen de Developpement Regional; INSERM; le Ministere de la Recherche; Association Gaetan Saleun	la Fondation Jerome Lejeune; le Fonds Europeen de Developpement Regional; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); le Ministere de la Recherche(Ministry of Research, France); Association Gaetan Saleun	This work was supported by la Fondation Jerome Lejeune (http://www.fondationlejeune.org/), le Fonds Europeen de Developpement Regional (http://www.feder.public.lu/) and INSERM (http://www.inserm.fr/). MLQ was supported by le Ministere de la Recherche (http://www.enseignementsup-recherche.gouv.fr/) and the Association Gaetan Saleun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baron D, 2007, IRBM, V28, P210; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Baron D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-113; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Biressi S, 2008, CELL DEATH DIFFER, V15, P94, DOI 10.1038/sj.cdd.4402230; Carat Solenne, 2010, Journal of Bioinformatics and Computational Biology, V8, P485, DOI 10.1142/S0219720010004689; Colasante G, 2009, DEV BIOL, V334, P59, DOI 10.1016/j.ydbio.2009.07.014; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Colombo E, 2004, DEV DYNAM, V231, P631, DOI 10.1002/dvdy.20164; Colombo E, 2007, J NEUROSCI, V27, P4786, DOI 10.1523/JNEUROSCI.0417-07.2007; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friocourt G, 2006, EUR J NEUROSCI, V23, P869, DOI 10.1111/j.1460-9568.2006.04629.x; Friocourt G, 2008, J NEUROSCI, V28, P5794, DOI 10.1523/JNEUROSCI.1067-08.2008; Fullenkamp AN, 2008, BIOCHEM BIOPH RES CO, V377, P73, DOI 10.1016/j.bbrc.2008.09.116; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kato M, 2003, NEUROLOGY, V61, P267, DOI 10.1212/01.WNL.0000068012.69928.92; Kato M, 2007, AM J HUM GENET, V81, P361, DOI 10.1086/518903; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Lamirault G, 2010, J CELL MOL MED, V14, P1443, DOI 10.1111/j.1582-4934.2009.00913.x; Marcorelles P, 2010, ACTA NEUROPATHOL, V120, P503, DOI 10.1007/s00401-010-0692-z; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Okazaki S, 2008, ACTA NEUROPATHOL, V116, P453, DOI 10.1007/s00401-008-0382-2; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Scheffer IE, 2002, NEUROLOGY, V59, P348, DOI 10.1212/WNL.59.3.348; Seufert DW, 2005, DEV DYNAM, V232, P313, DOI 10.1002/dvdy.20234; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	44	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25181	10.1371/journal.pone.0025181	http://dx.doi.org/10.1371/journal.pone.0025181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966449	Green Submitted, Green Published, gold			2022-12-27	WOS:000295265100071
J	Ueta, M; Sotozono, C; Yokoi, N; Inatomi, T; Kinoshita, S				Ueta, Mayumi; Sotozono, Chie; Yokoi, Norihiko; Inatomi, Tsutomu; Kinoshita, Shigeru			Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders	PLOS ONE			English	Article								Background: In our earlier genome-wide association study on Stevens-Johnson Syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), we found that in Japanese patients with these severe ocular surface complications there was an association with prostaglandin E receptor 3 (EP3) gene (PTGER3) polymorphisms. We also reported that EP3 is dominantly expressed in the ocular surface-, especially the conjunctival epithelium, and suggested that EP3 in the conjunctival epithelium may down-regulate ocular surface inflammation. In the current study we investigated the expression of EP3 protein in the conjunctiva of patients with various ocular surface diseases such as SJS/TEN, chemical eye burns, Mooren's ulcers, and ocular cicatricial pemphigoid (OCP). Methodology/Principal Findings: Conjunctival tissues were obtained from patients undergoing surgical reconstruction of the ocular surface due to SJS/TEN, chemical eye burns, and OCP, and from patients with Mooren's ulcers treated by resection of the inflammatory conjunctiva. The controls were nearly normal human conjunctival tissues acquired at surgery for conjunctivochalasis. We performed immunohistological analysis of the EP3 protein and evaluated the immunohistological staining of EP3 protein in the conjunctival epithelium of patients with ocular surface diseases. EP3 was expressed in the conjunctival epithelium of patients with chemical eye burns and Mooren's ulcer and in normal human conjunctival epithelium. However, it was markedly down-regulated in the conjunctival epithelium of SJS/TEN and OCP patients. Conclusions: We posit an association between the down-regulation of EP3 in conjunctival epithelium and the pathogenesis and pathology of SJS/TEN and OCP, and suggest a common mechanism(s) in the pathology of these diseases. The examination of EP3 protein expression in conjunctival epithelium may aid in the differential diagnosis of various ocular surface diseases.	[Ueta, Mayumi; Sotozono, Chie; Yokoi, Norihiko; Inatomi, Tsutomu; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Ueta, Mayumi] Doshisha Univ, Res Ctr Inflammat & Regenerat Med, Fac Life & Med Sci, Kyoto 602, Japan	Kyoto Prefectural University of Medicine; Doshisha University	Ueta, M (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.	mueta@koto.kpu-m.ac.jp			Japanese Ministry of Health, Labour and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology; CREST from JST; Kyoto Foundation for the Promotion of Medical Science; Kyoto Prefectural University of Medicine	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from JST(Core Research for Evolutional Science and Technology (CREST)); Kyoto Foundation for the Promotion of Medical Science(Kyoto Foundation for the Promotion of Medical Science); Kyoto Prefectural University of Medicine	This work was supported in part by grants-in-aid for scientific research from the Japanese Ministry of Health, Labour and Welfare, the Japanese Ministry of Education, Culture, Sports, Science and Technology, CREST from JST, a research grant from the Kyoto Foundation for the Promotion of Medical Science, and the Intramural Research Fund of Kyoto Prefectural University of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Honda T, 2009, J ALLERGY CLIN IMMUN, V124, P809, DOI 10.1016/j.jaci.2009.04.029; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; Razzaque MS, 2003, INVEST OPHTH VIS SCI, V44, P1998, DOI 10.1167/iovs.02-0967; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; Ueta M, 2011, BRIT J OPHTHALMOL, V95, P859, DOI 10.1136/bjo.2010.199679; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Ueta M, 2009, J ALLERGY CLIN IMMUN, V123, P466, DOI 10.1016/j.jaci.2008.09.044	8	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25209	10.1371/journal.pone.0025209	http://dx.doi.org/10.1371/journal.pone.0025209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966456	Green Published, Green Submitted, gold			2022-12-27	WOS:000295265100072
J	Yang, X; Kume, S; Tanaka, Y; Isshiki, K; Araki, S; Chin-Kanasaki, M; Sugimoto, T; Koya, D; Haneda, M; Sugaya, T; Li, DT; Han, P; Nishio, Y; Kashiwagi, A; Maegawa, H; Uzu, T				Yang, Xu; Kume, Shinji; Tanaka, Yuki; Isshiki, Keiji; Araki, Shin-ichi; Chin-Kanasaki, Masami; Sugimoto, Toshiro; Koya, Daisuke; Haneda, Masakazu; Sugaya, Takeshi; Li, Detian; Han, Ping; Nishio, Yoshihiko; Kashiwagi, Atsunori; Maegawa, Hiroshi; Uzu, Takashi			GW501516, a PPAR delta Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NF kappa B Pathway in Mice	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; PROXIMAL TUBULAR CELLS; HIGH-FAT DIET; RENAL INJURY; INSULIN SENSITIVITY; METABOLIC SYNDROME; MCP-1 EXPRESSION; BETA-OXIDATION; KAPPA-B; ALBUMIN	Peroxisome proliferator-activated receptors (PPARs) are a nuclear receptor family of ligand-inducible transcription factors, which have three different isoforms: PPAR alpha, delta and gamma. It has been demonstrated that PPAR alpha and gamma agonists have renoprotective effects in proteinuric kidney diseases; however, the role of PPAR delta agonists in kidney diseases remains unclear. Thus, we examined the renoprotective effect of GW501516, a PPAR delta agonist, in a protein-overload mouse nephropathy model and identified its molecular mechanism. Mice fed with a control diet or GW501516-containing diet were intraperitoneally injected with free fatty acid (FFA)-bound albumin or PBS(-). In the control group, protein overload caused tubular damages, macrophage infiltration and increased mRNA expression of MCP-1 and TNF alpha. These effects were prevented by GW501516 treatment. In proteinuric kidney diseases, excess exposure of proximal tubular cells to albumin, FFA bound to albumin or cytokines such as TNF alpha is detrimental. In vitro studies using cultured proximal tubular cells showed that GW501516 attenuated both TNF alpha- and FFA (palmitate)-induced, but not albumin-induced, MCP-1 expression via direct inhibition of the TGF-beta activated kinase 1 (TAK1)-NF kappa B pathway, a common downstream signaling pathway to TNF alpha receptor and toll-like receptor-4. In conclusion, we demonstrate that GW501516 has an anti-inflammatory effect in renal tubular cells and may serve as a therapeutic candidate to attenuate tubulointerstitial lesions in proteinuric kidney diseases.	[Yang, Xu; Kume, Shinji; Tanaka, Yuki; Isshiki, Keiji; Araki, Shin-ichi; Chin-Kanasaki, Masami; Sugimoto, Toshiro; Nishio, Yoshihiko; Kashiwagi, Atsunori; Maegawa, Hiroshi; Uzu, Takashi] Shiga Univ Med Sci, Dept Med, Shiga, Japan; [Yang, Xu; Li, Detian; Han, Ping] China Med Univ, Dept Med, Shengjing Hosp, Shenyang, Liaoning, Peoples R China; [Koya, Daisuke] Kanazawa Med Univ, Div Endocrinol & Metab, Kanazawa, Ishikawa, Japan; [Haneda, Masakazu] Asahikawa Med Coll, Dept Med, Asahikawa, Hokkaido 078, Japan; [Sugaya, Takeshi] St Marianna Univ, Sch Med, Kawasaki Ku, Kanagawa, Japan	Shiga University of Medical Science; China Medical University; Kanazawa Medical University; Asahikawa Medical College; Saint Marianna University	Yang, X (corresponding author), Shiga Univ Med Sci, Dept Med, Shiga, Japan.	takuzu@belle.shiga-med.ac.jp	Koya, Daisuke/J-3257-2014; Kashiwagi, Atsunori/H-8712-2019	Maegawa, Hiroshi/0000-0002-4611-8149	Shiga Medical Science Association for International Corporation	Shiga Medical Science Association for International Corporation	This work was supported with funds granted to XY by the Shiga Medical Science Association for International Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bahlmann FH, 2004, CIRCULATION, V110, P1006, DOI 10.1161/01.CIR.0000139335.04152.F3; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Burton C, 1996, AM J KIDNEY DIS, V27, P765, DOI 10.1016/S0272-6386(96)90512-0; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Drumm K, 2002, CELL PHYSIOL BIOCHEM, V12, P187, DOI 10.1159/000066278; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Ishikado A, 2009, ATHEROSCLEROSIS, V205, P404, DOI 10.1016/j.atherosclerosis.2009.01.010; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Isshiki K, 2000, DIABETES, V49, P1022, DOI 10.2337/diabetes.49.6.1022; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; Kamijo Y, 2007, J AM SOC NEPHROL, V18, P3089, DOI 10.1681/ASN.2007020238; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Kume S, 2008, PPAR RES, V2008, DOI 10.1155/2008/879523; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Piqueras L, 2009, J LEUKOCYTE BIOL, V86, P115, DOI [10.1189/jlb.0508284, 10.1189/JLB.0508284]; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Shimizu H, 2003, J AM SOC NEPHROL, V14, P1496, DOI 10.1097/01.ASN.0000069223.98703.8E; Shin SJ, 2009, HYPERTENS RES, V32, P835, DOI 10.1038/hr.2009.107; Soumura M, 2010, BIOCH BIOPHYS RES CO; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Takaya K, 2003, AM J PHYSIOL-RENAL, V284, pF1037, DOI 10.1152/ajprenal.00230.2002; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; THOMAS ME, 1993, AM J NEPHROL, V13, P385, DOI 10.1159/000168653; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x; Zoja C, 2009, FRONT BIOSCI-LANDMRK, V14, P1815, DOI 10.2741/3343	44	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25271	10.1371/journal.pone.0025271	http://dx.doi.org/10.1371/journal.pone.0025271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966476	Green Submitted, Green Published, gold			2022-12-27	WOS:000295265100078
J	Xiao, YP; Kavanau, C; Bertin, L; Kaplan, E				Xiao, Youping; Kavanau, Chistopher; Bertin, Lauren; Kaplan, Ehud			The Biological Basis of a Universal Constraint on Color Naming: Cone Contrasts and the Two-Way Categorization of Colors	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; STRIATE CORTEX; MACAQUE MONKEY; CHROMATIC MECHANISMS; QUANTITATIVE ASPECTS; SYSTEM; HUE; WAVELENGTH; ADAPTATION	Many studies have provided evidence for the existence of universal constraints on color categorization or naming in various languages, but the biological basis of these constraints is unknown. A recent study of the pattern of color categorization across numerous languages has suggested that these patterns tend to avoid straddling a region in color space at or near the border between the English composite categories of "warm" and "cool". This fault line in color space represents a fundamental constraint on color naming. Here we report that the two-way categorization along the fault line is correlated with the sign of the L- versus M-cone contrast of a stimulus color. Moreover, we found that the sign of the L-M cone contrast also accounted for the two-way clustering of the spatially distributed neural responses in small regions of the macaque primary visual cortex, visualized with optical imaging. These small regions correspond to the hue maps, where our previous study found a spatially organized representation of stimulus hue. Altogether, these results establish a direct link between a universal constraint on color naming and the cone-specific information that is represented in the primate early visual system.	[Xiao, Youping; Kavanau, Chistopher; Kaplan, Ehud] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Xiao, Youping; Kavanau, Chistopher; Kaplan, Ehud] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Bertin, Lauren] Bennington Coll, Bennington, VT USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Xiao, YP (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	Youping.Xiao@mssm.edu		Lauwereyns, Jan/0000-0003-0551-2550; Bertin, Lauren/0000-0002-4261-089X; Xiao, Youping/0000-0003-3954-3443	National Institutes of Health (NIH) [EY016371, EY12867, GM71558, EY01867]; Fight For Sight; NATIONAL EYE INSTITUTE [R01EY012867, R01EY016371, P30EY001867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fight For Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) grants EY016371, EY12867, GM71558 and core grant EY01867, and a grant from Fight For Sight to Y.X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Berlin B., 1969, BASIC COLOR TERMS TH; BOYNTON RM, 1987, COLOR RES APPL, V12, P94, DOI 10.1002/col.5080120209; CHAPARRO A, 1995, VISION RES, V35, P3103, DOI 10.1016/0042-6989(95)00069-C; Claeskens G, 2008, J MACHINE LEARNING R, V9, P18; Conway BR, 2010, J NEUROSCI, V30, P14955, DOI 10.1523/JNEUROSCI.4348-10.2010; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DeValois RL, 1997, VISION RES, V37, P885, DOI 10.1016/S0042-6989(96)00234-9; DEVALOIS RL, 1964, SCIENCE, V146, P1184, DOI 10.1126/science.146.3648.1184; DEVALOIS RL, 1965, COLD SPRING HARB SYM, V30, P567, DOI 10.1101/SQB.1965.030.01.055; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Goethe Johann Wolfgang, 1982, THEORY COLOURS; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hanazawa A, 2000, EUR J NEUROSCI, V12, P1753, DOI 10.1046/j.1460-9568.2000.00041.x; Hering, 1878, LEHR LICHTS; HURVICH LM, 1956, J OPT SOC AM, V46, P416, DOI 10.1364/JOSA.46.000416; JAMESON D, 1956, J OPT SOC AM, V46, P405, DOI 10.1364/JOSA.46.000405; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Johnson EN, 2004, J NEUROPHYSIOL; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; Kay P, COLOR CATEGORIES THO, P21; Komarova NI, 2008, J THEOR BIOL, V253, P680, DOI 10.1016/j.jtbi.2008.03.030; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3126, DOI 10.1152/jn.2002.87.6.3126; LENNIE P, 1990, J NEUROSCI, V10, P649; Lindsey DT, 2006, P NATL ACAD SCI USA, V103, P16608, DOI 10.1073/pnas.0607708103; Lindsey DT, 2002, PSYCHOL SCI, V13, P506, DOI 10.1111/1467-9280.00489; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; Regier T, 2005, P NATL ACAD SCI USA, V102, P8386, DOI 10.1073/pnas.0503281102; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Schwarz G, 1978, ANN STAT, V6, P4; SEBER GAF, 1984, MULTIVARIATE OBSERVA; SPATH H, 1985, CLUSTER DISSECTION A; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stockman A, 2008, J VISION, V8, DOI 10.1167/8.16.1; Vapnik V., 1998, STAT LEARNING THEORY; Wachtler T, 2003, NEURON, V37, P681, DOI 10.1016/S0896-6273(03)00035-7; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Wyszecki G, 1982, COLOR SCI, Vsecond; Xiao Y, 2008, IMPROVED MAPPING INF; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Yendrikhovskij SN, 2001, J IMAGING SCI TECHN, V45, P409; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P51, DOI 10.1016/0166-4328(95)00183-2	53	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24994	10.1371/journal.pone.0024994	http://dx.doi.org/10.1371/journal.pone.0024994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21977226	Green Published, Green Submitted, gold			2022-12-27	WOS:000295262100030
J	Coolen, MW; Statham, AL; Qu, WJ; Campbell, MJ; Henders, AK; Montgomery, GW; Martin, NG; Clark, SJ				Coolen, Marcel W.; Statham, Aaron L.; Qu, Wenjia; Campbell, Megan J.; Henders, Anjali K.; Montgomery, Grant W.; Martin, Nick G.; Clark, Susan J.			Impact of the Genome on the Epigenome Is Manifested in DNA Methylation Patterns of Imprinted Regions in Monozygotic and Dizygotic Twins	PLOS ONE			English	Article							GROWTH-FACTOR-II; BECKWITH-WIEDEMANN-SYNDROME; CTCF-BINDING SITES; COLORECTAL-CANCER; IGF2 GENE; H19; EXPRESSION; LOCUS; RISK; PSEUDOHYPOPARATHYROIDISM	One of the best studied read-outs of epigenetic change is the differential expression of imprinted genes, controlled by differential methylation of imprinted control regions (ICRs). To address the impact of genotype on the epigenome, we performed a detailed study in 128 pairs of monozygotic (MZ) and 128 pairs of dizygotic (DZ) twins, interrogating the DNA methylation status of the ICRs of IGF2, H19, KCNQ1, GNAS and the non-imprinted gene RUNX1. While we found a similar overall pattern of methylation between MZ and DZ twins, we also observed a high degree of variability in individual CpG methylation levels, notably at the H19/IGF2 loci. A degree of methylation plasticity independent of the genome sequence was observed, with both local and regional CpG methylation changes, discordant between MZ and DZ individual pairs. However, concordant gains or losses of methylation, within individual twin pairs were more common in MZ than DZ twin pairs, indicating that de novo and/or maintenance methylation is influenced by the underlying DNA sequence. Specifically, for the first time we showed that the rs10732516 [A] polymorphism, located in a critical CTCF binding site in the H19 ICR locus, is strongly associated with increased hypermethylation of specific CpG sites in the maternal H19 allele. Together, our results highlight the impact of the genome on the epigenome and demonstrate that while DNA methylation states are tightly maintained between genetically identical and related individuals, there remains considerable epigenetic variation that may contribute to disease susceptibility.	[Coolen, Marcel W.; Statham, Aaron L.; Qu, Wenjia; Clark, Susan J.] Garvan Inst Med Res, Epigenet Res Grp, Canc Program, Sydney, NSW, Australia; [Coolen, Marcel W.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Campbell, Megan J.; Henders, Anjali K.; Montgomery, Grant W.; Martin, Nick G.] Queensland Inst Med Res, Genet & Mol Epidemiol Labs, Brisbane, Qld 4006, Australia; [Clark, Susan J.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; Radboud University Nijmegen; QIMR Berghofer Medical Research Institute; University of New South Wales Sydney	Coolen, MW (corresponding author), Garvan Inst Med Res, Epigenet Res Grp, Canc Program, Sydney, NSW, Australia.	s.clark@garvan.org.au	Clark, Susan J/U-7365-2019; Montgomery, Grant W/B-7148-2008; Clark, Susan J/B-2272-2008; Martin, Nicholas/R-9235-2019; Henders, Anjali/E-3126-2017	Clark, Susan J/0000-0001-5925-5030; Montgomery, Grant W/0000-0002-4140-8139; Clark, Susan J/0000-0001-5925-5030; Martin, Nicholas/0000-0003-4069-8020; Coolen, Marcel/0000-0002-8188-8480; Henders, Anjali/0000-0003-3672-1451; Campbell, Megan/0000-0002-6056-6140	Australian National Health and Medical Research Council [NHMRC: 325622]; Cancer Institute; NHMRC [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498]; Australian Research Council [A7960034, A79906588, A79801419, DP0212016, DP0343921]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported in part by a grant from the Australian National Health and Medical Research Council [NH&MRC: 325622]. MWC was supported by a Cancer Institute NSW fellow and SJC is an NH&MRC Research Fellow. The collection of twin material at QIMR was supported by grants to NGM from the NH&MRC [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485 and 552498] and the Australian Research Council [A7960034, A79906588, A79801419, DP0212016 and DP0343921]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bataille V, 2000, JNCI-J NATL CANCER I, V92, P457, DOI 10.1093/jnci/92.6.457; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2001, CANCER RES, V61, P4947; Cui HM, 2002, CANCER RES, V62, P6442; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Feinberg AP, 2002, SEMIN CANCER BIOL, V12, P389, DOI 10.1016/S1044-579X(02)00059-7; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Kaaks R, 2009, CANCER RES, V69, P5400, DOI 10.1158/0008-5472.CAN-08-3020; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Lacey MR, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1489; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; Nakano S, 2006, CANCER SCI, V97, P1147, DOI 10.1111/j.1349-7006.2006.00305.x; OLLIKAINEN M, 2010, HUM MOL GENET; Peters J, 2007, EPIGENETICS, V2, P207, DOI 10.4161/epi.2.4.5380; Petronis A, 2006, TRENDS GENET, V22, P347, DOI 10.1016/j.tig.2006.04.010; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schneider E, 2010, NUCL ACIDS RES; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Torgersen S, 2009, SCAND J PSYCHOL, V50, P624, DOI 10.1111/j.1467-9450.2009.00788.x; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zhao ZZ, 2007, HUM REPROD, V22, P2389, DOI 10.1093/humrep/dem182	45	56	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25590	10.1371/journal.pone.0025590	http://dx.doi.org/10.1371/journal.pone.0025590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991322	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000045
J	Kozubowski, L; Thompson, JW; Cardenas, ME; Moseley, MA; Heitman, J				Kozubowski, Lukasz; Thompson, J. Will; Cardenas, Maria E.; Moseley, M. Arthur; Heitman, Joseph			Association of Calcineurin with the COPI Protein Sec28 and the COPII Protein Sec13 Revealed by Quantitative Proteomics	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; CRYPTOCOCCUS-NEOFORMANS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; HEAT-STRESS; GLUTAMATE-DEHYDROGENASE; CANDIDA-ALBICANS; GENE-EXPRESSION; LATE GOLGI	Calcineurin is a calcium-calmodulin-dependent serine/threonine specific protein phosphatase operating in key cellular processes governing responses to extracellular cues. Calcineurin is essential for growth at high temperature and virulence of the human fungal pathogen Cryptococcus neoformans but the underlying mechanism is unknown. We performed a mass spectrometry analysis to identify proteins that associate with the calcineurin A catalytic subunit (Cna1) in C. neoformans cells grown under non-stress and high temperature stress conditions. A novel prioritization strategy for mass spectrometry data from immunoprecipitation experiments identified putative substrates and proteins potentially operating with calcineurin in common pathways. Cna1 co-purified with proteins involved in membrane trafficking including the COPI component Sec28 and the COPII component Sec13. The association of Cna1 with Sec28 and Sec13 was confirmed by co-immunoprecipitation. Cna1 exhibited a dramatic change in subcellular localization during high temperature stress from diffuse cytoplasmic to ER-associated puncta and the mother-bud neck and co-localized with Sec28 and Sec13.	[Kozubowski, Lukasz; Cardenas, Maria E.; Heitman, Joseph] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA; [Thompson, J. Will; Moseley, M. Arthur] Duke Univ, Duke Prote Core Facil, Med Ctr, Durham, NC USA	Duke University; Duke University	Kozubowski, L (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA.	Lukasz.kozubowski@duke.edu	Heitman, Joseph/ABC-6006-2021		National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01 AI42159]; NATIONAL CANCER INSTITUTE [R01CA154499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042159, R01AI050438] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the National Institutes of Health/National Institute of Allergy and Infectious Diseases R01 AI42159 grant (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Bartz R, 2008, EMBO J, V27, P948, DOI 10.1038/emboj.2008.36; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Chen YL, 2010, CURR FUNGAL INFECT R, V4, P244, DOI 10.1007/s12281-010-0027-5; Conboy MJ, 2000, MOL BIOL CELL, V11, P2429, DOI 10.1091/mbc.11.7.2429; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Cowart LA, 2010, BIOCHEM J, V431, P31, DOI 10.1042/BJ20100307; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Fox DS, 2001, MOL MICROBIOL, V39, P835, DOI 10.1046/j.1365-2958.2001.02295.x; Fradin C, 2003, MOL MICROBIOL, V47, P1523, DOI 10.1046/j.1365-2958.2003.03396.x; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; Glinski M, 2005, MOL CELL PROTEOMICS, V4, P1614, DOI 10.1074/mcp.M500134-MCP200; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; HEMENWAY CS, 1995, GENETICS, V141, P833; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Keeling KM, 2006, MOL CELL BIOL, V26, P5237, DOI 10.1128/MCB.02448-05; KHALEKUMAR A, 1993, J BACTERIOL, V175, P6052, DOI 10.1128/JB.175.18.6052-6055.1993; KMETZSCH L, EUKARYOT CELL, V9, P1798; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; Mackiewicz P, 2002, YEAST, V19, P619, DOI 10.1002/yea.865; Miyakawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P633, DOI 10.1271/bbb.60495; Moorhead G, 1999, PLANT J, V18, P1, DOI 10.1046/j.1365-313X.1999.00417.x; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; PETERS J, 1979, J BACTERIOL, V137, P1134, DOI 10.1128/JB.137.3.1134-1139.1979; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; SONG HO, MOL CELLS, V30, P255; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; SUN T, J NEUROSCI, V30, P11838; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; TANIDA I, 1995, J BIOL CHEM, V270, P10113, DOI 10.1074/jbc.270.17.10113; Tokheim AM, 2006, PROTEINS, V64, P28, DOI 10.1002/prot.20996; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Vermeulen M, 2008, CURR OPIN BIOTECH, V19, P331, DOI 10.1016/j.copbio.2008.06.001; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; WEST M, J CELL BIOL, V193, P333; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001	64	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25280	10.1371/journal.pone.0025280	http://dx.doi.org/10.1371/journal.pone.0025280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984910	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000021
J	Veninga, H; Hoek, RM; de Vos, AF; de Bruin, AM; An, FQ; van der Poll, T; van Lier, RAW; Medof, ME; Hamann, J				Veninga, Henrike; Hoek, Robert M.; de Vos, Alex F.; de Bruin, Alex M.; An, Feng-Qi; van der Poll, Tom; van Lier, Rene A. W.; Medof, M. Edward; Hamann, Jorg			A Novel Role for CD55 in Granulocyte Homeostasis and Anti-Bacterial Host Defense	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; TRANSMEMBRANE RECEPTOR CD97; T-CELL IMMUNITY; BONE-MARROW; MOUSE CD97; C. ELEGANS; FACTOR DAF; COMPLEMENT; MICE; SUSCEPTIBILITY	Background: In addition to its complement-regulating activity, CD55 is a ligand of the adhesion class G protein-coupled receptor CD97; however, the relevance of this interaction has remained elusive. We previously showed that mice lacking a functional CD97 gene have increased numbers of granulocytes. Methodology/Results: Here, we demonstrate that CD55-deficient mice display a comparable phenotype with about two-fold more circulating granulocytes in the blood stream, the marginated pool, and the spleen. This granulocytosis was independent of increased complement activity. Augmented numbers of Gr-1-positive cells in cell cycle in the bone marrow indicated a higher granulopoietic activity in mice lacking either CD55 or CD97. Concomitant with the increase in blood granulocyte numbers, Cd55(-/-) mice challenged with the respiratory pathogen Streptococcus pneumoniae developed less bacteremia and died later after infection. Conclusions: Collectively, these data suggest that complement-independent interaction of CD55 with CD97 is functionally relevant and involved in granulocyte homeostasis and host defense.	[Veninga, Henrike; Hoek, Robert M.; de Bruin, Alex M.; van Lier, Rene A. W.; Hamann, Jorg] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, NL-1105 AZ Amsterdam, Netherlands; [An, Feng-Qi; Medof, M. Edward] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Case Western Reserve University	Veninga, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.veninga@vumc.nl		Hamann, Jorg/0000-0002-9448-1727; van Lier, Rene/0000-0002-3201-7144; Veninga, Henrike/0000-0001-8731-0615	Netherlands Organization for Scientific Research (NWO) [814.02.012]; Landsteiner Foundation for Bloodtransfusion Research (LSBR) [0310]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation for Bloodtransfusion Research (LSBR)	This work was supported by grants from the Netherlands Organization for Scientific Research (NWO 814.02.012) and the Landsteiner Foundation for Bloodtransfusion Research (LSBR 0310) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Gray JX, 1996, J IMMUNOL, V157, P5438; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hamann J, 2000, INT IMMUNOL, V12, P439, DOI 10.1093/intimm/12.4.439; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Hoek RM, 2010, ARTHRITIS RHEUM-US, V62, P1036, DOI 10.1002/art.27347; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Kwakkenbos MJ, 2004, IMMUNOGENETICS, V55, P655, DOI 10.1007/s00251-003-0625-2; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lawrence DW, 2003, J EXP MED, V198, P999, DOI 10.1084/jem.20030380; Lea S, 2002, BIOCHEM SOC T, V30, P1014, DOI 10.1042/bst0301014; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Li L, 2001, BRIT J CANCER, V84, P80, DOI 10.1054/bjoc.2000.1570; Lin F, 2004, J IMMUNOL, V172, P3836, DOI 10.4049/jimmunol.172.6.3836; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lin F, 2002, J CLIN INVEST, V110, P1269, DOI 10.1172/JCI200216086; Lin F, 2001, IMMUNOLOGY, V104, P215, DOI 10.1046/j.1365-2567.2001.01287.x; Lin HH, 2001, J BIOL CHEM, V276, P24160, DOI 10.1074/jbc.M101770200; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Miwa T, 2002, AM J PATHOL, V161, P1077, DOI 10.1016/S0002-9440(10)64268-X; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; NICHOLSONWELLER A, 1994, J LAB CLIN MED, V123, P485; Perianayagam MC, 2004, EUR J CLIN INVEST, V34, P50, DOI 10.1111/j.1365-2362.2004.01273.x; Qian YM, 1999, IMMUNOLOGY, V98, P303; Sogabe H, 2001, J IMMUNOL, V167, P2791, DOI 10.4049/jimmunol.167.5.2791; Steimel A, 2010, DEVELOPMENT, V137, P3663, DOI 10.1242/dev.054320; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; TERSTAPPEN LWMM, 1992, J LEUKOCYTE BIOL, V52, P652, DOI 10.1002/jlb.52.6.652; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; van Pel M, 2008, HAEMATOL-HEMATOL J, V93, P1137, DOI 10.3324/haematol.12838; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Wang T, 2007, INFECT IMMUN, V75, P1144, DOI 10.1128/IAI.00869-06; Yamada K, 2004, J IMMUNOL, V172, P3869, DOI 10.4049/jimmunol.172.6.3869; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24431	10.1371/journal.pone.0024431	http://dx.doi.org/10.1371/journal.pone.0024431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984892	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000002
J	Willis, C; Wang, CK; Osman, A; Simon, A; Pickering, D; Mulvenna, J; Riboldi-Tunicliffe, A; Jones, MK; Loukas, A; Hofmann, A				Willis, Charlene; Wang, Conan K.; Osman, Asiah; Simon, Anne; Pickering, Darren; Mulvenna, Jason; Riboldi-Tunicliffe, Alan; Jones, Malcolm K.; Loukas, Alex; Hofmann, Andreas			Insights into the Membrane Interactions of the Saposin-Like Proteins Na-SLP-1 and Ac-SLP-1 from Human and Dog Hookworm	PLOS ONE			English	Article							NK-LYSIN; ANCYLOSTOMA-CANINUM; CRYSTAL-STRUCTURE; LIPID-BINDING; ENTAMOEBA-HISTOLYTICA; DEGRADATION; GRANULYSIN; PEPTIDES	Saposin-like proteins (SAPLIPs) from soil-transmitted helminths play pivotal roles in host-pathogen interactions and have a high potential as targets for vaccination against parasitic diseases. We have identified two non-orthologous SAPLIPs from human and dog hookworm, Na-SLP-1 and Ac-SLP-1, and solved their three-dimensional crystal structures. Both proteins share the property of membrane binding as monitored by liposome co-pelleting assays and monolayer adsorption. Neither SAPLIP displayed any significant haemolytic or bactericidal activity. Based on the structural information, as well as the results from monolayer adsorption, we propose models of membrane interactions for both SAPLIPs. Initial membrane contact of the monomeric Na-SLP-1 is most likely by electrostatic interactions between the membrane surface and a prominent basic surface patch. In case of the dimeric Ac-SLP-1, membrane interactions are most likely initiated by a unique tryptophan residue that has previously been implicated in membrane interactions in other SAPLIPs.	[Willis, Charlene; Jones, Malcolm K.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Wang, Conan K.; Osman, Asiah; Hofmann, Andreas] Griffith Univ, Struct Chem Program, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Simon, Anne] Univ Lyon 1, CNRS, ICBMS, UMR 5246, F-69622 Villeurbanne, France; [Pickering, Darren; Mulvenna, Jason; Loukas, Alex] James Cook Univ, Cairns, Qld, Australia; [Riboldi-Tunicliffe, Alan] Australian Synchrotron, Clayton, Vic, Australia; [Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Hofmann, Andreas] Univ Melbourne, Dept Vet Sci, Melbourne, Vic 3010, Australia; [Loukas, Alex; Hofmann, Andreas] Queensland Trop Hlth Alliance, Townsville, Qld, Australia	QIMR Berghofer Medical Research Institute; Griffith University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; James Cook University; University of Queensland; University of Melbourne	Willis, C (corresponding author), Queensland Inst Med Res, Bramston Terrace, Herston, Qld 4006, Australia.	a.hofmann@griffith.edu.au	Loukas, Alex/B-7355-2014; Wang, Conan K/D-1481-2010; Osman, Asiah/AAK-5173-2021; SIMON, Anne/D-6046-2011; Hofmann, Andreas/B-9515-2008; Mulvenna, Jason/H-7110-2014; Willis, Charlene/U-1344-2017; Jones, Malcolm K/A-1097-2009; Hofmann, Andreas/M-9870-2019	Loukas, Alex/0000-0002-0896-8441; Wang, Conan K/0000-0002-7973-7632; Hofmann, Andreas/0000-0003-4408-5467; Mulvenna, Jason/0000-0003-3521-8061; Jones, Malcolm K/0000-0002-0035-6141; Hofmann, Andreas/0000-0003-4408-5467	Rebecca L. Cooper Foundation; James Kirby Foundation (AH); National Health & Medical Research Counci	Rebecca L. Cooper Foundation; James Kirby Foundation (AH); National Health & Medical Research Counci	The support from the Australian Synchrotron in form of beam time is gratefully acknowledged. The authors are further grateful for partial support of this study by the Rebecca L. Cooper Foundation and the James Kirby Foundation (AH). C. Willis and C. Wang are National Health and Medical Research Council (NHMRC) Postdoctoral Fellows. AL is an NHMRC Senior Research Fellow. Funding support was from an National Health & Medical Research Council program grant awarded to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; Andreu D, 1999, BIOCHEM J, V344, P845, DOI 10.1042/0264-6021:3440845; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Banyai L, 1998, BBA-PROTEIN STRUCT M, V1429, P259, DOI 10.1016/S0167-4838(98)00237-4; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; Braunewell KH, 2010, AUST J CHEM, V63, P350, DOI 10.1071/CH09355; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Bruhn H, 2001, BBA-BIOMEMBRANES, V1514, P14, DOI 10.1016/S0005-2736(01)00345-5; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Ciaffoni F, 2001, J BIOL CHEM, V276, P31583, DOI 10.1074/jbc.M102736200; de Silva A, 2003, AM J CLIN NUTR, V77, P234, DOI 10.1093/ajcn/77.1.234; DELANO, 2002, W PYMOL MOL GRAPHICS; Don TA, 2007, PARASITOLOGY, V134, P427, DOI 10.1017/S003118200600148X; Don TA, 2004, INT J PARASITOL, V34, P1029, DOI 10.1016/j.ijpara.2004.04.013; Espino AM, 2004, J PARASITOL, V90, P876, DOI 10.1645/GE-215R; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hecht O, 2004, J BIOL CHEM, V279, P17834, DOI 10.1074/jbc.M312978200; Hofmann A, 2003, METHOD ENZYMOL, V372, P186; Hofmann A, 2002, BIOINFORMATICS, V18, P209, DOI 10.1093/bioinformatics/18.1.209; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kervinen J, 1999, EMBO J, V18, P3947, DOI 10.1093/emboj/18.14.3947; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2002, BIOCHEM BIOPH RES CO, V296, P1238, DOI 10.1016/S0006-291X(02)02062-4; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Linke T, 2001, J BIOL CHEM, V276, P5760, DOI 10.1074/jbc.M006846200; Miteva M, 1999, FEBS LETT, V462, P155, DOI 10.1016/S0014-5793(99)01520-3; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Piatigorsky J, 2001, P NATL ACAD SCI USA, V98, P12362, DOI 10.1073/pnas.231310698; QI XY, 1994, J BIOL CHEM, V269, P16746; Qi XY, 2001, J BIOL CHEM, V276, P27010, DOI 10.1074/jbc.M101075200; Ranjit N, 2006, INT J PARASITOL, V36, P701, DOI 10.1016/j.ijpara.2006.01.015; Rasband W., 2005, IMAGEJ VERSION 1 30; Roeder T, 2010, DEV COMP IMMUNOL, V34, P203, DOI 10.1016/j.dci.2009.09.010; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; Ruysschaert JM, 1998, FEBS LETT, V425, P341, DOI 10.1016/S0014-5793(98)00261-0; Sandhoff K, 1996, TRENDS CELL BIOL, V6, P98, DOI 10.1016/0962-8924(96)80999-8; Torres D, 2006, INFECT IMMUN, V74, P4932, DOI 10.1128/IAI.00442-06; Wang Z, 2000, J IMMUNOL, V165, P1486, DOI 10.4049/jimmunol.165.3.1486; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271; Williamson AL, 2003, TRENDS PARASITOL, V19, P417, DOI 10.1016/S1471-4922(03)00189-2; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104	48	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25369	10.1371/journal.pone.0025369	http://dx.doi.org/10.1371/journal.pone.0025369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991310	Green Published, Green Accepted, gold			2022-12-27	WOS:000295943000027
J	Kaminski, JA; Korb, FM; Villringer, A; Ott, DVM				Kaminski, Jakob A.; Korb, Franziska M.; Villringer, Arno; Ott, Derek V. M.			Transcranial Magnetic Stimulation Intensities in Cognitive Paradigms	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; HUMAN MOTOR CORTEX; EVENT-RELATED FMRI; WORKING-MEMORY; PHOSPHENE THRESHOLDS; FUNCTIONAL CONNECTIVITY; CORTICAL EXCITABILITY; BRAIN-STIMULATION; COIL ORIENTATION; TMS	Background:Transcranial magnetic stimulation (TMS) has become an important experimental tool for exploring the brain's functional anatomy. As TMS interferes with neural activity, the hypothetical function of the stimulated area can thus be tested. One unresolved methodological issue in TMS experiments is the question of how to adequately calibrate stimulation intensities. The motor threshold (MT) is often taken as a reference for individually adapted stimulation intensities in TMS experiments, even if they do not involve the motor system. The aim of the present study was to evaluate whether it is reasonable to adjust stimulation intensities in each subject to the individual MT if prefrontal regions are stimulated prior to the performance of a cognitive paradigm. Methods and Findings: Repetitive TMS (rTMS) was applied prior to a working memory task, either at the 'fixed' intensity of 40% maximum stimulator output (MSO), or individually adapted at 90% of the subject's MT. Stimulation was applied to a target region in the left posterior middle frontal gyrus (pMFG), as indicated by a functional magnetic resonance imaging (fMRI) localizer acquired beforehand, or to a control site (vertex). Results show that MT predicted the effect size after stimulating subjects with the fixed intensity (i.e., subjects with a low MT showed a greater behavioral effect). Nevertheless, the individual adaptation of intensities did not lead to stable effects. Conclusion: Therefore, we suggest assessing MT and account for it as a measure for general cortical TMS susceptibility, even if TMS is applied outside the motor domain.	[Kaminski, Jakob A.; Korb, Franziska M.; Villringer, Arno; Ott, Derek V. M.] Max Planck Inst Human Cognit & Brain Sci, Dept Cognit Neurol, Leipzig, Germany; [Kaminski, Jakob A.; Villringer, Arno] Univ Leipzig, Fac Med, Leipzig, Germany; [Korb, Franziska M.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Ott, Derek V. M.] Univ Clin Leipzig, Dept Neurol, Leipzig, Germany	Max Planck Society; Leipzig University; Duke University; Leipzig University	Kaminski, JA (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Cognit Neurol, Leipzig, Germany.	ottd@cbs.mpg.de	Kaminski, Jakob/W-1349-2019	Kaminski, Jakob/0000-0001-8155-3683; Villringer, Arno/0000-0003-2604-2404; Korb, Franziska/0000-0002-1005-0090	Max Planck Institute for Human Cognitive and Brain Sciences; German National Academic Foundation	Max Planck Institute for Human Cognitive and Brain Sciences; German National Academic Foundation	This research was funded by the Max Planck Institute for Human Cognitive and Brain Sciences. JAK's work was additionally supported with two travel grants from the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; AMASSIAN VE, 1992, ELECTROEN CLIN NEURO, V85, P291, DOI 10.1016/0168-5597(92)90105-K; Antal A, 2004, NEUROREPORT, V15, P297, DOI 10.1097/00001756-200402090-00017; Baddeley A. D, 1986, WORKING MEMORY; BARKER AT, 1985, J PHYSIOL-LONDON, V369, pP3; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buelte D, 2008, BRAIN RES, V1217, P110, DOI 10.1016/j.brainres.2008.03.075; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Dell'Osso B, 2009, BIPOLAR DISORD, V11, P76, DOI 10.1111/j.1399-5618.2008.00651.x; Dormal V, 2012, CORTEX, V48, P623, DOI 10.1016/j.cortex.2011.05.019; Fitzgerald PB, 2009, DEPRESS ANXIETY, V26, P229, DOI 10.1002/da.20454; Friston K, 1994, STAT PARAMETRIC MAPP, P79; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gerwig M, 2003, J NEUROL SCI, V215, P75, DOI 10.1016/S0022-510X(03)00228-4; Guse B, 2010, J NEURAL TRANSM, V117, P105, DOI 10.1007/s00702-009-0333-7; Herbsman T, 2009, HUM BRAIN MAPP, V30, P2044, DOI 10.1002/hbm.20649; Hill AC, 2000, NEUROREPORT, V11, P3257, DOI 10.1097/00001756-200009280-00041; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Loo CK, 2000, BIOL PSYCHIAT, V47, P325, DOI 10.1016/S0006-3223(99)00285-1; McConnell KA, 2001, BIOL PSYCHIAT, V49, P454, DOI 10.1016/S0006-3223(00)01039-8; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Mottaghy FM, 2002, CEREB CORTEX, V12, P369, DOI 10.1093/cercor/12.4.369; Muggleton NG, 2006, NEUROPSYCHOLOGIA, V44, P1222, DOI 10.1016/j.neuropsychologia.2005.10.004; Munchau A, 2002, J NEUROSCI, V22, P554, DOI 10.1523/JNEUROSCI.22-02-00554.2002; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ott DVM, 2011, NEUROIMAGE, V57, P617, DOI 10.1016/j.neuroimage.2011.04.038; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Ragland JD, 2002, NEUROPSYCHOLOGY, V16, P370, DOI 10.1037//0894-4105.16.3.370; Rizzo S, 2007, BRAIN RES BULL, V71, P523, DOI 10.1016/j.brainresbull.2006.11.006; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Sack AT, 2009, J COGNITIVE NEUROSCI, V21, P207, DOI 10.1162/jocn.2009.21126; Sarfeld AS, 2012, HUM BRAIN MAPP, V33, P1107, DOI 10.1002/hbm.21272; Silvanto J, 2008, J NEUROPHYSIOL, V99, P2725, DOI 10.1152/jn.01392.2007; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Smith AE, 2011, J APPL PHYSIOL, V110, P206, DOI 10.1152/japplphysiol.00403.2010; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Speer AM, 2001, J ECT, V17, P259, DOI 10.1097/00124509-200112000-00005; Stern WM, 2007, J NEUROPSYCH CLIN N, V19, P179, DOI 10.1176/appi.neuropsych.19.2.179; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Talairach J., 1988, COPLANAR STEREOTAXIC, P122; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Viggiano MP, 2008, NEUROPSYCHOLOGIA, V46, P2725, DOI 10.1016/j.neuropsychologia.2008.05.004; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	68	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24836	10.1371/journal.pone.0024836	http://dx.doi.org/10.1371/journal.pone.0024836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980359	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600007
J	Dufau, S; Dunabeitia, JA; Moret-Tatay, C; McGonigal, A; Peeters, D; Alario, FX; Balota, DA; Brysbaert, M; Carreiras, M; Ferrand, L; Ktori, M; Perea, M; Rastle, K; Sasburg, O; Yap, MJ; Ziegler, JC; Grainger, J				Dufau, Stephane; Dunabeitia, Jon Andoni; Moret-Tatay, Carmen; McGonigal, Aileen; Peeters, David; Alario, F. -Xavier; Balota, David A.; Brysbaert, Marc; Carreiras, Manuel; Ferrand, Ludovic; Ktori, Maria; Perea, Manuel; Rastle, Kathy; Sasburg, Olivier; Yap, Melvin J.; Ziegler, Johannes C.; Grainger, Jonathan			Smart Phone, Smart Science: How the Use of Smartphones Can Revolutionize Research in Cognitive Science	PLOS ONE			English	Article							DIFFUSION-MODEL ACCOUNT; LEXICAL DECISION TASK	Investigating human cognitive faculties such as language, attention, and memory most often relies on testing small and homogeneous groups of volunteers coming to research facilities where they are asked to participate in behavioral experiments. We show that this limitation and sampling bias can be overcome by using smartphone technology to collect data in cognitive science experiments from thousands of subjects from all over the world. This mass coordinated use of smartphones creates a novel and powerful scientific "instrument" that yields the data necessary to test universal theories of cognition. This increase in power represents a potential revolution in cognitive science.	[Dufau, Stephane; Peeters, David; Alario, F. -Xavier; Ktori, Maria; Sasburg, Olivier; Ziegler, Johannes C.; Grainger, Jonathan] CNRS, UMR 6146, Marseille, France; [Dufau, Stephane; Alario, F. -Xavier; Ktori, Maria; Sasburg, Olivier; Ziegler, Johannes C.; Grainger, Jonathan] Aix Marseille Univ, UMR 6146, Marseille, France; [Dunabeitia, Jon Andoni; Carreiras, Manuel] Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain; [Moret-Tatay, Carmen] Univ Catolica Valencia, Valencia, Spain; [McGonigal, Aileen] INSERM, U751, F-13258 Marseille, France; [Peeters, David] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Balota, David A.] Washington Univ, St Louis, MO USA; [Brysbaert, Marc] Univ Ghent, B-9000 Ghent, Belgium; [Carreiras, Manuel] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Ferrand, Ludovic] Univ Clermont Ferrand, Photochim Mol & Macromol Lab, CNRS, F-63177 Clermont Ferrand, France; [Ferrand, Ludovic] Univ Clermont Ferrand, Clermont Ferrand, France; [Perea, Manuel] Univ Valencia, Valencia, Spain; [Rastle, Kathy] Univ London, Egham, Surrey, England; [Yap, Melvin J.] Natl Univ Singapore, Singapore, Singapore	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universidad Catolica de Valencia San Vicente Martir; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Washington University (WUSTL); Ghent University; Basque Foundation for Science; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); University of Valencia; University of London; Royal Holloway University London; National University of Singapore	Dufau, S (corresponding author), CNRS, UMR 6146, Marseille, France.	Stephane.Dufau@univ-provence.fr	Perea, Manuel/B-3345-2011; Carreiras, Manuel/D-5267-2009; Brysbaert, Marc/A-3910-2011; Peeters, David/U-7720-2018; Grainger, Jonathan/C-9299-2009; Duñabeitia, Jon Andoni/C-8503-2014; Moret-Tatay, Carmen/ABF-7652-2021; Moret-Tatay, Carmen/D-2590-2014; Dufau, Stephane/B-6349-2008; Ferrand, Ludovic/AAF-6658-2021; ALARIO, F.-Xavier/C-6786-2009; Moret-Tatay, Carmen/AAB-1265-2019; McGonigal, Aileen/V-3292-2018; Moret-Tatay, Carmen/GQH-5142-2022; Ziegler, Johannes/C-2234-2008	Perea, Manuel/0000-0002-3291-1365; Carreiras, Manuel/0000-0001-6726-7613; Brysbaert, Marc/0000-0002-3645-3189; Duñabeitia, Jon Andoni/0000-0002-3312-8559; Moret-Tatay, Carmen/0000-0002-2867-9399; Dufau, Stephane/0000-0002-2692-2084; ALARIO, F.-Xavier/0000-0002-8627-5034; Moret-Tatay, Carmen/0000-0002-2867-9399; McGonigal, Aileen/0000-0001-6775-5318; Moret-Tatay, Carmen/0000-0002-2867-9399; FERRAND, Ludovic/0000-0003-1631-7849; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Peeters, David/0000-0002-7974-9246; Rastle, Kathy/0000-0002-3070-7555; Ziegler, Johannes/0000-0002-2061-5729; Yap, Melvin/0000-0002-5372-4323	European Research Council (ERC) [230313]	European Research Council (ERC)(European Research Council (ERC))	This work was supported by a grant from the European Research Council (ERC# 230313) awarded to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Cattell James M. K., 1886, MIND, V11, P220, DOI DOI 10.1093/MIND/OS-XI.42.220; Donders F. C., 1868, SCHNELLIGKEIT PSYCHI, P657; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Luce RD, 1986, RESPONSE TIMES THEIR; MEYER RE, 1971, J EXP PSYCHOL, V90, P227; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Posner M.I., 1978, CHRONOMETRIC EXPLORA; Ratcliff R, 2004, PSYCHOL REV, V111, P159, DOI 10.1037/0033-295X.111.1.159; RUBENSTEIN H, 1970, J VERB LEARN VERB BE, V9, P487, DOI 10.1016/S0022-5371(70)80091-3; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Wagenmakers EJ, 2008, J MEM LANG, V58, P140, DOI 10.1016/j.jml.2007.04.006	12	111	112	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24974	10.1371/journal.pone.0024974	http://dx.doi.org/10.1371/journal.pone.0024974			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21980370	Green Published, gold			2022-12-27	WOS:000295936900019
J	Faumont, S; Rondeau, G; Thiele, TR; Lawton, KJ; McCormick, KE; Sottile, M; Griesbeck, O; Heckscher, ES; Roberts, WM; Doe, CQ; Lockery, SR				Faumont, Serge; Rondeau, Gary; Thiele, Tod R.; Lawton, Kristy J.; McCormick, Kathryn E.; Sottile, Matthew; Griesbeck, Oliver; Heckscher, Ellie S.; Roberts, William M.; Doe, Chris Q.; Lockery, Shawn R.			An Image-Free Opto-Mechanical System for Creating Virtual Environments and Imaging Neuronal Activity in Freely Moving Caenorhabditis elegans	PLOS ONE			English	Article							NEURAL ACTIVITY; IN-VIVO; INDICATORS; LOCOMOTION; BEHAVIOR; CHANNEL; MOTONEURONS; EXPRESSION; DROSOPHILA; RECEPTOR	Non-invasive recording in untethered animals is arguably the ultimate step in the analysis of neuronal function, but such recordings remain elusive. To address this problem, we devised a system that tracks neuron-sized fluorescent targets in real time. The system can be used to create virtual environments by optogenetic activation of sensory neurons, or to image activity in identified neurons at high magnification. By recording activity in neurons of freely moving C. elegans, we tested the long-standing hypothesis that forward and reverse locomotion are generated by distinct neuronal circuits. Surprisingly, we found motor neurons that are active during both types of locomotion, suggesting a new model of locomotion control in C. elegans. These results emphasize the importance of recording neuronal activity in freely moving animals and significantly expand the potential of imaging techniques by providing a mean to stabilize fluorescent targets.	[Faumont, Serge; Heckscher, Ellie S.; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA; [Rondeau, Gary] Appl Sci Instrumentat, Eugene, OR USA; [Thiele, Tod R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lawton, Kristy J.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Sottile, Matthew] Galois Inc, Portland, OR USA; [Griesbeck, Oliver] Max Planck Inst Neurobiol, Martinsried, Germany	Howard Hughes Medical Institute; University of Oregon; University of California System; University of California San Francisco; Cornell University; Max Planck Society	Faumont, S (corresponding author), Univ Oregon, Inst Neurosci, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA.	shawn@chinook.uoregon.edu	Sottile, Matthew/J-1386-2019	Sottile, Matthew/0000-0001-7436-5246; Thiele, Tod/0000-0003-2628-8359; Roberts, William/0000-0001-9762-4255; Griesbeck, Oliver/0000-0001-5883-5594	National Institutes of Health (NIH) [MH051383-13]; NIH National Center for Research Resources; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051383, R29MH051383, R21MH112105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the National Institutes of Health (NIH) grant MH051383-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gal Haspel for help in identifying motoneurons. Some strains were provided by the C. elegans Genetic Center, which is supported by the NIH National Center for Research Resources.	BARGMANN CI, 1990, COLD SH Q B, V55, P529; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; CULOTTI JG, 1978, GENETICS, V90, P243; Goodman MB, 2005, WORMBOOK, DOI [10.1895/wormbook.1.7.1, DOI 10.1895/W0RMBOOK.1.7.1]; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Haspel G, 2010, J NEUROSCI, V30, P11151, DOI 10.1523/JNEUROSCI.2244-10.2010; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Marder E, 2005, CURR BIOL, V15, pR685, DOI 10.1016/j.cub.2005.08.022; Mullins OJ, 2011, PROG NEUROBIOL, V93, P244, DOI 10.1016/j.pneurobio.2010.11.001; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schregardus DS, 2006, J NEUROSCI METH, V155, P62, DOI 10.1016/j.jneumeth.2005.12.028; Stiernagle Theresa, 2006, WormBook, P1; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1992, NATURE, V355, P838, DOI 10.1038/355838a0	35	82	86	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24666	10.1371/journal.pone.0024666	http://dx.doi.org/10.1371/journal.pone.0024666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969859	Green Published, gold			2022-12-27	WOS:000295936900010
J	Jarjour, AA; Durko, M; Luk, TL; Marcal, N; Shekarabi, M; Kennedy, TE				Jarjour, Andrew A.; Durko, Margaret; Luk, Tamarah L.; Marcal, Nathalie; Shekarabi, Masoud; Kennedy, Timothy E.			Autocrine Netrin Function Inhibits Glioma Cell Motility and Promotes Focal Adhesion Formation	PLOS ONE			English	Article							GROWTH-CONE ATTRACTION; COLORECTAL-CANCER DCC; SPINAL-CORD; AXON GUIDANCE; TYROSINE PHOSPHORYLATION; FILOPODIA FORMATION; BRAIN-TUMORS; RECEPTOR DCC; C-ELEGANS; EXPRESSION	Deregulation of mechanisms that control cell motility plays a key role in tumor progression by promoting tumor cell dissemination. Secreted netrins and their receptors, Deleted in Colorectal Cancer (DCC), neogenin, and the UNC5 homologues, regulate cell and axon migration, cell adhesion, and tissue morphogenesis. Netrin and netrin receptor expression have previously been shown to be disrupted in invasive tumors, including glioblastoma. We determined that the human glioblastoma cell lines U87, U343, and U373 all express neogenin, UNC5 homologues, and netrin-1 or netrin-3, but only U87 cells express DCC. Using transfilter migration assays, we demonstrate DCC-dependent chemoattractant migration of U87 cells up a gradient of netrin-1. In contrast, U343 and U373 cells, which do not express DCC, were neither attracted nor repelled. Ectopic expression of DCC by U343 and U373 cells resulted in these cells becoming competent to respond to a gradient of netrin-1 as a chemoattractant, and also slowed their rate of spontaneous migration. Here, in addition to netrins' well-characterized chemotropic activity, we demonstrate an autocrine function for netrin-1 and netrin-3 in U87 and U373 cells that slows migration. We provide evidence that netrins promote the maturation of focal complexes, structures associated with cell movement, into focal adhesions. Consistent with this, netrin, DCC, and UNC5 homologues were associated with focal adhesions, but not focal complexes. Disrupting netrin or DCC function did not alter cell proliferation or survival. Our findings provide evidence that DCC can slow cell migration, and that neogenin and UNC5 homologues are not sufficient to substitute for DCC function in these cells. Furthermore, we identify a role for netrins as autocrine inhibitors of cell motility that promote focal adhesion formation. These findings suggest that disruption of netrin signalling may disable a mechanism that normally restrains inappropriate cell migration.	[Jarjour, Andrew A.; Durko, Margaret; Luk, Tamarah L.; Marcal, Nathalie; Shekarabi, Masoud; Kennedy, Timothy E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Jarjour, AA (corresponding author), Univ Edinburgh, Scottish Ctr Regenerat Med, Edinburgh Ctr Multiple Sclerosis Res, Edinburgh, Midlothian, Scotland.	timothy.kennedy@mcgill.ca		Jarjour, Andrew/0000-0002-1550-1778	Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Biochem Pharma Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Biochem Pharma Inc.	This work was supported by grants from the Canadian Institutes of Health Research, the Multiple Sclerosis Society of Canada, and Biochem Pharma Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Ekstrand BC, 1995, ONCOGENE, V11, P2393; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Flores C, 2005, MOL PSYCHIATR, V10, P606, DOI 10.1038/sj.mp.4001607; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; GORDONWEEKS PR, 1992, EXP PHYSIOL, V77, P681, DOI 10.1113/expphysiol.1992.sp003634; Guillamo JS, 2001, J NEURO-ONCOL, V52, P205, DOI 10.1023/A:1010620420241; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; HUNTER DD, 1992, J COMP NEUROL, V323, P238, DOI 10.1002/cne.903230208; Jarjour AA, 2003, J NEUROSCI, V23, P3735; Jarjour AA, 2008, J NEUROSCI, V28, P11003, DOI 10.1523/JNEUROSCI.3285-08.2008; Kaufmann S, 2009, CELL ONCOL, V31, P415, DOI 10.3233/CLO-2009-0491; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006; KLINGELHUTZ AJ, 1995, ONCOGENE, V10, P1581; Knott JCA, 1998, INT J CANCER, V75, P864, DOI 10.1002/(SICI)1097-0215(19980316)75:6<864::AID-IJC8>3.0.CO;2-T; Koed K, 2005, CANCER RES, V65, P34; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Li WQ, 2006, J CELL SCI, V119, P47, DOI 10.1242/jcs.02697; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Manitt C, 2001, J NEUROSCI, V21, P3911, DOI 10.1523/JNEUROSCI.21-11-03911.2001; Manitt C, 2002, PROG BRAIN RES, V137, P425; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2003, BIOL CELL, V95, P425, DOI 10.1016/S0248-4900(03)00072-8; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Meyerhardt JA, 1999, CELL GROWTH DIFFER, V10, P35; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; NARAYANAN R, 1992, ONCOGENE, V7, P553; NISTER M, 1987, CANCER RES, V47, P4953; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Rajasekharan S, 2010, J NEUROCHEM, V113, P1589, DOI 10.1111/j.1471-4159.2010.06717.x; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Rasband W., 2006, IMAGEJ; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; ReyesMugica M, 1997, CANCER RES, V57, P382; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Shatzmiller RA, 2008, NEUROSCIENCE, V157, P621, DOI 10.1016/j.neuroscience.2008.09.031; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Sieg DJ, 1999, J CELL SCI, V112, P2677; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Tysnes BB, 1997, INVAS METAST, V17, P270; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; von Bulow C, 2001, J PATHOL, V193, P367, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH810>3.0.CO;2-1; Wang H, 1999, J NEUROSCI, V19, P4938; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; YIP JW, 1992, DEV BRAIN RES, V68, P23, DOI 10.1016/0165-3806(92)90244-Q; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	69	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25408	10.1371/journal.pone.0025408	http://dx.doi.org/10.1371/journal.pone.0025408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980448	Green Published, gold, Green Submitted			2022-12-27	WOS:000295936900060
J	Nakaoka, H; Cui, T; Tajima, A; Oka, A; Mitsunaga, S; Kashiwase, K; Homma, Y; Sato, S; Suzuki, Y; Inoko, H; Inoue, I				Nakaoka, Hirofumi; Cui, Tailin; Tajima, Atsushi; Oka, Akira; Mitsunaga, Shigeki; Kashiwase, Koichi; Homma, Yasuhiko; Sato, Shinji; Suzuki, Yasuo; Inoko, Hidetoshi; Inoue, Ituro			A Systems Genetics Approach Provides a Bridge from Discovered Genetic Variants to Biological Pathways in Rheumatoid Arthritis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SEVERE COMBINED IMMUNODEFICIENCY; JAPANESE POPULATION; LUPUS-ERYTHEMATOSUS; SUSCEPTIBILITY GENES; EUROPEAN POPULATIONS; COMMON DISEASE; RISK LOCUS; REVEALS ASSOCIATION; AUTOIMMUNE-DISEASES	Genome-wide association studies (GWAS) have yielded novel genetic loci underlying common diseases. We propose a systems genetics approach to utilize these discoveries for better understanding of the genetic architecture of rheumatoid arthritis (RA). Current evidence of genetic associations with RA was sought through PubMed and the NHGRI GWAS catalog. The associations of 15 single nucleotide polymorphisms and HLA-DRB1 alleles were confirmed in 1,287 cases and 1,500 controls of Japanese subjects. Among these, HLA-DRB1 alleles and eight SNPs showed significant associations and all but one of the variants had the same direction of effect as identified in the previous studies, indicating that the genetic risk factors underlying RA are shared across populations. By receiver operating characteristic curve analysis, the area under the curve (AUC) for the genetic risk score based on the selected variants was 68.4%. For seropositive RA patients only, the AUC improved to 70.9%, indicating good but suboptimal predictive ability. A simulation study shows that more than 200 additional loci with similar effect size as recent GWAS findings or 20 rare variants with intermediate effects are needed to achieve AUC = 80.0%. We performed the random walk with restart (RWR) algorithm to prioritize genes for future mapping studies. The performance of the algorithm was confirmed by leave-one-out cross-validation. The RWR algorithm pointed to ZAP70 in the first rank, in which mutation causes RA-like autoimmune arthritis in mice. By applying the hierarchical clustering method to a subnetwork comprising RA-associated genes and top-ranked genes by the RWR, we found three functional modules relevant to RA etiology: "leukocyte activation and differentiation", "pattern-recognition receptor signaling pathway", and "chemokines and their receptors". These results suggest that the systems genetics approach is useful to find directions of future mapping strategies to illuminate biological pathways.	[Nakaoka, Hirofumi; Inoue, Ituro] Natl Inst Genet, Dept Integrated Genet, Div Human Genet, Shizuoka, Japan; [Cui, Tailin; Tajima, Atsushi; Oka, Akira; Mitsunaga, Shigeki; Inoko, Hidetoshi; Inoue, Ituro] Tokai Univ, Sch Med, Div Mol Life Sci, Kanagawa 2591100, Japan; [Tajima, Atsushi] Univ Tokusima, Grad Sch, Inst Hlth Biosci, Dept Human Genet & Publ Hlth, Tokushima, Japan; [Kashiwase, Koichi] Japanese Red Cross Tokyo Blood Ctr, Dept Lab, Koto Ku, Tokyo, Japan; [Homma, Yasuhiko] Tokai Univ, Sch Med, Dept Clin Hlth Sci, Kanagawa 2591100, Japan; [Sato, Shinji; Suzuki, Yasuo] Tokai Univ, Sch Med, Div Rheumatol, Dept Internal Med, Kanagawa 2591100, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokai University; Tokai University; Tokai University	Nakaoka, H (corresponding author), Natl Inst Genet, Dept Integrated Genet, Div Human Genet, Shizuoka, Japan.	itinoue@lab.nig.ac.jp	Sato, Shinji/V-7271-2019; Tajima, Atsushi/C-1053-2008; Sato, Shinji/AAN-8803-2020	Tajima, Atsushi/0000-0001-6808-5491; Nakaoka, Hirofumi/0000-0002-8454-1159	Japanese Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research [23510242, 22510213, 23133507, 19101008] Funding Source: KAKEN	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Barnetche T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2379; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Barton A, 2009, HUM MOL GENET, V18, P2518, DOI 10.1093/hmg/ddp177; Begovich AB, 2007, ARTHRITIS RHEUM, V56, P3168, DOI 10.1002/art.22857; Burr ML, 2010, ANN RHEUM DIS, V69, P666, DOI 10.1136/ard.2009.111294; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Daha NA, 2009, ARTHRITIS RHEUM-US, V60, P1255, DOI 10.1002/art.24503; Delgado-Vega AM, 2007, AUTOIMMUN REV, V6, P402, DOI 10.1016/j.autrev.2006.11.004; Dieguez-Gonzalez R, 2008, ARTHRITIS RHEUM-US, V58, P1264, DOI 10.1002/art.23426; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Eleftherohorinou H, 2011, HUM MOL GENET, V20, P3494, DOI 10.1093/hmg/ddr248; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gulcher J, 2010, EUR J CLIN INVEST, V40, P56, DOI 10.1111/j.1365-2362.2009.02233.x; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Han SW, 2009, J RHEUMATOL, V36, P693, DOI 10.3899/jrheum.081054; Han SZ, 2005, HUM GENET, V118, P123, DOI 10.1007/s00439-005-0033-9; Harrison P, 2008, RHEUMATOLOGY, V47, P1768, DOI 10.1093/rheumatology/ken374; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ioannidis JPA, 2002, SEMIN ARTHRITIS RHEU, V31, P361, DOI 10.1053/sarh.2002.31725; Iwamoto T, 2006, RHEUMATOLOGY, V45, P804, DOI 10.1093/rheumatology/kel023; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Ji JD, 2010, MOL BIOL REP, V37, P141, DOI 10.1007/s11033-009-9553-z; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Jun KR, 2007, J KOREAN MED SCI, V22, P973, DOI 10.3346/jkms.2007.22.6.973; Kenny EM, 2011, DNA RES, V18, P31, DOI 10.1093/dnares/dsq029; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Kochi Y, 2009, J AUTOIMMUN, V32, P158, DOI 10.1016/j.jaut.2009.02.020; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Koike A, 2009, J HUM GENET, V54, P543, DOI 10.1038/jhg.2009.68; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lee YH, 2008, J RHEUMATOL, V35, P2129, DOI 10.3899/jrheum.080186; Lee YH, 2007, RHEUMATOL INT, V27, P827, DOI 10.1007/s00296-007-0320-y; Lee YH, 2007, J RHEUMATOL, V34, P43; Lee YH, 2010, RHEUMATOL INT, V30, P947, DOI 10.1007/s00296-009-1082-5; Lee YH, 2010, RHEUMATOL INT, V30, P661, DOI 10.1007/s00296-009-1051-z; Lee YH, 2009, J RHEUMATOL, V36, P12, DOI 10.3899/jrheum.080450; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lei C, 2005, EUR J HUM GENET, V13, P823, DOI 10.1038/sj.ejhg.5201423; Lindner E, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-33; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lu Q, 2008, AM J HUM GENET, V82, P641, DOI 10.1016/j.ajhg.2007.12.025; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2009, GENOME MED, V1, DOI 10.1186/gm66; Nadeau JH, 2011, SCIENCE, V331, P1015, DOI 10.1126/science.1203869; Nakaoka H, 2009, J HUM GENET, V54, P615, DOI 10.1038/jhg.2009.95; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Okada Y, 2008, J RHEUMATOL, V35, P1723; Orozco G, 2008, ARTHRITIS RHEUM-US, V58, P1974, DOI 10.1002/art.23549; Orozco G, 2010, ANN RHEUM DIS, V69, P813, DOI 10.1136/ard.2009.109579; Orozco G, 2010, EXPERT REV CLIN IMMU, V6, P61, DOI 10.1586/ECI.09.72; Patsopoulos NA, 2010, ANN RHEUM DIS, V69, P561, DOI 10.1136/ard.2009.109447; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Plant D, 2009, ANN RHEUM DIS, V68, P1373, DOI 10.1136/ard.2008.103572; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Plenge RM, 2009, CURR OPIN RHEUMATOL, V21, P262, DOI 10.1097/BOR.0b013e32832a2e2d; Prahalad S, 2006, GENES IMMUN, V7, P264, DOI 10.1038/sj.gene.6364298; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ransohoff DF, 2010, EUR J CLIN INVEST, V40, P64, DOI 10.1111/j.1365-2362.2009.02232.x; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Shimane K, 2010, ARTHRITIS RHEUM-US, V62, P574, DOI 10.1002/art.27190; Slatkin M, 2008, GENETICS, V179, P2253, DOI 10.1534/genetics.107.077719; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Suarez-Gestal M, 2009, ARTHRITIS RHEUM-US, V60, P2558, DOI 10.1002/art.24748; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115; Takata Y, 2008, J HUM GENET, V53, P163, DOI 10.1007/s10038-007-0232-4; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; van der Helm-van Mil AHM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2384; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wheeler J, 2007, ANTIVIR THER, V12, P233; WILLIAMS RC, 1995, HUM IMMUNOL, V42, P90, DOI 10.1016/0198-8859(94)00079-6; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang QH, 2003, AM J HUM GENET, V72, P636, DOI 10.1086/367923; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	109	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25389	10.1371/journal.pone.0025389	http://dx.doi.org/10.1371/journal.pone.0025389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980439	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900057
J	Sgroi, A; Gonelle-Gispert, C; Morel, P; Baertschiger, RM; Niclauss, N; Mentha, G; Majno, P; Serre-Beinier, V; Buhler, L				Sgroi, Antonino; Gonelle-Gispert, Carmen; Morel, Philippe; Baertschiger, Reto Marc; Niclauss, Nadja; Mentha, Gilles; Majno, Pietro; Serre-Beinier, Veronique; Buhler, Leo			Interleukin-1 Receptor Antagonist Modulates the Early Phase of Liver Regeneration after Partial Hepatectomy in Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; HEPATOCYTE GROWTH-FACTOR; HEPATIC ISCHEMIA-REPERFUSION; CELL-CYCLE PROGRESSION; INFLAMMATORY RESPONSE; MESSENGER-RNA; UP-REGULATION; FAILURE; IL-1; CYTOKINES	Background: Cytokine administration is a potential therapy for acute liver failure by reducing inflammatory responses and favour hepatocyte regeneration. The aim of this study was to evaluate the role of interleukin-1 receptor antagonist (IL-1ra) during liver regeneration and to study the effect of a recombinant human IL-1ra on liver regeneration. Methods: We performed 70%-hepatectomy in wild type (WT) mice, IL-1ra knock-out (KO) mice and in WT mice treated by anakinra. We analyzed liver regeneration at regular intervals by measuring the blood levels of cytokines, the hepatocyte proliferation by bromodeoxyuridin (BrdU) incorporation, proliferating cell nuclear antigen (PCNA) and Cyclin D1 expression. The effect of anakinra on hepatocyte proliferation was also tested in vitro using human hepatocytes. Results: At 24h and at 48h after hepatectomy, IL-1ra KO mice had significantly higher levels of pro-inflammatory cytokines (IL-6, IL-1 beta and MCP-1) and a reduced and delayed hepatocyte proliferation measured by BrdU incorporation, PCNA and Cyclin D1 protein levels, when compared to WT mice. IGFBP-1 and C/EBP beta expression was significantly decreased in IL-1ra KO compared to WT mice. WT mice treated with anakinra showed significantly decreased levels of IL-6 and significantly higher hepatocyte proliferation at 24h compared to untreated WT mice. In vitro, primary human hepatocytes treated with anakinra showed significantly higher proliferation at 24h compared to hepatocytes without treatment. Conclusion: IL1ra modulates the early phase of liver regeneration by decreasing the inflammatory stress and accelerating the entry of hepatocytes in proliferation. IL1ra might be a therapeutic target to improve hepatocyte proliferation.	[Sgroi, Antonino; Gonelle-Gispert, Carmen; Morel, Philippe; Baertschiger, Reto Marc; Serre-Beinier, Veronique; Buhler, Leo] Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland; [Sgroi, Antonino; Gonelle-Gispert, Carmen; Morel, Philippe; Baertschiger, Reto Marc; Serre-Beinier, Veronique; Buhler, Leo] Univ Geneva, Geneva, Switzerland	University of Geneva; University of Geneva	Sgroi, A (corresponding author), Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland.	leo.buhler@hcuge.ch	Baertschiger, Reto/AAA-3299-2021; Serre-Beinier, Véronique/T-8064-2019	Baertschiger, Reto/0000-0002-6284-1994; Serre-Beinier, Véronique/0000-0002-6016-1645; Buhler, Leo/0000-0002-9461-8498	Swiss National Science Foundation [323500-115048/1, 3100A0-109888]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by MD-PhD scholarship No. 323500-115048/1 from the Swiss National Science Foundation to A. S., research Grant No. 3100A0-109888 from the Swiss National Science Foundation to L. B. and C. G. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Assy N, 1997, J HEPATOL, V26, P945, DOI 10.1016/S0168-8278(97)80266-8; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; BOERMEESTER MA, 1995, HEPATOLOGY, V22, P1499, DOI 10.1016/0270-9139(95)90158-2; Boulton R, 1997, HEPATOLOGY, V26, P49; BROWN Z, 1992, KIDNEY INT, V42, P95, DOI 10.1038/ki.1992.266; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Cosgrove BD, 2008, HEPATOLOGY, V48, P276, DOI 10.1002/hep.22335; Dewberry RM, 2008, FEBS LETT, V582, P886, DOI 10.1016/j.febslet.2008.02.021; FISCHER E, 1991, AM J PHYSIOL, V261, pR442, DOI 10.1152/ajpregu.1991.261.2.R442; Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gabay C, 2001, EUR J IMMUNOL, V31, P490, DOI 10.1002/1521-4141(200102)31:2<490::AID-IMMU490>3.0.CO;2-H; Galun E, 2002, BBA-MOL CELL RES, V1592, P345, DOI 10.1016/S0167-4889(02)00326-9; Gramantieri L, 1999, CLIN EXP IMMUNOL, V115, P515; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Harada H, 2002, TRANSPLANTATION, V74, P1434, DOI 10.1097/00007890-200211270-00016; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Leifeld L, 2003, J PATHOL, V199, P335, DOI 10.1002/path.1298; Lentsch AB, 1998, HEPATOLOGY, V27, P507, DOI 10.1002/hep.510270226; Leu JI, 2003, MOL CELL BIOL, V23, P1251, DOI 10.1128/MCB.23.4.1251-1259.2003; Lieu HT, 2006, HEPATOLOGY, V44, P1452, DOI 10.1002/hep.21434; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; Massberg S, 2003, THROMB RES, V110, P187, DOI 10.1016/S0049-3848(03)00342-6; Masuhara M, 1996, HEPATOLOGY, V24, P323; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Molnar C, 2004, EUR CYTOKINE NETW, V15, P303; Ogiso T, 2007, J HEPATOL, V47, P816, DOI 10.1016/j.jhep.2007.06.017; Ostapowicz G, 2000, J GASTROEN HEPATOL, V15, P480, DOI 10.1046/j.1440-1746.2000.02074.x; Pahlavan PS, 2006, J SURG RES, V134, P238, DOI 10.1016/j.jss.2005.12.011; Schilsky ML, 2009, CLIN CHEST MED, V30, P71, DOI 10.1016/j.ccm.2008.10.001; SEKIYAMA KD, 1994, CLIN EXP IMMUNOL, V98, P71; Shinoda M, 2007, J SURG RES, V137, P130, DOI 10.1016/j.jss.2006.08.009; Shinoda M, 2006, TISSUE ENG, V12, P1313, DOI 10.1089/ten.2006.12.1313; SHIOTA G, 1995, HEPATOLOGY, V21, P106, DOI 10.1002/hep.1840210119; Shito M, 1997, TRANSPLANTATION, V63, P143, DOI 10.1097/00007890-199701150-00026; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; Straatsburg IH, 1996, J PATHOL, V179, P100, DOI 10.1002/(SICI)1096-9896(199605)179:1<100::AID-PATH532>3.0.CO;2-W; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340; Tellez N, 2005, GENE THER, V12, P120, DOI 10.1038/sj.gt.3302351; Valatas V, 2004, BRIT J PHARMACOL, V141, P477, DOI 10.1038/sj.bjp.0705633; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; VILLIGER PM, 1992, J CLIN INVEST, V90, P488, DOI 10.1172/JCI115885; Wang ZQ, 1998, HEPATOLOGY, V28, P430, DOI 10.1002/hep.510280221; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; Wustefeld T, 2000, HEPATOLOGY, V32, P514, DOI 10.1053/jhep.2000.16604; Xu Y, 1996, GASTROENTEROLOGY, V110, P1870, DOI 10.1053/gast.1996.v110.pm8964413	56	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25442	10.1371/journal.pone.0025442	http://dx.doi.org/10.1371/journal.pone.0025442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980458	Green Submitted, Green Published, gold			2022-12-27	WOS:000295933700035
J	Markegard, E; Trager, E; Yang, CWO; Zhang, WG; Weiss, A; Roose, JP				Markegard, Evan; Trager, Evan; Yang, Chih-wen Ou; Zhang, Weiguo; Weiss, Arthur; Roose, Jeroen P.			Basal LAT-diacylglycerol-RasGRP1 Signals in T Cells Maintain TCR alpha Gene Expression	PLOS ONE			English	Article							ANTIGEN RECEPTOR; RAS ACTIVATION; B-CELLS; LAT; LYMPHOCYTES; MUTATION; SELF; IMMUNOGLOBULIN; SENSITIVITY; ABLATION	In contrast to the well-characterized T cell receptor (TCR) signaling pathways that induce genes that drive T cell development or polarization of naive CD4 T cells into the diverse T(H)1, T(H)2, T(H)17 and T(reg) lineages, it is unclear what signals maintain specific gene expression in mature resting T cells. Resting T cells residing in peripheral lymphoid organs exhibit low-level constitutive signaling. Whereas tonic signals in B cells are known to be critical for survival, the roles of tonic signals in peripheral T cells are unknown. Here we demonstrate that constitutive signals in Jurkat T cell lines are transduced via the adapter molecule LAT and the Ras exchange factor RasGRP1 to maintain expression of TCR alpha mRNA and surface expression of the TCR/CD3 complex. Independent approaches of reducing basal activity through the LAT-diacylglycerol-RasGRP pathway led to reduced constitutive Ras-MEK-ERK signals and decreased TCR alpha mRNA and surface TCR expression in Jurkat cells. However, loss of TCR expression takes several days in these cell line experiments. In agreement with these in vitro approaches, inducible deletion of Lat in vivo results in reduced TCR alpha mRNA-and surface TCR-expression in a delayed temporal manner as well. Lastly, we demonstrate that loss of basal LAT-RasGRP signals appears to lead to silencing or repression of TCR alpha transcription. We postulate that basal LAT-diacylglycerol-RasGRP signals fulfill a regulatory function in peripheral T lymphocytes by maintaining proper gene expression programs.	[Markegard, Evan; Trager, Evan; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Yang, Chih-wen Ou; Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Markegard, E (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	jeroen.roose@ucsf.edu		Roose, Jeroen/0000-0003-4746-2811	National Institutes of Health-National Cancer Institute [K01CA113367]; Arthritis Foundation; NIH [AI048674, AI056156]; NATIONAL CANCER INSTITUTE [K01CA113367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048674, R56AI048674, R01AI056156, R56AI056156] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institutes of Health-National Cancer Institute (K01CA113367 and ARRA supplement) and Arthritis Foundation (JPR) and the NIH (grants AI048674 and AI056156 for WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Brownlie R, 2009, IMMUNITY, V31, P174, DOI 10.1016/j.immuni.2009.08.002; Chu Peter, 2003, J Biol, V2, P21, DOI 10.1186/1475-4924-2-21; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FIFE BT, 2009, NAT IMMUNOL; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; Hogquist KA, 2003, CURR BIOL, V13, pR239, DOI 10.1016/S0960-9822(03)00161-1; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lin J, 2001, J CELL SCI, V114, P243; LINDSTEN T, 1988, J IMMUNOL, V141, P1769; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Shen SD, 2009, J IMMUNOL, V182, P5596, DOI 10.4049/jimmunol.0803170; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Tomlinson MG, 2000, IMMUNOL TODAY, V21, P584, DOI 10.1016/S0167-5699(00)01716-3; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Vazquez BN, 2009, J IMMUNOL, V183, P6513, DOI 10.4049/jimmunol.0900839; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wilson CB, 2006, CURR OPIN IMMUNOL, V18, P143, DOI 10.1016/j.coi.2006.01.013; YOSHIKAI Y, 1984, NATURE, V312, P521, DOI 10.1038/312521a0; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	44	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25540	10.1371/journal.pone.0025540	http://dx.doi.org/10.1371/journal.pone.0025540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966541	gold, Green Published			2022-12-27	WOS:000295932100049
J	O'Brien, VA; Brown, CR				O'Brien, Valerie A.; Brown, Charles R.			Group Size and Nest Spacing Affect Buggy Creek Virus (Togaviridae: Alphavirus) Infection in Nestling House Sparrows	PLOS ONE			English	Article							FORT-MORGAN VIRUS; WEST-NILE-VIRUS; SWALLOW BUGS; CLIFF SWALLOWS; PARASITE TRANSMISSION; AVIAN DIVERSITY; GREAT-PLAINS; ARBOVIRUS; COLONIALITY; HOST	The transmission of parasites and pathogens among vertebrates often depends on host population size, host species diversity, and the extent of crowding among potential hosts, but little is known about how these variables apply to most vector-borne pathogens such as the arboviruses (arthropod-borne viruses). Buggy Creek virus (BCRV; Togaviridae: Alphavirus) is an RNA arbovirus transmitted by the swallow bug (Oeciacus vicarius) to the cliff swallow (Petrochelidon pyrrhonota) and the introduced house sparrow (Passer domesticus) that has recently invaded swallow nesting colonies. The virus has little impact on cliff swallows, but house sparrows are seriously affected by BCRV. For house sparrows occupying swallow nesting colonies in western Nebraska, USA, the prevalence of BCRV in nestling sparrows increased with sparrow colony size at a site but decreased with the number of cliff swallows present. If one nestling in a nest was infected with the virus, there was a greater likelihood that one or more of its nest-mates would also be infected than nestlings chosen at random. The closer a nest was to another nest containing infected nestlings, the greater the likelihood that some of the nestlings in the focal nest would be BCRV-positive. These results illustrate that BCRV represents a cost of coloniality for a vertebrate host (the house sparrow), perhaps the first such demonstration for an arbovirus, and that virus infection is spatially clustered within nests and within colonies. The decreased incidence of BCRV in sparrows as cliff swallows at a site increased reflects the "dilution effect," in which virus transmission is reduced when a vector switches to feeding on a less competent vertebrate host.	[O'Brien, Valerie A.; Brown, Charles R.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	University of Tulsa	O'Brien, VA (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.	charles-brown@utulsa.edu			National Institutes of Health (NIH) [AI057569]; National Science Foundation (NSF) [DEB-0514824]; American Ornithologists' Union; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057569] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); American Ornithologists' Union; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) (AI057569), National Science Foundation (NSF) (DEB-0514824), and the American Ornithologists' Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; ANDERSON R M, 1991; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Brault AC, 2009, J MED ENTOMOL, V46, P1203, DOI 10.1603/033.046.0531; Brown C. R., 1996, COLONIALITY CLIFF SW; Brown CR, 2008, MOL ECOL, V17, P2164, DOI 10.1111/j.1365-294X.2008.03747.x; Brown CR, 2007, VECTOR-BORNE ZOONOT, V7, P304, DOI 10.1089/vbz.2006.0646; Brown CR, 2010, J MED ENTOMOL, V47, P436, DOI 10.1603/ME09288; Brown CR, 2010, VECTOR-BORNE ZOONOT, V10, P355, DOI 10.1089/vbz.2009.0031; Brown CR, 2009, ECOLOGY, V90, P3168, DOI 10.1890/08-1731.1; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Brown CR, 2002, J MED ENTOMOL, V39, P115, DOI 10.1603/0022-2585-39.1.115; Brown CR, 2001, CURR ORNITHOL, V16, P1; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CALISHER CH, 1980, AM J TROP MED HYG, V29, P1428, DOI 10.4269/ajtmh.1980.29.1428; Carver S, 2011, OECOLOGIA, V166, P713, DOI 10.1007/s00442-010-1882-z; Cecere MC, 1997, MED VET ENTOMOL, V11, P383, DOI 10.1111/j.1365-2915.1997.tb00426.x; Cohen J., 2003, APPL MULTIPLE REGRES; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; de Jong M, 1995, EPIDEMIC MODELS THEI, P84; DIETZ K, 1988, PARASITOL TODAY, V4, P91, DOI 10.1016/0169-4758(88)90034-8; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Godfrey SS, 2009, BEHAV ECOL SOCIOBIOL, V63, P1045, DOI 10.1007/s00265-009-0730-9; HESS AD, 1970, AM J TROP MED HYG, V19, P327, DOI 10.4269/ajtmh.1970.19.327; Hodgson JC, 2001, J MED ENTOMOL, V38, P59, DOI 10.1603/0022-2585-38.1.59; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; HOPLA CE, 1993, J MED ENTOMOL, V30, P267, DOI 10.1093/jmedent/30.1.267; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; Hudson PJ, 1995, PARASITOLOGY, V111, pS49, DOI 10.1017/S0031182000075818; Huyvaert KP, 2008, J WILDLIFE DIS, V44, P331, DOI 10.7589/0090-3558-44.2.331; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Komar N, 1997, THESIS HARVARD U SCH; Kosciuch KL, 2004, AUK, V121, P257, DOI 10.1642/0004-8038(2004)121[0257:EOCVCS]2.0.CO;2; Lowther P.E., 2006, BIRDS N AM; MCGILLIVRAY WB, 1980, AUK, V97, P396; Moller A.P., 1990, NATO ASI Series Series G Ecological Sciences, V24, P269; Moore AT, 2007, J MED ENTOMOL, V44, P42, DOI 10.1603/0022-2585(2007)44[42:ECOBCV]2.0.CO;2; Nunn C, 2005, BEHAV ECOL SOCIOBIOL, V59, P30, DOI 10.1007/s00265-005-0005-z; O'Brien VA, 2011, P ROY SOC B-BIOL SCI, V278, P239, DOI 10.1098/rspb.2010.1098; O'Brien VA, 2010, AM J TROP MED HYG, V82, P937, DOI 10.4269/ajtmh.2010.09-0515; O'Brien VA, 2010, J WILDLIFE DIS, V46, P23, DOI 10.7589/0090-3558-46.1.23; O'Brien VA, 2008, WILSON J ORNITHOL, V120, P910, DOI 10.1676/08-028.1; OBRIEN VA, 2009, THESIS U TULSA TULSA; Padhi A, 2008, J GEN VIROL, V89, P2122, DOI 10.1099/vir.0.2008/001719-0; Pfeffer M, 2006, APPL ENVIRON MICROB, V72, P6886, DOI 10.1128/AEM.00868-06; POULIN R, 1991, CONDOR, V93, P418, DOI 10.2307/1368958; POULIN R, 1991, OECOLOGIA, V86, P390, DOI 10.1007/BF00317606; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Rannala B.H., 1995, DEMOGRAPHY GENETIC S; REISEN W K, 1990, Bulletin of the Society for Vector Ecology, V15, P11; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Royall R., 1997, STAT EVIDENCE LIKELI; RUSH WA, 1980, ANN ENTOMOL SOC AM, V73, P315, DOI 10.1093/aesa/73.3.315; RUSH WA, 1981, J MED ENTOMOL, V18, P425, DOI 10.1093/jmedent/18.5.425; SAS Institute, 2008, SAS STAT US GUID; Schmid-Hempel P., 1998, Parasites in social insects.; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; SCOTT TW, 1984, AM J TROP MED HYG, V33, P981, DOI 10.4269/ajtmh.1984.33.981; SHIELDS WM, 1987, ECOLOGY, V68, P1373, DOI 10.2307/1939221; SMITH G C, 1978, Journal of the Washington Academy of Sciences, V68, P23; STONER DAYTON, 1939, WILSON BULL, V51, P221; SUMMERSSMITH D, 1963, HOUSE SPARROW; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Weaver SC, 1997, J VIROL, V71, P613, DOI 10.1128/JVI.71.1.613-623.1997; [No title captured]	77	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25521	10.1371/journal.pone.0025521	http://dx.doi.org/10.1371/journal.pone.0025521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966539	gold, Green Published			2022-12-27	WOS:000295932100047
J	Sekizuka, T; Matsui, M; Yamane, K; Takeuchi, F; Ohnishi, M; Hishinuma, A; Arakawa, Y; Kuroda, M				Sekizuka, Tsuyoshi; Matsui, Mari; Yamane, Kunikazu; Takeuchi, Fumihiko; Ohnishi, Makoto; Hishinuma, Akira; Arakawa, Yoshichika; Kuroda, Makoto			Complete Sequencing of the bla(NDM-1)-Positive IncA/C Plasmid from Escherichia coli ST38 Isolate Suggests a Possible Origin from Plant Pathogens	PLOS ONE			English	Article							BETA-LACTAMASES; NDM-1; IDENTIFICATION; EMERGENCE; ALIGNMENT	The complete sequence of the plasmid pNDM-1_Dok01 carrying New Delhi metallo-beta-lactamase (NDM-1) was determined by whole genome shotgun sequencing using Escherichia coli strain NDM-1_Dok01 (multilocus sequence typing type: ST38) and the transconjugant E. coli DH10B. The plasmid is an IncA/C incompatibility type composed of 225 predicted coding sequences in 195.5 kb and partially shares a sequence with bla(CMY-2)-positive IncA/C plasmids such as E. coli AR060302 pAR060302 (166.5 kb) and Salmonella enterica serovar Newport pSN254 (176.4 kb). The bla(NDM-1) gene in pNDM-1_Dok01 is terminally flanked by two IS903 elements that are distinct from those of the other characterized NDM-1 plasmids, suggesting that the bla(NDM-1) gene has been broadly transposed, together with various mobile elements, as a cassette gene. The chaperonin groES and groEL genes were identified in the bla(NDM-1)-related composite transposon, and phylogenetic analysis and guanine-cytosine content (GC) percentage showed similarities to the homologs of plant pathogens such as Pseudoxanthomonas and Xanthomonas spp., implying that plant pathogens are the potential source of the bla(NDM-1) gene. The complete sequence of pNDM-1_Dok01 suggests that the bla(NDM-1) gene was acquired by a novel composite transposon on an extensively disseminated IncA/C plasmid and transferred to the E. coli ST38 isolate.	[Sekizuka, Tsuyoshi; Takeuchi, Fumihiko; Kuroda, Makoto] Natl Inst Infect Dis, Lab Bacterial Genom, Pathogen Genom Ctr, Tokyo, Japan; [Matsui, Mari; Yamane, Kunikazu; Arakawa, Yoshichika] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Hishinuma, Akira] Dokkyo Med Univ, Dept Infect Control, Mibu, Tochigi, Japan; [Hishinuma, Akira] Dokkyo Med Univ, Clin Lab Med, Mibu, Tochigi, Japan; [Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Dokkyo Medical University; Dokkyo Medical University; Nagoya University	Sekizuka, T (corresponding author), Natl Inst Infect Dis, Lab Bacterial Genom, Pathogen Genom Ctr, Tokyo, Japan.	makokuro@nih.go.jp	Arakawa, Yoshichika/P-5997-2015	Sekizuka, Tsuyoshi/0000-0002-1302-5472	Ministry of Health, Labor, and Welfare, Japan [H21 Shokuhin-Ippan-013]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid (No.:H21 Shokuhin-Ippan-013) from the Ministry of Health, Labor, and Welfare, Japan (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao H, 2009, BIOINFORMATICS, V25, P1554, DOI 10.1093/bioinformatics/btp255; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Call DR, 2010, ANTIMICROB AGENTS CH, V54, P590, DOI 10.1128/AAC.00055-09; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Chihara S, 2011, CLIN INFECT DIS, V52, P153, DOI 10.1093/cid/ciq054; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; D'Andrea MM, 2011, J CLIN MICROBIOL; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; GRINDLEY NDF, 1980, P NATL ACAD SCI-BIOL, V77, P7176, DOI 10.1073/pnas.77.12.7176; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Muga A, 2008, CURR PROTEIN PEPT SC, V9, P552, DOI 10.2174/138920308786733903; Olson AB, 2005, ANTIMICROB AGENTS CH, V49, P2112, DOI 10.1128/AAC.49.5.2112-2115.2005; Peirano G, 2011, ANTIMICROB AGENTS CH, V55, P2986, DOI 10.1128/AAC.01763-10; Peirano G, 2011, DIAGN MICR INFEC DIS, V69, P449, DOI 10.1016/j.diagmicrobio.2010.11.011; Pfeifer Y, 2011, ANTIMICROB AGENTS CH, V55, P1318, DOI 10.1128/AAC.01585-10; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Rodriguez MM, 2004, ANTIMICROB AGENTS CH, V48, P4895, DOI 10.1128/AAC.48.12.4895-4897.2004; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Samuelsen O, 2011, J ANTIMICROB CHEMOTH, V66, P670, DOI 10.1093/jac/dkq483; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Tamura K, 2011, MOL BIOL EVOLUTION; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Yamamoto T, 2011, J INFECT CHEMOTHER, V17, P435, DOI 10.1007/s10156-011-0232-3; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zheng BW, 2011, PROTEIN CELL, V2, P250, DOI 10.1007/s13238-011-1027-0	39	79	81	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25334	10.1371/journal.pone.0025334	http://dx.doi.org/10.1371/journal.pone.0025334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966500	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100046
J	Suzuki, K; Murphy, SH; Xia, YF; Yokota, M; Nakagomi, DK; Liu, F; Verma, IM; Nakajima, H				Suzuki, Kotaro; Murphy, Samantha H.; Xia, Yifeng; Yokota, Masaya; Nakagomi, Daiki; Liu, Fei; Verma, Inder M.; Nakajima, Hiroshi			Tumor Suppressor p53 Functions as a Negative Regulator in IgE-Mediated Mast Cell Activation	PLOS ONE			English	Article							NF-KAPPA-B; IKK-BETA; IN-VIVO; TRANSCRIPTION; DETERMINANTS; APOPTOSIS; RESPONSES; PROTEINS; PATHWAY	Mast cells are known to play a pivotal role in allergic diseases such as allergic rhinitis, asthma, and atopic dermatitis by releasing granules containing histamine, LTC4, and other preformed chemical mediators. Previous reports have demonstrated that IKK2 (also called IKK beta), a central intracellular component of NF-kappa B activation pathways, plays a critical role in IgE-mediated degranulation of mast cells and anaphylaxis in mice. In this study, we show that protein levels of tumor suppressor p53 are up-regulated upon IgE-mediated activation in mast cells and lack of p53 results in enhanced responses in both early and late phase anaphylaxis. p53 inhibits not only the catalytic activity of IKK2 presumably through the modulation of glycosylation but also p65 (RelA)-mediated transactivation. Our findings are the first to demonstrate that p53 functions as a negative regulator in mast cells.	[Suzuki, Kotaro; Murphy, Samantha H.; Xia, Yifeng; Liu, Fei; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Suzuki, Kotaro; Yokota, Masaya; Nakagomi, Daiki; Nakajima, Hiroshi] Chiba Univ, Dept Mol Genet, Grad Sch Med, Chiba, Japan	Salk Institute; Chiba University	Suzuki, K (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	suzuki_k@faculty.chiba-u.jp	Nakajima, Hiroshi/AFU-9313-2022; Xia, Yifeng/G-9850-2011	Nakajima, Hiroshi/0000-0001-8595-9381; 	Ministry of Education, Culture, Sports, Science, and Technology; Japanese Government; (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan; Grants-in-Aid for Scientific Research [23659496, 21390255] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048034, R01AI048034] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government; (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	K.S. is supported in part by Grants-in Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, the Japanese Government and by Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Suzuki K, 2002, J EXP MED, V196, P27, DOI 10.1084/jem.20011682; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106	30	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25412	10.1371/journal.pone.0025412	http://dx.doi.org/10.1371/journal.pone.0025412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966524	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100058
J	Sepe, M; Festa, L; Tolino, F; Bellucci, L; Sisto, L; Alfano, D; Ragno, P; Calabro, V; de Franciscis, V; La Mantia, G; Pollice, A				Sepe, Maria; Festa, Luisa; Tolino, Fabio; Bellucci, Luca; Sisto, Luca; Alfano, Daniela; Ragno, Pia; Calabro, Viola; de Franciscis, Vittorio; La Mantia, Girolama; Pollice, Alessandra			A Regulatory Mechanism Involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the Control of Cell Proliferation	PLOS ONE			English	Article							TAT-BINDING PROTEIN-1; TUMOR-SUPPRESSOR; 26S PROTEASOME; MDM2; DEGRADATION; UBIQUITINATION; SUBUNIT; PROTEOLYSIS; P53	TBP-1/Tat-Binding Protein 1 (also named Rpt-5, S6a or PSMC3) is a multifunctional protein, originally identified as a regulator of HIV-1-Tat mediated transcription. It is an AAA-ATPase component of the 19S regulative subunit of the proteasome and, as other members of this protein family, fulfils different cellular functions including proteolysis and transcriptional regulation. We and others reported that over expression of TBP-1 diminishes cell proliferation in different cellular contexts with mechanisms yet to be defined. Accordingly, we demonstrated that TBP-1 binds to and stabilizes the p14ARF oncosuppressor increasing its anti-oncogenic functions. However, TBP-1 restrains cell proliferation also in the absence of ARF, raising the question of what are the molecular pathways involved. Herein we demonstrate that stable knock-down of TBP-1 in human immortalized fibroblasts increases cell proliferation, migration and resistance to apoptosis induced by serum deprivation. We observe that TBP-1 silencing causes activation of the Akt/PKB kinase and that in turn TBP-1, itself, is a downstream target of Akt/PKB. Moreover, MDM2, a known Akt target, plays a major role in this regulation. Altogether, our data suggest the existence of a negative feedback loop involving Akt/PKB that might act as a sensor to modulate TBP-1 levels in proliferating cells.	[Sepe, Maria; Festa, Luisa; Tolino, Fabio; Bellucci, Luca; Sisto, Luca; Calabro, Viola; La Mantia, Girolama; Pollice, Alessandra] Univ Naples Federico II, Dipartimento Biol Strutturale & Funz, Naples, Italy; [Tolino, Fabio; de Franciscis, Vittorio] Consiglio Nazl Ric CNR G Salvatore, Ist Endocrinol & Oncol, Naples, Italy; [Alfano, Daniela; Ragno, Pia] Univ Salerno, Dipartimento Chim, I-84100 Salerno, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Salerno	Sepe, M (corresponding author), Univ Naples Federico II, Dipartimento Biol Strutturale & Funz, Naples, Italy.	apollice@unina.it	Calabro', Fabio/O-2250-2019; Calabro, Viola/H-6156-2013	Calabro', Fabio/0000-0002-7863-3540; Calabro, Viola/0000-0002-6508-8889	PRIN (Programmi di ricerca di Rilevante Interesse Nazionale); AIRC (Associazione Italiana Ricerca sul Cancro); MIUR-FIRB (Ministero Istruzione Universita e Ricerca-Fondo per gli Investimenti della Ricerca di Base) [RBIN04J4J7]	PRIN (Programmi di ricerca di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); MIUR-FIRB (Ministero Istruzione Universita e Ricerca-Fondo per gli Investimenti della Ricerca di Base)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants awarded to GLM and PR from PRIN (Programmi di ricerca di Rilevante Interesse Nazionale) and AIRC (Associazione Italiana Ricerca sul Cancro). VdF received funding from MIUR-FIRB (Ministero Istruzione Universita e Ricerca-Fondo per gli Investimenti della Ricerca di Base) (RBIN04J4J7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Barnes CJ, 2005, CLIN CANCER RES, V11, P2868, DOI 10.1158/1078-0432.CCR-04-1989; Chen Y, 1997, J BIOL CHEM, V272, P24081, DOI 10.1074/jbc.272.38.24081; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Corn PG, 2003, NAT GENET, V35, P229, DOI 10.1038/ng1254; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; El-Deiry WS, 2001, NAT CELL BIOL, V3, pE71, DOI 10.1038/35060148; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kulikov R, 2010, P NATL ACAD SCI USA, V107, P10038, DOI 10.1073/pnas.0911716107; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lavabre-Bertrand T, 2001, CANCER, V92, P2493, DOI 10.1002/1097-0142(20011115)92:10<2493::AID-CNCR1599>3.0.CO;2-F; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Park BW, 1999, P NATL ACAD SCI USA, V96, P6434, DOI 10.1073/pnas.96.11.6434; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pollice A, 2007, ONCOGENE, V26, P5154, DOI 10.1038/sj.onc.1210313; Pollice A, 2004, J BIOL CHEM, V279, P6345, DOI 10.1074/jbc.M310957200; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Satoh T, 2009, BIOCHEM BIOPH RES CO, V386, P697, DOI 10.1016/j.bbrc.2009.06.099; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang YJ, 2004, ONCOGENE, V23, P7132, DOI 10.1038/sj.onc.1207918; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zwickl P, 1999, NAT CELL BIOL, V1, pE97, DOI 10.1038/12097	37	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e22800	10.1371/journal.pone.0022800	http://dx.doi.org/10.1371/journal.pone.0022800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991300	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300001
J	Veyrac, A; Reibel, S; Sacquet, J; Mutin, M; Camdessanche, JP; Kolattukudy, P; Honnorat, J; Jourdan, F				Veyrac, Alexandra; Reibel, Sophie; Sacquet, Joelle; Mutin, Mireille; Camdessanche, Jean-Philippe; Kolattukudy, Pappachan; Honnorat, Jerome; Jourdan, Francois			CRMP5 Regulates Generation and Survival of Newborn Neurons in Olfactory and Hippocampal Neurogenic Areas of the Adult Mouse Brain	PLOS ONE			English	Article							RESPONSE MEDIATOR PROTEIN-1; DENDRITIC DEVELOPMENT; CELL-PROLIFERATION; EXPRESSION; MICE; SYSTEM; FAMILY; DEATH; BULB; FOREBRAIN	The Collapsin Response Mediator Proteins (CRMPs) are highly expressed in the developing brain, and in adult brain areas that retain neurogenesis, ie: the olfactory bulb (OB) and the dentate gyrus (DG). During brain development, CRMPs are essentially involved in signaling of axon guidance and neurite outgrowth, but their functions in the adult brain remain largely unknown. CRMP5 has been initially identified as the target of auto-antibodies involved in paraneoplasic neurological diseases and further implicated in a neurite outgrowth inhibition mediated by tubulin binding. Interestingly, CRMP5 is also highly expressed in adult brain neurogenic areas where its functions have not yet been elucidated. Here we observed in both neurogenic areas of the adult mouse brain that CRMP5 was present in proliferating and post-mitotic neuroblasts, while they migrate and differentiate into mature neurons. In CRMP5(-/-) mice, the lack of CRMP5 resulted in a significant increase of proliferation and neurogenesis, but also in an excess of apoptotic death of granule cells in the OB and DG. These findings provide the first evidence that CRMP5 is involved in the generation and survival of newly generated neurons in areas of the adult brain with a high level of activity-dependent neuronal plasticity.	[Veyrac, Alexandra; Sacquet, Joelle; Jourdan, Francois] Univ Lyon 1, Team Neuroplast & Neuropathol Olfactory Percept, Lyon Neurosci Res Ctr, INSERM,U1028,CNRS,UMR 5292, F-69365 Lyon, France; [Reibel, Sophie; Mutin, Mireille; Camdessanche, Jean-Philippe; Honnorat, Jerome] Univ Lyon 1, Team Neurooncol & Neuroinflammat, Lyon Neurosci Res Ctr, INSERM,U1028,CNRS,UMR 5292,Fac Laennec, F-69365 Lyon, France; [Kolattukudy, Pappachan] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; State University System of Florida; University of Central Florida	Veyrac, A (corresponding author), Univ Lyon 1, Team Neuroplast & Neuropathol Olfactory Percept, Lyon Neurosci Res Ctr, INSERM,U1028,CNRS,UMR 5292, F-69365 Lyon, France.	jourdan@olfac.univ-lyon1.fr	Veyrac, Alexandra/G-8313-2017; Camdessanché, Jean-Philippe/N-9652-2017; kolattukudy, pappachan e/A-1350-2012; Honnorat, jerome/G-6394-2017	Camdessanché, Jean-Philippe/0000-0002-5282-6707; Honnorat, jerome/0000-0002-4721-5952; VEYRAC, Alexandra/0000-0002-8063-4016	CNRS (Centre National de la Recherche Scientifique); INSERM 5 Institut National de la Recherche Medicale; French Research Ministry through Universite Claude Bernard Lyon 1	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM 5 Institut National de la Recherche Medicale; French Research Ministry through Universite Claude Bernard Lyon 1	Funding for this work was obtained from the French academic institutions CNRS (Centre National de la Recherche Scientifique), INSERM 5 Institut National de la Recherche Medicale and French Research Ministry through Universite Claude Bernard Lyon 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Auvergnon N, 2009, BRAIN RES, V1261, P1, DOI 10.1016/j.brainres.2009.01.006; Bath KG, 2012, DEV PSYCHOBIOL, V54, P578, DOI 10.1002/dev.20546; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Charrier E, 2006, GENES CELLS, V11, P1337, DOI 10.1111/j.1365-2443.2006.01024.x; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Duplan L, 2010, J NEUROSCI, V30, P785, DOI 10.1523/JNEUROSCI.5411-09.2010; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Honnorat J, 1999, EUR J NEUROSCI, V11, P4226, DOI 10.1046/j.1460-9568.1999.00864.x; Honnorat J, 2009, J NEUROL NEUROSUR PS, V80, P412, DOI 10.1136/jnnp.2007.138016; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; HOWARD C, 1998, UNBIASED STEREOLOGY, P41; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Inatome R, 2000, J BIOL CHEM, V275, P27291; McLaughlin D, 2008, NEUROSCI LETT, V432, P117, DOI 10.1016/j.neulet.2007.12.011; Meyronet D, 2008, AM J SURG PATHOL, V32, P1699, DOI 10.1097/PAS.0b013e31817dc37c; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Nacher J, 2000, J COMP NEUROL, V424, P628, DOI 10.1002/1096-9861(20000904)424:4<628::AID-CNE5>3.0.CO;2-4; Petreanu L, 2002, J NEUROSCI, V22, P6106; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Veyrac A, 2005, EXP NEUROL, V194, P444, DOI 10.1016/j.expneurol.2005.03.004; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; Veyrac A, 2011, FASEB J, V25, P1048, DOI 10.1096/fj.10-172635; Yamashita N, 2011, J NEUROSCI, V31, P1773, DOI 10.1523/JNEUROSCI.5337-10.2011; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	33	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e23721	10.1371/journal.pone.0023721	http://dx.doi.org/10.1371/journal.pone.0023721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991301	Green Submitted, Green Published, gold			2022-12-27	WOS:000295963300002
J	Hill, PJ; Stritzker, J; Scadeng, M; Geissinger, U; Haddad, D; Basse-Lusebrink, TC; Gbureck, U; Jakob, P; Szalay, AA				Hill, Philip J.; Stritzker, Jochen; Scadeng, Miriam; Geissinger, Ulrike; Haddad, Daniel; Basse-Luesebrink, Thomas C.; Gbureck, Uwe; Jakob, Peter; Szalay, Aladar A.			Magnetic Resonance Imaging of Tumors Colonized with Bacterial Ferritin-Expressing Escherichia coli	PLOS ONE			English	Article							BLOOD-BRAIN BARRIER; GENE-EXPRESSION; SALMONELLA-TYPHIMURIUM; TRANSGENE REPORTER; SUGAR-TRANSPORT; BREAST-TUMORS; MRI REPORTER; IRON-UPTAKE; THERAPY; PROTEINS	Background: Recent studies have shown that human ferritin can be used as a reporter of gene expression for magnetic resonance imaging (MRI). Bacteria also encode three classes of ferritin-type molecules with iron accumulation properties. Methods and Findings: Here, we investigated whether these bacterial ferritins can also be used as MRI reporter genes and which of the bacterial ferritins is the most suitable reporter. Bacterial ferritins were overexpressed in probiotic E. coli Nissle 1917. Cultures of these bacteria were analyzed and those generating highest MRI contrast were further investigated in tumor bearing mice. Among members of three classes of bacterial ferritin tested, bacterioferritin showed the most promise as a reporter gene. Although all three proteins accumulated similar amounts of iron when overexpressed individually, bacterioferritin showed the highest contrast change. By site-directed mutagenesis we also show that the heme iron, a unique part of the bacterioferritin molecule, is not critical for MRI contrast change. Tumor-specific induction of bacterioferritin-expression in colonized tumors resulted in contrast changes within the bacteria-colonized tumors. Conclusions: Our data suggest that colonization and gene expression by live vectors expressing bacterioferritin can be monitored by MRI due to contrast changes.	[Hill, Philip J.; Stritzker, Jochen; Geissinger, Ulrike; Szalay, Aladar A.] Genelux Corp, San Diego, CA 92109 USA; [Hill, Philip J.] Univ Nottingham, Sch Biosci, Leicester, Leics, England; [Hill, Philip J.] Univ Wurzburg, Sch Med, Virchow Ctr, Wurzburg, Germany; [Stritzker, Jochen; Szalay, Aladar A.] Bioctr, Inst Biochem, Wurzburg, Germany; [Stritzker, Jochen; Szalay, Aladar A.] Inst Mol Infect Biol, Wurzburg, Germany; [Haddad, Daniel; Basse-Luesebrink, Thomas C.; Jakob, Peter] Inst Expt Phys V, Wurzburg, Germany; [Haddad, Daniel; Basse-Luesebrink, Thomas C.; Jakob, Peter] MRB Res Ctr, Wurzburg, Germany; [Scadeng, Miriam] Univ Calif San Diego, Ctr Funct MRI, La Jolla, CA 92093 USA; [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, Wurzburg, Germany	University of Nottingham; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego; University of Wurzburg	Hill, PJ (corresponding author), Genelux Corp, San Diego, CA 92109 USA.	aaszalay@genelux.com	hill, phil/AAQ-1081-2020; Gbureck, Uwe/G-1430-2012	hill, phil/0000-0002-2250-1397; Jakob, Peter/0000-0002-3481-5545; Scadeng, Miriam/0000-0002-9593-2956	Research and Development Division of Genelux Corporation, San Diego, United States of America; Service Grant; Genelux Corp.; Research and Development Division of Genelux Corporation	Research and Development Division of Genelux Corporation, San Diego, United States of America; Service Grant; Genelux Corp.; Research and Development Division of Genelux Corporation	This research was supported by the Research and Development Division of Genelux Corporation, San Diego, United States of America, and a Service Grant to the University of Wurzburg, Germany. PJH was supported by a grant received from Genelux Corp.; JS and AAS are employees and shareholders of Genelux Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The research was supported by the Research and Development Division of Genelux Corporation and a Service Grant to the University of Wurzburg, Germany also funded by Genelux Corporation. PJH was supported by a grant received from Genelux Corporation; JS and AAS are employees and shareholders of Genelux Corporation. PJH, JS and AAS are co-inventors of the patents "Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders'' (US 7820184 B2 and US 7763420 B2). There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All of the other authors declare that they have no conflicts of interest.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; ANDREWS SC, 1991, BIOCHIM BIOPHYS ACTA, V1078, P111, DOI 10.1016/0167-4838(91)90099-L; ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R; Aung W, 2009, GENE THER, V16, P830, DOI 10.1038/gt.2009.55; Benoit MR, 2009, CLIN CANCER RES, V15, P5170, DOI 10.1158/1078-0432.CCR-08-3206; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; BRADER P, 2008, CLIN CAN RES; Brooks RA, 1998, MAGN RESON MED, V40, P227, DOI 10.1002/mrm.1910400208; BUSCHIAZZO PM, 1970, AM J PHYSIOL, V219, P1505, DOI 10.1152/ajplegacy.1970.219.5.1505; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497; Deans AE, 2006, MAGN RESON MED, V56, P51, DOI 10.1002/mrm.20914; EIDELBERG E, 1967, J PHYSIOL-LONDON, V191, P47, DOI 10.1113/jphysiol.1967.sp008236; FOLEY JE, 1978, AM J PHYSIOL, V234, pE112, DOI 10.1152/ajpendo.1978.234.2.E112; FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Gossuin Y, 2004, NMR BIOMED, V17, P427, DOI 10.1002/nbm.903; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; GROSSMAN MJ, 1992, P NATL ACAD SCI USA, V89, P2419, DOI 10.1073/pnas.89.6.2419; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Harrison PM, 1998, MET IONS BIOL SYST, V35, P435; Hasegawa S, 2010, MAGN RESON MED SCI, V9, P37, DOI 10.2463/mrms.9.37; HEMPSTEAD PD, 1994, FEBS LETT, V350, P258, DOI 10.1016/0014-5793(94)00781-0; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; HUDSON AJ, 1993, EUR J BIOCHEM, V218, P985, DOI 10.1111/j.1432-1033.1993.tb18457.x; Kim HS, 2010, CANCER RES, V70, P7315, DOI 10.1158/0008-5472.CAN-10-0241; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z; Liu J, 2009, TISSUE ENG PART C-ME, V15, P739, DOI 10.1089/ten.TEC.2008.0678; Loessner H, 2009, MICROBES INFECT, V11, P1097, DOI 10.1016/j.micinf.2009.08.002; Morrissey D, 2010, CURR GENE THER, V10, P3, DOI 10.2174/156652310790945575; Ono K, 2009, BIOCHEM BIOPH RES CO, V388, P589, DOI 10.1016/j.bbrc.2009.08.055; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; RIEDEL CU, 2007, APPL ENV MICROBIOL; Ryan RM, 2006, BIOESSAYS, V28, P84, DOI 10.1002/bies.20336; Soghomonyan SA, 2005, CANCER GENE THER, V12, P101, DOI 10.1038/sj.cgt.7700779; STRITZKER J, 2007, INT J MED MICROBIOL; Stritzker Jochen, 2010, Bioeng Bugs, V1, P139, DOI 10.4161/bbug.1.2.10286; Stritzker J, 2010, INT J MED MICROBIOL, V300, P449, DOI 10.1016/j.ijmm.2010.02.004; Taniguchi S, 2010, CANCER SCI, V101, P1925, DOI 10.1111/j.1349-7006.2010.01628.x; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; TRIKHA J, 1994, PROTEINS, V18, P107, DOI 10.1002/prot.340180204; Van Mellaert L, 2006, TRENDS MICROBIOL, V14, P190, DOI 10.1016/j.tim.2006.02.002; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Vymazal J, 1996, MAGN RESON MED, V36, P61, DOI 10.1002/mrm.1910360111; VYMAZAL J, 1992, MAGNET RESON MED, V27, P368, DOI 10.1002/mrm.1910270218; Wall DM, 2010, ONCOTARGET, V1, P721; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zurkiya O, 2008, MAGN RESON MED, V59, P1225, DOI 10.1002/mrm.21606	56	19	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25409	10.1371/journal.pone.0025409	http://dx.doi.org/10.1371/journal.pone.0025409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984917	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000029
J	Kanamori-Katayama, M; Kaiho, A; Ishizu, Y; Okamura-Oho, Y; Hino, O; Abe, M; Kishimoto, T; Sekihara, H; Nakamura, Y; Suzuki, H; Forrest, ARR; Hayashizaki, Y				Kanamori-Katayama, Mutsumi; Kaiho, Ai; Ishizu, Yuri; Okamura-Oho, Yuko; Hino, Okio; Abe, Masaaki; Kishimoto, Takumi; Sekihara, Hisahiko; Nakamura, Yukio; Suzuki, Harukazu; Forrest, Alistair R. R.; Hayashizaki, Yoshihide			LRRN4 and UPK3B Are Markers of Primary Mesothelial Cells	PLOS ONE			English	Article							MEGAKARYOCYTE POTENTIATING FACTOR; MALIGNANT MESOTHELIOMA; GENE-EXPRESSION; MOLECULAR-CLONING; ESTABLISHMENT; IDENTIFICATION; DIAGNOSIS; ASBESTOS; CANCER; DIFFERENTIATION	Background: Mesothelioma is a highly malignant tumor that is primarily caused by occupational or environmental exposure to asbestos fibers. Despite worldwide restrictions on asbestos usage, further cases are expected as diagnosis is typically 2040 years after exposure. Once diagnosed there is a very poor prognosis with a median survival rate of 9 months. Considering this the development of early pre clinical diagnostic markers may help improve clinical outcomes. Methodology: Microarray expression arrays on mesothelium and other tissues dissected from mice were used to identify candidate mesothelial lineage markers. Candidates were further tested by qRTPCR and in-situ hybridization across a mouse tissue panel. Two candidate biomarkers with the potential for secretion, uroplakin 3B (UPK3B), and leucine rich repeat neuronal 4 (LRRN4) and one commercialized mesothelioma marker, mesothelin (MSLN) were then chosen for validation across a panel of normal human primary cells, 16 established mesothelioma cell lines, 10 lung cancer lines, and a further set of 8 unrelated cancer cell lines. Conclusions: Within the primary cell panel, LRRN4 was only detected in primary mesothelial cells, but MSLN and UPK3B were also detected in other cell types. MSLN was detected in bronchial epithelial cells and alveolar epithelial cells and UPK3B was detected in retinal pigment epithelial cells and urothelial cells. Testing the cell line panel, MSLN was detected in 15 of the 16 mesothelioma cells lines, whereas LRRN4 was only detected in 8 and UPK3B in 6. Interestingly MSLN levels appear to be upregulated in the mesothelioma lines compared to the primary mesothelial cells, while LRRN4 and UPK3B, are either lost or down-regulated. Despite the higher fraction of mesothelioma lines positive for MSLN, it was also detected at high levels in 2 lung cancer lines and 3 other unrelated cancer lines derived from papillotubular adenocarcinoma, signet ring carcinoma and transitional cell carcinoma.	[Kanamori-Katayama, Mutsumi; Kaiho, Ai; Ishizu, Yuri; Suzuki, Harukazu; Forrest, Alistair R. R.; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, OMICs Sci Ctr, Kanagawa, Japan; [Okamura-Oho, Yuko] RIKEN Adv Sci Inst, Adv Computat Sci Dept, Wako, Saitama, Japan; [Hino, Okio; Abe, Masaaki] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 113, Japan; [Kishimoto, Takumi] Japan Labor Hlth & Welf Org Okayama Rosai Hosp, Dept Resp Med, Okayama, Japan; [Sekihara, Hisahiko] Japan Labour Hlth & Welf Org, Kawasaki, Kanagawa, Japan; [Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan	RIKEN; RIKEN; Juntendo University; RIKEN	Kanamori-Katayama, M (corresponding author), RIKEN Yokohama Inst, OMICs Sci Ctr, Kanagawa, Japan.	alistair.forrest@gmail.com; rgscerg@gsc.riken.jp	Hayashizaki, Yoshihide/N-6590-2015; Suzuki, Harukazu/N-9553-2015; Nakamura, Yukio/A-5263-2016	Suzuki, Harukazu/0000-0002-8087-0836; Nakamura, Yukio/0000-0001-8056-4946; Forrest, Alistair/0000-0003-4543-1675	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology to the RIKEN Omics Science Center to Yoshihide Hayashizaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameille Jacques, 2004, Rev Prat, V54, P1649; AMIN KM, 1995, AM J PATHOL, V146, P344; Aoe K, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e12007; ARMSTRONG BK, 1984, MED J AUSTRALIA, V141, P86, DOI 10.5694/j.1326-5377.1984.tb132709.x; Bando T, 2005, MOL CELL BIOL, V25, P4166, DOI 10.1128/MCB.25.10.4166-4175.2005; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMIN H, 2009, J CLIN ONCOL, V27; Beyer HL, 2007, CLIN CHEM, V53, P666, DOI 10.1373/clinchem.2006.079327; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chen Y, 2003, CANCER RES, V63, P1927; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eba S, 2009, Kyobu Geka, V62, P598; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Gordon GJ, 2002, CANCER RES, V62, P4963; Hagiwara Y, 2008, CANCER SCI, V99, P666, DOI 10.1111/j.1349-7006.2008.00731.x; HILL ID, 1966, P ROY SOC MED, V59, P59, DOI 10.1177/003591576605900126; Ichikawa M, 2005, NEUROBIOL DIS, V19, P378, DOI 10.1016/j.nbd.2005.01.021; Ishikawa K, 2009, PATHOL INT, V59, P161, DOI 10.1111/j.1440-1827.2009.02344.x; Ivanov SV, 2009, INT J CANCER, V124, P589, DOI 10.1002/ijc.23949; JASANI B, 1985, VIRCHOWS ARCH A, V406, P441, DOI 10.1007/BF00710235; Jirsova K, 2010, EXP EYE RES, V91, P623, DOI 10.1016/j.exer.2010.08.002; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Ladou J, 2010, ENVIRON HEALTH PERSP, V118, P897, DOI 10.1289/ehp.1002285; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Li Zhong-Qian, 2007, Expert Opin Med Diagn, V1, P137, DOI 10.1517/17530059.1.1.137; Liu CC, 2006, NUCLEIC ACIDS RES, V34, P4069, DOI 10.1093/nar/gkl583; Liu ZW, 2004, ANTICANCER RES, V24, P599; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Mazieres J, 2005, INT J CANCER, V117, P326, DOI 10.1002/ijc.21160; MCNULTY JC, 1962, MED J AUSTRALIA, V2, P953, DOI 10.5694/j.1326-5377.1962.tb24396.x; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Phelps RM, 1996, J CELL BIOCHEM, P32; Rihn BH, 2000, FEBS LETT, V480, P95, DOI 10.1016/S0014-5793(00)01913-X; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; SELIKOFF IJ, 1980, CANCER, V46, P2736, DOI 10.1002/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L; SHEIBANI K, 1991, AM J SURG PATHOL, V15, P779, DOI 10.1097/00000478-199108000-00008; Simon BA, 2006, AM J PHYSIOL-LUNG C, V291, pL851, DOI 10.1152/ajplung.00463.2005; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun XJ, 2005, J PATHOL, V207, P91, DOI 10.1002/path.1810; Suzuki H, 2004, FEBS LETT, V573, P214, DOI 10.1016/j.febslet.2004.07.068; Usami N, 2006, CANCER SCI, V97, P387, DOI 10.1111/j.1349-7006.2006.00184.x; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; VERSNEL M, 2002, HUMAN CELL CULTURE; VERSNEL MA, 1989, CANCER GENET CYTOGEN, V42, P115, DOI 10.1016/0165-4608(89)90014-9; WAGNER J C, 1960, Br J Ind Med, V17, P260; Wang IM, 2008, AM J RESP CRIT CARE, V177, P402, DOI 10.1164/rccm.200703-390OC; YUNG S, 1995, AM J PATHOL, V146, P520	51	52	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25391	10.1371/journal.pone.0025391	http://dx.doi.org/10.1371/journal.pone.0025391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984916	Green Submitted, gold, Green Published			2022-12-27	WOS:000295943000028
J	Lin, Y; Son, H; Lee, J; Min, K; Choi, GJ; Kim, JC; Lee, YW				Lin, Yang; Son, Hokyoung; Lee, Jungkwan; Min, Kyunghun; Choi, Gyung Ja; Kim, Jin-Cheol; Lee, Yin-Won			A Putative Transcription Factor MYT1 Is Required for Female Fertility in the Ascomycete Gibberella zeae	PLOS ONE			English	Article							FUSARIUM-GRAMINEARUM; FUNCTIONAL ANALYSES; HEAD-BLIGHT; C-MYB; SEXUAL DEVELOPMENT; FILAMENTOUS FUNGI; BINDING PROTEIN; GENE; WHEAT; DIFFERENTIATION	Gibberella zeae is an important pathogen of major cereal crops. The fungus produces ascospores that forcibly discharge from mature fruiting bodies, which serve as the primary inocula for disease epidemics. In this study, we characterized an insertional mutant Z39P105 with a defect in sexual development and identified a gene encoding a putative transcription factor designated as MYT1. This gene contains a Myb DNA-binding domain and is conserved in the subphylum Pezizomycotina of Ascomycota. The MYT1 protein fused with green fluorescence protein localized in nuclei, which supports its role as a transcriptional regulator. The MYT1 deletion mutant showed similar phenotypes to the wild-type strain in vegetative growth, conidia production and germination, virulence, and mycotoxin production, but had defect in female fertility. A mutant overexpressing MYT1 showed earlier germination, faster mycelia growth, and reduced mycotoxin production compared to the wild-type strain, suggesting that improper MYT1 expression affects the expression of genes involved in the cell cycle and secondary metabolite production. This study is the first to characterize a transcription factor containing a Myb DNA-binding domain that is specific to sexual development in G. zeae.	[Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Yin-Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Yin-Won] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Lee, Jungkwan] Dong A Univ, Dept Appl Biol, Pusan, South Korea; [Choi, Gyung Ja; Kim, Jin-Cheol] Korea Res Inst Chem Technol, Biol Funct Res Team, Taejon 305606, South Korea	Seoul National University (SNU); Seoul National University (SNU); Dong A University; Korea Research Institute of Chemical Technology (KRICT)	Lin, Y (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	lee2443@snu.ac.kr		Min, Kyunghun/0000-0002-2682-4660; Son, Hokyoung/0000-0001-5080-7951	National Research Foundation of Korea (NRF); Korean government (MEST) [2010-0001826]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2010-0001826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BLACKWELL PUB PROF; Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Desjardins AE, 2004, APPL ENVIRON MICROB, V70, P2437, DOI 10.1128/AEM.70.4.2437-2444.2004; DESJARDINS AE, FUSARIUM MYCOTOXINS; Dill-Macky R, 2000, PLANT DIS, V84, P71, DOI 10.1094/PDIS.2000.84.1.71; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; DYER PS, 1992, BIOL REV, V67, P421, DOI 10.1111/j.1469-185X.1992.tb01189.x; Gardiner DM, 2009, MOL PLANT MICROBE IN, V22, P1588, DOI 10.1094/MPMI-22-12-1588; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Han YK, 2007, MOL MICROBIOL, V63, P768, DOI 10.1111/j.1365-2958.2006.05557.x; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Hong SY, 2010, FUNGAL GENET BIOL, V47, P364, DOI 10.1016/j.fgb.2010.01.005; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Kwon SJ, 2009, VIRUS RES, V144, P96, DOI 10.1016/j.virusres.2009.04.004; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee J, 2010, BIOCHEM BIOPH RES CO, V401, P48, DOI 10.1016/j.bbrc.2010.09.005; Lee J, 2009, APPL ENVIRON MICROB, V75, P3289, DOI 10.1128/AEM.02287-08; Lee SH, 2009, EUKARYOT CELL, V8, P1155, DOI 10.1128/EC.00335-08; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Lee SH, 2006, FUNGAL GENET BIOL, V43, P295, DOI 10.1016/j.fgb.2005.12.007; Leslie JF, 1996, GENETICS, V144, P557; Lipsick JS, 1996, ONCOGENE, V13, P223; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Park J, 2008, NUCLEIC ACIDS RES, V36, pD562, DOI 10.1093/nar/gkm758; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; RAJU NB, 1992, MYCOL RES, V96, P241, DOI 10.1016/S0953-7562(09)80934-9; RAJU NB, 1986, MYCOLOGIA, V78, P901, DOI 10.2307/3807428; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rodriguez-Sanchez L, 2011, J CELL SCI, V124, P25, DOI 10.1242/jcs.070987; Sambrook J., 2001, MOL CLONING LAB MANU; Seo JA, 1996, MYCOPATHOLOGIA, V134, P31, DOI 10.1007/BF00437050; Shen WC, 1998, GENETICS, V148, P1031; Shim WB, 2006, MOL PLANT MICROBE IN, V19, P725, DOI 10.1094/MPMI-19-0725; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Trail F, 2000, MYCOLOGIA, V92, P130, DOI 10.2307/3761457; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zeller KA, 2004, MOL ECOL, V13, P563, DOI 10.1046/j.1365-294X.2004.02098.x; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001	62	21	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25586	10.1371/journal.pone.0025586	http://dx.doi.org/10.1371/journal.pone.0025586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984921	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000043
J	Agarwal, M; Guzman, MG; Morales-Matos, C; Diaz, RAD; Abramson, CI; Giray, T				Agarwal, Maitreyi; Guzman, Manuel Giannoni; Morales-Matos, Carla; Del Valle Diaz, Rafael Alejandro; Abramson, Charles I.; Giray, Tugrul			Dopamine and Octopamine Influence Avoidance Learning of Honey Bees in a Place Preference Assay	PLOS ONE			English	Article							STING EXTENSION REFLEX; APIS-MELLIFERA BRAIN; DIVISION-OF-LABOR; JUVENILE-HORMONE; BEHAVIORAL-DEVELOPMENT; FUNCTIONAL EXPRESSION; OLFACTORY MEMORIES; TYRAMINE; REWARD; RECEPTOR	Biogenic amines are widely characterized in pathways evaluating reward and punishment, resulting in appropriate aversive or appetitive responses of vertebrates and invertebrates. We utilized the honey bee model and a newly developed spatial avoidance conditioning assay to probe effects of biogenic amines octopamine (OA) and dopamine (DA) on avoidance learning. In this new protocol non-harnessed bees associate a spatial color cue with mild electric shock punishment. After a number of experiences with color and shock the bees no longer enter the compartment associated with punishment. Intrinsic aspects of avoidance conditioning are associated with natural behavior of bees such as punishment (lack of food, explosive pollination mechanisms, danger of predation, heat, etc.) and their association to floral traits or other spatial cues during foraging. The results show that DA reduces the punishment received whereas octopamine OA increases the punishment received. These effects are dose-dependent and specific to the acquisition phase of training. The effects during acquisition are specific as shown in experiments using the antagonists Pimozide and Mianserin for DA and OA receptors, respectively. This study demonstrates the integrative role of biogenic amines in aversive learning in the honey bee as modeled in a novel non-appetitive avoidance learning assay.	[Agarwal, Maitreyi] Univ Puerto Rico, Dept Chem, San Juan, PR 00936 USA; [Guzman, Manuel Giannoni; Morales-Matos, Carla; Del Valle Diaz, Rafael Alejandro; Giray, Tugrul] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Abramson, Charles I.] Oklahoma State Univ, Lab Behav Biol & Comparat Psychol, Stillwater, OK 74078 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Oklahoma State University System; Oklahoma State University - Stillwater	Agarwal, M (corresponding author), Univ Puerto Rico, Dept Chem, San Juan, PR 00936 USA.	tgiray2@yahoo.com	Abramson, Charles/AAD-5709-2019; Giray, Tugrul/K-9570-2013	Abramson, Charles/0000-0001-8961-3089; Giray, Tugrul/0000-0003-4383-4681	National Science Foundation, United States of America [OISE-1043057, DBI-0851651]; National Aeronautics and Space Administration Puerto Rico Space Grant Consortium [NASA-IDEAS-PR-08]; Direct For Biological Sciences [0851651] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [1043057] Funding Source: National Science Foundation	National Science Foundation, United States of America(National Science Foundation (NSF)); National Aeronautics and Space Administration Puerto Rico Space Grant Consortium; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	Parts of this work and its publication have been supported by grants from National Science Foundation, United States of America (OISE-1043057 to CA and TG and DBI-0851651), and National Aeronautics and Space Administration Puerto Rico Space Grant Consortium (NASA-IDEAS-PR-08 to TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; Abramson CI, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.12201; ABRAMSON CI, 1988, J EXP ANAL BEHAV, V50, P483, DOI 10.1901/jeab.1988.50-483; ABRAMSON CI, 1981, J GEN PSYCHOL, V104, P29, DOI 10.1080/00221309.1981.9921017; ABRAMSON CI, 1995, J COMP PSYCHOL, V109, P390, DOI 10.1037/0735-7036.109.4.390; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; Arenas A, 2008, J COMP PHYSIOL A, V194, P629, DOI 10.1007/s00359-008-0337-z; Avargues-Weber A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015370; Barron AB, 2005, J COMP PHYSIOL A, V191, P659, DOI 10.1007/s00359-005-0619-7; Barron AB, 2007, J INSECT PHYSIOL, V53, P187, DOI 10.1016/j.jinsphys.2006.11.009; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; Barron AB, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00163; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Blenau W, 1998, J NEUROCHEM, V70, P15; Cakmak I, 2010, J INSECT BEHAV, V23, P100, DOI 10.1007/s10905-009-9199-7; CAMPBELL BA, PUNISHMENT AVERSIVE; Carcaud J, 2009, J EXP BIOL, V212, P620, DOI 10.1242/jeb.026641; CHEN WY, 1970, ANIM BEHAV, V18, P725, DOI 10.1016/0003-3472(70)90018-7; De Marco RJ, 2006, J EXP BIOL, V209, P421, DOI 10.1242/jeb.02025; DISTERHOFT JF, 1971, PHYSIOL BEHAV, V7, P359, DOI 10.1016/0031-9384(71)90314-3; DISTERHOFT JF, 1972, J COMP PHYSIOL PSYCH, V79, P1, DOI 10.1037/h0032557; Farooqui T, 2004, J INSECT PHYSIOL, V50, P701, DOI 10.1016/j.jinsphys.2004.04.014; Farooqui T, 2003, J NEUROSCI, V23, P5370; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Giray T, 1996, P NATL ACAD SCI USA, V93, P11718, DOI 10.1073/pnas.93.21.11718; Giray T, 2005, P NATL ACAD SCI USA, V102, P3330, DOI 10.1073/pnas.0409560102; GIRAY T, 1994, BEHAV ECOL SOCIOBIOL, V35, P13, DOI 10.1007/BF00167054; Giray T, 2007, J INSECT PHYSIOL, V53, P691, DOI 10.1016/j.jinsphys.2007.03.016; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Giurfa M, 2009, LEARN MEMORY, V16, P761, DOI 10.1101/lm.1603009; Grohmann L, 2000, EUR J NEUROSCI, V12, P94; Harano K, 2008, J INSECT PHYSIOL, V54, P848, DOI 10.1016/j.jinsphys.2008.03.003; Hawes JJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1864, DOI 10.1038/sj.npp.1301579; Hunt GJ, 2007, J INSECT PHYSIOL, V53, P399, DOI 10.1016/j.jinsphys.2007.01.010; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; KOLMES SA, 1989, J NEW YORK ENTOMOL S, V97, P218; Lange AB, 2009, GEN COMP ENDOCR, V162, P18, DOI 10.1016/j.ygcen.2008.05.021; Libersat F, 2004, BIOSCIENCE, V54, P17, DOI 10.1641/0006-3568(2004)054[0017:MATOOB]2.0.CO;2; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004694; Mustard JA, 2010, J INSECT PHYSIOL, V56, P422, DOI 10.1016/j.jinsphys.2009.11.018; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; OSHEA M, 1979, J EXP BIOL, V79, P169; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; RAGLAND RS, 1965, PSYCHON SCI, V3, P117; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; ROEDER T, 1990, EUR J PHARMACOL, V191, P221, DOI 10.1016/0014-2999(90)94151-M; Sandoz JC, 2001, LEARN MEMORY, V8, P286, DOI 10.1101/lm.41401; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Schulz DJ, 2002, HORM BEHAV, V42, P222, DOI 10.1006/hbeh.2002.1806; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Seefeldt S, 2008, J EXP BIOL, V211, P3392, DOI 10.1242/jeb.017624; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; SMITH BH, 1991, J COMP PSYCHOL, V105, P345, DOI 10.1037/0735-7036.105.4.345; Sokal R.R., 2012, BIOMETRY; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; TAYLOR R C, 1971, Journal of Biological Psychology, V13, P36; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Younger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013309	72	70	73	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25371	10.1371/journal.pone.0025371	http://dx.doi.org/10.1371/journal.pone.0025371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980435	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300026
J	Zhang, Y; Johansson, E; Miller, ML; Janicke, RU; Ferguson, DJ; Plas, D; Meller, J; Anderson, MW				Zhang, Yu; Johansson, Elisabet; Miller, Marian L.; Jaenicke, Reiner U.; Ferguson, Donald J.; Plas, David; Meller, Jarek; Anderson, Marshall W.			Identification of a Conserved Anti-Apoptotic Protein That Modulates the Mitochondrial Apoptosis Pathway	PLOS ONE			English	Article							DRUG-INDUCED APOPTOSIS; KINASE-C INHIBITOR; PHASE-I TRIAL; ACTIVATION; COMBINATION; CASPASE-8; UCN-01; CELLS; 7-HYDROXYSTAUROSPORINE; CLEAVAGE	Here we identified an evolutionarily highly conserved and ubiquitously expressed protein ( C9orf82) that shows structural similarities to the death effector domain of apoptosis-related proteins. RNAi knockdown of C9orf82 induced apoptosis in A-549 and MCF7/casp3-10b lung and breast carcinoma cells, respectively, but not in cells lacking caspase-3, caspase-10 or both. Apoptosis was associated with activated caspases-3, -8, -9 and -10, and inactivation of caspases 10 or 3 was sufficient to block apoptosis in this pathway. Apoptosis upon knockdown of C9orf82 was associated with increased caspase-10 expression and activation, which was required for the generation of an 11 kDa tBid fragment and activation of Caspase-9. These data suggest that C9orf82 functions as an anti-apoptotic protein that modulates a caspase-10 dependent mitochondrial caspase-3/9 feedback amplification loop. We designate this ubiquitously expressed and evolutionarily conserved anti-apoptotic protein Conserved Anti-Apoptotic Protein (CAAP). We also demonstrated that treatment of MCF7/casp3-10b cells with staurosporine and etoposides induced apoptosis and knockdown of CAAP expression. This implies that the CAAP protein could be a target for chemotherapeutic agents.	[Zhang, Yu] Univ Cincinnati, Sch Pharm, Cincinnati, OH 45221 USA; [Johansson, Elisabet; Miller, Marian L.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Jaenicke, Reiner U.] Univ Dusseldorf, Lab Mol Radiooncol, Clin & Policlin Radiat Therapy & Radiooncol, Ctr Clin, Dusseldorf, Germany; [Ferguson, Donald J.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Plas, David] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Meller, Jarek] Univ Cincinnati, Med Ctr, Childrens Hosp, Div Biomed Informat,Dept Environm Hlth, Cincinnati, OH 45267 USA; [Meller, Jarek] Univ Cincinnati, Med Ctr, Childrens Hosp, Div Biomed Informat,Dept Biomed Engn, Cincinnati, OH 45267 USA; [Anderson, Marshall W.] Med Coll Wisconsin, Dept Med, Ctr Canc, Milwaukee, WI 53226 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Heinrich Heine University Dusseldorf; University System of Ohio; Miami University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Medical College of Wisconsin	Zhang, Y (corresponding author), Univ Cincinnati, Sch Pharm, Cincinnati, OH 45221 USA.	mwanderson@mcw.edu	Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253	University of Cincinnati College of Medicine; National Institute of Environmental Health Sciences (NIEHS) [P30 ES06096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	University of Cincinnati College of Medicine; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the University of Cincinnati College of Medicine and by a grant from the National Institute of Environmental Health Sciences (NIEHS) to the Center for Environmental Genetics (P30 ES06096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Engels IH, 2005, MOL CELL BIOL, V25, P2808, DOI 10.1128/MCB.25.7.2808-2818.2005; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Filomenko R, 2006, ONCOGENE, V25, P7635, DOI 10.1038/sj.onc.1209733; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Hotte SJ, 2006, ANN ONCOL, V17, P334, DOI 10.1093/annonc/mdj076; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jimeno A, 2008, CANCER CHEMOTH PHARM, V61, P423, DOI 10.1007/s00280-007-0485-9; Kortmansky J, 2005, J CLIN ONCOL, V23, P1875, DOI 10.1200/JCO.2005.03.116; Kummar S, 2010, CANCER CHEMOTH PHARM, V65, P383, DOI 10.1007/s00280-009-1154-y; Lee HJ, 2007, NAT CELL BIOL, V9, P1303, DOI 10.1038/ncb1650; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MANNS J, 2011, FASEB J; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Monnerat C, 2004, ANN ONCOL, V15, P316, DOI 10.1093/annonc/mdh052; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rikhof B, 2003, CANCER BIOL THER, V2, P707; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sampath D, 2006, BLOOD, V107, P2517, DOI 10.1182/blood-2005-08-3351; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; SHIIO Y, 1992, P NATL ACAD SCI USA, V89, P5206, DOI 10.1073/pnas.89.12.5206; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; WIEST JS, 1977, CANCER RES, V57, P1; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5	37	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25284	10.1371/journal.pone.0025284	http://dx.doi.org/10.1371/journal.pone.0025284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980415	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300023
J	Dong, GY; Xu, C; Wang, CM; Wu, B; Luo, J; Zhang, H; Nolte, DL; Deliberto, TJ; Duan, MX; Ji, GJ; He, HX				Dong, Guoying; Xu, Cong; Wang, Chengmin; Wu, Bin; Luo, Jing; Zhang, Hong; Nolte, Dale Louis; Deliberto, Thomas Jude; Duan, Mingxing; Ji, Guangju; He, Hongxuan			Reassortant H9N2 Influenza Viruses Containing H5N1-Like PB1 Genes Isolated from Black-Billed Magpies in Southern China	PLOS ONE			English	Article							A VIRUSES; MOLECULAR CHARACTERIZATION; AVIAN INFLUENZA; HONG-KONG; PHYLOGENETIC ANALYSIS; HUMAN INFECTION; MAINLAND CHINA; H5N1; EVOLUTION; DUCKS	H9N2 influenza A viruses have become endemic in different types terrestrial poultry and wild birds in Asia, and are occasionally transmitted to humans and pigs. To evaluate he role of black-billed magpies (Pica pica) in the evolution of influenza A virus, we conducted two epidemic surveys on avian influenza viruses in wild black-billed magpies in Guangxi, China in 2005 and characterized three isolated black-billed magpie H9N2 viruses (BbM viruses). Phylogenetic analysis indicated that three BbM viruses were almost identical with 99.7 to 100% nucleotide homology in their whole genomes, and were reassortants containing BJ94-like (Ck/BJ/1/94) HA, NA, M, and NS genes, SH/F/98-like (Ck/SH/F/98) PB2, PA, and NP genes, and H5N1-like (Ck/YN/1252/03, clade 1) PB1 genes. Genetic analysis showed that BbM viruses were most likely the result of multiple reassortments between co-circulating H9N2-like and H5N1-like viruses, and were genetically different from other H9N2 viruses because of the existence of H5N1-like PB1 genes. Genotypical analysis revealed that BbM viruses evolved from diverse sources and belonged to a novel genotype (B46) discovered in our recent study. Molecular analysis suggested that BbM viruses were likely low pathogenic reassortants. However, results of our pathogenicity study demonstrated that BbM viruses replicated efficiently in chickens and a mammalian mouse model but were not lethal for infected chickens and mice. Antigenic analysis showed that BbM viruses were antigenic heterologous with the H9N2 vaccine strain. Our study is probably the first report to document and characterize H9N2 influenza viruses isolated from black-billed magpies in southern China. Our results suggest that black-billed magpies were susceptible to H9N2 influenza viruses, which raise concerns over possible transmissions of reassortant H9N2 viruses among poultry and wild birds.	[Dong, Guoying; Wang, Chengmin; Wu, Bin; Luo, Jing; Zhang, Hong; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Dong, Guoying; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Xu, Cong] Southwest Univ, Coll Food Sci, Chongqing, Peoples R China; [Nolte, Dale Louis; Deliberto, Thomas Jude] USDA, Natl Wildlife Dis Program, USDA APHIS Wildlife Serv, Ft Collins, CO USA; [Duan, Mingxing] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Southwest University - China; United States Department of Agriculture (USDA); Tsinghua University	Dong, GY (corresponding author), Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	gj28@ibp.ac.cn; hehx@ioz.ac.cn		Zhang, Hong/0000-0002-3930-6731; Ji, Guangju/0000-0001-8626-3490	science & technology support project of the eleventh-five-year plan of China [2009BAI83B01]; National Key Basic Research and Development Program of China [2007BC109103]; Chinese Academy of Sciences [KSCX2-YW-N-063]; NWDP USDA-IOZ CAS [0760621234]	science & technology support project of the eleventh-five-year plan of China; National Key Basic Research and Development Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); NWDP USDA-IOZ CAS	This work was supported by grants from the science & technology support project of the eleventh-five-year plan of China (2009BAI83B01), the National Key Basic Research and Development Program of China (Grant No. 2007BC109103), the Knowledge Innovation Project of the Chinese Academy of Sciences (Grant No. KSCX2-YW-N-063) and NWDP USDA-IOZ CAS joint project (0760621234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1981, AVIAN PATHOL, V10, P281, DOI 10.1080/03079458108418477; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen H, 2003, VACCINE, V21, P4430, DOI 10.1016/S0264-410X(03)00430-4; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kwon HJ, 2006, AVIAN PATHOL, V35, P309, DOI 10.1080/03079450600821166; Lee DCW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-71; Lee YJ, 2007, VIROLOGY, V359, P313, DOI 10.1016/j.virol.2006.09.025; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu JH, 2003, VIRUS GENES, V27, P291, DOI 10.1023/A:1026304117797; Lu JH, 2005, VIRUS GENES, V31, P163, DOI 10.1007/s11262-005-1790-1; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu B, 2009, CHINESE SCI BULL, V54, P2179, DOI 10.1007/s11434-009-0421-y; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06	40	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25808	10.1371/journal.pone.0025808	http://dx.doi.org/10.1371/journal.pone.0025808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980538	Green Published, gold			2022-12-27	WOS:000295939600056
J	Guesdon, V; Bertin, A; Houdelier, C; Lumineau, S; Formanek, L; Kotrschal, K; Mostl, E; Richard-Yris, MA				Guesdon, Vanessa; Bertin, Aline; Houdelier, Cecilia; Lumineau, Sophie; Formanek, Laureline; Kotrschal, Kurt; Moestl, Erich; Richard-Yris, Marie-Annick			A Place to Hide in the Home-Cage Decreases Yolk Androgen Levels and Offspring Emotional Reactivity in Japanese Quail	PLOS ONE			English	Article							AMONG-CLUTCH VARIATION; TESTOSTERONE LEVELS; ENVIRONMENTAL ENRICHMENT; MATERNAL TESTOSTERONE; CORTICOSTERONE LEVELS; DEVELOPMENTAL STRESS; STEROID-HORMONES; WITHIN-CLUTCH; BEHAVIOR; EGGS	An animal's emotional responses are the result of its cognitive appraisal of a situation. This appraisal is notably influenced by the possibility of an individual to exert control over an aversive event. Although the fact that environment controllability decreases emotional responses in animals is well established, far less is known about its potential trans-generational effects. As the levels of avian yolk hormones can vary according to the mother's environment, we hypothesized that housing environment of mothers would modulate the quality of her eggs and in turn her offspring's behaviour. Two groups of female japanese quail were constituted: a group that had access to a place to hide in their home-cage (Hd, n = 20) and a group that had nowhere to hide (NoHd, n = 20) when stressed. Both groups were submitted to daily human disturbances for a twenty-day-period. Hd females produced eggs with both less testosterone and androstenedione than did NoHd females. The emotional and social reactivity of Hd female's offspring were lower and their growth wes slower than those of NoHd females' offspring. Our results show that a minor difference in housing environment had substantial effects on eggs and offspring. The presence of a shelter probably helped quail to cope with daily human disturbances, producing less reactive offspring. This transgenerational effect caused by an opportunity to hide could lead to applications in care of laboratory animals, conservation biology and animal welfare.	[Guesdon, Vanessa; Houdelier, Cecilia; Lumineau, Sophie; Formanek, Laureline; Richard-Yris, Marie-Annick] Univ Rennes 1, UMR CNRS 6552, Rennes, France; [Bertin, Aline; Kotrschal, Kurt] Univ Vienna, Konrad Lorenz Forsch Stelle, Grunau, Austria; [Moestl, Erich] Univ Vet Med, Dept Nat Sci, Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of Vienna; University of Veterinary Medicine Vienna	Guesdon, V (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	vguesdon@tours.inra.fr		Lumineau, Sophie/0000-0002-2076-9947	Foundation Fyssen; FWF (Fonds zur Forderung der Wissenschaftlichen Forschung) [P 18601-017]	Foundation Fyssen; FWF (Fonds zur Forderung der Wissenschaftlichen Forschung)(Austrian Science Fund (FWF))	This work was partly funded by the Foundation Fyssen and the FWF (Fonds zur Forderung der Wissenschaftlichen Forschung: The Austrian Science Fund) Project P 18601-017. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; Archer J., 1976, P231; AUBRAIS O, 1986, Gibier Faune Sauvage, V3, P317; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bertin A, 2009, HORM BEHAV, V56, P416, DOI 10.1016/j.yhbeh.2009.07.008; Bruggeman V, 2002, COMP BIOCHEM PHYS A, V131, P839, DOI 10.1016/S1095-6433(02)00022-3; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; FAURE JM, 1983, BIOL BEHAV, V8, P103; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gil D, 2003, ARDEOLA, V50, P281; Gil D, 2007, J EXP ZOOL PART A, V307A, P91, DOI 10.1002/jez.a.340; Greiveldinger L, 2009, PSYCHONEUROENDOCRINO, V34, P805, DOI 10.1016/j.psyneuen.2008.10.025; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guibert F, 2011, APPL ANIM BEHAV SCI, V132, P51, DOI 10.1016/j.applanim.2011.03.012; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Guyomarc'h J.C., 1998, BWP UPDATE, V2, P27; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Hegyi G, 2010, J AVIAN BIOL, V41, P258, DOI 10.1111/j.1600-048X.2009.04787.x; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Hirschenhauser K, 1999, GEN COMP ENDOCR, V114, P67, DOI 10.1006/gcen.1998.7236; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P66, DOI 10.1016/j.applanim.2006.09.016; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LAUNAY F, 1993, PHYSIOL BEHAV, V54, P111, DOI 10.1016/0031-9384(93)90051-G; LAUNAY F, 1993, THESIS U RENNES 1 FR; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; Love OP, 2008, HORM BEHAV, V53, P104, DOI 10.1016/j.yhbeh.2007.09.007; Love OP, 2011, J EVOLUTION BIOL, V24, P1497, DOI 10.1111/j.1420-9101.2011.02282.x; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; Mills A. D., 1994, COMPORTEMENT BIEN ET, P127; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1987, BRIT POULTRY SCI, V28, P177, DOI 10.1080/00071668708416950; MILLS AD, 1993, PHYSIOL BEHAV, V53, P183, DOI 10.1016/0031-9384(93)90029-F; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; North M.O., 1984, COMMERCIAL CHICKEN P; Odabasi AZ, 2007, POULTRY SCI, V86, P356, DOI 10.1093/ps/86.2.356; Okuliarova M, 2007, ACTA VET BRNO, V76, P325, DOI 10.2754/avb200776030325; Okuliarova M., 2006, NEW INSIGHTS FUNDAME, P173; Okuliarova M, 2010, GEN COMP ENDOCR, V165, P91, DOI 10.1016/j.ygcen.2009.06.007; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Puppe B, 2007, APPL ANIM BEHAV SCI, V105, P75, DOI 10.1016/j.applanim.2006.05.016; Rettenbacher S, 2005, ANN NY ACAD SCI, V1046, P193, DOI 10.1196/annals.1343.016; Rettenbacher S, 2009, GEN COMP ENDOCR, V164, P125, DOI 10.1016/j.ygcen.2009.05.019; Rubolini D, 2005, HORM BEHAV, V47, P592, DOI 10.1016/j.yhbeh.2005.01.006; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Saint-Dizier H, 2008, APPL ANIM BEHAV SCI, V112, P297, DOI 10.1016/j.applanim.2007.09.005; Scherer K. R., 1999, HDB COGNITION EMOTIO, P637, DOI [10.1002/0470013494.ch30, DOI 10.1002/0470013494.CH30]; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Smiseth PT, 2011, ANIM BEHAV, V81, P507, DOI 10.1016/j.anbehav.2010.11.029; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Tobler M, 2007, HORM BEHAV, V52, P640, DOI 10.1016/j.yhbeh.2007.07.016; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; von Engelhardt N, 2009, GEN COMP ENDOCR, V163, P175, DOI 10.1016/j.ygcen.2009.04.004; Weinberg J, 1980, COPING HLTH, P39; WEISS JM, 1972, SCI AM, V226, P104, DOI 10.1038/scientificamerican0672-104; Wells DL, 2009, APPL ANIM BEHAV SCI, V118, P1, DOI 10.1016/j.applanim.2009.01.002; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046	77	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e23941	10.1371/journal.pone.0023941	http://dx.doi.org/10.1371/journal.pone.0023941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980338	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600002
J	Renner, M; Domanov, Y; Sandrin, F; Izeddin, I; Bassereau, P; Triller, A				Renner, Marianne; Domanov, Yegor; Sandrin, Fanny; Izeddin, Ignacio; Bassereau, Patricia; Triller, Antoine			Lateral Diffusion on Tubular Membranes: Quantification of Measurements Bias	PLOS ONE			English	Article							BIOLOGICAL-MEMBRANES; NONPLANAR FORM; PROTEINS; DYNAMICS; TRACKING; TRAJECTORIES; MICROSCOPY; RECEPTORS; MOLECULES; VESICLES	Single Particle Tracking (SPT) is a powerful technique for analysis of the lateral diffusion of the lipid and protein components of biological membranes. In neurons, SPT allows the study of the real-time dynamics of receptors for neurotransmitters that diffuse continuously in and out synapses. In the simplest case where the membrane is flat and is parallel to the focal plane of the microscope the analysis of diffusion from SPT data is relatively straightforward. However, in most biological samples the membranes are carved, which complicates analysis and may lead to erroneous conclutions as for the mode of lateral diffusion. Here we considered the case of lateral diffusion in tubular membranes, such as axons, dendrites or the neck of dendritic spines. Monte Carlo simulations allowed us to evaluate the error in diffusion coefficient (D) calculation if the curvature is not taken into account. The underestimation is determined by the diameter of the tubular surface, the frequency of image acquisition and the degree of mobility itself. We found that projected trajectories give estimates that are 25 to 50% lower than the real D in case of 2D-SPT over the tubular surface. The use of 3D-SPT improved the measurements if the frequency of image acquisition was fast enough in relation to the mobility of the molecules and the diameter of the tube. Nevertheless, the calculation of D from the components of displacements in the axis of he tubular structure gave accurate estimate of D, free of geometrical artefacts. We show the application of this approach to analyze the diffusion of a lipid on model tubular membranes and of a membrane-bound GFP on neurites from cultured rat hippocampal neuron.	[Renner, Marianne; Sandrin, Fanny; Izeddin, Ignacio; Triller, Antoine] Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, IBENS, U1024,UMR8197, Paris, France; [Domanov, Yegor; Sandrin, Fanny; Bassereau, Patricia] Univ Paris 06, Ctr Natl Rech Sci, Membrane & Cell Funct Grp, Inst Curie,Ctr Rech,UMR168, Paris, France; [Izeddin, Ignacio] IBENS, Lab Kastler Brossel, Dept Phys, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Renner, M (corresponding author), Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, IBENS, U1024,UMR8197, Paris, France.	patricia.bassereau@curie.fr; triller@biologie.ens.fr	Izeddin, Ignacio/H-2628-2013; Renner, Marianne/H-5315-2011; Bassereau, Patricia/P-8657-2018	Izeddin, Ignacio/0000-0002-8476-3915; Renner, Marianne/0000-0002-8727-6581; Bassereau, Patricia/0000-0002-8544-6778; Domanov, Yegor/0000-0003-1531-6457; TRILLER, Antoine/0000-0002-7530-1233	Agence Nationale de la Recherche [ANR-Neur-043-02, ANR-08-Blan-0282-02]; Fondation Pierre-Gilles de Gennes; Marie Curie Actions; Netherlands Organisation for Scientific Research (NWO)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Pierre-Gilles de Gennes; Marie Curie Actions(European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Agence Nationale de la Recherche ANR-Neur-043-02 and ANR-08-Blan-0282-02, Fondation Pierre-Gilles de Gennes, Marie Curie Actions, and Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZENBUD BM, 1985, BIOPHYS J, V48, P543, DOI 10.1016/S0006-3495(85)83811-X; AIZENBUD BM, 1982, BIOPHYS J, V38, P287, DOI 10.1016/S0006-3495(82)84560-8; Almeida P.F.F, 1995, HDB BIOL PHYS STRUCT, V1, P305; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Berglund AJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011917; Cuvelier D, 2005, EUROPHYS LETT, V71, P1015, DOI 10.1209/epl/i2005-10173-4; Daniels DR, 2007, LANGMUIR, V23, P6667, DOI 10.1021/la0635000; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Fournier JB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.018103; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Goulian M, 2000, BIOPHYS J, V79, P2188, DOI 10.1016/S0006-3495(00)76467-8; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Long BR, 2010, BIOPHYS J, V98, P1712, DOI 10.1016/j.bpj.2009.12.4299; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]; Sbalzarini IF, 2006, BIOPHYS J, V90, P878, DOI 10.1529/biophysj.105.073809; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Wieser S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2822890	29	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25731	10.1371/journal.pone.0025731	http://dx.doi.org/10.1371/journal.pone.0025731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980531	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600051
J	Denapaite, D; Hakenbeck, R				Denapaite, Dalia; Hakenbeck, Regine			A New Variant of the Capsule 3 Cluster Occurs in Streptococcus pneumoniae from Deceased Wild Chimpanzees	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; INVASIVE-DISEASE; SEQUENCE TYPES; TYPE-3; GENES; SEROTYPES; MENINGOENCEPHALITIS; PNEUMOCOCCUS; PHOSPHOGLUCOMUTASE; TRANSFORMATION	The presence of new Streptococcus pneumoniae clones in dead wild chimpanzees from the Tai National Park, Cote d'Ivoire, with previous respiratory problems has been demonstrated recently by DNA sequence analysis from samples obtained from the deceased apes. In order to broadenour understanding on the relatedness of these pneumococcal clones to those from humans, the gene locus responsible for biosynthesis of the capsule polysaccharide (CPS) has now been characterized. DNA sequence analysis of PCR fragments identified a cluster named cps3(Tai) containing the four genes typical for serotype 3 CPS, but lacking a 5'-region of >= 2 kb which is degenerated in other cps3 loci and not required for type 3 biosynthesis. CPS3 is composed of a simple disaccharide repeat unit comprising glucose and glucuronic acid (GlcUA). The two genes ugd responsible for GlcUA synthesis and wchE encoding the type 3 synthase are essential for CPS3 biosynthesis, whereas both, galU and the 3'-truncated gene pgm are not required due to the presence of homologues elsewhere in the genome. The DNA sequence of cps3Tai " diverged considerably from those of other cps3 loci. Also, the gene pgm(Tai) " represents a full length version with a nonsense mutation at codon 179. The two genes ugd(Tai) " and wchE(Tai) " including the promoter region were transformed into a nonencapsulated laboratory strain S. pneumoniae R6. Transformants which expressed type 3 capsule polysaccharide were readily obtained, documenting that the gene products are functional. In summary, the data indicate that cps3(Tai) evolved independent from other cps3 loci, suggesting the presence of specialized serotype 3 S. pneumoniae clones endemic to the Tai National Park area.	[Denapaite, Dalia; Hakenbeck, Regine] Univ Kaiserslautern, Dept Microbiol, Kaiserslautern, Germany	University of Kaiserslautern	Denapaite, D (corresponding author), Univ Kaiserslautern, Dept Microbiol, Kaiserslautern, Germany.	hakenb@rhrk.uni-kl.de	Denapaite, Dalia/E-2657-2018	Denapaite, Dalia/0000-0002-0700-3437	Stiftung Rheinland Pfalz fur Innovation [838]; Network of Excellence EuroPathoGenomics [LSHB-CT-2005-512061]	Stiftung Rheinland Pfalz fur Innovation; Network of Excellence EuroPathoGenomics	This work was supported by the Stiftung Rheinland Pfalz fur Innovation (Project 838) and the Network of Excellence EuroPathoGenomics, LSHB-CT-2005-512061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Alloing G, 1996, MOL MICROBIOL, V21, P471; ARRECUBIETA C, 1994, J BACTERIOL, V176, P6375, DOI 10.1128/jb.176.20.6375-6383.1994; AUSTRIAN R, 1981, REV INFECT DIS, V3, pS1; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; BENSON CE, 1984, J CLIN MICROBIOL, V20, P1028, DOI 10.1128/JCM.20.6.1028-1030.1984; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bratcher PE, 2009, MICROBIOL-SGM, V155, P576, DOI 10.1099/mic.0.024521-0; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; BRUYN GAW, 1992, CLIN INFECT DIS, V14, P251, DOI 10.1093/clinids/14.1.251; BURCHALL JJ, 1965, MOL PHARMACOL, V1, P126; Caimano MJ, 1998, MICROB DRUG RESIST, V4, P11, DOI 10.1089/mdr.1998.4.11; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; Clarke SC, 2004, J CLIN MICROBIOL, V42, P4449, DOI 10.1128/JCM.42.10.4449-4452.2004; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Coffey TJ, 1999, MICROBIOL-SGM, V145, P2023, DOI 10.1099/13500872-145-8-2023; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; DAI JB, 1992, J BIOL CHEM, V267, P6322; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; Domenech M, 2009, ENVIRON MICROBIOL, V11, P2542, DOI 10.1111/j.1462-2920.2009.01979.x; FOX JG, 1971, LAB ANIM SCI, V21, P558; FOX JG, 1971, J AM VET MED ASSOC, V159, P1595; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HUBER L, 1988, CAN VET J, V29, P665; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; LAIBLE G, 1989, MOL MICROBIOL, V3, P1337, DOI 10.1111/j.1365-2958.1989.tb00115.x; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Mollerach M, 1998, J EXP MED, V188, P2047, DOI 10.1084/jem.188.11.2047; Mothibeli KM, 2010, J CLIN MICROBIOL, V48, P184, DOI 10.1128/JCM.01011-09; Nesin M, 1998, J INFECT DIS, V177, P707, DOI 10.1086/514242; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Reeves RE, 1941, J BIOL CHEM, V139, P511; Sadowy E, 2006, CLIN VACCINE IMMUNOL, V13, P139, DOI 10.1128/CVI.13.1.139-144.2006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SOLLEVELD HA, 1984, LAB ANIM SCI, V34, P86; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Linden M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008286; Watson D A, 1999, Semin Respir Infect, V14, P198; Whatmore AM, 1999, INFECT IMMUN, V67, P2776, DOI 10.1128/IAI.67.6.2776-2782.1999; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25119	10.1371/journal.pone.0025119	http://dx.doi.org/10.1371/journal.pone.0025119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969869	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900024
J	Weisberg, E; Ray, A; Nelson, E; Adamia, S; Barrett, R; Sattler, M; Zhang, CS; Daley, JF; Frank, D; Fox, E; Griffin, JD				Weisberg, Ellen; Ray, Arghya; Nelson, Erik; Adamia, Sophia; Barrett, Rosemary; Sattler, Martin; Zhang, Chengsheng; Daley, John F.; Frank, David; Fox, Edward; Griffin, James D.			Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITOR; INTERNAL TANDEM DUPLICATION; ACTIVATING MUTATION; POINT MUTATIONS; CONSTITUTIVE ACTIVATION; CLINICAL RESISTANCE; THERAPEUTIC TARGET; IN-VITRO; GENE	Objectives: Clinical responses achieved with FLT3 kinase inhibitors in acute myeloid leukemia (AML) are typically transient and partial. Thus, there is a need for identification of molecular mechanisms of clinical resistance to these drugs. In response, we characterized MOLM13 AML cell lines made resistant to two structurally-independent FLT3 inhibitors. Methods: MOLM13 cells were made drug resistant via prolonged exposure to midostaurin and HG-7-85-01, respectively. Cell proliferation was determined by Trypan blue exclusion. Protein expression was assessed by immunoblotting, immunoprecipitation, and flow cytometry. Cycloheximide was used to determine protein half-life. RT-PCR was performed to determine FLT3 mRNA levels, and FISH analysis was performed to determine FLT3 gene expression. Results and Conclusions: We found that MOLM13 cells readily developed cross-resistance when exposed to either midostaurin or HG-7-85-01. Resistance in both lines was associated with dramatically elevated levels of cell surface FLT3 and elevated levels of phosphor-MAPK, but not phospho-STAT5. The increase in FLT3-ITD expression was at least in part due to reduced turnover of the receptor, with prolonged half-life. Importantly, the drug-resistant phenotype could be rapidly reversed upon withdrawal of either inhibitor. Consistent with this phenotype, no significant evidence of FLT3 gene amplification, kinase domain mutations, or elevated levels of mRNA was observed, suggesting that protein turnover may be part of an auto-regulatory pathway initiated by FLT3 kinase activity. Interestingly, FLT3 inhibitor resistance also correlated with resistance to cytosine arabinoside. Over-expression of FLT3 protein in response to kinase inhibitors may be part of a novel mechanism that could contribute to clinical resistance.	[Weisberg, Ellen; Ray, Arghya; Nelson, Erik; Adamia, Sophia; Barrett, Rosemary; Sattler, Martin; Frank, David; Griffin, James D.] Dana Farber Canc Inst, Dept Med Oncol Hematol Neoplasia, Boston, MA 02115 USA; [Zhang, Chengsheng] Dana Farber Canc Inst, Cytogenet Core Facil, Boston, MA 02115 USA; [Daley, John F.] Dana Farber Canc Inst, Hematol Neoplasia Flow Cytometry Facil, Boston, MA 02115 USA; [Fox, Edward] Dana Farber Canc Inst, Mol Diagnost Lab, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Weisberg, E (corresponding author), Dana Farber Canc Inst, Dept Med Oncol Hematol Neoplasia, Boston, MA 02115 USA.	ellen_weisberg@dfci.harvard.edu	Adamia, Sophia/AAG-7502-2020		National Institutes of Health (NIH) [CA66996, CA134660-03]; NATIONAL CANCER INSTITUTE [R01CA134660, P01CA066996] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JDG is supported by National Institutes of Health (NIH) grant CA66996 and MS is supported by NIH grant CA134660-03. JDG has a financial interest with Novartis Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DH, 2006, MOL CANCER THER, V5, P995, DOI 10.1158/1535-7163.MCT-05-0410; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Chu SH, 2009, DRUG RESIST UPDATE, V12, P8, DOI 10.1016/j.drup.2008.12.001; Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Horiike S, 1997, LEUKEMIA, V11, P1442, DOI 10.1038/sj.leu.2400770; Jiang JR, 2004, BLOOD, V104, P1855, DOI 10.1182/blood-2004-02-0712; Jin GL, 2009, BIOCHEM BIOPH RES CO, V390, P1001, DOI 10.1016/j.bbrc.2009.10.094; Kang HJ, 2010, J KOREAN MED SCI, V25, P841, DOI 10.3346/jkms.2010.25.6.841; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kindler T, 2005, BLOOD, V105, P335, DOI 10.1182/blood-2004-02-0660; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kondo M, 1999, MED PEDIATR ONCOL, V33, P525; Kuchenbauer F, 2005, HAEMATOLOGICA, V90, P1617; Levis M, 2004, BLOOD, V104, P1145, DOI 10.1182/blood-2004-01-0388; Levis M, 2002, BLOOD, V99, P3885, DOI 10.1182/blood.V99.11.3885; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; Nakao M, 1996, LEUKEMIA, V10, P1911; Piloto O, 2007, BLOOD, V109, P1643, DOI 10.1182/blood-2006-05-023804; Pratz KW, 2010, BLOOD, V115, P1425, DOI 10.1182/blood-2009-09-242859; Pratz KW, 2009, BLOOD, V113, P3938, DOI 10.1182/blood-2008-09-177030; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Rombouts WJC, 2000, LEUKEMIA, V14, P675, DOI 10.1038/sj.leu.2401731; Ruggeri B, 2003, CANCER RES, V63, P5978; Sato TKS, 2009, BLOOD, V114; Schittenhelm MM, 2009, CELL CYCLE, V8, P2621, DOI 10.4161/cc.8.16.9355; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579; Shi L, 2010, ONCOTARGET, V1, P22, DOI 10.18632/oncotarget.105; Siendones E, 2007, HEMATOL ONCOL, V25, P30, DOI 10.1002/hon.805; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stolzel F, 2010, ANN HEMATOL, V89, P653, DOI 10.1007/s00277-009-0889-1; Stone R. M., 2004, Annals of Hematology, V83, pS89; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Vora HH, 2010, ASIA-PAC J CLIN ONCO, V6, P306, DOI 10.1111/j.1743-7563.2010.01322.x; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Weisberg E, 2010, MOL CANCER THER, V9, P2468, DOI 10.1158/1535-7163.MCT-10-0232; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	44	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25351	10.1371/journal.pone.0025351	http://dx.doi.org/10.1371/journal.pone.0025351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980431	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900054
J	Germain, M; Saut, N; Greliche, N; Dina, C; Lambert, JC; Perret, C; Cohen, W; Oudot-Mellakh, T; Antoni, G; Alessi, MC; Zelenika, D; Cambien, F; Tiret, L; Bertrand, M; Dupuy, AM; Letenneur, L; Lathrop, M; Emmerich, J; Amouyel, P; Tregouet, DA; Morange, PE				Germain, Marine; Saut, Noemie; Greliche, Nicolas; Dina, Christian; Lambert, Jean-Charles; Perret, Claire; Cohen, William; Oudot-Mellakh, Tiphaine; Antoni, Guillemette; Alessi, Marie-Christine; Zelenika, Diana; Cambien, Francois; Tiret, Laurence; Bertrand, Marion; Dupuy, Anne-Marie; Letenneur, Luc; Lathrop, Mark; Emmerich, Joseph; Amouyel, Philippe; Tregouet, David-Alexandre; Morange, Pierre-Emmanuel			Genetics of Venous Thrombosis: Insights from a New Genome Wide Association Study	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; SUSCEPTIBILITY LOCUS; PLASMA-LEVELS; PROTEIN-C; RISK; THROMBOEMBOLISM; POLYMORPHISMS; EPIDEMIOLOGY; TOOL	Background: Venous Thrombosis (VT) is a common multifactorial disease associated with a major public health burden. Genetics factors are known to contribute to the susceptibility of the disease but how many genes are involved and their contribution to VT risk still remain obscure. We aimed to identify genetic variants associated with VT risk. Methodology/Principal Findings: We conducted a genome-wide association study (GWAS) based on 551,141 SNPs genotyped in 1,542 cases and 1,110 controls. Twelve SNPs reached the genome-wide significance level of 2.0x10(-8) and encompassed four known VT-associated loci, ABO, F5, F11 and FGG. By means of haplotype analyses, we also provided novel arguments in favor of a role of HIVEP1, PROCR and STAB2, three loci recently hypothesized to participate in the susceptibility to VT. However, no novel VT-associated loci came out of our GWAS. Using a recently proposed statistical methodology, we also showed that common variants could explain about 35% of the genetic variance underlying VT susceptibility among which 3% could be attributable to the main identified VT loci. This analysis additionally suggested that the common variants left to be identified are not uniformly distributed across the genome and that chromosome 20, itself, could contribute to similar to 7% of the total genetic variance. Conclusions/Significance: This study might also provide a valuable source of information to expand our understanding of biological mechanisms regulating quantitative biomarkers for VT.	[Germain, Marine; Greliche, Nicolas; Perret, Claire; Oudot-Mellakh, Tiphaine; Antoni, Guillemette; Cambien, Francois; Tiret, Laurence; Tregouet, David-Alexandre] INSERM, UMR S 937, Paris, France; [Germain, Marine; Greliche, Nicolas; Perret, Claire; Oudot-Mellakh, Tiphaine; Antoni, Guillemette; Cambien, Francois; Tiret, Laurence; Tregouet, David-Alexandre] Univ Paris 06, ICAN Inst, Paris, France; [Saut, Noemie; Cohen, William; Alessi, Marie-Christine; Morange, Pierre-Emmanuel] INSERM, UMR S 626, F-13258 Marseille, France; [Saut, Noemie; Cohen, William; Alessi, Marie-Christine; Morange, Pierre-Emmanuel] Univ Mediterranee, Marseille, France; [Dina, Christian] Inst Thorax, Nantes, France; [Dina, Christian] CNRS, ERL3147, Nantes, France; [Dina, Christian] INSERM, UMR S 915, Nantes, France; [Lambert, Jean-Charles; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille Nord France, Lille, France; [Zelenika, Diana; Lathrop, Mark] Commissariat Energie Atom, Ctr Natl Genotypage, Inst Genom, Evry, France; [Bertrand, Marion] Univ Paris 06, INSERM, UMR S 708, Paris, France; [Dupuy, Anne-Marie] Hop Colombiere, INSERM, U888, Montpellier, France; [Letenneur, Luc] INSERM, U897, Bordeaux, France; [Letenneur, Luc] Univ Victor Segalen, Bordeaux, France; [Emmerich, Joseph] Univ Paris 05, Hop Europeen Georges Pompidou, INSERM, Med Vasc HTA,U765, Paris, France; [Amouyel, Philippe] CHRU Lille, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille	Germain, M (corresponding author), INSERM, UMR S 937, Paris, France.	david.tregouet@upmc.fr; pierre.morange@ap-hm.fr	Cambien, Francois/AAP-9751-2020; lambert, jean-charles/F-8787-2013; Greliche, Nicolas/P-4180-2015; Dina, Christian R/D-3535-2015; Morange, Pierre/T-9070-2019; Tregouet, David-Alexandre/E-3961-2016; ALESSI, Marie-christine/AAK-3582-2020; Lambert, jean-charles/A-9553-2014; Trégouët, David-Alexandre/P-9210-2019; LETENNEUR, Luc/T-4424-2019	lambert, jean-charles/0000-0003-0829-7817; Greliche, Nicolas/0000-0003-0683-2257; Dina, Christian R/0000-0002-7722-7348; Morange, Pierre/0000-0002-9065-722X; ALESSI, Marie-christine/0000-0003-3927-5792; Lambert, jean-charles/0000-0003-0829-7817; Trégouët, David-Alexandre/0000-0001-9084-7800; LETENNEUR, Luc/0000-0002-3274-937X; Germain, Marine/0000-0002-8489-8916; Amouyel, Philippe/0000-0001-9088-234X; dupuy, anne marie/0000-0001-6538-3944	Agence Nationale pour la Recherche [ANR-07-MRAR-021]; Program Hospitalier de recherche Clinique [PHRC2009 RENOVA-TV, PHRC 20002]; Fondation pour la Recherche Medicale; Fondation de France; Leducq Foundation; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon; Ministry of Research-Inserm; Eisai	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Program Hospitalier de recherche Clinique; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Leducq Foundation(Leducq Foundation); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon(Region Occitanie); Ministry of Research-Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Eisai(Eisai Co Ltd)	M.G. was supported by grants funded by the Agence Nationale pour la Recherche (Project ANR-07-MRAR-021) and the Program Hospitalier de recherche Clinique (PHRC2009 RENOVA-TV). T.O.M. was supported by a grant from the Fondation pour la Recherche Medicale. The MARTHA project was supported by a grant from the Program Hospitalier de Recherche Clinique and the FARIVE study by grants from the Fondation pour la Recherche Medicale, the Program Hospitalier de recherche Clinique (PHRC 20002; PHRC2009 RENOVA-TV), the Fondation de France, and the Leducq Foundation. Statistical analyses benefit from the C2BIG computing centre funded by the Fondation pour la Recherche Medicale and La Region Ile de France. The 3C Study is conducted under a partnership agreement between Inserm, the Victor Segalen -Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and first phase of the study. The 3C-Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, the Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme 'Cohorts and collection of biological material'. The Lille Genopole received an unconditional grant from Eisai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Antoni G, 2010, J THROMB HAEMOST, V8, P2671, DOI 10.1111/j.1538-7836.2010.04092.x; Beckman MG, 2010, AM J PREV MED, V38, pS495, DOI 10.1016/j.amepre.2009.12.017; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; Coombes R, 2005, BRIT MED J, V330, P559, DOI 10.1136/bmj.330.7491.559-c; de Willige SU, 2009, THROMB HAEMOSTASIS, V101, P1078, DOI 10.1160/TH08-12-0813; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Erdmann J, 2011, EUR HEART J, V32, P158, DOI 10.1093/eurheartj/ehq405; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Folsom AR, 2002, ARTERIOSCL THROM VAS, V22, P1018, DOI 10.1161/01.ATV.0000017470.08363.AB; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Houlihan LM, 2010, AM J HUM GENET, V86, P626, DOI 10.1016/j.ajhg.2010.02.016; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Larsen TB, 2003, EPIDEMIOLOGY, V14, P328, DOI 10.1097/00001648-200305000-00013; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; MacDougall DA, 2006, AM J HEALTH-SYST PH, V63, pS5, DOI 10.2146/ajhp060388; MANTEL N, 1959, J NATL CANCER I, V22, P719; Morange PE, 2011, J THROMB HAEMOST, V9, P229, DOI 10.1111/j.1538-7836.2010.04082.x; Morange PE, 2011, BLOOD, V117, P3692, DOI 10.1182/blood-2010-11-319053; Morange PE, 2010, AM J HUM GENET, V86, P592, DOI 10.1016/j.ajhg.2010.02.011; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Prandoni P, 2004, BMJ-BRIT MED J, V329, P484, DOI 10.1136/bmj.38167.684444.3A; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosendaal FR, 2009, J THROMB HAEMOST, V7, P301, DOI 10.1111/j.1538-7836.2009.03394.x; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith NL, 2011, BLOOD, V117, P6007, DOI 10.1182/blood-2010-10-315473; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Tang WH, 2010, BLOOD, V116, P5032, DOI 10.1182/blood-2010-05-283739; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	43	105	108	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25581	10.1371/journal.pone.0025581	http://dx.doi.org/10.1371/journal.pone.0025581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980494	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000295933700044
J	Jeisy-Scott, V; Davis, WG; Patel, JR; Bowzard, JB; Shieh, WJ; Zaki, SR; Katz, JM; Sambhara, S				Jeisy-Scott, Victoria; Davis, William G.; Patel, Jenish R.; Bowzard, John Bradford; Shieh, Wun-Ju; Zaki, Sherif R.; Katz, Jacqueline M.; Sambhara, Suryaprakash			Increased MDSC Accumulation and Th2 Biased Response to Influenza A Virus Infection in the Absence of TLR7 in Mice	PLOS ONE			English	Article							INNATE IMMUNE-SYSTEM; SUPPRESSOR-CELLS; ALVEOLAR MACROPHAGES; STRANDED-RNA; RIG-I; DENDRITIC CELLS; AVIAN H5N1; CROSS-TALK; TNF-ALPHA; RECOGNITION	Toll-like receptors (TLRs) play an important role in the induction of innate and adaptive immune response against influenza A virus (IAV) infection; however, the role of Toll-like receptor 7 (TLR7) during the innate immune response to IAV infection and the cell types affected by the absence of TLR7 are not clearly understood. In this study, we show that myeloid derived suppressor cells (MDSC) accumulate in the lungs of TLR7 deficient mice more so than in wild-type C57Bl/6 mice, and display increased cytokine expression. Furthermore, there is an increase in production of Th2 cytokines by TLR7(-/-) compared with wildtype CD4+ T-cells in vivo, leading to a Th2 polarized humoral response. Our findings indicate that TLR7 modulates the accumulation of MDSCs during an IAV infection in mice, and that lack of TLR7 signaling leads to a Th2-biased response.	[Jeisy-Scott, Victoria; Davis, William G.; Patel, Jenish R.; Bowzard, John Bradford; Katz, Jacqueline M.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp, Atlanta, GA 30333 USA; [Shieh, Wun-Ju; Zaki, Sherif R.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Jeisy-Scott, Victoria] Emory Univ, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Jeisy-Scott, V (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp, Atlanta, GA 30333 USA.	ssambhara@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021	Jeisy-Scott, Victoria/0000-0002-3967-5764; Patel, Jenish/0000-0001-5310-8160; Tripp, Ralph/0000-0002-2924-9956				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ARORA M, 2010, MUCOSAL IMMUNOL; Bessa J, 2009, J IMMUNOL, V183, P3788, DOI 10.4049/jimmunol.0804004; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Crozat K, 2009, IMMUNOL REV, V227, P129, DOI 10.1111/j.1600-065X.2008.00736.x; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Haverkamp JM, 2011, EUR J IMMUNOL, V41, P749, DOI 10.1002/eji.201041069; Hayes KS, 2007, PARASITE IMMUNOL, V29, P583, DOI 10.1111/j.1365-3024.2007.00980.x; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; Ichinohe T, 2008, EXPERT REV VACCINES, V7, P1435, DOI 10.1586/14760584.7.9.1435; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; KOERNER P, 2010, INFLAMM RES; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mueller Uwe, 2008, V15, P21, DOI 10.1159/000135684; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjan P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-102; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Reed M. J., 1938, AM J HYG, V27, P493; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; SEO SU, 2010, J VIROL; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Wang JP, 2007, CELL MICROBIOL, V9, P1641, DOI 10.1111/j.1462-5822.2007.00961.x; WEI CJ, SCI TRANSL MED, V2; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672	58	52	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25242	10.1371/journal.pone.0025242	http://dx.doi.org/10.1371/journal.pone.0025242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966467	Green Published, gold			2022-12-27	WOS:000295267100033
J	Mahendran, V; Riordan, SM; Grimm, MC; Thi, ATT; Major, J; Kaakoush, NO; Mitchell, H; Zhang, L				Mahendran, Vikneswari; Riordan, Stephen M.; Grimm, Michael C.; Thi Anh Tuyet Tran; Major, Joelene; Kaakoush, Nadeem O.; Mitchell, Hazel; Zhang, Li			Prevalence of Campylobacter Species in Adult Crohn's Disease and the Preferential Colonization Sites of Campylobacter Species in the Human Intestine	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CONCISUS; IDENTIFICATION; DIARRHEA; JEJUNI; HEALTH; PCR	Introduction: Crohn's disease (CD) and ulcerative colitis (UC) are the two major forms of inflammatory bowel disease (IBD). A high prevalence of Campylobacter concisus was previously detected in paediatric CD and adult UC. Currently, the prevalence of C. concisus in adult CD and the preferential colonization sites of Campylobacter species in the human intestine are unknown. In this study, we examined the prevalence of Campylobacter species in biopsies collected from multiple anatomic sites of adult patients with IBD and controls. Methods: Three hundred and one biopsies collected from ileum, caecum, descending colon and rectum of 28 patients IBD (15 CD and 13 UC) and 33 controls were studied. Biopsies were used for DNA extraction and detection of Campylobacter species by PCR-sequencing and Campylobacter cultivation. Results: A significantly higher prevalence of C. concisus in colonic biopsies of patients with CD (53%) was detected as compared with the controls (18%). Campylobacter genus-PCR positivity and C. concisus positivity in patients with UC were 85% and 77% respectively, being significantly higher than that in the controls (48% and 36%). C. concisus was more often detected in descending colonic and rectal biopsies from patients with IBD in comparison to the controls. C. concisus was isolated from patients with IBD. Conclusion: The high intestinal prevalence of C. concisus in patients with IBD, particularly in the proximal large intestine, suggests that future studies are needed to investigate the possible involvement of C. concisus in a subgroup of human IBD. To our knowledge, this is the first report of the association between adult CD and C. concisus as well as the first study of the preferential colonization sites of C. concisus in the human intestine.	[Mahendran, Vikneswari; Thi Anh Tuyet Tran; Major, Joelene; Kaakoush, Nadeem O.; Mitchell, Hazel; Zhang, Li] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Riordan, Stephen M.] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Riordan, Stephen M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Grimm, Michael C.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Mahendran, V (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	L.Zhang@unsw.edu.au	Kaakoush, Nadeem/ABG-9499-2020	Grimm, Michael/0000-0001-9426-3917; Kaakoush, Nadeem Omar/0000-0003-4017-1077; Zhang, Li/0000-0001-7506-8278	Broad Foundation [IBD0273-R]	Broad Foundation	This work was supported by the Broad Medical Research Program of the Broad Foundation (Grant No: IBD0273-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Aabenhus R, 2002, SCAND J INFECT DIS, V34, P248, DOI 10.1080/00365540110080566; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; BASTYNS K, 1995, MOL CELL PROBE, V9, P247, DOI 10.1016/S0890-8508(95)90114-0; CUMMINGS JH, 1983, LANCET, V1, P1206; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Engberg J, 2005, CLIN MICROBIOL INFEC, V11, P288, DOI 10.1111/j.1469-0691.2005.01111.x; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Guslandi M, 2005, EUR J GASTROEN HEPAT, V17, P145, DOI 10.1097/00042737-200502000-00003; Inglis GD, 2005, APPL ENVIRON MICROB, V71, P5145, DOI 10.1128/AEM.71.9.5145-5153.2005; Istivan TS, 2004, J MED MICROBIOL, V53, P483, DOI 10.1099/jmm.0.45554-0; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lastovica AJ, 2006, CLIN MICROBIOL NEWSL, V28, P7; LEVITT MD, 1969, NEW ENGL J MED, V281, P122, DOI 10.1056/NEJM196907172810303; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Macuch PJ, 2000, J DENT RES, V79, P785, DOI 10.1177/00220345000790021301; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Matsheka MI, 2001, J CLIN MICROBIOL, V39, P3684, DOI 10.1128/JCM.39.10.3684-3689.2001; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Newell DG, 2005, EUR J GASTROEN HEPAT, V17, P1013, DOI 10.1097/00042737-200510000-00001; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Snijders F, 1997, CLIN INFECT DIS, V24, P1107, DOI 10.1086/513643; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; VANDAMME P, 1989, J CLIN MICROBIOL, V27, P1775, DOI 10.1128/JCM.27.8.1775-1781.1989; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	34	88	88	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25417	10.1371/journal.pone.0025417	http://dx.doi.org/10.1371/journal.pone.0025417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966525	gold, Green Submitted, Green Published			2022-12-27	WOS:000295267100059
J	Lang, GI; Botstein, D				Lang, Gregory I.; Botstein, David			A Test of the Coordinated Expression Hypothesis for the Origin and Maintenance of the GAL Cluster in Yeast	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; SACCHAROMYCES-CEREVISIAE; SELFISH OPERONS; EVOLUTION; FUNGI; DIVERSIFICATION; INITIATION; PLANTS	Metabolic gene clusters-functionally related and physically clustered genes-are a common feature of some eukaryotic genomes. Two hypotheses have been advanced to explain the origin and maintenance of metabolic gene clusters: coordinated gene expression and genetic linkage. Here we test the hypothesis that selection for coordinated gene expression underlies the clustering of GAL genes in the yeast genome. We find that, although clustering coordinates the expression of GAL1 and GAL10, disrupting the GAL cluster does not impair fitness, suggesting that other mechanisms, such as genetic linkage, drive the origin and maintenance metabolic gene clusters.	[Lang, Gregory I.] Princeton Univ, Dept Mol & Cell Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Lang, GI (corresponding author), Princeton Univ, Dept Mol & Cell Biol, Princeton, NJ 08544 USA.	glang@princeton.edu			National Institute of General Medical Sciences (NIGMS) Centers of Excellence [GM071508]; National Institutes of Health (NIH) [GM046406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046406, R37GM046406, P50GM071508] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) Centers of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (NIGMS) Centers of Excellence grant GM071508 (to DB) and the individual National Institutes of Health (NIH) grant GM046406 (to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Hartl :D. L, 2000, PRIMER POPULATION GE; Hittinger CT, 2010, NATURE, V464, P54, DOI 10.1038/nature08791; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Khaldi N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003036; Lang GI, 2009, P NATL ACAD SCI USA, V106, P5755, DOI 10.1073/pnas.0901620106; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Lawrence JG, 1996, GENETICS, V143, P1843; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Patron NJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-174; Pedley KF, 2001, P NATL ACAD SCI USA, V98, P14174, DOI 10.1073/pnas.231491298; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; STAHL FW, 1966, GENETICS, V53, P569; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584	26	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25290	10.1371/journal.pone.0025290	http://dx.doi.org/10.1371/journal.pone.0025290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966486	Green Published, gold, Green Submitted			2022-12-27	WOS:000295265100083
J	Beaulieu, A; Poncin, G; Belaid-Choucair, Z; Humblet, C; Bogdanovic, G; Lognay, G; Boniver, J; Defresne, MP				Beaulieu, Aurore; Poncin, Geraldine; Belaid-Choucair, Zakia; Humblet, Chantal; Bogdanovic, Gordana; Lognay, Georges; Boniver, Jacques; Defresne, Marie-Paule			Leptin Reverts Pro-Apoptotic and Antiproliferative Effects of alpha-Linolenic Acids in BCR-ABL Positive Leukemic Cells: Involvement of PI3K Pathway	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BONE-MARROW ADIPOCYTES; SATURATED FATTY-ACIDS; PROSTATE-CANCER RISK; SIGNALING PATHWAY; PROLIFERATION; EXPRESSION; RECEPTOR; STEM; AKT	It is suspected that bone marrow (BM) microenvironmental factors may influence the evolution of chronic myeloid leukaemia (CML). In this study, we postulated that adipocytes and lipids could be involved in the progression of CML. To test this hypothesis, adipocytes were co-cultured with two BCR-ABL positive cell lines (PCMDS and K562). T cell (Jurkat) and stroma cell (HS-5) lines were used as controls. In the second set of experiments, leukemic cell lines were treated with stearic, oleic, linoleic or a-linolenic acids in presence or absence of leptin. Survival, proliferation, leptin production, OB-R isoforms (OB-Ra and OB-Rb), phosphoinositide 3-kinase (PI3k) and BCL-2 expression have been tested after 24h, 48h and 72h of treatment. Our results showed that adipocytes induced a decrease of CML proliferation and an increase in lipid accumulation in leukemic cells. In addition, CML cell lines induced adipocytes cell death. Chromatography analysis showed that BM microenvironment cells were full of saturated (SFA) and monounsaturated (MUFA) fatty acids, fatty acids that protect tumor cells against external agents. Stearic acid increased Bcl-2 expression in PCMDS, whereas oleic and linoleic acids had no effects. In contrast, a-linolenic acid decreased the proliferation and the survival of CML cell lines as well as BCL-2 and OB-R expression. The effect of a-linolenic acids seemed to be due to PI3K pathway and Bcl-2 inhibition. Leptin production was detected in the co-culture medium. In the presence of leptin, the effect of a-linolenic acid on proliferation, survival, OB-R and BCl-2 expression was reduced.	[Beaulieu, Aurore; Poncin, Geraldine; Humblet, Chantal; Boniver, Jacques; Defresne, Marie-Paule] Univ Liege, Dept Cytol Histol & Pathol Anat Giga R, Liege, Belgium; [Belaid-Choucair, Zakia] Univ Paris 05, CNRS, UMR 8147, Hop Necker, F-75270 Paris, France; [Bogdanovic, Gordana] Inst Oncol Sremska Kamenica, Sremska Kamenica, Serbia; [Lognay, Georges] Univ Liege, Dept Analyt Chem, Gembloux, Belgium	University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Liege	Beaulieu, A (corresponding author), Univ Liege, Dept Cytol Histol & Pathol Anat Giga R, Liege, Belgium.	abeaulieu@ulg.ac.be	Bogdanovic, Gordana M/E-2869-2019	Bogdanovic, Gordana M/0000-0003-4024-108X	Fonds National de la Recherche Scientifique [FNRS 7452809F]; GIGA-Cell Imaging; Flow Cytometry platform; FACS CantoII (Becton Dickinson, France)	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); GIGA-Cell Imaging; Flow Cytometry platform; FACS CantoII (Becton Dickinson, France)	This work was supported by the Fonds National de la Recherche Scientifique (FNRS 7452809F)http://www1.frs-fnrs.be/. Dr. Beaulieu, Dr. Poncin, and Dr. Belaid-Choucair are Televie (FNRS) fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We also thank the GIGA-Cell Imaging and Flow Cytometry platform for support with FACS CantoII (Becton Dickinson, France).	ALEXE DM, 2006, LEPTIN, P201; Anand M, 1998, HEMATOL ONCOL, V16, P143; Behan JW, 2009, CANCER RES, V69, P7867, DOI 10.1158/0008-5472.CAN-09-0800; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Cantoni O, 2008, METHOD ENZYMOL, V441, P73, DOI 10.1016/S0076-6879(08)01205-6; Carayol M, 2010, CANCER CAUSE CONTROL, V21, P347, DOI 10.1007/s10552-009-9465-1; Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8; Chan JL, 2006, P NATL ACAD SCI USA, V103, P8481, DOI 10.1073/pnas.0505429103; Couplan Elodie, 2009, Biotechnology Journal, V4, P1190, DOI 10.1002/biot.200800229; Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004; deGraffenried LA, 2003, ANN ONCOL, V14, P1051, DOI 10.1093/annonc/mdg291; Deshimaru Ryota, 2005, Keio Journal of Medicine, V54, P150, DOI 10.2302/kjm.54.150; Di Benedetto R, 2009, J FOOD LIPIDS, V16, P382, DOI 10.1111/j.1745-4522.2009.01153.x; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Drexler HG, 2009, LEUKEMIA RES, V33, P1011, DOI 10.1016/j.leukres.2009.03.005; EAVES AC, 1986, P NATL ACAD SCI USA, V83, P5306, DOI 10.1073/pnas.83.14.5306; FINSTAD HS, 1994, BLOOD, V84, P3799, DOI 10.1182/blood.V84.11.3799.bloodjournal84113799; Finstad HS, 1998, BIOCHEM J, V336, P451, DOI 10.1042/bj3360451; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frater JL, 2003, AM J CLIN PATHOL, V119, P833, DOI 10.1309/A4RGP4LF12GGH8MW; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Ghalaut VS, 2006, CLIN CHIM ACTA, V366, P239, DOI 10.1016/j.cca.2005.10.022; GILBERT S, 1983, CANCER, V51, P1428; Gullicksen PS, 2003, APOPTOSIS, V8, P327, DOI 10.1023/A:1024112716024; GUPTA PK, 2004, LEUKEMIA MJAFI, V60, P297; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hayhoe FGJ., 1994, HAEMATOLOGICAL CYTOC; HIRATA J, 1989, ACTA HAEMATOL-BASEL, V82, P35; Kim JY, 2009, ANN NY ACAD SCI, V1171, P190, DOI 10.1111/j.1749-6632.2009.04897.x; Kim JY, 2010, ONCOL REP, V23, P1369, DOI 10.3892/or_00000773; KUTO F, 1984, ULTRASTRUCT PATHOL, V6, P307, DOI 10.3109/01913128409018589; Laharrague P, 2000, EUR CYTOKINE NETW, V11, P634; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; LICHTMAN MA, 2011, NATURE IN PRESS; MAYANI H, 2008, LEUKEMIA RES, V33, P624; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Mouzaki A, 2009, CYTOKINE, V48, P203, DOI 10.1016/j.cyto.2009.07.006; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Pardini RS, 2006, CHEM-BIOL INTERACT, V162, P89, DOI 10.1016/j.cbi.2006.05.012; Reuter A, 2004, CELL MOL LIFE SCI, V61, P2092, DOI 10.1007/s00018-004-4193-x; Shah A, 2005, CLIN CANCER RES, V11, P2930, DOI 10.1158/1078-0432.CCR-04-1385; Sloma I, 2010, LEUKEMIA, V24, P1823, DOI 10.1038/leu.2010.159; SOEL DW, 2008, BIOCHEM BIOPH RES CO, V377, P508; Strom SS, 2009, CANCER EPIDEM BIOMAR, V18, P1501, DOI 10.1158/1055-9965.EPI-09-0028; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Uddin S, 2010, LEUKEMIA LYMPHOMA, V51, P1305, DOI 10.3109/10428191003802365; Uddin S, 2010, ENDOCR-RELAT CANCER, V17, P191, DOI 10.1677/ERC-09-0153; VITOLS S, 1990, P NATL ACAD SCI USA, V87, P2598, DOI 10.1073/pnas.87.7.2598; Vondracek J, 2001, EUR J PHARMACOL, V424, P1, DOI 10.1016/S0014-2999(01)01124-4; Yamamoto K, 2011, ANAL BIOANAL CHEM, V400, P1829, DOI 10.1007/s00216-011-4864-z	56	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25651	10.1371/journal.pone.0025651	http://dx.doi.org/10.1371/journal.pone.0025651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991326	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000050
J	Mitchell, L; Lau, A; Lambert, JP; Zhou, H; Fong, Y; Couture, JF; Figeys, D; Baetz, K				Mitchell, Leslie; Lau, Andrea; Lambert, Jean-Philippe; Zhou, Hu; Fong, Ying; Couture, Jean-Francois; Figeys, Daniel; Baetz, Kristin			Regulation of Septin Dynamics by the Saccharomyces cerevisiae Lysine Acetyltransferase NuA4	PLOS ONE			English	Article							HISTONE H4 ACETYLATION; GENETIC INTERACTION NETWORK; CELL-CYCLE; BUDDING YEAST; MORPHOGENESIS CHECKPOINT; FUNCTIONAL DISSECTION; CHITIN SYNTHASE-2; PROTEIN COMPLEXES; DELETION MUTANTS; DNA	In the budding yeast Saccharomyces cerevisiae, the lysine acetyltransferase NuA4 has been linked to a host of cellular processes through the acetylation of histone and non-histone targets. To discover proteins regulated by NuA4-dependent acetylation, we performed genome-wide synthetic dosage lethal screens to identify genes whose overexpression is toxic to non-essential NuA4 deletion mutants. The resulting genetic network identified a novel link between NuA4 and septin proteins, a group of highly conserved GTP-binding proteins that function in cytokinesis. We show that acetyltransferase-deficient NuA4 mutants have defects in septin collar formation resulting in the development of elongated buds through the Swe1-dependent morphogenesis checkpoint. We have discovered multiple sites of acetylation on four of the five yeast mitotic septins, Cdc3, Cdc10, Cdc12 and Shs1, and determined that NuA4 can acetylate three of the four in vitro. In vivo we find that acetylation levels of both Shs1 and Cdc10 are reduced in a catalytically inactive esa1 mutant. Finally, we determine that cells expressing a Shs1 protein with decreased acetylation in vivo have defects in septin localization that are similar to those observed in NuA4 mutants. These findings provide the first evidence that yeast septin proteins are acetylated and that NuA4 impacts septin dynamics.	[Mitchell, Leslie; Lau, Andrea; Lambert, Jean-Philippe; Zhou, Hu; Fong, Ying; Couture, Jean-Francois; Figeys, Daniel; Baetz, Kristin] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Mitchell, L (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	kbaetz@uottawa.ca	Baetz, Kristin/E-6859-2013	Mitchell, Leslie/0000-0001-7869-9817; Figeys, Daniel/0000-0002-5373-7546; Lambert, Jean-Philippe/0000-0002-0833-1221	Canadian Cancer Society [20309]; Ontario Government; Canada Research Chair (CRC) in Chemical and Functional Genomics	Canadian Cancer Society(Canadian Cancer Society (CCS)); Ontario Government; Canada Research Chair (CRC) in Chemical and Functional Genomics(Canada Research Chairs)	This research is funded by the Canadian Cancer Society (grant # 20309) and an Early Researcher Award from the Ontario Government to K. B. K. B. is a Canada Research Chair (CRC) in Chemical and Functional Genomics. D. F. is a CRC in Proteomics and Systems Biology and J.F.C. is a CRC in Structural Biology and Epigenetics. L. M. was supported by a Canada Institute for Health Research Ph.D. scholarship. A. L. was supported by a Natural Sciences and Engineering Research Council of Canada M.Sc Scholarship. J.-P.L. was supported by an Ontario Graduate Scholarship. http://www.cihr-irsc.gc.ca/.http://www.nserc-crsng.gc.ca/.http://www.hrsdc.gc.ca/eng/workplaceskills/foreign_workers/reschair.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Baetz K, 2006, CELL CYCLE, V5, P592, DOI 10.4161/cc.5.6.2583; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Egelhofer TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002022; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gillis AN, 2005, J CELL BIOL, V171, P773, DOI 10.1083/jcb.200507017; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2004, EUKARYOT CELL, V3, P847, DOI 10.1128/EC.3.4.847-854.2004; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197; Hoke SM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-46; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; KROGAN NJ, 2004, P NATL ACAD SCI US; Kroll ES, 1996, GENETICS, V143, P95; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma XJ, 1996, GENE DEV, V10, P1327, DOI 10.1101/gad.10.11.1327; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ruault M, 2006, GENETICS, V174, P1135, DOI 10.1534/genetics.106.059873; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Sigala B, 2005, EXP CELL RES, V310, P357, DOI 10.1016/j.yexcr.2005.07.030; SIKORSKI RS, 1989, GENETICS, V122, P19; SILVERMAN SJ, 1988, P NATL ACAD SCI USA, V85, P4735, DOI 10.1073/pnas.85.13.4735; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Stante M, 2009, P NATL ACAD SCI USA, V106, P5093, DOI 10.1073/pnas.0810869106; Stoynova L, 2004, BIOTECHNIQUES, V36, P402, DOI 10.2144/04363BM05; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang CSL, 2002, CELL CYCLE, V1, P42, DOI 10.4161/cc.1.1.99; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zou J, 2009, MOL BIOL CELL, V20, P3239, DOI 10.1091/mbc.E08-12-1255	77	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25336	10.1371/journal.pone.0025336	http://dx.doi.org/10.1371/journal.pone.0025336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984913	Green Submitted, gold, Green Published			2022-12-27	WOS:000295943000024
J	Garmire, LX; Garmire, DG; Huang, W; Yao, J; Glass, CK; Subramaniam, S				Garmire, Lana X.; Garmire, David G.; Huang, Wendy; Yao, Joyee; Glass, Christopher K.; Subramaniam, Shankar			A Global Clustering Algorithm to Identify Long Intergenic Non-Coding RNA - with Applications in Mouse Macrophages	PLOS ONE			English	Article							GENE-EXPRESSION; POL-II; IDENTIFICATION; CHIP; PREDICTION; MEDIATORS; REVEALS; CELLS	Identification of diffuse signals from the chromatin immunoprecipitation and high-throughput massively parallel sequencing (ChIP-Seq) technology poses significant computational challenges, and there are few methods currently available. We present a novel global clustering approach to enrich diffuse CHIP-Seq signals of RNA polymerase II and histone 3 lysine 4 trimethylation (H3K4Me3) and apply it to identify putative long intergenic non-coding RNAs (lincRNAs) in macrophage cells. Our global clustering method compares favorably to the local clustering method SICER that was also designed to identify diffuse CHIP-Seq signals. The validity of the algorithm is confirmed at several levels. First, 8 out of a total of 11 selected putative lincRNA regions in primary macrophages respond to lipopolysaccharides (LPS) treatment as predicted by our computational method. Second, the genes nearest to lincRNAs are enriched with biological functions related to metabolic processes under resting conditions but with developmental and immune-related functions under LPS treatment. Third, the putative lincRNAs have conserved promoters, modestly conserved exons, and expected secondary structures by prediction. Last, they are enriched with motifs of transcription factors such as PU.1 and AP.1, previously shown to be important lineage determining factors in macrophages, and 83% of them overlap with distal enhancers markers. In summary, GCLS based on RNA polymerase II and H3K4Me3 CHIP-Seq method can effectively detect putative lincRNAs that exhibit expected characteristics, as exemplified by macrophages in the study.	[Garmire, Lana X.; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, Jacobs Sch Engn, La Jolla, CA 92093 USA; [Garmire, David G.] Univ Hawaii Manoa, Dept Elect Engn, Honolulu, HI 96822 USA; [Huang, Wendy; Yao, Joyee; Glass, Christopher K.; Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California San Diego	Garmire, LX (corresponding author), Univ Calif San Diego, Dept Bioengn, Jacobs Sch Engn, La Jolla, CA 92093 USA.	shankar@ucsd.edu	Huang, Wendy Jia Men/AAF-2030-2021; Glass, Christopher/AAI-3933-2021	Huang, Wendy Jia Men/0000-0001-7425-8280; Glass, Christopher/0000-0003-4344-3592; Garmire, David/0000-0002-6913-6550	National Institutes of Health (NIH) [P01DK074868]; National Institute of General Medical Sciences (NIGMS) [U54 GM069338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants P01DK074868 and National Institute of General Medical Sciences (NIGMS) Large Scale Collaborative "Glue" Grant U54 GM069338 to CKG. and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Costa FF, 2007, GENE, V386, P1, DOI 10.1016/j.gene.2006.09.028; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Eskay R L, 1990, Adv Exp Med Biol, V274, P331; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2006, ARCH PHARM RES, V29, P890, DOI 10.1007/BF02973911; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; LANA X, 2010, 2010 IEEE INT C BIOI, P1; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Maurya MR, 2007, ADV EXP MED BIOL, V598, P62; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Shibata N, 2009, J LIPID RES, V50, pS277, DOI 10.1194/jlr.R800063-JLR200; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wermeling F, 2009, AUTOIMMUN REV, V9, P49, DOI 10.1016/j.autrev.2009.03.004; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	37	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24051	10.1371/journal.pone.0024051	http://dx.doi.org/10.1371/journal.pone.0024051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980340	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300003
J	Kim, S; Sandler, DP; Carswell, G; Weinberg, CR; Taylor, JA				Kim, Sangmi; Sandler, Dale P.; Carswell, Gleta; Weinberg, Clarice R.; Taylor, Jack A.			Reliability and Short-Term Intra-Individual Variability of Telomere Length Measurement Using Monochrome Multiplexing Quantitative PCR	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; CELLS; MEN	Background: Studies examining the association between telomere length and cancer risk have often relied on measurement of telomere length from a single blood draw using a real-time PCR technique. We examined the reliability of telomere length measurement using sequential samples collected over a 9-month period. Methods and Findings: Relative telomere length in peripheral blood was estimated using a single tube monochrome multiplex quantitative PCR assay in blood DNA samples from 27 non-pregnant adult women ( aged 35 to 74 years) collected in 7 visits over a 9-month period. A linear mixed model was used to estimate the components of variance for telomere length measurements attributed to variation among women and variation between time points within women. Mean telomere length measurement at any single visit was not significantly different from the average of 7 visits. Plates had a significant systematic influence on telomere length measurements, although measurements between different plates were highly correlated. After controlling for plate effects, 64% of the remaining variance was estimated to be accounted for by variance due to subject. Variance explained by time of visit within a subject was minor, contributing 5% of the remaining variance. Conclusion: Our data demonstrate good short-term reliability of telomere length measurement using blood from a single draw. However, the existence of technical variability, particularly plate effects, reinforces the need for technical replicates and balancing of case and control samples across plates.	[Kim, Sangmi; Sandler, Dale P.; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Carswell, Gleta; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC USA; [Weinberg, Clarice R.] Natl Inst Environm Hlth Sci, Biostat Branch, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kim, S (corresponding author), Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.	kims3@niehs.nih.gov	taylor, jack a/C-7154-2019	taylor, jack a/0000-0001-5303-6398; Sandler, Dale/0000-0002-6776-0018; Weinberg, Clarice/0000-0002-7713-8556	National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES044005, Z01 ES049033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102245, Z01ES044005, Z01ES049033, ZIAES044005, ZIAES049032] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES044005 and Z01 ES049033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2006, J CLIN ENDOCR METAB, V91, P635, DOI 10.1210/jc.2005-1814; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Ferre F, 1992, PCR Methods Appl, V2, P1; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Grabowski P, 2005, BLOOD, V105, P4807, DOI 10.1182/blood-2004-11-4394; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; Hornsby PJ, 2010, PFLUG ARCH EUR J PHY, V459, P291, DOI 10.1007/s00424-009-0723-6; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kim S, 2011, CANCER CAUSE CONTROL, V22, P1061, DOI 10.1007/s10552-011-9778-8; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	29	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25774	10.1371/journal.pone.0025774	http://dx.doi.org/10.1371/journal.pone.0025774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984947	Green Submitted, gold, Green Published			2022-12-27	WOS:000295941300057
J	Langen, K; Schwarzer, J; Kullmann, H; Bakker, TCM; Thunken, T				Langen, Kathrin; Schwarzer, Julia; Kullmann, Harald; Bakker, Theo C. M.; Thuenken, Timo			Microsatellite Support for Active Inbreeding in a Cichlid Fish	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; MUTUAL MATE CHOICE; NO EVIDENCE; POPULATION-STRUCTURE; NATURAL-POPULATION; GENOTYPING ERRORS; KIN RECOGNITION; NULL ALLELES; DEPRESSION; AVOIDANCE	In wild animal populations, the degree of inbreeding differs between species and within species between populations. Because mating with kin often results in inbreeding depression, observed inbreeding is usually regarded to be caused by limited outbreeding opportunities due to demographic factors like small population size or population substructuring. However, theory predicts inclusive benefits from mating with kin, and thus part of the observed variation in inbreeding might be due to active inbreeding preferences. Although some recent studies indeed report kin mating preferences, the evidence is still highly ambiguous. Here, we investigate inbreeding in a natural population of the West African cichlid fish Pelvicachromis taeniatus which showed clear kin mating preferences in standardized laboratory experiments but no inbreeding depression. The presented microsatellite analysis reveals that the natural population has, in comparison to two reference populations, a reduced allelic diversity (A = 3) resulting in a low heterozygosity (H-o = 0.167) pointing to a highly inbred population. Furthermore, we found a significant heterozygote deficit not only at population (F-is = 0.116) but also at subpopulation level (F-is = 0.081) suggesting that inbreeding is not only a by-product of population substructuring but possibly a consequence of behavioral kin preferences.	[Langen, Kathrin; Bakker, Theo C. M.; Thuenken, Timo] Univ Bonn, Inst Evolutionary Biol & Ecol, D-5300 Bonn, Germany; [Schwarzer, Julia] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Kullmann, Harald] Univ Munster, Zentrum Didakt Biol, Munster, Germany	University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Munster	Langen, K (corresponding author), Univ Bonn, Inst Evolutionary Biol & Ecol, D-5300 Bonn, Germany.	klangen@evolution.uni-bonn.de	Bakker, Theo/AAI-3587-2020		Deutsche Forschungsgemeinschaft [BA 2885/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft (www.dfg.de) (BA 2885/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese JF, 2008, MAR GENOM, V1, P103, DOI 10.1016/j.margen.2008.10.004; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Baldauf SA, 2011, BEHAV ECOL, V22, P478, DOI 10.1093/beheco/arq226; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; Bateson P., 1983, P257; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; Bilde T, 2005, EVOLUTION, V59, P160, DOI 10.1111/j.0014-3820.2005.tb00903.x; Boakes EH, 2007, HEREDITY, V98, P172, DOI 10.1038/sj.hdy.6800923; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURLEY N, 1990, ANIM BEHAV, V39, P775, DOI 10.1016/S0003-3472(05)80389-6; Castric V, 2002, HEREDITY, V89, P27, DOI 10.1038/sj.hdy.6800089; Chandler CH, 2008, MOL ECOL, V17, P1564, DOI 10.1111/j.1365-294X.2007.03614.x; Chapman TW, 1996, HEREDITY, V76, P65, DOI 10.1038/hdy.1996.8; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Cohen LB, 2004, ANIM BEHAV, V68, P1229, DOI 10.1016/j.anbehav.2003.12.021; Cornuet JM, 1996, GENETICS, V144, P2001; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; Coyne J.A., 2004, SPECIATION; CRAIG JL, 1988, AM NAT, V131, P58, DOI 10.1086/284773; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; Dobson FS, 1997, EVOLUTION, V51, P970, DOI 10.1111/j.1558-5646.1997.tb03677.x; Duarte LC, 2003, EVOLUTION, V57, P638; Earl D.A., 2011, STRUCTURE HARVESTER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; FAULKES CG, 1990, J ZOOL, V221, P87, DOI 10.1111/j.1469-7998.1990.tb03778.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Fox CW, 2008, EVOLUTION, V62, P2236, DOI 10.1111/j.1558-5646.2008.00441.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frommen JG, 2006, BIOL LETTERS, V2, P232, DOI 10.1098/rsbl.2005.0432; Glemin S, 2003, EVOLUTION, V57, P2678; Gow JL, 2008, MOL ECOL, V17, P1399, DOI 10.1111/j.1365-294X.2008.03691.x; GRAZIANO AM, RAULIN ML RANDOM NUM; Gross R, 2007, AQUACULTURE, V272, pS139, DOI 10.1016/j.aquaculture.2007.08.004; Gulisija D, 2007, EVOLUTION, V61, P1043, DOI 10.1111/j.1558-5646.2007.00088.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Hansson B, 2007, BEHAV ECOL, V18, P157, DOI 10.1093/beheco/arl062; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hedrick P.W., 2011, GENETICS POPULATIONS; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; HEDRICK PW, 1994, HEREDITY, V73, P363, DOI 10.1038/hdy.1994.183; Hinrichs D, 2007, HEREDITY, V99, P81, DOI 10.1038/sj.hdy.6800968; Holand O, 2007, BIOL LETTERS, V3, P36, DOI 10.1098/rsbl.2006.0575; Honeycutt R.L., 1991, P195; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keane B, 1996, BEHAV ECOL, V7, P480, DOI 10.1093/beheco/7.4.480; Keller LF, 1998, AM NAT, V152, P380, DOI 10.1086/286176; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kleven O, 2005, BIOL LETT-UK, V1, P389, DOI 10.1098/rsbl.2005.0376; Koch M, 2008, MOL ECOL, V17, P4500, DOI 10.1111/j.1365-294X.2008.03925.x; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kristensen TN, 2005, ANIM SCI, V80, P121, DOI 10.1079/ASC41960121; Lacy RC, 1998, EVOLUTION, V52, P900, DOI [10.2307/2411285, 10.1111/j.1558-5646.1998.tb03715.x]; Lane JE, 2007, ANIM BEHAV, V74, P611, DOI 10.1016/j.anbehav.2006.12.017; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Li BS, 2009, HUM HERED, V67, P104, DOI 10.1159/000179558; Lubin Y, 2007, ADV STUD BEHAV, V37, P83, DOI 10.1016/S0065-3454(07)37003-4; Mehlis M, 2008, ANIM COGN, V11, P643, DOI 10.1007/s10071-008-0154-3; Miller PS, 2001, J EVOLUTION BIOL, V14, P595, DOI 10.1046/j.1420-9101.2001.00303.x; Neff BD, 2000, T AM FISH SOC, V129, P584, DOI 10.1577/1548-8659(2000)129&lt;0584:MMIF&gt;2.0.CO;2; Park S.D.E., 2001, THESIS; Parker G.A., 1979, P123; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Poulet N, 2009, GENETICA, V135, P77, DOI 10.1007/s10709-008-9260-z; Pouyaud L, 1999, MOL ECOL, V8, P803; Pritchard JK, 2000, GENETICS, V155, P945; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; RATTI O, 1995, BEHAV ECOL SOCIOBIOL, V37, P419, DOI 10.1007/BF00170590; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REEVE HK, 1990, P NATL ACAD SCI USA, V87, P2496, DOI 10.1073/pnas.87.7.2496; ROBERTSON A, 1984, GENETICS, V107, P703; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; ROWLEY I, 1986, ANIM BEHAV, V34, P939, DOI 10.1016/S0003-3472(86)80086-0; Schjorring S, 2007, EVOLUTION, V61, P423, DOI 10.1111/j.1558-5646.2007.00028.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schultz JK, 2009, J HERED, V100, P25, DOI 10.1093/jhered/esn077; Sefc KM, 2008, MOL ECOL, V17, P2531, DOI 10.1111/j.1365-294X.2008.03763.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sherman CDH, 2008, P R SOC B, V275, P971, DOI 10.1098/rspb.2007.1626; Shields William M., 1993, P143; Shirak A, 2006, J IMMUNOL, V176, P390, DOI 10.4049/jimmunol.176.1.390; Simmons LW, 2008, BIOL LETTERS, V4, P183, DOI 10.1098/rsbl.2007.0578; SLATER PJB, 1981, Z TIERPSYCHOL, V57, P201; SMITH RH, 1979, HEREDITY, V43, P205, DOI 10.1038/hdy.1979.75; Stiver KA, 2008, BEHAV ECOL, V19, P816, DOI 10.1093/beheco/arn031; Stiver KA, 2007, MOL ECOL, V16, P2974, DOI 10.1111/j.1365-294X.2007.03350.x; Swindell WR, 2006, J EVOLUTION BIOL, V19, P1257, DOI 10.1111/j.1420-9101.2005.01074.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Taylor MI, 2001, P ROY SOC B-BIOL SCI, V268, P803, DOI 10.1098/rspb.2000.1580; Thunken T, 2007, ETHOLOGY, V113, P1107, DOI 10.1111/j.1439-0310.2007.01422.x; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; Thunken T, 2010, ANIM BEHAV, V80, P69, DOI 10.1016/j.anbehav.2010.04.001; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Viken A, 2006, ETHOLOGY, V112, P716, DOI 10.1111/j.1439-0310.2006.01225.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Waldman Bruce, 1993, P250; Waller Donald M., 1993, P97; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS, 1996, SINAUER ASS SUNDERL; Wilson GA, 2003, GENETICS, V163, P1177	119	37	37	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24689	10.1371/journal.pone.0024689	http://dx.doi.org/10.1371/journal.pone.0024689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980351	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300008
J	Sandoval, JM; Arenas, FA; Vasquez, CC				Sandoval, Juan M.; Arenas, Felipe A.; Vasquez, Claudio C.			Glucose-6-Phosphate Dehydrogenase Protects Escherichia coli from Tellurite-Mediated Oxidative Stress	PLOS ONE			English	Article							REACTIVE OXYGEN; SOXRS REGULON; SALMONELLA-TYPHIMURIUM; GLUTATHIONE-REDUCTASE; POTASSIUM TELLURITE; SUPEROXIDE STRESS; CELL-DEATH; IN-VIVO; DEHYDROGENASE; ANTIOXIDANT	The tellurium oxyanion tellurite induces oxidative stress in most microorganisms. In Escherichia coli, tellurite exposure results in high levels of oxidized proteins and membrane lipid peroxides, inactivation of oxidation-sensitive enzymes and reduced glutathione content. In this work, we show that tellurite-exposed E. coli exhibits transcriptional activation of the zwf gene, encoding glucose 6-phosphate dehydrogenase (G6PDH), which in turn results in augmented synthesis of reduced nicotinamide adenine dinucleotide phosphate (NADPH). Increased zwf transcription under tellurite stress results mainly from reactive oxygen species (ROS) generation and not from a depletion of cellular glutathione. In addition, the observed increase of G6PDH activity was paralleled by accumulation of glucose-6-phosphate (G6P), suggesting a metabolic flux shift toward the pentose phosphate shunt. Upon zwf overexpression, bacterial cells also show increased levels of antioxidant molecules (NADPH, GSH), better-protected oxidation-sensitive enzymes and decreased amounts of oxidized proteins and membrane lipids. These results suggest that by increasing NADPH content, G6PDH plays an important role in E. coli survival under tellurite stress.	[Sandoval, Juan M.; Arenas, Felipe A.; Vasquez, Claudio C.] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile	Universidad de Santiago de Chile	Sandoval, JM (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile.	claudio.vasquez@usach.cl		Appanna, Vasu/0000-0002-0138-5665	Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica) [1090097]; Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile); MECESUP (Mejoramiento de la Calidad y Equidad de la Educacion Superior), Chile; CONICYT (Comision Nacional de Ciencia y Tecnologia)	Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile); MECESUP (Mejoramiento de la Calidad y Equidad de la Educacion Superior), Chile; CONICYT (Comision Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by grants # 1090097 from Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica) and Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile) to C. C. V. J.M.S. was supported by a doctoral fellowship from MECESUP (Mejoramiento de la Calidad y Equidad de la Educacion Superior) UCH407, Chile. F. A. A. received doctoral fellowships from CONICYT (Comision Nacional de Ciencia y Tecnologia) and from MECESUP UCH607, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASNIS RE, 1955, J BIOL CHEM, V213, P77; Beriault R, 2007, BIOMETALS, V20, P165, DOI 10.1007/s10534-006-9024-0; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Borsetti F, 2005, RES MICROBIOL, V156, P807, DOI 10.1016/j.resmic.2005.03.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070; Calderon IL, 2009, MICROBIOL-SGM, V155, P1840, DOI 10.1099/mic.0.026260-0; Castro ME, 2008, BIOCHEM BIOPH RES CO, V375, P91, DOI 10.1016/j.bbrc.2008.07.119; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; CHIONG M, 1988, J BACTERIOL, V170, P3269, DOI 10.1128/jb.170.7.3269-3273.1988; Contreras ND, 2010, ARCH MICROBIOL, V192, P969, DOI 10.1007/s00203-010-0624-2; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Echave P, 2003, J BIOL CHEM, V278, P30193, DOI 10.1074/jbc.M304351200; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fuentes DE, 2007, J BACTERIOL, V189, P8953, DOI 10.1128/JB.01252-07; Gaudu P, 1997, J BIOL CHEM, V272, P5082, DOI 10.1074/jbc.272.8.5082; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Griffith KL, 2004, J MOL BIOL, V344, P1, DOI 10.1016/j.jmb.2004.09.007; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Hasan MR, 2010, J BIOL CHEM, V285, P19135, DOI 10.1074/jbc.M109.074310; HEBER UW, 1967, BIOCHIM BIOPHYS ACTA, V109, P390; HERRERA G, 2003, CURR PROTOC CYTOM; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; JOHNSON RM, 1994, BLOOD, V83, P1117; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Krapp AR, 2011, MICROBIOL-SGM, V157, P957, DOI 10.1099/mic.0.039461-0; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; Liochev SI, 1999, J BIOL CHEM, V274, P9479, DOI 10.1074/jbc.274.14.9479; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; Lundberg BE, 1999, INFECT IMMUN, V67, P436, DOI 10.1128/IAI.67.1.436-438.1999; Lushchak VI, 2001, AM J PHYSIOL-REG I, V280, pR100, DOI 10.1152/ajpregu.2001.280.1.R100; Miller JH, 1972, EXPT MOL GENETICS, P201; Minard KI, 2007, FREE RADICAL BIO MED, V42, P106, DOI 10.1016/j.freeradbiomed.2006.09.024; Murakami K, 2006, ARCH MICROBIOL, V186, P385, DOI 10.1007/s00203-006-0153-1; Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211; Petrat F, 2003, J BIOL CHEM, V278, P3298, DOI 10.1074/jbc.M204230200; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Rungrassamee W, 2008, ARCH MICROBIOL, V190, P41, DOI 10.1007/s00203-008-0361-y; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; Sambrook J., 2002, MOL CLONING LAB MANU; Sandoval JM, 2010, BIOMETALS, V23, P623, DOI 10.1007/s10534-010-9316-2; Semchyshyn H, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1238, DOI 10.1007/s10541-005-0253-6; SILIPRANDI D, 1973, FEBS LETT, V29, P101, DOI 10.1016/0014-5793(73)80535-6; SILIPRANDI D, 1971, BIOCHEM BIOPH RES CO, V45, P1071, DOI 10.1016/0006-291X(71)90446-3; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tremaroli V, 2007, ARCH MICROBIOL, V187, P127, DOI 10.1007/s00203-006-0179-4; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Turner RJ, 2001, CAN J MICROBIOL, V47, P33, DOI 10.1139/cjm-47-1-33; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701	57	52	55	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25573	10.1371/journal.pone.0025573	http://dx.doi.org/10.1371/journal.pone.0025573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984934	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300044
J	Bargues, MD; Artigas, P; Khoubbane, M; Flores, R; Gloer, P; Rojas-Garcia, R; Ashrafi, K; Falkner, G; Mas-Coma, S				Dolores Bargues, Maria; Artigas, Patricio; Khoubbane, Messaoud; Flores, Rosmary; Gloeer, Peter; Rojas-Garcia, Raul; Ashrafi, Keyhan; Falkner, Gerhard; Mas-Coma, Santiago			Lymnaea schirazensis, an Overlooked Snail Distorting Fascioliasis Data: Genotype, Phenotype, Ecology, Worldwide Spread, Susceptibility, Applicability	PLOS ONE			English	Article							GEOGRAPHIC INFORMATION-SYSTEM; NORTHERN BOLIVIAN ALTIPLANO; RIBOSOMAL-SUBUNIT RNA; HIGH-ALTITUDE; SEQUENCE CHARACTERIZATION; TRUNCATULA GASTROPODA; EVOLUTIONARY GENETICS; PHYLOGENETIC ANALYSIS; COUSINI JOUSSEAUME; MITOCHONDRIAL-DNA	Background: Lymnaeid snails transmit medical and veterinary important trematodiases, mainly fascioliasis. Vector specificity of fasciolid parasites defines disease distribution and characteristics. Different lymnaeid species appear linked to different transmission and epidemiological patterns. Pronounced susceptibility differences to absolute resistance have been described among lymnaeid populations. When assessing disease characteristics in different endemic areas, unexpected results were obtained in studies on lymnaeid susceptibility to Fasciola. We undertook studies to understand this disease transmission heterogeneity. Methodology/Principal Findings: A ten-year study in Iran, Egypt, Spain, the Dominican Republic, Mexico, Venezuela, Ecuador and Peru, demonstrated that such heterogeneity is not due to susceptibility differences, but to a hitherto overlooked cryptic species, Lymnaea schirazensis, confused with the main vector Galba truncatula and/or other Galba/Fossaria vectors. Nuclear rDNA and mtDNA sequences and phylogenetic reconstruction highlighted an old evolutionary divergence from other Galba/Fossaria species, and a low intraspecific variability suggesting a recent spread from one geographical source. Morphometry, anatomy and egg cluster analyses allowed for phenotypic differentiation. Selfing, egg laying, and habitat characteristics indicated a migration capacity by passive transport. Studies showed that it is not a vector species (n = 8572 field collected, 20 populations): snail finding and penetration by F. hepatica miracidium occur but never lead to cercarial production (n = 338 experimentally infected). Conclusions/Significance: This species has been distorting fasciolid specificity/susceptibility and fascioliasis geographical distribution data. Hence, a large body of literature on G. truncatula should be revised. Its existence has henceforth to be considered in research. Genetic data on livestock, archeology and history along the 10,000-year post-domestication period explain its wide spread from the Neolithic Fertile Crescent. It is an efficient biomarker for the follow-up of livestock movements, a crucial aspect in fascioliasis emergence. It offers an outstanding laboratory model for genetic studies on susceptibility/resistance in F. hepatica/lymnaeid interaction, a field of applied research with disease control perspectives.	[Dolores Bargues, Maria; Artigas, Patricio; Khoubbane, Messaoud; Flores, Rosmary; Mas-Coma, Santiago] Univ Valencia, Fac Farm, Dept Parasitol, E-46010 Valencia, Spain; [Gloeer, Peter] Friedrich Held Gesell, Munchner Malakol Mitteilungen Heldia, Hetlingen, Germany; [Rojas-Garcia, Raul] Benemerita Univ Autonoma Puebla, Escuela Biol, Lab Biol Parasitos & Vectores, Puebla, Mexico; [Ashrafi, Keyhan] Guilan Univ Med Sci, Sch Med, Dept Med Microbiol & Parasitol, Rasht, Iran; [Falkner, Gerhard] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany; [Falkner, Gerhard] Museum Natl Hist Nat, UMS Taxon & Collect, Dept Systemat & Evolut, F-75231 Paris, France	University of Valencia; Benemerita Universidad Autonoma de Puebla; Museum National d'Histoire Naturelle (MNHN)	Bargues, MD (corresponding author), Univ Valencia, Fac Farm, Dept Parasitol, E-46010 Valencia, Spain.	M.D.Bargues@uv.es	Artigas, Patricio/L-6122-2014; Ashrafi, Keyhan/G-5868-2017; Artigas, Patricio/AAW-2964-2020; khoubbane, messaoud/L-6346-2014; Bargues, Maria Dolores/L-8259-2014; Rostami-Nejad, Mohammad/I-8708-2019	Artigas, Patricio/0000-0002-2815-1324; Ashrafi, Keyhan/0000-0002-1742-1245; Artigas, Patricio/0000-0002-2815-1324; Rostami-Nejad, Mohammad/0000-0003-2495-1831; Ashrafi, Keyhan/0000-0002-2102-0284; BARGUES, MARIA DOLORES/0000-0003-2347-7269; Mas-Coma, Santiago/0000-0002-1685-7004	Ministry of Education and Ministry of Science and Innovation, Madrid [PM97-0099, BOS2000-0570-C02-02, BOS2002-01978, SAF2006-09278, SAF2010-20805]; Direccion General de Cooperacion al Desarrollo, Generalitat Valenciana, Valencia [3006/99]; Fondo de Investigacion Sanitaria (FIS), Ministry of Health, Madrid [PI030545]; Red de Investigacion de Centros de Enfermedades Tropicales, FIS, Ministry of Health, Madrid, Spain [C03/04, ISCIII2005-PI050574, ISCIII-RETIC RD06/0021/0017]; International Atomic Energy Agency (IAEA)(Animal Production and Health Section, Joint Food and Agriculture Organization/IAEA Division of Nuclear Techniques in Food and Agriculture. [RLA5049]; Agencia Espanola de Cooperacion Internacional, Ministry of Foreign Affairs, Madrid, Spain	Ministry of Education and Ministry of Science and Innovation, Madrid; Direccion General de Cooperacion al Desarrollo, Generalitat Valenciana, Valencia(Center for Forestry Research & Experimentation (CIEF)); Fondo de Investigacion Sanitaria (FIS), Ministry of Health, Madrid(Instituto de Salud Carlos III); Red de Investigacion de Centros de Enfermedades Tropicales, FIS, Ministry of Health, Madrid, Spain; International Atomic Energy Agency (IAEA)(Animal Production and Health Section, Joint Food and Agriculture Organization/IAEA Division of Nuclear Techniques in Food and Agriculture.(International Atomic Energy Agency); Agencia Espanola de Cooperacion Internacional, Ministry of Foreign Affairs, Madrid, Spain	Studies were funded by Projects No. PM97-0099, No. BOS2000-0570-C02-02, No. BOS2002-01978, No. SAF2006-09278 and No. SAF2010-20805 of the Ministry of Education and Ministry of Science and Innovation, Madrid; Project No. 3006/99 of the Direccion General de Cooperacion al Desarrollo, Generalitat Valenciana, Valencia; Project No. PI030545 of the Fondo de Investigacion Sanitaria (FIS), Ministry of Health, Madrid; and by the Red de Investigacion de Centros de Enfermedades Tropicales (Projects No. C03/04, No. ISCIII2005-PI050574 and No. ISCIII-RETIC RD06/0021/0017 of the Programa de Redes Tematicas de Investigacion Cooperativa RETICS/FEDER), FIS, Ministry of Health, Madrid, Spain. Joint coordination activities with Mexico, Venezuela and Peru were carried out within the frame of Project No. RLA5049 of the International Atomic Energy Agency (IAEA)(Animal Production and Health Section, Joint Food and Agriculture Organization/IAEA Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, IAEA Headquaters Vienna, Austria). Part of this work was made possible thanks to a personal fellowship granted to PA by the Agencia Espanola de Cooperacion Internacional, Ministry of Foreign Affairs, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding and supporting agencies.	Adema Coen M., 1997, P229; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albrecht C, 2008, HYDROBIOLOGIA, V615, P103, DOI 10.1007/s10750-008-9558-y; Andrews SJ, 1999, FASCIOLOSIS, P1; [Anonymous], 2001, PROVEN SOLUTION IMAG, p8/1; Ashrafi K, 2007, IRAN J PUBLIC HEALTH, V36, P42; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Bargues MD, 2007, ANN TROP MED PARASIT, V101, P621, DOI 10.1179/136485907X229077; Bargues MD, 2001, INFECT GENET EVOL, V1, P85, DOI 10.1016/S1567-1348(01)00019-3; Bargues M.D., 2006, Heldia, V6, P29; Bargues MD, 1997, MOL BIOL EVOL, V14, P569, DOI 10.1093/oxfordjournals.molbev.a025794; Bargues MD, 1997, J PARASITOL, V83, P1086, DOI 10.2307/3284367; Bargues MD, 2005, J HELMINTHOL, V79, P257, DOI 10.1079/JOH2005297; Bargues MD, 2003, PARASITE, V10, P243, DOI 10.1051/parasite/2003103243; Bargues MD, 2011, PLOS ONE IN PRESS; Bellini, 1904, Journal of Conchology, Vxi, P33; Bokonyi S, 2004, HIST HUMANIDAD PREHI, V1, P392; Boray J. C., 1969, Adv. Parasitol., V7, P95, DOI 10.1016/S0065-308X(08)60435-2; BORAY JC, 1978, VET PARASITOL, V4, P127, DOI 10.1016/0304-4017(78)90004-3; BORAY JC, 1966, ANN TROP MED PARASIT, V60, P114, DOI 10.1080/00034983.1966.11686394; Bourguignat JR, 1863, MALACOLOGIE ALGERIE, V1, P1; Brown DS, 1994, FRESHWATER SNAILS AF, DOI 10.1201/9781482295184; Brusina S, 1866, CONTRIBUZIONE PELLA, V16; Bulliet RW, 2004, HIST HUMANIDAD SIGO, V4, P95; BURCH J B, 1968, Malacological Review, V1, P15; BURCH J B, 1973, Malacological Review, V6, P61; Burch J.B., 1982, Walkerana, V1, P217; Burch JB, 1982, FRESHWATER SNAILS; Burch JB, 1987, CLAVE GENERICA IDENT; Chen SY, 2006, GENE, V376, P216, DOI 10.1016/j.gene.2006.03.009; Clark D, 2004, HIST HUMANIDAD PREHI, V1, P210; Claxton John R., 1997, Parasitology International, V46, P281, DOI 10.1016/S1383-5769(97)00039-1; Claxton JR, 1999, VET J, V157, P166, DOI 10.1053/tvjl.1998.0293; Clessin S, 1880, NEUE FOLGE, V3, P7745; Clessin S, 1879, MALAKOZOOLOGISCHE BL, V1, P3; Cramp S, 1977, P1; CRUZREYES A, 1987, VET PARASITOL, V24, P203, DOI 10.1016/0304-4017(87)90041-0; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; de Benavente T, 1994, RELACIONES NUEVA ESP; de Folin L, 1878, J CONCHYLIOL PARIS, V18, P329; De la Brosse G., 2008, LATLAS MIGRATIONS RO, P38; DeJong RJ, 2001, MOL BIOL EVOL, V18, P2225, DOI 10.1093/oxfordjournals.molbev.a003769; DERIJK P, 1992, NUCLEIC ACIDS RES, V20, P2075, DOI 10.1093/nar/20.suppl.2075; Diaz del Castillo Bernal, 1955, HIST VERDADERA CONQU; Bargues MD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-132; Duchemin I, 2008, ATLAS MIGRAGION LES, P24; Durr PA, 2005, PREV VET MED, V71, P157, DOI 10.1016/j.prevetmed.2005.07.013; Dutra LH, 2010, VET PARASITOL, V169, P76, DOI 10.1016/j.vetpar.2009.12.015; FALKNER G, 2002, PATRIMOINES NATURELS, V52, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fuentes MV, 2001, ACTA TROP, V79, P87, DOI 10.1016/S0001-706X(01)00106-1; Fuentes MV, 1999, ANN TROP MED PARASIT, V93, P835, DOI 10.1080/00034989957844; Gamrasni M., 2008, LATLAS MIGRATIONS RO, P28; Gasnier N, 2000, INT J PARASITOL, V30, P573, DOI 10.1016/S0020-7519(00)00038-2; Giber P, 1998, SUSSWASSERMOLLUSKEN; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; GOMEZ JD, 1986, NAUTILUS, V100, P130; Gutierrez A, 2003, EXP PARASITOL, V105, P211, DOI 10.1016/j.exppara.2003.12.006; Gutierrez A, 2003, PARASITOL RES, V90, P129, DOI 10.1007/s00436-002-0824-z; HUBENDICK BENGT, 1951, K SVENSKA VETENSKAPSAKAD HANDL, V3, P1; Huh OK, 2001, ACTA TROP, V79, P35, DOI 10.1016/S0001-706X(01)00101-2; International Commission on Zoological Nomenclature (ICZN), 1998, B ZOOL NOMENCLATURE, V55, P123; Jackiewicz Maria, 1998, Genus (Wroclaw), V9, P1; Kalbe M, 1997, PARASITOL RES, V83, P806, DOI 10.1007/s004360050344; Kear J, 2005, BIRD FAMILIES WORLD; KENDALL S. B., 1959, ANN TROP MED AND PARASITOL, V53, P220; Krister HC, 1862, SYSTEMATISCHES CONCH, P1; Kruglov N.D., 2005, MOLLUSCS FAMILY LYMN; KRUGLOV ND, 1985, ZOOL ZH, V64, P24; Lavalle B, 2005, FRANCISCO PIZARRO CO; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Lockyer AE, 2004, CAN J ZOOL, V82, P251, DOI [10.1139/z03-215, 10.1139/Z03-215]; Longo M, 2005, REV ASOC COL CIENCIA, V17, P47; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; MADSEN H, 1989, ACTA TROP, V46, P139, DOI 10.1016/0001-706X(89)90030-2; Malek EA, 1985, SNAIL HOSTS SCHISTOS; Malone JB, 1998, VET PARASITOL, V78, P87, DOI 10.1016/S0304-4017(98)00137-X; Malone JB, 1999, FASCIOLOSIS, P151; MALONE JB, 1987, AM J VET RES, V48, P1167; Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822; Mas-Coma S, 2005, J HELMINTHOL, V79, P207, DOI 10.1079/JOH2005296; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mas-Coma S., 1987, P253; Mas-Coma S, 2001, PARASITOLOGY, V123, pS115, DOI 10.1017/S0031182001008034; Mas-Coma S, 2009, ACTA TROP, V110, P112, DOI 10.1016/j.actatropica.2008.10.013; Mas-Coma S, 1999, TROP MED INT HEALTH, V4, P454, DOI 10.1046/j.1365-3156.1999.00418.x; Mas-Coma S, 2009, ADV PARASIT, V69, P41, DOI 10.1016/S0065-308X(09)69002-3; Mas-Coma S, 2009, VET PARASITOL, V163, P264, DOI 10.1016/j.vetpar.2009.03.024; Mazzotti L., 1955, Revista del Instituto de Salubridad y Enfermedades Tropicales Mexico, V15, P163; McCRAW BRUCE M., 1961, TRANS AMER MICROSC SOC, V80, P16, DOI 10.2307/3223701; Sierra RMY, 2009, VET PARASITOL, V166, P73, DOI 10.1016/j.vetpar.2009.08.001; Meunier C, 2004, MOL ECOL, V13, P2535, DOI 10.1111/j.1365-294X.2004.02242.x; Meunier C, 2004, HEREDITY, V92, P316, DOI 10.1038/sj.hdy.6800410; Meunier C, 2001, MOL ECOL, V10, P1333, DOI 10.1046/j.1365-294X.2001.01284.x; Mirol PM, 2003, HEREDITY, V91, P248, DOI 10.1038/sj.hdy.6800312; MORALES G, 1983, ANN PARASIT HUM COMP, V58, P27, DOI 10.1051/parasite/1983581027; Mousson A, 1874, J CONCHYLIOL, V22, P5; Moya Pons F, 2008, HIST CARIBE AZUCAR P; Ollerenshaw C. B., 1969, Adv. Parasitol., V7, P283; OLLERENSHAW C B, 1974, P33; Oviedo, 1965, HIST CONQUISTA POBLA, V2, p[82, 233]; Pallary P, 1922, J CONCHYLIOL, V66, P89; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pereira F, 2005, MOL ECOL, V14, P2313, DOI 10.1111/j.1365-294X.2005.02594.x; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; PEREZ-REYES R, 1985, Revista Latinoamericana de Microbiologia, V27, P367; Pointier JP, 2009, MEM I OSWALDO CRUZ, V104, P790, DOI 10.1590/S0074-02762009000500022; Pointier JP, 2007, PARASITOL RES, V101, P1389, DOI 10.1007/s00436-007-0656-y; Pointier JP, 2004, MEM I OSWALDO CRUZ, V99, P567, DOI 10.1590/S0074-02762004000600005; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puslednik L, 2009, MOL PHYLOGENET EVOL, V52, P643, DOI 10.1016/j.ympev.2009.03.033; Rapsch C, 2008, VET PARASITOL, V154, P242, DOI 10.1016/j.vetpar.2008.03.030; Remigio EA, 1997, J MOLLUS STUD, V63, P173, DOI 10.1093/mollus/63.2.173; Remigio EA, 1997, CAN J ZOOL, V75, P1540, DOI 10.1139/z97-779; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; Remigio EA, 2002, PARASITOL RES, V88, P687, DOI 10.1007/s00436-002-0658-8; Robart G, 1976, HALIOTIS, V8, P159; Rojas-Garcia R, 2000, THESIS BENEMERITA U; Rollinson D., 1985, Linnean Society Symposium Series, P91; RONDELAUD D, 1993, B SOC ZOOL FR, V118, P185; Rondelaud D, 1997, REV MED VET-TOULOUSE, V148, P329; Rondelaud D, 2009, LIMNEE TRONQUEE UNMO; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samadi S, 2000, J MOLLUS STUD, V66, P31, DOI 10.1093/mollus/66.1.31; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J, 1989, MOL CLONING LAB MANU, VIII, P1647; Sambrook J, 1989, MOL CLONING LAB MANU, VII, P1647; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLICKUM W R, 1974, Archiv fuer Molluskenkunde, V104, P73; Serrera RM, 1990, HIST ESPANA, V8, P127; Simon C., 1991, NATO ASI Series Series H Cell Biology, V57, P329; Simon P, 1992, NOTICIAS HIST VENEZU, VII; Sowerby II GB, 1872, CONCHOLOGIA ICONICA, V18; Staden R, 2001, Methods Biochem Anal, V43, P303; Stothard JR, 2000, J ZOOL, V252, P303, DOI 10.1111/j.1469-7998.2000.tb00625.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trouve S, 2005, J EVOLUTION BIOL, V18, P358, DOI 10.1111/j.1420-9101.2004.00831.x; Tum S, 2007, VET PARASITOL, V143, P364, DOI 10.1016/j.vetpar.2006.08.033; UENO H, 1975, NATL I ANIM HEALTH Q, V15, P61; Valero MA, 2005, J HELMINTHOL, V79, P217, DOI 10.1079/JOH2005301; Valero MA, 1998, VIE MILIEU, V48, P73; Valero MA, 2001, VET PARASITOL, V102, P85, DOI 10.1016/S0304-4017(01)00499-X; Valero MA, 2000, FOLIA PARASIT, V47, P17, DOI 10.14411/fp.2000.004; Van Damme D., 1984, FRESHWATER MOLLUSCA; Villavicencio A, 2005, MEM I OSWALDO CRUZ, V100, P735, DOI 10.1590/S0074-02762005000700010; Westerlund CA, 1885, FAUNA PAAARCTISCHEN, P49; Wethington AR, 2007, J MOLLUS STUD, V73, P241, DOI 10.1093/mollus/eym021; WINNEPENNICKX B, 1992, FEBS LETT, V309, P123, DOI 10.1016/0014-5793(92)81078-Z; World Health Organization (WHO), 1995, WHO TECHN REP SER, V849, P1; Wright CA, 1973, FLUKES SNAILS; Yong M, 1995, J MED APPL MALACOL, V7, P17	156	62	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e24567	10.1371/journal.pone.0024567	http://dx.doi.org/10.1371/journal.pone.0024567			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980347	Green Submitted, gold, Green Published			2022-12-27	WOS:000295939600004
J	Fazzi, R; Pacini, S; Carnicelli, V; Trombi, L; Montali, M; Lazzarini, E; Petrini, M				Fazzi, Rita; Pacini, Simone; Carnicelli, Vittoria; Trombi, Luisa; Montali, Marina; Lazzarini, Edoardo; Petrini, Mario			Mesodermal Progenitor Cells (MPCs) Differentiate into Mesenchymal Stromal Cells (MSCs) by Activation of Wnt5/Calmodulin Signalling Pathway	PLOS ONE			English	Article							HUMAN BONE-MARROW; ADULT STEM-CELLS; IDENTIFICATION; PROLIFERATION; PLURIPOTENCY; EXPRESSION; EXPANSION; NICHE; SERUM; WNTS	Background: Mesenchymal Stromal Cells (MSCs) remain poorly characterized because of the absence of manifest physical, phenotypic, and functional properties in cultured cell populations. Despite considerable research on MSCs and their clinical application, the biology of these cells is not fully clarified and data on signalling activation during mesenchymal differentiation and proliferation are controversial. The role of Wnt pathways is still debated, partly due to culture heterogeneity and methodological inconsistencies. Recently, we described a new bone marrow cell population isolated from MSC cultures that we named Mesodermal Progenitor Cells (MPCs) for their mesenchymal and endothelial differentiation potential. An optimized culture method allowed the isolation from human adult bone marrow of a highly pure population of MPCs (more than 97%), that showed the distinctive SSEA-4(+)CD105(+)CD90(neg) phenotype and not expressing MSCA-1 antigen. Under these selective culture conditions the percentage of MSCs (SSEA-4(neg)CD105(+)CD90(bright) and MSCA-1(+)), in the primary cultures, resulted lower than 2%. Methodology/Principal Finding: We demonstrate that MPCs differentiate to MSCs through an SSEA-4(+)CD105(+)CD90(bright) early intermediate precursor. Differentiation paralleled the activation of Wnt5/Calmodulin signalling by autocrine/paracrine intense secretion of Wnt5a and Wnt5b (p<0.05 vs uncondictioned media), which was later silenced in late MSCs (SSEA-4(neg)). We found the inhibition of this pathway by calmidazolium chloride specifically blocked mesenchymal induction (ID50 = 0.5 mu M, p<0.01), while endothelial differentiation was unaffected. Conclusion:The present study describes two different putative progenitors (early and kite MSCs) that, together with already described MPCs, could be co-isolated and expanded in different percentages depending on the culture conditions. These results suggest that some modifications to the widely accepted MSC nomenclature are required.	[Fazzi, Rita; Pacini, Simone; Trombi, Luisa; Montali, Marina; Lazzarini, Edoardo; Petrini, Mario] Univ Pisa, Div Hematol, Dept Oncol Transplants & New Adv Med, Pisa, Italy; [Carnicelli, Vittoria] Univ Pisa, Dipartimento Sci Uomo & Ambiente, Pisa, Italy	University of Pisa; University of Pisa	Fazzi, R (corresponding author), Univ Pisa, Div Hematol, Dept Oncol Transplants & New Adv Med, Pisa, Italy.	simone.pacini@do.unipi.it	Pacini, Simone/H-3318-2019; Lazzarini, Edoardo/J-8459-2018	Pacini, Simone/0000-0003-1701-6001; Lazzarini, Edoardo/0000-0001-6369-5442; Montali, Marina/0000-0001-8804-4320	Department of Oncology; Transplants and New Advances in Medicine, University of Pisa	Department of Oncology; Transplants and New Advances in Medicine, University of Pisa	The work was exclusively supported by institutional funds of the Department of Oncology, Transplants and New Advances in Medicine, University of Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Noggle SA, 2005, STEM CELL REV, V1, P111, DOI 10.1385/SCR:1:2:111; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Pacini S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009861; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Petrini M, 2009, STEM CELLS DEV, V18, P857, DOI 10.1089/scd.2008.0291; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poloni A, 2009, CYTOTHERAPY, V11, P153, DOI 10.1080/14653240802582125; Prockop DJ, 2001, CYTOTHERAPY, V3, P393, DOI 10.1080/146532401753277229; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Suda T, 2008, CELL, V132, P729, DOI 10.1016/j.cell.2008.02.017; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Trombi L, 2009, STEM CELLS DEV, V18, P1227, DOI 10.1089/scd.2009.0054; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1	33	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25600	10.1371/journal.pone.0025600	http://dx.doi.org/10.1371/journal.pone.0025600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980498	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600037
J	Reimann, K; Krishnamoorthy, G; Wier, WG; Wangemann, P				Reimann, Katrin; Krishnamoorthy, Gayathri; Wier, Withrow Gil; Wangemann, Philine			Gender Differences in Myogenic Regulation along the Vascular Tree of the Gerbil Cochlea	PLOS ONE			English	Article							KCNJ10 PROTEIN EXPRESSION; BLOOD-FLOW; NITRIC-OXIDE; STRIA-VASCULARIS; ISCHEMIA; ARTERY; AUTOREGULATION; ESTROGEN; HOMEOSTASIS; ISOFLURANE	Regulation of cochlear blood flow is critical for hearing due to its exquisite sensitivity to ischemia and oxidative stress. Many forms of hearing loss such as sensorineural hearing loss and presbyacusis may involve or be aggravated by blood flow males being more susceptible. Autoregulation of cochlear blood flow has been demonstrated in some animal models in vivo, suggesting that similar to the brain, blood vessels supplying the cochlea have the ability to control flow within normal limits, despite variations in systemic blood pressure. Here, we investigated myogenic regulation in the cochlear blood supply of the Mongolian gerbil, a widely used animal model in hearing research. The cochlear blood supply originates at the basilar artery, followed by the anterior inferior cerebellar artery, and inside the inner ear, by the spiral modiolar artery and female gerbils were isolated and pressurized using a concentric pipette system. Diameter changes in response to increasing luminal pressures were recorded by laser scanning microscopy. Our results show that cochlear vessels from male and female gerbils exhibit myogenic regulation but with important differences. Whereas in male gerbils, both spiral modiolar arteries and radiating arterioles exhibited pressure-dependent tone, in females, only radiating arterioles had this property. Male spiral modiolar arteries responded more to L-NNA than female spiral modiolar arteries, suggesting that NO-dependent mechanisms play a bigger role in the myogenic regulation of male than female gerbil cochlear vessels.	[Reimann, Katrin; Krishnamoorthy, Gayathri; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Wier, Withrow Gil] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Kansas State University; University System of Maryland; University of Maryland Baltimore	Reimann, K (corresponding author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.	wange@vet.ksu.edu	Wier, Withrow/AAE-2451-2020; Wangemann, Philine/N-2826-2013	Krishnamoorthy, Gayathri/0000-0002-2208-3244; Natarajan, Gayathri/0000-0001-7654-5013	NIH [R01-DC04280, R01-HL-091969, P20-RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the following grants: NIH-R01-DC04280 to PW, NIH-R01-HL-091969 to WGW, and NIH-P20-RR017686 to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1988, AM J OTOLARYNG, V9, P278, DOI 10.1016/S0196-0709(88)80036-X; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Boettcher FA, 2002, J ACOUST SOC AM, V112, P2948, DOI 10.1121/1.1513364; BRECHTELSBAUER PB, 1994, HEARING RES, V77, P38, DOI 10.1016/0378-5955(94)90251-8; BROWN JN, 1994, AM J PHYSIOL, V266, pH458, DOI 10.1152/ajpheart.1994.266.2.H458; Cipolla MJ, 2008, MICROCIRCULATION, V15, P495, DOI 10.1080/10739680801986742; Cipolla MJ, 2008, MICROCIRCULATION, P1; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; Gladwin MT, 2006, ADV EXP MED BIOL, V588, P189; de Segura IAG, 2009, LAB ANIM-UK, V43, P239, DOI 10.1258/la.2008.006065; GOODWIN PC, 1984, HEARING RES, V15, P215, DOI 10.1016/0378-5955(84)90030-3; Gratton M A, 1996, Hear Res, V102, P181, DOI 10.1016/S0378-5955(96)90017-9; HATA R, 1994, J NEUROL SCI, V121, P79, DOI 10.1016/0022-510X(94)90160-0; HAYASHI K, 1995, HYPERTENSION, V25, P1212, DOI 10.1161/01.HYP.25.6.1212; HONRUBIA V, 1969, J ACOUST SOC AM, V46, P388, DOI 10.1121/1.1911701; KAWAKAMI M, 1991, EUR ARCH OTO-RHINO-L, V248, P471, DOI 10.1007/BF00627636; KILBOURN RG, 1994, BIOCHEM BIOPH RES CO, V199, P155, DOI 10.1006/bbrc.1994.1208; Knot HJ, 1999, AM J PHYSIOL-HEART C, V276, pH961, DOI 10.1152/ajpheart.1999.276.3.H961; MARCUS DC, 1978, LARYNGOSCOPE, V88, P1825; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; OHLSEN KA, 1992, HEARING RES, V58, P19, DOI 10.1016/0378-5955(92)90004-7; PEARSON JD, 1995, J ACOUST SOC AM, V97, P1196, DOI 10.1121/1.412231; PRAZMA J, 1990, ARCH OTOLARYNGOL, V116, P932; Preckel MP, 1998, ANESTH ANALG, V87, P1002, DOI 10.1097/00000539-199811000-00004; QUIRK WS, 1989, HEARING RES, V41, P53, DOI 10.1016/0378-5955(89)90178-0; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; ROBINSON D W, 1988, British Journal of Audiology, V22, P5, DOI 10.3109/03005368809077793; SHAPIRO HM, 1971, AM J PHYSIOL, V221, P279, DOI 10.1152/ajplegacy.1971.221.1.279; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Skarsgard P, 1997, AM J PHYSIOL-HEART C, V273, pH2248, DOI 10.1152/ajpheart.1997.273.5.H2248; SOHMER H, 1989, HEARING RES, V40, P87, DOI 10.1016/0378-5955(89)90102-0; THALMANN R, 1972, LARYNGOSCOPE, V82, P2249, DOI 10.1288/00005537-197212000-00013; Vaquez BYS, 2008, AM J RESP CELL MOL, V38, P135, DOI 10.1165/rcmb.2007-0081OC; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; Wangemann P, 1998, HEARING RES, V115, P113, DOI 10.1016/S0378-5955(97)00184-6; Wangemann P, 2005, HEARING RES, V209, P91, DOI 10.1016/j.heares.2005.06.011; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wellman GC, 1996, CIRC RES, V79, P1024, DOI 10.1161/01.RES.79.5.1024	40	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25659	10.1371/journal.pone.0025659	http://dx.doi.org/10.1371/journal.pone.0025659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980520	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600047
J	Huang, T; Chen, L; Cai, YD; Chou, KC				Huang, Tao; Chen, Lei; Cai, Yu-Dong; Chou, Kuo-Chen			Classification and Analysis of Regulatory Pathways Using Graph Property, Biochemical and Physicochemical Property, and Functional Property	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN SECONDARY STRUCTURE; SUPPORT VECTOR MACHINE; SUBCELLULAR LOCATION; METABOLIC PATHWAYS; ENZYME DATA; MULTIORGANISM DATABASE; PROBABILISTIC NETWORKS; KYOTO ENCYCLOPEDIA; GENE ONTOLOGY	Given a regulatory pathway system consisting of a set of proteins, can we predict which pathway class it belongs to? Such a problem is closely related to the biological function of the pathway in cells and hence is quite fundamental and essential in systems biology and proteomics. This is also an extremely difficult and challenging problem due to its complexity. To address this problem, a novel approach was developed that can be used to predict query pathways among the following six functional categories: (i) "Metabolism", (ii) "Genetic Information Processing", (iii) "Environmental Information Processing", (iv) "Cellular Processes", (v) "Organismal Systems", and (vi) "Human Diseases". The prediction method was established trough the following procedures: (i) according to the general form of pseudo amino acid composition (PseAAC), each of the pathways concerned is formulated as a 5570-D (dimensional) vector; (ii) each of components in the 5570-D vector was derived by a series of feature extractions from the pathway system according to its graphic property, biochemical and physicochemical property, as well as functional property; (iii) the minimum redundancy maximum relevance (mRMR) method was adopted to operate the prediction. A cross-validation by the jackknife test on a benchmark dataset consisting of 146 regulatory pathways indicated that an overall success rate of 78.8% was achieved by our method in identifying query pathways among the above six classes, indicating the outcome is quite promising and encouraging. To the best of our knowledge, the current study represents the first effort in attempting to identity the type of a pathway system or its biological function. It is anticipated that our report may stimulate a series of follow-up investigations in this new and challenging area.	[Huang, Tao; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Maritime University	Huang, T (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009; Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTHAUS IW, 1993, J BIOL CHEM, V268, P14875; ALTHAUS IW, 1993, J BIOL CHEM, V268, P6119; ALTHAUS IW, 1993, BIOCHEMISTRY-US, V32, P6548, DOI 10.1021/bi00077a008; Andraos J, 2008, CAN J CHEM, V86, P342, DOI 10.1139/V08-020; BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3626, DOI 10.1093/nar/22.17.3626; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bouckaert R.R., 2004, BAYESIAN NETWORK CLA; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; Cai YD, 2003, BIOCHEM BIOPH RES CO, V305, P407, DOI 10.1016/S0006-291X(03)00775-7; Cai YD, 2008, BIOCHEM BIOPH RES CO, V372, P862, DOI 10.1016/j.bbrc.2008.05.143; Cai YD, 2010, MOL DIVERS, V14, P551, DOI 10.1007/s11030-009-9182-4; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Chakrabarti D, 2005, TOOLS LARGE GRAPH MI; Chang M, 2011, BMB REP, V44, P423, DOI 10.5483/BMBRep.2011.44.7.423; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Chen L, 2010, J COMPUT CHEM, V31, P1766, DOI 10.1002/jcc.21467; Chen L, 2009, J PROTEOME RES, V8, P5212, DOI 10.1021/pr900554a; Chen L, 2009, J COMPUT CHEM, V30, P2248, DOI 10.1002/jcc.21230; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng J, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P101; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHOU KC, 1980, EUR J BIOCHEM, V113, P195; Chou KC, 2006, J PROTEOME RES, V5, P316, DOI 10.1021/pr050331g; Chou KC, 1997, PROTEINS, V28, P99, DOI 10.1002/(SICI)1097-0134(199705)28:1<99::AID-PROT10>3.0.CO;2-C; CHOU KC, 1989, J BIOL CHEM, V264, P12074; CHOU KC, 1990, BIOPHYS CHEM, V35, P1, DOI 10.1016/0301-4622(90)80056-D; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, CURR DRUG METAB, V11, P369, DOI 10.2174/138920010791514261; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Dale JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-15; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; Gao CF, 2011, PROTEIN PEPTIDE LETT, V18, P831, DOI 10.2174/092986611795713916; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Klukas C, 2007, BIOINFORMATICS, V23, P344, DOI 10.1093/bioinformatics/btl611; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lobanova YS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P320, DOI 10.1134/S0006297907030108; Lu L, 2010, MOL DIVERS, V14, P81, DOI 10.1007/s11030-009-9149-5; Lu L, 2009, PEPTIDES, V30, P359, DOI 10.1016/j.peptides.2008.09.020; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pharkya P, 2003, METAB ENG, V5, P71, DOI 10.1016/S1096-7176(03)00008-9; Platt J., FAST TRAINING SUPPOR; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; SALZBERG S, 1992, J MOL BIOL, V227, P371, DOI 10.1016/0022-2836(92)90892-N; Schomburg I, 2002, TRENDS BIOCHEM SCI, V27, P54, DOI 10.1016/S0968-0004(01)02027-8; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Witten I. H., 2005, DATA MINING PRACTICA; Wu ZC, 2010, J THEOR BIOL, V267, P29, DOI 10.1016/j.jtbi.2010.08.007; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; ZHOU GP, 1984, BIOCHEM J, V222, P169, DOI 10.1042/bj2220169; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	91	83	83	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25297	10.1371/journal.pone.0025297	http://dx.doi.org/10.1371/journal.pone.0025297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980418	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900048
J	Tornavaca, O; Sarro, E; Pascual, G; Bardaji, B; Montero, MA; Salcedo, MT; Plana, M; Lopez-Hellin, J; Itarte, E; Meseguer, A				Tornavaca, Olga; Sarro, Eduard; Pascual, Gloria; Bardaji, Beatriz; Angeles Montero, M.; Teresa Salcedo, M.; Plana, Maria; Lopez-Hellin, Joan; Itarte, Emilio; Meseguer, Anna			KAP Degradation by Calpain Is Associated with CK2 Phosphorylation and Provides a Novel Mechanism for Cyclosporine A-Induced Proximal Tubule Injury	PLOS ONE			English	Article							CELL-SPECIFIC EXPRESSION; PROTEIN-KINASE CK2; THYROID-HORMONE; MESSENGER-RNA; KIDNEY INJURY; MEDIATED DEGRADATION; PEST SEQUENCES; B-ALPHA; NEPHROTOXICITY; GENE	The use of cyclosporine A (CsA) is limited by its severe nephrotoxicity that includes reversible vasoconstrictor effects and proximal tubule cell injury, the latter associated whith chronic kidney disease progression. The mechanisms of CsA-induced tubular injury, mainly on the S3 segment, have not been completely elucidated. Kidney androgen-regulated protein (KAP) is exclusively expressed in kidney proximal tubule cells, interacts with the CsA-binding protein cyclophilin B and its expression diminishes in kidneys of CsA-treated mice. Since we reported that KAP protects against CsA toxicity in cultured proximal tubule cells, we hypothesized that low KAP levels found in kidneys of CsA-treated mice might correlate with proximal tubule cell injury. To test this hypothesis, we used KAP Tg mice developed in our laboratory and showed that these mice are more resistant to CsA-induced tubular injury than control littermates. Furthermore, we found that calpain, which was activated by CsA in cell cultures and kidney, is involved in KAP degradation and observed that phosphorylation of serine and threonine residues found in KAP PEST sequences by protein kinase CK2 enhances KAP degradation by calpain. Moreover, we also observed that CK2 inhibition protected against CsA-induced cytotoxicity. These findings point to a novel mechanism for CsA-induced kidney toxicity that might be useful in developing therapeutic strategies aimed at preventing tubular cell damage while maintaining the immunosuppressive effects of CsA.	[Tornavaca, Olga; Sarro, Eduard; Pascual, Gloria; Bardaji, Beatriz; Lopez-Hellin, Joan; Meseguer, Anna] Hosp Univ Vall dHebron, Inst Recerca Vall dHebron, Ctr Invest Bioquim & Biol Mol CIBBIM, Barcelona, Spain; [Sarro, Eduard; Plana, Maria; Itarte, Emilio] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim Biociencies, Bellaterra, Spain; [Angeles Montero, M.; Teresa Salcedo, M.] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Meseguer, Anna] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim Med, Bellaterra, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Tornavaca, O (corresponding author), Hosp Univ Vall dHebron, Inst Recerca Vall dHebron, Ctr Invest Bioquim & Biol Mol CIBBIM, Barcelona, Spain.	ameseguer@ir.vhebron.net	Lopez-Hellin, Joan/M-2234-2014; Itarte, Emilio/Q-6246-2019; Montero, Angeles/AAQ-1696-2021; Sarró Tauler, Eduard/M-1660-2014; Angulo, Gloria Pascual/AAA-7668-2019; Navarro, Anna Meseguer/M-2222-2014; Itarte, Emilio/K-5275-2014; Plana Coll, Maria/L-3414-2014; Salcedo, Maria-Teresa/N-7091-2014	Lopez-Hellin, Joan/0000-0001-7286-3882; Montero, Angeles/0000-0002-2381-6833; Sarró Tauler, Eduard/0000-0001-7723-2916; Angulo, Gloria Pascual/0000-0003-3810-6647; Navarro, Anna Meseguer/0000-0003-3833-2249; Itarte, Emilio/0000-0002-9366-5807; Plana Coll, Maria/0000-0001-5808-9229; Bardaji de Quixano, Beatriz/0000-0001-7456-355X; Salcedo, Maria-Teresa/0000-0002-4822-5060	Ministerio de Ciencia e Innovacion [SAF2005-05167, BFU2009-10189]; Instituto de Salud Carlos III [FIS PI081351]; Fundacio La Marato de TV3 [002230, 002231]; Fundacion Senefro; Fundacion Mutua Madrilena; Red Nacional de Investigacion en Trasplantes del Instituto de Salud Carlos III; Beatriz Bardaji by Fundacion Renal Inigo Alvarez de Toledo; Fundacio Institut de Recerca Vall d'Hebron	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacio La Marato de TV3; Fundacion Senefro; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Red Nacional de Investigacion en Trasplantes del Instituto de Salud Carlos III; Beatriz Bardaji by Fundacion Renal Inigo Alvarez de Toledo; Fundacio Institut de Recerca Vall d'Hebron	This study was supported in part by grants (SAF2005-05167 to A. M and BFU2009-10189 to E. I.) from Ministerio de Ciencia e Innovacion; grant FIS PI081351 from Instituto de Salud Carlos III to A. M.; Fundacio La Marato de TV3 (grants 002230 and 002231) to A. M. and E. I.; Fundacion Senefro to A. M. and Fundacion Mutua Madrilena to A. M. Fellow funding was as follows: Dr. Olga Tornavaca was supported by the Red Nacional de Investigacion en Trasplantes del Instituto de Salud Carlos III; Beatriz Bardaji by Fundacion Renal Inigo Alvarez de Toledo and Gloria Pascual by Fundacio Institut de Recerca Vall d'Hebron. Dr. Meseguer's research group holds the "Quality'' mention from the Generalitat de Catalunya (Expediente 2009 SGR 75). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BATLLE DC, 1990, KIDNEY INT, V37, P21, DOI 10.1038/ki.1990.3; BENNETT WM, 1994, MINER ELECTROL METAB, V20, P214; Blomgren K, 2004, J BIOL CHEM, V13, P10191; BRONK SF, 1993, AM J PHYSIOL, V264, pG744, DOI 10.1152/ajpgi.1993.264.4.G744; Carillo S, 1996, BIOCHEM J, V313, P245, DOI 10.1042/bj3130245; Cebrian C, 2001, J BIOL CHEM, V276, P29410, DOI 10.1074/jbc.M102916200; Cheng CH, 2002, FEBS LETT, V516, P191, DOI 10.1016/S0014-5793(02)02563-2; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; da Costa MC, 2003, NEPHROL DIAL TRANSPL, V18, P2262, DOI 10.1093/ndt/gfg343; Edelstein CL, 1996, KIDNEY INT, V50, P1150, DOI 10.1038/ki.1996.422; EDELSTEIN CL, 1995, P NATL ACAD SCI USA, V92, P7662, DOI 10.1073/pnas.92.17.7662; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Inserte J, 2004, CARDIOVASC RES, V64, P105, DOI 10.1016/j.cardiores.2004.06.001; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Llorens F, 2003, BIOCHEM J, V375, P623, DOI 10.1042/BJ20030915; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MESEGUER A, 1987, MOL ENDOCRINOL, V1, P535, DOI 10.1210/mend-1-8-535; MESEGUER A, 1989, MOL ENDOCRINOL, V3, P962, DOI 10.1210/mend-3-6-962; MESEGUER A, 1990, MOL ENDOCRINOL, V4, P1240, DOI 10.1210/mend-4-8-1240; MESEGUER A, 1992, MOL CELL ENDOCRINOL, V89, P153, DOI 10.1016/0303-7207(92)90221-Q; MIHATSCH MJ, 1988, TRANSPLANT P, V20, P759; MIHATSCH MJ, 1986, CLIN NEPHROL, V25, pS2; Miyata Y, 1997, P NATL ACAD SCI USA, V94, P14500, DOI 10.1073/pnas.94.26.14500; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; MURRAY BM, 1985, KIDNEY INT, V28, P767, DOI 10.1038/ki.1985.196; MYERS BD, 1984, NEW ENGL J MED, V311, P699, DOI 10.1056/NEJM198409133111103; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Perez-Rojas J, 2007, AM J PHYSIOL-RENAL, V292, pF131, DOI 10.1152/ajprenal.00147.2006; Rasband W.S., 1997, IMAGE J; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Schnellmann RG, 1998, RENAL FAILURE, V20, P679, DOI 10.3109/08860229809045162; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; SOLE E, 1994, ENDOCRINOLOGY, V135, P2120, DOI 10.1210/en.135.5.2120; Sole E, 1996, MOL CELL ENDOCRINOL, V119, P147, DOI 10.1016/0303-7207(96)03603-9; Soler M, 2002, BIOCHEM J, V366, P757, DOI 10.1042/BJ20011807; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; SUZUKI S, 1987, TRANSPLANTATION, V44, P363, DOI 10.1097/00007890-198709000-00008; Teixido N, 2006, MOL ENDOCRINOL, V20, P389, DOI 10.1210/me.2005-0229; TOOLE JJ, 1979, CELL, V17, P441, DOI 10.1016/0092-8674(79)90170-3; Tornavaca O, 2009, CIRCULATION, V119, P1908, DOI 10.1161/CIRCULATIONAHA.108.808543; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; WILSON PD, 1991, CELL BIOL INT REP, V15, P1243, DOI 10.1016/0309-1651(91)90096-2; Womer KL, 2009, AM J TRANSPLANT, V9, P1265, DOI 10.1111/j.1600-6143.2009.02639.x; Wu MJ, 2004, J CELL PHYSIOL, V200, P395, DOI 10.1002/jcp.20028; Yanagawa T, 1997, BIOCHEM BIOPH RES CO, V241, P157, DOI 10.1006/bbrc.1997.7783	55	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25746	10.1371/journal.pone.0025746	http://dx.doi.org/10.1371/journal.pone.0025746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980535	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900095
J	Di Garbo, A; Mainardi, M; Chillemi, S; Maffei, L; Caleo, M				Di Garbo, Angelo; Mainardi, Marco; Chillemi, Santi; Maffei, Lamberto; Caleo, Matteo			Environmental Enrichment Modulates Cortico-Cortical Interactions in the Mouse	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; RAT VISUAL-CORTEX; SYNCHRONY; BRAIN; EXPERIENCE; BEHAVIOR; SYSTEMS; MODEL	Environmental enrichment (EE) is an experimental protocol based on a complex sensorimotor stimulation that dramatically affects brain development. While it is widely believed that the effects of EE result from the unique combination of different sensory and motor stimuli, it is not known whether and how cortico-cortical interactions are shaped by EE. Since the primary visual cortex (V1) is one of the best characterized targets of EE, we looked for direct cortico-cortical projections impinging on V1, and we identified a direct monosynaptic connection between motor cortex and V1 in the mouse brain. To measure the interactions between these areas under standard and EE rearing conditions, we used simultaneous recordings of local field potentials (LFPs) in awake, freely moving animals. LFP signals were analyzed by using different methods of linear and nonlinear analysis of time series (cross-correlation, mutual information, phase synchronization). We found that EE decreases the level of coupling between the electrical activities of the two cortical regions with respect to the control group. From a functional point of view, our results indicate, for the first time, that an enhanced sensorimotor experience impacts on the brain by affecting the functional crosstalk between different cortical areas.	[Di Garbo, Angelo; Chillemi, Santi] CNR, Inst Biophys, Natl Res Council, I-56100 Pisa, Italy; [Mainardi, Marco; Maffei, Lamberto; Caleo, Matteo] CNR, Natl Res Council, Inst Neurosci, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Di Garbo, A (corresponding author), CNR, Inst Biophys, Natl Res Council, I-56100 Pisa, Italy.	caleo@in.cnr.it	Mainardi, Marco/AAY-4025-2020	CALEO, MATTEO/0000-0002-4333-6378	Compagnia di San Paolo (Torino, Italy); Fondazione Cassa di Risparmio di Pisa (Pisa, Italy); Fondazione Cassa di Risparmio di Pisa	Compagnia di San Paolo (Torino, Italy)(Compagnia di San Paolo); Fondazione Cassa di Risparmio di Pisa (Pisa, Italy); Fondazione Cassa di Risparmio di Pisa	This work was supported by a Compagnia di San Paolo (Torino, Italy) grant to MC and by a Fondazione Cassa di Risparmio di Pisa (Pisa, Italy) grant to LM. MM is the recipient of a post-doctoral fellowship from Fondazione Cassa di Risparmio di Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Cover T. M., 1991, ELEMENTS INFORM THEO; Faes L, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026201; Guandalini P, 1998, BRAIN RES BULL, V47, P377, DOI 10.1016/S0361-9230(98)00122-1; Kantz H., 1997, NONLINEAR TIME SERIE; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kreuz T, 2007, PHYSICA D, V225, P29, DOI 10.1016/j.physd.2006.09.039; Mainardi M, 2010, J NEUROSCI RES, V88, P3048, DOI 10.1002/jnr.22461; Mormann F, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021912; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Piche M, 2007, NEUROSCIENCE, V145, P1144, DOI 10.1016/j.neuroscience.2006.12.050; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Press W., 1986, NUMERICAL RECIPES; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; ROSENZWEIG M R, 1969, Developmental Psychobiology, V2, P87, DOI 10.1002/dev.420020208; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Schiff SJ, 1996, PHYS REV E, V54, P6708, DOI 10.1103/PhysRevE.54.6708; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001	30	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25285	10.1371/journal.pone.0025285	http://dx.doi.org/10.1371/journal.pone.0025285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966482	Green Published, gold, Green Submitted			2022-12-27	WOS:000295265100080
J	Wang, ZQ; Zhang, S; Luo, C; Wu, QZ; Liu, QL; Zhou, YH; Hu, YL				Wang, Zhiqun; Zhang, Shu; Luo, Chao; Wu, Qianzhen; Liu, Qilan; Zhou, Yi-Hua; Hu, Yali			Transplacentally Acquired Maternal Antibody against Hepatitis B Surface Antigen in Infants and its Influence on the Response to Hepatitis B Vaccine	PLOS ONE			English	Article							IMMUNE-RESPONSE; HBS ANTIBODIES; VIRUS; IMMUNIZATION; IMMUNOGENICITY; INDIVIDUALS; INFECTION; EFFICACY; MICE; LIFE	Background: Passively acquired maternal antibodies in infants may inhibit active immune responses to vaccines. Whether maternal antibody against hepatitis B surface antigen (anti-HBs) in infants may influence the long-term immunogenicity of hepatitis B vaccine remains unknown. Methodology/Principal Findings: Totally 338 pairs of mothers and children were enrolled. All infants were routinely vaccinated against hepatitis B based on 0-, 1- and 6-month schedule. We characterized the transplacental transfer of maternal anti-HBs, and compared anti-HBs response in children of mothers with or without anti-HBs. In a prospective observation, all 63 anti-HBs positive mothers transferred anti-HBs to their infants; 84.1% of the infants had higher anti-HBs concentrations than their mothers. One and half years after vaccination with three doses of hepatitis B vaccine, the positive rate and geometric mean concentration (GMC) of anti-HBs in 32 infants with maternal anti-HBs were comparable with those in 32 infants without maternal antibody (90.6% vs 87.5%, P = 0.688, and 74.5 vs 73.5 mIU/ml, P = 0.742, respectively). In a retrospective analysis, five and half years after vaccination with three doses vaccine, the positive rates of anti-HBs in 88 children of mothers with anti-HBs >= 1000 mIU/ml, 94 children of mothers with anti-HBs 10-999 mIU/ml, and 61 children of mothers with anti-HBs,10 mIU/ml were 72.7%, 69.2%, and 63.9% (P = 0.521), respectively; anti-HBs GMC in these three groups were 38.9, 43.9, and 31.7 mIU/ml (P = 0.726), respectively. Conclusions/Significance: The data demonstrate that maternal anti-HBs in infants, even at high concentrations, does not inhibit the long-term immunogenicity of hepatitis B vaccine. Thus, current hepatitis B vaccination schedule for infants will be still effective in the future when most infants are positive for maternal anti-HBs due to the massive vaccination against hepatitis B.	[Wang, Zhiqun; Zhang, Shu; Luo, Chao; Wu, Qianzhen; Hu, Yali] Nanjing Univ, Sch Med, Dept Obstet & Gynecol, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Liu, Qilan] Jiangsu Family Planning Inst, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Sch Med, Dept Lab Med, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Sch Med, Dept Infect Dis, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua; Hu, Yali] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Wang, ZQ (corresponding author), Nanjing Univ, Sch Med, Dept Obstet & Gynecol, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.	yzh20061111@yahoo.com; dtylhu@126.com			Health Bureau of Nanjing City [ZKM06050]; Health Department of Jiangsu Province [LJ200628, RC2007005, XK200709]; Jiangsu Science and Technology Department [BK2008501]; Population Family Planning Commission of Jiangsu Province [2011208]; National Key Basic Research Project (973 Planning), China [2010CB945104]	Health Bureau of Nanjing City; Health Department of Jiangsu Province; Jiangsu Science and Technology Department; Population Family Planning Commission of Jiangsu Province; National Key Basic Research Project (973 Planning), China(National Basic Research Program of China)	This study was supported by a grant (ZKM06050 to YHZ) for the Development of Medical Sciences from the Health Bureau of Nanjing City, by Special Grants for Leading Principal Investigators (LJ200628 to YH), for Principal Investigators (RC2007005 to YHZ), and for Maternal-Fetal Medicine (XK200709 to YH) from the Health Department of Jiangsu Province, by Natural Science grant (BK2008501 to QL) from Jiangsu Science and Technology Department, and by a research grant (2011208) from Population Family Planning Commission of Jiangsu Province, and by a grant (2010CB945104 to YH) from the National Key Basic Research Project (973 Planning), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; AYOOLA EA, 1987, INT J GYNECOL OBSTET, V25, P297, DOI 10.1016/0020-7292(87)90289-X; Bell BP, 2007, PEDIATR INFECT DIS J, V26, P116, DOI 10.1097/01.inf.0000253253.85640.cc; But DYK, 2008, VACCINE, V26, P6587, DOI 10.1016/j.vaccine.2008.09.034; Dagan R, 2000, PEDIATR INFECT DIS J, V19, P1045, DOI 10.1097/00006454-200011000-00004; ESTEBAN JI, 1986, J MED VIROL, V18, P381, DOI 10.1002/jmv.1890180411; Glezen WP, 2003, VACCINE, V21, P3389, DOI 10.1016/S0264-410X(03)00339-6; Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010; HEIJTINK RA, 1995, HEPATOLOGY, V22, P1078, DOI 10.1016/0270-9139(95)90612-6; Hu YL, 2008, VACCINE, V26, P6064, DOI 10.1016/j.vaccine.2008.09.014; Johansson E, 2008, VACCINE, V26, P778, DOI 10.1016/j.vaccine.2007.11.089; Junqueira ALN, 2011, MEM I OSWALDO CRUZ, V106, P113, DOI 10.1590/S0074-02762011000100018; Kurubi J, 2009, TROP MED INT HEALTH, V14, P167, DOI 10.1111/j.1365-3156.2008.02214.x; Poovorawan Y, 2011, J VIRAL HEPATITIS, V18, P369, DOI 10.1111/j.1365-2893.2010.01312.x; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saffar MJ, 2009, EUR J CLIN MICROBIOL, V28, P845, DOI 10.1007/s10096-009-0702-z; Shokrgozar MA, 2002, VACCINE, V20, P2215, DOI 10.1016/S0264-410X(02)00116-0; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; van Nunen AB, 2002, J VIRAL HEPATITIS, V9, P221, DOI 10.1046/j.1365-2893.2002.00337.x; Wang LN, 2005, MED MICROBIOL IMMUN, V194, P33, DOI 10.1007/s00430-004-0225-2; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V30, P241, DOI 10.1016/S0928-8244(01)00231-0; XU ZY, 1995, J INFECT DIS, V171, P54, DOI 10.1093/infdis/171.1.54; Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002; 无, 2007, [江苏医药, Jiangsu Medical Journal], V33, P1218	26	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25130	10.1371/journal.pone.0025130	http://dx.doi.org/10.1371/journal.pone.0025130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966434	gold, Green Published, Green Submitted			2022-12-27	WOS:000295265100063
J	Ciapponi, A; Bardach, A; Glujovsky, D; Gibbons, L; Picconi, MA				Ciapponi, Agustin; Bardach, Ariel; Glujovsky, Demian; Gibbons, Luz; Alejandra Picconi, Maria			Type-Specific HPV Prevalence in Cervical Cancer and High-Grade Lesions in Latin America and the Caribbean: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN-PAPILLOMAVIRUS INFECTION; RISK HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; MEXICAN WOMEN; CHLAMYDIA-TRACHOMATIS; RECURRENT DISEASE; UTERINE CERVIX; HA-RAS; DNA; VIRUS	Background: Cervical cancer is a major public health problem in Latin America and the Caribbean (LA&C), showing some of the highest incidence and mortality rates worldwide. Information on HPV type distribution in high-grade cervical lesions (HSIL) and invasive cervical cancer (ICC) is crucial to predict the future impact of HPV16/18 vaccines and screening programmes, and to establish an appropriate post-vaccinal virologic surveillance. The aim was to assess the prevalence of HPV types in HSIL and ICC in studies in LA&C. Methods and Findings: We performed a systematic review, following the MOOSE guidelines for systematic reviews of observational studies, and the PRISMA statement for reporting systematic reviews and meta-analyses. Inclusion criteria were at least ten cases of HSIL/ICC, and HPV-type elicitation. The search, without language restrictions, was performed in MEDLINE, Cochrane Library, EMBASE, LILACS from inception date to December 2009, proceedings, reference lists and consulting experts. A meta-analysis was performed using arc-sine transformations to stabilize the variance of simple proportions. Seventy-nine studies from 18 countries were identified, including 2446 cases of HSIL and 5540 of ICC. Overall, 46.5% of HSIL cases harbored HPV 16 and 8.9% HPV18; in ICC, 53.2% of cases harbored HPV 16 and 13.2% HPV 18. The next five most common types, in decreasing frequency, were HPV 31, 58, 33, 45, and 52. Study's limitations comprise the cross-sectional design of most included studies and their inherent risk of bias, the lack of representativeness, and variations in the HPV type-specific sensitivity of different PCR protocols. Conclusions: This study is the broadest summary of HPV type distribution in HSIL and ICC in LA&C to date. These data are essential for local decision makers regarding HPV screening and vaccination policies. Continued HPV surveillance would be useful, to assess the potential for changing type-specific HPV prevalence in the post-vaccination era in Latin America.	[Ciapponi, Agustin; Bardach, Ariel; Glujovsky, Demian; Gibbons, Luz] Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina; [Alejandra Picconi, Maria] ANLIS, Natl Inst Infect Dis, Oncogen Viruses Serv, Natl Reference Lab HPV, Buenos Aires, DF, Argentina		Ciapponi, A (corresponding author), Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina.	aciapponi@iecs.org.ar	Bardach, Ariel/H-9566-2019; Glujovsky, Demian/AAJ-5743-2021; Bardach, Ariel E/E-6153-2012	Bardach, Ariel/0000-0003-4437-0073; Glujovsky, Demian/0000-0002-0586-9341; Ciapponi, Agustin/0000-0001-5142-6122; Gibbons, Luz/0000-0002-0235-1635	GlaxoSmithKline; Institute for Clinical Effectiveness and Health Policy (IECS)	GlaxoSmithKline(GlaxoSmithKline); Institute for Clinical Effectiveness and Health Policy (IECS)	The study was supported by an independent grant from GlaxoSmithKline and the Institute for Clinical Effectiveness and Health Policy (IECS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba M. C., 2003, Revista Argentina de Microbiologia, V35, P74; ACS J, 1989, CANCER RES, V49, P5725; Aedo S, 2007, REV MED CHILE, V135, P167; Aerssens A, 2009, CYTOPATHOLOGY, V20, P27, DOI 10.1111/j.1365-2303.2008.00567.x; Aerssens A, 2008, HISTOPATHOLOGY, V52, P381, DOI 10.1111/j.1365-2559.2007.02956.x; Alonio LV, 2003, J CLIN VIROL, V27, P263, DOI 10.1016/S1386-6532(02)00181-6; Alonio LV, 2000, MEDICINA-BUENOS AIRE, V60, P895; Alonio LV, 1990, CERVIX LOW FEMALE GE, V8, P339; [Anonymous], WHO HPV LAB NETW WHO; Armbruster-Moraes E, 2000, INT J GYNECOL OBSTET, V69, P223, DOI 10.1016/S0020-7292(00)00191-0; Bachtiary B, 2002, INT J CANCER, V102, P237, DOI 10.1002/ijc.10708; Bagarelli Lúcia Buchalla, 2004, Rev. Bras. Ginecol. Obstet., V26, P59, DOI 10.1590/S0100-72032004000100009; Bermudez-Morales VH, 2008, CANCER INVEST, V26, P1037, DOI 10.1080/07357900802112693; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Cambruzzi E, 2005, PATHOL ONCOL RES, V11, P114, DOI 10.1007/BF02893378; Roa JC, 2009, INT J GYNECOL OBSTET, V105, P150, DOI 10.1016/j.ijgo.2008.12.017; Carrillo A, 2004, SALUD PUBLICA MEXICO, V46, P7, DOI 10.1590/S0036-36342004000100002; Cathro HP, 2009, HUM PATHOL, V40, P942, DOI 10.1016/j.humpath.2008.12.015; CAVALCANTI SMB, 1994, MEM I OSWALDO CRUZ, V89, P575, DOI 10.1590/S0074-02761994000400013; Cavalcanti SMB, 1996, MEM I OSWALDO CRUZ, V91, P433, DOI 10.1590/S0074-02761996000400009; Chan PKS, 2006, INT J CANCER, V118, P243, DOI 10.1002/ijc.21299; Chouhy D, 2006, INT J MOL MED, V18, P995; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037; Deluca GD, 2002, GENOTIPIFICACIO VIRU; Deluca GD, 2006, MEDICINA-BUENOS AIRE, V66, P303; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Oliveira Ledy do Horto dos Santos, 2003, Sao Paulo Med. J., V121, P67, DOI 10.1590/S1516-31802003000200007; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; Ferlay J., 2004, GLOBOCAN 2002 CANC I; Fernandes JV, 2009, INT J GYNECOL OBSTET, V105, P21, DOI 10.1016/j.ijgo.2008.12.004; Fernandez-Tilapa G, 2007, AM J INFECT DIS, V3, P62, DOI 10.3844/ajidsp.2007.62.67; Ferrera A, 1999, INT J CANCER, V82, P799, DOI 10.1002/(SICI)1097-0215(19990909)82:6&lt;799::AID-IJC5&gt;3.0.CO;2-5; FOWKES FGR, 1991, BRIT MED J, V302, P1136, DOI 10.1136/bmj.302.6785.1136; Franco E, 1999, Rev Panam Salud Publica, V6, P223, DOI 10.1590/S1020-49891999000900001; Freitas Taíse Palmeiras, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P297, DOI 10.1590/S0036-46652007000500005; Giuliano AR, 2001, CANCER EPIDEM BIOMAR, V10, P1129; Golijow CD, 2005, GYNECOL ONCOL, V96, P181, DOI 10.1016/j.ygyno.2004.09.037; Gonzalez-Losa MD, 2004, J CLIN VIROL, V29, P202, DOI 10.1016/S1386-6532(03)00138-0; GONZALEZGARAY ML, 1992, REV INVEST CLIN, V44, P491; HernandezAvila M, 1997, ARCH MED RES, V28, P265; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindryckx P, 2006, SEX TRANSM INFECT, V82, P334, DOI 10.1136/sti.2006.019745; Iftner Thomas, 2003, J Natl Cancer Inst Monogr, P80; Illades-Aguiar B, 2009, CANCER DETECT PREV, V32, P300, DOI 10.1016/j.cdp.2008.09.001; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Krul EJT, 1999, INT J GYNECOL CANCER, V9, P206; Lazcano-Ponce E, 2009, ARCH MED RES, V40, P514, DOI 10.1016/j.arcmed.2009.07.008; Lewintre Jantus, 1998, NUEVAS TENDENCIAS ON, V7, P134; Lewis M, 2004, OPS J WASHINGTON DC; Li N, 2010, INT J CANC; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lizano M, 2006, GYNECOL ONCOL, V102, P230, DOI 10.1016/j.ygyno.2005.12.002; Lopez-Revilla R, 2008, INFECT AGENTS CANC, V3; Lorenzato F, 2000, INT J GYNECOL CANCER, V10, P143, DOI 10.1046/j.1525-1438.2000.00007.x; LORINCZ AT, 1986, J VIROL, V58, P225, DOI 10.1128/JVI.58.1.225-229.1986; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; Maciag PC, 2000, CANCER EPIDEM BIOMAR, V9, P1183; Matthews-Greer J, 2004, ARCH PATHOL LAB MED, V128, P553; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Melo A, 2003, REV MED CHILE, V131, P1382; Mendoza L, 2010, J MED VIROL IN PRESS; Meyer T, 1998, J INFECT DIS, V178, P252, DOI 10.1086/517447; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molano M, 2007, BIOSALUD, P45; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; Munoz N, 2009, BRIT J CANCER, V100, P1184, DOI 10.1038/sj.bjc.6604972; Murillo R, 2009, INFECT DIS OBSTET GY, V2009; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Noronha V, 1999, Rev Soc Bras Med Trop, V32, P235, DOI 10.1590/S0037-86821999000300003; Oliveira Ledy H.S., 2006, Rev. Inst. Med. trop. S. Paulo, V48, P279, DOI 10.1590/S0036-46652006000500008; Paez C, 1996, TOHOKU J EXP MED, V180, P261, DOI 10.1620/tjem.180.261; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perez LO, 2006, INT J GYNECOL PATHOL, V25, P42, DOI 10.1097/01.pgp.0000177996.30427.2b; Picconi MA, 2002, MEDICINA-BUENOS AIRE, V62, P209; Picconi MA, 2000, MEDICINA-BUENOS AIRE, V60, P889; Pina-Sanchez P, 2006, INT J GYNECOL CANCER, V16, P1041, DOI 10.1111/j.1525-1438.2006.00458.x; Pinheiro NA, 2001, BRAZ J MED BIOL RES, V34, P727, DOI 10.1590/S0100-879X2001000600005; PRUSSIA PR, 1993, W INDIAN MED J, V42, P144; Quint W, 2009, ONE HPV VIRUS ONE LE, P0603; Rabelo-Santos SH, 2003, MEM I OSWALDO CRUZ, V98, P181, DOI 10.1590/S0074-02762003000200003; Rabelo-Santos SH, 2009, INT J GYNECOL PATHOL, V28, P272, DOI 10.1097/PGP.0b013e318190ed27; Rattray C, 1996, J INFECT DIS, V173, P718, DOI 10.1093/infdis/173.3.718; Roa JC, 2007, REV MED CHILE, V135, P37; Rolon PA, 2000, INT J CANCER, V85, P486, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;486::AID-IJC7&gt;3.0.CO;2-S; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Santos C, 2001, BRIT J CANCER, V85, P966, DOI 10.1054/bjoc.2001.1948; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Sierra-Torres CH, 2006, ENVIRON MOL MUTAGEN, V47, P553, DOI 10.1002/em.20228; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Soto Y, 2007, SEX TRANSM DIS, V34, P974, DOI 10.1097/OLQ.0b013e31812e6b89; Souen J, 1995, REV BRAS GINECOL OBS, V17, P509; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Stuart A, 1994, KENDALLS ADV THEORY; Tatti S, 2007, AVANCES PREVENCION C; Terra APS, 2007, TUMORI J, V93, P572; Tonon S A, 1999, Infect Dis Obstet Gynecol, V7, P237, DOI 10.1155/S1064744999000435; Torroella-Kouri M, 1998, GYNECOL ONCOL, V70, P115, DOI 10.1006/gyno.1998.5055; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	108	78	89	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25493	10.1371/journal.pone.0025493	http://dx.doi.org/10.1371/journal.pone.0025493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991313	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300012
J	Chen, CS; Smits, C; Dodson, GG; Shevtsov, MB; Merlino, N; Gollnick, P; Antson, AA				Chen, Chao-Sheng; Smits, Callum; Dodson, Guy G.; Shevtsov, Mikhail B.; Merlino, Natalie; Gollnick, Paul; Antson, Alfred A.			How to Change the Oligomeric State of a Circular Protein Assembly: Switch from 11-Subunit to 12-Subunit TRAP Suggests a General Mechanism	PLOS ONE			English	Article							BINDING ATTENUATION PROTEIN; CRYSTAL-STRUCTURE; BACILLUS-HALODURANS; RNA; BIOSYNTHESIS; REFINEMENT; SEQUENCE; OPERON; MTRB	Background: Many critical cellular functions are performed by multisubunit circular protein oligomers whose internal geometry has evolved to meet functional requirements. The subunit number is arguably the most critical parameter of a circular protein assembly, affecting the internal and external diameters of the assembly and often impacting on the protein's function. Although accurate structural information has been obtained for several circular proteins, a lack of accurate information on alternative oligomeric states has prevented engineering such transitions. In this study we used the bacterial transcription regulator TRAP as a model system to investigate the features that define the oligomeric state of a circular protein and to question how the subunit number could be manipulated. Methodology/Principal Findings: We find that while Bacillus subtilis and Bacillus stearothermophilus TRAP form 11-subunit oligomers, the Bacillus halodurans TRAP exclusively forms 12-subunit assemblies. Significantly, the two states of TRAP are related by a simple rigid body rotation of individual subunits around inter-subunit axes. We tested if such a rotation could be induced by insertion or deletion mutations at the subunit interface. Using wild type 11-subunit TRAP, we demonstrate that removal of five C-terminal residues at the outer side of the inter-subunit axis or extension of an amino acid side chain at the opposite, inner side, increased the subunit number from 11 to 12. Our findings are supported by crystal structures of TRAP oligomers and by native mass spectrometry data. Conclusions/Significance: The subunit number of the TRAP oligomer can be manipulated by introducing deletion or addition mutations at the subunit interface. An analysis of available and emerging structural data on alternative oligomeric states indicates that the same principles may also apply to the subunit number of other circular assemblies suggesting that the deletion/addition approach could be used generally to engineer transitions between different oligomeric states.	[Chen, Chao-Sheng; Smits, Callum; Dodson, Guy G.; Shevtsov, Mikhail B.; Antson, Alfred A.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Shevtsov, Mikhail B.] Univ Portsmouth, Portsmouth, Hants, England; [Merlino, Natalie; Gollnick, Paul] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	University of York - UK; University of Portsmouth; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chen, CS (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	fred@ysbl.york.ac.uk	Shevtsov, Mikhail B/I-1823-2014; Antson, Alfred/N-2551-2016	Antson, Alfred/0000-0002-4533-3816; Shevtsov, Mikhail/0000-0001-8160-2967	Wild Fund award; National Institutes of Health [RO1GM62750]; National Science Foundation [1019960]; Wellcome Trust [081916]; Diamond Light Source; Direct For Biological Sciences [1019960] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062750] Funding Source: NIH RePORTER	Wild Fund award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); Diamond Light Source; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Wild Fund award (to C-SC), by National Institutes of Health grant RO1GM62750 and National Science Foundation Molecular and Cellular Biology grant 1019960 (both to PG) and by Wellcome Trust fellowship 081916 (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Sam Hart and Johan Turkenburg for help in collecting the X-ray data. We acknowledge support of the Diamond Light Source and we also thank ESRF for providing access to beamlines.	Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BABITZKE P, 1992, J BACTERIOL, V174, P2059, DOI 10.1128/JB.174.7.2059-2064.1992; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen XP, 1999, J MOL BIOL, V289, P1003, DOI 10.1006/jmbi.1999.2834; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Green BN, 2001, J MOL BIOL, V309, P553, DOI 10.1006/jmbi.2001.4704; Heddle JG, 2006, STRUCTURE, V14, P925, DOI 10.1016/j.str.2006.03.013; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; McCammon MG, 2004, J AM CHEM SOC, V126, P5950, DOI 10.1021/ja0317170; Minamino T, 2008, CURR OPIN STRUC BIOL, V18, P693, DOI 10.1016/j.sbi.2008.09.006; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naidoo N, 2008, J MOL BIOL, V377, P1357, DOI 10.1016/j.jmb.2008.01.007; OTRIDGE J, 1993, P NATL ACAD SCI USA, V90, P128, DOI 10.1073/pnas.90.1.128; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sallai L, 2005, J STRUCT BIOL, V151, P160, DOI 10.1016/j.jsb.2005.05.006; Shrive AK, 2009, J MOL BIOL, V386, P1240, DOI 10.1016/j.jmb.2009.01.008; Szigeti R, 2004, J BACTERIOL, V186, P818, DOI 10.1128/JB.186.3.818-828.2004; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Tharun S, 2009, INT REV CEL MOL BIO, V272, P149, DOI 10.1016/S1937-6448(08)01604-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Toro I, 2002, J MOL BIOL, V320, P129, DOI 10.1016/S0022-2836(02)00406-0; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Young HS, 2003, BIOPHYS J, V84, P571, DOI [10.1016/s0006-3495(03)74877-2, 10.1016/S0006-3495(03)74877-2]	34	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25296	10.1371/journal.pone.0025296	http://dx.doi.org/10.1371/journal.pone.0025296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984911	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000022
J	Wan, XW; Nardi, F; Zhang, B; Liu, YH				Wan, Xuanwu; Nardi, Francesco; Zhang, Bin; Liu, Yinghong			The Oriental Fruit Fly, Bactrocera dorsalis, in China: Origin and Gradual Inland Range Expansion Associated with Population Growth	PLOS ONE			English	Article							SAN-FRANCISCO BAY; GENETIC-STRUCTURE; OLIVE FLY; MICROSATELLITE MARKERS; MITOCHONDRIAL GENOME; DIPTERA; TEPHRITIDAE; CALIFORNIA; SPARTINA; INTRODUCTIONS	The oriental fruit fly, Bactrocera dorsalis, expanded throughout mainland China in the last century to become one of the most serious pests in the area, yet information on this process are fragmentary. Three mitochondrial genes (nad1, cytb and nad5) were used to infer the genetic diversity, population structure and demographic history of the oriental fruit fly from its entire distribution range in China. High levels of genetic diversity, as well as a significant correspondence between genetic and geographic distances, suggest that the invasion process might have been gradual, with no associated genetic bottlenecks. Three population groups could be identified, nevertheless the overall genetic structure was weak. The effective number of migrants between populations, estimated using the coalescent method, suggested asymmetric gene flow from the costal region of Guangdong to most inland regions. The demographic analysis indicates the oriental fruit fly underwent a recent population expansion in the Central China. We suggest the species originated in the costal region facing the South China Sea and gradually expanded to colonize mainland China, expanding here to high population numbers.	[Wan, Xuanwu; Zhang, Bin; Liu, Yinghong] Southwest Univ, Chongqing Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China; [Nardi, Francesco] Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy	Southwest University - China; University of Siena	Wan, XW (corresponding author), Southwest Univ, Chongqing Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China.	yhliu@swu.edu.cn	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022; Nardi, Francesco/E-5516-2011	Nardi, Francesco/0000-0003-0271-9855	National Basic Research Program of China [2009CB125903]	National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Basic Research Program of China (2009CB125903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409.x; Aketarawong N, 2006, MOL ECOL NOTES, V6, P1138, DOI 10.1111/j.1471-8286.2006.01463.x; Alaoui A, 2010, INT J AGRIC BIOL, V12, P291; Anttila CK, 2000, MOL ECOL, V9, P765, DOI 10.1046/j.1365-294x.2000.00935.x; Augustinos AA, 2005, GENETICA, V125, P231, DOI 10.1007/s10709-005-8692-y; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Baker DA, 2003, MOL ECOL, V12, P3303, DOI 10.1046/j.1365-294X.2003.02010.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Bryja J, 2010, MOL ECOL, V19, P4708, DOI 10.1111/j.1365-294X.2010.04844.x; Chen LianGen, 2010, Acta Agriculturae Shanghai, V26, P99; [陈鹏 CHEN Peng], 2007, [生态学报, Acta Ecologica Sinica], V27, P2468; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Daehler CC, 1997, AM J BOT, V84, P607, DOI 10.2307/2445896; Dai SM, 2004, MOL ECOL NOTES, V4, P629, DOI 10.1111/j.1471-8286.2004.00732.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Elfekih S, 2010, J APPL ENTOMOL, V134, P647, DOI 10.1111/j.1439-0418.2009.01500.x; Ellstrand NC, 2006, EUPHYTICA, V148, P35, DOI 10.1007/s10681-006-5939-3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Finn DS, 2006, MOL ECOL, V15, P3553, DOI 10.1111/j.1365-294X.2006.03034.x; Grapputo A, 2006, ITAL J ZOOL, V73, P67, DOI 10.1080/11250000500502111; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; He M, 1997, ANN ENTOMOL SOC AM, V90, P825, DOI 10.1093/aesa/90.6.825; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang Fan, 2001, Acta Agriculturae Universitatis Jiangxiensis, V23, P259; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JH, 2007, ENTOMOL SCI, V10, P11, DOI 10.1111/j.1479-8298.2006.00194.x; MANTEL N, 1967, CANCER RES, V27, P209; Meixner MD, 2002, MOL ECOL, V11, P891, DOI 10.1046/j.1365-294X.2002.01488.x; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Miller NJ, 2009, ENVIRON ENTOMOL, V38, P274, DOI 10.1603/022.038.0134; Mun J, 2003, MOL ECOL, V12, P2941, DOI 10.1046/j.1365-294X.2003.01978.x; Muraji M, 2008, APPL ENTOMOL ZOOL, V43, P609, DOI 10.1303/aez.2008.609; Nakahara S, 2008, APPL ENTOMOL ZOOL, V43, P457, DOI 10.1303/aez.2008.457; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Ohta T, 1996, THEOR POPUL BIOL, V49, P128, DOI 10.1006/tpbi.1996.0007; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schmitt T, 2005, BIOL CONSERV, V123, P11, DOI 10.1016/j.biocon.2004.09.018; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; Shi W, 2010, GENETICA, V138, P377, DOI 10.1007/s10709-009-9429-0; Siedchlag AC, 2010, MOL PHYLOGENET EVOL, V56, P622, DOI 10.1016/j.ympev.2010.04.027; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Suarez NM, 2009, MOL PHYLOGENET EVOL, V53, P556, DOI 10.1016/j.ympev.2009.07.018; Venkatesan M, 2007, MOL BIOL EVOL, V24, P1208, DOI 10.1093/molbev/msm040; Wang S. Q., 2009, PLANT PROTECTION HUB, V3, P5; Wang X J., 1996, ACTA ZOOTAXONOMICA S, V21, P53; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Yuan M., 2008, J ANHUI AGR SCI, V22, P9619; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; [周国梁 ZHOU GuoLiang], 2007, [生态学报, Acta Ecologica Sinica], V27, P3362	62	46	52	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25238	10.1371/journal.pone.0025238	http://dx.doi.org/10.1371/journal.pone.0025238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984907	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000018
J	Wang, ZW; Li, YH; During, HJ; Li, LH				Wang, Zhengwen; Li, Yuanheng; During, Heinjo J.; Li, Linghao			Do Clonal Plants Show Greater Division of Labour Morphologically and Physiologically at Higher Patch Contrasts?	PLOS ONE			English	Article							ENVIRONMENTAL HETEROGENEITY; FRAGARIA-CHILOENSIS; PHOTOSYNTHETIC CAPACITY; RECIPROCAL PATCHINESS; STOLONIFEROUS HERB; GLECHOMA-HEDERACEA; LIGHT; INTEGRATION; PLASTICITY; GROWTH	Background: When growing in reciprocal patches in terms of availability of different resources, connected ramets of clonal plants will specialize to acquire and exchange locally abundant resources more efficiently. This has been termed division of labour. We asked whether division of labour can occur physiologically as well as morphologically and will increase with patch contrasts. Methodology/Principal Findings: We subjected connected and disconnected ramet pairs of Potentilla anserina to Control, Low, Medium and High patch contrast by manipulating light and nutrient levels for ramets in each pair. Little net benefit of inter-ramet connection in terms of biomass was detected. Shoot-root ratio did not differ significantly between paired ramets regardless of connection under Control, Low and Medium. Under High, however, disconnected shaded ramets with ample nutrients showed significantly larger shoot-root ratios (2.8 similar to 6.5 fold) than fully-lit but nutrient-deficient ramets, and than their counterparts under any other treatment; conversely, fully-lit but nutrient-deficient ramets, when connected to shaded ramets with ample nutrients, had significantly larger shoot-root ratios (2.0 similar to 4.9 fold) than the latter and than their counterparts under any other treatment. Only under High patch contrast, fully-lit ramets, if connected to shaded ones, had 8.9% higher chlorophyll content than the latter, and 22.4% higher chlorophyll content than their isolated counterparts; the similar pattern held for photosynthetic capacity under all heterogeneous treatments. Conclusions/Significance: Division of labour in clonal plants can be realized by ramet specialization in morphology and in physiology. However, modest ramet specialization especially in morphology among patch contrasts may suggest that division of labour will occur when the connected ramets grow in reciprocal patches between which the contrast exceeds a threshold. Probably, this threshold patch contrast is the outcome of the clone-wide cost-benefit tradeoff and is significant for risk-avoidance, especially in the disturbance-prone environments.	[Wang, Zhengwen] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Wang, Zhengwen; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Changes, Beijing, Peoples R China; [Li, Yuanheng] Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot, Peoples R China; [During, Heinjo J.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Inner Mongolia Agricultural University; Utrecht University	Wang, ZW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	wangzw@iae.ac.cn	Wang, Zhengwen/A-8292-2011		State Key Basic Research Development Program of China [2007CB106800]; Natural Science Foundation of China [30521002, 30370268]	State Key Basic Research Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research Development Program of China (2007CB106800) and Natural Science Foundation of China (30521002, 30370268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P137; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Alpert P, 2002, FUNCT ECOL, V16, P191, DOI 10.1046/j.1365-2435.2002.00610.x; Anten NPR, 1996, FUNCT ECOL, V10, P491, DOI 10.2307/2389942; BAI B, 1994, MAIZE SCI, V2, P44; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; CARACO T, 1991, ECOLOGY, V72, P81, DOI 10.2307/1938904; Chu Y, 2006, J INTEGR PLANT BIOL, V48, P400, DOI 10.1111/j.1744-7909.2006.00237.x; de Kroon H, 2006, TRENDS ECOL EVOL, V21, P113, DOI 10.1016/j.tree.2005.11.021; de Kroon H, 2007, SCIENCE, V318, P1562, DOI 10.1126/science.1150726; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Du J, 2009, ANN BOT-LONDON, V104, P335, DOI 10.1093/aob/mcp130; Eriksson O., 1990, CLONAL GROWTH PLANTS, P79; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; Huang BR, 2000, BOOK SOIL P, P39; Hutchings Michael J., 1999, Plant Species Biology, V14, P1, DOI 10.1046/j.1442-1984.1999.00001.x; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Ikegami M, 2008, PLANT ECOL, V199, P55, DOI 10.1007/s11258-008-9411-4; Ikegami M, 2008, ECOL MODEL, V213, P156, DOI 10.1016/j.ecolmodel.2007.11.016; JACKSON RB, 1990, NATURE, V344, P58, DOI 10.1038/344058a0; Katahata SI, 2007, TREE PHYSIOL, V27, P199, DOI 10.1093/treephys/27.2.199; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Liao MJ, 2003, ACTA OECOL, V24, P231, DOI 10.1016/j.actao.2003.07.001; Liu J, 2008, PHOTOSYNTHETICA, V46, P299, DOI 10.1007/s11099-008-0054-4; Magyar G, 2007, NEW PHYTOL, V174, P182, DOI 10.1111/j.1469-8137.2007.01969.x; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; Pate J. S., 1983, Nitrogen as an ecological factor, P225; PATE JS, 1980, ANNU REV PLANT PHYS, V31, P313, DOI 10.1146/annurev.pp.31.060180.001525; Pilon J, 2002, J ECOL, V90, P859, DOI 10.1046/j.1365-2745.2002.00716.x; Pitelka L.F., 1985, POPULATION BIOL EVOL, P399; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; SAS Institute Inc, 2004, SAS 9 1 2 QUAL TOOLS; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SEEMANN JR, 1987, PLANT PHYSIOL, V84, P796, DOI 10.1104/pp.84.3.796; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Stuefer JF, 1998, ECOL MODEL, V111, P171, DOI 10.1016/S0304-3800(98)00101-X; Stuefer JF, 1999, ECOL LETT, V2, P135; STUEFER JF, 1994, OECOLOGIA, V100, P302, DOI 10.1007/BF00316958; van Kleunen M, 1999, OIKOS, V85, P135, DOI 10.2307/3546799; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; Yu FH, 2002, ACTA BOT SIN, V44, P468	53	29	39	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25401	10.1371/journal.pone.0025401	http://dx.doi.org/10.1371/journal.pone.0025401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980447	gold, Green Published, Green Submitted			2022-12-27	WOS:000295941300029
J	Huynh, C; Poliseno, L; Segura, MF; Medicherla, R; Haimovic, A; Menendez, S; Shang, SL; Pavlick, A; Shao, YZ; Darvishian, F; Boylan, JF; Osman, I; Hernando, E				Chanh Huynh; Poliseno, Laura; Segura, Miguel F.; Medicherla, Ratna; Haimovic, Adele; Menendez, Silvia; Shang, Shulian; Pavlick, Anna; Shao, Yongzhao; Darvishian, Farbod; Boylan, John F.; Osman, Iman; Hernando, Eva			The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; EXPRESSION; NOTCH; RESISTANCE; BRAF; SUBPOPULATION; PROGRESSION; PATHWAYS; TARGET	Several reports have demonstrated a role for aberrant NOTCH signaling in melanoma genesis and progression, prompting us to explore if targeting this pathway is a valid therapeutic approach against melanoma. We targeted NOTCH signaling using RO4929097, a novel inhibitor of gamma secretase, which is a key component of the enzymatic complex that cleaves and activates NOTCH. The effects of RO4929097 on the oncogenic and stem cell properties of a panel of melanoma cell lines were tested both in vitro and in vivo, using xenograft models. In human primary melanoma cell lines, RO4929097 decreased the levels of NOTCH transcriptional target HES1. This was accompanied by reduced proliferation and impaired ability to form Colonies in soft agar and to organize in tridimensional spheres. Moreover, RO4929097 affected the growth of human primary melanoma xenograft in NOD/SCID/IL2gammaR-/- mice and inhibited subsequent formation in a serial xenotransplantation model, suggesting that inhibition of NOTCH signaling suppresses the tumor initiating potential of melanoma cells. In addition, RO4929097 decreased tumor volume and blocked the invasive growth pattern of metastatic melanoma cell lines in vivo. Finally, increased gene expression of NOTCH signaling components correlated with shorter post recurrence survival in metastatic melanoma cases. Our data support NOTCH inhibition as a promising therapeutic strategy against melanoma.	[Chanh Huynh; Pavlick, Anna; Osman, Iman] NYU, Sch Med, Dept Med, New York, NY 10012 USA; [Poliseno, Laura; Medicherla, Ratna; Haimovic, Adele; Osman, Iman] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Segura, Miguel F.; Menendez, Silvia; Darvishian, Farbod; Hernando, Eva] NYU, Sch Med, Dept Pathol, New York, NY USA; [Shang, Shulian; Shao, Yongzhao] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Chanh Huynh; Poliseno, Laura; Segura, Miguel F.; Medicherla, Ratna; Haimovic, Adele; Menendez, Silvia; Pavlick, Anna; Osman, Iman; Hernando, Eva] NYU, Sch Med, Interdisciplinary Melanoma Cooperat Grp, New York, NY USA; [Boylan, John F.] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ 07110 USA	New York University; New York University; New York University; New York University; New York University; Roche Holding	Huynh, C (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10012 USA.	Iman.Osman@nyumc.org; Eva.Hernando-Monge@nyumc.org	Shang, Shulian/A-2173-2013; Segura, Miguel F/J-4749-2013; Poliseno, Laura/B-5711-2012	Segura, Miguel F/0000-0003-0916-3618; Hernando, Eva/0000-0003-1023-0312; Poliseno, Laura/0000-0001-6557-955X	New York University; National Cancer Center; National Institute of Health [T32 CA09454-19]; New York University CCGS [5 P30 CA016087]; Chemotherapy Foundation; Marc Jacobs campaign; NIH/NCI [P30 CA016087-30]; NATIONAL CANCER INSTITUTE [P30CA016087, T32CA009454] Funding Source: NIH RePORTER	New York University; National Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University CCGS; Chemotherapy Foundation; Marc Jacobs campaign; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CH has been supported by the New York University Physician Scientist Training Program, a National Cancer Center Postdoctoral fellowship and the National Institute of Health T32 CA09454-19 fellowship training grant. MFS is supported by a National Cancer Center Postdoctoral fellowship. This work was funded by the New York University CCGS support grant (5 P30 CA016087), Chemotherapy Foundation and the Marc Jacobs campaign to support melanoma research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the NYU Histopathology and Immunohistochemistry cores (supported in part by NIH/NCI P30 CA016087-30 grant at the NYU Cancer Institute) for tissue processing and histological staining, and Robert S. Kerbel (University of Toronto) for providing us WM239/131/4-5B1 (5B1) cells.	Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Handolias D, 2010, BRIT J CANCER, V102, P1219, DOI 10.1038/sj.bjc.6605635; Hardy KM, 2010, CANCER RES, V70, P10340, DOI 10.1158/0008-5472.CAN-10-0705; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Klein JP, 2002, CANC TREAT, V113, P37; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Ko JM, 2011, J PATHOL, V223, P241, DOI 10.1002/path.2804; Kwong Lawrence, 2007, Adv Dermatol, V23, P99, DOI 10.1016/j.yadr.2007.07.015; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Luistro L, 2009, CANCER RES, V69, P7672, DOI 10.1158/0008-5472.CAN-09-1843; Massi D, 2006, MODERN PATHOL, V19, P246, DOI 10.1038/modpathol.3800526; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Molife R, 2002, CRIT REV ONCOL HEMAT, V44, P81, DOI 10.1016/S1040-8428(02)00014-8; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Postovit LM, 2008, PIGM CELL MELANOMA R, V21, P348, DOI 10.1111/j.1755-148X.2008.00463.x; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Qin JZ, 2004, MOL CANCER THER, V3, P895; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rose AE, 2011, CANCER RES, V71, P2561, DOI 10.1158/0008-5472.CAN-10-2958; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shackleton M, 2010, MOL ONCOL, V4, P451, DOI 10.1016/j.molonc.2010.06.006; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; Yao K, 2011, INT J SURG PATHOL	53	47	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25264	10.1371/journal.pone.0025264	http://dx.doi.org/10.1371/journal.pone.0025264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980408	gold, Green Submitted, Green Published			2022-12-27	WOS:000295939600017
J	Simm, C; Luan, CH; Weiss, E; O'Halloran, T				Simm, Claudia; Luan, Chi-Hao; Weiss, Eric; O'Halloran, Thomas			High-Throughput Screen for Identifying Small Molecules That Target Fungal Zinc Homeostasis	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; UPTAKE SYSTEM; TRANSCRIPTIONAL ACTIVATOR; INTRACELLULAR ZINC; CANDIDA-ALBICANS; YEAST; SUSCEPTIBILITY; VIRULENCE; GROWTH	Resistance to traditional antifungal drugs has increased significantly over the past three decades making identification of novel antifungal agents and new targets an emerging priority. Based on the extraordinary zinc requirement of several fungal pathogens and their well-established sensitivity to zinc deprivation, we developed an efficient cell-based screen to identify new antifungal drugs that target the zinc homeostasis machinery. The screen is based on the zinc-regulated transcription factor Zap1 of Saccharomyces cerevisiae, which regulates transcription of genes like the high-affinity zinc transporter ZRT1. We generated a genetically modified strain of S. cerevisae that reports intracellular zinc deficiency by placing the coding sequence of green fluorescent protein (GFP) under the control of the Zap1-regulated ZRT1 promoter. After showing that the GFP fluorescence signal correlates with low intracellular zinc concentrations in this strain, a protocol was developed for screening small-molecule libraries for compounds that induce Zap1-dependent GFP expression. Comparison of control compounds and known modulators of metal metabolism from the library reveals a robust screen (Z' = 0.74) and validates this approach to the discovery of new classes of antifungal compounds that interfere with the intracellular zinc homeostasis. Given that growth of many pathogenic organisms is significantly impaired by zinc limitation; these results identify new types of antifungal drugs that target critical nutrient acquisition pathways.	[Simm, Claudia; Luan, Chi-Hao; Weiss, Eric; O'Halloran, Thomas] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Luan, Chi-Hao; Weiss, Eric; O'Halloran, Thomas] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [O'Halloran, Thomas] Northwestern Univ, Dept Chem, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University	Simm, C (corresponding author), Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.	t-ohalloran@northwestern.edu	O'Halloran, Thomas/ABE-6125-2021	O'Halloran, Thomas/0000-0001-8732-5059	Viamet Pharmaceuticals, Inc.; National Institutes of Health [R37 GM038784]; NASA [NNA04CC36G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038784, R37GM038784] Funding Source: NIH RePORTER	Viamet Pharmaceuticals, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this study was provided by grants from Viamet Pharmaceuticals, Inc. and National Institutes of Health grant R37 GM038784 (to TVO). Use of the ICP-MS in the Northwestern University Quantitative Bioelemental Imaging Center was supported by a grant from NASA (NNA04CC36G). Viamet Pharmaceuticals, Inc. provided advice on selection of the commercially available compound library. None of the funders provided input on data collection, evaluation, analysis or preparation of the manuscript.	Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Chen CY, 2001, FEMS MICROBIOL LETT, V202, P67, DOI 10.1111/j.1574-6968.2001.tb10781.x; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Fahrni CJ, 1999, J AM CHEM SOC, V121, P11448, DOI 10.1021/ja992709f; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Gow Neil A. R., 1997, Current Topics in Medical Mycology, V8, P43; ISMAIL A, 1986, MYCOPATHOLOGIA, V94, P45, DOI 10.1007/BF00437261; Kalliopi B, 2009, REV MED MICROBIOL, V20, P91, DOI 10.1097/MRM.0b013e3283341397; Kim MJ, 2008, J MICROBIOL BIOTECHN, V18, P242; Kim S, 2004, J VET MED SCI, V66, P1059, DOI 10.1292/jvms.66.1059; Lamore SD, 2011, BIOMETALS; Lee JY, 2004, J BIOL CHEM, V279, P8602, DOI 10.1074/jbc.M309730200; Li C, 2010, J ALZHEIMER IN PRESS; Lulloff SJ, 2004, J LAB CLIN MED, V144, P208, DOI 10.1016/j.lab.2004.07.007; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Mondal R, 2009, ANTIVIR RES, V82, P82, DOI 10.1016/j.antiviral.2008.12.012; Moreno MA, 2007, MOL MICROBIOL, V64, P1182, DOI 10.1111/j.1365-2958.2007.05726.x; Nguyen MH, 1996, AM J MED, V100, P617, DOI 10.1016/S0002-9343(95)00010-0; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangamwar AT, 2008, INDIAN J PHARM SCI, V70, P423, DOI 10.4103/0250-474X.44588; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sensi SL, 1997, J NEUROSCI, V17, P9554; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Sucher AJ, 2009, ANN PHARMACOTHER, V43, P1647, DOI 10.1345/aph.1M237; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Thompson ED, 2002, J EXP BIOL, V205, P3367; Vicentefranqueira R, 2005, EUKARYOT CELL, V4, P837, DOI 10.1128/EC.4.5.837-848.2005; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Winters MS, 2010, J INFECT DIS; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; YAMAGUCHI H, 1975, J GEN MICROBIOL, V86, P370, DOI 10.1099/00221287-86-2-370; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhu M, 2000, ANAL BIOCHEM, V287, P210, DOI 10.1006/abio.2000.4875	39	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25136	10.1371/journal.pone.0025136	http://dx.doi.org/10.1371/journal.pone.0025136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980385	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600011
J	Xiao, PJ; Peng, ZY; Huang, L; Li, Y; Chen, XH				Xiao, Ping-Jie; Peng, Zheng-Yu; Huang, Lu; Li, Ya; Chen, Xian-Hua			Dephosphorylated NSSR1 Is Induced by Androgen in Mouse Epididymis and Phosphorylated NSSR1 Is Increased during Sperm Maturation	PLOS ONE			English	Article							PRE-MESSENGER-RNA; TYROSINE PHOSPHORYLATION; SPLICING REPRESSOR; MINOR SPLICEOSOME; ACROSOME REACTION; RAT RETINA; EXPRESSION; PROTEIN; SRP38; LOCALIZATION	NSSR1 (Neural salient serine/arginine rich protein 1, alternatively SRp38) is a newly identified RNA splicing factor and predominantly expressed in neural tissues. Here, by Western blot analysis and immunofluorescent staining, we showed that the expression of dephosphorylated NISSR1 increased significantly during development of the caput epididymis. In adult mice, phosphorylated NISSR1 was mainly expressed in the apical side of epithelial cells, and dephosphorylated NSSR1 in caput epididymis was upregulated in a testosterone dependent manner. In addition, subcellular immunoreactive distribution of NSSR1 varied in different regions of the epididymis. With respect to the sperm, phosphorylated NSSR1 was detected in the mid-piece of the tail as well as the acrosome. Furthermore, NSSR1 was released from the sperm head during the capacitation and acrosome reaction. These findings for the first time provide the evidence for the potential roles of NSSR1 in sperm maturation and fertilization.	[Xiao, Ping-Jie; Peng, Zheng-Yu; Li, Ya; Chen, Xian-Hua] Fudan Univ, Inst Brain Sci, Lab Genom Physiol, Shanghai 200433, Peoples R China; [Xiao, Ping-Jie; Peng, Zheng-Yu; Li, Ya; Chen, Xian-Hua] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Peng, Zheng-Yu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Huang, Lu] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Xiao, PJ (corresponding author), Fudan Univ, Inst Brain Sci, Lab Genom Physiol, Shanghai 200433, Peoples R China.	xhchen@fudan.edu.cn	XIAO, PING-JIE/E-6399-2012; Huang, Lu/E-4250-2014; Xiao, Pingjie/G-4045-2012		National Foundation of Natural Sciences of China [30770661, 30971464, 81030020]; Shanghai Leading Academic Discipline Project [B111]; Shanghai Key project [07DJ14005]; Research Fund for the Doctoral Program of Higher Education of China [20070246053]	National Foundation of Natural Sciences of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Key project; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Foundation of Natural Sciences of China (No. 30770661, 30971464, 81030020), the Shanghai Leading Academic Discipline Project (No. B111), the Shanghai Key project (No. 07DJ14005), and Research Fund for the Doctoral Program of Higher Education of China (20070246053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Cherry J, 2006, IN VIVO, V20, P17; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Cooper TG, 1996, ANDROLOGIA, V28, P57; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Feng Y, 2008, NAT STRUCT MOL BIOL, V15, P1040, DOI 10.1038/nsmb.1485; Feng Y, 2009, DEV CELL, V16, P528, DOI 10.1016/j.devcel.2009.02.009; Furland NE, 2007, J BIOL CHEM, V282, P18151, DOI 10.1074/jbc.M700709200; Hastings ML, 2001, RNA, V7, P471, DOI 10.1017/S1355838201002552; HERAS MAD, 1987, J REPROD FERTIL, V79, P9, DOI 10.1530/jrf.0.0790009; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Johnson PM, 2007, REPRODUCTION, V134, P739, DOI 10.1530/REP-07-0363; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Komatsu M, 1999, GENES CELLS, V4, P593, DOI 10.1046/j.1365-2443.1999.00286.x; Lawson C, 2007, MOL HUM REPROD, V13, P307, DOI 10.1093/molehr/gam012; Ling IF, 2010, HUM MUTAT, V31, P702, DOI 10.1002/humu.21244; Liu L, 2004, NEUROREPORT, V15, P823, DOI 10.1097/00001756-200404090-00017; Liu L, 2003, NEUROREPORT, V14, P1847, DOI 10.1097/00001756-200310060-00018; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Luconi M, 1996, BIOL REPROD, V55, P207, DOI 10.1095/biolreprod55.1.207; Peng ZY, 2007, NEUROREPORT, V18, P1641, DOI 10.1097/WNR.0b013e3282f0b542; Peng ZY, 2009, NEUROCHEM RES, V34, P1083, DOI 10.1007/s11064-008-9878-3; Peng ZY, TUMOUR BIOL, V32, P359; Roberts KP, 2006, MOL CELL ENDOCRINOL, V250, P122, DOI 10.1016/j.mce.2005.12.034; Roberts KP, 2001, J ANDROL, V22, P157; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Steitz JA, 2008, P NATL ACAD SCI USA, V105, P8485, DOI 10.1073/pnas.0804024105; TALBOT P, 1976, J EXP ZOOL, V198, P383, DOI 10.1002/jez.1401980312; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; WHITTEN WK, 1968, J REPROD FERTIL, V17, P399, DOI 10.1530/jrf.0.0170399; Wilhelm B, 2008, HISTOCHEM CELL BIOL, V129, P331, DOI 10.1007/s00418-007-0362-y; Xao PJ, 2007, MOL REPROD DEV, V74, P1363, DOI 10.1002/mrd.20719	39	4	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25667	10.1371/journal.pone.0025667	http://dx.doi.org/10.1371/journal.pone.0025667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980524	Green Submitted, gold, Green Published			2022-12-27	WOS:000295939600048
J	Gomez-Posada, JC; Aivar, P; Alberdi, A; Alaimo, A; Etxeberria, A; Fernandez-Orth, J; Zamalloa, T; Roura-Ferrer, M; Villace, P; Areso, P; Casis, O; Villarroel, A				Gomez-Posada, Juan Camilo; Aivar, Paloma; Alberdi, Araitz; Alaimo, Alessandro; Etxeberria, Ainhoa; Fernandez-Orth, Juncal; Zamalloa, Teresa; Roura-Ferrer, Meritxell; Villace, Patricia; Areso, Pilar; Casis, Oscar; Villarroel, Alvaro			Kv7 Channels Can Function without Constitutive Calmodulin Tethering	PLOS ONE			English	Article							GO POTASSIUM CHANNELS; K+ CHANNELS; SURFACE EXPRESSION; HUMAN ETHER; TRAFFICKING; BINDING; INHIBITION; KCNQ2/KCNQ3; SUPPRESSION; MODULATION	M-channels are voltage-gated potassium channels composed of Kv7.2-7.5 subunits that serve as important regulators of neuronal excitability. Calmodulin binding is required for Kv7 channel function and mutations in Kv7.2 that disrupt calmodulin binding cause Benign Familial Neonatal Convulsions (BFNC), a dominantly inherited human epilepsy. On the basis that Kv7.2 mutants deficient in calmodulin binding are not functional, calmodulin has been defined as an auxiliary subunit of Kv7 channels. However, we have identified a presumably phosphomimetic mutation S511D that permits calmodulin-independent function. Thus, our data reveal that constitutive tethering of calmodulin is not required for Kv7 channel function.	[Gomez-Posada, Juan Camilo; Aivar, Paloma; Alberdi, Araitz; Alaimo, Alessandro; Etxeberria, Ainhoa; Fernandez-Orth, Juncal; Zamalloa, Teresa; Roura-Ferrer, Meritxell; Villace, Patricia; Villarroel, Alvaro] Univ Basque Country Euskal Herriko Unibersitatea, Consejo Super Invest Cient, Unidad Biofis, Leioa, Spain; [Casis, Oscar] Univ Basque Country, Dept Fisiol, Leioa, Spain; [Areso, Pilar] Univ Basque Country, Dept Farmacol, Leioa, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Basque Country	Gomez-Posada, JC (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	gbxvimua@ehu.es	Villarroel, Alvaro/H-5580-2015; Messier, Claude/A-2322-2008; Zamalloa, Teresa/AGT-7311-2022; Alaimo, Alessandro/C-6334-2016; Arco, Mariangeles/C-6181-2016	Messier, Claude/0000-0002-4791-1763; Zamalloa, Teresa/0000-0001-8050-496X; Alaimo, Alessandro/0000-0002-5888-6268; Arco, Mariangeles/0000-0002-0993-7460; CASIS SAENZ, OSCAR/0000-0002-6219-3317	Fondo de Investigaciones Sanitarias [PI071316]; Spanish Ministry of Education [BFU2009-07581, SAF2006-1450]; Spanish Ion Channel Initiative [CSD2008-00005]; Fondo Social Europeo; Funeacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spanish Ministry of Education(Spanish Government); Spanish Ion Channel Initiative; Fondo Social Europeo(European Social Fund (ESF)European Commission); Funeacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the VII European framework program managed by the Fondo de Investigaciones Sanitarias (PI071316), from the Spanish Ministry of Education (BFU2009-07581 and SAF2006-1450), and by the Spanish Ion Channel Initiative Consolider Project (CSD2008-00005). J.C.G-P. held an I3P CSIC Fellowship co-financed by the Fondo Social Europeo. A.A and A.E. were partially funded by Funeacion Biofisica Bizkaia. P.A. held a Formacion de Personal Investigador Fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hughes S, 2007, PFLUG ARCH EUR J PHY, V455, P115, DOI 10.1007/s00424-007-0259-6; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Maljevic S, 2010, PFLUG ARCH EUR J PHY, V460, P277, DOI 10.1007/s00424-010-0831-3; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zaika O, 2008, BIOPHYS J, V95, P5121, DOI 10.1529/biophysj.108.137604; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	37	22	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25508	10.1371/journal.pone.0025508	http://dx.doi.org/10.1371/journal.pone.0025508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980481	Green Published, gold			2022-12-27	WOS:000295936900073
J	Kim, TM; Ramirez, V; Barrera-Chimal, J; Bobadilla, NA; Park, PJ; Vaidya, VS				Kim, Tae-Min; Ramirez, Victoria; Barrera-Chimal, Jonatan; Bobadilla, Norma A.; Park, Peter J.; Vaidya, Vishal S.			Gene Expression Analysis Reveals the Cell Cycle and Kinetochore Genes Participating in Ischemia Reperfusion Injury and Early Development in Kidney	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; LIVER DEVELOPMENT; SET ENRICHMENT; BIOMARKERS; REGENERATION; RAT; ISCHEMIA/REPERFUSION; MOLECULE-1; PROTEINS; PATTERNS	Background: The molecular mechanisms that mediate the ischemia-reperfusion (I/R) injury in kidney are not completely understood. It is also largely unknown whether such mechanisms overlap with those governing the early development of kidney. Methodology/Principal Findings: We performed gene expression analysis to investigate the transcriptome changes during regeneration after I/R injury in the rat (0 hr, 6 hr, 24 hr, and 120 hr after reperfusion) and early development of mouse kidney (embryonic day 16 p. c. and postnatal 1 and 7 day). Pathway analysis revealed a wide spectrum of molecular functions that may participate in the regeneration and developmental processes of kidney as well as the functional association between them. While the genes associated with cell cycle, immunity, inflammation, and apoptosis were globally activated during the regeneration after I/R injury, the genes encoding various transporters and metabolic enzymes were down-regulated. We also observed that these injury-associated molecular functions largely overlap with those of early kidney development. In particular, the up-regulation of kinases and kinesins with roles in cell division was common during regeneration and early developmental kidney as validated by real-time PCR and immunohistochemistry. Conclusions: In addition to the candidate genes whose up-regulation constitutes an overlapping expression signature between kidney regeneration and development, this study lays a foundation for studying the functional relationship between two biological processes.	[Kim, Tae-Min; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02163 USA; [Ramirez, Victoria; Vaidya, Vishal S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA; [Barrera-Chimal, Jonatan; Bobadilla, Norma A.] Univ Nacl Autonoma Mexico, Mol Physiol Unit, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Ramirez, Victoria; Barrera-Chimal, Jonatan; Bobadilla, Norma A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nefrol & Metab Mineral, Mexico City, DF, Mexico; [Vaidya, Vishal S.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Harvard University; Harvard T.H. Chan School of Public Health	Kim, TM (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02163 USA.	vvaidya@partners.org	Barrera-Chimal, Jonatan/AAC-1380-2020; Ramirez, Victoria/I-8087-2012	Ramirez, Victoria/0000-0002-2782-1381; Park, Peter/0000-0001-9378-960X; Barrera-Chimal, JONATAN/0000-0002-0711-5092	National Institutes of Environmental Health Sciences [ES016723]; National Institute of General Medical Sciences [R01 GM082798]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082798] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Vaidya laboratory is supported by National Institutes of Environmental Health Sciences' Pathway to Independence Grant [ES016723]. TMK and PJP are supported by a grant from National Institute of General Medical Sciences (R01 GM082798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Giubettini M, 2011, J CELL SCI, V124, P113, DOI 10.1242/jcs.075457; Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x; Kelley-Loughnane N, 2002, HEPATOLOGY, V35, P525, DOI 10.1053/jhep.2002.31351; Kieran NE, 2003, KIDNEY INT, V64, P480, DOI 10.1046/j.1523-1755.2003.00106.x; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Lu Y, 2009, BIOINFORMATICS, V25, P1476, DOI 10.1093/bioinformatics/btp247; Maeshima A, 2002, J AM SOC NEPHROL, V13, P2850, DOI 10.1097/01.ASN.0000035086.93977.E9; Perco P, 2007, TRANSPL INT, V20, P2, DOI 10.1111/j.1432-2277.2006.00376.x; Ramirez V, 2004, CELL STRESS CHAPERON, V9, P198, DOI 10.1379/CSC-22R.1; Rensen WM, 2009, ONCOGENE, V28, P1748, DOI 10.1038/onc.2009.24; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Stuart RO, 2001, P NATL ACAD SCI USA, V98, P5649, DOI 10.1073/pnas.091110798; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; WITZGALL R, 1993, MOL CELL BIOL, V13, P1933, DOI 10.1128/MCB.13.3.1933; Yoshida T, 2002, BIOCHEM BIOPH RES CO, V291, P787, DOI 10.1006/bbrc.2002.6535; Yuen PST, 2006, PHYSIOL GENOMICS, V25, P375, DOI 10.1152/physiolgenomics.00223.2005	35	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25679	10.1371/journal.pone.0025679	http://dx.doi.org/10.1371/journal.pone.0025679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980527	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900091
J	Mika, JT; Krasnikov, V; van den Bogaart, G; de Haan, F; Poolman, B				Mika, Jacek T.; Krasnikov, Victor; van den Bogaart, Geert; de Haan, Foppe; Poolman, Bert			Evaluation of Pulsed-FRAP and Conventional-FRAP for Determination of Protein Mobility in Prokaryotic Cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; DIFFUSION; GROWTH	Background: Macromolecule mobility is often quantified with Fluorescence Recovery After Photobleaching (FRAP). Throughout literature a wide range of diffusion coefficients for GFP in the cytoplasm of Escherichia coli (3 to 14 mu m(2)/s) is reported using FRAP-based approaches. In this study, we have evaluated two of these methods: pulsed-FRAP and "conventional''-FRAP. Principal Findings: To address the question whether the apparent discrepancy in the diffusion data stems from methodological differences or biological variation, we have implemented and compared the two techniques on bacteria grown and handled in the same way. The GFP diffusion coefficients obtained under normal osmotic conditions and upon osmotic upshift were very similar for the different techniques. Conclusions: Our analyses indicate that the wide range of values reported for the diffusion coefficient of GFP in live cells are due to experimental conditions and/or biological variation rather than methodological differences.	[Mika, Jacek T.] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands	University of Groningen; University of Groningen	Mika, JT (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; van den Bogaart, Geert/GLV-3283-2022; van den Bogaart, Geert/A-1089-2014; Poolman, Bert/D-1882-2012	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; 	SysMo via the Biotechnology and Biological Sciences Research Council (BBSRC); Nederlandse Wetenschappelijke Organisatie (NWO) [700.56.302]	SysMo via the Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nederlandse Wetenschappelijke Organisatie (NWO)(Netherlands Organization for Scientific Research (NWO))	The authors acknowledge financial support from SysMo via the Biotechnology and Biological Sciences Research Council (BBSRC)-funded KosmoBac programme coordinated by Ian R. Booth (Aberdeen) and Nederlandse Wetenschappelijke Organisatie (NWO) (top-subsidy grant 700.56.302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; DENNIS PP, 1974, J BACTERIOL, V119, P270, DOI 10.1128/JB.119.1.270-281.1974; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ENGLISH BP, 2010, TRACKING INDIVIDUAL; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Konopka MC, 2009, J BACTERIOL, V191, P231, DOI 10.1128/JB.00536-08; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Mika JT, 2011, CURR OPIN BIOTECH, V22, P117, DOI 10.1016/j.copbio.2010.09.009; MIKA JT, 2010, MOL MICROBIOL; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; NENNINGER A, 2010, J BACTERIOL; Slade KM, 2009, J PHYS CHEM B, V113, P4837, DOI 10.1021/jp810642d; Slade KM, 2009, BIOCHEMISTRY-US, V48, P5083, DOI 10.1021/bi9004107; van den Bogaart G, 2007, MOL MICROBIOL, V64, P858, DOI 10.1111/j.1365-2958.2007.05705.x; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994	16	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25664	10.1371/journal.pone.0025664	http://dx.doi.org/10.1371/journal.pone.0025664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980523	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900089
J	Nacev, BA; Liu, JO				Nacev, Benjamin A.; Liu, Jun O.			Synergistic Inhibition of Endothelial Cell Proliferation, Tube Formation, and Sprouting by Cyclosporin A and Itraconazole	PLOS ONE			English	Article							GROWTH-FACTOR; CANDIDA-ALBICANS; ANGIOGENESIS; CALCINEURIN; EFFICACY; TARGET; CYP51	Pathological angiogenesis contributes to a number of diseases including cancer and macular degeneration. Although angiogenesis inhibitors are available in the clinic, their efficacy against most cancers is modest due in part to the existence of alternative and compensatory signaling pathways. Given that angiogenesis is dependent on multiple growth factors and a broad signaling network in vivo, we sought to explore the potential of multidrug cocktails for angiogenesis inhibition. We have screened 741 clinical drug combinations for the synergistic inhibition of endothelial cell proliferation. We focused specifically on existing clinical drugs since the re-purposing of clinical drugs allows for a more rapid and cost effective transition to clinical studies when compared to new drug entities. Our screen identified cyclosporin A (CsA), an immunosuppressant, and itraconazole, an antifungal drug, as a synergistic pair of inhibitors of endothelial cell proliferation. In combination, the IC50 dose of each drug is reduced by 3 to 9 fold. We also tested the ability of the combination to inhibit endothelial cell tube formation and sprouting, which are dependent on two essential processes in angiogenesis, endothelial cell migration and differentiation. We found that CsA and itraconazole synergistically inhibit tube network size and sprout formation. Lastly, we tested the combination on human foreskin fibroblast viability as well as Jurkat T cell and HeLa cell proliferation, and found that endothelial cells are selectively targeted. Thus, it is possible to combine existing clinical drugs to synergistically inhibit in vitro models of angiogenesis. This strategy may be useful in pursuing the next generation of antiangiogenesis therapy.	[Nacev, Benjamin A.; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Nacev, Benjamin A.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Nacev, BA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu			NCI [RO1 CA122814]; National Center for Research Resources (NCRR); National Institutes of Health (NIH) [T32GM07309]; NIH Roadmap for Medical Research [UL1 RR 025005]; Flight Attendant Medical Research Institute; Keck Foundation; Walsh Prostate Cancer Fund; Commonwealth Foundation; NATIONAL CANCER INSTITUTE [R01CA122814] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; Keck Foundation(W.M. Keck Foundation); Walsh Prostate Cancer Fund; Commonwealth Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NCI [Grant RO1 CA122814], the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research [Grant UL1 RR 025005], the Flight Attendant Medical Research Institute Fund, the Keck Foundation, the Walsh Prostate Cancer Fund, and the Commonwealth Foundation (J.O.L.), and by the NIH Medical Scientist Training Program [Grant T32GM07309] (B.A.N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benelli U, 1997, INVEST OPHTH VIS SCI, V38, P274; Blansfield JA, 2008, CLIN CANCER RES, V14, P270, DOI 10.1158/1078-0432.CCR-07-1562; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chong CR, 2006, J MED CHEM, V49, P2677, DOI 10.1021/jm051225t; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Korff T, 1999, J CELL SCI, V112, P3249; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Nacev BA, 2011, J PHARMACOL EXP THER, V338, P466, DOI 10.1124/jpet.111.180851; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; SHARPE RJ, 1989, ARCH DERMATOL, V125, P1359, DOI 10.1001/archderm.125.10.1359; Shim JS, 2010, JNCI-J NATL CANCER I, V102, P1855, DOI 10.1093/jnci/djq457; Trosken ER, 2006, TOXICOLOGY, V228, P24, DOI 10.1016/j.tox.2006.08.007; Webb JL, 1961, ENZYMES METABOL INH, V1, P66; Wei S, 2010, ACS MED CHEM LETT, V1, P155; Welti JC, 2011, ONCOGENE, V30, P1183, DOI 10.1038/onc.2010.503; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	37	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24793	10.1371/journal.pone.0024793	http://dx.doi.org/10.1371/journal.pone.0024793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969860	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900011
J	Sampson, DL; Parker, TJ; Upton, Z; Hurst, CP				Sampson, Dayle L.; Parker, Tony J.; Upton, Zee; Hurst, Cameron P.			A Comparison of Methods for Classifying Clinical Samples Based on Proteomics Data: A Case Study for Statistical and Machine Learning Approaches	PLOS ONE			English	Article							RANDOM FOREST; MASS-SPECTROMETRY; GRAPHICAL EXPLORATION; VARIABLE IMPORTANCE; CLASSIFICATION; MICROARRAY; EXPRESSION; IDENTIFICATION; PREDICTION; REDUCTION	The discovery of protein variation is an important strategy in disease diagnosis within the biological sciences. The current benchmark for elucidating information from multiple biological variables is the so called "omics" disciplines of the biological sciences. Such variability is uncovered by implementation of multivariable data mining techniques which come under two primary categories, machine learning strategies and statistical based approaches. Typically proteomic studies can produce hundreds or thousands of variables, p, per observation, n, depending on the analytical platform or method employed to generate the data. Many classification methods are limited by an n << p constraint, and as such, require pre-treatment to reduce the dimensionality prior to classification. Recently machine learning techniques have gained popularity in the field for their ability to successfully classify unknown samples. One limitation of such methods is the lack of a functional model allowing meaningful interpretation of results in terms of the features used for classification. This is a problem that might be solved using a statistical model-based approach where not only is the importance of the individual protein explicit, they are combined into a readily interpretable classification rule without relying on a black box approach. Here we incorporate statistical dimension reduction techniques Partial Least Squares (PLS) and Principal Components Analysis (PCA) followed by both statistical and machine learning classification methods, and compared them to a popular machine learning technique, Support Vector Machines (SVM). Both PLS and SVM demonstrate strong utility for proteomic classification problems.	[Sampson, Dayle L.; Parker, Tony J.; Upton, Zee] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Repair & Regenerat Program, Kelvin Grove, Qld, Australia; [Parker, Tony J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Workforce Hlth Innovat Program, Kelvin Grove, Qld, Australia; [Hurst, Cameron P.] Queensland Univ Technol, Sch Publ Hlth, Fac Hlth, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Sampson, DL (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Repair & Regenerat Program, Kelvin Grove, Qld, Australia.	sampsond@qut.edu.au	Hurst, Cameron/AAD-5753-2019; Hurst, Cameron P/P-5175-2017; Upton, Zee/ABC-4642-2021; Upton, Zee/I-9777-2012	Hurst, Cameron/0000-0002-4577-8962; Hurst, Cameron P/0000-0002-4577-8962; Parker, Tony/0000-0002-5118-524X; Upton, Zee/0000-0002-9928-5864	Queensland University of Technology	Queensland University of Technology	This project has been supported by funding from internal Queensland University of Technology research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ball G, 2002, BIOINFORMATICS, V18, P395, DOI 10.1093/bioinformatics/18.3.395; Barrett JH, 2008, STAT APPL GENET MOL, V7; Boulesteix AL, 2008, BIOINFORMATICS, V24, P1698, DOI 10.1093/bioinformatics/btn262; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Dai JJ, 2006, STAT APPL GENET MOL, V5; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Ding B, 2004, 5 BIOC PROJ; Ding BY, 2005, J COMPUT GRAPH STAT, V14, P280, DOI 10.1198/106186005X47697; Fearn T, 2008, STAT APPL GENET MOL, V7; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Hagen JB, 2000, NAT REV GENET, V1, P231, DOI 10.1038/35042090; Hand DJ, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1435; Hendriks MMWB, 2007, PROTEOMICS, V7, P3672, DOI 10.1002/pmic.200700046; Hilario M, 2008, BRIEF BIOINFORM, V9, P102, DOI 10.1093/bib/bbn005; Hoefsloot HCJ, 2008, STAT APPL GENET MOL, V7; Izmirlian G, 2004, ANN NY ACAD SCI, V1020, P154, DOI 10.1196/annals.1310.015; Jung E, 2011, J COMPUT AI IN PRESS; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Lee KR, 2003, PROTEOMICS, V3, P1680, DOI 10.1002/pmic.200300515; Lindgren F, 1998, PERSPECT DRUG DISCOV, V12, P105, DOI 10.1023/A:1017077804312; Luts J, 2010, ANAL CHIM ACTA, V665, P129, DOI 10.1016/j.aca.2010.03.030; Malley JD, 2011, STAT LEARNING BIOMED, P137; Martens H, 2001, CHEMOMETR INTELL LAB, V58, P85, DOI 10.1016/S0169-7439(01)00153-8; Mertens BJA, 2009, J PROTEOMICS, V72, P785, DOI 10.1016/j.jprot.2009.04.002; Mertens BJ, 2008, STAT APPL GENET MOL, V7; Meunier B, 2005, ANAL BIOCHEM, V340, P226, DOI 10.1016/j.ab.2005.02.028; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pittelkow Y, 2005, BIOMETRICS, V61, P630, DOI 10.1111/j.1541-0420.2005.00366.x; Pittelkow YE, 2003, STAT APPL GENET MOL, V2; Purohit PV, 2003, PROTEOMICS, V3, P1699, DOI 10.1002/pmic.200300518; Rajalahti T, 2009, ANAL CHEM, V81, P2581, DOI 10.1021/ac802514y; Schleif FM, 2009, ARTIF INTELL MED, V45, P215, DOI 10.1016/j.artmed.2008.07.018; SIMON R, 2003, SIGKDD EXPLORATIONS, V5, P31; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Smith FM, 2007, ANN SURG, V245, P259, DOI 10.1097/01.sla.0000245577.68151.bd; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Somorjai RL, 2003, BIOINFORMATICS, V19, P1484, DOI 10.1093/bioinformatics/btg182; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Wegelin J.A, 2000, 371 U WASH DEP STAT; Willingale R, 2006, PROTEOMICS, V6, P5903, DOI 10.1002/pmic.200600375; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P83, DOI 10.1016/S0169-7439(01)00152-6; Wouters L, 2003, BIOMETRICS, V59, P1131, DOI 10.1111/j.0006-341X.2003.00130.x	47	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24973	10.1371/journal.pone.0024973	http://dx.doi.org/10.1371/journal.pone.0024973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969867	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900018
J	Zhang, GH; Lv, MM; Wang, S; Chen, L; Qian, NS; Tang, Y; Zhang, XD; Ren, PC; Gao, CJ; Sun, XD; Xu, LX				Zhang, Gui-He; Lv, Miao-Miao; Wang, Shuang; Chen, Lei; Qian, Nian-Song; Tang, Yu; Zhang, Xu-Dong; Ren, Peng-Cheng; Gao, Chang-Jun; Sun, Xu-De; Xu, Li-Xian			Spinal Astrocytic Activation Is Involved in a Virally-Induced Rat Model of Neuropathic Pain	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLIA; POSTHERPETIC NEURALGIA; NITRIC-OXIDE; GLIAL ACTIVATION; PERSISTENT PAIN; HERPES-ZOSTER; PROINFLAMMATORY CYTOKINES; INFLAMMATORY HYPERALGESIA	Postherpetic neuralgia (PHN), the most common complication of herpes zoster (HZ), plays a major role in decreased life quality of HZ patients. However, the neural mechanisms underlying PHN remain unclear. Here, using a PHN rat model at 2 weeks after varicella zoster virus infection, we found that spinal astrocytes were dramatically activated. The mechanical allodynia and spinal central sensitization were significantly attenuated by intrathecally injected L-alpha-aminoadipate (astrocytic specific inhibitor) whereas minocycline (microglial specific inhibitor) had no effect, which indicated that spinal astrocyte but not microglia contributed to the chronic pain in PHN rat. Further study was taken to investigate the molecular mechanism of astrocyte-incudced allodynia in PHN rat at post-infection 2 weeks. Results showed that nitric oxide (NO) produced by inducible nitric oxide synthase mediated the development of spinal astrocytic activation, and activated astrocytes dramatically increased interleukin-1 beta expression which induced N-methyl-D-aspartic acid receptor (NMDAR) phosphorylation in spinal dorsal horn neurons to strengthen pain transmission. Taken together, these results suggest that spinal activated astrocytes may be one of the most important factors in the pathophysiology of PHN and "NO-Astrocyte-Cytokine-NMDAR-Neuron'' pathway may be the detailed neural mechanisms underlying PHN. Thus, inhibiting spinal astrocytic activation may represent a novel therapeutic strategy for clinical management of PHN.	[Zhang, Gui-He; Gao, Chang-Jun; Sun, Xu-De] Fourth Mil Med Univ, Dept Anesthesiol, Tangdu Hosp, Xian 710032, Peoples R China; [Zhang, Gui-He; Lv, Miao-Miao; Xu, Li-Xian] Fourth Mil Med Univ, Dept Anesthesiol, Sch Stomatol, Xian 710032, Peoples R China; [Wang, Shuang] Fourth Mil Med Univ, Cent Lab, Xian 710032, Peoples R China; [Chen, Lei] Naval Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China; [Qian, Nian-Song] Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Tang, Yu] PLA 302 Hosp, Dept Ultrasound, Beijing, Peoples R China; [Zhang, Xu-Dong; Ren, Peng-Cheng] Fourth Mil Med Univ, Dept Orthopaed, Tangdu Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Air Force Military Medical University	Zhang, GH (corresponding author), Fourth Mil Med Univ, Dept Anesthesiol, Tangdu Hosp, Xian 710032, Peoples R China.	gaocj74@163.com; sunxd65@163.com; hangguihefmmu@163.com			National Natural Science Foundation of China [81071527, 30972833]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Nos. 81071527, 30972833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bowsher D, 1995, NEUROLOGY, V45, pS56, DOI 10.1212/WNL.45.12_Suppl_8.S56; Bowsher D, 1997, POSTGRAD MED J, V73, P623, DOI 10.1136/pgmj.73.864.623; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brenner GJ, 2004, EUR J NEUROSCI, V20, P375, DOI 10.1111/j.1460-9568.2004.03506.x; Chen SR, 2000, NEUROSCIENCE, V101, P759, DOI 10.1016/S0306-4522(00)00415-2; Cho IH, 2006, BRAIN RES, V1072, P208, DOI 10.1016/j.brainres.2005.12.039; Christoph T, 2006, NEUROPHARMACOLOGY, V51, P12, DOI 10.1016/j.neuropharm.2006.02.007; Coyle DE, 1998, GLIA, V23, P75; Dalziel RG, 2004, BRAIN RES REV, V46, P234, DOI 10.1016/j.brainresrev.2004.07.008; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; Delaney A, 2009, NEUROTHERAPEUTICS, V6, P630, DOI 10.1016/j.nurt.2009.07.005; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Dworkin RH, 1996, PAIN, V67, P241, DOI 10.1016/0304-3959(96)03122-3; Feng QX, 2010, NEUROSCIENCE, V167, P501, DOI 10.1016/j.neuroscience.2010.02.005; Fleetwood-Walker SM, 1999, J GEN VIROL, V80, P2433, DOI 10.1099/0022-1317-80-9-2433; Garry EM, 2005, PAIN, V118, P97, DOI 10.1016/j.pain.2005.08.003; GILDEN DH, 1994, NEW ENGL J MED, V330, P932, DOI 10.1056/NEJM199403313301312; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hao JX, 1999, ACTA ANAESTH SCAND, V43, P1027, DOI 10.1034/j.1399-6576.1999.431010.x; Holguin A, 2004, PAIN, V110, P517, DOI 10.1016/j.pain.2004.02.018; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Jin SX, 2003, J NEUROSCI, V23, P4017; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; Liao YH, 2011, BRAIN RES, V1368, P324, DOI 10.1016/j.brainres.2010.10.044; Liu J, 2007, NEUROSCI LETT, V412, P268, DOI 10.1016/j.neulet.2006.11.022; Lydick E, 1995, NEUROLOGY, V45, pS52, DOI 10.1212/WNL.45.12_Suppl_8.S52; Medhurst SJ, 2008, PAIN, V138, P61, DOI 10.1016/j.pain.2007.11.006; Mei XP, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-50; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Rowbotham MC, 1996, BRAIN, V119, P347, DOI 10.1093/brain/119.2.347; SADZOTDELVAUX C, 1990, J NEUROSCI RES, V26, P83, DOI 10.1002/jnr.490260110; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Sweitzer S, 2001, NEUROSCIENCE, V103, P529, DOI 10.1016/S0306-4522(00)00574-1; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Ultenius C, 2006, NEUROSCI LETT, V399, P85, DOI 10.1016/j.neulet.2006.01.018; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006973; Watkins LR, 2003, ADV EXP MED BIOL, V521, P1; Watkins LR, 2001, PAIN, V93, P201, DOI 10.1016/S0304-3959(01)00359-1; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zanchet EM, 2004, BRAIN RES, V1021, P101, DOI 10.1016/j.brainres.2004.06.041; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	52	30	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e23059	10.1371/journal.pone.0023059	http://dx.doi.org/10.1371/journal.pone.0023059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969850	gold, Green Published, Green Submitted			2022-12-27	WOS:000295936900001
J	Eber, MR; Shardell, M; Schweizer, ML; Laxminarayan, R; Perencevich, EN				Eber, Michael R.; Shardell, Michelle; Schweizer, Marin L.; Laxminarayan, Ramanan; Perencevich, Eli N.			Seasonal and Temperature-Associated Increases in Gram-Negative Bacterial Bloodstream Infections among Hospitalized Patients	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ACINETOBACTER; SYSTEMS	Background: Knowledge of seasonal trends in hospital-associated infection incidence may improve surveillance and help guide the design and evaluation of infection prevention interventions. We estimated seasonal variation in the frequencies of inpatient bloodstream infections (BSIs) caused by common bacterial pathogens and examined associations of monthly BSI frequencies with ambient outdoor temperature, precipitation, and humidity levels. Methods: A database containing blood cultures from 132 U. S. hospitals collected between January 1999 and September 2006 was assembled. The database included monthly counts of inpatient blood cultures positive for several clinically important Gram-negative bacteria (Acinetobacter spp, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) and Gram-positive bacteria (Enterococcus spp and Staphylococcus aureus). Monthly mean temperature, total precipitation, and mean relative humidity in the postal ZIP codes of participating hospitals were obtained from national meteorological databases. Results: A total of 211,697 inpatient BSIs were reported during 9,423 hospital-months. Adjusting for long-term trends, BSIs caused by each Gram-negative organism examined were more frequent in summer months compared with winter months, with increases ranging from 12.2% for E. coli (95% CI 9.2-15.4) to 51.8% for Acinetobacter (95% CI 41.1-63.2). Summer season was associated with 8.7% fewer Enterococcus BSIs (95% CI 11.0-5.8) and no significant change in S. aureus BSI frequency relative to winter. Independent of season, monthly humidity, monthly precipitation, and long-term trends, each 5.6 degrees C (10 degrees F) rise in mean monthly temperature corresponded to increases in Gram-negative bacterial BSI frequencies ranging between 3.5% for E. coli (95% CI 2.1-4.9) to 10.8% for Acinetobacter (95% CI 6.9-14.7). The same rise in mean monthly temperature corresponded to an increase of 2.2% in S. aureus BSI frequency (95% CI 1.3-3.2) but no significant change in Enterococcus BSI frequency. Conclusions: Summer season and higher mean monthly outdoor temperature are associated with substantially increased	[Eber, Michael R.; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Shardell, Michelle] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Schweizer, Marin L.; Perencevich, Eli N.] Univ Iowa, Carver Sch Med, Iowa City, IA USA; [Laxminarayan, Ramanan] Princeton Environm Inst, Princeton, NJ USA; [Perencevich, Eli N.] Iowa City VA Med Ctr, Iowa City, IA USA	University System of Maryland; University of Maryland Baltimore; University of Iowa; Princeton University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Eber, MR (corresponding author), Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90089 USA.	mre_001@usc.edu	Laxminarayan, Ramanan/ABD-5050-2021	Perencevich, Eli/0000-0002-3721-3355; Schweizer, Marin/0000-0002-3604-0093	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	The funding source for this study was the Robert Wood Johnson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; [Anonymous], OVERVIEW NATIONWIDE; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; Freeman J, 2009, INFECT CONT HOSP EP, V30, P813, DOI 10.1086/597506; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Kaier K, 2010, INFECT CONT HOSP EP, V31, P1154, DOI 10.1086/656748; Magnus G., 1844, ANN PHYS CHEM, V61, P225, DOI [10.1002/andp.18441370202, DOI 10.1002/ANDP.18441370202]; MAKI DG, 1982, NEW ENGL J MED, V307, P1562, DOI 10.1056/NEJM198212163072507; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; McDonald LC, 1999, CLIN INFECT DIS, V29, P1133, DOI 10.1086/313441; McDonald LC, 1998, PEDIATR INFECT DIS J, V17, P716, DOI 10.1097/00006454-199808000-00011; Mermel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017925; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RATKOWSKY DA, 1983, J BACTERIOL, V154, P1222, DOI 10.1128/JB.154.3.1222-1226.1983; Sahm DF, 1999, CLIN INFECT DIS, V29, P259, DOI 10.1086/520195; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; SMITH PW, 1977, JAMA-J AM MED ASSOC, V237, P795, DOI 10.1001/jama.237.8.795; Smith TL, 2002, INFECT CONT HOSP EP, V23, P239, DOI 10.1086/502042; Tetens O., 1930, Z GEOPHYS, V6, P297, DOI DOI 10.1016/J.FOODCHEM.2008.07.023; Trent MS, 2004, BIOCHEM CELL BIOL, V82, P71, DOI 10.1139/o03-070	22	99	100	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25298	10.1371/journal.pone.0025298	http://dx.doi.org/10.1371/journal.pone.0025298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966489	Green Submitted, Green Published, gold			2022-12-27	WOS:000295932100034
J	Hwang, DY; Hung, CC; Riepe, FG; Auchus, RJ; Kulle, AE; Holterhus, PM; Chao, MC; Kuo, MC; Hwang, SJ; Chen, HC				Hwang, Daw-Yang; Hung, Chi-Chih; Riepe, Felix G.; Auchus, Richard J.; Kulle, Alexandra E.; Holterhus, Paul-Martin; Chao, Mei-Chyn; Kuo, Mei-Chuan; Hwang, Shang-Jyh; Chen, Hung-Chun			CYP17A1 Intron Mutation Causing Cryptic Splicing in 17 alpha-Hydroxylase Deficiency	PLOS ONE			English	Article							COMPOUND HETEROZYGOUS MUTATION; SITE MUTATION; 17-HYDROXYLASE DEFICIENCY; JAPANESE PATIENTS; ENZYME-ACTIVITY; GENE; DELETION; EXPRESSION; DISORDERS	17 alpha-hydroxylase/17, 20-lyase deficiency (17OHD) is an autosomal recessive disease causing congenital adrenal hyperplasia and a rare cause of hypertension with hypokalemia. The CYP17A1 gene mutation leads to 17OHD and its clinical features. We described an 18 y/o female with clinical features of 17a-hydroxylase/17, 20-lyase deficiency and characterized the functional consequences of an intronic CYP17A1 mutation. The coding regions and flanking intronic bases of the CYP17A1 gene were amplified by PCR and sequenced. The patient is a compound heterozygote for the previously described p.R358X and IVS1 +2T>C mutations. A first intron splice donor site mutation was re-created in minigene and full-length expression vectors. Pre-mRNA splicing of the variant CYP17A1 intron was studied in transfected cells and in a transformed lymphoblastoid cell line. When the full-length CYP17A1 gene and minigene containing the intronic mutation was expressed in transfected cells, the majority (>90%) of mRNA transcripts were incorrectly spliced. Only the p.R358X transcript was detected in the EBV-transformed lymphoblastoid cell line. The IVS1 +2T>C mutation abolished most 17 alpha-hydroxylase/17, 20-lyase enzyme activity by aberrant mRNA splicing to an intronic pseudo-exon, causing a frame shift and early termination.	[Hwang, Daw-Yang; Hung, Chi-Chih; Kuo, Mei-Chuan; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Dept Med, Div Nephrol, Kaohsiung, Taiwan; [Riepe, Felix G.; Kulle, Alexandra E.; Holterhus, Paul-Martin] Univ Kiel, Dept Pediat, Div Pediat Endocrinol, D-2300 Kiel, Germany; [Auchus, Richard J.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Chao, Mei-Chyn] Kaohsiung Med Univ Hosp, Dept Pediat, Div Genet Endocrinol & Metab, Kaohsiung, Taiwan; [Chao, Mei-Chyn] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Kuo, Mei-Chuan; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Kiel; University of Michigan System; University of Michigan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Hwang, DY (corresponding author), Kaohsiung Med Univ Hosp, Dept Med, Div Nephrol, Kaohsiung, Taiwan.	sjhwang@kmu.edu.tw			Kaohsiung Medical University Hospital	Kaohsiung Medical University Hospital	This research was supported by the Kaohsiung Medical University Hospital Nephrology Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2005, GENOME RES, V15, P111, DOI 10.1101/gr.3108805; AEBI M, 1987, CELL, V50, P237, DOI 10.1016/0092-8674(87)90219-4; Bhangoo A, 2008, J PEDIATR ENDOCR MET, V21, P185; Blason-Lauber A, 2000, J CLIN ENDOCR METAB, V85, P1226; Boldina G, 2009, INT J BIOL SCI, V5, P13; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Chang IC, 2006, CELL PROLIFERAT, V39, P457, DOI 10.1111/j.1365-2184.2006.00404.x; Costa-Santos M, 2004, J CLIN ENDOCR METAB, V89, P49, DOI 10.1210/jc.2003-031021; Costa-Santos M, 2004, J CLIN ENDOCR METAB, V89, P43, DOI 10.1210/jc.2003-031020; D'Souza-Li L, 2001, HUM MUTAT, V18, P411, DOI 10.1002/humu.1212; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Hwang DY, 2001, AM J PHYSIOL-CELL PH, V281, pC1365, DOI 10.1152/ajpcell.2001.281.4.C1365; KATER CE, 1994, ENDOCRIN METAB CLIN, V23, P341, DOI 10.1016/S0889-8529(18)30101-4; Kulle AE, 2010, J CLIN ENDOCR METAB, V95, P2399, DOI 10.1210/jc.2009-1670; Lee LS, 2006, MOL CELL ENDOCRINOL, V249, P16, DOI 10.1016/j.mce.2006.01.003; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Nie Min, 2007, Hum Genet, V121, P298; Qiao J, 2003, MOL CELL ENDOCRINOL, V201, P189, DOI 10.1016/S0303-7207(02)00156-9; RUIS BL, 1994, NUCLEIC ACIDS RES, V22, P5190, DOI 10.1093/nar/22.24.5190; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Suzuki Y, 1998, J CLIN ENDOCR METAB, V83, P199, DOI 10.1210/jc.83.1.199; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Won GS, 2007, METABOLISM, V56, P504, DOI 10.1016/j.metabol.2006.11.009; Wong SL, 2006, J FORMOS MED ASSOC, V105, P177, DOI 10.1016/S0929-6646(09)60342-9; Wu Q, 1997, RNA, V3, P586; Yamaguchi H, 1998, HUM GENET, V102, P635, DOI 10.1007/s004390050754; Yamaguchi H, 1997, J CLIN ENDOCR METAB, V82, P1934, DOI 10.1210/jc.82.6.1934; YAMAKITA N, 1989, ENDOCRINOL JAPON, V36, P515; Yao Fengxia, 2009, Hum Genet, V125, P351; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	31	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25492	10.1371/journal.pone.0025492	http://dx.doi.org/10.1371/journal.pone.0025492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966534	gold, Green Submitted, Green Published			2022-12-27	WOS:000295932100043
J	Namba, T; Mochizuki, H; Suzuki, R; Onodera, M; Yamaguchi, M; Namiki, H; Shioda, S; Seki, T				Namba, Takashi; Mochizuki, Hideki; Suzuki, Ryusuke; Onodera, Masafumi; Yamaguchi, Masahiro; Namiki, Hideo; Shioda, Seiji; Seki, Tatsunori			Time-Lapse Imaging Reveals Symmetric Neurogenic Cell Division of GFAP-Expressing Progenitors for Expansion of Postnatal Dentate Granule Neurons	PLOS ONE			English	Article							NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; SLICE CULTURES; RADIAL GLIA; RAT HIPPOCAMPUS; INTERMEDIATE PROGENITORS; TRANSCRIPTION FACTORS; PRECURSOR CELLS; IN-VIVO	Granule cells in the hippocampus, a region critical for memory and learning, are generated mainly during the early postnatal period but neurogenesis continues in adulthood. Postnatal neuronal production is carried out by primary progenitors that express glial fibrillary acidic protein (GFAP) and they are assumed to function as stem cells. A central question regarding postnatal dentate neurogenesis is how astrocyte-like progenitors produce neurons. To reveal cell division patterns and the process of neuronal differentiation of astrocyte-like neural progenitors, we performed time-lapse imaging in cultured hippocampal slices from early postnatal transgenic mice with mouse GFAP promoter-controlled enhanced green fluorescent protein (mGFAP-eGFP Tg mice) in combination with a retrovirus carrying a red fluorescent protein gene. Our results showed that the majority of GFAP-eGFP+ progenitor cells that express GFAP, Sox2 and nestin divided symmetrically to produce pairs of GFAP+ cells (45%) or pairs of neuron-committed cells (45%), whereas a minority divided asymmetrically to generate GFAP+ cells and neuron-committed cells (10%). The present results suggest that a substantial number of GFAP-expressing progenitors functions as transient amplifying progenitors, at least in an early postnatal dentate gyrus, although a small population appears to be stem cell-like progenitors. From the present data, we discuss possible cell division patterns of adult GFAP+ progenitors.	[Namba, Takashi; Seki, Tatsunori] Juntendo Univ, Sch Med, Dept Anat, Tokyo 113, Japan; [Namba, Takashi; Namiki, Hideo] Waseda Univ, Sch Sci & Engn, Tokyo 169, Japan; [Mochizuki, Hideki] Kitasato Univ, Sch Med, Dept Neurol, Kanagawa, Japan; [Suzuki, Ryusuke; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; [Onodera, Masafumi] Univ Tsukuba, Dept Hematol, Inst Clin Med, Ibaraki, Japan; [Yamaguchi, Masahiro] Univ Tokyo, Dept Otolaryngol, Tokyo 113, Japan; [Yamaguchi, Masahiro] Univ Tokyo, Dept Physiol, Grad Sch Med, Tokyo, Japan; [Seki, Tatsunori] Tokyo Med & Dent Univ, Dept Histol & Neuroanat, Tokyo, Japan	Juntendo University; Waseda University; Kitasato University; Showa University; University of Tsukuba; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Namba, T (corresponding author), Juntendo Univ, Sch Med, Dept Anat, Tokyo 113, Japan.	sekit@tokyo-med.ac.jp	Namba, Takashi/AAE-4439-2022; Namba, Takashi/ABF-4571-2020	Namba, Takashi/0000-0003-4875-666X	Japan Society for the Promotion of Science [17500238, 22500306]; Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [22500306] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (17500238 and 22500306) and in part by a High Technology Research Center Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kamada M, 2004, EUR J NEUROSCI, V20, P2499, DOI 10.1111/j.1460-9568.2004.03721.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Nacher J, 2001, EUR J NEUROSCI, V13, P512, DOI 10.1046/j.0953-816x.2000.01424.x; Namba T, 2005, EUR J NEUROSCI, V22, P1928, DOI 10.1111/j.1460-9568.2005.04396.x; Namba T, 2007, J NEUROSCI RES, V85, P1704, DOI 10.1002/jnr.21295; Namba T, 2009, GLIA, V57, P1082, DOI 10.1002/glia.20831; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Ozen I, 2007, EUR J NEUROSCI, V25, P2591, DOI 10.1111/j.1460-9568.2007.05541.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003; Raineteau O, 2006, MOL CELL NEUROSCI, V32, P344, DOI 10.1016/j.mcn.2006.05.006; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suzuki A, 2002, J NEUROCHEM, V82, P953, DOI 10.1046/j.1471-4159.2002.01048.x; Suzuki R, 2003, MOL BRAIN RES, V115, P10, DOI 10.1016/S0169-328X(03)00172-4; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yokose J, 2011, NEUROSCI RES, V69, P223, DOI 10.1016/j.neures.2010.11.010; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25303	10.1371/journal.pone.0025303	http://dx.doi.org/10.1371/journal.pone.0025303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966492	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100043
J	Skapski, A; Hygonenq, MC; Sagne, E; Guiral, S; Citti, C; Baranowski, E				Skapski, Agnes; Hygonenq, Marie-Claude; Sagne, Eveline; Guiral, Sebastien; Citti, Christine; Baranowski, Eric			Genome-Scale Analysis of Mycoplasma agalactiae Loci Involved in Interaction with Host Cells	PLOS ONE			English	Article							SIGNATURE-TAGGED MUTAGENESIS; TRANSPOSON MUTAGENESIS; STRESS TOLERANCE; TRIGGER FACTOR; CLUSTER; GENES; TRANSCRIPTION; IDENTIFICATION; PATHOGENICITY; GALLISEPTICUM	Mycoplasma agalactiae is an important pathogen of small ruminants, in which it causes contagious agalactia. It belongs to a large group of "minimal bacteria" with a small genome and reduced metabolic capacities that are dependent on their host for nutrients. Mycoplasma survival thus relies on intimate contact with host cells, but little is known about the factors involved in these interactions or in the more general infectious process. To address this issue, an assay based on goat epithelial and fibroblastic cells was used to screen a M. agalactiae knockout mutant library. Mutants with reduced growth capacities in cell culture were selected and 62 genomic loci were identified as contributing to this phenotype. As expected for minimal bacteria, "transport and metabolism" was the functional category most commonly implicated in this phenotype, but 50% of the selected mutants were disrupted in coding sequences (CDSs) with unknown functions, with surface lipoproteins being most commonly represented in this category. Since mycoplasmas lack a cell wall, lipoproteins are likely to be important in interactions with the host. A few intergenic regions were also identified that may act as regulatory sequences under co-culture conditions. Interestingly, some mutants mapped to gene clusters that are highly conserved across mycoplasma species but located in different positions. One of these clusters was found in a transcriptionally active region of the M. agalactiae chromosome, downstream of a cryptic promoter. A possible scenario for the evolution of these loci is discussed. Finally, several CDSs identified here are conserved in other important pathogenic mycoplasmas, and some were involved in horizontal gene transfer with phylogenetically distant species. These results provide a basis for further deciphering functions mediating mycoplasma-host interactions.	[Skapski, Agnes; Hygonenq, Marie-Claude; Sagne, Eveline; Guiral, Sebastien; Citti, Christine; Baranowski, Eric] IHAP, INRA, UMR1225, F-31931 Toulouse, France; [Skapski, Agnes; Hygonenq, Marie-Claude; Sagne, Eveline; Guiral, Sebastien; Citti, Christine; Baranowski, Eric] Univ Toulouse, INP, ENVT, IHAP,UMR1225, Toulouse, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Skapski, A (corresponding author), IHAP, INRA, UMR1225, F-31931 Toulouse, France.	e.baranowski@envt.fr	Baranowski, Eric/I-2655-2013	Baranowski, Eric/0000-0003-0660-1854; Citti, Christine/0000-0003-4754-6003	INRA; CIRAD; DGER	INRA; CIRAD; DGER	This work was supported by a joint grant from INRA (www.inra.fr) and CIRAD (www.cirad.fr) and by a doctoral fellowship to AS from INRA and DGER (www.envt.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Baranowski E, 2010, INFECT IMMUN, V78, P1542, DOI 10.1128/IAI.01195-09; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Bigot A, 2006, APPL ENVIRON MICROB, V72, P6623, DOI 10.1128/AEM.00624-06; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Burrack LS, 2007, CURR OPIN MICROBIOL, V10, P4, DOI 10.1016/j.mib.2006.11.004; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; EDWARD DG, 1967, SCIENCE, V155, P1694, DOI 10.1126/science.155.3770.1694; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Frey J, 2002, MOL BIOL PATHOGENICI, P73; Gardner SW, 2010, MICROBIOL-SGM, V156, P2305, DOI 10.1099/mic.0.038760-0; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; Hudson P, 2006, INFECT IMMUN, V74, P931, DOI 10.1128/IAI.74.2.931-939.2006; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lluch-Senar M, 2007, MICROBIOL-SGM, V153, P2743, DOI 10.1099/mic.0.2006/007559-0; Marenda M, 2006, J BACTERIOL, V188, P4137, DOI 10.1128/JB.00114-06; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; Mselli-Lakhal L, 2001, VET RES, V32, P429, DOI 10.1051/vetres:2001135; Mudahi-Orenstein S, 2003, INFECT IMMUN, V71, P3812, DOI 10.1128/IAI.71.7.3812-3820.2003; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; Pettersson B, 1996, INT J SYST BACTERIOL, V46, P1093, DOI 10.1099/00207713-46-4-1093; Pfutzner H, 1996, REV SCI TECH OIE, V15, P1477, DOI 10.20506/rst.15.4.987; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rincon-Enriquez G, 2008, MOL MICROBIOL, V67, P1257, DOI 10.1111/j.1365-2958.2008.06118.x; Runyen-Janecky L, 2008, INFECT IMMUN, V76, P1083, DOI 10.1128/IAI.01211-07; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Teixeira MFD, 1997, AM J VET RES, V58, P579; Uchiyama I, 2003, NUCLEIC ACIDS RES, V31, P58, DOI 10.1093/nar/gkg109; Weiner J, 2000, NUCLEIC ACIDS RES, V28, P4488, DOI 10.1093/nar/28.22.4488; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Zimmerman CU, 2005, FEMS MICROBIOL LETT, V253, P315, DOI 10.1016/j.femsle.2005.09.054	42	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25291	10.1371/journal.pone.0025291	http://dx.doi.org/10.1371/journal.pone.0025291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966487	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100041
J	Alvarez-Rueda, N; Desselle, A; Cochonneau, D; Chaumette, T; Clemenceau, B; Leprieur, S; Bougras, G; Supiot, S; Mussini, JM; Barbet, J; Saba, J; Paris, F; Aubry, J; Birkle, S				Alvarez-Rueda, Nidia; Desselle, Ariane; Cochonneau, Denis; Chaumette, Tanguy; Clemenceau, Beatrice; Leprieur, Stephanie; Bougras, Gwenola; Supiot, Stephane; Mussini, Jean-Marie; Barbet, Jacques; Saba, Julie; Paris, Francois; Aubry, Jacques; Birkle, Stephane			A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ISOTYPE-SWITCH VARIANTS; PHASE-I TRIAL; ANTI-GD2 ANTIBODY; FLOW-CYTOMETRY; O-ACETYLATION; NEUROBLASTOMA; CELLS; CANCER; APOPTOSIS	Background: Monoclonal antibodies (mAb) against GD2 ganglioside have been shown to be effective for the treatment of neuroblastoma. Beneficial actions are, however, associated with generalized pain due to the binding of anti-GD2 mAbs to peripheral nerve fibers followed by complement activation. Neuroblastoma cells that express GD2 also express its O-acetyl derivative, O-acetyl-GD2 ganglioside (OAcGD2). Hence, we investigated the distribution of OAcGD2 in human tissues using mAb 8B6 to study the cross-reactivity of mAb 8B6 with human tissues. Methodology/Principal Findings: The distribution of OAcGD2 was performed in normal and malignant tissues using an immunoperoxydase technique. Anti-tumor properties of mAb 8B6 were studied in vitro and in vivo in a transplanted tumor model in mice. We found that OAcGD2 is not expressed by peripheral nerve fibers. Furthermore, we demonstrated that mAb 8B6 was very effective in the in vitro and in vivo suppression of the growth of tumor cells. Importantly, mAb 8B6 anti-tumor efficacy was comparable to that of mAb 14G2a specific to GD2. Conclusion/Significance: Development of therapeutic antibodies specific to OAcGD2 may offer treatment options with reduced adverse side effects, thereby allowing dose escalation of antibodies.	[Alvarez-Rueda, Nidia] Univ Nantes, Dept Parasitol & Mycol Med,Ctr Rech Cancerol Nant, UFR Sci Pharmaceut & Biolog,Inserm, IICiMED UPRES EA 1155,Nantes Atlantique Univ, Nantes, France; [Mussini, Jean-Marie] Ctr Hospitalier Univ Nantes, Ctr Reference Maladies Neuro Musculaires Rares Na, Nantes, France; [Saba, Julie] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Alvarez-Rueda, N (corresponding author), Univ Nantes, Dept Parasitol & Mycol Med,Ctr Rech Cancerol Nant, UFR Sci Pharmaceut & Biolog,Inserm, IICiMED UPRES EA 1155,Nantes Atlantique Univ, Nantes, France.	Stephane.Birkle@univ-nantes.fr	Supiot, Stéphane/M-1586-2015; Chaumette, Tanguy/C-4219-2019; CLEMENCEAU, Béatrice BC/L-2605-2015; Barbet, Jacques/AAE-7089-2020; Paris, francois E/L-4915-2015; Barbet, Jacques/L-4866-2015	Supiot, Stéphane/0000-0003-2094-1708; Barbet, Jacques/0000-0002-9188-984X; Paris, francois E/0000-0002-0176-7348; Barbet, Jacques/0000-0002-9188-984X; ALVAREZ RUEDA, Nidia/0000-0002-5629-1930; Chaumette, Tanguy/0000-0002-5830-8767	Agence Nationale pour la Recherche; Comite Departemental du Maine et Loire et de la Vendee de la Ligue Nationale Contre le Cancer; Institut National du Cancer and Canceropole Grand Ouest; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Comite Departemental du Maine et Loire et de la Vendee de la Ligue Nationale Contre le Cancer; Institut National du Cancer and Canceropole Grand Ouest(Institut National du Cancer (INCA) France); Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale pour la Recherche (to NAR); Comite Departemental du Maine et Loire et de la Vendee de la Ligue Nationale Contre le Cancer; Institut National du Cancer and Canceropole Grand Ouest (MAB IMPACT, IMProving ACTivation of FcgRIIIa-expressing effector cells, pharmacogenetic-based optimistation of monoclonal antibody therapy for cancer, federative project) (to GB); the Ministere de l'Enseignement Superieur et de la Recherche (to AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aixinjueluo W, 2005, J BIOL CHEM, V280, P29828, DOI 10.1074/jbc.M414041200; Alvarez-Rueda N, 2007, CLIN CANCER RES, V13, p5613S, DOI 10.1158/1078-0432.CCR-07-1057; AZEREDO DS, 2002, J EXP MED, V195, P665; Bergman I, 2000, CANCER IMMUNOL IMMUN, V49, P259, DOI 10.1007/s002620000120; CAHAN LD, 1982, P NATL ACAD SCI-BIOL, V79, P7629, DOI 10.1073/pnas.79.24.7629; Cerato E, 1997, HYBRIDOMA, V16, P307, DOI 10.1089/hyb.1997.16.307; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen HY, 2002, J EXP MED, V196, P1529, DOI 10.1084/jem.20021915; CHERESH DA, 1986, CANCER RES, V46, P5112; Cheung NKV, 2006, J CLIN ONCOL, V24, P2885, DOI 10.1200/JCO.2005.04.6011; CHEUNG NKV, 1987, J CLIN ONCOL, V5, P1430, DOI 10.1200/JCO.1987.5.9.1430; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Erdmann M, 2006, GLYCOCONJUGATE J, V23, P627, DOI 10.1007/s10719-006-9000-5; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; GUNJI Y, 1989, J IMMUNOL, V142, P1748; HANDGRETINGER R, 1992, CANCER IMMUNOL IMMUN, V35, P199, DOI 10.1007/BF01756188; Imai M, 2005, CANCER RES, V65, P10562, DOI 10.1158/0008-5472.CAN-05-1894; Kohla G, 2002, NEUROCHEM RES, V27, P583, DOI 10.1023/A:1020211714104; Kowalczyk A, 2009, CANCER LETT, V281, P171, DOI 10.1016/j.canlet.2009.02.040; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Lynch CM, 2009, MABS-AUSTIN, V1, P2, DOI 10.4161/mabs.1.1.7377; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; MATTHAY KK, 1993, J CLIN ONCOL, V11, P2226, DOI 10.1200/JCO.1993.11.11.2226; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Matthay KK, 1997, ONCOLOGY, V11, P1869; MUJOO K, 1989, CANCER RES, V49, P2857; Mukherjee K, 2008, J CELL BIOCHEM, V105, P724, DOI 10.1002/jcb.21867; MURRAY JL, 1994, J CLIN ONCOL, V12, P184, DOI 10.1200/JCO.1994.12.1.184; Nakamura K, 2001, CANCER IMMUNOL IMMUN, V50, P275, DOI 10.1007/PL00006689; Ravindranath MH, 2007, BIOCHEM BIOPH RES CO, V353, P251, DOI 10.1016/j.bbrc.2006.12.001; SALEH MN, 1992, CANCER RES, V52, P4342; SCATCHARD G, 1949, CHEM REV, V44, P7, DOI 10.1021/cr60137a002; SCHULZ G, 1984, CANCER RES, V44, P5914; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; SJOGREN HO, 1965, EXP CELL RES, V40, P208, DOI 10.1016/0014-4827(65)90319-8; *SOC AC, 2009, CANC FACTS FIG 2009; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; VANHOOIJDONK CAEM, 1994, CYTOMETRY, V17, P185, DOI 10.1002/cyto.990170212; Wilkinson RW, 2001, J IMMUNOL METHODS, V258, P183, DOI 10.1016/S0022-1759(01)00474-4; YE JN, 1992, INT J CANCER, V50, P197, DOI 10.1002/ijc.2910500207; Yoshida S, 2001, CANCER RES, V61, P4244; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Yuki N, 1997, J NEUROL SCI, V149, P127, DOI 10.1016/S0022-510X(97)05390-2; Zeng GC, 1999, BIOCHEMISTRY-US, V38, P8762, DOI 10.1021/bi9906726; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018; Zhang H, 1998, CANCER RES, V58, P2844	46	59	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25220	10.1371/journal.pone.0025220	http://dx.doi.org/10.1371/journal.pone.0025220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966461	Green Published, gold, Green Submitted			2022-12-27	WOS:000295265100073
J	Menju, T; Hashimoto, S; Hashimoto, A; Otsuka, Y; Handa, H; Ogawa, E; Toda, Y; Wada, H; Date, H; Sabe, H				Menju, Toshi; Hashimoto, Shigeru; Hashimoto, Ari; Otsuka, Yutaro; Handa, Haruka; Ogawa, Eiji; Toda, Yoshinobu; Wada, Hiromi; Date, Hiroshi; Sabe, Hisataka			Engagement of Overexpressed Her2 with GEP100 Induces Autonomous Invasive Activities and Provides a Biomarker for Metastases of Lung Adenocarcinoma	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; HER-2/NEU OVEREXPRESSION; GENE AMPLIFICATION; CANCER; EXPRESSION; ARF6; TRASTUZUMAB; ACTIVATION; MUTATIONS; CARCINOMA	Overexpression of Her2/ErbB2/Neu in cancer is often correlated with recurrent distant metastasis, although the mechanism still remains largely elusive. We have previously shown that EGFR, when tyrosine-phosphorylated, binds to GEP100/BRAG2 to activate Arf6, which induces cancer invasion and metastasis. We now show that overexpressed Her2 in lung adenocarcinoma cells also employs GEP100. Like EGFR-GEP100 binding, this association is primarily mediated by the pleckstrin homology (PH) domain of GEP100 and Tyr1139/Tyr1196 of Her2. Tyr1139/Tyr1196 are autonomously phosphorylated, when Her2 is overexpressed. Accordingly, invasive activities mediated by the Her2-GEP100 pathway are not dependent on external factors. Blocking Her2-GEP100 binding, as well as its signaling pathway all inhibit cancer invasive activities. Moreover, our clinical study indicates that co-overexpression of Her2 with GEP100 in primary lung adenocarcinomas of patients is correlated with the presence of their node-metastasis with a statistical significance. Since the GEP100 PH domain interacts with both Her2 and EGFR, targeting this domain may provide novel cancer therapeutics.	[Menju, Toshi; Wada, Hiromi; Date, Hiroshi] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan; [Hashimoto, Shigeru; Hashimoto, Ari; Otsuka, Yutaro; Handa, Haruka; Sabe, Hisataka] Hokkaido Univ, Dept Mol Biol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ogawa, Eiji; Toda, Yoshinobu] Kyoto Univ Hosp, Lab Diagnost Pathol, Kyoto 606, Japan	Kyoto University; Hokkaido University; Kyoto University	Menju, T (corresponding author), Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan.	sabeh@med.hokudai.ac.jp	Hashimoto, Shigeru/D-7138-2012; Hashimoto, Ari/D-7125-2012; Sabe, Hisataka/A-4066-2012; Sabe, Hisataka/GPF-4385-2022	Handa, Haruka/0000-0002-8557-7479; Menju, Toshi/0000-0002-7341-6002	Ministry of Education, Science, Sports and Culture of Japan (MESSC); Takeda Foundation for Promotion of Science; Grants-in-Aid for Scientific Research [23590323] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan (MESSC)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Foundation for Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (MESSC) and Takeda Foundation for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bunn PA, 2001, CLIN CANCER RES, V7, P3239; Clamon G, 2005, CANCER-AM CANCER SOC, V103, P1670, DOI 10.1002/cncr.20950; Cox G, 2001, INT J CANCER, V92, P480, DOI 10.1002/ijc.1214; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Giatromanolaki A, 1996, ANTICANCER RES, V16, P3819; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hirsch FR, 2004, SEMIN ONCOL, V31, P75, DOI 10.1053/j.seminoncol.2003.12.018; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Hutcheson IR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1754; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; KERN JA, 1990, CANCER RES, V50, P5184; Kim IY, 2009, CANCER LETT, V275, P227, DOI 10.1016/j.canlet.2008.10.013; Lader AS, 2004, CANCER BIOL THER, V3, P624, DOI 10.4161/cbt.3.7.914; Meert AP, 2003, BRIT J CANCER, V89, P959, DOI 10.1038/sj.bjc.6601252; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Motoyama AB, 2002, CANCER RES, V62, P3151; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nakamura H, 2005, CANCER-AM CANCER SOC, V103, P1865, DOI 10.1002/cncr.20957; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Park DI, 2007, INT J COLORECTAL DIS, V22, P491, DOI 10.1007/s00384-006-0192-8; Park DI, 2006, DIGEST DIS SCI, V51, P1371, DOI 10.1007/s10620-005-9057-1; Potti A, 2003, CLIN CANCER RES, V9, P4872; Riou G, 2001, INT J CANCER, V95, P266, DOI 10.1002/1097-0215(20010720)95:4<266::AID-IJC1045>3.0.CO;2-E; SAMANTA A, 1994, P NATL ACAD SCI USA, V91, P1711, DOI 10.1073/pnas.91.5.1711; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Sonobe M, 2006, J MOL DIAGN, V8, P351, DOI 10.2353/jmoldx.2006.050132; Swanton C, 2006, CLIN CANCER RES, V12, p4377S, DOI 10.1158/1078-0432.CCR-06-0115; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Thomas M, 1999, EUR RESPIR J, V13, P424, DOI 10.1183/09031936.99.13242499; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokotsuka M, 2011, BREAST CANCER RES TR, V126, P311, DOI 10.1007/s10549-010-0896-x; YU DH, 1994, CANCER RES, V54, P3260	40	29	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25301	10.1371/journal.pone.0025301	http://dx.doi.org/10.1371/journal.pone.0025301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966491	Green Published, Green Submitted, gold			2022-12-27	WOS:000295265100084
J	Zang, YG; Kammerer, B; Eisenkolb, M; Lohr, K; Kiefer, H				Zang, Yuguo; Kammerer, Bernd; Eisenkolb, Maike; Lohr, Katrin; Kiefer, Hans			Towards Protein Crystallization as a Process Step in Downstream Processing of Therapeutic Antibodies: Screening and Optimization at Microbatch Scale	PLOS ONE			English	Article							STABILITY; MACROMOLECULES; PURIFICATION; NUCLEATION; CRYSTALS; INSULIN; PHASE	Crystallization conditions of an intact monoclonal IgG4 (immunoglobulin G, subclass 4) antibody were established in vapor diffusion mode by sparse matrix screening and subsequent optimization. The procedure was transferred to microbatch conditions and a phase diagram was built showing surprisingly low solubility of the antibody at equilibrium. With up-scaling to process scale in mind, purification efficiency of the crystallization step was investigated. Added model protein contaminants were excluded from the crystals to more than 95%. No measurable loss of Fc-binding activity was observed in the crystallized and redissolved antibody. Conditions could be adapted to crystallize the antibody directly from concentrated and diafiltrated cell culture supernatant, showing purification efficiency similar to that of Protein A chromatography. We conclude that crystallization has the potential to be included in downstream processing as a low-cost purification or formulation step.	[Zang, Yuguo; Eisenkolb, Maike] Biberach Univ Appl Sci, Inst Pharmaceut Biotechnol, Biberach, Germany; [Lohr, Katrin] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Boehringer Ingelheim	Zang, YG (corresponding author), Biberach Univ Appl Sci, Inst Pharmaceut Biotechnol, Biberach, Germany.	zang@hochschule-bc.de		Kiefer, Hans/0000-0002-8574-9867	BMBF (Federal Ministry of Education and Research, Germany) [0315338A]; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Boehringer Ingelheim GmbH	BMBF (Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany(Boehringer Ingelheim); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	This program is supported by BMBF (Federal Ministry of Education and Research, Germany), grant no. 0315338A (http://www.bmbf.de/en/index.php), and Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany (http://www.boehringer-ingelheim.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KL is employed at Boehringer Ingelheim GmbH, who contributed material (antibody mAb04c) and a minor part of financial support (<15%) to this project. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahamed T, 2007, BIOPHYS J, V93, P610, DOI 10.1529/biophysj.106.098293; Basu SK, 2004, EXPERT OPIN BIOL TH, V4, P301, DOI 10.1517/eobt.4.3.301.27331; Bergfors T., 2009, PROTEIN CRYSTALLIZAT; BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1; Bonnete F, 2002, ACTA CRYSTALLOGR D, V58, P1571, DOI 10.1107/S090744490201418X; BRANGE J, 1992, PHARMACEUT RES, V9, P715, DOI 10.1023/A:1015835017916; Brange J., 1987, GALENICS INSULIN; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Jacobsen C, 1998, BIOTECHNOL BIOENG, V57, P666, DOI 10.1002/(SICI)1097-0290(19980320)57:6<666::AID-BIT4>3.0.CO;2-J; JUDGE RA, 1995, BIOTECHNOL BIOENG, V48, P316, DOI 10.1002/bit.260480404; Klyushnichenko V, 2003, CURR OPIN DRUG DISC, V6, P848; Kuznetsov YG, 2001, J CRYST GROWTH, V232, P30, DOI 10.1016/S0022-0248(01)01058-2; LACMANN R, 1958, GROWTH PERFECTION CR; Lewus RA, 2011, BIOTECHNOL PROGR, V27, P280, DOI 10.1002/btpr.536; Mullin J. W., 1993, CRYSTALLIZATION; MYERSON AS, 1990, ACS S SERIES, V438; NAONO H, 1965, B CHEM SOC JPN, V38, P80, DOI 10.1246/bcsj.38.80; Ng JD, 1996, J CRYST GROWTH, V168, P50, DOI 10.1016/0022-0248(96)00362-4; PANEC M, 2006, MICROBELIBRARY PLAQU; Peters J, 2005, PROTEIN EXPRES PURIF, V39, P43, DOI 10.1016/j.pep.2004.09.011; Pikal MJ, 1997, PHARMACEUT RES, V14, P1379, DOI 10.1023/A:1012164520429; Shenoy B, 2001, BIOTECHNOL BIOENG, V73, P358, DOI 10.1002/bit.1069; Vitzthum F, 1999, ANAL BIOCHEM, V276, P59, DOI 10.1006/abio.1999.4298	23	34	36	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25282	10.1371/journal.pone.0025282	http://dx.doi.org/10.1371/journal.pone.0025282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966480	Green Submitted, Green Published, gold			2022-12-27	WOS:000295265100079
J	Advani, A; Connelly, KA; Yuen, DA; Zhang, YL; Advani, SL; Trogadis, J; Kabir, MG; Shachar, E; Kuliszewski, MA; Leong-Poi, H; Stewart, DJ; Gilbert, RE				Advani, Andrew; Connelly, Kim A.; Yuen, Darren A.; Zhang, Yanling; Advani, Suzanne L.; Trogadis, Judy; Kabir, M. Golam; Shachar, Etai; Kuliszewski, Michael A.; Leong-Poi, Howard; Stewart, Duncan J.; Gilbert, Richard E.			Fluorescent Microangiography Is a Novel and Widely Applicable Technique for Delineating the Renal Microvasculature	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; REMNANT KIDNEY MODEL; AMINOPEPTIDASE-P; POTENTIAL ROLE; CELLS; PROGRESSION; INJURY; MICROCIRCULATION; REGRESSION; REDUCTION	Rarefaction of the renal microvasculature correlates with declining kidney function. However, current technologies commonly used for its evaluation are limited by their reliance on endothelial cell antigen expression and assessment in two dimensions. We set out to establish a widely applicable and unbiased optical sectioning method to enable three dimensional imaging and reconstruction of the renal microvessels based on their luminal filling. The kidneys of subtotally nephrectomized (SNx) rats and their sham-operated counterparts were subjected to either routine two-dimensional immunohistochemistry or the novel technique of fluorescent microangiography (FMA). The latter was achieved by perfusion of the kidney with an agarose suspension of fluorescent polystyrene microspheres followed by optical sectioning of 200 mm thick cross-sections using a confocal microscope. The fluorescent microangiography method enabled the three-dimensional reconstruction of virtual microvascular casts and confirmed a reduction in both glomerular and peritubular capillary density in the kidneys of SNx rats, despite an overall increase in glomerular volume. FMA is an uncomplicated technique for evaluating the renal microvasculature that circumvents many of the limitations imposed by conventional analysis of two-dimensional tissue sections.	[Advani, Andrew; Connelly, Kim A.; Yuen, Darren A.; Zhang, Yanling; Advani, Suzanne L.; Trogadis, Judy; Kabir, M. Golam; Shachar, Etai; Kuliszewski, Michael A.; Leong-Poi, Howard; Gilbert, Richard E.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Stewart, Duncan J.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute	Advani, A (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	advania@smh.ca; richard.gilbert@utoronto.ca	Connelly, Kim A/S-5160-2017	Connelly, Kim A/0000-0002-1031-3137	CIHR [MOP-97791]; Heart and Stroke Foundation of Ontario; KRESCENT postdoctoral fellowship	CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); KRESCENT postdoctoral fellowship	These studies were supported by CIHR grant MOP-97791 to Dr. Advani and a CIHR Team Grant to Dr. Gilbert. Dr. Advani is a Canadian Diabetes Association Clinician Scientist, Dr. Gilbert is a Canada Research Chair in Diabetes Complications and this work was supported thanks, in part, to the Canadian Diabetes Association and the Canada Research Chair Program. Dr. Connelly and Dr. Leong-Poi are supported by Clinician Scientist Awards from the Heart and Stroke Foundation of Ontario. Dr. Yuen is supported by a KRESCENT postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Antiga L, 2001, MICROVASC RES, V62, P346, DOI 10.1006/mvre.2001.2351; Bertram JF, 1995, INT REV CYTOL, V161, P111; Dutly AE, 2006, LAB INVEST, V86, P409, DOI 10.1038/labinvest.3700399; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fogo AB, 2005, CURR OPIN NEPHROL HY, V14, P201, DOI 10.1097/01.mnh.0000165883.08675.ab; Gilbert RE, 2011, KIDNEY INT, V79, P1312, DOI 10.1038/ki.2011.39; Haylor J, 1996, NEPHROL DIAL TRANSPL, V11, P643, DOI 10.1093/oxfordjournals.ndt.a027353; Kang DH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133806; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Kosugi T, 2010, AM J PHYSIOL-RENAL, V298, pF609, DOI 10.1152/ajprenal.00377.2009; Lasch J, 1998, BIOL CHEM, V379, P705, DOI 10.1515/bchm.1998.379.6.705; Matsui K, 2003, J AM SOC NEPHROL, V14, P1981, DOI 10.1097/01.ASN.0000076078.50889.43; MILLER PL, 1990, J CLIN INVEST, V85, P1119, DOI 10.1172/JCI114543; Mondy WL, 2009, TISSUE ENG PART C-ME, V15, P729, DOI [10.1089/ten.tec.2008.0583, 10.1089/ten.TEC.2008.0583]; Nagaoka T, 2006, INVEST OPHTH VIS SCI, V47, P1113, DOI 10.1167/iovs.05-0218; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Pillebout E, 2001, AM J PATHOL, V159, P547, DOI 10.1016/S0002-9440(10)61726-9; Prior HM, 1998, CARDIOVASC RES, V37, P780, DOI 10.1016/S0008-6363(97)00237-X; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Scruggs BS, 2011, AM J PATHOL, V178, P1891, DOI 10.1016/j.ajpath.2010.12.029; Sharman JE, 2009, HYPERTENSION, V54, P1092, DOI 10.1161/HYPERTENSIONAHA.109.135525; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Terayama H, 2011, J TISSUE ENG REGEN M, V5, P32, DOI 10.1002/term.285; Yuen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009543	28	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24695	10.1371/journal.pone.0024695	http://dx.doi.org/10.1371/journal.pone.0024695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984894	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000004
J	Giraudo, M; Califano, J; Hilliou, F; Tran, T; Taquet, N; Feyereisen, R; Le Goff, G				Giraudo, Maeva; Califano, Jerome; Hilliou, Frederique; Tran, Trang; Taquet, Nathalie; Feyereisen, Rene; Le Goff, Gaelle			Effects of Hormone Agonists on Sf9 Cells, Proliferation and Cell Cycle Arrest	PLOS ONE			English	Article							NONSTEROIDAL ECDYSONE AGONIST; BEETLE TRIBOLIUM-CASTANEUM; INSECT GROWTH-REGULATORS; VACUOLAR H+-ATPASE; RED FLOUR BEETLE; JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; METHOPRENE-TOLERANT; MICROARRAY DATA; V-ATPASE	Methoxyfenozide and methoprene are two insecticides that mimic the action of the main hormones involved in the control of insect growth and development, 20-hydroxyecdysone and juvenile hormone. We investigated their effect on the Spodoptera frugiperda Sf9 cell line. Methoxyfenozide was more toxic than methoprene in cell viability tests and more potent in the inhibition of cellular proliferation. Cell growth arrest occurred in the G2/M phase after a methoprene treatment and more modestly in G1 after methoxyfenozide treatment. Microarray experiments and real-time quantitative PCR to follow the expression of nuclear receptors ultraspiracle and ecdysone receptor were performed to understand the molecular action of these hormone agonists. Twenty-six genes were differentially expressed after methoxyfenozide treatment and 55 genes after methoprene treatment with no gene in common between the two treatments. Our results suggest two different signalling pathways in Sf9 cells.	[Giraudo, Maeva; Califano, Jerome; Hilliou, Frederique; Tran, Trang; Taquet, Nathalie; Feyereisen, Rene; Le Goff, Gaelle] Univ Nice Sophia Antipolis, Inst Natl Rech Agron, UMR Interact Biot & Sante Vegetale 1301, CNRS,UMR 6243, Sophia Antipolis, France; [Giraudo, Maeva] Univ Clermont Ferrand, CNRS, UMR 6023, Aubiere, France; [Califano, Jerome] Dept Affaires Reglementaires, Grasse, France; [Tran, Trang] Lanaud Gest Pole Lanaud, Boisseuil, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Giraudo, M (corresponding author), Univ Nice Sophia Antipolis, Inst Natl Rech Agron, UMR Interact Biot & Sante Vegetale 1301, CNRS,UMR 6243, Sophia Antipolis, France.	legoff@sophia.inra.fr	Feyereisen, René/I-3140-2012; Feyereisen, René/Y-7514-2019; Legoff, Gaelle/B-7501-2015; Giraudo, Maeva/GVS-6750-2022; Hilliou, Frédérique/T-5714-2019; Giraudo, Maeva/ABE-4328-2021	Feyereisen, René/0000-0002-9560-571X; Feyereisen, René/0000-0002-9560-571X; Legoff, Gaelle/0000-0003-1973-7136; Giraudo, Maeva/0000-0003-4296-146X; hilliou, frederique/0000-0002-3020-2987	Agence Nationale pour la Recherche [ANR 06BLAN0346]; Institut National de la Recherche Agronomique; region Provence Alpes Cote d'Azur	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National de la Recherche Agronomique; region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur)	We thank Agence Nationale pour la Recherche (ANR 06BLAN0346) for funding. M. Giraudo was supported by a PhD fellowship from Institut National de la Recherche Agronomique and region Provence Alpes Cote d'Azur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; ATMANN F, 1999, GLYCOCONJ J, V2, P109; Auzoux-Bordenave S, 2005, INSECT BIOCHEM MOLEC, V35, P1033, DOI 10.1016/j.ibmb.2005.04.004; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Carlson GR, 2001, PEST MANAG SCI, V57, P115, DOI 10.1002/1526-4998(200102)57:2<115::AID-PS245>3.0.CO;2-A; Crissman H A, 1975, Methods Cell Biol, V9, P179, DOI 10.1016/S0091-679X(08)60076-X; Crossin KL, 1997, P NATL ACAD SCI USA, V94, P2687, DOI 10.1073/pnas.94.6.2687; Decombel L, 2005, ARCH INSECT BIOCHEM, V58, P145, DOI 10.1002/arch.20048; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Fallon AM, 2010, J INSECT PHYSIOL, V56, P1396, DOI 10.1016/j.jinsphys.2010.03.016; Gauhar Z, 2009, GENOME RES, V19, P1006, DOI 10.1101/gr.081349.108; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerenday A, 2004, J INSECT PHYSIOL, V50, P831, DOI 10.1016/j.jinsphys.2004.06.005; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HENRICK CA, 1973, J AGR FOOD CHEM, V21, P354, DOI 10.1021/jf60187a043; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; Jones G, 2001, INSECT BIOCHEM MOLEC, V32, P33, DOI 10.1016/S0965-1748(01)00077-7; Jones G, 1997, P NATL ACAD SCI USA, V94, P13499, DOI 10.1073/pnas.94.25.13499; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Merzendorfer H, 2000, BBA-BIOMEMBRANES, V1467, P369, DOI 10.1016/S0005-2736(00)00233-9; Mikitani K, 1996, BIOCHEM BIOPH RES CO, V227, P427, DOI 10.1006/bbrc.1996.1524; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Mosallanejad H, 2010, J INSECT PHYSIOL, V56, P1973, DOI 10.1016/j.jinsphys.2010.08.022; Mottier V, 2004, INSECT BIOCHEM MOLEC, V34, P51, DOI 10.1016/j.ibmb.2003.09.003; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Oberlander H, 2000, J INSECT PHYSIOL, V46, P259, DOI 10.1016/S0022-1910(99)00178-X; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; QUACK S, 1995, EUR J ENTOMOL, V92, P341; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; SILHACEK DL, 1990, ARCH INSECT BIOCHEM, V15, P201, DOI 10.1002/arch.940150402; Smagghe G, 2002, INSECT BIOCHEM MOLEC, V32, P187, DOI 10.1016/S0965-1748(01)00109-6; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STAAL GB, 1975, ANNU REV ENTOMOL, V20, P417, DOI 10.1146/annurev.en.20.010175.002221; STEVENS B, 1980, CELL, V22, P675, DOI 10.1016/0092-8674(80)90543-7; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Swevers L, 2008, INSECT BIOCHEM MOLEC, V38, P825, DOI 10.1016/j.ibmb.2008.06.001; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Willis DK, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6601; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; WING KD, 1988, SCIENCE, V241, P467, DOI 10.1126/science.3393913; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yang YH, 2003, INST MATH S, V40, P403; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	64	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25708	10.1371/journal.pone.0025708	http://dx.doi.org/10.1371/journal.pone.0025708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991338	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000058
J	Hakuno, F; Yamauchi, Y; Kaneko, G; Yoneyama, Y; Nakae, J; Chida, K; Kadowaki, T; Yamanouchi, K; Nishihara, M; Takahashi, SI				Hakuno, Fumihiko; Yamauchi, Yoko; Kaneko, Gen; Yoneyama, Yosuke; Nakae, Jun; Chida, Kazuhiro; Kadowaki, Tatsuhiko; Yamanouchi, Keitaro; Nishihara, Masugi; Takahashi, Shin-Ichiro			Constitutive Expression of Insulin Receptor Substrate (IRS)-1 Inhibits Myogenic Differentiation through Nuclear Exclusion of Foxo1 in L6 Myoblasts	PLOS ONE			English	Article							GROWTH-FACTOR-I; TRANSCRIPTION FACTOR FKHR; MUSCLE DIFFERENTIATION; SIGNALING PATHWAYS; ADULT MYOGENESIS; TYROSINE KINASE; IRS PROTEINS; DEGRADATION; CELLS; SYSTEM	Insulin-like growth factors (IGFs) are well known to play essential roles in enhancement of myogenic differentiation. In this report we showed that initial IGF-I signal activation but long-term IGF-1 signal termination are required for myogenic differentiation. L6 myoblast stably transfected with myc-epitope tagged insulin receptor substrate-1, myc-IRS-1 (L6-mIRS1) was unable to differentiate into myotubes, indicating that IRS-1 constitutive expression inhibited myogenesis. To elucidate the molecular mechanisms underlying myogenic inhibition, IGF-I signaling was examined. IGF-I treatment of control L6 cells for 18 h resulted in a marked suppression of IGF-I stimulated IRS-1 association with the p85 PI 3-kinase and suppression of activation of Akt that correlated with a down regulation of IRS-1 protein. L6-mIRS1 cells, in contrast, had sustained high levels of IRS-1 protein following 18 h of IGF-I treatment with persistent p85 PI 3-kinase association with IRS-1, Akt phosphorylation and phosphorylation of the downstream Akt substrate, Foxo1. Consistent with Foxo1 phosphorylation, Foxo1 protein was excluded from the nuclei in L6-mIRS1 cells, whereas Foxo1 was localized in the nuclei in control L6 cells during induction of differentiation. In addition, L6 cells stably expressing a dominant-interfering form of Foxo1, Delta 256Foxo1 (L6-Delta 256Foxo1) were unable to differentiate into myotubes. Together, these data demonstrate that IGF-I regulation of Foxo1 nuclear localization is essential for the myogenic program in L6 cells but that persistent activation of IGF-1 signaling pathways results in a negative feedback to prevent myogenesis.	[Hakuno, Fumihiko; Kaneko, Gen; Yoneyama, Yosuke; Chida, Kazuhiro; Takahashi, Shin-Ichiro] Univ Tokyo, Dept Anim Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Yamauchi, Yoko; Kadowaki, Tatsuhiko] Nagoya Univ, Dept Bioengn Sci, Grad Sch Bioagr Sci, Aichi, Japan; [Nakae, Jun] Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol,Shinjuku Ku, Tokyo, Japan; [Yamanouchi, Keitaro; Nishihara, Masugi] Univ Tokyo, Dept Vet Med Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Nagoya University; Keio University; University of Tokyo	Hakuno, F (corresponding author), Univ Tokyo, Dept Anim Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp	Yamanouchi, Keitaro/R-5003-2019; Kaneko/B-3359-2008	Kaneko/0000-0003-4295-5123; Hakuno, Fumihiko/0000-0002-4447-6225; Takahashi, Shin-Ichiro/0000-0002-2323-2010	Ministry of Education, Science and Culture of Japan [11460126, 16208028, 2248030, 21580345]; Program for Promotion of Basic Research Activities for Innovative Biosciences; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research [21580345] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Biosciences; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research [to S-IT, (B)(2) #11460126 and (A)(2) #16208028 and #2248030, and to FH, (C) #21580345] from the Ministry of Education, Science and Culture of Japan (http://www.jsps.go.jp/english/e-grants/grants.html), and was supported partially by the Program for Promotion of Basic Research Activities for Innovative Biosciences (to FH and KY) and the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to S-IT) (http://brain.naro.affrc.go.jp/tokyo/marumoto/inv_up/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALLEN RE, 1991, J CELL PHYSIOL, V149, P525, DOI 10.1002/jcp.1041490323; Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Conejo R, 2002, ONCOGENE, V21, P3739, DOI 10.1038/sj.onc.1205469; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; Hribal ML, 2000, J CLIN ENDOCR METAB, V85, P2004, DOI 10.1210/jc.85.5.2004; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lim MJ, 2007, MOL ENDOCRINOL, V21, P2282, DOI 10.1210/me.2007-0114; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Miller MG, 2003, BIOCHEM BIOPH RES CO, V310, P796, DOI 10.1016/j.bbrc.2003.09.080; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Suzue N, 2006, J BONE MINER RES, V21, P722, DOI 10.1359/JBMR.060207; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wu AL, 2008, ENDOCRINOLOGY, V149, P1407, DOI 10.1210/en.2007-1470; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	46	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25655	10.1371/journal.pone.0025655	http://dx.doi.org/10.1371/journal.pone.0025655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991327	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000051
J	Liu, R; Hu, JJ				Liu, Rong; Hu, Jianjun			Computational Prediction of Heme-Binding Residues by Exploiting Residue Interaction Network	PLOS ONE			English	Article							PROTEIN STRUCTURES; KEY RESIDUES; CONSERVATION; RECOGNITION; CENTRALITY; DIVERSITY; FAMILIES; VIEW	Computational identification of heme-binding residues is beneficial for predicting and designing novel heme proteins. Here we proposed a novel method for heme-binding residue prediction by exploiting topological properties of these residues in the residue interaction networks derived from three-dimensional structures. Comprehensive analysis showed that key residues located in heme-binding regions are generally associated with the nodes with higher degree, closeness and betweenness, but lower clustering coefficient in the network. HemeNet, a support vector machine (SVM) based predictor, was developed to identify heme-binding residues by combining topological features with existing sequence and structural features. The results showed that incorporation of network-based features significantly improved the prediction performance. We also compared the residue interaction networks of heme proteins before and after heme binding and found that the topological features can well characterize the heme-binding sites of apo structures as well as those of holo structures, which led to reliable performance improvement as we applied HemeNet to predicting the binding residues of proteins in the heme-free state. HemeNet web server is freely accessible at http://mleg.cse.sc.edu/hemeNet/.	[Liu, Rong; Hu, Jianjun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Liu, R (corresponding author), Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA.	jianjunh@cse.sc.edu			National Science Foundation [BIO-DBI-0845381]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Career Award (Grant BIO-DBI-0845381). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; [Anonymous], LIBSVM LIB SUPPORT V; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bikiel DE, 2006, PHYS CHEM CHEM PHYS, V8, P5611, DOI 10.1039/b611741b; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; DIJKSTRA KE, 1959, NUMER MATH, V1, P269; Fufezan C, 2008, PROTEINS, V73, P690, DOI 10.1002/prot.22097; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; GUENGERICH FP, 1984, ACCOUNTS CHEM RES, V17, P9, DOI 10.1021/ar00097a002; Illingworth CJR, 2010, J COMPUT CHEM, V31, P2677, DOI 10.1002/jcc.21561; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Li YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-14; Liu R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-207; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Schneider S, 2007, NAT PROD REP, V24, P621, DOI 10.1039/b604186h; SMITH A, 1993, J BIOL CHEM, V268, P7365; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Terwilliger NB, 1998, J EXP BIOL, V201, P1085; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591	35	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25560	10.1371/journal.pone.0025560	http://dx.doi.org/10.1371/journal.pone.0025560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991319	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000040
J	Tjondrokoesoemo, A; Park, KH; Ferrante, C; Komazaki, S; Lesniak, S; Brotto, M; Ko, JK; Zhou, JS; Weisleder, N; Ma, JJ				Tjondrokoesoemo, Andoria; Park, Ki Ho; Ferrante, Christopher; Komazaki, Shinji; Lesniak, Sebastian; Brotto, Marco; Ko, Jae-Kyun; Zhou, Jingsong; Weisleder, Noah; Ma, Jianjie			Disrupted Membrane Structure and Intracellular Ca2+ Signaling in Adult Skeletal Muscle with Acute Knockdown of Bin1	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; TUMOR-SUPPRESSOR; OSMOTIC-STRESS; RELEASE; SPARKS; FIBERS; AMPHIPHYSIN; CHANNELS; DEPOLARIZATION	Efficient intracellular Ca2+ ([Ca2+]i) homeostasis in skeletal muscle requires intact triad junctional complexes comprised of t-tubule invaginations of plasma membrane and terminal cisternae of sarcoplasmic reticulum. Bin1 consists of a specialized BAR domain that is associated with t-tubule development in skeletal muscle and involved in tethering the dihydropyridine receptors (DHPR) to the t-tubule. Here, we show that Bin1 is important for Ca2+ homeostasis in adult skeletal muscle. Since systemic ablation of Bin1 in mice results in postnatal lethality, in vivo electroporation mediated transfection method was used to deliver RFP-tagged plasmid that produced short -hairpin (sh) RNA targeting Bin1 (shRNA-Bin1) to study the effect of Bin1 knockdown in adult mouse FDB skeletal muscle. Upon confirming the reduction of endogenous Bin1 expression, we showed that shRNA-Bin1 muscle displayed swollen t-tubule structures, indicating that Bin1 is required for the maintenance of intact membrane structure in adult skeletal muscle. Reduced Bin1 expression led to disruption of t-tubule structure that was linked with alterations to intracellular Ca2+ release. Voltage-induced Ca2+ released in isolated single muscle fibers of shRNA-Bin1 showed that both the mean amplitude of Ca2+ current and SR Ca2+ transient were reduced when compared to the shRNA-control, indicating compromised coupling between DHPR and ryanodine receptor 1. The mean frequency of osmotic stress induced Ca2+ sparks was reduced in shRNA-Bin1, indicating compromised DHPR activation. ShRNA-Bin1 fibers also displayed reduced Ca2+ sparks' amplitude that was attributed to decreased total Ca2+ stores in the shRNA-Bin1 fibers. Human mutation of Bin1 is associated with centronuclear myopathy and SH3 domain of Bin1 is important for sarcomeric protein organization in skeletal muscle. Our study showing the importance of Bin1 in the maintenance of intact t-tubule structure and ([Ca2+]i) homeostasis in adult skeletal muscle could provide mechanistic insight on the potential role of Bin1 in skeletal muscle contractility and pathology of myopathy.	[Tjondrokoesoemo, Andoria; Park, Ki Ho; Ferrante, Christopher; Lesniak, Sebastian; Ko, Jae-Kyun; Weisleder, Noah; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Saitama, Japan; [Brotto, Marco] Univ Missouri, Muscle Biol Res Grp, Kansas City, MO 64110 USA; [Zhou, Jingsong] Rush Univ, Dept Physiol & Mol Biophys, Chicago, IL 60612 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Saitama Medical University; University of Missouri System; University of Missouri Kansas City; Rush University	Tjondrokoesoemo, A (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	weisleno@umdnj.edu	Park, Ki Ho/N-8153-2017; Weisleder, Noah L/A-7098-2013	Park, Ki Ho/0000-0002-6193-9826; Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088	National Institutes of Health (NIH) [AG28614, HL69000, AR054793]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057404, R00AR054793, K99AR054793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants to Dr. Ma (AG28614 and HL69000) and Dr. Weileder (AR054793). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brotto MAP, 2004, CELL RES, V14, P373, DOI 10.1038/sj.cr.7290237; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; DiFranco M, 2009, J VIS EXP; Fernando P, 2009, J BIOL CHEM, V284, P27674, DOI 10.1074/jbc.M109.029538; Glund S, 2009, ENDOCRINOLOGY, V150, P600, DOI 10.1210/en.2008-1204; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; JIMENEZMORENO R, 2010, PFLUGERS ARCH; Launikonis BS, 2006, J GEN PHYSIOL, V128, P45, DOI 10.1085/jgp.200609545; Lee EH, 2004, AM J PHYSIOL-CELL PH, V286, pC179, DOI 10.1152/ajpcell.00176.2003; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Murayama T, 2005, AM J PHYSIOL-CELL PH, V288, pC1222, DOI 10.1152/ajpcell.00415.2004; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pickering JD, 2009, J GEN PHYSIOL, V133, P511, DOI 10.1085/jgp.200910191; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Shirokova N, 1998, J PHYSIOL-LONDON, V512, P377, DOI 10.1111/j.1469-7793.1998.377be.x; Teichmann MDH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003644; Toth A, 1998, AM J PHYSIOL-HEART C, V275, pH1652, DOI 10.1152/ajpheart.1998.275.5.H1652; TOUSSAINT A, 2010, ACTA NEUROPATHOL; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Weisleder N, 2007, CELL CALCIUM, V42, P548, DOI 10.1016/j.ceca.2007.01.009; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Weisleder N, 2006, ACTA PHARMACOL SIN, V27, P791, DOI 10.1111/j.1745-7254.2006.00384.x; Yang DM, 2001, J BIOL CHEM, V276, P40210, DOI 10.1074/jbc.M106944200; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhou JS, 2010, J BIOL CHEM, V285, P705, DOI 10.1074/jbc.M109.041319	36	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25740	10.1371/journal.pone.0025740	http://dx.doi.org/10.1371/journal.pone.0025740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984944	Green Submitted, Green Published, gold			2022-12-27	WOS:000295941300054
J	Miller, DL; Budde, MW; Roth, MB				Miller, Dana L.; Budde, Mark W.; Roth, Mark B.			HIF-1 and SKN-1 Coordinate the Transcriptional Response to Hydrogen Sulfide in Caenorhabditis elegans	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; ISCHEMIA-REPERFUSION INJURY; ANIMATION-LIKE STATE; OXIDATIVE STRESS; LIFE-SPAN; LONGEVITY; PROTEINS	Hydrogen sulfide (H2S) has dramatic physiological effects on animal that are associated with improved survival. C. elegan grown in H2S are long-lived and thermotolerant. To identify mechanisms by which adaptation to H2S effects physiological functions, we have measured transcriptional responses to H2S exposure. Using microarray analysis we observe rapid changes in the abundance of specific mRNAs. The number and magnitude of transcriptional changes increased with the duration of H2S exposure. Functional annotation suggests that genes associated with protein homeostasis are upregulated upon prolonged exposure to H2S. Previous work has shown that the hypoxia-inducible transcription factor, HIF-1 is required for survival in H2S. In fact, we show that hif-1 requried for most, if not all, early transcriptional changes in H2S. Moreover, our data demonstrate that SKN-1, the C. elegans homologue of NRF2, also contribute to H2S-dependent changes in transcription. We show that these results are functionally important, as skn-1 is essential to survive exposure to H2S. Our results suggest a model in which HIF-1 and SKN-1 coordinate a broad transcriptional response to H2S that culminates in a global reorganization of protein homeostasis networks.	[Miller, Dana L.] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; [Miller, Dana L.; Budde, Mark W.; Roth, Mark B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Budde, Mark W.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Miller, DL (corresponding author), Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA.	dlm16@uw.edu; mroth@fhcrc.org		Miller, Dana/0000-0003-3983-0493	National Institutes of Health [K99/R00 AG033050]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE ON AGING [R00AG033050, K99AG033050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant K99/R00 AG033050 to Dana L Miller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Microarray experiments and analysis were performed with the expert assistance of Dr. Jeff Delrow (FHCRC DNA Array Facility), and Dr. Jerry Davison (FHCRC Computational Biology) provided valuable assistance with data analysis. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; BOWERMAN B, 1992, DEVELOPMENT, V116, P1113; BRENNER S, 1974, GENETICS, V77, P71; Budde MW, 2010, MOL BIOL CELL, V21, P212, DOI 10.1091/mbc.E09-03-0199; Budde MW, 2011, GENETICS; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Morrison ML, 2008, J TRAUMA, V65, P183, DOI 10.1097/TA.0b013e3181507579; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Robertson SM, 2004, DEV BIOL, V276, P493, DOI 10.1016/j.ydbio.2004.09.015; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Simon F, 2008, SHOCK, V30, P359, DOI 10.1097/SHK.0b013e3181674185; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348	40	32	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25476	10.1371/journal.pone.0025476	http://dx.doi.org/10.1371/journal.pone.0025476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980473	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600029
J	Nadezhdin, EV; Brody, MS; Price, CW				Nadezhdin, Eugene V.; Brody, Margaret S.; Price, Chester W.			An alpha/beta Hydrolase and Associated Per-ARNT-Sim Domain Comprise a Bipartite Sensing Module Coupled with Diverse Output Domains	PLOS ONE			English	Article							SIGMA(B) TRANSCRIPTION FACTOR; ENERGY STRESS ACTIVATION; BACILLUS-SUBTILIS; PAS DOMAIN; SIGNALING MECHANISM; CRYSTAL-STRUCTURES; PHOSPHATASE 2C; PROTEIN; OXYGEN; DIMERIZATION	The RsbQ alpha/beta hydrolase and RsbP serine phosphatase form a signaling pair required to activate the general stress factor sigma(B) of Bacillus subtilis in response to energy limitation. RsbP has a predicted N-terminal Per-ARNT-Sim (PAS) domain, a central coiled-coil, and a C-terminal protein phosphatase M (PPM) domain. Previous studies support a model in which RsbQ provides an activity needed for PAS to regulate the phosphatase domain via the coiled-coil. RsbQ and the PAS domain (RsbP-PAS) therefore appear to form a sensory module. Here we test this hypothesis using bioinformatic and genetic analysis. We found 45 RsbQ and RsbP-PAS homologues encoded by adjacent genes in diverse bacteria, with PAS and a predicted coiled-coil fused to one of three output domains: PPM phosphatase (Gram positive bacteria), histidine protein kinase (Gram negative bacteria), and diguanylate cyclase (both lineages). Multiple alignment of the RsbP-PAS homologues suggested nine residues that distinguish the class. Alanine substitutions at four of these conferred a null phenotype in B. subtilis, indicating their functional importance. The F55A null substitution lay in the F alpha helix of an RsbP-PAS model. F55A inhibited interaction of RsbP with RsbQ in yeast two-hybrid and pull-down assay but did not significantly affect interaction of RsbP with itself. We propose that RsbQ directly contacts the PAS domains of an RsbP oligomer to provide the activating signal, which is propagated to the phosphatase domains via the coiled-coil. A similar mechanism would allow the RsbQ-PAS module to convey a common input signal to structurally diverse output domains, controlling a variety of physiological responses.	[Nadezhdin, Eugene V.; Brody, Margaret S.; Price, Chester W.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis	Nadezhdin, EV (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	cwprice@ucdavis.edu	Price, Chester/M-6900-2019	Nadezhdin, Eugene/0000-0002-8682-1189	National Institute of General Medical Sciences [GM42077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042077] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Public Health Service grant GM42077 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper S, 1996, J MOL BIOL, V260, P165, DOI 10.1006/jmbi.1996.0390; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antelmann H, 2010, SENSORY MECHANISMS IN BACTERIA: MOLECULAR ASPECTS OF SIGNAL RECOGNITION, P199; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Avila-Perez M, 2010, J BACTERIOL, V192, P755, DOI 10.1128/JB.00826-09; BENSON AK, 1993, J BACTERIOL, V175, P2347, DOI 10.1128/JB.175.8.2347-2356.1993; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; BOYLAN SA, 1992, J BACTERIOL, V174, P3695, DOI 10.1128/JB.174.11.3695-3706.1992; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; Brody MS, 2009, MOL MICROBIOL, V72, P1221, DOI 10.1111/j.1365-2958.2009.06722.x; Brody MS, 2001, J BACTERIOL, V183, P6422, DOI 10.1128/JB.183.21.6422-6428.2001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Eymann C, 2001, FEMS MICROBIOL LETT, V199, P221, DOI 10.1111/j.1574-6968.2001.tb10678.x; Glaser P, 2001, SCIENCE, V294, P849; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Kaneko T, 2005, PROTEIN SCI, V14, P558, DOI 10.1110/ps.041170005; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; Makino M, 2009, ACTA CRYSTALLOGR F, V65, P559, DOI 10.1107/S1744309109014158; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2010, J MOL BIOL, V400, P477, DOI 10.1016/j.jmb.2010.05.019; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Ondrusch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016151; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PIGGOT PJ, 1973, J BACTERIOL, V114, P1241, DOI 10.1128/JB.114.3.1241-1253.1973; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005; Zhang WW, 2004, MICROBIOL-SGM, V150, P4189, DOI 10.1099/mic.0.27480-0; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25418	10.1371/journal.pone.0025418	http://dx.doi.org/10.1371/journal.pone.0025418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980452	gold, Green Published, Green Submitted			2022-12-27	WOS:000295939600024
J	Wan, CY; Bazen, L; Baars, R; Libenson, A; Zipse, L; Zuk, J; Norton, A; Schlaug, G				Wan, Catherine Y.; Bazen, Loes; Baars, Rebecca; Libenson, Amanda; Zipse, Lauryn; Zuk, Jennifer; Norton, Andrea; Schlaug, Gottfried			Auditory-Motor Mapping Training as an Intervention to Facilitate Speech Output in Non-Verbal Children with Autism: A Proof of Concept Study	PLOS ONE			English	Article							MELODIC INTONATION THERAPY; MIRROR NEURON SYSTEM; FOLLOW-UP; SPECTRUM DISORDERS; LANGUAGE; MUSIC; REPRESENTATION; IMITATION; SPEAKING; NETWORK	Although up to 25% of children with autism are non-verbal, there are very few interventions that can reliably produce significant improvements in speech output. Recently, a novel intervention called Auditory-Motor Mapping Training (AMMT) has been developed, which aims to promote speech production directly by training he association between sounds and articulatory actions using intonation and bimanual motor activities. AMMT capitalizes on the inherent musical strengths of children with autism, and offers activities that they intrinsically enjoy. It also engages and potentially stimulates a network of brain regions that may be dysfunctional in autism. Here we report an initial efficacy study to provide 'proof of concept' for AMMT. Six non-verbal children with autism participated. Prior to treatment, the children had no intelligible words. They each received 40 individual sessions of AMMT 5 times per week, over an 8-week period. Probe assessments were conducted periodically during baseline, therapy, and follow-up sessions. After therapy, all children showed significant improvements in their ability to articulate words and phrases, with generalization to items that were not practiced during therapy sessions. Because these children had no or minimal vocal output prior to treatment, the acquisition of speech sounds and word approximations through AMMT represents a critical step in expressive language development in children with autism.	[Wan, Catherine Y.; Bazen, Loes; Baars, Rebecca; Libenson, Amanda; Zuk, Jennifer; Norton, Andrea; Schlaug, Gottfried] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mus & Neuroimaging Lab,Dept Neurol, Boston, MA 02215 USA; [Zipse, Lauryn] MGH Inst Hlth Profess, Dept Commun Sci & Disorders, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wan, CY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mus & Neuroimaging Lab,Dept Neurol, Boston, MA 02215 USA.	cwan@bidmc.harvard.edu		Zuk, Jennifer/0000-0001-9113-3973	The Nancy Lurie Marks Family Foundation; Deborah Munroe Noonan Memorial Research Fund; National Institutes of Health (NIH) [1RO1 DC008796, 3RO1DC008796-02S1, RO1DC009823-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009823, R01DC008796] Funding Source: NIH RePORTER	The Nancy Lurie Marks Family Foundation; Deborah Munroe Noonan Memorial Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by The Nancy Lurie Marks Family Foundation (Dr. Schlaug) and the Deborah Munroe Noonan Memorial Research Fund (Dr. Wan). Dr. Schlaug also acknowledges additional support from the National Institutes of Health (NIH) (1RO1 DC008796, 3RO1DC008796-02S1, RO1DC009823-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT ML, 1973, ARCH NEUROL-CHICAGO, V29, P130, DOI 10.1001/archneur.1973.00490260074018; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; BIJOU SW, 1989, ADV CHILD DEV BEHAV, V21, P221, DOI 10.1016/S0065-2407(08)60288-8; Francis K, 2005, DEV MED CHILD NEUROL, V47, P493, DOI 10.1017/S0012162205000952; Hadjikhani N., 2007, PROGR AUTISM RES, P151; Heaton P, 1998, MUSIC PERCEPT, V15, P291; Heaton P, 2008, COGN NEUROPSYCHOL, V25, P771, DOI 10.1080/02643290802336277; Hoelzley P., 1993, CANADIAN J MUSIC THE, V1, P54; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; KEITH RL, 1975, BRAIN LANG, V2, P483, DOI 10.1016/S0093-934X(75)80085-X; Koegel RL, 2009, J AUTISM DEV DISORD, V39, P1587, DOI 10.1007/s10803-009-0765-9; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lord C, 2006, ARCH GEN PSYCHIAT, V63, P694, DOI 10.1001/archpsyc.63.6.694; Lord C, 2004, DEV LANGUAGE DISORDE, P1; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; Meister IG, 2009, EUR J NEUROSCI, V29, P2074, DOI 10.1111/j.1460-9568.2009.06729.x; MILLER SB, 1979, J CLIN PSYCHIAT, V40, P201; MONSEN RB, 1976, J SPEECH HEAR RES, V19, P279, DOI 10.1044/jshr.1902.279; Mullen E.M., 1995, MULLENS SCALES EARLY; Newmeyer AJ, 2007, CLIN PEDIATR, V46, P604, DOI 10.1177/0009922807299545; Norton A, 2009, ANN NY ACAD SCI, V1169, P431, DOI 10.1111/j.1749-6632.2009.04859.x; Oberman LM, 2008, NEUROPSYCHOLOGIA, V46, P1558, DOI 10.1016/j.neuropsychologia.2008.01.010; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Ozdemir E, 2006, NEUROIMAGE, V33, P628, DOI 10.1016/j.neuroimage.2006.07.013; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Pickett E, 2009, COGN BEHAV NEUROL, V22, P1, DOI 10.1097/WNN.0b013e318190d185; Rogers SJ, 2006, J AUTISM DEV DISORD, V36, P1007, DOI 10.1007/s10803-006-0142-x; Schlaug G, 2008, MUSIC PERCEPT, V25, P315, DOI 10.1525/MP.2008.25.4.315; Schlosser RW, 2008, AM J SPEECH-LANG PAT, V17, P212, DOI 10.1044/1058-0360(2008/021); Schopler E, CHILDHOOD AUTISM RAT, V2nd; Sherer MR, 2005, J CONSULT CLIN PSYCH, V73, P525, DOI 10.1037/0022-006X.73.3.525; SHRIBERG LD, 1993, J SPEECH HEAR RES, V36, P105, DOI 10.1044/jshr.3601.105; Smith T, 2007, J AUTISM DEV DISORD, V37, P354, DOI 10.1007/s10803-006-0173-3; SPARKS R, 1974, Cortex, V10, P303; Turner LM, 2006, AUTISM, V10, P243, DOI 10.1177/1362361306063296; Uozumi T, 2004, NEUROLOGY, V62, P757, DOI 10.1212/01.WNL.0000113731.75479.25; VENTER A, 1992, J CHILD PSYCHOL PSYC, V33, P489, DOI 10.1111/j.1469-7610.1992.tb00887.x; Wan CY, 2010, FUTUR NEUROL, V5, P797, DOI 10.2217/FNL.10.55; Wan CY, 2010, BRAIN RES BULL, V82, P161, DOI 10.1016/j.brainresbull.2010.04.010; Wan CY, 2010, MUSIC PERCEPT, V27, P287, DOI 10.1525/MP.2010.27.4.287; Warner-Czyz AD, 2010, J SPEECH LANG HEAR R, V53, P2, DOI 10.1044/1092-4388(2009/0163); Wigram T., 2002, BRIT J MUSIC THER, V16, P11, DOI [10.1177/135945750201600104, DOI 10.1177/135945750201600104]; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8; Williams K.T., 2007, EVT 2 EXPRESSIVE VOC	48	71	73	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25505	10.1371/journal.pone.0025505	http://dx.doi.org/10.1371/journal.pone.0025505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834DM	21980480	Green Published, Green Submitted, gold			2022-12-27	WOS:000295939600032
J	Campione, NE; Evans, DC				Campione, Nicolas E.; Evans, David C.			Cranial Growth and Variation in Edmontosaurs (Dinosauria: Hadrosauridae): Implications for Latest Cretaceous Megaherbivore Diversity in North America	PLOS ONE			English	Article							ORNITHOPODA; EXTINCTION; PHYLOGENY; TAXA	The well-sampled Late Cretaceous fossil record of North America remains the only high-resolution dataset for evaluating patterns of dinosaur diversity leading up to the terminal Cretaceous extinction event. Hadrosaurine hadrosaurids (Dinosauria: Ornithopoda) closely related to Edmontosaurus are among the most common megaherbivores in latest Campanian and Maastrichtian deposits of western North America. However, interpretations of edmontosaur species richness and biostratigraphy have been in constant flux for almost three decades, although the clade is generally thought to have undergone a radiation in the late Maastrichtian. We address the issue of edmontosaur diversity for the first time using rigorous morphometric analyses of virtually all known complete edmontosaur skulls. Results suggest only two valid species, Edmontosaurus regalis from the late Campanian, and E. annectens from the late Maastrichtian, with previously named taxa, including the controversial Anatotitan copei, erected on hypothesized transitional morphologies associated with ontogenetic size increase and allometric growth. A revision of North American hadrosaurid taxa suggests a decrease in both hadrosaurid diversity and disparity from the early to late Maastrichtian, a pattern likely also present in ceratopsid dinosaurs. A decline in the disparity of dominant megaherbivores in the latest Maastrichtian interval supports the hypothesis that dinosaur diversity decreased immediately preceding the end Cretaceous extinction event.	[Campione, Nicolas E.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Evans, David C.] Royal Ontario Museum, Dept Palaeobiol, Toronto, ON M5S 2C6, Canada	University of Toronto; Royal Ontario Museum	Campione, NE (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	nicolas.campione@utoronto.ca	Campione, Nicolas/R-6862-2018	Campione, Nicolas/0000-0002-4205-9794	National Sciences and Engineering Research Council; Royal Ontario Museum Louise Hawley Stone Charitable Trust	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Ontario Museum Louise Hawley Stone Charitable Trust	Funding for this project was provided by a National Sciences and Engineering Research Council Post-Graduate Scholarship (to N.E.C.), a National Sciences and Engineering Research Council Discovery Grant (to D. C. E.), and the Royal Ontario Museum Louise Hawley Stone Charitable Trust (to D.C.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bakker RT., 1986, DINOSAUR HERESIES; Bakker RT, 1977, PATTERNS EVOLUTION I, P441; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Bell PR, 2011, CRETACEOUS RES, V32, P30, DOI 10.1016/j.cretres.2010.10.002; Boyd CA, 2009, J VERTEBR PALEONTOL, V29, P758, DOI 10.1671/039.029.0328; BRETTSURMAN MK, 1979, NATURE, V277, P560, DOI 10.1038/277560a0; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Chapman R.E., 1990, P163, DOI 10.1017/CBO9780511608377.015; Cope E., 1883, P NATL ACAD NAT SCI, V35, P97; Cope E.D., 1869, T AM PHIL SOC, V14, P1; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Gangloff RA, 2010, PALAIOS, V25, P299, DOI 10.2110/palo.2009.p09-103r; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gilmore CW, 1924, CANADA DEP MINES B G, V43, P13; Henderson Donald M., 2010, P293; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; Lambe L. M., 1917, Ottawa Naturalist, V31; Legendre P, 2008, MODEL 2 REGRESSION, V1; Lillegraven JA, 1986, AM MUS NOVIT, V2840, p1 ; Lloyd GT, 2011, BIOL LETT; Longrich Nick, 2008, P135; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Marsh O. C., 1892, American Journal of Science, V(3), P449; Marsh O.C., 1881, AM J SCI, V21, P167, DOI DOI 10.2475/AJS.S3-21.122.167; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Ripley B.D., 2002, STAT COMPUTING MODER; Rohlf F. J., 2010, TPSDIG 2 16; Rohlf FJ, 2010, TPSRELW 1 49; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; Russell DA, 2002, GEOL S AM S, P169; RUSSELL DALE A., 1967, NAT MUS CAN NATUR HIST PAP, V35., P1; Rybczynski N, 2008, PALAEONTOL ELECTRON, V11, P14; Sampson SD, 2005, J VERTEBR PALEONTOL, V25, P469, DOI 10.1671/0272-4634(2005)025[0469:TRFTUC]2.0.CO;2; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; SHEEHAN PM, 1991, SCIENCE, V254, P835, DOI 10.1126/science.11536489; Sheets H. D., 2004, IMP INTEGRATED MORPH; SLOAN RE, 1986, SCIENCE, V232, P629, DOI 10.1126/science.232.4750.629; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STERNBERG C. M., 1926, CANADA DEPT MINES GEOL SURV BULL, V44, P73; Sullivan Robert M., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P403; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Weishampel D.B., 1990, P534; Wills MA, 2002, FOSSILS PHYLOGENY FO, P55; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	54	112	113	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25186	10.1371/journal.pone.0025186	http://dx.doi.org/10.1371/journal.pone.0025186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969872	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900030
J	Gomez, ND; Safeukui, I; Adelani, AA; Tewari, R; Reddy, JK; Rao, S; Holder, A; Buffet, P; Mohandas, N; Haldar, K				Gomez, Noe D.; Safeukui, Innocent; Adelani, Aanuoluwa A.; Tewari, Rita; Reddy, Janardan K.; Rao, Sam; Holder, Anthony; Buffet, Pierre; Mohandas, Narla; Haldar, Kasturi			Deletion of a Malaria Invasion Gene Reduces Death and Anemia, in Model Hosts	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-7; HIGH-EFFICIENCY TRANSFECTION; PLASMODIUM-FALCIPARUM; ERYTHROPOIESIS; DESTRUCTION; SUPPRESSION; INFECTIONS; ANTIBODIES; VIRULENCE; SELECTION	Malaria parasites induce complex cellular and clinical phenotypes, including anemia, cerebral malaria and death in a wide range of mammalian hosts. Host genes and parasite 'toxins' have been implicated in malarial disease, but the contribution of parasite genes remains to be fully defined. Here we assess disease in BALB/c mice and Wistar rats infected by the rodent malaria parasite Plasmodium berghei with a gene knock out for merozoite surface protein (MSP) 7. MSP7 is not essential for infection but in P. falciparum, it enhances erythrocyte invasion by 20%. In vivo, as compared to wild type, the P. berghei Delta msp7 mutant is associated with an abrogation of death and a decrease from 3% to 2% in peak, circulating parasitemia. The Delta msp7 mutant is also associated with less anemia and modest increase in the size of follicles in the spleen. Together these data show that deletion of a single parasite invasion ligand modulates blood stage disease, as measured by death and anemia. This work is the first to assess the contribution of a gene present in all plasmodial species in severe disease.	[Gomez, Noe D.; Safeukui, Innocent; Adelani, Aanuoluwa A.; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Gomez, Noe D.; Reddy, Janardan K.; Rao, Sam] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Tewari, Rita] Univ Nottingham, Ctr Genet & Genom, Sch Biol, Nottingham NG7 2RD, England; [Holder, Anthony] MRC Natl Inst Med Res, Div Parasitol, London, England; [Buffet, Pierre] Univ Paris 06, INSERM, UMR S945, Paris, France; [Mohandas, Narla] New York Blood Ctr, New York, NY 10021 USA	University of Notre Dame; Northwestern University; Feinberg School of Medicine; University of Nottingham; MRC National Institute for Medical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; New York Blood Center	Gomez, ND (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Adelani, Aanuoluwa/J-8964-2012; Adelani, Aanuoluwa/I-4385-2015; Tewari, Rita/M-5698-2014; Haldar, Kasturi/C-6685-2014; Holder, Anthony A/A-7554-2013; Buffet, Pierre A/O-6189-2017	Adelani, Aanuoluwa/0000-0002-8763-1010; Holder, Anthony A/0000-0002-8490-6058; Buffet, Pierre A/0000-0003-4010-929X; Tewari, Rita/0000-0003-3943-1847	National Institutes of Health [F31 HL09277, P01HL078826]; UK MRC [U117532067]; MRC [G0900109]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826] Funding Source: NIH RePORTER; Medical Research Council [MC_U117532067, G0900109] Funding Source: researchfish; MRC [MC_U117532067] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported in part by grants from the National Institutes of Health F31 HL09277 (NG) and P01HL078826 (KH, AH, NM, PB). RT is holder of an MRC Investigator Award (G0900109) and AH is funded in part by the UK MRC (U117532067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awandare GA, 2009, J INFECT DIS, V200, P629, DOI 10.1086/600894; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; Carvalho TG, 2005, CURR ISSUES MOL BIOL, V7, P39, DOI 10.21775/cimb.007.039; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Evans KJ, 2006, BLOOD, V107, P1192, DOI 10.1182/blood-2005-08-3460; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Lamb TJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-68; Langhorne J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-23; Layez C, 2005, BLOOD, V106, P3632, DOI 10.1182/blood-2005-04-1574; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mello K, 2004, INFECT IMMUN, V72, P1010, DOI 10.1128/IAI.72.2.1010-1018.2004; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Tewari R, 2005, BLOOD, V105, P394, DOI 10.1182/blood-2004-06-2106; Thawan N, 2009, HAEMATOL-HEMATOL J, V94, P195, DOI 10.3324/haematol.13422; Wang L, 2003, PARASITE IMMUNOL, V25, P403, DOI 10.1111/j.1365-3024.2003.00647.x; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Woehlbier U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-77	30	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25477	10.1371/journal.pone.0025477	http://dx.doi.org/10.1371/journal.pone.0025477			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980474	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900070
J	Hirokawa, J; Sadakane, O; Sakata, S; Bosch, M; Sakurai, Y; Yamamori, T				Hirokawa, Junya; Sadakane, Osamu; Sakata, Shuzo; Bosch, Miquel; Sakurai, Yoshio; Yamamori, Tetsuo			Multisensory Information Facilitates Reaction Speed by Enlarging Activity Difference between Superior Colliculus Hemispheres in Rats	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; VISUAL-AUDITORY INTERACTIONS; NIGRA PARS RETICULATA; NEURONAL-ACTIVITY; TARGET SELECTION; ELECTRICAL-STIMULATION; SUBSTANTIA-NIGRA; FIXATION CELLS; SENSORY INPUTS; REACTION-TIME	Animals can make faster behavioral responses to multisensory stimuli than to unisensory stimuli. The superior colliculus (SC), which receives multiple inputs from different sensory modalities, is considered to be involved in the initiation of motor responses. However, the mechanism by which multisensory information facilitates motor responses is not yet understood. Here, we demonstrate that multisensory information modulates competition among SC neurons to elicit faster responses. We conducted multiunit recordings from the SC of rats performing a two-alternative spatial discrimination task using auditory and/or visual stimuli. We found that a large population of SC neurons showed direction-selective activity before the onset of movement in response to the stimuli irrespective of stimulation modality. Trial-by-trial correlation analysis showed that the premovement activity of many SC neurons increased with faster reaction speed for the contraversive movement, whereas the premovement activity of another population of neurons decreased with faster reaction speed for the ipsiversive movement. When visual and auditory stimuli were presented simultaneously, the premovement activity of a population of neurons for the contraversive movement was enhanced, whereas the premovement activity of another population of neurons for the ipsiversive movement was depressed. Unilateral inactivation of SC using muscimol prolonged reaction times of contraversive movements, but it shortened those of ipsiversive movements. These findings suggest that the difference in activity between the SC hemispheres regulates the reaction speed of motor responses, and multisensory information enlarges the activity difference resulting in faster responses.	[Hirokawa, Junya; Sadakane, Osamu; Bosch, Miquel; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Hirokawa, Junya] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sakata, Shuzo] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Sakata, Shuzo] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Bosch, Miquel] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; [Sakurai, Yoshio] Kyoto Univ, Dept Psychol, Kyoto, Japan; [Sakurai, Yoshio] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Cold Spring Harbor Laboratory; Rutgers State University Newark; Rutgers State University New Brunswick; University of Strathclyde; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Kyoto University; Japan Science & Technology Agency (JST)	Hirokawa, J (corresponding author), Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan.	yamamori@nibb.ac.jp	Yamamori, Tetsuo/N-6536-2015; Bosch, Miquel/B-4928-2011; Hirokawa, Junya/GSE-5964-2022	Yamamori, Tetsuo/0000-0001-5016-0078; Bosch, Miquel/0000-0002-7103-2574; Hirokawa, Junya/0000-0003-1238-5713; Sakata, Shuzo/0000-0001-6796-411X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (Molecular Brain Science) to T.Y. and a Grant-in-Aid for Young Scientists (B) to J.H. from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the CREST Program from the Japan Science and Technology Agency (Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JC, 2007, J NEUROPHYSIOL, V97, P3193, DOI 10.1152/jn.00018.2007; BANKMAN IN, 1993, IEEE T BIO-MED ENG, V40, P836, DOI 10.1109/10.238472; BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Basso MA, 2002, J NEUROSCI, V22, P1883, DOI 10.1523/JNEUROSCI.22-05-01883.2002; Basso MA, 1998, J NEUROSCI, V18, P7519; Bell AH, 2005, J NEUROPHYSIOL, V93, P3659, DOI 10.1152/jn.01214.2004; Burnett LR, 2004, NEUROSCIENCE, V124, P535, DOI 10.1016/j.neuroscience.2003.12.026; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; Cooper BG, 1998, HIPPOCAMPUS, V8, P340, DOI 10.1002/(SICI)1098-1063(1998)8:4<340::AID-HIPO4>3.0.CO;2-L; DEAN P, 1988, NEUROSCIENCE, V24, P491, DOI 10.1016/0306-4522(88)90344-2; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 1997, J NEUROSCI, V17, P8566; EDWARDS SB, 1977, J COMP NEUROL, V173, P23, DOI 10.1002/cne.901730103; Everling S, 1999, J NEUROSCI, V19, P2740; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Frens MA, 1998, BRAIN RES BULL, V46, P211, DOI 10.1016/S0361-9230(98)00007-0; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1285, DOI 10.1152/jn.1983.49.5.1285; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; Isa T, 2009, J NEUROPHYSIOL, V102, P2581, DOI 10.1152/jn.00498.2009; Jiang H, 2003, NATURE, V423, P982, DOI 10.1038/nature01698; Jiang W, 2002, J COGNITIVE NEUROSCI, V14, P1240, DOI 10.1162/089892902760807230; Kadunce DC, 1997, J NEUROPHYSIOL, V78, P2834, DOI 10.1152/jn.1997.78.6.2834; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; KILPATRICK IC, 1982, NEUROSCIENCE, V7, P207, DOI 10.1016/0306-4522(82)90161-0; Kim B, 2008, J NEUROSCI, V28, P2991, DOI 10.1523/JNEUROSCI.5424-07.2008; KING AJ, 1983, J PHYSIOL-LONDON, V342, P361, DOI 10.1113/jphysiol.1983.sp014856; KING AJ, 1985, EXP BRAIN RES, V60, P492; Krauzlis RJ, 2003, J NEUROSCI, V23, P4333; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Marino RA, 2008, J NEUROPHYSIOL, V100, P2564, DOI 10.1152/jn.90688.2008; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; MCHAFFIE JG, 1982, BRAIN RES, V247, P243, DOI 10.1016/0006-8993(82)91249-5; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; McPeek RM, 2008, J NEUROPHYSIOL, V99, P2694, DOI 10.1152/jn.00591.2007; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Meredith MA, 1998, J NEUROPHYSIOL, V79, P1597, DOI 10.1152/jn.1998.79.3.1597; MUNOZ DP, 1992, J NEUROPHYSIOL, V67, P1000, DOI 10.1152/jn.1992.67.4.1000; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; Munoz DP, 2002, PROG BRAIN RES, V140, P3; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peck CK, 1996, PROG BRAIN RES, V112, P167; PECK CK, 1987, BRAIN RES, V420, P162, DOI 10.1016/0006-8993(87)90253-8; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; SAHIBZADA N, 1986, J NEUROSCI, V6, P723; Sakata S, 2005, NEUROSCIENCE, V134, P1099, DOI 10.1016/j.neuroscience.2005.05.018; Sakata S, 2004, EXP BRAIN RES, V159, P409, DOI 10.1007/s00221-004-1962-6; Sakurai Y, 1996, J NEUROSCI, V16, P2809; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Skaliora I, 2004, J NEUROPHYSIOL, V92, P2933, DOI 10.1152/jn.00450.2004; Sparks D L, 1989, Rev Oculomot Res, V3, P213; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; STEIN BE, 1979, J COMP NEUROL, V183, P269, DOI 10.1002/cne.901830205; STEIN BE, 1981, BEHAV BRAIN RES, V3, P175, DOI 10.1016/0166-4328(81)90046-2; Stein BE., 1993, MERGING SENSES; Takahashi M, 2007, J NEUROPHYSIOL, V98, P2664, DOI 10.1152/jn.00696.2007; Takahashi M, 2005, J NEUROPHYSIOL, V94, P1707, DOI 10.1152/jn.00347.2005; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Wang S, 1997, NEUROSCIENCE, V81, P967, DOI 10.1016/S0306-4522(97)00191-7; Watanabe M, 2005, J NEUROPHYSIOL, V93, P519, DOI 10.1152/jn.00558.2004; Wilkinson LK, 1996, EXP BRAIN RES, V112, P1; Zahar Y, 2009, J NEUROPHYSIOL, V101, P2380, DOI 10.1152/jn.91193.2008	86	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25283	10.1371/journal.pone.0025283	http://dx.doi.org/10.1371/journal.pone.0025283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966481	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000295932100032
J	Zhang, YQ; Gao, H; Wang, L; Xiao, X; Tan, YF; Guo, ZB; Zhou, DS; Yang, RF				Zhang, Yiquan; Gao, He; Wang, Li; Xiao, Xiao; Tan, Yafang; Guo, Zhaobiao; Zhou, Dongsheng; Yang, Ruifu			Molecular Characterization of Transcriptional Regulation of rovA by PhoP and RovA in Yersinia pestis	PLOS ONE			English	Article							RECEPTOR PROTEIN; VIRULENCE; EXPRESSION; GENE; PSEUDOTUBERCULOSIS; INVASIN; REGULON; ENTEROCOLITICA; SURVIVAL; BIOVAR	Background: Yersinia pestis is the causative agent of plague. The two transcriptional regulators, PhoP and RovA, are required for the virulence of Y. pestis through the regulation of various virulence-associated loci. They are the global regulators controlling two distinct large complexes of cellular pathways. Methodology/Principal Findings: Based on the LacZ fusion, primer extension, gel mobility shift, and DNase I footprinting assays, RovA is shown to recognize both of the two promoters of its gene in Y. pestis. The autoregulation of RovA appears to be a conserved mechanism shared by Y. pestis and its closely related progenitor, Y. pseudotuberculosis. In Y. pestis, the PhoP regulator responds to low magnesium signals and then negatively controls only one of the two promoters of rovA through PhoP-promoter DNA association. Conclusions/Significance: RovA is a direct transcriptional activator for its own gene in Y. pestis, while PhoP recognizes the promoter region of rovA to repress its transcription. The direct regulatory association between PhoP and RovA bridges the PhoP and RovA regulons in Y. pestis.	[Zhang, Yiquan; Gao, He; Wang, Li; Xiao, Xiao; Tan, Yafang; Guo, Zhaobiao; Zhou, Dongsheng; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Gao, He] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, YQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	dongshengzhou1977@gmail.com; ruifuyang@gmail.com	Zhang, Yiquan/AAP-3311-2021; Yang, Ruifu/A-2273-2011	Zhang, Yiquan/0000-0003-3935-4079; Yang, Ruifu/0000-0003-3219-7269; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [30930001, 30900823, 30771179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this study came from the National Natural Science Foundation of China (30930001, 30900823, and 30771179) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Derbise A, 2007, MOL MICROBIOL, V63, P1145, DOI 10.1111/j.1365-2958.2006.05570.x; Dube PH, 2003, INFECT IMMUN, V71, P3512, DOI 10.1128/IAI.71.6.3512-3520.2003; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Ellison DW, 2004, TRENDS MICROBIOL, V12, P296, DOI 10.1016/j.tim.2004.04.006; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hitchen PG, 2002, MOL MICROBIOL, V44, P1637, DOI 10.1046/j.1365-2958.2002.02990.x; Huang XZ, 2004, INFECT IMMUN, V72, P7212, DOI 10.1128/IAI.72.12.7212-7219.2004; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Lawrenz MB, 2007, J BACTERIOL, V189, P5963, DOI 10.1128/JB.00528-07; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Li YL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-128; Li YL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-143; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Norte VA, 2003, J BACTERIOL, V185, P3508, DOI 10.1128/JB.185.12.3508-3514.2003; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Perez JC, 2009, P NATL ACAD SCI USA, V106, P4319, DOI 10.1073/pnas.0810343106; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Simonet M, 1996, INFECT IMMUN, V64, P375, DOI 10.1128/IAI.64.1.375-379.1996; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Song HW, 2008, J BIOL CHEM, V283, P28158, DOI 10.1074/jbc.M801058200; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Yang FK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012840; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08; Zhou DS, 2005, FEMS MICROBIOL LETT, V250, P85, DOI 10.1016/j.femsle.2005.06.053; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	47	43	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25484	10.1371/journal.pone.0025484	http://dx.doi.org/10.1371/journal.pone.0025484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966533	Green Published, Green Submitted, gold			2022-12-27	WOS:000295932100042
J	Dronamraju, R; Mason, JM				Dronamraju, Raghuvar; Mason, James M.			MU2 and HP1a Regulate the Recognition of Double Strand Breaks in Drosophila melanogaster	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; HETEROCHROMATIN PROTEIN-1; CHROMATIN-STRUCTURE; GAMMA-H2AX FOCI; CELL-CYCLE; IONIZING-RADIATION; GENE; ATM; TRANSCRIPTION; MITOSIS	Chromatin structure regulates the dynamics of the recognition and repair of DNA double strand breaks; open chromatin enhances the recruitment of DNA damage response factors, while compact chromatin is refractory to the assembly of radiation-induced repair foci. MU2, an orthologue of human MDC1, a scaffold for ionizing radiation-induced repair foci, is a widely distributed chromosomal protein in Drosophila melanogaster that moves to DNA repair foci after irradiation. Here we show using yeast 2 hybrid screens and co-immunoprecipitation that MU2 binds the chromoshadow domain of the heterochromatin protein HP1 in untreated cells. We asked what role HP1 plays in the formation of repair foci and cell cycle control in response to DNA damage. After irradiation repair foci form in heterochromatin but are shunted to the edge of heterochromatic regions an HP1-dependent manner, suggesting compartmentalized repair. Hydroxyurea-induced repair foci that form at collapsed replication forks, however, remain in the heterochromatic compartment. HP1a depletion in irradiated imaginal disc cells increases apoptosis and disrupts G2/M arrest. Further, cells irradiated in mitosis produced more and brighter repair foci than to cells irradiated during interphase. Thus, the interplay between MU2 and HP1a is dynamic and may be different in euchromatin and heterochromatin during DNA break recognition and repair.	[Dronamraju, Raghuvar; Mason, James M.] NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dronamraju, R (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	masonj@niehs.nih.gov			National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES021054] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2005, SCIENCE, V308, P510, DOI 10.1126/science.1112069; ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Andreyeva EN, 2008, CHROMOSOME RES, V16, P851, DOI 10.1007/s10577-008-1244-4; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub N, 2009, CELL CYCLE, V8, P2945; Ayoub N, 2009, CELL CYCLE, V8, P1494, DOI 10.4161/cc.8.10.8501; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; BIESSMANN H, 1988, EMBO J, V7, P1081, DOI 10.1002/j.1460-2075.1988.tb02916.x; Bradbury JM, 2003, BIOCHEM SOC T, V31, P40, DOI 10.1042/bst0310040; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Ciapponi L, 2006, GENETICS, V173, P1447, DOI 10.1534/genetics.106.058081; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; DeGrado-Warren J, 2008, BIOTECHNIQUES, V44, P265, DOI 10.2144/000112674; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Dronamraju R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000473; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fernandez-Capetillo O, 2008, MOL CELL, V31, P303, DOI 10.1016/j.molcel.2008.07.004; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; Hunter N, 2008, CELL, V132, P731, DOI 10.1016/j.cell.2008.02.026; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; Kasravi A, 1999, GENETICS, V152, P1025; Kato TA, 2008, MUTAT RES-FUND MOL M, V639, P108, DOI 10.1016/j.mrfmmm.2007.11.006; KELLUM R, 1995, J CELL SCI, V108, P1407; Kruhlak Michael J., 2009, V523, P125, DOI 10.1007/978-1-59745-190-1_9; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Mason J M, 1989, Prog Clin Biol Res, V318, P73; MASON JM, 1984, P NATL ACAD SCI-BIOL, V81, P6090, DOI 10.1073/pnas.81.19.6090; Mason JM, 1997, GENETICS, V146, P1381; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Mueller H. -Arno J., 2008, V420, P207, DOI 10.1007/978-1-59745-583-1_12; Oikemus SR, 2006, PLOS GENET, V2, P693, DOI 10.1371/journal.pgen.0020071; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; SAWADA N, 1988, CANCER RES, V48, P1618; Scott SP, 2006, J CELL BIOCHEM, V99, P1463, DOI 10.1002/jcb.21067; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137	60	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25439	10.1371/journal.pone.0025439	http://dx.doi.org/10.1371/journal.pone.0025439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966530	Green Submitted, Green Published, gold			2022-12-27	WOS:000295267100061
J	Li, XD; Garcia, K; Sun, ZF; Xiao, ZG				Li, Xiangdong; Garcia, Karla; Sun, Zhifeng; Xiao, Zhengguo			Temporal Regulation of Rapamycin on Memory CTL Programming by IL-12	PLOS ONE			English	Article							CD8 T-CELLS; CLONAL EXPANSION; MAMMALIAN TARGET; PRECURSOR FREQUENCY; EFFECTOR FUNCTION; GAMMA PRODUCTION; VIRAL-INFECTION; I IFN; MTOR; DIFFERENTIATION	Mammalian target of rapamycin (mTOR) is a master regulator of cell growth. Recent reports have defined its important role in memory cytotoxic T lymphocyte (CTL) differentiation in infections and memory programming. We report that rapamycin regulated memory CTL programming by IL-12 to a similar level in a wide range of concentrations, and the enhanced memory CTLs by rapamycin were functional and provided similar protection against Listeria Monocytogenes challenge compared to the control. In addition, rapamycin-experienced CTLs went through substantially enhanced proliferation after transfer into recipients. Furthermore, the regulatory function of rapamycin on CD62L expression in memory CTLs was mainly contributed by the presence of rapamycin in the first 24-hr of stimulation in vitro, whereas the effective window of rapamycin on the size of memory CTLs was determined between 24 to 72 hrs. In conclusion, rapamycin regulates IL-12-driven programming of CTLs to a similar level in a wide range of concentrations, and regulates the phenotype and the size of memory CTLs in different temporal windows.	[Li, Xiangdong; Garcia, Karla; Sun, Zhifeng; Xiao, Zhengguo] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Li, XD (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	xiao0028@umd.edu	; li, xiangdong/T-6019-2017	Xiao, Zhengguo/0000-0002-3359-6491; li, xiangdong/0000-0002-4635-1602				Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; [Anonymous], 2007, HIV VACCINE FAILURE, V449, P390; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Berstein G, 2008, NAT IMMUNOL, V9, P455, DOI 10.1038/ni0508-455; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Colombetti S, 2006, J IMMUNOL, V176, P2730, DOI 10.4049/jimmunol.176.5.2730; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kroczynska B, 2009, CYTOKINE, V48, P138, DOI 10.1016/j.cyto.2009.07.009; Kusaba H, 2005, J BIOL CHEM, V280, P1037, DOI 10.1074/jbc.M405204200; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mondino A, 2007, SEMIN IMMUNOL, V19, P162, DOI 10.1016/j.smim.2007.02.008; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Prlic M, 2009, NATURE, V460, P41, DOI 10.1038/460041a; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vodenik B, 2009, Transplant Proc, V41, pS31, DOI 10.1016/j.transproceed.2009.06.159; Way SS, 2007, J IMMUNOL, V178, P4498, DOI 10.4049/jimmunol.178.7.4498; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yea SS, 2011, SCIENCE, V332, P1270, DOI 10.1126/science.1208071	42	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25177	10.1371/journal.pone.0025177	http://dx.doi.org/10.1371/journal.pone.0025177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966447	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100024
J	Cavalcanti, MG; Mesquita, JS; Madi, K; Feijo, DF; Assuncao-Miranda, I; Souza, HSP; Bozza, MT				Cavalcanti, Marta G.; Mesquita, Jacilene S.; Madi, Kalil; Feijo, Daniel F.; Assuncao-Miranda, Iranaia; Souza, Heitor S. P.; Bozza, Marcelo T.			MIF Participates in Toxoplasma gondii-Induced Pathology Following Oral Infection	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; SMALL-INTESTINE; PERORAL INFECTION; HOST-RESISTANCE; C57BL/6 MICE; IFN-GAMMA; MACROPHAGE; CYTOKINE; NECROSIS; CELLS	Background: Macrophage migration inhibitory factor (MIF) is essential for controlling parasite burden and survival in a model of systemic Toxoplasma gondii infection. Peroral T. gondii infection induces small intestine necrosis and death in susceptible hosts, and in many aspects resembles inflammatory bowel disease (IBD). Considering the critical role of MIF in the pathogenesis of IBD, we hypothesized that MIF participates in the inflammatory response induced by oral infection with T. gondii. Methodology/Principal Findings: Mif deficient (Mif(-/-)) and wild-type mice in the C57Bl/6 background were orally infected with T. gondii strain ME49. Mif(-/-) mice had reduced lethality, ileal inflammation and tissue damage despite of an increased intestinal parasite load compared to wt mice. Lack of MIF caused a reduction of TNF-alpha, IL-12, IFN-gamma and IL-23 and an increased expression of IL-22 in ileal mucosa. Moreover, suppressed pro-inflammatory responses at the ileal mucosa observed in Mif(-/-) mice was not due to upregulation of IL-4, IL-10 or TGF-beta. MIF also affected the expression of matrix metalloproteinase-9 (MMP-9) but not MMP-2 in the intestine of infected mice. Signs of systemic inflammation including the increased concentrations of inflammatory cytokines in the plasma and liver damage were less pronounced in Mif(-/-) mice compared to wild-type mice. Conclusion/Significance: In conclusion, our data suggested that in susceptible hosts MIF controls T. gondii infection with the cost of increasing local and systemic inflammation, tissue damage and death.	[Cavalcanti, Marta G.; Mesquita, Jacilene S.; Feijo, Daniel F.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Cavalcanti, Marta G.] Univ Fed Rio de Janeiro, Serv Doencas Infecciosas & Parasitarias, Rio De Janeiro, Brazil; [Souza, Heitor S. P.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Clin Med, Lab Multidisciplinar Pesquisa, Rio De Janeiro, Brazil; [Madi, Kalil] Univ Fed Rio de Janeiro, Dept Patol, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil; [Madi, Kalil] Lab Sergio Franco, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Cavalcanti, MG (corresponding author), Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.	cavalcanti.marta66@gmail.com; mbozza@micro.ufrj.br	Ferreira Feijó, Daniel/Y-6067-2018; de Souza, Heitor Siffert Pereira/G-3297-2012	de Souza, Heitor Siffert Pereira/0000-0002-3647-7324; Bozza, Marcelo/0000-0003-3683-7550; Miranda, Iranaia/0000-0001-5684-4788	CNPq; FAPERJ; Pronex (Programa de Apoio a Nucleos de Excelencia - Pronex/FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Pronex (Programa de Apoio a Nucleos de Excelencia - Pronex/FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by CNPq, FAPERJ and Pronex (Programa de Apoio a Nucleos de Excelencia - Pronex/FAPERJ (www.faperj.br/interna.phtml?ctx_cod = 1.11)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assuncao-Miranda I, 2010, J MED VIROL, V82, P164, DOI 10.1002/jmv.21649; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brembilla NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018741; Bucala R, 1996, FASEB J, V10, P1607, DOI 10.1096/fasebj.10.14.9002552; Buzoni-Gatel D, 2006, CELL MICROBIOL, V8, P535, DOI 10.1111/j.1462-5822.2006.00692.x; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dunne DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011343; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gomes AD, 2011, AM J PATHOL, V178, P2792, DOI 10.1016/j.ajpath.2011.02.005; He XX, 2009, MOL MED, V15, P1, DOI 10.2119/molmed.2008.00107; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Kompalic-Cristo A, 2007, PARASITOL RES, V101, P619, DOI 10.1007/s00436-007-0524-9; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Magalhaes ES, 2007, EUR J IMMUNOL, V37, P1097, DOI 10.1002/eji.200635968; Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248; McDevitt MA, 2006, J EXP MED, V193, P1; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Neves ES, 2009, MEM I OSWALDO CRUZ, V104, P393, DOI 10.1590/S0074-02762009000200039; Nickdel MB, 2004, PARASITE IMMUNOL, V26, P75, DOI 10.1111/j.0141-9838.2004.00686.x; Ohkawara T, 2006, IMMUNOL LETT, V107, P148, DOI 10.1016/j.imlet.2006.09.002; Paiva CN, 2009, J LEUKOCYTE BIOL, V85, P855, DOI 10.1189/jlb.0108009; Pakozdi A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2021; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7; Reyes JL, 2006, INFECT IMMUN, V72, P3571; Roberts CW, 1996, INFECT IMMUN, V64, P897, DOI 10.1128/IAI.64.3.897-904.1996; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Tait ED, 2009, MEM I OSWALDO CRUZ, V104, P201, DOI 10.1590/S0074-02762009000200013; Terrazas CA, 2010, EXP PARASITOL, V126, P348, DOI 10.1016/j.exppara.2010.03.009; Ferro EAV, 2008, AM J PATHOL, V172, P50, DOI 10.2353/ajpath.2008.070432; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	54	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25259	10.1371/journal.pone.0025259	http://dx.doi.org/10.1371/journal.pone.0025259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21977228	Green Published, gold, Green Submitted			2022-12-27	WOS:000295265100077
J	Chou, YH; Woon, PY; Chen, WC; Hsu, YW; Chang, JM; Hwang, DY; Chiu, YC; Kuo, HC; Chang, WP; Hou, MF; Liu, ME; Chang, JG; Chang, WC				Chou, Yii-Her; Woon, Peng Yeong; Chen, Wei-Chiao; Hsu, Yu-Wen; Chang, Jer-Ming; Hwang, Daw-Yang; Chiu, Yi-Ching; Kuo, Ho-Chang; Chang, Wei-Pin; Hou, Ming-Feng; Liu, Mu-En; Chang, Jan-Gowth; Chang, Wei-Chiao			A Genetic Polymorphism (rs17251221) in the Calcium-Sensing Receptor Gene (CASR) Is Associated with Stone Multiplicity in Calcium Nephrolithiasis	PLOS ONE			English	Article							KIDNEY-STONES; DISEASE; HYPERCALCIURIA; TAIWAN; HEALTH	Calcium nephrolithiasis is one of the most common causes of renal stones. While the prevalence of this disease has increased steadily over the last 3 decades, its pathogenesis is still unclear. Previous studies have indicated that a genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with the total serum calcium levels. In this study, we collected DNA samples from 480 Taiwanese subjects (189 calcium nephrolithiasis patients and 291 controls) for genotyping the CASR gene. Our results indicated no significant association between the CASR polymorphism (rs17251221) and the susceptibility of calcium nephrolithiasis. However, we found a significant association between rs17251221 and stone multiplicity. The risk of stone multiplicity was higher in patients with the GG+GA genotype than in those with the AA genotype (chi-square test: P = 0.008; odds ratio = 4.79;95% confidence interval, 1.44-15.92;Yates' correction for chi-square test: P = 0.013). In conclusion, our results provide evidence supporting the genetic effects of CASR on the pathogenesis of calcium nephrolithiasis.	[Chou, Yii-Her] Kaohsiung Med Univ, Coll Med, Dept Urol, Kaohsiung, Taiwan; [Chou, Yii-Her] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Chen, Wei-Chiao; Hsu, Yu-Wen; Chiu, Yi-Ching; Liu, Mu-En; Chang, Wei-Chiao] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Hou, Ming-Feng; Chang, Jan-Gowth; Chang, Wei-Chiao] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Chang, Jan-Gowth] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Woon, Peng Yeong] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chang, Jer-Ming; Hwang, Daw-Yang] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Med, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Allergy Immunol & Rheumatol, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Cardiol, Dept Pediat, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Coll Med, Dept Surg, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Ctr Resources Res & Dev, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tzu Chi University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chou, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Urol, Kaohsiung, Taiwan.	wcc@kmu.edu.tw	Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984; Hou, Ming-Feng/0000-0001-6030-9702; Chang, Wei-Chiao/0000-0002-8573-5924	Department of Health, Executive Yuan, Taiwan, Republic of China [DOH100-TD-C-111-002]; National Science Council, Taiwan, Republic of China [NSC100-2320-B-037-002, NSC99-2314-B-037-019-MY3]; Kaohsiung Medical University [Q-Q100005]	Department of Health, Executive Yuan, Taiwan, Republic of China; National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University	This study was partly supported by an excellence for cancer research center grant, Department of Health, Executive Yuan, Taiwan, Republic of China (NO.DOH100-TD-C-111-002), by grants (NSC100-2320-B-037-002; NSC99-2314-B-037-019-MY3) from the National Science Council, Taiwan, Republic of China and by a grant (Q-Q100005) from Kaohsiung Medical University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN EM, 1995, NEW ENGL J MED, V333, P234, DOI 10.1056/NEJM199507273330407; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Chou YH, 2007, KAOHSIUNG J MED SCI, V23, P63, DOI 10.1016/S1607-551X(09)70376-6; D'Souza-Li Lília, 2006, Arq Bras Endocrinol Metab, V50, P628, DOI 10.1590/S0004-27302006000400008; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Latta K, 2010, NEW ENGL J MED, V363, P2470, DOI 10.1056/NEJMc1011349; Lee YH, 2002, UROL INT, V68, P172, DOI 10.1159/000048445; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; Pasch A, 2008, NEPHROL DIAL TRANSPL, V23, P2563, DOI 10.1093/ndt/gfn091; Reh CMS, 2011, J CLIN ENDOCR METAB, V96, pE707, DOI 10.1210/jc.2010-1306; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; ROBERTSON WG, 1980, NEPHRON, V26, P105, DOI 10.1159/000181963; Scillitani A, 2007, J CLIN ENDOCR METAB, V92, P277, DOI 10.1210/jc.2006-0857; Shakhssalim N, 2010, SCAND J UROL NEPHROL, V44, P406, DOI 10.3109/00365599.2010.497770; Tasca A, 2011, CURR OPIN UROL, V21, P129, DOI 10.1097/MOU.0b013e3283435cbc; Vezzoli G, 2007, KIDNEY INT, V71, P1155, DOI 10.1038/sj.ki.5002156; VEZZOLI G, 2010, GENETICS CALCIUM NEP	19	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25227	10.1371/journal.pone.0025227	http://dx.doi.org/10.1371/journal.pone.0025227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966463	gold, Green Published, Green Submitted			2022-12-27	WOS:000295265100074
J	Mowrer, SM; Jahn, AA; Abduljalil, A; Cunningham, WA				Mowrer, Samantha M.; Jahn, Andrew A.; Abduljalil, Amir; Cunningham, William A.			The Value of Success: Acquiring Gains, Avoiding Losses, and Simply Being Successful	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; VENTROMEDIAL PREFRONTAL CORTEX; DECISION-MAKING; HUMAN STRIATUM; HUMAN BRAIN; REWARD; VALUATION; ACTIVATION; EXPERIENCE; STIMULUS	A large network of spatially contiguous, yet anatomically distinct regions in medial frontal cortex is involved in reward processing. Although it is clear these regions play a role in critical aspects of reward-related learning and decision-making, the individual contributions of each component remains unclear. We explored dissociations in reward processing throughout several key regions in the reward system and aimed to clarify the nature of previously observed outcome-related activity in a portion of anterior medial orbitofrontal cortex (mOFC). Specifically, we tested whether activity in anterior mOFC was related to processing successful actions, such that this region would respond similarly to rewards with and without tangible benefits, or whether this region instead encoded only quantifiable outcome values (e. g., money). Participants performed a task where they encountered monetary gains and losses (and non-gains and non-losses) during fMRI scanning. Critically, in addition to the outcomes with monetary consequences, the task included trials that provided outcomes without tangible benefits (participants were simply told that they were correct or incorrect). We found that anterior mOFC responded to all successful outcomes regardless of whether they carried tangible benefits (monetary gains and non-losses) or not (controls). These results support the hypothesis that anterior mOFC processes rewards in terms of a common currency and is capable of providing reward-based signals for everything we value, whether it be primary or secondary rewards or simply a successful experience without objectively quantifiable benefits.	[Mowrer, Samantha M.; Cunningham, William A.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Jahn, Andrew A.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Abduljalil, Amir] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Cunningham, William A.] Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Columbus, OH 43210 USA	Ohio State University; Indiana University System; Indiana University Bloomington; Ohio State University; Ohio State University	Mowrer, SM (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	cunningham.417@osu.edu		Jahn, Andrew/0000-0001-5286-049X	Social Cognitive Science Lab at The Ohio State University	Social Cognitive Science Lab at The Ohio State University	We would like to thank Dr. Jay Van Bavel for his feedback and assistance in designing and running this study as well as Francisco Aguila for his help with fMRI data collection. We would also like to thank the members of the Social Cognitive Science Lab at The Ohio State University for providing helpful feedback and support throughout the course of this study.	Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Bray S, 2010, J NEUROPHYSIOL, V103, P2506, DOI 10.1152/jn.01030.2009; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; CUNNINGHAM WA, OXFORD HDB IN PRESS; Cunningham WA, 2007, SOC COGNITION, V25, P736, DOI 10.1521/soco.2007.25.5.736; Cunningham WA, 2011, SOC COGN AFFECT NEUR, V6, P286, DOI 10.1093/scan/nsq038; Cunningham WA, 2009, J COGNITIVE NEUROSCI, V21, P1956, DOI 10.1162/jocn.2008.21148; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; LIN A, 2011, SOC COGN AFFECT NEUR; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2008, CURR DIR PSYCHOL SCI, V17, P119, DOI 10.1111/j.1467-8721.2008.00560.x; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; Walter M, 2009, ARCH GEN PSYCHIAT, V66, P478, DOI 10.1001/archgenpsychiatry.2009.39; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	33	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25307	10.1371/journal.pone.0025307	http://dx.doi.org/10.1371/journal.pone.0025307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825IJ	21966494	gold, Green Submitted, Green Published			2022-12-27	WOS:000295265100085
J	Settles, M; Etzrodt, M; Kosanke, K; Schiemann, M; Zimmermann, A; Meier, R; Braren, R; Huber, A; Rummeny, EJ; Weissleder, R; Swirski, FK; Wildgruber, M				Settles, Marcus; Etzrodt, Martin; Kosanke, Katja; Schiemann, Matthias; Zimmermann, Alexander; Meier, Reinhard; Braren, Rickmer; Huber, Armin; Rummeny, Ernst J.; Weissleder, Ralph; Swirski, Filip K.; Wildgruber, Moritz			Different Capacity of Monocyte Subsets to Phagocytose Iron-Oxide Nanoparticles	PLOS ONE			English	Article							MR CONTRAST AGENTS; BLOOD MONOCYTES; DENDRITIC CELLS; IN-VITRO; DISEASE; USPIO; INFLAMMATION; ENDOTHELIUM; EXPRESSION; METASTASES	Objective: To explore the capacity of human CD14(+)CD16(++) and CD14(++)CD16(-) monocytes to phagocyte iron-oxide nanoparticles in vitro. Methods: Human monocytes were labeled with four different magnetic nanoparticle preparations (Ferumoxides, SHU 555C, CLIO-680, MION-48) exhibiting distinct properties and cellular uptake was quantitatively assessed by flow cytometry, fluorescence microscopy, atomic absorption spectrometry and Magnetic Resonance Imaging (MRI). Additionally we determined whether cellular uptake of the nanoparticles resulted in phenotypic changes of cell surface markers. Results: Cellular uptake differed between the four nanoparticle preparations. However for each nanoparticle tested, CD14(++)CD16(-) monocytes displayed a significantly higher uptake compared to CD14(+)CD16(++) monocytes, this resulted in significantly lower T1 and T2 relaxation times of these cells. The uptake of iron-oxide nanoparticles further resulted in a remarkable shift of expression of cell surface proteins indicating that the labeling procedure affects the phenotype of CD14(+)CD16(++) and CD14(++)CD16(-) monocytes differently. Conclusion: Human monocyte subsets internalize different magnetic nanoparticle preparations differently, resulting in variable loading capacities, imaging phenotypes and likely biological properties.	[Settles, Marcus; Kosanke, Katja; Meier, Reinhard; Braren, Rickmer; Huber, Armin; Rummeny, Ernst J.; Wildgruber, Moritz] Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-8000 Munich, Germany; [Etzrodt, Martin; Weissleder, Ralph; Swirski, Filip K.; Wildgruber, Moritz] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA; [Schiemann, Matthias] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Mikrobiol Immunol & Hyg, D-8000 Munich, Germany; [Schiemann, Matthias] Helmholtzzentrum Munchen, Clin Cooperat Grp Antigen Specif Immunotherapy, Munich, Germany; [Zimmermann, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Gefasschirurg, D-8000 Munich, Germany	Technical University of Munich; Harvard University; Harvard Medical School; Massachusetts General Hospital; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Settles, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-8000 Munich, Germany.	moritz.wildgruber@tum.de	Swirski, Filip/AAF-1340-2019; Etzrodt, Martin/P-3325-2015; Braren, Rickmer/U-3254-2018; Meier, Reinhard/B-2882-2014	Etzrodt, Martin/0000-0003-1928-3904; Braren, Rickmer/0000-0001-6039-6957; Meier, Reinhard/0000-0002-2169-4780; /0000-0003-0828-4143; Swirski, Filip/0000-0002-3163-9152; Zimmermann, Alexander/0000-0003-0635-8591	NHLBI NIH HHS [R01 HL095612] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Brochet B, 2006, NEUROIMAGE, V32, P266, DOI 10.1016/j.neuroimage.2006.03.028; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; DENKLEEF JJEI, 1987, MAGN RESON MED, V5, P513, DOI 10.1002/mrm.1910050602; Dousset V, 1999, AM J NEURORADIOL, V20, P223; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; Ebert SN, 2007, STEM CELLS, V25, P2936, DOI 10.1634/stemcells.2007-0216; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; FINGERLE G, 1993, BLOOD, V82, P3170; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guimaraes AR, 2011, MOL IMAGING BIOL, V13, P314, DOI 10.1007/s11307-010-0357-2; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Henning TD, 2007, EUR RADIOL, V17, P1226, DOI 10.1007/s00330-006-0522-9; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jain S, 2003, INT J PHARM, V261, P43, DOI 10.1016/S0378-5173(03)00269-2; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; Metz S, 2004, EUR RADIOL, V14, P1851, DOI 10.1007/s00330-004-2405-2; Muller WA, 1999, J LEUKOCYTE BIOL, V66, P698, DOI 10.1002/jlb.66.5.698; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Persigehl T, 2007, RADIOLOGY, V244, P449, DOI 10.1148/radiol.2442060371; Pittet MJ, 2006, NAT PROTOC, V1, P73, DOI 10.1038/nprot.2006.11; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Seneterre E, 1996, RADIOLOGY, V200, P785, DOI 10.1148/radiology.200.3.8756932; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tang TY, 2009, J AM COLL CARDIOL, V53, P2039, DOI 10.1016/j.jacc.2009.03.018; Ulrich C, 2006, NEPHROL DIAL TRANSPL, V21, P1596, DOI 10.1093/ndt/gfl008; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140; Wildgruber M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005663; Wunderbaldinger P, 2002, ACAD RADIOL, V9, pS304, DOI 10.1016/S1076-6332(03)80210-6; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	42	28	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25197	10.1371/journal.pone.0025197	http://dx.doi.org/10.1371/journal.pone.0025197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984904	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000015
J	Gabbe, BJ; Harrison, JE; Lyons, RA; Jolley, D				Gabbe, Belinda J.; Harrison, James E.; Lyons, Ronan A.; Jolley, Damien			Modelling Long Term Disability following Injury: Comparison of Three Approaches for Handling Multiple Injuries	PLOS ONE			English	Article							MAJOR TRAUMA; HEALTH STATES; REGISTRY; MORTALITY; OUTCOMES; WORK; COMORBIDITY; PREDICTORS; RETURN; ICD	Background: Injury is a leading cause of the global burden of disease (GBD). Estimates of non-fatal injury burden have been limited by a paucity of empirical outcomes data. This study aimed to (i) establish the 12-month disability associated with each GBD 2010 injury health state, and (ii) compare approaches to modelling the impact of multiple injury health states on disability as measured by the Glasgow Outcome Scale - Extended (GOS-E). Methods: 12-month functional outcomes for 11,337 survivors to hospital discharge were drawn from the Victorian State Trauma Registry and the Victorian Orthopaedic Trauma Outcomes Registry. ICD-10 diagnosis codes were mapped to the GBD 2010 injury health states. Cases with a GOS-E score >6 were defined as "recovered.'' A split dataset approach was used. Cases were randomly assigned to development or test datasets. Probability of recovery for each health state was calculated using the development dataset. Three logistic regression models were evaluated: a) additive, multivariable; b) "worst injury;'' and c) multiplicative. Models were adjusted for age and comorbidity and investigated for discrimination and calibration. Findings: A single injury health state was recorded for 46% of cases (1-16 health states per case). The additive (C-statistic 0.70, 95% CI: 0.69, 0.71) and "worst injury" (C-statistic 0.70; 95% CI: 0.68, 0.71) models demonstrated higher discrimination than the multiplicative (C-statistic 0.68; 95% CI: 0.67, 0.70) model. The additive and "worst injury" models demonstrated acceptable calibration. Conclusions: The majority of patients survived with persisting disability at 12-months, highlighting the importance of improving estimates of non-fatal injury burden. Additive and "worst" injury models performed similarly. GBD 2010 injury states were moderately predictive of recovery 1-year post-injury. Further evaluation using additional measures of health status and functioning and comparison with the GBD 2010 disability weights will be needed to optimise injury states for future GBD studies.	[Gabbe, Belinda J.; Jolley, Damien] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Gabbe, Belinda J.] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Harrison, James E.] Flinders Univ S Australia, Res Ctr Injury Studies, Adelaide, SA 5001, Australia; [Lyons, Ronan A.] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Monash University; Flinders University South Australia; Swansea University	Gabbe, BJ (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	belinda.gabbe@monash.edu	Lyons, Ronan/G-7741-2012; Harrison, James/B-8958-2009	Lyons, Ronan/0000-0001-5225-000X; Harrison, James/0000-0001-9893-8491; Gabbe, Belinda/0000-0001-7096-7688	Victorian State Trauma Registry is a Department of Health (Victoria); Transport Accident Commission; Institute for Safety, Compensation and Recovery Research and the Transport Accident Commission; National Health and Medical Research Council of Australia [465103]	Victorian State Trauma Registry is a Department of Health (Victoria); Transport Accident Commission; Institute for Safety, Compensation and Recovery Research and the Transport Accident Commission; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The Victorian State Trauma Registry is a Department of Health (Victoria) and Transport Accident Commission funded initiative. The Victorian Orthopaedic Trauma Outcomes Registry is funded by the Institute for Safety, Compensation and Recovery Research and the Transport Accident Commission. Prof. Belinda Gabbe was supported by a Career Development Award (465103) from the National Health and Medical Research Council of Australia during the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Currens JAB, 2000, INJURY, V31, P93, DOI 10.1016/S0020-1383(99)00244-2; Dale W, 2008, MED DECIS MAKING, V28, P102, DOI 10.1177/0272989X07309639; Davie G, 2008, INJURY PREV, V14, P250, DOI 10.1136/ip.2007.017640; Edwards ER, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2005.02.027; FLANAGAN W, 2006, POPUL HLTH METR, V4; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Hanmer J, 2010, J CLIN EPIDEMIOL, V63, P331, DOI 10.1016/j.jclinepi.2009.06.013; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; LOPEZ A, 2005, GLOBAL HLTH, V1, DOI DOI 10.1186/1744-8603-1181-1185; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; Mathers C., 1999, BURDEN DIS INJURY AU; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Willis CD, 2010, ANZ J SURG, V80, P802, DOI 10.1111/j.1445-2197.2010.05432.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	36	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25862	10.1371/journal.pone.0025862	http://dx.doi.org/10.1371/journal.pone.0025862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984951	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300062
J	Helbig, R; Nickerl, J; Neinhuis, C; Werner, C				Helbig, Ralf; Nickerl, Julia; Neinhuis, Christoph; Werner, Carsten			Smart Skin Patterns Protect Springtails	PLOS ONE			English	Article							SURFACES; ROUGHNESS; WATER; SUPERHYDROPHOBICITY; COLLEMBOLA	Springtails, arthropods who live in soil, in decaying material, and on plants, have adapted to demanding conditions by evolving extremely effective and robust anti-adhesive skin patterns. However, details of these unique properties and their structural basis are still unknown. Here we demonstrate that collembolan skin can resist wetting by many organic liquids and at elevated pressures. We show that the combination of bristles and a comb-like hexagonal or rhombic mesh of interconnected nanoscopic granules distinguish the skin of springtails from anti-adhesive plant surfaces. Furthermore, the negative overhang in the profile of the ridges and granules were revealed to be a highly effective, but as yet neglected, design principle of collembolan skin. We suggest an explanation for the non-wetting characteristics of surfaces consisting of such profiles irrespective of the chemical composition. Many valuable opportunities arise from the translation of the described comb-like patterns and overhanging profiles of collembolan skin into man-made surfaces that combine stability against wear and friction with superior non-wetting and anti-adhesive characteristics.	[Helbig, Ralf; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, Dresden, Germany; [Nickerl, Julia; Neinhuis, Christoph] Tech Univ Dresden, Inst Bot, Dresden, Germany; [Neinhuis, Christoph; Werner, Carsten] Tech Univ Dresden, CUBE Innovat Ctr Mol Bioengn B, Dresden, Germany	Leibniz Institut fur Polymerforschung Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Helbig, R (corresponding author), Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, Dresden, Germany.	werner@ipfdd.de	Werner, Carsten/F-8127-2010; Werner, Carsten/AAF-1510-2019; Neinhuis, Christoph/AAT-9137-2020	Werner, Carsten/0000-0003-0189-3448; Neinhuis, Christoph/0000-0001-9965-4394				Bayley M, 1999, SCIENCE, V285, P1909, DOI 10.1126/science.285.5435.1909; Boreyko JB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.184501; CASSAGNAU P, 1985, REV ECOL BIOL SOL, V22, P381; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Cortese B, 2008, LANGMUIR, V24, P2712, DOI 10.1021/la702764x; Dunger W., 1983, TIERE BODEN; HALE W. G., 1966, REV ECOL BIOL SOL, V3, P343; Herminghaus S, 2000, EUROPHYS LETT, V52, P165, DOI 10.1209/epl/i2000-00418-8; HINTON HE, 1976, J INSECT PHYSIOL, V22, P1061, DOI 10.1016/0022-1910(76)90114-1; Hinton HE, 1960, J INSECT PHYSL, V4, P138; Holmstrup M, 2002, P NATL ACAD SCI USA, V99, P5716, DOI 10.1073/pnas.082580699; Hopkin S. P., 1997, BIOL SPRINGTAILS; Jeong HE, 2010, LANGMUIR, V26, P2223, DOI 10.1021/la904290g; Kim S, 2009, LANGMUIR, V25, P7196, DOI 10.1021/la900732h; KING PE, 1990, J NAT HIST, V24, P673, DOI 10.1080/00222939000770461; Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003; LAWRENCE P N, 1973, Revue d'Ecologie et de Biologie du Sol, V10, P77; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682; MASSOUD Z, 1969, MUSEUM NATL HIST NAT, V10, P1407; Moore PD, 2002, NATURE, V418, P381, DOI 10.1038/418381a; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; NOBLENESBITT J, 1963, J EXP BIOL, V40, P681; Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; THORPE WH, 1947, J EXP BIOL, V24, P227; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Wagner P, 2003, J EXP BOT, V54, P1295, DOI 10.1093/jxb/erg127; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]	32	109	111	10	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25105	10.1371/journal.pone.0025105	http://dx.doi.org/10.1371/journal.pone.0025105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980383	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300019
J	Hollander, FA; Van Dyck, H; Martin, GS; Titeux, N				Hollander, Franck A.; Van Dyck, Hans; Martin, Gilles San; Titeux, Nicolas			Maladaptive Habitat Selection of a Migratory Passerine Bird in a Human-Modified Landscape	PLOS ONE			English	Article							ECOLOGICAL TRAPS; POPULATION-DYNAMICS; REPRODUCTIVE-PERFORMANCE; SOCIAL INFORMATION; LANIUS-COLLURIO; CONSERVATION; QUALITY; FITNESS; ARRIVAL; GREAT	In human-altered environments, organisms may preferentially settle in poor-quality habitats where fitness returns are lower relative to available higher-quality habitats. Such ecological trapping is due to a mismatch between the cues used during habitat selection and the habitat quality. Maladaptive settlement decisions may occur when organisms are time-constrained and have to rapidly evaluate habitat quality based on incomplete knowledge of the resources and conditions that will be available later in the season. During a three-year study, we examined settlement decision-making in the long-distance migratory, open-habitat bird, the Red-backed shrike (Lanius collurio), as a response to recent land-use changes. In Northwest Europe, the shrikes typically breed in open areas under a management regime of extensive farming. In recent decades, Spruce forests have been increasingly managed with large-size cutblocks in even-aged plantations, thereby producing early-successional vegetation areas that are also colonised by the species. Farmland and open areas in forests create mosaics of two different types of habitats that are now occupied by the shrikes. We examined redundant measures of habitat preference (order of settlement after migration and distribution of dominant individuals) and several reproductive performance parameters in both habitat types to investigate whether habitat preference is in line with habitat quality. Territorial males exhibited a clear preference for the recently created open areas in forests with higher-quality males settling in this habitat type earlier. Reproductive performance was, however, higher in farmland, with higher nest success, offspring quantity, and quality compared to open areas in forests. The results showed strong among-year consistency and we can therefore exclude a transient situation. This study demonstrates a case of maladaptive habitat selection in a farmland bird expanding its breeding range to human-created open habitats in plantations. We discuss the reasons that could explain this decision-making and the possible consequences for the population dynamics and persistence.	[Hollander, Franck A.; Van Dyck, Hans; Martin, Gilles San] Catholic Univ Louvain, Behav Ecol & Conservat Grp, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium; [Titeux, Nicolas] Gabriel Lippmann Publ Res Ctr, Dept Environm & Agrobiotechnol, Belvaux, Luxembourg	Universite Catholique Louvain	Hollander, FA (corresponding author), Catholic Univ Louvain, Behav Ecol & Conservat Grp, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium.	titeux@lippmann.lu	San Martin, Gilles/B-7827-2015; Titeux, Nicolas/G-4723-2016; Titeux, Nicolas/AAD-4439-2019	San Martin, Gilles/0000-0002-0434-9416; Titeux, Nicolas/0000-0002-7719-7417; Titeux, Nicolas/0000-0002-7719-7417	Belgian National Fund of Scientific Research	Belgian National Fund of Scientific Research(Fonds de la Recherche Scientifique - FNRS)	The study was funded by the Belgian National Fund of Scientific Research (FRIA PhD-grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antczak M, 2009, ETHOL ECOL EVOL, V21, P127, DOI 10.1080/08927014.2009.9522501; Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Becker PH, 2008, P NATL ACAD SCI USA, V105, P12349, DOI 10.1073/pnas.0804179105; Betts MG, 2008, ECOGRAPHY, V31, P592, DOI 10.1111/j.0906-7590.2008.05490.x; Blondel J, 1999, SCIENCE, V285, P1399, DOI 10.1126/science.285.5432.1399; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Choi YS, 2010, ZOOL STUD, V49, P398; de Warnaffe GD, 2008, BIODIVERS CONSERV, V17, P1041, DOI 10.1007/s10531-008-9364-x; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Fletcher RJ, 2006, AM NAT, V168, P207, DOI 10.1086/505764; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GEBHARDTHENRICH S, 1998, CAUSES GROWTH VARIAT; Gillespie DOS, 2008, P ROY SOC B-BIOL SCI, V275, P713, DOI 10.1098/rspb.2007.1000; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; HANSSON L, 1994, LANDSCAPE ECOL, V9, P105; Hels T, 2002, ECOGRAPHY, V25, P303, DOI 10.1034/j.1600-0587.2002.250307.x; Hromada M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003930; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; JAKOBER H, 1989, J ORNITHOL, V130, P247, DOI 10.1007/BF01649759; Jakober H, 2000, J ORNITHOL, V141, P408, DOI 10.1007/BF01651570; JAKOBER H, 1983, J ORNITHOL, V124, P29, DOI 10.1007/BF01650659; Jose S, 2008, AGROFORESTRY DESIGN, DOI 10.1007/978-1-4020-6572-9; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kristan WB, 2003, OIKOS, V103, P457; Lefranc N., 1997, SHRIKES GUIDE SHRIKE; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Marshall MR, 2004, ECOLOGY, V85, P432, DOI 10.1890/02-0548; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Nocera JJ, 2009, ECOGRAPHY, V32, P143, DOI 10.1111/j.1600-0587.2008.05614.x; Olsson Viking, 1995, Ornis Svecica, V5, P101; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Paquet JY, 2006, FOREST ECOL MANAG, V227, P59, DOI 10.1016/j.foreco.2006.02.009; Part T, 2007, J ORNITHOL, V148, pS327, DOI 10.1007/s10336-007-0226-1; Acuna MP, 2011, BIOL CONSERV, V144, P1577, DOI 10.1016/j.biocon.2011.02.003; Pfister L., 2005, ATLAS CLIMATIQUE GRA; Pidgeon AM, 2006, BIOL CONSERV, V132, P199, DOI 10.1016/j.biocon.2006.03.024; Pulliam H. R., 1996, POPULATION DYNAMICS; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2007, CONDOR, V109, P109, DOI 10.1650/0010-5422(2007)109[109:ISHFAE]2.0.CO;2; Roos S, 2002, OECOLOGIA, V133, P608, DOI 10.1007/s00442-002-1056-8; Schaub M., 2011, OECOLOGIA IN PRESS; Scheirs J, 2000, P ROY SOC B-BIOL SCI, V267, P2065, DOI 10.1098/rspb.2000.1250; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schmidt KA, 2010, OIKOS, V119, P245, DOI 10.1111/j.1600-0706.2009.17824.x; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skagen SK, 2011, CONSERV BIOL, V25, P48, DOI 10.1111/j.1523-1739.2010.01571.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Soderstrom B, 2001, IBIS, V143, P561, DOI 10.1111/j.1474-919X.2001.tb04883.x; Soderstrom B, 2011, J ORNITHOL, V152, P313, DOI 10.1007/s10336-010-0587-8; STAMPS JA, 2001, HABITAT SELECTION DI; Storch D, 1999, EVOL ECOL, V13, P591, DOI 10.1023/A:1006765422475; Svenning JC, 2002, BIOL CONSERV, V104, P133, DOI 10.1016/S0006-3207(01)00162-8; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Tarof SA, 2005, P ROY SOC B-BIOL SCI, V272, P1121, DOI 10.1098/rspb.2005.3053; Thomson RL, 2006, ECOGRAPHY, V29, P507; TITEUX N, 2010, SERIE FAUNE FLORE HA, V5; Titeux N, 2007, BIOL CONSERV, V138, P207, DOI 10.1016/j.biocon.2007.04.019; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Weldon AJ, 2005, ECOLOGY, V86, P1422, DOI 10.1890/04-0913; Wilson JD, 2009, ECOL BIODIVERS CONS, P1; [No title captured]	71	57	62	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25703	10.1371/journal.pone.0025703	http://dx.doi.org/10.1371/journal.pone.0025703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984940	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300050
J	Nascimento, DS; Valente, M; Esteves, T; de Pina, MD; Guedes, JG; Freire, A; Quelhas, P; Pinto-do-O, P				Nascimento, Diana S.; Valente, Mariana; Esteves, Tiago; de Pina, Maria de Fatima; Guedes, Joana G.; Freire, Ana; Quelhas, Pedro; Pinto-do-O, Perpetua			MIQuant - Semi-Automation of Infarct Size Assessment in Models of Cardiac Ischemic Injury	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; MYOCARDIAL-INFARCTION; STEM-CELLS; GENE DELIVERY; HEART-DISEASE; MICE; REGENERATION; MULTIPOTENT; RATS	Background: The cardiac regenerative potential of newly developed therapies is traditionally evaluated in rodent models of surgically induced myocardial ischemia. A generally accepted key parameter for determining the success of the applied therapy is the infarct size. Although regarded as a gold standard method for infarct size estimation in heart ischemia, histological planimetry is time-consuming and highly variable amongst studies. The purpose of this work is to contribute towards the standardization and simplification of infarct size assessment by providing free access to a novel semiautomated software tool. The acronym MIQuant was attributed to this application. Methodology/Principal Findings: Mice were subject to permanent coronary artery ligation and the size of chronic infarcts was estimated by area and midline-length methods using manual planimetry and with MIQuant. Repeatability and reproducibility of MIQuant scores were verified. The validation showed high correlation (r midline length = 0.981; r area = 0.970) and agreement (Bland-Altman analysis), free from bias for midline length and negligible bias of 1.21% to 3.72% for area quantification. Further analysis demonstrated that MIQuant reduced by 4.5-fold the time spent on the analysis and, importantly, MIQuant effectiveness is independent of user proficiency. The results indicate that MIQuant can be regarded as a better alternative to manual measurement. Conclusions: We conclude that MIQuant is a reliable and an easy-to-use software for infarct size quantification. The widespread use of MIQuant will contribute towards the standardization of infarct size assessment across studies and, therefore, to the systematization of the evaluation of cardiac regenerative potential of emerging therapies.	[Nascimento, Diana S.; Valente, Mariana; Esteves, Tiago; de Pina, Maria de Fatima; Guedes, Joana G.; Freire, Ana; Quelhas, Pedro; Pinto-do-O, Perpetua] Univ Porto, INEB, P-4100 Oporto, Portugal; [Valente, Mariana] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Esteves, Tiago; Freire, Ana; Quelhas, Pedro] Univ Porto, Fac Engn, P-4100 Oporto, Portugal; [de Pina, Maria de Fatima] Univ Porto, Dept Epidemiol Clin Med Predit & Saude Publ, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Nascimento, DS (corresponding author), Univ Porto, INEB, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	perpetua@ineb.up.pt	Pinto-do-Ó, Perpetua/ABD-7205-2020; Valente, Mariana/D-9692-2014; Nascimento, Diana S/J-8532-2013; Pinto-do-Ó, Perpetua/K-3742-2012; Pina, Maria de Fatima/N-7574-2014	Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Valente, Mariana/0000-0002-0735-6814; Nascimento, Diana S/0000-0001-6402-4245; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Gusmao Guedes, Joana/0000-0002-4082-1853; Goncalves Freire, Ana Sofia/0000-0001-9527-6082; Pina, Maria de Fatima/0000-0002-1521-7865	Fundacao para a Ciencia e a Tecnologia (FCT); Fundo Europeu de Desenvolvimento Regional (FEDER); Programa Operacional Factores de competitividade-COMPETE; Quadro de Referencia Estrategico Nacional (QREN) [PTDC/SAU-OSM-68473/2006]; Boehringer Ingelheim Fonds; APBRF-American Portuguese Biomedical Research Fund;  [SFRH/BD/64715/2009];  [SFRH/BPD/42254/2007];  [SFRH/BD/74218/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional Factores de competitividade-COMPETE; Quadro de Referencia Estrategico Nacional (QREN); Boehringer Ingelheim Fonds(Boehringer Ingelheim); APBRF-American Portuguese Biomedical Research Fund; ; ; 	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT), Fundo Europeu de Desenvolvimento Regional (FEDER), Programa Operacional Factores de competitividade-COMPETE, Quadro de Referencia Estrategico Nacional (QREN) [grant PTDC/SAU-OSM-68473/2006], and by the grants SFRH/BD/64715/2009 to Dr. Freire, SFRH/BPD/42254/2007 to Dr. Nascimento, and SFRH/BD/74218/2010 to Dr. Valente. Dr. Pinto-do-O and Dr. Quelhas are Ciencia2007 and Ciencia2008 awardees, respectively. Travel funds were awarded by Boehringer Ingelheim Fonds to Dr. Nascimento, and by APBRF-American Portuguese Biomedical Research Fund to Dr. Pinto-do-O and to Dr. Nascimento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008576; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bohl S, 2009, AM J PHYSIOL-HEART C, V296, pH1200, DOI 10.1152/ajpheart.01294.2008; Dawson D, 2004, CIRCULATION, V110, P1632, DOI 10.1161/01.CIR.0000142049.14227.AD; ESTEVES T, 2011, P IB C PATT REC IM A; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Gao XM, 2000, CARDIOVASC RES, V45, P330, DOI 10.1016/S0008-6363(99)00274-6; Gonzales C, 2009, EXP CELL RES, V315, P3077, DOI 10.1016/j.yexcr.2009.09.006; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Minicucci MF, 2007, ARQ BRAS CARDIOL, V89, P93, DOI 10.1590/S0066-782X2007001400004; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Protti A, 2010, J MAGN RESON IMAGING, V32, P878, DOI 10.1002/jmri.22325; Ramani R, 2011, CTS-CLIN TRANSL SCI, V4, P24, DOI 10.1111/j.1752-8062.2010.00252.x; Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; WU Q, 1996, MICROSCOPE IMAGE PRO; Yang ZQ, 2004, CIRCULATION, V109, P1161, DOI 10.1161/01.CIR.0000118495.88442.32; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V93, P434, DOI 10.1590/S0066-782X2009001000018	31	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25045	10.1371/journal.pone.0025045	http://dx.doi.org/10.1371/journal.pone.0025045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980376	gold, Green Published			2022-12-27	WOS:000295941300016
J	Stanojcic, S; Gimenez, S; Permal, E; Cousserans, F; Quesneville, H; Fournier, P; d'Alencon, E				Stanojcic, Slavica; Gimenez, Sylvie; Permal, Emmanuelle; Cousserans, Francois; Quesneville, Hadi; Fournier, Philippe; d'Alencon, Emmanuelle			Correlation of LNCR rasiRNAs Expression with Heterochromatin Formation during Development of the Holocentric Insect Spodoptera frugiperda	PLOS ONE			English	Article							REPEATED DNA-SEQUENCE; SMALL RNAS; DROSOPHILA-MELANOGASTER; MOLECULAR CHARACTERIZATION; PATHWAY; RETROTRANSPOSONS; CHROMOSOMES; PIWI; ELEMENTS; ASSOCIATION	Repeat-associated small interfering RNAs (rasiRNAs) are derived from various genomic repetitive elements and ensure genomic stability by silencing endogenous transposable elements. Here we describe a novel subset of 46 rasiRNAs named LNCR rasiRNAs due to their homology with one long non-coding RNA (LNCR) of Spodoptera frugiperda. LNCR operates as the intermediate of an unclassified transposable element (TE-LNCR). TE-LNCR is a very invasive transposable element, present in high copy numbers in the S. frugiperda genome. LNCR rasiRNAs are single-stranded RNAs without a prominent nucleotide motif, which are organized in two distinct, strand-specific clusters. The expression of LNCR and LNCR rasiRNAs is developmentally regulated. Formation of heterochromatin in the genomic region where three copies of the TE-LNCR are embedded was followed by chromatin immunoprecipitation (ChIP) and we observed this chromatin undergo dynamic changes during development. In summary, increased LNCR expression in certain developmental stages is followed by the appearance of a variety of LNCR rasiRNAs which appears to correlate with subsequent accumulation of a heterochromatic histone mark and silencing of the genomic region with TE-LNCR. These results support the notion that a repeat-associated small interfering RNA pathway is linked to heterochromatin formation and/or maintenance during development to establish repression of the TE-LNCR transposable element. This study provides insights into the rasiRNA silencing pathway and its role in the formation of fluctuating heterochromatin during the development of one holocentric organism.	[Stanojcic, Slavica; Gimenez, Sylvie; Cousserans, Francois; Fournier, Philippe; d'Alencon, Emmanuelle] Univ Montpellier 2, INRA UMR1333, Montpellier, France; [Permal, Emmanuelle; Quesneville, Hadi] Ctr Rech Versailles, INRA, UR1164, Versailles, France	INRAE; Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Stanojcic, S (corresponding author), Univ Montpellier 2, INRA UMR1333, Montpellier, France.	alencon@supagro.inra.fr	d'Alençon, Emmanuelle/AAD-3069-2020; Quesneville, Hadi/AAG-1048-2020	Quesneville, Hadi/0000-0003-3001-4908	French National Research Agency [ANR-07-BLAN-0057-01]	French National Research Agency(French National Research Agency (ANR))	This work was supported by the French National Research Agency grant (ANR-07-BLAN-0057-01; http://www.agence-nationale-recherche.fr/). SS and EP held postdoctoral fellowships through the same grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Criniti A, 2005, GENETICA, V124, P93, DOI 10.1007/s10709-004-8154-y; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Du YQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000835; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Gerbal M, 2000, IN VITRO CELL DEV-AN, V36, P117, DOI 10.1290/1071-2690(2000)036<0117:AOAICL>2.0.CO;2; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Lee HR, 2006, MOL BIOL EVOL, V23, P2505, DOI 10.1093/molbev/msl127; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lu BY, 1998, DEVELOPMENT, V125, P2223; Lu Y.-J., 1994, Insect Molecular Biology, V3, P123, DOI 10.1111/j.1365-2583.1994.tb00159.x; Mandrioli M, 1999, CHROMOSOMA, V108, P436, DOI 10.1007/s004120050395; Mandrioli M, 2007, CHROMOSOME RES, V15, P1015, DOI 10.1007/s10577-007-1176-4; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; MURAKAMI A, 1974, CHROMOSOMA, V47, P167, DOI 10.1007/BF00331804; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]	50	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e24746	10.1371/journal.pone.0024746	http://dx.doi.org/10.1371/journal.pone.0024746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980354	Green Published, Green Submitted, gold			2022-12-27	WOS:000295941300009
J	Wang, L; Wu, ZQ; Bystriakova, N; Ansell, SW; Xiang, QP; Heinrichs, J; Schneider, H; Zhang, XC				Wang, Li; Wu, Zhi-Qiang; Bystriakova, Nadia; Ansell, Stephen W.; Xiang, Qiao-Ping; Heinrichs, Jochen; Schneider, Harald; Zhang, Xian-Chun			Phylogeography of the Sino-Himalayan Fern Lepisorus clathratus on "The Roof of the World"	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; TAXONOMIC REVISION; DNA HAPLOTYPES; CHLOROPLAST; QUATERNARY; MITOCHONDRIAL; HISTORY; POLYPODIACEAE; COLONIZATION; GLACIATION	Background: The Qinghai-Tibetan Plateau (QTP) and its southern and southeastern mountain ranges, Himalaya-Hengduan Mountains (HHM), are one of the most extensive habitats for alpine plants in the world. How ferns occurring in QTP and HHM changed their distribution ranges in response to Quaternary climatic oscillations remains almost unknown. Methodology and Results: We employed sequences of two chloroplast DNA regions, rps4-trnS and trnL-trnF, to reconstruct phylogeography of the Sino-Himalayan fern Lepisorus clathratus, occurring mainly in the QTP and HHM. Individuals of this species have either dehiscent or indehiscent sporangia with the latter evolved from the plesiomorphic dehiscent forms. Based on a range-wide sampling, we detected 27 cpDNA haplotypes that were divided into five groups by network analyses. Populations in the Hengduan Mountains possess the highest genetic diversity, while a single haplogroup is detected across the north-central region. A distinct phylogeographical subdivision was detected between the Hengduan Mountains and north-central region by AMOVA analysis. The haplogroup distribution pattern, coalescence and AMOVA analysis suggest that a long term survival area (refugia) of the species was located in the Hengduan Mountains during glaciations, with probable range expansions into north-central regions during interglacial periods. Populations with indehiscent sporangium can carry private haplotypes and are inclined to maintain genetic homogeneity. One group with indehiscent sporangia most likely survived in situ on the QTP during glaciations. Conclusions/Significance: This study for the first time sheds light on the response of alpine ferns in the QTP and HHM to the Quaternary climatic oscillations.	[Wang, Li; Wu, Zhi-Qiang; Xiang, Qiao-Ping; Zhang, Xian-Chun] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China; [Wang, Li; Heinrichs, Jochen; Schneider, Harald] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Wang, Li; Bystriakova, Nadia; Ansell, Stephen W.; Schneider, Harald] Nat Hist Museum, Dept Bot, London SW7 5BD, England; [Wang, Li; Wu, Zhi-Qiang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; University of Gottingen; Natural History Museum London; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, L (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	h.schneider@nhm.ac.uk; zhangxc@ibcas.ac.cn	Wu, Zhiqiang/CAG-6688-2022; , wuzhiqiang/C-7843-2017; Schneider, Harald/B-6681-2008	Wu, Zhiqiang/0000-0002-4238-7317; , wuzhiqiang/0000-0002-4238-7317; Schneider, Harald/0000-0002-4548-7268	National Natural Science Foundation of China [31070196, 30770166, 13183A1001]; Chinese Academy of Sciences Foundation [91136G1001]; Deutsche Forschungsgemeinschaft (DFG) [SCHN 785/2-2]; DAAD-CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DAAD-CAS	This project is financially supported by the National Natural Science Foundation of China Grant (NSFC No. 31070196, No. 30770166 and No. 13183A1001), Chinese Academy of Sciences Foundation 91136G1001, the Deutsche Forschungsgemeinschaft (DFG Grant SCHN 785/2-2), and a scholarship granted to L. Wang by the DAAD-CAS Joint Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise J, 2004, MOL MARKERS NATURAL; Bohner J, 2006, BOREAS, V35, P279, DOI 10.1080/03009480500456073; BROWNSEY PJ, 1977, EVOLUTION, V31, P294, DOI 10.1111/j.1558-5646.1977.tb01010.x; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; CHING R-C, 1980, Acta Botanica Yunnanica, V2, P67; CHING RC, 1983, ACTA BOT YUNNAN, V2, P382; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ehlers J, 2004, QUATERNARY GLACIAT 3; *ESRI, 1999, ARCMAP VERS 9 3; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fraser- Jenkins C. R., 2008, TAXONOMIC REVISION 3; Fraser-Jenkins C.R., 1992, PAKISTAN SYST, V5, P85; Fraser-Jenkins CR., 1997, NEW SPECIES SYNDROME; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall T.A., 1999, BIOEDIT USER FRIENDL; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HIJMANS RJ, 2005, DIVA GIS VSN 7 1 7 2; HUSON DH, 2008, ESTIMATING PHYLOGENE; Ingold C. T., 1939, SPORE DISCHARGE LAND; KRAMER K U, 1977, Gardens' Bulletin (Singapore), V30, P79; Kuhle M., 1988, GeoJournal, V17, P457; Li Xi-Wen, 1993, Acta Botanica Yunnanica, V15, P217; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Lin YX, 1996, BULL BOT RES, V16, P3; LIN YX, 2000, FLORA CHINA, P32; Liu QR, 2008, J SYST EVOL, V46, P906, DOI 10.3724/SP.J.1002.2008.08036; MADDISON DR, 2002, MACCLADE 4 ANAL PHYL; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; NADOT S, 1995, MOL PHYLOGENET EVOL, V4, P257, DOI 10.1006/mpev.1995.1024; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Owen LA, 2005, QUATERNARY SCI REV, V24, P1391, DOI 10.1016/j.quascirev.2004.10.014; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qi XP, 2009, J SYST EVOL, V47, P581, DOI 10.1111/j.1759-6831.2009.00056.x; Schafer JM, 2002, EARTH PLANET SC LETT, V194, P287, DOI 10.1016/S0012-821X(01)00573-8; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Shimono A, 2010, HEREDITY, V104, P534, DOI 10.1038/hdy.2009.158; Smith AR, 2002, AM FERN J, V92, P131, DOI 10.1640/0002-8444(2002)092[0131:IROTTF]2.0.CO;2; SOLTIS DE, 1992, AM J BOT, V79, P97, DOI 10.2307/2445202; Song BH, 2003, MOL ECOL, V12, P2995, DOI 10.1046/j.1365-294X.2003.01962.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TEMPLETON AR, 1995, GENETICS, V140, P767; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Wang L, 2010, MOL PHYLOGENET EVOL, V54, P211, DOI 10.1016/j.ympev.2009.08.032; Wang LY, 2009, J INTEGR PLANT BIOL, V51, P698, DOI 10.1111/j.1744-7909.2009.00818.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang W. T., 1993, VASCULAR PLANTS HENG, V1; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu, 1988, J JPN BOT, V63, P297; Wu C.-Y., 1980, VEGETATION CHINA; Wubs ERJ, 2010, ANN BOT-LONDON, V106, P583, DOI 10.1093/aob/mcq157; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang XC, 2002, ACTA PHYTOTAXON SIN, V41, P401; Zwickl DJ., 2006, THESIS	68	59	62	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25896	10.1371/journal.pone.0025896	http://dx.doi.org/10.1371/journal.pone.0025896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984953	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300064
J	Wong, KKL; Abbott, D				Wong, Kelvin Kian Loong; Abbott, Derek			Automatic Target Recognition Based on Cross-Plot	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; IMAGE RETRIEVAL; OBJECT RECOGNITION; SHAPE; SEGMENTATION; DESCRIPTORS; ALGORITHM; PLANE	Automatic target recognition that relies on rapid feature extraction of real-time target from photo-realistic imaging will enable efficient identification of target patterns. To achieve this objective, Cross-plots of binary patterns are explored as potential signatures for the observed target by high-speed capture of the crucial spatial features using minimal computational resources. Target recognition was implemented based on the proposed pattern recognition concept and tested rigorously for its precision and recall performance. We conclude that Cross-plotting is able to produce a digital fingerprint of a target that correlates efficiently and effectively to signatures of patterns having its identity in a target repository.	[Wong, Kelvin Kian Loong] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic, Australia; [Wong, Kelvin Kian Loong; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Royal Melbourne Institute of Technology (RMIT); University of Adelaide	Wong, KKL (corresponding author), RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic, Australia.	k.wong@rmit.edu.au	Abbott, Derek/E-8352-2011; Wong, Kelvin/AAL-8636-2021; Wong, Kelvin Kian Loong/ABA-3915-2021	Abbott, Derek/0000-0002-0945-2674; Wong, Kelvin Kian Loong/0000-0002-8600-1105				Arya S, 1998, J ACM, V45, P891, DOI 10.1145/293347.293348; BARUCH O, 1988, PATTERN RECOGN, V21, P581, DOI 10.1016/0031-3203(88)90031-3; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Bieniek A, 1998, CONNECTED COMPONENT; BKP Horn, 1988, ROBOT VISION; BRIGO D, 1998, IEEE T AUTOMATIC CON, V68, P181; Burroughs C, 2001, SANDIA LAB NEWS SAND, V53, P6; DUDANI SA, 1977, IEEE T COMPUT, V26, P39, DOI 10.1109/TC.1977.5009272; ElBadawy O., 2002, INT J IMAGE GRAPHICS, V2, P375; Falconer K., 2014, FRACTAL GEOMETRY MAT; Fukunaga K., 2013, INTRO STAT PATTERN R; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Greenacre M, 2003, J APPL STAT, V30, P1101, DOI 10.1080/0266476032000107132; KERVRANN C, 1995, IEEE T IMAGE PROCESS, V4, P856, DOI 10.1109/83.388090; Khan JF, 2009, APPL OPTICS, V48, P464, DOI 10.1364/AO.48.000464; Kliot M, 1998, COMPUT VIS IMAGE UND, V71, P182, DOI 10.1006/cviu.1998.0709; Lam CP, 1996, World Patent Information, V18, P249, Patent No. 18249249; Landry JW, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031303; Lee L, 1999, MEASURES DISTRIBUTIO, P25; LEONARD J, 1990, COMPUT CHEM ENG, V14, P337, DOI 10.1016/0098-1354(90)87070-6; Li S, 2009, IEEE T SYST MAN CY A, V39, P227, DOI 10.1109/TSMCA.2008.2007988; Ling HB, 2007, IEEE T PATTERN ANAL, V29, P286, DOI 10.1109/TPAMI.2007.41; Ling HB, 2005, PROC CVPR IEEE, P719; Lu GJ, 1997, J INFORM SCI, V23, P119, DOI 10.1177/016555159702300203; Mehtre BM, 1997, INFORM PROCESS MANAG, V33, P319, DOI 10.1016/S0306-4573(96)00069-6; Messer K., 1999, BMVC99. Proceedings of the 10th British Machine Vision Conference, P443; Mori G, 2005, IEEE T PATTERN ANAL, V27, P1832, DOI 10.1109/TPAMI.2005.220; NIBLACK W, 1993, P SOC PHOTO-OPT INS, V1908, P173; Oakley JP, 1996, P SOC PHOTO-OPT INS, V2666, P266, DOI 10.1117/12.234751; Oncel AO, 2002, B SEISMOL SOC AM, V92, P339, DOI 10.1785/0120000844; Pan J.-Y., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P405, DOI 10.1145/584792.584859; Park JA, 2003, IEICE T COMMUN, VE86B, P3662; Persoon E, 1997, IEEE T SYST MAN CYB, V7, P170; Petrakis EGM, 2002, IMAGE VISION COMPUT, V20, P59, DOI 10.1016/S0262-8856(01)00077-4; Safar M, 2002, SHAPE ANAL RETRIEVAL; Sajjanhar A, 1997, AUST COMPUT J, V29, P131; SAMET H, 1981, J ACM, V28, P487, DOI 10.1145/322261.322267; Sang N, 1996, P SOC PHOTO-OPT INS, V2666, P259, DOI 10.1117/12.234750; SCHETTINI R, 1994, PATTERN RECOGN LETT, V15, P1089, DOI 10.1016/0167-8655(94)90124-4; Schmidt M, 2003, BIOPHYS J, V84, P2112, DOI 10.1016/S0006-3495(03)75018-8; Shen DG, 1999, PATTERN RECOGN, V32, P151, DOI 10.1016/S0031-3203(98)00137-X; Silbert LE, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051302; Stimets RW, 1996, SPIE IMAGE VIDEO PRO, P2; Tao Y., 1999, 7 SPIE S STOR RETR I, P631; Tepper M, 2009, LECT NOTES COMPUT SC, V5856, P129, DOI 10.1007/978-3-642-10268-4_15; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; TRAHANIAS PE, 1992, PATTERN RECOGN, V25, P1277, DOI 10.1016/0031-3203(92)90141-5; Trier OD, 1996, PATTERN RECOGN, V29, P641, DOI 10.1016/0031-3203(95)00118-2; Wang Y, 2002, INT J IMAGE GRAPHICS, V2, P361; Wong KKL, 2003, 2 WORKSH CONJ 9 ACM; Wu JK, 1994, LECT NOTES COMPUTER, V819, P109; Zaharia T, 2003, 5 ACM SIGMM INT WORK, P39; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949; Zhang DS, 2002, SIGNAL PROCESS-IMAGE, V17, P825, DOI 10.1016/S0923-5965(02)00084-X; Zhang H, 1992, ACM SE REG C RAL N C, P437; Zhuang Y, 2001, J COMPUT PHYS, V171, P79, DOI 10.1006/jcph.2001.6771	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25621	10.1371/journal.pone.0025621	http://dx.doi.org/10.1371/journal.pone.0025621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980508	Green Published, gold, Green Submitted			2022-12-27	WOS:000295939600042
J	Atwood, AA; Jerrell, R; Sealy, L				Atwood, Allison A.; Jerrell, Rachel; Sealy, Linda			Negative Regulation of C/EBPbeta1 by Sumoylation in Breast Cancer Cells	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; PHOSPHORYLATION; SUMO; ALPHA; DIFFERENTIATION; PROLIFERATION; ISOFORMS; PATHWAY	Sumoylation is a post-translational modification that is oftentimes deregulated in diseases such as cancer. Transcription factors are frequent targets of sumoylation and modification by SUMO can affect subcellular localization, transcriptional activity, and stability of the target protein. C/EBPbeta1 is one such transcription factor that is modified by SUMO-2/3. Non-sumoylated C/EBPbeta1, p52-C/EBPbeta1, is expressed in normal mammary epithelial cells but not breast cancer cell lines and plays a role in oncogene-induced senescence, a tumor suppressive mechanism. Although p52-C/EBPbeta1 is not observed via immunoblot in breast cancer cell lines, higher molecular weight bands are observed when breast cancer cell lines are subjected to immunoblot analysis with a C/EBPbeta1-specific antibody. We show that exogenously expressed C/EBPbeta1 is sumoylated in breast cancer cells, and that the higher molecular weight bands we observe in anti-C/EBPbeta1 immunoblots of breast cancer cell lines is sumoylated C/EBPbeta1. Phosphorylation oftentimes enhances sumoylation, and phosphorylation cascades are activated in breast cancer cells. We demonstrate that phosphorylation of C/EBPbeta1Thr235 by Erk-2 enhances sumoylation of C/EBPbeta1 in vitro. In addition, sumoylated C/EBPbeta1 is phosphorylated on Thr235 and mutation of Thr235 to alanine leads to a decrease in sumoylation of C/EBPbeta1. Finally, using a C/EBPbeta1-SUMO fusion protein we show that constitutive sumoylation of C/EBPbeta1 completely blocks its capability to induce senescence in WI38 fibroblasts expressing hTERT. Thus, sumolylation of C/EBPbeta1 in breast cancer cells may be a mechanism to circumvent oncogene-induced senescence.	[Atwood, Allison A.; Sealy, Linda] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Jerrell, Rachel; Sealy, Linda] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Atwood, AA (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	linda.sealy@vanderbilt.edu			National Institutes of Health, NIH [GM69634]; Cell Biology and Molecular Sciences training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069634] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Biology and Molecular Sciences training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health, NIH GM69634, and the Cell Biology and Molecular Sciences training grant to Vanderbilt University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MM, 2010, EXP CELL RES, V316, P3227, DOI 10.1016/j.yexcr.2010.07.021; Atwood AA, 2010, ONCOGENE, V29, P6004, DOI 10.1038/onc.2010.336; Atwood AA, 2011, SMALL GTPASES, V2, P1; Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Calkhoven CF, 2000, GENE DEV, V14, P1920; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Grignani F, 1998, CANCER RES, V58, P14; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Horie R, 2007, MICROBES INFECT, V9, P721, DOI 10.1016/j.micinf.2007.02.017; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kim KI, 2009, INT REV CEL MOL BIO, V273, P265, DOI 10.1016/S1937-6448(08)01807-8; Koslowski M, 2009, J BIOL CHEM, V284, P28607, DOI 10.1074/jbc.M109.031120; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Vanhatupa S, 2008, BIOCHEM J, V409, P179, DOI 10.1042/BJ20070620; Vu EH, 2007, BIOCHEMISTRY-US, V46, P9795, DOI 10.1021/bi700316g; Wang CY, 2008, DIABETES-METAB RES, V24, P93, DOI 10.1002/dmrr.797; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25205	10.1371/journal.pone.0025205	http://dx.doi.org/10.1371/journal.pone.0025205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980398	gold, Green Submitted, Green Published			2022-12-27	WOS:000295936900033
J	Hogins, J; Crawford, DC; Zorumski, CF; Mennerick, S				Hogins, Joshua; Crawford, Devon C.; Zorumski, Charles F.; Mennerick, Steven			Excitotoxicity Triggered by Neurobasal Culture Medium	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; AMINO-ACIDS; NEUROPSYCHIATRIC DISORDERS; GLUTAMATE NEUROTOXICITY; GLUCOSE DEPRIVATION; NERVOUS-SYSTEM; L-CYSTEINE; MECHANISMS	Neurobasal defined culture medium has been optimized for survival of rat embryonic hippocampal neurons and is now widely used for many types of primary neuronal cell culture. Therefore, we were surprised that routine medium exchange with serum-and supplement-free Neurobasal killed as many as 50% of postnatal hippocampal neurons after a 4 h exposure at day in vitro 12-15. Minimal Essential Medium (MEM), in contrast, produced no significant toxicity. Detectable Neurobasal-induced neuronal death occurred with as little as 5 min exposure, measured 24 h later. D-2-Amino-5-phosphonovalerate (D-APV) completely prevented Neurobasal toxicity, implicating direct or indirect N-methyl-D-aspartate (NMDA) receptor-mediated neuronal excitotoxicity. Whole-cell recordings revealed that Neurobasal but not MEM directly activated D-APVsensitive currents similar in amplitude to those gated by 1 mu M glutamate. We hypothesized that L-cysteine likely mediates the excitotoxic effects of Neurobasal incubation. Although the original published formulation of Neurobasal contained only 10 mu M L-cysteine, commercial recipes contain 260 mu M, a concentration in the range reported to activate NMDA receptors. Consistent with our hypothesis, 260 mu M L-cysteine in bicarbonate-buffered saline gated NMDA receptor currents and produced toxicity equivalent to Neurobasal. Although NMDA receptor-mediated depolarization and Ca2+ influx may support survival of young neurons, NMDA receptor agonist effects on development and survival should be considered when employing Neurobasal culture medium.	[Hogins, Joshua; Crawford, Devon C.; Zorumski, Charles F.; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Zorumski, Charles F.; Mennerick, Steven] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Crawford, Devon C.] Washington Univ, Sch Med, Grad Program Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hogins, J (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	menneris@wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Crawford, Devon/0000-0002-9354-4976	Bantly Foundation; National Institutes of Health [DA07261, NS066611, MH07791, AA017413, MH078823, NS52823]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261] Funding Source: NIH RePORTER	Bantly Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the Bantly Foundation and the following National Institutes of Health grants: DA07261 (to JH), NS066611 (to DCC), MH07791 (to CFZ), AA017413 (to CFZ), MH078823 (to SM) and NS52823 (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brewer LD, 2007, BRAIN RES, V1151, P20, DOI 10.1016/j.brainres.2007.03.020; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Crawford DC, 2011, J NEUROSCI, V31, P979, DOI 10.1523/JNEUROSCI.4960-10.2011; Croucher MJ, 2001, BRIT J PHARMACOL, V133, P815, DOI 10.1038/sj.bjp.0704138; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FERKANY J, 1986, J NEUROSCI RES, V16, P491, DOI 10.1002/jnr.490160305; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; GUSTAFSSON B, 1990, PROG BRAIN RES, V83, P223; Hogins J, 2011, NEUROBIOL DIS, V43, P516, DOI 10.1016/j.nbd.2011.05.005; IZUMI Y, 1992, NEUROSCI LETT, V137, P245, DOI 10.1016/0304-3940(92)90414-3; Janaky R, 2000, NEUROCHEM RES, V25, P1397, DOI 10.1023/A:1007616817499; Mathisen GA, 1996, NEUROCHEM RES, V21, P293, DOI 10.1007/BF02531643; MATTSON MP, 1991, BRAIN RES, V565, P94, DOI 10.1016/0006-8993(91)91740-R; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mennerick S, 1996, J PHYSIOL-LONDON, V490, P405, DOI 10.1113/jphysiol.1996.sp021154; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; MONYER H, 1992, NEURON, V8, P967, DOI 10.1016/0896-6273(92)90211-U; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Moulder KL, 2003, J NEUROSCI, V23, P1825; Moulder KL, 2007, J NEUROSCI, V27, P9846, DOI 10.1523/JNEUROSCI.2803-07.2007; NUNN PB, 1991, SCIENCE, V251, P1619, DOI 10.1126/science.1859531; Olney JW, 2003, CURR OPIN PHARMACOL, V3, P101, DOI 10.1016/S1471-4892(02)00002-4; OLNEY JW, 1990, SCIENCE, V248, P596, DOI 10.1126/science.2185543; PAN ZZ, 1993, NEURON, V11, P85; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PETERSON C, 1989, DEV BRAIN RES, V48, P187, DOI 10.1016/0165-3806(89)90075-8; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Shanker G, 2001, J NEUROSCI RES, V66, P998, DOI 10.1002/jnr.10066; Shi Q, 2003, J PHARMACOL EXP THER, V305, P131, DOI 10.1124/jpet.102.047092; Shute AA, 2005, NEUROSCIENCE, V131, P349, DOI 10.1016/j.neuroscience.2004.11.025; Tang XC, 2003, ANN NY ACAD SCI, V1003, P472, DOI 10.1196/annals.1300.056; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; WEISS JH, 1988, SCIENCE, V241, P973, DOI 10.1126/science.3136549; Zorumski CF, 1996, J PHYSIOL-LONDON, V494, P465, DOI 10.1113/jphysiol.1996.sp021506; ZORUMSKI CF, 1993, PHARMACOL THERAPEUT, V59, P145, DOI 10.1016/0163-7258(93)90043-D	42	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25633	10.1371/journal.pone.0025633	http://dx.doi.org/10.1371/journal.pone.0025633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980512	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900084
J	Nishimura, Y; Onoe, H; Onoe, K; Morichika, Y; Tsukada, H; Isa, T				Nishimura, Yukio; Onoe, Hirotaka; Onoe, Kayo; Morichika, Yosuke; Tsukada, Hideo; Isa, Tadashi			Neural Substrates for the Motivational Regulation of Motor Recovery after Spinal-Cord Injury	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; MEDIAL FRONTAL-CORTEX; EVENT-RELATED FMRI; MAJOR DEPRESSION; PARKINSONS-DISEASE; REWARD PREDICTION; PREFRONTAL CORTEX; DOPAMINE; NUCLEUS	It is believed that depression impedes and motivation enhances functional recovery after neuronal damage such as spinal-cord injury and stroke. However, the neuronal substrate underlying such psychological effects on functional recovery remains unclear. A longitudinal study of brain activation in the non-human primate model of partial spinal-cord injury using positron emission tomography (PET) revealed a contribution of the primary motor cortex (M1) to the recovery of finger dexterity through the rehabilitative training. Here, we show that activity of the ventral striatum, including the nucleus accumbens (NAc), which plays a critical role in processing of motivation, increased and its functional connectivity with M1 emerged and was progressively strengthened during the recovery. In addition, functional connectivities among M1, the ventral striatum and other structures belonging to neural circuits for processing motivation, such as the orbitofrontal cortex, anterior cingulate cortex and pedunculopontine tegmental nucleus were also strengthened during the recovery. These results give clues to the neuronal substrate for motivational regulation of motor learning required for functional recovery after spinal-cord injury.	[Nishimura, Yukio; Morichika, Yosuke; Isa, Tadashi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan; [Nishimura, Yukio] Japan Sci & Technol Agcy, Tokyo, Japan; [Nishimura, Yukio; Onoe, Hirotaka; Tsukada, Hideo; Isa, Tadashi] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan; [Onoe, Hirotaka] RIKEN, Ctr Mol Imaging Sci, Funct Probe Res Lab, Kobe, Hyogo, Japan; [Onoe, Kayo] RIKEN, Ctr Mol Imaging Sci, Mol Dynam Lab, Kobe, Hyogo, Japan; [Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Nishimura, Yukio; Isa, Tadashi] Grad Univ Adv Studies SOKENDAI, Hayama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); RIKEN; RIKEN; Hamamatsu Photonics; Graduate University for Advanced Studies - Japan	Nishimura, Y (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan.	yukio@nips.ac.jp			Precursory Research for Embryonic Science and Technology (PRESTO); Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Nakayama Foundation for Human Science; Grants-in-Aid for Scientific Research [21300205] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakayama Foundation for Human Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research was supported by Precursory Research for Embryonic Science and Technology (PRESTO) and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), the Molecular Imaging Program on "Research Base for Exploring New Drugs" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Nakayama Foundation for Human Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman RM, 2000, BIOL PSYCHIAT, V47, P332, DOI 10.1016/S0006-3223(99)00243-7; Chemerinski E, 2001, STROKE, V32, P113, DOI 10.1161/01.STR.32.1.113; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Doyon WM, 2005, J NEUROCHEM, V93, P1469, DOI 10.1111/j.1471-4159.2005.03137.x; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; Graves DE, 2008, J SPINAL CORD MED, V31, P177, DOI 10.1080/10790268.2008.11760709; Higo N, 2009, J COMP NEUROL, V516, P493, DOI 10.1002/cne.22121; HORWITZ B, 1990, INT J BIOMED COMPUT, V26, P149, DOI 10.1016/0020-7101(90)90039-W; HORWITZ B, 1991, J CEREBRAL BLOOD FLO, V11, P114; Juckel G, 2006, PSYCHOPHARMACOLOGY, V187, P222, DOI 10.1007/s00213-006-0405-4; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kobayashi Y, 2007, ANN NY ACAD SCI, V1104, P310, DOI 10.1196/annals.1390.003; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; Miyachi S, 2006, NEUROSCI RES, V56, P300, DOI 10.1016/j.neures.2006.07.012; NAUTA WJH, 1984, CIBA F SYMP, V107, P3; NISHIMURA Y, 2011, EXP NEUROL; Nishimura Y, 2007, NEUROSCI RES, V59, P243, DOI 10.1016/j.neures.2007.07.003; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nishimura Y, 2009, NEUROSCIENTIST, V15, P436, DOI 10.1177/1073858408331375; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; Ohnishi T, 2004, BIOL PSYCHIAT, V55, P484, DOI 10.1016/j.biopsych.2003.09.016; Osteraker AL, 2005, SPINAL CORD, V43, P223, DOI 10.1038/sj.sc.3101703; Paquet F, 2008, EXP BRAIN RES, V185, P227, DOI 10.1007/s00221-007-1147-1; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Saxena SK, 2007, ACTA NEUROL SCAND, V115, P339, DOI 10.1111/j.1600-0404.2006.00751.x; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Teulings HL, 2002, J NEUROL NEUROSUR PS, V72, P315, DOI 10.1136/jnnp.72.3.315; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996	34	27	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e24854	10.1371/journal.pone.0024854	http://dx.doi.org/10.1371/journal.pone.0024854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969864	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900015
J	Thumkeo, D; Shinohara, R; Watanabe, K; Takebayashi, H; Toyoda, Y; Tohyama, K; Ishizaki, T; Furuyashiki, T; Narumiya, S				Thumkeo, Dean; Shinohara, Ryota; Watanabe, Keisuke; Takebayashi, Hirohide; Toyoda, Yosuke; Tohyama, Kiyoshi; Ishizaki, Toshimasa; Furuyashiki, Tomoyuki; Narumiya, Shuh			Deficiency of mDia, an Actin Nucleator, Disrupts Integrity of Neuroepithelium and Causes Periventricular Dysplasia	PLOS ONE			English	Article							VENTRAL BODY-WALL; PROTEIN-KINASE; ADHERENS JUNCTIONS; RHO-GTPASES; ROCK-I; LOCALIZATION; ORGANIZATION; HETEROTOPIA; MECHANISM; MOVEMENT	During development of the central nervous system, the apical-basal polarity of neuroepithelial cells is critical for homeostasis of proliferation and differentiation of neural stem cells. While adherens junctions at the apical surface of neuroepithelial cells are important for maintaining the polarity, the molecular mechanism regulating integrity of these adherens junctions remains largely unknown. Given the importance of actin cytoskeleton in adherens junctions, we have analyzed the role of mDia, an actin nucleator and a Rho effector, in the integrity of the apical adherens junction. Here we show that mDia1 and mDia3 are expressed in the developing brain, and that mDia3 is concentrated in the apical surface of neuroepithelium. Mice deficient in both mDia1 and mDia3 develop periventricular dysplastic mass widespread throughout the developing brain, where neuroepithelial cell polarity is impaired with attenuated apical actin belts and loss of apical adherens junctions. In addition, electron microscopic analysis revealed abnormal shrinkage and apical membrane bulging of neuroepithelial cells in the remaining areas. Furthermore, perturbation of Rho, but not that of ROCK, causes loss of the apical actin belt and adherens junctions similarly to mDia-deficient mice. These results suggest that actin cytoskeleton regulated by Rho-mDia pathway is critical for the integrity of the adherens junctions and the polarity of neuroepithelial cells, and that loss of this signaling induces aberrant, ectopic proliferation and differentiation of neural stem cells.	[Thumkeo, Dean; Shinohara, Ryota; Toyoda, Yosuke; Tohyama, Kiyoshi; Ishizaki, Toshimasa; Furuyashiki, Tomoyuki; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Watanabe, Keisuke; Takebayashi, Hirohide] Kumamoto Univ, Dept Morphol Neural Sci, Grad Sch Med Sci, Kumamoto, Japan	Kyoto University; Kumamoto University	Thumkeo, D (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Furuyashiki, Tomoyuki/B-8760-2014; Furuyashiki, Tomoyuki/AAG-5283-2019; Takebayashi, Hirohide/AAO-1693-2020; Shinohara, Ryota/AAN-1274-2021	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Shinohara, Ryota/0000-0001-5279-2642; Toyoda, Yosuke/0000-0002-2245-4666	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology, Japan(Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Grant-in-aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Core Research for Evolutional Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; de Wit OA, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-4; Eda M, 2001, J CELL SCI, V114, P3273; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Lu J, 2005, EPILEPSY BEHAV, V7, P143, DOI 10.1016/j.yebeh.2005.05.001; MORII N, 1995, METHOD ENZYMOL, V256, P196; Mullin JP, 2010, J NEUROSURG-PEDIATR, V6, P267, DOI 10.3171/2010.5.PEDS10220; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	42	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25465	10.1371/journal.pone.0025465	http://dx.doi.org/10.1371/journal.pone.0025465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980468	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900069
J	Diaz-Moralli, S; Tarrado-Castellarnau, M; Alenda, C; Castells, A; Cascante, M				Diaz-Moralli, Santiago; Tarrado-Castellarnau, Miriam; Alenda, Cristina; Castells, Antoni; Cascante, Marta			Transketolase-Like 1 Expression Is Modulated during Colorectal Cancer Progression and Metastasis Formation	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; CELL-PROLIFERATION; METABOLIC-CONTROL; DNA-METHYLATION; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; RIBOSE SYNTHESIS; TUMOR-CELLS; TKTL1; HYPOXIA	Background: Transketolase-like 1 (TKTL1) induces glucose degradation through anaerobic pathways, even in presence of oxygen, favoring the malignant aerobic glycolytic phenotype characteristic of tumor cells. As TKTL1 appears to be a valid biomarker for cancer prognosis, the aim of the current study was to correlate its expression with tumor stage, probability of tumor recurrence and survival, in a series of colorectal cancer patients. Methodolody/Principal Findings: Tumor tissues from 63 patients diagnosed with colorectal cancer at different stages of progression were analyzed for TKTL1 by immunohistochemistry. Staining was quantified by computational image analysis, and correlations between enzyme expression, local growth, lymph-node involvement and metastasis were assessed. The highest values for TKTL1 expression were detected in the group of stage III tumors, which showed significant differences from the other groups (Kruskal-Wallis test, P = 0.000008). Deeper analyses of T, N and M classifications revealed a weak correlation between local tumor growth and enzyme expression (Mann-Whitney test, P = 0.029), a significant association of the enzyme expression with lymph-node involvement (Mann-Whitney test, P = 0.0014) and a significant decrease in TKTL1 expression associated with metastasis (Mann-Whitney test, P = 0.0004). Conclusions/Significance: To our knowledge, few studies have explored the association between variations in TKTL1 expression in the primary tumor and metastasis formation. Here we report downregulation of enzyme expression when metastasis appears, and a correlation between enzyme expression and regional lymph-node involvement in colon cancer. This finding may improve our understanding of metastasis and lead to new and more efficient therapies against cancer.	[Diaz-Moralli, Santiago; Tarrado-Castellarnau, Miriam; Cascante, Marta] Univ Barcelona IBUB, Inst Biomed, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Diaz-Moralli, Santiago; Tarrado-Castellarnau, Miriam; Cascante, Marta] Univ Barcelona, IDIBAPS Hosp Clin, Barcelona, Spain; [Alenda, Cristina] Hosp Gen Univ Alicante, Dept Pathol, Alicante, Spain; [Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Hosp Clin, IDIBAPS,CIBEREHD, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; General University Hospital of Alicante; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Diaz-Moralli, S (corresponding author), Univ Barcelona IBUB, Inst Biomed, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain.	martacascante@ub.edu	Tarrado-Castellarnau, Míriam/E-4419-2018; CASCANTE, MARTA/AFK-5991-2022; Castells, Antoni/ABC-1002-2021; Alenda, Cristina/AAR-3433-2020; CASCANTE, MARTA/AAG-4355-2022	Tarrado-Castellarnau, Míriam/0000-0001-9757-2686; CASCANTE, MARTA/0000-0002-2062-4633; Castells, Antoni/0000-0001-8431-2033; CASCANTE, MARTA/0000-0002-2062-4633; Diaz-Moralli, Santiago/0000-0002-2729-0613; Alenda, Cristina/0000-0002-0560-1759	regional autonomous Government of Catalonia (Generalitat) through the "Agencia de Gestio ad'juts Universitaris i de Recerca" [2009 SGR 849, 2009 SGR 1308]; Ministerio de Ciencia e Innovacion-Spanish Government; European Regional Development Funds (ERDF) "Una manera de hacer Europa" [SAF2010-19273, SAF2011-25726]; Instituto de Salud Carlos III [RD06_0020_0046]; CIBEREHD; "Asociacion Espanola contra el Cancer" ("Fundacion Cientifica y Junta de Barcelona"); ICREA Academia; ICREA foundation-Generalitat de Catalunya	regional autonomous Government of Catalonia (Generalitat) through the "Agencia de Gestio ad'juts Universitaris i de Recerca"; Ministerio de Ciencia e Innovacion-Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Funds (ERDF) "Una manera de hacer Europa"(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBEREHD; "Asociacion Espanola contra el Cancer" ("Fundacion Cientifica y Junta de Barcelona"); ICREA Academia(ICREA); ICREA foundation-Generalitat de Catalunya(ICREA)	This study was supported by the regional autonomous Government of Catalonia (Generalitat) through the "Agencia de Gestio ad'juts Universitaris i de Recerca" (2009 SGR 849 and 2009 SGR 1308), the Ministerio de Ciencia e Innovacion-Spanish Government and European Regional Development Funds (ERDF) "Una manera de hacer Europa" (SAF2010-19273 and SAF2011-25726), "Instituto de Salud Carlos III" through ISCIII-RTICC (RD06_0020_0046) and CIBEREHD, and "Asociacion Espanola contra el Cancer" ("Fundacion Cientifica y Junta de Barcelona"). MC acknowledges the support received through the prize "ICREA Academia" for excellence in research, funded by ICREA foundation-Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2006, LANCET, V367, P618, DOI 10.1016/S0140-6736(06)68228-7; Atsumi T, 2002, CANCER RES, V62, P5881; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Boren J, 2006, J HISTOCHEM CYTOCHEM, V54, P191, DOI 10.1369/jhc.5A6745.2005; Boren J, 2002, MOL BIOL REP, V29, P7, DOI 10.1023/A:1020333730485; Boros LG, 2001, PANCREAS, V23, P141, DOI 10.1097/00006676-200108000-00004; Boros LG, 2001, PANCREAS, V22, P1, DOI 10.1097/00006676-200101000-00001; Boros LG, 1997, CANCER RES, V57, P4242; Chen H, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-43; Comin-Anduix B, 2002, J BIOL CHEM, V277, P46408, DOI 10.1074/jbc.M206150200; Comin-Anduix B, 2001, EUR J BIOCHEM, V268, P4177, DOI 10.1046/j.1432-1327.2001.02329.x; Coy JF, 2005, CLIN LAB, V51, P257; Du MX, 2004, J BIOMOL SCREEN, V9, P427, DOI 10.1177/1087057104263913; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Foldi M, 2007, ONCOL REP, V17, P841; Frederiks WM, 2008, INT J EXP PATHOL, V89, P232, DOI 10.1111/j.1365-2613.2008.00582.x; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; Hidvegi M, 1999, CANCER BIOTHER RADIO, V14, P277, DOI 10.1089/cbr.1999.14.277; Hou P, 2008, CANCER, V113, P2440, DOI 10.1002/cncr.23869; Hu LH, 2007, ANTI-CANCER DRUG, V18, P427, DOI 10.1097/CAD.0b013e328013d99e; Jakab F, 2003, BRIT J CANCER, V89, P465, DOI 10.1038/sj.bjc.6601153; Kohrenhagen N, 2008, J OBSTET GYNAECOL RE, V34, P293, DOI 10.1111/j.1447-0756.2008.00749.x; KOLE HK, 1991, ARCH BIOCHEM BIOPHYS, V286, P586, DOI 10.1016/0003-9861(91)90084-V; Krockenberger M, 2007, INT J GYNECOL CANCER, V17, P101, DOI 10.1111/j.1525-1438.2007.00799.x; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; Mazon Pelaez I, 2010, INT J BIOCH CELL BIO; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; NEWELL K, 1993, P NATL ACAD SCI USA, V90, P1127, DOI 10.1073/pnas.90.3.1127; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Patra SK, 2008, CANCER METAST REV, V27, P315, DOI 10.1007/s10555-008-9118-y; Patra SK, 2008, EXP CELL RES, V314, P1193, DOI 10.1016/j.yexcr.2008.01.012; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Rais B, 1999, FEBS LETT, V456, P113, DOI 10.1016/S0014-5793(99)00924-2; Ramos-Montoya A, 2006, INT J CANCER, V119, P2733, DOI 10.1002/ijc.22227; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595; SCHLAPPACK OK, 1991, BRIT J CANCER, V64, P663, DOI 10.1038/bjc.1991.378; Schmidt M, 2008, EUR J OBSTET GYN R B, V139, P72, DOI 10.1016/j.ejogrb.2008.02.009; Schmidt M, 2010, J CANCER RES CLIN, V136, P219, DOI 10.1007/s00432-009-0652-y; Schultz H, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-35; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Staiger WI, 2006, ONCOL REP, V16, P657; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; SZYF M, 1995, J BIOL CHEM, V270, P12690, DOI 10.1074/jbc.270.21.12690; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Van Noorden CJF, 1992, ENZYME HISTOCHEMISTR; Vizan P, 2008, METABOLOMICS, V4, P1, DOI 10.1007/s11306-007-0101-3; Vizan P, 2009, INT J CANCER, V124, P2789, DOI 10.1002/ijc.24262; Warburg O, 1924, BIOCHEM Z, V152, P309; Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078; Zerilli M, 2008, CANCER, V113, P936, DOI 10.1002/cncr.23683; Zhang S, 2007, CANCER LETT, V253, P108, DOI 10.1016/j.canlet.2007.01.010; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	65	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25323	10.1371/journal.pone.0025323	http://dx.doi.org/10.1371/journal.pone.0025323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980427	gold, Green Submitted, Green Published			2022-12-27	WOS:000295933700027
J	Ananiev, G; Williams, EC; Li, HD; Chang, Q				Ananiev, Gene; Williams, Emily Cunningham; Li, Hongda; Chang, Qiang			Isogenic Pairs of Wild Type and Mutant Induced Pluripotent Stem Cell (iPSC) Lines from Rett Syndrome Patients as In Vitro Disease Model	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; NEURAL DEVELOPMENT; MOUSE MODELS; MECP2; MUTATIONS; NEURONS; METHYLATION; MORPHOLOGY	Rett syndrome (RTT) is an autism spectrum developmental disorder caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene. Excellent RTT mouse models have been created to study the disease mechanisms, leading to many important findings with potential therapeutic implications. These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss-or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients. However, because of potential differences in the underlying biology between humans and common research animals, there is a need to establish cell culture-based human models for studying disease mechanisms to validate and expand the knowledge acquired in animal models. Taking advantage of the nonrandom pattern of X chromosome inactivation in female induced pluripotent stem cells (iPSC), we have generated isogenic pairs of wild type and mutant iPSC lines from several female RTT patients with common and rare RTT mutations. R294X (arginine 294 to stop codon) is a common mutation carried by 5-6% of RTT patients. iPSCs carrying the R294X mutation has not been studied. We differentiated three R294X iPSC lines and their isogenic wild type control iPSC into neurons with high efficiency and consistency, and observed characteristic RTT pathology in R294X neurons. These isogenic iPSC lines provide unique resources to the RTT research community for studying disease pathology, screening for novel drugs, and testing toxicology.	[Ananiev, Gene; Williams, Emily Cunningham; Chang, Qiang] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Ananiev, Gene; Li, Hongda; Chang, Qiang] Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI 53705 USA; [Williams, Emily Cunningham; Li, Hongda; Chang, Qiang] Univ Wisconsin, Genet Training Program, Madison, WI 53705 USA; [Chang, Qiang] Univ Wisconsin, Dept Genet & Neurol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ananiev, G (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	qchang@waisman.wisc.edu	Li, Hongda/F-3034-2017	Li, Hongda/0000-0001-6754-5150	Friends of the Waisman Center [5T32GM07133]; Stem Cell and Regenerative Medicine Center at University of Wisconsin at Madison; National Institutes of Health [P30HD03352];  [T32AG027566]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG027566] Funding Source: NIH RePORTER	Friends of the Waisman Center; Stem Cell and Regenerative Medicine Center at University of Wisconsin at Madison; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GA was supported by a postdoctoral training grant (T32AG027566). ECW was supported by a predoctoral training grant (5T32GM07133) and a graduate student fellowship from the Friends of the Waisman Center. HL was supported by a predoctoral fellowship from the Stem Cell and Regenerative Medicine Center at University of Wisconsin at Madison. This work was partially supported by a grant from National Institutes of Health (P30HD03352 to the Waisman Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amenduni M, 2011, EUR J HUM GENET, V19, P1246, DOI 10.1038/ejhg.2011.131; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Belichenko NP, 2008, J COMP NEUROL, V508, P184, DOI 10.1002/cne.21673; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P5; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Jugloff DGM, 2005, NEUROBIOL DIS, V19, P18, DOI 10.1016/j.nbd.2004.11.002; Katz DM, 2009, RESP PHYSIOL NEUROBI, V168, P101, DOI 10.1016/j.resp.2009.04.017; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, AM J MED GENET, V111, P164, DOI 10.1002/ajmg.10557; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	35	152	161	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25255	10.1371/journal.pone.0025255	http://dx.doi.org/10.1371/journal.pone.0025255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966470	Green Published, gold, Green Submitted			2022-12-27	WOS:000295932100030
J	Lira-Navarrete, E; Valero-Gonzalez, J; Villanueva, R; Martinez-Julvez, M; Tejero, T; Merino, P; Panjikar, S; Hurtado-Guerrero, R				Lira-Navarrete, Erandi; Valero-Gonzalez, Jessika; Villanueva, Raquel; Martinez-Julvez, Marta; Tejero, Tomas; Merino, Pedro; Panjikar, Santosh; Hurtado-Guerrero, Ramon			Structural Insights into the Mechanism of Protein O-Fucosylation	PLOS ONE			English	Article							THROMBOSPONDIN TYPE-1 REPEATS; GROWTH FACTOR-LIKE; NOTCH-DELTA INTERACTIONS; LIGAND-BINDING DOMAIN; HUMAN ALPHA-1,3-FUCOSYL-TRANSFERASE; CRYSTAL-STRUCTURE; C-MANNOSYLATION; LINKED FUCOSE; TRANSFERASE; CLUSPRO	Protein O-fucosylation is an essential post-translational modification, involved in the folding of target proteins and in the role of these target proteins during embryonic development and adult tissue homeostasis, among other things. Two different enzymes are responsible for this modification, Protein O-fucosyltransferase 1 and 2 (POFUT1 and POFUT2, respectively). Both proteins have been characterised biologically and enzymatically but nothing is known at the molecular or structural level. Here we describe the first crystal structure of a catalytically functional POFUT1 in an apo-form and in complex with GDP-fucose and GDP. The enzyme belongs to the GT-B family and is not dependent on manganese for activity. GDP-fucose/GDP is localised in a conserved cavity connected to a large solvent exposed pocket, which we show is the binding site of epidermal growth factor (EGF) repeats in the extracellular domain of the Notch Receptor. Through both mutational and kinetic studies we have identified which residues are involved in binding and catalysis and have determined that the Arg240 residue is a key catalytic residue. We also propose a novel S(N)1-like catalytic mechanism with formation of an intimate ion pair, in which the glycosidic bond is cleaved before the nucleophilic attack; and theoretical calculations at a DFT (B3LYP/6-31+G(d,p) support this mechanism. Thus, the crystal structure together with our mutagenesis studies explain the molecular mechanism of POFUT1 and provide a new starting point for the design of functional inhibitors to this critical enzyme in the future.	[Lira-Navarrete, Erandi; Valero-Gonzalez, Jessika; Villanueva, Raquel; Martinez-Julvez, Marta; Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, Zaragoza, Spain; [Martinez-Julvez, Marta] Univ Zaragoza, Dept Biochem & Mol & Cellular Biol, Zaragoza, Spain; [Tejero, Tomas; Merino, Pedro] Univ Zaragoza, CSIC, Dept Organ Chem, Inst Chem Synth & Homogenoeus Catalysis ISQCH, Zaragoza, Spain; [Panjikar, Santosh] EMBL Hamburt Outstn, Hamburg, Germany; [Hurtado-Guerrero, Ramon] Diputac Gen Aragon, Fdn ARAID, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC-UZA - Instituto de Sintesis Quimica y Catalisis Homogenea (ISQCH); University of Zaragoza; European Molecular Biology Laboratory (EMBL)	Lira-Navarrete, E (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, Zaragoza, Spain.	rhurtado@bifi.es	Lira-Navarrete, Erandi/L-5359-2015; Valero, Jessika/P-4888-2017; Panjikar, Santosh/D-2709-2012; Martinez-Julvez, Marta M/G-5392-2012; Merino, Pedro/K-2742-2014; Martinez-Julvez, Marta/G-3839-2017; /F-3830-2016	Panjikar, Santosh/0000-0001-7429-3879; Martinez-Julvez, Marta M/0000-0001-9047-0046; Merino, Pedro/0000-0002-2202-3460; Martinez-Julvez, Marta/0000-0001-9047-0046; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; /0000-0003-3433-6701	Fundacion ARAID (Gobierno de Aragon); Ministerio de Educacion y Ciencia [BFU2010-19504]; Ministerio de Ciencia e Innovacion [CTQ2010-19606]	Fundacion ARAID (Gobierno de Aragon)(Gobierno de Aragon); Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Fundacion ARAID (Gobierno de Aragon), Ministerio de Educacion y Ciencia (Project BFU2010-19504) and Ministerio de Ciencia e Innovacion (Project CTQ2010-19606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Brzezinski K, 2007, ACTA BIOCHIM POL, V54, P537, DOI 10.18388/abp.2007_3227; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chazalet V, 2001, J BACTERIOL, V183, P7067, DOI 10.1128/JB.183.24.7067-7075.2001; Chen DP, 2004, ANN CLIN LAB SCI, V34, P437; Comeau SR, 2005, PROTEINS, V60, P239, DOI 10.1002/prot.20564; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; DAVIS C G, 1990, New Biologist, V2, P410; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch G. W., 2013, GAUSSIAN 09; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; HALLGREN P, 1975, J BIOL CHEM, V250, P5312; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Jafar-Nejad H, 2010, GLYCOBIOLOGY, V20, P931, DOI 10.1093/glycob/cwq053; Jundt F, 2008, CURR MOL MED, V8, P51, DOI 10.2174/156652408783565540; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLINGER MM, 1981, J BIOL CHEM, V256, P7932; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Loriol C, 2007, FEBS J, V274, P1202, DOI 10.1111/j.1742-4658.2007.05663.x; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Murray BW, 1997, BIOCHEMISTRY-US, V36, P823, DOI 10.1021/bi962284z; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Pancewicz J, 2010, P NATL ACAD SCI USA, V107, P16619, DOI 10.1073/pnas.1010722107; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; RAea Laskowski, 1993, J APPL CRYST, V26; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shao L, 2003, CELL MOL LIFE SCI, V60, P241, DOI 10.1007/s000180300019; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200	60	70	73	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25365	10.1371/journal.pone.0025365	http://dx.doi.org/10.1371/journal.pone.0025365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966509	Green Published, Green Submitted, gold			2022-12-27	WOS:000295932100036
J	Zimmermann, D; Motaal, BA; von Voithenberg, LV; Schliwa, M; Okten, Z				Zimmermann, Dennis; Motaal, Basma Abdel; von Voithenberg, Lena Voith; Schliwa, Manfred; Oekten, Zeynep			Diffusion of Myosin V on Microtubules: A Fine-Tuned Interaction for Which E-Hooks Are Dispensable	PLOS ONE			English	Article							ONE-DIMENSIONAL DIFFUSION; PROCESSIVE RUN-LENGTH; XENOPUS MELANOPHORES; MOLECULAR MOTORS; KINESIN MOTOR; WEAK BINDING; ACTIN; TUBULIN; TRANSPORT; DYNAMICS	Organelle transport in eukaryotes employs both microtubule and actin tracks to deliver cargo effectively to their destinations, but the question of how the two systems cooperate is still largely unanswered. Recently, in vitro studies revealed that the actin-based processive motor myosin V also binds to, and diffuses along microtubules. This biophysical trick enables cells to exploit both tracks for the same transport process without switching motors. The detailed mechanisms underlying this behavior remain to be solved. By means of single molecule Total Internal Reflection Microscopy (TIRFM), we show here that electrostatic tethering between the positively charged loop 2 and the negatively charged C-terminal E-hooks of microtubules is dispensable. Furthermore, our data indicate that in addition to charge-charge interactions, other interaction forces such as non-ionic attraction might account for myosin V diffusion. These findings provide evidence for a novel way of myosin tethering to microtubules that does not interfere with other E-hook-dependent processes.	[Zimmermann, Dennis; Motaal, Basma Abdel; von Voithenberg, Lena Voith; Schliwa, Manfred; Oekten, Zeynep] Univ Munich, Inst Anat & Cell Biol, Munich, Germany	University of Munich	Zimmermann, D (corresponding author), Univ Munich, Inst Anat & Cell Biol, Munich, Germany.	zoekten@ph.tum.de		Voith von Voithenberg, Lena/0000-0002-8646-2817	Long Term European Molecular Biology Organization (EMBO) [1134-2006]; Deutsche Forschungsgemeinschaft (DFG) [OE 501/1-1]; Friedrich-Baur-Stiftung [01/09];  [SFB 863]	Long Term European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Baur-Stiftung; 	This work was supported by a Long Term European Molecular Biology Organization (EMBO) fellowship to ZO (#1134-2006) and grants from the Deutsche Forschungsgemeinschaft (DFG, #OE 501/1-1) and the Friedrich-Baur-Stiftung (#01/09) to ZO and MS. Z.O. acknowledges support from SFB 863. URL EMBO: http://www.embo.org; URL DFG: http://www.dfg.de; URL Friedrich-Baur-Stiftung: http://www.baur-stiftung.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Alonso MC, 1998, EMBO J, V17, P945, DOI 10.1093/emboj/17.4.945; AUDEBERT S, 1994, J CELL SCI, V107, P2313; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Brunstein M, 2009, BIOPHYS J, V97, P1548, DOI 10.1016/j.bpj.2009.06.048; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Claesson PM, 2006, PHYS CHEM CHEM PHYS, V8, P5501, DOI 10.1039/b610295f; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; KUZNETSOV SA, 1992, NATURE, V356, P722, DOI 10.1038/356722a0; Lakamper S, 2005, BIOPHYS J, V89, P3223, DOI 10.1529/biophysj.104.057505; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; MEEUSEN RL, 1979, J CELL BIOL, V82, P57, DOI 10.1083/jcb.82.1.57; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Minoura I, 2010, BIOPHYS J, V98, P1589, DOI 10.1016/j.bpj.2009.12.4323; Nishikawa M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.128103; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Okada Y, 1999, MOL BIOL CELL, V10, p236A; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Tuszynski JA, 2005, MATH COMPUT MODEL, V41, P1055, DOI 10.1016/j.mcm.2005.05.002; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	54	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25473	10.1371/journal.pone.0025473	http://dx.doi.org/10.1371/journal.pone.0025473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966532	gold, Green Published, Green Submitted			2022-12-27	WOS:000295932100041
J	Papadopoulos, A				Papadopoulos, Anthony			Stochastic Ontogenetic Allometry: The Statistical Dynamics of Relative Growth	PLOS ONE			English	Article							HETEROCHRONY; SIZE	Background: In the absence of stochasticity, allometric growth throughout ontogeny is axiomatically described by the logarithm-transformed power-law model, theta(t) = log(a) b + k phi(t), where theta(t): theta(t) and phi(t): phi(t) are the logarithmic sizes of two traits at any given time t. Realistically, however, stochasticity is an inherent property of ontogenetic allometry. Due to the inherent stochasticity in both theta(t) and phi(t), the ontogenetic allometry coefficients, log(a) b and k, can vary with t and have intricate temporal distributions that are governed by the central and mixed moments of the random ontogenetic growth functions, theta(t) and phi(t). Unfortunately, there is no probabilistic model for analyzing these informative ontogenetic statistical moments. Methodology/Principal Findings: This study treats theta(t) and phi(t) as correlated stochastic processes to formulate the exact probabilistic version of each of the ontogenetic allometry coefficients. In particular, the statistical dynamics of relative growth is addressed by analyzing the allometric growth factors that affect the temporal distribution of the probabilistic version of the relative growth rate, k = Dt(u <Omega(t)>)/D-t(v <Omega(t)>, where <Omega(t)> is the expected value of the ratio of stochastic theta(t) to stochastic phi(t), and u <Omega(t)> and nu <Omega(t)> are the numerator and the denominator of <Omega(t)>, respectively. These allometric growth factors, which provide important insight into ontogenetic allometry but appear only when stochasticity is introduced, describe the central and mixed moments of theta(t) and phi(t) as differentiable real-valued functions of t. Conclusions/Significance: Failure to account for the inherent stochasticity in both theta(t) and phi(t) leads not only to the miscalculation of k, but also to the omission of all of the informative ontogenetic statistical moments that affect the size of traits and the timing and rate of development of traits. Furthermore, even though the stochastic process theta(t) and the stochastic process phi(t) are linearly related, k can vary with t.	Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Papadopoulos, A (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	anthony.papadopoulos@ttu.edu			National Science Foundation (NSF) [DEB-0616942]	National Science Foundation (NSF)(National Science Foundation (NSF))	Support for this study was provided by National Science Foundation (NSF) award DEB-0616942 to Sean H. Rice. NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; [Anonymous], 1991, HETEROCHRONY EVOLUTI; ATCHLEY WR, 1984, AM NAT, V123, P519, DOI 10.1086/284220; Azarina S. V, 2009, INT J DIFFERENCE EQU, V4, P27; Bervian G, 2006, J FISH BIOL, V68, P196, DOI 10.1111/j.0022-1112.2006.00890.x; Heijmans R, 1999, STAT PAP, V40, P107, DOI 10.1007/BF02927114; Huxley J., 1932, PROBLEMS RELATIVE GR; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Huxley JS, 1924, NATURE, V114, P895, DOI 10.1038/114895a0; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; KLINGENBERG CP, 1993, EVOLUTION, V47, P1834, DOI [10.2307/2410225, 10.1111/j.1558-5646.1993.tb01273.x]; KLINGENBERG CP, 1992, AM NAT, V140, P601, DOI 10.1086/285430; LAIRD AK, 1965, GROWTH, V29, P249; LAIRD AK, 1968, GROWTH, V32, P347; Li HY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001245; Lutes L.D., 2004, RANDOM VIBRATIONS AN; NELSON E, 1966, PHYS REV, V150, P1079, DOI 10.1103/PhysRev.150.1079; Nelson E., 1967, DYNAMICAL THEORY BRO; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Pleasants AB, 1997, J AUST MATH SOC B, V38, P477, DOI 10.1017/S0334270000000813; Rice SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007130; Stevens Charles F, 2009, J Biol, V8, P14, DOI 10.1186/jbiol119; West D, 2011, EPL, V94, P1	23	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25267	10.1371/journal.pone.0025267	http://dx.doi.org/10.1371/journal.pone.0025267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966474	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100035
J	Sutherland, JS; Hill, PC; Adetifa, IM; de Jong, BC; Donkor, S; Joosten, SA; Opmeer, L; Haks, MC; Ottenhoff, THM; Adegbola, RA; Ota, MOC				Sutherland, Jayne S.; Hill, Philip C.; Adetifa, Ifedayo M.; de Jong, Bouke C.; Donkor, Simon; Joosten, Simone A.; Opmeer, Lizet; Haks, Marielle C.; Ottenhoff, Tom H. M.; Adegbola, Richard A.; Ota, Martin O. C.			Identification of Probable Early-Onset Biomarkers for Tuberculosis Disease Progression	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PREDICTIVE-VALUE; INFECTION; EXPRESSION; ASSAY	Determining what constitutes protective immunity to TB is critical for the development of improved diagnostics and vaccines. The comparison of the immune system between contacts of TB patients, who later develop TB disease (progressors), versus contacts who remain healthy (non-progressors), allows for identification of predictive markers of TB disease. This study provides the first comprehensive analysis of the immune system of progressors and non-progressors using a well-characterised TB case-contact (TBCC) platform in The Gambia, West Africa. 22 progressors and 31 non-progressors were analysed at recruitment, 3 months and 18 months (time to progression: median[IQR] of 507[187-714] days). Immunophenotyping of PBMC, plasma cytokine levels and RT-MLPA analysis of whole blood-derived RNA was performed to capture key immune system parameters. At recruitment, progressors had lower PBMC proportions of CD4+ T cells, NKT cells and B cells relative to non-progressors. Analysis of the plasma showed higher levels of IL-18 in progressors compared to non-progressors and analysis of the RNA showed significantly lower gene expression of Bcl2 but higher CCR7 in progressors compared to non-progressors. This study shows several markers that may predict the onset of active TB at a very early stage after infection. Once these markers have been validated in larger studies, they provide avenues to prospectively identify people at risk of developing TB, a key issue in the testing of new TB vaccines.	[Sutherland, Jayne S.; Hill, Philip C.; Adetifa, Ifedayo M.; de Jong, Bouke C.; Donkor, Simon; Adegbola, Richard A.; Ota, Martin O. C.] MRC Unit, Vaccinol Theme Grp, Fajara, Gambia; [Joosten, Simone A.; Opmeer, Lizet; Haks, Marielle C.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sutherland, JS (corresponding author), MRC Unit, Vaccinol Theme Grp, Fajara, Gambia.	jsutherland@mrc.gm	Joosten, Simone/E-4731-2011; de Jong, Bouke/A-3636-2013; Joosten, Simone A/F-1357-2011	de Jong, Bouke/0000-0002-1017-4675; Joosten, Simone A/0000-0002-9878-0863; Sutherland, Jayne/0000-0002-7083-4997	MRC Unit, The Gambia; Medical Research Council [MC_UP_A900_1122, MC_U190071468] Funding Source: researchfish; MRC [MC_U190071468, MC_UP_A900_1122] Funding Source: UKRI	MRC Unit, The Gambia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the MRC Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2010, EUR J IMMUNOL, V40, P291, DOI 10.1002/eji.200939856; Adolfo RBV, 2006, EUR J IMMUNOL, V36, P345, DOI 10.1002/eji.200535202; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Doherty M, 2009, CURR OPIN PULM MED, V15, P181, DOI 10.1097/MCP.0b013e328326f42c; Eldering E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng153; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Hoogerwerf JJ, 2010, J INNATE IMMUN, V2, P461, DOI 10.1159/000317035; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Joosten SA, 2011, GENES IMMUN IN PRESS; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Schultz H, 2007, CLIN CHIM ACTA, V384, P12, DOI 10.1016/j.cca.2007.07.005; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; STOP TB Partnership, GLOB PLAN STOP TB 20; Sutherland JS, 2009, TUBERCULOSIS, V89, P398, DOI 10.1016/j.tube.2009.07.004; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Yamada G, 2000, AM J RESP CRIT CARE, V161, P1786, DOI 10.1164/ajrccm.161.6.9911054	29	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25230	10.1371/journal.pone.0025230	http://dx.doi.org/10.1371/journal.pone.0025230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966464	Green Published, gold, Green Submitted			2022-12-27	WOS:000295267100031
J	Verma, S; Mehta, A; Shaha, C				Verma, Smriti; Mehta, Ashish; Shaha, Chandrima			CYP5122A1, a Novel Cytochrome P450 Is Essential for Survival of Leishmania donovani	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNELS; LIPID-METABOLISM; PARASITE; TRYPANOSOMA; INHIBITION; RESISTANCE; MILTEFOSINE; CHOLESTEROL; ERGOSTEROL; APOPTOSIS	Background: Cytochrome P450s (CYP450s) are hemoproteins catalysing diverse biochemical reactions important for metabolism of xenobiotics and synthesis of physiologically important compounds such as sterols. Therefore, they are functionally important for survival of invading pathogens. One such opportunistic pathogen Leishmania donovani causes visceral leishmaniasis worldwide, which is an important public health problem due to significant disease burden. The parasite genome database, Gene DB, annotates 3 CYP450s in Leishmania, however, the functional role of cytochrome P450 enzymes in Leishmania spp. remains elusive. Methodology/Principal Findings: A CYP450-like gene cloned from Leishmania donovani was identified as a novel CYP450, the CYP5122A1. Upon co-localization with organelle specific markers, CYP5122A1 distribution was shown to be localized in the promastigote ER, mitochondria and the glycosomes. Replacement of one allele of CYP5122A1 with either neomycin or hygromycin gene by homologous recombination in Leishmania promastigotes induced substantial reduction of CYP5122A1 expression. These parasites showed impaired growth, lower mitochondrial Ca2+ and membrane potential resulting in low ATP generation. Also, these parasites were less infective in vitro and in vivo than their wild-type counterparts as assessed by incubation of Leishmania promastigotes with macrophages in vitro as well as through administration of parasites into hamsters. The HKOs were more susceptible to drugs like miltefosine and antimony, but showed reduced sensitivity to amphotericin B. Removal of two alleles of CYP5122A1 did not allow the parasites to survive. The mutant parasites showed 3.5 times lower ergosterol level as compared to the wild-type parasites when estimated by Gas chromatography/mass spectrometry. Complementation of CYP5122A1 through episomal expression of protein by using pXG-GFP+2 vector partially rescued CYP5122A1 expression and restored ergosterol levels by 1.8 times. Phenotype reversal included restored growth pattern and lesser drug susceptibility. Conclusions/Significance: In summary, this study establishes CYP5122A1 as an important molecule linked to processes like cell growth, infection and ergosterol biosynthesis in Leishmania donovani.	[Verma, Smriti; Mehta, Ashish; Shaha, Chandrima] Natl Inst Immunol, Ctr Mol Med, Cell Death & Differentiat Res Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Verma, S (corresponding author), Natl Inst Immunol, Ctr Mol Med, Cell Death & Differentiat Res Lab, New Delhi 110067, India.	cshaha@nii.ac.in	Verma, Smriti/J-9950-2019; Mehta, Ashish/A-5537-2011	Verma, Smriti/0000-0002-3760-8090; Mehta, Ashish/0000-0002-0187-4477	Department of Biotechnology, New Delhi, India; National Institute of Immunology [BT/03/033/88]; Centre for Molecular Medicine, New Delhi [BT/PR/14549/MED/14/1291]; Council of Scientific and Industrial Research (CSIR), India [9/485(142)/05-EMR-I]; Life Science Research Board, New Delhi [DLS/81/48222/LSRB-169/ID/2008]	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); National Institute of Immunology; Centre for Molecular Medicine, New Delhi; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Life Science Research Board, New Delhi	This work was supported by grants from the Department of Biotechnology, New Delhi, India (http://dbtindia.nic.in/index.asp) to the National Institute of Immunology (Grant No. BT/03/033/88) and Centre for Molecular Medicine, New Delhi (Grant No. BT/PR/14549/MED/14/1291). The author SV was supported by a fellowship from the Council of Scientific and Industrial Research (CSIR), India (Award No. 9/485(142)/05-EMR-I). The author AM was supported by fellowship from Life Science Research Board, New Delhi (Grant No. DLS/81/48222/LSRB-169/ID/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Arora A, 2004, BIOCHEM BIOPH RES CO, V318, P920, DOI 10.1016/j.bbrc.2004.04.118; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; BERGER BJ, 1993, BIOCHEM PHARMACOL, V46, P149, DOI 10.1016/0006-2952(93)90359-5; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Chen CK, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000372; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cohen BE, 1998, INT J PHARM, V162, P95, DOI 10.1016/S0378-5173(97)00417-1; Conklin KA, 2004, J NUTR, V134, p3201S, DOI 10.1093/jn/134.11.3201S; Croft SL, 2006, T ROY SOC TROP MED H, V100, pS4, DOI 10.1016/j.trstmh.2006.03.009; Croft SL, 2006, INDIAN J MED RES, V123, P399; Fonseca-Silva F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014666; Galea AM, 2009, FREE RADICAL BIO MED, V47, P880, DOI 10.1016/j.freeradbiomed.2009.06.027; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Iyer JP, 2008, MOL MICROBIOL, V68, P372, DOI 10.1111/j.1365-2958.2008.06154.x; Jain R, 2010, CELL MICROBIOL, V12, P432, DOI 10.1111/j.1462-5822.2009.01406.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva G, 2008, LIPIDS, V43, P1117, DOI 10.1007/s11745-008-3225-y; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mbongo N, 1998, ANTIMICROB AGENTS CH, V42, P352; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Nelson David R., 2009, Human Genomics, V4, P59; Olsher M, 2005, BIOCHEMISTRY-US, V44, P2080, DOI 10.1021/bi047710s; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; Ouellette Marc, 2008, P159; Panwar SL, 2001, YEAST, V18, P1117, DOI 10.1002/yea.762; Rakotomanga M, 2007, ANTIMICROB AGENTS CH, V51, P1425, DOI 10.1128/AAC.01123-06; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; SACKS DL, 1985, J IMMUNOL, V135, P564; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Sundar S, 2006, INDIAN J MED RES, V123, P345; Urbina JA, 1997, PARASITOLOGY, V114, pS91, DOI 10.1017/S0031182097001194; van Hellemond JJ, 2006, FEBS LETT, V580, P5552, DOI 10.1016/j.febslet.2006.07.056; Venkateswarlu K, 1997, J MED VET MYCOL, V35, P19	43	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25273	10.1371/journal.pone.0025273	http://dx.doi.org/10.1371/journal.pone.0025273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966477	Green Published, Green Submitted, gold			2022-12-27	WOS:000295267100037
J	Pal, M; Tan, MJ; Huang, RL; Goh, YY; Wang, XL; Tang, MBY; Tan, NS				Pal, Mintu; Tan, Ming Jie; Huang, Royston-Luke; Goh, Yan Yih; Wang, Xiao Ling; Tang, Mark Boon Yang; Tan, Nguan Soon			Angiopoietin-Like 4 Regulates Epidermal Differentiation	PLOS ONE			English	Article							WOUND-HEALING DRUGS; SIGNAL-TRANSDUCTION; KERATINOCYTE GROWTH; PPAR-BETA/DELTA; ADIPOSE-TISSUE; CELL-ADHESION; PROTEINS; MIGRATION; TARGET; EXPRESSION	The nuclear hormone receptor PPAR beta/delta is integral to efficient wound re-epithelialization and implicated in epidermal maturation. However, the mechanism underlying the latter process of epidermal differentiation remains unclear. We showed that ligand-activated PPAR beta/delta indirectly stimulated keratinocyte differentiation, requiring de novo gene transcription and protein translation. Using organotypic skin cultures constructed from PPAR beta/delta- and angiopoietin-like 4 (ANGPTL4)-knockdown human keratinocytes, we showed that the expression of ANGPTL4, a PPAR beta/delta target gene, is essential for the receptor mediated epidermal differentiation. The pro-differentiation effect of PPAR beta/delta agonist GW501516 was also abolished when keratinocytes were co-treated with PPAR beta/delta antagonist GSK0660 and similarly in organotypic skin culture incubated with blocking ANGPTL4 monoclonal antibody targeted against the C-terminal fibrinogen-like domain. Our focused real-time PCR gene expression analysis comparing the skin biopsies from wildtype and ANGPTL4-knockout mice confirmed a consistent down-regulation of numerous genes involved in epidermal differentiation and proliferation in the ANGPTL4-knockout skin. We further showed that the deficiency of ANGPTL4 in human keratinocytes and mice skin have diminished expression of various protein kinase C isotypes and phosphorylated transcriptional factor activator protein-1, which are well-established for their roles in keratinocyte differentiation. Chromatin immunoprecipitation confirmed that ANGPTL4 stimulated the activation and binding of JUNB and c-JUN to the promoter region of human involucrin and transglutaminase type 1 genes, respectively. Taken together, we showed that PPAR beta/delta regulates epidermal maturation via ANGPTL4-mediated signalling pathway.	[Pal, Mintu; Tan, Ming Jie; Huang, Royston-Luke; Goh, Yan Yih; Wang, Xiao Ling; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Coll Sci, Singapore, Singapore; [Tang, Mark Boon Yang] Natl Skin Ctr, Singapore 1130, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Skin Centre	Pal, M (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Coll Sci, Singapore, Singapore.	nstan@ntu.edu.sg	Goh, Yan Yih/J-1926-2015; Tan, Nguan Soon/A-2220-2011	Goh, Yan Yih/0000-0002-8922-9869; Tan, Nguan Soon/0000-0003-0136-7341	National Medical Research Council (NMRC) [IRG10MAY017]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This work was supported by a grant from National Medical Research Council (NMRC) (IRG10MAY017) to N.S.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Dutton S, 2008, BRIT J NUTR, V100, P18, DOI 10.1017/S0007114507882961; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hanley K, 1997, PEDIATR RES, V42, P610, DOI 10.1203/00006450-199711000-00010; Ito Y, 2003, CANCER RES, V63, P6651; Kamioka N, 2010, BIOCHEM BIOPH RES CO, V394, P106, DOI 10.1016/j.bbrc.2010.02.125; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Komuves LG, 1998, J INVEST DERMATOL, V111, P429, DOI 10.1046/j.1523-1747.1998.00296.x; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Rutberg SE, 1996, ONCOGENE, V13, P167; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190; Stapleton CM, 2010, EXP CELL RES, V316, P507, DOI 10.1016/j.yexcr.2009.12.004; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tan NS, 2005, J BIOL CHEM, V280, P18163, DOI 10.1074/jbc.M412829200; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2003, AM J CLIN DERMATOL, V4, P523, DOI 10.2165/00128071-200304080-00001; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tan SH, 2009, J BIOL CHEM, V284, P18047, DOI 10.1074/jbc.M109.002691; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	41	27	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25377	10.1371/journal.pone.0025377	http://dx.doi.org/10.1371/journal.pone.0025377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966511	Green Published, gold			2022-12-27	WOS:000295265100095
J	Hollen, LI; Bell, MBV; Russell, A; Niven, F; Ridley, AR; Radford, AN				Hollen, Linda I.; Bell, Matthew B. V.; Russell, Alexis; Niven, Fraser; Ridley, Amanda R.; Radford, Andrew N.			Calling by Concluding Sentinels: Coordinating Cooperation or Revealing Risk?	PLOS ONE			English	Article							WATCHMANS SONG HYPOTHESIS; BREEDING PIED BABBLER; SELFISH SENTINELS; SOCIAL BIRD; VIGILANCE; BEHAVIOR; PREDATION; HABITAT; URGENCY; SAFE	Efficient cooperation requires effective coordination of individual contributions to the cooperative behaviour. Most social birds and mammals involved in cooperation produce a range of vocalisations, which may be important in regulating both individual contributions and the combined group effort. Here we investigate the role of a specific call in regulating cooperative sentinel behaviour in pied babblers (Turdoides bicolor). 'Fast-rate chuck' calls are often given by sentinels as they finish guard bouts and may potentially coordinate the rotation of individuals as sentinels, minimising time without a sentinel, or may signal the presence or absence of predators, regulating the onset of the subsequent sentinel bout. We ask (i) when fast-rate chuck calls are given and (ii) what effect they have on the interval between sentinel bouts. Contrary to expectation, we find little evidence that these calls are involved in regulating the pied babbler sentinel system: observations revealed that their utterance is influenced only marginally by wind conditions and not at all by habitat, while observations and experimental playback showed that the giving of these calls has no effect on inter-bout interval. We conclude that pied babblers do not seem to call at the end of a sentinel bout to maximise the efficiency of this cooperative act, but may use vocalisations at this stage to influence more individually driven behaviours.	[Hollen, Linda I.; Radford, Andrew N.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Bell, Matthew B. V.] Univ Cambridge, Dept Zool, Cambridge, England; [Russell, Alexis; Niven, Fraser] Pied Babbler Res Project, Vanzylsrus, No Cape, South Africa; [Ridley, Amanda R.] Univ Cape Town, Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa	University of Bristol; University of Cambridge; University of Cape Town	Hollen, LI (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	linda.hollen@bristol.ac.uk	Ridley, Amanda/D-2636-2011; Bell, Matthew/B-6353-2013; Ridley, Amanda/B-5759-2009	Ridley, Amanda/0000-0001-5886-0992; Radford, Andrew N/0000-0001-5470-3463	Magdalene College, Cambridge; CoE at the Fitzpatrick Institute; Biotechnology and Biological Sciences Research Council (BBSRC); Marie Curie Fellowship; Percy Fitzpatrick Institute of African Ornithology in Cape Town; Biotechnology and Biological Sciences Research Council [BB/C520555/2, BB/C520555/1] Funding Source: researchfish	Magdalene College, Cambridge; CoE at the Fitzpatrick Institute; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Fellowship(European Commission); Percy Fitzpatrick Institute of African Ornithology in Cape Town; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Dr. Hollen was funded by a Marie Curie Fellowship, Dr. Bell was supported by a Junior Research Fellowship from Magdalene College, Cambridge, Dr. Ridley by the CoE at the Fitzpatrick Institute, and Dr. Radford by a Biotechnology and Biological Sciences Research Council (BBSRC) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr and Mrs Kotze, the Kalahari Research Trust, Tim Clutton-Brock and Marta Manser for access to land and logistics; the Northern Cape Conservation Authority for research permission; the Percy Fitzpatrick Institute of African Ornithology in Cape Town for funding to maintain the Pied Babbler Project; Krystyna Golabek, Martha Nelson-Flower and Nichola Raihani for habituation help; Rachel Smith and Alex Thompson for help locating groups and obtaining call recordings; and Isa-Rita Russo and Martha Nelson-Flower for molecular sexing.	[Anonymous], 2010, R LANG ENV STAT COMP; Baayen RH, 2010, LANGUAGER DATA SETS; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bednekoff PA, 2003, ETHOLOGY, V109, P895, DOI 10.1046/j.0179-1613.2003.00926.x; Bednekoff PA, 1997, AM NAT, V150, P373, DOI 10.1086/286070; Bednekoff PA, 2008, ETHOLOGY, V114, P313, DOI 10.1111/j.1439-0310.2008.01467.x; Bell MBV, 2010, P ROY SOC B-BIOL SCI, V277, P3223, DOI 10.1098/rspb.2010.0643; Bell MBV, 2009, P ROY SOC B-BIOL SCI, V276, P2997, DOI 10.1098/rspb.2009.0276; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; GASTON AJ, 1977, ANIM BEHAV, V25, P828, DOI 10.1016/0003-3472(77)90036-7; Griesser M, 2009, BEHAV ECOL, V20, P709, DOI 10.1093/beheco/arp045; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hilton GM, 1999, OIKOS, V87, P295, DOI 10.2307/3546744; Hollen LI, 2008, CURR BIOL, V18, P576, DOI 10.1016/j.cub.2008.02.078; Leavesley AJ, 2005, ANIM BEHAV, V70, P365, DOI 10.1016/j.anbehav.2004.10.017; MACEDONIA JM, 1993, ETHOLOGY, V93, P177, DOI 10.1111/j.1439-0310.1993.tb00988.x; Manser MB, 1999, P ROY SOC B-BIOL SCI, V266, P1013, DOI 10.1098/rspb.1999.0737; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MCGOWAN KJ, 1989, ANIM BEHAV, V37, P1000, DOI 10.1016/0003-3472(89)90144-9; METCALFE NB, 1984, ANIM BEHAV, V32, P981, DOI 10.1016/S0003-3472(84)80210-9; Nelson-Flower MJ, 2011, BEHAV ECOL, V22, P559, DOI 10.1093/beheco/arr018; Radford AN, 2004, ETHOLOGY, V110, P11, DOI 10.1046/j.1439-0310.2003.00943.x; Radford AN, 2008, ANIM BEHAV, V75, P519, DOI 10.1016/j.anbehav.2007.05.016; Radford AN, 2007, BIOLOGY LETT, V3, P249, DOI 10.1098/rsbl.2007.0110; Radford AN, 2006, CURR BIOL, V16, P1700, DOI 10.1016/j.cub.2006.06.053; Radford AN, 2011, EVOLUTION, V65, P900, DOI 10.1111/j.1558-5646.2010.01180.x; Radford AN, 2009, P ROY SOC B-BIOL SCI, V276, P2437, DOI 10.1098/rspb.2009.0187; Raihani NJ, 2007, ANIM BEHAV, V74, P1303, DOI 10.1016/j.anbehav.2007.02.025; RASA OAE, 1986, ETHOLOGY, V71, P340, DOI 10.1111/j.1439-0310.1986.tb00598.x; Ridley AR, 2007, BEHAV ECOL, V18, P324, DOI 10.1093/beheco/arl092; Ridley AR, 2010, BIOL LETTERS, V6, P445, DOI 10.1098/rsbl.2010.0023; Townsend SW, 2011, BEHAV ECOL SOCIOBIOL, V65, P1927, DOI 10.1007/s00265-011-1202-6; WICKLER W, 1985, Z TIERPSYCHOL, V69, P250; Wright J, 2001, ANIM BEHAV, V62, P973, DOI 10.1006/anbe.2001.1838; Wright J, 2001, J ANIM ECOL, V70, P1070, DOI 10.1046/j.0021-8790.2001.00565.x; [No title captured]; [No title captured]	37	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25010	10.1371/journal.pone.0025010	http://dx.doi.org/10.1371/journal.pone.0025010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984898	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000008
J	Kong, XQ; Ouyang, SS; Liang, ZJ; Lu, JY; Chen, L; Shen, BR; Li, DH; Zheng, MY; Li, KK; Luo, C; Jiang, HL				Kong, Xiangqian; Ouyang, Sisheng; Liang, Zhongjie; Lu, Junyan; Chen, Liang; Shen, Bairong; Li, Donghai; Zheng, Mingyue; Li, Keqin Kathy; Luo, Cheng; Jiang, Hualiang			Catalytic Mechanism Investigation of Lysine-Specific Demethylase 1 (LSD1): A Computational Study	PLOS ONE			English	Article							MONOAMINE-OXIDASE-A; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; POLYAMINE OXIDASE; STRUCTURAL BASIS; AMINE OXIDATION; PH-DEPENDENCE; SUBSTRATE; INSIGHTS; COMPLEX	Lysine-specific demethylase 1 (LSD1), the first identified histone demethylase, is a flavin-dependent amine oxidase which specifically demethylates mono-or dimethylated H3K4 and H3K9 via a redox process. It participates in a broad spectrum of biological processes and is of high importance in cell proliferation, adipogenesis, spermatogenesis, chromosome segregation and embryonic development. To date, as a potential drug target for discovering anti-tumor drugs, the medical significance of LSD1 has been greatly appreciated. However, the catalytic mechanism for the rate-limiting reductive half-reaction in demethylation remains controversial. By employing a combined computational approach including molecular modeling, molecular dynamics (MD) simulations and quantum mechanics/molecular mechanics (QM/MM) calculations, the catalytic mechanism of dimethylated H3K4 demethylation by LSD1 was characterized in details. The three-dimensional (3D) model of the complex was composed of LSD1, CoREST, and histone substrate. A 30-ns MD simulation of the model highlights the pivotal role of the conserved Tyr761 and lysine-water-flavin motif in properly orienting flavin adenine dinucleotide (FAD) with respect to substrate. The synergy of the two factors effectively stabilizes the catalytic environment and facilitated the demethylation reaction. On the basis of the reasonable consistence between simulation results and available mutagenesis data, QM/MM strategy was further employed to probe the catalytic mechanism of the reductive half-reaction in demethylation. The characteristics of the demethylation pathway determined by the potential energy surface and charge distribution analysis indicates that this reaction belongs to the direct hydride transfer mechanism. Our study provides insights into the LSD1 mechanism of reductive half-reaction in demethylation and has important implications for the discovery of regulators against LSD1 enzymes.	[Kong, Xiangqian; Ouyang, Sisheng; Liang, Zhongjie; Lu, Junyan; Chen, Liang; Zheng, Mingyue; Luo, Cheng; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Shen, Bairong; Luo, Cheng] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Li, Donghai] Nanjing Univ, Sch Life Sci, Jiangsu Diabet Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China; [Li, Keqin Kathy] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Jiang, Hualiang] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Soochow University - China; Nanjing University; Chinese Academy of Sciences; Shanghai Jiao Tong University; East China University of Science & Technology	Kong, XQ (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	kli@epigenetic.us; cluo@mail.shcnc.ac.cn	Zheng, Mingyue/HHZ-4062-2022; Shen, Bairong/E-6431-2012; Shen, Bairong/W-1254-2019; Kong, Xiangqian/J-4500-2017; Liang, Zhongjie/F-2108-2019; Zheng, Mingyue/B-4860-2010; Zheng, Mingyue/Z-3582-2019; Zheng, Mingyue/AAJ-8027-2020	Zheng, Mingyue/0000-0002-3323-3092; Shen, Bairong/0000-0003-2899-1531; Shen, Bairong/0000-0003-2899-1531; Kong, Xiangqian/0000-0002-9596-7825; Liang, Zhongjie/0000-0003-0763-5407; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Lu, Junyan/0000-0002-9211-0746	State Key Program of Basic Research of China [2009CB918502]; National Natural Science Foundation of China [20972174, 21021063, 31000323, 91029704]; Shanghai Committee of Science and Technology [10410703900]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100091120023]; Chinese Academy of Sciences [XDA01040305]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors gratefully acknowledge financial support from the State Key Program of Basic Research of China grant (2009CB918502), the National Natural Science Foundation of China grants (20972174, 21021063, 31000323 and 91029704), Shanghai Committee of Science and Technology grants (10410703900), Specialized Research Fund for the Doctoral Program of Higher Education of China (20100091120023) and the Chinese Academy of Sciences (XDA01040305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2011, STRUCTURE, V19, P212, DOI 10.1016/j.str.2011.01.001; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Binda C, 1999, STRUCTURE, V7, P265, DOI 10.1016/S0969-2126(99)80037-9; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Brinkley DW, 2005, J AM CHEM SOC, V127, P15720, DOI 10.1021/ja056025l; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen Y, 2006, P NATL ACAD SCI USA, V103, P13956, DOI 10.1073/pnas.0606381103; Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dunn RV, 2008, FEBS J, V275, P3850, DOI 10.1111/j.1742-4658.2008.06532.x; Edmondson DE, 2007, ARCH BIOCHEM BIOPHYS, V464, P269, DOI 10.1016/j.abb.2007.05.006; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Forneris F, 2009, FEBS J, V276, P4304, DOI 10.1111/j.1742-4658.2009.07142.x; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frisch M.J., 2003, GAUSSIAN 03 REVISION; Gaweska H, 2009, BIOCHEMISTRY-US, V48, P5440, DOI 10.1021/bi900499w; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurtz KA, 2000, J AM CHEM SOC, V122, P12896, DOI 10.1021/ja002528+; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liang ZJ, 2010, J PHYS CHEM B, V114, P11927, DOI 10.1021/jp1054183; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Lv SA, 2010, EUR J CELL BIOL, V89, P557, DOI 10.1016/j.ejcb.2010.01.004; MASERAS F, 1995, J COMPUT CHEM, V16, P1170, DOI 10.1002/jcc.540160911; MENON V, 1995, BIOORG CHEM, V23, P42, DOI 10.1006/bioo.1995.1004; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Polticelli F, 2005, BIOCHEMISTRY-US, V44, P16108, DOI 10.1021/bi050983i; Pozzi MH, 2010, ARCH BIOCHEM BIOPHYS, V498, P83, DOI 10.1016/j.abb.2010.04.015; Pozzi MH, 2009, BIOCHEMISTRY-US, V48, P12305, DOI 10.1021/bi901694s; Pozzi MH, 2009, BIOCHEMISTRY-US, V48, P1508, DOI 10.1021/bi802227m; Raghavachari K, 2000, THEOR CHEM ACC, V103, P361, DOI 10.1007/s002149900065; Ralph EC, 2005, BIOCHEMISTRY-US, V44, P3074, DOI 10.1021/bi047716h; Ralph EC, 2007, BIOCHEMISTRY-US, V46, P7655, DOI 10.1021/bi700482h; Ralph EC, 2006, BIOCHEMISTRY-US, V45, P15844, DOI 10.1021/bi061894o; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saramaki A, 2009, J BIOL CHEM, V284, P8073, DOI 10.1074/jbc.M808090200; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SILVERMAN RB, 1995, ACCOUNTS CHEM RES, V28, P335, DOI 10.1021/ar00056a003; SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Svensson M, 1996, J CHEM PHYS, V105, P3654, DOI 10.1063/1.472235; Tilocca A, 2002, BIOCHEMISTRY-US, V41, P14111, DOI 10.1021/bi020309q; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Vreven T, 2001, J CHEM PHYS, V115, P62, DOI 10.1063/1.1376127; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Vreven T, 2000, J COMPUT CHEM, V21, P1419, DOI 10.1002/1096-987X(200012)21:16<1419::AID-JCC1>3.0.CO;2-C; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yuan HL, 2011, BIOCHEMISTRY-US, V50, P770, DOI 10.1021/bi101837u	79	28	29	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25444	10.1371/journal.pone.0025444	http://dx.doi.org/10.1371/journal.pone.0025444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984927	gold, Green Submitted, Green Published			2022-12-27	WOS:000295941300031
J	Rick, IP; Mehlis, M; Bakker, TCM				Rick, Ingolf P.; Mehlis, Marion; Bakker, Theo C. M.			Male Red Ornamentation Is Associated with Female Red Sensitivity in Sticklebacks	PLOS ONE			English	Article							SEXUAL SELECTION; MATE-CHOICE; GASTEROSTEUS-ACULEATUS; ARTIFICIAL SELECTION; SENSORY DRIVE; SPECTRAL SENSITIVITY; GENETIC CORRELATION; MATING PREFERENCES; OPTOMOTOR RESPONSE; COLOR PATTERNS	Sexual selection theory proposes correlated evolutionary changes in mating preferences and secondary sexual characters based on a positive genetic correlation between preference and the preferred trait. Empirical work has provided support for a genetic covariation between female preference and male attractiveness in several taxa. Here, we study parent and offspring visual traits in threespine sticklebacks, Gasterosteus aculeatus. While focusing on the proximate basis of mating preferences, we compare the red breeding coloration of males, which strongly contributes to female choice, with their daughters' red sensitivity measured by optomotor response thresholds. We show that the red color expression of fathers correlates well with their daughters' red sensitivity. Given that a within-population genetic correlation between signal and preference was experimentally confirmed for the red coloration in sticklebacks, our results indicate a proximate mechanism in terms of perceptual sensitivity being involved in the co-evolution of female preferences and male mating signals.	[Rick, Ingolf P.; Mehlis, Marion; Bakker, Theo C. M.] Univ Bonn, Inst Evolutionary Biol & Ecol, D-5300 Bonn, Germany	University of Bonn	Rick, IP (corresponding author), Univ Bonn, Inst Evolutionary Biol & Ecol, D-5300 Bonn, Germany.	irick@evolution.uni-bonn.de	Bakker, Theo/AAI-3587-2020; Rick, Ingolf P/AAP-2531-2020; Rick, Ingolf P/C-1387-2010	Rick, Ingolf P/0000-0001-8072-6933; 				Allison JD, 2008, J EVOLUTION BIOL, V21, P1666, DOI 10.1111/j.1420-9101.2008.01595.x; Andersson Malte, 1994; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; Bakker TCM, 1999, NATURE, V401, P234, DOI 10.1038/45727; BAKKER TCM, 1993, MAR BEHAV PHYSIOL, V23, P287; BAKKER TCM, 1991, BEHAV ECOL SOCIOBIOL, V29, P205, DOI 10.1007/BF00166402; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Baugh AT, 2009, BEHAV ECOL, V20, P1153, DOI 10.1093/beheco/arp120; Bleiweiss R, 2007, EVOLUTION, V61, P2861, DOI 10.1111/j.1558-5646.2007.00217.x; BOAKE CRB, 1991, TRENDS ECOL EVOL, V6, P225, DOI 10.1016/0169-5347(91)90027-U; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Boulcott P, 2007, EVOL ECOL, V21, P601, DOI 10.1007/s10682-006-9138-4; BREDEN F, 1994, HEREDITY, V73, P291, DOI 10.1038/hdy.1994.136; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; BUTLIN RK, 1989, BIOL J LINN SOC, V37, P237, DOI 10.1111/j.1095-8312.1989.tb01902.x; Candolin U, 1999, P ROY SOC B-BIOL SCI, V266, P785, DOI 10.1098/rspb.1999.0706; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 2000, BEHAV ECOL SOCIOBIOL, V49, P57, DOI 10.1007/s002650000267; Candolin U, 2009, AM NAT, V173, P273, DOI 10.1086/595753; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Cronin TW, 2001, NATURE, V411, P547, DOI 10.1038/35079184; CRONLYDILLON J, 1968, J EXP BIOL, V49, P679; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Endler JA, 2001, AM NAT, V158, P36, DOI 10.1086/320862; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fisher RA, 1930, GENETICAL THEORY NAT; Flamarique IN, 2005, J COMP PHYSIOL A, V191, P37, DOI 10.1007/s00359-004-0573-9; FLEISHMAN LJ, 1988, ANIM BEHAV, V36, P1420, DOI 10.1016/S0003-3472(88)80212-4; Fukamachi S, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-64; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gray DA, 1999, EVOLUTION, V53, P848, DOI [10.2307/2640724, 10.1111/j.1558-5646.1999.tb05378.x]; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; Griggio M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-261; Heckel G, 2002, CONSERV GENET, V3, P79, DOI 10.1023/A:1014255027870; HOUDE AE, 1994, P ROY SOC B-BIOL SCI, V256, P125, DOI 10.1098/rspb.1994.0059; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kawata M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-99; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; Kraak SBM, 1999, BEHAV ECOL, V10, P696, DOI 10.1093/beheco/10.6.696; Kroger RHH, 2003, J EXP BIOL, V206, P1643, DOI 10.1242/jeb.00337; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; MCDONALD CG, 1995, J COMP PHYSIOL A, V176, P255; MCLENNAN DA, 1990, CAN J ZOOL, V68, P482, DOI 10.1139/z90-071; McLennan Deborah A., 2007, P179; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; MILINSKI M, 1992, P ROY SOC B-BIOL SCI, V250, P229, DOI 10.1098/rspb.1992.0153; Montgomerie R., 2006, BIRD COLORATION, P90; Mulard H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-147; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P5, DOI 10.1016/S0169-5347(00)02030-9; Rick IP, 2008, NATURWISSENSCHAFTEN, V95, P631, DOI 10.1007/s00114-008-0365-0; Rick IP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-189; Ronnestad I, 1998, COMP BIOCHEM PHYS A, V119, P787, DOI 10.1016/S1095-6433(98)01017-4; Rowe MP, 2004, J COMP PHYSIOL A, V190, P241, DOI 10.1007/s00359-004-0493-8; Rowland William J., 1994, P297; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; Schaerer S, 1996, VISION RES, V36, P4025, DOI 10.1016/S0042-6989(96)00149-6; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shand J, 2008, J EXP BIOL, V211, P1495, DOI 10.1242/jeb.012047; Simmons LW, 2007, P NATL ACAD SCI USA, V104, P16604, DOI 10.1073/pnas.0704871104; Toomey MB, 2010, J EXP BIOL, V213, P1709, DOI 10.1242/jeb.041004; Uetz GW, 2007, BEHAV ECOL SOCIOBIOL, V61, P631, DOI 10.1007/s00265-006-0293-y; Von Helversen D, 2004, ANIM BEHAV, V68, P131, DOI 10.1016/j.anbehav.2003.10.020; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Wiley C, 2010, EVOLUTION, V64, P2238, DOI 10.1111/j.1558-5646.2010.01007.x; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; ZIMMERMAN WF, 1971, SCIENCE, V171, P1167, DOI 10.1126/science.171.3976.1167	77	30	30	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25554	10.1371/journal.pone.0025554	http://dx.doi.org/10.1371/journal.pone.0025554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984930	Green Submitted, gold, Green Published			2022-12-27	WOS:000295941300040
J	Chaves, OM; Stoner, KE; Angeles-Campos, S; Arroyo-Rodriguez, V				Chaves, Oscar M.; Stoner, Kathryn E.; Angeles-Campos, Sergio; Arroyo-Rodriguez, Victor			Wood Consumption by Geoffroyi's Spider Monkeys and Its Role in Mineral Supplementation	PLOS ONE			English	Article							ALOUATTA-SENICULUS; BARK CONSUMPTION; ATELES-GEOFFROYI; COLOBUS-GUEREZA; DIET; FOREST; WILD; PATTERNS; PRIMATES; PROTEIN	Wood consumption is a rare behavior in frugivorous primates; however, it can be necessary for nutritional balancing as it may provide macro and/or micronutrients that are scarce in the most frequently eaten items (fruits). We tested this hypothesis in six spider monkey (Ateles geoffroyi) communities inhabiting continuous and fragmented rainforests in Lacandona, Mexico. We investigated the importance of both live and decayed wood in the diet of the monkeys, and assessed if wood consumption is related to the nutritional composition of these items. In general, wood consumption was focused on trees of Licania platypus (Chrysobalanaceae) and Ficus spp. (Moraceae), and was similar in continuous forest and in fragments (mean +/- SD; 24 +/- 20% vs 18 +/- 16% of total feeding time, respectively), but marginally higher in females than in males (16 +/- 14% vs 5 +/- 4%, respectively). Live and decayed wood were both poorer in lipids, proteins, total nonstructural carbohydrates, and total digestible nutrients compared to mature and immature fruits. Moreover, decayed wood of L. platypus showed consistently higher levels of sodium and calcium compared to fruits. In conclusion, our findings suggest that wood from decaying trees of L. platypus and Ficus spp. and young branch piths of L. platypus represents an important source of sodium and/or calcium in the diet of spider monkeys, particularly in the case of females. The protection of decaying trees within forests and fragments is therefore necessary for the appropriate management and conservation of this endangered primate species.	[Chaves, Oscar M.] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil; [Chaves, Oscar M.; Stoner, Kathryn E.; Arroyo-Rodriguez, Victor] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Stoner, Kathryn E.] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX USA; [Angeles-Campos, Sergio] Univ Nacl Autonoma Mexico, Dept Nutr Anim & Bioquim, Fac Med Vet & Zootecn, Delegacion Coyoacan, Mexico	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidad Nacional Autonoma de Mexico; Texas A&M University System; Texas A&M University Kingsville; Universidad Nacional Autonoma de Mexico	Chaves, OM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil.	ochaba@gmail.com	Stoner, Kathryn E/E-1510-2015; Arroyo-Rodríguez, Víctor/C-9255-2009; Chaves, Óscar M./AAF-1886-2021; Chaves, Óscar/I-6028-2015	Stoner, Kathryn E/0000-0002-9964-1697; Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Chaves, Óscar M./0000-0001-6246-1265; 	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [CB-2005-51043, CB-2006-56799]; Secretaria de Relaciones Exteriores de Mexico (SRE)	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Relaciones Exteriores de Mexico (SRE)	This research was supported by a grant from the Consejo Nacional de Ciencia y Tecnologia to K. E. Stoner (CONACyT Grant CB-2005-51043 and CB-2006-56799) and by a scholarship to O. M. Chaves provided by the Secretaria de Relaciones Exteriores de Mexico (SRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana AM, 2009, THESIS CBM SWEDISH B; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2003, MINERALS ANIMAL HUMA, DOI DOI 10.1016/B978-0-444-51367-0.50006-4; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Beeson KC, 1976, SOIL FACTOR NUTR ANI; Blake JG, 2010, INT J PRIMATOL, V31, P471, DOI 10.1007/s10764-010-9407-5; Calegaro-Marques C., 1994, ACTA BIOL LEOPOLD, V16, P69; Cant J.G.H., 1990, Human Evolution, V5, P269, DOI 10.1007/BF02437243; Chapman CA, 2003, INT J PRIMATOL, V24, P317, DOI 10.1023/A:1023049200150; CHAPMAN CA, 1990, BEHAV ECOL SOCIOBIOL, V26, P409; Chaves OM, 2012, BIOTROPICA, V44, P105, DOI 10.1111/j.1744-7429.2011.00766.x; Conklin-Brittain NL, 1999, J CHEM ECOL, V25, P2601, DOI 10.1023/A:1020835120701; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Deblauwe I, 2008, AM J PHYS ANTHROPOL, V135, P42, DOI 10.1002/ajpa.20703; Dew JL, 2005, INT J PRIMATOL, V26, P1107, DOI 10.1007/s10764-005-6461-5; Di Fiore A, 2008, CAM S BIO EVOL ANTHR, V55, P81; Dimov M, 2010, J PHYS ACT HEALTH, V7, P239, DOI 10.1123/jpah.7.2.239; Fashing PJ, 2007, INT J PRIMATOL, V28, P673, DOI 10.1007/s10764-006-9096-2; Felton AM, 2008, INT J PRIMATOL, V29, P379, DOI 10.1007/s10764-008-9241-1; Felton AM, 2009, INT J PRIMATOL, V30, P675, DOI 10.1007/s10764-009-9367-9; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Ghiglieri M.P., 1984, CHIMPANZEES KIBALE F; HANSSON L, 1991, J CHEM ECOL, V17, P735, DOI 10.1007/BF00994196; Helrich K., 1990, ASS OFFICIAL ANAL CH; Holdridge L.R., 1971, FOREST ENV TROPICAL; Huffman Michael A., 1994, P129; IZAWA K, 1993, INT J PRIMATOL, V14, P229, DOI 10.1007/BF02192633; JULLIOT C, 1993, INT J PRIMATOL, V14, P527, DOI 10.1007/BF02215446; Kalkwarf HJ, 1999, J CLIN ENDOCR METAB, V84, P464, DOI 10.1210/jc.84.2.464; Klein L. L, 1977, P153; Krebs J. C., 1999, ECOLOGICAL METHODOLO; Krishnamani R, 2000, ANIM BEHAV, V59, P899, DOI 10.1006/anbe.1999.1376; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; Lambert JE, 2000, AFR J ECOL, V38, P360, DOI 10.1046/j.1365-2028.2000.00219.x; Lehman A., 2005, JMP BASIC UNIVARIATE; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Milton K, 2003, COMP BIOCHEM PHYS A, V136, P47, DOI 10.1016/S1095-6433(03)00084-9; National Research Council US, 2003, NUTR REQ NONH PRIM; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; NRC (National Research Council), 1989, REC DIET ALL, V10th; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Pinto LP, 2004, INT J PRIMATOL, V25, P1197, DOI 10.1023/B:IJOP.0000043958.75534.7f; Reynolds V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006194; Riley EP, 2007, INT J PRIMATOL, V28, P107, DOI 10.1007/s10764-006-9104-6; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rode KD, 2003, INT J PRIMATOL, V24, P541, DOI 10.1023/A:1023788330155; Rothman JM, 2007, J TROP ECOL, V23, P673, DOI 10.1017/S0266467407004555; Rothman JM, 2008, AM J PRIMATOL, V70, P690, DOI 10.1002/ajp.20540; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480; Sandstrom B, 2001, BRIT J NUTR, V85, pS181, DOI 10.1079/BJN2000312; Simmen B, 1996, INT J PRIMATOL, V17, P661, DOI 10.1007/BF02735260; Slater KY, 2009, AM J PRIMATOL, V71, P21, DOI 10.1002/ajp.20618; Stephens SA, 2006, BIOTROPICA, V38, P617, DOI 10.1111/j.1744-7429.2006.00197.x; Suarez SA, 2006, INT J PRIMATOL, V27, P411, DOI 10.1007/s10764-006-9023-6; Underwood EJ, 1999, MINERAL NUTR LIVE ST; Van Wambeke A., 1992, SOILS TROPICS PROPER; Yanai J, 2009, SOIL SCI PLANT NUTR, V55, P215, DOI 10.1111/j.1747-0765.2008.00346.x; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	59	9	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25070	10.1371/journal.pone.0025070	http://dx.doi.org/10.1371/journal.pone.0025070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21969868	gold, Green Submitted, Green Published			2022-12-27	WOS:000295936900021
J	Jurvansuu, JM; Goldman, A				Jurvansuu, Jaana M.; Goldman, Adrian			Obesity Risk Gene TMEM18 Encodes a Sequence-Specific DNA-Binding Protein	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL LINES; LOCI; VARIANTS; MC4R; MASS; BMI	Transmembrane protein 18 (TMEM18) has previously been connected to cell migration and obesity. However, the molecular function of the protein has not yet been described. Here we show that TMEM18 localises to the nuclear membrane and binds to DNA in a sequence-specific manner. The protein binds DNA with its positively charged C-terminus that contains also a nuclear localisation signal. Increase in the amount of TMEM18 in cells suppresses expression from a reporter vector with the TMEM18 target sequence. TMEM18 is a small protein of 140 residues and is predicted to be mostly alpha-helical with three transmembrane parts. As a consequence the DNA binding by TMEM18 would bring the chromatin very near to nuclear membrane. We speculate that this closed perinuclear localisation of TMEM18-bound DNA might repress transcription from it.	[Jurvansuu, Jaana M.; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki	Jurvansuu, JM (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	jaana.jurvansuu@helsinki.fi	Jurvansuu, Jaana/H-1599-2012; Jurvansuu, Jaana/AAZ-8835-2020	Jurvansuu, Jaana/0000-0002-7801-3237; Goldman, Adrian/0000-0001-8032-9700	Academy of Finland [1128207, 1114752]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland (1128207 to J.M.J., 1114752 to A.G., www.aka.fi); and the Sigrid Juselius Foundation (www.sigridjuselius.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004470; Almen MS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-58; den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Haupt A, 2010, OBESITY, V18, P1212, DOI 10.1038/oby.2009.413; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Jurvansuu J, 2008, CANCER RES, V68, P4614, DOI 10.1158/0008-5472.CAN-07-5291; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Laukkanen ML, 1996, BIOCHEM BIOPH RES CO, V226, P755, DOI 10.1006/bbrc.1996.1425; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Moriuchi M, 1999, J IMMUNOL, V162, P5986; Orkunoglu-Suer FE, 2011, OBESITY, V19, P662, DOI 10.1038/oby.2010.180; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Ratajewski M, 2009, GENOMICS, V94, P407, DOI 10.1016/j.ygeno.2009.08.014; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yamashita R, 2008, NUCLEIC ACIDS RES, V36, P3707, DOI 10.1093/nar/gkn248; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	30	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25317	10.1371/journal.pone.0025317	http://dx.doi.org/10.1371/journal.pone.0025317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980424	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900052
J	Tang, XR; Yang, Y; Amar, S				Tang, Xiaoren; Yang, Yu; Amar, Salomon			Novel Regulation of CCL2 Gene Expression by Murine LITAF and STAT6B	PLOS ONE			English	Article							TARGETING INFLAMMATORY PATHWAYS; TNF-ALPHA FACTOR; TRANSCRIPTION FACTOR; PREVENTION; LIPOPOLYSACCHARIDE; CYTOKINE; BINDING; SIGNAL	Inflammation is a multifaceted process: beneficial as a defense mechanism but also detrimental depending on its severity and duration. At the site of injury, inflammatory cells are activated by a cascade of mediators, one of which is LITAF, a transcription regulator known to upregulate TNF-alpha. We previously showed that human LITAF forms a complex with human STAT6B, which translocates into the nucleus to upregulate cytokine transcription. To dissect the molecular implications of this complex, a murine model was developed and interactions between mouse STAT6B (mSTAT6B) and mouse LITAF (mLITAF) were analyzed. Both mLITAF and mSTAT6B expression were MyD88- and TLR ligand-dependent. Furthermore, mLITAF was found to mediate LPS-induced CCL2 gene transcription with the cooperation of mSTAT6B leading to CCL2 protein expression. In LITAF-deficient mice, mLITAF-mediated CCL2 production in macrophages was significantly reduced compared to the wild-type control animals. Mice knockdown for mSTAT6B by 6BsiRNA1 tail vein injection resulted in a decrease in serum TNF-alpha and CCL2 production. mLITAF/mSTAT6B complex is proposed to play a role in LPS-induced CCL2 expression and possibly other cytokines.	[Tang, Xiaoren; Yang, Yu; Amar, Salomon] Boston Univ, Sch Dent Med, Ctr Antiinflammatory Therapeut, Boston, MA 02215 USA	Boston University	Tang, XR (corresponding author), Boston Univ, Sch Dent Med, Ctr Antiinflammatory Therapeut, Boston, MA 02215 USA.	samar@bu.edu		Tang, Xiaoren/0000-0002-2402-3659; Amar, Salomon/0000-0002-0017-5930	National Institutes of Health-National Institute of Dental and Craniofacial [RO1 14079]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014079] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Dental and Craniofacial; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by National Institutes of Health-National Institute of Dental and Craniofacial Research grant #RO1 14079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Chen YF, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10420; Chung CP, 2007, CLIN RHEUMATOL, V26, P1228, DOI 10.1007/s10067-007-0548-7; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Fassett RG, 2009, FUTUR CARDIOL, V5, P333, DOI 10.2217/FCA.09.19; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Klein R, 2010, ARCH DERMATOL, V146, P780, DOI 10.1001/archdermatol.2010.142; La Cava A, 2010, IMMUNOTHERAPY-UK, V2, P575, DOI 10.2217/IMT.10.29; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Oberbach A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010882; Oyegunwa AO, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-59; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Patel BKR, 1998, GENOMICS, V52, P192, DOI 10.1006/geno.1998.5436; Peters M, 2010, J ALLERGY CLIN IMMUN, V126, P648, DOI 10.1016/j.jaci.2010.05.011; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tang XR, 2005, P NATL ACAD SCI USA, V102, P5132, DOI 10.1073/pnas.0501159102; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Weyrich AS, 2009, AM J THER, V16, P164, DOI 10.1097/MJT.0b013e31814b17bf; Yang SJ, 2009, DIABETOLOGIA, V52, P972, DOI 10.1007/s00125-009-1309-8; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	23	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25083	10.1371/journal.pone.0025083	http://dx.doi.org/10.1371/journal.pone.0025083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980379	Green Published, Green Submitted, gold			2022-12-27	WOS:000295936900022
J	Tokumoto, T; Yamaguchi, T; Ii, S; Tokumoto, M				Tokumoto, Toshinobu; Yamaguchi, Toshiya; Ii, Sanae; Tokumoto, Mika			In Vivo Induction of Oocyte Maturation and Ovulation in Zebrafish	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; MEMBRANE PROGESTIN RECEPTOR; GERMINAL VESICLE BREAKDOWN; MEIOTIC MATURATION; FISH OOCYTES; IDENTIFICATION; INTERMEDIARY; CLONING; TROUT; VITRO	The maturation of fish oocytes is a well-characterized system induced by progestins via non-genomic actions. In a previous study, we demonstrated that diethylstilbestrol (DES), a non-steroidal estrogen, induces fish oocyte maturation via the membrane progestin receptor (mPR). Here, we attempted to evaluate the effect of DES as an environmental endocrine disrupting chemical (EDC) upon fish oocyte maturation using live zebrafish. DES triggered oocyte maturation within several hours in vivo when administrated directly into the surrounding water. The natural teleost maturation-inducing hormone, 17alpha, 20beta-dihydroxy-4-pregnen-3-one (17,20beta-DHP) also induced oocyte maturation in vivo. Steroids such as testosterone, progesterone or 17alpha-hydroxyprogesterone were also effective in vivo. Further studies indicated that externally applied 17,20beta-DHP even induced ovulation. In contrast to 17,20beta -DHP, DES induced maturation but not ovulation. Theoretically this assay system provides a means to distinguish pathways involved in the induction of ovulation, which are known to be induced by genomic actions from the pathway normally involved in the induction of oocyte maturation, a typical non-genomic action-dependent pathway. In summary, we have demonstrated the effect of EDCs on fish oocyte maturation in vivo. To address the effects, we have explored a conceptually new approach to distinguish between the genomic and non-genomic actions induced by steroids. The assay can be applied to screens of progestin-like effects upon oocyte maturation and ovulation for small molecules of pharmacological agents or EDCs.	[Tokumoto, Toshinobu; Yamaguchi, Toshiya; Ii, Sanae; Tokumoto, Mika] Shizuoka Univ, Dept Biol, Fac Sci, Natl Univ Corp, Shizuoka, Japan	Shizuoka University	Tokumoto, T (corresponding author), Shizuoka Univ, Dept Biol, Fac Sci, Natl Univ Corp, Shizuoka, Japan.	sbttoku@ipc.shizuoka.ac.jp	Tokumoto, Toshinobu/R-7653-2019	Tokumoto, Toshinobu/0000-0001-9086-3608	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Environmental Agency; Naito Foundation; Suntory Institute for Bioorganic Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Environmental Agency; Naito Foundation(Naito Memorial Foundation); Suntory Institute for Bioorganic Research(Suntory Foundation for Life Sciences)	This work was supported by the Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Japanese Environmental Agency (ExTEND2005 FS to T. T.), a grant from The Naito Foundation (to T. T.) and a SUNBOR grant from Suntory Institute for Bioorganic Research (to T. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Bonnet E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-55; Das S, 1999, ENDOCRINOLOGY, V140, P1953, DOI 10.1210/en.140.4.1953; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; EATON RC, 1974, COPEIA, P195; Fort DJ, 2002, DRUG CHEM TOXICOL, V25, P293, DOI 10.1081/DCT-120005892; GOETZ FW, 1979, GEN COMP ENDOCR, V37, P273, DOI 10.1016/0016-6480(79)90001-7; Hanna RN, 2011, MOL CELL ENDOCRINOL, V337, P80, DOI 10.1016/j.mce.2011.02.004; HISAOKA KK, 1962, COPEIA, P788; NAGAHAMA Y, 1995, CURR TOP DEV BIOL, V30, P103, DOI 10.1016/S0070-2153(08)60565-7; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Ogiwara K, 2005, P NATL ACAD SCI USA, V102, P8442, DOI 10.1073/pnas.0502423102; Pickford DB, 1999, ENVIRON HEALTH PERSP, V107, P285, DOI 10.2307/3434595; Pinter J, 1999, GEN COMP ENDOCR, V115, P200, DOI 10.1006/gcen.1999.7312; Tokumoto M, 2006, GEN COMP ENDOCR, V145, P101, DOI 10.1016/j.ygcen.2005.07.002; Tokumoto T, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-69; Tokumoto T, 2004, P NATL ACAD SCI USA, V101, P3686, DOI 10.1073/pnas.0400072101; Tokumoto T, 2008, MAR ENVIRON RES, V66, P372, DOI 10.1016/j.marenvres.2008.05.011; Tokumoto T, 2007, ENDOCRINOLOGY, V148, P3459, DOI 10.1210/en.2006-1694; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	21	40	41	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25206	10.1371/journal.pone.0025206	http://dx.doi.org/10.1371/journal.pone.0025206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980399	Green Published, gold			2022-12-27	WOS:000295936900034
J	Girard, MB; Kasumovic, MM; Elias, DO				Girard, Madeline B.; Kasumovic, Michael M.; Elias, Damian O.			Multi-Modal Courtship in the Peacock Spider, Maratus volans (OP-Cambridge, 1874)	PLOS ONE			English	Article							MALE JUMPING SPIDERS; SEXUAL SELECTION; SOUND PRODUCTION; SEISMIC SIGNALS; MATE-CHOICE; SONG ELABORATION; WOLF SPIDERS; ARANEAE; COMMUNICATION; SALTICIDAE	The peacock spider, Maratus volans, has one of the most elaborate courtship displays in arthropods. Using regular and highspeed video segments captured in the lab, we provide detailed descriptions of complete male courtship dances. As research on jumping spiders has demonstrated that males of some species produce vibrations concurrently with visual displays, we also used laser vibrometry to uncover such elements for this species. Our recordings reveal and describe for the first time, that M. volans males use vibratory signals in addition to complex body ornaments and motion displays. The peacock spider and other closely related species are outstanding study organisms for testing hypotheses about the evolution and functional significance of complex displays, thus, this descriptive study establishes a new model system for behavioral ecology, one that certainly stands to make important contributions to the field.	[Girard, Madeline B.; Elias, Damian O.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kasumovic, Michael M.] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of California System; University of California Berkeley; University of New South Wales Sydney	Girard, MB (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	maddiegirard34@berkeley.edu	Elias, Damian O/C-4954-2013	Kasumovic, Michael/0000-0003-0158-5517	National Science Foundation [IOS-1021385]; Direct For Biological Sciences [1021385] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a National Science Foundation Grant to DOE (IOS-1021385) and an NSF Graduate Research Fellowship Program to MBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Badyaev AV, 2002, EVOLUTION, V56, P412; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Clark DL, 2001, P ROY SOC B-BIOL SCI, V268, P2461, DOI 10.1098/rspb.2001.1819; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Dunn R. A., 1947, Memoirs of the National Museum of Victoria, VNo. 16, P82; EDWARDS G B, 1981, Psyche (Cambridge), V88, P199, DOI 10.1155/1981/56173; Elias D.O., 2011, USE VIBRATIONS COMMU; Elias DO, 2006, J ARACHNOL, V34, P545, DOI 10.1636/S05-77.1; Elias DO, 2006, BEHAV ECOL, V17, P765, DOI 10.1093/beheco/arl005; Elias DO, 2006, J COMP PHYSIOL A, V192, P785, DOI 10.1007/s00359-006-0116-7; Elias DO, 2005, ANIM BEHAV, V69, P931, DOI 10.1016/j.anbehav.2004.06.024; Elias DO, 2003, J EXP BIOL, V206, P4029, DOI 10.1242/jeb.00634; Elias DO, 2004, J EXP BIOL, V207, P4105, DOI 10.1242/jeb.01261; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Foelix R., 2011, BIOL SPIDERS, V3; Gibson JS, 2008, ANIM BEHAV, V75, P1253, DOI 10.1016/j.anbehav.2007.09.026; GWYNNE DT, 1985, J ZOOL, V207, P35; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hill David E., 2011, Peckhamia, V89.1, P1; Hill David E., 2009, Peckhamia, V75.1, P1; Hill David Edwin, 2009, Peckhamia, V74.1, P1; Huber BA, 2005, BIOL REV, V80, P363, DOI 10.1017/S1464793104006700; IWASA Y, 1994, EVOLUTION, V48, P853, DOI 10.1111/j.1558-5646.1994.tb01367.x; Jackson RR, 1982, SPIDER COMMUNICATION; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Li JJ, 2008, CURR BIOL, V18, P699, DOI 10.1016/j.cub.2008.04.020; Lim MLM, 2008, BEHAV ECOL, V19, P61, DOI 10.1093/beheco/arm100; Maddison W, 2003, SYST ENTOMOL, V28, P1, DOI 10.1046/j.1365-3113.2003.00195.x; Maddison W, 2000, SYST BIOL, V49, P400, DOI 10.1080/10635159950127312; MADDISON WP, 1988, J ARACHNOL, V16, P267; Maddison WP, 2003, INVERTEBR SYST, V17, P529, DOI 10.1071/IS02044; MADDISON WP, 1988, J ARACHNOL, V16, P199; Masta SE, 2002, P NATL ACAD SCI USA, V99, P4442, DOI 10.1073/pnas.072493099; Masta SE, 2000, EVOLUTION, V54, P1699; Noordam Aart P., 2002, Entomologische Berichten (Amsterdam), V62, P17; Otto Juergen C., 2010, Peckhamia, V79.1, P1; PARRY DA, 1957, Q J MICROSC SCI, V98, P331; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Pomiankowski A, 1998, P NATL ACAD SCI USA, V95, P5106, DOI 10.1073/pnas.95.9.5106; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Scheffer SJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P17, DOI 10.1007/s002650050212; SHUTLER D, 1990, EVOLUTION, V44, P1967, DOI 10.1111/j.1558-5646.1990.tb04303.x; Sivalinghem S, 2010, BEHAV ECOL, V21, P1308, DOI 10.1093/beheco/arq150; Snell-Rood EC, 2008, OECOLOGIA, V157, P545, DOI 10.1007/s00442-008-1092-0; Taylor LA, 2007, CURR BIOL, V17, pR592, DOI 10.1016/j.cub.2007.05.064; Uhl G, 2011, SPIDER BEHAV FLEXIBI; ZABKA M, 1987, Annales Zoologici (Warsaw), V40, P451	51	85	88	6	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25390	10.1371/journal.pone.0025390	http://dx.doi.org/10.1371/journal.pone.0025390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980440	Green Published, gold, Green Submitted			2022-12-27	WOS:000295933700030
J	Krishnan, B; Genzer, KM; Pollandt, SW; Liu, J; Gallagher, JP; Shinnick-Gallagher, P				Krishnan, Balaji; Genzer, Kathy M.; Pollandt, Sebastian W.; Liu, Jie; Gallagher, Joel P.; Shinnick-Gallagher, Patricia			Dopamine-Induced Plasticity, Phospholipase D (PLD) Activity and Cocaine-Cue Behavior Depend on PLD-Linked Metabotropic Glutamate Receptors in Amygdala	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CORTICOTROPIN-RELEASING-FACTOR; CONDITIONED PLACE PREFERENCE; SELF-ADMINISTRATION BEHAVIOR; BASOLATERAL AMYGDALA; SEEKING BEHAVIOR; PREFRONTAL CORTEX; EXCITOTOXIC LESIONS; NEURITE OUTGROWTH; MESSENGER-RNA	Cocaine-cue associations induce synaptic plasticity with long lasting molecular and cellular changes in the amygdala, a site crucial for cue-associated memory mechanisms. The underlying neuroadaptations can include marked alterations in signaling via dopamine (DA) receptors (DRs) and metabotropic glutamate (Glu) receptors (mGluRs). Previously, we reported that DR antagonists blocked forms of synaptic plasticity in amygdala slices of Sprague-Dawley rats withdrawn from repeated cocaine administration. In the present study, we investigated synaptic plasticity induced by exogenous DA and its dependence on mGluR signaling and a potential role for phospholipase D (PLD) as a downstream element linked to mGluR and DR signaling. Utilizing a modified conditioned place preference (CPP) paradigm as a functional behavioral measure, we studied the neurophysiological effects after two-weeks to the last cocaine conditioning. We recorded, electrophysiologically, a DR-induced synaptic potentiation in the basolateral to lateral capsula central amygdala (BLA-lcCeA) synaptic pathway that was blocked by antagonists of group I mGluRs, particularly, the PLD-linked mGluR. In addition, we observed 2-2.5 fold increase in PLD expression and 3.7-fold increase in basal PLD enzyme activity. The enhanced PLD activity could be further stimulated (9.3 fold) by a DA D1-like (D1/5R) receptor agonist, and decreased to control levels by mGluR1 and PLD-linked mGluR antagonists. Diminished CPP was observed by infusion of a PLD-linked mGluR antagonist, PCCG-13, in the amygdala 15 minutes prior to testing, two weeks after the last cocaine injection. These results imply a functional interaction between D1/5Rs, group I mGluRs via PLD in the amygdala synaptic plasticity associated with cocaine-cues.	[Krishnan, Balaji; Genzer, Kathy M.; Pollandt, Sebastian W.; Liu, Jie; Gallagher, Joel P.; Shinnick-Gallagher, Patricia] Univ Texas Med Branch Galveston, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Liu, Jie] Columbia Univ, Presbyterian Hosp, Dept Anesthesiol, New York, NY USA	University of Texas System; University of Texas Medical Branch Galveston; Columbia University; NewYork-Presbyterian Hospital	Krishnan, B (corresponding author), Univ Texas Med Branch Galveston, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	bakrishn@utmb.edu	Pollandt, Sebastian/I-8055-2019; Krishnan, Balaji/M-9914-2019	Pollandt, Sebastian/0000-0003-1540-7439; Krishnan, Balaji/0000-0003-2074-4165	National Institutes of Health [DA017727, DA017727-06S1]; NRSA F32 Ruth L. Kirschstein postdoctoral grant [DA023316]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017727, F32DA023316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA F32 Ruth L. Kirschstein postdoctoral grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grant DA017727 to PSG, DA017727-06S1 to JL, and by NRSA F32 Ruth L. Kirschstein postdoctoral grant DA023316 to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1992, J BIOL CHEM, V267, P13361; Albani-Torregrossa S, 1999, MOL PHARMACOL, V55, P699; Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Attucci S, 2001, NEUROCHEM RES, V26, P1151, DOI 10.1023/A:1012327007733; Backstrom P, 2006, NEUROPSYCHOPHARMACOL, V31, P778, DOI 10.1038/sj.npp.1300845; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; BOSS V, 1992, J NEUROCHEM, V59, P2340; BOSS V, 1994, MOL PHARMACOL, V45, P1177; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brinley-Reed M, 1999, BRAIN RES, V850, P127, DOI 10.1016/S0006-8993(99)02112-5; BROWN EE, 1993, PSYCHOPHARMACOLOGY, V113, P123, DOI 10.1007/BF02244344; BROWN EE, 1992, J NEUROSCI, V12, P4112; Buffalari DM, 2010, CURR TOP BEHAV NEURO, V3, P73, DOI 10.1007/7854_2009_18; Burgdorf C, 2010, J CARDIOVASC PHARM, V55, P555, DOI 10.1097/FJC.0b013e3181d8bec5; Cabello N, 2009, J NEUROCHEM, V109, P1497, DOI 10.1111/j.1471-4159.2009.06078.x; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; CAINE SB, 1995, BRAIN RES, V692, P47; CALLAHAN PM, 1995, PHARMACOL BIOCHEM BE, V51, P759, DOI 10.1016/0091-3057(95)00027-T; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; CARR GD, 1989, NEUROLOGICAL BASIS R, P284; CHARIFSON PS, 1989, J MED CHEM, V32, P2050, DOI 10.1021/jm00129a006; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Disse J, 2009, BLOOD, V113, P973, DOI 10.1182/blood-2008-06-165282; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; FIBIGER HC, 1992, CIBA F SYMP, V166, P96; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Fu Y, 2007, J NEUROPHYSIOL, V97, P937, DOI 10.1152/jn.00349.2006; Fuchs RA, 2002, BRAIN RES, V929, P15, DOI 10.1016/S0006-8993(01)03366-2; Gardiner TW, 1999, CONTEMP TOP LAB ANIM, V38, P56; Goffin D, 2008, J NEUROCHEM, V107, P964, DOI 10.1111/j.1471-4159.2008.05679.x; Gorbatyuk OS, 2010, MOL THER, V18, P1758, DOI 10.1038/mt.2010.137; Goussakov I, 2006, EUR J NEUROSCI, V23, P239, DOI 10.1111/j.1460-9568.2005.04538.x; Grimm JW, 2002, BEHAV PHARMACOL, V13, P379, DOI 10.1097/00008877-200209000-00011; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; HALL RA, 2004, RECEPTOR BIOCH METHO, P165; Hayakawa K, 1999, NEUROSCI LETT, V265, P127, DOI 10.1016/S0304-3940(99)00228-1; HOLLER T, 1993, J NEUROCHEM, V61, P1569, DOI 10.1111/j.1471-4159.1993.tb13659.x; HOLLER T, 1994, BIOCHEM PHARMACOL, V47, P411, DOI 10.1016/0006-2952(94)90033-7; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Hurd YL, 2000, BEHAV BRAIN RES, V116, P177, DOI 10.1016/S0166-4328(00)00271-0; Hurd YL, 1997, EUR J NEUROSCI, V9, P2541, DOI 10.1111/j.1460-9568.1997.tb01683.x; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kanaho Y, 2009, BBA-MOL CELL BIOL L, V1791, P898, DOI 10.1016/j.bbalip.2009.03.010; Kantak KM, 2002, J NEUROSCI, V22, P1126, DOI 10.1523/JNEUROSCI.22-03-01126.2002; Kawasaki S, 2008, NEUROSCI RES, V60, P147, DOI 10.1016/j.neures.2007.10.003; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kim M, 2010, ACTA HISTOCHEM, V112, P81, DOI 10.1016/j.acthis.2008.09.004; Klein J, 2005, J NEUROCHEM, V94, P1473, DOI 10.1111/j.1471-4159.2005.03315.x; Klein J, 1997, NEUROPHARMACOLOGY, V36, P305, DOI 10.1016/S0028-3908(97)00024-5; KOBAYASHI M, 1987, J NEUROCHEM, V48, P1597, DOI 10.1111/j.1471-4159.1987.tb05707.x; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krishnan B, 2010, EUR J NEUROSCI, V31, P1027, DOI 10.1111/j.1460-9568.2010.07148.x; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; Kruzich PJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-14-j0002.2001; LAURIER LG, 1994, BRAIN RES, V634, P31, DOI 10.1016/0006-8993(94)90255-0; Le Vasseur M, 2008, NEUROSCIENCE, V151, P28, DOI 10.1016/j.neuroscience.2007.09.071; Li YQ, 2008, J NEUROSCI, V28, P13248, DOI 10.1523/JNEUROSCI.3027-08.2008; Liu J, 2004, J NEUROSCI, V24, P4020, DOI 10.1523/JNEUROSCI.5531-03.2004; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lu L, 2007, BIOL PSYCHIAT, V61, P591, DOI 10.1016/j.biopsych.2006.04.011; Luedtke RR, 1999, J NEUROIMMUNOL, V101, P170, DOI 10.1016/S0165-5728(99)00142-3; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Maggos CE, 1997, SYNAPSE, V26, P55, DOI 10.1002/(SICI)1098-2396(199705)26:1<55::AID-SYN6>3.0.CO;2-D; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MATSUMOTO M, 1988, J PHYSIOL-LONDON, V407, P199, DOI 10.1113/jphysiol.1988.sp017410; McGinty JF, 2008, J NEUROCHEM, V104, P1440, DOI 10.1111/j.1471-4159.2008.05240.x; MCGREGOR A, 1993, BRAIN RES, V624, P245, DOI 10.1016/0006-8993(93)90084-Z; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Mottola DM, 1996, J MED CHEM, V39, P285, DOI 10.1021/jm9502100; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Oliveira TG, 2010, BBA-MOL CELL BIOL L, V1801, P799, DOI 10.1016/j.bbalip.2010.04.004; Orozco-Cabal L, 2008, J NEUROSCI, V28, P529, DOI 10.1523/JNEUROSCI.2666-07.2008; Otani S, 1999, J NEUROSCI, V19, P9788; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Pape HC, 2005, NEURON, V48, P877, DOI 10.1016/j.neuron.2005.12.002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PellegriniGiampietro DE, 1996, BRIT J PHARMACOL, V118, P1035, DOI 10.1111/j.1476-5381.1996.tb15503.x; Pellicciari R, 1999, J MED CHEM, V42, P2716, DOI 10.1021/jm990128v; PENG X, 2011, ACTA PHYSL OXF; Poisik OV, 2007, EUR J NEUROSCI, V26, P852, DOI 10.1111/j.1460-9568.2007.05710.x; Pollandt S, 2006, EUR J NEUROSCI, V24, P1733, DOI 10.1111/j.1460-9568.2006.05049.x; Rashid AJ, 2007, TRENDS PHARMACOL SCI, V28, P551, DOI 10.1016/j.tips.2007.10.001; Rico MJ, 2004, J NEUROPHYSIOL, V91, P2385, DOI 10.1152/jn.01140.2003; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Rouillon C, 2008, BRAIN RES, V1198, P44, DOI 10.1016/j.brainres.2008.01.025; Royer S, 1999, J NEUROSCI, V19, P10575; Ryman-Rasmussen JP, 2005, MOL PHARMACOL, V68, P1039, DOI 10.1124/mol.105.012153; Schmidt K, 2011, EUR J NEUROSCI, V34, P177, DOI 10.1111/j.1460-9568.2011.07769.x; Schotanus SM, 2008, NEUROPHARMACOLOGY, V54, P837, DOI 10.1016/j.neuropharm.2007.12.012; SCIBILIA RJ, 1992, SYNAPSE, V11, P146, DOI 10.1002/syn.890110208; See RE, 2003, ANN NY ACAD SCI, V985, P294; See RE, 2001, PSYCHOPHARMACOLOGY, V154, P301, DOI 10.1007/s002130000636; Senogles SE, 2000, MOL PHARMACOL, V58, P455, DOI 10.1124/mol.58.2.455; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shimosato K, 2000, PHARMACOL BIOCHEM BE, V66, P285, DOI 10.1016/S0091-3057(00)00185-4; Shinomura T, 2000, BRIT J PHARMACOL, V131, P1011, DOI 10.1038/sj.bjp.0703651; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Tran-Nguyen LTL, 1998, NEUROPSYCHOPHARMACOL, V19, P48; Volkow ND, 2010, BIOESSAYS, V32, P748, DOI 10.1002/bies.201000042; Voulalas PJ, 2005, J NEUROSCI, V25, P3763, DOI 10.1523/JNEUROSCI.4574-04.2005; Watanabe H, 2004, J BIOL CHEM, V279, P37870, DOI 10.1074/jbc.M402610200; Watanabe H, 2004, J NEUROCHEM, V89, P142, DOI 10.1111/j.1471-4159.2004.02308.x; Weiss F, 2000, P NATL ACAD SCI USA, V97, P4321, DOI 10.1073/pnas.97.8.4321; Weiss F, 2001, NEUROPSYCHOPHARMACOL, V25, P361, DOI 10.1016/S0893-133X(01)00238-X; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; WILSON JM, 1994, BRAIN RES, V668, P39, DOI 10.1016/0006-8993(94)90508-8; Xie XH, 2010, PSYCHOPHARMACOLOGY, V208, P1, DOI 10.1007/s00213-009-1700-7; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; Zhang Y, 2005, J NEUROSCI, V25, P1797, DOI 10.1523/jneurosci.4850-04.2005; Zhang Y, 2004, GLIA, V46, P74, DOI 10.1002/glia.10322	131	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25639	10.1371/journal.pone.0025639	http://dx.doi.org/10.1371/journal.pone.0025639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980514	gold, Green Submitted, Green Published			2022-12-27	WOS:000295933700049
J	Lahiry, P; Lee, LJ; Frey, BJ; Rupar, CA; Siu, VM; Blencowe, BJ; Hegele, RA				Lahiry, Piya; Lee, Leo J.; Frey, Brendan J.; Rupar, C. Anthony; Siu, Victoria M.; Blencowe, Benjamin J.; Hegele, Robert A.			Transcriptional Profiling of Endocrine Cerebro-Osteodysplasia Using Microarray and Next-Generation Sequencing	PLOS ONE			English	Article							RNA-SEQ; HUMAN-DISEASE; KINASE; IDENTIFICATION; GENES; MRK	Background: Transcriptome profiling of patterns of RNA expression is a powerful approach to identify networks of genes that play a role in disease. To date, most mRNA profiling of tissues has been accomplished using microarrays, but next-generation sequencing can offer a richer and more comprehensive picture. Methodology/Principal Findings: ECO is a rare multi-system developmental disorder caused by a homozygous mutation in ICK encoding intestinal cell kinase. We performed gene expression profiling using both cDNA microarrays and next-generation mRNA sequencing (mRNA-seq) of skin fibroblasts from ECO-affected subjects. We then validated a subset of differentially expressed transcripts identified by each method using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Finally, we used gene ontology (GO) to identify critical pathways and processes that were abnormal according to each technical platform. Methodologically, mRNA-seq identifies a much larger number of differentially expressed genes with much better correlation to qRT-PCR results than the microarray (r(2) = 0.794 and 0.137, respectively). Biologically, cDNA microarray identified functional pathways focused on anatomical structure and development, while the mRNA-seq platform identified a higher proportion of genes involved in cell division and DNA replication pathways. Conclusions/Significance: Transcriptome profiling with mRNA-seq had greater sensitivity, range and accuracy than the microarray. The two platforms generated different but complementary hypotheses for further evaluation.	[Lahiry, Piya; Hegele, Robert A.] Robarts Res Inst, London, ON N6A 5C1, Canada; [Lahiry, Piya; Hegele, Robert A.] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada; [Rupar, C. Anthony; Hegele, Robert A.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Rupar, C. Anthony; Siu, Victoria M.] Univ Western Ontario, Dept Pediat, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada; [Lee, Leo J.; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Lee, Leo J.; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Lee, Leo J.; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Rupar, C. Anthony; Siu, Victoria M.] Lawson Hlth Res Inst, Childrens Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Toronto; Western University (University of Western Ontario)	Lahiry, P (corresponding author), Robarts Res Inst, London, ON N6A 5C1, Canada.	hegele@robarts.ca	Hegele, Robert/G-3301-2011; Hegele, Robert/AAF-6482-2020	Hegele, Robert/0000-0003-2861-5325	Canadian Institutes of Health Research [CTP-79853]; Heart and Stroke Foundation of Ontario; Genome Canada through the Ontario Genomics Institute; Jacob J. Wolfe Distinguished Medical Research Chair; Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I); Martha G. Blackburn Chair in Cardiovascular Research; Scriver Family MD/PhD Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Genome Canada through the Ontario Genomics Institute(Genome Canada); Jacob J. Wolfe Distinguished Medical Research Chair; Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I); Martha G. Blackburn Chair in Cardiovascular Research; Scriver Family MD/PhD Scholarship	This work was supported by a team grant from the Canadian Institutes of Health Research (CTP-79853), the Heart and Stroke Foundation of Ontario and Genome Canada through the Ontario Genomics Institute. Dr. Hegele is supported by the Jacob J. Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I), the Martha G. Blackburn Chair in Cardiovascular Research, and operating grants from the Canadian Institutes for Health Research, the Heart and Stroke Foundation of Ontario, and Genome Canada through the Ontario Genomics Institute. Dr. Lahiry is supported by the Scriver Family MD/PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1995, ONCOGENE, V11, P2187; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Greene JG, 2010, NEUROBIOL DIS; Illumina Inc, 2008, MRNA EXPR AN ILL; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turaga K, 2010, CANCER CONTROL, V17, P177, DOI 10.1177/107327481001700306; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yang T, 2002, BIOMOL ENG, V19, P1, DOI 10.1016/S1389-0344(02)00002-3	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25400	10.1371/journal.pone.0025400	http://dx.doi.org/10.1371/journal.pone.0025400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980446	Green Submitted, gold, Green Published			2022-12-27	WOS:000295933700032
J	Steinmann, P; Utzinger, J; Du, ZW; Jiang, JY; Chen, JX; Hattendorf, J; Zhou, H; Zhou, XN				Steinmann, Peter; Utzinger, Juerg; Du, Zun-Wei; Jiang, Jin-Yong; Chen, Jia-Xu; Hattendorf, Jan; Zhou, Hui; Zhou, Xiao-Nong			Efficacy of Single-Dose and Triple-Dose Albendazole and Mebendazole against Soil-Transmitted Helminths and Taenia spp.: A Randomized Controlled Trial	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; YUNNAN PROVINCE; TRICHURIS-TRICHIURA; INFECTIONS; HOOKWORM; MULTIPARASITISM; ECHINOCOCCOSIS; CYSTICERCOSIS; IVERMECTIN; VILLAGE	Background: The control of soil-transmitted helminth (STH) infections currently relies on the large-scale administration of single-dose oral albendazole or mebendazole. However, these treatment regimens have limited efficacy against hookworm and Trichuris trichiura in terms of cure rates (CR), whereas fecal egg reduction rates (ERR) are generally high for all common STH species. We compared the efficacy of single-dose versus triple-dose treatment against hookworm and other STHs in a community-based randomized controlled trial in the People's Republic of China. Methodology/Principal findings: The hookworm CR and fecal ERR were assessed in 314 individuals aged >= 5 years who submitted two stool samples before and 34 weeks after administration of single-dose oral albendazole (400 mg) or mebendazole (500 mg) or triple-dose albendazole (36400 mg over 3 consecutive days) or mebendazole (36500 mg over 3 consecutive days). Efficacy against T. trichiura, Ascaris lumbricoides, and Taenia spp. was also assessed. Albendazole cured significantly more hookworm infections than mebendazole in both treatment regimens (single dose: respective CRs 69% (95% confidence interval [CI]: 55-81%) and 29% (95% CI: 20-45%); triple dose: respective CRs 92% (95% CI: 81-98%) and 54% (95% CI: 46-71%)). ERRs followed the same pattern (single dose: 97% versus 84%; triple dose: 99.7% versus 96%). Triple-dose regimens outperformed single doses against T. trichiura; three doses of mebendazole the most efficacious treatment tested cured 71% (95% CI: 57-82%). Both single and triple doses of either drug were highly efficacious against A. lumbricoides (CR: 93-97%; ERR: all >99.9%). Triple dose regimens cured all Taenia spp. infections, whereas single dose applications cured only half of them. Conclusions/Significance: Single-dose oral albendazole is more efficacious against hookworm than mebendazole. To achieve high CRs against both hookworm and T. trichiura, triple-dose regimens are warranted.	[Steinmann, Peter; Utzinger, Juerg; Hattendorf, Jan] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Steinmann, Peter; Utzinger, Juerg; Hattendorf, Jan] Univ Basel, Basel, Switzerland; [Steinmann, Peter; Chen, Jia-Xu; Zhou, Hui; Zhou, Xiao-Nong] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China; [Du, Zun-Wei; Jiang, Jin-Yong] Yunnan Inst Parasit Dis, Helminthiasis Div, Simao Puer, Peoples R China	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention	Steinmann, P (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	peter.steinmann@unibas.ch	Hattendorf, Jan/F-5371-2010; Steinmann, Peter/AAU-9269-2021	Hattendorf, Jan/0000-0002-1176-401X; Steinmann, Peter/0000-0003-4800-3019				Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126; Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; CHAVARRIA AP, 1973, AM J TROP MED HYG, V22, P592, DOI 10.4269/ajtmh.1973.22.592; Craig P, 2007, CURR OPIN INFECT DIS, V20, P524, DOI 10.1097/QCO.0b013e3282ef579e; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Ezeamama AE, 2005, J INFECT DIS, V192, P2160, DOI 10.1086/498219; Flohr C, 2007, AM J TROP MED HYG, V76, P732, DOI 10.4269/ajtmh.2007.76.732; Garcia HH, 2007, CURR OPIN INFECT DIS, V20, P489, DOI 10.1097/QCO.0b013e3282a95e39; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; Horton J, 2002, CURR OPIN INFECT DIS, V15, P599, DOI 10.1097/00001432-200212000-00008; Horton J, 2000, PARASITOLOGY, V121, pS113, DOI 10.1017/S0031182000007290; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Ito A, 2003, ACTA TROP, V86, P3, DOI 10.1016/S0001-706X(02)00269-3; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Knopp S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001036; Knopp S, 2010, CLIN INFECT DIS, V51, P1420, DOI 10.1086/657310; Kotze AC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001203; Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009; Li LH, 2007, PARASITOL INT, V56, P281, DOI 10.1016/j.parint.2007.06.001; MARTIN LK, 1968, AM J TROP MED HYG, V17, P382, DOI 10.4269/ajtmh.1968.17.382; Mohammed KA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000171; Montresor A, 2006, PARASITOL INT, V55, pS301, DOI 10.1016/j.parint.2005.11.045; *OIE, 2005, WHO AN HLTH TERR AN; Olsen A, 2007, T ROY SOC TROP MED H, V101, P747, DOI 10.1016/j.trstmh.2007.03.006; Olsen A, 2009, T ROY SOC TROP MED H, V103, P443, DOI 10.1016/j.trstmh.2008.12.010; Pullan R, 2008, PARASITOLOGY, V135, P783, DOI 10.1017/S0031182008000346; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Savioli L., 1998, GUIDELINES EVALUATIO; Steinmann P, 2008, AM J TROP MED HYG, V78, P760, DOI 10.4269/ajtmh.2008.78.760; Steinmann P, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000075; Steinmann P, 2010, ADV PARASIT, V73, P21, DOI 10.1016/S0065-308X(10)73002-5; WHO, 2006, PROTECTING GROUNDWAT, P1; Willingham AL, 2006, ADV PARASIT, V61, P509, DOI 10.1016/S0065-308X(05)61012-3; World Health Organization, 2002, WHO TECHN REP SER, V912, P1; Zhan B, 2001, J PARASITOL, V87, P1227, DOI 10.1645/0022-3395(2001)087[1227:SSIOHH]2.0.CO;2	42	100	103	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25003	10.1371/journal.pone.0025003	http://dx.doi.org/10.1371/journal.pone.0025003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980373	Green Published, Green Submitted, gold			2022-12-27	WOS:000295933700015
J	Kawaguchi, K; Yurimoto, H; Oku, M; Sakai, Y				Kawaguchi, Kosuke; Yurimoto, Hiroya; Oku, Masahide; Sakai, Yasuyoshi			Yeast Methylotrophy and Autophagy in a Methanol-Oscillating Environment on Growing Arabidopsis thaliana Leaves	PLOS ONE			English	Article							CANDIDA-BOIDINII; PHYSIOLOGICAL-ROLE; METHYLOBACTERIUM-EXTORQUENS; SP NOV.; METABOLISM; SYSTEM; GENE; DEHYDROGENASE; FORMALDEHYDE; PEROXISOMES	The yeast Candida boidinii capable of growth on methanol proliferates and survives on the leaves of Arabidopsis thaliana. The local methanol concentration at the phyllosphere of growing A. thaliana exhibited daily periodicity, and yeast cells responded by altering both the expression of methanol-inducible genes and peroxisome proliferation. Even under these dynamically changing environmental conditions, yeast cells proliferated 3 to 4 times in 11 days. Among the C1-metabolic enzymes, enzymes in the methanol assimilation pathway, but not formaldehyde dissimilation or anti-oxidizing enzymes, were necessary for yeast proliferation at the phyllosphere. Furthermore, both peroxisome assembly and pexophagy, a selective autophagy pathway that degrades peroxisomes, were necessary for phyllospheric proliferation. Thus, the present study sheds light on the life cycle and physiology of yeast in the natural environment at both the molecular and cellular levels.	[Kawaguchi, Kosuke; Yurimoto, Hiroya; Oku, Masahide; Sakai, Yasuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Sakai, Yasuyoshi] Kyoto Univ, Res Unit Physiol Chem, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan; [Sakai, Yasuyoshi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Kawaguchi, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan.	ysakai@kais.kyoto-u.ac.jp	Yurimoto, Hiroya/N-6538-2018; Oku, Masahide/AAW-4752-2021; Oku, Masahide/R-9389-2019	Yurimoto, Hiroya/0000-0001-7506-6184; Oku, Masahide/0000-0001-5991-6281; Oku, Masahide/0000-0001-5991-6281; Kawaguchi, Kosuke/0000-0002-5115-7169	Ministry of Education, Culture, Sports, Science and Technology of Japan [22380052, 18076002, 22310046]; Science and Technology Agency of Japan; Grants-in-Aid for Scientific Research [22380052] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Agency of Japan(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) 22380052, Grants-in-Aid for Scientific Research on Priority Areas 18076002, and Grants-in-Aid for Scientific Research (B) 22310046 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a CREST grant from the Science and Technology Agency of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Asakura M, 2009, PLANT CELL, V21, P1291, DOI 10.1105/tpc.108.060996; Barnett J. A., 1983, YEASTS CHARACTERISTI; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; HOAGLAND DR, 1950, AGR EXP STN CIRC, V347, P1036; Horiguchi H, 2001, J BIOL CHEM, V276, P14279, DOI 10.1074/jbc.M011661200; Horiguchi H, 2001, J BACTERIOL, V183, P6372, DOI 10.1128/JB.183.21.6372-6383.2001; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ivanova E G, 2001, Mikrobiologiia, V70, P452; Ivanova EG, 2000, MICROBIOLOGY+, V69, P646, DOI 10.1023/A:1026693805653; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Lee B, 2002, MICROBIOL-SGM, V148, P2697, DOI 10.1099/00221287-148-9-2697; Limtong S, 2008, INT J SYST EVOL MICR, V58, P302, DOI 10.1099/ijs.0.65380-0; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mukaiyama H, 2004, MOL BIOL CELL, V15, P58, DOI 10.1091/mbc.e03-05-0340; Nakagawa T, 2000, APPL ENVIRON MICROB, V66, P4253, DOI 10.1128/AEM.66.10.4253-4257.2000; Nakagawa T, 1999, YEAST, V15, P1223, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1223::AID-YEA450>3.3.CO;2-O; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; OGATA K, 1969, AGR BIOL CHEM TOKYO, V33, P1519, DOI 10.1080/00021369.1969.10859497; Omer ZS, 2004, PLANT GROWTH REGUL, V43, P93, DOI 10.1023/B:GROW.0000038360.09079.ad; Peter G, 2009, FEMS YEAST RES, V9, P936, DOI 10.1111/j.1567-1364.2009.00547.x; Sakai Y, 1998, J BACTERIOL, V180, P5885, DOI 10.1128/JB.180.22.5885-5890.1998; Sakai Y, 1997, J BACTERIOL, V179, P4480, DOI 10.1128/jb.179.14.4480-4485.1997; SAKAI Y, 1991, J BACTERIOL, V173, P7458, DOI 10.1128/jb.173.23.7458-7463.1991; Sakai Y, 1998, YEAST, V14, P1175, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1175::AID-YEA319>3.3.CO;2-Z; Sakai Y, 1996, J CELL BIOL, V134, P37, DOI 10.1083/jcb.134.1.37; SAKAI Y, 1988, APPL ENVIRON MICROB, V54, P485, DOI 10.1128/AEM.54.2.485-489.1988; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; Thauer RK, 2010, ANGEW CHEM INT EDIT, V49, P6712, DOI 10.1002/anie.201002967; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yurimoto H, 2000, BBA-GENE STRUCT EXPR, V1493, P56, DOI 10.1016/S0167-4781(00)00157-3; Yurimoto H, 2003, MICROBIOL-SGM, V149, P1971, DOI 10.1099/mic.0.26320-0	40	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25257	10.1371/journal.pone.0025257	http://dx.doi.org/10.1371/journal.pone.0025257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966472	gold, Green Published, Green Submitted			2022-12-27	WOS:000295932100031
J	Satler, JD; Starrett, J; Hayashi, CY; Hedin, M				Satler, Jordan D.; Starrett, James; Hayashi, Cheryl Y.; Hedin, Marshal			Inferring Species Trees from Gene Trees in a Radiation of California Trapdoor Spiders (Araneae, Antrodiaetidae, Aliatypus)	PLOS ONE			English	Article							SALAMANDERS PLETHODONTIDAE; COMPARATIVE PHYLOGEOGRAPHY; LINEAGE DIVERSIFICATION; ENSATINA-ESCHSCHOLTZII; POPULATION SUBDIVISION; MULTIPLE ALIGNMENTS; NICHE CONSERVATISM; BAYESIAN-INFERENCE; NATURAL-HISTORY; SIERRA-NEVADA	Background: The California Floristic Province is a biodiversity hotspot, reflecting a complex geologic history, strong selective gradients, and a heterogeneous landscape. These factors have led to high endemic diversity across many lifeforms within this region, including the richest diversity of mygalomorph spiders (tarantulas, trapdoor spiders, and kin) in North America. The trapdoor spider genus Aliatypus encompasses twelve described species, eleven of which are endemic to California. Several Aliatypus species show disjunct distributional patterns in California (some are found on both sides of the vast Central Valley), and the genus as a whole occupies an impressive variety of habitats. Methodology/Principal Findings: We collected specimens from 89 populations representing all described species. DNA sequence data were collected from seven gene regions, including two newly developed for spider systematics. Bayesian inference (in individual gene tree and species tree approaches) recovered a general "3 clade" structure for the genus (A. gulosus, californicus group, erebus group), with three other phylogenetically isolated species differing slightly in position across different phylogenetic analyses. Because of extremely high intraspecific divergences in mitochondrial COI sequences, the relatively slowly evolving 28S rRNA gene was found to be more useful than mitochondrial data for identification of morphologically indistinguishable immatures. For multiple species spanning the Central Valley, explicit hypothesis testing suggests a lack of monophyly for regional populations (e.g., western Coast Range populations). Phylogenetic evidence clearly shows that syntopy is restricted to distant phylogenetic relatives, consistent with ecological niche conservatism. Conclusions/Significance: This study provides fundamental insight into a radiation of trapdoor spiders found in the biodiversity hotspot of California. Species relationships are clarified and undescribed lineages are discovered, with more geographic sampling likely to lead to additional species diversity. These dispersal-limited taxa provide novel insight into the biogeography and Earth history processes of California.	[Satler, Jordan D.; Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Starrett, James; Hayashi, Cheryl Y.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	California State University System; San Diego State University; University of California System; University of California Riverside	Satler, JD (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jsatle1@tigers.lsu.edu			American Arachnological Society; Vincent Roth Research Funds; Army Research Office [W911NF-06-1-0455]; National Science Foundation [DEB-0910365, DEB 0108575]	American Arachnological Society; Vincent Roth Research Funds; Army Research Office; National Science Foundation(National Science Foundation (NSF))	Funding was provided by the American Arachnological Society (American Arachnological Society and Vincent Roth Research Funds to JDS), the Army Research Office (W911NF-06-1-0455 to CYH), and the National Science Foundation (DEB-0910365 to CYH and JS). Some fieldwork was supported by a National Science Foundation grant to M. Hedin and Jason Bond (DEB 0108575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chatzimanolis S, 2007, EVOLUTION, V61, P2127, DOI 10.1111/j.1558-5646.2007.00186.x; COYLE F A, 1974, Psyche (Cambridge), V81, P431, DOI 10.1155/1974/69634; COYLE FA, 1994, J ARACHNOL, V22, P218; COYLE FA, 1994, J ARACHNOL, V22, P225; Cranston KA, 2007, SYST BIOL, V56, P578, DOI 10.1080/10635150701485091; Davis EB, 2008, MOL ECOL, V17, P120, DOI 10.1111/j.1365-294X.2007.03469.x; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2009, TRENDS ECOLOGY EVOLU, V24; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Drummond AJ, 2010, GENEIOUS V5 3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupre WR, 1990, GEOLOGY TECTONICS CE, P185; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Feldman CR, 2006, MOL ECOL, V15, P2201, DOI 10.1111/j.1365-294X.2006.02930.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall CAJ, 2002, GEOL SOC AM SPECIAL, V489, P357; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2011, ZOOTAXA, P55; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2007, MOL PHYLOGENET EVOL, V42, P738, DOI 10.1016/j.ympev.2006.09.010; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jockusch EL, 2002, BIOL J LINN SOC, V76, P361, DOI 10.1046/j.1095-8312.2002.d01-6.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles LL, 2010, ESTIMATING SPECIES T, P1; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kuchta SR, 2006, BIOL J LINN SOC, V89, P213, DOI 10.1111/j.1095-8312.2006.00665.x; Kuchta SR, 2009, J BIOGEOGR, V36, P982, DOI 10.1111/j.1365-2699.2008.02052.x; Kuchta SR, 2009, MOL PHYLOGENET EVOL, V50, P240, DOI 10.1016/j.ympev.2008.10.019; Lapointe FJ, 2005, AM NAT, V166, P290, DOI 10.1086/431283; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martinez-Solano I, 2007, MOL ECOL, V16, P4335, DOI 10.1111/j.1365-294X.2007.03527.x; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Matocq MD, 2002, MOL ECOL, V11, P229, DOI 10.1046/j.0962-1083.2001.01430.x; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; McGuire G, 1997, MOL BIOL EVOL, V14, P1125, DOI 10.1093/oxfordjournals.molbev.a025722; Miller RE, 2002, SYST BIOL, V51, P740, DOI 10.1080/10635150290102401; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Parham JF, 2009, CONSERV GENET, V10, P169, DOI 10.1007/s10592-008-9544-y; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Ramirez MG, 2004, BIOL J LINN SOC, V82, P27, DOI 10.1111/j.1095-8312.2004.00312.x; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; RIVAS LR, 1964, SYST ZOOL, V13, P42, DOI 10.2307/2411436; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rovito SM, 2010, MOL ECOL, V19, P4554, DOI 10.1111/j.1365-294X.2010.04825.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Spinks PQ, 2005, MOL ECOL, V14, P2047, DOI 10.1111/j.1365-294X.2005.02564.x; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Thomson RC, 2008, MOL PHYLOGENET EVOL, V49, P514, DOI 10.1016/j.ympev.2008.08.006; Wakabayashi J, 2001, J GEOL, V109, P539, DOI 10.1086/321962; Wake DB, 2006, ANN MO BOT GARD, V93, P8, DOI 10.3417/0026-6493(2006)93[8:PWSPAP]2.0.CO;2; WAKE DB, 1986, EVOLUTION, V40, P702, DOI 10.1111/j.1558-5646.1986.tb00532.x; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Wilm A, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-19; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	77	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2011	6	9							e25355	10.1371/journal.pone.0025355	http://dx.doi.org/10.1371/journal.pone.0025355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BK	21966507	Green Published, Green Submitted, gold			2022-12-27	WOS:000295932100035
J	John, L; Thomas, S; Herchenroder, O; Putzer, BM; Schaefer, S				John, Lijo; Thomas, Saijo; Herchenroeder, Ottmar; Puetzer, Brigitte M.; Schaefer, Stephan			Hepatitis E Virus ORF2 Protein Activates the Pro-Apoptotic Gene CHOP and Anti-Apoptotic Heat Shock Proteins	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FAST INTERACTION REFINEMENT; MAMMALIAN-CELLS; MONOCLONAL-ANTIBODIES; TRANSCRIPTION FACTOR; CHAPERONE FUNCTION; MOLECULAR DOCKING; SENSITIZES CELLS; CAPSID PROTEIN; EXPRESSION	Background: Hepatitis E virus (HEV) is a non-enveloped plus-strand RNA virus that causes acute hepatitis. The capsid protein open reading frame 2 (ORF2) is known to induce endoplasmic reticulum stress in ORF2 expressing cells. Methodology/Principal Findings: In this study we found that HEV ORF2 activates the expression of the pro-apoptotic gene C/EBP homologous protein (CHOP). ORF2 stimulates the CHOP promoter mainly through AARE (amino acid response elements) and to a minor extent the ERSE (endoplasmic reticulum stress response elements). Activating transcription factor 4 (ATF4) protein binds and activates the AARE regulatory sites of the CHOP promoter. ORF2 expression also leads to increased phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha) that in turn initiates the translation of ATF4 mRNA. The pro-apoptotic gene CHOP is an important trigger to initiate endoplasmic reticulum stress induced apoptosis. However, the activation of CHOP by ORF2 in this study did not induce apoptosis, nor did BCL2-associated X protein (Bax) translocate to mitochondria. Microarray analysis revealed an ORF2 specific increased expression of chaperones Hsp72, Hsp70B', and cochaperone Hsp40. Co-immunoprecipitation (Co-IP) and in silico molecular docking analysis suggests that HEV ORF2 interacts with Hsp72. In addition, Hsp72 shows nuclear accumulation in ORF2 expressing cells. Conclusions/Significance: These data provide new insight into simultaneously occurring counter-acting effects of HEV ORF2 that may be part of a strategy to prevent host suicide before completion of the viral replication cycle.	[John, Lijo; Thomas, Saijo; Herchenroeder, Ottmar; Puetzer, Brigitte M.; Schaefer, Stephan] Univ Rostock, Sch Med, Dept Vectorol & Expt Gene Therapy, Biomed Res Ctr, Rostock, Germany	University of Rostock	John, L (corresponding author), Univ Rostock, Sch Med, Dept Vectorol & Expt Gene Therapy, Biomed Res Ctr, Rostock, Germany.	brigitte.puetzer@med.uni-rostock.de			Marie Curie Fellowship; DAAD	Marie Curie Fellowship(European Commission); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	Lijo John was supported by Marie Curie Fellowship and Saijo Thomas by a DAAD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; AHMAD I, 2011, VIRUS RES; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Chow AM, 2009, CELL STRESS CHAPERON, V14, P253, DOI 10.1007/s12192-008-0079-4; Ciccaglione AR, 2007, VIRUS RES, V126, P128, DOI 10.1016/j.virusres.2007.02.006; Creagh EM, 2000, EXP CELL RES, V257, P58, DOI 10.1006/excr.2000.4856; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Hageman J, 2007, J BIOL CHEM, V282, P34334, DOI 10.1074/jbc.M703876200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; John K, 2011, CELL DEATH DIFFER, V18, P874, DOI 10.1038/cdd.2010.153; Kato K, 1999, BIOL PHARM BULL, V22, P1185; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Knowlton AA, 2000, AM J PHYSIOL-HEART C, V278, pH2143, DOI 10.1152/ajpheart.2000.278.6.H2143; Kwok SCM, 2008, MOL CELL BIOCHEM, V319, P203, DOI 10.1007/s11010-008-9893-3; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Offman MN, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-34; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Riddell MA, 2000, J VIROL, V74, P8011, DOI 10.1128/JVI.74.17.8011-8017.2000; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schofield DJ, 2003, VACCINE, V22, P257, DOI 10.1016/j.vaccine.2003.07.008; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Thomas S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-327; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsarev SA, 1997, VACCINE, V15, P1834, DOI 10.1016/S0264-410X(97)00145-X; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Ubeda M, 2000, NUCLEIC ACIDS RES, V28, P4987, DOI 10.1093/nar/28.24.4987; Volloch V, 1998, CELL STRESS CHAPERON, V3, P265, DOI 10.1054/csac.1998.0120; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yamazaki T, 2010, LIFE SCI, V87, P294, DOI 10.1016/j.lfs.2010.07.006; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young P, 2008, J GEN VIROL, V89, P866, DOI 10.1099/vir.0.83414-0; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Yu H, 2011, J MOL MODEL, V17, P987, DOI 10.1007/s00894-010-0794-5; Zafrullah M, 1999, J VIROL, V73, P4074, DOI 10.1128/JVI.73.5.4074-4082.1999; Zhang MD, 2001, VACCINE, V20, P853, DOI 10.1016/S0264-410X(01)00399-1; Zheng ZZ, 2010, J GEN VIROL, V91, P1728, DOI 10.1099/vir.0.019323-0; Zhou YH, 2004, VACCINE, V22, P2578, DOI 10.1016/j.vaccine.2003.12.017; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	69	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25378	10.1371/journal.pone.0025378	http://dx.doi.org/10.1371/journal.pone.0025378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966512	gold, Green Published, Green Submitted			2022-12-27	WOS:000295267100050
J	Turbic, A; Leong, SY; Turnley, AM				Turbic, Alisa; Leong, Soo Yuen; Turnley, Ann M.			Chemokines and Inflammatory Mediators Interact to Regulate Adult Murine Neural Precursor Cell Proliferation, Survival and Differentiation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; STEM-CELLS; PROGENITOR CELLS; SPINAL-CORD; SUBVENTRICULAR ZONE; INTERFERON-GAMMA; IFN-GAMMA; OLIGODENDROCYTE PRECURSORS; NEURONAL DIFFERENTIATION	Adult neural precursor cells (NPCs) respond to injury or disease of the CNS by migrating to the site of damage or differentiating locally to replace lost cells. Factors that mediate this injury induced NPC response include chemokines and pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF alpha) and interferon-gamma (IFN gamma), which we have shown previously promotes neuronal differentiation. RT-PCR was used to compare expression of chemokines and their receptors in normal adult mouse brain and in cultured NPCs in response to IFN gamma and TNF alpha. Basal expression of many chemokines and their receptors was found in adult brain, predominantly in neurogenic regions, with OB >> SVZ > hippocampus and little or no expression in non-neurogenic regions, such as cortex. Treatment of SVZ-derived NPCs with IFN gamma and TNF alpha (alone and in combination) resulted in significant upregulation of expression of specific chemokines, with CXCL1, CXCL9 and CCL2 most highly upregulated and CCL19 downregulated. Unlike IFN gamma, chemokine treatment of NPCs in vitro had little or no effect on survival, proliferation or migration. Neuronal differentiation was promoted by CXCL9, CCL2 and CCL21, while astrocyte and total oligodendrocyte differentiation was not affected. However, IFN gamma, CXCL1, CXCL9 and CCL2 promoted oligodendrocyte maturation. Therefore, not only do NPCs express chemokine receptors, they also produce several chemokines, particularly in response to inflammatory mediators. This suggests that autocrine or paracrine production of specific chemokines by NPCs in response to inflammatory mediators may regulate differentiation into mature neural cell types and may alter NPC responsiveness to CNS injury or disease.	[Turbic, Alisa; Leong, Soo Yuen; Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia	University of Melbourne	Turbic, A (corresponding author), Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au		Turnley, Ann/0000-0002-8442-127X; Turbic, Alisa/0000-0002-9703-2484	National Health and Medical Research Council of Australia [454384, 350226]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council of Australia Project grant (#454384) and Fellowship to AMT (#350226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Berman JW, 1996, J IMMUNOL, V156, P3017; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Carter SL, 2007, GLIA, V55, P1728, DOI 10.1002/glia.20587; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Chintawar S, 2009, STEM CELLS, V27, P838, DOI 10.1002/stem.25; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; Filipovic R, 2008, GLIA, V56, P1, DOI 10.1002/glia.20582; Gomez-Nicola D, 2010, J NEUROIMMUNOL, V227, P87, DOI 10.1016/j.jneuroim.2010.06.018; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Guan YT, 2008, EXP MOL PATHOL, V85, P232, DOI 10.1016/j.yexmp.2008.07.003; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Knerlich-Lukoschus F, 2010, GLIA, V58, P916, DOI 10.1002/glia.20974; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Lalor SJ, 2010, J NEUROIMMUNOL, V224, P56, DOI 10.1016/j.jneuroim.2010.05.017; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Liu XS, 2008, BRAIN RES, V1226, P18, DOI 10.1016/j.brainres.2008.06.013; Liu XS, 2007, J NEUROSCI RES, V85, P2120, DOI 10.1002/jnr.21359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Ni HT, 2004, DEV BRAIN RES, V152, P159, DOI 10.1016/j.devbrainres.2004.06.015; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Owens T, 2005, BRAIN RES REV, V48, P178, DOI 10.1016/j.brainresrev.2004.12.007; Padovani-Claudio DA, 2006, GLIA, V54, P471, DOI 10.1002/glia.20383; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Robinson S, 1998, J NEUROSCI, V18, P10457; Suyama T, 2005, CANCER-AM CANCER SOC, V103, P258, DOI 10.1002/cncr.20747; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009	53	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2011	6	9							e25406	10.1371/journal.pone.0025406	http://dx.doi.org/10.1371/journal.pone.0025406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IZ	21966521	gold, Green Published			2022-12-27	WOS:000295267100057
J	Tian, J; Dang, HN; Yong, J; Chui, WS; Dizon, MPG; Yaw, CKY; Kaufman, DL				Tian, Jide; Dang, Hoa N.; Yong, Jing; Chui, Wing-Sheung; Dizon, Matthew P. G.; Yaw, Catherine K. Y.; Kaufman, Daniel L.			Oral Treatment with gamma-Aminobutyric Acid Improves Glucose Tolerance and Insulin Sensitivity by Inhibiting Inflammation in High Fat Diet-Fed Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; OBESITY; RESISTANCE; CELLS; ADIPOCYTOKINES; COMPLICATIONS; RESPONSES; GABA	Adipocyte and beta-cell dysfunction and macrophage-related chronic inflammation are critical for the development of obesity-related insulin resistance and type 2 diabetes mellitus (T2DM), which can be negatively regulated by Tregs. Our previous studies and those of others have shown that activation of gamma-aminobutyric acid (GABA) receptors inhibits inflammation in mice. However, whether GABA could modulate high fat diet (HFD)-induced obesity, glucose intolerance and insulin resistance has not been explored. Here, we show that although oral treatment with GABA does not affect water and food consumption it inhibits the HFD-induced gain in body weights in C57BL/6 mice. Furthermore, oral treatment with GABA significantly reduced the concentrations of fasting blood glucose, and improved glucose tolerance and insulin sensitivity in the HFD-fed mice. More importantly, after the onset of obesity and T2DM, oral treatment with GABA inhibited the continual HFD-induced gain in body weights, reduced the concentrations of fasting blood glucose and improved glucose tolerance and insulin sensitivity in mice. In addition, oral treatment with GABA reduced the epididymal fat mass, adipocyte size, and the frequency of macrophage infiltrates in the adipose tissues of HFD-fed mice. Notably, oral treatment with GABA significantly increased the frequency of CD4(+) Foxp3(+) Tregs in mice. Collectively, our data indicated that activation of peripheral GABA receptors inhibited the HFD-induced glucose intolerance, insulin resistance, and obesity by inhibiting obesity-related inflammation and up-regulating Treg responses in vivo. Given that GABA is safe for human consumption, activators of GABA receptors may be valuable for the prevention of obesity and intervention of T2DM in the clinic.	[Tian, Jide; Dang, Hoa N.; Yong, Jing; Chui, Wing-Sheung; Dizon, Matthew P. G.; Yaw, Catherine K. Y.; Kaufman, Daniel L.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Tian, J (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	jtian@mednet.ucla.edu	Kaufman, Daniel/AAU-1228-2021; Yong, Jing/I-2150-2012	Kaufman, Daniel/0000-0002-9844-5918; Yong, Jing/0000-0001-8579-1558	NIDDK NIH HHS [R21 DK080461, R21 DK075070] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075070, R21DK080461] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dyck DJ, 2009, APPL PHYSIOL NUTR ME, V34, P396, DOI 10.1139/H09-037; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Nicolaysen A, 2007, J LIPID RES, V48, P2123, DOI 10.1194/jlr.M700021-JLR200; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Reyes-Garcia MG, 2007, J NEUROIMMUNOL, V188, P64, DOI 10.1016/j.jneuroim.2007.05.013; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shoelson SE, 2009, NAT MED, V15, P373, DOI 10.1038/nm0409-373; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; TIAN J, 2011, PLOS ONE IN PRESS; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Tian JD, 2011, AUTOIMMUNITY, V44, P465, DOI 10.3109/08916934.2011.571223; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	32	106	118	8	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25338	10.1371/journal.pone.0025338	http://dx.doi.org/10.1371/journal.pone.0025338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	21966503	gold, Green Published, Green Submitted			2022-12-27	WOS:000295265100092
J	Li, YC; Chen, CC; Chen, JH				Li, Yi-Chia; Chen, Chien-Chung; Chen, Jyh-Horng			Impact of Visual Repetition Rate on Intrinsic Properties of Low Frequency Fluctuations in the Visual Network	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; CEREBRAL HEMODYNAMICS; FMRI; SIGNAL; OSCILLATIONS; ACTIVATION; COHERENCE; AMPLITUDE; CORTEX	Background: Visual processing network is one of the functional networks which have been reliably identified to consistently exist in human resting brains. In our work, we focused on this network and investigated the intrinsic properties of low frequency (0.01-0.08 Hz) fluctuations (LFFs) during changes of visual stimuli. There were two main questions to be discussed in this study: intrinsic properties of LFFs regarding (1) interactions between visual stimuli and resting-state; (2) impact of repetition rate of visual stimuli. Methodology/Principal Findings: We analyzed scanning sessions that contained rest and visual stimuli in various repetition rates with a novel method. The method included three numerical approaches involving ICA (Independent Component Analyses), fALFF (fractional Amplitude of Low Frequency Fluctuation), and Coherence, to respectively investigate the modulations of visual network pattern, low frequency fluctuation power, and interregional functional connectivity during changes of visual stimuli. We discovered when resting-state was replaced by visual stimuli, more areas were involved in visual processing, and both stronger low frequency fluctuations and higher interregional functional connectivity occurred in visual network. With changes of visual repetition rate, the number of areas which were involved in visual processing, low frequency fluctuation power, and interregional functional connectivity in this network were also modulated. Conclusions/Significance: To combine the results of prior literatures and our discoveries, intrinsic properties of LFFs in visual network are altered not only by modulations of endogenous factors (eye-open or eye-closed condition; alcohol administration) and disordered behaviors (early blind), but also exogenous sensory stimuli (visual stimuli with various repetition rates). It demonstrates that the intrinsic properties of LFFs are valuable to represent physiological states of human brains.	[Li, Yi-Chia] Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei 10764, Taiwan; [Li, Yi-Chia; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Li, YC (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei 10764, Taiwan.	d97945006@ntu.edu.tw	; Chen, Zhiwei/B-7793-2019	Chen, Chien-Chung/0000-0002-3848-0180; Chen, Zhiwei/0000-0002-4511-2888	National Science Council [NSC 99-2321-B-002-007]	National Science Council(Ministry of Science and Technology, Taiwan)	The research was supported by the National Science Council grant NSC 99-2321-B-002-007 to Jyh-Horng Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, AM J NEURORADIOL, V29, P1722, DOI 10.3174/ajnr.A1220; Anderson SJ, 1996, P ROY SOC B-BIOL SCI, V263, P423, DOI 10.1098/rspb.1996.0064; Bartley S.H., 1968, CONTRIBUTIONS SENSOR, V3, P82; Beall EB, 2007, NEUROIMAGE, V37, P1286, DOI 10.1016/j.neuroimage.2007.07.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chu C, 2011, NEUROIMAGE, V56, P662, DOI 10.1016/j.neuroimage.2010.03.058; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Emir UE, 2008, NEUROSCI LETT, V436, P185, DOI 10.1016/j.neulet.2008.03.021; Esposito F, 2010, NEUROIMAGE, V53, P534, DOI 10.1016/j.neuroimage.2010.06.061; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; Fylan F, 1997, NEUROIMAGE, V6, P47, DOI 10.1006/nimg.1997.0273; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; GRUSSER OJ, 1957, PFLUG ARCH GES PHYS, V263, P668, DOI 10.1007/BF00362854; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V65, P294, DOI 10.1016/j.ijpsycho.2007.03.009; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hu HH, 1999, J CEREBR BLOOD F MET, V19, P460, DOI 10.1097/00004647-199904000-00012; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Huk AC, 2002, J NEUROSCI, V22, P7195; Kikuchi M, 2000, CLIN ELECTROENCEPHAL, V31, P170, DOI 10.1177/155005940003100404; KOURTZI Z, 2005, FITTING MIND WORLD A, pCH6; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Liu XA, 2011, NEUROIMAGE, V54, P2278, DOI 10.1016/j.neuroimage.2010.10.001; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkes LM, 2004, NEUROIMAGE, V21, P236, DOI 10.1016/j.neuroimage.2003.08.025; Pastor MA, 2003, J NEUROSCI, V23, P11621; Ross MH, 1997, NEUROLOGY, V48, P173, DOI 10.1212/WNL.48.1.173; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Schopf V, 2010, MAGN RESON MATER PHY, V23, P317, DOI 10.1007/s10334-010-0212-0; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Singh M, 2003, MAGNET RESON MED, V49, P108, DOI 10.1002/mrm.10335; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tse CY, 2010, BIOL PSYCHOL, V85, P79, DOI 10.1016/j.biopsycho.2010.05.007; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	40	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e18954	10.1371/journal.pone.0018954	http://dx.doi.org/10.1371/journal.pone.0018954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21966483	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800002
J	Cook, S; Conrad, C; Fowlkes, AL; Mohebbi, MH				Cook, Samantha; Conrad, Corrie; Fowlkes, Ashley L.; Mohebbi, Matthew H.			Assessing Google Flu Trends Performance in the United States during the 2009 Influenza Virus A (H1N1) Pandemic	PLOS ONE			English	Article								Background: Google Flu Trends (GFT) uses anonymized, aggregated internet search activity to provide near-real time estimates of influenza activity. GFT estimates have shown a strong correlation with official influenza surveillance data. The 2009 influenza virus A (H1N1) pandemic [pH1N1] provided the first opportunity to evaluate GFT during a non-seasonal influenza outbreak. In September 2009, an updated United States GFT model was developed using data from the beginning of pH1N1. Methodology/Principal Findings: We evaluated the accuracy of each U. S. GFT model by comparing weekly estimates of ILI (influenza-like illness) activity with the U. S. Outpatient Influenza-like Illness Surveillance Network (ILINet). For each GFT model we calculated the correlation and RMSE (root mean square error) between model estimates and ILINet for four time periods: pre-H1N1, Summer H1N1, Winter H1N1, and H1N1 overall (Mar 2009-Dec 2009). We also compared the number of queries, query volume, and types of queries (e. g., influenza symptoms, influenza complications) in each model. Both models' estimates were highly correlated with ILINet pre-H1N1 and over the entire surveillance period, although the original model underestimated the magnitude of ILI activity during pH1N1. The updated model was more correlated with ILINet than the original model during Summer H1N1 (r = 0.95 and 0.29, respectively). The updated model included more search query terms than the original model, with more queries directly related to influenza infection, whereas the original model contained more queries related to influenza complications. Conclusions: Internet search behavior changed during pH1N1, particularly in the categories "influenza complications'' and "term for influenza.'' The complications associated with pH1N1, the fact that pH1N1 began in the summer rather than winter, and changes in health-seeking behavior each may have played a part. Both GFT models performed well prior to and during pH1N1, although the updated model performed better during pH1N1, especially during the summer months.	[Cook, Samantha; Mohebbi, Matthew H.] Google Inc, New York, NY USA; [Conrad, Corrie] Google Inc, London, England; [Fowlkes, Ashley L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Google Incorporated; Google Incorporated; Centers for Disease Control & Prevention - USA	Cook, S (corresponding author), Google Inc, New York, NY USA.	cconrad@google.com		Behmer, Spencer/0000-0002-5038-1046; Cook, Samantha/0000-0002-2173-4471	Google.org; Google Inc.	Google.org; Google Inc.(Google Incorporated)	This research was funded by Google.org, the non-profit arm of Google Inc. This funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Three of the authors (SC, CC, MM) are employees of one of the funders of the study (Google Inc.) and were involved with the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; Yes, the authors have the following competing interest. This study was supported by funding from Google Inc., and three of the authors (SC, CC, MM) are employees of Google Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; *CDC, 2007, MMWR-MORBID MORTAL W, V57, P692; *CDC, CDC SEAS INFL FLU FL; *CDCP CDC, INF 2009 H1N1 IMP RA; DEAN J, 2004, OSDI 60 S OP SYST DE; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google.org, 2009, GOOGL FLU TRENDS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed C, 2011, CLIN INFECT DIS, V52, pS90, DOI 10.1093/cid/ciq024; Wilson N, 2009, EUROSURVEILLANCE, V14; [No title captured]	13	225	237	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23610	10.1371/journal.pone.0023610	http://dx.doi.org/10.1371/journal.pone.0023610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886802	Green Published, Green Submitted, gold			2022-12-27	WOS:000294128100022
J	Liu, WS; Baker, SS; Baker, RD; Nowak, NJ; Zhu, LX				Liu, Wensheng; Baker, Susan S.; Baker, Robert D.; Nowak, Norma J.; Zhu, Lixin			Upregulation of Hemoglobin Expression by Oxidative Stress in Hepatocytes and Its Implication in Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GENE-EXPRESSION; PATHOGENESIS; MECHANISMS; INSIGHTS; NEURONS; GLOBIN; RAT	Recent studies revealed that hemoglobin is expressed in some non-erythrocytes and it suppresses oxidative stress when overexpressed. Oxidative stress plays a critical role in the pathogenesis of non-alcoholic steatohepatitis (NASH). This study was designed to investigate whether hemoglobin is expressed in hepatocytes and how it is related to oxidative stress in NASH patients. Analysis of microarray gene expression data revealed a significant increase in the expression of hemoglobin alpha (HBA1) and beta (HBB) in liver biopsies from NASH patients. Increased hemoglobin expression in NASH was validated by quantitative real time PCR. However, the expression of hematopoietic transcriptional factors and erythrocyte specific marker genes were not increased, indicating that increased hemoglobin expression in NASH was not from erythropoiesis, but could result from increased expression in hepatocytes. Immunofluorescence staining demonstrated positive HBA1 and HBB expression in the hepatocytes of NASH livers. Hemoglobin expression was also observed in human hepatocellular carcinoma HepG2 cell line. Furthermore, treatment with hydrogen peroxide, a known oxidative stress inducer, increased HBA1 and HBB expression in HepG2 and HEK293 cells. Importantly, hemoglobin overexpression suppressed oxidative stress in HepG2 cells. We concluded that hemoglobin is expressed by hepatocytes and oxidative stress upregulates its expression. Suppression of oxidative stress by hemoglobin could be a mechanism to protect hepatocytes from oxidative damage in NASH.	[Liu, Wensheng; Baker, Susan S.; Baker, Robert D.; Zhu, Lixin] SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Buffalo, NY 14260 USA; [Nowak, Norma J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Nowak, Norma J.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Nowak, Norma J.] Roswell Pk Canc Inst, Microarray & Genom Facil, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Liu, WS (corresponding author), SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Buffalo, NY 14260 USA.	lixinzhu@buffalo.edu	liu, wen/HGE-3071-2022	Zhu, Lixin/0000-0001-7904-1769	Peter and Tommy Fund, Inc., Buffalo, NY	Peter and Tommy Fund, Inc., Buffalo, NY	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, NY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SS, 2010, PLOS ONE, V5, pA82, DOI 10.1371/journal.pone.0009570; Baskol G, 2007, CLIN BIOCHEM, V40, P776, DOI 10.1016/j.clinbiochem.2007.02.006; Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891; Bhaskaran M, 2005, BIOCHEM BIOPH RES CO, V333, P1348, DOI 10.1016/j.bbrc.2005.06.042; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Kaser S, 2010, INT J CLIN PRACT, V64, P968, DOI 10.1111/j.1742-1241.2009.02327.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kojima H, 2008, HEPATOL RES, V38, P202, DOI 10.1111/j.1872-034X.2007.00209.x; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; Leclercq IA, 2004, CLIN SCI, V106, P235, DOI 10.1042/CS20030368; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Ney PA, 2006, CURR OPIN HEMATOL, V13, P203, DOI 10.1097/01.moh.0000231415.18333.2c; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Pasumarthy L, 2010, SOUTH MED J, V103, P547, DOI 10.1097/SMJ.0b013e3181de0ce0; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P907, DOI 10.1167/iovs.09-4014; Tezel TH, 2009, INVEST OPHTH VIS SCI, V50, P1911, DOI 10.1167/iovs.07-1372; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trak-Smayra V, 2009, GUT, V58, P825, DOI 10.1136/gut.2007.140087; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Tsutsui M, 2010, J CLIN GASTROENTEROL, V44, P440, DOI 10.1097/MCG.0b013e3181bdefe2; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Widmer CC, 2010, ANTIOXID REDOX SIGN, V12, P185, DOI 10.1089/ars.2009.2826; Xu L, 2009, GUT, V58, P1706, DOI 10.1136/gut.2009.186668; Zhu LX, 2011, METABOLISM, V60, P1001, DOI 10.1016/j.metabol.2010.10.003	44	136	141	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24363	10.1371/journal.pone.0024363	http://dx.doi.org/10.1371/journal.pone.0024363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21980346	Green Published, gold, Green Submitted			2022-12-27	WOS:000294803200016
J	Qiu, C; Tian, D; Wan, YM; Zhang, WJ; Qiu, CL; Zhu, ZQ; Ye, RQ; Song, ZG; Zhou, MZ; Yuan, SH; Shi, BS; Wu, M; Liu, Y; Gu, SM; Wei, J; Zhou, ZT; Zhang, XY; Zhang, ZY; Hu, YW; Yuan, ZH; Xu, JQ				Qiu, Chao; Tian, Di; Wan, Yanmin; Zhang, Wanju; Qiu, Chenli; Zhu, Zhaoqin; Ye, Ruiqi; Song, Zhigang; Zhou, Mingzhe; Yuan, Songhua; Shi, Bisheng; Wu, Min; Liu, Yi; Gu, Shimin; Wei, Jun; Zhou, Zhitong; Zhang, Xiaoyan; Zhang, Zhiyong; Hu, Yunwen; Yuan, Zhenghong; Xu, Jianqing			Early Adaptive Humoral Immune Responses and Virus Clearance in Humans Recently Infected with Pandemic 2009 H1N1 Influenza Virus	PLOS ONE			English	Article							ORIGIN; ANTIBODIES	Few studies on the humoral immune responses in human during natural influenza infection have been reported. Here, we used serum samples from pandemic 2009 H1N1 influenza infected patients to characterize the humoral immune responses to influenza during natural infection in humans. We observed for the first time that the pandemic 2009 H1N1 influenza induced influenza A-specific IgM within days after symptoms onset, whereas the unit of IgG did not changed. The magnitude of influenza A-specific IgM antibodies might have a value in predicting the rate of virus clearance to some degree. However, the newly developed IgM was not associated with hemagglutination inhibition (HI) activities in the same samples but correlated with HI activities of subsequently collected sera which were mediated by IgG antibodies, indicating that IgM was critical for influenza infection and influences subsequent IgG antibody responses. These findings provide new important insights on the human immunity to natural influenza infection.	[Qiu, Chao; Tian, Di; Wan, Yanmin; Zhang, Wanju; Qiu, Chenli; Zhu, Zhaoqin; Ye, Ruiqi; Song, Zhigang; Zhou, Mingzhe; Yuan, Songhua; Shi, Bisheng; Wu, Min; Liu, Yi; Gu, Shimin; Zhou, Zhitong; Zhang, Xiaoyan; Zhang, Zhiyong; Hu, Yunwen; Yuan, Zhenghong; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Yuan, Zhenghong; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ Hlth, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Xu, Jianqing] China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wei, Jun] Yuncheng CDC, Yuncheng, Peoples R China	Fudan University; Fudan University; Chinese Center for Disease Control & Prevention	Qiu, C (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org; jianqingxu2008@gmail.com	Zhou, Mingzhe/AED-5236-2022; Qiu, Chao/M-6702-2014; , yanmin/GQH-2789-2022	Qiu, Chao/0000-0001-9401-5219; , yanmin/0000-0001-5027-9423; Zhang, Wanju/0000-0001-9913-8584; Zhou, Mingzhe/0000-0002-5518-7330; Zhou, Shi-Rong/0000-0003-2594-3198	National Grand Program on Key Infectious Disease Control [2008ZX10001-002, 2009ZX10602-11]; China Ministry of Health; China National Program on Key Basic Research Projects (973 Program) [2005CB522903]; China Ministry of Science and Technology, China; Key Basic Research Project [10JC1413600]; Science and Technology Commission of Shanghai Municipality, Shanghai	National Grand Program on Key Infectious Disease Control; China Ministry of Health; China National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); China Ministry of Science and Technology, China(Ministry of Science and Technology, China); Key Basic Research Project; Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by the National Grand Program on Key Infectious Disease Control (Grant #2008ZX10001-002 and 2009ZX10602-11), China Ministry of Health, and by the China National Program on Key Basic Research Projects (973 Program) (No. 2005CB522903), the China Ministry of Science and Technology, China, and by the Key Basic Research Project (10JC1413600), Science and Technology Commission of Shanghai Municipality, Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], MMWR MORB MORTAL WKL; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; McCracken J, 2009, LANCET, V373, P2107, DOI 10.1016/S0140-6736(09)61141-7; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Zhang H, 2009, LANCET INFECT DIS, V9, P456, DOI 10.1016/S1473-3099(09)70181-1	12	66	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22603	10.1371/journal.pone.0022603	http://dx.doi.org/10.1371/journal.pone.0022603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21966459	gold, Green Submitted, Green Published			2022-12-27	WOS:000294253500001
J	Du, J; Xu, R; Hu, ZZ; Tian, YH; Zhu, YC; Gu, L; Zhou, L				Du, Jun; Xu, Rui; Hu, Zhenzhen; Tian, Yinhui; Zhu, Yichao; Gu, Luo; Zhou, Lei			PI3K and ERK-Induced Rac1 Activation Mediates Hypoxia-Induced HIF-1 alpha Expression in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROXIMAL TUBULE CELLS; ANGIOGENESIS IN-VITRO; INDUCIBLE FACTOR-1-ALPHA; GENE-TRANSCRIPTION; EPITHELIAL-CELLS; NADPH OXIDASE; UP-REGULATION; TUMOR-GROWTH; ROS	Background: Hypoxia-inducible factor 1 (HIF-1 alpha) expression induced by hypoxia plays a critical role in promoting tumor angiogenesis and metastasis. However, the molecular mechanisms underlying the induction of HIF-1 alpha in tumor cells remain unknown. Methodology/Principal Findings: In this study, we reported that hypoxia could induce HIF-1 alpha and VEGF expression accompanied by Rac1 activation in MCF-7 breast cancer cells. Blockade of Rac1 activation with ectopic expression of an inactive mutant form of Rac1 (T17N) or Rac1 siRNA downregulated hypoxia-induced HIF-1 alpha and VEGF expression. Furthermore, Hypoxia increased PI3K and ERK signaling activity. Both PI3K inhibitor LY294002 and ERK inhibitor U0126 suppressed hypoxia-induced Rac1 activation as well as HIF-1 alpha expression. Moreover, hypoxia treatment resulted in a remarkable production of reactive oxygen species (ROS). N-acetyl-L-cysteine, a scavenger of ROS, inhibited hypoxia-induced ROS generation, PI3K, ERK and Rac1 activation as well as HIF-1 alpha expression. Conclusions/Significance: Taken together, our study demonstrated that hypoxia-induced HIF-1 alpha expression involves a cascade of signaling events including ROS generation, activation of PI3K and ERK signaling, and subsequent activation of Rac1.	[Du, Jun; Xu, Rui; Hu, Zhenzhen; Tian, Yinhui; Gu, Luo] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China; [Xu, Rui; Hu, Zhenzhen; Tian, Yinhui] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Zhu, Yichao; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Peoples R China; [Zhou, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Du, J (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China.	lgu@njmu.edu.cn; zhoulei7005@hotmail.com			National Natural Science Foundation of China [30872926]; Program for Advanced Talents within Six Industries of Jiangsu Province [08-D]; Postdoctoral Science Foundation of Jiangsu Province; Science Development Foundation of Nanjing Medical University [2010NJMUZ35]; School of Basic Medical Sciences, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Advanced Talents within Six Industries of Jiangsu Province; Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation); Science Development Foundation of Nanjing Medical University; School of Basic Medical Sciences, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	This work was supported by grants from the National Natural Science Foundation of China (No. 30872926) and the Program for Advanced Talents within Six Industries of Jiangsu Province (08-D) to Dr. Luo Gu, the Postdoctoral Science Foundation of Jiangsu Province, the Science Development Foundation of Nanjing Medical University (2010NJMUZ35) and the Research Program funded by the School of Basic Medical Sciences, Nanjing Medical University to Dr. Jun Du. This work was also partially supported by a research grant from State Key Laboratory of Reproductive Medicine, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros P, 2009, MOL CELL BIOL, V29, P4156, DOI 10.1128/MCB.01813-08; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chen MJ, 2007, J CELL BIOCHEM, V101, P1316, DOI 10.1002/jcb.21254; Choi UJ, 2009, CELL BIOCHEM FUNCT, V27, P40, DOI 10.1002/cbf.1532; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Chung BH, 2010, PHYTOTHER RES, V24, P934, DOI 10.1002/ptr.3063; Colley NJ, 2000, SCIENCE, V290, P1902, DOI 10.1126/science.290.5498.1902; Criss AK, 2001, J CELL SCI, V114, P1331; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Desireddi JR, 2010, ANTIOXID REDOX SIGN, V12, P595, DOI 10.1089/ars.2009.2862; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Du J, 2010, CELL PHYSIOL BIOCHEM, V25, P501, DOI 10.1159/000303055; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hess AR, 2003, CANCER RES, V63, P4757; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kim J, 2008, MOL BIOL CELL, V19, P433, DOI 10.1091/mbc.E07-02-0182; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Lee TK, 2006, CLIN CANCER RES, V12, P5082, DOI 10.1158/1078-0432.CCR-05-2794; Li SM, 2010, ENDOCRINOLOGY, V151, P5315, DOI 10.1210/en.2010-0178; Lim JH, 2004, ONCOGENE, V23, P9427, DOI 10.1038/sj.onc.1208003; McDonald P, 2007, AM J PHYSIOL-CELL PH, V292, pC1216, DOI 10.1152/ajpcell.00467.2006; Nijmeh J, 2010, AM J PHYSIOL-LUNG C, V299, pL535, DOI 10.1152/ajplung.00002.2010; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; PARK JH, 2011, ONCOGENE; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Ribatti D, 2010, STEM CELLS DEV, V19, P1, DOI 10.1089/scd.2009.0402; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Tobar N, 2008, CANCER LETT, V267, P125, DOI 10.1016/j.canlet.2008.03.011; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Whaley-Connell AT, 2007, AM J NEPHROL, V27, P15, DOI 10.1159/000098432; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xue Y, 2006, INT J CANCER, V118, P2965, DOI 10.1002/ijc.21763; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yuan LP, 2010, CLIN EXP METASTAS, V27, P481, DOI 10.1007/s10585-010-9337-9; Yuan YG, 2011, AM J PHYSIOL-RENAL, V300, pF393, DOI 10.1152/ajprenal.00418.2010; Zhang Jun, 2007, Cancer Ther, V5, P273; ZHANG L, 2011, J PHARM EXP THER; Zhang L, 2011, PHARMACOLOGY, V87, P265, DOI 10.1159/000326082	61	128	136	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25213	10.1371/journal.pone.0025213	http://dx.doi.org/10.1371/journal.pone.0025213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980400	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700021
